PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Asnani, MR; McCaw-Binns, AM; Reid, ME				Asnani, Monika R.; McCaw-Binns, Affette M.; Reid, Marvin E.			Excess Risk of Maternal Death from Sickle Cell Disease in Jamaica: 1998-2007	PLOS ONE			English	Article							PREGNANCY OUTCOMES; DEVELOPING-COUNTRY; PREVENT ECLAMPSIA; MORTALITY; BAHRAIN; STRATEGIES; EXPERIENCE; MANAGEMENT; MORBIDITY; CARE	Background: Decreases in direct maternal deaths in Jamaica have been negated by growing indirect deaths. With sickle cell disease (SCD) a consistent underlying cause, we describe the epidemiology of maternal deaths in this population. Methods: Demographic, service delivery and cause specific mortality rates were compared among women with (n = 42) and without SCD (n = 376), and between SCD women who died in 1998-2002 and 2003-7. Results: Women with SCD had fewer viable pregnancies (p: 0.02) despite greater access to high risk antenatal care (p: 0.001), and more often died in an intensive care unit (p: 0.002). In the most recent period (2003-7) SCD women achieved more pregnancies (median 2 vs. 3; p: 0.009), made more antenatal visits (mean 3.3 vs. 7.3; p: 0.01) and were more often admitted antenatally (p:<0.0001). The maternal mortality ratio for SCD decedents was 7-11 times higher than the general population, with 41% of deaths attributable to their disorder. Cause specific mortality was higher for cardiovascular complications, gestational hypertension and haemorrhage. Respiratory failure was the leading immediate cause of death. Conclusions: Women with SCD experience a significant excess risk of dying in pregnancy and childbirth [MMR: (SCD) 719/100,000, (non SCD) 78/100,000]. MDG5 cannot be realised without improving care for women with SCD. Tertiary services (e. g. ventilator support) are needed at regional centres to improve outcomes in this and other high risk populations. Universal SCD screening in pregnancy in populations of African and Mediterranean descent is needed as are guidelines for managing SCD pregnancies and educating families with SCD.	[Asnani, Monika R.; Reid, Marvin E.] Univ W Indies, Res Inst Trop Med, Sickle Cell Unit, Kingston 7, Jamaica; [McCaw-Binns, Affette M.] Univ W Indies, Dept Community Hlth & Psychiat, Kingston 7, Jamaica	University West Indies Mona Jamaica; University West Indies Mona Jamaica	Asnani, MR (corresponding author), Univ W Indies, Res Inst Trop Med, Sickle Cell Unit, Kingston 7, Jamaica.	monika.parshadasnani@uwimona.edu.jm	Reid, Marvin/J-2884-2014	Reid, Marvin/0000-0003-4005-9384				Afolabi BB, 2009, J OBSTET GYNAECOL, V29, P104, DOI 10.1080/01443610802667112; Al Arrayed S, 2005, COMMUNITY GENET, V8, P52, DOI 10.1159/000083340; Barfield WD, 2010, AM J PREV MED, V38, pS542, DOI 10.1016/j.amepre.2009.12.020; Chakravarty EF, 2008, OBSTET GYNECOL, V111, P927, DOI 10.1097/01.AOG.0000308710.86880.a6; Dauphin-McKenzie N, 2006, OBSTET GYNECOL SURV, V61, P343, DOI 10.1097/01.ogx.0000216976.15100.29; ELSHAFEI AM, 1988, AUST NZ J OBSTET GYN, V28, P41; Geelhoed DW, 2003, EUR J OBSTET GYN R B, V107, P135, DOI 10.1016/S0301-2115(02)00224-5; James AH, 2006, AM J OBSTET GYNECOL, V194, P1311, DOI 10.1016/j.ajog.2005.11.008; James AH, 2005, OBSTET GYNECOL, V106, P509, DOI 10.1097/01.AOG.0000172428.78411.b0; KAMPIKAHO A, 1991, E AFR MED J, V68, P624; Litos M, 2007, EUR J OBSTET GYN R B, V133, P169, DOI 10.1016/j.ejogrb.2006.08.009; MacGillivray I, 2004, INT J GYNECOL OBSTET, V87, P295, DOI 10.1016/j.ijgo.2004.07.009; McCaw-Binns A, 2008, INT J GYNECOL OBSTET, V100, P31, DOI 10.1016/j.ijgo.2007.06.054; McCaw-Binns A, 2007, INT J GYNECOL OBSTET, V96, P226, DOI 10.1016/j.ijgo.2006.12.002; McCaw-Binns AM, 2004, INT J GYNECOL OBSTET, V87, P286, DOI 10.1016/j.ijgo.2004.07.008; Okpala I, 2002, EUR J HAEMATOL, V68, P157, DOI 10.1034/j.1600-0609.2002.01523.x; Pattinson R, 2009, B WORLD HEALTH ORGAN, V87, P734, DOI 10.2471/BLT.09.071001; Perez A, 2010, MEDICC REV, V12, P27, DOI 10.37757/MR2010.V12.N2.7; Rahimy MC, 2000, BLOOD, V96, P1685, DOI 10.1182/blood.V96.5.1685.h8001685_1685_1689; Rajab KE, 2006, INT J GYNECOL OBSTET, V93, P171, DOI 10.1016/j.ijgo.2006.02.007; Rajab KE, 2004, SAUDI MED J, V25, P265; Sandhu A. K., 2008, Eastern Mediterranean Health Journal, V14, P720; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Serjeant GR, 2005, BJOG-INT J OBSTET GY, V112, P1308, DOI 10.1111/j.1471-0528.2005.00678.x; Serjeant GR, 1997, LANCET, V350, P725, DOI 10.1016/S0140-6736(97)07330-3; Smith JA, 1996, OBSTET GYNECOL, V87, P199, DOI 10.1016/0029-7844(95)00367-3; *STAT I JAM, 2008, DEM STAT 2007; Sun PM, 2001, AM J OBSTET GYNECOL, V184, P1127, DOI 10.1067/mob.2001.115477; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Unuigbe J A, 1988, Trop J Obstet Gynaecol, V1, P13	30	27	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26281	10.1371/journal.pone.0026281	http://dx.doi.org/10.1371/journal.pone.0026281			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039456	Green Published, gold, Green Submitted			2022-12-27	WOS:000296515200009
J	Eldakar, OT; Gallup, AC				Eldakar, Omar Tonsi; Gallup, Andrew C.			The Group-Level Consequences of Sexual Conflict in Multigroup Populations	PLOS ONE			English	Article							GROUP SELECTION; FORAGING SUCCESS; MALE-AGGRESSION; WATER STRIDERS; MATING COSTS; EVOLUTION; TRAGEDY; DIFFERENTIATION; ASSORTMENT; HARASSMENT	In typical sexual conflict scenarios, males best equipped to exploit females are favored locally over more prudent males, despite reducing female fitness. However, local advantage is not the only relevant form of selection. In multigroup populations, groups with less sexual conflict will contribute more offspring to the next generation than higher conflict groups, countering the local advantage of harmful males. Here, we varied male aggression within-and between-groups in a laboratory population of water striders and measured resulting differences in local population growth over a period of three weeks. The overall pool fitness (i.e., adults produced) of less aggressive pools exceeded that of high aggression pools by a factor of three, with the high aggression pools essentially experiencing no population growth over the course of the study. When comparing the fitness of individuals across groups, aggression appeared to be under stabilizing selection in the multigroup population. The use of contextual analysis revealed that overall stabilizing selection was a product of selection favoring aggression within groups, but selected against it at the group-level. Therefore, this report provides further evidence to show that what evolves in the total population is not merely an extension of within-group dynamics.	[Eldakar, Omar Tonsi] Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA; [Gallup, Andrew C.] SUNY Binghamton, Dept Biol Sci, Binghamton, NY USA	University of Arizona; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton	Eldakar, OT (corresponding author), Univ Arizona, Ctr Insect Sci, Tucson, AZ 85721 USA.	oeldakar@gmail.com		Eldakar, Omar/0000-0002-4807-4979	Center for Insect Science, University of Arizona; National Institutes of Health [5 K12 GM0007080]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000708] Funding Source: NIH RePORTER	Center for Insect Science, University of Arizona; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Center for Insect Science, University of Arizona, National Institutes of Health grant (5 K12 GM0007080). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktipis CA, 2004, J THEOR BIOL, V231, P249, DOI 10.1016/j.jtbi.2004.06.020; Arnqvist Goran, 2005, pUnpaginated; Bauer S, 2005, BEHAV ECOL, V16, P239, DOI 10.1093/beheco/arh158; Blanckenhorn WV, 1991, BEHAV ECOL, V2, P46, DOI 10.1093/beheco/2.1.46; BLANCKENHORN WU, 1994, ANIM BEHAV, V48, P169, DOI 10.1006/anbe.1994.1223; CARCAMO HA, 1994, OIKOS, V70, P412, DOI 10.2307/3545779; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Darden SK, 2008, BIOL LETTERS, V4, P449, DOI 10.1098/rsbl.2008.0308; Eldakar OT, 2010, BEHAVIOUR, V147, P1615, DOI 10.1163/000579510X510520; Eldakar OT, 2010, EVOLUTION, V64, P3183, DOI 10.1111/j.1558-5646.2010.01087.x; Eldakar OT, 2009, SCIENCE, V326, P816, DOI 10.1126/science.1180183; Eldakar OT, 2009, BEHAV ECOL SOCIOBIOL, V64, P25, DOI 10.1007/s00265-009-0814-6; GOODNIGHT CJ, 1992, AM NAT, V140, P743, DOI 10.1086/285438; Hanski I., 1999, METAPOPULATION ECOLO; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; HEISLER IL, 1987, AM NAT, V130, P582, DOI 10.1086/284732; Kokko H, 2003, ANN ZOOL FENN, V40, P207; KRUPA JJ, 1993, BEHAV ECOL SOCIOBIOL, V33, P107, DOI 10.1007/BF00171662; Le Galliard JF, 2005, P NATL ACAD SCI USA, V102, P18231, DOI 10.1073/pnas.0505172102; MAGURRAN AE, 1991, P ROY SOC B-BIOL SCI, V246, P31, DOI 10.1098/rspb.1991.0121; MAGURRAN AE, 1994, P ROY SOC B-BIOL SCI, V258, P89, DOI 10.1098/rspb.1994.0147; Okasha S., 2006, EVOLUTION LEVELS SEL, DOI [10.1093/acprof:oso/9780199267972.001.0001, DOI 10.1093/ACPROF:OSO/9780199267972.001.0001]; Pepper JW, 2007, ARTIF LIFE, V13, P1, DOI 10.1162/artl.2007.13.1.1; Pepper JW, 2002, AM NAT, V160, P205, DOI 10.1086/341018; PRICE GR, 1972, ANN HUM GENET, V35, P485, DOI 10.1111/j.1469-1809.1957.tb01874.x; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Rankin DJ, 2007, J EVOLUTION BIOL, V20, P173, DOI 10.1111/j.1420-9101.2006.01211.x; Rankin DJ, 2007, TRENDS ECOL EVOL, V22, P643, DOI 10.1016/j.tree.2007.07.009; Rankin DJ, 2006, TRENDS ECOL EVOL, V21, P225, DOI 10.1016/j.tree.2006.02.013; Rankin DJ, 2005, OIKOS, V111, P616; Sih A, 2005, BEHAVIOUR, V142, P1417, DOI 10.1163/156853905774539454; SMUTS BB, 1993, ADV STUD BEHAV, V22, P1, DOI 10.1016/S0065-3454(08)60404-0; SPENCE JR, 1991, OIKOS, V62, P333, DOI 10.2307/3545498; SPENCE JR, 1994, ANNU REV ENTOMOL, V39, P101, DOI 10.1146/annurev.en.39.010194.000533; Turlure C, 2009, BEHAV ECOL SOCIOBIOL, V64, P1; WADE MJ, 1984, EVOLUTION, V38, P1047, DOI 10.1111/j.1558-5646.1984.tb00375.x; WADE MJ, 1980, EVOLUTION, V34, P799, DOI [10.2307/2408034, 10.1111/j.1558-5646.1980.tb04019.x]; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; WILCOX RS, 1982, BEHAV ECOL SOCIOBIOL, V11, P85, DOI 10.1007/BF00300096; Williams G. C., 1966, P307; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809	41	13	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26451	10.1371/journal.pone.0026451	http://dx.doi.org/10.1371/journal.pone.0026451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039491	gold, Green Published, Green Submitted			2022-12-27	WOS:000296515200020
J	Huang, L; Ho, P; Yu, J; Zhu, L; Lee, KH; Chen, CH				Huang, Li; Ho, Phong; Yu, Jie; Zhu, Lei; Lee, Kuo-Hsiung; Chen, Chin-Ho			Picomolar Dichotomous Activity of Gnidimacrin Against HIV-1	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROTEIN-KINASE-C; ANTIRETROVIRAL THERAPY; BLOOD-LYMPHOCYTES; PKC-BETA; PROSTRATIN; EXPRESSION; INFECTION; INHIBITION; ACTIVATION	Highly active antiretroviral therapy (HAART) has offered a promising approach for controlling HIV-1 replication in infected individuals. However, with HARRT, HIV-1 is suppressed rather than eradicated due to persistence of HIV-1 in latent viral reservoirs. Thus, purging the virus from latent reservoirs is an important strategy toward eradicating HIV-1 infection. In this study, we discovered that the daphnane diterpene gnidimacrin, which was previously reported to have potent anti-cancer cell activity, activated HIV-1 replication and killed persistently-infected cells at picomolar concentrations. In addition to its potential to purge HIV-1 from latently infected cells, gnidimacrin potently inhibited a panel of HIV-1 R5 virus infection of peripheral blood mononuclear cells (PBMCs) at an average concentration lower than 10 pM. In contrast, gnidimacrin only partially inhibited HIV-164 virus infection of PBMCs. The strong anti-HIV-1 R5 virus activity of gnidimacrin was correlated with its effect on down-regulation of the HIV-1 coreceptor CCR5. The anti-R5 virus activity of gnidimacrin was completely abrogated by a selective protein kinase C beta inhibitor enzastaurin, which suggests that protein kinase C beta plays a key role in the potent anti-HIV-1 activity of gnidimacrin in PBMCs. In summary, these results suggest that gnidimacrin could activate latent HIV-1, specifically kill HIV-1 persistently infected cells, and inhibit R5 viruses at picomolar concentrations.	[Huang, Li; Ho, Phong; Yu, Jie; Zhu, Lei; Chen, Chin-Ho] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Lee, Kuo-Hsiung] Univ N Carolina, Eshelman Sch Pharm, Nat Prod Res Labs, Chapel Hill, NC USA; [Lee, Kuo-Hsiung] China Med Univ & Hosp, Chinese Med Res & Dev Ctr, Taichung, Taiwan	Duke University; University of North Carolina; University of North Carolina Chapel Hill; China Medical University Taiwan; China Medical University Hospital - Taiwan	Huang, L (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	chc@duke.edu		Huang, Li/0000-0001-5659-4053	National Institutes of Health National Institute of Allergy and Infectious Disease [AI065310, AI033066]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI033066] Funding Source: NIH RePORTER	National Institutes of Health National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health National Institute of Allergy and Infectious Disease [Grants AI065310] and the National Institutes of Health National Institute of Allergy and Infectious Disease [AI033066]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada Y, 2011, ORG LETT, V13, P2904, DOI 10.1021/ol200889s; Bedoya LM, 2009, BIOCHEM PHARMACOL, V77, P965, DOI 10.1016/j.bcp.2008.11.025; Biancotto A, 2004, J VIROL, V78, P10507, DOI 10.1128/JVI.78.19.10507-10515.2004; Bocklandt S, 2003, ANTIVIR RES, V59, P89, DOI 10.1016/S0166-3542(03)00034-2; BORRIS RP, 1988, J ETHNOPHARMACOL, V24, P41, DOI 10.1016/0378-8741(88)90138-9; Brown BK, 2005, J VIROL, V79, P6089, DOI 10.1128/JVI.79.10.6089-6101.2005; Chun TW, 1997, NATURE, V387, P183, DOI 10.1038/387183a0; Dau B, 2009, DRUGS, V69, P31, DOI 10.2165/00003495-200969010-00003; Faul MM, 2003, BIOORG MED CHEM LETT, V13, P1857, DOI 10.1016/S0960-894X(03)00286-5; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; FOLKS TM, 1987, SCIENCE, V238, P800, DOI 10.1126/science.3313729; FOLKS TM, 1989, P NATL ACAD SCI USA, V86, P2365, DOI 10.1073/pnas.86.7.2365; Fujiwara M, 1996, ANTIMICROB AGENTS CH, V40, P271, DOI 10.1128/AAC.40.1.271; GUSTAFSON KR, 1992, J MED CHEM, V35, P1978, DOI 10.1021/jm00089a006; HOLLINGER FB, 1992, J CLIN MICROBIOL, V30, P1787, DOI 10.1128/JCM.30.7.1787-1794.1992; Kulkosky J, 2001, BLOOD, V98, P3006, DOI 10.1182/blood.V98.10.3006; Marquez N, 2008, BIOCHEM PHARMACOL, V75, P1370, DOI 10.1016/j.bcp.2007.12.004; Mehla R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011160; Nelson TJ, 2009, TRENDS BIOCHEM SCI, V34, P136, DOI 10.1016/j.tibs.2008.11.006; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Pereira CF, 2004, CURR PHARM DESIGN, V10, P4005, DOI 10.2174/1381612043382459; Persaud D, 2003, J VIROL, V77, P1659, DOI 10.1128/JVI.77.3.1659-1665.2003; Rullas J, 2004, ANTIVIR THER, V9, P545; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Warrilow D, 2006, AIDS RES HUM RETROV, V22, P854, DOI 10.1089/aid.2006.22.854; WENDER PA, 1986, P NATL ACAD SCI USA, V83, P4214, DOI 10.1073/pnas.83.12.4214; Wender PA, 2008, SCIENCE, V320, P649, DOI 10.1126/science.1154690; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Yoshida M, 2003, INT J CANCER, V105, P601, DOI 10.1002/ijc.11157; Yoshida M, 1998, INT J CANCER, V77, P243, DOI 10.1002/(SICI)1097-0215(19980717)77:2<243::AID-IJC13>3.0.CO;2-C; YOSHIDA M, 1996, INT J CANCER, V66, P68; Zhang L, 2010, PHYTOCHEMISTRY, V71, P1879, DOI 10.1016/j.phytochem.2010.08.008; Zhang L, 2010, ORG LETT, V12, P152, DOI 10.1021/ol9025638	33	25	29	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26677	10.1371/journal.pone.0026677	http://dx.doi.org/10.1371/journal.pone.0026677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039528	gold, Green Published, Green Submitted			2022-12-27	WOS:000296515200040
J	Montero-Pedrazuela, A; Fernandez-Lamo, I; Alieva, M; Pereda-Perez, I; Venero, C; Guadano-Ferraz, A				Montero-Pedrazuela, Ana; Fernandez-Lamo, Ivan; Alieva, Maria; Pereda-Perez, Inmaculada; Venero, Cesar; Guadano-Ferraz, Ana			Adult-Onset Hypothyroidism Enhances Fear Memory and Upregulates Mineralocorticoid and Glucocorticoid Receptors in the Amygdala	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; THYROID-HORMONE ACTION; RAT-BRAIN; HIPPOCAMPAL NEUROGENESIS; CORTICOSTERONE SECRETION; BASOLATERAL AMYGDALA; NERVOUS-SYSTEM; DENTATE GYRUS; EXPRESSION; EXTINCTION	Hypothyroidism is the most common hormonal disease in adults, which is frequently accompanied by learning and memory impairments and emotional disorders. However, the deleterious effects of thyroid hormones deficiency on emotional memory are poorly understood and often underestimated. To evaluate the consequences of hypothyroidism on emotional learning and memory, we have performed a classical Pavlovian fear conditioning paradigm in euthyroid and adult-thyroidectomized Wistar rats. In this experimental model, learning acquisition was not impaired, fear memory was enhanced, memory extinction was delayed and spontaneous recovery of fear memory was exacerbated in hypothyroid rats. The potentiation of emotional memory under hypothyroidism was associated with an increase of corticosterone release after fear conditioning and with higher expression of glucocorticoid and mineralocorticoid receptors in the lateral and basolateral nuclei of the amygdala, nuclei that are critically involved in the circuitry of fear memory. Our results demonstrate for the first time that adult-onset hypothyroidism potentiates fear memory and also increases vulnerability to develop emotional memories. Furthermore, our findings suggest that enhanced corticosterone signaling in the amygdala is involved in the pathophysiological mechanisms of fear memory potentiation. Therefore, we recommend evaluating whether inappropriate regulation of fear in patients with post-traumatic stress and other mental disorders is associated with abnormal levels of thyroid hormones, especially those patients refractory to treatment.	[Montero-Pedrazuela, Ana; Fernandez-Lamo, Ivan; Alieva, Maria; Guadano-Ferraz, Ana] Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Dept Nervous Syst & Endocrine Pathophysiol, Madrid, Spain; [Pereda-Perez, Inmaculada; Venero, Cesar] Univ Nacl Educ Distancia, Dept Psychobiol, E-28040 Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); Universidad Nacional de Educacion a Distancia (UNED)	Montero-Pedrazuela, A (corresponding author), Univ Autonoma Madrid, Consejo Super Invest Cient, Inst Invest Biomed Alberto Sols, Dept Nervous Syst & Endocrine Pathophysiol, Madrid, Spain.	cvenero@psi.uned.es; aguadano@iib.uam.es	Guadaño-Ferraz, Ana/J-7870-2013; Venero, César/G-2789-2011; Montero-Pedrazuela, Ana/J-7723-2013; Alieva, Maria/ACQ-0401-2022; Venero, César/AAP-7263-2021	Guadaño-Ferraz, Ana/0000-0002-0666-935X; Montero-Pedrazuela, Ana/0000-0003-2308-0894; Venero, César/0000-0003-4879-3495; Alieva, Maria/0000-0002-1425-9908	Spanish Ministry of Science and Innovation [BFU2007-62979, BFU 2010-16498, SAF2009-09129]; Ministry of Science and Innovation, Spain	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work was supported by grants BFU2007-62979 and BFU 2010-16498 (A.G.-F) and SAF2009-09129 (C.V.) from the Spanish Ministry of Science and Innovation. I.F.-L. was recipient of a fellowship and A.M.-P. of a contract both from the Ministry of Science and Innovation, Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzoubi KH, 2009, HIPPOCAMPUS, V19, P66, DOI 10.1002/hipo.20476; Ambrogini P, 2005, NEUROENDOCRINOLOGY, V81, P244, DOI 10.1159/000087648; ANNAU Z, 1961, J COMP PHYSIOL PSYCH, V54, P428, DOI 10.1037/h0042199; BAUER M, 1994, PSYCHIAT RES, V51, P61, DOI 10.1016/0165-1781(94)90047-7; Baumgartner A, 1998, J NEUROCHEM, V71, P817; Bernal J, 2003, THYROID, V13, P1005, DOI 10.1089/105072503770867174; Bernal J, 2002, HORMONES BRAIN BEHAV, P543; Bernal Juan, 2002, Methods Mol Biol, V202, P71; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; BRADLEY DJ, 1992, J NEUROSCI, V12, P2288; Burmeister LA, 2001, THYROID, V11, P1177, DOI 10.1089/10507250152741037; Conrad C D, 2001, Stress, V4, P305; Constantinou C, 2005, MOL CELL BIOCHEM, V278, P93, DOI 10.1007/s11010-005-6934-z; Cordero MI, 1998, BEHAV NEUROSCI, V112, P885, DOI 10.1037/0735-7044.112.4.885; Cordero MI, 2003, HORM BEHAV, V44, P338, DOI 10.1016/S0018-506X(03)00160-0; DEESCOBAR GM, 1985, ENDOCRINOLOGY, V117, P1890, DOI 10.1210/endo-117-5-1890; Desouza LA, 2005, MOL CELL NEUROSCI, V29, P414, DOI 10.1016/j.mcn.2005.03.010; Diez D, 2008, ENDOCRINOLOGY, V149, P3989, DOI 10.1210/en.2008-0350; Dluhy RG, 2005, WERNERS INGBARS THYR, P602; Dugbartey AT, 1998, ARCH INTERN MED, V158, P1413, DOI 10.1001/archinte.158.13.1413; Duntas LH, 2007, EUR J ENDOCRINOL, V156, P13, DOI 10.1530/eje.1.02310; Etgen AM, 2009, HORMONES, BRAIN AND BEHAVIOR, VOLS 1-5, 2ND EDITION, P1121; EYSENCK HJ, 1979, BEHAV RES THER, V17, P511, DOI 10.1016/0005-7967(79)90067-6; Fanselow MS, 1999, NEURON, V23, P229, DOI 10.1016/S0896-6273(00)80775-8; FANSELOW MS, 1979, J COMP PHYSIOL PSYCH, V93, P736, DOI 10.1037/h0077609; Fernandez-Lamo I, 2009, EUR J NEUROSCI, V30, P679, DOI 10.1111/j.1460-9568.2009.06862.x; Gerges NZ, 2001, BRAIN RES, V922, P250, DOI 10.1016/S0006-8993(01)03181-X; GOLD MS, 1981, JAMA-J AM MED ASSOC, V245, P1919, DOI 10.1001/jama.245.19.1919; Gomez-Sanchez CE, 2006, ENDOCRINOLOGY, V147, P1343, DOI 10.1210/en.2005-0860; Guadano-Ferraz A, 2003, MOL PSYCHIATR, V8, P30, DOI 10.1038/sj.mp.4001196; Guadano-Ferraz A, 1999, J NEUROSCI, V19, P3430; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; Haviland MG, 2006, CHILD ABUSE NEGLECT, V30, P589, DOI 10.1016/j.chiabu.2005.11.011; Helmreich DL, 2011, HORM BEHAV, V60, P284, DOI 10.1016/j.yhbeh.2011.06.003; Hui GK, 2004, NEUROBIOL LEARN MEM, V81, P67, DOI 10.1016/j.nlm.2003.09.002; Iniguez MA, 1996, ENDOCRINOLOGY, V137, P1032, DOI 10.1210/en.137.3.1032; IRANMANESH A, 1990, J CLIN ENDOCR METAB, V70, P155, DOI 10.1210/jcem-70-1-155; Kamoi K, 2006, ENDOCR J, V53, P511, DOI 10.1507/endocrj.K06-022; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee E, 2008, J TOXICOL SCI, V33, P299, DOI 10.2131/jts.33.299; Lo MJ, 1998, J INVEST MED, V46, P444; Lopez-Fernandez MA, 2007, J NEUROSCI, V27, P4552, DOI 10.1523/JNEUROSCI.0396-07.2007; MCEWEN BS, 1986, PHYSIOL REV, V66, P1121, DOI 10.1152/physrev.1986.66.4.1121; Milad MR, 2008, J PSYCHIATR RES, V42, P515, DOI 10.1016/j.jpsychires.2008.01.017; Miller KJ, 2007, J NEUROPSYCH CLIN N, V19, P132, DOI 10.1176/appi.neuropsych.19.2.132; Montero-Pedrazuela A, 2006, MOL PSYCHIATR, V11, P361, DOI 10.1038/sj.mp.4001802; Morte B, 2002, P NATL ACAD SCI USA, V99, P3985, DOI 10.1073/pnas.062413299; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; OBREGON MJ, 1981, ENDOCRINOLOGY, V109, P908, DOI 10.1210/endo-109-3-908; Orr SP, 2000, J ABNORM PSYCHOL, V109, P290, DOI 10.1037//0021-843X.109.2.290; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; PORTERFIELD SP, 1993, ENDOCR REV, V14, P94, DOI 10.1210/er.14.1.94; Puymirat J, 1991, Thyroid, V1, P173, DOI 10.1089/thy.1991.1.173; Rescorla RA, 1997, Q J EXP PSYCHOL-B, V50, P238; Roberts CGP, 2004, LANCET, V363, P793, DOI 10.1016/S0140-6736(04)15696-1; Rodrigues SM, 2009, ANNU REV NEUROSCI, V32, P289, DOI 10.1146/annurev.neuro.051508.135620; Roozendaal B, 1996, NEUROBIOL LEARN MEM, V65, P1, DOI 10.1006/nlme.1996.0001; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Rothbaum BO, 2003, ANN NY ACAD SCI, V1008, P112, DOI 10.1196/annals.1301.012; RUIZMARCOS A, 1988, EXP BRAIN RES, V73, P583, DOI 10.1007/BF00406617; Sadow PM, 2003, MOL CELL ENDOCRINOL, V203, P65, DOI 10.1016/S0303-7207(03)00122-9; SANCHEZFRANCO F, 1989, HORM METAB RES, V21, P550, DOI 10.1055/s-2007-1009285; Sarabdjitsingh RA, 2010, BRAIN RES, V1331, P1, DOI 10.1016/j.brainres.2010.03.052; Siegmund A, 2006, ANN NY ACAD SCI, V1071, P324, DOI 10.1196/annals.1364.025; Sui L, 2006, BRAIN RES, V1096, P53, DOI 10.1016/j.brainres.2006.04.042; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Vanderpump MPJ, 2002, THYROID, V12, P839, DOI 10.1089/105072502761016458; Venero C, 2005, GENE DEV, V19, P2152, DOI 10.1101/gad.346105; Wang S, 1999, PSYCHOSOM MED, V61, P131, DOI 10.1097/00006842-199903000-00001; Whybrow PC, 2005, WERNER INGBARS THYRO, P842; World Health Organization, 1990, 43 WORLD HLTH ASS; Yang RJ, 2008, NEUROPSYCHOPHARMACOL, V33, P2595, DOI 10.1038/sj.npp.1301665; Yang YL, 2006, NEUROPSYCHOPHARMACOL, V31, P912, DOI 10.1038/sj.npp.1300899; YEHUDA R, 1993, BIOL PSYCHIAT, V33, P479, DOI 10.1016/0006-3223(93)90001-T; Zorawski M, 2002, NEUROBIOL LEARN MEM, V78, P458, DOI 10.1006/nlme.2002.4075	75	15	17	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26582	10.1371/journal.pone.0026582	http://dx.doi.org/10.1371/journal.pone.0026582			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039511	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200028
J	D'Amore, DC; Moreno, K; McHenry, CR; Wroe, S				D'Amore, Domenic C.; Moreno, Karen; McHenry, Colin R.; Wroe, Stephen			The Effects of Biting and Pulling on the Forces Generated during Feeding in the Komodo Dragon (Varanus komodoensis)	PLOS ONE			English	Article							BITE-FORCE; PREDATORY BEHAVIOR; TYRANNOSAURUS REX; CRANIAL MECHANICS; PERFORMANCE; ALLIGATOR; MUSCLES; DESIGN; MARKS; SIZE	In addition to biting, it has been speculated that the forces resulting from pulling on food items may also contribute to feeding success in carnivorous vertebrates. We present an in vivo analysis of both bite and pulling forces in Varanus komodoensis, the Komodo dragon, to determine how they contribute to feeding behavior. Observations of cranial modeling and behavior suggest that V. komodoensis feeds using bite force supplemented by pulling in the caudal/ventrocaudal direction. We tested these observations using force gauges/transducers to measure biting and pulling forces. Maximum bite force correlates with both body mass and total body length, likely due to increased muscle mass. Individuals showed consistent behaviors when biting, including the typical medial-caudal head rotation. Pull force correlates best with total body length, longer limbs and larger postcranial motions. None of these forces correlated well with head dimensions. When pulling, V. komodoensis use neck and limb movements that are associated with increased caudal and ventral oriented force. Measured bite force in Varanus komodoensis is similar to several previous estimations based on 3D models, but is low for its body mass relative to other vertebrates. Pull force, especially in the ventrocaudal direction, would allow individuals to hunt and deflesh with high success without the need of strong jaw adductors. In future studies, pull forces need to be considered for a complete understanding of vertebrate carnivore feeding dynamics.	[D'Amore, Domenic C.] Rutgers State Univ, Grad Program Ecol & Evolut, New Brunswick, NJ 08903 USA; [D'Amore, Domenic C.] Daemen Coll, Dept Nat Sci, Amherst, NY USA; [Moreno, Karen; Wroe, Stephen] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [Moreno, Karen] Univ Austral Chile, Lab Paleontol, Valdivia, Chile; [Moreno, Karen] Lab Anthropol Mol & Imagerie Synth, Toulouse, France; [Moreno, Karen] Geosci Environm Toulouse, Toulouse, France; [McHenry, Colin R.] Univ Newcastle, Sch Engn, Callaghan, NSW 2308, Australia; [McHenry, Colin R.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3800, Australia	Rutgers State University New Brunswick; University of New South Wales Sydney; Universidad Austral de Chile; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Newcastle; Monash University	D'Amore, DC (corresponding author), Rutgers State Univ, Grad Program Ecol & Evolut, New Brunswick, NJ 08903 USA.	ddamore@daemen.edu	Moreno, Karen/B-6127-2009; Wroe, Stephen/A-4462-2010	Moreno, Karen/0000-0002-5949-133X; Wroe, Stephen/0000-0002-5813-9182; Wroe, Stephen/0000-0002-6365-5915	Australian Research Council [DP0666374]; University of New South Wales Internal Strategic Initiatives	Australian Research Council(Australian Research Council); University of New South Wales Internal Strategic Initiatives	This research was funded by the Australian Research Council (DP0666374) and University of New South Wales Internal Strategic Initiatives Grants to SW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auffenberg W., 1981, BEHAV ECOLOGY KOMODO; BEMIS WE, 1983, ZOOL J LINN SOC-LOND, V77, P75, DOI 10.1111/j.1096-3642.1983.tb01722.x; Binder WJ, 2000, J ZOOL, V252, P273, DOI 10.1111/j.1469-7998.2000.tb00622.x; Burden W. D., 1928, American Museum Novitates, V316, P1; BUSBEY AB, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P173; Christiansen P, 2007, ECOLOGY, V88, P347, DOI 10.1890/0012-9658(2007)88[347:BFAEAT]2.0.CO;2; D'Amore DC, 2009, PALEOBIOLOGY, V35, P525, DOI 10.1666/0094-8373-35.4.525; D'Amore DC, 2009, ANAT REC, V292, P1297, DOI 10.1002/ar.20977; DECHOW PC, 1983, J BIOMECH, V16, P797, DOI 10.1016/0021-9290(83)90003-9; Ellis JL, 2008, J ANAT, V212, P769, DOI 10.1111/j.1469-7580.2008.00911.x; Erickson GM, 1996, J VERTEBR PALEONTOL, V16, P175, DOI 10.1080/02724634.1996.10011297; Erickson GM, 2003, J ZOOL, V260, P317, DOI 10.1017/S0952836903003819; Erickson GM, 1996, NATURE, V382, P706, DOI 10.1038/382706a0; Farlow J.O., 1991, Modern Geology, V16, P161; Fish FE, 2007, J EXP BIOL, V210, P2811, DOI 10.1242/jeb.004267; FRAZZETTA TH, 1988, ZOOMORPHOLOGY, V108, P93, DOI 10.1007/BF00539785; Fry BG, 2009, P NATL ACAD SCI USA, V106, P8969, DOI 10.1073/pnas.0810883106; GANS C, 1985, AM J ANAT, V173, P219, DOI 10.1002/aja.1001730306; GANS C, 1969, COPEIA, P855, DOI 10.2307/1441816; Glamann Kristof, 1995, BEER MARBLE C JACOBS; Head JJ, 2009, ZOOL J LINN SOC-LOND, V155, P445, DOI 10.1111/j.1096-3642.2008.00448.x; HELFMAN GS, 1986, COPEIA, P679, DOI 10.2307/1444949; Herrel A, 2001, J EXP ZOOL, V290, P101, DOI 10.1002/jez.1039; Herrel A, 2002, J EVOLUTION BIOL, V15, P1083, DOI 10.1046/j.1420-9101.2002.00459.x; Herrel A, 1999, FUNCT ECOL, V13, P289, DOI 10.1046/j.1365-2435.1999.00305.x; Hocknull SA, 2009, PLOS ONE, V4; Huber DR, 2005, J EXP BIOL, V208, P3553, DOI 10.1242/jeb.01816; Huber DR, 2004, J EXP ZOOL PART A, V301A, P26, DOI 10.1002/jez.a.20003; LANGSTON W JR, 1975, Fieldiana Geology, V33, P291; McHenry CR, 2007, P NATL ACAD SCI USA, V104, P16010, DOI 10.1073/pnas.0706086104; Measey GJ, 2006, BIOL LETTERS, V2, P485, DOI 10.1098/rsbl.2006.0516; Meers Mason B., 2002, Historical Biology, V16, P1; Mertens R., 1942, Abhandlungen der Senckenbergischen Naturforschenden Gesellschaft, VNo. 462, 465-466, P1; Moreno K, 2008, J ANAT, V212, P736, DOI 10.1111/j.1469-7580.2008.00899.x; OYEN OJ, 1991, AM J ORTHOD DENTOFAC, V99, P298, DOI 10.1016/0889-5406(91)70012-L; Paul G., 1988, PREDATORY DINOSAURS; Rayfield EJ, 2004, P ROY SOC B-BIOL SCI, V271, P1451, DOI 10.1098/rspb.2004.2755; Rayfield EJ, 2001, NATURE, V409, P1033, DOI 10.1038/35059070; Rieppel O., 1979, Gegenbaurs Morphologisches Jahrbuch, V125, P797; Rohlf FJ., 2006, TPSDIG VERSION 2 10; Sheets HD, 2005, CHAINMAN3D MORE IMP; SINCLAIR AG, 1987, J ZOOL, V213, P107, DOI 10.1111/j.1469-7998.1987.tb03681.x; Snively E, 2007, ANAT REC, V290, P934, DOI 10.1002/ar.20563; Therrien F, 2005, LIFE O PAST, P179; THOMASON JJ, 1990, CAN J ZOOL, V68, P318, DOI 10.1139/z90-047; Van Valkenburgh B, 2002, PALEOBIOLOGY, V28, P527, DOI 10.1666/0094-8373(2002)028<0527:DAMPC>2.0.CO;2; Wroe S, 2008, J ZOOL, V274, P332, DOI 10.1111/j.1469-7998.2007.00389.x; Wroe S, 2005, P ROY SOC B-BIOL SCI, V272, P619, DOI 10.1098/rspb.2004.2986; Wroe S, 2008, J ZOOL, V276, P336, DOI 10.1111/j.1469-7998.2008.00494.x; Wroe S, 2007, P ROY SOC B-BIOL SCI, V274, P2819, DOI 10.1098/rspb.2007.0906	50	21	21	0	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26226	10.1371/journal.pone.0026226	http://dx.doi.org/10.1371/journal.pone.0026226			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028837	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800028
J	Duguay, D; Belanger-Nelson, E; Mongrain, V; Beben, A; Khatchadourian, A; Cermakian, N				Duguay, David; Belanger-Nelson, Erika; Mongrain, Valerie; Beben, Anna; Khatchadourian, Armen; Cermakian, Nicolas			Dynein Light Chain Tctex-Type 1 Modulates Orexin Signaling through Its Interaction with Orexin 1 Receptor	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTORS; CYTOPLASMIC DYNEIN; DIFFERENTIAL EXPRESSION; SUBUNIT HETEROGENEITY; MULTIPLE MECHANISMS; INTERMEDIATE CHAIN; BETA-ARRESTIN; NEURONS; ENDOCYTOSIS; SLEEP	Orexins (OX-A, OX-B) are neuropeptides involved in the regulation of the sleep-wake cycle, feeding and reward, via activation of orexin receptors 1 and 2 (OX1R, OX2R). The loss of orexin peptides or functional OX2R has been shown to cause the sleep disorder, narcolepsy. Since the regulation of orexin receptors remains largely undefined, we searched for novel protein partners of the intracellular tail of orexin receptors. Using a yeast two-hybrid screening strategy in combination with co-immunoprecipitation experiments, we found interactions between OX1R and the dynein light chains Tctex-type 1 and 3 (Dynlt1, Dynlt3). These interactions were mapped to the C-terminal region of the dynein light chains and to specific residues within the last 10 amino acids of OX1R. Hence, we hypothesized that dynein light chains could regulate orexin signaling. In HEK293 cells expressing OX1R, stimulation with OX-A produced a less sustained extracellular signal-regulated kinases 1/2 (ERK1/2) activation when Dynlt1 was co-expressed, while it was prolonged under reduced Dynlt1 expression. The amount of OX1R located at the plasma membrane as well as the kinetics and extent of OX-A-induced internalization of OX1R (disappearance from membrane) were not altered by Dynlt1. However, Dynlt1 reduced the localization of OX1R in early endosomes following initial internalization. Taken together, these data suggest that Dynlt1 modulates orexin signaling by regulating OX1R, namely its intracellular localization following ligand-induced internalization.	[Duguay, David; Belanger-Nelson, Erika; Mongrain, Valerie; Beben, Anna; Khatchadourian, Armen; Cermakian, Nicolas] Douglas Mental Hlth Univ Inst, Lab Mol Chronobiol, Montreal, PQ, Canada; [Duguay, David; Mongrain, Valerie; Cermakian, Nicolas] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Belanger-Nelson, Erika; Cermakian, Nicolas] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada	McGill University; McGill University	Duguay, D (corresponding author), Douglas Mental Hlth Univ Inst, Lab Mol Chronobiol, Montreal, PQ, Canada.	nicolas.cermakian@mcgill.ca	Mongrain, Valérie/A-3931-2012	Cermakian, Nicolas/0000-0003-4517-9131	Canadian Institutes of Health Research (CIHR) [MOP-67167, MOP-84441]; Fonds de la Recherche en Sante du Quebec (FRSQ); CIHR/Frederick Banting and Charles Best Canada Graduate Scholarship - Master's Award; Natural Sciences and Engineering Research Council; McGill Faculty of Medicine award	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); CIHR/Frederick Banting and Charles Best Canada Graduate Scholarship - Master's Award(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); McGill Faculty of Medicine award	This work was supported by Canadian Institutes of Health Research (CIHR) (CIHR MOP-67167 and MOP-84441). DD was supported by a fellowship from Fonds de la Recherche en Sante du Quebec (FRSQ). EB-N was supported by a CIHR/Frederick Banting and Charles Best Canada Graduate Scholarship - Master's Award. VM was supported by FRSQ and Natural Sciences and Engineering Research Council fellowships. NC was supported by an FRSQ salary award and a McGill Faculty of Medicine award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310; Ammoun S, 2006, MOL ENDOCRINOL, V20, P80, DOI 10.1210/me.2004-0389; Boss C, 2009, J MED CHEM, V52, P891, DOI 10.1021/jm801296d; Campbell KS, 1998, J IMMUNOL, V161, P1728; Carter ME, 2009, J NEUROSCI, V29, P10939, DOI 10.1523/JNEUROSCI.1205-09.2009; Carter ME, 2009, CURR OPIN PHARMACOL, V9, P39, DOI 10.1016/j.coph.2008.12.018; Chuang JZ, 2001, J NEUROSCI, V21, P5501, DOI 10.1523/JNEUROSCI.21-15-05501.2001; CONDE C, J NEUROSCI, V30, P6793; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dupre DJ, 2009, ANNU REV PHARMACOL, V49, P31, DOI 10.1146/annurev-pharmtox-061008-103038; El Firar A, 2009, FASEB J, V23, P4069, DOI 10.1096/fj.09-131367; Estabrooke IV, 2001, J NEUROSCI, V21, P1656, DOI 10.1523/JNEUROSCI.21-05-01656.2001; Evans NA, 2001, J NEUROCHEM, V77, P476, DOI 10.1046/j.1471-4159.2001.00269.x; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Harris GC, 2005, NATURE, V437, P556, DOI 10.1038/nature04071; Holmqvist T, 2005, J BIOL CHEM, V280, P6570, DOI 10.1074/jbc.M407397200; Kelkar SA, 2004, J VIROL, V78, P10122, DOI 10.1128/JVI.78.18.10122-10132.2004; King SM, 2000, BBA-MOL CELL RES, V1496, P60, DOI 10.1016/S0167-4889(00)00009-4; King SM, 1998, BIOCHEMISTRY-US, V37, P15033, DOI 10.1021/bi9810813; Kukkonen JP, 2002, AM J PHYSIOL-CELL PH, V283, pC1567, DOI 10.1152/ajpcell.00055.2002; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lo KWH, 2007, J BIOL CHEM, V282, P11205, DOI 10.1074/jbc.M611279200; Loubery S, 2008, TRAFFIC, V9, P492, DOI 10.1111/j.1600-0854.2008.00704.x; Machado RD, 2003, HUM MOL GENET, V12, P3277, DOI 10.1093/hmg/ddg365; MANDERS EMM, 1993, J MICROSC-OXFORD, V169, P375, DOI 10.1111/j.1365-2818.1993.tb03313.x; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Milasta S, 2005, BIOCHEM J, V387, P573, DOI 10.1042/BJ20041745; Mileykovskiy BY, 2005, NEURON, V46, P787, DOI 10.1016/j.neuron.2005.04.035; Mok YK, 2001, J BIOL CHEM, V276, P14067, DOI 10.1074/jbc.M011358200; Nishino S, 2000, LANCET, V355, P39, DOI 10.1016/S0140-6736(99)05582-8; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; PASCHAL BM, 1987, NATURE, V330, P672, DOI 10.1038/330672a0; Peyron C, 1998, J NEUROSCI, V18, P9996; Pfister KK, 2005, J CELL BIOL, V171, P411, DOI 10.1083/jcb.200508078; Ritter SL, 2009, NAT REV MOL CELL BIO, V10, P819, DOI 10.1038/nrm2803; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Roy S, 2007, MOL ENDOCRINOL, V21, P1656, DOI 10.1210/me.2007-0041; Sachdev P, 2007, EMBO J, V26, P2621, DOI 10.1038/sj.emboj.7601716; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Saper CB, 2005, NATURE, V437, P1257, DOI 10.1038/nature04284; SCHNEIDER MA, CELL MICROBIOL; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Sugai M, 2003, BIOCHEM BIOPH RES CO, V311, P24, DOI 10.1016/j.bbrc.2003.09.157; Tai AW, 1999, CELL, V97, P877, DOI 10.1016/S0092-8674(00)80800-4; Tai AW, 2001, J CELL BIOL, V153, P1499, DOI 10.1083/jcb.153.7.1499; Takesono A, 1999, J BIOL CHEM, V274, P33202, DOI 10.1074/jbc.274.47.33202; Voisin T, 2003, CELL MOL LIFE SCI, V60, P72, DOI 10.1007/s000180300005; Voisin T, 2008, FASEB J, V22, P1993, DOI 10.1096/fj.07-098723; Williams JC, 2005, J BIOL CHEM, V280, P21981, DOI 10.1074/jbc.M414643200; Williams JC, 2007, P NATL ACAD SCI USA, V104, P10028, DOI 10.1073/pnas.0703614104; Wu HW, 2005, STRUCTURE, V13, P213, DOI 10.1016/j.str.2004.11.013; Zhu Y, 2003, J PHARMACOL SCI, V92, P259	54	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26430	10.1371/journal.pone.0026430	http://dx.doi.org/10.1371/journal.pone.0026430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028875	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800042
J	Schwartz, JL; Rountree, W; Kashuba, ADM; Brache, V; Creinin, MD; Poindexter, A; Kearney, BP				Schwartz, Jill L.; Rountree, Wes; Kashuba, Angela D. M.; Brache, Vivian; Creinin, Mitchell D.; Poindexter, Alfred; Kearney, Brian P.			A Multi-Compartment, Single and Multiple Dose Pharmacokinetic Study of the Vaginal Candidate Microbicide 1% Tenofovir Gel	PLOS ONE			English	Article							IN-VITRO; K65R MUTATION; PREEXPOSURE; SAFETY; HIV-1	Background: Tenofovir (TFV) gel is being evaluated as a microbicide with pericoital and daily regimens. To inhibit viral replication locally, an adequate concentration in the genital tract is critical. Methods and Findings: Forty-nine participants entered a two-phase study: single-dose (SD) and multi-dose (MD), were randomized to collection of genital tract samples (endocervical cells [ECC], cervicovaginal aspirate and vaginal biopsies) at one of seven time points [0.5, 1, 2, 4, 6, 8, or 24 hr(s)] post-dose following SD exposure of 4 mL 1% TFV gel and received a single dose. Forty-seven were randomized to once (QD) or twice daily (BID) dosing for 2 weeks and to collection of genital tract samples at 4, 8 or 24 hrs after the final dose, but two discontinued prior to gel application. Blood was collected during both phases at the seven times post-dose. TFV exposure was low in blood plasma for SD and MD; median C-max was 4.0 and 3.4 ng/mL, respectively (C <= 29 ng/mL). TFV concentrations were high in aspirates and tissue after SD and MD, ranging from 1.2x10(4) to 9.9x10(6) ng/mL and 2.1x10(2) to 1.4x10(6) ng/mL, respectively, and did not noticeably differ between proximal and distal tissue. TFV diphosphate (TFV-DP), the intracellular active metabolite, was high in ECC, ranging from 7.1x10(3) to 8.8x10(6) ng/mL. TFV-DP was detectable in approximately 40% of the tissue samples, ranging from 1.8x10(2) to 3.5x10(4) ng/mL. AUC for tissue TFV-DP was two logs higher after MD compared to SD, with no noticeable differences when comparing QD and BID. Conclusions: Single-dose and multiple-dose TFV gel exposure resulted in high genital tract concentrations for at least 24 hours post-dose with minimal systemic absorption. These results support further study of TFV gel for HIV prevention. registration:	[Schwartz, Jill L.] EVMS, CONRAD, Arlington, VA USA; [Rountree, Wes] Family Hlth Int, Res Triangle Pk, NC 27709 USA; [Kashuba, Angela D. M.] Univ N Carolina, Eshelman Sch Pharm, Chapel Hill, NC USA; [Kashuba, Angela D. M.] Univ N Carolina, CFAR Clin Pharmacol & Analyt Chem Core Lab, Chapel Hill, NC USA; [Brache, Vivian] PROFAMILIA, Santo Domingo, Dominican Rep; [Creinin, Mitchell D.] Univ Pittsburgh, Ctr Family Planning Res, Pittsburgh, PA USA; [Creinin, Mitchell D.] Magee Womens Res Inst, Pittsburgh, PA USA; [Poindexter, Alfred] Adv Hlth Inc, Houston, TX USA; [Kearney, Brian P.] Gilead Sci, Foster City, CA USA	Eastern Virginia Medical School; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; PROFAMILIA; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Gilead Sciences	Schwartz, JL (corresponding author), EVMS, CONRAD, Arlington, VA USA.	jschwartz@conrad.org	Creinin, Mitchell/AAH-3488-2020	Creinin, Mitchell/0000-0001-5967-8180; Ravel, Jacques/0000-0002-0851-2233	U.S. Agency for International Development [GPO-A-00-05-00041-00]; CTSA GRANT [1 UL1 RR024153-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	U.S. Agency for International Development(United States Agency for International Development (USAID)); CTSA GRANT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Support for this subproject was provided by the U.S. Agency for International Development (www.usaid.gov), under the terms of Award Number GPO-A-00-05-00041-00 to the International Partnership for Microbicides (IPM). University of Pittsburgh and Magee-Womens Research Institute received funding from CTSA GRANT 1 UL1 RR024153-01. The opinions expressed do not necessarily reflect the views of the U.S. Agency for International Development. USAID had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, REP GLOB HIV AIDS EP; BALZARINI J, 1993, ANTIMICROB AGENTS CH, V37, P332, DOI 10.1128/AAC.37.2.332; Borroto-Esoda K, 2006, ANTIVIR THER, V11, P377; Brenner Bluma G., 2009, HIV Therapy, V3, P583, DOI [10.2217/hiv.09.40, 10.2217/HIV.09.40]; CHAPMAN EH, 1981, J CLIN PATHOL, V34, P1083, DOI 10.1136/jcp.34.10.1083; Dumond JB, 2007, AIDS, V21, P1899, DOI 10.1097/QAD.0b013e328270385a; Hawkins T, 2005, JAIDS-J ACQ IMM DEF, V39, P406, DOI 10.1097/01.qai.0000167155.44980.e8; HILLIER S, 2008, MICR 2008 FEBR 24 27; Hoetelmans RMW, 2007, BRIT J CLIN PHARMACO, V64, P655, DOI 10.1111/j.1365-2125.2007.02957.x; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Karim SSA, 2011, LANCET, V378, P279, DOI 10.1016/S0140-6736(11)60878-7; Mayer KH, 2006, AIDS, V20, P543, DOI 10.1097/01.aids.0000210608.70762.c3; Parikh UM, 2005, ANTIMICROB AGENTS CH, V49, P1139, DOI 10.1128/AAC.49.3.1139-1144.2005; Parikh UM, 2009, J VIROL, V83, P10358, DOI 10.1128/JVI.01073-09; Robbins BL, 1998, ANTIMICROB AGENTS CH, V42, P612, DOI 10.1128/AAC.42.3.612; Rohan LC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009310; Schwartz JL, 2009, INT J STD AIDS, V20, P384, DOI 10.1258/ijsa.2008.008309; St Claire RL, 2000, RAPID COMMUN MASS SP, V14, P1625, DOI 10.1002/1097-0231(20000915)14:17<1625::AID-RCM72>3.0.CO;2-0; Thurman AR, 2011, AM J REPROD IMMUNOL, V65, P89, DOI 10.1111/j.1600-0897.2010.00902.x; Wainberg MA, 1999, ANTIVIR THER, V4, P87	20	79	79	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25974	10.1371/journal.pone.0025974	http://dx.doi.org/10.1371/journal.pone.0025974			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039430	Green Published, gold, Green Accepted			2022-12-27	WOS:000296507500026
J	Tano, N; Kim, HW; Ashraf, M				Tano, Nobuko; Kim, Ha Won; Ashraf, Muhammad			microRNA-150 Regulates Mobilization and Migration of Bone Marrow-Derived Mononuclear Cells by Targeting Cxcr4	PLOS ONE			English	Article							STEM-CELLS; MYOCARDIAL-INFARCTION; ISCHEMIC MYOCARDIUM; NEOVASCULARIZATION; DIFFERENTIATION; TRANSPLANTATION; EXPRESSION; REPAIR; ANGIOBLASTS; BIOGENESIS	The interaction between chemokine receptor type 4 (CXCR4) and its ligand, stromal cell-derived factor (SDF)-1, plays an important role in stem cell mobilization and migration in ischemic tissues. MicroRNAs (miRs) are key regulators of stem cell function and are involved in regulation of stem cell survival and differentiation to adopt different cell lineages. In this study, we show that ischemia inhibits the expression of miR-150 in BM-derived mononuclear cells (MNC) and activates its target Cxcr4 gene. Our results show that miR-150/CXCR4 cascade enhances MNC mobilization and migration. By using mouse acute myocardial infarction (MI) model, we found that MNCs in peripheral blood (PB) were increased significantly at day 5 after AMI as compared to control group and the number of CXCR4 positive MNCs both in bone marrow (BM) and PB was also markedly increased after MI. Analysis by microarray-based miRNA profiling and real-time PCR revealed that the expression of miR-150 which targets Cxcr4 gene as predicted was significantly downregulated in BM-MNCs after MI. Abrogation of miR-150 markedly increased CXCR4 protein expression suggesting its target gene. To show that miR-150 regulates MNC mobilization, knockdown of miR-150 in BM-MNCs by specific antisense inhibitor resulted in their higher migration ability in vitro as compared to scramble-transfected MNCs. Furthermore, in vivo BM transplantation of MNCs lacking miR-150 expression by lentiviral vector into the irradiated wild type mice resulted in the increased number of MNCs in PB after AMI as compared to control. In conclusion, this study demonstrates that ischemia mobilizes BM stem cells via miR-150/CXCR4 dependent mechanism and miR-150 may be a novel therapeutic target for stem cell migration to the ischemic tissue for neovascularization and repair.	[Tano, Nobuko; Kim, Ha Won; Ashraf, Muhammad] Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45221 USA	University System of Ohio; University of Cincinnati	Tano, N (corresponding author), Univ Cincinnati, Dept Pathol & Lab Med, Cincinnati, OH 45221 USA.	Ashrafm@ucmail.uc.edu	Ashraf, Muhammad/ABB-3463-2021	Kim, Ha Won/0000-0001-6272-4248	National Institutes of Health [R37-HL074272, HL-080686, HL087246, HL087288, HL089535, HL106190-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106190, R37HL074272, R01HL087288, R01HL087246, R01HL089535] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding was provided by National Institutes of Health grants R37-HL074272; HL-080686; HL087246 (M. A) and HL087288; HL089535; HL106190-01 (K. H. H). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral FC, 2009, J CLIN ENDOCR METAB, V94, P320, DOI 10.1210/jc.2008-1451; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Dignat-George F, 2000, EUR J HAEMATOL, V65, P215, DOI 10.1034/j.1600-0609.2000.065004215.x; Donahue RE, 2009, BLOOD, V114, P2530, DOI 10.1182/blood-2009-04-214403; Duran-Struuck R, 2009, J AM ASSOC LAB ANIM, V48, P11; Georgantas RW, 2007, P NATL ACAD SCI USA, V104, P2750, DOI 10.1073/pnas.0610983104; Haider HK, 2008, CIRC RES, V103, P1300, DOI 10.1161/CIRCRESAHA.108.186742; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jin P, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-39; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Lessner SM, 2002, AM J PATHOL, V160, P2145, DOI 10.1016/S0002-9440(10)61163-7; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Pokushalov E, 2010, J CARDIOVASC TRANSL, V3, P160, DOI 10.1007/s12265-009-9123-8; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Shintani S, 2001, CIRCULATION, V103, P897, DOI 10.1161/01.CIR.103.6.897; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Tang YL, 2009, CIRC RES, V104, P1209, DOI 10.1161/CIRCRESAHA.109.197723; Tsitsiou E, 2009, CURR OPIN PHARMACOL, V9, P514, DOI 10.1016/j.coph.2009.05.003; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Yin YG, 2010, CARDIOVASC PATHOL, V19, P218, DOI 10.1016/j.carpath.2009.04.002; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010	26	75	80	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e23114	10.1371/journal.pone.0023114	http://dx.doi.org/10.1371/journal.pone.0023114			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039399	gold, Green Published, Green Submitted			2022-12-27	WOS:000296507500001
J	Zhao, JJ; Pan, K; Li, JJ; Chen, YB; Chen, JG; Lv, L; Wang, DD; Pan, QZ; Chen, MS; Xia, JC				Zhao, Jing-jing; Pan, Ke; Li, Jian-jun; Chen, Yi-bing; Chen, Ju-gao; Lv, Lin; Wang, Dan-dan; Pan, Qiu-zhong; Chen, Min-shan; Xia, Jian-chuan			Identification of LZAP as a New Candidate Tumor Suppressor in Hepatocellular Carcinoma	PLOS ONE			English	Article							BINDING PROTEIN; CHECKPOINT; EXPRESSION; KINASE	Background: LZAP was isolated as a binding protein of the Cdk5 activator p35. LZAP has been highly conserved during evolution and has been shown to function as a tumor suppressor in various cancers. This study aimed to investigate LZAP expression and its prognostic value in hepatocellular carcinoma (HCC). Meanwhile, the function of LZAP in hepatocarcinogenesis was further investigated in cell culture models and mouse models. Methods: Real-time quantitative PCR, western blot and immunohistochemistry were used to explore LZAP expression in HCC cell lines and primary HCC clinical specimens. The functions of LZAP in the proliferation, colony formation, cell cycle, migration, invasion and apoptosis of HCC cell lines were also analyzed by infecting cells with an adenovirus containing full-length LZAP. The effect of LZAP on tumorigenicity in nude mice was also investigated. Results: LZAP expression was significantly decreased in the tumor tissues and HCC cell lines. Clinicopathological analysis showed that LZAP expression was significantly correlated with tumor size, histopathological classification and serum alpha-fetoprotein (AFP). The Kaplan-Meier survival curves revealed that decreasing LZAP expression was associated with poor prognosis in HCC patients. LZAP expression was an independent prognostic marker of overall HCC patient survival in a multivariate analysis. The re-introduction of LZAP expression in the HepG2 and sk-Hep1 HCC cell lines significantly inhibited proliferation and colony formation in the HCC cells and induced G1 phase arrest and apoptosis of the HCC cells in vitro. Restoring LZAP expression in the HCC cell lines also inhibited migration and invasion. In addition, experiments with a mouse model revealed that LZAP overexpression could suppress HCC tumorigenicity in vivo. Conclusions: Our data suggest that LZAP may play an important role in HCC progression and could be a potential molecular therapy target for HCC.	[Zhao, Jing-jing; Pan, Ke; Li, Jian-jun; Chen, Yi-bing; Chen, Ju-gao; Lv, Lin; Wang, Dan-dan; Pan, Qiu-zhong; Chen, Min-shan; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China; [Zhao, Jing-jing; Pan, Ke; Li, Jian-jun; Chen, Yi-bing; Chen, Ju-gao; Lv, Lin; Wang, Dan-dan; Pan, Qiu-zhong; Chen, Min-shan; Xia, Jian-chuan] Sun Yat Sen Univ, Ctr Canc, Dept Expt Res, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Min-shan] Sun Yat Sen Univ, Ctr Canc, Dept Hepatobiliary Oncol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Zhao, JJ (corresponding author), Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol So China, Guangzhou 510275, Guangdong, Peoples R China.	xiajch@mail.sysu.edu.cn			National Natural Science Foundation of China [u0772002, 30700985, 30973398]; Guangdong Natural Science Foundation [925100890]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was supported by the National Natural Science Foundation of China (u0772002, 30700985, 30973398) and Guangdong Natural Science Foundation (925100890). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ding Y, 2009, INT J CANCER, V124, P653, DOI 10.1002/ijc.23954; Frau M, 2010, MOL ASPECTS MED, V31, P179, DOI 10.1016/j.mam.2010.02.007; Giannelli G, 2006, J CLIN GASTROENTEROL, V40, P842, DOI 10.1097/01.mcg.0000225543.11503.17; Hu TH, 2003, CANCER, V97, P1929, DOI 10.1002/cncr.11266; Itoh S, 2004, CLIN CANCER RES, V10, P2812, DOI 10.1158/1078-0432.CCR-1046-03; Jiang H, 2005, J BIOL CHEM, V280, P20651, DOI 10.1074/jbc.M413431200; Jiang H, 2009, CELL RES, V19, P458, DOI 10.1038/cr.2009.14; Kwon J, 2010, J BIOL CHEM, V285, P12232, DOI 10.1074/jbc.M109.065920; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Okuda K, 1997, J GASTROEN HEPATOL, V12, pS314, DOI 10.1111/j.1440-1746.1997.tb00515.x; Thomas MB, 2005, J CLIN ONCOL, V23, P2892, DOI 10.1200/JCO.2005.03.196; Wang JL, 2007, CANCER CELL, V12, P239, DOI 10.1016/j.ccr.2007.07.002; Wang JL, 2006, BIOCHEM J, V393, P489, DOI 10.1042/BJ20050960	13	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26608	10.1371/journal.pone.0026608	http://dx.doi.org/10.1371/journal.pone.0026608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028922	gold, Green Published, Green Submitted			2022-12-27	WOS:000296507500096
J	Torrado, M; Iglesias, R; Centeno, A; Lopez, E; Mikhailov, AT				Torrado, Mario; Iglesias, Raquel; Centeno, Alberto; Lopez, Eduardo; Mikhailov, Alexander T.			Targeted Gene-Silencing Reveals the Functional Significance of Myocardin Signaling in the Failing Heart	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; DILATED CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; CARDIOVASCULAR DEVELOPMENT; MESSENGER-RNA; EXPRESSION; CELLS; FAILURE; DISEASE; GROWTH	Background: Myocardin (MYOCD), a potent transcriptional coactivator of smooth muscle (SM) and cardiac genes, is upregulated in failing myocardium in animal models and human end-stage heart failure (HF). However, the molecular and functional consequences of myocd upregulation in HF are still unclear. Methodology/Principal Findings: The goal of the present study was to investigate if targeted inhibition of upregulated expression of myocd could influence failing heart gene expression and function. To this end, we used the doxorubicin (Dox)-induced diastolic HF (DHF) model in neonatal piglets, in which, as we show, not only myocd but also myocd-dependent SM-marker genes are highly activated in failing left ventricular (LV) myocardium. In this model, intra-myocardial delivery of short-hairpin RNAs, designed to target myocd variants expressed in porcine heart, leads on day 2 post-delivery to: (1) a decrease in the activated expression of myocd and myocd-dependent SM-marker genes in failing myocardium to levels seen in healthy control animals, (2) amelioration of impaired diastolic dysfunction, and (3) higher survival rates of DHF piglets. The posterior restoration of elevated myocd expression (on day 7 post-delivery) led to overexpression of myocd-dependent SM-marker genes in failing LV-myocardium that was associated with a return to altered diastolic function. Conclusions/Significance: These data provide the first evidence that a moderate inhibition (e. g., normalization) of the activated MYOCD signaling in the diseased heart may be promising from a therapeutic point of view.	[Torrado, Mario; Iglesias, Raquel; Mikhailov, Alexander T.] Univ A Coruna, Inst Hlth Sci, Dev Biol Grp, La Coruna, Spain; [Centeno, Alberto; Lopez, Eduardo] Univ Hosp Ctr La Coruna, Expt Surg Unit, La Coruna, Spain	Universidade da Coruna; Complejo Hospitalario Universitario A Coruna	Torrado, M (corresponding author), Univ A Coruna, Inst Hlth Sci, Dev Biol Grp, La Coruna, Spain.	margot@udc.es	Mikhailov, Alexander T./H-1897-2012; Iglesias, Raquel/D-3212-2019	Mikhailov, Alexander/0000-0002-1146-4113; Iglesias, Raquel/0000-0002-0212-3616	Spanish Ministry of Science and Innovation [SAF2008-00337]; Autonomic Government of Galicia [08CSA008161PR]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Autonomic Government of Galicia	This work was supported by a grant (SAF2008-00337) from the Spanish Ministry of Science and Innovation and by a grant (08CSA008161PR) from the Autonomic Government of Galicia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi S, 1998, LIFE SCI, V63, P1779, DOI 10.1016/S0024-3205(98)00452-4; Badorff C, 2005, CIRC RES, V97, P645, DOI 10.1161/01.RES.0000184684.88750.FE; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Berni R, 2009, AM J PHYSIOL-HEART C, V296, pH1625, DOI 10.1152/ajpheart.01057.2008; Cataliotti A, 2011, CIRCULATION, V123, P1297, DOI 10.1161/CIRCULATIONAHA.110.981720; Cen B, 2004, J CELL BIOCHEM, V93, P74, DOI 10.1002/jcb.20199; Chen JF, 2008, ANAT REC, V291, P1200, DOI 10.1002/ar.20756; Chiu CZ, 2010, CLIN SCI, V119, P273, DOI 10.1042/CS20100084; Chow N, 2007, P NATL ACAD SCI USA, V104, P823, DOI 10.1073/pnas.0608251104; Creemers EE, 2006, DEVELOPMENT, V133, P4245, DOI 10.1242/dev.02610; Creemers EE, 2006, MOL CELL, V23, P83, DOI 10.1016/j.molcel.2006.05.026; Dewey FE, 2011, CIRC-CARDIOVASC GENE, V4, P26, DOI 10.1161/CIRCGENETICS.110.941757; Dunlay SM, 2008, CIRCULATION, V118, P625, DOI 10.1161/CIRCULATIONAHA.107.759191; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Hoofnagle MH, 2011, AM J PHYSIOL-HEART C, V300, pH1707, DOI 10.1152/ajpheart.01192.2010; Huang JH, 2009, P NATL ACAD SCI USA, V106, P18734, DOI 10.1073/pnas.0910749106; Imamura M, 2010, GENE, V464, P1, DOI 10.1016/j.gene.2010.03.012; Kang S, 2011, J BIOL CHEM, V286, P18465, DOI 10.1074/jbc.M110.200022; Kass DA, 2004, CIRC RES, V94, P1533, DOI 10.1161/01.RES.0000129254.25507.d6; Kaye DM, 2007, J AM COLL CARDIOL, V50, P253, DOI 10.1016/j.jacc.2007.03.047; Kim M, 2008, J MOL CELL CARDIOL, V45, P270, DOI 10.1016/j.yjmcc.2008.05.006; Kimura Y, 2010, CANCER RES, V70, P501, DOI 10.1158/0008-5472.CAN-09-1469; Kontaraki JE, 2007, CARDIOVASC PATHOL, V16, P329, DOI 10.1016/j.carpath.2007.04.004; Kreusser MM, 2008, J MOL CELL CARDIOL, V44, P380, DOI 10.1016/j.yjmcc.2007.10.019; Lamarcq LH, 2006, J BIOMOL SCREEN, V11, P236, DOI 10.1177/1087057105284342; Leenders JJ, 2010, J BIOL CHEM, V285, P27449, DOI 10.1074/jbc.M110.107292; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Liu N, 2006, CURR OPIN CELL BIOL, V18, P715, DOI 10.1016/j.ceb.2006.10.003; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; McKinsey TA, 2007, NAT REV DRUG DISCOV, V6, P617, DOI 10.1038/nrd2193; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miano JM, 2010, LAB INVEST, V90, P1274, DOI 10.1038/labinvest.2010.104; Mikhailov AT, 2010, SHAPING HEART DEV DI, P145; Milyavsky M, 2007, CANCER CELL, V11, P133, DOI 10.1016/j.ccr.2006.11.022; Most P, 2007, AM J PHYSIOL-REG I, V293, pR568, DOI 10.1152/ajpregu.00075.2007; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Parlakian A, 2005, CIRCULATION, V112, P2930, DOI 10.1161/CIRCULATIONAHA.105.533778; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Pattison JS, 2008, TRANSGENIC RES, V17, P157, DOI 10.1007/s11248-007-9139-2; Periasamy Muthu, 2008, Heart Fail Clin, V4, P13, DOI 10.1016/j.hfc.2007.10.007; Pipes GCT, 2006, GENE DEV, V20, P1545, DOI 10.1101/gad.1428006; Pipes GCT, 2005, DEV BIOL, V288, P502, DOI 10.1016/j.ydbio.2005.10.014; Rathinavel A, 2005, EUR J CARDIOV PREV R, V12, P601, DOI 10.1097/00149831-200512000-00014; Scherrer-Crosbie M, 2010, J MOL CELL CARDIOL, V48, P512, DOI 10.1016/j.yjmcc.2009.07.004; Schwartz RJ, 2010, HEART DEV REGENERATI, P617; Small EM, 2005, DEVELOPMENT, V132, P987, DOI 10.1242/dev.01684; Small EM, 2011, NATURE, V469, P336, DOI 10.1038/nature09783; Steenman M, 2003, PHYSIOL GENOMICS, V12, P97, DOI 10.1152/physiolgenomics.00148.2002; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; Tan WQ, 2008, J BIOL CHEM, V283, P29730, DOI 10.1074/jbc.M805514200; Tang RH, 2008, P NATL ACAD SCI USA, V105, P3362, DOI 10.1073/pnas.0705842105; Taxman DJ, 2006, BMC BIOTECHNOL, V6, DOI 10.1186/1472-6750-6-7; Torrado M, 2003, J MOL MED, V81, P566, DOI 10.1007/s00109-003-0470-7; Torrado M, 2006, FEBS LETT, V580, P4182, DOI 10.1016/j.febslet.2006.06.073; Torrado M, 2010, EXP BIOL MED, V235, P941, DOI 10.1258/ebm.2010.010078; Torrado M, 2009, INT J DEV BIOL, V53, P1457, DOI 10.1387/ijdb.072366mt; Torrado M, 2009, GENE, V440, P28, DOI 10.1016/j.gene.2009.03.017; Ueyama T, 2003, MOL CELL BIOL, V23, P9222, DOI 10.1128/MCB.23.24.9222-9232.2003; van Gaal EVB, 2006, PHARM RES-DORDR, V23, P1053, DOI 10.1007/s11095-006-0164-2; van Tuyn J, 2005, CARDIOVASC RES, V67, P245, DOI 10.1016/j.cardiores.2005.04.013; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang K, 2010, J BIOL CHEM, V285, P11903, DOI 10.1074/jbc.M109.098004; Xin YF, 2011, FOOD CHEM TOXICOL, V49, P259, DOI 10.1016/j.fct.2010.10.028; Xing WB, 2006, CIRC RES, V98, P1089, DOI 10.1161/01.RES.0000218781.23144.3e; Yasuno S, 2009, AM J PHYSIOL-HEART C, V296, pH1804, DOI 10.1152/ajpheart.01033.2008; Zhang XM, 2004, J BIOL CHEM, V279, P55626, DOI 10.1074/jbc.M405945200	67	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26392	10.1371/journal.pone.0026392	http://dx.doi.org/10.1371/journal.pone.0026392			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028870	Green Published, gold, Green Submitted			2022-12-27	WOS:000296186900058
J	Creaney, J; Dick, IM; Yeoman, D; Wong, S; Robinson, BWS				Creaney, Jenette; Dick, Ian M.; Yeoman, Deborah; Wong, Sarah; Robinson, Bruce W. S.			Auto-Antibodies to beta-F1-ATPase and Vimentin in Malignant Mesothelioma	PLOS ONE			English	Article							MEGAKARYOCYTE POTENTIATING FACTOR; ATP SYNTHASE; BIOENERGETIC SIGNATURE; SERUM MESOTHELIN; CANCER; DIAGNOSIS; PROGNOSIS; PROTEINS; WARBURG; OSTEOPONTIN	Patients with Malignant Mesothelioma (MM) develop unidentified auto-antibodies to MM tumour antigens. This study was conducted to identify the targets of MM patient auto-antibodies in order to try to understand more of the anti-tumour response and to determine if these antibodies might be helpful for diagnosis or prognostication. Using MM patient sera in a Western immunoblott screening strategy, no common immunoreactive proteins were identified. The sera from one long-term survivor recognised a protein band of 50-60 kDa present in cell lysates from four of five MM cell lines tested. The immunoreactive proteins in this band were identified by 2D electrophoretic separation of a MM cell line protein lysate, followed by analysis of excised immunoreactive proteins on a MALDI TOF mass spectrometer and peptide mass fingerprinting. The immunoreactive proteins identified were vimentin (accession gi55977767) and the ATP synthase (F1-ATPase) beta chain (accession gi114549 and gi47606749). ELISA assays were developed for antibodies to these proteins. Neither vimentin (median and 95% CI 0.346; 0.32-0.468 for MM patients, 0.327; 0.308-0.428 for controls) nor beta-F1-ATPase (0.257; 0.221-0.453 for MM patients, 0.263; 0.22-0.35 for controls) showed significant differences in autoantibody levels between a group of MM patients and controls. Using a dichotomized antibody level (high, low) for these targets we demonstrated that vimentin antibody levels were not associated with survival. In contrast, high beta-F1-ATPase antibody levels were significantly associated with increased median survival (18 months) compared to low beta F1 ATPase antibody levels (9 months; p = 0.049). Immunohistochemical analysis on a MM tissue microarray showed cytoplasmic staining in 28 of 33 samples for vimentin and strong cytoplasmic staining in 14 and weak in 16 samples for beta-F1-ATPase. Therefore antibodies to neither vimentin nor beta-F1-ATPase are useful for differential diagnosis of MM, however high antibody levels to beta-F1-ATPase may be associated with increased survival and this warrants further investigation.	[Creaney, Jenette; Dick, Ian M.; Yeoman, Deborah; Wong, Sarah; Robinson, Bruce W. S.] Univ Western Australia, Natl Ctr Asbestos Related Dis, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Creaney, Jenette; Robinson, Bruce W. S.] Sir Charles Gairdner Hosp, Australian Mesothelioma Tissue Bank, Nedlands, WA 6009, Australia; [Robinson, Bruce W. S.] Sir Charles Gairdner Hosp, Dept Resp Med, Nedlands, WA 6009, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Creaney, J (corresponding author), Univ Western Australia, Natl Ctr Asbestos Related Dis, Sch Med & Pharmacol, Nedlands, WA 6009, Australia.	creaneyj@cyllene.uwa.edu.au	Robinson, Bruce/N-1900-2014		National Health and Medical Research Council of Australia [PG 458532]; Insurance Commission of Western Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Insurance Commission of Western Australia	This study was funded in part by research grants from the National Health and Medical Research Council of Australia PG 458532 (http://www.nhmrc.gov.au/) and the Insurance Commission of Western Australia (http://www.icwa.wa.gov.au/id/id_medical.shtml). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOYLE P, 2010, ANN ONCOL; Chen YT, 1997, P NATL ACAD SCI USA, V94, P1914, DOI 10.1073/pnas.94.5.1914; Chi SL, 2006, ANN MED, V38, P429, DOI 10.1080/07853890600928698; Creaney J, 2008, BRIT J CANCER, V98, P1562, DOI 10.1038/sj.bjc.6604340; Creaney J, 2001, BRIT J CANCER, V84, P52, DOI 10.1054/bjoc.2000.1529; CREANEY J, 2010, CANC EPIDEMIOL BIOMA; Creaney J, 2008, J THORAC ONCOL, V3, P851, DOI 10.1097/JTO.0b013e318180477b; Creaney J, 2007, CHEST, V132, P1239, DOI 10.1378/chest.07-0013; Cuezva JM, 2004, CARCINOGENESIS, V25, P1157, DOI 10.1093/carcin/bgh113; Cuezva JM, 2002, CANCER RES, V62, P6674; Cuezva JM, 2007, J BIOENERG BIOMEMBR, V39, P259, DOI 10.1007/s10863-007-9087-9; Farlow EC, 2010, CLIN CANCER RES, V16, P3452, DOI 10.1158/1078-0432.CCR-09-3192; Grigoriu B, 2009, CLIN BIOCHEM, V42, P1046, DOI 10.1016/j.clinbiochem.2009.03.007; Grigoriu BD, 2007, CLIN CANCER RES, V13, P2928, DOI 10.1158/1078-0432.CCR-06-2144; Hollevoet K, 2010, AM J RESP CRIT CARE, V181, P620, DOI 10.1164/rccm.200907-1020OC; Huang TC, 2008, J PROTEOME RES, V7, P1433, DOI 10.1021/pr700742h; Isidoro A, 2005, CARCINOGENESIS, V26, P2095, DOI 10.1093/carcin/bgi188; Jones FG, 1999, AUTOIMMUNITY, V30, P157, DOI 10.3109/08916939908993850; Lin PC, 2008, INT J COLORECTAL DIS, V23, P1223, DOI 10.1007/s00384-008-0539-4; Lock RA, 2001, PATHOLOGY, V33, P365; Mahesh B, 2007, AM J PATHOL, V170, P1415, DOI 10.2353/ajpath.2007.060728; MANNING LS, 1991, INT J CANCER, V47, P285, DOI 10.1002/ijc.2910470219; Mathupala SP, 2010, BBA-BIOENERGETICS, V1797, P1225, DOI 10.1016/j.bbabio.2010.03.025; Mewar D, 2006, BIOMED PHARMACOTHER, V60, P648, DOI 10.1016/j.biopha.2006.09.002; Ordonez NG, 2003, AM J SURG PATHOL, V27, P1031, DOI 10.1097/00000478-200308000-00001; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Robinson BWS, 2005, NEW ENGL J MED, V353, P1591, DOI 10.1056/NEJMra050152; Robinson BWS, 2003, LANCET, V362, P1612, DOI 10.1016/S0140-6736(03)14794-0; Robinson C, 1998, LUNG CANCER, V20, P175, DOI 10.1016/S0169-5002(98)00014-2; Robinson C, 2000, AM J RESP CELL MOL, V22, P550, DOI 10.1165/ajrcmb.22.5.3930; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Scotet E, 2005, IMMUNITY, V22, P71, DOI 10.1016/j.immuni.2004.11.012; Tan EM, 2008, IMMUNOL REV, V222, P328, DOI 10.1111/j.1600-065X.2008.00611.x; VACIRCA D, 2010, NEUROBIOL AGING; Vantourout P, 2008, MOL IMMUNOL, V45, P485, DOI 10.1016/j.molimm.2007.05.026; Veitonmaki N, 2004, CANCER RES, V64, P3679, DOI 10.1158/0008-5472.CAN-03-1754	36	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26515	10.1371/journal.pone.0026515	http://dx.doi.org/10.1371/journal.pone.0026515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022619	Green Submitted, gold, Green Published			2022-12-27	WOS:000295984400063
J	Walcott, BP; Coumans, JV; Mian, MK; Nahed, BV; Kahle, KT				Walcott, Brian P.; Coumans, Jean-Valery; Mian, Matthew K.; Nahed, Brian V.; Kahle, Kristopher T.			Interfacility Helicopter Ambulance Transport of Neurosurgical Patients: Observations, Utilization, and Outcomes from a Quaternary Level Care Hospital	PLOS ONE			English	Article							HEAD-INJURED PATIENTS; INTRACEREBRAL HEMORRHAGE; EXTRADURAL HEMATOMA; TRAUMA CENTERS; SERVICES; STROKE; IMPACT; MORTALITY; TRANSFERS; IMPROVE	Background: The clinical benefit of helicopter transport over ground transportation for interfacility transport is unproven. We sought to determine actual practice patterns, utilization, and outcomes of patients undergoing interfacility transport for neurosurgical conditions. Methodology/Principal Findings: We retrospectively examined all interfacility helicopter transfers to a single trauma center during 2008. We restricted our analysis to those transfers leading either to admission to the neurosurgical service or to formal consultation upon arrival. Major exclusion criteria included transport from the scene, death during transport, and transport to any area of the hospital other than the emergency department. The primary outcome was time interval to invasive intervention. Secondary outcomes were estimated ground transportation times from the referring hospital, admitting disposition, and discharge disposition. Of 526 candidate interfacility helicopter transfers to our emergency department in 2008, we identified 167 meeting study criteria. Seventy-five (45%) of these patients underwent neurosurgical intervention. The median time to neurosurgical intervention ranged from 1.0 to 117.8 hours, varying depending on the diagnosis. For 101 (60%) of the patients, estimated driving time from the referring institution was less than one hour. Four patients (2%) expired in the emergency department, and 34 patients (20%) were admitted to a non-ICU setting. Six patients were discharged home within 24 hours. For those admitted, in-hospital mortality was 28%. Conclusions/Significance: Many patients undergoing interfacility transfer for neurosurgical evaluation are inappropriately triaged to helicopter transport, as evidenced by actual times to intervention at the accepting institution and estimated ground transportation times from the referring institution. In a time when there is growing interest in health care cost containment, practitioners must exercise discretion in the selection of patients for air ambulance transport-particularly when it may not bear influence on clinical outcome. Neurosurgical evaluation via telemedicine may be one strategy for improving air transport triage.	[Walcott, Brian P.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Walcott, BP (corresponding author), Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA.	walcott.brian@mgh.harvard.edu	Nahed, Brian/E-4239-2014	Nahed, Brian/0000-0001-8537-106X	Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Institutes of Health [UL1 RR 025758]; Harvard University; Massachusetts General Hospital, Department of Neurosurgery; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; Massachusetts General Hospital, Department of Neurosurgery; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was conducted with support from Harvard Catalyst | The Harvard Clinical and Translational Science Center (National Institutes of Health Award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health. Additional research support was provided using departmental research funds from the Massachusetts General Hospital, Department of Neurosurgery. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleccia J, 2009, AIR AMBULANCES LEAVE; Arfken CL, 1998, J TRAUMA, V45, P785, DOI 10.1097/00005373-199810000-00031; Ashkenazi I, 2007, EMERG MED J, V24, P550, DOI 10.1136/emj.2006.044461; BABU MA, 2011, NEUROSURGERY; Bershad EM, 2008, NEUROCRIT CARE, V9, P287, DOI 10.1007/s12028-008-9051-5; Bledsoe Bryan E, 2003, Prehosp Emerg Care, V7, P94, DOI 10.1080/10903120390937175; Brazier J, 1996, J Health Serv Res Policy, V1, P232; BRICOLO AP, 1984, NEUROSURGERY, V14, P8, DOI 10.1227/00006123-198401000-00003; Brown JB, 2011, J TRAUMA, V70, P310, DOI 10.1097/TA.0b013e3182032b4f; Carlson AP, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.8.FOCUS10182; Chappell VL, 2002, J TRAUMA, V52, P486, DOI 10.1097/00005373-200203000-00012; DELZOPPO GJ, STROKE, V40, P2945; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Grunwald IQ, 2011, AM J NEURORADIOL, V32, P238, DOI 10.3174/ajnr.A2346; Hoh BL, 2010, STROKE, V41, P337, DOI 10.1161/STROKEAHA.109.569269; Koval KJ, 2006, J BONE JOINT SURG AM, V88A, P2124, DOI 10.2106/JBJS.F.00245; Lawton MT, 2005, NEUROSURGERY, V57, P9, DOI 10.1227/01.NEU.0000163082.20941.EF; Marler JR, 2000, NEUROLOGY, V55, P1649, DOI 10.1212/WNL.55.11.1649; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; Nogueira RG, 2009, CURR TREAT OPTION NE, V11, P433, DOI 10.1007/s11940-009-0047-z; POON WS, 1991, INJURY, V22, P323, DOI 10.1016/0020-1383(91)90016-8; Qureshi AI, 2010, ARCH NEUROL-CHICAGO, V67, P570, DOI 10.1001/archneurol.2010.61; Rost NS, 2008, STROKE, V39, P2304, DOI 10.1161/STROKEAHA.107.512202; Samuels O, 2011, NEUROCRIT CARE, V14, P334, DOI 10.1007/s12028-011-9505-z; Sasser Scott M., 2009, Morbidity and Mortality Weekly Report, V58, P1; Southard PA, 2005, ACAD EMERG MED, V12, P653, DOI 10.1197/j.aem.2005.03.515; Spain DA, 2007, J TRAUMA, V62, P63, DOI 10.1097/TA.0b013e31802d9716; Svenson James E, 2006, Air Med J, V25, P170, DOI 10.1016/j.amj.2006.04.003; Taylor CB, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2009.09.030; Vuori J, 2010, INT J CIRCUMPOL HEAL, V69, P512, DOI 10.3402/ijch.v69i5.17694; Wester K, 1999, NEUROSURGERY, V44, P495, DOI 10.1097/00006123-199903000-00034	31	19	19	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26216	10.1371/journal.pone.0026216	http://dx.doi.org/10.1371/journal.pone.0026216			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022572	gold, Green Submitted, Green Published			2022-12-27	WOS:000295976000089
J	Doonan, RJ; Scheffler, P; Yu, A; Egiziano, G; Mutter, A; Bacon, S; Carli, F; Daskalopoulos, ME; Daskalopoulou, SS				Doonan, Robert J.; Scheffler, Patrick; Yu, Alice; Egiziano, Giordano; Mutter, Andrew; Bacon, Simon; Carli, Franco; Daskalopoulos, Marios E.; Daskalopoulou, Stella S.			Altered Arterial Stiffness and Subendocardial Viability Ratio in Young Healthy Light Smokers after Acute Exercise	PLOS ONE			English	Article							CENTRAL BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; PULSE PRESSURE; PLASMA ENDOTHELIN-1; RESPIRATORY CHANGES; CIGARETTE-SMOKING; PASSIVE SMOKING; AORTIC PRESSURE; NITRIC-OXIDE; AUGMENTATION	Background: Studies showed that long-standing smokers have stiffer arteries at rest. However, the effect of smoking on the ability of the vascular system to respond to increased demands (physical stress) has not been studied. The purpose of this study was to estimate the effect of smoking on arterial stiffness and subendocardial viability ratio, at rest and after acute exercise in young healthy individuals. Methods/Results: Healthy light smokers (n = 24, pack-years = 2.9) and non-smokers (n = 53) underwent pulse wave analysis and carotid-femoral pulse wave velocity measurements at rest, and 2, 5, 10, and 15 minutes following an exercise test to exhaustion. Smokers were tested, 1) after 12h abstinence from smoking (chronic condition) and 2) immediately after smoking one cigarette (acute condition). At rest, chronic smokers had higher augmentation index and lower aortic pulse pressure than non-smokers, while subendocardial viability ratio was not significantly different. Acute smoking increased resting augmentation index and decreased subendocardial viability ratio compared with non-smokers, and decreased subendocardial viability ratio compared with the chronic condition. After exercise, subendocardial viability ratio was lower, and augmentation index and aortic pulse pressure were higher in non-smokers than smokers in the chronic and acute conditions. cfPWV rate of recovery of was greater in non-smokers than chronic smokers after exercise. Non-smokers were also able to achieve higher workloads than smokers in both conditions. Conclusion: Chronic and acute smoking appears to diminish the vascular response to physical stress. This can be seen as an impaired 'vascular reserve' or a blunted ability of the blood vessels to accommodate the changes required to achieve higher workloads. These changes were noted before changes in arterial stiffness or subendocardial viability ratio occurred at rest. Even light smoking in young healthy individuals appears to have harmful effects on vascular function, affecting the ability of the vascular bed to respond to increased demands.	[Doonan, Robert J.; Scheffler, Patrick; Yu, Alice; Egiziano, Giordano; Mutter, Andrew; Daskalopoulou, Stella S.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Bacon, Simon] Concordia Univ, Dept Exercise Sci, Montreal, PQ, Canada; [Bacon, Simon] Hop Sacre Coeur, Montreal Behav Med Ctr, Montreal, PQ H4J 1C5, Canada; [Bacon, Simon] Montreal Heart Inst, Res Ctr, Montreal, PQ H1T 1C8, Canada; [Carli, Franco] McGill Univ, Fac Med, Dept Anesthesia, Montreal, PQ, Canada; [Daskalopoulos, Marios E.] Univ Athens, Dept Vasc Surg, Athens, Greece	McGill University; Concordia University - Canada; Universite de Montreal; Universite de Montreal; McGill University; National & Kapodistrian University of Athens	Doonan, RJ (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	stella.daskalopoulou@mcgill.ca	Bacon, Simon/B-2637-2012; Santana, Fábio/C-8745-2012; Stefanadis, Christodoulos/ABH-2232-2020	Bacon, Simon/0000-0001-7075-0358; Stefanadis, Christodoulos/0000-0001-5974-6454	Canadian Institutes of Health Research [102626]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This study was funded by a grant from the Canadian Institutes of Health Research grant number 102626 (cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliverti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005550; Argacha JF, 2008, HYPERTENSION, V51, P1506, DOI 10.1161/HYPERTENSIONAHA.107.104059; Arnett DK, 2005, J HYPERTENS, V23, P1141, DOI 10.1097/01.hjh.0000170376.23461.f7; Astrand PO, 2003, TXB WORK PHYSL PHYSL, V4th; Bartal M, 2001, Monaldi Arch Chest Dis, V56, P545; Bernstein RD, 1996, CIRC RES, V79, P840, DOI 10.1161/01.RES.79.4.840; Brooks B, 1999, DIABETES CARE, V22, P1722, DOI 10.2337/diacare.22.10.1722; Brooks BA, 2001, DIABETIC MED, V18, P374, DOI 10.1046/j.1464-5491.2001.00479.x; Cacciola RR, 2007, CURR MED CHEM, V14, P1887; Campbell R, 2011, J HUM HYPERTENS, V25, P262, DOI 10.1038/jhh.2010.53; CELERMAJER DS, 1993, CIRCULATION, V88, P2149, DOI 10.1161/01.CIR.88.5.2149; Celermajer DS, 1996, NEW ENGL J MED, V334, P150, DOI 10.1056/NEJM199601183340303; Center for Disease Control, 2011, VIT SIGN CURR CIG SM, P1135; Chemla D, 2008, CLIN EXP PHARMACOL P, V35, P909, DOI 10.1111/j.1440-1681.2008.04927.x; Chen CH, 1997, CIRCULATION, V95, P1827; Crilly M, 2007, BLOOD PRESSURE, V16, P262, DOI 10.1080/08037050701464385; Cruickshank JK, 2009, HYPERTENSION, V53, P602, DOI 10.1161/HYPERTENSIONAHA.108.128033; Doonan RJ, 2010, HYPERTENS RES, V33, P398, DOI 10.1038/hr.2010.25; Esen AM, 2004, CIRC J, V68, P1123, DOI 10.1253/circj.68.1123; Fairclough DL, 1997, STAT MED, V16, P1197, DOI 10.1002/(SICI)1097-0258(19970615)16:11<1197::AID-SIM531>3.3.CO;2-0; Gibbs CR, 2001, CLIN CARDIOL, V24, P724, DOI 10.1002/clc.4960241107; *HLTH CAN, 2008, CAN TOB US MON SURV; Holland DJ, 2008, AM J HYPERTENS, V21, P1100, DOI 10.1038/ajh.2008.253; Husten CG, 2009, NICOTINE TOB RES, V11, P111, DOI 10.1093/ntr/ntp010; KARAMANOGLU M, 1993, EUR HEART J, V14, P160, DOI 10.1093/eurheartj/14.2.160; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Maeda S, 2002, CIRCULATION, V106, P2188, DOI 10.1161/01.CIR.0000038362.16740.A2; Maeda S, 1996, LIFE SCI, V58, P1259, DOI 10.1016/0024-3205(96)00087-2; MAEDA S, 1994, J APPL PHYSIOL, V77, P1399, DOI 10.1152/jappl.1994.77.3.1399; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; McAllister RM, 1998, MED SCI SPORT EXER, V30, P375, DOI 10.1097/00005768-199803000-00006; Merkus D, 2003, CARDIOVASC RES, V59, P745, DOI 10.1016/S0008-6363(03)00479-6; Michard F, 1999, AM J RESP CRIT CARE, V159, P935, DOI 10.1164/ajrccm.159.3.9805077; Michard F, 2000, AM J RESP CRIT CARE, V162, P134, DOI 10.1164/ajrccm.162.1.9903035; Mitchell GF, 2010, CIRCULATION, V121, P505, DOI 10.1161/CIRCULATIONAHA.109.886655; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Montgomery HE, 1996, ARTERIOSCL THROM VAS, V16, P386, DOI 10.1161/01.ATV.16.3.386; Moore D., 2006, INTRO PRACTICE STAT; O'Rourke M, 1999, J AM COLL CARDIOL, V34, P951; Pauca AL, 2001, HYPERTENSION, V38, P932, DOI 10.1161/hy1001.096106; Physicians for a Smoke-Free Canada, 2010, PHYS SMOKE FREE CANA; Prince CT, 2010, ATHEROSCLEROSIS, V213, P469, DOI 10.1016/j.atherosclerosis.2010.08.080; Prince CT, 2010, DIABETES VASC DIS RE, V7, P216, DOI 10.1177/1479164110375297; Prince CT, 2010, DIABETES CARE, V33, P652, DOI 10.2337/dc09-1936; Rabi DM, 2011, CAN J CARDIOL, V27, P415, DOI 10.1016/j.cjca.2011.03.015; Rahman MM, 2007, CURR VASC PHARMACOL, V5, P276, DOI 10.2174/157016107782023406; Sharman JE, 2007, J HYPERTENS, V25, P1249, DOI 10.1097/HJH.0b013e3280be5911; Sharman JE, 2006, HYPERTENSION, V47, P1203, DOI 10.1161/01.HYP.0000223013.60612.72; Tsiachris D, 2011, J HUM HYPERTENS; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Weber T, 2005, EUR HEART J, V26, P2657, DOI 10.1093/eurheartj/ehi504; Wilkinson IB, 1998, J HYPERTENS, V16, P2079, DOI 10.1097/00004872-199816121-00033	53	37	37	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26151	10.1371/journal.pone.0026151	http://dx.doi.org/10.1371/journal.pone.0026151			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028821	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000295971700044
J	Haeussinger, FB; Heinzel, S; Hahn, T; Schecklmann, M; Ehlis, AC; Fallgatter, AJ				Haeussinger, Florian B.; Heinzel, Sebastian; Hahn, Tim; Schecklmann, Martin; Ehlis, Ann-Christine; Fallgatter, Andreas J.			Simulation of Near-Infrared Light Absorption Considering Individual Head and Prefrontal Cortex Anatomy: Implications for Optical Neuroimaging	PLOS ONE			English	Article							BEER-LAMBERT LAW; ADULT HEAD; HUMAN BRAIN; SPECTROSCOPY FNIRS; PHOTON MIGRATION; PROPAGATION; SCATTERING; MODEL; TISSUES; MEDIA	Functional near-infrared spectroscopy (fNIRS) is an established optical neuroimaging method for measuring functional hemodynamic responses to infer neural activation. However, the impact of individual anatomy on the sensitivity of fNIRS measuring hemodynamics within cortical gray matter is still unknown. By means of Monte Carlo simulations and structural MRI of 23 healthy subjects (mean age: (25.0 +/- 2.8) years), we characterized the individual distribution of tissue-specific NIR-light absorption underneath 24 prefrontal fNIRS channels. We, thereby, investigated the impact of scalp-cortex distance (SCD), frontal sinus volume as well as sulcal morphology on gray matter volumes (V-gray) traversed by NIR-light, i.e. anatomy-dependent fNIRS sensitivity. The NIR-light absorption between optodes was distributed describing a rotational ellipsoid with a mean penetration depth of (23.6 +/- 0.7) mm considering the deepest 5% of light. Of the detected photon packages scalp and bone absorbed (96.4 +/- 9: 7)% and V-gray absorbed (3.1 +/- 1.8)% of the energy. The mean V-gray volume (1.1 +/- 0.4)cm(3) was negatively correlated (r = - .76) with the SCD and frontal sinus volume (r = - .57) and was reduced by 41.5% in subjects with relatively large compared to small frontal sinus. Head circumference was significantly positively correlated with the mean SCD (r = .46) and the traversed frontal sinus volume (r = .43). Sulcal morphology had no significant impact on V-gray. Our findings suggest to consider individual SCD and frontal sinus volume as anatomical factors impacting fNIRS sensitivity. Head circumference may represent a practical measure to partly control for these sources of error variance.	[Haeussinger, Florian B.; Heinzel, Sebastian; Ehlis, Ann-Christine; Fallgatter, Andreas J.] Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany; [Heinzel, Sebastian; Hahn, Tim] Univ Wurzburg, Dept Psychiat Psychosomat & Psychotherapy, Wurzburg, Germany; [Heinzel, Sebastian] German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Hahn, Tim] Goethe Univ Frankfurt, Dept Cognit Psychol 2, Frankfurt, Germany; [Schecklmann, Martin] Univ Regensburg, Dept Psychiat & Psychotherapy, Regensburg, Germany	Eberhard Karls University of Tubingen; University of Wurzburg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Goethe University Frankfurt; University of Regensburg	Haeussinger, FB (corresponding author), Univ Tubingen, Dept Psychiat & Psychotherapy, Tubingen, Germany.	Sebastian.Heinzel@med.uni-tuebingen.de	Heinzel, Sebastian/AFK-4188-2022; Hahn, Tim/C-7045-2011; Hahn, Tim/N-7250-2013	Hahn, Tim/0000-0002-1177-3346; Hahn, Tim/0000-0002-8929-4134; Heinzel, Sebastian/0000-0003-4516-0529; Ehlis, Ann-Christine/0000-0002-8142-9743				Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Binzoni T, 2006, PHYS MED BIOL, V51, pN313, DOI 10.1088/0031-9155/51/17/N04; Boas DA, 2002, OPT EXPRESS, V10, P159, DOI 10.1364/OE.10.000159; Brooks JO, 2009, PSYCHIAT RES-NEUROIM, V172, P200, DOI 10.1016/j.pscychresns.2008.06.007; CHANCE B, 1988, P NATL ACAD SCI USA, V85, P4971, DOI 10.1073/pnas.85.14.4971; CHEONG WF, 1990, IEEE J QUANTUM ELECT, V26, P2166, DOI 10.1109/3.64354; COPE M, 1988, MED BIOL ENG COMPUT, V26, P289, DOI 10.1007/BF02447083; CRIPPA PR, 1978, BIOCHIM BIOPHYS ACTA, V538, P164, DOI 10.1016/0304-4165(78)90260-X; Cui X, 2011, NEUROIMAGE, V54, P2808, DOI 10.1016/j.neuroimage.2010.10.069; Cyranoski D, 2011, NATURE, V469, P148, DOI 10.1038/469148a; Fukui Y, 2003, APPL OPTICS, V42, P2881, DOI 10.1364/AO.42.002881; Henyey L. G., 1940, ANN ASTROPHYS, V3, P117; Kawaguchi H, 2007, APPL OPTICS, V46, P1658, DOI 10.1364/AO.46.001658; Kim S, 2005, ETRI J, V27, P377, DOI 10.4218/etrij.05.0104.0056; Koyama T, 2005, APPL OPTICS, V44, P2094, DOI 10.1364/AO.44.002094; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lee CK, 2005, OPT EXPRESS, V13, P8339, DOI 10.1364/OPEX.13.008339; Linden DEJ, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.049.2009; Lorenzetti V, 2009, J AFFECT DISORDERS, V117, P1, DOI 10.1016/j.jad.2008.11.021; Minagawa-Kawai Y, 2009, CEREB CORTEX, V19, P284, DOI 10.1093/cercor/bhn081; Nenadic I, 2010, NEUROIMAGE, V49, P1153, DOI 10.1016/j.neuroimage.2009.10.014; Okada E, 2003, APPL OPTICS, V42, P2915, DOI 10.1364/AO.42.002915; Okada E, 2003, APPL OPTICS, V42, P2906, DOI 10.1364/AO.42.002906; Okada E, 1997, APPL OPTICS, V36, P21, DOI 10.1364/AO.36.000021; Okada E, 2010, ADV EXP MED BIOL, V662, P231, DOI 10.1007/978-1-4419-1241-1_33; Park IH, 2010, INT J PEDIATR OTORHI, V74, P1347, DOI 10.1016/j.ijporl.2010.08.018; Pawley J, 2006, HDB BIOL CONFOCAL MI; Pirner S, 2009, EUR ARCH OTO-RHINO-L, V266, P507, DOI 10.1007/s00405-008-0777-7; Plichta MM, 2007, HUM BRAIN MAPP, V28, P733, DOI 10.1002/hbm.20303; Plichta MM, 2006, NEUROIMAGE, V31, P116, DOI 10.1016/j.neuroimage.2005.12.008; Reynolds MD, 1999, NEUROLOGY, V53, P228, DOI 10.1212/WNL.53.1.228; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; Sassaroli A, 2004, PHYS MED BIOL, V49, pN255, DOI 10.1088/0031-9155/49/14/N07; Schecklmann M, 2008, NEUROIMAGE, V43, P147, DOI 10.1016/j.neuroimage.2008.06.032; TEARNEY GJ, 1995, OPT LETT, V20, P2258, DOI 10.1364/OL.20.002258; Toronov V, 2010, NEUROIMAGE, V34, P1136; Tsuchiya Y, 2001, PHYS MED BIOL, V46, P2067, DOI 10.1088/0031-9155/46/8/303; Van der Zee P, 1987, Adv Exp Med Biol, V215, P179; VANDERZEE P, 1990, ADV EXP MED BIOL, V277, P79; Villringer A, 1997, TRENDS NEUROSCI, V20, P435, DOI 10.1016/S0166-2236(97)01132-6; WANG LH, 1995, COMPUT METH PROG BIO, V47, P131, DOI 10.1016/0169-2607(95)01640-F; Yaroslavsky AN, 2002, PHYS MED BIOL, V47, P2059, DOI 10.1088/0031-9155/47/12/305; Zhang XF, 2005, OPT EXPRESS, V13, P5513, DOI 10.1364/OPEX.13.005513	43	165	166	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26377	10.1371/journal.pone.0026377	http://dx.doi.org/10.1371/journal.pone.0026377			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039475	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200017
J	van Beilen, M; de Jong, BM; Gieteling, EW; Renken, R; Leenders, KL				van Beilen, Marije; de Jong, Bauke M.; Gieteling, Esther W.; Renken, Remco; Leenders, Klaus L.			Abnormal Parietal Function in Conversion Paresis	PLOS ONE			English	Article							PREFRONTAL CORTEX; BRAIN ACTIVATION; MOTOR IMAGERY; PARALYSIS; DISORDER; MECHANISMS; MOVEMENT; SYMPTOMS; PAIN; CONNECTIVITY	The etiology of medically unexplained symptoms such as conversion disorder is poorly understood. This is partly because the interpretation of neuroimaging results in conversion paresis has been complicated by the use of different control groups, tasks and statistical comparisons. The present study includes these different aspects in a single data set. In our study we included both normal controls and feigners to control for conversion paresis. We studied both movement execution and imagery, and we contrasted both within-group and between-group activation. Moreover, to reveal hemisphere-specific effects that have not been reported before, we performed these analyses using both flipped and unflipped data. This approach resulted in the identification of abnormal parietal activation which was specific for conversion paresis patients. Patients also showed reduced activity in the prefrontal cortex, supramarginal gyrus and precuneus, including hemisphere-specific activation that is lateralized in the same hemisphere, regardless of right-or left-sided paresis. We propose that these regions are candidates for an interface between psychological mechanisms and disturbed higher-order motor control. Our study presents an integrative neurophysiological view of the mechanisms that contribute to the etiology of this puzzling psychological disorder, which can be further investigated with other types of conversion symptoms.	[van Beilen, Marije; de Jong, Bauke M.; Gieteling, Esther W.; Leenders, Klaus L.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [van Beilen, Marije; de Jong, Bauke M.; Gieteling, Esther W.; Renken, Remco; Leenders, Klaus L.] Univ Groningen, Univ Med Ctr Groningen, BCN NeuroImaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen	van Beilen, M (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands.	m.van.beilen@neuro.umcg.nl	van Beilen, Marije/A-7435-2011	Renken, Remco Jan/0000-0002-7777-9484; de Jong, Bauke M./0000-0002-6568-5739	University Medical Centre Groningen, University of Groningen	University Medical Centre Groningen, University of Groningen	This study was funded by the University Medical Centre Groningen, University of Groningen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beudel M, 2009, CEREB CORTEX, V19, P2361, DOI 10.1093/cercor/bhn254; Binkofski F, 1998, NEUROLOGY, V50, P1253, DOI 10.1212/WNL.50.5.1253; Bluhm RL, 2009, J PSYCHIATR NEUROSCI, V34, P187; Brown RJ, 2004, PSYCHOL BULL, V130, P793, DOI 10.1037/0033-2909.130.5.793; Burgmer M, 2006, NEUROIMAGE, V29, P1336, DOI 10.1016/j.neuroimage.2005.08.033; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cojan Y, 2009, NEURON, V62, P862, DOI 10.1016/j.neuron.2009.05.021; Cojan Y, 2009, NEUROIMAGE, V47, P1026, DOI 10.1016/j.neuroimage.2009.05.023; de Jong BM, 2001, NEUROIMAGE, V14, P1128, DOI 10.1006/nimg.2001.0911; de Jong BM, 1999, COGNITIVE BRAIN RES, V8, P45, DOI 10.1016/S0926-6410(99)00005-1; de Lange FP, 2008, CORTEX, V44, P494, DOI 10.1016/j.cortex.2007.09.002; de Lange FP, 2007, NEUROPSYCHOLOGIA, V45, P2051, DOI 10.1016/j.neuropsychologia.2007.02.002; de Lange FP, 2010, NEUROPSYCHOLOGIA, V48, P1782, DOI 10.1016/j.neuropsychologia.2010.02.029; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Elsinger CL, 2006, NEUROIMAGE, V31, P1177, DOI 10.1016/j.neuroimage.2006.01.041; FREUD S, 1909, STUDIES HYSTERIA SEL; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; FRITH CD, 1991, P ROY SOC B-BIOL SCI, V244, P241, DOI 10.1098/rspb.1991.0077; GEORGOPOULOS AP, 1991, ANNU REV NEUROSCI, V14, P361, DOI 10.1146/annurev.ne.14.030191.002045; Ghaffar O, 2006, NEUROLOGY, V67, P2036, DOI 10.1212/01.wnl.0000247275.68402.fc; Gieteling EW, 2008, PAIN, V134, P302, DOI 10.1016/j.pain.2007.04.029; Janet P, 1907, MAJOR SYMPTOMS HYSTE, DOI 10.1037/10008-000; Mailis-Gagnon A, 2003, NEUROLOGY, V60, P1501, DOI 10.1212/WNL.60.9.1501; Maquet P, 1999, BIOL PSYCHIAT, V45, P327, DOI 10.1016/S0006-3223(97)00546-5; Marshall JC, 1997, COGNITION, V64, pB1, DOI 10.1016/S0010-0277(97)00020-6; Nahab FB, 2011, CEREB CORTEX, V21, P48, DOI 10.1093/cercor/bhq059; Oakley D A, 1999, Cogn Neuropsychiatry, V4, P243, DOI 10.1080/135468099395954; Passingham RE., 1993, FRONTAL LOBES VOLUNT; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Rainville P, 1999, J COGNITIVE NEUROSCI, V11, P110, DOI 10.1162/089892999563175; Rizzolatti Giacomo, 2006, Novartis Found Symp, V270, P129; Roberts R, 2008, J SPORT EXERCISE PSY, V30, P200, DOI 10.1123/jsep.30.2.200; Roelofs K, 2006, BIOL PSYCHOL, V71, P316, DOI 10.1016/j.biopsycho.2005.07.002; Roelofs K, 2005, J NERV MENT DIS, V193, P508, DOI 10.1097/01.nmd.0000172472.60197.4d; SAKATA H, 1995, CEREB CORTEX, V5, P429, DOI 10.1093/cercor/5.5.429; Scott RL, 2009, MOTOR CONTROL, V13, P161, DOI 10.1123/mcj.13.2.161; Spence SA, 2000, LANCET, V355, P1243, DOI 10.1016/S0140-6736(00)02096-1; Stone J, 2007, PSYCHOSOM MED, V69, P961, DOI 10.1097/PSY.0b013e31815b6c14; Tanji J, 1996, CURR OPIN NEUROBIOL, V6, P782, DOI 10.1016/S0959-4388(96)80028-6; TIIHONEN J, 1995, BIOL PSYCHIAT, V37, P134, DOI 10.1016/0006-3223(94)00230-Z; van Beilen M, 2009, EUR J NEUROL, V16, P1118, DOI 10.1111/j.1468-1331.2009.02655.x; van Beilen M, 2009, MOVEMENT DISORD, V24, P922, DOI 10.1002/mds.22428; Van Strien J. W., 1992, NEDERLANDS TIJDSCHRI, V47, P88; VANBEILEN N, 2009, J NEUROL SCI, P1878; VANDERHOEVEN R, 2011, PERSONALITY DI UNPUB; Vogt B. A., 2009, CINGULATE NEUROBIOLO; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Voon V, 2010, NEUROLOGY, V74, P223, DOI 10.1212/WNL.0b013e3181ca00e9; Vuilleumier P, 2001, BRAIN, V124, P1077, DOI 10.1093/brain/124.6.1077; Ward N S, 2003, Cogn Neuropsychiatry, V8, P295, DOI 10.1080/13546800344000200; Werring DJ, 2004, PSYCHOL MED, V34, P583, DOI 10.1017/S0033291703008985	51	37	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e25918	10.1371/journal.pone.0025918	http://dx.doi.org/10.1371/journal.pone.0025918			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039428	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200004
J	Kolodziej, LE; Lodolce, JP; Chang, JE; Schneider, JR; Grimm, WA; Bartulis, SJ; Zhu, XR; Messer, JS; Murphy, SF; Reddy, N; Turner, JR; Boone, DL				Kolodziej, Lauren E.; Lodolce, James P.; Chang, Jonathan E.; Schneider, Jeffrey R.; Grimm, Wesley A.; Bartulis, Sarah J.; Zhu, Xiaorong; Messer, Jeannette S.; Murphy, Stephen F.; Reddy, Nishith; Turner, Jerrold R.; Boone, David L.			TNFAIP3 Maintains Intestinal Barrier Function and Supports Epithelial Cell Tight Junctions	PLOS ONE			English	Article							NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; MOLECULAR-BASIS; CROHNS-DISEASE; ENZYME A20; PERMEABILITY; ACTIVATION; PROTEIN; LIPOPOLYSACCHARIDE; UBIQUITINATION	Tight junctions between intestinal epithelial cells mediate the permeability of the intestinal barrier, and loss of intestinal barrier function mediated by TNF signaling is associated with the inflammatory pathophysiology observed in Crohn's disease and celiac disease. Thus, factors that modulate intestinal epithelial cell response to TNF may be critical for the maintenance of barrier function. TNF alpha-induced protein 3 (TNFAIP3) is a cytosolic protein that acts in a negative feedback loop to regulate cell signaling induced by Toll-like receptor ligands and TNF, suggesting that TNFAIP3 may play a role in regulating the intestinal barrier. To investigate the specific role of TNFAIP3 in intestinal barrier function we assessed barrier permeability in TNFAIP3(-/-) mice and LPS-treated villin-TNFAIP3 transgenic mice. TNFAIP3(-/-) mice had greater intestinal permeability compared to wild-type littermates, while villin-TNFAIP3 transgenic mice were protected from increases in permeability seen within LPS-treated wild-type littermates, indicating that barrier permeability is controlled by TNFAIP3. In cultured human intestinal epithelial cell lines, TNFAIP3 expression regulated both TNF-induced and myosin light chain kinase-regulated tight junction dynamics but did not affect myosin light chain kinase activity. Immunohistochemistry of mouse intestine revealed that TNFAIP3 expression inhibits LPS-induced loss of the tight junction protein occludin from the apical border of the intestinal epithelium. We also found that TNFAIP3 deubiquitinates polyubiquitinated occludin. These in vivo and in vitro studies support the role of TNFAIP3 in promoting intestinal epithelial barrier integrity and demonstrate its novel ability to maintain intestinal homeostasis through tight junction protein regulation.	[Kolodziej, Lauren E.; Lodolce, James P.; Chang, Jonathan E.; Schneider, Jeffrey R.; Grimm, Wesley A.; Bartulis, Sarah J.; Zhu, Xiaorong; Messer, Jeannette S.; Murphy, Stephen F.; Boone, David L.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Reddy, Nishith] Illinois Math & Sci Acad, Aurora, IL USA; [Turner, Jerrold R.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Kolodziej, LE (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	dboone@medicine.bsd.uchicago.edu	Turner, Jerrold/H-1502-2019	Messer, Jeannette/0000-0002-5072-3835	Gastrointestinal Research Foundation (GIRF); GIRF Associates Board; Crohn's and Colitis Foundation of America; National Institute of Allergy and Infectious Diseases [1F32AI077235-01A1]; National Institute of Diabetes and Digestive and Kidney Diseases [5R01DK061931-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI077235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061931] Funding Source: NIH RePORTER	Gastrointestinal Research Foundation (GIRF); GIRF Associates Board; Crohn's and Colitis Foundation of America; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This research was completed with support from the Gastrointestinal Research Foundation (GIRF) and the GIRF Associates Board (http://girf.org/); and by the Crohn's and Colitis Foundation of America (http://www.ccfa.org) to DB; and National Institute of Allergy and Infectious Diseases 1F32AI077235-01A1 to JPL and National Institute of Diabetes and Digestive and Kidney Diseases 5R01DK061931-10 to JRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arrieta MC, 2009, GUT, V58, P41, DOI 10.1136/gut.2008.150888; Arsenescu R, 2008, MUCOSAL IMMUNOL, V1, P399, DOI 10.1038/mi.2008.32; Beutler B, 1995, J CARDIOVASC PHARM, V25, pS1, DOI 10.1097/00005344-199500252-00002; Bishop BL, 2010, BIOCHEM BIOPH RES CO, V394, P254, DOI 10.1016/j.bbrc.2010.02.091; Blair SA, 2006, LAB INVEST, V86, P191, DOI 10.1038/labinvest.3700373; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; de Kort S, 2011, OBES REV, V12, P449, DOI 10.1111/j.1467-789X.2010.00845.x; DIXIT VM, 1990, J BIOL CHEM, V265, P2973; Ebert EC, 2011, J CLIN GASTROENTEROL, V45, P436, DOI 10.1097/MCG.0b013e31820f81b8; Ebert EC, 2011, DIGEST DIS SCI, V56, P295, DOI 10.1007/s10620-010-1508-7; Fujiya M, 2007, CELL HOST MICROBE, V1, P299, DOI 10.1016/j.chom.2007.05.004; Gerova VA, 2011, WORLD J GASTROENTERO, V17, P2211, DOI [10.3748/wjg.v17.i17.2211, 10.3748/wjg.v17.i17.]; Graham RR, 2008, NAT GENET, V40, P1059, DOI 10.1038/ng.200; HERMISTON ML, 1995, SCIENCE, V270, P1203, DOI 10.1126/science.270.5239.1203; Hollander D, 1999, Curr Gastroenterol Rep, V1, P410, DOI 10.1007/s11894-999-0023-5; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Hymowitz SG, 2010, NAT REV CANCER, V10, P332, DOI 10.1038/nrc2775; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kawanishi M, 2000, VIROLOGY, V270, P258, DOI 10.1006/viro.2000.0296; KRIKOS A, 1992, J BIOL CHEM, V267, P17971; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Lodolce JP, 2010, J IMMUNOL, V184, P7001, DOI 10.4049/jimmunol.1000324; Lui WY, 2005, J CELL PHYSIOL, V203, P564, DOI 10.1002/jcp.20254; Madsen KL, 1999, INFLAMM BOWEL DIS, V5, P262, DOI 10.1097/00054725-199911000-00004; Malynn BA, 2009, J EXP MED, V206, P977, DOI 10.1084/jem.20090765; Marchiando AM, 2010, J CELL BIOL, V189, P111, DOI 10.1083/jcb.200902153; Marchiando AM, 2010, ANNU REV PATHOL-MECH, V5, P119, DOI 10.1146/annurev.pathol.4.110807.092135; Matsumoto S, 1998, GUT, V43, P71, DOI 10.1136/gut.43.1.71; Meddings J, 2008, GUT, V57, P438, DOI 10.1136/gut.2007.143172; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698; Orozco G, 2009, HUM MOL GENET, V18, P2693, DOI 10.1093/hmg/ddp193; Oshima N, 2010, CLIN EXP IMMUNOL, V159, P185, DOI 10.1111/j.1365-2249.2009.04048.x; Owens SE, 2005, PHARM RES-DORDR, V22, P703, DOI 10.1007/s11095-005-2584-9; Plenge RM, 2007, NAT GENET, V39, P1477, DOI 10.1038/ng.2007.27; Roulis M, 2011, P NATL ACAD SCI USA, V108, P5396, DOI 10.1073/pnas.1007811108; Ruemmele FM, 2002, GUT, V51, P842, DOI 10.1136/gut.51.6.842; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schreiber S, 2005, NAT REV GENET, V6, P376, DOI 10.1038/nrg1607; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shen L, 2008, J CELL BIOL, V181, P683, DOI 10.1083/jcb.200711165; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Su LP, 2009, GASTROENTEROLOGY, V136, P551, DOI 10.1053/j.gastro.2008.10.081; SUNDBERG JP, 1994, GASTROENTEROLOGY, V107, P1726, DOI 10.1016/0016-5085(94)90813-3; Thomson W, 2007, NAT GENET, V39, P1431, DOI 10.1038/ng.2007.32; Traweger A, 2002, J BIOL CHEM, V277, P10201, DOI 10.1074/jbc.M111384200; Trynka G, 2009, GUT, V58, P1078, DOI 10.1136/gut.2008.169052; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; Vereecke L, 2010, J EXP MED, V207, P1513, DOI 10.1084/jem.20092474; Vereecke L, 2009, TRENDS IMMUNOL, V30, P383, DOI 10.1016/j.it.2009.05.007; Wang J, 2009, J IMMUNOL, V183, P1384, DOI 10.4049/jimmunol.0803987; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Welcker K, 2004, EUR J MED RES, V9, P456; Weng M, 2007, PEDIATR RES, V62, P542, DOI 10.1203/PDR.0b013e318155a422; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794	66	54	62	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26352	10.1371/journal.pone.0026352	http://dx.doi.org/10.1371/journal.pone.0026352			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031828	gold, Green Published, Green Submitted			2022-12-27	WOS:000296513200017
J	Vallejo, AN; Hamel, DL; Mueller, RG; Ives, DG; Michel, JJ; Boudreau, RM; Newman, AB				Vallejo, Abbe N.; Hamel, David L., Jr.; Mueller, Robert G.; Ives, Diane G.; Michel, Joshua J.; Boudreau, Robert M.; Newman, Anne B.			NK-Like T Cells and Plasma Cytokines, but Not Anti-Viral Serology, Define Immune Fingerprints of Resilience and Mild Disability in Exceptional Aging	PLOS ONE			English	Article							DWELLING OLDER-ADULTS; CARDIOVASCULAR HEALTH; COGNITIVE IMPAIRMENT; REPLICATIVE SENESCENCE; EXPRESSION; RECEPTORS; PHENOTYPE; PEOPLE; SPEED; DIFFERENTIATION	Exceptional aging has been defined as maintenance of physical and cognitive function beyond the median lifespan despite a history of diseases and/or concurrent subclinical conditions. Since immunity is vital to individual fitness, we examined immunologic fingerprint(s) of highly functional elders. Therefore, survivors of the Cardiovascular Health Study in Pittsburgh, Pennsylvania, USA were recruited (n = 140; mean age = 86 years) and underwent performance testing. Blood samples were collected and examined blindly for humoral factors and T cell phenotypes. Based on results of physical and cognitive performance testing, elders were classified as "impaired" or "unimpaired", accuracy of group assignment was verified by discriminant function analysis. The two groups showed distinct immune profiles as determined by factor analysis. The dominant immune signature of impaired elders consisted of interferon (IFN)-gamma, interleukin (IL)-6, tumor necrosis factor-a, and T cells expressing inhibitory natural killer-related receptors (NKR) CD158a, CD158e, and NKG2A. In contrast, the dominant signature of unimpaired elders consisted of IL-5, IL-12p70, and IL-13 with co-expression of IFN-gamma, IL-4, and IL-17, and T cells expressing stimulatory NKRs CD56, CD16, and NKG2D. In logistic regression models, unimpaired phenotype was predicted independently by IL-5 and by CD4(+)CD28(null)CD56(+)CD57(+) T cells. All elders had high antibody titers to common viruses including cytomegalovirus. In cellular bioassays, T cell receptor (TCR)-independent ligation of either CD56 or NKG2D elicited activation of T cells. Collectively, these data demonstrate the importance of immunological parameters in distinguishing between health phenotypes of older adults. NKR+ T cells and cytokine upregulation indicate a unique physiologic environment in old age. Correlation of particular NKR+ T cell subsets and IL-5 with unimpaired performance, and NKR-driven TCR-independent activation of T cells suggest novel immunopathway(s) that could be exploited to improve immunity in old age.	[Vallejo, Abbe N.; Hamel, David L., Jr.; Mueller, Robert G.; Michel, Joshua J.] Univ Pittsburgh, Sch Med, Dept Pediat, Childrens Hosp Pittsburgh,Med Ctr, Pittsburgh, PA 15261 USA; [Vallejo, Abbe N.] Univ Pittsburgh, Dept Immunol, Inst Canc, Pittsburgh, PA USA; [Vallejo, Abbe N.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Vallejo, Abbe N.; Hamel, David L., Jr.; Newman, Anne B.] Univ Pittsburgh, Sch Med, Med Student Training Aging Res Program, Div Geriatr Med, Pittsburgh, PA USA; [Ives, Diane G.; Boudreau, Robert M.; Newman, Anne B.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Epidemiol, Ctr Aging & Populat Hlth, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vallejo, AN (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Childrens Hosp Pittsburgh,Med Ctr, Pittsburgh, PA 15261 USA.	andv26@pitt.edu	Newman, Anne B./C-6408-2013	Newman, Anne B./0000-0002-0106-1150; Boudreau, Robert/0000-0003-0162-5187	United States National Institutes of Health (NIH) [R01 AG030734, R01 AG022379S1, R01 AG023629]; center of excellence [P30 AG024827]; NIH [N01 HC85239, N01 HC85079, HC85086, N01 HC35129, N01 HC15103, N01 HC55222, N01 HC75150, N01 HC45133];  [T35 AG026778];  [U01 HL080295]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC085079, N01HC075150, N01HC035129, N01HC015103, N01HC045133] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL080295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG024827, R01AG030734, R01AG023629, T35AG026778, R01AG022379] Funding Source: NIH RePORTER	United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); center of excellence; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the United States National Institutes of Health (NIH) through investigator-initiated research grants R01 AG030734, R01 AG022379S1, and R01 AG023629, center of excellence grant P30 AG024827, and training grant T35 AG026778. The cohort of the Cardiovascular Health Study from which participants were recruited into this study was supported by NIH contracts N01 HC85239, N01 HC85079 through HC85086, N01 HC35129, N01 HC15103, N01 HC55222, N01 HC75150, and N01 HC45133, and by U01 HL080295. Neither the NIH nor the United States Federal Government had any role in the design and conduct of this study. Views expressed in this publication are those by the authors, and are neither those by nor constitute endorsement by the NIH or the United States Federal Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin S, 2005, EXP GERONTOL, V40, P537, DOI 10.1016/j.exger.2005.04.012; Agrawal A, 2011, AGEING RES REV, V10, P336, DOI 10.1016/j.arr.2010.06.004; Anfossi N, 2004, J IMMUNOL, V173, P7223, DOI 10.4049/jimmunol.173.12.7223; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Auyeung TW, 2008, NEUROEPIDEMIOLOGY, V31, P167, DOI 10.1159/000154929; Barnes DE, 2006, ARCH GEN PSYCHIAT, V63, P273, DOI 10.1001/archpsyc.63.3.273; Bate SL, 2010, CLIN INFECT DIS, V50, P1439, DOI 10.1086/652438; Bernabei P, 2001, J LEUKOCYTE BIOL, V70, P950; Bernstein E, 1999, VACCINE, V17, P82, DOI 10.1016/S0264-410X(98)00117-0; Brach JS, 2007, J GERONTOL A-BIOL, V62, P983, DOI 10.1093/gerona/62.9.983; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; Cooper MA, 2001, TRENDS IMMUNOL, V22, P633, DOI 10.1016/S1471-4906(01)02060-9; Covinsky KE, 2006, MED CARE, V44, P149, DOI 10.1097/01.mlr.0000196955.99704.64; de Magalhaes JP, 2005, PHYSIOLOGY, V20, P252, DOI 10.1152/physiol.00010.2005; Deschenes MR, 2011, CURR AGING IN PRESS; Erickson KI, 2010, NEUROLOGY, V75, P1415, DOI 10.1212/WNL.0b013e3181f88359; ETTINGER WH, 1994, J AM GERIATR SOC, V42, P1035, DOI 10.1111/j.1532-5415.1994.tb06206.x; Frasca D, 2011, AGEING RES REV, V10, P330, DOI 10.1016/j.arr.2010.08.004; Fried Linda P., 1991, Annals of Epidemiology, V1, P263; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Gire W, 2004, EMBO J, V23, P2554, DOI 10.1038/sj.emboj.7600259; Gonzalez S, 2008, TRENDS IMMUNOL, V29, P397, DOI 10.1016/j.it.2008.04.007; Ives Diane G., 1995, Annals of Epidemiology, V5, P278, DOI 10.1016/1047-2797(94)00093-9; Krabbe KS, 2004, EXP GERONTOL, V39, P687, DOI 10.1016/j.exger.2004.01.009; Larbi A, 2011, AGEING RES REV, V10, P370, DOI 10.1016/j.arr.2010.09.008; Lemster BH, 2008, J IMMUNOL, V180, P1979, DOI 10.4049/jimmunol.180.3.1979; Leng SX, 2011, EXP GERONTOL, V46, P679, DOI 10.1016/j.exger.2011.04.002; Naumov YN, 2011, J IMMUNOL, V186, P6617, DOI 10.4049/jimmunol.1100091; NCHS, 2010, HLTH US 2009 SPEC FE; Newman Anne B, 2004, Am J Geriatr Cardiol, V13, P59, DOI 10.1111/j.1076-7460.2004.02126.x; Newman AB, 2009, J AM GERIATR SOC, V57, P432, DOI 10.1111/j.1532-5415.2008.02152.x; Novelli F, 2004, CYTOKINE GROWTH F R, V15, P367, DOI 10.1016/j.cytogfr.2004.03.009; Ozaki K, 2002, J BIOL CHEM, V277, P29355, DOI 10.1074/jbc.R200003200; Pawelec G, 2005, IMMUNOL REV, V205, P257, DOI 10.1111/j.0105-2896.2005.00271.x; Peralbo E, 2007, EXP GERONTOL, V42, P703, DOI 10.1016/j.exger.2007.05.002; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Ridda I, 2009, VACCINE, V27, P1628, DOI 10.1016/j.vaccine.2008.11.098; Rosano C, 2010, J GERONTOL A-BIOL, V65, P639, DOI 10.1093/gerona/glq038; Schwaiger S, 2003, J IMMUNOL, V170, P613, DOI 10.4049/jimmunol.170.1.613; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Singh T, 2011, AGEING RES REV, V10, P319, DOI 10.1016/j.arr.2010.11.002; Snyder MR, 2002, J IMMUNOL, V168, P3839, DOI 10.4049/jimmunol.168.8.3839; Soumare A, 2009, J GERONTOL A-BIOL, V64, P1058, DOI 10.1093/gerona/glp077; Strotmeyer ES, 2010, J AM GERIATR SOC, V58, P696, DOI 10.1111/j.1532-5415.2010.02770.x; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Tell G S, 1993, Ann Epidemiol, V3, P358, DOI 10.1016/1047-2797(93)90062-9; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Thomas DM, 2003, CANCER BIOL THER, V2, P124, DOI 10.4161/cbt.2.2.235; Vallejo AN, 2007, TRENDS MOL MED, V13, P94, DOI 10.1016/j.molmed.2007.01.005; Vallejo AN, 2011, AGEING RES REV, V10, P354, DOI 10.1016/j.arr.2010.09.006; Vallejo AN, 2005, IMMUNOL REV, V205, P158, DOI 10.1111/j.0105-2896.2005.00256.x; Vallejo AN, 1999, J IMMUNOL, V162, P6572; van Bergen J, 2004, J IMMUNOL, V173, P6719, DOI 10.4049/jimmunol.173.11.6719; van Bergen J, 2010, IMMUNOLOGY, V131, P301, DOI 10.1111/j.1365-2567.2010.03337.x; Venkatraman VK, 2010, NEUROIMAGE, V49, P3436, DOI 10.1016/j.neuroimage.2009.11.019; Wikby A, 2005, J GERONTOL A-BIOL, V60, P556, DOI 10.1093/gerona/60.5.556; Xu J, 2005, J BIOL CHEM, V280, P24277, DOI 10.1074/jbc.M500727200; Zaghouani H, 2009, TRENDS IMMUNOL, V30, P585, DOI 10.1016/j.it.2009.09.002; Zwaan Bas J, 2003, Sci Aging Knowledge Environ, V2003, ppe32, DOI 10.1126/sageke.2003.47.pe32	60	34	34	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26558	10.1371/journal.pone.0026558	http://dx.doi.org/10.1371/journal.pone.0026558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028907	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000296510800053
J	von Oheimb, PV; Albrecht, C; Riedel, F; Du, LN; Yang, JX; Aldridge, DC; Bossneck, U; Zhang, HC; Wilke, T				von Oheimb, Parm Viktor; Albrecht, Christian; Riedel, Frank; Du, Lina; Yang, Junxing; Aldridge, David C.; Boessneck, Ulrich; Zhang, Hucai; Wilke, Thomas			Freshwater Biogeography and Limnological Evolution of the Tibetan Plateau - Insights from a Plateau-Wide Distributed Gastropod Taxon (Radix spp.)	PLOS ONE			English	Article							QUATERNARY GLACIATION; AQUATIC ORGANISMS; MOLECULAR CLOCK; CYTOCHROME-B; PHYLOGEOGRAPHY; CYPRINIDAE; DISPERSAL; PHYLOGENY; ALGORITHM; DNA	Background: The Tibetan Plateau is not only the highest and largest plateau on earth; it is also home to numerous freshwater lakes potentially harbouring endemic faunal elements. As it remains largely unknown whether these lakes have continuously existed during the Last Glacial Maximum (LGM), questions arise as to whether taxa have been able to exist on the plateau since before the latest Pleistocene, from where and how often the plateau was colonized, and by which mechanisms organisms conquered remote high altitude lentic freshwater systems. In this study, species of the plateau-wide distributed freshwater gastropod genus Radix are used to answer these biogeographical questions. Methodology/Principal Findings: Based on a broad spatial sampling of Radix spp. on the Tibetan Plateau, and phylogenetic analyses of mtDNA sequence data, three probably endemic and one widespread major Radix clade could be identified on the plateau. Two of the endemic clades show a remarkably high genetic diversity, indicating a relatively great phylogenetic age. Phylogeographical analyses of individuals belonging to the most widely distributed clade indicate that intra-plateau distribution cannot be explained by drainage-related dispersal alone. Conclusions/Significance: Our study reveals that Radix spp. persisted throughout the LGM on the Tibetan Plateau. Therefore, we assume the continuous existence of suitable water bodies during that time. The extant Radix diversity on the plateau might have been caused by multiple colonization events combined with a relatively long intra-plateau evolution. At least one colonization event has a Palaearctic origin. In contrast to freshwater fishes, passive dispersal, probably by water birds, might be an important mechanism for conquering remote areas on the plateau. Patterns found in Radix spp. are shared with some terrestrial plateau taxa, indicating that Radix may be a suitable model taxon for inferring general patterns of biotic origin, dispersal and survival on the Tibetan Plateau.	[von Oheimb, Parm Viktor; Albrecht, Christian; Wilke, Thomas] Univ Giessen, Dept Anim Ecol & Systemat, Giessen, Germany; [Riedel, Frank] Free Univ Berlin, Inst Geol Sci, Berlin, Germany; [Du, Lina; Yang, Junxing] Chinese Acad Sci, State Key Lab Genet Resources & Evolut, Kunming, Peoples R China; [Aldridge, David C.] Univ Cambridge, Dept Zool, Cambridge, England; [Boessneck, Ulrich] Nat Hist Museum, Erfurt, Germany; [Zhang, Hucai] Yunnan Normal Univ, Key Lab Plateau Lake Ecol & Global Change, Coll Tourism & Geog, Kunming, Peoples R China; [Zhang, Hucai] Chinese Acad Sci, State Key Lab Lake Sci & Environm, Nanjing, Peoples R China	Justus Liebig University Giessen; Free University of Berlin; Chinese Academy of Sciences; University of Cambridge; Yunnan Normal University; Chinese Academy of Sciences	von Oheimb, PV (corresponding author), Univ Giessen, Dept Anim Ecol & Systemat, Giessen, Germany.	parm.v.oheimb@allzool.bio.uni-giessen.de	Albrecht, Christian/AFV-5313-2022; Albrecht, Christian/AAJ-5484-2020; Wilke, Thomas/G-1517-2012	Wilke, Thomas/0000-0001-8263-7758; Aldridge, David/0000-0001-9067-8592	Deutsche Forschungsgemeinschaft [WI 1902/7, RI 809/21, 1372]; World Bank GEF [DM01333]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); World Bank GEF	This study was funded by the Deutsche Forschungsgemeinschaft (WI 1902/7 and RI 809/21) within the priority programme 1372: "Tibetan Plateau: Formation - Climate - Ecosystems" (TiP). Collection of material from southwest China was supported by World Bank GEF Grant DM01333 to D. C. Aldridge and J. Yang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht C, 2008, HYDROBIOLOGIA, V615, P103, DOI 10.1007/s10750-008-9558-y; Anderson MJ, 2008, PERMANOVA PRIMER GUI, P214; Banarescu P, 1992, DISTRIBUTION DISPERS, V2, P520; Benke M, 2009, MOL ECOL, V18, P890, DOI 10.1111/j.1365-294X.2008.04073.x; Chang C.F., 1989, TECTONIC EVOLUTION T, P415, DOI [10.1007/978-94-009-2253-2_18, DOI 10.1007/978-94-009-2253-2_18]; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cowie Robert H., 2003, P93; Cox CB, 2001, J BIOGEOGR, V28, P511; DERBYSHIRE E, 1991, QUATERNARY SCI REV, V10, P485, DOI 10.1016/0277-3791(91)90042-S; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Figuerola J, 2002, FRESHWATER BIOL, V47, P483, DOI 10.1046/j.1365-2427.2002.00829.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guo XG, 2005, MOL PHYLOGENET EVOL, V35, P344, DOI 10.1016/j.ympev.2004.12.015; Haase M, 2010, J MOLLUS STUD, V76, P101, DOI 10.1093/mollus/eyp051; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HARRISON TM, 1992, SCIENCE, V255, P1663, DOI 10.1126/science.255.5052.1663; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; He DK, 2006, J BIOGEOGR, V33, P1448, DOI 10.1111/j.1365-2699.2006.01510.x; Hubert N, 2006, J BIOGEOGR, V33, P1414, DOI 10.1111/j.1365-2699.2006.01518.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Jin YT, 2008, MOL ECOL, V17, P1971, DOI 10.1111/j.1365-294X.2008.03721.x; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kjer KM, 2009, SEQUENCE ALIGNMENT: METHODS, MODELS, CONCEPTS, AND STRATEGIES, P105; Legendre P, 1999, ECOL MONOGR, V69, P1, DOI 10.1890/0012-9615(1999)069[0001:DBRATM]2.0.CO;2; Lehmkuhl F, 2005, BOREAS, V34, P87, DOI 10.1080/03009480510012908; Lehmkuhl F, 2000, QUATERN INT, V65-6, P121, DOI 10.1016/S1040-6182(99)00040-3; Lehmkuhl F, 1998, QUATERN INT, V45-6, P123, DOI 10.1016/S1040-6182(97)00010-4; Li J, 2009, GLOBAL ECOL BIOGEOGR, V18, P264, DOI 10.1111/j.1466-8238.2008.00430.x; Loytynoja A, 2005, P NATL ACAD SCI USA, V102, P10557, DOI 10.1073/pnas.0409137102; Lydeard C, 2000, MOL PHYLOGENET EVOL, V15, P83, DOI 10.1006/mpev.1999.0719; MALONE CR, 1965, ECOLOGY, V46, P551, DOI 10.2307/1934894; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Mischke S, 2010, J PALEOLIMNOL, V43, P589, DOI 10.1007/s10933-009-9355-2; MOLNAR P, 1975, SCIENCE, V189, P419, DOI 10.1126/science.189.4201.419; Morrone JJ, 2002, J BIOGEOGR, V29, P149, DOI 10.1046/j.1365-2699.2002.00662.x; Murphy MA, 2009, EARTH PLANET SC LETT, V282, P1, DOI 10.1016/j.epsl.2009.01.006; Palumbi SR, 1991, SIMPLE FOOLS GUIDE P, P46; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRASHAD B., 1933, REC INDIAN MUS, V35, P1; Qi DL, 2007, FRESHWATER BIOL, V52, P1090, DOI 10.1111/j.1365-2427.2007.01731.x; Qiu J, 2008, NATURE, V454, P393, DOI 10.1038/454393a; Revenga C., 1998, WATERSHEDS WORLD ECO; Ronquist F, 2010, ANNU REV ENTOMOL, V55, P189, DOI 10.1146/annurev.ento.54.110807.090529; Rowley DB, 2006, NATURE, V439, P677, DOI 10.1038/nature04506; Royden LH, 2008, SCIENCE, V321, P1054, DOI 10.1126/science.1155371; SCHONIGER M, 1994, MOL PHYLOGENET EVOL, V3, P240, DOI 10.1006/mpev.1994.1026; Spicer RA, 2003, NATURE, V421, P622, DOI 10.1038/nature01356; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STAROBOGATOV Y.I., 1970, FAUNA MOLLYUSKOV ZOO; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tapponnier P, 2001, SCIENCE, V294, P1671, DOI 10.1126/science.105978; Tavare S., 1986, LECT MATH LIFE SCI, V17, P57; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wesselingh FP, 1999, GEOL MIJNBOUW-N J G, V78, P165, DOI 10.1023/A:1003766516646; Wiens JJ, 2003, SYST BIOL, V52, P528, DOI 10.1080/10635150390218330; Wilke T, 2000, BIOL J LINN SOC, V70, P89, DOI 10.1111/j.1095-8312.2000.tb00202.x; Wilke T, 2007, J BIOGEOGR, V34, P1807, DOI 10.1111/j.1365-2699.2007.01727.x; Wilke T, 2009, AM MALACOL BULL, V27, P25, DOI 10.4003/006.027.0203; WILLIAMS WD, 1991, HYDROBIOLOGIA, V210, P39, DOI 10.1007/BF00014322; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Wu YQ, 2001, GEOMORPHOLOGY, V36, P203, DOI 10.1016/S0169-555X(00)00057-X; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Xu BQ, 2009, P NATL ACAD SCI USA, V106, P22114, DOI [10.1073/pnas.0910444106, 10.1073/pnas.pnas.0910444106]; Yang SJ, 2006, MOL PHYLOGENET EVOL, V41, P257, DOI 10.1016/j.ympev.2006.06.003; Yang SJ, 2009, PROG NAT SCI-MATER, V19, P789, DOI 10.1016/j.pnsc.2008.10.006; Yu G, 2001, 4243 MAXPLANCK I BIO, V4, P243; Zhang Q, 2005, MOL ECOL, V14, P3513, DOI 10.1111/j.1365-294X.2005.02677.x; Zhang YH, 2010, MOL PHYLOGENET EVOL, V57, P1162, DOI 10.1016/j.ympev.2010.08.033; Zhao K, 2009, MOL ECOL, V18, P3616, DOI 10.1111/j.1365-294X.2009.04274.x; Zheng M., 1997, INTRO SALINE LAKES Q, DOI [10.1007/978-94-011-5458-1, DOI 10.1007/978-94-011-5458-1]	76	44	45	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26307	10.1371/journal.pone.0026307	http://dx.doi.org/10.1371/journal.pone.0026307			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028853	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800034
J	Zhou, J; Zhu, XS; Cai, ZH				Zhou, Jin; Zhu, Xiao-Shan; Cai, Zhong-Hua			Influences of DMP on the Fertilization Process and Subsequent Embryogenesis of Abalone (Haliotis diversicolor supertexta) by Gametes Exposure	PLOS ONE			English	Article							MATERNAL EXPOSURE; PHTHALATE-ESTERS; MUSSEL; SPERM; REPRODUCTION; EXPRESSION; TOXICITY; SURVIVAL; EMBRYOS; COPPER	Di-methyl phthalate (DMP), a typical endocrine disrupting chemical (EDC), is ubiquitously distributed in aquatic environments; yet studies regarding its impact on gametes and the resulting effects on embryogenesis in marine gastropods are relatively scarce. In this study, the influences of DMP on the gametes and subsequent developmental process of abalone (Haliotis diversicolor supertexta, a representative marine benthic gastropod) were assessed. Newborn abalone eggs and sperm were exposed separately to different DMP concentrations (1, 10 or 100 ppb) for 60 min. At the end-point of exposure, the DMP-treated eggs and sperm were collected for analysis of their ultra-structures, ATPase activities and total lipid levels, and the fertilized gametes (embryos) were collected to monitor related reproductive parameters (fertilization rate, abnormal development rate and hatching success rate). Treatment with DMP did not significantly alter the structure or total lipid content of eggs at any of the doses tested. Hatching failures and morphological abnormalities were only observed with the highest dose of DMP (100 ppb). However, DMP exposure did suppress sperm ATPase activities and affect the morphological character of their mitochondria. DMP-treated sperm exhibited dose-dependent decreases in fertilization efficiency, morphogenesis and hatchability. Relatively obvious toxicological effects were observed when both sperm and eggs were exposed to DMP. Furthermore, RT-PCR results indicate that treatment of gametes with DMP changed the expression patterns of physiologically-regulated genes (cyp3a, 17 beta-HSD-11 and 17 beta-HSD-12) in subsequent embryogenesis. Taken together, this study proofed that pre-fertilization exposure of abalone eggs, sperm or both to DMP adversely affects the fertilization process and subsequent embryogenesis.	[Zhou, Jin; Zhu, Xiao-Shan; Cai, Zhong-Hua] Tsinghua Univ, Ocean Sci & Technol Div, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China	Tsinghua University; University Town of Shenzhen; Tsinghua Shenzhen International Graduate School	Zhou, J (corresponding author), Tsinghua Univ, Ocean Sci & Technol Div, Grad Sch Shenzhen, Shenzhen 518057, Peoples R China.	caizh@sz.tsinghua.edu.cn	Zhu, Xiaoshan/HCG-9804-2022; Zhu, Xiaoshan/B-2179-2015	Zhu, Xiaoshan/0000-0003-1223-1415	National Natural Science Foundation of China [41106087]; Natural Science Foundation of Guangdong Province, China [10451805702004177]; SZSITIC Commission of Shenzhen [ZYA200903260036A]; Key Laboratory of Marine Environmental Science and Engineering, SOA [MESE-2010-02]; Laboratory of Marine Ecosystem and Biogeochemistry, SOA [LMEB201105]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province, China(National Natural Science Foundation of Guangdong Province); SZSITIC Commission of Shenzhen; Key Laboratory of Marine Environmental Science and Engineering, SOA; Laboratory of Marine Ecosystem and Biogeochemistry, SOA	This study was supported by National Natural Science Foundation of China (41106087), the PhD Start-up Fund of the Natural Science Foundation of Guangdong Province, China (10451805702004177), the International Cooperative Project of the SZSITIC Commission of Shenzhen (ZYA200903260036A), the Open Fund of the Key Laboratory of Marine Environmental Science and Engineering, SOA (MESE-2010-02), and the Open Fund of the Laboratory of Marine Ecosystem and Biogeochemistry, SOA (LMEB201105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken RJ, 2004, NATURE, V432, P48, DOI 10.1038/432048a; Akbarsha MA, 2000, J REPROD FERTIL, V120, P385, DOI 10.1530/reprod/120.2.385; Aluru N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010741; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown KH, 2008, P NATL ACAD SCI USA, V105, P19786, DOI 10.1073/pnas.0808333105; Castro LFC, 2008, CECE 2008 24 C EUR C; Cripe GM, 2010, ENVIRON TOXICOL CHEM, V29, P2079, DOI [10.1002/ete.261, 10.1002/etc.261]; Davidson E. H., 1986, GENE ACTIVITY EARLY; EARNSHAW MJ, 1986, MAR ENVIRON RES, V20, P261, DOI 10.1016/0141-1136(86)90052-8; EYSTER LS, 1984, ARCH ENVIRON CON TOX, V13, P641, DOI 10.1007/BF01056344; Fatta-Kassinos D, 2011, SCI TOTAL ENVIRON, V409, P3555, DOI 10.1016/j.scitotenv.2010.03.036; Favret KP, 2010, ARCH ENVIRON CON TOX, V58, P973, DOI 10.1007/s00244-009-9410-z; Fent K, 2004, TOXICOLOGY, V205, P223, DOI 10.1016/j.tox.2004.06.060; FOLCH J, 1957, J BIOL CHEM, V226, P497; Forget-Leray J, 2005, ECOTOX ENVIRON SAFE, V60, P288, DOI 10.1016/j.ecoenv.2004.06.008; Fridman O, 2004, ENVIRON HEALTH PERSP, V112, P862, DOI 10.1289/ehp.6647; Hamdoun A, 2007, P NATL ACAD SCI USA, V104, P1745, DOI 10.1073/pnas.0610108104; HINSHELWOOD MM, 1994, MOL BIOL FEMALE REPR, P129; His E, 2000, ADV MAR BIOL, V37, P1; Hollows CF, 2007, MAR ECOL PROG SER, V333, P51, DOI 10.3354/meps333051; HUM DW, 1993, CLIN CHEM, V39, P333; Imai Y, 2006, CLIN EXP ALLERGY, V36, P1462, DOI 10.1111/j.1365-2222.2006.02574.x; Ioannides C., 2008, CYTOCHROMES P450 ROL; Janer G, 2005, AQUAT TOXICOL, V75, P32, DOI 10.1016/j.aquatox.2005.01.012; Jiang H, 2008, J TOXICOL, V2, P48; Kikuchi S., 1982, B TOHOKU REG FISH R, V44, P83; Lafont R, 2007, ECOTOXICOLOGY, V16, P109, DOI 10.1007/s10646-006-0113-1; LEVINE AE, 1978, DEV BIOL, V63, P299, DOI 10.1016/0012-1606(78)90135-5; Lewis C, 2009, ENVIRON SCI TECHNOL, V43, P928, DOI 10.1021/es802215d; Lewis Ceri, 2010, Integr Environ Assess Manag, V6, P188, DOI 10.1002/ieam.23; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyche JL, 2009, J TOXICOL ENV HEAL B, V12, P225, DOI 10.1080/10937400903094091; Mackintosh CE, 2006, ENVIRON SCI TECHNOL, V40, P3481, DOI 10.1021/es0519637; MELNICK RL, 1982, ENVIRON HEALTH PERSP, V45, P51, DOI 10.2307/3429383; Mwatibo JM, 1997, B ENVIRON CONTAM TOX, V58, P589, DOI 10.1007/s001289900375; Nye JA, 2007, AQUAT TOXICOL, V82, P242, DOI 10.1016/j.aquatox.2007.02.011; Oehlmann J, 2009, PHILOS T R SOC B, V364, P2047, DOI 10.1098/rstb.2008.0242; Ostrach DJ, 2008, P NATL ACAD SCI USA, V105, P19354, DOI 10.1073/pnas.0802616105; Patyna PJ, 2006, ECOTOX ENVIRON SAFE, V65, P36, DOI 10.1016/j.ecoenv.2005.05.023; Pushpalatha T, 2003, NATURWISSENSCHAFTEN, V90, P40, DOI 10.1007/s00114-002-0384-1; Raloff J, 2011, SCIENCENEWS; Roepke TA, 2006, J EXP ZOOL PART A, V305A, P830, DOI 10.1002/jez.a.320; Schatten GP, CURRENT TOPICS DEV B; Schultz I, 2008, MAR ENVIRON RES, V66, P47, DOI 10.1016/j.marenvres.2008.02.018; Schwarzenbach RP, 2006, SCIENCE, V313, P1072, DOI 10.1126/science.1127291; Shioda T, 2000, CHEMOSPHERE, V40, P239, DOI 10.1016/S0045-6535(99)00235-0; Soares J, 2009, AQUAT TOXICOL, V95, P330, DOI 10.1016/j.aquatox.2009.07.021; Song XL, 2007, FISHERIES SCI, V6, P34; Spitsbergen Jan M., 2003, Toxicologic Pathology, V31, P62, DOI 10.1080/01926230309774; Staples CA, 1997, CHEMOSPHERE, V35, P667, DOI 10.1016/S0045-6535(97)00195-1; Uren-Webster TM, 2010, AQUAT TOXICOL, V99, P360, DOI 10.1016/j.aquatox.2010.05.015; Wang KH, 2001, REPRO HLTH, V2, P56; Westerlund L, 2000, ENVIRON TOXICOL CHEM, V19, P1582, DOI 10.1002/etc.5620190615; Wilson JT, 2002, AQUAT TOXICOL, V59, P163, DOI 10.1016/S0166-445X(01)00249-1; Yang AG, 2006, HATCHERY SEED PRODUC; Zanette J, 2010, MAR ENVIRON RES, V69, pS1, DOI 10.1016/j.marenvres.2009.10.013; Zhou J, 2011, MOL CELL BIOCHEM, V354, P123, DOI 10.1007/s11010-011-0811-8; Zhou J, 2011, ENVIRON POLLUT, V159, P1114, DOI 10.1016/j.envpol.2011.02.016; Zhou Lin, 2010, Integrated Environmental Assessment and Management, V6, P492, DOI [10.1002/ieam.47, 10.1002/IEAM.47]; [No title captured]	60	7	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25951	10.1371/journal.pone.0025951	http://dx.doi.org/10.1371/journal.pone.0025951			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028799	Green Submitted, Green Published, gold			2022-12-27	WOS:000296510800011
J	Cornaciu, I; Boeszoermenyi, A; Lindermuth, H; Nagy, HM; Cerk, IK; Ebner, C; Salzburger, B; Gruber, A; Schweiger, M; Zechner, R; Lass, A; Zimmermann, R; Oberer, M				Cornaciu, Irina; Boeszoermenyi, Andras; Lindermuth, Hanna; Nagy, Harald M.; Cerk, Ines K.; Ebner, Catharina; Salzburger, Barbara; Gruber, Astrid; Schweiger, Martina; Zechner, Rudolf; Lass, Achim; Zimmermann, Robert; Oberer, Monika			The Minimal Domain of Adipose Triglyceride Lipase (ATGL) Ranges until Leucine 254 and Can Be Activated and Inhibited by CGI-58 and G0S2, Respectively	PLOS ONE			English	Article							COMPARATIVE GENE IDENTIFICATION-58; HORMONE-SENSITIVE LIPASE; LIPID DROPLET BINDING; CRYSTAL-STRUCTURE; TERMINAL REGION; FAMILY-MEMBERS; PROTEIN; LIPOLYSIS; TRIACYLGLYCEROL; EXPRESSION	Adipose triglyceride lipase (ATGL) is the rate-limiting enzyme of lipolysis. ATGL specifically hydrolyzes triacylglycerols (TGs), thereby generating diacylglycerols and free fatty acids. ATGL's enzymatic activity is co-activated by the protein comparative gene identification-58 (CGI-58) and inhibited by the protein G0/G1 switch gene 2 (G0S2). The enzyme is predicted to act through a catalytic dyad (Ser47, Asp166) located within the conserved patatin domain (Ile10-Leu178). Yet, neither an experimentally determined 3D structure nor a model of ATGL is currently available, which would help to understand how CGI-58 and G0S2 modulate ATGL's activity. In this study we determined the minimal active domain of ATGL. This minimal fragment of ATGL could still be activated and inhibited by CGI-58 and G0S2, respectively. Furthermore, we show that this minimal domain is sufficient for protein-protein interaction of ATGL with its regulatory proteins. Based on these data, we generated a 3D homology model for the minimal domain. It strengthens our experimental finding that amino acids between Leu178 and Leu254 are essential for the formation of a stable protein domain related to the patatin fold. Our data provide insights into the structure-function relationship of ATGL and indicate higher structural similarities in the N-terminal halves of mammalian patatin-like phospholipase domain containing proteins, (PNPLA1, -2,- 3 and -5) than originally anticipated.	[Cornaciu, Irina; Boeszoermenyi, Andras; Lindermuth, Hanna; Nagy, Harald M.; Cerk, Ines K.; Ebner, Catharina; Salzburger, Barbara; Gruber, Astrid; Schweiger, Martina; Zechner, Rudolf; Lass, Achim; Zimmermann, Robert; Oberer, Monika] Graz Univ, Inst Mol Biosci, Graz, Austria	University of Graz	Cornaciu, I (corresponding author), Graz Univ, Inst Mol Biosci, Graz, Austria.	m.oberer@uni-graz.at	Lass, Achim/C-3332-2008; Boeszoermenyi, Andras/AAD-9808-2020	Lass, Achim/0000-0002-8190-7151; Boeszoermenyi, Andras/0000-0001-9810-7241; Schweiger, Martina/0000-0002-3419-1007; Zimmermann, Robert/0000-0002-7354-870X; Oberer, Monika/0000-0003-2525-9513; Zechner, Rudolf/0000-0001-5483-1182	GOLD III; Austrian Federal Ministry of Science and Research; FFG; SFB LIPOTOX [F30]; doctoral school 'DK Molecular Enzymology' [W901-B05]; Austrian Science Fund (FWF);  [P22170]; Austrian Science Fund (FWF) [F 3002, P 22170, Z 136, W 901] Funding Source: researchfish	GOLD III; Austrian Federal Ministry of Science and Research; FFG; SFB LIPOTOX(German Research Foundation (DFG)); doctoral school 'DK Molecular Enzymology'; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); ; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by grants from 'GOLD III', which is part of the Austrian Genome Project 'GEN-AU Genome Research in Austria' and is funded by the Austrian Federal Ministry of Science and Research and FFG. Support is also provided by project P22170, the SFB LIPOTOX (F30), and the doctoral school 'DK Molecular Enzymology' (W901-B05), which are funded by the Austrian Science Fund (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2011, CELL METAB, V13, P739, DOI 10.1016/j.cmet.2011.05.002; Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Coassin S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001239; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; Duncan RE, 2010, J LIPID RES, V51, P309, DOI 10.1194/jlr.M000729; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; FREDRIKSON G, 1986, BIOCHIM BIOPHYS ACTA, V876, P288, DOI 10.1016/0005-2760(86)90286-9; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Gruber A, 2010, J BIOL CHEM, V285, P12289, DOI 10.1074/jbc.M109.064469; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kim SC, 2006, J PROTEOME RES, V5, P3446, DOI 10.1021/pr0603396; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; KOBAYASHI K, 2008, J CLIN ENDOCRINOL ME; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Lass A, 2011, PROG LIPID RES, V50, P14, DOI 10.1016/j.plipres.2010.10.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; Lu X, 2010, CELL CYCLE, V9, P2719, DOI 10.4161/cc.9.14.12181; Moon AF, 2010, PROTEIN SCI, V19, P901, DOI 10.1002/pro.368; Oberer M, 2011, CURR OPIN LIPIDOL, V22, P149, DOI 10.1097/MOL.0b013e328346230e; Rydel TJ, 2003, BIOCHEMISTRY-US, V42, P6696, DOI 10.1021/bi027156r; Schweiger M, 2006, J BIOL CHEM; SCHWEIGER M, 2009, AM J PHYSL ENDOCRINO; Schweiger M, 2008, J BIOL CHEM, V283, P17211, DOI 10.1074/jbc.M710566200; Soni KG, 2009, J CELL SCI, V122, P1834, DOI 10.1242/jcs.045849; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	36	62	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26349	10.1371/journal.pone.0026349	http://dx.doi.org/10.1371/journal.pone.0026349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039468	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500054
J	Cotter, MM; Loomis, DA; Simpson, SW; Latimer, B; Hernandez, CJ				Cotter, Meghan M.; Loomis, David A.; Simpson, Scott W.; Latimer, Bruce; Hernandez, Christopher J.			Human Evolution and Osteoporosis-Related Spinal Fractures	PLOS ONE			English	Article							FINITE-ELEMENT MODELS; BONE-MINERAL DENSITY; CANCELLOUS BONE; VERTEBRAL BODY; TRABECULAR MICROARCHITECTURE; JOINT; AGE; RISK; SIZE; STRENGTH	The field of evolutionary medicine examines the possibility that some diseases are the result of trade-offs made in human evolution. Spinal fractures are the most common osteoporosis-related fracture in humans, but are not observed in apes, even in cases of severe osteopenia. In humans, the development of osteoporosis is influenced by peak bone mass and strength in early adulthood as well as age-related bone loss. Here, we examine the structural differences in the vertebral bodies (the portion of the vertebra most commonly involved in osteoporosis-related fractures) between humans and apes before age-related bone loss occurs. Vertebrae from young adult humans and chimpanzees, gorillas, orangutans, and gibbons (T8 vertebrae, n = 8-14 per species, male and female, humans: 20-40 years of age) were examined to determine bone strength (using finite element models), bone morphology (external shape), and trabecular microarchitecture (micro-computed tomography). The vertebrae of young adult humans are not as strong as those from apes after accounting for body mass (p < 0.01). Human vertebrae are larger in size (volume, cross-sectional area, height) than in apes with a similar body mass. Young adult human vertebrae have significantly lower trabecular bone volume fraction (0.26 +/- 0.04 in humans and 0.37 +/- 0.07 in apes, mean +/- SD, p < 0.01) and thinner vertebral shells than apes (after accounting for body mass, p < 0.01). Since human vertebrae are more porous and weaker than those in apes in young adulthood (after accounting for bone mass), even modest amounts of age-related bone loss may lead to vertebral fracture in humans, while in apes, larger amounts of bone loss would be required before a vertebral fracture becomes likely. We present arguments that differences in vertebral bone size and shape associated with reduced bone strength in humans is linked to evolutionary adaptations associated with bipedalism.	[Cotter, Meghan M.; Simpson, Scott W.] Case Western Reserve Univ, Sch Med, Dept Anat, Cleveland, OH 44106 USA; [Cotter, Meghan M.; Loomis, David A.] Case Western Reserve Univ, Musculoskeletal Mech & Mat Lab, Dept Mech & Aerosp Engn, Cleveland, OH 44106 USA; [Cotter, Meghan M.; Simpson, Scott W.; Latimer, Bruce; Hernandez, Christopher J.] Case Western Reserve Univ, Ctr Human Origins, Cleveland, OH 44106 USA; [Latimer, Bruce] Case Western Reserve Univ, Dept Anthropol, Cleveland, OH 44106 USA; [Hernandez, Christopher J.] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Cornell University	Cotter, MM (corresponding author), Case Western Reserve Univ, Sch Med, Dept Anat, Cleveland, OH 44106 USA.	cjh275@cornell.edu	Simpson, Scott/GRS-0081-2022; Hernandez, Christopher J/B-5290-2009	Hernandez, Christopher J/0000-0002-0712-6533	Case Western Reserve University	Case Western Reserve University	The study was funded by Case Western Reserve University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander C, 2001, ANN RHEUM DIS, V60, P554, DOI 10.1136/ard.60.6.554; Banse X, 2001, BONE, V28, P563, DOI 10.1016/S8756-3282(01)00425-2; BOBBERT MF, 1992, J BIOMECH, V25, P223, DOI 10.1016/0021-9290(92)90022-S; Brown KAR, 2002, J HUM EVOL, V43, P189, DOI 10.1006/jhev.2002.0568; Buckley JM, 2007, BONE, V40, P767, DOI 10.1016/j.bone.2006.10.025; Carlson K, 2008, INT J PRIMATOL, V29, P1401, DOI 10.1007/s10764-008-9297-y; Cerroni AM, 2000, AM J PHYS ANTHROPOL, V113, P389, DOI 10.1002/1096-8644(200011)113:3<389::AID-AJPA9>3.0.CO;2-I; Cooper Cyrus, 1996, P419; Cotter MM, 2009, ANAT REC, V292, P1098, DOI 10.1002/ar.20932; Cotter MM, 2011, GROSS MORPHOLOGY MIC; Crawford RP, 2003, BONE, V33, P744, DOI 10.1016/S8756-3282(03)00210-2; Crawford RP, 2003, J BIOMECH ENG-T ASME, V125, P434, DOI 10.1115/1.1589772; Currey J.D., 2002, BONES STRUCTURE MECH; Duan YB, 2001, J BONE MINER RES, V16, P2276, DOI 10.1359/jbmr.2001.16.12.2276; EASTELL R, 1991, J BONE MINER RES, V6, P207; Eswaran SK, 2007, BONE, V41, P733, DOI 10.1016/j.bone.2007.05.017; FLEAGLE JG, 1999, PRIMATE ADAPTATION E; GARLAND T, 1994, PHYSIOL ZOOL, V67, P797, DOI 10.1086/physzool.67.4.30163866; Glantz S, 2001, PRIMER APPL REGRESSI; Gunji H, 2003, PRIMATES, V44, P145, DOI 10.1007/s10329-002-0030-8; Heaney RP, 2003, BONE, V33, P457, DOI 10.1016/S8756-3282(03)00236-9; Hernandez CJ, 2009, J HUM EVOL, V56, P462, DOI 10.1016/j.jhevol.2008.12.007; Hernandez CJ, 2003, OSTEOPOROSIS INT, V14, P843, DOI 10.1007/s00198-003-1454-8; Hildebrand TOR, 1997, Comput Methods Biomech Biomed Engin, V1, P15, DOI 10.1080/01495739708936692; Homminga J, 2001, SPINE, V26, P1555, DOI 10.1097/00007632-200107150-00010; Homminga J, 2004, BONE, V34, P510, DOI 10.1016/j.bone.2003.12.001; Hussein AI, 2009, PREDICTIONS VERTEBRA; Ismail AA, 1999, OSTEOPOROSIS INT, V9, P206, DOI 10.1007/s001980050138; Iwamoto M, 2007, DEV BIOL, V305, P40, DOI 10.1016/j.ydbio.2007.01.037; JUNGERS WL, 1988, J HUM EVOL, V17, P247, DOI 10.1016/0047-2484(88)90056-5; Jurmain R, 2000, J HUM EVOL, V39, P185, DOI 10.1006/jhev.2000.0413; Karasik D, 2008, HUM GENET, V124, P349, DOI 10.1007/s00439-008-0559-8; Ketcham RA, 2004, J MICROSC-OXFORD, V213, P158, DOI 10.1111/j.1365-2818.2004.01277.x; KEYAK JH, 1994, J BIOMED MATER RES, V28, P1329, DOI 10.1002/jbm.820281111; Kneissel M, 1997, CALCIFIED TISSUE INT, V61, P95; KNEISSEL M, 1994, BONE, V15, P539, DOI 10.1016/8756-3282(94)90278-X; LATIMER B, 1989, AM J PHYS ANTHROPOL, V78, P369, DOI 10.1002/ajpa.1330780306; Latimer B, 2005, ANN BIOMED ENG, V33, P3, DOI 10.1007/s10439-005-8957-8; Lentle BC, 2007, CAN ASSOC RADIOL J, V58, P27; Lieberman DE, 2001, AM J PHYS ANTHROPOL, V116, P266, DOI 10.1002/ajpa.1123; Lovejoy CO, 2005, GAIT POSTURE, V21, P95, DOI 10.1016/j.gaitpost.2004.01.001; Lovell NC, 1990, PATTERNS INJURY ILLN; Maga M, 2006, AM J PHYS ANTHROPOL, V129, P410, DOI 10.1002/ajpa.20276; Mays S, 1998, INT J OSTEOARCHAEOL, V8, P97, DOI 10.1002/(SICI)1099-1212(199803/04)8:2<97::AID-OA412>3.0.CO;2-U; MCHENRY HM, 1992, AM J PHYS ANTHROPOL, V87, P407, DOI 10.1002/ajpa.1330870404; Oxnard C.E., 1981, Symposia of the Zoological Society of London, P127; Ritchie RO, 2008, BONE, V43, P798, DOI 10.1016/j.bone.2008.04.027; Rizzoli R, 2001, J MOL ENDOCRINOL, V26, P79, DOI 10.1677/jme.0.0260079; Rizzoli R, 2010, BONE, V46, P294, DOI 10.1016/j.bone.2009.10.005; RUFF C, 1988, J HUM EVOL, V17, P687, DOI 10.1016/0047-2484(88)90025-5; Ruff C. B., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P202; Sambrook P, 2006, LANCET, V367, P2010, DOI 10.1016/S0140-6736(06)68891-0; Settle SH, 2003, DEV BIOL, V254, P116, DOI 10.1016/S0012-1606(02)00022-2; SHAPIRO LJ, 1994, AM J PHYS ANTHROPOL, V93, P491, DOI 10.1002/ajpa.1330930408; Sokol R.R., 1995, BIOMETRY; SUMNER DR, 1989, AM J PHYS ANTHROPOL, V79, P225, DOI 10.1002/ajpa.1330790210; Trevathan W., 2008, EVOLUTIONARY MED HLT; ZIHLMAN AL, 1990, J ZOOL, V221, P37, DOI 10.1111/j.1469-7998.1990.tb03773.x	58	19	20	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26658	10.1371/journal.pone.0026658	http://dx.doi.org/10.1371/journal.pone.0026658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028933	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500104
J	Moody, MA; Zhang, RJ; Walter, EB; Woods, CW; Ginsburg, GS; McClain, MT; Denny, TN; Chen, X; Munshaw, S; Marshall, DJ; Whitesides, JF; Drinker, MS; Amos, JD; Gurley, TC; Eudailey, JA; Foulger, A; DeRosa, KR; Parks, R; Meyerhoff, RR; Yu, JS; Kozink, DM; Barefoot, BE; Ramsburg, EA; Khurana, S; Golding, H; Vandergrift, NA; Alam, SM; Tomaras, GD; Kepler, TB; Kelsoe, G; Liao, HX; Haynes, BF				Moody, M. Anthony; Zhang, Ruijun; Walter, Emmanuel B.; Woods, Christopher W.; Ginsburg, Geoffrey S.; McClain, Micah T.; Denny, Thomas N.; Chen, Xi; Munshaw, Supriya; Marshall, Dawn J.; Whitesides, John F.; Drinker, Mark S.; Amos, Joshua D.; Gurley, Thaddeus C.; Eudailey, Joshua A.; Foulger, Andrew; DeRosa, Katherine R.; Parks, Robert; Meyerhoff, R. Ryan; Yu, Jae-Sung; Kozink, Daniel M.; Barefoot, Brice E.; Ramsburg, Elizabeth A.; Khurana, Surender; Golding, Hana; Vandergrift, Nathan A.; Alam, S. Munir; Tomaras, Georgia D.; Kepler, Thomas B.; Kelsoe, Garnett; Liao, Hua-Xin; Haynes, Barton F.			H3N2 Influenza Infection Elicits More Cross-Reactive and Less Clonally Expanded Anti-Hemagglutinin Antibodies Than Influenza Vaccination	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODIES; MEMORY B-CELLS; VIRUS HEMAGGLUTININ; NEUTRALIZING ANTIBODIES; SEASONAL INFLUENZA; IMMUNE-RESPONSE; UNITED-STATES; A VIRUS; AFFINITY; BINDING	Background: During the recent H1N1 influenza pandemic, excess morbidity and mortality was seen in young but not older adults suggesting that prior infection with influenza strains may have protected older subjects. In contrast, a history of recent seasonal trivalent vaccine in younger adults was not associated with protection. Methods and Findings: To study hemagglutinin (HA) antibody responses in influenza immunization and infection, we have studied the day 7 plasma cell repertoires of subjects immunized with seasonal trivalent inactivated influenza vaccine (TIV) and compared them to the plasma cell repertoires of subjects experimentally infected (EI) with influenza H3N2 A/Wisconsin/67/2005. The majority of circulating plasma cells after TIV produced influenza-specific antibodies, while most plasma cells after EI produced antibodies that did not react with influenza HA. While anti-HA antibodies from TIV subjects were primarily reactive with single or few HA strains, anti-HA antibodies from EI subjects were isolated that reacted with multiple HA strains. Plasma cell-derived anti-HA antibodies from TIV subjects showed more evidence of clonal expansion compared with antibodies from EI subjects. From an H3N2-infected subject, we isolated a 4-member clonal lineage of broadly cross-reactive antibodies that bound to multiple HA subtypes and neutralized both H1N1 and H3N2 viruses. This broad reactivity was not detected in post-infection plasma suggesting this broadly reactive clonal lineage was not immunodominant in this subject. Conclusion: The presence of broadly reactive subdominant antibody responses in some EI subjects suggests that improved vaccine designs that make broadly reactive antibody responses immunodominant could protect against novel influenza strains.	[Moody, M. Anthony; Zhang, Ruijun; Denny, Thomas N.; Chen, Xi; Marshall, Dawn J.; Whitesides, John F.; Drinker, Mark S.; Amos, Joshua D.; Gurley, Thaddeus C.; Eudailey, Joshua A.; Foulger, Andrew; DeRosa, Katherine R.; Parks, Robert; Meyerhoff, R. Ryan; Yu, Jae-Sung; Kozink, Daniel M.; Barefoot, Brice E.; Ramsburg, Elizabeth A.; Vandergrift, Nathan A.; Alam, S. Munir; Tomaras, Georgia D.; Kepler, Thomas B.; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27706 USA; [Moody, M. Anthony; Walter, Emmanuel B.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA; [Woods, Christopher W.; Ginsburg, Geoffrey S.; McClain, Micah T.; Denny, Thomas N.; Whitesides, John F.; Yu, Jae-Sung; Vandergrift, Nathan A.; Alam, S. Munir; Liao, Hua-Xin; Haynes, Barton F.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Woods, Christopher W.; Ginsburg, Geoffrey S.; Ramsburg, Elizabeth A.; Alam, S. Munir] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA; [Tomaras, Georgia D.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Tomaras, Georgia D.; Kelsoe, Garnett; Haynes, Barton F.] Duke Univ, Med Ctr, Dept Immunol, Durham, NC USA; [Munshaw, Supriya; Kepler, Thomas B.] Duke Univ, Med Ctr, Dept Biostat & Bioinformat, Durham, NC USA; [Ramsburg, Elizabeth A.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA; [Woods, Christopher W.; Ginsburg, Geoffrey S.] Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC USA; [Woods, Christopher W.; McClain, Micah T.] Durham Vet Affairs Med Ctr, Div Infect Dis, Durham, NC USA; [Khurana, Surender; Golding, Hana] US FDA, Div Viral Prod, Ctr Biol Evaluat & Res, Bethesda, MD USA	Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; Duke University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; US Food & Drug Administration (FDA)	Moody, MA (corresponding author), Duke Univ, Med Ctr, Duke Human Vaccine Inst, Durham, NC 27706 USA.	moody007@mc.duke.edu	Tomaras, Georgia/J-5041-2016; Moody, M/AAB-6947-2020; Zhang, RUIJUN/AAD-6887-2021; Alam, S. Munir/AAC-6711-2019	Moody, M/0000-0002-3890-5855; Zhang, RUIJUN/0000-0001-6785-9619; Denny, Thomas/0000-0002-7364-8276; Vandergrift, Nathan/0000-0001-9994-5466; Kepler, Thomas/0000-0002-1383-6865; Meyerhoff, Ryan/0000-0003-1253-2250	Bill and Melinda Gates Foundation; Center For HIV/AIDS Vaccine Immunology (CHAVI) [U19 AI067854]; United States Defense Advanced Research Projects Agency [N66001-07-C-2024]; Duke Translational Medicine Institute [NCRR/NIH 5UL1-RR024128-03]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081579, U19AI067854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007171] Funding Source: NIH RePORTER; Veterans Affairs [IK2CX000611] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Center For HIV/AIDS Vaccine Immunology (CHAVI); United States Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Duke Translational Medicine Institute; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	Support for this work was provided by a Collaboration for AIDS Vaccine Discovery grant to BH from the Bill and Melinda Gates Foundation and by the Center For HIV/AIDS Vaccine Immunology (CHAVI; grant U19 AI067854). Support was also provided by a contract to GG from the United States Defense Advanced Research Projects Agency (contract N66001-07-C-2024) and to EW from the Duke Translational Medicine Institute (Robert Califf PI, NCRR/NIH 5UL1-RR024128-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; CLARKE S, 1990, J IMMUNOL, V145, P2286; CLARKE SH, 1985, J EXP MED, V161, P687, DOI 10.1084/jem.161.4.687; CLARKE SH, 1990, J IMMUNOL, V144, P2795; Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; Dal Porto JM, 2002, J EXP MED, V195, P1215, DOI 10.1084/jem.20011550; DAVENPORT FM, 1953, J EXP MED, V98, P641, DOI 10.1084/jem.98.6.641; De Filette M, 2005, VIROLOGY, V337, P149, DOI 10.1016/j.virol.2005.04.004; DESTFAZEKAS G, 1966, J EXP MED, V124, P331, DOI DOI 10.1084/JEM.124.3.331; Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fazekas St de G, 1966, J EXP MED, V124, P347; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; Forgie SE, 2011, CLIN INFECT DIS, V52, P10, DOI 10.1093/cid/ciq030; Gray ES, 2009, J VIROL, V83, P8925, DOI 10.1128/JVI.00758-09; Hedestam GBK, 2008, NAT REV MICROBIOL, V6, P143, DOI 10.1038/nrmicro1819; JACKSON GG, 1958, ARCH INTERN MED, V101, P267, DOI 10.1001/archinte.1958.00260140099015; Johnson NPAS, 2002, B HIST MED, V76, P105, DOI 10.1353/bhm.2002.0022; Kashyap AK, 2008, P NATL ACAD SCI USA, V105, P5986, DOI 10.1073/pnas.0801367105; Kashyap AK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000990; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Kepler TB, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-444; Khurana S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000624; Knossow M, 2006, IMMUNOLOGY, V119, P1, DOI 10.1111/j.1365-2567.2006.02421.x; Krause JC, 2010, J VIROL, V84, P3127, DOI 10.1128/JVI.02184-09; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Lau LLH, 2010, J INFECT DIS, V201, P1509, DOI 10.1086/652241; Laurie KL, 2010, J INFECT DIS, V202, P1011, DOI 10.1086/656188; Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; RENFREY S, 1994, VACCINE, V12, P747, DOI 10.1016/0264-410X(94)90227-5; Sangster MY, 2000, J IMMUNOL, V164, P1820, DOI 10.4049/jimmunol.164.4.1820; Sasso EH, 1996, J CLIN INVEST, V97, P2074, DOI 10.1172/JCI118644; Schotsaert M, 2009, EXPERT REV VACCINES, V8, P499, DOI [10.1586/erv.09.6, 10.1586/ERV.09.6]; Shih TAY, 2002, NAT IMMUNOL, V3, P570, DOI 10.1038/ni803; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Steel J, 2010, MBIO, V1, DOI 10.1128/mBio.00018-10; Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Throsby M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003942; Tomaras GD, 2008, J VIROL, V82, P12449, DOI 10.1128/JVI.01708-08; Volpe JM, 2006, BIOINFORMATICS, V22, P438, DOI 10.1093/bioinformatics/btk004; Wang TT, 2010, P NATL ACAD SCI USA, V107, P18979, DOI 10.1073/pnas.1013387107; Wang TT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000796; WEBSTER RG, 1966, J IMMUNOL, V97, P177; Wei CJ, 2010, SCIENCE, V329, P1060, DOI 10.1126/science.1192517; WHITTLE J, 2011, P NATL ACAD IN PRESS; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Wrammert J, 2011, J EXP MED, V208, P181, DOI 10.1084/jem.20101352; Yu XC, 2008, NATURE, V455, P532, DOI 10.1038/nature07231; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; 2009, MMWR MORB MORTAL WKL, V58, P1100; 2009, MMWR MORB MORTAL WKL, V58, P1009	60	132	140	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25797	10.1371/journal.pone.0025797	http://dx.doi.org/10.1371/journal.pone.0025797			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039424	gold, Green Submitted, Green Published			2022-12-27	WOS:000296507500022
J	Carlsson, MC; Cederfur, C; Schaar, V; Balog, CIA; Lepur, A; Touret, F; Salomonsson, E; Deelder, AM; Ferno, M; Olsson, H; Wuhrer, M; Leffler, H				Carlsson, Michael C.; Cederfur, Cecilia; Schaar, Viveka; Balog, Crina I. A.; Lepur, Adriana; Touret, Franck; Salomonsson, Emma; Deelder, Andre M.; Ferno, Marten; Olsson, Hakan; Wuhrer, Manfred; Leffler, Hakon			Galectin-1-Binding Glycoforms of Haptoglobin with Altered Intracellular Trafficking, and Increase in Metastatic Breast Cancer Patients	PLOS ONE			English	Article							PROSTATE-SPECIFIC ANTIGEN; HUMAN SERUM GLYCOPROTEINS; MANNAN-BINDING LECTIN; CHRONIC INFLAMMATION; N-ACETYLLACTOSAMINE; TUMOR PROGRESSION; COLON-CANCER; HUMAN PLASMA; GALECTINS; GLYCOSYLATION	Sera from 25 metastatic breast cancer patients and 25 healthy controls were subjected to affinity chromatography using immobilized galectin-1. Serum from the healthy subjects contained on average 1.2 mg per ml (range 0.7-2.2) galectin-1 binding glycoproteins, whereas serum from the breast cancer patients contained on average 2.2 mg/ml (range 0.8-3.9), with a higher average for large primary tumours. The major bound glycoproteins were alpha-2-macroglobulin, IgM and haptoglobin. Both the IgM and haptoglobin concentrations were similar in cancer compared to control sera, but the percentage bound to galectin-1 was lower for IgM and higher for haptoglobin: about 50% (range 20-80) in cancer sera and about 30% (range 25-50) in healthy sera. Galectin-1 binding and non-binding fractions were separated by affinity chromatography from pooled haptoglobin from healthy sera. The N-glycans of each fraction were analyzed by mass spectrometry, and the structural differences and galectin-1 mutants were used to identify possible galectin-1 binding sites. Galectin-1 binding and non-binding fractions were also analyzed regarding their haptoglobin function. Both were similar in forming complex with haemoglobin and mediate its uptake into alternatively activated macrophages. However, after uptake there was a dramatic difference in intracellular targeting, with the galectin-1 non-binding fraction going to a LAMP-2 positive compartment (lysosomes), while the galectin-1 binding fraction went to larger galectin-1 positive granules. In conclusion, galectin-1 detects a new type of functional biomarker for cancer: a specific type of glycoform of haptoglobin, and possibly other serum glycoproteins, with a different function after uptake into tissue cells.	[Carlsson, Michael C.; Cederfur, Cecilia; Schaar, Viveka; Lepur, Adriana; Touret, Franck; Salomonsson, Emma; Leffler, Hakon] Lund Univ, Dept Lab Med, Sect MIG Microbiol Immunol Glycobiol, Lund, Sweden; [Balog, Crina I. A.; Deelder, Andre M.; Wuhrer, Manfred] Leiden Univ, Med Ctr, Dept Parasitol, Biomol Mass Spectrometry Unit, Leiden, Netherlands; [Ferno, Marten; Olsson, Hakan] Univ Lund Hosp, Dept Oncol, S-22185 Lund, Sweden	Lund University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Lund University; Skane University Hospital	Carlsson, MC (corresponding author), Lund Univ, Dept Lab Med, Sect MIG Microbiol Immunol Glycobiol, Lund, Sweden.	michael.carlsson@med.lu.se; hakon.leffler@med.lu.se	Wuhrer, Manfred/ABE-9168-2020; Leffler, Hakon/A-2416-2019; Touret, Franck/ABD-3236-2020	Wuhrer, Manfred/0000-0002-0814-4995; Touret, Franck/0000-0002-4734-2249; Olsson, Hakan/0000-0002-8794-9635; Leffler, Hakon/0000-0003-4482-8945	Swedish Research Council (Vetenskapsradet); Swedish Cancer Society, Lund University Hospital Foundation; Region Skane	Swedish Research Council (Vetenskapsradet)(Swedish Research Council); Swedish Cancer Society, Lund University Hospital Foundation(Swedish Cancer Society); Region Skane	This work was supported by grants from the Swedish Research Council (Vetenskapsradet) to HL and from the Swedish Cancer Society, Lund University Hospital Foundation and Region Skane to MF and HO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Hamid UM, 2008, GLYCOBIOLOGY, V18, P1105, DOI 10.1093/glycob/cwn095; Allen HJ, 1998, GLYCOCONJUGATE J, V15, P691, DOI 10.1023/A:1006988515346; Arnold JN, 2008, PROTEOMICS, V8, P3284, DOI 10.1002/pmic.200800163; Arnold JN, 2011, J PROTEOME RES, V10, P1755, DOI 10.1021/pr101034t; Arnold JN, 2006, J BIOL CHEM, V281, P6955, DOI 10.1074/jbc.M511432200; Arnold JN, 2005, J BIOL CHEM, V280, P29080, DOI 10.1074/jbc.M504528200; Bresalier RS, 2004, GASTROENTEROLOGY, V127, P741, DOI 10.1053/j.gastro.2004.06.016; Carlsson A, 2008, EUR J CANCER, V44, P472, DOI 10.1016/j.ejca.2007.11.025; Cazet A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2577; Cederfur C, 2008, GLYCOBIOLOGY, V18, P384, DOI 10.1093/glycob/cwn015; Ceroni A, 2008, J PROTEOME RES, V7, P1650, DOI 10.1021/pr7008252; CID MC, 1993, J CLIN INVEST, V91, P977, DOI 10.1172/JCI116319; Dabelsteen E, 1996, J PATHOL, V179, P358; Dam TK, 2005, BIOCHEMISTRY-US, V44, P12564, DOI 10.1021/bi051144z; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Drake PM, 2010, CLIN CHEM, V56, P223, DOI 10.1373/clinchem.2009.136333; Fajka-Boja R, 2008, CELL MOL LIFE SCI, V65, P2586, DOI 10.1007/s00018-008-8143-x; Ferens-Sieczkowska M, 2001, Z NATURFORSCH C, V56, P122; Fortin S, 2010, BRAIN PATHOL, V20, P39, DOI 10.1111/j.1750-3639.2008.00227.x; Fujita T, 2011, JPN J CLIN ONCOL, V41, P394, DOI 10.1093/jjco/hyq190; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gornik O, 2009, GLYCOBIOLOGY, V19, P1547, DOI 10.1093/glycob/cwp134; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Graversen JH, 2002, INT J BIOCHEM CELL B, V34, P309, DOI 10.1016/S1357-2725(01)00144-3; Hakomori S, 2002, FEBS LETT, V531, P88, DOI 10.1016/S0014-5793(02)03479-8; Harazono A, 2008, J CHROMATOGR B, V869, P20, DOI 10.1016/j.jchromb.2008.05.006; HEUSER J, 1989, J CELL BIOL, V108, P855, DOI 10.1083/jcb.108.3.855; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Holmstrom B, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3537; HUANG CL, 2011, PFLUGERS ARCH EUROPE; Kannagi R, 2008, BBA-GEN SUBJECTS, V1780, P525, DOI 10.1016/j.bbagen.2007.10.007; Kovtunovych G, 2010, BLOOD, V116, P6054, DOI 10.1182/blood-2010-03-272138; Langlois MR, 1996, CLIN CHEM, V42, P1589; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lauc G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001256; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Leppanen A, 2005, J BIOL CHEM, V280, P5549, DOI 10.1074/jbc.m412019200; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Madsen M, 2001, REDOX REP, V6, P386, DOI 10.1179/135100001101536490; MEEZAN E, 1969, BIOCHEMISTRY-US, V8, P2518, DOI 10.1021/bi00834a039; Miyoshi E, 2008, PROTEOMICS, V8, P3257, DOI 10.1002/pmic.200800046; Nielsen MJ, 2007, J BIOL CHEM, V282, P1072, DOI 10.1074/jbc.M605684200; Nishi N, 2008, GLYCOBIOLOGY, V18, P1065, DOI 10.1093/glycob/cwn089; Ohyama C, 2004, GLYCOBIOLOGY, V14, P671, DOI 10.1093/glycob/cwh071; Park SY, 2010, INT J CANCER, V126, P142, DOI 10.1002/ijc.24685; Polticelli F, 2008, FEBS J, V275, P5648, DOI 10.1111/j.1742-4658.2008.06690.x; Pucic M, 2010, GLYCOBIOLOGY, V20, P970, DOI 10.1093/glycob/cwq052; Puig-Kroger A, 2009, CANCER RES, V69, P9395, DOI 10.1158/0008-5472.CAN-09-2050; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Salomonsson E, 2010, BIOCHEMISTRY-US, V49, P9518, DOI 10.1021/bi1009584; Saussez S, 2008, ORAL ONCOL, V44, P86, DOI 10.1016/j.oraloncology.2006.12.014; Song XZ, 2009, CHEM BIOL, V16, P36, DOI 10.1016/j.chembiol.2008.11.004; SPARROW CP, 1987, J BIOL CHEM, V262, P7383; STEEN H, 2002, SCI STKE 2002; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stowell SR, 2004, GLYCOBIOLOGY, V14, P157, DOI 10.1093/glycob/cwh018; TANIUCHI K, 2011, ONCOGENE; Thompson IM, 2007, CAN MED ASSOC J, V176, P1853, DOI 10.1503/cmaj.060955; Tsai CM, 2011, J IMMUNOL, V187, P1643, DOI 10.4049/jimmunol.1100297; Xu W, 2007, EUR J IMMUNOL, V37, P1594, DOI 10.1002/eji.200737042; YAMASHITA K, 1989, J BIOL CHEM, V264, P2415; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	65	47	47	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26560	10.1371/journal.pone.0026560	http://dx.doi.org/10.1371/journal.pone.0026560			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028908	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900074
J	Thorlund, K; Imberger, G; Walsh, M; Chu, R; Gluud, C; Wetterslev, J; Guyatt, G; Devereaux, PJ; Thabane, L				Thorlund, Kristian; Imberger, Georgina; Walsh, Michael; Chu, Rong; Gluud, Christian; Wetterslev, Jorn; Guyatt, Gordon; Devereaux, Philip J.; Thabane, Lehana			The Number of Patients and Events Required to Limit the Risk of Overestimation of Intervention Effects in Meta-Analysis-A Simulation Study	PLOS ONE			English	Article							TRIAL SEQUENTIAL-ANALYSIS; MONITORING BOUNDARIES; METAANALYSIS; TIME	Background: Meta-analyses including a limited number of patients and events are prone to yield overestimated intervention effect estimates. While many assume bias is the cause of overestimation, theoretical considerations suggest that random error may be an equal or more frequent cause. The independent impact of random error on meta-analyzed intervention effects has not previously been explored. It has been suggested that surpassing the optimal information size (i.e., the required meta-analysis sample size) provides sufficient protection against overestimation due to random error, but this claim has not yet been validated. Methods: We simulated a comprehensive array of meta-analysis scenarios where no intervention effect existed (i.e., relative risk reduction (RRR) = 0%) or where a small but possibly unimportant effect existed (RRR = 10%). We constructed different scenarios by varying the control group risk, the degree of heterogeneity, and the distribution of trial sample sizes. For each scenario, we calculated the probability of observing overestimates of RRR>20% and RRR>30% for each cumulative 500 patients and 50 events. We calculated the cumulative number of patients and events required to reduce the probability of overestimation of intervention effect to 10%, 5%, and 1%. We calculated the optimal information size for each of the simulated scenarios and explored whether meta-analyses that surpassed their optimal information size had sufficient protection against overestimation of intervention effects due to random error. Results: The risk of overestimation of intervention effects was usually high when the number of patients and events was small and this risk decreased exponentially over time as the number of patients and events increased. The number of patients and events required to limit the risk of overestimation depended considerably on the underlying simulation settings. Surpassing the optimal information size generally provided sufficient protection against overestimation. Conclusions: Random errors are a frequent cause of overestimation of intervention effects in meta-analyses. Surpassing the optimal information size will provide sufficient protection against overestimation.	[Thorlund, Kristian; Walsh, Michael; Chu, Rong; Guyatt, Gordon; Devereaux, Philip J.; Thabane, Lehana] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada; [Thorlund, Kristian; Imberger, Georgina; Gluud, Christian; Wetterslev, Jorn] Copenhagen Univ Hosp, Rigshosp, Copenhagen Trial Unit, Ctr Clin Intervent Res,Dept 3344, Copenhagen, Denmark; [Chu, Rong; Thabane, Lehana] St Josephs Healthcare Hamilton, Biostat Unit, Father Sean OSullivan Res Ctr, Hamilton, ON, Canada; [Devereaux, Philip J.] McMaster Univ, Publ Hlth Res Inst, Hamilton, ON L8S 4L8, Canada	McMaster University; Rigshospitalet; University of Copenhagen; McMaster University; McMaster University	Thorlund, K (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada.	thorluk@mcmaster.ca	Wetterslev, Jørn/ABF-1251-2020; Devereaux, PJ/AAF-2862-2019; Gluud, Christian/AAY-1027-2021; Devereaux, PJ/AAY-1757-2021; Gluud, Christian/HGB-3191-2022; Walsh, Michael/ABE-1278-2021	Wetterslev, Jørn/0000-0001-7778-1771; Gluud, Christian/0000-0002-8861-0799; Walsh, Michael/0000-0001-8292-2014; Devereaux, PJ/0000-0003-2935-637X				Berkey CS, 1996, CONTROL CLIN TRIALS, V17, P357, DOI 10.1016/S0197-2456(96)00014-1; Borm GF, 2009, J CLIN EPIDEMIOL, V62, P825, DOI 10.1016/j.jclinepi.2008.08.010; Brok J, 2009, INT J EPIDEMIOL, V38, P287, DOI 10.1093/ije/dyn188; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Devereaux PJ, 2005, BMJ-BRIT MED J, V331, P313, DOI 10.1136/bmj.38503.623646.8F; Gehr Bernhard T, 2006, BMC Med Res Methodol, V6, P25, DOI 10.1186/1471-2288-6-25; Guyatt G, 2011, J CLIN EPID IN PRESS; Guyatt G, 2002, JAMA-J AM MED ASSOC, V284, P1290; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2011, STAT MED, V30, P903, DOI 10.1002/sim.4088; Ioannidis JPA, 2001, P NATL ACAD SCI USA, V98, P831, DOI 10.1073/pnas.021529998; LAU J, 1995, J CLIN EPIDEMIOL, V48, P45, DOI 10.1016/0895-4356(94)00106-Z; Pereira TV, 2011, J CLIN EPIDEMIOL, V64, P1060, DOI 10.1016/j.jclinepi.2010.12.012; Pogue J, 1998, LANCET, V351, P47, DOI 10.1016/S0140-6736(97)08461-4; Pogue JM, 1997, CONTROL CLIN TRIALS, V18, P580, DOI 10.1016/S0197-2456(97)00051-2; Sidik K, 2005, J R STAT SOC C-APPL, V54, P367, DOI 10.1111/j.1467-9876.2005.00489.x; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Trikalinos TA, 2004, J CLIN EPIDEMIOL, V57, P1124, DOI 10.1016/j.jclinepi.2004.02.018; van der Tweel I, 2010, CLIN TRIALS, V7, P136, DOI 10.1177/1740774509360994; Wetterslev J, 2008, J CLIN EPIDEMIOL, V61, P64, DOI 10.1016/j.jclinepi.2007.03.013; Wetterslev J, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-86; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	24	229	231	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25491	10.1371/journal.pone.0025491	http://dx.doi.org/10.1371/journal.pone.0025491			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028777	Green Submitted, gold, Green Published			2022-12-27	WOS:000296186900007
J	Xiong, W; Liu, T; Wang, YS; Chen, XW; Sun, L; Guo, N; Zheng, H; Zheng, LH; Ruat, M; Han, WP; Zhang, CX; Zhou, Z				Xiong, Wei; Liu, Tao; Wang, Yeshi; Chen, Xiaowei; Sun, Lei; Guo, Ning; Zheng, Hui; Zheng, Lianghong; Ruat, Martial; Han, Weiping; Zhang, Claire Xi; Zhou, Zhuan			An Inhibitory Effect of Extracellular Ca2+ on Ca2+-Dependent Exocytosis	PLOS ONE			English	Article							ADRENAL CHROMAFFIN CELLS; ROOT GANGLION NEURONS; CALCIUM-SENSING RECEPTOR; SYNAPTIC VESICLE EXOCYTOSIS; TRANSMITTER RELEASE; CA2+-SENSING RECEPTOR; CATION CHANNEL; NEUROTRANSMITTER RELEASE; PRESYNAPTIC CALCIUM; HIPPOCAMPAL-NEURONS	Aim: Neurotransmitter release is elicited by an elevation of intracellular Ca2+ concentration ([Ca2+](i)). The action potential triggers Ca2+ influx through Ca2+ channels which causes local changes of [Ca2+](i) for vesicle release. However, any direct role of extracellular Ca2+ (besides Ca2+ influx) on Ca2+-dependent exocytosis remains elusive. Here we set out to investigate this possibility on rat dorsal root ganglion (DRG) neurons and chromaffin cells, widely used models for studying vesicle exocytosis. Results: Using photolysis of caged Ca 2+ and caffeine-induced release of stored Ca2+, we found that extracellular Ca2+ inhibited exocytosis following moderate [Ca2+](i) rises (2-3 mM). The IC50 for extracellular Ca2+ inhibition of exocytosis (ECIE) was 1.38 mM and a physiological reduction (similar to 30%) of extracellular Ca2+ concentration ([Ca2+](o)) significantly increased the evoked exocytosis. At the single vesicle level, quantal size and release frequency were also altered by physiological [Ca2+](o). The calcimimetics Mg2+, Cd2+, G418, and neomycin all inhibited exocytosis. The extracellular Ca2+-sensing receptor (CaSR) was not involved because specific drugs and knockdown of CaSR in DRG neurons did not affect ECIE. Conclusion/Significance: As an extension of the classic Ca2+ hypothesis of synaptic release, physiological levels of extracellular Ca2+ play dual roles in evoked exocytosis by providing a source of Ca2+ influx, and by directly regulating quantal size and release probability in neuronal cells.	[Xiong, Wei; Liu, Tao; Wang, Yeshi; Chen, Xiaowei; Sun, Lei; Guo, Ning; Zheng, Hui; Zheng, Lianghong; Zhang, Claire Xi; Zhou, Zhuan] Peking Univ, State Key Lab Biomembrane Engn, Beijing 100871, Peoples R China; [Xiong, Wei; Liu, Tao; Wang, Yeshi; Chen, Xiaowei; Sun, Lei; Guo, Ning; Zheng, Hui; Zheng, Lianghong; Zhang, Claire Xi; Zhou, Zhuan] Peking Univ, Ctr Life Sci, Inst Mol Med, Beijing 100871, Peoples R China; [Ruat, Martial] CNRS, UPR9040, Inst Neurobiol Alfred Fessard IFR 2118, Gif Sur Yvette, France; [Zhang, Claire Xi] Agcy Sci Technol & Res, Lab Metab Med, Singapore Bioimaging Consortium, Singapore, Singapore	Peking University; Peking University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC)	Xiong, W (corresponding author), Peking Univ, State Key Lab Biomembrane Engn, Beijing 100871, Peoples R China.	clairexz@pku.edu.cn; zzhou@pku.edu.cn	zheng, Hui/I-3573-2013; Ruat, Martial/E-5544-2016; Xiong, Wei/AAY-5944-2020; Xiong, Wei/A-6170-2012	zheng, Hui/0000-0002-2504-9092; Xiong, Wei/0000-0002-2784-7696; 	National Basic Research Program of China [G2000077800, 2012CB518006, 2006CB500800]; National Natural Science Foundation of China [30728009, 30770521, 30770788, 30970660, 30911120491, 30830043]; French Agence Nationale de la Recherche (ANR-PhysioPatho)	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); French Agence Nationale de la Recherche (ANR-PhysioPatho)(French National Research Agency (ANR))	This work was supported by grants from the National Basic Research Program of China (G2000077800, 2012CB518006 and 2006CB500800) and the National Natural Science Foundation of China (30728009, 30770521, 30770788, 30970660, 30911120491 and 30830043). Dr. Ruat is supported by a grant from the French Agence Nationale de la Recherche (ANR-PhysioPatho). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ales E, 1999, NAT CELL BIOL, V1, P40, DOI 10.1038/9012; ARTALEJO CR, 1995, P NATL ACAD SCI USA, V92, P8328, DOI 10.1073/pnas.92.18.8328; Atlas D, 2010, CELL SIGNAL, V22, P1597, DOI 10.1016/j.cellsig.2010.04.003; AUGUSTINE GJ, 1987, ANNU REV NEUROSCI, V10, P633, DOI 10.1146/annurev.ne.10.030187.003221; Awumey EM, 2007, AM J PHYSIOL-CELL PH, V292, pC1895, DOI 10.1152/ajpcell.00404.2006; Borst JGG, 1999, J PHYSIOL-LONDON, V521, P123, DOI 10.1111/j.1469-7793.1999.00123.x; BROWN EM, 1993, NATURE, V366, P575, DOI 10.1038/366575a0; BURGOYNE RD, 1994, FEBS LETT, V344, P139, DOI 10.1016/0014-5793(94)00361-0; CAMPBELL DT, 1976, J GEN PHYSIOL, V67, P309, DOI 10.1085/jgp.67.3.309; Chen XW, 2008, J CELL BIOL, V181, P791, DOI 10.1083/jcb.200711021; Chen XK, 2005, NAT NEUROSCI, V8, P1160, DOI 10.1038/nn1529; CHOW RH, 1992, NATURE, V356, P60, DOI 10.1038/356060a0; Cohen JE, 2004, NEUROSCIENTIST, V10, P12, DOI 10.1177/1073858403259440; ELLISDAVIES GCR, 1994, P NATL ACAD SCI USA, V91, P187, DOI 10.1073/pnas.91.1.187; Faure H, 2009, CELL CALCIUM, V46, P323, DOI 10.1016/j.ceca.2009.09.004; FERNANDEZ JM, 1984, NATURE, V312, P453, DOI 10.1038/312453a0; Ferry S, 2000, EUR J NEUROSCI, V12, P872, DOI 10.1046/j.1460-9568.2000.00980.x; Gad H, 1998, NEURON, V21, P607, DOI 10.1016/S0896-6273(00)80570-X; Gillis Kevin D., 1995, P155; HABLITZ JJ, 1986, BIOPHYS J, V50, P753, DOI 10.1016/S0006-3495(86)83515-9; Han WP, 2005, J BIOL CHEM, V280, P5089, DOI 10.1074/jbc.M408757200; Heyeraas KJ, 2008, CALCIFIED TISSUE INT, V82, P57, DOI 10.1007/s00223-007-9096-z; Hille B, 2001, ION CHANNELS EXCITAB, P646; Hofer AM, 2003, NAT REV MOL CELL BIO, V4, P530, DOI 10.1038/nrm1154; Huang HP, 2007, P NATL ACAD SCI USA, V104, P1401, DOI 10.1073/pnas.0608897104; Huang LYM, 1996, NEURON, V17, P135, DOI 10.1016/S0896-6273(00)80287-1; KATZ B, 1967, J PHYSIOL-LONDON, V189, P535, DOI 10.1113/jphysiol.1967.sp008183; KATZ B, 1969, RELEASE NEURAL TRANS, P1; Kishimoto T, 2006, EMBO J, V25, P673, DOI 10.1038/sj.emboj.7600983; Lerner I, 2006, J NEUROCHEM, V97, P116, DOI 10.1111/j.1471-4159.2006.03709.x; Lu BX, 2010, NEURON, V68, P488, DOI 10.1016/j.neuron.2010.09.014; Moser T, 1997, J NEUROSCI, V17, P2314; Nagy G, 2004, NEURON, V41, P417, DOI 10.1016/S0896-6273(04)00038-8; NEHER E, 1993, NEURON, V10, P21, DOI 10.1016/0896-6273(93)90238-M; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nemeth EF, 1999, TRENDS ENDOCRIN MET, V10, P66, DOI 10.1016/S1043-2760(98)00119-2; NICHOLSON C, 1978, J NEUROPHYSIOL, V41, P1026, DOI 10.1152/jn.1978.41.4.1026; Ouyang KF, 2005, P NATL ACAD SCI USA, V102, P12259, DOI 10.1073/pnas.0408494102; Petrel C, 2004, J BIOL CHEM, V279, P18990, DOI 10.1074/jbc.M400724200; Phillips CG, 2008, J NEUROSCI, V28, P12062, DOI 10.1523/JNEUROSCI.4134-08.2008; RUAT M, 1995, P NATL ACAD SCI USA, V92, P3161, DOI 10.1073/pnas.92.8.3161; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Smith SM, 2004, NEURON, V41, P243, DOI 10.1016/S0896-6273(03)00837-7; Stanley EF, 2000, J NEUROPHYSIOL, V83, P477, DOI 10.1152/jn.2000.83.1.477; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Voets T, 2001, P NATL ACAD SCI USA, V98, P11680, DOI 10.1073/pnas.201398798; Wei WL, 2007, P NATL ACAD SCI USA, V104, P16323, DOI 10.1073/pnas.0701149104; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; Wu B, 2005, FRONT BIOSCI-LANDMRK, V10, P761, DOI 10.2741/1570; Xiong ZG, 1997, P NATL ACAD SCI USA, V94, P7012, DOI 10.1073/pnas.94.13.7012; Xu T, 1999, CELL, V99, P713, DOI 10.1016/S0092-8674(00)81669-4; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yang DY, 2004, J AM COLL NUTR, V23, p552S, DOI 10.1080/07315724.2004.10719402; Zhang C, 2004, NEURON, V42, P225, DOI 10.1016/S0896-6273(04)00189-8; Zhang C, 2002, NAT NEUROSCI, V5, P425, DOI 10.1038/nn845; ZHANG ET, 1990, J CEREBR BLOOD F MET, V10, P136, DOI 10.1038/jcbfm.1990.18; Zhang X, 2007, P NATL ACAD SCI USA, V104, P9864, DOI 10.1073/pnas.0611048104; Zheng H, 2009, BIOPHYS J, V96, P2449, DOI 10.1016/j.bpj.2008.11.037; Zhou Z, 1996, BIOPHYS J, V70, P1543, DOI 10.1016/S0006-3495(96)79718-7; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; Zhou Z, 1996, J BIOL CHEM, V271, P270, DOI 10.1074/jbc.271.1.270	65	6	7	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e24573	10.1371/journal.pone.0024573	http://dx.doi.org/10.1371/journal.pone.0024573			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028769	gold, Green Published, Green Submitted			2022-12-27	WOS:000296186900002
J	Chang, ML; Lin, SM; Yeh, CT				Chang, Ming-Ling; Lin, Shi-Ming; Yeh, Chau-Ting			HURP Expression-Assisted Risk Scores Identify Prognosis Distinguishable Subgroups in Early Stage Liver Cancer	PLOS ONE			English	Article							NEEDLE-ASPIRATION-CYTOLOGY; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; ALPHA-FETOPROTEIN; AURORA-A; DIAGNOSIS; GENE; CIRRHOSIS; CELLS; PREDICTORS	Background: Hepatoma up-regulated protein (HURP) is a component of the chromatin-dependent pathway for spindle assembly. We examined the prognostic predictive value of HURP in human hepatocellular carcinoma (HCC). Methods: HURP expression was evaluated by immunocytochemistry of fine needle aspirated hepatoma cells in 97 HCC patients with Barcelona Clinic Liver Cancer (BCLC) stage A. Subsequently, these patients underwent partial hepatectomy (n = 18) or radiofrequency ablation (n = 79) and were followed for 2 to 35 months. The clinicopathological parameters were submitted for survival analysis. Results: HURP expression in aspirated HCC cells was detected in 19.6% patients. Kaplan-Meier survival analysis showed that positive HURP expression (P = 0.023), cytological grading >= 3 (P = 0.008), AFP >= 35 ng/mL (P = 0.039), bilirubin >= 1.3 mg/dL (P = 0.010), AST >= 50 U/L (P = 0.003) and ALT >= 35 U/L (P = 0.005) were all associated with a shorter disease-free survival. A stepwise multivariate Cox proportional hazard model revealed that positive HURP expression (HR, 2.334; 95% CI, 1.165-4.679, P = 0.017), AST >= 50 U/L (HR, 3.697; 95% CI, 1.868-7.319, p<0.001), cytological grade >= 3 (HR, 4.249; 95% CI, 2.061-8.759, P<0.001) and tumor number >1 (HR, 2.633; 95% CI, 1.212-5.722, P = 0.014) were independent predictors for disease-free survival. By combining the 4 independent predictors, patients with different risk scores (RS) showed distinguishable disease-free survival (RS <= 1 vs. RS = 2, P = 0.001; RS = 2 vs. RS = 3, P<0.001). In contrast, the patients cannot be separated into prognosis distinguishable subgroups by using AJCC/UICC TNM staging system. Conclusion: HCC patients with BCLC stage A can be separated into three prognosis-distinguishable groups by use of a risk score that is based upon HURP expression in aspirated HCC cells, ALT, cytological grade and tumor number.	[Chang, Ming-Ling; Lin, Shi-Ming; Yeh, Chau-Ting] Chang Gung Mem Hosp, Liver Res Ctr, Tao Yuan, Taiwan; [Chang, Ming-Ling; Lin, Shi-Ming; Yeh, Chau-Ting] Chang Gung Mem Hosp, Dept Hepatol, Tao Yuan, Taiwan; [Chang, Ming-Ling; Yeh, Chau-Ting] Chang Gung Univ, Coll Med, Grad Inst Clin Med Sci, Tao Yuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Chang, ML (corresponding author), Chang Gung Mem Hosp, Liver Res Ctr, Tao Yuan, Taiwan.	chauting@adm.cgmh.org.tw			Chang Gung Medical Research Program [CMRP-370693]	Chang Gung Medical Research Program	This project was supported by grant from Chang Gung Medical Research Program (CMRP-370693). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Betz MJ, 2009, NAT REV ENDOCRINOL, V5, P297, DOI 10.1038/nrendo.2009.93; Bischoff JR, 1999, TRENDS CELL BIOL, V9, P454, DOI 10.1016/S0962-8924(99)01658-X; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Chen MS, 2006, ANN SURG, V243, P321, DOI 10.1097/01.sla.0000201480.65519.b8; Chiu AW, 2002, UROLOGY, V60, P181, DOI 10.1016/S0090-4295(02)01672-2; Cho YK, 2010, HEPATOLOGY, V51, P1284, DOI 10.1002/hep.23466; Chun JM, 2011, J SURG ONCOL, V103, P148, DOI 10.1002/jso.21786; Daniele B, 2004, GASTROENTEROLOGY, V127, pS108, DOI 10.1053/j.gastro.2004.09.023; Davis TN, 2007, TRENDS CELL BIOL, V17, P377, DOI 10.1016/j.tcb.2007.08.001; de Reynies A, 2009, J CLIN ONCOL, V27, P1108, DOI 10.1200/JCO.2008.18.5678; Degos F, 2000, GUT, V47, P131, DOI 10.1136/gut.47.1.131; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fernandes ML, 2009, BRIT J SURG, V96, P756, DOI 10.1002/bjs.6645; Goldberg SN, 2003, RADIOLOGY, V228, P335, DOI 10.1148/radiol.2282021787; Gudmundsson KO, 2007, STEM CELLS, V25, P1498, DOI 10.1634/stemcells.2005-0479; Hsu JM, 2004, J BIOL CHEM, V279, P32592, DOI 10.1074/jbc.M404950200; Huang GT, 1996, J HEPATOL, V25, P334, DOI 10.1016/S0168-8278(96)80120-6; HUANG J, 2010, J GASTROINTEST  1030; Huang YL, 2003, ANTICANCER RES, V23, P2729; KOMATSU S, 2011, BR J SURG       0119; Kuo TC, 2010, BIOCHEM PHARMACOL, V80, P1093, DOI 10.1016/j.bcp.2010.06.003; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lin CC, 2008, J GASTROEN HEPATOL, V23, pE146, DOI 10.1111/j.1440-1746.2007.04924.x; Lin ZZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-461; Liu Da-quan, 2006, Nan Fang Yi Ke Da Xue Xue Bao, V26, P1149; Lok AS, 2010, GASTROENTEROLOGY, V138, P493, DOI 10.1053/j.gastro.2009.10.031; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.0.CO;2-O; Murakata A, 2011, ANN SURG, V253, P94, DOI 10.1097/SLA.0b013e3181f9bc00; Nazir RT, 2010, JCPSP-J COLL PHYSICI, V20, P373, DOI 06.2010/JCPSP.373376; NOGUCHI S, 1986, CANCER, V58, P321, DOI 10.1002/1097-0142(19860715)58:2<321::AID-CNCR2820580219>3.0.CO;2-B; PORTELLA G, 2010, CURR MED CHEM   1214; Rossi S, 2011, HEPATOLOGY, V53, P136, DOI 10.1002/hep.23965; RUSTGI VK, 1987, GASTROENTEROL CLIN N, V16, P545; Sanderson HS, 2006, CURR BIOL, V16, pR466, DOI 10.1016/j.cub.2006.05.032; SHAH SA, 2007, ANN SURG, V245, P51; Talwalkar JA, 2004, GASTROENTEROLOGY, V127, pS126, DOI 10.1053/j.gastro.2004.09.026; Tsai CY, 2008, J BIOL CHEM, V283, P26302, DOI 10.1074/jbc.C800117200; Tsou AP, 2003, ONCOGENE, V22, P298, DOI 10.1038/sj.onc.1206129; Wang YC, 2006, BIOCHEM BIOPH RES CO, V340, P244, DOI 10.1016/j.bbrc.2005.12.005; Wilde A, 2006, J CELL BIOL, V173, P829, DOI 10.1083/jcb.200605150; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Wong J, 2006, J CELL BIOL, V173, P879, DOI 10.1083/jcb.200511132; Yeh CT, 2010, HEPATOLOGY, V52, P1922, DOI 10.1002/hep.23898; YOSHITAKE K, 2011, ANN SURG ONCOL  0201; Yu CTR, 2005, MOL CELL BIOL, V25, P5789, DOI 10.1128/MCB.25.14.5789-5800.2005; Zavaglia C, 2005, AM J GASTROENTEROL, V100, P2708, DOI 10.1111/j.1572-0241.2005.00289.x; Zhou YM, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-78	50	17	17	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26323	10.1371/journal.pone.0026323	http://dx.doi.org/10.1371/journal.pone.0026323			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022601	gold, Green Submitted, Green Published			2022-12-27	WOS:000295984400046
J	Perfetti, B; Tesse, M; Varanese, S; Saggino, A; Onofrj, M				Perfetti, Bernardo; Tesse, Marcello; Varanese, Sara; Saggino, Aristide; Onofrj, Marco			Irrelevant Features of a Stimulus Can Either Facilitate or Disrupt Performance in a Working Memory Task: The Role of Fluid Intelligence	PLOS ONE			English	Article							SHORT-TERM-MEMORY; FUNCTIONAL NEUROANATOMY; PREFRONTAL CORTEX; INFORMATION; MECHANISMS; CAPACITY; INTERFERENCE; SPAN	It has been shown that fluid intelligence (gf) is fundamental to overcome interference due to information of a previously encoded item along a task-relevant domain. However, the biasing effect of task-irrelevant dimensions is still unclear as well as its relation with gf. The present study aimed at clarifying these issues. Gf was assessed in 60 healthy subjects. In a different session, the same subjects performed two versions (letter-detection and spatial) of a three-back working memory task with a set of physically identical stimuli (letters) presented at different locations on the screen. In the letter-detection task, volunteers were asked to match stimuli on the basis of their identity whereas, in the spatial task, they were required to match items on their locations. Cross-domain bias was manipulated by pseudorandomly inserting a match between the current and the three back items on the irrelevant domain. Our findings showed that a task-irrelevant feature of a salient stimulus can actually bias the ongoing performance. We revealed that, at trials in which the current and the three-back items matched on the irrelevant domain, group accuracy was lower (interference). On the other hand, at trials in which the two items matched on both the relevant and irrelevant domains, the group showed an enhancement of the performance (facilitation). Furthermore, we demonstrated that individual differences in fluid intelligence covaries with the ability to override cross-domain interference in that higher gf subjects showed better performance at interference trials than low gf subjects. Altogether, our findings suggest that stimulus features irrelevant to the task can affect cognitive performance along the relevant domain and that gf plays an important role in protecting relevant memory contents from the hampering effect of such a bias.	[Perfetti, Bernardo] CUNY City Coll, Sophie Davis Sch Med, Dept Physiol & Pharmacol, New York, NY 10031 USA; [Tesse, Marcello; Saggino, Aristide; Onofrj, Marco] Univ Chieti Pescara G Annunzio, Dept Neurosci & Imaging, Chieti, Italy; [Varanese, Sara] NYU, Dept Neurol, Sch Med, Div Movement Disorders, New York, NY 10016 USA	City University of New York (CUNY) System; City College of New York (CUNY); Sophie Davis School of Biomedical Education; G d'Annunzio University of Chieti-Pescara; New York University	Perfetti, B (corresponding author), CUNY City Coll, Sophie Davis Sch Med, Dept Physiol & Pharmacol, New York, NY 10031 USA.	perfetti@inwind.it	onofrj, marco/K-7710-2016	onofrj, marco/0000-0002-0480-2495				BADDDELEY AD, 1986, WORKING MEMORY; Burgess GC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012861; Carroll JB, 2003, SCIENTIFIC STUDY OF GENERAL INTELLIGENCE: TRIBUTE TO ARTHUR R. J ENSEN, P5, DOI 10.1016/B978-008043793-4/50036-2; Chein JM, 2011, NEUROIMAGE, V54, P550, DOI 10.1016/j.neuroimage.2010.07.067; Conway ARA, 2005, PSYCHON B REV, V12, P769, DOI 10.3758/BF03196772; D'Esposito M, 1998, COGNITIVE BRAIN RES, V7, P1, DOI 10.1016/S0926-6410(98)00004-4; DUNCAN J, 1995, NEUROPSYCHOLOGIA, V33, P261, DOI 10.1016/0028-3932(94)00124-8; Duncan J., 2005, MEASURING MIND SPEED, P249, DOI DOI 10.1093/ACPROF:OSO/9780198566427.003.0010; Engle Randall W., 1999, P515; Engle RW, 1999, J EXP PSYCHOL GEN, V128, P309, DOI 10.1037/0096-3445.128.3.309; GEVINS A, 1993, ELECTROEN CLIN NEURO, V87, P128, DOI 10.1016/0013-4694(93)90119-G; Gray JR, 2003, NAT NEUROSCI, V6, P316, DOI 10.1038/nn1014; Gruber O, 2003, NEUROIMAGE, V19, P797, DOI 10.1016/S1053-8119(03)00089-2; Jonides J, 2006, NEUROSCIENCE, V139, P181, DOI 10.1016/j.neuroscience.2005.06.042; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Kane MJ, 2005, PSYCHOL BULL, V131, P66, DOI 10.1037/0033-2909.131.1.66; Kane MJ, 2004, J EXP PSYCHOL GEN, V133, P189, DOI 10.1037/0096-3445.133.2.189; KINCHLA RA, 1974, PERCEPT PSYCHOPHYS, V16, P117, DOI 10.3758/BF03203263; Majerus S, 2010, J COGNITIVE NEUROSCI, V22, P2570, DOI 10.1162/jocn.2009.21378; Meegan DV, 2005, NEUROIMAGE, V25, P1043, DOI 10.1016/j.neuroimage.2004.12.061; Melara RD, 2003, PSYCHOL REV, V110, P422, DOI 10.1037/0033-295X.110.3.422; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; MONSELL S, 1978, COGNITIVE PSYCHOL, V10, P36; Morey CC, 2005, J EXP PSYCHOL LEARN, V31, P703, DOI 10.1037/0278-7393.31.4.703; Morey CC, 2004, PSYCHON B REV, V11, P296, DOI 10.3758/BF03196573; Muller NG, 2006, NEUROSCIENCE, V139, P51, DOI 10.1016/j.neuroscience.2005.09.018; NICKERSON RS, 1973, PSYCHOL REV, V80, P489, DOI 10.1037/h0035437; Nystrom LE, 2000, NEUROIMAGE, V11, P424, DOI 10.1006/nimg.2000.0572; Perfetti B, 2009, HUM BRAIN MAPP, V30, P497, DOI 10.1002/hbm.20519; Postle BR, 1999, J COGNITIVE NEUROSCI, V11, P585, DOI 10.1162/089892999563652; Raven J. C., 1965, ADV PROGR MATRICES S; Ricker TJ, 2010, PSYCHON B REV, V17, P516, DOI 10.3758/PBR.17.4.516; ROSEN WM, 1998, J MEM LANG, V39, P418; SAGGINO A, 2006, INTELLIGENCE NEW RES; Sandrini M, 2008, NEUROPSYCHOLOGIA, V46, P2056, DOI 10.1016/j.neuropsychologia.2008.02.003; Smith EE, 1997, COGNITIVE PSYCHOL, V33, P5, DOI 10.1006/cogp.1997.0658; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Stevanovski B, 2007, VIS COGN, V15, P532, DOI 10.1080/13506280600871917; Swets JA, 1996, SCI PSYCH S; Szmalec A, 2011, J EXP PSYCHOL HUMAN, V37, P137, DOI 10.1037/a0020365; Walter H, 2003, CORTEX, V39, P897, DOI 10.1016/S0010-9452(08)70869-4; Zurowski B, 2002, NEUROIMAGE, V15, P45, DOI 10.1006/nimg.2001.0968	42	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26249	10.1371/journal.pone.0026249	http://dx.doi.org/10.1371/journal.pone.0026249			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834RQ	22022580	Green Published, gold			2022-12-27	WOS:000295981600043
J	Intskirveli, I; Metherate, R; Cramer, KS				Intskirveli, Irakli; Metherate, Raju; Cramer, Karina S.			Null Mutations in EphB Receptors Decrease Sharpness of Frequency Tuning in Primary Auditory Cortex	PLOS ONE			English	Article							EPHRIN-AS; THALAMOCORTICAL PROJECTIONS; IN-VIVO; FUNCTIONAL-ORGANIZATION; SPECTRAL INTEGRATION; RETINOTECTAL SYSTEM; INFERIOR COLLICULUS; STRUCTURED ACTIVITY; SYNAPSE FORMATION; MAPS	Primary auditory cortex (A1) exhibits a tonotopic representation of characteristic frequency (CF). The receptive field properties of A1 neurons emerge from a combination of thalamic inputs and intracortical connections. However, the mechanisms that guide growth of these inputs during development and shape receptive field properties remain largely unknown. We previously showed that Eph family proteins help establish tonotopy in the auditory brainstem. Moreover, other studies have shown that these proteins shape topography in visual and somatosensory cortices. Here, we examined the contribution of Eph proteins to cortical organization of CF, response thresholds and sharpness of frequency tuning. We examined mice with null mutations in EphB2 and EphB3, as these mice show significant changes in auditory brainstem connectivity. We mapped A1 using local field potential recordings in adult EphB2(-/-); EphB3(-/-) and EphB3(-/-) mice, and in a central A1 location inserted a 16-channel probe to measure tone-evoked current-source density (CSD) profiles. Based on the shortest-latency current sink in the middle layers, which reflects putative thalamocortical input, we determined frequency receptive fields and sharpness of tuning (Q(20)) for each recording site. While both mutant mouse lines demonstrated increasing CF values from posterior to anterior A1 similar to wild type mice, we found that the double mutant mice had significantly lower Q(20) values than either EphB3(-/-) mice or wild type mice, indicating broader tuning. In addition, we found that the double mutants had significantly higher CF thresholds and longer onset latency at threshold than mice with wild type EphB2. These results demonstrate that EphB receptors influence auditory cortical responses, and suggest that EphB signaling has multiple functions in auditory system development.	[Intskirveli, Irakli] Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA; Univ Calif Irvine, Ctr Hearing Res, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Intskirveli, I (corresponding author), Univ Calif Irvine, Dept Neurobiol & Behav, Irvine, CA 92717 USA.	cramerk@uci.edu		Cramer, Karina/0000-0003-3793-4862	NIH [R01 NIDCD 005771, NIH P30DC008369, NIH R01 DA12929]; NSF [IOS-0642346]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005771, P30DC008369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012929] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants NIH R01 NIDCD 005771, NIH P30DC008369, NIH R01 DA12929 and NSF IOS-0642346. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay S, 2010, NAT NEUROSCI, V13, P361, DOI 10.1038/nn.2490; Bishop KM, 2002, J NEUROSCI, V22, P7627; Bolz J, 2004, J NEUROBIOL, V59, P82, DOI 10.1002/neu.10346; Braisted JE, 1997, DEV BIOL, V191, P14, DOI 10.1006/dbio.1997.8706; Cang JH, 2005, NEURON, V48, P577, DOI 10.1016/j.neuron.2005.10.026; Cang JH, 2008, J NEUROSCI, V28, P11015, DOI 10.1523/JNEUROSCI.2478-08.2008; Cang JH, 2008, NEURON, V57, P511, DOI 10.1016/j.neuron.2007.12.025; Chen ZY, 2004, J NEUROSCI, V24, P2366, DOI 10.1523/JNEUROSCI.4711-03.2004; Cowan CA, 2000, NEURON, V26, P417, DOI 10.1016/S0896-6273(00)81174-5; Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5; Dufour A, 2003, NEURON, V39, P453, DOI 10.1016/S0896-6273(03)00440-9; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Feldheim DA, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001768; Flanagan JG, 1997, CELL, V90, P403; Gabriele ML, 2011, DEV NEUROBIOL, V71, P182, DOI 10.1002/dneu.20842; Gale NW, 1996, NEURON, V17, P9, DOI 10.1016/S0896-6273(00)80276-7; Gao PP, 1998, P NATL ACAD SCI USA, V95, P5329, DOI 10.1073/pnas.95.9.5329; Grove EA, 2003, ANNU REV NEUROSCI, V26, P355, DOI 10.1146/annurev.neuro.26.041002.131137; Hackett TA, 2011, J NEUROSCI, V31, P2983, DOI 10.1523/JNEUROSCI.5333-10.2011; Happel MFK, 2010, J NEUROSCI, V30, P11114, DOI 10.1523/JNEUROSCI.0689-10.2010; Haustead DJ, 2008, J NEUROSCI, V28, P7376, DOI 10.1523/JNEUROSCI.1135-08.2008; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Hsieh CY, 2010, J NEUROSCI, V30, P9840, DOI 10.1523/JNEUROSCI.0386-10.2010; Huffman KJ, 2007, DEV NEUROBIOL, V67, P1655, DOI 10.1002/dneu.20535; Kandler K, 2009, NAT NEUROSCI, V12, P711, DOI 10.1038/nn.2332; Kaur S, 2005, NEUROSCIENCE, V134, P1033, DOI 10.1016/j.neuroscience.2005.04.052; Kaur S, 2004, J NEUROPHYSIOL, V91, P2551, DOI 10.1152/jn.01121.2003; Kawai H, 2011, J NEUROSCI IN PRESS; Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007; Kim G, 2003, NAT NEUROSCI, V6, P282, DOI 10.1038/nn1015; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lim BK, 2008, NAT NEUROSCI, V11, P160, DOI 10.1038/nn2033; Mann F, 2002, NEURON, V35, P461, DOI 10.1016/S0896-6273(02)00786-9; Marin O, 2001, DEV BIOL, V234, P289, DOI 10.1006/dbio.2001.0268; McClelland AC, 2009, P NATL ACAD SCI USA, V106, P20487, DOI 10.1073/pnas.0811862106; McLaughlin T, 2003, DEVELOPMENT, V130, P2407, DOI 10.1242/dev.00467; McLaughlin T, 2005, ANNU REV NEUROSCI, V28, P327, DOI 10.1146/annurev.neuro.28.061604.135714; MERZENICH MM, 1975, J NEUROPHYSIOL, V38, P231, DOI 10.1152/jn.1975.38.2.231; Miko IJ, 2007, J COMP NEUROL, V505, P669, DOI 10.1002/cne.21530; MULLERPREUSS P, 1984, HEARING RES, V16, P133, DOI 10.1016/0378-5955(84)90003-0; O'Leary DDM, 2002, CURR OPIN NEUROBIOL, V12, P14, DOI 10.1016/S0959-4388(02)00285-4; Pfeiffenberger C, 2006, J NEUROSCI, V26, P12873, DOI 10.1523/JNEUROSCI.3595-06.2006; Prakash N, 2000, J NEUROSCI, V20, P5841, DOI 10.1523/JNEUROSCI.20-15-05841.2000; Rubel EW, 2002, ANNU REV NEUROSCI, V25, P51, DOI 10.1146/annurev.neuro.25.112701.142849; Schreiner CE, 2007, NEURON, V56, P356, DOI 10.1016/j.neuron.2007.10.013; Szymanski FD, 2009, J NEUROPHYSIOL, V102, P1483, DOI 10.1152/jn.00240.2009; Vanderhaeghen P, 2000, NAT NEUROSCI, V3, P358, DOI 10.1038/73929; Zhang LI, 2002, P NATL ACAD SCI USA, V99, P2309, DOI 10.1073/pnas.261707398; Zhang YF, 2005, HEARING RES, V201, P145, DOI 10.1016/j.heares.2004.10.003	50	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26192	10.1371/journal.pone.0026192	http://dx.doi.org/10.1371/journal.pone.0026192			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022561	Green Published, gold			2022-12-27	WOS:000295976000083
J	Piskun, CM; Muthuswamy, A; Huelsmeyer, MK; Thompson, V; Stein, TJ				Piskun, Caroline M.; Muthuswamy, Anantharaman; Huelsmeyer, Michael K.; Thompson, Victoria; Stein, Timothy J.			Wnt/beta-Catenin Expression Does Not Correlate with Serum Alkaline Phosphatase Concentration in Canine Osteosarcoma Patients	PLOS ONE			English	Article							APPENDICULAR OSTEOSARCOMA; BETA-CATENIN; PROGNOSTIC-FACTORS; DIFFERENTIATION; METASTASIS; AMPUTATION; DIAGNOSIS; DOGS	Osteosarcoma is an aggressive malignancy of the bone and an increase in serum alkaline phosphatase concentration has clinical prognostic value in both humans and canines. Increased serum alkaline phosphatase concentration at the time of diagnosis has been associated with poorer outcomes for osteosarcoma patients. The biology underlying this negative prognostic factor is poorly understood. Given that activation of the Wnt signaling pathway has been associated with alkaline phosphatase expression in osteoblasts, we hypothesized that the Wnt/beta-catenin signaling pathway would be differentially activated in osteosarcoma tissue based on serum ALP status. Archived canine osteosarcoma samples and primary canine osteosarcoma cell lines were used to evaluate the status of Wnt/beta-catenin signaling pathway activity through immunohistochemical staining, western immunoblot analyses, quantitative reverse-transcription polymerase chain reaction, and a Wnt-responsive promoter activity assay. We found no significant difference in beta-catenin expression or activation between OSA populations differing in serum ALP concentration. Pathway activity was mildly increased in the primary OSA cell line generated from a patient with increased serum ALP compared to the normal serum ALP OSA cell line. Further investigation into the mechanisms underlying differences in serum ALP concentration is necessary to improve our understanding of the biological implications of this negative prognostic indicator.	[Piskun, Caroline M.; Huelsmeyer, Michael K.; Thompson, Victoria; Stein, Timothy J.] Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA; [Muthuswamy, Anantharaman] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Piskun, CM (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Med Sci, Madison, WI 53706 USA.	tjstein@wisc.edu			National Institutes of Health [T32 RR17503]; CTSA/NCRR [1UL1RR025011]; NATIONAL CENTER FOR RESEARCH RESOURCES [T32RR017503, UL1RR025011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CTSA/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health grants T32 RR17503 (CMP) and CTSA/NCRR 1UL1RR025011 (TJS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Cai YP, 2010, J PATHOL, V220, P24, DOI 10.1002/path.2628; DERNELL W.S., 2007, WITHROW MACEWENS SMA, P540; Ehrhart N, 1998, J AM VET MED ASSOC, V213, P1002; Fukuda T, 2010, DIFFERENTIATION, V80, P46, DOI 10.1016/j.diff.2010.05.002; Garzotto CK, 2000, J VET INTERN MED, V14, P587, DOI 10.1892/0891-6640(2000)014&lt;0587:PSOSAP&gt;2.3.CO;2; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Gorlick R, 2010, J BONE MINER RES, V25, P683, DOI 10.1002/jbmr.77; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Guo Y, 2008, CLIN ORTHOP RELAT R, V466, P2039, DOI 10.1007/s11999-008-0344-y; Haydon RC, 2002, INT J CANCER, V102, P338, DOI 10.1002/ijc.10719; Henthorn PS, 1999, DYNAMICS BONE CARTIL, P130; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Iwaya K, CLIN EXP METASTASIS, V20, P525; Liptak JM, 2004, COMP CONT EDUC PRACT, V26, P172; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Matsuzaki E, 2006, J BONE MINER RES, V21, P1307, DOI 10.1359/JBMR.060512; Matushansky I, 2007, J CLIN INVEST, V117, P3248, DOI 10.1172/JCI31377; Mirabello L, 2009, INT J CANCER, V125, P229, DOI 10.1002/ijc.24320; Mirabello L, 2009, CANCER-AM CANCER SOC, V115, P1531, DOI 10.1002/cncr.24121; Morello E, 2011, VET J, V189, P268, DOI 10.1016/j.tvjl.2010.08.014; Paoloni M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-625; Philips B, 2009, J AM ANIM HOSP ASSOC, V45, P33, DOI 10.5326/0450033; Polakis P, 2000, GENE DEV, V14, P1837; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Rubin EM, 2010, MOL CANCER THER, V9, P731, DOI 10.1158/1535-7163.MCT-09-0147; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; SPODNICK GJ, 1992, J AM VET MED ASSOC, V200, P995; Stein TJ, 2011, VET COMP ONCOL, V9, P65, DOI 10.1111/j.1476-5829.2010.00236.x; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Wang LA, 2010, CELL PHYSIOL BIOCHEM, V26, P1093, DOI 10.1159/000323987; Winkler DG, 2005, J BIOL CHEM, V280, P2498, DOI 10.1074/jbc.M400524200; Yan Y, 2009, J CELL SCI, V122, P3566, DOI 10.1242/jcs.051904	36	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26106	10.1371/journal.pone.0026106	http://dx.doi.org/10.1371/journal.pone.0026106			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022527	gold, Green Published, Green Submitted			2022-12-27	WOS:000295973200036
J	Buhimschi, CS; Bhandari, V; Dulay, AT; Nayeri, UA; Abdel-Razeq, SS; Pettker, CM; Thung, S; Zhao, GM; Han, YPW; Bizzarro, M; Buhimschi, IA				Buhimschi, Catalin S.; Bhandari, Vineet; Dulay, Antonette T.; Nayeri, Unzila A.; Abdel-Razeq, Sonya S.; Pettker, Christian M.; Thung, Stephen; Zhao, Guomao; Han, Yiping W.; Bizzarro, Matthew; Buhimschi, Irina A.			Proteomics Mapping of Cord Blood Identifies Haptoglobin "Switch- On" Pattern as Biomarker of Early-Onset Neonatal Sepsis in Preterm Newborns	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; INTRAAMNIOTIC INFLAMMATION; AMNIOTIC-FLUID; INTRAVENTRICULAR HEMORRHAGE; NECROTIZING ENTEROCOLITIS; WEEKS GESTATION; DIAGNOSIS; BIRTH; EXPRESSION; BINDING	Background: Intra-amniotic infection and/or inflammation (IAI) are important causes of preterm birth and early-onset neonatal sepsis (EONS). A prompt and accurate diagnosis of EONS is critical for improved neonatal outcomes. We sought to explore the cord blood proteome and identify biomarkers and functional protein networks characterizing EONS in preterm newborns. Methodology/Principal Findings: We studied a prospective cohort of 180 premature newborns delivered May 2004-September 2009. A proteomics discovery phase employing two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry identified 19 differentially-expressed proteins in cord blood of newborns with culture-confirmed EONS (n = 3) versus GA-matched controls (n = 3). Ontological classifications of the proteins included transfer/carrier, immunity/defense, protease/extracellular matrix. The 1(st)-level external validation conducted in the remaining 174 samples confirmed elevated haptoglobin and haptoglobin-related protein immunoreactivity (Hp&HpRP) in newborns with EONS (presumed and culture-confirmed) independent of GA at birth and birthweight (P<0.001). Western blot concurred in determining that EONS babies had conspicuous Hp&HpRP bands in cord blood ("switch-on pattern'') as opposed to non-EONS newborns who had near-absent "switch-off pattern'' (P<0.001). Fetal Hp phenotype independently impacted Hp&HpRP. A Bayesian latent-class analysis (LCA) was further used for unbiased classification of all 180 cases based on probability of "antenatal IAI exposure'' as latent variable. This was then subjected to 2(nd)-level validation against indicators of adverse short-term neonatal outcome. The optimal LCA algorithm combined Hp&HpRP switch pattern (most input), interleukin-6 and neonatal hematological indices yielding two non-overlapping newborn clusters with low (<= 20%) versus high (>= 70%) probability of IAI exposure. This approach reclassified -30% of clinical EONS diagnoses lowering the number needed to harm and increasing the odds ratios for several adverse outcomes including intra-ventricular hemorrhage. Conclusions/Significance: Antenatal exposure to IAI results in precocious switch-on of Hp&HpRP expression. As EONS biomarker, cord blood Hp&HpRP has potential to improve the selection of newborns for prompt and targeted treatment at birth.	[Buhimschi, Catalin S.; Bhandari, Vineet; Dulay, Antonette T.; Nayeri, Unzila A.; Abdel-Razeq, Sonya S.; Pettker, Christian M.; Thung, Stephen; Zhao, Guomao; Buhimschi, Irina A.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA; [Bhandari, Vineet; Bizzarro, Matthew] Yale Univ, Sch Med, Dept Pediat, Div Perinatal Med, New Haven, CT 06510 USA; [Han, Yiping W.] Case Western Reserve Univ, Sch Dent Med, Dept Periodont, Cleveland, OH 44106 USA	Yale University; Yale University; Case Western Reserve University	Buhimschi, CS (corresponding author), Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06520 USA.	catalin.buhimschi@yale.edu	Buhimschi, Irina/AAY-6619-2021; Bhandari, Vineet/AAS-3365-2020	Buhimschi, Irina/0000-0002-1701-1326	National Institutes of Health [RO1 HD 047321, R01HD062007-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD062007] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047321] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Grant RO1 HD 047321 (IAB) and R01HD062007-01A1 (CSB & IAB). The funders had no role in the design and conduct of the study, collection, management, analysis and interpretation of the data or the preparation, review or approval of the manuscript.	ACOG Committee on Practice Bulletins-Obstetrics, 2007, Obstet Gynecol, V109, P1007; Arnon S, 2008, CURR OPIN INFECT DIS, V21, P223, DOI 10.1097/QCO.0b013e3282fa15dd; Arredouani MS, 2005, IMMUNOLOGY, V114, P263, DOI 10.1111/j.1365-2567.2004.02071.x; BASELER MW, 1983, INFLAMMATION, V7, P387, DOI 10.1007/BF00916303; Benitz WE, 2010, CLIN PERINATOL, V37, P421, DOI 10.1016/j.clp.2009.12.001; BENSI G, 1985, EMBO J, V4, P119, DOI 10.1002/j.1460-2075.1985.tb02325.x; Bhandari A, 2009, PEDIATRICS, V123, P1562, DOI 10.1542/peds.2008-1962; Bhandari V, 2008, PEDIATRICS, V121, P129, DOI 10.1542/peds.2007-1308; Bizzarro MJ, 2008, INFECT CONT HOSP EP, V29, P914, DOI 10.1086/591323; Buhimschi CS, 2009, BJOG-INT J OBSTET GY, V116, P257, DOI 10.1111/j.1471-0528.2008.01925.x; Buhimschi CS, 2007, PLOS MED, V4, P84, DOI 10.1371/journal.pmed.0040018; Buhimschi CS, 2007, PEDIATR RES, V61, P318, DOI 10.1203/01.pdr.0000252439.48564.37; Buhimschi CS, 2009, CURR OPIN INFECT DIS, V22, P235, DOI 10.1097/QCO.0b013e32832a5963; Buhimschi IA, 2005, BJOG-INT J OBSTET GY, V112, P173, DOI 10.1111/j.1471-0528.2004.00340.x; Buhimschi IA, 2005, CLIN DIAGN LAB IMMUN, V12, P837, DOI 10.1128/CDLI.12.7.837-844.2005; Buhimschi IA, 2010, CLIN PERINATOL, V37, P355, DOI 10.1016/j.clp.2010.03.002; Buttery JP, 2002, ARCH DIS CHILD-FETAL, V87, pF25, DOI 10.1136/fn.87.1.F25; Cotten CM, 2009, PEDIATRICS, V123, P58, DOI 10.1542/peds.2007-3423; DAY JR, 1992, INT J CLIN LAB RES, V21, P256, DOI 10.1007/BF02591656; DUDICH E, TUMOUR BIOL, V19, P30; Edwards R K, 2001, Infect Dis Obstet Gynecol, V9, P209, DOI 10.1155/S1064744901000345; FLEISCHER JG, 2011, INNATE IMMUN; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; GARNER A, 1984, ARCH OPHTHALMOL-CHIC, V102, P1130; Garry D, 1996, AM J OBSTET GYNECOL, V175, P1336, DOI 10.1016/S0002-9378(96)70051-0; Gerdes JS, 2004, PEDIATR CLIN N AM, V51, P939, DOI 10.1016/j.pcl.2004.03.009; GITLIN D, 1967, J CLIN INVEST, V46, P1010, DOI 10.1172/JCI105590; Goldenberg RL, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.07.033; Gomme PT, 2004, TRENDS BIOTECHNOL, V22, P340, DOI 10.1016/j.tibtech.2004.05.001; Guetta J, 2007, ATHEROSCLEROSIS, V191, P48, DOI 10.1016/j.atherosclerosis.2006.04.032; HADLOCK FP, 1983, J CLIN ULTRASOUND, V11, P313, DOI 10.1002/jcu.1870110605; Han YW, 2009, J CLIN MICROBIOL, V47, P38, DOI 10.1128/JCM.01206-08; Hatada S, 2003, GENE, V319, P55, DOI 10.1016/S0378-1119(03)00791-1; He QY, 2003, PROTEOMICS, V3, P666, DOI 10.1002/pmic.200300394; Hunt NH, 2001, REDOX REP, V6, P389, DOI 10.1179/135100001101536508; Irony-Tur-Sinai M, 2009, J NEUROL SCI, V279, P80, DOI 10.1016/j.jns.2008.12.014; Kalayci AG, 2000, TURK J MED SCI, V30, P151; KALENIC S, 1993, J HOSP INFECT, V23, P35, DOI 10.1016/0195-6701(93)90128-M; KANAKOUDI F, 1995, CLIN CHEM, V41, P605; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Klinger G, 2010, PEDIATRICS, V125, pE736, DOI 10.1542/peds.2009-2017; Kolialexi A, 2008, MASS SPECTROM REV, V27, P624, DOI 10.1002/mas.20181; Langlois MR, 1996, CLIN CHEM, V42, P1589; MAEDA N, 1986, ANNU REV GENET, V20, P81; McCrea HL, 2008, CLIN PERINATOL, V35, P777, DOI 10.1016/j.clp.2008.07.014; MILLER ME, 1977, PEDIATR CLIN N AM, V24, P413; Miyano A, 1998, PEDIATR DEVEL PATHOL, V1, P513, DOI 10.1007/s100249900070; MTITIMILA EI, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004495.PUB2; Naef RW, 1998, AM J OBSTET GYNECOL, V178, P126, DOI 10.1016/S0002-9378(98)70638-6; Naeye RL., 1992, DISORDERS PLACENTA F, P118; Ng PC, 2010, J CLIN INVEST, V120, P2989, DOI 10.1172/JCI40196; NORDOY A, 1984, ATHEROSCLEROSIS, V50, P307, DOI 10.1016/0021-9150(84)90078-9; NYMAN M, 1959, Scand J Clin Lab Invest, V11 Supp 39, P1; OH SK, 1990, J LEUKOCYTE BIOL, V47, P142, DOI 10.1002/jlb.47.2.142; OLIVIERO S, 1989, EMBO J, V8, P1145, DOI 10.1002/j.1460-2075.1989.tb03485.x; PAIK YK, 1988, J BIOL CHEM, V263, P13340; PAPILE LA, 1978, J PEDIATR-US, V92, P529, DOI 10.1016/S0022-3476(78)80282-0; Peters RPH, 2004, LANCET INFECT DIS, V4, P751, DOI 10.1016/S1473-3099(04)01205-8; Polonovski M, 1938, CR SOC BIOL, V129, P457; Quaye IK, 2008, T ROY SOC TROP MED H, V102, P735, DOI 10.1016/j.trstmh.2008.04.010; Ramstrom M, 2005, J PROTEOME RES, V4, P410, DOI 10.1021/pr049812a; RAUSEN AR, 1961, NATURE, V191, P717, DOI 10.1038/191717a0; Reyes CS, 2003, ACTA PAEDIATR, V92, P221, DOI 10.1111/j.1651-2227.2003.tb00530.x; ROBERTSON CM, 2007, JAMA-J AM MED ASSOC, V24, P2733; RODWELL RL, 1988, J PEDIATR-US, V112, P761, DOI 10.1016/S0022-3476(88)80699-1; ROVAMO L, 1984, PEDIATR RES, V18, P1104, DOI 10.1203/00006450-198411000-00010; SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383; SALMI TT, 1973, ACTA PAEDIATR SCAND, P1; Scott AN, 2008, STAT MED, V27, P140, DOI 10.1002/sim.2899; Shifman MA, 2007, J PROTEOME RES, V6, P4019, DOI 10.1021/pr070325f; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; SMITHIES O, 1962, NATURE, V196, P232, DOI 10.1038/196232a0; SPEER C, 1983, ACTA PAEDIATR SCAND, V72, P679, DOI 10.1111/j.1651-2227.1983.tb09793.x; Spitzer Alan R, 2005, J Perinatol, V25, P265, DOI 10.1038/sj.jp.7211252; Stoll BJ, 2011, PEDIATRICS, V127, P817, DOI 10.1542/peds.2010-2217; Thomson R, 2009, FUTURE MICROBIOL, V4, P789, DOI [10.2217/fmb.09.57, 10.2217/FMB.09.57]; Tita ATN, 2010, CLIN PERINATOL, V37, P339, DOI 10.1016/j.clp.2010.02.003; UAUY RD, 1991, J PEDIATR-US, V119, P630, DOI 10.1016/S0022-3476(05)82418-7; Vergani P, 2000, PLACENTA, V21, P402, DOI 10.1053/plac.1999.0499; Vermunt JK, 2002, APPL LATENT CLASS AN, P89, DOI DOI 10.1017/CBO9780511499531.004; White TC, 2008, J THROMB HAEMOST, V6, P995, DOI 10.1111/j.1538-7836.2008.02979.x; Yurdakok M, 1998, TURKISH J PEDIATR, V40, P17	82	47	50	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26111	10.1371/journal.pone.0026111	http://dx.doi.org/10.1371/journal.pone.0026111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028810	Green Published, Green Submitted, gold			2022-12-27	WOS:000295971700040
J	Barlow, PG; Svoboda, P; Mackellar, A; Nash, AA; York, IA; Pohl, J; Davidson, DJ; Donis, RO				Barlow, Peter G.; Svoboda, Pavel; Mackellar, Annie; Nash, Anthony A.; York, Ian A.; Pohl, Jan; Davidson, Donald J.; Donis, Ruben O.			Antiviral Activity and Increased Host Defense against Influenza Infection Elicited by the Human Cathelicidin LL-37	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE LL-37; HERPES-SIMPLEX-VIRUS; ANTIBACTERIAL PEPTIDES; HUMAN MACROPHAGES; EPITHELIAL-CELLS; INNATE IMMUNITY; NS1 PROTEIN; VITAMIN-D; A VIRUS; ALPHA	The extensive world-wide morbidity and mortality caused by influenza A viruses highlights the need for new insights into the host immune response and novel treatment approaches. Cationic Host Defense Peptides (CHDP, also known as antimicrobial peptides), which include cathelicidins and defensins, are key components of the innate immune system that are upregulated during infection and inflammation. Cathelicidins have immunomodulatory and anti-viral effects, but their impact on influenza virus infection has not been previously assessed. We therefore evaluated the effect of cathelicidin peptides on disease caused by influenza A virus in mice. The human cathelicidin, LL-37, and the murine cathelicidin, mCRAMP, demonstrated significant anti-viral activity in vivo, reducing disease severity and viral replication in infected mice to a similar extent as the well-characterized influenza virus-specific antiviral drug zanamivir. In vitro and in vivo experiments suggested that the peptides may act directly on the influenza virion rather than via receptor-based mechanisms. Influenza virus-infected mice treated with LL-37 had lower concentrations of pro-inflammatory cytokines in the lung than did infected animals that had not been treated with cathelicidin peptides. These data suggest that treatment of influenza-infected individuals with cathelicidin-derived therapeutics, or modulation of endogenous cathelicidin production may provide significant protection against disease.	[Barlow, Peter G.; York, Ian A.; Donis, Ruben O.] Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA; [Svoboda, Pavel; Pohl, Jan] Ctr Dis Control & Prevent, Biotechnol Core Facil Branch, Div Sci Resources, Atlanta, GA USA; [Mackellar, Annie; Davidson, Donald J.] Univ Edinburgh, MRC, Ctr Inflammat Res, Queens Med Res Inst, Edinburgh, Midlothian, Scotland; [Nash, Anthony A.] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Nash, Anthony A.] Univ Edinburgh, Ctr Infect Dis, Edinburgh, Midlothian, Scotland	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Barlow, PG (corresponding author), Edinburgh Napier Univ, Sch Life Sport & Social Sci, Edinburgh, Midlothian, Scotland.	rdonis@cdc.gov	York, Ian/X-9351-2019; Barlow, Peter/O-4078-2019	York, Ian/0000-0002-3478-3344; Barlow, Peter/0000-0002-6516-9312; Molodiuc, Veaceslav/0000-0002-3014-4203	Norman Salvesen Emphysema Research Trust; Medical Research Council [G1002046]; MRC [G0901697, G1002046] Funding Source: UKRI; Medical Research Council [G9900991B, G0901697] Funding Source: researchfish	Norman Salvesen Emphysema Research Trust; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding: Part of this work was funded by the Norman Salvesen Emphysema Research Trust, and DD is funded by a Medical Research Council Senior Non Clinical Fellow (G1002046). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerberth B, 2006, CURR TOP MICROBIOL, V306, P67; Alalwani SM, 2010, EUR J IMMUNOL, V40, P1118, DOI 10.1002/eji.200939275; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; Bals R, 1999, INFECT IMMUN, V67, P6084, DOI 10.1128/IAI.67.11.6084-6089.1999; Barlow PG, 2010, AM J RESP CELL MOL, V43, P692, DOI 10.1165/rcmb.2009-0250OC; Benincasa M, 2003, PEPTIDES, V24, P1723, DOI 10.1016/j.peptides.2003.07.025; Bergman P, 2007, CURR HIV RES, V5, P410; Bjorstad A, 2009, ANTIMICROB AGENTS CH, V53, P1027, DOI 10.1128/AAC.01310-08; Bowdish DME, 2006, CURR TOP MICROBIOL, V306, P27; Chen Christiane I-U, 2004, J Cyst Fibros, V3, P45, DOI 10.1016/j.jcf.2003.12.008; Cheung QCK, 2008, ANTIMICROB AGENTS CH, V52, P1812, DOI 10.1128/AAC.01530-07; Chromek M, 2006, NAT MED, V12, P636, DOI 10.1038/nm1407; Davidson DJ, 2004, J IMMUNOL, V172, P1146, DOI 10.4049/jimmunol.172.2.1146; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Doss M, 2009, J IMMUNOL, V182, P7878, DOI 10.4049/jimmunol.0804049; Elssner A, 2004, J IMMUNOL, V172, P4987, DOI 10.4049/jimmunol.172.8.4987; Fortney K, 1998, ANTIMICROB AGENTS CH, V42, P2690, DOI 10.1128/AAC.42.10.2690; Gordon YJ, 2005, CURR EYE RES, V30, P385, DOI 10.1080/02713680590934111; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763; Huang LC, 2007, INVEST OPHTH VIS SCI, V48, P4498, DOI 10.1167/iovs.07-0274; Ichinohe T, 2009, J EXP MED, V206, P79, DOI 10.1084/jem.20081667; Iimura M, 2005, J IMMUNOL, V174, P4901, DOI 10.4049/jimmunol.174.8.4901; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Li HN, 2009, J LEUKOCYTE BIOL, V86, P891, DOI 10.1189/jlb.0209050; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Morrison G, 2002, INFECT IMMUN, V70, P3053, DOI 10.1128/IAI.70.6.3053-3060.2002; Moser C, 2002, INFECT IMMUN, V70, P3068, DOI 10.1128/IAI.70.6.3068-3072.2002; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Putsep K, 2002, LANCET, V360, P1144, DOI 10.1016/S0140-6736(02)11201-3; Ryan LK, 2011, J LEUKOCYTE BIOL, V90, P343, DOI 10.1189/jlb.0209079; Sabetta JR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011088; Salvatore M, 2007, J INFECT DIS, V196, P835, DOI 10.1086/521027; Schaller-Bals S, 2002, AM J RESP CRIT CARE, V165, P992, DOI 10.1164/ajrccm.165.7.200110-020; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Soehnlein O, 2008, BLOOD, V112, P1461, DOI 10.1182/blood-2008-02-139634; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Steinstraesser L, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-2; Tecle T, 2007, J IMMUNOL, V178, P8046, DOI 10.4049/jimmunol.178.12.8046; Thomas PG, 2009, IMMUNITY, V30, P566, DOI 10.1016/j.immuni.2009.02.006; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Urashima M, 2010, AM J CLIN NUTR; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; World Health Organization, 2002, WHO MAN AN INFL DIAG; Wu S, 2011, CURR OPIN INFECT DIS; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069; Yasin B, 1996, INFECT IMMUN, V64, P709, DOI 10.1128/IAI.64.3.709-713.1996; Yasin B, 2000, EUR J CLIN MICROBIOL, V19, P187, DOI 10.1007/s100960050457; Yu FS, 2010, J IMMUNOL, V185, P1142, DOI 10.4049/jimmunol.1000509; Yu J, 2007, J IMMUNOL, V179, P7684, DOI 10.4049/jimmunol.179.11.7684; Yuk JM, 2009, CELL HOST MICROBE, V6, P231, DOI 10.1016/j.chom.2009.08.004; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zhang ZF, 2008, J LEUKOCYTE BIOL, V84, P780, DOI 10.1189/jlb.0208086; Zhang ZF, 2009, EUR J IMMUNOL, V39, P3181, DOI 10.1002/eji.200939496; Zughaier SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013627	62	223	234	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e25333	10.1371/journal.pone.0025333	http://dx.doi.org/10.1371/journal.pone.0025333			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031815	Green Published, Green Submitted, gold			2022-12-27	WOS:000296513200002
J	Wergeland, S; Torkildsen, O; Myhr, KM; Aksnes, L; Mork, SJ; Bo, L				Wergeland, Stig; Torkildsen, Oivind; Myhr, Kjell-Morten; Aksnes, Lage; Mork, Sverre Jarl; Bo, Lars			Dietary Vitamin D3 Supplements Reduce Demyelination in the Cuprizone Model	PLOS ONE			English	Article							SUPERIOR CEREBELLAR PEDUNCLE; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; 1,25-DIHYDROXYVITAMIN D-3; 25-HYDROXYVITAMIN-D LEVELS; CELL-DIFFERENTIATION; PARKINSON-DISEASE; MENSTRUAL-CYCLE; SERUM; RISK	Vitamin D is emerging as a probably important environmental risk factor in multiple sclerosis, affecting both susceptibility and disease progression. It is not known to what extent this effect is due to a modulation of peripheral lymphocyte function, or to intrathecal effects of vitamin D. We investigated the effect of dietary vitamin D3 content on de/remyelination in the cuprizone model, which is a well established toxic model of demyelination, with no associated lymphocyte infiltration. The mice received diets either deficient of (<50 IU/kg), or supplemented with low (500 IU/kg), high (6200 IU/kg) or very high (12500 IU/kg) amounts of vit D3. Cuprizone (0.2%) was added to the diet for six weeks, starting two weeks after onset of the experimental diets. Mouse brain tissue was histopathologically evaluated for myelin and oligodendrocyte loss, microglia/macrophage activation, and lymphocyte infiltration after six weeks of cuprizone exposure, and two weeks after discontinuation of cuprizone exposure. High and very high doses of vitamin D3 significantly reduced the extent of white matter demyelination (p = 0.004) and attenuated microglia activation (p = 0.001). No differences in the density of oligodendrocytes were observed between the diet groups. Two weeks after discontinuation of cuprizone exposure, remyelination was only detectable in the white matter of mice receiving diets deficient of or with low vitamin D3 content. In conclusion, high dietary doses of vitamin D3 reduce the extent of demyelination, and attenuate microglia activation and macrophage infiltration in a toxic model of demyelination, independent of lymphocyte infiltration.	[Wergeland, Stig; Torkildsen, Oivind; Myhr, Kjell-Morten; Bo, Lars] Haukeland Hosp, Norwegian Multiple Sclerosis Competence Ctr, Dept Neurol, N-5021 Bergen, Norway; [Wergeland, Stig; Torkildsen, Oivind; Myhr, Kjell-Morten; Bo, Lars] Haukeland Hosp, KG Jebsen Ctr Multiple Sclerosis Res, N-5021 Bergen, Norway; [Wergeland, Stig; Torkildsen, Oivind; Myhr, Kjell-Morten; Aksnes, Lage; Bo, Lars] Univ Bergen, Dept Clin Med, Bergen, Norway; [Mork, Sverre Jarl] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital	Wergeland, S (corresponding author), Haukeland Hosp, Norwegian Multiple Sclerosis Competence Ctr, Dept Neurol, N-5021 Bergen, Norway.	stig.wergeland@gmail.com	Torkildsen, Øivind/A-1606-2008; Mörk, Sverre Jarl/AAW-1330-2020; Myhr, Kjell-Morten/H-1528-2018	Torkildsen, Øivind/0000-0001-5294-2866; Myhr, Kjell-Morten/0000-0002-0980-510X	Western Norway Regional Health Authority; Biogen Idec	Western Norway Regional Health Authority; Biogen Idec(Biogen)	The study has been funded by the Western Norway Regional Health Authority, and supported by a grant from Biogen Idec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AARSKOG D, 1983, J CLIN ENDOCR METAB, V57, P1155, DOI 10.1210/jcem-57-6-1155; ACHESON E. D., 1960, ACTA PSYCHIATR ET NEUROL SCAND SUPPL, V35, P132, DOI 10.1111/j.1600-0447.1960.tb08674.x; AKSNES L, 1994, J PEDIATR GASTR NUTR, V18, P339, DOI 10.1097/00005176-199404000-00015; BLAKEMORE WF, 1973, J NEUROL SCI, V20, P63, DOI 10.1016/0022-510X(73)90118-4; BLAKEMORE WF, 1974, J NEUROL SCI, V22, P121, DOI 10.1016/0022-510X(74)90059-8; Boonstra A, 2001, J IMMUNOL, V167, P4974, DOI 10.4049/jimmunol.167.9.4974; Cantorna MT, 1999, J NUTR, V129, P1966, DOI 10.1093/jn/129.11.1966; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; CHEEMA C, 1989, J CLIN INVEST, V83, P537, DOI 10.1172/JCI113915; CHEN KS, 1995, BBA-GENE STRUCT EXPR, V1263, P1, DOI 10.1016/0167-4781(95)00060-T; Chen S, 2007, J IMMUNOL, V179, P1634, DOI 10.4049/jimmunol.179.3.1634; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Elenkov IJ, 2001, J CLIN ENDOCR METAB, V86, P4933, DOI 10.1210/jc.86.10.4933; Evatt ML, 2008, ARCH NEUROL-CHICAGO, V65, P1348, DOI 10.1001/archneur.65.10.1348; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Freedman DM, 2000, OCCUP ENVIRON MED, V57, P418, DOI 10.1136/oem.57.6.418; Garcion E, 2002, TRENDS ENDOCRIN MET, V13, P100, DOI 10.1016/S1043-2760(01)00547-1; GRAY TK, 1982, AM J OBSTET GYNECOL, V144, P880, DOI 10.1016/0002-9378(82)90177-6; Griffin MD, 2000, BIOCHEM BIOPH RES CO, V270, P701, DOI 10.1006/bbrc.2000.2490; Grytten N, 2006, NEUROLOGY, V66, P182, DOI 10.1212/01.wnl.0000195549.95448.b9; Hesse A, 2010, NEUROBIOL DIS, V37, P362, DOI 10.1016/j.nbd.2009.10.016; Kampman MT, 2007, J NEUROL, V254, P471, DOI 10.1007/s00415-006-0395-5; Knekt P, 2010, ARCH NEUROL-CHICAGO, V67, P808, DOI 10.1001/archneurol.2010.120; Kuhlmann T, 2007, J NEUROPATH EXP NEUR, V66, P238, DOI 10.1097/01.jnen.0000248559.83573.71; Lindner M, 2008, NEUROPATH APPL NEURO, V34, P105, DOI 10.1111/j.1365-2990.2007.00879.x; Mackay-Sim A, 2004, INT REV NEUROBIOL, V59, P351; Matsushima GK, 2001, BRAIN PATHOL, V11, P107; McGrath J, 2004, SCHIZOPHR RES, V67, P237, DOI 10.1016/j.schres.2003.08.005; MICHAYLOVA V, 1971, ANAL CHIM ACTA, V53, P194, DOI 10.1016/S0003-2670(01)80088-X; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Munger KL, 2004, NEUROLOGY, V62, P60, DOI 10.1212/01.WNL.0000101723.79681.38; Myhr KM, 2009, J NEUROL SCI, V286, P104, DOI 10.1016/j.jns.2009.05.002; Oudshoorn C, 2008, DEMENT GERIATR COGN, V25, P539, DOI 10.1159/000134382; Overbergh L, 2000, CLIN EXP IMMUNOL, V120, P139, DOI 10.1046/j.1365-2249.2000.01204.x; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Sato Y, 1997, NEUROLOGY, V49, P1273, DOI 10.1212/WNL.49.5.1273; Seewann A, 2009, ARCH NEUROL-CHICAGO, V66, P601, DOI 10.1001/archneurol.2009.57; Simpson S, 2010, ANN NEUROL, V68, P193, DOI 10.1002/ana.22043; Smolders J, 2008, MULT SCLER J, V14, P1220, DOI 10.1177/1352458508094399; Smolders J, 2008, J NEUROIMMUNOL, V194, P7, DOI 10.1016/j.jneuroim.2007.11.014; Smolders J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006635; Soilu-Hanninen M, 2005, MULT SCLER J, V11, P266, DOI 10.1191/1352458505ms1157oa; Streit WJ, 2002, GLIA, V40, P133, DOI 10.1002/glia.10154; SUTHERLAND JM, 1962, BRAIN, V85, P149, DOI 10.1093/brain/85.1.149; Taylor DL, 2010, J NEUROSCI RES, V88, P1632, DOI 10.1002/jnr.22335; Taylor LC, 2010, J NEUROSCI RES, V88, P391, DOI 10.1002/jnr.22215; TJELLESEN L, 1983, ACTA ENDOCRINOL-COP, V102, P476, DOI 10.1530/acta.0.1020476; Torkildsen O, 2009, CLIN NUTR, V28, P83, DOI 10.1016/j.clnu.2008.10.015; Torkildsen O, 2009, EXP NEUROL, V215, P160, DOI 10.1016/j.expneurol.2008.09.026; van der Mei IAF, 2001, NEUROEPIDEMIOLOGY, V20, P168, DOI 10.1159/000054783; Veldman CM, 2000, ARCH BIOCHEM BIOPHYS, V374, P334, DOI 10.1006/abbi.1999.1605; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888	53	66	66	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26262	10.1371/journal.pone.0026262	http://dx.doi.org/10.1371/journal.pone.0026262			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028844	gold, Green Published, Green Submitted			2022-12-27	WOS:000296510800032
J	Gibson, TM; Brennan, P; Han, S; Karami, S; Zaridze, D; Janout, V; Kollarova, H; Bencko, V; Navratilova, M; Szeszenia-Dabrowska, N; Mates, D; Slamova, A; Pfeiffer, RM; Stolzenberg-Solomon, RZ; Mayne, ST; Yeager, M; Chanock, S; Rothman, N; Chow, WH; Rosenberg, PS; Boffetta, P; Moore, LE				Gibson, Todd M.; Brennan, Paul; Han, Summer; Karami, Sara; Zaridze, David; Janout, Vladimir; Kollarova, Helen; Bencko, Vladimir; Navratilova, Marie; Szeszenia-Dabrowska, Neonila; Mates, Dana; Slamova, Alena; Pfeiffer, Ruth M.; Stolzenberg-Solomon, Rachael Z.; Mayne, Susan T.; Yeager, Meredith; Chanock, Stephen; Rothman, Nat; Chow, Wong-Ho; Rosenberg, Philip S.; Boffetta, Paolo; Moore, Lee E.			Comprehensive Evaluation of One-Carbon Metabolism Pathway Gene Variants and Renal Cell Cancer Risk	PLOS ONE			English	Article							REDUCED FOLATE CARRIER; CASE-CONTROL ASSOCIATION; CENTRAL-EUROPE; METHYLENETETRAHYDROFOLATE REDUCTASE; MTHFR POLYMORPHISMS; COLORECTAL-CANCER; PANCREATIC-CANCER; VEGETABLE INTAKE; COMMON MUTATION; KIDNEY CANCER	Introduction: Folate and one-carbon metabolism are linked to cancer risk through their integral role in DNA synthesis and methylation. Variation in one-carbon metabolism genes, particularly MTHFR, has been associated with risk of a number of cancers in epidemiologic studies, but little is known regarding renal cancer. Methods: Tag single nucleotide polymorphisms (SNPs) selected to produce high genomic coverage of 13 gene regions of one-carbon metabolism (ALDH1L1, BHMT, CBS, FOLR1, MTHFR, MTR, MTRR, SHMT1, SLC19A1, TYMS) and the closely associated glutathione synthesis pathway (CTH, GGH, GSS) were genotyped for 777 renal cell carcinoma (RCC) cases and 1,035 controls in the Central and Eastern European Renal Cancer case-control study. Associations of individual SNPs (n = 163) with RCC risk were calculated using unconditional logistic regression adjusted for age, sex and study center. Minimum p-value permutation (Min-P) tests were used to identify gene regions associated with risk, and haplotypes were evaluated within these genes. Results: The strongest associations with RCC risk were observed for SLC19A1 (Pmin-P = 0.03) and MTHFR (Pmin-P = 0.13). A haplotype consisting of four SNPs in SLC19A1 (rs12483553, rs2838950, rs2838951, and rs17004785) was associated with a 37% increased risk (p = 0.02), and exploratory stratified analysis suggested the association was only significant among those in the lowest tertile of vegetable intake. Conclusions: To our knowledge, this is the first study to comprehensively examine variation in one-carbon metabolism genes in relation to RCC risk. We identified a novel association with SLC19A1, which is important for transport of folate into cells. Replication in other populations is required to confirm these findings.	[Gibson, Todd M.; Han, Summer; Karami, Sara; Pfeiffer, Ruth M.; Stolzenberg-Solomon, Rachael Z.; Yeager, Meredith; Chanock, Stephen; Rothman, Nat; Chow, Wong-Ho; Rosenberg, Philip S.; Moore, Lee E.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Gibson, Todd M.; Mayne, Susan T.] Yale Sch Publ Hlth, New Haven, CT USA; [Brennan, Paul; Boffetta, Paolo] Int Agcy Res Canc, F-69372 Lyon, France; [Zaridze, David] Russian Acad Med Sci, Canc Res Ctr, Inst Carcinogenesis, Moscow, Russia; [Janout, Vladimir; Kollarova, Helen] Palacky Univ, Fac Med, Dept Prevent Med, CR-77147 Olomouc, Czech Republic; [Bencko, Vladimir; Slamova, Alena] Charles Univ Prague, Fac Med 1, Inst Hyg & Epidemiol, Prague, Czech Republic; [Navratilova, Marie] Masaryk Mem Canc Inst, Dept Canc Epidemiol & Genet, Brno, Czech Republic; [Szeszenia-Dabrowska, Neonila] Inst Occupat Med, Dept Epidemiol, Lodz, Poland; [Mates, Dana] Inst Publ Hlth, Bucharest, Romania; [Yeager, Meredith; Chanock, Stephen] NCI, Core Genotyping Facil, Gaithersburg, MD USA; [Boffetta, Paolo] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY USA; [Boffetta, Paolo] Int Canc Prevent Res Inst, Lyon, France	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Yale University; World Health Organization; International Agency for Research on Cancer (IARC); Russian Academy of Medical Sciences; Palacky University Olomouc; Charles University Prague; Masaryk Memorial Cancer Institute; Nofer Institute of Occupational Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Icahn School of Medicine at Mount Sinai	Gibson, TM (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	gibsontm@mail.nih.gov	Boffetta, Paolo/AAI-7767-2021; Bencko, Vladimir/H-8598-2017; Stolzenberg-Solomon, Rachael/Y-9280-2018; Szeszenia-Dabrowska, Neonila/F-7190-2010; Gibson, Todd M/N-6999-2018; Zaridze, David/K-5605-2013; Yeager, Meredith/AAA-5322-2020; Slamova, Alena/C-8326-2017; Janout, Vladimir/M-5133-2014	Boffetta, Paolo/0000-0002-3811-2791; Bencko, Vladimir/0000-0003-1935-2228; Stolzenberg-Solomon, Rachael/0000-0003-3698-7006; Gibson, Todd M/0000-0002-8718-699X; Slamova, Alena/0000-0002-2006-0225; mates, dana/0000-0002-6219-9807; Rosenberg, Philip/0000-0001-6349-9126; Kollarova, Helena/0000-0001-6951-6716	US National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics [TU2-CA-105666]; NATIONAL CANCER INSTITUTE [ZIACP010136, TU2CA105666] Funding Source: NIH RePORTER	US National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by the Intramural Research Program of the US National Institutes of Health, National Cancer Institute, Division of Cancer Epidemiology and Genetics, and by grant TU2-CA-105666. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Carlson CS, 2004, AM J HUM GENET, V74, P106, DOI 10.1086/381000; Chango A, 2000, MOL GENET METAB, V70, P310, DOI 10.1006/mgme.2000.3034; Chen BSE, 2006, GENET EPIDEMIOL, V30, P495, DOI 10.1002/gepi.20162; Choi SW, 2000, J NUTR, V130, P129, DOI 10.1093/jn/130.2.129; Collin SM, 2009, CANCER EPIDEM BIOMAR, V18, P2528, DOI 10.1158/1055-9965.EPI-09-0223; Devlin AM, 2006, AM J CLIN NUTR, V83, P708, DOI 10.1093/ajcn.83.3.708; Ferlay J, 2010, GLOBOCAN 2008 V1 2 C; Figueiredo JC, 2010, CANCER CAUSE CONTROL, V21, P597, DOI 10.1007/s10552-009-9489-6; Franco R., 2007, Archives of Physiology and Biochemistry, V113, P234, DOI 10.1080/13813450701661198; Fredriksen A, 2007, HUM MUTAT, V28, P856, DOI 10.1002/humu.20522; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Gibson TM, 2010, CANCER CAUSE CONTROL, V21, P1061, DOI 10.1007/s10552-010-9534-5; Hsu CC, 2007, AM J EPIDEMIOL, V166, P62, DOI 10.1093/aje/kwm043; Hung RJ, 2007, CARCINOGENESIS, V28, P1334, DOI 10.1093/carcin/bgm067; Kim YI, 2007, MOL NUTR FOOD RES, V51, P267, DOI 10.1002/mnfr.200600191; Kim YI, 2009, FUTURE ONCOL, V5, P523, DOI 10.2217/FON.09.26; Larsson SC, 2006, GASTROENTEROLOGY, V131, P1271, DOI 10.1053/j.gastro.2006.08.010; Lee Sang-Ah, 2009, J Prev Med Public Health, V42, P360, DOI 10.3961/jpmph.2009.42.6.360; Levine AJ, 2011, CANCER CAUSE CONTROL, V22, P541, DOI 10.1007/s10552-011-9726-7; Lissowska J, 2007, INT J CANCER, V120, P2696, DOI 10.1002/ijc.22604; Matherly LH, 2007, CANCER METAST REV, V26, P111, DOI 10.1007/s10555-007-9046-2; Moore LE, 2007, CARCINOGENESIS, V28, P1960, DOI 10.1093/carcin/bgm151; Moore LE, 2008, INT J CANCER, V122, P1710, DOI 10.1002/ijc.23318; Moore LE, 2007, INT J CANCER, V120, P2452, DOI 10.1002/ijc.22565; Packer BR, 2006, NUCLEIC ACIDS RES, V34, pD617, DOI 10.1093/nar/gkj151; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Rosenberg PS, 2006, STAT MED, V25, P3134, DOI 10.1002/sim.2407; Sharp L, 2004, AM J EPIDEMIOL, V159, P423, DOI 10.1093/aje/kwh066; Shen M, 2005, LUNG CANCER-J IASLC, V49, P299, DOI 10.1016/j.lungcan.2005.04.002; Stanislawska-Sachadyn A, 2009, ANN HUM GENET, V73, P484, DOI 10.1111/j.1469-1809.2009.00529.x; Stolzenberg-Solomon RZ, 2001, AM J EPIDEMIOL, V153, P680, DOI 10.1093/aje/153.7.680; Ulrich CM, 2005, CANCER EPIDEM BIOMAR, V14, P2509, DOI 10.1158/1055-9965.EPI-05-0261; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Wacholder S, 2002, CANCER EPIDEM BIOMAR, V11, P513; Wang LN, 2006, EUR J CANCER, V42, P3206, DOI 10.1016/j.ejca.2006.04.022; Westfall Peter H, 2002, Methods Mol Biol, V184, P143	38	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26165	10.1371/journal.pone.0026165	http://dx.doi.org/10.1371/journal.pone.0026165			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039442	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500036
J	Wang, L; Si, YQ; Dedow, LK; Shao, Y; Liu, P; Brutnell, TP				Wang, Lin; Si, Yaqing; Dedow, Lauren K.; Shao, Ying; Liu, Peng; Brutnell, Thomas P.			A Low-Cost Library Construction Protocol and Data Analysis Pipeline for Illumina-Based Strand-Specific Multiplex RNA-Seq	PLOS ONE			English	Article							TRANSCRIPTOMES; EXPRESSION; ALIGNMENT	The emergence of NextGen sequencing technology has generated much interest in the exploration of transcriptomes. Currently, Illumina Inc. (San Diego, CA) provides one of the most widely utilized sequencing platforms for gene expression analysis. While Illumina reagents and protocols perform adequately in RNA-sequencing (RNA-seq), alternative reagents and protocols promise a higher throughput at a much lower cost. We have developed a low-cost and robust protocol to produce Illumina-compatible (GAIIx and HiSeq2000 platforms) RNA-seq libraries by combining several recent improvements. First, we designed balanced adapter sequences for multiplexing of samples; second, dUTP incorporation in 2(nd) strand synthesis was used to enforce strand-specificity; third, we simplified RNA purification, fragmentation and library size-selection steps thus drastically reducing the time and increasing throughput of library construction; fourth, we included an RNA spike-in control for validation and normalization purposes. To streamline informatics analysis for the community, we established a pipeline within the iPlant Collaborative. These scripts are easily customized to meet specific research needs and improve on existing informatics and statistical treatments of RNA-seq data. In particular, we apply significance tests for determining differential gene expression and intron retention events. To demonstrate the potential of both the library-construction protocol and data-analysis pipeline, we characterized the transcriptome of the rice leaf. Our data supports novel gene models and can be used to improve current rice genome annotation. Additionally, using the rice transcriptome data, we compared different methods of calculating gene expression and discuss the advantages of a strand-specific approach to detect bona-fide anti-sense transcripts and to detect intron retention events. Our results demonstrate the potential of this low cost and robust method for RNA-seq library construction and data analysis.	[Wang, Lin; Dedow, Lauren K.; Brutnell, Thomas P.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Si, Yaqing; Liu, Peng] Iowa State Univ, Dept Stat, Ames, IA USA; [Shao, Ying] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY USA	Cornell University; Boyce Thompson Institute for Plant Research; Iowa State University; Cornell University	Wang, L (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	tpb8@cornell.edu	Brutnell, Thomas/M-2840-2013	Brutnell, Thomas/0000-0002-3581-8211	National Science Foundation [IOS-0701736, IOS-0714978]; iPlant Collaborative [IOS-0735191]	National Science Foundation(National Science Foundation (NSF)); iPlant Collaborative(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work is supported by grants from the National Science Foundation (IOS-0701736 to TB and PL and IOS-0714978 to PL) and the iPlant Collaborative (IOS-0735191 to TB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bryant DW, 2010, BIOINFORMATICS, V26, P1500, DOI 10.1093/bioinformatics/btq206; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Craig DW, 2008, NAT METHODS, V5, P887, DOI 10.1038/NMETH.1251; Filichkin SA, 2010, GENOME RES, V20, P45, DOI 10.1101/gr.093302.109; Finocchiaro G, 2007, NUCLEIC ACIDS RES, V35, P1488, DOI 10.1093/nar/gkm027; Gadbury GL, 2004, STAT METHODS MED RES, V13, P325, DOI 10.1191/0962280204sm369ra; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hwang JTG, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1587; Kiyosawa H, 2005, GENOME RES, V15, P463, DOI 10.1101/gr.3155905; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Levin JZ, 2010, NAT METHODS, V7, P709, DOI [10.1038/NMETH.1491, 10.1038/nmeth.1491]; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li PH, 2010, NAT GENET, V42, P1060, DOI 10.1038/ng.703; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lindberg J, 2010, GENOMICS, V95, P1, DOI 10.1016/j.ygeno.2009.08.010; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lonnstedt I, 2002, STAT SINICA, V12, P31; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Ozsolak F, 2011, NAT REV GENET, V12, P87, DOI 10.1038/nrg2934; Park PJ, 2009, NAT REV GENET, V10, P669, DOI 10.1038/nrg2641; Parkhomchuk D, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp596; Pickrell JK, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001236; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sato M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001011; Sawers RJH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-12; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Wang L, 2010, BRIEF FUNCT GENOMICS, V9, P118, DOI 10.1093/bfgp/elp057; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yassour M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r87	36	98	108	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26426	10.1371/journal.pone.0026426	http://dx.doi.org/10.1371/journal.pone.0026426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039485	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500067
J	Garcia-Mayoral, MF; Castano, R; Fanarraga, ML; Zabala, JC; Rico, M; Bruix, M				Flor Garcia-Mayoral, Ma; Castano, Raquel; Fanarraga, Monica L.; Carlos Zabala, Juan; Rico, Manuel; Bruix, Marta			The Solution Structure of the N-Terminal Domain of Human Tubulin Binding Cofactor C Reveals a Platform for Tubulin Interaction	PLOS ONE			English	Article							BETA-TUBULIN; CRYSTAL-STRUCTURE; CAENORHABDITIS-ELEGANS; RETINITIS-PIGMENTOSA-2 PROTEIN; CYTOPLASMIC CHAPERONIN; ARABIDOPSIS-THALIANA; MICROTUBULE-BINDING; FUNCTIONAL-ANALYSIS; FOLDING COFACTOR; RELEASE FACTOR	Human Tubulin Binding Cofactor C (TBCC) is a post-chaperonin involved in the folding and assembly of alpha- and beta-tubulin monomers leading to the release of productive tubulin heterodimers ready to polymerize into microtubules. In this process it collaborates with other cofactors (TBC's A, B, D, and E) and forms a supercomplex with TBCD, beta-tubulin, TBCE and alpha-tubulin. Here, we demonstrate that TBCC depletion results in multipolar spindles and mitotic failure. Accordingly, TBCC is found at the centrosome and is implicated in bipolar spindle formation. We also determine by NMR the structure of the N-terminal domain of TBCC. The TBCC N-terminal domain adopts a spectrin-like fold topology composed of a left-handed 3-stranded a-helix bundle. Remarkably, the 30-residue N-terminal segment of the TBCC N-terminal domain is flexible and disordered in solution. This unstructured region is involved in the interaction with tubulin. Our data lead us to propose a testable model for TBCC N-terminal domain/tubulin recognition in which the highly charged N-terminus as well as residues from the three helices and the loops interact with the acidic hypervariable regions of tubulin monomers.	[Flor Garcia-Mayoral, Ma; Rico, Manuel; Bruix, Marta] CSIC, Inst Quim Fis Rocasolano, Dept Quim Fis Biol, Madrid, Spain; [Castano, Raquel; Fanarraga, Monica L.; Carlos Zabala, Juan] Univ Cantabria, Dept Biol Mol, Inst Formac & Invest Marques de Valdecilla, Fac Med, E-39005 Santander, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Fisica Rocasolano (IQFR); Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria	Garcia-Mayoral, MF (corresponding author), CSIC, Inst Quim Fis Rocasolano, Dept Quim Fis Biol, Madrid, Spain.	mbruix@iqfr.csic.es	Fanarraga, Monica/AAE-5804-2019; Fanarraga, Mónica L./M-6177-2014; Zabala, Juan Carlos/K-5163-2014; Bruix, Marta/H-4161-2011	Fanarraga, Monica/0000-0003-4754-311X; Fanarraga, Mónica L./0000-0003-4754-311X; Zabala, Juan Carlos/0000-0003-2679-5473; Bruix, Marta/0000-0002-0096-3558	IFIMAV;  [Centrosome-3D];  [CSD2006-00023];  [Centrosome-CM S-GEN-0166-2006];  [BQU2008-0080];  [BFU2007-64882];  [BFU2010-18948]	IFIMAV; ; ; ; ; ; 	This work was supported by the projects Consolider-Ingenio Centrosome-3D CSD2006-00023, Centrosome-CM S-GEN-0166-2006, BQU2008-0080, BFU2007-64882, BFU2010-18948 and the IFIMAV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; AVILA J, 2008, CURR PROTOC CELL BIO, pCH3; Bartolini F, 2002, J BIOL CHEM, V277, P14629, DOI 10.1074/jbc.M200128200; Briknarova K, 2001, NAT STRUCT BIOL, V8, P349, DOI 10.1038/86236; CAMPO R, 1994, FEBS LETT, V353, P162, DOI 10.1016/0014-5793(94)01036-6; Case D, 2006, AMBER 9; Cormier A, 2009, J BIOL CHEM, V284, P6909, DOI 10.1074/jbc.M808249200; Devred F, 2004, BIOCHEMISTRY-US, V43, P10520, DOI 10.1021/bi0493160; FANARRAGA ML, METHODS CELL BIOL, V95, P59; Feldman JL, 2009, CURR BIOL, V19, P1238, DOI 10.1016/j.cub.2009.05.071; FONTALBA A, 1993, J CELL SCI, V106, P627; Freeman NL, 2000, CELL MOTIL CYTOSKEL, V45, P106, DOI 10.1002/(SICI)1097-0169(200002)45:2<106::AID-CM3>3.0.CO;2-3; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; GAO Y, 1994, J CELL BIOL, V125, P989, DOI 10.1083/jcb.125.5.989; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Garcia-Mayoral MF, 2010, BIOMOL NMR ASSIGN, V4, P219, DOI 10.1007/s12104-010-9250-9; Goddard T. D., SPARKY 3; Goncalves J, 2010, EMBO REP, V11, P194, DOI 10.1038/embor.2010.5; Grynberg M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-46; Guasch A, 2002, J MOL BIOL, V318, P1139, DOI 10.1016/S0022-2836(02)00185-7; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hage-Sleiman R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-135; HAWKINS GD, 1995, CHEM PHYS LETT, V246, P122, DOI 10.1016/0009-2614(95)01082-K; Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kirik V, 2002, CURR BIOL, V12, P1519, DOI 10.1016/S0960-9822(02)01109-0; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kuhnel K, 2006, STRUCTURE, V14, P367, DOI 10.1016/j.str.2005.11.008; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewis SA, 1997, TRENDS CELL BIOL, V7, P479, DOI 10.1016/S0962-8924(97)01168-9; Li SL, 2002, J BIOL CHEM, V277, P48596, DOI 10.1074/jbc.M208512200; Llosa M, 1996, FEBS LETT, V397, P283, DOI 10.1016/S0014-5793(96)01198-2; Lopez-Fanarraga M, 2007, J NEUROCHEM, V100, P1680, DOI 10.1111/j.1471-4159.2006.04328.x; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; Lu L, 2010, FEBS LETT, V584, P3533, DOI 10.1016/j.febslet.2010.07.017; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/0968-0004(96)10052-9; Melki R, 1996, BIOCHEMISTRY-US, V35, P10422, DOI 10.1021/bi960788r; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Mishima M, 2007, P NATL ACAD SCI USA, V104, P10346, DOI 10.1073/pnas.0703876104; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; REUTER G, 1983, CHROMOSOMA, V88, P277, DOI 10.1007/BF00292904; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353; Steinbacher S, 1999, NAT STRUCT BIOL, V6, P1029, DOI 10.1038/14912; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Subramanian R, 2010, CELL, V142, P433, DOI 10.1016/j.cell.2010.07.012; SULLIVAN KF, 1986, P NATL ACAD SCI USA, V83, P4327, DOI 10.1073/pnas.83.12.4327; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; VOTER WA, 1982, J ULTRA MOL STRUCT R, V80, P374, DOI 10.1016/S0022-5320(82)80051-8; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Zhu ZQC, 2009, J BIOL CHEM, V284, P32651, DOI 10.1074/jbc.M109.013466; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	58	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25912	10.1371/journal.pone.0025912	http://dx.doi.org/10.1371/journal.pone.0025912			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028797	Green Published, gold			2022-12-27	WOS:000296186900022
J	Smith, CI; Tank, S; Godsoe, W; Levenick, J; Strand, E; Esque, T; Pellmyr, O				Smith, Christopher Irwin; Tank, Shantel; Godsoe, William; Levenick, Jim; Strand, Eva; Esque, Todd; Pellmyr, Olle			Comparative Phylogeography of a Coevolved Community: Concerted Population Expansions in Joshua Trees and Four Yucca Moths	PLOS ONE			English	Article							HOST-SPECIFICITY; TIME DEPENDENCY; EVOLUTIONARY ECOLOGY; MAXIMUM-LIKELIHOOD; POLLINATING WASPS; LEPIDOPTERA; DIVERGENCE; DIVERSITY; MITOCHONDRIAL; PRODOXIDAE	Comparative phylogeographic studies have had mixed success in identifying common phylogeographic patterns among co-distributed organisms. Whereas some have found broadly similar patterns across a diverse array of taxa, others have found that the histories of different species are more idiosyncratic than congruent. The variation in the results of comparative phylogeographic studies could indicate that the extent to which sympatrically-distributed organisms share common biogeographic histories varies depending on the strength and specificity of ecological interactions between them. To test this hypothesis, we examined demographic and phylogeographic patterns in a highly specialized, coevolved community - Joshua trees (Yucca brevifolia) and their associated yucca moths. This tightly-integrated, mutually interdependent community is known to have experienced significant range changes at the end of the last glacial period, so there is a strong a priori expectation that these organisms will show common signatures of demographic and distributional changes over time. Using a database of >5000 GPS records for Joshua trees, and multi-locus DNA sequence data from the Joshua tree and four species of yucca moth, we combined paleaodistribution modeling with coalescent-based analyses of demographic and phylgeographic history. We extensively evaluated the power of our methods to infer past population size and distributional changes by evaluating the effect of different inference procedures on our results, comparing our palaeodistribution models to Pleistocene-aged packrat midden records, and simulating DNA sequence data under a variety of alternative demographic histories. Together the results indicate that these organisms have shared a common history of population expansion, and that these expansions were broadly coincident in time. However, contrary to our expectations, none of our analyses indicated significant range or population size reductions at the end of the last glacial period, and the inferred demographic changes substantially predate Holocene climate changes.	[Smith, Christopher Irwin] Willamette Univ, Dept Biol, Salem, OR 97301 USA; [Tank, Shantel; Godsoe, William; Pellmyr, Olle] Univ Idaho, Dept Biol Sci, Moscow, ID 83843 USA; [Levenick, Jim] Willamette Univ, Dept Comp Sci, Salem, OR 97301 USA; [Strand, Eva] Univ Idaho, Dept Forest Ecol & Biogeosci, Moscow, ID 83843 USA; [Esque, Todd] US Geol Survey, Western Ecol Res Ctr, Henderson, NV USA	Willamette University; Idaho; University of Idaho; Willamette University; Idaho; University of Idaho; United States Department of the Interior; United States Geological Survey	Smith, CI (corresponding author), Willamette Univ, Dept Biol, Salem, OR 97301 USA.	csmith@willamette.edu	Godsoe, William/E-4344-2015; Godsoe, William/L-7987-2013	Godsoe, William/0000-0003-1697-6916	National Science Foundation [DEB-0516841]	National Science Foundation(National Science Foundation (NSF))	Funding for this project was provided by a grant from the National Science Foundation to OP and CIS (DEB-0516841). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON RS, 1991, REV PALAEOBOT PALYNO, V68, P1, DOI 10.1016/0034-6667(91)90054-7; Arbogast BS, 2001, J BIOGEOGR, V28, P819, DOI 10.1046/j.1365-2699.2001.00594.x; Armbruster WS, 2009, EVOL ECOL, V23, P159, DOI 10.1007/s10682-008-9259-z; Avise JC, 2009, J BIOGEOGR, V36, P3, DOI 10.1111/j.1365-2699.2008.02032.x; Bazin E, 2006, SCIENCE, V312, P570, DOI 10.1126/science.1122033; Betancourt JL., 1990, PACKRAT MIDDENS LAST, P259; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; BRONSTEIN JL, 1991, OIKOS, V61, P175, DOI 10.2307/3545335; Callaway RM, 1997, OECOLOGIA, V112, P143, DOI 10.1007/s004420050293; Cannella J. A., 2003, DIGITAL RANGE MAP JO; Carstens BC, 2004, SYST BIOL, V53, P781, DOI 10.1080/10635150490522296; Carstens BC, 2005, EVOLUTION, V59, P1639, DOI 10.1554/04-661.1; Carstens BC, 2005, MOL ECOL, V14, P255, DOI 10.1111/j.1365-294X.2004.02404.x; Carstens BC, 2007, EVOLUTION, V61, P1439, DOI 10.1111/j.1558-5646.2007.00117.x; Clements F.E., 1916, PLANT SUCCESSION ANA; Cole KL, 2011, ECOL APPL, V21, P137, DOI 10.1890/09-1800.1; Davis MB, 1983, LATE QUATERNARY US V, V2, P166; Debruyne R, 2009, SYST BIOL, V58, P348, DOI 10.1093/sysbio/syp028; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond CS, 2010, HEREDITY, V105, P183, DOI 10.1038/hdy.2009.154; DumolinLapegue S, 1997, GENETICS, V146, P1475; Dyer LA, 2007, NATURE, V448, P696, DOI 10.1038/nature05884; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Ersts P.J, 2007, GEOGRAPHIC DISTANCE; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FARRELL BD, 1991, AM NAT, V138, P881, DOI 10.1086/285258; Farrell BD, 1998, SCIENCE, V281, P555, DOI 10.1126/science.281.5376.555; Fay JC, 1999, MOL BIOL EVOL, V16, P1003, DOI 10.1093/oxfordjournals.molbev.a026175; Freeman E., 2007, PRESENCEABSENCE R PA; Fu YX, 1997, GENETICS, V147, P915; FUTUYMA DJ, 1988, ANNU REV ECOL SYST, V19, P207, DOI 10.1146/annurev.es.19.110188.001231; Gaunt MW, 2002, MOL BIOL EVOL, V19, P748, DOI 10.1093/oxfordjournals.molbev.a004133; Gillson L, 2008, LANDSCAPE ECOL, V23, P757, DOI 10.1007/s10980-008-9243-6; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Godsoe W, 2009, SYST BIOL, V59, P298; GRANT V, 1949, EVOLUTION, V3, P82, DOI 10.2307/2405454; Haine ER, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-83; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Heled J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-289; Herre EA, 2008, ANNU REV ECOL EVOL S, V39, P439, DOI 10.1146/annurev.ecolsys.37.091305.110232; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Ho SYW, 2007, SYST BIOL, V56, P515, DOI 10.1080/10635150701435401; Ho SYW, 2006, TRENDS GENET, V22, P79, DOI 10.1016/j.tig.2005.11.006; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Jackson ST, 2000, PALEOBIOLOGY, V26, P194, DOI 10.1666/0094-8373(2000)26[194:ROPPAC]2.0.CO;2; Jackson ST, 2004, ANNU REV EARTH PL SC, V32, P495, DOI 10.1146/annurev.earth.32.101802.120435; JAENIKE J, 1990, ANNU REV ECOL SYST, V21, P243, DOI 10.1146/annurev.es.21.110190.001331; JANZEN DH, 1979, ANNU REV ECOL SYST, V10, P13, DOI 10.1146/annurev.es.10.110179.000305; Knowles LL, 2007, CURR BIOL, V17, P940, DOI 10.1016/j.cub.2007.04.033; Knowles LL, 2004, J EVOLUTION BIOL, V17, P1, DOI 10.1046/j.1420-9101.2003.00644.x; KOEHLER PA, 1995, QUATERNARY RES, V43, P238, DOI 10.1006/qres.1995.1024; Kuhner MK, 1998, GENETICS, V149, P429; Kuhner MK, 2006, BIOINFORMATICS, V22, P768, DOI 10.1093/bioinformatics/btk051; KUTZBACH JE, 1986, J ATMOS SCI, V43, P1726, DOI 10.1175/1520-0469(1986)043<1726:TIOCOP>2.0.CO;2; LABANDEIRA CC, 1994, P NATL ACAD SCI USA, V91, P12278, DOI 10.1073/pnas.91.25.12278; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lapointe FJ, 2005, AM NAT, V166, P290, DOI 10.1086/431283; Lemey P, 2010, MOL BIOL EVOL, V27, P1877, DOI 10.1093/molbev/msq067; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Locke SA, 2010, MOL ECOL, V19, P2813, DOI 10.1111/j.1365-294X.2010.04713.x; Lopez-Vaamonde C, 2002, ZOOL J LINN SOC-LOND, V136, P637, DOI 10.1046/j.1096-3642.2002.00040.x; Machado CA, 1996, J BIOGEOGR, V23, P531, DOI 10.1111/j.1365-2699.1996.tb00015.x; Machado CA, 2005, P NATL ACAD SCI USA, V102, P6558, DOI 10.1073/pnas.0501840102; MADDISON WP, 2006, MESQUITE MODULAR SYS; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McKelvey S. D., 1938, YUCCAS SW US; Merriam CH, 1893, DEATH VALLEY EXPEDIT, P345; Mikheyev AS, 2008, MOL ECOL, V17, P4480, DOI 10.1111/j.1365-294X.2008.03940.x; MITTER C, 1988, AM NAT, V132, P107, DOI 10.1086/284840; Molbo D, 2003, P NATL ACAD SCI USA, V100, P5867, DOI 10.1073/pnas.0930903100; Moorcroft PR, 2006, J THEOR BIOL, V241, P601, DOI 10.1016/j.jtbi.2005.12.019; Moussalli A, 2009, MOL ECOL, V18, P483, DOI 10.1111/j.1365-294X.2008.04035.x; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nogues-Bravo D, 2009, GLOBAL ECOL BIOGEOGR, V18, P521, DOI 10.1111/j.1466-8238.2009.00476.x; Odenbaugh J, 2007, PHILOS SCI, V74, P628, DOI 10.1086/525609; Pannell JR, 2003, EVOLUTION, V57, P949; Pellmyr O, 2000, ANN ENTOMOL SOC AM, V93, P432, DOI 10.1603/0013-8746(2000)093[0432:SOTYMG]2.0.CO;2; Pellmyr O, 2000, AM NAT, V156, pS62, DOI 10.1086/303416; Pellmyr O, 2006, SYST ENTOMOL, V31, P1, DOI 10.1111/j.1365-3113.2005.00301.x; Pellmyr O, 1999, SYST ENTOMOL, V24, P243, DOI 10.1046/j.1365-3113.1999.00079.x; Pellmyr O, 2003, ANN ENTOMOL SOC AM, V96, P716, DOI 10.1603/0013-8746(2003)096[0716:PDWAOM]2.0.CO;2; Pellmyr O, 1996, NATURE, V380, P155, DOI 10.1038/380155a0; Pellmyr O, 2003, ANN MO BOT GARD, V90, P35, DOI 10.2307/3298524; Pellmyr O, 2008, ZOOL J LINN SOC-LOND, V152, P297, DOI 10.1111/j.1096-3642.2007.00361.x; Posada D, 2001, SYST BIOL, V50, P580, DOI 10.1080/106351501750435121; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Development Core Team, 2006, R LANG ENV STAT COMP; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Richards CL, 2007, J BIOGEOGR, V34, P1833, DOI 10.1111/j.1365-2699.2007.01814.x; Ridgeway G., 2006, GBM GEN BOOSTED REGR; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rowe KC, 2006, MOL ECOL, V15, P4003, DOI 10.1111/j.1365-294X.2006.03063.x; ROWLANDS P. G., 1978, THESIS U CALIFORNIA; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Santucci F, 1998, MOL ECOL, V7, P1163, DOI 10.1046/j.1365-294x.1998.00436.x; Sargent RD, 2004, P ROY SOC B-BIOL SCI, V271, P603, DOI 10.1098/rspb.2003.2644; Segraves KA, 2008, ECOL ENTOMOL, V33, P765, DOI 10.1111/j.1365-2311.2008.01031.x; Segraves KA, 2004, EVOLUTION, V58, P2266; Smith CI, 2008, EVOLUTION, V62, P2676, DOI 10.1111/j.1558-5646.2008.00500.x; Smith CI, 2008, P ROY SOC B-BIOL SCI, V275, P249, DOI 10.1098/rspb.2007.1405; Smith MA, 2008, P NATL ACAD SCI USA, V105, P12359, DOI 10.1073/pnas.0805319105; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Solomon SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002738; Soltis DE, 2006, MOL ECOL, V15, P4261, DOI 10.1111/j.1365-294X.2006.03061.x; Spaulding WG, 1985, US GEOLOGICAL SURVEY, P83; STEBBINS G. L., 1970, Annual review of ecology and systematics., V1, P307, DOI 10.1146/annurev.es.01.110170.001515; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; STRONG DR, 1984, INSECTS PLANTS; STUIVER M, 1993, RADIOCARBON, V35, P35, DOI 10.1017/S0033822200013801; Sunnucks P, 2006, MOL ECOL, V15, P4513, DOI 10.1111/j.1365-294X.2006.03107.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P597; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; Tedersoo L, 2009, NEW PHYTOL, V182, P727, DOI 10.1111/j.1469-8137.2009.02792.x; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson RS, 2000, J BIOGEOGR, V27, P555, DOI 10.1046/j.1365-2699.2000.00427.x; Van Devender T.R., 1990, PACKRAT MIDDENS LAST, P104; Van Devender T.R., 1990, PACKRAT MIDDENS LAST; Vander Wall SB, 2006, ECOSCIENCE, V13, P539, DOI 10.2980/1195-6860(2006)13[539:JTYBSA]2.0.CO;2; VANDEVENDER TR, 1987, QUATERNARY RES, V27, P51, DOI 10.1016/0033-5894(87)90049-4; Vilella AJ, 2005, BIOINFORMATICS, V21, P2791, DOI 10.1093/bioinformatics/bti403; Wahlberg N, 2001, EVOLUTION, V55, P522, DOI 10.1554/0014-3820(2001)055[0522:TPABOH]2.0.CO;2; Wares JP, 2001, EVOLUTION, V55, P2455; Weiblen GD, 2002, ANNU REV ENTOMOL, V47, P299, DOI 10.1146/annurev.ento.47.091201.145213; West SA, 1996, J BIOGEOGR, V23, P447, DOI 10.1111/j.1365-2699.1996.tb00006.x; Whiteman NK, 2007, MOL ECOL, V16, P4759, DOI 10.1111/j.1365-294X.2007.03512.x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wilf P, 1999, SCIENCE, V284, P2153, DOI 10.1126/science.284.5423.2153; Woodhams M, 2006, MOL BIOL EVOL, V23, P2271, DOI 10.1093/molbev/msl107; Wright Jr. HE, 1993, GLOBAL CLIMATE SICNE; WRIGHT S, 1978, EVOLUTION GENETICS P, V4, P590; Zink RM, 2001, CONDOR, V103, P1, DOI 10.1650/0010-5422(2001)103[0001:CPOSAB]2.0.CO;2	140	49	49	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25628	10.1371/journal.pone.0025628	http://dx.doi.org/10.1371/journal.pone.0025628			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028785	Green Published, gold, Green Submitted			2022-12-27	WOS:000296186900014
J	Li, YZ; Tong, XP; Rumala, C; Clemons, K; Wang, SX				Li, Yanzhang; Tong, Xiaopeng; Rumala, Courtney; Clemons, Kate; Wang, Shuxia			Thrombospondin1 Deficiency Reduces Obesity-Associated Inflammation and Improves Insulin Sensitivity in a Diet-Induced Obese Mouse Model	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ADIPOSE-TISSUE DEVELOPMENT; ENDOTHELIAL-CELLS; IN-VIVO; MAJOR ACTIVATOR; RESISTANCE; EXPRESSION; PROTEIN; BINDING; BLOOD	Background: Obesity is prevalent worldwide and is associated with insulin resistance. Advanced studies suggest that obesity-associated low-grade chronic inflammation contributes to the development of insulin resistance and other metabolic complications. Thrombospondin 1 (TSP1) is a multifunctional extracellular matrix protein that is up-regulated in inflamed adipose tissue. A recent study suggests a positive correlation of TSP1 with obesity, adipose inflammation, and insulin resistance. However, the direct effect of TSP1 on obesity and insulin resistance is not known. Therefore, we investigated the role of TSP1 in mediating obesity-associated inflammation and insulin resistance by using TSP1 knockout mice. Methodology/Principal Findings: Male TSP1-/- mice and wild type littermate controls were fed a low-fat (LF) or a high-fat (HF) diet for 16 weeks. Throughout the study, body weight and fat mass increased similarly between the TSP1-/- mice and WT mice under HF feeding conditions, suggesting that TSP1 deficiency does not affect the development of obesity. However, obese TSP1-/- mice had improved glucose tolerance and increased insulin sensitivity compared to the obese wild type mice. Macrophage accumulation and inflammatory cytokine expression in adipose tissue were reduced in obese TSP1-/- mice. Consistent with the local decrease in pro-inflammatory cytokine levels, systemic inflammation was also decreased in the obese TSP1-/- mice. Furthermore, in vitro data demonstrated that TSP1 deficient macrophages had decreased mobility and a reduced inflammatory phenotype. Conclusion: TSP1 deficiency did not affect the development of high-fat diet induced obesity. However, TSP1 deficiency reduced macrophage accumulation in adipose tissue and protected against obesity related inflammation and insulin resistance. Our data demonstrate that TSP1 may play an important role in regulating macrophage function and mediating obesity-induced inflammation and insulin resistance. These data suggest that TSP1 may serve as a potential therapeutic target to improve the inflammatory and metabolic complications of obesity.	[Li, Yanzhang; Tong, Xiaopeng; Rumala, Courtney; Clemons, Kate; Wang, Shuxia] Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY 40536 USA	University of Kentucky	Li, YZ (corresponding author), Univ Kentucky, Grad Ctr Nutr Sci, Lexington, KY 40536 USA.	swang7@uky.edu			National Center for Research Resources [P20RR021954]; National Institutes of Health [DK081555]; Interdisciplinary Cardiovascular Training Program [T32 HL 072743]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021954] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL072743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081555] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Interdisciplinary Cardiovascular Training Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by an award P20RR021954 from the National Center for Research Resources, a grant from National Institutes of Health DK081555 and an Interdisciplinary Cardiovascular Training Program-T32 HL 072743.	Alessi MC, 2000, DIABETES, V49, P1374, DOI 10.2337/diabetes.49.8.1374; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; BAENZIGE.NL, 1971, P NATL ACAD SCI USA, V68, P240, DOI 10.1073/pnas.68.1.240; Bornstein P, 2001, J CLIN INVEST, V107, P929, DOI 10.1172/JCI12749; Chandrasekaran L, 2000, MOL BIOL CELL, V11, P2885, DOI 10.1091/mbc.11.9.2885; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Daniel C, 2004, KIDNEY INT, V65, P459, DOI 10.1111/j.1523-1755.2004.00395.x; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; DONOVIEL DB, 1990, J CELL PHYSIOL, V145, P16, DOI 10.1002/jcp.1041450104; Frazier WA, 1999, J BIOL CHEM, V274, P8554, DOI 10.1074/jbc.274.13.8554; Frolova EG, 2010, CIRC RES, V107, P1313, DOI 10.1161/CIRCRESAHA.110.232371; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; HUGO C, 1995, KIDNEY INT, V48, P1846, DOI 10.1038/ki.1995.483; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; LAWLER J, 1988, J CELL BIOL, V107, P2351, DOI 10.1083/jcb.107.6.2351; LAWLER JW, 1978, J BIOL CHEM, V253, P8609; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; MANSFIELD PJ, 1994, J IMMUNOL, V153, P4219; Martin-Manso G, 2008, CANCER RES, V68, P7090, DOI 10.1158/0008-5472.CAN-08-0643; McMaken S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019654; Mertens I, 2006, INT J OBESITY, V30, P1308, DOI 10.1038/sj.ijo.0803189; Mikhailenko I, 1997, J BIOL CHEM, V272, P6784, DOI 10.1074/jbc.272.10.6784; MURPHYULLRICH JE, 1987, J CELL BIOL, V105, P1603, DOI 10.1083/jcb.105.4.1603; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Okuno M, 2002, FEBS LETT, V519, P108, DOI 10.1016/S0014-5793(02)02720-5; Olson BA, 1999, PHARMACOLOGY, V58, P200, DOI 10.1159/000028282; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Phelan MW, 1998, J LAB CLIN MED, V132, P519, DOI 10.1016/S0022-2143(98)90131-7; Ramis JM, 2002, CELL MOL LIFE SCI, V59, P1960, DOI 10.1007/PL00012518; Samad F, 1997, MOL MED, V3, P37, DOI 10.1007/BF03401666; SCHULTZCHERRY S, 1994, J BIOL CHEM, V269, P26783; SCHULTZCHERRY S, 1993, J CELL BIOL, V122, P923, DOI 10.1083/jcb.122.4.923; Shang CA, 2002, MOL CELL ENDOCRINOL, V189, P213, DOI 10.1016/S0303-7207(01)00590-1; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; TARABOLETTI G, 1987, J CELL BIOL, V105, P2409, DOI 10.1083/jcb.105.5.2409; Varma V, 2008, DIABETES, V57, P432, DOI 10.2337/db07-0840; Voros G, 2006, J THROMB HAEMOST, V4, P277, DOI 10.1111/j.1538-7836.2005.01696.x; Voros G, 2005, ENDOCRINOLOGY, V146, P4545, DOI 10.1210/en.2005-0532; Wang SX, 2004, J CELL BIOCHEM, V91, P766, DOI 10.1002/jcb.10781; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wu HZ, 2010, ARTERIOSCL THROM VAS, V30, P186, DOI 10.1161/ATVBAHA.109.198044; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Young GD, 2004, J BIOL CHEM, V279, P38032, DOI 10.1074/jbc.M405658200	43	53	54	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26656	10.1371/journal.pone.0026656	http://dx.doi.org/10.1371/journal.pone.0026656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039525	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200037
J	Furukawa, K; Furukawa, T; Hohmann, S				Furukawa, Kentaro; Furukawa, Takako; Hohmann, Stefan			Efficient Construction of Homozygous Diploid Strains Identifies Genes Required for the Hyper-Filamentous Phenotype in Saccharomyces cerevisiae	PLOS ONE			English	Article							LARGE-SCALE ANALYSIS; INVASIVE GROWTH; MAP KINASE; SIGNALING PATHWAYS; CANDIDA-ALBICANS; MATING-TYPE; FLO11 GENE; YEAST; MECHANISMS; GENOME	Yeast cells undergo diploid-specific developments such as spore formation via meiosis and pseudohyphal development under certain nutrient-limited conditions. Studies on these aspects require homozygous diploid mutants, which are generally constructed by crossing strains of opposite mating-type with the same genetic mutation. So far, there has been no direct way to generate and select diploids from haploid cells. Here, we developed a method for efficient construction of homozygous diploids using a PGAL1-HO gene (galactose-inducible mating-type switch) and a PSTE18-URA3 gene (counter selection marker for diploids). Diploids are generated by transient induction of the HO endonuclease, which is followed by mating of part of the haploid population. Since the STE18 promoter is repressed in diploids, diploids carrying PSTE18-URA3 can be selected on 5-fluoroorotic acid (5-FOA) plates where the uracil prototrophic haploids cannot grow. To demonstrate that this method is useful for genetic studies, we screened suppressor mutations of the complex colony morphology, strong agar invasion and/or hyper-filamentous growth caused by lack of the Hog1 MAPK in the diploid Sigma 1278b strain background. Following this approach, we identified 49 suppressor mutations. Those include well-known positive regulator genes for filamentous growth signaling pathways, genes involved in mitochondrial function, DNA damage checkpoint, chromatin remodeling, and cell cycle, and also previously uncharacterized genes. Our results indicate that combinatorial use of the PGAL1-HO and PSTE18-URA3 genes is suitable to efficiently construct and select diploids and that this approach is useful for genetic studies especially when combined with large-scale screening.	[Furukawa, Kentaro; Furukawa, Takako; Hohmann, Stefan] Univ Gothenburg, Dept Cell & Mol Biol Microbiol, Gothenburg, Sweden	University of Gothenburg	Furukawa, K (corresponding author), Univ Gothenburg, Dept Cell & Mol Biol Microbiol, Gothenburg, Sweden.	kentaro.furukawa@cmb.gu.se; stefan.hohmann@gu.se	Hohmann, Stefan/K-9895-2013	Hohmann, Stefan/0000-0002-0809-1985; Furukawa, Kentaro/0000-0002-1551-1538	Swedish Research Council; Science Faculty at the University of Gothenburg; European Commission [043310, 201142]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Science Faculty at the University of Gothenburg; European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the Swedish Research Council, the Science Faculty at the University of Gothenburg Platform program, the European Commission funded projects FP6 CELLCOMPUT (Contract No. 043310) and FP7 UNICELLSYS (Contract No. 201142). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Monge R, 2009, MICROBIOL-SGM, V155, P413, DOI 10.1099/mic.0.023309-0; Amberg DC., 2005, METHODS YEAST GENETI; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Braus GH, 2003, MOL BIOL CELL, V14, P4272, DOI 10.1091/mbc.e03-01-0042; BURNS N, 1994, GENE DEV, V8, P1087, DOI 10.1101/gad.8.9.1087; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Drinnenberg IA, 2009, SCIENCE, V326, P544, DOI 10.1126/science.1176945; Furukawa K, 2009, MOL MICROBIOL, V74, P1272, DOI 10.1111/j.1365-2958.2009.06933.x; Gagiano M, 1999, MOL MICROBIOL, V31, P103, DOI 10.1046/j.1365-2958.1999.01151.x; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Granek JA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000823; HERSKOWITZ I, 1991, METHOD ENZYMOL, V194, P132; Hohmann S, 2007, METHOD ENZYMOL, V428, P29, DOI 10.1016/S0076-6879(07)28002-4; HUXLEY C, 1990, TRENDS GENET, V6, P236, DOI 10.1016/0168-9525(90)90190-H; Jin R, 2008, MOL BIOL CELL, V19, P284, DOI 10.1091/mbc.E07-05-0519; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; Kang CM, 2005, YEAST, V22, P79, DOI 10.1002/yea.1195; Klar AJS, 2010, GENETICS, V186, P443, DOI 10.1534/genetics.110.122531; Li WS, 1997, GENETICS, V145, P63; Liu HP, 1996, GENETICS, V144, P967; Lo HJ, 1997, CELL, V90, P939, DOI 10.1016/S0092-8674(00)80358-X; Loeb JDJ, 1999, GENETICS, V153, P1535; Mosch HU, 1997, GENETICS, V145, P671; NICKOLOFF JA, 1989, J MOL BIOL, V207, P527, DOI 10.1016/0022-2836(89)90462-2; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Park YU, 2006, EUKARYOT CELL, V5, P2120, DOI 10.1128/EC.00121-06; ROBERTS RL, 1994, GENE DEV, V8, P2974, DOI 10.1101/gad.8.24.2974; Rupp S, 1999, EMBO J, V18, P1257, DOI 10.1093/emboj/18.5.1257; Saito H, 2010, CURR OPIN MICROBIOL, V13, P677, DOI 10.1016/j.mib.2010.09.001; Tiedje C, 2008, MOL BIOL CELL, V19, P2885, DOI 10.1091/mbc.E07-11-1152	32	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26584	10.1371/journal.pone.0026584	http://dx.doi.org/10.1371/journal.pone.0026584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039512	Green Submitted, Green Published, gold			2022-12-27	WOS:000296513200032
J	Landrette, SF; Cornett, JC; Ni, TK; Bosenberg, MW; Xu, T				Landrette, Sean F.; Cornett, Jonathan C.; Ni, Thomas K.; Bosenberg, Marcus W.; Xu, Tian			piggyBac Transposon Somatic Mutagenesis with an Activated Reporter and Tracker (PB-SMART) for Genetic Screens in Mice	PLOS ONE			English	Article							RENAL-CELL CARCINOMAS; INSERTIONAL MUTAGENESIS; SLEEPING-BEAUTY; MOUSE MODEL; DROSOPHILA; EXPRESSION; FUSION; DOMAIN; DIFFERENTIATION; GENOME	Somatic forward genetic screens have the power to interrogate thousands of genes in a single animal. Retroviral and transposon mutagenesis systems in mice have been designed and deployed in somatic tissues for surveying hematopoietic and solid tumor formation. In the context of cancer, the ability to visually mark mutant cells would present tremendous advantages for identifying tumor formation, monitoring tumor growth over time, and tracking tumor infiltrations and metastases into wild-type tissues. Furthermore, locating mutant clones is a prerequisite for screening and analyzing most other somatic phenotypes. For this purpose, we developed a system using the piggyBac (PB) transposon for somatic mutagenesis with an activated reporter and tracker, called PB-SMART. The PB-SMART mouse genetic screening system can simultaneously induce somatic mutations and mark mutated cells using bioluminescence or fluorescence. The marking of mutant cells enable analyses that are not possible with current somatic mutagenesis systems, such as tracking cell proliferation and tumor growth, detecting tumor cell infiltrations, and reporting tissue mutagenesis levels by a simple ex vivo visual readout. We demonstrate that PB-SMART is highly mutagenic, capable of tumor induction with low copy transposons, which facilitates the mapping and identification of causative insertions. We further integrated a conditional transposase with the PB-SMART system, permitting tissue-specific mutagenesis with a single cross to any available Cre line. Targeting the germline, the system could also be used to conduct F1 screens. With these features, PB-SMART provides an integrated platform for individual investigators to harness the power of somatic mutagenesis and phenotypic screens to decipher the genetic basis of mammalian biology and disease.	[Landrette, Sean F.; Cornett, Jonathan C.; Ni, Thomas K.; Xu, Tian] Yale Univ, Sch Med, Howard Hughes Med Inst, Boyer Ctr Mol Med,Dept Genet, New Haven, CT 06510 USA; [Bosenberg, Marcus W.] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA; [Bosenberg, Marcus W.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Xu, Tian] Fudan Univ, Inst Dev Biol & Mol Med, Fudan Yale Ctr Biomed Res, Sch Life Sci, Shanghai 200433, Peoples R China	Howard Hughes Medical Institute; Yale University; Yale University; Yale University; Fudan University	Landrette, SF (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Boyer Ctr Mol Med,Dept Genet, New Haven, CT 06510 USA.	tian.xu@yale.edu	Ni, Thomas K/I-3604-2013; Wilson, Matthew H/K-3193-2013	Ni, Thomas K/0000-0003-2961-0593; 	Howard Hughes Medical Institute; National Cancer Institute [F32CA132320]; Anna Fuller Fund Fellowship in Molecular Oncology; American Cancer Society; Genetics Training Grant [T32 GM007499]; National Institutes of Health [T32 HG003198]; NATIONAL CANCER INSTITUTE [F32CA132320] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG003198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007499] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Anna Fuller Fund Fellowship in Molecular Oncology; American Cancer Society(American Cancer Society); Genetics Training Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Howard Hughes Medical Institute as well as the following sources: JCC was supported by a fellowship from the National Cancer Institute (F32CA132320); SFL was supported by an Anna Fuller Fund Fellowship in Molecular Oncology and an American Cancer Society New England Division Fellowship; TKN was supported by the Genetics Training Grant (T32 GM007499) and the Training Program in Genomics and Proteomics Technologies (T32 HG003198) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Argani P, 2001, AM J PATHOL, V159, P179, DOI 10.1016/S0002-9440(10)61684-7; Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Bender AM, CANC RES, P3557; Bosenberg M, 2006, GENESIS, V44, P262, DOI 10.1002/dvg.20205; Collier LS, 2009, CANCER RES, V69, P8429, DOI 10.1158/0008-5472.CAN-09-1760; Collier LS, 2005, NATURE, V436, P272, DOI 10.1038/nature03681; COOLEY L, 1988, SCIENCE, V239, P1121, DOI 10.1126/science.2830671; Dankort D, 2007, GENE DEV, V21, P379, DOI 10.1101/gad.1516407; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Davis IJ, 2003, P NATL ACAD SCI USA, V100, P6051, DOI 10.1073/pnas.0931430100; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Dupuy AJ, 2005, NATURE, V436, P221, DOI 10.1038/nature03691; Elick TA, 1996, GENETICA, V98, P33, DOI 10.1007/BF00120216; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Haq R, J CLIN ONCOL, V3474-3482; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Joo J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007608; Keng VW, 2009, NAT BIOTECHNOL, V27, P264, DOI 10.1038/nbt.1526; KLECKNER N, 1977, J MOL BIOL, V116, P125, DOI 10.1016/0022-2836(77)90123-1; Kuiper RP, 2003, HUM MOL GENET, V12, P1661, DOI 10.1093/hmg/ddg178; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; LITTLEWOOD TD, 1995, NUCLEIC ACIDS RES, V23, P1686, DOI 10.1093/nar/23.10.1686; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Rad R, 2010, SCIENCE, V330, P1104, DOI 10.1126/science.1193004; Roessler E, 2005, HUM MOL GENET, V14, P2181, DOI 10.1093/hmg/ddi222; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Shao XL, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016444.90348.50; Sidhar SK, 1996, HUM MOL GENET, V5, P1333, DOI 10.1093/hmg/5.9.1333; Starr TK, 2009, SCIENCE, V323, P1747, DOI 10.1126/science.1163040; Uren AG, 2009, NAT PROTOC, V4, P789, DOI 10.1038/nprot.2009.64; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wang GY, CANC CELL, V19, P114; Weterman MAJ, 1996, P NATL ACAD SCI USA, V93, P15294, DOI 10.1073/pnas.93.26.15294; White RM, 2008, CELL STEM CELL, V2, P183, DOI 10.1016/j.stem.2007.11.002; Wu S, 2007, NAT GENET, V39, P922, DOI 10.1038/ng2060; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; XU T, 1993, DEVELOPMENT, V117, P1223; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; YUAN Y, 1995, EMBO J, V14, P159, DOI 10.1002/j.1460-2075.1995.tb06986.x	47	18	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26650	10.1371/journal.pone.0026650	http://dx.doi.org/10.1371/journal.pone.0026650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039523	Green Submitted, Green Published, gold			2022-12-27	WOS:000296513200036
J	Pattanayak, GK; Tripathy, BC				Pattanayak, Gopal K.; Tripathy, Baishnab C.			Overexpression of Protochlorophyllide Oxidoreductase C Regulates Oxidative Stress in Arabidopsis	PLOS ONE			English	Article							INDUCED PHOTODYNAMIC DAMAGE; SINGLET OXYGEN; TETRAPYRROLE BIOSYNTHESIS; CHLOROPHYLL BIOSYNTHESIS; TEMPERATURE-STRESS; PROTOPORPHYRIN-IX; ACID SYNTHESIS; LIGHT; PROTEIN; PORB	Light absorbed by colored intermediates of chlorophyll biosynthesis is not utilized in photosynthesis; instead, it is transferred to molecular oxygen, generating singlet oxygen (O-1(2)). As there is no enzymatic detoxification mechanism available in plants to destroy O-1(2), its generation should be minimized. We manipulated the concentration of a major chlorophyll biosynthetic intermediate i.e., protochlorophyllide in Arabidopsis by overexpressing the light-inducible protochlorophyllide oxidoreductase C (PORC) that effectively phototransforms endogenous protochlorophyllide to chlorophyllide leading to minimal accumulation of the photosensitizer protochlorophyllide in light-grown plants. In PORC overexpressing (PORCx) plants exposed to high-light, the O-1(2) generation and consequent malonedialdehyde production was minimal and the maximum quantum efficiency of photosystem II remained unaffected demonstrating that their photosynthetic apparatus and cellular organization were intact. Further, PORCx plants treated with 5-aminolevulinicacid when exposed to light, photo-converted over-accumulated protochlorophyllide to chlorophyllide, reduced the generation of O-1(2) and malonedialdehyde production and reduced plasma membrane damage. So PORCx plants survived and bolted whereas, the 5-aminolevulinicacid-treated wild-type plants perished. Thus, overexpression of PORC could be biotechnologically exploited in crop plants for tolerance to O-1(2)-induced oxidative stress, paving the use of 5-aminolevulinicacid as a selective commercial light-activated biodegradable herbicide. Reduced protochlorophyllide content in PORCx plants released the protochlorophyllide-mediated feed-back inhibition of 5-aminolevulinicacid biosynthesis that resulted in higher 5-aminolevulinicacid production. Increase of 5-aminolevulinicacid synthesis upregulated the gene and protein expression of several downstream chlorophyll biosynthetic enzymes elucidating a regulatory net work of expression of genes involved in 5-aminolevulinicacid and tetrapyrrole biosynthesis.	[Pattanayak, Gopal K.; Tripathy, Baishnab C.] Jawaharlal Nehru Univ, Sch Life Sci, New Delphi, India		Pattanayak, GK (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, 920 E 58Th St, Chicago, IL 60637 USA.	bctripathy@mail.jnu.ac.in			Department of Biotechnology, Government of India [BT/PR6074/AGR/02/311/2005]; CSIR, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by a grant from the Department of Biotechnology, Government of India (BT/PR6074/AGR/02/311/2005) to BCT. GKP was the recipient of a CSIR fellowship, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	ARMSTRONG GA, 1995, PLANT PHYSIOL, V108, P1505, DOI 10.1104/pp.108.4.1505; ASADA K, 1984, METHOD ENZYMOL, V105, P422; Asada K, 1996, PHOTOSYNTHESIS ENV, P123, DOI DOI 10.1007/0-306-48135-9_5; BENNETT J, 1981, EUR J BIOCHEM, V118, P61, DOI 10.1111/j.1432-1033.1981.tb05486.x; Bozell JJ, 2000, RESOUR CONSERV RECY, V28, P227, DOI 10.1016/S0921-3449(99)00047-6; CHAKRABORTY N, 1992, PLANT PHYSIOL, V98, P7, DOI 10.1104/pp.98.1.7; Choi C, 1999, BIOTECHNOL LETT, V21, P551, DOI 10.1023/A:1005520007230; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dutta S, 2009, PLANT PHYSIOL, V150, P1050, DOI 10.1104/pp.109.137265; FEINBAUM RL, 1991, MOL GEN GENET, V226, P449, DOI 10.1007/BF00260658; Fischer BB, 2007, FEBS LETT, V581, P5555, DOI 10.1016/j.febslet.2007.11.003; FOOTE CS, 1991, PHOTOCHEM PHOTOBIOL, V54, P659, DOI 10.1111/j.1751-1097.1991.tb02071.x; Franck F, 2000, PLANT PHYSIOL, V124, P1678, DOI 10.1104/pp.124.4.1678; Frick G, 2003, PLANT J, V35, P141, DOI 10.1046/j.1365-313X.2003.01798.x; Govindjee, 2004, ADV PHOTOSYNTH RESP, V19, P1; Graham MY, 2005, PLANT PHYSIOL, V139, P1784, DOI 10.1104/pp.105.068676; GRIFFITHS WT, 1978, BIOCHEM J, V174, P681, DOI 10.1042/bj1740681; Harpaz-Saad S, 2007, PLANT CELL, V19, P1007, DOI 10.1105/tpc.107.050633; Hayes DJ, 2006, BIOREFINERIES - INDUSTRIAL PROCESSES AND PRODUCTS: STATUS QUO AND FUTURE DIRECTIONS, VOL 1, P139; Hodges DM, 1999, PLANTA, V207, P604, DOI 10.1007/s004250050524; HOLTORF H, 1995, P NATL ACAD SCI USA, V92, P3254, DOI 10.1073/pnas.92.8.3254; Holtorf S, 1995, PLANT MOL BIOL, V29, P637, DOI 10.1007/BF00041155; Horigome D, 2007, J BIOL CHEM, V282, P6525, DOI 10.1074/jbc.M609458200; Hu GS, 1998, PLANT CELL, V10, P1095, DOI 10.1105/tpc.10.7.1095; HUKMANI P, 1992, ANAL BIOCHEM, V206, P125, DOI 10.1016/S0003-2697(05)80021-1; Huq E, 2004, SCIENCE, V305, P1937, DOI 10.1126/science.1099728; Jilani A, 1996, PHYSIOL PLANTARUM, V96, P139, DOI 10.1111/j.1399-3054.1996.tb00194.x; Jung S, 2008, PLANT MOL BIOL, V67, P535, DOI 10.1007/s11103-008-9338-0; KRUSE E, 1995, EMBO J, V14, P3712, DOI 10.1002/j.1460-2075.1995.tb00041.x; Lebedev N, 1995, PLANT CELL, V7, P2081, DOI 10.1105/tpc.7.12.2081; Ledford HK, 2007, EUKARYOT CELL, V6, P919, DOI 10.1128/EC.00207-06; Lee KP, 2007, P NATL ACAD SCI USA, V104, P10270, DOI 10.1073/pnas.0702061104; Masuda T, 2003, PLANT CELL PHYSIOL, V44, P963, DOI 10.1093/pcp/pcg128; MEHLER AH, 1951, ARCH BIOCHEM BIOPHYS, V33, P65, DOI 10.1016/0003-9861(51)90082-3; Mock HP, 1997, PLANT PHYSIOL, V113, P1101, DOI 10.1104/pp.113.4.1101; Mohanty S, 2006, PLANTA, V224, P692, DOI 10.1007/s00425-006-0248-6; Mohapatra A, 2002, BIOCHEM BIOPH RES CO, V299, P751, DOI 10.1016/S0006-291X(02)02703-1; Mohapatra A, 2007, PHOTOSYNTH RES, V94, P401, DOI 10.1007/s11120-007-9209-6; Moulin M, 2005, BIOCHEM SOC T, V33, P737, DOI 10.1042/BST0330737; Mozzo M, 2008, J BIOL CHEM, V283, P6184, DOI 10.1074/jbc.M708961200; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Oosawa N, 2000, FEBS LETT, V474, P133, DOI 10.1016/S0014-5793(00)01568-4; op den Camp RGL, 2003, PLANT CELL, V15, P2320, DOI 10.1105/tpc.014662; Paddock TN, 2010, PLANT MOL BIOL, V72, P445, DOI 10.1007/s11103-009-9582-y; Pattanayak GK, 2005, BIOCHEM BIOPH RES CO, V326, P466, DOI 10.1016/j.bbrc.2004.11.049; Pattanayak GK, 2002, BIOCHEM BIOPH RES CO, V291, P921, DOI 10.1006/bbrc.2002.6543; Pollmann S, 2007, P NATL ACAD SCI USA, V104, P2019, DOI 10.1073/pnas.0610934104; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; REBEIZ CA, 1990, PHOTOCHEM PHOTOBIOL, V52, P1099, DOI 10.1111/j.1751-1097.1990.tb08451.x; REBEIZ CA, 1988, CRIT REV PLANT SCI, V6, P385, DOI 10.1080/07352688809382256; Reinbothe S, 1996, PLANT CELL, V8, P763, DOI 10.1105/tpc.8.5.763; Richter A, 2010, PLANT CELL PHYSIOL, V51, P670, DOI 10.1093/pcp/pcq047; Runge S, 1996, PLANT J, V9, P513, DOI 10.1046/j.1365-313X.1996.09040513.x; Schmidt K, 2003, BIOCHEMISTRY-US, V42, P7427, DOI 10.1021/bi034207r; Shalygo NV, 1998, J PHOTOCH PHOTOBIO B, V42, P151, DOI 10.1016/S1011-1344(98)00067-0; Sperling U, 1997, PLANT J, V12, P649, DOI 10.1046/j.1365-313X.1997.00649.x; Sperling U, 1998, PLANT CELL, V10, P283, DOI 10.1105/tpc.10.2.283; STOBART AK, 1984, BIOCHEM J, V222, P419, DOI 10.1042/bj2220419; Su QX, 2001, PLANT MOL BIOL, V47, P805, DOI 10.1023/A:1013699721301; TANAKA A, 1994, PLANTA, V192, P92; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tewari AK, 1998, PLANT PHYSIOL, V117, P851, DOI 10.1104/pp.117.3.851; Triantaphylides C, 2009, TRENDS PLANT SCI, V14, P219, DOI 10.1016/j.tplants.2009.01.008; Tripathy BC, 2007, BBA-BIOENERGETICS, V1767, P860, DOI 10.1016/j.bbabio.2007.03.008; Tripathy BC, 2010, ADV PHOTOSYNTH RESP, V31, P397; TRIPATHY BC, 1991, PLANT PHYSIOL, V96, P761, DOI 10.1104/pp.96.3.761; Wagner D, 2004, SCIENCE, V306, P1183, DOI 10.1126/science.1103178; Welburn AR, 1984, ADV PHOTOSYNTHESIS R, VII, P9	68	49	50	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26532	10.1371/journal.pone.0026532	http://dx.doi.org/10.1371/journal.pone.0026532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031838	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200027
J	Alcazar, MAA; Morty, RE; Lendzian, L; Vohlen, C; Oestreicher, I; Plank, C; Schneider, H; Dotsch, J				Alcazar, Miguel Angel Alejandre; Morty, Rory E.; Lendzian, Lisa; Vohlen, Christina; Oestreicher, Iris; Plank, Christian; Schneider, Holm; Doetsch, Joerg			Inhibition of TGF-beta Signaling and Decreased Apoptosis in IUGR-Associated Lung Disease in Rats	PLOS ONE			English	Article							INTRAUTERINE GROWTH-RETARDATION; MOUSE LUNG; TRANSFORMING GROWTH-FACTOR-BETA-1; MATRIX METALLOPROTEINASE-1; BRANCHING MORPHOGENESIS; PLACENTAL INSUFFICIENCY; DEVELOPMENTAL ORIGINS; RESPIRATORY HEALTH; TISSUE INHIBITORS; EXPRESSION	Intrauterine growth restriction is associated with impaired lung function in adulthood. It is unknown whether such impairment of lung function is linked to the transforming growth factor (TGF)-beta system in the lung. Therefore, we investigated the effects of IUGR on lung function, expression of extracellular matrix (ECM) components and TGF-beta signaling in rats. IUGR was induced in rats by isocaloric protein restriction during gestation. Lung function was assessed with direct plethysmography at postnatal day (P) 70. Pulmonary activity of the TGF-beta system was determined at P1 and P70. TGF-beta signaling was blocked in vitro using adenovirus-delivered Smad7. At P70, respiratory airway compliance was significantly impaired after IUGR. These changes were accompanied by decreased expression of TGF-beta 1 at P1 and P70 and a consistently dampened phosphorylation of Smad2 and Smad3. Furthermore, the mRNA expression levels of inhibitors of TGF-beta signaling (Smad7 and Smurf2) were reduced, and the expression of TGF-beta-regulated ECM components (e. g. collagen I) was decreased in the lungs of IUGR animals at P1; whereas elastin and tenascin N expression was significantly upregulated. In vitro inhibition of TGF-beta signaling in NIH/3T3, MLE 12 and endothelial cells by adenovirus-delivered Smad7 demonstrated a direct effect on the expression of ECM components. Taken together, these data demonstrate a significant impact of IUGR on lung development and function and suggest that attenuated TGF-beta signaling may contribute to the pathological processes of IUGR-associated lung disease.	[Alcazar, Miguel Angel Alejandre; Vohlen, Christina; Doetsch, Joerg] Univ Cologne, Dept Pediat & Adolescent Med, Cologne, Germany; [Morty, Rory E.] Univ Giessen, Dept Internal Med, Lung Ctr, D-6300 Giessen, Germany; [Oestreicher, Iris] Charite Univ Med Ctr, Dept Neonatol, Berlin, Germany; [Lendzian, Lisa; Plank, Christian; Schneider, Holm] Univ Hosp Erlangen, Dept Pediat & Adolescent Med, Erlangen, Germany	University of Cologne; Justus Liebig University Giessen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Erlangen Nuremberg	Alcazar, MAA (corresponding author), Univ Cologne, Dept Pediat & Adolescent Med, Cologne, Germany.	miguel.alejandre-alcazar@uk-koeln.de		Alejandre Alcazar, Miguel Angel/0000-0002-3176-0411	Deutsche Forschungsgemeinschaft, Bonn, Germany, Collaborative Research Centre of the German Research Foundation [SFB 423, B13]; Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN) Erlangen; Koln Fortune, University of Cologne	Deutsche Forschungsgemeinschaft, Bonn, Germany, Collaborative Research Centre of the German Research Foundation(German Research Foundation (DFG)); Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN) Erlangen; Koln Fortune, University of Cologne	The animal experiments were in part supported by a grant to Jorg Dotsch, Christian Plank and Wolfgang Rascher by the Deutsche Forschungsgemeinschaft, Bonn, Germany; SFB 423, Collaborative Research Centre of the German Research Foundation: Kidney Injury: Pathogenesis and Regenerative Mechanisms, Project B13; by a grant to Christian Plank and Miguel Angel Alejandre Alcazar by the Erlanger Leistungsbezogene Anschubfinanzierung und Nachwuchsforderung (ELAN) Erlangen; and by a grant to Miguel Angel Alejandre Alcazar by Koln Fortune, University of Cologne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejandre-Alcazar MA, 2008, DEV DYNAM, V237, P259, DOI 10.1002/dvdy.21403; Alejandre-Alcazar MA, 2007, AM J PHYSIOL-LUNG C, V292, pL537, DOI 10.1152/ajplung.00050.2006; Anand D, 2003, ARCH DIS CHILD, V88, P135, DOI 10.1136/adc.88.2.135; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Barker DJP, 1998, CLIN SCI, V95, P115, DOI 10.1042/CS19980019; Boezen HM, 2002, EUR RESPIR J, V20, P383, DOI 10.1183/09031936.02.00234102; Bonniaud P, 2004, J IMMUNOL, V173, P2099, DOI 10.4049/jimmunol.173.3.2099; Chen CM, 2004, PEDIATR RES, V56, P329, DOI 10.1203/01.PDR.0000134254.83113.8E; Chen H, 2005, AM J PHYSIOL-LUNG C, V288, pL683, DOI 10.1152/ajplung.00298.2004; Chu WF, 2010, J CELL PHYS IN PRESS; Copland I, 2004, PAEDIAT RESP REV SA, V5, P259, DOI DOI 10.1016/S1526-0542(04)90049-8; Dezateux C, 2004, THORAX, V59, P60; Dik WA, 2001, PEDIATR RES, V50, P761, DOI 10.1203/00006450-200112000-00022; Freathy C, 2000, HEPATOLOGY, V32, P750, DOI 10.1053/jhep.2000.18329; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Hosford GE, 2004, PEDIATR RES, V56, P26, DOI 10.1203/01.PDR.0000130658.45564.1F; Jankov RP, 2004, PAEDIAT RESP REV SA, V5, P265; Joss-Moore LA, 2011, PHYSL GENOM IN PRESS; Joss-Moore LA, 2011, BIRTH DEF A IN PRESS; Joyce BJ, 2001, PEDIATR RES, V50, P641, DOI 10.1203/00006450-200111000-00018; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Ke XR, 2010, PHYSIOL GENOMICS, V42, P177, DOI 10.1152/physiolgenomics.00201.2009; Kotecha SJ, 2010, AM J RESP CRIT CARE, V181, P969, DOI 10.1164/rccm.200906-0897OC; LangleyEvans SC, 1997, J NUTR, V127, P202, DOI 10.1093/jn/127.2.202; Liu J, 2000, DEV DYNAM, V217, P343, DOI 10.1002/(SICI)1097-0177(200004)217:4<343::AID-DVDY2>3.0.CO;2-F; Maritz GS, 2005, EARLY HUM DEV, V81, P763, DOI 10.1016/j.earlhumdev.2005.07.002; Maritz GS, 2004, PEDIATR RES, V55, P287, DOI 10.1203/01.PDR.0000106314.99930.65; Maritz GS, 2001, PEDIATR PULM, V32, P201, DOI 10.1002/ppul.1109; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Masumoto K, 2005, HISTOPATHOLOGY, V47, P410, DOI 10.1111/j.1365-2559.2005.02228.x; McDevitt TM, 2007, AM J PHYSIOL-LUNG C, V292, pL249, DOI 10.1152/ajplung.00088.2006; Morty Rory E, 2009, Proc Am Thorac Soc, V6, P607, DOI 10.1513/pats.200908-087RM; Nicola T, 2011, AM J PHYSIOL-LUNG C, V301, pL125, DOI 10.1152/ajplung.00074.2011; Nusken KD, 2011, ENDOCRINOLO IN PRESS; Nuyt AM, 2008, CLIN SCI, V114, P1, DOI 10.1042/CS20070113; Ostlund E, 2002, OBSTET GYNECOL, V100, P567, DOI 10.1016/S0029-7844(02)02173-7; Park JH, 2008, J CLIN INVEST, V118, P2316, DOI [10.1172/JC133655, 10.1172/JCI33655]; Plank C, 2006, KIDNEY INT, V70, P1974, DOI 10.1038/sj.ki.5001966; Pulichino AM, 2008, AM J RESP CELL MOL, V39, P324, DOI 10.1165/rcmb.2007-0186OC; RONA RJ, 1993, BMJ-BRIT MED J, V306, P817, DOI 10.1136/bmj.306.6881.817; Roth-Kleiner M, 2005, PEDIATR PULM, V40, P113, DOI 10.1002/ppul.20252; Roth-Kleiner M, 2003, BIOL NEONATE, V84, P83, DOI 10.1159/000071009; RYAN RM, 1994, AM J PHYSIOL, V266, pL17, DOI 10.1152/ajplung.1994.266.1.L17; Ryu J, 2005, THROMB HAEMOSTASIS, V94, P175, DOI 10.1160/TH04-10-0656; Simmons RA, 2007, PEDIATR RES, V61, p64R, DOI 10.1203/pdr.0b013e3180457623; Song JS, 2011, EXP MOL MED IN PRESS; Torrance HL, 2008, EARLY HUM DEV, V84, P465, DOI 10.1016/j.earlhumdev.2007.12.006; Undevia NS, 2004, AM J PHYSIOL-LUNG C, V287, pL515, DOI 10.1152/ajplung.00044.2004; Vicencio AG, 2004, AM J RESP CELL MOL, V31, P650, DOI 10.1165/rcmb.2004-0092OC; Vicencio AG, 2002, J APPL PHYSIOL, V93, P1123, DOI 10.1152/japplphysiol.00031.2002; Warburton D, 2000, MECH DEVELOP, V92, P55, DOI 10.1016/S0925-4773(99)00325-1; Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED; Warburton D, 2004, PAEDIAT RESP REV SA, V5, P283; Zhang FJ, 2004, AM J RESP CELL MOL, V31, P679, DOI 10.1165/rcmb.2004-0182OC; Zhao JS, 2000, J BIOL CHEM, V275, P23992, DOI 10.1074/jbc.M002433200; Zhao JS, 1998, DEV BIOL, V194, P182, DOI 10.1006/dbio.1997.8825; Zhao JS, 1996, DEV BIOL, V180, P242, DOI 10.1006/dbio.1996.0298; Zhao Y, 1999, MOL CELL ENDOCRINOL, V150, P91, DOI 10.1016/S0303-7207(99)00021-0	58	26	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26371	10.1371/journal.pone.0026371	http://dx.doi.org/10.1371/journal.pone.0026371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028866	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800038
J	Espinoza, JL; Takami, A; Nakata, K; Onizuka, M; Kawase, T; Akiyama, H; Miyamura, K; Morishima, Y; Fukuda, T; Kodera, Y; Nakao, S				Espinoza, J. Luis; Takami, Akiyoshi; Nakata, Katsuya; Onizuka, Makoto; Kawase, Takakazu; Akiyama, Hideki; Miyamura, Koichi; Morishima, Yasuo; Fukuda, Takahiro; Kodera, Yoshihisa; Nakao, Shinji		Japan Marrow Donor Program	A Genetic Variant in the IL-17 Promoter Is Functionally Associated with Acute Graft-Versus-Host Disease after Unrelated Bone Marrow Transplantation	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS SYNOVIOCYTES; INFLAMMATORY-BOWEL-DISEASE; RENAL-ALLOGRAFT REJECTION; ACTIVATED T-CELLS; NUCLEAR FACTOR; HLA ALLELE; INTERLEUKIN-17; DONOR; EXPRESSION; RISK	Interleukin IL-17 is a proinflammatory cytokine that has been implicated in the pathogenesis of various autoimmune diseases. The single nucleotide polymorphism (SNP), rs2275913, in the promoter region of the IL-17 gene is associated with susceptibility to ulcerative colitis. When we examined the impact of rs2275913 in a cohort consisting of 438 pairs of patients and their unrelated donors transplanted through the Japan Marrow Donor Program, the donor IL-17 197A allele was found to be associated with a higher risk of acute graft-versus-host disease (GVHD; hazard ratio [HR], 1.46; 95% confidence interval [CI], 1.00 to 2.13; P = 0.05). Next, we investigated the functional relevance of the rs2275913 SNP. In vitro stimulated T cells from healthy individuals possessing the 197A allele produced significantly more IL-17 than those without the 197A allele. In a gene reporter assay, the 197A allele construct induced higher luciferase activity than the 197G allele, and the difference was higher in the presence of T cell receptor activation and was abrogated by cyclosporine treatment. Moreover, the 197A allele displayed a higher affinity for the nuclear factor activated T cells (NFAT), a critical transcription factor involved in IL-17 regulation. These findings substantiate the functional relevance of the rs2275913 polymorphism and indicate that the higher IL-17 secretion by individuals with the 197A allele likely accounts for their increased risk for acute GVHD and certain autoimmune diseases.	[Espinoza, J. Luis; Takami, Akiyoshi; Nakata, Katsuya; Nakao, Shinji] Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan; [Onizuka, Makoto] Tokai Univ, Sch Med, Dept Hematol & Oncol, Isehara, Kanagawa 25911, Japan; [Kawase, Takakazu; Morishima, Yasuo] Aichi Canc Res Ctr, Div Epidemiol & Prevent, Nagoya, Aichi, Japan; [Akiyama, Hideki] Komagome Hosp, Div Hematol, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; [Miyamura, Koichi] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nagoya, Aichi, Japan; [Fukuda, Takahiro] Natl Canc Ctr, Hematopoiet Stem Cell Transplantat Unit, Tokyo, Japan; [Kodera, Yoshihisa] Aichi Med Univ, Dept Promot Blood & Marrow Transplantat, Nagoya, Aichi, Japan	Kanazawa University; Tokai University; Aichi Cancer Center; Tokyo Metropolitan Cancer & Infectious Diseases Center Komagome Hospital; Red Cross Nagoya Daiichi Hospital; National Cancer Center - Japan; Aichi Medical University	Espinoza, JL (corresponding author), Kanazawa Univ Hosp, Dept Hematol & Oncol, Kanazawa, Ishikawa, Japan.	takami@med3.m.kanazawa-u.ac.jp	Takami, Akiyoshi/O-5677-2019; Espinoza, Luis/L-1586-2013	Takami, Akiyoshi/0000-0002-1822-9976; Espinoza, Luis/0000-0002-1794-6666; ONIZUKA, MAKOTO/0000-0003-3864-0823	Ministry of Health, Labor and Welfare of Japan [H23-010]; Ministry of Education, Culture, Sports and Technology of Japan; Mitani Research and Development Assistance Organization (Kanazawa, Japan); Japan Leukemia Research Fund (Tokyo, Japan); Hokkoku Gan Kikin Fund (Kanazawa, Japan)	Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Mitani Research and Development Assistance Organization (Kanazawa, Japan); Japan Leukemia Research Fund (Tokyo, Japan); Hokkoku Gan Kikin Fund (Kanazawa, Japan)	This study was supported by grants from the Ministry of Health, Labor and Welfare of Japan, and the Ministry of Education, Culture, Sports and Technology of Japan, and Funds from the Mitani Research and Development Assistance Organization (Kanazawa, Japan), by the Japan Leukemia Research Fund (Tokyo, Japan), and by Hokkoku Gan Kikin Fund (Kanazawa, Japan). This work was supported in part by the Research on Allergic Disease and Immunology (H23-010) in Health and Labor Science Grant from the Ministry of Health, Labor and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2008, J RHEUMATOL, V35, P515; Antonysamy MA, 1999, J IMMUNOL, V162, P577; Arisawa T, 2008, J CLIN IMMUNOL, V28, P44, DOI 10.1007/s10875-007-9125-8; Carlson MJ, 2009, BLOOD, V113, P1365, DOI 10.1182/blood-2008-06-162420; Chabaud M, 1998, J IMMUNOL, V161, P409; Ciprandi G., 2009, ALLERGY; Duffner UA, 2004, J IMMUNOL, V172, P7393, DOI 10.4049/jimmunol.172.12.7393; ESPINOZA JL, 2011, BONE MARROW TRANSPLA; Espinoza LJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023827; Filipovich AH, 2005, BIOL BLOOD MARROW TR, V11, P945, DOI 10.1016/j.bbmt.2005.09.004; Fujino S, 2003, GUT, V52, P65, DOI 10.1136/gut.52.1.65; Giralt S, 2009, BIOL BLOOD MARROW TR, V15, P367, DOI 10.1016/j.bbmt.2008.12.497; Gooley TA, 1999, STAT MED, V18, P695, DOI 10.1002/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.3.CO;2-F; ICLOZAN C, 2009, BIOL BLOOD MARROW TR; Kappel LW, 2009, BLOOD, V113, P945, DOI 10.1182/blood-2008-08-172155; Kawase T, 2007, BLOOD, V110, P2235, DOI 10.1182/blood-2007-02-072405; Kim DH, 2007, TRANSPLANTATION, V84, P917, DOI 10.1097/01.tp.0000284583.15810.6e; Kirkham BW, 2006, ARTHRITIS RHEUM, V54, P1122, DOI 10.1002/art.21749; Kitamura N, 2006, J IMMUNOL METHODS, V312, P105, DOI 10.1016/j.jim.2006.02.015; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Leppkes M, 2009, GASTROENTEROLOGY, V136, P257, DOI 10.1053/j.gastro.2008.10.018; Li X, 2010, BIOCHEM BIOPH RES CO, V397, P131, DOI 10.1016/j.bbrc.2010.05.111; Liu XKK, 2004, J BIOL CHEM, V279, P52762, DOI 10.1074/jbc.M405764200; Lohr J, 2006, J EXP MED, V203, P2785, DOI 10.1084/jem.20061341; Loong CC, 2002, J PATHOL, V197, P322, DOI 10.1002/path.1117; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Morishima Y, 2007, BIOL BLOOD MARROW TR, V13, P315, DOI 10.1016/j.bbmt.2006.10.027; Nordang GBN, 2009, RHEUMATOLOGY, V48, P367, DOI 10.1093/rheumatology/ken512; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; Rovedatti L, 2009, GUT, V58, P1629, DOI 10.1136/gut.2009.182170; Rowlings PA, 1997, BRIT J HAEMATOL, V97, P855, DOI 10.1046/j.1365-2141.1997.1112925.x; Sasazuki T, 1998, NEW ENGL J MED, V339, P1177, DOI 10.1056/NEJM199810223391701; Scrucca L, 2007, BONE MARROW TRANSPL, V40, P381, DOI 10.1038/sj.bmt.1705727; Shibata T, 2009, HUM IMMUNOL, V70, P547, DOI 10.1016/j.humimm.2009.04.030; Shlomchik WD, 1999, SCIENCE, V285, P412, DOI 10.1126/science.285.5426.412; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Soyland E, 2011, BRIT J DERMATOL, V164, P344, DOI 10.1111/j.1365-2133.2010.10149.x; Sugihara T, 2010, CLIN EXP IMMUNOL, V160, P386, DOI 10.1111/j.1365-2249.2010.04093.x; Tawara I, 2008, EXP HEMATOL, V36, P988, DOI 10.1016/j.exphem.2008.02.010; Teshima T, 2002, NAT MED, V8, P575, DOI 10.1038/nm0602-575; Van Kooten C, 1998, J AM SOC NEPHROL, V9, P1526; Vanaudenaerde BM, 2006, EUR RESPIR J, V27, P779, DOI 10.1183/09031936.06.00019405; Yi TS, 2008, BLOOD, V112, P2101, DOI 10.1182/blood-2007-12-126987; Yi TS, 2009, BLOOD, V114, P3101, DOI 10.1182/blood-2009-05-219402; Zrioual S, 2009, J IMMUNOL, V182, P3112, DOI 10.4049/jimmunol.0801967	45	150	157	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26229	10.1371/journal.pone.0026229	http://dx.doi.org/10.1371/journal.pone.0026229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028838	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800029
J	Morard, R; Quillevere, F; Douady, CJ; de Vargas, C; de Garidel-Thoron, T; Escarguel, G				Morard, Raphael; Quillevere, Frederic; Douady, Christophe J.; de Vargas, Colomban; de Garidel-Thoron, Thibault; Escarguel, Gilles			Worldwide Genotyping in the Planktonic Foraminifer Globoconella inflata: Implications for Life History and Paleoceanography	PLOS ONE			English	Article							MOLECULAR EVIDENCE; GENETIC TYPES; DIVERSITY; BACILLARIOPHYCEAE; RECONSTRUCTION; DIVERGENCE; SIGNATURE	The planktonic foraminiferal morpho-species Globoconella inflata is widely used as a stratigraphic and paleoceanographic index. While G. inflata was until now regarded as a single species, we show that it rather constitutes a complex of two pseudo-cryptic species. Our study is based on SSU and ITS rDNA sequence analyses and genotyping of 497 individuals collected at 49 oceanic stations covering the worldwide range of the morpho-species. Phylogenetic analyses unveil the presence of two divergent genotypes. Type I inhabits transitional and subtropical waters of both hemispheres, while Type II is restricted to the Antarctic subpolar waters. The two genetic species exhibit a strictly allopatric distribution on each side of the Antarctic Subpolar Front. On the other hand, sediment data show that G. inflata was restricted to transitional and subtropical environments since the early Pliocene, and expanded its geographic range to southern subpolar waters similar to 700 kyrs ago, during marine isotopic stage 17. This datum may correspond to a peripatric speciation event that led to the partition of an ancestral genotype into two distinct evolutionary units. Biometric measurements performed on individual G. inflata from plankton tows north and south of the Antarctic Subpolar Front indicate that Types I and II display slight but significant differences in shell morphology. These morphological differences may allow recognition of the G. inflata pseudo-cryptic species back into the fossil record, which in turn may contribute to monitor past movements of the Antarctic Subpolar Front during the middle and late Pleistocene.	[Morard, Raphael; Quillevere, Frederic; Escarguel, Gilles] Univ Lyon 1, CNRS, UMR 5276, Lab Geol Lyon Terre Planetes Environm, F-69622 Villeurbanne, France; [Morard, Raphael; de Vargas, Colomban] UPMC, CNRS, UMR Evolut Plancton & PaleoOceans 7144, Stn Biol Roscoff, Roscoff, France; [Douady, Christophe J.] Univ Lyon 1, CNRS, UMR Ecol Hydrosyst Fluviaux 5023, F-69622 Villeurbanne, France; [Douady, Christophe J.] Inst Univ France, Paris, France; [de Garidel-Thoron, Thibault] Aix Marseille Univ, CEREGE UMR6635, Aix En Provence, France; [de Garidel-Thoron, Thibault] CNRS, CEREGE UMR6635, Aix En Provence, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Institut Universitaire de France; UDICE-French Research Universities; PSL Research University Paris; College de France; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; PSL Research University Paris; College de France; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD)	Morard, R (corresponding author), Univ Lyon 1, CNRS, UMR 5276, Lab Geol Lyon Terre Planetes Environm, F-69622 Villeurbanne, France.	raphael.morard@sb-roscoff.fr	Douady, Christophe J/N-1357-2014; Escarguel, Gilles/C-3297-2011; de Garidel-Thoron, Thibault/B-1204-2008; Douady, Christophe/N-3069-2019; Quillévéré, Frédéric/C-8317-2012	Douady, Christophe J/0000-0002-4503-8040; de Garidel-Thoron, Thibault/0000-0001-8983-9571; Douady, Christophe/0000-0002-4503-8040; Escarguel, Gilles/0000-0003-0985-6369; de Vargas, Colomban/0000-0002-6476-6019; Quillevere, Frederic/0000-0002-6248-0447	Universite Lyon 1 (Molecular analysis and morphometric analysis) [IFR41]; INSU INTERRVIE program (Molecular analysis and morphometric analysis); Fondation pour la Recherche sur la Biodiversite [ANR-06-JCJC-0142 PALEO-CTD]; ANR Blanc FORCLIM [ANR-09-BLAN-0348 POSEIDON]; BIOMARKS - Biodiversity of marine eukaryotes; Eranet Biodiversa	Universite Lyon 1 (Molecular analysis and morphometric analysis); INSU INTERRVIE program (Molecular analysis and morphometric analysis); Fondation pour la Recherche sur la Biodiversite; ANR Blanc FORCLIM(French National Research Agency (ANR)); BIOMARKS - Biodiversity of marine eukaryotes; Eranet Biodiversa	The authors declare funding from the following programs (see details for the role of each funders): Grants from the IFR41 of Universite Lyon 1 (Molecular analysis and morphometric analysis); INSU INTERRVIE program (Molecular analysis and morphometric analysis); Fondation pour la Recherche sur la Biodiversite: (morphometric analysis); ANR-06-JCJC-0142 PALEO-CTD (sample collection); ANR Blanc FORCLIM (sample collection); ANR-09-BLAN-0348 POSEIDON (molecular analysis); BIOMARKS - Biodiversity of marine eukaryotes, funded by the FP7 Eranet Biodiversa (Molecular analysis). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Aurahs R, 2011, MAR MICROPALEONTOL, V79, P1, DOI 10.1016/j.marmicro.2010.12.001; Aurahs R, 2009, MOL ECOL, V18, P1692, DOI 10.1111/j.1365-294X.2009.04136.x; Be A.W.H., 1977, ECOLOGICAL ZOOGEOGRA; Behnke A, 2004, J PHYCOL, V40, P193, DOI 10.1046/j.1529-8817.2004.03037.x; Berggren W. A., 1995, GEOCHRONOLOGY TIME S, P129, DOI DOI 10.2110/PEC.95.04.0129; Beszteri B, 2005, PROTIST, V156, P317, DOI 10.1016/j.protis.2005.07.002; Bolli HM, 1985, PLANKTON STRATIGRAPH, P228; Bowser Samuel S., 2008, P78; Brayard A, 2005, J ZOOL SYST EVOL RES, V43, P178, DOI 10.1111/j.1439-0469.2005.00311.x; Carter L., 2008, DEV EARTH ENV SCI, P85, DOI DOI 10.1016/S1571-9197(08)00004-9; Casteleyn G, 2008, HARMFUL ALGAE, V7, P241, DOI 10.1016/j.hal.2007.08.004; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chiessi CM, 2007, MAR MICROPALEONTOL, V64, P52, DOI 10.1016/j.marmicro.2007.02.002; Cleroux C, 2007, GEOCHEMISTERY GEOPHY, V8, P1; Darling KF, 2008, MAR MICROPALEONTOL, V67, P216, DOI 10.1016/j.marmicro.2008.01.009; Darling KF, 2006, PALEOCEANOGRAPHY, V21, DOI 10.1029/2005PA001189; Darling KF, 2007, P NATL ACAD SCI USA, V104, P5002, DOI 10.1073/pnas.0700520104; Darling KF, 2000, NATURE, V405, P43, DOI 10.1038/35011002; Darling KF, 2004, P NATL ACAD SCI USA, V101, P7657, DOI 10.1073/pnas.0402401101; Darling KF, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2001PA000723; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; de Vargas C, 2001, PALEOBIOLOGY, V27, P104, DOI 10.1666/0094-8373(2001)027<0104:PARIGT>2.0.CO;2; de Vargas C, 2002, MAR MICROPALEONTOL, V45, P101, DOI 10.1016/S0377-8398(02)00037-3; de Vargas C, 1999, P NATL ACAD SCI USA, V96, P2864, DOI 10.1073/pnas.96.6.2864; DIETRICH G, 1980, GEN OCEANOGRAPHY; FAIRBANKS RG, 1982, NATURE, V298, P841, DOI 10.1038/298841a0; Farmer EC, 2007, PALEOCEANOGRAPHY, V22, DOI 10.1029/2006PA001361; Ganssen GM, 2000, J GEOL SOC LONDON, V157, P693, DOI 10.1144/jgs.157.3.693; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Huber BT, 1997, PALEOBIOLOGY, V23, P33, DOI 10.1017/S0094837300016638; Katz ME, 2010, J FORAMIN RES, V40, P165, DOI 10.2113/gsjfr.40.2.165; KEANY J, 1972, DEEP-SEA RES, V19, P529, DOI 10.1016/0011-7471(72)90038-1; Keigwin LD, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001074; Kennett J.P., 1983, NEOGENE PLANKTONIC F; KENNETT JP, 1970, DEEP-SEA RES, V17, P125, DOI 10.1016/0011-7471(70)90092-6; King AL, 2005, MAR MICROPALEONTOL, V56, P1, DOI 10.1016/j.marmicro.2005.02.008; KNOWLTON N, 1993, ANNU REV ECOL SYST, V24, P189, DOI 10.1146/annurev.es.24.110193.001201; Kucera M, 2005, QUATERNARY SCI REV, V24, P813, DOI 10.1016/j.quascirev.2004.07.017; KUSTANOWICH S., 1963, NEW ZEALAND J GEOL AND GEOPHYS, V6, P534; Locarnini RA, 2006, WORLD OCEAN ATLAS, V61; Martinez-Garcia A, 2010, SCIENCE, V328, P1550, DOI 10.1126/science.1184480; Martinez-Garcia A, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001657; Morard R, 2009, MAR MICROPALEONTOL, V71, P148, DOI 10.1016/j.marmicro.2009.03.001; Norris RD, 2000, PALEOBIOLOGY, V26, P236, DOI 10.1666/0094-8373(2000)26[236:PSDBAE]2.0.CO;2; NORRIS RD, 1994, MAR MICROPALEONTOL, V23, P121, DOI 10.1016/0377-8398(94)90004-3; Pawlowski J, 2007, MOL ECOL, V16, P4089, DOI 10.1111/j.1365-294X.2007.03465.x; Pawlowski J, 2000, MICROPALEONTOLOGY, V46, P1; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; PRELL WL, 1999, DATA CONTRIBUTION SE; Quillevere F, 2011, PALAEOGEOGR IN PRESS; Ravelo AC, 1992, PALEOCEANOGRAPHY, V7, P815, DOI 10.1029/92PA02092; Scott GH, 2007, MAR MICROPALEONTOL, V62, P235, DOI 10.1016/j.marmicro.2006.08.007; Sokal R.R., 2012, BIOMETRY; Stewart IA, 2001, MAR MICROPALEONTOL, V43, P143, DOI 10.1016/S0377-8398(01)00024-X; Thornhill DJ, 2007, MOL ECOL, V16, P5326, DOI 10.1111/j.1365-294X.2007.03576.x; Van Oppen MJH, 2005, MOL ECOL, V14, P2403, DOI 10.1111/j.1365-294X.2005.02545.x; Vanormelingen P, 2008, PROTIST, V159, P73, DOI 10.1016/j.protis.2007.08.004; Wilke I, 2006, MAR MICROPALEONTOL, V58, P243, DOI 10.1016/j.marmicro.2005.11.005	61	35	38	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26665	10.1371/journal.pone.0026665	http://dx.doi.org/10.1371/journal.pone.0026665			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028935	Green Published, gold			2022-12-27	WOS:000296510800064
J	Sadik, CD; Kim, ND; Alekseeva, E; Luster, AD				Sadik, Christian D.; Kim, Nancy D.; Alekseeva, Elena; Luster, Andrew D.			IL-17RA Signaling Amplifies Antibody-Induced Arthritis	PLOS ONE			English	Article							COLLAGEN-INDUCED ARTHRITIS; AUTOANTIBODY-MEDIATED ARTHRITIS; RHEUMATOID-ARTHRITIS; T-CELLS; CXC CHEMOKINE; MAST-CELLS; TH17 CELLS; INTERLEUKIN-17; EXPRESSION; MICE	Objective: To investigate the role of IL-17RA signaling in the effector phase of inflammatory arthritis using the K/BxN serum-transfer model. Methods: Wild-type and Il17ra(-/-) mice were injected with serum isolated from arthritic K/BxN mice and their clinical score was recorded daily. Mice were also harvested on days 12 and 21 and ankles were analyzed for cytokine and chemokine mRNA expression by qPCR on day 12 and for bone and cartilage erosions by histology on day 21, respectively. The induction of cytokine and chemokine expression levels by IL-17A in synovial-like fibroblasts was also analyzed using qPCR. Results: Il17ra(-/-) mice were partially protected from clinical signs of arthritis and had markedly fewer cartilage and bone erosions. The expression of several pro-inflammatory mediators, including the chemokines KC/CXCL1, MIP-2/CXCL2, LIX/CXCL5 MIP-1c/CCL9, MCP-3/CCL7, MIP-3a/CCL20, the cytokines IL-1b, IL-6, RANKL and the matrix metalloproteinases MMP2, MMP3, and MMP13 were decreased in the ankles of Il17ra(-/-) mice compared to wild-type mice. Many of these proinflammatory genes attenuated in the ankles of Il17ra(-/-) mice were shown to be directly induced by IL-17A in synovial fibroblasts in vitro. Conclusions: IL-17RA signaling plays a role as an amplifier of the effector phase of inflammatory arthritis. This effect is likely mediated by direct activation of synovial fibroblasts by IL-17RA to produce multiple inflammatory mediators, including chemokines active on neutrophils. Therefore, interrupting IL-17RA signaling maybe a promising pharmacological target for the treatment of inflammatory arthritis.	[Sadik, Christian D.; Kim, Nancy D.; Alekseeva, Elena; Luster, Andrew D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Sadik, CD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Boston, MA 02115 USA.	aluster@mgh.harvard.edu	Sadik, Christian/E-8404-2012; Sadik, Christian David/G-9593-2014; Luster, Andrew/ABE-6504-2020	Sadik, Christian David/0000-0001-6701-048X; Luster, Andrew/0000-0001-9679-7912	Deutsche Forschungsgemeinschaft [Sa1960/1-1]; National Institutes of Health [R01-AI050892, K08-AR054094]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR054094] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants of the Deutsche Forschungsgemeinschaft (Sa1960/1-1 to C. D. S.; www.dfg.de)) and of the National Institutes of Health (R01-AI050892 to A. D. L. and K08-AR054094 to N.D.K.; www.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chabaud M, 1999, ARTHRITIS RHEUM-US, V42, P963, DOI 10.1002/1529-0131(199905)42:5<963::AID-ANR15>3.0.CO;2-E; Chou RC, 2010, IMMUNITY, V33, P266, DOI 10.1016/j.immuni.2010.07.018; Doodes PD, 2008, J IMMUNOL, V181, P329, DOI 10.4049/jimmunol.181.1.329; Gaffen SL, 2009, NAT REV IMMUNOL, V9, P556, DOI 10.1038/nri2586; Hu Y, 2010, J IMMUNOL; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Ito Y, 2009, ARTHRITIS RHEUM-US, V60, P2294, DOI 10.1002/art.24687; Jacobs JP, 2009, P NATL ACAD SCI USA, V106, P21789, DOI 10.1073/pnas.0912152106; Ji H, 2002, IMMUNITY, V16, P157, DOI 10.1016/S1074-7613(02)00275-3; Joosten LAB, 2009, ARTHRITIS RHEUM, V60, P3651, DOI 10.1002/art.25006; Kirkham BW, 2006, ARTHRITIS RHEUM, V54, P1122, DOI 10.1002/art.21749; Koenders MI, 2006, ANN RHEUM DIS, V65, P29, DOI 10.1136/ard.2006.058529; Koenders MI, 2006, J IMMUNOL, V176, P6262, DOI 10.4049/jimmunol.176.10.6262; Koenders MI, 2005, ARTHRITIS RHEUM-US, V52, P3239, DOI 10.1002/art.21342; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kotake S, 1999, J CLIN INVEST, V103, P1345, DOI 10.1172/JCI5703; Leipe J, 2010, ARTHRITIS RHEUM-US, V62, P2876, DOI 10.1002/art.27622; Lemos HP, 2009, P NATL ACAD SCI USA, V106, P5954, DOI 10.1073/pnas.0812782106; Lubberts E, 2001, J IMMUNOL, V167, P1004, DOI 10.4049/jimmunol.167.2.1004; Lubberts E, 2010, SEMIN IMMUNOPATHOL, V32, P43, DOI 10.1007/s00281-009-0189-9; Matsui T, 2001, CLIN EXP IMMUNOL, V125, P155, DOI 10.1046/j.1365-2249.2001.01542.x; Matsuyama Y, 2010, J RHEUMATOL, V37, P18, DOI 10.3899/jrheum.090492; Monach PA, 2010, ARTHRITIS RHEUM-US, V62, P753, DOI 10.1002/art.27238; Nakae S, 2003, J IMMUNOL, V171, P6173, DOI 10.4049/jimmunol.171.11.6173; Nakae S, 2003, P NATL ACAD SCI USA, V100, P5986, DOI 10.1073/pnas.1035999100; Nigrovic PA, 2007, P NATL ACAD SCI USA, V104, P2325, DOI 10.1073/pnas.0610852103; Nigrovic PA, 2010, ARTHRITIS RHEUM-US, V62, P3322, DOI 10.1002/art.27659; Okamatsu Y, 2004, J IMMUNOL, V173, P2084, DOI 10.4049/jimmunol.173.3.2084; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Pappu R, 2010, J CLIN IMMUNOL, V30, P185, DOI 10.1007/s10875-010-9369-6; Pelletier M, 2010, BLOOD, V115, P335, DOI 10.1182/blood-2009-04-216085; Pettit AR, 2001, AM J PATHOL, V159, P1689, DOI 10.1016/S0002-9440(10)63016-7; Pickens SR, 2010, J IMMUNOL, V184, P3233, DOI 10.4049/jimmunol.0903271; Toh ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013416; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Verri Jr. W.A., 2010, ANN RHEUM DIS; Wipke BT, 2001, J IMMUNOL, V167, P1601, DOI 10.4049/jimmunol.167.3.1601; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001; Xu DM, 2010, J IMMUNOL, V184, P2620, DOI 10.4049/jimmunol.0902685; Ye P, 2001, J EXP MED, V194, P519, DOI 10.1084/jem.194.4.519; Ziolkowska N, 2000, J IMMUNOL, V164, P2832, DOI 10.4049/jimmunol.164.5.2832; Zrioual S, 2008, J IMMUNOL, V180, P655, DOI 10.4049/jimmunol.180.1.655; Zrioual S, 2009, J IMMUNOL, V182, P3112, DOI 10.4049/jimmunol.0801967	44	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26342	10.1371/journal.pone.0026342	http://dx.doi.org/10.1371/journal.pone.0026342			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028860	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800036
J	Kuwana, Y; Takei, M; Yajima, M; Imadome, KI; Inomata, H; Shiozaki, M; Ikumi, N; Nozaki, T; Shiraiwa, H; Kitamura, N; Takeuchi, J; Sawada, S; Yamamoto, N; Shimizu, N; Ito, M; Fujiwara, S				Kuwana, Yoshikazu; Takei, Masami; Yajima, Misako; Imadome, Ken-Ichi; Inomata, Hirotake; Shiozaki, Masaaki; Ikumi, Natsumi; Nozaki, Takamasa; Shiraiwa, Hidetaka; Kitamura, Noboru; Takeuchi, Jin; Sawada, Shigemasa; Yamamoto, Naoki; Shimizu, Norio; Ito, Mamoru; Fujiwara, Shigeyoshi			Epstein-Barr Virus Induces Erosive Arthritis in Humanized Mice	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSES; RHEUMATOID-ARTHRITIS; NUCLEAR ANTIGEN; GLYCOPROTEIN GP110; T-CELLS; EPITOPE; CHAIN; LOAD; INFECTION; FREQUENCY	Epstein-Barr virus (EBV) has been implicated in the pathogenesis of rheumatoid arthritis (RA) on the basis of indirect evidence, such as its presence in affected joint tissues, antigenic cross reactions between EBV and human proteins, and elevated humoral and cellular anti-EBV immune responses in patients. Here we report development of erosive arthritis closely resembling RA in humanized mice inoculated with EBV. Human immune system components were reconstituted in mice of the NOD/Shi-scid/IL-2R gamma(null) (NOG) strain by transplantation with CD34(+) hematopoietic stem cells isolated from cord blood. These humanized mice were then inoculated with EBV and examined pathologically for the signs of arthritis. Erosive arthritis accompanied by synovial membrane proliferation, pannus formation, and bone marrow edema developed in fifteen of twenty-three NOG mice transplanted with human HSC and inoculated with EBV, but not in the nine NOG mice that were transplanted with HSC but not inoculated with EBV. This is the first report of an animal model of EBV-induced arthritis and strongly suggest a causative role of the virus in RA.	[Kuwana, Yoshikazu; Takei, Masami; Inomata, Hirotake; Shiozaki, Masaaki; Ikumi, Natsumi; Nozaki, Takamasa; Shiraiwa, Hidetaka; Kitamura, Noboru; Takeuchi, Jin; Sawada, Shigemasa] Nihon Univ, Sch Med, Dept Med, Div Hematol & Rheumatol, Tokyo, Japan; [Yajima, Misako; Yamamoto, Naoki] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117595, Singapore; [Imadome, Ken-Ichi; Fujiwara, Shigeyoshi] Natl Res Inst Child Hlth & Dev, Dept Infect Dis, Tokyo, Japan; [Shimizu, Norio] Tokyo Med & Dent Univ, Med Res Inst, Div Med Sci, Dept Virol, Tokyo, Japan; [Ito, Mamoru] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan	Nihon University; National University of Singapore; National Center for Child Health & Development - Japan; Tokyo Medical & Dental University (TMDU)	Kuwana, Y (corresponding author), Nihon Univ, Sch Med, Dept Med, Div Hematol & Rheumatol, Tokyo, Japan.	takei.masami@nihon-u.ac.jp; shige@nch.go.jp	Yajima, Misako/ABH-7217-2020	Yajima, Misako/0000-0002-6437-1404	Ministry of Health, Labour and Welfare of Japan [H22-Nanchi-080, H22-AIDS-002]; National Center for Child Health and Development [22A-9]; MEXT [S0801033 2010]; Grants-in-Aid for Scientific Research [22590430] Funding Source: KAKEN	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Center for Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Ministry of Health, Labour and Welfare of Japan (H22-Nanchi-080 and H22-AIDS-002:http://www.mhlw.go.jp/), the Grant of National Center for Child Health and Development (22A-9:http://www.ncchd.go.jp/), and Strategic Research Base Development; Program for Private Universities subsidized by MEXT (S0801033 2010: http://www.mext.go.jp/a_menu/koutou/shinkou/07021403/002/002/1218299.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALSPAUGH MA, 1978, J EXP MED, V147, P1018, DOI 10.1084/jem.147.4.1018; Balandraud N, 2003, ARTHRITIS RHEUM, V48, P1223, DOI 10.1002/art.10933; BILLINGS PB, 1983, P NATL ACAD SCI-BIOL, V80, P7104, DOI 10.1073/pnas.80.23.7104; Filipovich AH, 2010, BLOOD, V116, P3398, DOI 10.1182/blood-2010-03-275909; FOX R, 1986, J CLIN INVEST, V77, P1539, DOI 10.1172/JCI112469; Kimura H, 1999, J CLIN MICROBIOL, V37, P132, DOI 10.1128/JCM.37.1.132-136.1999; Lunemann JD, 2008, J IMMUNOL, V181, P991, DOI 10.4049/jimmunol.181.2.991; OCHI T, 1988, J RHEUMATOL, V15, P1609; RHODES G, 1985, J IMMUNOL, V134, P211; ROUDIER J, 1988, SCAND J IMMUNOL, V27, P367, DOI 10.1111/j.1365-3083.1988.tb02359.x; ROUDIER J, 1989, P NATL ACAD SCI USA, V86, P5104, DOI 10.1073/pnas.86.13.5104; RUMPOLD H, 1987, J IMMUNOL, V138, P593; Scotet E, 1996, J EXP MED, V184, P1791, DOI 10.1084/jem.184.5.1791; Takei M, 2001, INT IMMUNOL, V13, P559, DOI 10.1093/intimm/13.4.559; Takei M, 1997, INT IMMUNOL, V9, P739, DOI 10.1093/intimm/9.5.739; TOSATO G, 1981, NEW ENGL J MED, V305, P1238, DOI 10.1056/NEJM198111193052102; TOSATO G, 1984, J CLIN INVEST, V73, P1789, DOI 10.1172/JCI111388; Watanabe S, 2007, J VIROL, V81, P13259, DOI 10.1128/JVI.01353-07; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Yajima M, 2008, J INFECT DIS, V198, P673, DOI 10.1086/590502; Yajima M, 2009, J INFECT DIS, V200, P1611, DOI 10.1086/644644	21	45	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26630	10.1371/journal.pone.0026630	http://dx.doi.org/10.1371/journal.pone.0026630			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028930	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500101
J	Rothermel, M; Ng, BSW; Grabska-Barwinska, A; Hatt, H; Jancke, D				Rothermel, Markus; Ng, Benedict Shien Wei; Grabska-Barwinska, Agnieszka; Hatt, Hanns; Jancke, Dirk			Nasal Chemosensory-Stimulation Evoked Activity Patterns in the Rat Trigeminal Ganglion Visualized by In Vivo Voltage-Sensitive Dye Imaging	PLOS ONE			English	Article							OLFACTORY-BULB; CAPSAICIN RECEPTOR; RESPONSES; DYNAMICS; NEURONS; CORTEX; SYSTEM; ORGANIZATION; ACTIVATION; CHANNELS	Mammalian nasal chemosensation is predominantly mediated by two independent neuronal pathways, the olfactory and the trigeminal system. Within the early olfactory system, spatiotemporal responses of the olfactory bulb to various odorants have been mapped in great detail. In contrast, far less is known about the representation of volatile chemical stimuli at an early stage in the trigeminal system, the trigeminal ganglion (TG), which contains neurons directly projecting to the nasal cavity. We have established an in vivo preparation that allows high-resolution imaging of neuronal population activity from a large region of the rat TG using voltage-sensitive dyes (VSDs). Application of different chemical stimuli to the nasal cavity elicited distinct, stimulus-category specific, spatiotemporal activation patterns that comprised activated as well as suppressed areas. Thus, our results provide the first direct insights into the spatial representation of nasal chemosensory information within the trigeminal ganglion imaged at high temporal resolution.	[Rothermel, Markus; Hatt, Hanns] Ruhr Univ Bochum, Lehrstuhl Zellphysiol, Bochum, Germany; [Grabska-Barwinska, Agnieszka; Jancke, Dirk] Ruhr Univ Bochum, Bernstein Grp Computat Neurosci, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum	Rothermel, M (corresponding author), Ruhr Univ Bochum, Lehrstuhl Zellphysiol, Bochum, Germany.	Hanns.Hatt@rub.de	Rothermel, Markus/T-6848-2018; Jancke, Dirk/A-6721-2015; Jancke, Dirk/A-2961-2015	Rothermel, Markus/0000-0002-0929-993X; Jancke, Dirk/0000-0001-8440-6259	DFG [SFB-509]; BMBF (Bundesministerium fur Bildung und Forschung); International Graduate School of Neuroscience (IGSN), Ruhr-University Bochum, Germany; Wilhelm und Gunter Esser Stiftung, Ruhr-University Bochum, Germany	DFG(German Research Foundation (DFG)); BMBF (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); International Graduate School of Neuroscience (IGSN), Ruhr-University Bochum, Germany; Wilhelm und Gunter Esser Stiftung, Ruhr-University Bochum, Germany	Deutsche Forschungsgemeinschaft: Collaborative Research Centre SFB 874 (Integration and Representation of Sensory Processes), Graduiertenkolleg 736 "Development and Plasticity of the Nervous System: Molecular, Synaptic and Cellular Mechanisms'', Ruhr-University Bochum, Germany [http://www.ruhr-uni-bochum.de/neuro-gk/] (MR, HH), Ruhr-University Research School funded by the DFG in the framework of the Excellence Initiative [http://www.research-school.rub.de/] (MR, BN, HH, DJ), DFG Neurovision SFB-509 [http://www.dfg.de/]); BMBF (Bundesministerium fur Bildung und Forschung, start-up Junior Professorship, Bernstein Group for Computational Neuroscience) [http://www.bmbf.de/] (DJ), International Graduate School of Neuroscience (IGSN), Ruhr-University Bochum, Germany [http://www. ruhr-uni-bochum.de/igsn/index.shtml] (BN, HH, DJ), Wilhelm und Gunter Esser Stiftung, Ruhr-University Bochum, Germany [http://www.ruhr-uni-bochum.de/] (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimohammadi H, 2000, CHEM SENSES, V25, P61, DOI 10.1093/chemse/25.1.61; Arieli A, 1996, SCIENCE, V273, P1868, DOI 10.1126/science.273.5283.1868; BELMONTE C, 1991, J PHYSIOL-LONDON, V437, P709, DOI 10.1113/jphysiol.1991.sp018621; Belmonte Carlos, 2004, Ocul Surf, V2, P248; Belmonte C, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-14; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Damann N, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-46; DOTY RL, 1978, PHYSIOL BEHAV, V20, P175, DOI 10.1016/0031-9384(78)90070-7; Elsberg CA, 1935, B NEUROL I NY, V4, P270; FELDMAN JL, 1995, REGULATION BREATHING, P39; Greene E.C., 1935, T AM PHILOS SOC, V27, P1, DOI DOI 10.2307/1005513; Hanani M, 2005, BRAIN RES REV, V48, P457, DOI 10.1016/j.brainresrev.2004.09.001; Hummel T, 2000, INT J PSYCHOPHYSIOL, V36, P147, DOI 10.1016/S0167-8760(99)00108-7; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; JESSEL TM, 2000, PRINCIPLES NEURAL SC, P430; Laska M, 1997, CHEM SENSES, V22, P447, DOI 10.1093/chemse/22.4.447; Leiser SC, 2006, J NEUROPHYSIOL, V95, P3129, DOI 10.1152/jn.00157.2005; MARFURT CF, 1981, ANAT REC, V201, P105, DOI 10.1002/ar.1092010113; Palagina G, 2009, P NATL ACAD SCI USA, V106, P8743, DOI 10.1073/pnas.0900068106; Parker GH, 1912, J ACAD NATL SCI PHIL, V15, P221; Petersen CCH, 2003, J NEUROSCI, V23, P1298, DOI 10.1523/JNEUROSCI.23-04-01298.2003; RENNER B, 1998, 20 ANN M ASS CHEM SC, P602; Rothermel M, 2009, J NEUROVIROL, V15, P458, DOI 10.3109/13550280903473460; Sandler VM, 1998, NEUROSCIENCE, V83, P891, DOI 10.1016/S0306-4522(97)00415-6; Sekizawa S, 1996, RESP PHYSIOL, V103, P211, DOI 10.1016/0034-5687(95)00091-7; Sharon D, 2007, CEREB CORTEX, V17, P2866, DOI 10.1093/cercor/bhm019; SILVER WL, 1982, PHYSIOL BEHAV, V28, P927, DOI 10.1016/0031-9384(82)90216-5; SILVER WL, 1990, CHEM SENSES, V15, P701, DOI 10.1093/chemse/15.6.701; SILVER WL, 1991, SMELL TASTE HLTH DIS, P97; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Spors H, 2006, J NEUROSCI, V26, P1247, DOI 10.1523/JNEUROSCI.3100-05.2006; Sterkin A, 1998, NEUROSCI LETT, pS41; Stotz SC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002082; Thalakoti S, 2007, HEADACHE, V47, P1008, DOI 10.1111/j.1526-4610.2007.00854.x; Thuerauf N, 1999, PSYCHOPHARMACOLOGY, V142, P236, DOI 10.1007/s002130050885; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Trevisani M, 2002, NAT NEUROSCI, V5, P546, DOI 10.1038/nn852; Tucker D., 1971, P151; Wachowiak M, 2004, P NATL ACAD SCI USA, V101, P9097, DOI 10.1073/pnas.0400438101; Wang YYY, 2010, J NEUROSCI, V30, P12958, DOI 10.1523/JNEUROSCI.2715-10.2010; Wise PM, 2003, CHEM SENSES, V28, P751, DOI 10.1093/chemse/bjg065; Xu HX, 2006, NAT NEUROSCI, V9, P628, DOI 10.1038/nn1692; Yaksi E, 2007, PLOS BIOL, V5, P1453, DOI 10.1371/journal.pbio.0050178; YU HH, 1974, BRAIN RES, V75, P328, DOI 10.1016/0006-8993(74)90756-2	44	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26158	10.1371/journal.pone.0026158	http://dx.doi.org/10.1371/journal.pone.0026158			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039441	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500035
J	Zhang, WZ; Yano, N; Deng, MZ; Mao, QF; Shaw, SK; Tseng, YT				Zhang, Weizhi; Yano, Naohiro; Deng, Minzi; Mao, Quanfu; Shaw, Sunil K.; Tseng, Yi-Tang			beta-Adrenergic Receptor-PI3K Signaling Crosstalk in Mouse Heart: Elucidation of Immediate Downstream Signaling Cascades	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; FOXO TRANSCRIPTION FACTORS; PROTEIN-KINASE-B; CARDIAC-HYPERTROPHY; BETA(2)-ADRENERGIC RECEPTORS; CARDIOMYOCYTE HYPERTROPHY; MYOCARDIAL-CONTRACTILITY; MUSCLE ATROPHY; ACTIVATION; AKT	Sustained beta-adrenergic receptors (beta AR) activation leads to cardiac hypertrophy and prevents left ventricular (LV) atrophy during LV unloading. The immediate signaling pathways downstream from bAR stimulation, however, have not been well investigated. The current study was to examine the early cardiac signaling mechanism(s) following bAR stimulation. In adult C57BL/6 mice, acute beta AR stimulation induced significant increases in PI3K activity and activation of Akt and ERK1/2 in the heart, but not in lungs or livers. In contrast, the same treatment did not elicit these changes in beta(1)/beta(2)AR double knockout mice. We further showed the specificity of beta(2)AR in this crosstalk as treatment with formoterol, a beta(2)AR-selective agonist, but not dobutamine, a predominantly beta(1)AR agonist, activated cardiac Akt and ERK1/2. Acute beta AR stimulation also significantly increased the phosphorylation of mTOR (the mammalian target of rapamycin), P70S6K, ribosomal protein S6, GSK-3 alpha/beta (glycogen synthase kinase-3 alpha/beta), and FOXO1/3a (the forkhead box family of transcription factors 1 and 3a). Moreover, acute beta AR stimulation time-dependently decreased the mRNA levels of the muscle-specific E3 ligases atrogin-1 and muscle ring finger protein-1 (MuRF1) in mouse heart. Our results indicate that acute beta AR stimulation in vivo affects multiple cardiac signaling cascades, including the PI3K signaling pathway, ERK1/2, atrogin-1 and MuRF1. These data 1) provide convincing evidence for the crosstalk between beta AR and PI3K signaling pathways; 2) confirm the beta(2)AR specificity in this crosstalk in vivo; and 3) identify novel signaling factors involved in cardiac hypertrophy and LV unloading. Understanding of the intricate interplay between beta(2)AR activation and these signaling cascades should provide critical clues to the pathogenesis of cardiac hypertrophy and enable identification of targets for early clinical interaction of cardiac lesions.	[Zhang, Weizhi] Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China; [Zhang, Weizhi; Yano, Naohiro; Deng, Minzi; Mao, Quanfu; Shaw, Sunil K.; Tseng, Yi-Tang] Brown Univ, Women & Infants Hosp, Dept Pediat, Warren Alpert Med Sch, Providence, RI 02908 USA	Central South University; Brown University; Women & Infants Hospital Rhode Island	Zhang, WZ (corresponding author), Cent S Univ, Xiangya Hosp 2, Dept Cardiothorac Surg, Changsha, Hunan, Peoples R China.	YTseng@wihri.org		Shaw, Sunil/0000-0001-9701-6065	National Institutes of Health [1 P20 RR018728, R21 HL093561]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL093561] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant 1 P20 RR018728 (to Y.T.T and S. K. S), and by National Institutes of Health R21 HL093561 (to S. K. S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Alessi DR, 1997, CURR BIOL, V7, P776, DOI 10.1016/S0960-9822(06)00336-8; Arya R, 2004, J CELL BIOL, V167, P1147, DOI 10.1083/jcb.200402033; Birks EJ, 2006, NEW ENGL J MED, V355, P1873, DOI 10.1056/NEJMoa053063; CARON MG, 1993, RECENT PROG HORM RES, V48, P277; Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; EMORINE LJ, 1989, SCIENCE, V245, P1118, DOI 10.1126/science.2570461; FRIELLE T, 1987, P NATL ACAD SCI USA, V84, P7920, DOI 10.1073/pnas.84.22.7920; Gong HB, 2002, CIRCULATION, V105, P2497, DOI 10.1161/01.CIR.0000017187.61348.95; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hardt SE, 2002, CIRC RES, V90, P1055, DOI 10.1161/01.RES.0000018952.70505.F1; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jo SH, 2002, CIRC RES, V91, P46, DOI 10.1161/01.RES.0000024115.67561.54; Kinali M, 2002, NEUROLOGY, V59, P609, DOI 10.1212/WNL.59.4.609; KOBILKA BK, 1987, J BIOL CHEM, V262, P7321; Leblais V, 2004, CIRC RES, V95, P1183, DOI 10.1161/01.RES.0000150049.74539.8a; Leger B, 2006, J PHYSIOL-LONDON, V576, P923, DOI 10.1113/jphysiol.2006.116715; Li HH, 2004, J CLIN INVEST, V114, P1058, DOI 10.1172/JCl200422220; MARTINEAU L, 1992, CLIN SCI, V83, P615, DOI 10.1042/cs0830615; Mearini G, 2010, CARDIOVASC RES, V85, P357, DOI 10.1093/cvr/cvp348; Morisco C, 2005, CIRC RES, V96, P180, DOI 10.1161/01.RES.0000152968.71868.c3; Morisco C, 2000, J BIOL CHEM, V275, P14466, DOI 10.1074/jbc.275.19.14466; Morisco C, 2001, J MOL CELL CARDIOL, V33, P561, DOI 10.1006/jmcc.2000.1332; Morris JB, 2005, ENDOCRINOLOGY, V146, P4370, DOI 10.1210/en.2005-0162; Nakayama H, 2010, CIRC RES, V107, P659, DOI 10.1161/CIRCRESAHA.110.220038; Osadchii OE, 2007, HEART FAIL REV, V12, P66, DOI 10.1007/s10741-007-9007-4; Oudit GY, 2003, CIRCULATION, V108, P2147, DOI 10.1161/01.CIR.0000091403.62293.2B; Paradis S, 1998, GENE DEV, V12, P2488, DOI 10.1101/gad.12.16.2488; Pavoine C, 2005, CELL SIGNAL, V17, P141, DOI 10.1016/j.cellsig.2004.09.001; Rohrer DK, 1999, J BIOL CHEM, V274, P16701, DOI 10.1074/jbc.274.24.16701; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schluter KD, 1998, CARDIOVASC RES, V40, P174, DOI 10.1016/S0008-6363(98)00171-0; Shah AS, 2000, CIRCULATION, V101, P408, DOI 10.1161/01.CIR.101.4.408; Shioi T, 2000, EMBO J, V19, P2537, DOI 10.1093/emboj/19.11.2537; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Skurk C, 2005, J BIOL CHEM, V280, P20814, DOI 10.1074/jbc.M500528200; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Steinberg SE, 2004, J MOL CELL CARDIOL, V37, P407, DOI 10.1016/j.yjmcc.2004.04.018; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tevaearai HT, 2002, CIRCULATION, V106, P124, DOI 10.1161/01.CIR.0000020220.79105.FD; Tseng YT, 2005, AM J PHYSIOL-HEART C, V289, pH1834, DOI 10.1152/ajpheart.00435.2005; Tseng YT, 2001, FASEB J, V15, P1921, DOI 10.1096/fj.01-0151com; TUTTLE RR, 1975, CIRC RES, V36, P185, DOI 10.1161/01.RES.36.1.185; Ueyama T, 2000, J MOL CELL CARDIOL, V32, P947, DOI 10.1006/jmcc.2000.1135; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Webb IG, 2010, CARDIOVASC RES, V87, P494, DOI 10.1093/cvr/cvq061; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; XIAO RP, 1993, CIRC RES, V73, P286, DOI 10.1161/01.RES.73.2.286; Yano N, 2008, AM J PHYSIOL-HEART C, V295, pH1690, DOI 10.1152/ajpheart.00531.2008; Yano N, 2007, AM J PHYSIOL-HEART C, V293, pH385, DOI 10.1152/ajpheart.01318.2006; Yano N, 2008, ENDOCRINOLOGY, V149, P6449, DOI 10.1210/en.2008-0292; Zhai PY, 2007, J BIOL CHEM, V282, P33181, DOI 10.1074/jbc.M705133200; Zheng M, 2005, PHARMACOL THERAPEUT, V108, P257, DOI 10.1016/j.pharmthera.2005.04.006; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607; Zou YZ, 2001, CIRCULATION, V104, P102, DOI 10.1161/hc2601.090987	61	73	74	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26581	10.1371/journal.pone.0026581	http://dx.doi.org/10.1371/journal.pone.0026581			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028912	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500090
J	Steingoetter, A; Menne, D; Braren, RF				Steingoetter, Andreas; Menne, Dieter; Braren, Rickmer F.			Assessing Antiangiogenic Therapy Response by DCE-MRI: Development of a Physiology Driven Multi-Compartment Model Using Population Pharmacometrics	PLOS ONE			English	Article							PARAMETERS; RAT	Dynamic contrast enhanced (DCE-) MRI is commonly applied for the monitoring of antiangiogenic therapy in oncology. Established pharmacokinetic (PK) analysis methods of DCE-MRI data do not sufficiently reflect the complex anatomical and physiological constituents of the analyzed tissue. Hence, accepted endpoints such as Ktrans reflect an unknown multitude of local and global physiological effects often rendering an understanding of specific local drug effects impossible. In this work a novel multi-compartment PK model is presented, which for the first time allows the separation of local and systemic physiological effects. DCE-MRI data sets from multiple, simultaneously acquired tissues, i.e. spinal muscle, liver and tumor tissue, of hepatocellular carcinoma (HCC) bearing rats were applied for model development. The full Markov chain Monte Carlo (MCMC) Bayesian analysis method was applied for model parameter estimation and model selection was based on histological and anatomical considerations and numerical criteria. A population PK model (MTL3 model) consisting of 3 measured and 6 latent (unobserved) compartments was selected based on Bayesian chain plots, conditional weighted residuals, objective function values, standard errors of model parameters and the deviance information criterion. Covariate model building, which was based on the histology of tumor tissue, demonstrated that the MTL3 model was able to identify and separate tumor specific, i.e. local, and systemic, i.e. global, effects in the DCE-MRI data. The findings confirm the feasibility to develop physiology driven multi-compartment PK models from DCE-MRI data. The presented MTL3 model allowed the separation of a local, tumor specific therapy effect and thus has the potential for identification and specification of effectors of vascular and tissue physiology in antiangiogenic therapy monitoring.	[Steingoetter, Andreas] Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland; [Steingoetter, Andreas] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Steingoetter, Andreas] ETH, Zurich, Switzerland; [Menne, Dieter] Menne Biomed Consulting, Tubingen, Germany; [Braren, Rickmer F.] Tech Univ Munich, Klinikum Rechts Isar, Inst Radiol, D-8000 Munich, Germany	University of Zurich; University Zurich Hospital; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technical University of Munich	Steingoetter, A (corresponding author), Univ Zurich Hosp, Div Gastroenterol & Hepatol, CH-8091 Zurich, Switzerland.	steingoetter@biomed.ee.ethz.ch	Braren, Rickmer/U-3254-2018	Braren, Rickmer/0000-0001-6039-6957; Steingoetter, Andreas/0000-0001-8046-1314	German Research Foundation (DFG) within the SFB-Initiative [824, SFB824, C6]	German Research Foundation (DFG) within the SFB-Initiative(German Research Foundation (DFG))	This work was supported by the German Research Foundation (DFG) within the SFB-Initiative 824 (collaborative research center), "Imaging for Selection, Monitoring and Individualization of Cancer Therapies" (SFB824, project C6). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beal S, 1989, NONMEM USERS GUIDES; Brendel K, 2007, CLIN PHARMACOKINET, V46, P221, DOI 10.2165/00003088-200746030-00003; Brix G, 2010, EUR J NUCL MED MOL I, V37, pS30, DOI 10.1007/s00259-010-1448-7; DIMEOLA HJ, 1974, J APPL PHYSIOL, V36, P261, DOI 10.1152/jappl.1974.36.2.261; Gabrielsson J., 2007, PHARMACOKINETIC PHAR, V4th; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Jonsson EN, 1999, COMPUT METH PROG BIO, V58, P51, DOI 10.1016/S0169-2607(98)00067-4; Karcher JC, 2010, I S BIOMED IMAGING, P724, DOI 10.1109/ISBI.2010.5490074; Kwon Y., 2001, HDB ESSENTIAL PHARMA; Lunn DJ, 2002, J PHARMACOKINET PHAR, V29, P271, DOI 10.1023/A:1020206907668; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; R Core Team, 2018, R LANG ENV STAT COMP; Schmid VJ, 2006, IEEE T MED IMAGING, V25, P1627, DOI 10.1109/TMI.2006.884210; Schmid VJ, 2009, MAGN RESON MED, V61, P163, DOI 10.1002/mrm.21807; SHEINER LB, 1985, J PHARMACOKINET BIOP, V13, P515, DOI 10.1007/BF01059333; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Steingoetter A, 2011, MAGN RESON MED, V65, P229, DOI 10.1002/mrm.22589; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Whitcher B, 2011, MAGN RESON MATER PHY, V24, P85, DOI 10.1007/s10334-010-0238-3; Yankeelov TE, 2005, MAGN RESON IMAGING, V23, P519, DOI 10.1016/j.mri.2005.02.013	20	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26366	10.1371/journal.pone.0026366	http://dx.doi.org/10.1371/journal.pone.0026366			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028864	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000296186900054
J	Jiang, XY; Sun, CF; Zhang, QG; Zou, SM				Jiang, Xia-Yun; Sun, Cheng-Fei; Zhang, Quan-Gen; Zou, Shu-Ming			ENU-Induced Mutagenesis in Grass Carp (Ctenopharyngodon idellus) by Treating Mature Sperm	PLOS ONE			English	Article							LYMPHOCYSTIS DISEASE; GENETIC SCREEN; ZEBRAFISH; MUTATIONS; IDENTIFICATION; CONSERVATION; DIVERGENCE; RESISTANCE; SYSTEM; FISH	N-ethyl-N-nitrosourea (ENU) mutagenesis is a useful approach for genetic improvement of plants, as well as for inducing functional mutants in animal models including mice and zebrafish. In the present study, mature sperm of grass carp (Ctenopharyngodon idellus) were treated with a range of ENU concentrations for 45 min, and then wild-type eggs were fertilized. The results indicated that the proportion of embryos with morphological abnormalities at segmentation stage or dead fry at hatching stage increased with increasing ENU dose up to 10 mM. Choosing a dose that was mutagenic, but provided adequate numbers of viable fry, an F1 population was generated from 1 mM ENU-treated sperm for screening purposes. The ENU-treated F1 population showed large variations in growth during the first year. A few bigger mutants with morphologically normal were generated, as compared to the controls. Analysis of DNA from 15 F1 ENU-treated individuals for mutations in partial coding regions of igf-2a, igf-2b, mstn-1, mstn-2, fst-1 and fst-2 loci revealed that most ENU-treated point mutations were GC to AT or AT to GC substitution, which led to nonsense, nonsynonymous and synonymous mutations. The average mutation rate at the examined loci was 0.41%. These results indicate that ENU treatment of mature sperm can efficiently induce point mutations in grass carp, which is a potentially useful approach for genetic improvement of these fish.	[Jiang, Xia-Yun; Sun, Cheng-Fei; Zhang, Quan-Gen; Zou, Shu-Ming] Shanghai Ocean Univ, Key Lab Aquat Genet Resources & Utilizat, Shanghai, Peoples R China	Shanghai Ocean University	Jiang, XY (corresponding author), Shanghai Ocean Univ, Key Lab Aquat Genet Resources & Utilizat, Shanghai, Peoples R China.	smzou@shou.edu.cn			Ministry of Agriculture of China [200903045]; China 863 project [2011AA100403, 2009AA10Z105]; Shanghai Educational Committee [08SG50]	Ministry of Agriculture of China(Ministry of Agriculture & Rural Affairs); China 863 project(National High Technology Research and Development Program of China); Shanghai Educational Committee	This research was supported by grants from the Special Funding from the Ministry of Agriculture of China (200903045) to Zou, by China 863 project (2011AA100403,2009AA10Z105) to Zou, and by the Shu-Guang Project of Shanghai Educational Committee (08SG50) to Zou. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsterdam A, 2006, TRENDS GENET, V22, P473, DOI 10.1016/j.tig.2006.06.011; BONEY SE, 1984, T AM FISH SOC, V113, P348, DOI 10.1577/1548-8659(1984)113&lt;348:SRABOG&gt;2.0.CO;2; Driever W, 1996, DEVELOPMENT, V123, P37; *FEMA, 2008, CHIN FISH YB, P8; Fuji K, 2007, AQUACULTURE, V272, P291, DOI 10.1016/j.aquaculture.2007.07.210; Fuji K, 2006, AQUACULTURE, V254, P203, DOI 10.1016/j.aquaculture.2005.11.024; Goda T, 2006, PLOS GENET, V2, P811, DOI 10.1371/journal.pgen.0020091; [韩启霞 Han Qixia], 2010, [中国水产科学, Journal of Fishery Sciences of China], V17, P895; HITOTSUMACHI S, 1985, P NATL ACAD SCI USA, V82, P6619, DOI 10.1073/pnas.82.19.6619; Imai Y, 2000, GENETICS, V155, P261; Ishikawa Y, 2000, BIOESSAYS, V22, P487, DOI 10.1002/(SICI)1521-1878(200005)22:5&lt;487::AID-BIES11&gt;3.0.CO;2-8; Jin P, 2004, CHINESE SCI BULL, V49, P2154, DOI 10.1360/982004-188; Khoo SK, 2004, FISH PATHOL, V39, P95, DOI 10.3147/jsfp.39.95; KIRPICHNIKOV VS, 1981, GENETIC BASES FISH S, P302; Knapik EW, 2000, MAMM GENOME, V11, P511, DOI 10.1007/s003350010098; Li M, 2001, CHINESE SCI BULL, V46, P1523, DOI 10.1007/BF02900572; Liu F, 2009, AQUACULTURE, V297, P51, DOI 10.1016/j.aquaculture.2009.09.008; Liu S., 1988, Journal of Fisheries of China, V12, P81; Loosli F, 2000, MECH DEVELOP, V97, P133, DOI 10.1016/S0925-4773(00)00406-8; LOU Y, 1999, FISH BREEDING, P136; MULLINS MC, 1994, CURR BIOL, V4, P189, DOI 10.1016/S0960-9822(00)00048-8; Nickerson DA, 1997, NUCLEIC ACIDS RES, V25, P2745, DOI 10.1093/nar/25.14.2745; Ozaki A, 2001, MOL GENET GENOMICS, V265, P23, DOI 10.1007/s004380000392; Ozaki A, 2010, AQUACULTURE, V308, pS62, DOI 10.1016/j.aquaculture.2010.07.039; RILEY BB, 1995, P NATL ACAD SCI USA, V92, P5997, DOI 10.1073/pnas.92.13.5997; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SHIBUYA T, 1993, MUTAT RES, V297, P3, DOI 10.1016/0165-1110(93)90005-8; SHIMA A, 1991, P NATL ACAD SCI USA, V88, P2545, DOI 10.1073/pnas.88.6.2545; van Eeden FJM, 1999, METHOD CELL BIOL, V60, P21; Wansleeben C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019357; Xia JH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-135; Xu Zu-yuan, 2002, Yichuan, V24, P548; YU X, 2011, MOD FISH INFORM, V26, P29; Yuan XN, 2011, GENE, V470, P46, DOI 10.1016/j.gene.2010.10.003; Zhang H, 2011, MAR BIOTECHNOL, V13, P1017, DOI 10.1007/s10126-011-9365-8; Zhao JL, 2011, ENVIRON BIOL FISH, V90, P85, DOI 10.1007/s10641-010-9720-z; Zou SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007026	37	13	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26475	10.1371/journal.pone.0026475	http://dx.doi.org/10.1371/journal.pone.0026475			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022617	Green Published, gold			2022-12-27	WOS:000295984400061
J	Francis, R; Xu, X; Park, H; Wei, CJ; Chang, S; Chatterjee, B; Lo, C				Francis, Richard; Xu, Xin; Park, Hyunsoo; Wei, Chin-Jen; Chang, Stephen; Chatterjee, Bishwanath; Lo, Cecilia			Connexin43 Modulates Cell Polarity and Directional Cell Migration by Regulating Microtubule Dynamics	PLOS ONE			English	Article							GAP JUNCTIONAL COMMUNICATION; NEURAL CREST CELLS; N-CADHERIN; FIBROBLAST MIGRATION; NEURONAL MIGRATION; EPITHELIAL-CELLS; PLASMA-MEMBRANE; TGF-BETA; MICE; EXPRESSION	Knockout mice deficient in the gap junction gene connexin43 exhibit developmental anomalies associated with abnormal neural crest, primordial germ cell, and proepicardial cell migration. These migration defects are due to a loss of directional cell movement, and are associated with abnormal actin stress fiber organization and a loss of polarized cell morphology. To elucidate the mechanism by which Cx43 regulates cell polarity, we used a wound closure assays with mouse embryonic fibroblasts (MEFs) to examine polarized cell morphology and directional cell movement. Studies using embryonic fibroblasts from Cx43 knockout (Cx43KO) mice showed Cx43 deficiency caused cell polarity defects as characterized by a failure of the Golgi apparatus and the microtubule organizing center to reorient with the direction of wound closure. Actin stress fibers at the wound edge also failed to appropriately align, and stabilized microtubule (Glu-tubulin) levels were markedly reduced. Forced expression of Cx43 with deletion of its tubulin-binding domain (Cx43dT) in both wildtype MEFs and neural crest cell explants recapitulated the cell migration defects seen in Cx43KO cells. However, forced expression of Cx43 with point mutation causing gap junction channel closure had no effect on cell motility. TIRF imaging revealed increased microtubule instability in Cx43KO cells, and microtubule targeting of membrane localized Cx43 was reduced with expression of Cx43dT construct in wildtype cells. Together, these findings suggest the essential role of Cx43 gap junctions in development is mediated by regulation of the tubulin cytoskeleton and cell polarity by Cx43 via a nonchannel function.	[Francis, Richard; Lo, Cecilia] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15260 USA; [Xu, Xin; Park, Hyunsoo; Wei, Chin-Jen; Chang, Stephen; Chatterjee, Bishwanath] NHLBI, Genet & Dev Biol Ctr, Bethesda, MD 20892 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Francis, R (corresponding author), Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15260 USA.	cel36@pitt.edu	Francis, Richard/P-2524-2015	Francis, Richard/0000-0002-4401-1946; Chang, Stephen/0000-0001-7385-075X	NHLBI [ZO1-HL005701]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [Z01HL005701] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NHLBI grant ZO1-HL005701. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates DC, 2007, GLIA, V55, P1554, DOI 10.1002/glia.20569; Bukauskas FF, 2004, BBA-BIOMEMBRANES, V1662, P42, DOI 10.1016/j.bbamem.2004.01.008; Chaldoupi SM, 2009, CARDIOVASC RES, V84, P15, DOI 10.1093/cvr/cvp203; Churko JM, 2011, HUM MUTAT, V32, P456, DOI 10.1002/humu.21472; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; Clauss SB, 2006, DEV DYNAM, V235, P2786, DOI 10.1002/dvdy.20887; Cruciani V, 2006, CELL MOL LIFE SCI, V63, P1125, DOI 10.1007/s00018-005-5571-8; Dai P, 2007, MOL BIOL CELL, V18, P2264, DOI 10.1091/mbc.E06-12-1064; Elias LAB, 2007, NATURE, V448, P901, DOI 10.1038/nature06063; Ewart JL, 1997, DEVELOPMENT, V124, P1281; Fushiki S, 2003, J NEUROPATH EXP NEUR, V62, P304, DOI 10.1093/jnen/62.3.304; Giepmans BNG, 2001, CELL COMMUN ADHES, V8, P219, DOI 10.3109/15419060109080727; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Giessmann D, 2005, ANAT EMBRYOL, V209, P391, DOI 10.1007/s00429-005-0456-z; Gomes ER, 2006, METHOD ENZYMOL, V406, P579, DOI 10.1016/S0076-6879(06)06045-9; Gourdie RG, 2006, ANN NY ACAD SCI, V1080, P49, DOI 10.1196/annals.1380.005; GUNDERSEN GG, 1994, J CELL SCI, V107, P645; GUNDERSEN GG, 1988, P NATL ACAD SCI USA, V85, P5946, DOI 10.1073/pnas.85.16.5946; Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777; Guo YH, 2003, AM J PHYSIOL-LUNG C, V285, pL1213, DOI 10.1152/ajplung.00066.2003; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; Huang GY, 1998, J CELL BIOL, V143, P1725, DOI 10.1083/jcb.143.6.1725; Hutson Mary Redmond, 2003, Birth Defects Research, V69, P2, DOI 10.1002/bdrc.10002; Ishii Y, 2009, CELL TISSUE RES, V335, P67, DOI 10.1007/s00441-008-0663-z; Itoh M, 1997, J CELL BIOL, V138, P181, DOI 10.1083/jcb.138.1.181; Jordan K, 1999, MOL BIOL CELL, V10, P2033, DOI 10.1091/mbc.10.6.2033; Kretz M, 2003, J CELL SCI, V116, P3443, DOI 10.1242/jcs.00638; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; Lauf U, 2002, P NATL ACAD SCI USA, V99, P10446, DOI 10.1073/pnas.162055899; Lengner CJ, 2004, J CELL PHYSIOL, V200, P327, DOI 10.1002/jcp.20118; Li WEI, 2002, DEVELOPMENT, V129, P2031; LI Z, 2008, CLIN EXP METASTASIS; Liu YY, 2007, ACTA BIOCH BIOPH SIN, V39, P391, DOI 10.1111/j.1745-7270.2007.00296.x; Lo CW, 1997, DEV GENET, V20, P119, DOI 10.1002/(SICI)1520-6408(1997)20:2<119::AID-DVG5>3.0.CO;2-A; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Majoul I, 2007, HISTOCHEM CELL BIOL, V127, P355, DOI 10.1007/s00418-007-0273-y; McLachlan E, 2006, CANCER RES, V66, P9886, DOI 10.1158/0008-5472.CAN-05-4302; Mellor H, 2004, CURR BIOL, V14, pR434, DOI 10.1016/j.cub.2004.05.038; Mori R, 2006, J CELL SCI, V119, P5193, DOI 10.1242/jcs.03320; Olk S, 2010, GLIA, V58, P494, DOI 10.1002/glia.20942; Pollmann MA, 2005, BREAST CANCER RES, V7, pR522, DOI 10.1186/bcr1042; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Rhee DY, 2009, DEVELOPMENT, V136, P3185, DOI 10.1242/dev.032334; Shaw RM, 2007, CELL, V128, P547, DOI 10.1016/j.cell.2006.12.037; Shibayama J, 2005, CIRC RES, V96, pE83, DOI 10.1161/01.RES.0000168369.79972.d2; Squecco R, 2006, MOL BIOL CELL, V17, P4896, DOI 10.1091/mbc.E06-03-0243; Sullivan R, 1998, DEV BIOL, V204, P224, DOI 10.1006/dbio.1998.9089; Taliana L, 2005, INVEST OPHTH VIS SCI, V46, P96, DOI 10.1167/iovs.04-0145; Thomas T, 2005, J CELL SCI, V118, P4451, DOI 10.1242/jcs.02569; Vinogradova T, 2009, CELL CYCLE, V8, P2168, DOI 10.4161/cc.8.14.9074; Walker DL, 2005, DEV BIOL, V284, P479, DOI 10.1016/j.ydbio.2005.06.004; Wang CM, 2007, DIABETES, V56, P2809, DOI 10.2337/db07-0613; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Wei CJ, 2005, J BIOL CHEM, V280, P19925, DOI 10.1074/jbc.M412921200; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Wiencken-Barger AE, 2007, GLIA, V55, P675, DOI 10.1002/glia.20484; Xu X, 2001, CELL COMMUN ADHES, V8, P321, DOI 10.3109/15419060109080746; Xu X, 2001, J CELL BIOL, V154, P217, DOI 10.1083/jcb.200105047; Xu X, 2006, DEVELOPMENT, V133, P3629, DOI 10.1242/dev.02543; Zhang W, 2003, J NEUROSURG, V99, P1039, DOI 10.3171/jns.2003.99.6.1039	61	75	78	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26379	10.1371/journal.pone.0026379	http://dx.doi.org/10.1371/journal.pone.0026379			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022608	Green Accepted, Green Published, gold			2022-12-27	WOS:000295981600056
J	Tajadura-Jimenez, A; Pantelidou, G; Rebacz, P; Vastfjall, D; Tsakiris, M				Tajadura-Jimenez, Ana; Pantelidou, Galini; Rebacz, Pawel; Vastfjall, Daniel; Tsakiris, Manos			I-Space: The Effects of Emotional Valence and Source of Music on Interpersonal Distance	PLOS ONE			English	Article							PERSONAL-SPACE; TOOL-USE	Background: The ubiquitous use of personal music players in over-crowded public transport alludes to the hypothesis that apart from making the journey more pleasant, listening to music through headphones may also affect representations of our personal space, that is, the emotionally-tinged zone around the human body that people feel is "their space". We evaluated the effects of emotional valence (positive versus negative) and source (external, i.e. loudspeakers, versus embedded, i.e. headphones) of music on the participant's interpersonal distance when interacting with others. Methodology/Principal Findings: Personal space was evaluated as the comfort interpersonal distance between participant and experimenter during both active and passive approach tasks. Our results show that, during passive approach tasks, listening to positive versus negative emotion-inducing music reduces the representation of personal space, allowing others to come closer to us. With respect to a no-music condition, an embedded source of positive emotion-inducing music reduced personal space, while an external source of negative emotion-inducing music expanded personal space. Conclusions/Significance: The results provide the first empirical evidence of the relation between induced emotional state, as a result of listening to positive music through headphones, and personal space when interacting with others. This research might help to understand the benefit that people find in using personal music players in crowded situations, such as when using the public transport in urban settings.	[Tajadura-Jimenez, Ana; Pantelidou, Galini; Tsakiris, Manos] Univ London, Dept Psychol, Surrey, England; [Rebacz, Pawel] Univ London, Dept Psychol, London, England; [Vastfjall, Daniel] Chalmers Univ Technol, Div Appl Acoust, S-41296 Gothenburg, Sweden	University of London; Royal Holloway University London; University of London; Chalmers University of Technology	Tajadura-Jimenez, A (corresponding author), Univ London, Dept Psychol, Surrey, England.	ana.tajadura@rhul.ac.uk	Tajadura-Jimenez, Ana/B-2355-2015; TSAKIRIS, MANOS/C-1529-2008; Tajadura-Jimenez, Ana/O-2906-2019; Västfjäll, Daniel/F-9629-2014	Tajadura-Jimenez, Ana/0000-0003-3166-3512; TSAKIRIS, MANOS/0000-0001-7753-7576; Tajadura-Jimenez, Ana/0000-0003-3166-3512; Vastfjall, Daniel/0000-0003-2873-4500	Volkswagen Stiftung	Volkswagen Stiftung(Volkswagen)	The research was supported by "European Platform for Life Sciences, Mind Sciences, and the Humanities" grant by the Volkswagen Stiftung for the "Body-Project: Interdisciplinary investigations on bodily experiences" to MT. http://www.volkswagenstiftung.de/index.html?L = 1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIELLO JR, 1980, ADV THEORY RES, V4, P107; Baumeister R.F., 2001, REV GEN PSYCHOL, V5, P323, DOI [10.1037//1089-2680.5.4.323, DOI 10.1037//1089-2680.5.4.323, https://doi.org/10.1037/1089-2680.5.4.323, DOI 10.1037/1089-2680.5.4.323]; Benjamin W., 2002, ARCADES PROJECT; Bickart KC, 2011, NAT NEUROSCI, V14, P163, DOI 10.1038/nn.2724; Bull M, 2001, NEW MEDIA SOC, V3, P179, DOI 10.1177/14614440122226047; Bull Michael, 2008, SOUND MOVES IPOD CUL; Cardinali L, 2009, CURR BIOL, V19, pR478, DOI 10.1016/j.cub.2009.05.009; Culham JC, 2006, NEUROPSYCHOLOGIA, V44, P2668, DOI 10.1016/j.neuropsychologia.2005.11.003; Deus Valentina, 2006, Psychiatr Danub, V18, P150; DOSEY MA, 1969, J PERS SOC PSYCHOL, V11, P93, DOI 10.1037/h0027040; EVANS GW, 1973, PSYCHOL BULL, V80, P334, DOI 10.1037/h0034946; Farne A, 2002, J COGNITIVE NEUROSCI, V14, P1030, DOI 10.1162/089892902320474481; Fredrickson BL, 2001, AM PSYCHOL, V56, P218, DOI 10.1037/0003-066X.56.3.218; GIBSON W, 1993, TIME OUT        1006, V49; GIFFORD R, 1993, CAN J BEHAV SCI, V25, P165, DOI 10.1037/h0078784; Graziano MSA, 1999, NATURE, V397, P428, DOI 10.1038/17115; Graziano MSA, 1998, CURR OPIN NEUROBIOL, V8, P195, DOI 10.1016/S0959-4388(98)80140-2; Graziano MSA, 2006, NEUROPSYCHOLOGIA, V44, P845, DOI 10.1016/j.neuropsychologia.2005.09.009; Hall E.T., 1966, HIDDEN DIMENSION, V609; HAYDUK LA, 1983, PSYCHOL BULL, V94, P293, DOI 10.1037/0033-2909.94.2.293; Hormby T, 2006, STORY SONY WALKMAN; HOROWITZ MJ, 1964, ARCH GEN PSYCHIAT, V11, P651; Jewell G, 2000, NEUROPSYCHOLOGIA, V38, P93, DOI 10.1016/S0028-3932(99)00045-7; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Kallinen K, 2007, COMPUT HUM BEHAV, V23, P303, DOI 10.1016/j.chb.2004.10.014; Kennedy DP, 2011, NATURE, V474, P452, DOI 10.1038/474452a; Kennedy DP, 2009, NAT NEUROSCI, V12, P1226, DOI 10.1038/nn.2381; Kitagawa N, 2006, JPN PSYCHOL RES, V48, P158, DOI 10.1111/j.1468-5884.2006.00317.x; Ladavas E, 2002, TRENDS COGN SCI, V6, P17, DOI 10.1016/S1364-6613(00)01814-3; Lang P, 1980, TECHNOLOGY MENTAL HL, P119, DOI DOI 10.1016/J.LINDIF.2013.01.005; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; Levenson R. W., 1994, NATURE EMOTION FUNDA, V1, P123, DOI DOI 10.4324/9780203075630-22; Lloyd DM, 2009, PERCEPTION, V38, P617, DOI 10.1068/p6317; Lloyd DM, 2009, NEUROSCI BIOBEHAV R, V33, P297, DOI 10.1016/j.neubiorev.2008.09.007; Longo MR, 2007, EXP BRAIN RES, V177, P285, DOI 10.1007/s00221-007-0855-x; Longo MR, 2006, NEUROPSYCHOLOGIA, V44, P977, DOI 10.1016/j.neuropsychologia.2005.09.003; Lourenco SF, 2011, COGNITION, V119, P448, DOI 10.1016/j.cognition.2011.02.009; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Schwarz N., 2007, SOCIAL PSYCHOL HDB B, V(2nd), P385, DOI DOI 10.1023/A:1021223113233; Sloboda J.A., 2001, SERIES AFFECTIVE SCI; SOMMER R, 1959, SOCIOMETRY, V22, P247, DOI 10.2307/2785668; Sommer R., 2002, HDB ENV PSYCHOL, V1937; Tajadura-Jimenez A, 2008, CYBERPSYCHOL BEHAV, V11, P33, DOI 10.1089/cpb.2007.0002; Tajadura-Jimenez A, 2010, EMOTION, V10, P416, DOI 10.1037/a0018423; Tajadura-Jimenez A, 2009, NEUROPSYCHOLOGIA, V47, P195, DOI 10.1016/j.neuropsychologia.2008.07.025; VieIllard S, 2008, COGNITION EMOTION, V22, P720, DOI 10.1080/02699930701503567	47	41	41	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26083	10.1371/journal.pone.0026083	http://dx.doi.org/10.1371/journal.pone.0026083			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834PW	22022516	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000065
J	Azpiroz, MF; Bascuas, T; Lavina, M				Azpiroz, Maria F.; Bascuas, Thais; Lavina, Magela			Microcin H47 System: An Escherichia coli Small Genomic Island with Novel Features	PLOS ONE			English	Article							PATHOGENICITY ISLANDS; CHROMOSOME; DIRECTIONALITY; RECOMBINATION; INTEGRASE; EXCISION	Genomic islands are DNA regions containing variable genetic information related to secondary metabolism. Frequently, they have the ability to excise from and integrate into replicons through site-specific recombination. Thus, they are usually flanked by short direct repeats that act as attachment sites, and contain genes for an integrase and an excisionase which carry out the genetic exchange. These mobility events would be at the basis of the horizontal transfer of genomic islands among bacteria. Microcin H47 is a ribosomally-synthesized antibacterial peptide that belongs to the group of chromosome-encoded microcins. The 13 kb-genetic system responsible for its production resides in the chromosome of the Escherichia coli H47 strain and is flanked by extensive and imperfect direct repeats. In this work, both excision and integration of the microcin H47 system were experimentally detected. The analyses were mainly performed in E. coli K12 cells carrying the microcin system cloned in a multicopy plasmid. As expected of a site-specific recombination event, the genetic exchange also occurred in a context deficient for homologous recombination. The DNA sequence of the attachment sites resulting from excision were hybrid between the sequences of the direct repeats. Unexpectedly, different hybrid attachment sites appeared which resulted from recombination in four segments of identity between the direct repeats. Genes encoding the trans-acting proteins responsible for the site-specific recombination were shown to be absent in the microcin H47 system. Therefore, they should be provided by the remaining genetic context, not only in the H47 strain but also in E. coli K12 cells, where both excision and integration occurred. Moreover, a survey of the attachment sites in data banks revealed that they are widely spread among E. coli strains. It is concluded that the microcin system is a small island H47 genomic island-that would employ a parasitic strategy for its mobility.	[Azpiroz, Maria F.; Bascuas, Thais; Lavina, Magela] Fac Ciencias, Secc Fisiol & Genet Bacterianas, Montevideo, Uruguay	Universidad de la Republica, Uruguay	Azpiroz, MF (corresponding author), Fac Ciencias, Secc Fisiol & Genet Bacterianas, Montevideo, Uruguay.	fernanda@fcien.edu.uy		Bascuas, Thais/0000-0002-3011-2201; Azpiroz, Fernando/0000-0002-7327-960X	Programa de Desarrollo de las Ciencias Basicas (PEDECIBA), Uruguay	Programa de Desarrollo de las Ciencias Basicas (PEDECIBA), Uruguay	This work was funded by Programa de Desarrollo de las Ciencias Basicas (PEDECIBA), Uruguay. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azpiroz MF, 2009, MICROB PATHOGENESIS, V47, P274, DOI 10.1016/j.micpath.2009.09.003; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Chaudhuri RR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008801; Douard G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015302; GAGGERO C, 1993, J BACTERIOL, V175, P5420, DOI 10.1128/JB.175.17.5420-5427.1993; Hacker J, 2000, ANNU REV MICROBIOL, V54, P641, DOI 10.1146/annurev.micro.54.1.641; Hayashi K, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100049; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; LAVINA M, 1990, J BACTERIOL, V172, P6585, DOI 10.1128/jb.172.11.6585-6588.1990; Lesic B, 2004, MOL MICROBIOL, V52, P1337, DOI 10.1111/j.1365-2958.2004.04073.x; Lewis JA, 2001, NUCLEIC ACIDS RES, V29, P2205, DOI 10.1093/nar/29.11.2205; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Murphy RA, 2008, J BACTERIOL, V190, P636, DOI 10.1128/JB.00562-07; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Poey ME, 2006, ANTIMICROB AGENTS CH, V50, P1411, DOI 10.1128/AAC.50.4.1411-1418.2006; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Santiviago CA, 2010, J BACTERIOL, V192, P2246, DOI 10.1128/JB.00270-09; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; Waldor MK, 2010, MOL MICROBIOL, V78, P537, DOI 10.1111/j.1365-2958.2010.07365.x	22	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26179	10.1371/journal.pone.0026179	http://dx.doi.org/10.1371/journal.pone.0026179			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022554	gold, Green Published, Green Submitted			2022-12-27	WOS:000295973200046
J	Wu, ZY; Yuan, H; Zhang, XJ; Liu, WW; Xu, JH; Zhang, W; Guan, M				Wu, Zhiyuan; Yuan, Hong; Zhang, Xinju; Liu, Weiwei; Xu, Jinhua; Zhang, Wei; Guan, Ming			Development and Inter-Laboratory Validation of Unlabeled Probe Melting Curve Analysis for Detection of JAK2 V617F Mutation in Polycythemia Vera	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; TYROSINE KINASE JAK2; REAL-TIME PCR; MYELOID METAPLASIA; DYE CONCENTRATION; DNA; AMPLIFICATION; IDENTIFICATION; ASSAY; GENE	Background: JAK2 V617F, a somatic point mutation that leads to constitutive JAK2 phosphorylation and kinase activation, has been incorporated into the WHO classification and diagnostic criteria of myeloid neoplasms. Although various approaches such as restriction fragment length polymorphism, amplification refractory mutation system and real-time PCR have been developed for its detection, a generic rapid closed-tube method, which can be utilized on routine genetic testing instruments with stability and cost-efficiency, has not been described. Methodology/Principal Findings: Asymmetric PCR for detection of JAK2 V617F with a 3'-blocked unlabeled probe, saturate dye and subsequent melting curve analysis was performed on a Rotor-Gene (R) Q real-time cycler to establish the methodology. We compared this method to the existing amplification refractory mutation systems and direct sequencing. Hereafter, the broad applicability of this unlabeled probe melting method was also validated on three diverse real-time systems (Roche LightCycler (R) 480, Applied Biosystems ABI (R) 7500 and Eppendorf Mastercycler (R) ep realplex) in two different laboratories. The unlabeled probe melting analysis could genotype JAK2 V617F mutation explicitly with a 3% mutation load detecting sensitivity. At level of 5% mutation load, the intra-and inter-assay CVs of probe-DNA heteroduplex (mutation/wild type) covered 3.14%/3.55% and 1.72%/1.29% respectively. The method could equally discriminate mutant from wild type samples on the other three real-time instruments. Conclusions: With a high detecting sensitivity, unlabeled probe melting curve analysis is more applicable to disclose JAK2 V617F mutation than conventional methodologies. Verified with the favorable inter- and intra-assay reproducibility, unlabeled probe melting analysis provided a generic mutation detecting alternative for real-time instruments.	[Wu, Zhiyuan; Liu, Weiwei; Guan, Ming] Fudan Univ, Dept Lab Med, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Yuan, Hong] Dalian Med Univ, Dept Clin Lab, Affiliated Hosp 1, Dalian, Peoples R China; [Zhang, Xinju; Guan, Ming] Fudan Univ, Cent Lab, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Xu, Jinhua; Guan, Ming] Fudan Univ, Dept Dermatol, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Zhang, Wei] Shenzhen PKU HKUST Med Ctr, Shenzhen Key Lab Translat Med Dermatol, Shenzhen, Peoples R China	Fudan University; Dalian Medical University; Fudan University; Fudan University; Hong Kong University of Science & Technology; Peking University; Shenzhen PKU-HKUST Medical Center	Wu, ZY (corresponding author), Fudan Univ, Dept Lab Med, Huashan Hosp, Shanghai Med Coll, Shanghai 200433, Peoples R China.	guanming88@yahoo.com			Shanghai Science and Technology Committee [10411950200]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	This study is funded by the Biomedical Key Project of Shanghai Science and Technology Committee (10411950200). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal M, 2011, CANCER-AM CANCER SOC, V117, P662, DOI 10.1002/cncr.25672; Atallah E, 2009, EXPERT REV ANTICANC, V9, P663, DOI 10.1586/ERA.09.14; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bell JM, 2010, ANTIMICROB AGENTS CH, V54, P1378, DOI 10.1128/AAC.01476-09; Cruz RE, 2010, J CLIN MICROBIOL, V48, P3081, DOI 10.1128/JCM.00634-10; De Leeneer K, 2009, J MOL DIAGN, V11, P415, DOI 10.2353/jmoldx.2009.090032; Guan M, 2011, RHEUMATOLOGY, V50, P473, DOI 10.1093/rheumatology/keq353; Gudnason H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm671; Gundry CN, 2003, CLIN CHEM, V49, P396, DOI 10.1373/49.3.396; Habalova V, 2009, MOL CELL PROBE, V23, P52, DOI 10.1016/j.mcp.2008.10.001; Herrmann MG, 2007, CLIN CHEM, V53, P1544, DOI 10.1373/clinchem.2007.088120; Herrmann MG, 2006, CLIN CHEM, V52, P494, DOI 10.1373/clinchem.2005.063438; Jelinek J, 2005, BLOOD, V106, P3370, DOI 10.1182/blood-2005-05-1800; Jones AV, 2005, BLOOD, V106, P2162, DOI 10.1182/blood-2005-03-1320; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lay M, 2006, J MOL DIAGN, V8, P330, DOI 10.2353/jmoldx.2006.050130; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Liew M, 2007, AM J CLIN PATHOL, V127, P341, DOI 10.1309/N7RARXH3623AVKDV; Loeb LA, 2003, P NATL ACAD SCI USA, V100, P776, DOI 10.1073/pnas.0334858100; Margraf RL, 2007, J MOL DIAGN, V9, P184, DOI 10.2353/jmoldx.2007.060091; Monis PT, 2005, ANAL BIOCHEM, V340, P24, DOI 10.1016/j.ab.2005.01.046; Ochsenreither S, 2010, MOL DIAGN THER, V14, P185, DOI 10.2165/11536330-000000000-00000; Olsen RJ, 2006, ARCH PATHOL LAB MED, V130, P997; Pardanani A, 2011, LEUKEMIA, V25, P218, DOI 10.1038/leu.2010.269; Poodt J, 2006, HEMATOL ONCOL, V24, P227, DOI 10.1002/hon.800; Qian J, 2010, CLIN CHIM ACTA; Rapado I, 2009, J MOL DIAGN, V11, P155, DOI 10.2353/jmoldx.2009.080110; RYE HS, 1992, NUCLEIC ACIDS RES, V20, P2803, DOI 10.1093/nar/20.11.2803; Sidon P, 2006, LEUKEMIA, V20, P1622, DOI 10.1038/sj.leu.2404292; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tefferi A, 2005, BRIT J HAEMATOL, V131, P320, DOI 10.1111/j.1365-2141.2005.05776.x; Tindall EA, 2009, HUM MUTAT, V30, P876, DOI 10.1002/humu.20919; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Verstovsek S, 2006, LEUKEMIA, V20, P2067, DOI 10.1038/sj.leu.2404379; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200; Zhou LM, 2005, CLIN CHEM, V51, P1770, DOI 10.1373/clinchem.2005.054924; Zhou LM, 2004, CLIN CHEM, V50, P1328, DOI 10.1373/clinchem.2004.034322	39	12	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26534	10.1371/journal.pone.0026534	http://dx.doi.org/10.1371/journal.pone.0026534			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028900	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800051
J	Lazaro, E; Tram, LT; Bellecave, P; Guidicelli, GL; Anies, G; Huynh, HKT; Debelleix, MP; Vray, M; Recordon-Pinson, P; Taupin, JL; Truong, TXL; Fleury, H				Lazaro, Estibaliz; Luong Thu Tram; Bellecave, Pantxika; Guidicelli, Gwenda-Line; Anies, Guerric; Huynh Hoang Khanh Thu; Debelleix, Marie Pillot; Vray, Muriel; Recordon-Pinson, Patricia; Taupin, Jean-Luc; Truong Thi Xuan Lien; Fleury, Herve			Molecular Characterization of HIV-1 CRF01_AE in Mekong Delta, Vietnam, and Impact of T-Cell Epitope Mutations on HLA Recognition (ANRS 12159)	PLOS ONE			English	Article							DRUG-RESISTANCE MUTATIONS; IMMUNODEFICIENCY-VIRUS TYPE-1; IMMUNE-RESPONSES; SEQUENCE-ANALYSIS; CLASS-I; ESCAPE; POPULATION; HAPLOTYPES; INFECTION; GAG	Background: To date, 11 HIV-1 subtypes and 48 circulating recombinant forms have been described worldwide. The underlying reason why their distribution is so heterogeneous is not clear. Host genetic factors could partly explain this distribution. The aim of this study was to describe HIV-1 strains circulating in an unexplored area of Mekong Delta, Vietnam, and to assess the impact of optimal epitope mutations on HLA binding. Methods: We recruited 125 chronically antiretroviral-naive HIV-1-infected subjects from five cities in the Mekong Delta. We performed high-resolution DNA typing of HLA class I alleles, sequencing of Gag and RT-Prot genes and phylogenetic analysis of the strains. Epitope mutations were analyzed in patients bearing the HLA allele restricting the studied epitope. Optimal wild-type epitopes from the Los Alamos database were used as reference. T-cell epitope recognition was predicted using the immune epitope database tool according to three different scores involved in antigen processing (TAP and proteasome scores) and HLA binding (MHC score). Results: All sequences clustered with CRF01_AE. HLA class I genotyping showed the predominance of Asian alleles as A*11:01 and B*46:01 with a Vietnamese specificity held by two different haplotypes. The percentage of homology between Mekong and B consensus HIV-1 sequences was above 85%. Divergent epitopes had TAP and proteasome scores comparable with wild-type epitopes. MHC scores were significantly lower in divergent epitopes with a mean of 2.4 (+/- 0.9) versus 2 (+/- 0.7) in non-divergent ones (p<0.0001). Conclusions: Our study confirms the wide predominance of CRF01_AE in the Mekong Delta where patients harbor a specific HLA pattern. Moreover, it demonstrates the lower MHC binding affinity among divergent epitopes. This weak immune pressure combined with a narrow genetic diversity favors immune escape and could explain why CRF01_AE is still predominant in Vietnam, particularly in the Mekong area.	[Lazaro, Estibaliz; Bellecave, Pantxika; Debelleix, Marie Pillot; Recordon-Pinson, Patricia; Fleury, Herve] CHU Bordeaux, Virol Lab, Bordeaux, France; [Lazaro, Estibaliz; Bellecave, Pantxika; Debelleix, Marie Pillot; Recordon-Pinson, Patricia; Fleury, Herve] Univ Bordeaux 2, CNRS, UMR 5234, F-33076 Bordeaux, France; [Luong Thu Tram; Huynh Hoang Khanh Thu; Truong Thi Xuan Lien] Inst Pasteur, Ho Chi Minh City, Vietnam; [Guidicelli, Gwenda-Line; Anies, Guerric; Taupin, Jean-Luc] CHU Bordeaux, Lab Immunol & Immunogenet, Bordeaux, France; [Anies, Guerric; Taupin, Jean-Luc] Univ Bordeaux 2, UMR 5164, CNRS, F-33076 Bordeaux, France; [Vray, Muriel] Inst Pasteur, Paris, France	CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Lazaro, E (corresponding author), CHU Bordeaux, Virol Lab, Bordeaux, France.	herve.fleury@viro.u-bordeaux2.fr	Vray, Muriel/M-7947-2018; Recordon-Pinson, Patricia/AAV-1295-2021	Recordon-Pinson, Patricia/0000-0001-6002-0941; Huynh, Hoang Khanh Thu/0000-0001-9199-6103	Agence Nationale de Recherches Sur le sida et les hepatites virales (ANRS) [ANRS 12159]; European Community [223131]	Agence Nationale de Recherches Sur le sida et les hepatites virales (ANRS)(ANRSFrench National Research Agency (ANR)); European Community(European Commission)	This study was supported by Agence Nationale de Recherches Sur le sida et les hepatites virales (ANRS) (ANRS 12159). PB was supported by a fellowship from the European Community's Seventh Framework Program (FP7/2007-2013) under the "Collaborative HIV and Anti-HIV Drug Resistance Network'' project (grant no. 223131). The funders had no role in study design, data collection, decision to publish or preparation of the manuscript.	Abdulla MA, 2009, SCIENCE, V326, P1541, DOI 10.1126/science.1177074; Aidoo M, 2008, VACCINE, V26, P4830, DOI 10.1016/j.vaccine.2008.06.097; Altfeld M, 2003, AIDS, V17, P2581, DOI 10.1097/00002030-200312050-00005; Bailey JR, 2006, J EXP MED, V203, P1357, DOI 10.1084/jem.20052319; Bangham CRM, 2009, EUR J IMMUNOL, V39, P1700, DOI 10.1002/eji.200939451; Bennett DE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004724; Bhattacharya T, 2007, SCIENCE, V315, P1583, DOI 10.1126/science.1131528; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Brumme ZL, 2009, J EXP MED, V206, P1215, DOI 10.1084/jem.20091094; Carrington M, 2003, ANNU REV MED, V54, P535, DOI 10.1146/annurev.med.54.101601.152346; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Caumont A, 2001, AIDS RES HUM RETROV, V17, P1285, DOI 10.1089/088922201750461357; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Draenert R, 2004, J EXP MED, V199, P905, DOI 10.1084/jem.20031982; Hoa BK, 2008, TISSUE ANTIGENS, V71, P127, DOI 10.1111/j.1399-0039.2007.00982.x; Hudgens MG, 2002, AM J EPIDEMIOL, V155, P159, DOI 10.1093/aje/155.2.159; Ishizaki A, 2009, AIDS RES HUM RETROV, V25, P175, DOI 10.1089/aid.2008.0193; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kent SJ, 2005, TRENDS MICROBIOL, V13, P243, DOI 10.1016/j.tim.2005.03.011; Kilmarx PH, 2009, CURR OPIN HIV AIDS, V4, P240, DOI 10.1097/COH.0b013e32832c06db; Lambotte O, 2005, CLIN INFECT DIS, V41, P1053, DOI 10.1086/433188; Lazaro E, 2005, AIDS RES HUM RETROV, V21, P586, DOI 10.1089/aid.2005.21.586; Lazaro E, 2009, J INFECT DIS, V200, P236, DOI 10.1086/599837; Le Gall S, 2007, J CLIN INVEST, V117, P3563, DOI 10.1172/JCI32047; Leslie A, 2005, J EXP MED, V201, P891, DOI 10.1084/jem.20041455; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Maiers M, 2007, HUM IMMUNOL, V68, P779, DOI 10.1016/j.humimm.2007.04.005; Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019; Marsh SGE, 2010, TISSUE ANTIGENS, V75, P291, DOI 10.1111/j.1399-0039.2010.01466.x; McMichael AJ, 2001, NATURE, V410, P980, DOI 10.1038/35073658; McMichael AJ, 2010, NAT REV IMMUNOL, V10, P11, DOI 10.1038/nri2674; Migueles SA, 2000, P NATL ACAD SCI USA, V97, P2709, DOI 10.1073/pnas.050567397; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nguyen THL, 2003, AIDS RES HUM RETROV, V19, P925, DOI 10.1089/088922203322493111; Rolland M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012463; Shen CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013458; Shi L, 2010, INT J IMMUNOGENET, V37, P467, DOI 10.1111/j.1744-313X.2010.00949.x; Shi L, 2008, HUM IMMUNOL, V69, P58, DOI 10.1016/j.humimm.2007.11.007; Solberg OD, 2008, HUM IMMUNOL, V69, P443, DOI 10.1016/j.humimm.2008.05.001; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Phan TTC, 2010, AIDS RES HUM RETROV, V26, P233, DOI 10.1089/aid.2009.0206; Tishkoff SA, 2004, NAT GENET, V36, pS21, DOI 10.1038/ng1438; Tran TTH, 2004, AIDS RES HUM RETROV, V20, P341; Wright JK, 2010, J VIROL, V84, P10820, DOI 10.1128/JVI.01084-10	44	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26244	10.1371/journal.pone.0026244	http://dx.doi.org/10.1371/journal.pone.0026244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039450	gold, Green Submitted, Green Published			2022-12-27	WOS:000296507500044
J	Lund, O; Nascimento, EJM; Maciel, M; Nielsen, M; Larsen, MV; Lundegaard, C; Harndahl, M; Lamberth, K; Buus, S; Salmon, J; August, TJ; Marques, ETA				Lund, Ole; Nascimento, Eduardo J. M.; Maciel, Milton, Jr.; Nielsen, Morten; Larsen, Mette Voldby; Lundegaard, Claus; Harndahl, Mikkel; Lamberth, Kasper; Buus, Soren; Salmon, Jerome; August, Thomas J.; Marques, Ernesto T. A., Jr.			Human Leukocyte Antigen (HLA) Class I Restricted Epitope Discovery in Yellow Fewer and Dengue Viruses: Importance of HLA Binding Strength	PLOS ONE			English	Article							JAPANESE ENCEPHALITIS VACCINES; T-LYMPHOCYTE RESPONSES; DOUBLE-KNOCKOUT MICE; CELL RESPONSES; FEVER VACCINE; CTL EPITOPES; PROTEINS; TARGETS; CONSULTATION; SAFETY	Epitopes from all available full-length sequences of yellow fever virus (YFV) and dengue fever virus (DENV) restricted by Human Leukocyte Antigen class I (HLA-I) alleles covering 12 HLA-I supertypes were predicted using the NetCTL algorithm. A subset of 179 predicted YFV and 158 predicted DENV epitopes were selected using the EpiSelect algorithm to allow for optimal coverage of viral strains. The selected predicted epitopes were synthesized and approximately 75% were found to bind the predicted restricting HLA molecule with an affinity, K-D, stronger than 500 nM. The immunogenicity of 25 HLA-A*02:01, 28 HLA-A*24:02 and 28 HLA-B*07:02 binding peptides was tested in three HLA-transgenic mice models and led to the identification of 17 HLA-A*02: 01, 4 HLA-A*2402 and 4 HLA-B*07: 02 immunogenic peptides. The immunogenic peptides bound HLA significantly stronger than the non-immunogenic peptides. All except one of the immunogenic peptides had K-D below 100 nM and the peptides with K-D below 5 nM were more likely to be immunogenic. In addition, all the immunogenic peptides that were identified as having a high functional avidity had K-D below 20 nM. A*02:01 transgenic mice were also inoculated twice with the 17DD YFV vaccine strain. Three of the YFV A*02:01 restricted peptides activated T-cells from the infected mice in vitro. All three peptides that elicited responses had an HLA binding affinity of 2 nM or less. The results indicate the importance of the strength of HLA binding in shaping the immune response.	[Lund, Ole; Nielsen, Morten; Larsen, Mette Voldby; Lundegaard, Claus] Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Harndahl, Mikkel; Lamberth, Kasper; Buus, Soren] Univ Copenhagen, Panum Inst, Inst Med Microbiol & Immunol, Div Expt Immunol, DK-2200 Copenhagen, Denmark; [Nascimento, Eduardo J. M.; Marques, Ernesto T. A., Jr.] Univ Pittsburgh, Ctr Vaccine Res, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Maciel, Milton, Jr.; Salmon, Jerome; August, Thomas J.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Marques, Ernesto T. A., Jr.] Oswaldo Cruz Fdn FIOCRUZ, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil	Technical University of Denmark; University of Copenhagen; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Johns Hopkins University; Fundacao Oswaldo Cruz	Lund, O (corresponding author), Tech Univ Denmark, Ctr Biol Sequence Anal, Dept Syst Biol, DK-2800 Lyngby, Denmark.	lund@cbs.dtu.dk	Marques, Ernesto T. A/L-4967-2013; Buus, Soren/F-5446-2010; Lundegaard, Claus/B-3938-2012; Nascimento, Eduardo/J-4590-2014; Nielsen, Morten/AAL-8700-2020; Nielsen, Morten/E-7754-2011; Lund, Ole/F-4437-2014; Marques, Ernesto/L-4514-2013; Publica, Inct Saude/J-9544-2013	Marques, Ernesto T. A/0000-0003-3826-9358; Nascimento, Eduardo/0000-0002-9851-2332; Nielsen, Morten/0000-0001-7885-4311; Nielsen, Morten/0000-0001-7885-4311; Lund, Ole/0000-0003-1108-0491; Marques, Ernesto/0000-0003-3826-9358; Buus, Soren/0000-0001-8363-1999	NIAID [HHSN266200400083C, HHSN266200400025C]	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIAID contracts HHSN266200400083C, HHSN266200400025C (http://www.niaid.nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braga-Neto UM, 2006, PLOS COMPUT BIOL, V2, P651, DOI 10.1371/journal.pcbi.0020081; Brusic V, 2005, EXPERT REV VACCINES, V4, P407, DOI 10.1586/14760584.4.3.407; Co MDT, 2002, VIROLOGY, V293, P151, DOI 10.1006/viro.2001.1255; De Groot AS, 2006, DRUG DISCOV TODAY, V11, P203, DOI 10.1016/S1359-6446(05)03720-7; Domingo C, 2009, EXPERT OPIN DRUG SAF, V8, P211, DOI [10.1517/14740330902808086, 10.1517/14740330902808086 ]; Duggan ST, 2009, DRUGS, V69, P115, DOI 10.2165/00003495-200969010-00008; Ferguson M, 2007, VACCINE, V25, P5233, DOI 10.1016/j.vaccine.2007.05.034; Khan AM, 2006, CELL IMMUNOL, V244, P141, DOI 10.1016/j.cellimm.2007.02.005; Khan AM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000272; Larsen MV, 2005, EUR J IMMUNOL, V35, P2295, DOI 10.1002/eji.200425811; Loke H, 2001, J INFECT DIS, V184, P1369, DOI 10.1086/324320; Lu Y, 2003, VACCINE, V21, P2178, DOI 10.1016/S0264-410X(03)00009-4; Pascolo S, 1997, J EXP MED, V185, P2043, DOI 10.1084/jem.185.12.2043; Pedersen LO, 2001, EUR J IMMUNOL, V31, P2986, DOI 10.1002/1521-4141(2001010)31:10<2986::AID-IMMU2986>3.0.CO;2-R; Pengsaa K, 2009, PEDIATR INFECT DIS J, V28, P335, DOI 10.1097/INF.0b013e3181906351; Perez CL, 2008, J IMMUNOL, V180, P5092, DOI 10.4049/jimmunol.180.7.5092; Rao XY, 2009, J IMMUNOL, V182, P1526, DOI 10.4049/jimmunol.182.3.1526; Raviprakash K, 2001, VIROLOGY, V290, P74, DOI 10.1006/viro.2001.1136; Rohrlich PS, 2003, INT IMMUNOL, V15, P765, DOI 10.1093/intimm/dxg073; Roukens AH, 2008, EXPERT OPIN BIOL TH, V8, P1787, DOI [10.1517/14712598.8.11.1787, 10.1517/14712598.8.11.1787 ]; Screaton Gavin, 2006, Novartis Found Symp, V277, P164, DOI 10.1002/0470058005.ch12; Sette Alessandro, 2005, Immunity, V22, P155, DOI 10.1016/j.immuni.2005.01.009; Sylvester-Hvid C, 2004, TISSUE ANTIGENS, V63, P395, DOI 10.1111/j.0001-2815.2004.00221.x; Sylvester-Hvid C, 2002, TISSUE ANTIGENS, V59, P251, DOI 10.1034/j.1399-0039.2002.590402.x; Tauber E, 2008, BIOL CHEM, V389, P547, DOI 10.1515/BC.2008.062; Thomas SJ, 2009, VACCINE, V27, P355, DOI 10.1016/j.vaccine.2008.10.086; van der Most RG, 2002, VIROLOGY, V296, P117, DOI 10.1006/viro.2002.1432; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	29	23	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26494	10.1371/journal.pone.0026494	http://dx.doi.org/10.1371/journal.pone.0026494			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039500	Green Accepted, Green Published, gold			2022-12-27	WOS:000296507500078
J	Stamper, BD; Park, SS; Beyer, RP; Bammler, TK; Farin, FM; Mecham, B; Cunningham, ML				Stamper, Brendan D.; Park, Sarah S.; Beyer, Richard P.; Bammler, Theo K.; Farin, Frederico M.; Mecham, Brig; Cunningham, Michael L.			Differential Expression of Extracellular Matrix-Mediated Pathways in Single-Suture Craniosynostosis	PLOS ONE			English	Article							FETAL HEAD CONSTRAINT; PROBE LEVEL DATA; CORONAL SYNOSTOSIS; IN-VITRO; APERT CRANIOSYNOSTOSIS; MATERNAL SMOKING; BETA-CATENIN; CELL FATE; GROWTH; WNT	Craniosynostosis is a disease defined by premature fusion of one or more cranial sutures. The mechanistic pathology of single-suture craniosynostosis is complex and while a number of genetic biomarkers and environmental predispositions have been identified, in many cases the causes remain controversial and inconclusive. In this study, gene expression data from 199 patients with isolated sagittal (n = 100), unilateral coronal (n = 50), and metopic (n = 49) synostosis are compared against both a control population (n = 50), as well as each other. After controlling for variables contributing to potential bias, FGF7, SFRP4, and VCAM1 emerged as genes associated with single-suture craniosynostosis due to their significantly large changes in gene expression compared to the control population. Pathway analysis implicated focal adhesion and extracellular matrix (ECM)-receptor interaction as differentially regulated gene networks when comparing all cases of singlesuture synostosis and controls. Lastly, overall gene expression was found to be highly conserved between coronal and metopic cases, as evidenced by the fact that WNT2 and IGFBP2 were the only genes differentially regulated to a significantly large extent in a direct comparison. The identification of genes and gene networks associated with Fgf/Igf/Wnt signaling and ECM-mediated focal adhesion not only support the involvement of biomarkers previously reported to be related to craniosynostosis, but also introduce novel transcripts and pathways that may play critical roles in its pathogenesis.	[Stamper, Brendan D.; Park, Sarah S.; Cunningham, Michael L.] Seattle Childrens Res Inst, Ctr Tissue & Cell Sci, Seattle, WA USA; [Beyer, Richard P.; Bammler, Theo K.; Farin, Frederico M.] Univ Washington, Dept Environm & Occupat Hlth Sci, Seattle, WA 98195 USA; [Mecham, Brig] Sage Bionetworks, Seattle, WA USA; [Cunningham, Michael L.] Univ Washington, Div Craniofacial Med, Seattle, WA 98195 USA; [Cunningham, Michael L.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Stamper, BD (corresponding author), Seattle Childrens Res Inst, Ctr Tissue & Cell Sci, Seattle, WA USA.	brendan.stamper@seattlechildrens.org			National Institute of Health (NIH) [NIH/NIDCR R01 DE018227, NIH/NIEHS P30ES07033, NIH/NICHD P30HD02274]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD002274] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018227] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007033] Funding Source: NIH RePORTER	National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the following National Institute of Health (NIH) grants: (NIH/NIDCR R01 DE018227) awarded to MLC, (NIH/NIEHS P30ES07033), (NIH/NICHD P30HD02274). MLC also obtained support for this work from the Jean Renny Endowment for Craniofacial Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleck Kirk, 2004, Semin Pediatr Neurol, V11, P256, DOI 10.1016/j.spen.2004.10.005; Bayle J, 2008, J INVEST DERMATOL, V128, P871, DOI 10.1038/sj.jid.5701101; Behr B, 2010, DEV BIOL, V344, P922, DOI 10.1016/j.ydbio.2010.06.009; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bochukova EG, 2010, J MED GENET, V47, P803, DOI 10.1136/jmg.2009.069617; Bodo M, 1997, EUR J CLIN INVEST, V27, P36, DOI 10.1046/j.1365-2362.1997.660618.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Boulet SL, 2008, AM J MED GENET A, V146A, P984, DOI 10.1002/ajmg.a.32208; Brault V, 2001, DEVELOPMENT, V128, P1253; Carinci F, 2002, MOL MED, V8, P638, DOI 10.1007/BF03402174; COHEN MM, 2000, EPIDEMIOLOGY CRANIOS; Coussens AK, 2008, DIFFERENTIATION, V76, P531, DOI 10.1111/j.1432-0436.2007.00244.x; Coussens AK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-458; Cunningham ML, 2007, ORTHOD CRANIOFAC RES, V10, P67, DOI 10.1111/j.1601-6343.2007.00389.x; Cunningham ML, 2011, AM J MED GENET A, V155A, P91, DOI 10.1002/ajmg.a.33781; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fanganiello RD, 2007, MOL MED, V13, P422, DOI 10.2119/2007-00027.Fanganiello; Firth SM, 2002, ENDOCR REV, V23, P824, DOI 10.1210/er.2001-0033; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRAHAM JM, 1979, J PEDIATR-US, V95, P747, DOI 10.1016/S0022-3476(79)80728-3; GRAHAM JM, 1980, PEDIATRICS, V65, P1000; GRAHAM JM, 1980, PEDIATRICS, V65, P995; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hoflich A, 1998, FEBS LETT, V434, P329, DOI 10.1016/S0014-5793(98)01011-4; Honein MA, 2000, TERATOLOGY, V62, P145, DOI 10.1002/1096-9926(200009)62:3<145::AID-TERA1>3.0.CO;2-7; Horvath LG, 2004, CLIN CANCER RES, V10, P615, DOI 10.1158/1078-0432.CCR-0707-03; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; Kallen K, 1999, TERATOLOGY, V60, P146; Karsenty G, 1999, GENE DEV, V13, P3037, DOI 10.1101/gad.13.23.3037; Kuang ZH, 2007, BIOCHEMISTRY-US, V46, P13720, DOI 10.1021/bi701251d; LAJEUNIE E, 1995, AM J MED GENET, V55, P500, DOI 10.1002/ajmg.1320550422; Lan Y, 2006, DEV DYNAM, V235, P1448, DOI 10.1002/dvdy.20723; Le Floch N, 2004, FASEB J, V18, P144, DOI 10.1096/fj.04-2373fje; Lee JM, 2008, DEV BIOL, V314, P341, DOI 10.1016/j.ydbio.2007.11.033; Lemonnier J, 2001, J BONE MINER RES, V16, P832, DOI 10.1359/jbmr.2001.16.5.832; LEPPIG KA, 1987, J PEDIATR-US, V110, P531, DOI 10.1016/S0022-3476(87)80543-7; Liu B, 2007, DEV BIOL, V301, P298, DOI 10.1016/j.ydbio.2006.10.018; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lomri A, 1998, J CLIN INVEST, V101, P1310; Maruyama T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000727; MASON IJ, 1994, MECH DEVELOP, V45, P15, DOI 10.1016/0925-4773(94)90050-7; Miraoui H, 2010, HUM MOL GENET, V19, P1678, DOI 10.1093/hmg/ddq045; Muenke M, 1997, AM J HUM GENET, V60, P555; Mulliken JB, 1999, PLAST RECONSTR SURG, V104, P1603, DOI 10.1097/00006534-199911000-00001; Mulliken JB, 2004, PLAST RECONSTR SURG, V113, P1899, DOI 10.1097/01.PRS.0000122202.26792.bf; Nakanishi R, 2008, J BONE MINER RES, V23, P271, DOI 10.1359/JBMR.071007; Niemann S, 2004, AM J HUM GENET, V74, P558, DOI 10.1086/382196; Ornitz DM, 2002, GENE DEV, V16, P1446, DOI 10.1101/gad.990702; Ornitz DM, 1996, J BIOL CHEM, V271, P15292, DOI 10.1074/jbc.271.25.15292; Passos-Bueno Maria Rita, 2008, V12, P107, DOI 10.1159/000115035; Rasmussen SA, 2008, AM J MED GENET A, V146A, P149, DOI 10.1002/ajmg.a.32106; Reefhuis J, 2003, PEDIATRICS, V111, P1163; Reinhold MI, 2006, J BIOL CHEM, V281, P1381, DOI 10.1074/jbc.M504875200; Renier D, 2000, J NEUROSURG, V92, P631, DOI 10.3171/jns.2000.92.4.0631; Seto ML, 2007, AM J MED GENET A, V143A, P678, DOI 10.1002/ajmg.a.31630; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sousa KM, 2010, J BIOL CHEM, V285, P7246, DOI 10.1074/jbc.M109.079822; Speltz ML, 2007, PLAST RECONSTR SURG, V119, P1874, DOI 10.1097/01.prs.0000259184.88265.3f; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; ten Berge D, 2008, DEVELOPMENT, V135, P3247, DOI 10.1242/dev.023176; Wilkie AOM, 2010, PEDIATRICS, V126, pE391, DOI 10.1542/peds.2009-3491; Yu HMI, 2005, DEVELOPMENT, V132, P1995, DOI 10.1242/dev.01786; Zhou YX, 2000, HUM MOL GENET, V9, P2001, DOI 10.1093/hmg/9.13.2001	69	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26557	10.1371/journal.pone.0026557	http://dx.doi.org/10.1371/journal.pone.0026557			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028906	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500089
J	Kuster, SP; Shah, PS; Coleman, BL; Lam, PP; Tong, A; Wormsbecker, A; McGeer, A				Kuster, Stefan P.; Shah, Prakesh S.; Coleman, Brenda L.; Lam, Po-Po; Tong, Agnes; Wormsbecker, Anne; McGeer, Allison			Incidence of Influenza in Healthy Adults and Healthcare Workers: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							LONG-TERM-CARE; SEASONAL INFLUENZA; VIRUS-INFECTIONS; CONTROLLED-TRIAL; COST-BENEFIT; HOME STAFF; PREVENTION; VACCINE; EFFICACY; MORTALITY	Background: Working in healthcare is often considered a risk factor for influenza; however, this risk has not been quantified. We aimed to systematically review evidence describing the annual incidence of influenza among healthy adults and healthcare workers (HCWs). Methods and Findings: We searched OVID MEDLINE (1950 to 2010), EMBASE (1947 to 2010) and reference lists of identified articles. Observational studies or randomized trials reporting full season or annual influenza infection rates for healthy, working age adult subjects and HCWs were included. Influenza infection was defined as a four-fold rise in antibody titer, or positive viral culture or polymerase chain reaction. From 24,707 citations, 29 studies covering 97 influenza seasons with 58,245 study participants were included. Pooled influenza incidence rates (IR) (95% confidence intervals (CI)) per 100 HCWs per season and corresponding incidence rate ratios (IRR) (95% CI) as compared to healthy adults were as follows. All infections: IR 18.7 (95% CI, 15.8 to 22.1), IRR 3.4 (95% CI, 1.2 to 5.7) in unvaccinated HCWs; IR 6.5 (95% CI, 4.6 to 9.1), IRR 5.4 (95% CI, 2.8 to 8.0) in vaccinated HCWs. Symptomatic infections: IR 7.5 (95% CI, 4.9 to 11.7), IRR 1.5 (95% CI, 0.4 to 2.5) in unvaccinated HCWs, IR 4.8 (95% CI, 3.2 to 7.2), IRR 1.6 (95% CI, 0.5 to 2.7) in vaccinated HCWs. Conclusions: Compared to adults working in non-healthcare settings, HCWs are at significantly higher risk of influenza.	[Kuster, Stefan P.; Shah, Prakesh S.; Coleman, Brenda L.; Lam, Po-Po; Wormsbecker, Anne; McGeer, Allison] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada; [Kuster, Stefan P.; Shah, Prakesh S.; Coleman, Brenda L.; Lam, Po-Po; Wormsbecker, Anne; McGeer, Allison] Univ Toronto, Toronto, ON, Canada; [Tong, Agnes] Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada; [Wormsbecker, Anne] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kuster, SP (corresponding author), Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada.	amcgeer@mtsinai.on.ca	Shah, Prakesh S/I-8098-2013; mcgeer, allison/H-7747-2014; Kuster, Stefan/T-7388-2019; McGeer, Allison/AAB-6885-2020; Shah, Prakesh/AAA-9884-2020	mcgeer, allison/0000-0001-5647-6137; Kuster, Stefan/0000-0002-0525-6529; McGeer, Allison/0000-0001-5647-6137; Coleman, Brenda L./0000-0002-7144-4827	Swiss National Science Foundation [PBZHP3-125576]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was supported by a research fellowship of the Swiss National Science Foundation (grant number PBZHP3-125576) to SPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beran J, 2009, J INFECT DIS, V200, P1861, DOI 10.1086/648406; Beran J, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-2; Borenstein M., 2009, INTRO METAANALYSIS; Bridges CB, 2003, CLIN INFECT DIS, V37, P1094, DOI 10.1086/378292; Bridges CB, 2000, JAMA-J AM MED ASSOC, V284, P1655, DOI 10.1001/jama.284.13.1655; Carman WF, 2000, LANCET, V355, P93, DOI 10.1016/S0140-6736(99)05190-9; DEWOLF F, 1988, J ROY COLL GEN PRACT, V38, P443; Elder AG, 1996, BRIT MED J, V313, P1241, DOI 10.1136/bmj.313.7067.1241; FEERY BJ, 1979, J INFECT DIS, V139, P237, DOI 10.1093/infdis/139.2.237; FOX JP, 1982, AM J EPIDEMIOL, V116, P212, DOI 10.1093/oxfordjournals.aje.a113407; FOY HM, 1987, AM J EPIDEMIOL, V126, P506, DOI 10.1093/oxfordjournals.aje.a114683; FOY HM, 1976, J INFECT DIS, V134, P362, DOI 10.1093/infdis/134.4.362; FRANK AL, 1983, AM J EPIDEMIOL, V118, P313, DOI 10.1093/oxfordjournals.aje.a113638; GLEZEN WP, 1991, AM J EPIDEMIOL, V133, P296, DOI 10.1093/oxfordjournals.aje.a115874; Hayden FG, 2000, NEW ENGL J MED, V343, P1282, DOI 10.1056/NEJM200011023431801; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; Hayward AC, 2006, BRIT MED J, V333, P1241, DOI 10.1136/bmj.39010.581354.55; Jackson LA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-71; JORDAN WS, 1958, AM J HYG, V68, P190, DOI 10.1093/oxfordjournals.aje.a119962; Keitel WA, 1997, VACCINE, V15, P1114, DOI 10.1016/S0264-410X(97)00003-0; Kumpulainen V, 1997, SCAND J INFECT DIS, V29, P181, DOI 10.3109/00365549709035881; Lemaitre M, 2009, J AM GERIATR SOC, V57, P1580, DOI 10.1111/j.1532-5415.2009.02402.x; Loeb M, 2009, JAMA-J AM MED ASSOC, V302, P1865, DOI 10.1001/jama.2009.1466; MAIR HJ, 1974, J HYG-CAMBRIDGE, V73, P317, DOI 10.1017/S0022172400024189; MANN PG, 1981, J HYG-CAMBRIDGE, V87, P191, DOI 10.1017/S0022172400069400; Monto AS, 2009, NEW ENGL J MED, V361, P1260, DOI 10.1056/NEJMoa0808652; MONTO AS, 1993, EPIDEMIOL INFECT, V110, P145, DOI 10.1017/S0950268800050779; Monto AS, 2002, J INFECT DIS, V186, P1582, DOI 10.1086/345722; OEHLERT GW, 1992, AM STAT, V46, P27, DOI 10.2307/2684406; Ohmit SE, 2008, J INFECT DIS, V198, P312, DOI 10.1086/589885; Ohmit SE, 2006, NEW ENGL J MED, V355, P2513, DOI 10.1056/NEJMoa061850; Potter J, 1997, J INFECT DIS, V175, P1, DOI 10.1093/infdis/175.1.1; Salgado CD, 2002, LANCET INFECT DIS, V2, P145, DOI 10.1016/S1473-3099(02)00221-9; Shah PS, 2009, BJOG-INT J OBSTET GY, V116, P1425, DOI 10.1111/j.1471-0528.2009.02278.x; Sirivichayakul Chukiat, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P57; Stevenson CG, 2001, CAN MED ASSOC J, V164, P1413; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; TANNOCK GA, 1993, FAM PRACT, V10, P378, DOI 10.1093/fampra/10.4.378; TANNOCK GA, 1988, EPIDEMIOL INFECT, V101, P611, DOI 10.1017/S0950268800029484; Treanor JJ, 2007, JAMA-J AM MED ASSOC, V297, P1577, DOI 10.1001/jama.297.14.1577; Viboud C, 2004, INT CONGR SER, V1263, P291, DOI 10.1016/j.ics.2004.01.013; WALDMAN RH, 1969, J AMER MED ASSOC, V207, P520, DOI 10.1001/jama.207.3.520; Weber DJ, 2010, CRIT CARE MED, V38, pS306, DOI 10.1097/CCM.0b013e3181e69ebd; Wells G.A., NEWCASTLE OTTAWA SCA; Wilde JA, 1999, JAMA-J AM MED ASSOC, V281, P908, DOI 10.1001/jama.281.10.908; Williams CJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-8	46	151	169	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26239	10.1371/journal.pone.0026239	http://dx.doi.org/10.1371/journal.pone.0026239			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028840	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000296186900038
J	Wei, CG; Wang, GQ; Chen, X; Huang, HL; Liu, B; Xu, Y; Li, F				Wei, Chengguo; Wang, Guoqing; Chen, Xin; Huang, Honglan; Liu, Bin; Xu, Ying; Li, Fan			Identification and Typing of Human Enterovirus: A Genomic Barcode Approach	PLOS ONE			English	Article							VP1; MECHANISMS; PHYLOGENY; EVOLUTION; OUTBREAKS; PROTEIN; REGION; AGENTS; PCR	Identification and typing of human enterovirus (HEVs) are important to pathogen detection and therapy. Previous phylogeny-based typing methods are mainly based on multiple sequence alignments of specific genes in the HEVs, but the results are not stable with respect to different choices of genes. Here we report a novel method for identification and typing of HEVs based on information derived from their whole genomes. Specifically, we calculate the k-mer based barcode image for each genome, HEV or other human viruses, for a fixed k, 1<k<7, where a genome barcode is defined in terms of the k-mer frequency distribution across the whole genome for all combinations of k-mers. A phylogenetic tree is constructed using a barcode-based distance and a neighbor-joining method among a set of 443 representative non-HEV human viruses and 395 HEV sequences. The tree shows a clear separation of the HEV viruses from all the non-HEV viruses with 100% accuracy and a separation of the HEVs into four distinct clads with 93.4% consistency with a multiple sequence alignment-based phylogeny. Our detailed analyses of the HEVs having different typing results by the two methods indicate that our results are in better agreement with known information about the HEVs.	[Wei, Chengguo; Wang, Guoqing; Huang, Honglan; Li, Fan] Jilin Univ, Norman Bethune Med Coll, Dept Pathogeny Biol, Changchun 130023, Jilin, Peoples R China; [Xu, Ying] Univ Georgia, Dept Biochem & Mol Biol, Computat Syst Biol Lab, Athens, GA 30602 USA; [Xu, Ying] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Chen, Xin; Xu, Ying] Jilin Univ, Coll Comp Sci & Technol, Changchun 130023, Jilin, Peoples R China; [Liu, Bin] Jilin Univ, Bethune Hosp 1, Changchun 130023, Jilin, Peoples R China	Jilin University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Jilin University; Jilin University	Wei, CG (corresponding author), Jilin Univ, Norman Bethune Med Coll, Dept Pathogeny Biol, Changchun 130023, Jilin, Peoples R China.	xyn@bmb.uga.edu; lifan@jlu.edu.cn	Huang, Honglan/GRR-2513-2022		National Basic Research Program of China (973 program) [2011CB512003]; National Natural Science Foundation of China [30872415, 81071424, 81101295]; China Postdoctoral Science Foundation [20110491311]; National Science Foundation [DEB-0830024]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Science Foundation(National Science Foundation (NSF))	This work was supported by National Basic Research Program of China (973 program, 2011CB512003) and National Natural Science Foundation of China (30872415). It is also supported in part by National Natural Science Foundation of China (81071424 and 81101295), China Postdoctoral Science Foundation (20110491311) and National Science Foundation (DEB-0830024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown B, 2003, J VIROL, V77, P8973, DOI 10.1128/JVI.77.16.8973-8984.2003; Cardosa MJ, 2003, EMERG INFECT DIS, V9, P461; Chang CH, 2003, GRAEF ARCH CLIN EXP, V241, P554, DOI 10.1007/s00417-003-0680-2; FAUQUET CM, 2005, 8 IUOMS VIR DIV INT; GRANDIEN M, 1989, DIAGNOSTIC PROCEDURE, P513; Heinsbroek E, 2010, VACCINE, V28, P3778, DOI 10.1016/j.vaccine.2010.02.095; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Ishiko H, 2002, J INFECT DIS, V185, P744, DOI 10.1086/339298; JUN EJ, 2010, INVEST OPHTH VIS SCI, V52, P58; KAPSENBERG JG, 1988, LABORATORY DIAGNOSIS, V2, P692; Kearney MT, 2001, POSTGRAD MED J, V77, P4, DOI 10.1136/pmj.77.903.4; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; Kim KS, 2001, REV MED VIROL, V11, P355, DOI 10.1002/rmv.326; Kottaridi C, 2006, ARCH VIROL, V151, P1117, DOI 10.1007/s00705-005-0697-4; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Miyazawa I, 2008, JPN J INFECT DIS, V61, P247; Nasri D, 2007, EXPERT REV MOL DIAGN, V7, P419, DOI 10.1586/14737159.7.4.419; Nasri D, 2007, J CLIN MICROBIOL, V45, P2370, DOI 10.1128/JCM.00093-07; Norder H, 2003, J GEN VIROL, V84, P827, DOI 10.1099/vir.0.18647-0; Oberste MS, 2010, J CLIN VIROL, V49, P73, DOI 10.1016/j.jcv.2010.06.022; Oberste MS, 2005, J GEN VIROL, V86, P445, DOI 10.1099/vir.0.80475-0; Oberste MS, 2004, J GEN VIROL, V85, P3205, DOI 10.1099/vir.0.80148-0; Oberste MS, 1999, J VIROL, V73, P1941, DOI 10.1128/JVI.73.3.1941-1948.1999; Palacios G, 2005, J NEUROVIROL, V11, P424, DOI 10.1080/13550280591002531; Pallansch M., 2007, FIELDS VIROLOGY, P839; Richer MJ, 2009, AUTOIMMUN REV, V8, P611, DOI 10.1016/j.autrev.2009.02.006; Savolainen-Kopra C, 2010, REV MED VIROL, V20, P358, DOI 10.1002/rmv.663; Stadnick E, 2004, J VIROL, V78, P13987, DOI 10.1128/JVI.78.24.13987-14002.2004; Stanway G, 2005, VIRUS TAXONOMY, P757; Xiao XL, 2009, J VIROL METHODS, V159, P23, DOI 10.1016/j.jviromet.2009.02.022; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhou FF, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-546; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	34	2	2	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26296	10.1371/journal.pone.0026296	http://dx.doi.org/10.1371/journal.pone.0026296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022592	gold, Green Submitted, Green Published			2022-12-27	WOS:000295981600050
J	Cook, DC; Fraser, RW; Paini, DR; Warden, AC; Lonsdale, WM; De Barro, PJ				Cook, David C.; Fraser, Rob W.; Paini, Dean R.; Warden, Andrew C.; Lonsdale, W. Mark; De Barro, Paul J.			Biosecurity and Yield Improvement Technologies Are Strategic Complements in the Fight against Food Insecurity	PLOS ONE			English	Article							MAJOR CROPS; WHEAT; SPREAD; INVASIONS; LOSSES	The delivery of food security via continued crop yield improvement alone is not an effective food security strategy, and must be supported by pre- and post-border biosecurity policies to guard against perverse outcomes. In the wake of the green revolution, yield gains have been in steady decline, while post-harvest crop losses have increased as a result of insufficiently resourced and uncoordinated efforts to control spoilage throughout global transport and storage networks. This paper focuses on the role that biosecurity is set to play in future food security by preventing both pre- and post-harvest losses, thereby protecting crop yield. We model biosecurity as a food security technology that may complement conventional yield improvement policies if the gains in global farm profits are sufficient to offset the costs of implementation and maintenance. Using phytosanitary measures that slow global spread of the Ug99 strain of wheat stem rust as an example of pre-border biosecurity risk mitigation and combining it with post-border surveillance and invasive alien species control efforts, we estimate global farm profitability may be improved by over US$4.5 billion per annum.	[Cook, David C.] Dept Agr & Food Western Australia, Bunbury, WA, Australia; [Cook, David C.; Paini, Dean R.; De Barro, Paul J.] Cooperat Res Ctr Natl Plant Biosecur, Bruce, ACT, Australia; [Fraser, Rob W.] Univ Kent, Dept Econ, Kent, OH USA; [Paini, Dean R.; Warden, Andrew C.; Lonsdale, W. Mark; De Barro, Paul J.] CSIRO Ecosyst Sci, Canberra, ACT, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Cook, DC (corresponding author), Dept Agr & Food Western Australia, Bunbury, WA, Australia.	david.cook@agric.wa.gov.au	Paini, Dean R/C-2341-2009; Warden, Andrew C/C-1484-2008; Cook, David C/C-1064-2009; De Barro, Paul J/C-1724-2008; Lonsdale, Mark/C-1403-2008	Warden, Andrew C/0000-0003-2683-9798; Cook, David C/0000-0002-2954-7697; Lonsdale, Mark/0000-0002-6163-3691	Cooperative Research Centre for National Plant Biosecurity [CRC10162]; Australian Government's Cooperative Research Centres	Cooperative Research Centre for National Plant Biosecurity(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government's Cooperative Research Centres(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This research was supported by the Cooperative Research Centre for National Plant Biosecurity (Project No. CRC10162), established and supported under the Australian Government's Cooperative Research Centres Program (http://www.crcplantbiosecurity.com.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDOW DA, 1990, LANDSCAPE ECOL, V4, P177, DOI 10.1007/BF00132860; Barrett C., 2002, HDB AGR EC, V2; Biosecurity Australia, 2001, GUID IMP RISK AN; Byerlee D., 1993, IMPACTS INT WHEAT BR; Cook DC, 2010, RISK ANAL, V30, P1303, DOI 10.1111/j.1539-6924.2010.01439.x; COOK DC, 2003, PRIORITISING EXOTIC, P185; Cribb J, 2010, COMING FAMINE: THE GLOBAL FOOD CRISIS AND WHAT WE CAN DO TO AVOID IT, P1; DWYER G, 1992, ECOLOGY, V73, P479, DOI 10.2307/1940754; Edkins Jenny, 2000, WHOSE HUNGER CONCEPT; FAO, 2010, FAOSTAT DAT; *FAPRI, 2010, ELAST; Fisher RA, 1937, ANN EUGENIC, V7, P355, DOI 10.1111/j.1469-1809.1937.tb02153.x; Food and Agriculture Organization (FAO), 2010, STATE FOOD INSECURIT; Hengeveld B., 1989, DYNAMICS BIOL INVASI; Hengeweld R., 1989, DYNAMICS BIOL INVASI; Hinchy M. D., 1991, COST BENEFIT ANAL QU; Hodson DP, 2007, J AGR SCI-CAMBRIDGE, V145, P115, DOI 10.1017/S0021859607006855; HOLMES EE, 1993, AM NAT, V142, P779, DOI 10.1086/285572; *INT MON FUND, 2010, PRIM COMM PRIC; KHETARPA RK, 2008, INT C WHEAT STEM RUS, P71; LAL D, 1992, POLITICAL EC INTERAC, P27; Lantican M.A., 2005, IMPACTS INT WHEAT BR; LANTICAN MA, 2002, CIM MYT WORLD WHEAT, P39; Leff B, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002108; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Lewis M., 1997, SPATIAL ECOLOGY ROLE, P46; LUCIA MD, 1994, AGR ENG DEV POST HAR; Maxwell S, 1996, FOOD POLICY, V21, P155, DOI 10.1016/0306-9192(95)00074-7; McCann K, 2000, THEOR POPUL BIOL, V57, P97, DOI 10.1006/tpbi.1999.1444; MEERBURG BG, 2009, PEST MANAGEMENT SCI, V65; MOODY ME, 1988, J APPL ECOL, V25, P1009, DOI 10.2307/2403762; Neethirajan S, 2007, FOOD CONTROL, V18, P157, DOI 10.1016/j.foodcont.2005.09.008; Normile D, 2010, SCIENCE, V327, P806, DOI 10.1126/science.327.5967.806; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Oerke EC, 2004, CROP PROT, V23, P275, DOI 10.1016/j.cropro.2003.10.001; Okubo A., 2002, DIFFUSION ECOLOGICAL; PAINI DR, 2010, CRC10001 NAT PLANT B; Pennisi E, 2010, SCIENCE, V327, P804, DOI 10.1126/science.327.5967.804; PRABHU KV, 2008, INT C WHEAT STEM RUS, P67; Reynolds MP, 2006, J AGR SCI-CAMBRIDGE, V144, P3, DOI 10.1017/S0021859606005867; Sapoukhina N, 2010, ECOL MODEL, V221, P2793, DOI 10.1016/j.ecolmodel.2010.08.020; SEN A, 1981, Q J ECON, V96, P433, DOI 10.2307/1882681; SEN AM, 1992, POLITICAL EC DEV UND, P5; Shigesada N., 1997, BIOL INVASIONS THEOR; Singh RP, 2008, ADV AGRON, V98, P271, DOI 10.1016/S0065-2113(08)00205-8; Stoeckel A., 2008, HIGH FOOD PRICES CAU; Stokstad E, 2007, SCIENCE, V315, P1786, DOI 10.1126/science.315.5820.1786; Trethowan RM, 2002, CROP SCI, V42, P1441, DOI 10.2135/cropsci2002.1441; TROSTLE R, 2008, WRS0801 USDA, P30; U.S. Department of State, 2008, COUNTR REP HUM RIGHT; *UN, 2002, WORLD POP PROSP 2000; Walker P., 1989, FAMINE EARLY WARNING; Wilby, 2005, NEW AGENDA BIOSECURI	53	21	21	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26084	10.1371/journal.pone.0026084	http://dx.doi.org/10.1371/journal.pone.0026084			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022517	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000066
J	Hughes, BG; Hekimi, S				Hughes, Bryan G.; Hekimi, Siegfried			A Mild Impairment of Mitochondrial Electron Transport Has Sex-Specific Effects on Lifespan and Aging in Mice	PLOS ONE			English	Article							C-OXIDASE DEFICIENCY; MN SUPEROXIDE-DISMUTASE; SYSTEMATIC RNAI SCREEN; LIVED MCLK1(+/-) MICE; OXIDATIVE-PHOSPHORYLATION; CAENORHABDITIS-ELEGANS; RESPIRATORY-CHAIN; BRAIN MITOCHONDRIA; METABOLIC-RATE; COMPLEX-III	Impairments of various aspects of mitochondrial function have been associated with increased lifespan in various model organisms ranging from Caenorhabditis elegans to mice. For example, disruption of the function of the 'Rieske' iron-sulfur protein (RISP) of complex III of the mitochondrial electron transport chain can result in increased lifespan in the nematode worm C. elegans. However, the mechanisms by which impaired mitochondrial function affects aging remain under investigation, including whether or not they require decreased electron transport. We have generated knock-in mice with a loss-of-function Risp mutation that is homozygous lethal. However, heterozygotes (Risp(+/P224S)) were viable and had decreased levels of RISP protein and complex III enzymatic activity. This decrease was sufficient to impair mitochondrial respiration and to decrease overall metabolic rate in males, but not females. These defects did not appear to exert an overtly deleterious effect on the health of the mutants, since young Risp(+/P224S) mice are outwardly normal, with unaffected performance and fertility. Furthermore, biomarkers of oxidative stress were unaffected in both young and aged animals. Despite this, the average lifespan of male Risp(+/P224S) mice was shortened and aged Risp(+/P224S) males showed signs of more rapidly deteriorating health. In spite of these differences, analysis of Gompertz mortality parameters showed that Risp heterozygosity decreased the rate of increase of mortality with age and increased the intrinsic vulnerability to death in both sexes. However, the intrinsic vulnerability was increased more dramatically in males, which resulted in their shortened lifespan. For females, the slower acceleration of age-dependent mortality results in significantly increased survival of Risp(+/P224S) mice in the second half of lifespan. These results demonstrate that even relatively small perturbations of the mitochondrial electron transport chain can have significant physiological effects in mammals, and that the severity of those effects can be sex-dependent.	[Hughes, Bryan G.; Hekimi, Siegfried] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	McGill University	Hughes, BG (corresponding author), McGill Univ, Dept Biol, 1205 Doctor Penfield Ave, Montreal, PQ H3A 1B1, Canada.	Siegfried.Hekimi@McGill.ca	Hughes, Bryan/L-4964-2017	Hughes, Bryan/0000-0002-2718-3818; Hekimi, Siegfried/0000-0002-3592-5711	Canadian Institute of Health Research [89761]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR))	The work was supported by a grant from the Canadian Institute of Health Research (89761) to SH. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agostino A, 2003, HUM MOL GENET, V12, P399, DOI 10.1093/hmg/ddg038; Arguelles S, 2004, BBA-GEN SUBJECTS, V1674, P251, DOI 10.1016/j.bbagen.2004.06.023; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Cai WJ, 2007, AM J PATHOL, V170, P1893, DOI 10.2353/ajpath.2007.061281; Copeland JM, 2009, CURR BIOL, V19, P1591, DOI 10.1016/j.cub.2009.08.016; CRAWLEY JN, 2000, MOTOR FUNCTIONS WHAT; Davey GP, 1998, J BIOL CHEM, V273, P12753, DOI 10.1074/jbc.273.21.12753; Davey GP, 1996, J NEUROCHEM, V66, P1617; de Lonlay P, 2001, NAT GENET, V29, P57, DOI 10.1038/ng706; Dell'Agnello C, 2007, HUM MOL GENET, V16, P431, DOI 10.1093/hmg/ddl477; Diaz F, 2005, HUM MOL GENET, V14, P2737, DOI 10.1093/hmg/ddi307; Dillin A, 2002, SCIENCE, V298, P2398, DOI 10.1126/science.1077780; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Doubal S, 1997, AGE, V20, P229, DOI 10.1007/s11357-997-0023-z; Edmond Jane C, 2009, Int Ophthalmol Clin, V49, P27, DOI 10.1097/IIO.0b013e3181a8de58; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Felkai S, 1999, EMBO J, V18, P1783, DOI 10.1093/emboj/18.7.1783; Feng JL, 2001, DEV CELL, V1, P633, DOI 10.1016/S1534-5807(01)00071-5; Finch CE, 1990, LONGEVITY SENESCENCE; Gates AC, 2007, CELL METAB, V6, P497, DOI 10.1016/j.cmet.2007.10.010; GATTI DL, 1989, J MOL BIOL, V205, P421, DOI 10.1016/0022-2836(89)90352-5; Graham BH, 1997, NAT GENET, V16, P226, DOI 10.1038/ng0797-226; Greenberg JA, 2000, MECH AGEING DEV, V113, P37, DOI 10.1016/S0047-6374(99)00094-9; Hagen TM, 1997, P NATL ACAD SCI USA, V94, P3064, DOI 10.1073/pnas.94.7.3064; Hamilton B, 2005, GENE DEV, V19, P1544, DOI 10.1101/gad.1308205; Hausladen A, 1996, METHOD ENZYMOL, V269, P37; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Iwata S, 1998, SCIENCE, V281, P64, DOI 10.1126/science.281.5373.64; Jang YC, 2009, J GERONTOL A-BIOL, V64, P1114, DOI 10.1093/gerona/glp100; Kayser EB, 2004, J BIOL CHEM, V279, P54479, DOI 10.1074/jbc.M403066200; Kwong LK, 2000, ARCH BIOCHEM BIOPHYS, V373, P16, DOI 10.1006/abbi.1999.1495; Lapointe J, 2008, J BIOL CHEM, V283, P26217, DOI 10.1074/jbc.M803287200; Lapointe J, 2009, J BIOL CHEM, V284, P20364, DOI 10.1074/jbc.M109.006569; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Liu XX, 2005, GENE DEV, V19, P2424, DOI 10.1101/gad.1352905; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Madamanchi NR, 2007, CIRC RES, V100, P460, DOI 10.1161/01.RES.0000258450.44413.96; McLean J., 1987, ANIMAL HUMAN CALORIM; Pallotti F, 2001, METHOD CELL BIOL, V65, P1, DOI 10.1016/S0091-679X(01)65002-7; Ran Q, 2007, J GERONTOL A-BIOL, V62, P932, DOI 10.1093/gerona/62.9.932; Rolfe DFS, 1997, PHYSIOL REV, V77, P731, DOI 10.1152/physrev.1997.77.3.731; Rossignol R, 1999, J BIOL CHEM, V274, P33426, DOI 10.1074/jbc.274.47.33426; Sango K, 1996, NAT GENET, V14, P348, DOI 10.1038/ng1196-348; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; SHIMADA A, 1992, J NEUROPATH EXP NEUR, V51, P440, DOI 10.1097/00005072-199207000-00006; TAYLOR RW, 1994, J BIOL CHEM, V269, P3523; Thouvarecq R, 2001, BEHAV BRAIN RES, V118, P209, DOI 10.1016/S0166-4328(00)00330-2; Tiranti V, 1998, AM J HUM GENET, V63, P1609, DOI 10.1086/302150; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Turrens JF, 1997, BIOSCIENCE REP, V17, P3, DOI 10.1023/A:1027374931887; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; Van Raamsdonk JM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000361; Ventura B, 2002, BBA-BIOENERGETICS, V1553, P249, DOI 10.1016/S0005-2728(01)00246-8; Wang DT, 2010, J IMMUNOL, V184, P582, DOI 10.4049/jimmunol.0902352; Yang H, 2010, HUM MOL GENET, V19, P170, DOI 10.1093/hmg/ddp477; Yang W, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000556; Yang W, 2010, AGING CELL, V9, P433, DOI 10.1111/j.1474-9726.2010.00571.x; Yap LP, 2009, ADV DRUG DELIVER REV, V61, P1283, DOI 10.1016/j.addr.2009.07.015; Yuan R, 2009, AGING CELL, V8, P277, DOI 10.1111/j.1474-9726.2009.00478.x; Zhang YQ, 2009, J GERONTOL A-BIOL, V64, P1212, DOI 10.1093/gerona/glp132; Zhang ZL, 1998, NATURE, V392, P677, DOI 10.1038/33612; Zini R, 2007, FREE RADICAL RES, V41, P1159, DOI 10.1080/10715760701635074	62	39	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26116	10.1371/journal.pone.0026116	http://dx.doi.org/10.1371/journal.pone.0026116			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028811	gold, Green Submitted, Green Published			2022-12-27	WOS:000295971700041
J	Abdala-Valencia, H; Berdnikovs, S; Cook-Mills, JM				Abdala-Valencia, Hiam; Berdnikovs, Sergejs; Cook-Mills, Joan M.			Mechanisms for Vascular Cell Adhesion Molecule-1 Activation of ERK1/2 during Leukocyte Transendothelial Migration	PLOS ONE			English	Article							PROTEIN-KINASE KINASE; MICROVASCULAR ENDOTHELIAL-CELLS; INTRACELLULAR SIGNAL-TRANSDUCTION; AIRWAY EPITHELIAL PERMEABILITY; NADPH OXIDASE; MAP KINASES; IN-VITRO; LYMPHOCYTE MIGRATION; REGULATED KINASES; VCAM-1 ACTIVATION	Background: During inflammation, adhesion molecules regulate recruitment of leukocytes to inflamed tissues. It is reported that vascular cell adhesion molecule-1 (VCAM-1) activates extracellular regulated kinases 1 and 2 (ERK1/2), but the mechanism for this activation is not known. Pharmacological inhibitors of ERK1/2 partially inhibit leukocyte transendothelial migration in a multi-receptor system but it is not known whether VCAM-1 activation of ERK1/2 is required for leukocyte transendothelial migration (TEM) on VCAM-1. Methodology/Principal Findings: In this study, we identified a mechanism for VCAM-1 activation of ERK1/2 in human and mouse endothelial cells. VCAM-1 signaling, which occurs through endothelial cell NADPH oxidase, protein kinase C alpha (PKC alpha), and protein tyrosine phosphatase 1B (PTP1B), activates endothelial cell ERK1/2. Inhibition of these signals blocked VCAM-1 activation of ERK1/2, indicating that ERK1/2 is activated downstream of PTP1B during VCAM-1 signaling. Furthermore, VCAM-1-specific leukocyte migration under physiological laminar flow of 2 dynes/cm(2) was blocked by pretreatment of endothelial cells with dominant-negative ERK2 K52R or the MEK/ERK inhibitors, PD98059 and U0126, indicating for the first time that ERK regulates VCAM-1-dependent leukocyte transendothelial migration. Conclusions/Significance: VCAM-1 activation of endothelial cell NADPH oxidase/PKC alpha/PTP1B induces transient ERK1/2 activation that is necessary for VCAM-1-dependent leukocyte TEM.	[Abdala-Valencia, Hiam; Berdnikovs, Sergejs; Cook-Mills, Joan M.] Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Abdala-Valencia, H (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Allergy Immunol, Chicago, IL 60611 USA.	j-cookmills@northwestern.edu		Abdala Valencia, Hiam/0000-0003-3384-5299	National Institutes of Health (NIH) [R01 AT004837]; American Heart Association [2260905]; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R01AT004837] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	This work was supported by National Institutes of Health (NIH) Grant R01 AT004837 and American Heart Association Grant 2260905. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala-Valencia H, 2007, AM J PHYSIOL-LUNG C, V292, pL1111, DOI 10.1152/ajplung.00208.2006; Abdala-Valencia H, 2006, J IMMUNOL, V177, P6379, DOI 10.4049/jimmunol.177.9.6379; AGER A, 1988, EUR J IMMUNOL, V18, P1265, DOI 10.1002/eji.1830180818; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; BARON JL, 1993, J EXP MED, V177, P57, DOI 10.1084/jem.177.1.57; Berdnikovs S, 2009, J IMMUNOL, V182, P4395, DOI 10.4049/jimmunol.0803659; Berk BC, 2008, CIRCULATION, V117, P1082, DOI 10.1161/CIRCULATIONAHA.107.720730; Cai S, 2005, J CELL SCI, V118, P889, DOI 10.1242/jcs.01674; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; CHEN L, 2011, VASCUL PHARM; Chin JE, 1997, AM J PHYSIOL-LUNG C, V272, pL219, DOI 10.1152/ajplung.1997.272.2.L219; Choi H, 2007, IMMUNOL INVEST, V36, P59, DOI 10.1080/08820130600745703; Cook-Mills JM, 2004, BIOCHEM J, V378, P539, DOI 10.1042/BJ20030794; Cook-Mills JM, 2011, ANTIOXID REDOX SIGN, V15, P1607, DOI 10.1089/ars.2010.3522; CookMills JM, 1996, IN VITRO CELL DEV-AN, V32, P167; Cuvelier SL, 2005, J EXP MED, V202, P865, DOI 10.1084/jem.20041315; Datla SR, 2007, ARTERIOSCL THROM VAS, V27, P2319, DOI 10.1161/ATVBAHA.107.149450; Deem TL, 2004, BLOOD, V104, P2385, DOI 10.1182/blood-2004-02-0665; Deem TL, 2007, J IMMUNOL, V178, P3865, DOI 10.4049/jimmunol.178.6.3865; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Gould MC, 2000, EXP CELL RES, V260, P175, DOI 10.1006/excr.2000.5014; Hartel FV, 2010, AM J PHYSIOL-CELL PH, V298, pC1501, DOI 10.1152/ajpcell.00333.2009; Harrington EO, 2003, AM J RESP CELL MOL, V28, P626, DOI 10.1165/rcmb.2002-0085OC; Hu YY, 2000, J IMMUNOL, V165, P2142, DOI 10.4049/jimmunol.165.4.2142; Huang Q, 2011, ACTA DIABETOL; Kempna P, 2003, FREE RADICAL BIO MED, V34, P1458, DOI 10.1016/S0891-5849(03)00173-4; Keshavan P, 2005, J IMMUNOL, V174, P3709, DOI 10.4049/jimmunol.174.6.3709; Klinge CM, 2005, J BIOL CHEM, V280, P7460, DOI 10.1074/jbc.M411565200; KOLCH W, 1993, NATURE, V364, P249, DOI 10.1038/364249a0; Krunkosky TM, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-12; LAWRENCE MB, 1987, BLOOD, V70, P1284; Lawson C, 1999, J IMMUNOL, V162, P2990; Lazaar AL, 2001, J IMMUNOL, V166, P155, DOI 10.4049/jimmunol.166.1.155; LAZAR DF, 1995, J BIOL CHEM, V270, P20801, DOI 10.1074/jbc.270.35.20801; Lee YH, 2010, MOL BIOL CELL, V21, P4240, DOI 10.1091/mbc.E10-04-0341; Lipowsky HH, 2005, MICROCIRCULATION, V12, P5, DOI 10.1080/10739680590894966; LUBOS E, 2011, J BIOL CHEM; Matheny HE, 2000, J IMMUNOL, V164, P6550, DOI 10.4049/jimmunol.164.12.6550; Mavria G, 2006, CANCER CELL, V9, P33, DOI 10.1016/j.ccr.2005.12.021; Milovanova T, 2008, BBA-MOL CELL RES, V1783, P1866, DOI 10.1016/j.bbamcr.2008.05.010; Montezano AC, 2010, CIRC RES, V106, P1363, DOI 10.1161/CIRCRESAHA.109.216036; Nguyen A, 2006, P NATL ACAD SCI USA, V103, P6530, DOI 10.1073/pnas.0511011103; NOBIS U, 1985, MICROVASC RES, V29, P295, DOI 10.1016/0026-2862(85)90020-2; Patibandla PK, 2009, J CELL PHYSIOL, V221, P195, DOI 10.1002/jcp.21845; Puddicombe SM, 2000, CLIN EXP ALLERGY, V30, P7; Qureshi MH, 2003, J IMMUNOL, V171, P4700, DOI 10.4049/jimmunol.171.9.4700; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Sano H, 1998, BIOCHEM BIOPH RES CO, V250, P694, DOI 10.1006/bbrc.1998.9385; Secchiero P, 2003, CIRCULATION, V107, P2250, DOI 10.1161/01.CIR.0000062702.60708.C4; Serikov VB, 2004, AM J RESP CELL MOL, V30, P261, DOI 10.1165/rcmb.2003-0053OC; Shibata T, 2002, IMMUNOL CELL BIOL, V80, P226, DOI 10.1046/j.1440-1711.2002.01079.x; Smith ML, 2003, BIOPHYS J, V85, P637, DOI 10.1016/S0006-3495(03)74507-X; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Srinivasan R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008283; Stein BN, 2003, J IMMUNOL, V171, P6097, DOI 10.4049/jimmunol.171.11.6097; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; Tsakadze NL, 2002, TRENDS CARDIOVAS MED, V12, P101, DOI 10.1016/S1050-1738(01)00157-8; Tudor KSRS, 2000, BIOCHEM CELL BIOL, V78, P99, DOI 10.1139/bcb-78-2-99; Tudor KSRS, 2001, CYTOKINE, V15, P196, DOI 10.1006/cyto.2001.0922; Wang Q, 2003, J BIOL CHEM, V278, P47731, DOI 10.1074/jbc.M308466200; Wang Q, 2001, J IMMUNOL, V166, P6877, DOI 10.4049/jimmunol.166.11.6877; Wang Y, 2004, EXP EYE RES, V78, P125, DOI 10.1016/j.exer.2003.09.002; WHISLER RL, 1995, ARCH BIOCHEM BIOPHYS, V319, P23, DOI 10.1006/abbi.1995.1263	65	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26706	10.1371/journal.pone.0026706	http://dx.doi.org/10.1371/journal.pone.0026706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031842	gold, Green Submitted, Green Published			2022-12-27	WOS:000296513200045
J	DiLeo, MV; Strahan, GD; den Bakker, M; Hoekenga, OA				DiLeo, Matthew V.; Strahan, Gary D.; den Bakker, Meghan; Hoekenga, Owen A.			Weighted Correlation Network Analysis (WGCNA) Applied to the Tomato Fruit Metabolome	PLOS ONE			English	Article							GENE-EXPRESSION; ARABIDOPSIS; REVEALS; IDENTIFICATION; INTEGRATION; PATHWAYS; ETHYLENE	Background: Advances in "omics'' technologies have revolutionized the collection of biological data. A matching revolution in our understanding of biological systems, however, will only be realized when similar advances are made in informatic analysis of the resulting "big data.'' Here, we compare the capabilities of three conventional and novel statistical approaches to summarize and decipher the tomato metabolome. Methodology: Principal component analysis (PCA), batch learning self-organizing maps (BL-SOM) and weighted gene co-expression network analysis (WGCNA) were applied to a multivariate NMR dataset collected from developmentally staged tomato fruits belonging to several genotypes. While PCA and BL-SOM are appropriate and commonly used methods, WGCNA holds several advantages in the analysis of highly multivariate, complex data. Conclusions: PCA separated the two major genetic backgrounds (AC and NC), but provided little further information. Both BL-SOM and WGCNA clustered metabolites by expression, but WGCNA additionally defined "modules'' of co-expressed metabolites explicitly and provided additional network statistics that described the systems properties of the tomato metabolic network. Our first application of WGCNA to tomato metabolomics data identified three major modules of metabolites that were associated with ripening-related traits and genetic background.	[DiLeo, Matthew V.; den Bakker, Meghan; Hoekenga, Owen A.] Cornell Univ, Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [DiLeo, Matthew V.; den Bakker, Meghan; Hoekenga, Owen A.] ARS, Robert W Holley Ctr Agr & Hlth, USDA, Ithaca, NY USA; [Strahan, Gary D.] ARS, Eastern Reg Res Ctr, USDA, Wyndmoor, PA USA	Cornell University; Boyce Thompson Institute for Plant Research; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	DiLeo, MV (corresponding author), Keygene Inc, Rockville, MD USA.	Owen.Hoekenga@ars.usda.gov		Hoekenga, Owen/0000-0003-4427-2000	Agricultural Research Service of the US Department of Agriculture	Agricultural Research Service of the US Department of Agriculture(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the Agricultural Research Service of the US Department of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams-Phillips L, 2004, TRENDS PLANT SCI, V9, P331, DOI 10.1016/j.tplants.2004.05.004; Akiyama Kenji, 2008, In Silico Biology, V8, P339; Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Andersen O. M., 2006, FLAVONOIDS CHEM BIOC; [Anonymous], 2010, R LANG ENV STAT COMP; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Aten JE, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-34; Bader DA, 2004, COMMUN ACM, V47, P34, DOI 10.1145/1029496.1029523; Bai YL, 2007, ANN BOT-LONDON, V100, P1085, DOI 10.1093/aob/mcm150; Barenco M, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.84; Bertin N, 2009, J EXP BOT, V60, P237, DOI 10.1093/jxb/ern281; Bino RJ, 2004, TRENDS PLANT SCI, V9, P418, DOI 10.1016/j.tplants.2004.07.004; Carrari F, 2006, J EXP BOT, V57, P1883, DOI 10.1093/jxb/erj020; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Champy MF, 2004, MAMM GENOME, V15, P768, DOI 10.1007/s00335-004-2393-1; DAVIES JN, 1975, J SCI FOOD AGR, V26, P1103, DOI 10.1002/jsfa.2740260808; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Dong J, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-24; Dunn WB, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/011001; Fait A, 2008, PLANT PHYSIOL, V148, P730, DOI 10.1104/pp.108.120691; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Gardner RG, 2006, HORTSCIENCE, V41, P261, DOI 10.21273/HORTSCI.41.1.261; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Goddard T, 2008, SPARKY 3 COMPUTER PR; Goff SA, 2006, SCIENCE, V311, P815, DOI 10.1126/science.1112614; Harborne JB, 1999, HDB NATURAL FLAVONOI, V2, P879; Hirai MY, 2005, J BIOL CHEM, V280, P25590, DOI 10.1074/jbc.M502332200; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Hoekenga Owen A, 2008, J Biomol Tech, V19, P159; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jolliffe I, 2004, PRINCIPAL COMPONENT; Kim JK, 2007, J EXP BOT, V58, P415, DOI 10.1093/jxb/erl216; Kohl M, 2011, METHODS MOL BIOL, V696, P291, DOI 10.1007/978-1-60761-987-1_18; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Le Gall G, 2003, J AGR FOOD CHEM, V51, P2447, DOI 10.1021/jf0259967; LINCOLN JE, 1988, PLANT PHYSIOL, V88, P370, DOI 10.1104/pp.88.2.370; Maltsev N, 2006, CTWATCH Q, V2; Mathieu S, 2009, J EXP BOT, V60, P325, DOI 10.1093/jxb/ern294; Moco S, 2007, J EXP BOT, V58, P4131, DOI 10.1093/jxb/erm271; Mounet F, 2009, PLANT PHYSIOL, V149, P1505, DOI 10.1104/pp.108.133967; Neelam A, 2008, J EXP BOT, V59, P2337, DOI 10.1093/jxb/ern100; Ringner M, 2008, NAT BIOTECHNOL, V26, P303, DOI 10.1038/nbt0308-303; Roessner-Tunali U, 2003, PLANT PHYSIOL, V133, P84, DOI 10.1104/pp.103.023572; Samal A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-118; Sawada Y, 2009, PLANT CELL PHYSIOL, V50, P37, DOI 10.1093/pcp/pcn183; Schripsema J, 2010, PHYTOCHEM ANALYSIS, V21, P14, DOI 10.1002/pca.1185; Slimestad R, 2009, J SCI FOOD AGR, V89, P1255, DOI 10.1002/jsfa.3605; Sobolev AP, 2003, MAGN RESON CHEM, V41, P237, DOI 10.1002/mrc.1176; Tiziani S, 2006, J AGR FOOD CHEM, V54, P6094, DOI 10.1021/jf061154m; USDA-ARS, 2007, DAT FLAV CONT SEL FO; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Zhang PF, 2010, PLANT PHYSIOL, V153, P1479, DOI 10.1104/pp.110.157396; [No title captured]	56	120	123	21	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26683	10.1371/journal.pone.0026683	http://dx.doi.org/10.1371/journal.pone.0026683			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039529	gold, Green Published, Green Submitted			2022-12-27	WOS:000296513200039
J	Petursson, H; Sigurdsson, JA; Bengtsson, C; Nilsen, TIL; Getz, L				Petursson, Halfdan; Sigurdsson, Johann A.; Bengtsson, Calle; Nilsen, Tom I. L.; Getz, Linn			Body Configuration as a Predictor of Mortality: Comparison of Five Anthropometric Measures in a 12 Year Follow-Up of the Norwegian HUNT 2 Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; WAIST-HIP RATIO; CARDIOVASCULAR RISK; MASS INDEX; ADIPOSE-TISSUE; ABDOMINAL OBESITY; US ADULTS; FAT; CIRCUMFERENCE	Background: Distribution of body fat is more important than the amount of fat as a prognostic factor for life expectancy. Despite that, body mass index (BMI) still holds its status as the most used indicator of obesity in clinical work. Methods: We assessed the association of five different anthropometric measures with mortality in general and cardiovascular disease (CVD) mortality in particular using Cox proportional hazards models. Predictive properties were compared by computing integrated discrimination improvement and net reclassification improvement for two different prediction models. The measures studied were BMI, waist circumference, hip circumference, waist-to-hip ratio (WHR), and waist-to-height ratio (WHtR). The study population was a prospective cohort of 62,223 Norwegians, age 20-79, followed up for mortality from 1995-1997 to the end of 2008 (mean follow-up 12.0 years) in the Nord-Trondelag Health Study (HUNT 2). Results: After adjusting for age, smoking and physical activity WHR and WHtR were found to be the strongest predictors of death. Hazard ratios (HRs) for CVD mortality per increase in WHR of one standard deviation were 1.23 for men and 1.27 for women. For WHtR, these HRs were 1.24 for men and 1.23 for women. WHR offered the greatest integrated discrimination improvement to the prediction models studied, followed by WHtR and waist circumference. Hip circumference was in strong inverse association with mortality when adjusting for waist circumference. In all analyses, BMI had weaker association with mortality than three of the other four measures studied. Conclusions: Our study adds further knowledge to the evidence that BMI is not the most appropriate measure of obesity in everyday clinical practice. WHR can reliably be measured and is as easy to calculate as BMI and is currently better documented than WHtR. It appears reasonable to recommend WHR as the primary measure of body composition and obesity.	[Petursson, Halfdan; Getz, Linn] Norwegian Univ Sci & Technol NTNU, Res Unit Gen Practice, Dept Publ Hlth & Gen Practice, Trondheim, Norway; [Sigurdsson, Johann A.] Univ Iceland, Dept Family Med, Reykjavik, Iceland; [Sigurdsson, Johann A.] Primary Hlth Care Capital Area, Ctr Dev, Reykjavik, Iceland; [Bengtsson, Calle] Univ Gothenburg, Dept Primary Hlth Care, Sahlgrenska Acad, Gothenburg, Sweden; [Nilsen, Tom I. L.] Norwegian Univ Sci & Technol NTNU, Dept Human Movement Sci, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); University of Iceland; University of Gothenburg; Norwegian University of Science & Technology (NTNU)	Petursson, H (corresponding author), Norwegian Univ Sci & Technol NTNU, Res Unit Gen Practice, Dept Publ Hlth & Gen Practice, Trondheim, Norway.	halfdanpe@gmail.com		Sigurdsson, Johann Agust/0000-0002-5646-6411	Research Unit of General Practice, Department of Public Health and General Practice, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Norwegian Medical Association; Icelandic College of Family Physicians	Research Unit of General Practice, Department of Public Health and General Practice, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; Norwegian Medical Association; Icelandic College of Family Physicians	This work was supported by the Research Unit of General Practice, Department of Public Health and General Practice, Norwegian University of Science and Technology (NTNU), Trondheim, Norway; The Norwegian Medical Association's Funds for Research in General Practice; and the Research Fund of the Icelandic College of Family Physicians. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bigaard J, 2004, INT J OBESITY, V28, P741, DOI 10.1038/sj.ijo.0802635; Bjorntorp P, 1997, NUTRITION, V13, P795, DOI 10.1016/S0899-9007(97)00191-3; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Deurenberg P, 2003, ACTA DIABETOL, V40, pS246, DOI 10.1007/s00592-003-0077-z; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Gelber RP, 2008, J AM COLL CARDIOL, V52, P605, DOI 10.1016/j.jacc.2008.03.066; Gluckman PD, 2009, NAT REV ENDOCRINOL, V5, P401, DOI 10.1038/nrendo.2009.102; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Heitmann BL, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3292; Heitmann BL, 2004, OBES RES, V12, P482, DOI 10.1038/oby.2004.54; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Huxley R, 2010, EUR J CLIN NUTR, V64, P16, DOI 10.1038/ejcn.2009.68; KROTKIEWSKI M, 1983, J CLIN INVEST, V72, P1150, DOI 10.1172/JCI111040; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Kuzawa CW, 2009, AM J HUM BIOL, V21, P2, DOI 10.1002/ajhb.20822; LAPIDUS L, 1984, BMJ-BRIT MED J, V289, P1257, DOI 10.1136/bmj.289.6454.1257; LARSSON B, 1984, BRIT MED J, V288, P1401, DOI 10.1136/bmj.288.6428.1401; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lindqvist P, 2006, EUR J EPIDEMIOL, V21, P789, DOI 10.1007/s10654-006-9074-1; Lissner L, 2001, OBES RES, V9, P644, DOI 10.1038/oby.2001.85; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/eht151, 10.1093/eurheartj/ehm236]; Manolopoulos KN, 2010, INT J OBESITY, V34, P949, DOI 10.1038/ijo.2009.286; Mhurchu CN, 2006, ASIA PAC J CLIN NUTR, V15, P287; Midthjell K, 2011, FOLKEHELSE ENDRING H, P60; Morkedal B, 2011, EUR J EPIDEMIOL, V26, P457, DOI 10.1007/s10654-011-9572-7; Oliveira A, 2010, INT J OBESITY, V34, P733, DOI 10.1038/ijo.2009.281; Organization WH, 2011, WAIST CIRCUMFERENCE; Page JH, 2009, EPIDEMIOLOGY, V20, P361, DOI 10.1097/EDE.0b013e31819f38f1; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Price GM, 2006, AM J CLIN NUTR, V84, P449; Schneider HJ, 2007, J CLIN ENDOCR METAB, V92, P589, DOI 10.1210/jc.2006-0254; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Sebo P, 2008, PREV MED, V47, P389, DOI 10.1016/j.ypmed.2008.06.012; Snijder MB, 2006, INT J EPIDEMIOL, V35, P83, DOI 10.1093/ije/dyi253; Stevens J, 1998, NEW ENGL J MED, V338, P1, DOI 10.1056/NEJM199801013380101; Taylor AE, 2010, AM J CLIN NUTR, V91, P547, DOI 10.3945/ajcn.2009.28757; VAGUE J, 1956, AM J CLIN NUTR, V4, P20, DOI 10.1093/ajcn/4.1.20; World Health Organization, 2000, WHO TECH REP SER, pi; World Health Organization, 2007, PREV CARD DIS GUID A; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Zhang C, 2008, CIRCULATION, V117, P1658, DOI 10.1161/CIRCULATIONAHA.107.739714	50	89	91	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26621	10.1371/journal.pone.0026621	http://dx.doi.org/10.1371/journal.pone.0026621			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028926	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800061
J	Steven, P; Bock, F; Huttmann, G; Cursiefen, C				Steven, Philipp; Bock, Felix; Huettmann, Gereon; Cursiefen, Claus			Intravital Two-Photon Microscopy of Immune Cell Dynamics in Corneal Lymphatic Vessels	PLOS ONE			English	Article							IN-VIVO; LYMPHANGIOGENESIS; INFLAMMATION; ENDOTHELIUM; MACROPHAGES; EXPRESSION; INDUCTION; MIGRATION; TUMOR	Background: The role of lymphatic vessels in tissue and organ transplantation as well as in tumor growth and metastasis has drawn great attention in recent years. Methodology/Principal Findings: We now developed a novel method using non-invasive two-photon microscopy to simultaneously visualize and track specifically stained lymphatic vessels and autofluorescent adjacent tissues such as collagen fibrils, blood vessels and immune cells in the mouse model of corneal neovascularization in vivo. The mouse cornea serves as an ideal tissue for this technique due to its easy accessibility and its inducible and modifiable state of pathological hem-and lymphvascularization. Neovascularization was induced by suture placement in corneas of Balb/C mice. Two weeks after treatment, lymphatic vessels were stained intravital by intrastromal injection of a fluorescently labeled LYVE-1 antibody and the corneas were evaluated in vivo by two-photon microscopy (TPM). Intravital TPM was performed at 710 nm and 826 nm excitation wavelengths to detect immunofluorescence and tissue autofluorescence using a custom made animal holder. Corneas were then harvested, fixed and analyzed by histology. Time lapse imaging demonstrated the first in vivo evidence of immune cell migration into lymphatic vessels and luminal transport of individual cells. Cells immigrated within 1-5.5 min into the vessel lumen. Mean velocities of intrastromal corneal immune cells were around 9 mm/min and therefore comparable to those of T-cells and macrophages in other mucosal surfaces. Conclusions: To our knowledge we here demonstrate for the first time the intravital real-time transmigration of immune cells into lymphatic vessels. Overall this study demonstrates the valuable use of intravital autofluorescence two-photon microscopy in the model of suture-induced corneal vascularizations to study interactions of immune and subsequently tumor cells with lymphatic vessels under close as possible physiological conditions.	[Steven, Philipp] Univ Lubeck, Dept Ophthalmol, Lubeck, Germany; [Steven, Philipp] Univ Lubeck, Inst Anat, Lubeck, Germany; [Bock, Felix; Cursiefen, Claus] Univ Clin Cologne, Dept Ophthalmol, Cologne, Germany; [Bock, Felix; Cursiefen, Claus] Harvard Univ, Sch Med, Schepens Eye Res Inst, Boston, MA USA; [Huettmann, Gereon] Univ Lubeck, Inst Biomed Opt, Lubeck, Germany	University of Lubeck; University of Lubeck; University of Cologne; Harvard University; Harvard Medical School; Schepens Eye Research Institute; University of Lubeck	Steven, P (corresponding author), Univ Lubeck, Dept Ophthalmol, Lubeck, Germany.	philipp.steven@uk-koeln.de	Cursiefen, Claus/ABE-5284-2020; Hüttmann, Gereon/A-9072-2012	Hüttmann, Gereon/0000-0002-5051-3037; Steven, Philipp/0000-0001-6892-3619; cursiefen, claus/0000-0002-1958-411X	German Research Foundation (DFG) [SFB 643 [TP B10]]; Interdisciplinary Center for Clinical Research (IZKF) Erlangen [A9]; Sektion Kornea, Deutsche Ophthalmologische Gesellschaft; University of Luebeck [TP3]	German Research Foundation (DFG)(German Research Foundation (DFG)); Interdisciplinary Center for Clinical Research (IZKF) Erlangen; Sektion Kornea, Deutsche Ophthalmologische Gesellschaft; University of Luebeck	Funding provided by the German Research Foundation (DFG: SFB 643 [TP B10] to CC); Interdisciplinary Center for Clinical Research (IZKF) Erlangen (A9 to CC); Sektion Kornea, Deutsche Ophthalmologische Gesellschaft (to PS); University of Luebeck, Medical Faculty Grant (TP3 to PS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bock F, 2007, INVEST OPHTH VIS SCI, V48, P2545, DOI 10.1167/iovs.06-0570; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Chen L, 2004, NAT MED, V10, P813, DOI 10.1038/nm1078; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Cursiefen C, 2006, P NATL ACAD SCI USA, V103, P11405, DOI 10.1073/pnas.0506112103; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Dietrich T, 2010, J IMMUNOL, V184, P535, DOI 10.4049/jimmunol.0903180; Fisher KE, 2009, J CELL SCI, V122, P4558, DOI 10.1242/jcs.050724; Grabher C, 2007, J LEUKOCYTE BIOL, V81, P263, DOI 10.1189/jlb.0806526; Hammer T, 2009, MICROVASC RES, V78, P25, DOI 10.1016/j.mvr.2009.02.007; Hamrah P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1132, DOI 10.1001/archopht.121.8.1132; Hamrah P, 2003, INVEST OPHTH VIS SCI, V44, P581, DOI 10.1167/iovs.02-0838; HOLLAND EJ, 1994, CORNEA, V13, P317, DOI 10.1097/00003226-199407000-00006; Johnson LA, 2008, ANN NY ACAD SCI, V1131, P119, DOI 10.1196/annals.1413.011; Johnson LA, 2006, J EXP MED, V203, P2763, DOI 10.1084/jem.20051759; Kerjaschki D, 2006, NAT MED, V12, P230, DOI 10.1038/nm1340; Kwon Sunkuk, 2007, Lymphatic Research and Biology, V5, P219, DOI 10.1089/lrb.2007.1013; LEE EJ, INVEST OPHTHALMOL VI, V51, P2101; LEU AJ, 1994, AM J PHYSIOL-HEART C, V267, pH1507, DOI 10.1152/ajpheart.1994.267.4.H1507; Maruyama K, 2005, J CLIN INVEST, V115, P2363, DOI 10.1172/JCI23874; McElroy M, 2009, J SURG RES, V151, P68, DOI 10.1016/j.jss.2007.12.769; Miller MJ, 2002, SCIENCE, V296, P1869, DOI 10.1126/science.1070051; PEEBO BB, INVEST OPHTHALMOL VI, V51, P830; Pflicke H, 2009, J EXP MED, V206, P2925, DOI 10.1084/jem.20091739; Pillai RG, 2008, BRIT J OPHTHALMOL, V92, P259, DOI 10.1136/bjo.2007.115923; RICE WL, PLOS ONE, V5; Rosenbaum JT, 2002, CURR EYE RES, V24, P214, DOI 10.1076/ceyr.24.3.214.8303; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Steven P, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275475; VANGOETHEM E, EUR J CELL BIOL, V90, P224; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427	31	50	50	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26253	10.1371/journal.pone.0026253	http://dx.doi.org/10.1371/journal.pone.0026253			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028842	Green Submitted, Green Published, gold			2022-12-27	WOS:000296510800031
J	Allen, JF; Santabarbara, S; Allen, CA; Puthiyaveetil, S				Allen, John F.; Santabarbara, Stefano; Allen, Carol A.; Puthiyaveetil, Sujith			Discrete Redox Signaling Pathways Regulate Photosynthetic Light-Harvesting and Chloroplast Gene Transcription	PLOS ONE			English	Article							CHLOROPHYLL PROTEIN COMPLEX; STATE TRANSITIONS; PHOTOSYSTEM-II; FLUORESCENCE SPECTROSCOPY; STATE-1-STATE-2 TRANSITIONS; CYANOBACTERIAL CELLS; PLASTOQUINONE POOL; ELECTRON FLOW; SIGMA-FACTOR; PHOSPHORYLATION	In photosynthesis in chloroplasts, two related regulatory processes balance the actions of photosystems I and II. These processes are short-term, post-translational redistribution of light-harvesting capacity, and long-term adjustment of photosystem stoichiometry initiated by control of chloroplast DNA transcription. Both responses are initiated by changes in the redox state of the electron carrier, plastoquinone, which connects the two photosystems. Chloroplast Sensor Kinase (CSK) is a regulator of transcription of chloroplast genes for reaction centres of the two photosystems, and a sensor of plastoquinone redox state. We asked whether CSK is also involved in regulation of absorbed light energy distribution by phosphorylation of light-harvesting complex II (LHC II). Chloroplast thylakoid membranes isolated from a CSK T-DNA insertion mutant and from wild-type Arabidopsis thaliana exhibit similar light-and redox-induced 32 P-labelling of LHC II and changes in 77 K chlorophyll fluorescence emission spectra, while room-temperature chlorophyll fluorescence emission transients from Arabidopsis leaves are perturbed by inactivation of CSK. The results indicate indirect, pleiotropic effects of reaction centre gene transcription on regulation of photosynthetic light-harvesting in vivo. A single, direct redox signal is transmitted separately to discrete transcriptional and post-translational branches of an integrated cytoplasmic regulatory system.	[Allen, John F.; Allen, Carol A.; Puthiyaveetil, Sujith] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Santabarbara, Stefano] CNR, Ist Biofis, I-20133 Milan, Italy	University of London; Queen Mary University London; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Allen, JF (corresponding author), Queen Mary Univ London, Sch Biol & Chem Sci, London, England.	j.f.allen@qmul.ac.uk	Allen, John/K-6309-2019; Puthiyaveetil, Sujith/S-3098-2016	Allen, John/0000-0002-0950-0429; Puthiyaveetil, Sujith/0000-0001-7505-4511; Santabarbara, Stefano/0000-0002-7993-2614	Leverhulme Trust [F/07 476/AQ, ECF/2009/0180]	Leverhulme Trust(Leverhulme Trust)	The Leverhulme Trust, Research Grant F/07 476/AQ (http://www.leverhulme.ac.uk/); The Leverhulme Trust, Early Career Research Fellowship ECF/2009/0180 (http://www.leverhulme.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen J.F., 2008, PHOTOSYNTHESIS ENERG, P1155; Allen JF, 2000, PHILOS T R SOC B, V355, P1351, DOI 10.1098/rstb.2000.0697; ALLEN JF, 1981, FEBS LETT, V123, P67, DOI 10.1016/0014-5793(81)80021-X; ALLEN JF, 1993, FEBS LETT, V332, P203, DOI 10.1016/0014-5793(93)80631-4; ALLEN JF, 1989, PHOTOSYNTH RES, V22, P157, DOI 10.1007/BF00034860; ALLEN JF, 1981, NATURE, V291, P25, DOI 10.1038/291025a0; Allen JF, 2001, TRENDS PLANT SCI, V6, P317, DOI 10.1016/S1360-1385(01)02010-6; ALLEN JF, 1983, TRENDS BIOCHEM SCI, V8, P369, DOI 10.1016/0968-0004(83)90364-X; Allen JF, 2003, SCIENCE, V299, P1530, DOI 10.1126/science.1082833; ALLEN JF, 1992, BIOCHIM BIOPHYS ACTA, V1098, P275, DOI 10.1016/S0005-2728(09)91014-3; ALLEN JF, 2011, TRENDS PLAN IN PRESS; ANDERSSON B, 1982, FEBS LETT, V149, P181, DOI 10.1016/0014-5793(82)81097-1; [Anonymous], 2002, PHOTOSYNTHETICA; Baginsky S, 1999, PLANT MOL BIOL, V39, P1013, DOI 10.1023/A:1006177807844; Bauer C, 2003, PHILOS T R SOC B, V358, P147, DOI 10.1098/rstb.2002.1189; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; BENNETT J, 1977, NATURE, V269, P344, DOI 10.1038/269344a0; BENNETT J, 1980, EUR J BIOCHEM, V104, P85, DOI 10.1111/j.1432-1033.1980.tb04403.x; BENNETT J, 1979, EUR J BIOCHEM, V99, P133, DOI 10.1111/j.1432-1033.1979.tb13239.x; Bjorn LO, 2009, CURR SCI INDIA, V96, P1466; Bonardi V, 2005, NATURE, V437, P1179, DOI 10.1038/nature04016; BONAVENTURA C, 1969, BIOCHIM BIOPHYS ACTA, V189, P366, DOI 10.1016/0005-2728(69)90168-6; CHOW WS, 1990, P NATL ACAD SCI USA, V87, P7502, DOI 10.1073/pnas.87.19.7502; Depege N, 2003, SCIENCE, V299, P1572, DOI 10.1126/science.1081397; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; GRAY MW, 1992, INT REV CYTOL, V141, P233, DOI 10.1016/S0074-7696(08)62068-9; HARRISON MA, 1991, BIOCHIM BIOPHYS ACTA, V1058, P289, DOI 10.1016/S0005-2728(05)80249-X; HILL R, 1960, NATURE, V186, P136, DOI 10.1038/186136a0; KRAUSE GH, 1983, BIOCHIM BIOPHYS ACTA, V723, P176, DOI 10.1016/0005-2728(83)90117-2; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; KRAUSE GH, 1983, BIOCHIM BIOPHYS ACTA, V723, P169, DOI 10.1016/0005-2728(83)90116-0; LARSSON UK, 1983, EUR J BIOCHEM, V136, P25, DOI 10.1111/j.1432-1033.1983.tb07700.x; Lemeille S, 2010, PHOTOSYNTH RES, V106, P33, DOI 10.1007/s11120-010-9538-8; Li H, 2000, J BACTERIOL, V182, P4268, DOI 10.1128/JB.182.15.4268-4277.2000; Link G, 2003, ANTIOXID REDOX SIGN, V5, P79, DOI 10.1089/152308603321223568; Martin W, 2002, P NATL ACAD SCI USA, V99, P12246, DOI 10.1073/pnas.182432999; MELIS A, 1989, Z NATURFORSCH C, V44, P109; MULLINEAUX CW, 1990, PHOTOSYNTH RES, V23, P297, DOI 10.1007/BF00034860; MULLINEAUX CW, 1986, FEBS LETT, V205, P155, DOI 10.1016/0014-5793(86)80885-7; Murakami A, 1997, PLANT CELL PHYSIOL, V38, P392, DOI 10.1093/oxfordjournals.pcp.a029181; MURATA N, 1969, BIOCHIM BIOPHYS ACTA, V172, P242, DOI 10.1016/0005-2728(69)90067-X; MYERS J, 1971, ANN REV PLANT PHYSIO, V22, P289, DOI 10.1146/annurev.pp.22.060171.001445; Pesaresi P., 2010, BIOCHIM BIOPHYS ACTA, V1807, P887; Pesaresi P, 2009, PLANT CELL, V21, P2402, DOI 10.1105/tpc.108.064964; Pfannschmidt T, 1999, IUBMB LIFE, V48, P271, DOI 10.1080/713803507; Pfannschmidt T, 1999, NATURE, V397, P625, DOI 10.1038/17624; Pfannschmidt T, 2003, TRENDS PLANT SCI, V8, P33, DOI 10.1016/S1360-1385(02)00005-5; Pribil M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000288; PUTHIYAVEETIL S, 2011, PLANT CELL IN PRESS; Puthiyaveetil S, 2008, P NATL ACAD SCI USA, V105, P10061, DOI 10.1073/pnas.0803928105; Puthiyaveetil S, 2008, BIOCHEM BIOPH RES CO, V368, P871, DOI 10.1016/j.bbrc.2008.01.167; Puthiyaveetil S, 2011, FEBS LETT, V585, P1717, DOI 10.1016/j.febslet.2011.04.076; Puthiyaveetil S, 2010, GENOME BIOL EVOL, V2, P888, DOI 10.1093/gbe/evq073; Puthiyaveetil S, 2009, P ROY SOC B-BIOL SCI, V276, P2133, DOI 10.1098/rspb.2008.1426; Raven JA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-209; Rochaix J, 2007, FEBS J, V274, P26; Schweer J, 2010, PLANT J, V62, P192, DOI 10.1111/j.1365-313X.2010.04138.x; Shapiguzov A, 2010, P NATL ACAD SCI USA, V107, P4782, DOI 10.1073/pnas.0913810107; Shimizu M, 2010, P NATL ACAD SCI USA, V107, P10760, DOI 10.1073/pnas.0911692107; SILVERSTEIN T, 1993, FEBS LETT, V334, P101, DOI 10.1016/0014-5793(93)81690-2; TELFER A, 1983, BIOCHIM BIOPHYS ACTA, V722, P176, DOI 10.1016/0005-2728(83)90171-8; Tullberg A, 2000, PLANT CELL PHYSIOL, V41, P1045, DOI 10.1093/pcp/pcd031; Vener AV, 1997, P NATL ACAD SCI USA, V94, P1585, DOI 10.1073/pnas.94.4.1585; WILLIAMS WP, 1987, PHOTOSYNTH RES, V13, P19, DOI 10.1007/BF00032263; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Wuichet K, 2010, CURR OPIN MICROBIOL, V13, P219, DOI 10.1016/j.mib.2009.12.011; Zito F, 1999, EMBO J, V18, P2961, DOI 10.1093/emboj/18.11.2961	67	24	27	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26372	10.1371/journal.pone.0026372	http://dx.doi.org/10.1371/journal.pone.0026372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039472	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500057
J	Berg, JS; Lin, KK; Sonnet, C; Boles, NC; Weksberg, DC; Nguyen, H; Holt, LJ; Rickwood, D; Daly, RJ; Goodell, MA				Berg, Jonathan S.; Lin, Kuanyin K.; Sonnet, Corinne; Boles, Nathan C.; Weksberg, David C.; Hoang Nguyen; Holt, Lowenna J.; Rickwood, Danny; Daly, Roger J.; Goodell, Margaret A.			Imprinted Genes That Regulate Early Mammalian Growth Are Coexpressed in Somatic Stem Cells	PLOS ONE			English	Article							HEMATOPOIETIC STEM; ADULT STEM; MOLECULAR SIGNATURE; PROGENITOR CELLS; NONCODING RNA; EXPRESSION; IDENTIFICATION; ACTIVATION; H19; P53	Lifelong, many somatic tissues are replenished by specialized adult stem cells. These stem cells are generally rare, infrequently dividing, occupy a unique niche, and can rapidly respond to injury to maintain a steady tissue size. Despite these commonalities, few shared regulatory mechanisms have been identified. Here, we scrutinized data comparing genes expressed in murine long-term hematopoietic stem cells with their differentiated counterparts and observed that a disproportionate number were members of the developmentally-important, monoallelically expressed imprinted genes. Studying a subset, which are members of a purported imprinted gene network (IGN), we found their expression in HSCs rapidly altered upon hematopoietic perturbations. These imprinted genes were also predominantly expressed in stem/progenitor cells of the adult epidermis and skeletal muscle in mice, relative to their differentiated counterparts. The parallel down-regulation of these genes postnatally in response to proliferation and differentiation suggests that the IGN could play a mechanistic role in both cell growth and tissue homeostasis.	[Berg, Jonathan S.; Weksberg, David C.; Goodell, Margaret A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Lin, Kuanyin K.; Sonnet, Corinne; Hoang Nguyen; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Boles, Nathan C.; Goodell, Margaret A.] Baylor Coll Med, Interdept Program Cell & Mol Biol, Houston, TX 77030 USA; [Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Holt, Lowenna J.] Garvan Inst Med Res, Diabet & Obes Res Program, Sydney, NSW, Australia; [Rickwood, Danny; Daly, Roger J.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Garvan Institute of Medical Research; Garvan Institute of Medical Research	Berg, JS (corresponding author), Univ N Carolina, Dept Genet, Chapel Hill, NC 27515 USA.	goodell@bcm.edu		Goodell, Margaret A./0000-0003-1111-2932; Holt, Lowenna/0000-0002-4703-9696; Daly, Roger/0000-0002-5739-8027; Berg, Jonathan/0000-0003-2360-2664	National Institutes of Health [HL086223, DK58192, AG034451, DK060445, EB005173, P50CA126752, 1RC2AG036562]; NATIONAL CANCER INSTITUTE [P30CA125123, P50CA126752] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL086223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059122] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK060445, R01DK058192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [RC2AG036562, R21AG034451] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the National Institutes of Health (HL086223 to Dr. Berg and DK58192, AG034451, and DK060445 to Dr. Goodell, and EB005173, P50CA126752, and 1RC2AG036562). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beaudet AL, 2002, AM J HUM GENET, V70, P1389, DOI 10.1086/340969; Besson V, 2011, P NATL ACAD SCI USA, V108, P11470, DOI 10.1073/pnas.1103873108; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Cai XZ, 2007, RNA, V13, P313, DOI 10.1261/rna.351707; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Feng CG, 2008, CELL STEM CELL, V2, P83, DOI 10.1016/j.stem.2007.10.007; Finkielstain GP, 2009, ENDOCRINOLOGY, V150, P1791, DOI 10.1210/en.2008-0868; Fortunel NO, 2003, SCIENCE, V302, P393; Frazer KA, 2007, NATURE, V448, P1050, DOI 10.1038/nature06067; Gabory A, 2009, DEVELOPMENT, V136, P3413, DOI 10.1242/dev.036061; Hernandez L, 2003, P NATL ACAD SCI USA, V100, P13344, DOI 10.1073/pnas.2234026100; Holm TM, 2005, CANCER CELL, V8, P275, DOI 10.1016/j.ccr.2005.09.007; Huang SM, 2001, ONCOGENE, V20, P2134, DOI 10.1038/sj.onc.1204298; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jiang YH, 2004, ANNU REV GENOM HUM G, V5, P479, DOI 10.1146/annurev.genom.5.061903.180014; KANEKOISHINO T, 1995, NAT GENET, V11, P52, DOI 10.1038/ng0995-52; Kernohan KD, 2010, DEV CELL, V18, P191, DOI 10.1016/j.devcel.2009.12.017; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KING KY, 2011, BLOOD; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Kubota Y, 2009, BLOOD, V114, P4383, DOI 10.1182/blood-2009-07-230292; Lavker RM, 2000, P NATL ACAD SCI USA, V97, P13473, DOI 10.1073/pnas.250380097; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lui JC, 2008, AM J PHYSIOL-REG I, V295, pR189, DOI 10.1152/ajpregu.00182.2008; Majetl R, 2009, P NATL ACAD SCI USA, V106, P3396, DOI 10.1073/pnas.0900089106; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Nunez C, 2000, J PATHOL, V190, P61, DOI 10.1002/(SICI)1096-9896(200001)190:1<61::AID-PATH502>3.0.CO;2-#; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Pantoja C, 2005, CANCER RES, V65, P26; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Relaix F, 2000, P NATL ACAD SCI USA, V97, P2105, DOI 10.1073/pnas.040378897; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sakajiri S, 2005, LEUKEMIA, V19, P1404, DOI 10.1038/sj.leu.2403832; Sandhu KS, 2009, GENE DEV, V23, P2598, DOI 10.1101/gad.552109; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Scandura JM, 2004, P NATL ACAD SCI USA, V101, P15231, DOI 10.1073/pnas.0406771101; Schulz R, 2008, EPIGENETICS-US, V3, P89, DOI 10.4161/epi.3.2.5900; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; SZABO PE, 1995, GENE DEV, V9, P1857, DOI 10.1101/gad.9.15.1857; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Tessema M, 2005, INT J ONCOL, V26, P499; Tycko B, 2002, J CELL PHYSIOL, V192, P245, DOI 10.1002/jcp.10129; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wood AJ, 2006, PLOS GENET, V2, P1677, DOI 10.1371/journal.pgen.0020147; Wu Q, 2008, J REPROD DEVELOP, V54, P177, DOI 10.1262/jrd.19146; Yan Z, 2003, J BIOL CHEM, V278, P8826, DOI 10.1074/jbc.M209879200; ZACHAREK SJ, 2011, CELL STEM C IN PRESS, P1; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zhou Y, 2007, J BIOL CHEM, V282, P24731, DOI 10.1074/jbc.M702029200	63	57	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26410	10.1371/journal.pone.0026410	http://dx.doi.org/10.1371/journal.pone.0026410			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039481	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500063
J	Gredeback, G; Melinder, A				Gredeback, Gustaf; Melinder, Annika			Teleological Reasoning in 4-Month-Old Infants: Pupil Dilations and Contextual Constraints	PLOS ONE			English	Article							GOAL; PERCEPTION	Four-month-old infants were presented with feeding actions performed in a rational or irrational manner. Infants reacted to the irrational feeding actions by dilating their pupils, but only in the presence of rich contextual constraints. The study demonstrates that teleological processes are online at 4 months of age and illustrates the usefulness of pupil dilations as a measure of social cognitive processes early in infancy.	[Gredeback, Gustaf] Uppsala Univ, Dept Psychol, Uppsala, Sweden; [Melinder, Annika] Univ Oslo, Dept Psychol, Oslo, Norway	Uppsala University; University of Oslo	Gredeback, G (corresponding author), Uppsala Univ, Dept Psychol, Uppsala, Sweden.	gustaf.gredeback@psyk.uu.se	Melinder, Annika/L-6782-2016; Gredebäck, Gustaf/C-1676-2009	Melinder, Annika/0000-0001-7773-0579; Gredebäck, Gustaf/0000-0003-3046-0043	Norwegian Directorate for Children, Youth and Family Affairs [06/34707]; Marie-Curie ITN RobotDoc	Norwegian Directorate for Children, Youth and Family Affairs; Marie-Curie ITN RobotDoc	The study was supported by grants from the Norwegian Directorate for Children, Youth and Family Affairs (06/34707) and Marie-Curie ITN RobotDoc (2010-2013). http://www.sv.uio.no/psi/forskning/grupper/ekup/. www.robotdoc.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin DA, 2001, TRENDS COGN SCI, V5, P171, DOI 10.1016/S1364-6613(00)01615-6; Craighero L, 2011, COGNITION, V120, P26, DOI 10.1016/j.cognition.2011.02.011; Csibra G, 2008, COGNITION, V107, P705, DOI 10.1016/j.cognition.2007.08.001; Csibra G, 2007, ACTA PSYCHOL, V124, P60, DOI 10.1016/j.actpsy.2006.09.007; D'Entremont B, 2000, DEVELOPMENTAL SCI, V3, P302, DOI 10.1111/1467-7687.00124; Daum MM, 2011, EXP BRAIN RES, V208, P297, DOI 10.1007/s00221-010-2479-9; Dionisio DP, 2001, PSYCHOPHYSIOLOGY, V38, P205, DOI 10.1017/S0048577201990717; Falck-Ytter T, 2008, AUTISM RES, V1, P297, DOI 10.1002/aur.45; Farroni T, 2002, P NATL ACAD SCI USA, V99, P9602, DOI 10.1073/pnas.152159999; Farroni T, 2007, EUR J DEV PSYCHOL, V4, P2, DOI 10.1080/17405620601046832; Gergely G, 2003, TRENDS COGN SCI, V7, P287, DOI 10.1016/S1364-6613(03)00128-1; GREDEBACK G, INFANCY IN PRESS; Gredeback G, 2010, DEVELOPMENTAL SCI, V13, P839, DOI 10.1111/j.1467-7687.2009.00945.x; Gredeback G, 2010, COGNITION, V114, P197, DOI 10.1016/j.cognition.2009.09.004; Gredeback G, 2009, DEV PSYCHOL, V45, P1190, DOI 10.1037/a0015667; Hamlin JK, 2010, DEVELOPMENTAL SCI, V13, P923, DOI 10.1111/j.1467-7687.2010.00951.x; Hespos SJ, 2009, DEV PSYCHOL, V45, P575, DOI 10.1037/a0014145; Jackson I, 2009, DEVELOPMENTAL SCI, V12, P670, DOI 10.1111/j.1467-7687.2008.00805.x; Kamewari K, 2005, COGNITIVE DEV, V20, P303, DOI 10.1016/j.cogdev.2005.04.004; Kochukhova O, 2010, CHILD DEV, V81, P1729, DOI 10.1111/j.1467-8624.2010.01506.x; LAENG B, PERSPECTIVE IN PRESS; Luo Y, 2005, PSYCHOL SCI, V16, P601, DOI 10.1111/j.1467-9280.2005.01582.x; RUFFMAN T, BRIT J DEV IN PRESS; Saylor MM, 2007, J COGN DEV, V8, P113, DOI 10.1207/s15327647jcd0801_6; Sommerville JA, 2005, COGNITION, V96, pB1, DOI 10.1016/j.cognition.2004.07.004; Spelke ES, 2007, DEVELOPMENTAL SCI, V10, P89, DOI 10.1111/j.1467-7687.2007.00569.x; Vo MLH, 2008, PSYCHOPHYSIOLOGY, V45, P130, DOI 10.1111/j.1469-8986.2007.00606.x; WINN B, 1994, INVEST OPHTH VIS SCI, V35, P1132	28	23	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26487	10.1371/journal.pone.0026487	http://dx.doi.org/10.1371/journal.pone.0026487			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841JB	22039499	Green Published, gold			2022-12-27	WOS:000296507500077
J	Liu, M; Gao, H; Shang, P; Zhou, XL; Ashforth, E; Zhuo, Y; Chen, DF; Ren, BA; Liu, ZH; Zhang, LX				Liu, Mei; Gao, Hong; Shang, Peng; Zhou, Xianlong; Ashforth, Elizabeth; Zhuo, Ying; Chen, Difei; Ren, Biao; Liu, Zhiheng; Zhang, Lixin			Magnetic Field Is the Dominant Factor to Induce the Response of Streptomyces avermitilis in Altered Gravity Simulated by Diamagnetic Levitation	PLOS ONE			English	Article							ESCHERICHIA-COLI; GENE-EXPRESSION; GROWTH; MICROGRAVITY; COELICOLOR	Background: Diamagnetic levitation is a technique that uses a strong, spatially varying magnetic field to simulate an altered gravity environment, as in space. In this study, using Streptomyces avermitilis as the test organism, we investigate whether changes in magnetic field and altered gravity induce changes in morphology and secondary metabolism. We find that a strong magnetic field (12T) inhibit the morphological development of S. avermitilis in solid culture, and increase the production of secondary metabolites. Methodology/Principal Findings: S. avermitilis on solid medium was levitated at 0 g*, 1 g* and 2 g* in an altered gravity environment simulated by diamagnetic levitation and under a strong magnetic field, denoted by the asterix. The morphology was obtained by electromicroscopy. The production of the secondary metabolite, avermectin, was determined by OD245 nm. The results showed that diamagnetic levitation could induce a physiological response in S. avermitilis. The difference between 1 g* and the control group grown without the strong magnetic field (1 g), showed that the magnetic field was a more dominant factor influencing changes in morphology and secondary metabolite production, than altered gravity. Conclusion/Significance: We have discovered that magnetic field, rather than altered gravity, is the dominant factor in altered gravity simulated by diamagnetic levitation, therefore care should to be taken in the interpretation of results when using diamagnetic levitation as a technique to simulate altered gravity. Hence, these results are significant, and timely to researchers considering the use of diamagnetic levitation to explore effects of weightlessness on living organisms and on physical phenomena.	[Liu, Mei; Gao, Hong; Zhou, Xianlong; Ashforth, Elizabeth; Zhuo, Ying; Chen, Difei; Ren, Biao; Liu, Zhiheng; Zhang, Lixin] Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China; [Liu, Mei; Zhuo, Ying; Chen, Difei] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China; [Shang, Peng] Northwestern Polytech Univ, Fac Life Sci, Key Lab Space Biosci & Biotechnol, Xian 710072, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Liu, M (corresponding author), Chinese Acad Sci, Inst Microbiol, Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.	Zhanglixin@im.ac.cn	Ren, Biao/P-1067-2015	Ren, Biao/0000-0003-4215-2873; Gao, Hong/0000-0002-8544-7826; Zhang, Lixin/0000-0003-0894-9520	National Natural Science Foundation of China [31000057]; 973 Program [2012CB721000]; National Key Technology RD Program [2007BAI26B02]; Key Project of International Cooperation [2007DFB31620]; National Science & Technology Pillar Program [200703295000-02]; Important National Science & Technology Specific Projects [2008ZX09401-005]; Hundred Talents Program	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); National Key Technology RD Program(National Key Technology R&D Program); Key Project of International Cooperation; National Science & Technology Pillar Program; Important National Science & Technology Specific Projects; Hundred Talents Program(Chinese Academy of Sciences)	This work was supported in part by a grant from National Natural Science Foundation of China (No. 31000057), 973 Program (No. 2012CB721000), National Key Technology R&D Program 2007BAI26B02, Key Project of International Cooperation (2007DFB31620), the National Science & Technology Pillar Program (No. 200703295000-02), Important National Science & Technology Specific Projects (No. 2008ZX09401-005). LZ received funding from the Hundred Talents Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beuls E, 2009, ASTROBIOLOGY, V9, P797, DOI 10.1089/ast.2009.0383; Coleman CB, 2007, BIOTECHNOL BIOENG, V98, P854, DOI 10.1002/bit.21526; Dijkstra CE, 2011, J R SOC INTERFACE, V8, P334, DOI 10.1098/rsif.2010.0294; Fang A, 2000, APPL MICROBIOL BIOT, V54, P33, DOI 10.1007/s002539900303; Gao H, 2010, APPL ENVIRON MICROB, V76, P4583, DOI 10.1128/AEM.01682-09; Gao H, 2010, APPL MICROBIOL BIOT, V85, P1219, DOI 10.1007/s00253-009-2345-5; Gao H, 2009, BIORESOURCE TECHNOL, V100, P4012, DOI 10.1016/j.biortech.2009.03.013; Guevorkian K, 2006, P NATL ACAD SCI USA, V103, P13051, DOI 10.1073/pnas.0601839103; Hejnowicz Z, 1998, PLANT CELL ENVIRON, V21, P1293, DOI 10.1046/j.1365-3040.1998.00375.x; Ikehata M, 1999, MUTAT RES-FUND MOL M, V427, P147, DOI 10.1016/S0027-5107(99)00087-1; Iwasaka M, 2004, BIOELECTROCHEMISTRY, V65, P59, DOI 10.1016/j.bioelechem.2004.04.002; Ji YL, 2010, BIORESOURCE TECHNOL, V101, P8535, DOI 10.1016/j.biortech.2010.05.094; Kuznetsov OA, 1996, PLANTA, V198, P87; Lewis RA, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-682; Liu YM, 2010, ADV SPACE RES, V45, P208, DOI 10.1016/j.asr.2009.08.033; Qi F, 2011, APPL BIOCHEM BIOTECH, V163, P162, DOI 10.1007/s12010-010-9025-x; Qian AR, 2009, IEEE T APPL SUPERCON, V19, P42, DOI 10.1109/TASC.2009.2012422; Valles JM, 1997, BIOPHYS J, V73, P1130, DOI 10.1016/S0006-3495(97)78145-1; VALLES JM, 2002, J GRAVIT PHYSL, V9, P11; Viollier PH, 2003, MOL MICROBIOL, V47, P699, DOI 10.1046/j.1365-2958.2003.03302.x; Wakayama NI, 2006, ANN NY ACAD SCI, V1077, P184, DOI 10.1196/annals.1362.024; Wang CX, 2010, MICROBIOL RES, V165, P221, DOI 10.1016/j.micres.2009.05.003; Wilson JW, 2007, P NATL ACAD SCI USA, V104, P16299, DOI 10.1073/pnas.0707155104; Zhang QM, 2003, INT J RADIAT BIOL, V79, P281, DOI 10.1080/0955300031000096289; Zhang SF, 2002, ANALYST, V127, P373, DOI 10.1039/b109617f	25	18	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e24697	10.1371/journal.pone.0024697	http://dx.doi.org/10.1371/journal.pone.0024697			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039402	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500003
J	Ando, T; Xuan, WJ; Xu, T; Dai, TH; Sharma, SK; Kharkwal, GB; Huang, YY; Wu, QH; Whalen, MJ; Sato, S; Obara, M; Hamblin, MR				Ando, Takahiro; Xuan, Weijun; Xu, Tao; Dai, Tianhong; Sharma, Sulbha K.; Kharkwal, Gitika B.; Huang, Ying-Ying; Wu, Qiuhe; Whalen, Michael J.; Sato, Shunichi; Obara, Minoru; Hamblin, Michael R.			Comparison of Therapeutic Effects between Pulsed and Continuous Wave 810-nm Wavelength Laser Irradiation for Traumatic Brain Injury in Mice	PLOS ONE			English	Article							CONTROLLED CORTICAL IMPACT; HELIUM-NEON LASER; TERM NEUROLOGICAL DEFICITS; LEVEL LIGHT THERAPY; CLOSED-HEAD INJURY; SPINAL-CORD-INJURY; PROMOTES REGENERATION; FUNCTIONAL RECOVERY; MEMORY PERFORMANCE; ISCHEMIC-STROKE	Background and Objective: Transcranial low-level laser therapy (LLLT) using near-infrared light can efficiently penetrate through the scalp and skull and could allow non-invasive treatment for traumatic brain injury (TBI). In the present study, we compared the therapeutic effect using 810-nm wavelength laser light in continuous and pulsed wave modes in a mouse model of TBI. Study Design/Materials and Methods: TBI was induced by a controlled cortical-impact device and 4-hours post-TBI 1-group received a sham treatment and 3-groups received a single exposure to transcranial LLLT, either continuous wave or pulsed at 10-Hz or 100-Hz with a 50% duty cycle. An 810-nm Ga-Al-As diode laser delivered a spot with diameter of 1-cm onto the injured head with a power density of 50-mW/cm(2) for 12-minutes giving a fluence of 36-J/cm(2). Neurological severity score (NSS) and body weight were measured up to 4 weeks. Mice were sacrificed at 2, 15 and 28 days post-TBI and the lesion size was histologically analyzed. The quantity of ATP production in the brain tissue was determined immediately after laser irradiation. We examined the role of LLLT on the psychological state of the mice at 1 day and 4 weeks after TBI using tail suspension test and forced swim test. Results: The 810-nm laser pulsed at 10-Hz was the most effective judged by improvement in NSS and body weight although the other laser regimens were also effective. The brain lesion volume of mice treated with 10-Hz pulsed-laser irradiation was significantly lower than control group at 15-days and 4-weeks post-TBI. Moreover, we found an antidepressant effect of LLLT at 4-weeks as shown by forced swim and tail suspension tests. Conclusion: The therapeutic effect of LLLT for TBI with an 810-nm laser was more effective at 10-Hz pulse frequency than at CW and 100-Hz. This finding may provide a new insight into biological mechanisms of LLLT.	[Ando, Takahiro; Xuan, Weijun; Xu, Tao; Dai, Tianhong; Sharma, Sulbha K.; Kharkwal, Gitika B.; Huang, Ying-Ying; Wu, Qiuhe; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Ando, Takahiro; Obara, Minoru] Keio Univ, Dept Elect & Elect Engn, Yokohama, Kanagawa 223, Japan; [Xuan, Weijun; Xu, Tao; Dai, Tianhong; Kharkwal, Gitika B.; Huang, Ying-Ying; Wu, Qiuhe; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Xuan, Weijun] Tradit Chinese Med Univ Guangxi, Dept Otolaryngol, Nanning, Peoples R China; [Xu, Tao] Shanghai Jiao Tong Univ, Lab Anesthesiol, Shanghai 200030, Peoples R China; [Huang, Ying-Ying] Guangxi Med Univ, Aesthet & Plast Ctr, Nanning, Peoples R China; [Wu, Qiuhe] Shandong Univ, Jinan Cent Hosp, Dept Burns & Plast Surg, Jinan 250100, Peoples R China; [Whalen, Michael J.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Sato, Shunichi] Natl Def Med Coll, Res Inst, Div Biomed Informat Sci, Tokorozawa, Saitama 359, Japan; [Hamblin, Michael R.] Harvard Univ, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Keio University; Harvard University; Harvard Medical School; Shanghai Jiao Tong University; Guangxi Medical University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Harvard University; Massachusetts General Hospital; National Defense Medical College - Japan; Harvard University	Ando, T (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	hamblin@helix.mgh.harvard.edu	Ando, Takahiro/R-8374-2019; Huang, Ying-ying/G-3153-2011; Hamblin, Mike/AAB-2511-2022; Hamblin, Michael R/H-2758-2019; Dai, Tianhong/P-5961-2018; Ando, Takahiro/H-5209-2019; Huang, yingying/J-7329-2012	Huang, Ying-ying/0000-0003-3066-6981; Hamblin, Michael R/0000-0001-6431-4605; Dai, Tianhong/0000-0001-8960-8896; Huang, yingying/0000-0002-4038-0277; Xu, Tao/0000-0001-5868-4079	National Institutes of Health (NIH) [R01AI050875]; Center for Integration of Medicine and Innovative Technology [DAMD17-02-2-0006]; Congressionally Directed Medical Research Program in Traumatic Brain Injury [W81XWH-09-1-0514]; Air Force Office of Scientific Research [FA9950-04-1-0079]; Ministry of Education, Culture, Sport, Science and Technology, Japan; Japan Society for the Promotion of Science (JSPS); Grants-in-Aid for Scientific Research [10J04881] Funding Source: KAKEN; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Integration of Medicine and Innovative Technology; Congressionally Directed Medical Research Program in Traumatic Brain Injury; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Ministry of Education, Culture, Sport, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by National Institutes of Health (NIH) grant R01AI050875 (to Dr. Hamblin), Center for Integration of Medicine and Innovative Technology (DAMD17-02-2-0006), Congressionally Directed Medical Research Program in Traumatic Brain Injury (W81XWH-09-1-0514) and Air Force Office of Scientific Research Military Photomedicine Program (FA9950-04-1-0079). Dr. Ando was supported in part by a Grant-in-Aid for the Global Center of Excellence for High-Level Global Cooperation for Leading-Edge Platform on Access Spaces from the Ministry of Education, Culture, Sport, Science and Technology, Japan, and a Grant-in-Aid for Research Fellows of the Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEY KO, 1989, N-S ARCH PHARMACOL, V339, P306; ANDERS JJ, 1993, LASER SURG MED, V13, P72, DOI 10.1002/lsm.1900130113; Anders JJ, 2004, NEUROL RES, V26, P233, DOI 10.1179/016164104225013914; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brondon P, 2009, LASER SURG MED, V41, P222, DOI 10.1002/lsm.20740; Byrnes KR, 2005, LASER SURG MED, V36, P171, DOI 10.1002/lsm.20143; Castro-e-Silva O, 2003, LASER SURG MED, V32, P50, DOI 10.1002/lsm.10141; Davis PJ, 2007, METHODS NUMERICAL IN, Vxii, P612; DeTaboada L, 2006, LASER SURG MED, V38, P70, DOI 10.1002/lsm.20256; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Finkelstein E., 2006, INCIDENCE EC BURDEN, DOI [10.1093/acprof:oso/9780195179484.001.0001, DOI 10.1093/ACPROF:OSO/9780195179484.001.0001]; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; GREEN JD, 1954, J NEUROPHYSIOL, V17, P533, DOI 10.1152/jn.1954.17.6.533; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003437.pub3; Hashmi JT, 2010, LASER SURG MED, V42, P450, DOI 10.1002/lsm.20950; Hu WP, 2007, J INVEST DERMATOL, V127, P2048, DOI 10.1038/sj.jid.5700826; Huang L, 2011, J CELL PHYSIOL, V226, P588, DOI 10.1002/jcp.22367; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Ilic S, 2006, PHOTOMED LASER SURG, V24, P458, DOI 10.1089/pho.2006.24.458; Karu T, 1999, J PHOTOCH PHOTOBIO B, V49, P1, DOI 10.1016/S1011-1344(98)00219-X; Karu T, 1998, SCI LOW OWER LASER T; Karu TI, 2005, LASER SURG MED, V36, P307, DOI 10.1002/lsm.20148; Kharkwal GB, 2011, P SPIE; Kymplova J, 2003, J CLIN LASER MED SUR, V21, P35, DOI 10.1089/10445470360516725; Lampl Y, 2007, STROKE, V38, P1843, DOI 10.1161/STROKEAHA.106.478230; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Lapchak PA, 2008, STROKE, V39, P3073, DOI 10.1161/STROKEAHA.108.516393; Lapchak PA, 2010, ANN MED, V42, P576, DOI 10.3109/07853890.2010.532811; Lapchak PA, 2010, BRAIN RES, V1306, P100, DOI 10.1016/j.brainres.2009.10.022; Lin F, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-16; Lucki I, 2001, PSYCHOPHARMACOLOGY, V155, P315, DOI 10.1007/s002130100694; Marion DW, 1998, NEUROL CLIN, V16, P485, DOI 10.1016/S0733-8619(05)70073-6; Mayorga AJ, 2001, J PHARMACOL EXP THER, V298, P1101; McMarthy T, 2011, P SPIE; Michalikova S, 2008, NEUROBIOL LEARN MEM, V89, P480, DOI 10.1016/j.nlm.2007.07.014; Mochizuki-Oda N, 2002, NEUROSCI LETT, V323, P207, DOI 10.1016/S0304-3940(02)00159-3; Oron A, 2007, J NEUROTRAUM, V24, P651, DOI 10.1089/neu.2006.0198; Oron A, 2006, STROKE, V37, P2620, DOI 10.1161/01.STR.0000242775.14642.b8; PASSARELLA S, 1984, FEBS LETT, V175, P95, DOI 10.1016/0014-5793(84)80577-3; Pastore D, 1996, BIOCHEM MOL BIOL INT, V39, P149; Porsolt RD, 2000, REV NEUROSCIENCE, V11, P53; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; PRIESTLEY T, 1994, MOL PHARMACOL, V46, P1191; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Sauerbeck A, 2011, EXP NEUROL, V227, P128, DOI 10.1016/j.expneurol.2010.10.003; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Sushko B S, 2007, Fiziol Zh, V53, P51; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Ueda Y, 2003, J CLIN LASER MED SUR, V21, P271, DOI 10.1089/104454703322564479; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; Walker PA, 2009, DIS MODEL MECH, V2, P23, DOI 10.1242/dmm.001198; WINSON J, 1972, BEHAV BIOL, V7, P479, DOI 10.1016/S0091-6773(72)80210-4; Wong-Riley MTT, 2005, J BIOL CHEM, V280, P4761, DOI 10.1074/jbc.M409650200; Wu Q, 2010, P SPIE; Wu SN, 2009, J CELL PHYSIOL, V218, P603, DOI 10.1002/jcp.21636; Wu XJ, 2009, LASER SURG MED, V41, P36, DOI 10.1002/lsm.20729; Zhang Q, 2000, J BIOMED OPT, V5, P206, DOI 10.1117/1.429988	67	109	111	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26212	10.1371/journal.pone.0026212	http://dx.doi.org/10.1371/journal.pone.0026212			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028832	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900034
J	Becerra, L; Pendse, G; Chang, PC; Bishop, J; Borsook, D				Becerra, Lino; Pendse, Gautam; Chang, Pei-Ching; Bishop, James; Borsook, David			Robust Reproducible Resting State Networks in the Awake Rodent Brain	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; BOLD SIGNAL FLUCTUATIONS; FUNCTIONAL CONNECTIVITY; SPATIOTEMPORAL DYNAMICS; INSULAR CORTEX; DEFAULT MODE; FREQUENCY; RATS; ORGANIZATION; INTEROCEPTION	Resting state networks (RSNs) have been studied extensively with functional MRI in humans in health and disease to reflect brain function in the un-stimulated state as well as reveal how the brain is altered with disease. Rodent models of disease have been used comprehensively to understand the biology of the disease as well as in the development of new therapies. RSN reported studies in rodents, however, are few, and most studies are performed with anesthetized rodents that might alter networks and differ from their non-anesthetized state. Acquiring RSN data in the awake rodent avoids the issues of anesthesia effects on brain function. Using high field fMRI we determined RSNs in awake rats using an independent component analysis (ICA) approach, however, ICA analysis can produce a large number of components, some with biological relevance (networks). We further have applied a novel method to determine networks that are robust and reproducible among all the components found with ICA. This analysis indicates that 7 networks are robust and reproducible in the rat and their putative role is discussed.	[Becerra, Lino; Pendse, Gautam; Chang, Pei-Ching; Bishop, James; Borsook, David] Massachusetts Gen Hosp, Pain & Analgesia Imaging Neurosci Grp, AA Martinos Ctr Biomed Imaging, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Becerra, L (corresponding author), Massachusetts Gen Hosp, Pain & Analgesia Imaging Neurosci Grp, AA Martinos Ctr Biomed Imaging, Boston, MA 02114 USA.	becerra@nmr.mgh.harvard.edu	Håkansson, Gustaf/F-5409-2011		National Institute of Drug Abuse [K24NS064050-DB]; Herlands Fund for Pain Research; National Center For Research Resources [S10RR031599, 1S10RR023401, 1S10RR019307, 1S10RR023043]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031599, S10RR019307, S10RR023043, S10RR023401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS064050] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Herlands Fund for Pain Research; National Center For Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by National Institute of Drug Abuse (grant number K24NS064050-DB) and The Herlands Fund for Pain Research (DB, LB). The project described was supported by Award Numbers S10RR031599, 1S10RR023401, 1S10RR019307, and 1S10RR023043 from the National Center For Research Resources. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center For Research Resources or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer DP, 2008, MAGN RESON IMAGING, V26, P1055, DOI 10.1016/j.mri.2008.05.008; Barbas H, 2007, ANN NY ACAD SCI, V1121, P10, DOI 10.1196/annals.1401.015; Bardin L, 2009, BEHAV BRAIN RES, V205, P360, DOI 10.1016/j.bbr.2009.07.005; Becerra L, 2011, NEUROIMAGE, V54, P1355, DOI 10.1016/j.neuroimage.2010.08.056; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; BEHBEHANI MM, 1995, PROG NEUROBIOL, V46, P575, DOI 10.1016/0301-0082(95)00009-K; Benarroch EE, 1998, BRAIN PATHOL, V8, P527; Berridge CW, 2008, BRAIN RES REV, V58, P1, DOI 10.1016/j.brainresrev.2007.10.013; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Cameron OG, 2001, PSYCHOSOM MED, V63, P697, DOI 10.1097/00006842-200109000-00001; Carreno M, 2011, SEIZURE-EUR J EPILEP, V20, P580, DOI 10.1016/j.seizure.2011.04.010; Cole MW, 2010, NEUROIMAGE, V49, P3132, DOI 10.1016/j.neuroimage.2009.11.001; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Craig AD, 2003, CURR OPIN NEUROBIOL, V13, P500, DOI 10.1016/S0959-4388(03)00090-4; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2005, EXP BRAIN RES, V167, P587, DOI 10.1007/s00221-005-0059-1; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Habas C, 2010, CEREBELLUM, V9, P22, DOI 10.1007/s12311-009-0119-3; Habas C, 2009, J NEUROSCI, V29, P8586, DOI 10.1523/JNEUROSCI.1868-09.2009; Hutchison RM, 2011, NEUROIMAGE, V56, P1546, DOI 10.1016/j.neuroimage.2011.02.063; Hutchison RM, 2010, J NEUROPHYSIOL, V103, P3398, DOI 10.1152/jn.00141.2010; JOEL D, 1994, NEUROSCIENCE, V63, P363, DOI 10.1016/0306-4522(94)90536-3; Jones CL, 2010, J NEUROL NEUROSUR PS, V81, P611, DOI 10.1136/jnnp.2009.193672; Kalthoff D, 2011, NEUROIMAGE, V54, P2828, DOI 10.1016/j.neuroimage.2010.10.053; Kannurpatti SS, 2008, NEUROIMAGE, V40, P1738, DOI 10.1016/j.neuroimage.2007.05.061; King JA, 2005, J NEUROSCI METH, V148, P154, DOI 10.1016/j.jneumeth.2005.04.011; Liang ZF, 2011, J NEUROSCI, V31, P3776, DOI 10.1523/JNEUROSCI.4557-10.2011; Liu XA, 2011, CEREB CORTEX, V21, P374, DOI 10.1093/cercor/bhq105; Liu XA, 2011, NEUROIMAGE, V54, P2278, DOI 10.1016/j.neuroimage.2010.10.001; LOEWY AD, 1991, PROG BRAIN RES, V87, P253; Lu H, 2007, P NATL ACAD SCI USA, V104, P18265, DOI 10.1073/pnas.0705791104; Majeed W, 2011, NEUROIMAGE, V54, P1140, DOI 10.1016/j.neuroimage.2010.08.030; Majeed W, 2009, J MAGN RESON IMAGING, V30, P384, DOI 10.1002/jmri.21848; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mason P, 2005, J COMP NEUROL, V493, P2, DOI 10.1002/cne.20751; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; Morcom AM, 2007, NEUROIMAGE, V37, P1073, DOI 10.1016/j.neuroimage.2006.09.013; Moulton EA, 2010, BRAIN RES REV, V65, P14, DOI 10.1016/j.brainresrev.2010.05.005; Nagai M, 2010, J AM SOC HYPERTENS, V4, P174, DOI 10.1016/j.jash.2010.05.001; Pawela CP, 2008, MAGN RESON MED, V59, P1021, DOI 10.1002/mrm.21524; Pawela CP, 2009, NEUROIMAGE, V46, P1137, DOI 10.1016/j.neuroimage.2009.03.004; Paxinos G., 2004, RAT BRAIN STEREOTAXI; Pendse GV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027594; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rempel-Clower NL, 1998, J COMP NEUROL, V398, P393, DOI 10.1002/(SICI)1096-9861(19980831)398:3<393::AID-CNE7>3.0.CO;2-V; Robinson S, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-137; Shibata H, 1998, EUR J NEUROSCI, V10, P3210, DOI 10.1046/j.1460-9568.1998.00328.x; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Taylor KS, 2009, HUM BRAIN MAPP, V30, P2731, DOI 10.1002/hbm.20705; Toni R, 2004, J Endocrinol Invest, V27, P73; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; Wang K, 2011, NMR BIOMED, V24, P61, DOI 10.1002/nbm.1556; Woolrich MW, 2006, IEEE T MED IMAGING, V25, P1380, DOI 10.1109/TMI.2006.880682; Yang Z, 2008, HUM BRAIN MAPP, V29, P711, DOI 10.1002/hbm.20432; Zhang NY, 2010, J NEUROSCI METH, V189, P186, DOI 10.1016/j.jneumeth.2010.04.001; Zhao FQ, 2008, NEUROIMAGE, V39, P248, DOI 10.1016/j.neuroimage.2007.07.063; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	62	85	88	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25701	10.1371/journal.pone.0025701	http://dx.doi.org/10.1371/journal.pone.0025701			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028788	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900016
J	Cot, M; Ray, A; Gilleron, M; Vercellone, A; Larrouy-Maumus, G; Armau, E; Gauthier, S; Tiraby, G; Puzo, G; Nigou, J				Cot, Marlene; Ray, Aurelie; Gilleron, Martine; Vercellone, Alain; Larrouy-Maumus, Gerald; Armau, Elise; Gauthier, Sophie; Tiraby, Gerard; Puzo, Germain; Nigou, Jerome			Lipoteichoic Acid in Streptomyces hygroscopicus: Structural Model and Immunomodulatory Activities	PLOS ONE			English	Article							GRAM-POSITIVE BACTERIA; TOLL-LIKE RECEPTOR-2; STAPHYLOCOCCUS-AUREUS; CELL-WALL; CYTOKINE INDUCTION; TEICHOIC-ACIDS; MYCOBACTERIUM-TUBERCULOSIS; LIPOARABINOMANNAN; ACTINOMYCETE; MACROAMPHIPHILES	Gram positive bacteria produce cell envelope macroamphiphile glycopolymers, i.e. lipoteichoic acids or lipoglycans, whose functions and biosynthesis are not yet fully understood. We report for the first time a detailed structure of lipoteichoic acid isolated from a Streptomyces species, i.e. Streptomyces hygroscopicus subsp. hygroscopicus NRRL 2387T. Chemical, MS and NMR analyses revealed a polyglycerolphosphate backbone substituted with alpha-glucosaminyl and alpha-N-acetyl-glucosaminyl residues but devoid of any amino-acid substituent. This structure is very close, if not identical, to that of the wall teichoic acid of this organism. These data not only contribute to the growing recognition that lipoteichoic acid is a cell envelope component of Gram positive Actinobacteria but also strongly support the recently proposed hypothesis of an overlap between the pathways of lipoteichoic acid and wall teichoic acid synthesis in these bacteria. S. hygroscopicus lipoteichoic acid induced signalling by human innate immune receptor TLR2, confirming its role as a microbe-associated molecular pattern. Its activity was partially dependant on TLR1, TLR6 and CD14. Moreover, it stimulated TNF-alpha and IL-6 production by a human macrophage cell line to an extent similar to that of Staphylococcus aureus lipoteichoic acid. These results provide new clues on lipoteichoic acid structure/function relationships, most particularly on the role of the polyglycerolphosphate backbone substituents.	[Cot, Marlene; Ray, Aurelie; Gilleron, Martine; Vercellone, Alain; Larrouy-Maumus, Gerald; Puzo, Germain; Nigou, Jerome] CNRS, IPBS, Toulouse, France; [Cot, Marlene; Ray, Aurelie; Gilleron, Martine; Vercellone, Alain; Larrouy-Maumus, Gerald; Puzo, Germain; Nigou, Jerome] Univ Toulouse, UPS, IPBS, Toulouse, France; [Armau, Elise; Gauthier, Sophie; Tiraby, Gerard] Cayla InvivoGen, Res Dept, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Cot, M (corresponding author), CNRS, IPBS, Toulouse, France.	jerome.nigou@ipbs.fr	Nigou, Jérôme/D-6802-2019	Nigou, Jérôme/0000-0002-6233-2487; GILLERON, Martine/0000-0002-2581-3302; Larrouy-Maumus, Gerald/0000-0001-6614-8698	French Research Ministry; CNRS; Universite Paul Sabatier; Region Midi-Pyrenees; European structural funds	French Research Ministry(Ministry of Research, France); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paul Sabatier; Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); European structural funds	The IPBS NMR equipment was financed by the French Research Ministry, CNRS, Universite Paul Sabatier, the Region Midi-Pyrenees, and European structural funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Bunk S, 2010, J IMMUNOL, V185, P3708, DOI 10.4049/jimmunol.0901660; Chen FTA, 1998, GLYCOBIOLOGY, V8, P1045, DOI 10.1093/glycob/8.11.1045; Deininger S, 2003, J IMMUNOL, V170, P4134, DOI 10.4049/jimmunol.170.8.4134; Doran KS, 2005, J CLIN INVEST, V115, P2499, DOI 10.1172/JCI23829; Draing C, 2008, IMMUNOBIOLOGY, V213, P285, DOI 10.1016/j.imbio.2007.12.001; Fedtke I, 2007, MOL MICROBIOL, V65, P1078, DOI 10.1111/j.1365-2958.2007.05854.x; FISCHER W, 1993, ANAL BIOCHEM, V208, P49, DOI 10.1006/abio.1993.1007; FISCHER W, 1983, EUR J BIOCHEM, V133, P523, DOI 10.1111/j.1432-1033.1983.tb07495.x; FISCHER W, 1988, ADV MICROB PHYSIOL, V29, P233, DOI 10.1016/S0065-2911(08)60349-5; Fischer W, 1994, BACTERIAL CELL WALL, P199; Garton NJ, 2002, J BIOL CHEM, V277, P31722, DOI 10.1074/jbc.M203008200; Gibson KJC, 2005, J BIOL CHEM, V280, P28347, DOI 10.1074/jbc.M505498200; Gilleron M, 2000, J BIOL CHEM, V275, P677, DOI 10.1074/jbc.275.1.677; Gilleron M, 2005, J BACTERIOL, V187, P854, DOI 10.1128/JB.187.3.854-861.2005; Ginsburg I, 2002, LANCET INFECT DIS, V2, P171, DOI 10.1016/S1473-3099(02)00226-8; GNILOZUB VA, 1994, MICROBIOLOGY+, V63, P275; Grundling A, 2007, P NATL ACAD SCI USA, V104, P8478, DOI 10.1073/pnas.0701821104; Han SH, 2003, INFECT IMMUN, V71, P5541, DOI 10.1128/IAI.71.10.5541-5548.2003; Hashimoto M, 2007, INFECT IMMUN, V75, P1926, DOI 10.1128/IAI.02083-05; Hashimoto M, 2006, J IMMUNOL, V177, P3162, DOI 10.4049/jimmunol.177.5.3162; Hoischen C, 1997, J BACTERIOL, V179, P3430, DOI 10.1128/jb.179.11.3430-3436.1997; Kang JY, 2009, IMMUNITY, V31, P873, DOI 10.1016/j.immuni.2009.09.018; Lehner MD, 2001, J IMMUNOL, V166, P5161, DOI 10.4049/jimmunol.166.8.5161; Morath S, 2002, J EXP MED, V195, P1635, DOI 10.1084/jem.20020322; Morath S, 2001, J EXP MED, V193, P393, DOI 10.1084/jem.193.3.393; Morelle W, 2007, NAT PROTOC, V2, P1585, DOI 10.1038/nprot.2007.227; Nigou J, 2003, BIOCHIMIE, V85, P153, DOI 10.1016/S0300-9084(03)00048-8; POTEKHINA N V, 1983, Mikrobiologiya, V52, P434; Rahman O, 2009, LETT APPL MICROBIOL, V48, P226, DOI 10.1111/j.1472-765X.2008.02514.x; Rahman O, 2009, TRENDS MICROBIOL, V17, P219, DOI 10.1016/j.tim.2009.03.003; Rahman O, 2009, J BACTERIOL, V191, P152, DOI 10.1128/JB.01105-08; Seo HS, 2008, J BACTERIOL, V190, P2379, DOI 10.1128/JB.01795-07; Seo HS, 2008, INFECT IMMUN, V76, P206, DOI 10.1128/IAI.01140-07; Seo HS, 2009, CLIN VACCINE IMMUNOL, V16, P1187, DOI 10.1128/CVI.00115-09; Shashkov AS, 2006, CARBOHYD RES, V341, P796, DOI 10.1016/j.carres.2006.01.020; Shashkov AS, 2002, EUR J BIOCHEM, V269, P6020, DOI 10.1046/j.1432-1033.2002.03274.x; Shashkov AS, 2002, CARBOHYD RES, V337, P2255, DOI 10.1016/S0008-6215(02)00188-X; Siri N, 2006, ELECTROPHORESIS, V27, P4446, DOI 10.1002/elps.200600165; Sutcliffe Iain C., 1994, Systematic and Applied Microbiology, V17, P467; SUTCLIFFE IC, 1991, J BACTERIOL, V173, P7065, DOI 10.1128/jb.173.22.7065-7069.1991; Sutcliffe IC, 1995, ARCH ORAL BIOL, V40, P1119, DOI 10.1016/0003-9969(95)00086-0; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; Triantafilou M, 2004, J BIOL CHEM, V279, P40882, DOI 10.1074/jbc.M400466200; Tulskaya EM, 1997, BIOCHEMISTRY-MOSCOW+, V62, P289; Weidenmaier C, 2008, NAT REV MICROBIOL, V6, P276, DOI 10.1038/nrmicro1861; Whale GA, 2004, ANTON LEEUW INT J G, V86, P77, DOI 10.1023/B:ANTO.0000024911.67625.27; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	48	16	18	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26316	10.1371/journal.pone.0026316	http://dx.doi.org/10.1371/journal.pone.0026316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028855	Green Published, gold, Green Submitted			2022-12-27	WOS:000296186900048
J	Everman, S; Yi, ZP; Langlais, P; Mandarino, LJ; Luo, ML; Roberts, C; Katsanos, CS				Everman, Sarah; Yi, Zhengping; Langlais, Paul; Mandarino, Lawrence J.; Luo, Moulun; Roberts, Christine; Katsanos, Christos S.			Reproducibility of an HPLC-ESI-MS/MS Method for the Measurement of Stable-Isotope Enrichment of in Vivo-Labeled Muscle ATP Synthase Beta Subunit	PLOS ONE			English	Article							SKELETAL-MUSCLE; PROTEIN-SYNTHESIS; MITOCHONDRIAL; INSULIN; BETA-F1-ATPASE; RATES; EXPRESSION; TURNOVER; DYNAMICS	We sought to evaluate the reproducibility of a liquid chromatography-tandem mass spectrometry (LC-MS/MS)-based approach to measure the stable-isotope enrichment of in vivo-labeled muscle ATP synthase beta subunit (beta-F1-ATPase), a protein most directly involved in ATP production, and whose abundance is reduced under a variety of circumstances. Muscle was obtained from a rat infused with stable-isotope-labeled leucine. The muscle was homogenized, beta-F1-ATPase immunoprecipitated, and the protein was resolved using 1D-SDS PAGE. Following trypsin digestion of the isolated protein, the resultant peptide mixtures were subjected to analysis by HPLC-ESI-MS/MS, which resulted in the detection of multiple beta-F1-ATPase peptides. There were three beta-F1-ATPase unique peptides with a leucine residue in the amino acid sequence, and which were detected with high intensity relative to other peptides and assigned with >95% probability to beta-F1-ATPase. These peptides were specifically targeted for fragmentation to access their stable-isotope enrichment based on MS/MS peak areas calculated from extracted ion chromatographs for selected labeled and unlabeled fragment ions. Results showed best linearity (R(2) = 0.99) in the detection of MS/MS peak areas for both labeled and unlabeled fragment ions, over a wide range of amounts of injected protein, specifically for the beta-F1-ATPase(134-143) peptide. Measured stable-isotope enrichment was highly reproducible for the beta-F1-ATPase(134-143) peptide (CV = 2.9%). Further, using mixtures of synthetic labeled and unlabeled peptides we determined that there is an excellent linear relationship (R(2) = 0.99) between measured and predicted enrichment for percent enrichments ranging between 0.009% and 8.185% for the beta-F1-ATPase(134-143) peptide. The described approach provides a reliable approach to measure the stable-isotope enrichment of in-vivo-labeled muscle beta-F1-ATPase based on the determination of the enrichment of the beta-F1-ATPase(134-143) peptide.	[Everman, Sarah; Yi, Zhengping; Langlais, Paul; Mandarino, Lawrence J.; Luo, Moulun; Roberts, Christine; Katsanos, Christos S.] Arizona State Univ, Sch Life Sci, Ctr Metab & Vasc Biol, Tempe, AZ 85287 USA; [Everman, Sarah; Yi, Zhengping; Langlais, Paul; Mandarino, Lawrence J.; Luo, Moulun; Roberts, Christine; Katsanos, Christos S.] Mayo Clin Arizona, Scottsdale, AZ USA; [Yi, Zhengping] Wayne State Univ, Dept Pharmaceut Sci, Eugene Applebaum Coll Pharm Hlth Sci, Detroit, MI USA	Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic Phoenix; Wayne State University	Everman, S (corresponding author), Arizona State Univ, Sch Life Sci, Ctr Metab & Vasc Biol, Tempe, AZ 85287 USA.	christos.katsanos@asu.edu			Arizona State University; National Institutes of Health [R01DK47936]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047936] Funding Source: NIH RePORTER	Arizona State University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The work conducted at the Center for Metabolic and Vascular Biology at Arizona State University and was partially supported by Arizona State University start-up funds (to CK) and by the National Institutes of Health grant R01DK47936 (to LM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman RJ, 2007, J AM SOC MASS SPECTR, V18, P997, DOI 10.1016/j.jasms.2007.02.009; Boirie Y, 2001, DIABETES, V50, P2652, DOI 10.2337/diabetes.50.12.2652; Burd Nicholas A, 2011, Nutr Metab (Lond), V8, P15, DOI 10.1186/1743-7075-8-15; Chinkes D, 1996, AM J PHYSIOL-ENDOC M, V270, pE67, DOI 10.1152/ajpendo.1996.270.1.E67; Doherty MK, 2005, PROTEOMICS, V5, P522, DOI 10.1002/pmic.200400959; Guillet C, 2009, J CLIN ENDOCR METAB, V94, P3044, DOI 10.1210/jc.2008-2216; Hojlund K, 2010, DIABETOLOGIA, V53, P541, DOI 10.1007/s00125-009-1624-0; Hwang H, 2010, DIABETES, V59, P33, DOI 10.2337/db09-0214; IZQUIERDO JM, 1995, EUR J BIOCHEM, V232, P344, DOI 10.1111/j.1432-1033.1995.tb20817.x; Jaleel A, 2008, AM J PHYSIOL-ENDOC M, V295, pE1255, DOI 10.1152/ajpendo.90586.2008; Lefort N, 2009, J PROTEOMICS, V72, P1046, DOI 10.1016/j.jprot.2009.06.011; Lin PC, 2008, INT J COLORECTAL DIS, V23, P1223, DOI 10.1007/s00384-008-0539-4; Lombardi A, 2009, J PROTEOMICS, V72, P708, DOI 10.1016/j.jprot.2009.02.007; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Newcomer B, 2001, INT J OBESITY, V25, P1309, DOI 10.1038/sj.ijo.0801673; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Willers IM, 2010, BIOCHEM J, V426, P319, DOI 10.1042/BJ20091570; Wolfe RR, 2004, ISOTOPE TRACERS META; Yi ZP, 2007, DIABETES, V56, P1508, DOI 10.2337/db06-1355	20	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26171	10.1371/journal.pone.0026171	http://dx.doi.org/10.1371/journal.pone.0026171			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022551	gold, Green Published, Green Submitted			2022-12-27	WOS:000295976000079
J	Abou-Kheir, W; Hynes, PG; Martin, P; Yin, JJ; Liu, YN; Seng, V; Lake, R; Spurrier, J; Kelly, K				Abou-Kheir, Wassim; Hynes, Paul G.; Martin, Philip; Yin, Juan Juan; Liu, Yen-Nien; Seng, Victoria; Lake, Ross; Spurrier, Joshua; Kelly, Kathleen			Self-Renewing Pten(-/-)TP53(-/-) Protospheres Produce Metastatic Adenocarcinoma Cell Lines with Multipotent Progenitor Activity	PLOS ONE			English	Article							TUMOR-INITIATING CELLS; PROSTATE-CANCER CELLS; STEM-CELLS; PTEN; BONE; TUMORIGENESIS; POPULATION; SURVIVAL; PATHWAY; ORIGIN	Prostate cancers of luminal adenocarcinoma histology display a range of clinical behaviors. Although most prostate cancers are slow-growing and indolent, a proportion is aggressive, developing metastasis and resistance to androgen deprivation treatment. One hypothesis is that a portion of aggressive cancers initiate from stem-like, androgen-independent tumor-propagating cells. Here we demonstrate the in vitro creation of a mouse cell line, selected for growth as self-renewing stem/progenitor cells, which manifests many in vivo properties of aggressive prostate cancer. Normal mouse prostate epithelium containing floxed Pten and TP53 alleles was subjected to CRE-mediated deletion in vitro followed by serial propagation as protospheres. A polyclonal cell line was established from dissociated protospheres and subsequently a clonal daughter line was derived. Both lines demonstrate a mature luminal phenotype in vitro. The established lines contain a stable minor population of progenitor cells with protosphere-forming ability and multi-lineage differentiation capacity. Both lines formed orthotopic adenocarcinoma tumors with metastatic potential to lung. Intracardiac inoculation resulted in brain and lung metastasis, while intra-tibial injection induced osteoblastic bone formation, recapitulating the bone metastatic phenotype of human prostate cancer. The cells showed androgen receptor dependent growth in vitro. Importantly, in vivo, the deprivation of androgens from established orthotopic tumors resulted in tumor regression and eventually castration-resistant growth. These data suggest that transformed prostate progenitor cells preferentially differentiate toward luminal cells and recapitulate many characteristics of the human disease.	[Abou-Kheir, Wassim; Hynes, Paul G.; Martin, Philip; Yin, Juan Juan; Liu, Yen-Nien; Seng, Victoria; Lake, Ross; Spurrier, Joshua; Kelly, Kathleen] NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA; [Abou-Kheir, Wassim] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Beirut, Lebanon	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); American University of Beirut	Abou-Kheir, W (corresponding author), NCI, Cell & Canc Biol Branch, NIH, Bethesda, MD 20892 USA.	kellyka@mail.nih.gov	Abou-Kheir, Wassim/AAP-2587-2020; Liu, Yen-Nien/AAW-4698-2021	Abou-Kheir, Wassim/0000-0001-9719-9324; Spurrier, Joshua/0000-0002-6267-7231	National Institutes of Health, National Cancer Institute, Center for Cancer Research, United States of America; NATIONAL CANCER INSTITUTE [ZIABC010802] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute, Center for Cancer Research, United States of America(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge the support of the Intramural Research Program of the National Institutes of Health, National Cancer Institute, Center for Cancer Research, United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Kheir WG, 2010, STEM CELLS, V28, P2129, DOI 10.1002/stem.538; Agell L, 2008, MODERN PATHOL, V21, P1470, DOI 10.1038/modpathol.2008.145; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Goldstein AS, 2010, MOL ONCOL, V4, P385, DOI 10.1016/j.molonc.2010.06.009; Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Li H, 2008, CANCER RES, V68, P1820, DOI 10.1158/0008-5472.CAN-07-5878; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Logothetis CJ, 2005, NAT REV CANCER, V5, P21, DOI 10.1038/nrc1528; MARTIN PL, 2011, AM J PATHOLOGY; Mellado B, 2009, CLIN TRANSL ONCOL, V11, P5, DOI 10.1007/s12094-009-0304-3; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Rajasekhar VK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1159; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Roudier MP, 2008, J UROLOGY, V180, P1154, DOI 10.1016/j.juro.2008.04.140; Roudier MP, 2003, HUM PATHOL, V34, P646, DOI 10.1016/S0046-8177(03)00190-4; Schlomm T, 2008, MODERN PATHOL, V21, P1371, DOI 10.1038/modpathol.2008.104; Sircar K, 2009, J PATHOL, V218, P505, DOI 10.1002/path.2559; Song MS, 2011, CELL, V144, P187, DOI 10.1016/j.cell.2010.12.020; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wang ZA, 2011, ONCOGENE, V30, P1261, DOI 10.1038/onc.2010.530	29	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26112	10.1371/journal.pone.0026112	http://dx.doi.org/10.1371/journal.pone.0026112			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022528	Green Submitted, gold, Green Published			2022-12-27	WOS:000295973200037
J	Teschke, M; Wendt, S; Kawaguchi, S; Kramer, A; Meyer, B				Teschke, Mathias; Wendt, Sabrina; Kawaguchi, So; Kramer, Achim; Meyer, Bettina			A Circadian Clock in Antarctic Krill: An Endogenous Timing System Governs Metabolic Output Rhythms in the Euphausid Species Euphausia superba	PLOS ONE			English	Article							CRUSTACEAN HYPERGLYCEMIC HORMONE; FUNCTIONAL-ANALYSIS; NOCTURNAL RODENTS; LIGHT; ENTRAINMENT; PACEMAKERS; ZEITGEBER; EYESTALK; RANGE; CRY	Antarctic krill, Euphausia superba, shapes the structure of the Southern Ocean ecosystem. Its central position in the food web, the ongoing environmental changes due to climatic warming, and increasing commercial interest on this species emphasize the urgency of understanding the adaptability of krill to its environment. Krill has evolved rhythmic physiological and behavioral functions which are synchronized with the daily and seasonal cycles of the complex Southern Ocean ecosystem. The mechanisms, however, leading to these rhythms are essentially unknown. Here, we show that krill possesses an endogenous circadian clock that governs metabolic and physiological output rhythms. We found that expression of the canonical clock gene cry2 was highly rhythmic both in a light-dark cycle and in constant darkness. We detected a remarkable short circadian period, which we interpret as a special feature of the krill's circadian clock that helps to entrain the circadian system to the extreme range of photoperiods krill is exposed to throughout the year. Furthermore, we found that important key metabolic enzymes of krill showed bimodal circadian oscillations (similar to 9-12 h period) in transcript abundance and enzymatic activity. Oxygen consumption of krill showed similar to 9-12 h oscillations that correlated with the temporal activity profile of key enzymes of aerobic energy metabolism. Our results demonstrate the first report of an endogenous circadian timing system in Antarctic krill and its likely link to metabolic key processes. Krill's circadian clock may not only be critical for synchronization to the solar day but also for the control of seasonal events. This study provides a powerful basis for the investigation into the mechanisms of temporal synchronization in this marine key species and will also lead to the first comprehensive analyses of the circadian clock of a polar marine organism through the entire photoperiodic cycle.	[Teschke, Mathias; Wendt, Sabrina; Kramer, Achim] Charite, Lab Chronobiol, D-13353 Berlin, Germany; [Kawaguchi, So] Australian Antarctic Div, Dept Environm & Heritage, Kingston, Tas, Australia; [Kawaguchi, So] Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Meyer, Bettina] Alfred Wegener Inst Polar & Marine Res, Sci Div Polar Biol Oceanog, D-2850 Bremerhaven, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Australian Antarctic Division; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Teschke, M (corresponding author), Charite, Lab Chronobiol, D-13353 Berlin, Germany.	mathias.teschke@charite.de; achim.kramer@charite.de	Meyer, Bettina/ABB-5311-2020	Meyer, Bettina/0000-0001-6804-9896; Kawaguchi, So/0000-0002-2042-5095; Kramer, Achim/0000-0001-9671-6078	German Ministry of Education and Research (BMBF) [03F0400A]; German Research Foundation (DFG) [TE 618/3-1]; EU	German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); EU(European Commission)	This work was supported by the German Ministry of Education and Research (BMBF) through project Lazarev Sea Krill Study (LAKRIS, 03F0400A). MT was supported by funding of the German Research Foundation (DFG) through project Photoperiodic Time Measurement in Antarctic krill (TE 618/3-1). Research in A.K.'s laboratory is supported by the 6 th EU framework programme EUCLOCK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Aguzzi J, 2004, J CRUSTACEAN BIOL, V24, P282, DOI 10.1651/C-2458; Arechiga H, 1998, P ROY SOC B-BIOL SCI, V265, P1819, DOI 10.1098/rspb.1998.0507; ASCHOFF J, 1978, NATURWISSENSCHAFTEN, V65, P80, DOI 10.1007/BF00440545; Atkinson A, 2004, NATURE, V432, P100, DOI 10.1038/nature02996; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; DAAN S, 1976, J COMP PHYSIOL, V106, P253, DOI 10.1007/BF01417857; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Emery P, 2000, NATURE, V404, P456, DOI 10.1038/35006558; ERLANGER BF, 1961, ARCH BIOCHEM BIOPHYS, V95, P271, DOI 10.1016/0003-9861(61)90145-X; Fanjul-Moles ML, 2004, J EXP BIOL, V207, P1453, DOI 10.1242/jeb.00900; Folk GE, 2006, BIOL RHYTHM RES, V37, P455, DOI 10.1080/09291010600738551; Gaten E, 2008, J GENET, V87, P473, DOI 10.1007/s12041-008-0070-y; Gatti S, 2002, MAR BIOL, V140, P1075, DOI 10.1007/s00227-002-0786-9; Godlewska Malgorzata, 1996, Polskie Archiwum Hydrobiologii, V43, P9; jami Al-Ahmadi K, 2008, RES J MICROBIOL, V3, P395; KALLEN JL, 1990, BIOL BULL-US, V179, P351, DOI 10.2307/1542327; Kawaguchi S, 2007, POLAR BIOL, V30, P689, DOI 10.1007/s00300-006-0226-2; Kawaguchi S, 2010, DEEP-SEA RES PT II, V57, P683, DOI 10.1016/j.dsr2.2009.10.017; King R, 2003, MAR FRESHW BEHAV PHY, V36, P271, DOI 10.1080/10236240310001614457; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu WQ, 2010, CURR BIOL, V20, P533, DOI 10.1016/j.cub.2010.01.042; Fanjul-Moles ML, 2010, CHRONOBIOL INT, V27, P34, DOI 10.3109/07420520903398526; MAYZAUD P, 1978, LIMNOL OCEANOGR, V23, P1144, DOI 10.4319/lo.1978.23.6.1144; Mazzotta GM, 2010, CHRONOBIOL INT, V27, P425, DOI 10.3109/07420521003697494; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Meyer B, 2002, MAR BIOL, V141, P855, DOI 10.1007/s00227-002-0877-7; Meyer B, 2010, MAR ECOL PROG SER, V398, P1, DOI 10.3354/meps08371; MEZYKOWSKI T, 1979, MEERESFORSCHUNG, V27, P124; MOLODTSOV NV, 1972, COMP BIOCHEM PHYSIOL, V41, P113, DOI 10.1016/0305-0491(72)90013-2; Oster H, 2006, J BIOL RHYTHM, V21, P350, DOI 10.1177/0748730406293053; PITTENDRIGH CS, 1993, ANNU REV PHYSIOL, V55, P16; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P291, DOI 10.1007/BF01417859; Pohl H, 1999, PHYSIOL BEHAV, V67, P327, DOI 10.1016/S0031-9384(99)00070-0; Richter S, 2002, ORG DIVERS EVOL, V2, P217, DOI 10.1078/1439-6092-00048; Rosato E, 2001, PHILOS T R SOC B, V356, P1769, DOI 10.1098/rstb.2001.0961; Rubin EB, 2006, GENOME RES, V16, P1352, DOI 10.1101/gr.5094806; Schiermeier Q, 2010, NATURE, V467, P15, DOI 10.1038/467015a; Seear P, 2009, J EXP MAR BIOL ECOL, V381, P57, DOI 10.1016/j.jembe.2009.09.010; Silverin B, 2009, HORM BEHAV, V56, P163, DOI 10.1016/j.yhbeh.2009.04.002; Stitt M.., 1984, METHODS ENZYMATIC AN, V4, P353; Strauss J, 2010, FRONT BIOSCI-LANDMRK, V15, P1040, DOI 10.2741/3661; Sullivan JM, 2009, CHRONOBIOL INT, V26, P1136, DOI 10.1080/07420520903217960; Teschke M, 2007, LIMNOL OCEANOGR, V52, P1046, DOI 10.4319/lo.2007.52.3.1046; van Oort BEH, 2005, NATURE, V438, P1095, DOI 10.1038/4381095a; Yang JS, 2006, BRAIN RES, V1067, P13, DOI 10.1016/j.brainres.2005.10.003; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	47	43	43	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2011	6	10							e26090	10.1371/journal.pone.0026090	http://dx.doi.org/10.1371/journal.pone.0026090			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OC	22022521	Green Submitted, Green Published, gold			2022-12-27	WOS:000295970300058
J	Botwinick, IC; Shonkwiler, RJ; Steele, J; Yu, G; Chabot, JA				Botwinick, Isadora C.; Shonkwiler, R. Joseph; Steele, John; Yu, Gary; Chabot, John A.			Atrial Fibrillation and Delayed Gastric Emptying	PLOS ONE			English	Article							POSTOPERATIVE ILEUS; SURGERY; CELLS	Background: Atrial fibrillation and delayed gastric emptying (DGE) are common after pancreaticoduodenectomy. Our aim was to investigate a potential relationship between atrial fibrillation and DGE, which we defined as failure to tolerate a regular diet by the 7(th) postoperative day. Methods: We performed a retrospective chart review of 249 patients who underwent pancreaticoduodenectomy at our institution between 2000 and 2009. Data was analyzed with Fisher exact test for categorical variables and Mann-Whitney U or unpaired T-test for continuous variables. Results: Approximately 5% of the 249 patients included in the analysis experienced at least one episode of postoperative atrial fibrillation. Median age of patients with atrial fibrillation was 74 years, compared with 66 years in patients without atrial fibrillation (p = 0.0005). Patients with atrial fibrillation were more likely to have a history of atrial fibrillation (p = 0.03). 92% of the patients with atrial fibrillation suffered from DGE, compared to 46% of patients without atrial fibrillation (p = 0.0007). This association held true when controlling for age. Conclusion: Patients with postoperative atrial fibrillation are more likely to experience delayed gastric emptying. Interventions to manage delayed gastric function might be prudent in patients at high risk for postoperative atrial fibrillation.	[Botwinick, Isadora C.; Shonkwiler, R. Joseph; Steele, John; Yu, Gary; Chabot, John A.] Columbia Univ, Dept Surg, New York Presbyterian Hosp, Columbia Univ Med Ctr, New York, NY 10027 USA	Columbia University; NewYork-Presbyterian Hospital	Botwinick, IC (corresponding author), Columbia Univ, Dept Surg, New York Presbyterian Hosp, Columbia Univ Med Ctr, New York, NY 10027 USA.	Isadora.botwinick@gmail.com						Aranha GV, 2003, J AM COLL SURGEONS, V197, P223, DOI 10.1016/S1072-7515(03)00331-4; Bielefeldt K, 2005, NEUROGASTROENT MOTIL, V17, P488, DOI 10.1111/j.1365-2982.2005.00671.x; Cha YM, 2004, CIRCULATION, V109, P2839, DOI 10.1161/01.CIR.0000132470.78896.A8; CHUNG SA, 1994, AM J PHYSIOL-GASTR L, V267, pG800, DOI 10.1152/ajpgi.1994.267.5.G800; de Jonge WJ, 2005, NAT IMMUNOL, V6, P844, DOI 10.1038/ni1229; ECKBERG DL, 1983, J APPL PHYSIOL, V54, P961, DOI 10.1152/jappl.1983.54.4.961; Engel DR, 2010, NAT MED, V16, P1407, DOI 10.1038/nm.2255; KANNEL WB, 1982, NEW ENGL J MED, V306, P1018, DOI 10.1056/NEJM198204293061703; Liebregts T, 2011, AM J GASTROENTEROL, V106, P1089, DOI 10.1038/ajg.2010.512; McCarthy DO, 2000, RES NURS HEALTH, V23, P222, DOI 10.1002/1098-240X(200006)23:3<222::AID-NUR6>3.0.CO;2-3; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; Polanczyk CA, 1998, ANN INTERN MED, V129, P279, DOI 10.7326/0003-4819-129-4-199808150-00003; Rosso R, 2010, J CARDIOVASC ELECTR, V21, P489, DOI 10.1111/j.1540-8167.2009.01658.x; van den Berg MP, 2003, HEART, V89, P333, DOI 10.1136/heart.89.3.333; Wehner S, 2007, GUT, V56, P176, DOI 10.1136/gut.2005.089615; Wente MN, 2007, SURGERY, V142, P761, DOI 10.1016/j.surg.2007.05.005; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25499	10.1371/journal.pone.0025499	http://dx.doi.org/10.1371/journal.pone.0025499			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028778	Green Submitted, Green Published, gold			2022-12-27	WOS:000296510800007
J	Samuel, S; Gaur, P; Fan, F; Xia, L; Gray, MJ; Dallas, NA; Bose, D; Rodriguez-Aguayo, C; Lopez-Berestein, G; Plowman, G; Bagri, A; Sood, AK; Ellis, LM				Samuel, Shaija; Gaur, Puja; Fan, Fan; Xia, Ling; Gray, Michael J.; Dallas, Nikolaos A.; Bose, Debashish; Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel; Plowman, Greg; Bagri, Anil; Sood, Anil K.; Ellis, Lee M.			Neuropilin-2 Mediated beta-Catenin Signaling and Survival in Human Gastro-Intestinal Cancer Cell Lines	PLOS ONE			English	Article							WNT PATHWAY ACTIVATION; EXPRESSION; GROWTH; SUPPRESSION; VEGF; RNA	NRP-2 is a high-affinity kinase-deficient receptor for ligands belonging to the class 3 semaphorin and vascular endothelial growth factor families. NRP-2 has been detected on the surface of several types of human cancer cells, but its expression and function in gastrointestinal (GI) cancer cells remains to be determined. We sought to determine the function of NRP-2 in mediating downstream signals regulating the growth and survival of human gastrointestinal cancer cells. In human gastric cancer specimens, NRP-2 expression was detected in tumor tissues but not in adjacent normal mucosa. In CNDT 2.5 cells, shRNA mediated knockdown NRP-2 expression led to decreased migration and invasion in vitro (p < 0.01). Focused gene-array analysis demonstrated that loss of NRP-2 reduced the expression of a critical metastasis mediator gene, S100A4. Steady-state levels and function of beta-catenin, a known regulator of S100A4, were also decreased in the shNRP-2 clones. Furthermore, knockdown of NRP-2 sensitized CNDT 2.5 cells in vitro to 5FU toxicity. This effect was associated with activation of caspases 3 and 7, cleavage of PARP, and downregulation of Bcl-2. In vivo growth of CNDT 2.5 cells in the livers of nude mice was significantly decreased in the shNRP-2 group (p < 0.05). Intraperitoneal administration of NRP-2 siRNA-DOPC decreased the tumor burden in mice (p = 0.01). Collectively, our results demonstrate that tumor cell-derived NRP-2 mediates critical survival signaling in gastrointestinal cancer cells.	[Samuel, Shaija; Fan, Fan; Xia, Ling; Lopez-Berestein, Gabriel; Sood, Anil K.; Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Gaur, Puja; Gray, Michael J.; Dallas, Nikolaos A.; Bose, Debashish; Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA; [Sood, Anil K.] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA; [Rodriguez-Aguayo, Cristian; Lopez-Berestein, Gabriel] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Lopez-Berestein, Gabriel; Sood, Anil K.; Ellis, Lee M.] Univ Texas MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNA, Houston, TX 77030 USA; [Plowman, Greg; Bagri, Anil] Genentech Inc, Tumor Biol & Angiogenesis, San Francisco, CA 94080 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Roche Holding; Genentech	Samuel, S (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	lellis@mdanderson.org	Plowman, Greg/O-8032-2019; Khaitan, Puja/AAQ-6413-2020	Khaitan, Puja/0000-0001-8654-062X; RODRIGUEZ-AGUAYO, CRISTIAN/0000-0002-7880-7723	R. E. "Bob" Smith Fund for Cancer Research; National Institutes of Health [5 T32 CA09599, R01 CA112390]; Center for RNA Interference and Non-Coding RNA; Ovarian Cancer Research Fund; The William C. Liedtke, Jr., Chair for Cancer Research; Cytometry Core Facility (NIH) [CA16672]; NATIONAL CANCER INSTITUTE [P30CA016672, T32CA009599, R01CA112390] Funding Source: NIH RePORTER	R. E. "Bob" Smith Fund for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for RNA Interference and Non-Coding RNA; Ovarian Cancer Research Fund; The William C. Liedtke, Jr., Chair for Cancer Research; Cytometry Core Facility (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	R. E. "Bob" Smith Fund for Cancer Research (SS); National Institutes of Health grant 5 T32 CA09599 (ND, PG, and DB); the Center for RNA Interference and Non-Coding RNA (GL-B, AS), and a Program Project Development Grant form the Ovarian Cancer Research Fund (GL-B, AS); The William C. Liedtke, Jr., Chair for Cancer Research (LE); National Institutes of Health grant R01 CA112390 (LE). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Genentech, Inc. paid for salary and research infrastructure for their employees GP and AB, but had no role in study design, data collection and analysis, or preparation of the manuscript. Genentech, Inc. approved the publication of the manuscript.; We thank Pablo Elias Vivas-Mejia, Hua Wang, and Huang Li for generation of lentiviral and liposomal reagents. We thank the Cytometry Core Facility (NIH Grant CA16672) at M. D. Anderson Cancer Center for assistance with flow cytometry. We thank Sunita Patterson (Department of Scientific Publications) and Rita Hernandez for editorial assistance.	Caunt M, 2008, CANCER CELL, V13, P331, DOI 10.1016/j.ccr.2008.01.029; Clements WM, 2002, CANCER RES, V62, P3503; Cohen T, 2002, J PATHOL, V198, P77, DOI 10.1002/path.1179; Dallas NA, 2008, CLIN CANCER RES, V14, P8052, DOI 10.1158/1078-0432.CCR-08-1520; Ellis LM, 2010, CLIN CANCER RES, V16, P5365, DOI 10.1158/1078-0432.CCR-10-2550; Fakhari M, 2002, CANCER-AM CANCER SOC, V94, P258, DOI 10.1002/cncr.10177; Gray MJ, 2008, J NATL CANCER I, V100, P109, DOI 10.1093/jnci/djm279; Grum-Schwensen B, 2005, CANCER RES, V65, P3772, DOI 10.1158/0008-5472.CAN-04-4510; Handa A, 2000, INT J ONCOL, V17, P291; Kawakami T, 2002, CANCER, V95, P2196, DOI 10.1002/cncr.10936; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Lantuejoul S, 2003, J PATHOL, V200, P336, DOI 10.1002/path.1367; Mahon PC, 2007, CANCER RES, V67, P6786, DOI 10.1158/0008-5472.CAN-07-0440; Oshima H, 2006, GASTROENTEROLOGY, V131, P1086, DOI 10.1053/j.gastro.2006.07.014; Pan Q, 2007, CANCER CELL, V11, P53, DOI 10.1016/j.ccr.2006.10.018; Sanchez-Carbayo M, 2003, AM J PATHOL, V163, P505, DOI 10.1016/S0002-9440(10)63679-6; Shraga-Heled N, 2007, FASEB J, V21, P915, DOI 10.1096/fj.06-6277com; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Takenaga K, 1997, ONCOGENE, V14, P331, DOI 10.1038/sj.onc.1200820; Tsukamoto Y, 2008, J PATHOL, V216, P471, DOI 10.1002/path.2424; Van Buren G, 2007, CLIN CANCER RES, V13, P4704, DOI 10.1158/1078-0432.CCR-06-2723; Wang LD, 2009, CANCER CELL, V15, P207, DOI 10.1016/j.ccr.2009.01.018	23	26	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e23208	10.1371/journal.pone.0023208	http://dx.doi.org/10.1371/journal.pone.0023208			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028766	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800001
J	Vitoriano, I; Saraiva-Pava, KD; Rocha-Goncalves, A; Santos, A; Lopes, AI; Oleastro, M; Roxo-Rosa, M				Vitoriano, Ines; Saraiva-Pava, Kathy D.; Rocha-Goncalves, Alexandra; Santos, Andrea; Lopes, Ana I.; Oleastro, Monica; Roxo-Rosa, Monica			Ulcerogenic Helicobacter pylori Strains Isolated from Children: A Contribution to Get Insight into the Virulence of the Bacteria	PLOS ONE			English	Article							PEPTIC-ULCER DISEASE; GASTRIC MUCIN SYNTHESIS; GASTRODUODENAL DISEASES; RISK-FACTORS; INFECTION; IDENTIFICATION; ACID; COLONIZATION; METABOLISM; HP0958	Infection with Helicobacter pylori is the major cause for the development of peptic ulcer disease (PUD). In children, with no other etiology for the disease, this rare event occurs shortly after infection. In these young patients, habits of smoking, diet, consumption of alcohol and non-steroid anti-inflammatory drugs and stress, in addition to the genetic susceptibility of the patient, represent a minor influence. Accordingly, the virulence of the implicated H. pylori strain should play a crucial role in the development of PUD. Corroborating this, our in vitro infection assays comparing a pool of five H. pylori strains isolated from children with PUD to a pool of five other pediatric clinical isolates associated with non-ulcer dyspepsia (NUD) showed the greater ability of PUD strains to induce a marked decrease in the viability of gastric cells and to cause severe damage in the cells cytoskeleton as well as an impairment in the production/secretion of mucins. To uncover virulence features, we compared the proteome of these two groups of H. pylori strains. Two-dimensional gel electrophoresis followed by mass-spectrometry allowed us to detect 27 differentially expressed proteins between them. In addition to the presence of genes encoding well established virulence factors, namely cagA, vacAs1, oipA "on'' status, homB and jhp562 genes, the pediatric ulcerogenic strains shared a proteome profile characterized by changes in the abundance of: motility-associated proteins, accounting for higher motility; antioxidant proteins, which may confer increased resistance to inflammation; and enzymes involved in key steps in the metabolism of glucose, amino acids and urea, which may be advantageous to face fluctuations of nutrients. In conclusion, the enhanced virulence of the pediatric ulcerogenic H. pylori strains may result from a synergy between their natural ability to better adapt to the hostile human stomach and the expression of the established virulence factors.	[Vitoriano, Ines; Saraiva-Pava, Kathy D.; Roxo-Rosa, Monica] Univ Catolica Portuguesa, Fac Engn, Rio De Mouro, Portugal; [Rocha-Goncalves, Alexandra] Univ Coimbra, Dept Quim, Coimbra, Portugal; [Santos, Andrea; Oleastro, Monica] Inst Nacl Saude Dr Ricardo Jorge, Dept Doencas Infecciosas, Lisbon, Portugal; [Lopes, Ana I.] Hosp Univ Santa Maria, Fac Med Lisboa, Dept Pediat, Lisbon, Portugal	Universidade Catolica Portuguesa; Universidade de Coimbra; Instituto Nacional de Saude Dr. Ricardo Jorge; Universidade de Lisboa; Hospital Santa Maria	Vitoriano, I (corresponding author), Univ Catolica Portuguesa, Fac Engn, Rio De Mouro, Portugal.	roxorosa@hotmail.com	Roxo-Rosa, Mónica/J-7890-2013; lopes, ana isabel g c f/R-2042-2017	/0000-0002-9575-2592; Roxo-Rosa, Monica/0000-0002-5719-039X; Oleastro, Monica/0000-0001-6360-2576; Santos, Andrea/0000-0002-5857-8599	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal [PPCDT/SAL-IMI/57297/2004]; FCT [SFRH/BD/38634/2007, SFRH/BD/72849/2011]	Fundacao para a Ciencia e a Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by PPCDT/SAL-IMI/57297/2004 research grant from the Fundacao para a Ciencia e a Tecnologia (FCT), Portugal. I. Vitoriano and K.D. Saraiva-Pava are the recipients of doctoral fellowships (SFRH/BD/38634/2007, FCT and SFRH/BD/72849/2011, respectively). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREICA V, 1990, GASTROEN CLIN BIOL, V14, P437; Ang S, 2001, INFECT IMMUN, V69, P1679, DOI 10.1128/IAI.69.3.1679-1686.2001; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8; Basque JR, 2001, J CELL BIOCHEM, V81, P241, DOI 10.1002/1097-4644(20010501)81:2&lt;241::AID-JCB1039&gt;3.0.CO;2-B; Bottomley JR, 1996, BIOCHEM J, V319, P559, DOI 10.1042/bj3190559; Byrd JC, 2000, GASTROENTEROLOGY, V118, P1072, DOI 10.1016/S0016-5085(00)70360-X; Byrd JC, 2000, WORLD J GASTROENTERO, V6, P475; Chalker AF, 2001, J BACTERIOL, V183, P1259, DOI 10.1128/JB.183.4.1259-1268.2001; Cornally D, 2008, FEBS J, V275, P3041, DOI 10.1111/j.1742-4658.2008.06456.x; CorthesyTheulaz IE, 1997, J BIOL CHEM, V272, P25659, DOI 10.1074/jbc.272.41.25659; D'Elios MM, 2007, CLIN CHIM ACTA, V381, P32, DOI 10.1016/j.cca.2007.02.026; Doig P, 1999, MICROBIOL MOL BIOL R, V63, P675, DOI 10.1128/MMBR.63.3.675-707.1999; Douillard FP, 2008, J BACTERIOL, V190, P7975, DOI 10.1128/JB.00879-08; Gao L, 2009, CANCER RES, V69, P6164, DOI 10.1158/0008-5472.CAN-09-0596; HUGHES NJ, 1995, J BACTERIOL, V177, P3953, DOI 10.1128/jb.177.14.3953-3959.1995; Icatlo FC, 2000, GASTROENTEROLOGY, V119, P358, DOI 10.1053/gast.2000.9372; Kalach N, 2010, EUR J GASTROEN HEPAT, V22, P1174, DOI 10.1097/MEG.0b013e32833d36de; Kelly DJ, 2001, J APPL MICROBIOL, V90, p16S, DOI 10.1046/j.1365-2672.2001.01350.x; Konturek PC, 2009, J PHYSIOL PHARMACOL, V60, P3; Krah A, 2004, INT J CANCER, V108, P456, DOI 10.1002/ijc.11557; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Lai LH, 2007, BEST PRACT RES CL GA, V21, P261, DOI 10.1016/j.bpg.2006.10.002; Leduc D, 2010, INFECT IMMUN, V78, P2782, DOI 10.1128/IAI.00149-10; Linden S, 2010, HELICOBACTER, V15, P251, DOI 10.1111/j.1523-5378.2010.00765.x; Loke MF, 2007, FEMS IMMUNOL MED MIC, V50, P231, DOI 10.1111/j.1574-695X.2007.00248.x; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Marais A, 1999, MICROBIOL MOL BIOL R, V63, P642, DOI 10.1128/MMBR.63.3.642-674.1999; Mendz GL, 1996, MICROBIOL-UK, V142, P2959, DOI 10.1099/13500872-142-10-2959; Merrell DS, 2003, INFECT IMMUN, V71, P6510, DOI 10.1128/IAI.71.11.6510-6525.2003; Mouery K, 2006, J BACTERIOL, V188, P5494, DOI 10.1128/JB.00366-06; Oleastro M, 2006, INFECT IMMUN, V74, P4064, DOI 10.1128/IAI.00123-06; Oleastro M, 2008, J INFECT DIS, V198, P1379, DOI 10.1086/592166; Oleastro M, 2011, J ANTIMICROB CHEMOTH, V66, P2308, DOI 10.1093/jac/dkr293; Oleastro M, 2011, HELICOBACTER, V16, P363, DOI 10.1111/j.1523-5378.2011.00858.x; Oleastro M, 2010, J CLIN MICROBIOL, V48, P2885, DOI 10.1128/JCM.00401-10; Oleastro M, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-12; Ottemann KM, 2002, INFECT IMMUN, V70, P1984, DOI 10.1128/IAI.70.4.1984-1990.2002; Pereira L, 2005, J BACTERIOL, V187, P4463, DOI 10.1128/JB.187.13.4463-4469.2005; Pyndiah S, 2007, MOL CELL PROTEOMICS, V6, P193, DOI 10.1074/mcp.M600363-MCP200; Ryan KA, 2005, FEMS MICROBIOL LETT, V248, P47, DOI 10.1016/j.femsle.2005.05.022; SCHUBERT TT, 1993, AM J MED, V94, P413, DOI 10.1016/0002-9343(93)90153-G; St Maurice M, 2007, J BACTERIOL, V189, P4764, DOI 10.1128/JB.00287-07; Stingl K, 2005, INT J MED MICROBIOL, V295, P307, DOI 10.1016/j.ijmm.2005.06.006; Sycuro LK, 2010, CELL, V141, P822, DOI 10.1016/j.cell.2010.03.046; Vitoriano I, 2011, HELICOBACTER, V16, P153, DOI 10.1111/j.1523-5378.2011.00825.x; Waidner B, 2002, INFECT IMMUN, V70, P3923, DOI 10.1128/IAI.70.7.3923-3929.2002; Waidner B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000669; WALSH JH, 1995, NEW ENGL J MED, V333, P984, DOI 10.1056/NEJM199510123331508; Wang G, 2006, INFECT IMMUN, V74, P6839, DOI 10.1128/IAI.00991-06; Wang G, 2006, MOL MICROBIOL, V61, P847, DOI 10.1111/j.1365-2958.2006.05302.x; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107	52	14	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26265	10.1371/journal.pone.0026265	http://dx.doi.org/10.1371/journal.pone.0026265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039453	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500046
J	Ding, D; Li, WH; Song, GL; Qi, HY; Liu, JB; Tang, JH				Ding, Dong; Li, Weihua; Song, Guiliang; Qi, Hongyuan; Liu, Jingbao; Tang, Jihua			Identification of QTLs for Arsenic Accumulation in Maize (Zea mays L.) Using a RIL Population	PLOS ONE			English	Article							ORYZA-SATIVA L.; OXIDATIVE STRESS; PHOSPHATE-TRANSPORT; HOLCUS-LANATUS; CHEMICAL FORM; WEST-BENGAL; PADDY RICE; GROWTH; TOLERANCE; CONTAMINATION	The Arsenic (As) concentration in different tissues of maize was analyzed using a set of RIL populations derived from an elite hybrid, Nongda108. The results showed that the trend of As concentration in the four measured tissues was leaves>stems>bracts>kernels. Eleven QTLs for As concentration were detected in the four tissues. Three QTLs for As concentration in leaves were mapped on chromosomes 1, 5, and 8, respectively. For As concentration in the bracts, two QTLs were identified, with 9.61% and 10.03% phenotypic variance. For As concentration in the stems, three QTLs were detected with 8.24%, 14.86%, and 15.23% phenotypic variance. Three QTLs were identified for kernels on chromosomes 3, 5, and 7, respectively, with 10.73%, 8.52%, and 9.10% phenotypic variance. Only one common chromosomal region between SSR marker bnlg1811 and umc1243 was detected for QTLs qLAV1 and qSAC1. The results implied that the As accumulation in different tissues in maize was controlled by different molecular mechanism. The study demonstrated that maize could be a useful plant for phytoremediation of As-contaminated paddy soil, and the QTLs will be useful for selecting inbred lines and hybrids with low As concentration in their kernels.	[Ding, Dong; Li, Weihua; Song, Guiliang; Qi, Hongyuan; Tang, Jihua] Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China; [Liu, Jingbao] Huazhong Agr Univ, Coll Plant Sci & Technol, Wuhan, Peoples R China	Henan Agricultural University; Huazhong Agricultural University	Ding, D (corresponding author), Henan Agr Univ, Coll Agron, Key Lab Physiol Ecol & Genet Improvement Food Cro, Zhengzhou, Peoples R China.	Tangjihua1@163.com			National Nature Foundation of China [30871537]; Major State Basic Research Development Program of China [2009CB118401]	National Nature Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program of China(National Basic Research Program of China)	This work was supported by a grant from the National Nature Foundation of China (30871537) and the Major State Basic Research Development Program of China (2009CB118401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedin MJ, 2002, PLANT SOIL, V240, P311, DOI 10.1023/A:1015792723288; Abedin MJ, 2002, PLANT SOIL, V243, P57, DOI 10.1023/A:1019918100451; Abercrombie JM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-87; Alam MGM, 2003, SCI TOTAL ENVIRON, V308, P83, DOI 10.1016/S0048-9697(02)00651-4; Baig JA, 2010, FOOD CHEM TOXICOL, V48, P3051, DOI 10.1016/j.fct.2010.07.043; BARRACHINA AC, 1995, J PLANT NUTR, V18, P1237, DOI 10.1080/01904169509364975; Carbonell-Barrachina AA, 1998, PLANT SOIL, V198, P33, DOI 10.1023/A:1004285625998; Catarecha P, 2007, PLANT CELL, V19, P1123, DOI 10.1105/tpc.106.041871; Chowdhury UK, 2000, ENVIRON HEALTH PERSP, V108, P393, DOI 10.2307/3454378; Clemens S, 1999, EMBO J, V18, P3325, DOI 10.1093/emboj/18.12.3325; Cobbett C, 2002, ANNU REV PLANT BIOL, V53, P159, DOI 10.1146/annurev.arplant.53.100301.135154; Cox MS, 1996, J PLANT NUTR, V19, P1599, DOI 10.1080/01904169609365224; CULLEN WR, 1989, CHEM REV, V89, P713, DOI 10.1021/cr00094a002; Dasgupta T, 2004, NEW PHYTOL, V163, P45, DOI 10.1111/j.1469-8137.2004.01109.x; Hartley-Whitaker J, 2001, PLANT CELL ENVIRON, V24, P713, DOI 10.1046/j.0016-8025.2001.00721.x; Huang RQ, 2006, SCI TOTAL ENVIRON, V368, P531, DOI 10.1016/j.scitotenv.2006.03.013; Kabata-Pendias A., 1992, TRACE ELEMENTS SOIL; Kamiya T, 2009, J BIOL CHEM, V284, P2114, DOI 10.1074/jbc.M806881200; Kang LiJuan, 1996, Journal of Jilin Agricultural University, V18, P58; Knauer K, 1999, AQUAT TOXICOL, V46, P221, DOI 10.1016/S0166-445X(98)00131-3; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Liao XY, 2005, ENVIRON INT, V31, P791, DOI 10.1016/j.envint.2005.05.030; Liu WJ, 2006, ENVIRON SCI TECHNOL, V40, P5730, DOI 10.1021/es060800v; Liu XL, 2005, CHEMOSPHERE, V61, P293, DOI 10.1016/j.chemosphere.2005.01.088; Ma JF, 2008, P NATL ACAD SCI USA, V105, P9931, DOI 10.1073/pnas.0802361105; MARIN AR, 1993, J PLANT NUTR, V16, P865, DOI 10.1080/01904169309364580; MARIN AR, 1992, PLANT SOIL, V139, P175, DOI 10.1007/BF00009308; MARIN AR, 1993, PLANT SOIL, V152, P245, DOI 10.1007/BF00029094; Meharg AA, 2004, TRENDS PLANT SCI, V9, P415, DOI 10.1016/j.tplants.2004.07.002; Meharg AA, 2003, NEW PHYTOL, V157, P39, DOI 10.1046/j.1469-8137.2003.00655.x; Meharg AA, 2001, ARS AS PAC REG WORKS, P45; Mylona PV, 1998, FREE RADICAL BIO MED, V25, P576, DOI 10.1016/S0891-5849(98)00090-2; Nickson R, 1998, NATURE, V395, P338, DOI 10.1038/26387; Norton GJ, 2008, J EXP BOT, V59, P2277, DOI 10.1093/jxb/ern098; ODANAKA Y, 1987, J PESTIC SCI, V12, P199; Pilon-Smits E, 2005, ANNU REV PLANT BIOL, V56, P15, DOI 10.1146/annurev.arplant.56.032604.144214; Quaghebeur M, 2003, PLANT PHYSIOL, V132, P1600, DOI 10.1104/pp.103.021741; Rahman MA, 2007, CHEMOSPHERE, V69, P942, DOI 10.1016/j.chemosphere.2007.05.044; Rahman MA, 2007, CHEMOSPHERE, V67, P1072, DOI 10.1016/j.chemosphere.2006.11.061; Rahman MA, 2006, SCI TOTAL ENVIRON, V370, P51, DOI 10.1016/j.scitotenv.2006.05.018; Requejo R, 2005, PHYTOCHEMISTRY, V66, P1519, DOI 10.1016/j.phytochem.2005.05.003; Roychowdhury T, 2003, SCI TOTAL ENVIRON, V308, P15, DOI 10.1016/S0048-9697(02)00612-5; SCOTT N, 1993, CHEM RES TOXICOL, V6, P102, DOI 10.1021/tx00031a016; Shin H, 2004, PLANT J, V39, P629, DOI 10.1111/j.1365-313X.2004.02161.x; Shri M, 2009, ECOTOX ENVIRON SAFE, V72, P1102, DOI 10.1016/j.ecoenv.2008.09.022; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Smith E, 2008, SCI TOTAL ENVIRON, V392, P277, DOI 10.1016/j.scitotenv.2007.11.023; Stone R, 2008, SCIENCE, V321, P184, DOI 10.1126/science.321.5886.184; Sung DY, 2009, PLANT J, V59, P802, DOI 10.1111/j.1365-313X.2009.03914.x; TAKAMATSU T, 1982, SOIL SCI, V133, P239, DOI 10.1097/00010694-198204000-00007; TSUTSUMI M, 1980, SOIL SCI PLANT NUTR, V26, P561, DOI 10.1080/00380768.1980.10431243; Ullah S. M., 1998, INT C ARS POLL GROUN; ULLRICHEBERIUS CI, 1989, J EXP BOT, V40, P119, DOI 10.1093/jxb/40.1.119; Williams PN, 2006, ENVIRON SCI TECHNOL, V40, P4903, DOI 10.1021/es060222i; Wu C, 2011, J EXPT BOT, V3, P1; Xie HL, 2010, GENES GENOM, V32, P55, DOI 10.1007/s13258-010-0801-3; ZENG ZB, 1994, GENETICS, V136, P1457; Zhu YG, 2008, ENVIRON SCI TECHNOL, V42, P5008, DOI 10.1021/es8001103	61	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25646	10.1371/journal.pone.0025646	http://dx.doi.org/10.1371/journal.pone.0025646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028786	Green Published, gold, Green Submitted			2022-12-27	WOS:000296186900015
J	Hu, G; Qiu, WY; Ceulemans, A				Hu, Guang; Qiu, Wen-Yuan; Ceulemans, Arnout			A New Euler's Formula for DNA Polyhedra	PLOS ONE			English	Article							MOLECULAR DESIGN; ARCHITECTURE; TOPOLOGY	DNA polyhedra are cage-like architectures based on interlocked and interlinked DNA strands. We propose a formula which unites the basic features of these entangled structures. It is based on the transformation of the DNA polyhedral links into Seifert surfaces, which removes all knots. The numbers of components mu, of crossings c, and of Seifert circles s are related by a simple and elegant formula: s+mu = c+2. This formula connects the topological aspects of the DNA cage to the Euler characteristic of the underlying polyhedron. It implies that Seifert circles can be used as effective topological indices to describe polyhedral links. Our study demonstrates that, the new Euler's formula provides a theoretical framework for the stereo-chemistry of DNA polyhedra, which can characterize enzymatic transformations of DNA and be used to characterize and design novel cages with higher genus.	[Hu, Guang] Lanzhou Univ, State Key Lab Appl Organ Chem, Dept Chem, Lanzhou 730000, Peoples R China; [Hu, Guang; Ceulemans, Arnout] Katholieke Univ Leuven, Dept Chem, Louvain, Belgium; [Hu, Guang; Ceulemans, Arnout] Katholieke Univ Leuven, INPAC Inst Nanoscale Phys & Chem, Louvain, Belgium	Lanzhou University; KU Leuven; KU Leuven	Hu, G (corresponding author), Lanzhou Univ, State Key Lab Appl Organ Chem, Dept Chem, Lanzhou 730000, Peoples R China.	wyqiu@lzu.edu.cn	Hu, Guang/B-2909-2012	Hu, Guang/0000-0002-8754-1541	National Natural Science Foundation of China [20973085, 10831001]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20090211110006]; Leuven INPAC institute	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Leuven INPAC institute	This work was supported by grants from the National Natural Science Foundation of China (Nos. 20973085 and 10831001) and Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20090211110006). Financial support from the Leuven INPAC institute is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldaye FA, 2008, SCIENCE, V321, P1795, DOI 10.1126/science.1154533; Andersen FF, 2008, NUCLEIC ACIDS RES, V36, P1113, DOI 10.1093/nar/gkm1124; [Anonymous], 2008, EULERS GEM POLYHEDRO; Castle T, 2009, NEW J CHEM, V33, P2107, DOI 10.1039/b907338h; CEULEMANS A, 1991, NATURE, V353, P52, DOI 10.1038/353052a0; CHEN JH, 1991, NATURE, V350, P631, DOI 10.1038/350631a0; CRONWELL PR, 2004, KNOTS LINKS; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Goodman RP, 2005, SCIENCE, V310, P1661, DOI 10.1126/science.1120367; GRUNBAUM B, 1973, CONVEX POLYTOPES; He Y, 2009, ANGEW CHEM INT EDIT, V48, P128, DOI 10.1002/anie.200802230; He Y, 2008, NATURE, V452, P198, DOI 10.1038/nature06597; Hu G, 2011, B MATH BIOL, V73, P3030, DOI 10.1007/s11538-011-9659-z; Hu GA, 2010, J MATH CHEM, V48, P401, DOI 10.1007/s10910-010-9682-6; Hu G, 2009, J MATH CHEM, V46, P592, DOI 10.1007/s10910-008-9487-z; Hyde ST, 2007, ACTA CRYSTALLOGR A, V63, P186, DOI 10.1107/S0108767306052421; Jablan S., POLYHEDRAL KNOTS LIN; Jonoska N, 2002, LNCS, V340, P70; JONOSKA N, 2008, J PHYS A, V14; Lijnen E, 2005, J CHEM INF MODEL, V45, P1719, DOI 10.1021/ci0502496; NEUWIRTH L, 1979, SCI AM, V240, P110, DOI 10.1038/scientificamerican0679-110; Oliveira CLP, 2010, ACS NANO, V4, P1367, DOI 10.1021/nn901510v; Qiu WY, 2010, DNA PROP MODIF FUNCT, P1; Qiu WY, 2008, SCI CHINA SER B, V51, P13, DOI 10.1007/s11426-008-0018-3; Qiu WY, 2000, MATH CHEM S, V6, P175; Qiu WY, 2005, J MOL STRUC-THEOCHEM, V756, P163, DOI 10.1016/j.theochem.2005.09.014; QIU WY, 2010, MATH CHEM CHEM RES A, P327; Seifert H, 1935, MATH ANN, V110, P571, DOI 10.1007/BF01448044; Zhang C, 2008, P NATL ACAD SCI USA, V105, P10665, DOI 10.1073/pnas.0803841105; Zhang CA, 2009, FARADAY DISCUSS, V143, P221, DOI 10.1039/b905313c; Zhang C, 2009, J AM CHEM SOC, V131, P1413, DOI 10.1021/ja809666h; [No title captured]	33	26	27	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26308	10.1371/journal.pone.0026308	http://dx.doi.org/10.1371/journal.pone.0026308			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022596	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400045
J	Vuononvirta, J; Toivonen, L; Grondahl-Yli-Hannuksela, K; Barkoff, AM; Lindholm, L; Mertsola, J; Peltola, V; He, QS				Vuononvirta, Juho; Toivonen, Laura; Grondahl-Yli-Hannuksela, Kirsi; Barkoff, Alex-Mikael; Lindholm, Laura; Mertsola, Jussi; Peltola, Ville; He, Qiushui			Nasopharyngeal Bacterial Colonization and Gene Polymorphisms of Mannose-Binding Lectin and Toll-Like Receptors 2 and 4 in Infants	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; RESPIRATORY-TRACT INFECTIONS; STREPTOCOCCUS-PNEUMONIAE; MICROBIAL INTERACTIONS; MORAXELLA-CATARRHALIS; STAPHYLOCOCCUS-AUREUS; OTITIS-MEDIA; ASSOCIATION; CHILDREN; SUSCEPTIBILITY	Background: Human nasopharynx is often colonized by potentially pathogenic bacteria. Gene polymorphisms in mannose-binding lectin (MBL), toll-like receptor (TLR) 2 and TLR4 have been reported. The present study aimed to investigate possible association between nasopharyngeal bacterial colonization and gene polymorphisms of MBL, TLR2 and TLR4 in healthy infants. Methodology/Principal Findings: From August 2008 to June 2010, 489 nasopharyngeal swabs and 412 blood samples were taken from 3-month-old healthy Finnish infants. Semi-quantitative culture was performed and pyrosequencing was used for detection of polymorphisms in MBL structural gene at codons 52, 54, and 57, TLR2 Arg753Gln and TLR4 Asp299Gly. Fifty-nine percent of subjects were culture positive for at least one of the four species: 11% for Streptococcus pneumoniae, 23% for Moraxella catarrhalis, 1% for Haemophilus influenzae and 25% for Staphylococcus aureus. Thirty-two percent of subjects had variant types in MBL, 5% had polymorphism of TLR2, and 18% had polymorphism of TLR4. Colonization rates of S. pneumoniae and S. aureus were significantly higher in infants with variant types of MBL than those with wild type (p = .011 and p = .024). Colonization rates of S. aureus and M. catarrhalis were significantly higher in infants with polymorphisms of TLR2 and of TLR4 than those without (p = .027 and p = .002). Conclusions: Our study suggests that there is an association between nasopharyngeal bacterial colonization and genetic variation of MBL, TLR2 and TLR4 in young infants. This finding supports a role for these genetic variations in susceptibility of children to respiratory infections.	[Vuononvirta, Juho; Grondahl-Yli-Hannuksela, Kirsi; Barkoff, Alex-Mikael; He, Qiushui] Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Turku, Finland; [Toivonen, Laura; Mertsola, Jussi; Peltola, Ville] Turku Univ Hosp, Dept Pediat, FIN-20520 Turku, Finland; [Toivonen, Laura; Peltola, Ville] Univ Turku, Turku Inst Child & Youth Res, Turku, Finland; [Lindholm, Laura] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland	Finland National Institute for Health & Welfare; University of Turku; University of Turku; University of Turku	Vuononvirta, J (corresponding author), Natl Inst Hlth & Welf, Dept Infect Dis Surveillance & Control, Turku, Finland.	qiushui.he@thl.fi	Mertsola, Jussi/AAE-3460-2021		Academy of Finland; Special Governmental Fund for University Hospitals (EVO)	Academy of Finland(Academy of Finland); Special Governmental Fund for University Hospitals (EVO)	This work was supported by the Academy of Finland and the Special Governmental Fund for University Hospitals (EVO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad-Nejad Parviz, 2009, V496, P73, DOI 10.1007/978-1-59745-553-4_7; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Dahl MR, 2001, IMMUNITY, V15, P127, DOI 10.1016/S1074-7613(01)00161-3; Dommett RM, 2006, TISSUE ANTIGENS, V68, P193, DOI 10.1111/j.1399-0039.2006.00649.x; El-Helou O, 2011, HUM IMMUNOL, V72, P47, DOI 10.1016/j.humimm.2010.10.001; Harrison LM, 1999, FEMS IMMUNOL MED MIC, V25, P19, DOI 10.1111/j.1574-695X.1999.tb01323.x; Hong J, 2007, J GASTROEN HEPATOL, V22, P1760, DOI 10.1111/j.1440-1746.2006.04727.x; Jack DL, 2001, IMMUNOL REV, V180, P86, DOI 10.1034/j.1600-065X.2001.1800108.x; Jourdain S, 2011, CLIN MICROBIOL INFEC, V17, P907, DOI 10.1111/j.1469-0691.2010.03410.x; Koch A, 2001, JAMA-J AM MED ASSOC, V285, P1316, DOI 10.1001/jama.285.10.1316; LEACH AJ, 1994, PEDIATR INFECT DIS J, V13, P983, DOI 10.1097/00006454-199411000-00009; Lebon A, 2011, CLIN VACCINE IMMUNOL, V18, P180, DOI 10.1128/CVI.00357-10; Lofgren J, 2010, PEDIATR PULM, V45, P687, DOI 10.1002/ppul.21248; Lorenz E, 2000, INFECT IMMUN, V68, P6398, DOI 10.1128/IAI.68.11.6398-6401.2000; Merx S, 2007, HUM MOL GENET, V16, P1225, DOI 10.1093/hmg/ddm070; Murphy TF, 2009, PEDIATR INFECT DIS J, V28, pS121, DOI 10.1097/INF.0b013e3181b6d7ec; Murphy TF, 2009, CLIN INFECT DIS, V49, P124, DOI 10.1086/599375; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Rantala A, 2008, J INFECT DIS, V198, P1247, DOI 10.1086/591912; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Regev-Yochay G, 2006, J BACTERIOL, V188, P4996, DOI 10.1128/JB.00317-06; Rock FL, 1998, P NATL ACAD SCI USA, V95, P588, DOI 10.1073/pnas.95.2.588; Roos A, 2006, J IMMUNOL METHODS, V309, P108, DOI 10.1016/j.jim.2005.11.017; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Syrjanen RK, 2001, J INFECT DIS, V184, P451, DOI 10.1086/322048; Takahashi K, 2006, CURR OPIN IMMUNOL, V18, P16, DOI 10.1016/j.coi.2005.11.014; Vergison A, 2010, LANCET INFECT DIS, V10, P195, DOI 10.1016/S1473-3099(10)70012-8; Verhaegh SJC, 2010, CLIN MICROBIOL INFEC, V16, P992, DOI 10.1111/j.1469-0691.2009.03008.x; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Weyrich P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013980; Wochrle T, 2008, CYTOKINE, V41, P322, DOI 10.1016/j.cyto.2007.12.006	33	51	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26198	10.1371/journal.pone.0026198	http://dx.doi.org/10.1371/journal.pone.0026198			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022564	Green Submitted, Green Published, gold			2022-12-27	WOS:000295978600044
J	Mayoral, RJ; Deho, L; Rusca, N; Bartonicek, N; Saini, HK; Enright, AJ; Monticelli, S				Mayoral, Ramon J.; Deho, Lorenzo; Rusca, Nicole; Bartonicek, Nenad; Saini, Harpreet Kaur; Enright, Anton J.; Monticelli, Silvia			MiR-221 Influences Effector Functions and Actin Cytoskeleton in Mast Cells	PLOS ONE			English	Article							SYSTEMIC MASTOCYTOSIS; MICRORNA CONTROL; IMMUNE-SYSTEM; KIT RECEPTOR; EXPRESSION; DIFFERENTIATION; ERYTHROPOIESIS; ACTIVATION; SEQUENCES; SURVIVAL	Mast cells have essential effector and immunoregulatory functions in IgE-associated allergic disorders and certain innate and adaptive immune responses, but the role of miRNAs in regulating mast cell functions is almost completely unexplored. To examine the role of the activation-induced miRNA miR-221 in mouse mast cells, we developed robust lentiviral systems for miRNA overexpression and depletion. While miR-221 favored mast cell adhesion and migration towards SCF or antigen in trans-well migration assays, as well as cytokine production and degranulation in response to IgE-antigen complexes, neither miR-221 overexpression, nor its ablation, interfered with mast cell differentiation. Transcriptional profiling of miR-221-overexpressing mast cells revealed modulation of many transcripts, including several associated with the cytoskeleton; indeed, miR-221 overexpression was associated with reproducible increases in cortical actin in mast cells, and with altered cellular shape and cell cycle in murine fibroblasts. Our bioinformatics analysis showed that this effect was likely mediated by the composite effect of miR-221 on many primary and secondary targets in resting cells. Indeed, miR-221-induced cellular alterations could not be recapitulated by knockdown of one of the major targets of miR-221. We propose a model in which miR-221 has two different roles in mast cells: in resting cells, basal levels of miR-221 contribute to the regulation of the cell cycle and cytoskeleton, a general mechanism probably common to other miR-221-expressing cell types, such as fibroblasts. Vice versa, upon induction in response to mast cell stimulation, miR-221 effects are mast cell-specific and activation-dependent, contributing to the regulation of degranulation, cytokine production and cell adherence. Our studies provide new insights into the roles of miR-221 in mast cell biology, and identify novel mechanisms that may contribute to mast cell-related pathological conditions, such as asthma, allergy and mastocytosis.	[Mayoral, Ramon J.; Deho, Lorenzo; Rusca, Nicole; Monticelli, Silvia] Inst Res Biomed, Bellinzona, Switzerland; [Bartonicek, Nenad; Saini, Harpreet Kaur; Enright, Anton J.] EMBL European Bioinformat Inst, Cambridge, England	Universita della Svizzera Italiana; European Molecular Biology Laboratory (EMBL)	Mayoral, RJ (corresponding author), Inst Res Biomed, Bellinzona, Switzerland.	silvia.monticelli@irb.unisi.ch	Bartonicek, Nenad/B-6675-2016; Enright, Anton/F-3094-2011; Monticelli, Silvia/ABE-7054-2020; Saini, Harpreet/F-3882-2011	Bartonicek, Nenad/0000-0003-2144-1887; Enright, Anton/0000-0002-6090-3100; Saini, Harpreet/0000-0002-3733-7657; Monticelli, Silvia/0000-0002-5909-8802	San Raffaele University (Italy); Swiss National Science Foundation [31003A_121991]	San Raffaele University (Italy); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	RJM was the recipient of a pre-doctoral fellowship from the San Raffaele University (Italy). This work was supported by the Swiss National Science Foundation grant 31003A_121991 to SM and by a contribution from the Ceresio Foundation (Switzerland) to SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bartonicek N, 2010, BIOINFORMATICS; Bartonicek N, 2010, BIOINFORMAT IN PRESS; Belletti B, 2010, MOL CELL BIOL, V30, P2229, DOI 10.1128/MCB.00723-09; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Besson A, 2004, GENE DEV, V18, P862, DOI 10.1101/gad.1185504; Blank U, 2006, CURR PROTOC CELL BIO; Brown BD, 2009, NAT REV GENET, V10, P578, DOI 10.1038/nrg2628; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Deho' L, 2010, ARCH IMMUNOL THER EX, V58, P279, DOI 10.1007/s00005-010-0086-x; Demo SD, 1999, CYTOMETRY, V36, P340, DOI 10.1002/(SICI)1097-0320(19990801)36:4<340::AID-CYTO9>3.0.CO;2-C; Doulatov S, 2009, GENE DEV, V23, P2076, DOI 10.1101/gad.1788109; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Galli SJ, 2010, EUR J IMMUNOL, V40, P1843, DOI 10.1002/eji.201040559; Gentner B, 2009, NAT METHODS, V6, P63, DOI [10.1038/NMETH.1277, 10.1038/nmeth.1277]; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hollmann TJ, 2008, AM J SURG PATHOL, V32, P139, DOI 10.1097/PAS.0b013e3180ca9a02; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Kanellopoulou C, 2008, SEMIN CANCER BIOL, V18, P79, DOI 10.1016/j.semcancer.2008.01.002; Kawakami T, 2002, NAT REV IMMUNOL, V2, P773, DOI 10.1038/nri914; Kondo M, 2003, ANNU REV IMMUNOL, V21, P759, DOI 10.1146/annurev.immunol.21.120601.141007; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu S, 2011, IMMUNOL CELL BIOL; Mayerhofer M, 2008, J IMMUNOL, V180, P5466, DOI 10.4049/jimmunol.180.8.5466; Mayoral RJ, 2010, METHODS MOL BIOL, V667, P205, DOI 10.1007/978-1-60761-811-9_14; Mayoral RJ, 2009, J IMMUNOL, V182, P433, DOI 10.4049/jimmunol.182.1.433; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Navarro F, 2010, J IMMUNOL, V184, P5939, DOI 10.4049/jimmunol.0902567; RAZIN E, 1984, J IMMUNOL, V132, P1479; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shelburne CP, 2001, IMMUNOL REV, V179, P82, DOI 10.1034/j.1600-065X.2001.790109.x; Sotlar K, 2004, AM J SURG PATHOL, V28, P1319, DOI 10.1097/01.pas.0000138181.89743.7b; Spinello I, 2009, ONCOGENE, V28, P2276, DOI 10.1038/onc.2009.87; Teodosio C, 2010, J ALLERGY CLIN IMMUN, V125, P719, DOI 10.1016/j.jaci.2009.10.020; Thomas-Chollier M, 2008, NUCLEIC ACIDS RES, V36, pW119, DOI 10.1093/nar/gkn304; van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267; Xiang Z, 2001, J EXP MED, V194, P1561, DOI 10.1084/jem.194.11.1561; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zappulla JP, 2005, J EXP MED, V202, P1635, DOI 10.1084/jem.20050807	43	69	75	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26133	10.1371/journal.pone.0026133	http://dx.doi.org/10.1371/journal.pone.0026133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022537	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000072
J	Sheridan, SD; Theriault, KM; Reis, SA; Zhou, F; Madison, JM; Daheron, L; Loring, JF; Haggarty, SJ				Sheridan, Steven D.; Theriault, Kraig M.; Reis, Surya A.; Zhou, Fen; Madison, Jon M.; Daheron, Laurence; Loring, Jeanne F.; Haggarty, Stephen J.			Epigenetic Characterization of the FMR1 Gene and Aberrant Neurodevelopment in Human Induced Pluripotent Stem Cell Models of Fragile X Syndrome	PLOS ONE			English	Article							REPEAT EXPANSION; MESSENGER-RNA; METHYLATION; DIFFERENTIATION; PROTEIN; INVOLVEMENT; INSTABILITY; EXPRESSION; MECHANISM; ALLELES	Fragile X syndrome (FXS) is the most common inherited cause of intellectual disability. In addition to cognitive deficits, FXS patients exhibit hyperactivity, attention deficits, social difficulties, anxiety, and other autistic-like behaviors. FXS is caused by an expanded CGG trinucleotide repeat in the 59 untranslated region of the Fragile X Mental Retardation (FMR1) gene leading to epigenetic silencing and loss of expression of the Fragile X Mental Retardation protein (FMRP). Despite the known relationship between FMR1 CGG repeat expansion and FMR1 silencing, the epigenetic modifications observed at the FMR1 locus, and the consequences of the loss of FMRP on human neurodevelopment and neuronal function remain poorly understood. To address these limitations, we report on the generation of induced pluripotent stem cell (iPSC) lines from multiple patients with FXS and the characterization of their differentiation into post-mitotic neurons and glia. We show that clones from reprogrammed FXS patient fibroblast lines exhibit variation with respect to the predominant CGG-repeat length in the FMR1 gene. In two cases, iPSC clones contained predominant CGG-repeat lengths shorter than measured in corresponding input population of fibroblasts. In another instance, reprogramming a mosaic patient having both normal and pre-mutation length CGG repeats resulted in genetically matched iPSC clonal lines differing in FMR1 promoter CpG methylation and FMRP expression. Using this panel of patient-specific, FXS iPSC models, we demonstrate aberrant neuronal differentiation from FXS iPSCs that is directly correlated with epigenetic modification of the FMR1 gene and a loss of FMRP expression. Overall, these findings provide evidence for a key role for FMRP early in human neurodevelopment prior to synaptogenesis and have implications for modeling of FXS using iPSC technology. By revealing disease-associated cellular phenotypes in human neurons, these iPSC models will aid in the discovery of novel therapeutics for FXS and other autism-spectrum disorders sharing common pathophysiology.	[Sheridan, Steven D.; Theriault, Kraig M.; Reis, Surya A.; Zhou, Fen; Madison, Jon M.; Haggarty, Stephen J.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02115 USA; [Sheridan, Steven D.; Reis, Surya A.; Zhou, Fen; Madison, Jon M.; Haggarty, Stephen J.] Broad Inst Harvard & Massachusetts Inst Technol, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Daheron, Laurence] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Daheron, Laurence] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Loring, Jeanne F.] Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Scripps Research Institute	Sheridan, SD (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Human Genet Res, Boston, MA 02115 USA.	haggarty@chgr.mgh.harvard.edu	Haggarty, Stephen J/M-9495-2016; Loring, Jeanne F/A-1620-2011	Haggarty, Stephen J/0000-0002-7872-168X; Loring, Jeanne F/0000-0001-6226-9767	FRAXA Research Foundation; Harvard Stem Cell Institute; Stanley Medical Research Institute; National Institute Of Mental Health [R33MH087896]; NATIONAL INSTITUTE OF MENTAL HEALTH [R33MH087896, R21MH087896] Funding Source: NIH RePORTER	FRAXA Research Foundation; Harvard Stem Cell Institute; Stanley Medical Research Institute; National Institute Of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported in part by the FRAXA Research Foundation, a seed grant from the Harvard Stem Cell Institute, the Stanley Medical Research Institute, and a grant (#R33MH087896) from the National Institute Of Mental Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute Of Mental Health or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham S, 2010, BIOCHEM BIOPH RES CO, V393, P211, DOI 10.1016/j.bbrc.2010.01.101; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bhattacharyya A, 2008, STEM CELLS DEV, V17, P107, DOI 10.1089/scd.2007.0073; Bontekoe CJM, 2001, HUM MOL GENET, V10, P1693, DOI 10.1093/hmg/10.16.1693; Bontekoe CJM, 1997, EUR J HUM GENET, V5, P293, DOI 10.1159/000484780; Brakensiek K, 2007, CLIN CHEM, V53, P17, DOI 10.1373/clinchem.2007.072629; Braun K, 2000, CEREB CORTEX, V10, P1045, DOI 10.1093/cercor/10.10.1045; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Castren M, 2005, P NATL ACAD SCI USA, V102, P17834, DOI 10.1073/pnas.0508995102; Castren M, 2006, CELL CYCLE, V5, P1528, DOI 10.4161/cc.5.14.3096; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Datta S, 2011, CHROMOSOME RES, V19, P445, DOI 10.1007/s10577-011-9206-7; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; FENG Y, 1995, SCIENCE, V268, P731, DOI 10.1126/science.7732383; Geschwind DH, 2009, ANNU REV MED, V60, P367, DOI 10.1146/annurev.med.60.053107.121225; Godde JS, 1996, J BIOL CHEM, V271, P24325, DOI 10.1074/jbc.271.40.24325; Hagerman RJ, 2009, PEDIATRICS, V123, P378, DOI 10.1542/peds.2008-0317; Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776; Jacquemont S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001708; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Kumari D, 2010, HUM MOL GENET, V19, P4634, DOI 10.1093/hmg/ddq394; Kumari D, 2009, J BIOL CHEM, V284, P7413, DOI 10.1074/jbc.R800026200; Luo YP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000898; Maddalena A., 2001, GENET MED, V3, P200, DOI DOI 10.1097/00125817-200105000-00010; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Martin JP, 1943, J NEUROL PSYCHIATRY, V6, P154, DOI 10.1136/jnnp.6.3-4.154; Meisner LF, 2008, METHODS, V45, P133, DOI 10.1016/j.ymeth.2008.03.005; MONTERMINI L, 1995, AM J HUM GENET, V57, P1061; NOLIN SL, 1994, AM J MED GENET, V51, P509, DOI 10.1002/ajmg.1320510444; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Sheridan SD, 2008, METHOD CELL BIOL, V86, P29, DOI 10.1016/S0091-679X(08)00003-4; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; SONEOKA Y, 1995, NUCLEIC ACIDS RES, V23, P628, DOI 10.1093/nar/23.4.628; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tost J, 2003, BIOTECHNIQUES, V35, P152, DOI 10.2144/03351md02; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; Wohrle D, 2001, AM J HUM GENET, V69, P504, DOI 10.1086/322739	44	219	226	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26203	10.1371/journal.pone.0026203	http://dx.doi.org/10.1371/journal.pone.0026203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022567	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000085
J	LaCrue, AN; Scheel, M; Kennedy, K; Kumar, N; Kyle, DE				LaCrue, Alexis N.; Scheel, Misty; Kennedy, Katherine; Kumar, Nikesh; Kyle, Dennis E.			Effects of Artesunate on Parasite Recrudescence and Dormancy in the Rodent Malaria Model Plasmodium vinckei	PLOS ONE			English	Article							FALCIPARUM-MALARIA; MURINE MALARIA; ARTEMISININ; MICE; SPLENECTOMY; SENSITIVITY; MEFLOQUINE; QINGHAOSU; KINETICS; FAILURE	Artemisinin (ART) is the recommended first line therapy for treating uncomplicated and drug-resistant Plasmodium falciparum, the most pathogenic form of malaria. However, treatment failure following ART monotherapy is not uncommon and resistance to this rapidly acting drug has been reported in the Thai-Cambodian border. Recent in vitro studies have shown that following treatment with dihydroartemisinin (DHA), the development of ring-stage parasites is arrested for up to 20 days. These arrested (i.e. dormant) rings could be responsible for the recrudescence of infection that is observed following ART monotherapy. To develop a better understanding of the stage-specific effects of ART and determine if dormancy occurs in vivo, the ART derivative artesunate (AS) was used to treat mice infected with the synchronous rodent malaria parasites P. vinckei petteri (non-lethal) and P. v. vinckei (lethal). Results show that in both the non-lethal and lethal strains, ring-stage parasites are the least susceptible to treatment with AS and that the day of treatment has more of an impact on recrudescence than the total dose administered. Additionally, 24 hrs post-treatment with AS, dormant forms similar in morphology to those seen in vitro were observed. Finally, rate of recrudescence studies suggest that there is a positive correlation between the number of dormant parasites present and when recrudescence occurs in the vertebrate host. Collectively, these data suggest that dormancy occurs in vivo and contributes to recrudescence that is observed following AS treatment. It is possible that this may represent a novel mechanism of parasite survival following treatment with AS.	[LaCrue, Alexis N.; Scheel, Misty; Kennedy, Katherine; Kumar, Nikesh; Kyle, Dennis E.] Univ S Florida, Dept Global Hlth, Tampa, FL 33620 USA	State University System of Florida; University of South Florida	LaCrue, AN (corresponding author), Univ S Florida, Dept Global Hlth, Tampa, FL 33620 USA.	alacrue@health.usf.edu; dkyle@health.usf.edu		Kyle, Dennis/0000-0002-0238-965X	National Institutes of Health NIAID [R01 AI058973]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058973] Funding Source: NIH RePORTER	National Institutes of Health NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was funded by the National Institutes of Health NIAID (grant #R01 AI058973), http://www.niaid.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bei AK, 2010, AM J HEMATOL, V85, P234, DOI 10.1002/ajh.21642; BETHELL D, PLOS ONE, V6; BOONE KE, 1995, BRIT MED J, V311, P1273, DOI 10.1136/bmj.311.7015.1273; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Buffet PA, 2006, BLOOD, V107, P3745, DOI 10.1182/blood-2005-10-4094; Buffet PA, 2011, BLOOD, V117, P381, DOI 10.1182/blood-2010-04-202911; CAILLARD V, 1995, J PARASITOL, V81, P295, DOI 10.2307/3283937; CAILLARD V, 1992, EXP PARASITOL, V75, P449, DOI 10.1016/0014-4894(92)90258-C; CODD A, MALAR J, V10, P56; Negreiros RMD, 2009, ACTA CIR BRAS, V24, P437, DOI 10.1590/S0102-86502009000600003; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; GROOM AC, 1991, SCANNING MICROSCOPY, V5, P159; HIEN TT, 1993, LANCET, V341, P603; Ittarat W, 2003, AM J TROP MED HYG, V68, P147, DOI 10.4269/ajtmh.2003.68.147; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Kyle D E, 1998, Med Trop (Mars), V58, P38; Menard D, 2005, AM J TROP MED HYG, V73, P616, DOI 10.4269/ajtmh.2005.73.616; MOK S, BMC GENOMICS, V12, P391; Moore BR, 2008, EXP PARASITOL, V118, P458, DOI 10.1016/j.exppara.2007.10.011; Nakazawa S, 1995, EXP PARASITOL, V81, P556, DOI 10.1006/expr.1995.1149; Newton PN, 2001, BLOOD, V98, P450, DOI 10.1182/blood.V98.2.450; PERLMANN H, 1995, INFECT IMMUN, V63, P3987, DOI 10.1128/IAI.63.10.3987-3993.1995; Rogers WO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-10; SAINTYVES IFM, 1977, PAPUA NEW GUINEA MED, V20, P33; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; Teuscher F, 2010, J INFECT DIS, V202, P1362, DOI 10.1086/656476; Tuteja R, 2007, FEBS J, V274, P4670, DOI 10.1111/j.1742-4658.2007.05997.x; Voza T, 2005, INFECT IMMUN, V73, P4777, DOI 10.1128/IAI.73.8.4777-4786.2005; WASSERMAN GM, 1993, INFECT IMMUN, V61, P1958, DOI 10.1128/IAI.61.5.1958-1963.1993; White N J, 1998, Med Trop (Mars), V58, P54; *WHO, 2008, GLOB MAL ACT PLAN KE; Witkowski B, 2010, ANTIMICROB AGENTS CH, V54, P1872, DOI 10.1128/AAC.01636-09; Xie LH, 2006, ANTIMICROB AGENTS CH, V50, P1649, DOI 10.1128/AAC.50.5.1649-1655.2006	33	49	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26689	10.1371/journal.pone.0026689	http://dx.doi.org/10.1371/journal.pone.0026689			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039533	Green Submitted, Green Published, gold			2022-12-27	WOS:000296515200042
J	Bansal, P; Wang, SL; Liu, SH; Xiang, YY; Lu, WY; Wang, QH				Bansal, Paul; Wang, Shuanglian; Liu, Shenghao; Xiang, Yun-Yan; Lu, Wei-Yang; Wang, Qinghua			GABA Coordinates with Insulin in Regulating Secretory Function in Pancreatic INS-1 beta-Cells	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; ISLET ALPHA-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; GLUCAGON-SECRETION; ENDOCRINE PANCREAS; GLUCOSE-INHIBITION; RECEPTOR; RELEASE; EXPRESSION; CHANNELS	Pancreatic islet beta-cells produce large amounts of c-aminobutyric acid (GABA), which is co-released with insulin. GABA inhibits glucagon secretion by hyperpolarizing alpha-cells via type-A GABA receptors (GABA(A)Rs). We and others recently reported that islet beta-cells also express GABA(A)Rs and that activation of GABA(A)Rs increases insulin release. Here we investigate the effects of insulin on the GABA-GABA(A)R system in the pancreatic INS-1 cells using perforated-patch recording. The results showed that GABA produces a rapid inward current and depolarizes INS-1 cells. However, pre-treatment of the cell with regular insulin (1 mu M) suppressed the GABA-induced current (I-GABA) by 43%. Zinc-free insulin also suppressed I-GABA to the same extent of inhibition by regular insulin. The inhibition of I-GABA occurs within 30 seconds after application of insulin. The insulin-induced inhibition of I-GABA persisted in the presence of PI3-kinase inhibitor, but was abolished upon inhibition of ERK, indicating that insulin suppresses GABA(A)Rs through a mechanism that involves ERK activation. Radioimmunoassay revealed that the secretion of C-peptide was enhanced by GABA, which was blocked by pre-incubating the cells with picrotoxin (50 mu M, p<0.01) and insulin (1 mu M, p<0.01), respectively. Together, these data suggest that autocrine GABA, via activation of GABA(A)Rs, depolarizes the pancreatic beta-cells and enhances insulin secretion. On the other hand, insulin down-regulates GABA-GABA(A)R signaling presenting a feedback mechanism for fine-tuning beta-cell secretion.	[Bansal, Paul; Liu, Shenghao; Wang, Qinghua] Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Bansal, Paul; Liu, Shenghao; Wang, Qinghua] Univ Toronto, Fac Med, Dept Med, Toronto, ON M5S 1A8, Canada; [Bansal, Paul; Liu, Shenghao; Wang, Qinghua] St Michaels Hosp, Div Endocrinol & Metab, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Wang, Shuanglian; Xiang, Yun-Yan; Lu, Wei-Yang] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada; [Wang, Shuanglian; Xiang, Yun-Yan; Lu, Wei-Yang] Univ Western Ontario, Robarts Res Inst, London, ON, Canada	University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Western University (University of Western Ontario); Western University (University of Western Ontario)	Bansal, P (corresponding author), Univ Toronto, Fac Med, Dept Physiol, Toronto, ON M5S 1A8, Canada.	wlu53@uwo.ca; qinghua.wang@utoronto.ca	Lu, Wei-Yang/K-4404-2013; Wang, Qinghua/GVT-3252-2022		Canadian Institute for Health Research (CIHR) [MOP-79534, MOP-84517]; Canadian Diabetes Association (CDA); Juvenile Diabetes Research Foundation	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Diabetes Association (CDA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation)	Funding: This work was supported by grants from the Canadian Institute for Health Research (CIHR) (MOP-79534 to Q. Wang and MOP-84517 to W. Y. Lu). Research in Dr. Wang's laboratory was also supported by grants from the Canadian Diabetes Association (CDA) and the Juvenile Diabetes Research Foundation. Q. Wang is presently supported by the New Investigator Program from CIHR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeghate E, 2002, TISSUE CELL, V34, P1, DOI 10.1054/tice.2002.0217; AGUAYO LG, 1993, J PHARMACOL EXP THER, V267, P1414; Aspinwall CA, 1999, J BIOL CHEM, V274, P6360, DOI 10.1074/jbc.274.10.6360; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Assmann A, 2009, MOL CELL BIOL, V29, P3219, DOI 10.1128/MCB.01489-08; Bailey SJ, 2007, DIABETES, V56, P320, DOI 10.2337/db06-0712; Bansal P, 2008, AM J PHYSIOL-ENDOC M, V295, pE751, DOI 10.1152/ajpendo.90295.2008; Bell-Horner CL, 2006, J NEUROBIOL, V66, P1467, DOI 10.1002/neu.20327; Blankenfeld G, 1995, PFLUGERS ARCH, V430, P381, DOI [10.1007/BF00373913, DOI 10.1007/BF00373913]; BORMANN J, 1988, TRENDS NEUROSCI, V11, P112, DOI 10.1016/0166-2236(88)90156-7; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; Chausmer AB, 1998, J AM COLL NUTR, V17, P109, DOI 10.1080/07315724.1998.10718735; Chen G, 1996, J PHYSIOL-LONDON, V494, P451, DOI 10.1113/jphysiol.1996.sp021505; Collier JJ, 2004, BIOCHEM BIOPH RES CO, V324, P1018, DOI 10.1016/j.bbrc.2004.09.149; Davies SL, 2004, BBA-BIOMEMBRANES, V1667, P7, DOI 10.1016/j.bbamem.2004.08.005; Dong H, 2006, DIABETOLOGIA, V49, P697, DOI 10.1007/s00125-005-0123-1; ELAHI D, 1982, NEW ENGL J MED, V306, P1196, DOI 10.1056/NEJM198205203062002; Eto K, 2002, DIABETES, V51, P87, DOI 10.2337/diabetes.51.1.87; GERBER JC, 1979, DIABETES, V28, P1073, DOI 10.2337/diabetes.28.12.1073; Glassmeier G, 1998, ANN NY ACAD SCI, V859, P241, DOI 10.1111/j.1749-6632.1998.tb11138.x; Hosie AM, 2003, NAT NEUROSCI, V6, P362, DOI 10.1038/nn1030; Jimenez-Feltstrom J, 2004, REGUL PEPTIDES, V122, P109, DOI 10.1016/j.regpep.2004.06.004; Khan FA, 2001, DIABETES, V50, P2192, DOI 10.2337/diabetes.50.10.2192; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Li J, 2007, BRIT J PHARMACOL, V151, P483, DOI 10.1038/sj.bjp.0707259; Ligon B, 2007, DIABETOLOGIA, V50, P764, DOI 10.1007/s00125-007-0601-8; Liu F, 2000, NATURE, V403, P274, DOI 10.1038/35002014; Ludwig A, 2003, EUR J NEUROSCI, V18, P3199, DOI 10.1111/j.1460-9568.2003.03069.x; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; OKADA Y, 1976, SCIENCE, V194, P620, DOI 10.1126/science.185693; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Persaud SJ, 2002, FEBS LETT, V510, P225, DOI 10.1016/S0014-5793(01)03268-9; REETZ A, 1991, EMBO J, V10, P1275, DOI 10.1002/j.1460-2075.1991.tb08069.x; RORSMAN P, 1989, NATURE, V341, P233, DOI 10.1038/341233a0; Smismans A, 1997, DIABETOLOGIA, V40, P1411, DOI 10.1007/s001250050843; SMITH GD, 1984, P NATL ACAD SCI-BIOL, V81, P7093, DOI 10.1073/pnas.81.22.7093; Soltani N, 2011, P NATL ACAD SCI USA, V108, P11692, DOI 10.1073/pnas.1102715108; Sugita M, 2004, J GEN PHYSIOL, V124, P59, DOI 10.1085/jgp.200308948; Takayama C, 2010, NEUROSCI RES, V67, P137, DOI 10.1016/j.neures.2010.02.010; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; VINCENT SR, 1983, NEUROENDOCRINOLOGY, V36, P197, DOI 10.1159/000123456; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; Wang QH, 2009, ISLETS, V1, P95, DOI 10.4161/isl.1.2.9263; Wendt A, 2004, DIABETES, V53, P1038, DOI 10.2337/diabetes.53.4.1038; Williams DB, 2008, NEUROSCI LETT, V443, P27, DOI 10.1016/j.neulet.2008.07.038; Winnock F, 2002, AM J PHYSIOL-ENDOC M, V282, pE937, DOI 10.1152/ajpendo.00071.2001; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015; Xu GG, 1998, DIABETES, V47, P1243, DOI 10.2337/diabetes.47.8.1243; Zhang Y, 2008, DIABETOLOGIA, V51, P2290, DOI 10.1007/s00125-008-1166-x; Zhao JW, 2008, CELL PHYSIOL BIOCHEM, V21, P445, DOI 10.1159/000129637	53	43	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26225	10.1371/journal.pone.0026225	http://dx.doi.org/10.1371/journal.pone.0026225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031825	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200012
J	Fermino, ML; Polli, CD; Toledo, KA; Liu, FT; Hsu, DK; Roque-Barreira, MC; Pereira-da-Silva, G; Bernardes, ES; Halbwachs-Mecarelli, L				Fermino, Marise Lopes; Polli, Claudia Danella; Toledo, Karina Alves; Liu, Fu-Tong; Hsu, Dan K.; Roque-Barreira, Maria Cristina; Pereira-da-Silva, Gabriela; Bernardes, Emerson Soares; Halbwachs-Mecarelli, Lise			LPS-Induced Galectin-3 Oligomerization Results in Enhancement of Neutrophil Activation	PLOS ONE			English	Article							LIPOPOLYSACCHARIDE (LPS)-BINDING PROTEIN; IGE-BINDING PROTEIN; LUNG INJURY; SOLUBLE CD14; STREPTOCOCCUS-PNEUMONIAE; ISCHEMIA-REPERFUSION; SIGNAL-TRANSDUCTION; PRIMES NEUTROPHILS; BETA-2 INTEGRINS; IMMUNE-RESPONSE	Galectin-3 (Gal 3) is a glycan-binding protein that can be secreted by activated macrophages and mast cells at inflammation sites and plays an important role in inflammatory diseases caused by Bacteria and their products, such as lipopolysaccharides (LPS). Although it is well established that Gal 3 can interact with LPS, the pathophysiological importance of LPS/Gal 3 interactions is not fully understood. Data presented herein demonstrate for the first time that the interaction of Gal 3, either via its carbohydrate binding C-terminal domain or via its N-terminal part, with LPS from different bacterial strains, enhances the LPS-mediated neutrophil activation in vitro. Gal 3 allowed low LPS concentrations (1 mu g/mL without serum, 1 ng/mL with serum) to upregulate CD11b expression and reactive oxygen species (ROS) generation on human neutrophils in vitro and drastically enhanced the binding efficiency of LPS to the neutrophil surface. These effects required LPS preincubation with Gal 3, before neutrophil stimulation and involved specific Gal 3/LPS interaction. A C-terminal Gal-3 fragment, which retains the lectin domain but lacks the N-terminal part, was still able to bind both to Escherichia coli LPS and to neutrophils, but had lost the ability to enhance neutrophil response to LPS. This result emphasizes the importance of an N-terminus-mediated Gal 3 oligomerization induced by its interaction with LPS. Finally we demonstrated that Balb/C mice were more susceptible to LPS-mediated shock when LPS was pretreated with Gal 3. Altogether, these results suggest that multimeric interactions between Gal 3 oligomers and LPS potentiate its proinflammatory effects on neutrophils.	[Fermino, Marise Lopes; Polli, Claudia Danella; Toledo, Karina Alves; Halbwachs-Mecarelli, Lise] Univ Paris 05, Paris, France; [Fermino, Marise Lopes; Toledo, Karina Alves; Roque-Barreira, Maria Cristina; Halbwachs-Mecarelli, Lise] Univ Sao Paulo, Fac Med, Dept Cellular & Mol Biol & Pathogen Bioagents, Sao Paulo, Brazil; [Polli, Claudia Danella] Univ Sao Paulo, Fac Med, Program Basic & Appl Immunol, Sao Paulo, Brazil; [Toledo, Karina Alves] Univ Sao Paulo, Dept Biol Sci, Sao Paulo, Brazil; [Pereira-da-Silva, Gabriela] Univ Sao Paulo, Ribeirao Preto Coll Nursing, Sao Paulo, Brazil; [Liu, Fu-Tong; Hsu, Dan K.] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA; [Bernardes, Emerson Soares] Univ Porto, Inst Mol Pathol & Immunol, P-4100 Oporto, Portugal	UDICE-French Research Universities; Universite Paris Cite; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of California System; University of California Davis; Universidade do Porto	Fermino, ML (corresponding author), Univ Paris 05, Paris, France.	ebernardes@ipatimup.pt; lise.halbwachs@inserm.fr	Bisson, Gabriela/Q-2383-2016; Roque-Barreira, Maria-Cristina/A-4552-2008; Bernardes, Emerson Soares/D-3711-2017; Toledo, Karina Alves/C-9452-2012; Liu, FU-TONG/A-5749-2019	Bisson, Gabriela/0000-0002-6743-0553; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; Bernardes, Emerson Soares/0000-0002-0029-7313; Toledo, Karina Alves/0000-0001-7212-6794; Liu, FU-TONG/0000-0002-3354-1001	Coordenacao de Aperfeicoamento e Pessoal de Nivel Superior (CAPES) Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (COFECUB) [597/08]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/60757-4]	Coordenacao de Aperfeicoamento e Pessoal de Nivel Superior (CAPES) Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (COFECUB)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	Funding: This work was supported by fellowships granted to MLF, CDP and KAT: Coordenacao de Aperfeicoamento e Pessoal de Nivel Superior (CAPES) Comite Francais d'Evaluation de la Cooperation Universitaire et Scientifique avec le Bresil (COFECUB, 597/08). Support was also received from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2006/60757-4). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Almkvist J, 2004, EXP CELL RES, V298, P74, DOI 10.1016/j.yexcr.2004.04.006; Almkvist J, 2001, INFECT IMMUN, V69, P832, DOI 10.1128/IAI.69.2.832-837.2001; Barboni E, 2005, FEBS LETT, V579, P6749, DOI 10.1016/j.febslet.2005.11.005; BREWER FC, 2002, BIOCHIM BIOPHYS ACTA, V1572, P255; de Haas CJC, 2000, J IMMUNOL METHODS, V242, P79, DOI 10.1016/S0022-1759(00)00207-6; Farnworth SL, 2008, AM J PATHOL, V172, P395, DOI 10.2353/ajpath.2008.070870; FEIZI T, 1994, BIOCHEMISTRY-US, V33, P6342, DOI 10.1021/bi00186a038; Fernandez GC, 2005, GLYCOBIOLOGY, V15, P519, DOI 10.1093/glycob/cwi026; Ferraz LC, 2008, EUR J IMMUNOL, V38, P2762, DOI 10.1002/eji.200737986; Gutsmann T, 2001, INFECT IMMUN, V69, P6942, DOI 10.1128/IAI.69.11.6942-6950.2001; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; HO MK, 1982, J IMMUNOL, V128, P2281; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; HSU DK, 1992, J BIOL CHEM, V267, P14167; JAESCHKE H, 1990, FASEB J, V4, P3355, DOI 10.1096/fasebj.4.15.2253850; JAESCHKE H, 1991, AM J PHYSIOL, V261, pG1051, DOI 10.1152/ajpgi.1991.261.6.G1051; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Karlsson A, 1998, BLOOD, V91, P3430, DOI 10.1182/blood.V91.9.3430.3430_3430_3438; Li Y, 2008, J IMMUNOL, V181, P2781, DOI 10.4049/jimmunol.181.4.2781; Liew Alan Wee-Chung, 2005, Int J Bioinform Res Appl, V1, P181, DOI 10.1504/IJBRA.2005.007577; Liu FT, 2005, INT ARCH ALLERGY IMM, V136, P385, DOI 10.1159/000084545; Liu Fu-Tong, 2002, Expert Opin Ther Targets, V6, P461, DOI 10.1517/14728222.6.4.461; MASSA SM, 1993, BIOCHEMISTRY-US, V32, P260, DOI 10.1021/bi00052a033; Mey A, 1996, J IMMUNOL, V156, P1572; MULLIGAN MS, 1993, J IMMUNOL, V150, P2407; MULLIGAN MS, 1993, J IMMUNOL, V150, P2401; Nieminen J, 2005, J LEUKOCYTE BIOL, V78, P1127; Nieminen J, 2008, J IMMUNOL, V180, P2466, DOI 10.4049/jimmunol.180.4.2466; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; O'Brien JM, 2007, AM J MED, V120, P1012, DOI 10.1016/j.amjmed.2007.01.035; Rabinovich GA, 2002, TRENDS IMMUNOL, V23, P313, DOI 10.1016/S1471-4906(02)02232-9; RAETZ CRH, 1991, FASEB J, V5, P2652, DOI 10.1096/fasebj.5.12.1916089; Remer KA, 2003, IMMUNOL LETT, V85, P75, DOI 10.1016/S0165-2478(02)00210-9; Salomonsson E, 2010, J BIOL CHEM, V285, P35079, DOI 10.1074/jbc.M109.098160; Sarter K, 2009, BIOCHEM BIOPH RES CO, V379, P155, DOI 10.1016/j.bbrc.2008.12.024; Sato S, 2002, J IMMUNOL, V168, P1813, DOI 10.4049/jimmunol.168.4.1813; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; SEEKAMP A, 1993, AM J PATHOL, V143, P464; Tobias PS, 1997, J BIOL CHEM, V272, P18682, DOI 10.1074/jbc.272.30.18682; TOBIAS PS, 1995, J BIOL CHEM, V270, P10482, DOI 10.1074/jbc.270.18.10482; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Villar J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006818; WORTHEN GS, 1992, J CLIN INVEST, V90, P2526, DOI 10.1172/JCI116146; WURFEL MM, 1995, J EXP MED, V181, P1743, DOI 10.1084/jem.181.5.1743; YAMAOKA A, 1995, J IMMUNOL, V154, P3479; Yang RY, 2003, CELL MOL LIFE SCI, V60, P267, DOI 10.1007/s000180300022; YEE J, 1993, J IMMUNOL, V150, P1988; Yu B, 1996, J BIOL CHEM, V271, P4100	49	61	65	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26004	10.1371/journal.pone.0026004	http://dx.doi.org/10.1371/journal.pone.0026004			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031821	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200008
J	Jain, RA; Wolman, MA; Schmidt, LA; Burgess, HA; Granato, M				Jain, Roshan A.; Wolman, Marc A.; Schmidt, Lauren A.; Burgess, Harold A.; Granato, Michael			Molecular-Genetic Mapping of Zebrafish Mutants with Variable Phenotypic Penetrance	PLOS ONE			English	Article							LARVAL ZEBRAFISH; PREPULSE INHIBITION; BEHAVIORAL SCREEN; GATING DEFICITS; STARTLE REFLEX; SCHIZOPHRENIA; MODULATION; NEURONS; DISEASE; MARKERS	Forward genetic screens in vertebrates are powerful tools to generate models relevant to human diseases, including neuropsychiatric disorders. Variability in phenotypic penetrance and expressivity is common in these disorders and behavioral mutant models, making their molecular-genetic mapping a formidable task. Using a 'phenotyping by segregation' strategy, we molecularly map the hypersensitive zebrafish houdini mutant despite its variable phenotypic penetrance, providing a generally applicable strategy to map zebrafish mutants with subtle phenotypes.	[Jain, Roshan A.; Wolman, Marc A.; Schmidt, Lauren A.; Burgess, Harold A.; Granato, Michael] Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania	Jain, RA (corresponding author), Univ Penn, Sch Med, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA.	granatom@mail.med.upenn.edu	Burgess, Harold/B-8474-2015	Burgess, Harold/0000-0003-1966-7801; Jain, Roshan/0000-0003-3838-6044	NRSA [5F32NS065637-02, 5F32EY019434-03]; National Institutes of Health [MH092257]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008884] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [F32EY019434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092257] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS065637] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by a NRSA postdoctoral fellowship (5F32NS065637-02) to R.A.J., a NRSA postdoctoral fellowship (5F32EY019434-03) to M. A. W., and a National Institutes of Health grant (MH092257) to M. G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert KB, 1996, P NATL ACAD SCI USA, V93, P15503, DOI 10.1073/pnas.93.26.15503; Bakker Mirte J, 2009, J Psychiatry Neurosci, V34, P314; Brennan CH, 2011, REV NEUROSCIENCE, V22, P37, DOI 10.1515/RNS.2011.006; BROCKERHOFF SE, 1995, P NATL ACAD SCI USA, V92, P10545, DOI 10.1073/pnas.92.23.10545; Burgess HA, 2009, GENES BRAIN BEHAV, V8, P500, DOI 10.1111/j.1601-183X.2009.00499.x; Burgess HA, 2007, J EXP BIOL, V210, P2526, DOI 10.1242/jeb.003939; Burgess HA, 2007, J NEUROSCI, V27, P4984, DOI 10.1523/JNEUROSCI.0615-07.2007; Burgess Harold A., 2008, Briefings in Functional Genomics & Proteomics, V7, P474, DOI 10.1093/bfgp/eln039; Downes GB, 2004, DEV BIOL, V270, P232, DOI 10.1016/j.ydbio.2004.02.027; Duley AR, 2007, INT J PSYCHOPHYSIOL, V64, P157, DOI 10.1016/j.ijpsycho.2007.01.006; Gomes Erissandra, 2008, Pró-Fono R. Atual. Cient., V20, P279, DOI 10.1590/S0104-56872008000400013; Gould KA, 1996, GENETICS, V144, P1777; Granato M, 1996, DEVELOPMENT, V123, P399; GREENSPAN SI, 1997, J DEV LEARNING DISOR, V1, P1; Grillon C, 2003, CLIN NEUROPHYSIOL, V114, P1557, DOI 10.1016/S1388-2457(03)00202-5; GUO S, 2011, DEV NEUROBI IN PRESS; KIMMEL CB, 1974, DEV PSYCHOBIOL, V7, P47, DOI 10.1002/dev.420070109; Knapik EW, 1996, DEVELOPMENT, V123, P451; LINGENHOHL K, 1994, J NEUROSCI, V14, P1176, DOI 10.1523/JNEUROSCI.14-03-01176.1994; Meincke U, 2004, PSYCHIAT RES, V126, P51, DOI 10.1016/j.psychres.2004.01.003; MICHELMORE RW, 1991, P NATL ACAD SCI USA, V88, P9828, DOI 10.1073/pnas.88.21.9828; Moens PB, 2006, GENOME, V49, P205, DOI 10.1139/G06-021; Muto A, 2005, PLOS GENET, V1, P575, DOI 10.1371/JOURNAL.PGEN.0010066; Neuhauss SCF, 1999, J NEUROSCI, V19, P8603; Perry W, 2007, BIOL PSYCHIAT, V61, P482, DOI 10.1016/j.biopsych.2005.09.025; RAUCH GJ, 1997, POLYMORPHIC ZEBRAFIS; Schneider K, 1997, DEVELOPMENT, V124, P1789; Schoonheim PJ, 2010, J NEUROSCI, V30, P7111, DOI 10.1523/JNEUROSCI.5193-09.2010; Shimoda N, 1999, GENOMICS, V58, P219, DOI 10.1006/geno.1999.5824; Smear MC, 2007, NEURON, V53, P65, DOI 10.1016/j.neuron.2006.12.013; Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4; Swerdlow NR, 2006, ARCH GEN PSYCHIAT, V63, P1325, DOI 10.1001/archpsyc.63.12.1325; WOLMAN M, 2011, DEV NEUROBI IN PRESS; Wolman MA, 2011, P NATL ACAD SCI USA, V108, P15468, DOI 10.1073/pnas.1107156108; Zhang J, 2004, NAT NEUROSCI, V7, P1303, DOI 10.1038/nn1350	35	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26510	10.1371/journal.pone.0026510	http://dx.doi.org/10.1371/journal.pone.0026510			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039502	Green Published, gold			2022-12-27	WOS:000296507500080
J	Liu, CF; Cao, Y; Liu, CH; Zhang, JC; Xu, PP				Liu, Chufeng; Cao, Yang; Liu, Conghua; Zhang, Jincai; Xu, Pingping			Rapid Maxillary Anterior Teeth Retraction En Masse by Bone Compression: A Canine Model	PLOS ONE			English	Article							REGIONAL ACCELERATORY PHENOMENON; TOOTH MOVEMENT; ROOT RESORPTION; PERIODONTAL-LIGAMENT; SURFACE RESORPTION; REPAIR; CORTICOTOMY; DISTRACTION; ORTHODONTICS; EXPANSION	Objective: The present study sought to establish an animal model to study the feasibility and safety of rapid retraction of maxillary anterior teeth en masse aided by alveolar surgery in order to reduce orthodontic treatment time. Method: Extraction of the maxillary canine and alveolar surgery were performed on twelve adult beagle dogs. After that, the custom-made tooth-borne distraction devices were placed on beagles' teeth. Nine of the dogs were applied compression at 0.5 mm/d for 12 days continuously. The other three received no force as the control group. The animals were killed in 1, 14, and 28 days after the end of the application of compression. Results: The tissue responses were assessed by craniometric measurement as well as histological examination. Gross alterations were evident in the experimental group, characterized by anterior teeth crossbite. The average total movements of incisors within 12 days were 4.63 +/- 0.10 mm and the average anchorage losses were 1.25 +/- 0.12 mm. Considerable root resorption extending into the dentine could be observed 1 and 14 days after the compression. But after consolidation of 28 days, there were regenerated cementum on the dentine. There was no apparent change in the control group. No obvious tooth loosening, gingival necrosis, pulp degeneration, or other adverse complications appeared in any of the dogs. Conclusions: This is the first experimental study for testing the technique of rapid anterior teeth retraction en masse aided by modified alveolar surgery. Despite a preliminary animal model study, the current findings pave the way for the potential clinical application that can accelerate orthodontic tooth movement without many adverse complications. Clinical Relevance: It may become a novel method to shorten the clinical orthodontic treatment time in the future.	[Liu, Chufeng; Liu, Conghua] So Med Univ, Guangdong Prov Stomatol Hosp, Dept Orthodont, Guangzhou, Guangdong, Peoples R China; [Cao, Yang] Sun Yat Sen Univ, Guanghua Coll Stomatol, Dept Orthodont, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Jincai] So Med Univ, Guangdong Prov Stomatol Hosp, Dept Periodontol, Guangzhou, Guangdong, Peoples R China; [Xu, Pingping] So Med Univ, Guangdong Prov Stomatol Hosp, Dept Oral & Maxillofacial Surg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Sun Yat Sen University; Southern Medical University - China; Southern Medical University - China	Liu, CF (corresponding author), So Med Univ, Guangdong Prov Stomatol Hosp, Dept Orthodont, Guangzhou, Guangdong, Peoples R China.	sci8620@gmail.com			Guangdong Provincial Natural Science Fund [8151026003000008]; Guangdong Provincial Science & Technology Projects [2009B080701032, 2009B030801182]	Guangdong Provincial Natural Science Fund; Guangdong Provincial Science & Technology Projects	The study was supported by the Guangdong Provincial Natural Science Fund (http://gdsf.gdstc.gov.cn/) (No. 8151026003000008) and Guangdong Provincial Science & Technology Projects (http://www.gdstc.gov.cn/) (No. 2009B080701032, No. 2009B030801182). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSTENDIG HS, 1972, ANGLE ORTHOD, V42, P50; BARON R, 1975, ORTHOPEDIE DENTOFACI, P328; Bilodeau JE, 2005, AM J ORTHOD DENTOFAC, V128, P388, DOI 10.1016/j.ajodo.2004.05.021; BOGOCH E, 1993, J ORTHOPAED RES, V11, P285, DOI 10.1002/jor.1100110216; Chung K R, 2001, J Clin Orthod, V35, P331; FROST HM, 1989, CLIN ORTHOP RELAT R, P283; FROST HM, 1989, CLIN ORTHOP RELAT R, P294; GANTES B, 1990, J PERIODONTOL, V61, P234, DOI 10.1902/jop.1990.61.4.234; GENERSON RM, 1978, J ORAL SURG, V36, P216; GREVSTAD HJ, 1987, SCAND J DENT RES, V95, P428; Iino S, 2007, AM J ORTHOD DENTOFAC, V131, DOI 10.1016/j.ajodo.2006.08.014; Kisnisci RS, 2002, J ORAL MAXIL SURG, V60, P389, DOI 10.1053/joms.2002.31226; KOLE H, 1959, Oral Surg Oral Med Oral Pathol, V12, P515, DOI 10.1016/0030-4220(59)90153-7; LANGFORD SR, 1982, AM J ORTHOD DENTOFAC, V81, P108, DOI 10.1016/0002-9416(82)90034-3; Lee W, 2008, J DENT RES, V87, P861, DOI 10.1177/154405910808700904; Liou EJ, 2001, CRANIOFACIAL DISTRAC, P461; Liou EJW, 1998, AM J ORTHOD DENTOFAC, V114, P372, DOI 10.1016/S0889-5406(98)70181-7; MCFADDEN WM, 1989, AM J ORTHOD DENTOFAC, V96, P390, DOI 10.1016/0889-5406(89)90323-5; Miyawaki S, 2000, J CLIN ORTHOD, V34, P367; OwmanMoll P, 1995, ANGLE ORTHOD, V65, P403; OwmanMoll P, 1995, ANGLE ORTHOD, V65, P395; Paetyangkul A, 2011, AM J ORTHOD DENTOFAC, V139, DOI 10.1016/j.ajodo.2010.07.021; PROFFIT WR, 1993, CONT ORTHODONTICS, P317; REITAN K, 1967, AMER J ORTHODONTICS, V53, P721, DOI 10.1016/0002-9416(67)90118-2; Reitan K., 1985, ORTHODONTICS CURRENT, P101; RYGH P, 1989, BIOL TOOTH MOVEMENT, P9; SCHEIDEMAN GB, 1985, J ORAL MAXIL SURG, V43, P408, DOI 10.1016/S0278-2391(85)80048-3; Schilling T, 1998, CALCIFIED TISSUE INT, V63, P160, DOI 10.1007/s002239900508; SISMANIDOU C, 1995, EUR J ORAL SCI, V103, P292, DOI 10.1111/j.1600-0722.1995.tb00029.x; STENVIK A, 1970, AMER J ORTHODONTICS, V57, P370, DOI 10.1016/S0002-9416(70)90219-8; Suya H., 1991, MECH BIOL BASICS ORT, P207; VARDIMON AD, 1991, ANGLE ORTHOD, V61, P113; Wilcko WM, 2001, INT J PERIODONT REST, V21, P9	33	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26398	10.1371/journal.pone.0026398	http://dx.doi.org/10.1371/journal.pone.0026398			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039479	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500061
J	Mahar, I; Tan, S; Davoli, MA; Dominguez-Lopez, S; Qiang, C; Rachalski, A; Turecki, G; Mechawar, N				Mahar, Ian; Tan, Stephanie; Davoli, Maria Antonietta; Dominguez-Lopez, Sergio; Qiang, Calvin; Rachalski, Adeline; Turecki, Gustavo; Mechawar, Naguib			Subchronic Peripheral Neuregulin-1 Increases Ventral Hippocampal Neurogenesis and Induces Antidepressant-Like Effects	PLOS ONE			English	Article							LONG-TERM POTENTIATION; ADULT-RAT HIPPOCAMPUS; NEURAL STEM-CELLS; CEREBRAL-CORTEX; SYNAPTIC PLASTICITY; NEUROTROPHIC FACTOR; BIPOLAR DISORDER; RADIAL GLIA; ASSOCIATION ANALYSIS; CHRONIC FLUOXETINE	Background: Adult hippocampal neurogenesis has been implicated in the mechanism of antidepressant action, and neurotrophic factors can mediate the neurogenic changes underlying these effects. The neurotrophic factor neuregulin-1 (NRG1) is involved in many aspects of brain development, from cell fate determination to neuronal maturation. However, nothing is known about the influence of NRG1 on neurodevelopmental processes occurring in the mature hippocampus. Methods: Adult male mice were given subcutaneous NRG1 or saline to assess dentate gyrus proliferation and neurogenesis, as well as cell fate determination. Mice also underwent behavioral testing. Expression of ErbB3 and ErbB4 NRG1 receptors in newborn dentate gyrus cells was assessed at various time points between birth and maturity. The phenotype of ErbB-expressing progenitor cells was also characterized with cell type-specific markers. Results: The current study shows that subchronic peripheral NRG1 beta administration selectively increased cell proliferation (by 71%) and neurogenesis (by 50%) in the caudal dentate gyrus within the ventral hippocampus. This pro-proliferative effect did not alter neuronal fate, and may have been mediated by ErbB3 receptors, which were expressed by newborn dentate gyrus cells from cell division to maturity and colocalized with SOX2 in the subgranular zone. Furthermore, four weeks after cessation of subchronic treatment, animals displayed robust antidepressant-like behavior in the absence of changes in locomotor activity, whereas acute treatment did not produce antidepressant effects. Conclusions: These results show that neuregulin-1 beta has pro-proliferative, neurogenic and antidepressant properties, further highlight the importance of peripheral neurotrophic factors in neurogenesis and mood, and support the role of hippocampal neurogenesis in mediating antidepressant effects.	[Mahar, Ian; Tan, Stephanie; Davoli, Maria Antonietta; Qiang, Calvin; Rachalski, Adeline; Turecki, Gustavo; Mechawar, Naguib] McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Verdun, PQ, Canada; [Dominguez-Lopez, Sergio; Turecki, Gustavo; Mechawar, Naguib] Dept Psychiat, Montreal, PQ, Canada; [Mahar, Ian; Turecki, Gustavo; Mechawar, Naguib] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada	McGill University; McGill University	Mahar, I (corresponding author), McGill Univ, Douglas Mental Hlth Univ Inst, McGill Grp Suicide Studies, Verdun, PQ, Canada.	naguib.mechawar@mcgill.ca	Mahar, Ian/R-8226-2017; Turecki, Gustavo/K-5100-2015; Tan, Stephanie/GRR-6503-2022	Mahar, Ian/0000-0002-8792-0437; Turecki, Gustavo/0000-0003-4075-2736; Dominguez-Lopez, Sergio/0000-0001-9534-4727	NSERC [341479-07, 345952-07]; Reseau Quebecois de Recherche sur le Suicide (FRSQ)	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Reseau Quebecois de Recherche sur le Suicide (FRSQ)(Fonds de la Recherche en Sante du Quebec)	This research was supported by NSERC Discovery (#341479-07) and RTI (345952-07) grants (http://www.nserc-crsng.gc.ca/) to NM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the Cell Imaging and Analysis Network (CIAN) at McGill University, Montreal, for expert advice in confocal microscopy, as well as Amanda Knezevic for technical assistance and Marissa Maheu, Jesse Jackson, Sylvain Williams and Lalit Srivastava for constructive feedback on the manuscript. We thank the laboratory of Dr. Derek van der Kooy for the generous donation of nestin-GFP mice. IM was supported in part by a scholarship from the Reseau Quebecois de Recherche sur le Suicide (FRSQ). SDL is a CONACYT scholar. NM is an FRSQ chercheur-boursier.	Aberg MAI, 2000, J NEUROSCI, V20, P2896; Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Anton ES, 1997, DEVELOPMENT, V124, P3501; Banasr M, 2006, BIOL PSYCHIAT, V59, P1087, DOI 10.1016/j.biopsych.2005.11.025; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; Bertram I, 2007, ANN NY ACAD SCI, V1096, P147, DOI 10.1196/annals.1397.080; Bjarkam CR, 2003, HIPPOCAMPUS, V13, P21, DOI 10.1002/hipo.10042; Boldrini M, 2009, NEUROPSYCHOPHARMACOL, V34, P2376, DOI 10.1038/npp.2009.75; Boucher AA, 2007, NEUROSCIENCE, V149, P861, DOI 10.1016/j.neuroscience.2007.08.020; Boucher AA, 2007, PSYCHOPHARMACOLOGY, V192, P325, DOI 10.1007/s00213-007-0721-3; Carlsson T, 2011, J NEUROCHEM, V117, P1066, DOI 10.1111/j.1471-4159.2011.07284.x; Cavallaro M, 2008, DEVELOPMENT, V135, P541, DOI 10.1242/dev.010801; Chaudhury AR, 2003, J NEUROPATH EXP NEUR, V62, P42, DOI 10.1093/jnen/62.1.42; Cui K, 2009, SCHIZOPHR RES, V113, P288, DOI 10.1016/j.schres.2009.05.003; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; Detke MJ, 1997, EXP CLIN PSYCHOPHARM, V5, P107, DOI 10.1037/1064-1297.5.2.107; Diniz BS, 2010, WORLD J BIOL PSYCHIA, V11, P550, DOI 10.3109/15622970903544620; Drew Michael R., 2007, CNS & Neurological Disorders-Drug Targets, V6, P205, DOI 10.2174/187152707780619353; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Duman CH, 2009, BEHAV BRAIN RES, V198, P366, DOI 10.1016/j.bbr.2008.11.016; Elizalde N, 2010, PSYCHOPHARMACOLOGY, V210, P393, DOI 10.1007/s00213-010-1835-6; Eto K, 2010, MOL CELL BIOCHEM, V339, P119, DOI 10.1007/s11010-009-0375-z; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Flames N, 2004, NEURON, V44, P251, DOI 10.1016/j.neuron.2004.09.028; FRANKLIN KBJ, 2007, MOUSE BRAIN STEREOTA, P351; GAGE FH, 1980, BRAIN RES BULL, V5, P771, DOI 10.1016/0361-9230(80)90220-8; Gao RL, 2010, J AM COLL CARDIOL, V55, P1907, DOI 10.1016/j.jacc.2009.12.044; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Georgieva L, 2008, BIOL PSYCHIAT, V64, P419, DOI 10.1016/j.biopsych.2008.03.025; Gerecke KM, 2001, J COMP NEUROL, V433, P86, DOI 10.1002/cne.1127; Ghashghaei HT, 2006, P NATL ACAD SCI USA, V103, P1930, DOI 10.1073/pnas.0510410103; Gierdalski M, 2005, J NEUROSCI, V25, P8498, DOI 10.1523/JNEUROSCI.1476-05.2005; Goes FS, 2009, AM J MED GENET B, V150B, P693, DOI 10.1002/ajmg.b.30895; Hobin JA, 2006, HIPPOCAMPUS, V16, P174, DOI 10.1002/hipo.20144; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Ishikawa A, 2006, J NEUROPHYSIOL, V96, P2134, DOI 10.1152/jn.00069.2006; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Jackson-Fisher AJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2198; Jacobs BL, 2000, MOL PSYCHIATR, V5, P262, DOI 10.1038/sj.mp.4000712; Jayatissa MN, 2006, NEUROPSYCHOPHARMACOL, V31, P2395, DOI 10.1038/sj.npp.1301041; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Kastin AJ, 2004, J NEUROCHEM, V88, P965, DOI 10.1046/j.1471-4159.2003.02224.x; Kato T, 2011, MOL PSYCHIATR, V16, P307, DOI 10.1038/mp.2010.10; Kempermann G, 2003, BIOL PSYCHIAT, V54, P499, DOI 10.1016/S0006-3223(03)00319-6; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2002, BIPOLAR DISORD, V4, P17, DOI 10.1034/j.1399-5618.2002.40101.x; Kjelstrup KG, 2002, P NATL ACAD SCI USA, V99, P10825, DOI 10.1073/pnas.152112399; Lee D, 2009, J CLIN INVEST, V119, P2702, DOI 10.1172/JCI36435; Lipska BK, 2002, NEUROTOX RES, V4, P469, DOI 10.1080/1029842021000022089; Liu Y, 2005, DEV BIOL, V283, P437, DOI 10.1016/j.ydbio.2005.04.038; Lopez-Bendito G, 2006, CELL, V125, P127, DOI 10.1016/j.cell.2006.01.042; Lu CL, 2010, NEUROSCI LETT, V481, P120, DOI 10.1016/j.neulet.2010.06.067; Maggio N, 2007, J NEUROSCI, V27, P5757, DOI 10.1523/JNEUROSCI.0155-07.2007; Maggio N, 2007, HIPPOCAMPUS, V17, P10, DOI 10.1002/hipo.20237; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Maren S, 2004, BEHAV NEUROSCI, V118, P97, DOI 10.1037/0735-7044.118.1.97; Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Miller EJ, 2010, NEUROSCIENCE, V165, P601, DOI 10.1016/j.neuroscience.2009.10.036; Nason MW, 2011, NEUROPSYCHOPHARMACOL, V36, P488, DOI 10.1038/npp.2010.180; Naz M, 2011, MOL BIOL REP, V38, P4709, DOI 10.1007/s11033-010-0606-0; Neddens J, 2010, HIPPOCAMPUS, V20, P724, DOI 10.1002/hipo.20675; Nettles KW, 2000, BRAIN RES, V858, P181, DOI 10.1016/S0006-8993(99)02281-7; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Oomen CA, 2010, J NEUROSCI, V30, P6635, DOI 10.1523/JNEUROSCI.0247-10.2010; Paizanis E, 2009, INT J NEUROPSYCHOPH, P1; Parlapani E, 2010, WORLD J BIOL PSYCHIA, V11, P243, DOI 10.3109/15622970802022376; Pentkowski NS, 2006, EUR J NEUROSCI, V23, P2185, DOI 10.1111/j.1460-9568.2006.04754.x; Perera TD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017600; Prata DP, 2009, PSYCHIAT GENET, V19, P113, DOI 10.1097/YPG.0b013e32832a4f69; Reif A, 2006, MOL PSYCHIATR, V11, P514, DOI 10.1038/sj.mp.4001791; Rieff HI, 2006, EUR J NEUROSCI, V23, P2225, DOI 10.1111/j.1460-9568.2006.04727.x; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Scharfman H, 2005, EXP NEUROL, V192, P348, DOI 10.1016/j.expneurol.2004.11.016; Schmid RS, 2003, P NATL ACAD SCI USA, V100, P4251, DOI 10.1073/pnas.0630496100; SCHMIDT HD, 2010, NEUROPSYCHOPHARMACOL; Sen S, 2008, BIOL PSYCHIAT, V64, P527, DOI 10.1016/j.biopsych.2008.05.005; Seshadri S, 2010, P NATL ACAD SCI USA, V107, P5622, DOI 10.1073/pnas.0909284107; Shibuya M, 2010, J NEURAL TRANSM, V117, P887, DOI 10.1007/s00702-010-0418-3; Shirayama Y, 2002, J NEUROSCI, V22, P3251, DOI 10.1523/JNEUROSCI.22-08-03251.2002; SNYDER JS, 2011, NATURE; Stefansson H, 2003, AM J HUM GENET, V72, P83, DOI 10.1086/345442; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Surget A, 2011, MOL PSYCHIATR, V16, P1177, DOI 10.1038/mp.2011.48; Surget A, 2008, BIOL PSYCHIAT, V64, P293, DOI 10.1016/j.biopsych.2008.02.022; Talmage DA, 2004, J COMP NEUROL, V472, P134, DOI 10.1002/cne.20091; Vaidya Vidita A, 2007, Expert Rev Neurother, V7, P853, DOI 10.1586/14737175.7.7.853; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; VANGROEN T, 1990, J COMP NEUROL, V302, P515, DOI 10.1002/cne.903020308; Walker RM, 2010, NEUROSCI LETT, V478, P9, DOI 10.1016/j.neulet.2010.04.056; Wang JW, 2008, BIOL PSYCHIAT, V63, P640, DOI 10.1016/j.biopsych.2008.01.008; WEN DZ, 1994, MOL CELL BIOL, V14, P1909, DOI 10.1128/MCB.14.3.1909; Wilson Christina, 2010, Clin Schizophr Relat Psychoses, V4, P124, DOI 10.3371/CSRP.4.2.4; WILSON MA, 1991, NEUROSCIENCE, V44, P555, DOI 10.1016/0306-4522(91)90077-2; Xu ZF, 2006, J CEREBR BLOOD F MET, V26, P527, DOI 10.1038/sj.jcbfm.9600212; Xu ZF, 2004, BIOCHEM BIOPH RES CO, V322, P440, DOI 10.1016/j.bbrc.2004.07.149; Yau HJ, 2003, CEREB CORTEX, V13, P252, DOI 10.1093/cercor/13.3.252; Zhang HX, 2008, NEUROSCI LETT, V438, P1, DOI 10.1016/j.neulet.2007.09.051	100	43	46	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26610	10.1371/journal.pone.0026610	http://dx.doi.org/10.1371/journal.pone.0026610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028923	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500097
J	McCambridge, J; Butor-Bhavsar, K; Witton, J; Elbourne, D				McCambridge, Jim; Butor-Bhavsar, Kaanan; Witton, John; Elbourne, Diana			Can Research Assessments Themselves Cause Bias in Behaviour Change Trials? A Systematic Review of Evidence from Solomon 4-Group Studies	PLOS ONE			English	Review							RANDOMIZED CONTROLLED-TRIAL; MISUSE PREVENTION PROGRAM; CONTROLLED CLINICAL-TRIAL; ALCOHOL-USE; EMERGENCY-DEPARTMENT; HAZARDOUS DRINKING; HEALTH-PSYCHOLOGY; CERVICAL-CANCER; NORTH-CAROLINA; SOCIAL-SKILLS	Background: The possible effects of research assessments on participant behaviour have attracted research interest, especially in studies with behavioural interventions and/or outcomes. Assessments may introduce bias in randomised controlled trials by altering receptivity to intervention in experimental groups and differentially impacting on the behaviour of control groups. In a Solomon 4-group design, participants are randomly allocated to one of four arms: (1) assessed experimental group; (2) unassessed experimental group (3) assessed control group; or (4) unassessed control group. This design provides a test of the internal validity of effect sizes obtained in conventional two-group trials by controlling for the effects of baseline assessment, and assessing interactions between the intervention and baseline assessment. The aim of this systematic review is to evaluate evidence from Solomon 4-group studies with behavioural outcomes that baseline research assessments themselves can introduce bias into trials. Methodology/Principal Findings: Electronic databases were searched, supplemented by citation searching. Studies were eligible if they reported appropriately analysed results in peer-reviewed journals and used Solomon 4-group designs in non-laboratory settings with behavioural outcome measures and sample sizes of 20 per group or greater. Ten studies from a range of applied areas were included. There was inconsistent evidence of main effects of assessment, sparse evidence of interactions with behavioural interventions, and a lack of convincing data in relation to the research question for this review. Conclusions/Significance: There were too few high quality completed studies to infer conclusively that biases stemming from baseline research assessments do or do not exist. There is, therefore a need for new rigorous Solomon 4-group studies that are purposively designed to evaluate the potential for research assessments to cause bias in behaviour change trials.	[McCambridge, Jim; Butor-Bhavsar, Kaanan] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Ctr Res Drugs & Hlth Behav, London WC1, England; [Witton, John] Kings Coll London, Inst Psychiat, Natl Addict Ctr, London WC2R 2LS, England; [Elbourne, Diana] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Med Stat, London WC1, England	University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; University of London; London School of Hygiene & Tropical Medicine	McCambridge, J (corresponding author), London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Ctr Res Drugs & Hlth Behav, London WC1, England.	Jim.McCambridge@lshtm.ac.uk		McCambridge, Jim/0000-0002-5461-7001	Wellcome Trust [WT086516MA]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust award to the first author (WT086516MA). The funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braeken APBM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-177; BRAVER MCW, 1988, PSYCHOL BULL, V104, P150, DOI 10.1037/0033-2909.104.1.150; CAMPANELLI PC, 1989, HEALTH EDUC QUART, V16, P113, DOI 10.1177/109019818901600112; CAMPBELL DT, 1957, PSYCHOL BULL, V54, P297, DOI 10.1037/h0040950; Carey KB, 2006, J CONSULT CLIN PSYCH, V74, P943, DOI 10.1037/0022-006X.74.5.943; Cherpitel CJ, 2010, ALCOHOL CLIN EXP RES, V34, P1922, DOI 10.1111/j.1530-0277.2010.01281.x; Clemes SA, 2009, MED SCI SPORT EXER, V41, P674, DOI 10.1249/MSS.0b013e31818cae32; Clifford PR, 2007, J STUD ALCOHOL DRUGS, V68, P519, DOI 10.15288/jsad.2007.68.519; Coyne JC, 2010, HEALTH PSYCHOL, V29, P107, DOI 10.1037/a0017633; Daeppen JB, 2007, ADDICTION, V102, P1224, DOI 10.1111/j.1360-0443.2007.01869.x; del Junco DJ, 2008, JNCI-J NATL CANCER I, V100, P333, DOI 10.1093/jnci/djn027; Dignan M, 1996, J NATL CANCER I, V88, P1670, DOI 10.1093/jnci/88.22.1670; Dignan MB, 1998, HEALTH EDUC RES, V13, P545, DOI 10.1093/her/13.4.545; DURYEA EJ, 1983, J SCHOOL HEALTH, V53, P250, DOI 10.1111/j.1746-1561.1983.tb01139.x; Fox MC, 2011, PSYCHOL BULL, V137, P316, DOI 10.1037/a0021663; Freeman GD, 2003, J EDUC RES, V96, P131, DOI 10.1080/00220670309598801; French DP, 2010, BRIT J HEALTH PSYCH, V15, P453, DOI 10.1348/135910710X492341; Godin G, 2008, HEALTH PSYCHOL, V27, P179, DOI 10.1037/0278-6133.27.2.179; Institute for Government & UK Government Cabinet Office, 2010, MIND SPACE INFL BEH; Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25; Kirsch I, 2000, BIOL PSYCHIAT, V47, P733, DOI 10.1016/S0006-3223(00)00832-5; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; KRAUT RE, 1973, PUBLIC OPIN QUART, V37, P398, DOI 10.1086/268101; Kvalem IL, 1996, HEALTH EDUC QUART, V23, P34, DOI 10.1177/109019819602300103; Kypri K, 2007, ADDICTION, V102, P62, DOI 10.1111/j.1360-0443.2006.01632.x; Kypri K, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-42; LAWSON DM, 1982, J BEHAV ASSESS, V4, P287, DOI 10.1007/BF01341224; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lusk SL, 1999, HUM FACTORS, V41, P487, DOI 10.1518/001872099779610969; McCambridge J, 2011, PLOS ONE IN PRESS; McCambridge J, 2011, J MED INTER IN PRESS; McCambridge J, 2008, ADDICTION, V103, P241, DOI 10.1111/j.1360-0443.2007.02080.x; Mccambridge J, 2009, ADDICTION, V104, P1311, DOI 10.1111/j.1360-0443.2009.02684.x; McCarney R, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-30; MUNGAS DM, 1979, J CONSULT CLIN PSYCH, V47, P216, DOI 10.1037/0022-006X.47.1.216; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; Sandberg T, 2009, BRIT J SOC PSYCHOL, V48, P221, DOI 10.1348/014466608X347001; SHOPE JT, 1992, J STUD ALCOHOL, V53, P106, DOI 10.15288/jsa.1992.53.106; SOLOMON RL, 1949, PSYCHOL BULL, V46, P137, DOI 10.1037/h0062958; Spence JC, 2009, PSYCHOL HEALTH, V24, P777, DOI 10.1080/08870440801989938; Traeen B, 2003, J COMMUNITY APPL SOC, V13, P207, DOI 10.1002/casp.712; van Sluijs EMF, 2006, J CLIN EPIDEMIOL, V59, P404, DOI 10.1016/j.jclinepi.2005.08.016; Walters ST, 2009, ADDICTION, V104, P1305, DOI 10.1111/j.1360-0443.2009.02632.x; WILLSON VL, 1982, AM EDUC RES J, V19, P249, DOI 10.3102/00028312019002249	45	52	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25223	10.1371/journal.pone.0025223	http://dx.doi.org/10.1371/journal.pone.0025223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841JB	22039407	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000296507500008
J	McKenzie, AJ; Campbell, SL; Howe, AK				McKenzie, Andrew J.; Campbell, Shirley L.; Howe, Alan K.			Protein Kinase A Activity and Anchoring Are Required for Ovarian Cancer Cell Migration and Invasion	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; AKAP SIGNALING COMPLEXES; ALPHA SUBUNIT; EPAC PROTEINS; LEADING-EDGE; PKA; METASTASIS; INVASIVENESS; ACTIVATION; DYNAMICS	Epithelial ovarian cancer (EOC) is the deadliest of the gynecological malignancies, due in part to its clinically occult metastasis. Therefore, understanding the mechanisms governing EOC dissemination and invasion may provide new targets for antimetastatic therapies or new methods for detection of metastatic disease. The cAMP-dependent protein kinase (PKA) is often dysregulated in EOC. Furthermore, PKA activity and subcellular localization by A-kinase anchoring proteins (AKAPs) are important regulators of cytoskeletal dynamics and cell migration. Thus, we sought to study the role of PKA and AKAP function in both EOC cell migration and invasion. Using the plasma membrane-directed PKA biosensor, pmAKAR3, and an improved migration/invasion assay, we show that PKA is activated at the leading edge of migrating SKOV-3 EOC cells, and that inhibition of PKA activity blocks SKOV-3 cell migration. Furthermore, we show that while the PKA activity within the leading edge of these cells is mediated by anchoring of type-II regulatory PKA subunits (RII), inhibition of anchoring of either RI or RII PKA subunits blocks cell migration. Importantly, we also show - for the first time - that PKA activity is up-regulated at the leading edge of SKOV-3 cells during invasion of a three-dimensional extracellular matrix and, as seen for migration, inhibition of either PKA activity or AKAP-mediated PKA anchoring blocks matrix invasion. These data are the first to demonstrate that the invasion of extracellular matrix by cancer cells elicits activation of PKA within the invasive leading edge and that both PKA activity and anchoring are required for matrix invasion. These observations suggest a role for PKA and AKAP activity in EOC metastasis.	[McKenzie, Andrew J.; Howe, Alan K.] Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA; [McKenzie, Andrew J.; Campbell, Shirley L.; Howe, Alan K.] Univ Vermont, Coll Med, Vermont Canc Ctr, Burlington, VT USA	University of Vermont; University of Vermont	McKenzie, AJ (corresponding author), Univ Vermont, Coll Med, Dept Pharmacol, Burlington, VT 05405 USA.	Alan.Howe@uvm.edu			National Institutes of Health/National Institute of General Medical Sciences [R01GM074204]; Vermont Cancer Center; Lake Champlain Cancer Research Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097495, R01GM074204] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Vermont Cancer Center; Lake Champlain Cancer Research Organization; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by grant #R01GM074204 (to AKH) from the National Institutes of Health/National Institute of General Medical Sciences (http://www.nigms.nih.gov) and from a postdoctoral fellowship (to SLC) from the Vermont Cancer Center and Lake Champlain Cancer Research Organization (http://www.vermontcancer.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Alper O, 1999, ONCOGENE, V18, P4999, DOI 10.1038/sj.onc.1202830; Bai F, 2006, INT J GYNECOL CANCER, V16, P202, DOI 10.1111/j.1525-1438.2006.00296.x; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Bossis I, 2004, ENDOCRINOLOGY, V145, P5452, DOI 10.1210/en.2004-0900; Breckler M, 2011, CELL SIGNAL, V23, P1257, DOI 10.1016/j.cellsig.2011.03.007; Capo-Chichi CD, 2009, MOL CELL BIOL, V29, P4766, DOI 10.1128/MCB.00087-09; Cardone RA, 2007, MOL BIOL CELL, V18, P1768, DOI 10.1091/mbc.E06-07-0617; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; Cheadle C, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-43; ChoChung YS, 1995, CRIT REV ONCOL HEMAT, V21, P33, DOI 10.1016/1040-8428(94)00166-9; Choi JH, 2006, CANCER RES, V66, P3912, DOI 10.1158/0008-5472.CAN-05-1785; Cramer DW, 2011, CANCER PREV RES, V4, P365, DOI 10.1158/1940-6207.CAPR-10-0195; Curto M, 2004, CANCER CELL, V5, P113, DOI 10.1016/S1535-6108(04)00031-5; Dabizzi S, 2003, CANCER RES, V63, P4281; Deming PB, 2008, J BIOL CHEM, V283, P35199, DOI 10.1074/jbc.M804448200; Diviani D, 2001, J CELL SCI, V114, P1431; Dutta S, 2010, CANCER BIOL THER, V9, P668, DOI 10.4161/cbt.9.9.11610; Edin ML, 2001, EXP CELL RES, V270, P214, DOI 10.1006/excr.2001.5345; Estecha A, 2009, J CELL SCI, V122, P3492, DOI 10.1242/jcs.053157; Even-Ram S, 2005, CURR OPIN CELL BIOL, V17, P524, DOI 10.1016/j.ceb.2005.08.015; Fernando HS, 2008, J UROLOGY, V180, P1515, DOI 10.1016/j.juro.2008.06.004; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gilles C, 1999, J CELL SCI, V112, P4615; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Gubbels JAA, 2010, J OVARIAN RES, V3, DOI 10.1186/1757-2215-3-8; Hanprasertpong J, 2011, EUR J CANCER CARE, V20, P287, DOI 10.1111/j.1365-2354.2010.01224.x; Hasegawa K, 2004, INT J CANCER, V108, P86, DOI 10.1002/ijc.11565; Hochbaum D, 2011, J BIOL CHEM, V286, P859, DOI 10.1074/jbc.M110.163816; Howe AK, 2005, P NATL ACAD SCI USA, V102, P14320, DOI 10.1073/pnas.0507072102; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; HOWE AK, 2011, CURR OPIN C IN PRESS, V23; Hundsrucker C, 2006, BIOCHEM SOC T, V34, P472, DOI 10.1042/BST0340472; Iwashita S, 2004, BIOCHEM BIOPH RES CO, V320, P1063, DOI 10.1016/j.bbrc.2004.06.067; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jones SL, 2005, J LEUKOCYTE BIOL, V78, P248, DOI 10.1189/jlb.0804459; Kabbarah O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010770; Kam Y, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-198; Kedrin D, 2007, J MAMMARY GLAND BIOL, V12, P143, DOI 10.1007/s10911-007-9046-4; Kenny HA, 2007, INT J CANCER, V121, P1463, DOI 10.1002/ijc.22874; Kurisu S, 2005, ONCOGENE, V24, P1309, DOI 10.1038/sj.onc.1208177; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lim CJ, 2008, MOL BIOL CELL, V19, P4930, DOI 10.1091/mbc.E08-06-0564; Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561; Lochner A, 2006, CARDIOVASC DRUG REV, V24, P261, DOI 10.1111/j.1527-3466.2006.00261.x; Lyle KS, 2008, CELL SIGNAL, V20, P1104, DOI 10.1016/j.cellsig.2008.01.018; Mai PL, 2011, CANCER PREV RES, V4, P303, DOI 10.1158/1940-6207.CAPR-11-0053; McDaid HM, 1999, BRIT J CANCER, V79, P933, DOI 10.1038/sj.bjc.6690149; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Naviglio S, 2009, EXPERT OPIN THER TAR, V13, P83, DOI [10.1517/14728220802602349, 10.1517/14728220802602349 ]; Ni Q, 2006, METHODS, V40, P279, DOI 10.1016/j.ymeth.2006.06.013; Paulucci-Holthauzen AA, 2009, J BIOL CHEM, V284, P5956, DOI 10.1074/jbc.M805606200; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Pidoux G, 2010, J MOL ENDOCRINOL, V44, P271, DOI 10.1677/JME-10-0010; Pignata S, 2011, CANCER LETT, V303, P73, DOI 10.1016/j.canlet.2011.01.026; Ramirez I, 2011, CANCER CONTROL, V18, P22, DOI 10.1177/107327481101800104; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rivard RL, 2009, CELL MOTIL CYTOSKEL, V66, P693, DOI 10.1002/cm.20399; Sabbisetti VS, 2005, INT J CANCER, V117, P551, DOI 10.1002/ijc.21158; Schafer C, 2010, CELL ADHES MIGR, V4, P215, DOI 10.4161/cam.4.2.10745; Sharma S, 2005, GYNECOL ONCOL, V99, P183, DOI 10.1016/j.ygyno.2005.06.006; Shield K, 2009, GYNECOL ONCOL, V113, P143, DOI 10.1016/j.ygyno.2008.11.032; Skroblin P, 2010, INT REV CEL MOL BIO, V283, P235, DOI 10.1016/S1937-6448(10)83005-9; Su B, 2010, J BIOL CHEM, V285, P4578, DOI 10.1074/jbc.M109.073494; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Xia W, 2001, CANCER RES, V61, P5644; Ydrenius L, 1997, BIOCHEM BIOPH RES CO, V235, P445, DOI 10.1006/bbrc.1997.6822; Yilmaz M, 2010, MOL CANCER RES, V8, P629, DOI 10.1158/1541-7786.MCR-10-0139; YOUNG MRI, 1995, INT J CANCER, V61, P104, DOI 10.1002/ijc.2910610118; Zhang DL, 2010, MOL CELL BIOCHEM, V335, P1, DOI 10.1007/s11010-009-0234-y	71	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26552	10.1371/journal.pone.0026552	http://dx.doi.org/10.1371/journal.pone.0026552			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028904	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500088
J	Quiroz, TS; Nieto, PA; Tobar, HE; Salazar-Echegarai, FJ; Lizana, RJ; Quezada, CP; Santiviago, CA; Araya, DV; Riedel, CA; Kalergis, AM; Bueno, SM				Quiroz, Tania S.; Nieto, Pamela A.; Tobar, Hugo E.; Salazar-Echegarai, Francisco J.; Lizana, Rodrigo J.; Quezada, Carolina P.; Santiviago, Carlos A.; Araya, Daniela V.; Riedel, Claudia A.; Kalergis, Alexis M.; Bueno, Susan M.			Excision of an Unstable Pathogenicity Island in Salmonella enterica Serovar Enteritidis Is Induced during Infection of Phagocytic Cells	PLOS ONE			English	Article							PRECISE EXCISION; VIBRIO-CHOLERAE; IDENTIFICATION; EVOLUTIONARY; RESISTANCE; INTEGRASE; MUTATIONS; DELETION; PROTEIN; TET	The availability of the complete genome sequence of several Salmonella enterica serovars has revealed the presence of unstable genetic elements in these bacteria, such as pathogenicity islands and prophages. This is the case of Salmonella enterica serovar Enteritidis (S. Enteritidis), a bacterium that causes gastroenteritis in humans and systemic infection in mice. The whole genome sequence analysis for S. Enteritidis unveiled the presence of several genetic regions that are absent in other Salmonella serovars. These regions have been denominated "regions of difference'' (ROD). In this study we show that ROD21, one of such regions, behaves as an unstable pathogenicity island. We observed that ROD21 undergoes spontaneous excision by two independent recombination events, either under laboratory growth conditions or during infection of murine cells. Importantly, we also found that one type of excision occurred at higher rates when S. Enteritidis was residing inside murine phagocytic cells. These data suggest that ROD21 is an unstable pathogenicity island, whose frequency of excision depends on the environmental conditions found inside phagocytic cells.	[Quiroz, Tania S.; Nieto, Pamela A.; Tobar, Hugo E.; Salazar-Echegarai, Francisco J.; Lizana, Rodrigo J.; Araya, Daniela V.; Kalergis, Alexis M.; Bueno, Susan M.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Millennium Inst Immunol & Immunotherapy, Santiago, Chile; [Quezada, Carolina P.; Santiviago, Carlos A.] Univ Chile, Dept Bioquim & Biol Mol, Fac Ciencias Quim & Farmaceut, Santiago, Chile; [Riedel, Claudia A.] Univ Andres Bello, Millennium Inst Immunol & Immunotherapy, Fac Ciencias Biol, Santiago, Chile; [Riedel, Claudia A.] Univ Andres Bello, Millennium Inst Immunol & Immunotherapy, Fac Med, Santiago, Chile; [Kalergis, Alexis M.] Pontificia Univ Catolica Chile, Fac Med, Dept Reumatol, Santiago, Chile	Pontificia Universidad Catolica de Chile; Universidad de Chile; Universidad Andres Bello; Universidad Andres Bello; Pontificia Universidad Catolica de Chile	Quiroz, TS (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Dept Mol Genet & Microbiol, Millennium Inst Immunol & Immunotherapy, Alameda 340, Santiago, Chile.	sbueno@bio.puc.cl	Quezada, Carolina Paz/AAG-1981-2019; Santiviago, Carlos/N-9991-2018	Quezada, Carolina Paz/0000-0002-0260-5754; Santiviago, Carlos/0000-0002-7043-7908; Kalergis, Alexis/0000-0001-7622-5263; Bueno, Susan M./0000-0002-7551-8088; Salazar-Echegarai, Francisco/0000-0001-6709-699X; Riedel, Claudia/0000-0001-6168-8601	FONDEYT [11075060, 1070352, 1050979, 1040349, 1100971, 1100092, SavinMuco-Path-INCO-CT-2006-032296]; IFS [B/3764-1]; Anillo [ADI-08/2006, VRAID-INICIO 20/2007, Red 15 PBCT]; Millennium Nucleus on Immunology and Immunotherapy [P-07-088-F]	FONDEYT; IFS(International Foundation for Science); Anillo(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/ANILLOS); Millennium Nucleus on Immunology and Immunotherapy	Support for this study was provided by: FONDEYT n<SUP>o</SUP> 11075060, FONDECYT n<SUP>o</SUP> 1070352, FONDECYT n<SUP>o</SUP> 1050979, FONDECYT n<SUP>o</SUP> 1040349, FONDECYT 1100971, FONDECYT 1100092, SavinMuco-Path-INCO-CT-2006-032296; IFS#B/3764-1, Anillo ADI-08/2006, VRAID-INICIO 20/2007, Red 15 PBCT, and Millennium Nucleus on Immunology and Immunotherapy (P-07-088-F). HET and PAN are CONICYT Fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almagro-Moreno S, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-306; Araya DV, 2010, VACCINE, V28, P5458, DOI 10.1016/j.vaccine.2010.05.073; Bach S, 1999, INFECT IMMUN, V67, P5091, DOI 10.1128/IAI.67.10.5091-5099.1999; Banks DJ, 2003, INFECT IMMUN, V71, P7079, DOI 10.1128/IAI.71.12.7079-7086.2003; Bueno SM, 2004, J BACTERIOL, V186, P3202, DOI 10.1128/JB.186.10.3202-3213.2004; Bueno SM, 2008, IMMUNOLOGY, V124, P522, DOI 10.1111/j.1365-2567.2008.02805.x; Cotter PA, 2000, ANNU REV MICROBIOL, V54, P519, DOI 10.1146/annurev.micro.54.1.519; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Deiwick J, 1999, MOL MICROBIOL, V31, P1759, DOI 10.1046/j.1365-2958.1999.01312.x; Gantois I, 2009, FEMS MICROBIOL REV, V33, P718, DOI 10.1111/j.1574-6976.2008.00161.x; Guard-Petter J, 2001, ENVIRON MICROBIOL, V3, P421, DOI 10.1046/j.1462-2920.2001.00213.x; Hidalgo AA, 2004, GENETICS, V167, P1069, DOI 10.1534/genetics.104.026682; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; Hochhut B, 2006, MOL MICROBIOL, V61, P584, DOI 10.1111/j.1365-2958.2006.05255.x; Juhas M, 2009, FEMS MICROBIOL REV, V33, P376, DOI 10.1111/j.1574-6976.2008.00136.x; Kobayashi H, 2005, J FOOD PROTECT, V68, P932, DOI 10.4315/0362-028X-68.5.932; Lesic B, 2005, J BACTERIOL, V187, P3352, DOI 10.1128/JB.187.10.3352-3358.2005; Lesic B, 2004, MOL MICROBIOL, V52, P1337, DOI 10.1111/j.1365-2958.2004.04073.x; Lovell HC, 2009, CURR BIOL, V19, P1586, DOI 10.1016/j.cub.2009.08.018; MALOY SR, 1981, J BACTERIOL, V145, P1110, DOI 10.1128/JB.145.2.1110-1111.1981; Manson JM, 2006, MOL MICROBIOL, V61, P555, DOI 10.1111/j.1365-2958.2006.05262.x; MCMURRY LM, 1992, J BACTERIOL, V174, P6294, DOI 10.1128/JB.174.19.6294-6297.1992; Middendorf B, 2004, J BACTERIOL, V186, P3086, DOI 10.1128/JB.186.10.3086-3096.2004; MOYED HS, 1983, J BACTERIOL, V155, P549, DOI 10.1128/JB.155.2.549-556.1983; MOYED HS, 1983, J BACTERIOL, V155, P557, DOI 10.1128/JB.155.2.557-564.1983; Murphy RA, 2008, J BACTERIOL, V190, P636, DOI 10.1128/JB.00562-07; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Porwollik S, 2005, J BACTERIOL, V187, P6545, DOI 10.1128/JB.187.18.6545-6555.2005; Ramsay JP, 2009, MOL MICROBIOL, V73, P1141, DOI 10.1111/j.1365-2958.2009.06843.x; Sambrook J., 1982, MOL CLONING LAB MANU, P545; Santiviago CA, 2010, J BACTERIOL, V192, P2246, DOI 10.1128/JB.00270-09; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Thomson NR, 2008, GENOME RES, V18, P1624, DOI 10.1101/gr.077404.108; Turner SA, 2001, J BACTERIOL, V183, P5535, DOI 10.1128/JB.183.19.5535-5543.2001; Williamson HS, 2005, MOL MICROBIOL, V55, P808, DOI 10.1111/j.1365-2958.2004.04421.x	35	25	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26031	10.1371/journal.pone.0026031	http://dx.doi.org/10.1371/journal.pone.0026031			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039432	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500028
J	Sieber, MW; Claus, RA; Witte, OW; Frahm, C				Sieber, Matthias W.; Claus, Ralf A.; Witte, Otto W.; Frahm, Christiane			Attenuated Inflammatory Response in Aged Mice Brains following Stroke	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; CENTRAL-NERVOUS-SYSTEM; NF-KAPPA-B; IMMUNE-SYSTEM; RAT-BRAIN; FOCAL ISCHEMIA; YOUNG-RATS; INJURY; CYTOKINES; EXPRESSION	Background: Increased age is a major risk factor for stroke incidence, post-ischemic mortality, and severe and long-term disability. Stroke outcome is considerably influenced by post-ischemic mechanisms. We hypothesized that the inflammatory response following an ischemic injury is altered in aged organisms. Methods and Results: To that end, we analyzed the expression pattern of pro-inflammatory cytokines (TNF, IL-1 alpha, IL-1 beta, IL-6), anti-inflammatory cytokines (IL-10, TGF beta 1), and chemokines (Mip-1 alpha, MCP-1, RANTES) of adult (2 months) and aged (24 months) mice brains at different reperfusion times (6 h, 12 h, 24 h, 2 d, 7 d) following transient occlusion of the middle cerebral artery. The infarct size was assessed to monitor possible consequences of an altered inflammatory response in aged mice. Our data revealed an increased neuro-inflammation with age. Above all, we found profound age-related alterations in the reaction to stroke. The response of pro-inflammatory cytokines (TNF, and IL-1 beta) and the level of chemokines (Mip-1 alpha, and MCP-1) were strongly diminished in the aged post-ischemic brain tissue. IL-6 showed the strongest age-dependent decrease in its post-ischemic expression profile. Anti-inflammatory cytokines (TGF beta 1, and IL-10) revealed no significant age dependency after ischemia. Aged mice brains tend to develop smaller infarcts. Conclusion: The attenuated inflammatory response to stroke in aged animals may contribute to their smaller infarcts. The results presented here highlight the importance of using aged animals to investigate age-associated diseases like stroke, and should be considered as a major prerequisite in the development of age-adjusted therapeutic interventions.	[Sieber, Matthias W.; Witte, Otto W.; Frahm, Christiane] Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Thuringia, Germany; [Sieber, Matthias W.; Claus, Ralf A.] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Thuringia, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Sieber, MW (corresponding author), Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Thuringia, Germany.	Otto.Witte@med.uni-jena.de	Witte, Otto/P-4127-2018; Claus, Ralf A./Q-4035-2016	Witte, Otto/0000-0003-2101-4105; Claus, Ralf A./0000-0001-7232-4088	European Union [LSHB-CT-2006-018936]; Jena centre for systems biology of ageing - Jenage [BMBF 0315581]	European Union(European Commission); Jena centre for systems biology of ageing - Jenage	The study was funded by the European Union (STREP, FP6, 'Age-dependent inflammatory response after stroke' - ARGES [LSHB-CT-2006-018936]) and is part of the research program of the Jena centre for systems biology of ageing - Jenage (BMBF 0315581). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone FC, 1997, STROKE, V28, P1233, DOI 10.1161/01.STR.28.6.1233; Barone FC, 2006, CLIN NEUROSCI RES, V6, P329, DOI 10.1016/j.cnr.2006.09.010; Buga AM, 2008, J CELL MOL MED, V12, P2731, DOI 10.1111/j.1582-4934.2008.00252.x; Campuzano O, 2009, J NEUROSCI RES, V87, P2484, DOI 10.1002/jnr.22074; Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021; Che XM, 2001, BRAIN RES, V902, P171, DOI 10.1016/S0006-8993(01)02328-9; DAVIS M, 1995, STROKE, V26, P1072, DOI 10.1161/01.STR.26.6.1072; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Dilger RN, 2008, J LEUKOCYTE BIOL, V84, P932, DOI 10.1189/jlb.0208108; DiNapoli VA, 2010, NEUROSCIENCE, V170, P633, DOI 10.1016/j.neuroscience.2010.07.011; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Doyle KP, J NEUROINFLAMMATION, V7, P62; Dubal DB, 2001, ENDOCRINOLOGY, V142, P43, DOI 10.1210/en.142.1.43; Engelter ST, 2003, CEREBROVASC DIS, V15, P188, DOI 10.1159/000068826; Felzien LK, 2001, BRAIN RES, V890, P137, DOI 10.1016/S0006-8993(00)03090-0; Feuerstein GZ, 2001, ARCH NEUROL-CHICAGO, V58, P672, DOI 10.1001/archneur.58.4.672; GINSBERG MD, 1989, STROKE, V20, P1627, DOI 10.1161/01.STR.20.12.1627; Grubeck-Loebenstein B, 2002, ADV IMMUNOL, V80, P243, DOI 10.1016/S0065-2776(02)80017-7; Jaenisch N, 2010, STROKE, V41, pE151, DOI 10.1161/STROKEAHA.109.570424; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Kyrkanides S, 2001, J NEUROIMMUNOL, V119, P269, DOI 10.1016/S0165-5728(01)00404-0; Lee JC, 2009, J NEUROTRAUM, V26, P1567, DOI 10.1089/neu.2008.0630; Lee WH, 2010, NEUROSCI LETT, V476, P89, DOI 10.1016/j.neulet.2010.04.009; Makinodan T, 1980, Adv Immunol, V29, P287, DOI 10.1016/S0065-2776(08)60047-4; NAKAYAMA H, 1994, STROKE, V25, P808, DOI 10.1161/01.STR.25.4.808; Nawashiro H, 1997, J CEREBR BLOOD F MET, V17, P483, DOI 10.1097/00004647-199705000-00001; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Ohtsuki T, 1996, J CEREBR BLOOD F MET, V16, P1137, DOI 10.1097/00004647-199611000-00007; Perera MN, 2006, J CLIN NEUROSCI, V13, P1, DOI 10.1016/j.jocn.2005.07.005; Petcu EB, 2008, GERONTOLOGY, V54, P6, DOI 10.1159/000112845; Planas AM, 2006, BIOCHEM SOC T, V34, P1267, DOI 10.1042/BST0341267; Popa-Wagner A, 1998, STROKE, V29, P2196, DOI 10.1161/01.STR.29.10.2196; Popa-Wagner A, 2007, ACTA NEUROPATHOL, V113, P277, DOI 10.1007/s00401-006-0164-7; Popp A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004764; Rink L, 1998, MECH AGEING DEV, V102, P199, DOI 10.1016/S0047-6374(97)00153-X; Rosen CL, 2005, J NEUROSURG, V103, P687, DOI 10.3171/jns.2005.103.4.0687; Sandhir R, 2004, NEUROSCI LETT, V369, P28, DOI 10.1016/j.neulet.2004.07.032; Saposnik G, 2009, STROKE, V40, P3328, DOI 10.1161/STROKEAHA.109.558759; SAWADA M, 1992, BRAIN RES, V583, P296, DOI 10.1016/S0006-8993(10)80037-X; SCHROETER M, 1994, J NEUROIMMUNOL, V55, P195, DOI 10.1016/0165-5728(94)90010-8; Sheng JG, 1998, ACTA NEUROPATHOL, V95, P229, DOI 10.1007/s004010050792; Sieber MW, 2010, NEUROBIOL AGING, V31, P654, DOI 10.1016/j.neurobiolaging.2008.05.023; Sieber MW, 2010, ANAL BIOCHEM, V401, P303, DOI 10.1016/j.ab.2010.03.007; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Suzuki S, 2009, J CEREBR BLOOD F MET, V29, P464, DOI 10.1038/jcbfm.2008.141; Takami S, 2001, J CEREBR BLOOD F MET, V21, P1430, DOI 10.1097/00004647-200112000-00007; Terao S, 2008, STROKE, V39, P2560, DOI 10.1161/STROKEAHA.107.513150; Truelsen T, 2006, EUR J NEUROL, V13, P581, DOI 10.1111/j.1468-1331.2006.01138.x; Tuttolomondo A, 2008, CURR PHARM DESIGN, V14, P3574, DOI 10.2174/138161208786848739; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Vexler ZS, 2006, CLIN NEUROSCI RES, V6, P293, DOI 10.1016/j.cnr.2006.09.008; Whitaker JN, 2001, ARCH NEUROL-CHICAGO, V58, P674, DOI 10.1001/archneur.58.4.674; Zhang L, 2005, STROKE, V36, P847, DOI 10.1161/01.STR.0000158923.19956.73; Zhao CS, 2005, BEHAV BRAIN RES, V156, P85, DOI 10.1016/j.bbr.2004.05.011; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	57	74	77	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26288	10.1371/journal.pone.0026288	http://dx.doi.org/10.1371/journal.pone.0026288			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028848	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900042
J	Acosta, A; Hurtado, MD; Gorbatyuk, O; La Sala, M; Duncan, D; Aslanidi, G; Campbell-Thompson, M; Zhang, L; Herzog, H; Voutetakis, A; Baum, BJ; Zolotukhin, S				Acosta, Andres; Hurtado, Maria D.; Gorbatyuk, Oleg; La Sala, Michael; Duncan, David; Aslanidi, George; Campbell-Thompson, Martha; Zhang, Lei; Herzog, Herbert; Voutetakis, Antonis; Baum, Bruce J.; Zolotukhin, Sergei			Salivary PYY: A Putative Bypass to Satiety	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; TASTE SENSITIVITY; EXPRESSION; RECEPTOR; GLANDS; MICE; LEPTIN; SECRETION; CELLS; CHOLECYSTOKININ	Peptide YY3-36 is a satiation hormone released postprandially into the bloodstream from L-endocrine cells in the gut epithelia. In the current report, we demonstrate PYY3-36 is also present in murine as well as in human saliva. In mice, salivary PYY3-36 derives from plasma and is also synthesized in the taste cells in taste buds of the tongue. Moreover, the cognate receptor Y2R is abundantly expressed in the basal layer of the progenitor cells of the tongue epithelia and von Ebner's gland. The acute augmentation of salivary PYY3-36 induced stronger satiation as demonstrated in feeding behavioral studies. The effect is mediated through the activation of the specific Y2 receptor expressed in the lingual epithelial cells. In a longterm study involving diet-induced obese (DIO) mice, a sustained increase in PYY3-36 was achieved using viral vector-mediated gene delivery targeting salivary glands. The chronic increase in salivary PYY3-36 resulted in a significant long-term reduction in food intake (FI) and body weight (BW). Thus this study provides evidence for new functions of the previously characterized gut peptide PYY3-36 suggesting a potential simple and efficient alternative therapeutic approach for the treatment of obesity.	[Acosta, Andres; Hurtado, Maria D.; Gorbatyuk, Oleg; La Sala, Michael; Duncan, David; Aslanidi, George; Campbell-Thompson, Martha; Zolotukhin, Sergei] Univ Florida, Gainesville, FL 32611 USA; [Zhang, Lei; Herzog, Herbert] Garvan Inst Med Res, Sydney, NSW, Australia; [Voutetakis, Antonis; Baum, Bruce J.] NIDCR, Mol Physiol & Therapeut Branch, NIH, Bethesda, MD USA	State University System of Florida; University of Florida; Garvan Institute of Medical Research; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Acosta, A (corresponding author), Univ Florida, Gainesville, FL 32611 USA.	szlt@ufl.edu	/B-6258-2012; Herzog, Herbert/B-8294-2008; Campbell-Thompson, Martha/A-7584-2010; Aslanidi, George/C-5680-2019	Hurtado, Maria Daniela/0000-0002-2322-7334; Campbell-Thompson, Martha/0000-0001-6878-1235; Duncan, David/0000-0003-2768-576X; , Herbert/0000-0002-1713-1029; Aslanidi, George/0000-0002-2726-8627	NIH/NIDDK [1R01DK62302-01]; The Division of Intramural Research of the National Institute of Dental and Craniofacial Research; NHMRC of Australia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062302] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); The Division of Intramural Research of the National Institute of Dental and Craniofacial Research; NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by the following: SZ - 1R01DK62302-01 (NIH/NIDDK); BB - The Division of Intramural Research of the National Institute of Dental and Craniofacial Research in part supported this research, HH is funded by a NHMRC of Australia Senior Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aslanidi G, 2007, AM J PHYSIOL-ENDOC M, V293, pE726, DOI 10.1152/ajpendo.00248.2007; Batterham RL, 2002, NATURE, V418, P650, DOI 10.1038/nature00887; Boey D, 2006, DIABETOLOGIA, V49, P1360, DOI 10.1007/s00125-006-0237-0; BOHORQUEZ DV, J MOL HISTOL; Castle D, 1998, CRIT REV ORAL BIOL M, V9, P4, DOI 10.1177/10454411980090010301; Chen ZW, 2001, FEBS LETT, V492, P119, DOI 10.1016/S0014-5793(01)02234-7; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Doods H, 1999, EUR J PHARMACOL, V384, pR3, DOI 10.1016/S0014-2999(99)00650-0; Elson AET, 2010, FASEB J, V24, P3960, DOI 10.1096/fj.10-158105; Erickson JC, 1996, NATURE, V381, P415, DOI 10.1038/381415a0; Groschl M, 2005, CLIN CHEM, V51, P997, DOI 10.1373/clinchem.2004.040667; Groschl M, 2001, J CLIN ENDOCR METAB, V86, P5234, DOI 10.1210/jc.86.11.5234; Halatchev IG, 2005, CELL METAB, V1, P159, DOI 10.1016/j.cmet.2005.02.003; HERNESS MS, 1989, NEUROSCIENCE, V33, P411, DOI 10.1016/0306-4522(89)90220-0; Herness S, 2002, J NEUROSCI, V22, P10018; Hoque ATMS, 2001, J DRUG TARGET, V9, P485, DOI 10.3109/10611860108998782; Katano H, 2006, GENE THER, V13, P594, DOI 10.1038/sj.gt.3302691; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; Keire DA, 2008, REGUL PEPTIDES, V151, P61, DOI 10.1016/j.regpep.2008.04.001; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2009, ANN NY ACAD SCI, V1170, P98, DOI 10.1111/j.1749-6632.2009.03920.x; Michlig S, 2007, J COMP NEUROL, V502, P1003, DOI 10.1002/cne.21354; Morimoto R, 2008, NUTRITION, V24, P878, DOI 10.1016/j.nut.2008.06.011; Nguyen CQ, 2007, J IMMUNOL, V179, P2318, DOI 10.4049/jimmunol.179.4.2318; Ogawa Y, 2008, BIOL PHARM BULL, V31, P1059, DOI 10.1248/bpb.31.1059; Okubo T, 2009, STEM CELLS, V27, P442, DOI 10.1634/stemcells.2008-0611; Raimondi AR, 2006, AM J PATHOL, V168, P1654, DOI 10.2353/ajpath.2006.050847; SAHARA N, 1984, CELL TISSUE RES, V235, P427; Seta Y, 2006, ARCH HISTOL CYTOL, V69, P273, DOI 10.1679/aohc.69.273; Shen T, 2005, NEUROSCIENCE, V130, P229, DOI 10.1016/j.neuroscience.2004.09.017; Shin YK, 2008, J NEUROCHEM, V106, P455, DOI 10.1111/j.1471-4159.2008.05397.x; Shin YK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012729; Stanic D, 2006, J COMP NEUROL, V499, P357, DOI 10.1002/cne.21046; Tang SC, 2003, BIOCHEM BIOPH RES CO, V303, P645, DOI 10.1016/S0006-291X(03)00399-1; Toda M, 2007, ACTA DIABETOL, V44, P20, DOI 10.1007/s00592-007-0236-8; Tschenett A, 2003, EUR J NEUROSCI, V18, P143, DOI 10.1046/j.1460-9568.2003.02725.x; Tschop M, 2004, NATURE, V430, DOI 10.1038/nature02665; VALLEJO G, 1984, DIABETOLOGIA, V27, P437, DOI 10.1007/BF00273907; Voutetakis A, 2004, P NATL ACAD SCI USA, V101, P3053, DOI 10.1073/pnas.0400136101; Wang JH, 2005, HUM GENE THER, V16, P571, DOI 10.1089/hum.2005.16.571; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	42	38	42	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26137	10.1371/journal.pone.0026137	http://dx.doi.org/10.1371/journal.pone.0026137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028819	gold, Green Published, Green Submitted			2022-12-27	WOS:000295971700043
J	Zou, SM; Li, Q; Kong, LF; Yu, H; Zheng, XD				Zou, Shanmei; Li, Qi; Kong, Lingfeng; Yu, Hong; Zheng, Xiaodong			Comparing the Usefulness of Distance, Monophyly and Character-Based DNA Barcoding Methods in Species Identification: A Case Study of Neogastropoda	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; TAXONOMY; GENUS; DIVERSITY; DISCOVERY; GENETICS; DIPTERA; GENERA; TOOL; GAP	Background: DNA barcoding has recently been proposed as a promising tool for the rapid species identification in a wide range of animal taxa. Two broad methods (distance and monophyly-based methods) have been used. One method is based on degree of DNA sequence variation within and between species while another method requires the recovery of species as discrete clades (monophyly) on a phylogenetic tree. Nevertheless, some issues complicate the use of both methods. A recently applied new technique, the character-based DNA barcode method, however, characterizes species through a unique combination of diagnostic characters. Methodology/Principal Findings: Here we analyzed 108 COI and 102 16S rDNA sequences of 40 species of Neogastropoda from a wide phylogenetic range to assess the performance of distance, monophyly and character-based methods of DNA barcoding. The distance-based method for both COI and 16S rDNA genes performed poorly in terms of species identification. Obvious overlap between intraspecific and interspecific divergences for both genes was found. The "10 x rule" threshold resulted in lumping about half of distinct species for both genes. The neighbour-joining phylogenetic tree of COI could distinguish all species studied. However, the 16S rDNA tree could not distinguish some closely related species. In contrast, the character-based barcode method for both genes successfully identified 100% of the neogastropod species included, and performed well in discriminating neogastropod genera. Conclusions/Significance: This present study demonstrates the effectiveness of the character-based barcoding method for species identification in different taxonomic levels, especially for discriminating the closely related species. While distance and monophyly-based methods commonly use COI as the ideal gene for barcoding, the character-based approach can perform well for species identification using relatively conserved gene markers (e. g., 16S rDNA in this study). Nevertheless, distance and monophyly-based methods, especially the monophyly-based method, can still be used to flag species.	[Zou, Shanmei; Li, Qi; Kong, Lingfeng; Yu, Hong; Zheng, Xiaodong] Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao, Peoples R China	Ocean University of China	Zou, SM (corresponding author), Ocean Univ China, Minist Educ, Key Lab Mariculture, Qingdao, Peoples R China.	qili66@ouc.edu.cn	Kong, Lingfeng/AAJ-3402-2021; Kong, Lingfeng/AAG-2473-2019	Kong, Lingfeng/0000-0001-5263-1697	National High Technology Research and Development Program [2007AA09Z433]; 973 Program [2010CB126406]; National Natural Science Foundation of China [40906064]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the grants from National High Technology Research and Development Program (2007AA09Z433), 973 Program (2010CB126406) and National Natural Science Foundation of China (40906064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bely AE, 2006, EVOL DEV, V8, P491, DOI 10.1111/j.1525-142X.2006.00122.x; Bergmann T, 2009, BERL MUNCH TIERARZTL, V122, P446, DOI 10.2376/0005-9366-122-446; Bertolazzi P, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S7; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; BOUCHET P, 1990, MALACOLOGIA, V32, P69; Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Carstens BC, 2007, SYST BIOL, V56, P400, DOI [10.1080/10635150701405560, 10.1080/10635150701701091]; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Damm S, 2010, MOL ECOL, V19, P3881, DOI 10.1111/j.1365-294X.2010.04720.x; Dayrat B, 2005, BIOL J LINN SOC, V85, P407, DOI 10.1111/j.1095-8312.2005.00503.x; DeSaille R, 2007, BIOESSAYS, V29, P1289, DOI 10.1002/bies.20667; DeSalle R, 2005, PHILOS T R SOC B, V360, P1905, DOI 10.1098/rstb.2005.1722; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Frezal L, 2008, INFECT GENET EVOL, V8, P727, DOI 10.1016/j.meegid.2008.05.005; Goldstein PZ, 2011, BIOESSAYS, V33, P135, DOI 10.1002/bies.201000036; Goldstein PZ, 2000, CONSERV BIOL, V14, P120, DOI 10.1046/j.1523-1739.2000.98122.x; Gomez A, 2007, P ROY SOC B-BIOL SCI, V274, P199, DOI 10.1098/rspb.2006.3718; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Hudson RR, 2002, EVOLUTION, V56, P1557, DOI 10.1111/j.0014-3820.2002.tb01467.x; Janzen DH, 2005, PHILOS T R SOC B, V360, P1835, DOI 10.1098/rstb.2005.1715; Kantor Yuri I., 1996, P221; Kantor Yuri I., 2002, Bollettino Malacologico, V38, P161; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Kerr KCR, 2009, FRONT ZOOL, V6, DOI 10.1186/1742-9994-6-29; Kizirian D, 2004, MOL PHYLOGENET EVOL, V32, P1072, DOI 10.1016/j.ympev.2004.05.001; Knowlton N, 1998, P ROY SOC B-BIOL SCI, V265, P2257, DOI 10.1098/rspb.1998.0568; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Lowenstein JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007866; Lukhtanov VA, 2009, MOL ECOL RESOUR, V9, P1302, DOI 10.1111/j.1755-0998.2009.02577.x; Maddison WP, 2009, MESQUITE MODULAR SYS; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Neigel J, 2007, CORAL REEFS, V26, P487, DOI 10.1007/s00338-007-0248-4; Nielsen R, 2006, SYST BIOL, V55, P162, DOI 10.1080/10635150500431239; Palumbi Stephen R., 1996, P205; PAMILO P, 1988, MOL BIOL EVOL, V5, P568; Ponder WF, 1997, ZOOL J LINN SOC-LOND, V119, P83, DOI 10.1111/j.1096-3642.1997.tb00137.x; Ponder WF, 1974, MALACOLOGIA, V12, P295; Ponder Winston F., 2008, P331; Rach J, 2008, P ROY SOC B-BIOL SCI, V275, P237, DOI 10.1098/rspb.2007.1290; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reid BN, 2011, MOL ECOL RESOUR, V11, P956, DOI 10.1111/j.1755-0998.2011.03032.x; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; RODRIGO AG, 1993, INT J PARASITOL, V23, P507, DOI 10.1016/0020-7519(93)90040-6; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Rubinoff D, 2006, J HERED, V97, P581, DOI 10.1093/jhered/esl036; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Sarkar IN, 2002, MOL PHYLOGENET EVOL, V24, P388; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Smith MA, 2006, P NATL ACAD SCI USA, V103, P3657, DOI 10.1073/pnas.0511318103; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor J.D., 1988, Malacological Review Supplement, P167; Trewick SA, 2008, CLADISTICS, V24, P240, DOI 10.1111/j.1096-0031.2007.00174.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Waugh J, 2007, BIOESSAYS, V29, P188, DOI 10.1002/bies.20529; Wiemers M, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-8; Wild AL, 2009, SYST ENTOMOL, V34, P49, DOI 10.1111/j.1365-3113.2008.00435.x; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x; WINNEPENNINCKX B, 1993, TRENDS GENET, V9, P407; Witt JDS, 2006, MOL ECOL, V15, P3073, DOI 10.1111/j.1365-294X.2006.02999.x; Yassin A, 2010, MOL PHYLOGENET EVOL, V57, P509, DOI 10.1016/j.ympev.2010.08.020; Zou SM, 2012, MAR BIOTECHNOL, V14, P21, DOI 10.1007/s10126-011-9384-5	73	58	64	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26619	10.1371/journal.pone.0026619	http://dx.doi.org/10.1371/journal.pone.0026619			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039517	Green Published, gold, Green Submitted			2022-12-27	WOS:000296515200033
J	Kreshuk, A; Straehle, CN; Sommer, C; Koethe, U; Cantoni, M; Knott, G; Hamprecht, FA				Kreshuk, Anna; Straehle, Christoph N.; Sommer, Christoph; Koethe, Ullrich; Cantoni, Marco; Knott, Graham; Hamprecht, Fred A.			Automated Detection and Segmentation of Synaptic Contacts in Nearly Isotropic Serial Electron Microscopy Images	PLOS ONE			English	Article							NEURAL TISSUE; RANDOM FOREST; SYNAPSES; RECONSTRUCTION; CLASSIFICATION; VOLUME; SELECTION; NUMBER	We describe a protocol for fully automated detection and segmentation of asymmetric, presumed excitatory, synapses in serial electron microscopy images of the adult mammalian cerebral cortex, taken with the focused ion beam, scanning electron microscope (FIB/SEM). The procedure is based on interactive machine learning and only requires a few labeled synapses for training. The statistical learning is performed on geometrical features of 3D neighborhoods of each voxel and can fully exploit the high z-resolution of the data. On a quantitative validation dataset of 111 synapses in 409 images of 194861342 pixels with manual annotations by three independent experts the error rate of the algorithm was found to be comparable to that of the experts (0.92 recall at 0.89 precision). Our software offers a convenient interface for labeling the training data and the possibility to visualize and proofread the results in 3D. The source code, the test dataset and the ground truth annotation are freely available on the website http://www.ilastik.org/synapse-detection.	[Kreshuk, Anna; Straehle, Christoph N.; Sommer, Christoph; Koethe, Ullrich; Hamprecht, Fred A.] Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany; [Cantoni, Marco; Knott, Graham] Ecole Polytech Fed Lausanne, Lausanne, Switzerland	Ruprecht Karls University Heidelberg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Kreshuk, A (corresponding author), Heidelberg Univ, Interdisciplinary Ctr Sci Comp, Heidelberg, Germany.	fred.hamprecht@iwr.uni-heidelberg.de	Cantoni, Marco/C-4227-2011	Cantoni, Marco/0000-0002-1356-9541; Kreshuk, Anna/0000-0003-1334-6388; Koethe, Ullrich/0000-0001-6036-1287; Knott, Graham W/0000-0002-2956-9052	Heidelberg Graduate School for Mathematical and Computational Methods for the Sciences; Excellence Cluster Cellular Networks; SBcancer research initiatives; Robert Bosch GmbH; German Research Foundation (DFG) [HA-4364/6-1]	Heidelberg Graduate School for Mathematical and Computational Methods for the Sciences; Excellence Cluster Cellular Networks; SBcancer research initiatives; Robert Bosch GmbH; German Research Foundation (DFG)(German Research Foundation (DFG))	Funding: The authors gratefully acknowledge partial funding by the Heidelberg Graduate School for Mathematical and Computational Methods for the Sciences (http://mathcomp.uni-heidelberg.de/), by the Excellence Cluster Cellular Networks (http://www.cellnetworks.uni-hd.de/), by the ViroQuant (http://www.viroquant.uni-hd.de/) and SBcancer (http://www.dkfz.de/en/sbcancer/index.html) research initiatives, the Robert Bosch GmbH (http://www.bosch.com/worldsite_startpage/en/default.aspx) and the German Research Foundation (DFG, http://www.dfg.de/en/index.jsp) under grant no. HA-4364/6-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Anderson JR, 2009, PLOS BIOL, V7, P493, DOI 10.1371/journal.pbio.1000074; Andres B, 2008, LECT NOTES COMPUT SC, V5096, P142, DOI 10.1007/978-3-540-69321-5_15; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Cardona A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000502; Caruana R., 2006, P 23 INT C MACH LEAR, P161, DOI DOI 10.1145/1143844.1143865; Chklovskii DB, 2010, CURR OPIN NEUROBIOL, V20, P667, DOI 10.1016/j.conb.2010.08.002; Coggeshall RE, 1996, J COMP NEUROL, V364, P6, DOI 10.1002/(SICI)1096-9861(19960101)364:1<6::AID-CNE2>3.0.CO;2-9; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Geinisman Y, 1996, J NEUROCYTOL, V25, P805, DOI 10.1007/BF02284843; Guo L, 2004, 15TH INTERNATIONAL SYMPOSIUM ON SOFTWARE RELIABILITY ENGINEERING, PROCEEDINGS, P417; Helmstaedter M, 2011, NAT NEUROSCI, V14, P1081, DOI 10.1038/nn.2868; Helmstaedter M, 2008, CURR OPIN NEUROBIOL, V18, P633, DOI 10.1016/j.conb.2009.03.005; Herold J, 2010, J BIOTECHNOL, V149, P299, DOI 10.1016/j.jbiotec.2010.03.004; Jain V, 2010, PROC CVPR IEEE, P2488, DOI 10.1109/CVPR.2010.5539950; Jain V, 2010, CURR OPIN NEUROBIOL, V20, P653, DOI 10.1016/j.conb.2010.07.004; Jurrus E, 2010, MED IMAGE ANAL, V14, P770, DOI 10.1016/j.media.2010.06.002; Jurrus E, 2009, MED IMAGE ANAL, V13, P180, DOI 10.1016/j.media.2008.05.002; Kaynig V, 2010, PROC CVPR IEEE, P2902, DOI 10.1109/CVPR.2010.5540029; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Knott GW, 2002, NEURON, V34, P265, DOI 10.1016/S0896-6273(02)00663-3; Kreshuk A, 2011, P ISBI CHIC IL US; Kubota Y, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.004.2009; Lucchi A, 2010, P MICCAI BEIJ CHIN; Mayhew TM, 1996, J NEUROCYTOL, V25, P793, DOI 10.1007/BF02284842; Menze BH, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-213; Merchan-Perez A, 2009, FRONT NEUROANAT, V3, DOI 10.3389/neuro.05.018.2009; Mishchenko Y, 2010, NEURON, V67, P1009, DOI 10.1016/j.neuron.2010.08.014; Mishchenko Y, 2009, J NEUROSCI METH, V176, P276, DOI 10.1016/j.jneumeth.2008.09.006; Narasimha R, 2009, PATTERN RECOGN, V42, P1067, DOI 10.1016/j.patcog.2008.08.009; Schmitz SK, J NEUROSCIENCE UNPUB; Schroeder W., 2006, VISUALIZATION TOOLKI, DOI DOI 10.1016/B978-012387582-2/50003-4; Sommer C, 2011, P ISBI CHIC IL US; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Turaga SC, 2009, P NIPS; Vazquez-Reina A, 2009, PROC CVPR IEEE, P2020, DOI 10.1109/CVPRW.2009.5206524	36	92	94	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e24899	10.1371/journal.pone.0024899	http://dx.doi.org/10.1371/journal.pone.0024899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031814	Green Submitted, gold, Green Published			2022-12-27	WOS:000296513200001
J	Stephens, R; Seddon, B; Langhorne, J				Stephens, Robin; Seddon, Benedict; Langhorne, Jean			Homeostatic Proliferation and IL-7R Alpha Expression Do Not Correlate with Enhanced T Cell Proliferation and Protection in Chronic Mouse Malaria	PLOS ONE			English	Article							PLASMODIUM-CHABAUDI-CHABAUDI; RECEPTOR-DEFICIENT MICE; PHENOTYPE CD8(+) CELLS; MEMORY CELLS; IMMUNOLOGICAL MEMORY; CD4; INTERLEUKIN-7; GENERATION; INFECTION; EXPANSION	While chronic infection has been shown to enhance protection from disease caused by several pathogens, the mechanisms are not known. The gamma-c family of cytokines IL-7, IL-2, and IL-15 are implicated in homeostatic proliferation, which is thought to maintain T cell memory. However in chronic infection, prolonged antigen exposure itself may contribute to lymphocyte survival. We have previously observed that chronic malaria infection enhances protection to re-infection, as well as enhancing B cell responses. Here, we show that chronic Plasmodium chabaudi malaria infection in mice enhances the expansion of CD4(+) T cells in a second infection, and that this correlates with increased expression of the IL-2/15 Receptor beta (CD122) on memory T cells, as well as increasing IL-2 producers on re-infection. IL-2 has been recently linked to improved secondary proliferation, while the role of IL-7 in maintenance of CD4(+) memory cells has been demonstrated in homeostatic proliferation, but its role in protective memory populations in infectious disease protective has not been fully investigated. Increased IL-7R alpha (CD127) expression correlated, as previously reported with increased turnover of CD4 memory cells, however, this was not linked to protection or enhanced response to rechallenge, These data support the idea that antigen or IL-2 production resulting from chronic stimulation may play a role in an enhanced secondary T cell response.	[Stephens, Robin; Langhorne, Jean] MRC Natl Inst Med Res, Div Parasitol, London, England; [Seddon, Benedict] MRC Natl Inst Med Res, Div Immune Cell Biol, London, England	MRC National Institute for Medical Research; MRC National Institute for Medical Research	Stephens, R (corresponding author), Univ Texas Med Branch, Dept Internal Med, Div Infect Dis, Galveston, TX 77555 USA.	jlangho@nimr.mrc.ac.uk		Seddon, Benedict/0000-0003-4352-3373; Langhorne, Jean/0000-0002-2257-9733	MRC, UK [U117584248]; Evimalar European Network of Excellence; Medical Research Council [MC_U117584248, MC_U117573801] Funding Source: researchfish; MRC [MC_U117573801, MC_U117584248] Funding Source: UKRI	MRC, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Evimalar European Network of Excellence; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the MRC, UK (U117584248, www.mrc.ac.uk) and the Evimalar European Network of Excellence in the 7th Framework Programme (www.evimalar.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achtman AH, 2007, PARASITE IMMUNOL, V29, P435, DOI 10.1111/j.1365-3024.2007.00960.x; Akashi K, 1997, CELL, V89, P1033, DOI 10.1016/S0092-8674(00)80291-3; Boyman O, 2006, J EXP MED, V203, P1817, DOI 10.1084/jem.20052495; Dooms H, 2007, J EXP MED, V204, P547, DOI 10.1084/jem.20062381; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; HAND T, 2007, P NATL ACAD SCI US, V104; Haring JS, 2008, J IMMUNOL, V180, P2855, DOI 10.4049/jimmunol.180.5.2855; Hunt P, 2004, MOL BIOCHEM PARASIT, V133, P27, DOI 10.1016/j.molbiopara.2003.08.010; Jelley-Gibbs DM, 2005, J EXP MED, V202, P697, DOI 10.1084/jem.20050227; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kassiotis G, 2002, NAT IMMUNOL, V3, P244, DOI 10.1038/ni766; Kondrack RM, 2003, J EXP MED, V198, P1797, DOI 10.1084/jem.20030735; Lacombe MH, 2005, J IMMUNOL, V175, P4400, DOI 10.4049/jimmunol.175.7.4400; Lenz DC, 2004, P NATL ACAD SCI USA, V101, P9357, DOI 10.1073/pnas.0400640101; Li C, 2000, INFECT IMMUN, V68, P5724, DOI 10.1128/IAI.68.10.5724-5730.2000; Li JC, 2003, J EXP MED, V198, P1807, DOI 10.1084/jem.20030725; MacLeod MKL, 2008, P NATL ACAD SCI USA, V105, P14521, DOI 10.1073/pnas.0807449105; Marrack P, 2000, NAT IMMUNOL, V1, P107, DOI 10.1038/77778; MEDING SJ, 1991, EUR J IMMUNOL, V21, P1433, DOI 10.1002/eji.1830210616; MIYAZAKI T, 1995, CELL, V81, P223, DOI 10.1016/0092-8674(95)90332-1; Obst R, 2005, J EXP MED, V201, P1555, DOI 10.1084/jem.20042521; Okwor I, 2008, IMMUNOL RES, V41, P123, DOI 10.1007/s12026-008-8016-2; PERIGNON JL, 1994, MEM I OSWALDO CRUZ, V89, P51, DOI 10.1590/S0074-02761994000600013; PESCHON JJ, 1994, J EXP MED, V180, P1955, DOI 10.1084/jem.180.5.1955; Purton JF, 2007, J EXP MED, V204, P951, DOI 10.1084/jem.20061805; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Schmidt NW, 2008, P NATL ACAD SCI USA, V105, P14017, DOI 10.1073/pnas.0805452105; Seddon B, 2003, NAT IMMUNOL, V4, P680, DOI 10.1038/ni946; STEPHENS R, 2005, BLOOD; Stephens R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001208; Swain SL, 1999, SCIENCE, V286, P1381, DOI 10.1126/science.286.5443.1381; Tan JT, 2002, J EXP MED, V195, P1523, DOI 10.1084/jem.20020066; VONFREEDENJEFFRY U, 1995, J EXP MED, V181, P1519, DOI 10.1084/jem.181.4.1519	33	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26686	10.1371/journal.pone.0026686	http://dx.doi.org/10.1371/journal.pone.0026686			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039531	Green Published, Green Submitted, gold			2022-12-27	WOS:000296513200041
J	Lugtenberg, M; Burgers, JS; Clancy, C; Westert, GP; Schneider, EC				Lugtenberg, Marjolein; Burgers, Jako S.; Clancy, Carolyn; Westert, Gert P.; Schneider, Eric C.			Current Guidelines Have Limited Applicability to Patients with Comorbid Conditions: A Systematic Analysis of Evidence-Based Guidelines	PLOS ONE			English	Article							MULTIPLE CHRONIC CONDITIONS; QUALITY-OF-LIFE; CLINICAL GUIDELINES; CARE; HEALTH; PREVALENCE; RECOMMENDATIONS; DEPRESSION; DISEASES; ABSENCE	Background: Guidelines traditionally focus on the diagnosis and treatment of single diseases. As almost half of the patients with a chronic disease have more than one disease, the applicability of guidelines may be limited. The aim of this study was to assess the extent that guidelines address comorbidity and to assess the supporting evidence of recommendations related to comorbidity. Methodology/Principal Findings: We conducted a systematic analysis of evidence-based guidelines focusing on four highly prevalent chronic conditions with a high impact on quality of life: chronic obstructive pulmonary disease, depressive disorder, diabetes mellitus type 2, and osteoarthritis. Data were abstracted from each guideline on the extent that comorbidity was addressed (general comments, specific recommendations), the type of comorbidity discussed (concordant, discordant), and the supporting evidence of the comorbidity-related recommendations (level of evidence, translation of evidence). Of the 20 guidelines, 17 (85%) addressed the issue of comorbidity and 14 (70%) provided specific recommendations on comorbidity. In general, the guidelines included few recommendations on patients with comorbidity (mean 3 recommendations per guideline, range 0 to 26). Of the 59 comorbidity-related recommendations provided, 46 (78%) addressed concordant comorbidities, 8 (14%) discordant comorbidities, and for 5 (8%) the type of comorbidity was not specified. The strength of the supporting evidence was moderate for 25% (15/59) and low for 37% (22/59) of the recommendations. In addition, for 73% (43/59) of the recommendations the evidence was not adequately translated into the guidelines. Conclusions/Significance: Our study showed that the applicability of current evidence-based guidelines to patients with comorbid conditions is limited. Most guidelines do not provide explicit guidance on treatment of patients with comorbidity, particularly for discordant combinations. Guidelines should be more explicit about the applicability of their recommendations to patients with comorbidity. Future clinical trials should also include patients with the most prevalent combinations of chronic conditions.	[Lugtenberg, Marjolein; Westert, Gert P.] Tilburg Univ, Sci Ctr Care & Welf Tranzo, NL-5000 LE Tilburg, Netherlands; [Lugtenberg, Marjolein; Burgers, Jako S.; Westert, Gert P.] Radboud Univ Nijmegen, Med Ctr, Sci Inst Qual Healthcare IQ Healthcare, NL-6525 ED Nijmegen, Netherlands; [Burgers, Jako S.] Dutch Coll Gen Practitioners NHG, Utrecht, Netherlands; [Clancy, Carolyn] AHRQ, Rockville, MD USA; [Schneider, Eric C.] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Schneider, Eric C.] RAND Corp, Boston, MA USA; [Schneider, Eric C.] Brigham & Womens Hosp, Div Gen Med & Primary Care, Boston, MA 02115 USA	Tilburg University; Radboud University Nijmegen; Agency for Healthcare Research & Quality; Harvard University; Harvard T.H. Chan School of Public Health; RAND Corporation; Harvard University; Brigham & Women's Hospital	Lugtenberg, M (corresponding author), Tilburg Univ, Sci Ctr Care & Welf Tranzo, NL-5000 LE Tilburg, Netherlands.	m.lugtenberg@iq.umcn.nl	Westert, G.P./H-8115-2014	Westert, G.P./0000-0003-3744-8207; Schneider, Eric/0000-0002-1132-5084	The Commonwealth Fund	The Commonwealth Fund	Support was provided by The Commonwealth Fund (http://www.commonwealthfund.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views presented here are those of the authors and should not be attributed to The Commonwealth Fund or its directors, officers, or staff.	Alderson P, 2004, BMJ-BRIT MED J, V328, P476, DOI 10.1136/bmj.328.7438.476; Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P38; ALTMAN DG, 1995, BRIT MED J, V311, P485, DOI 10.1136/bmj.311.7003.485; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Burgers JS, 2010, EVAL HEALTH PROF, V33, P343, DOI 10.1177/0163278710375695; Burgers JS, 2002, DIABETES CARE, V25, P1933, DOI 10.2337/diacare.25.11.1933; de Grauw WJC, 1999, FAM PRACT, V16, P133, DOI 10.1093/fampra/16.2.133; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Francke AL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-38; Grol R, 2001, JAMA-J AM MED ASSOC, V286, P2578, DOI 10.1001/jama.286.20.2578; Gross CP, 2002, ANN INTERN MED, V137, P10, DOI 10.7326/0003-4819-137-1-200207020-00007; GURWITZ JH, 1992, JAMA-J AM MED ASSOC, V268, P1417, DOI 10.1001/jama.1992.03490110055029; GUYATT GH, 1994, JAMA-J AM MED ASSOC, V271, P59, DOI 10.1001/jama.271.1.59; Hoffman C, 1996, JAMA-J AM MED ASSOC, V276, P1473, DOI 10.1001/jama.276.18.1473; Hussain T, 2009, INT J MED INFORM, V78, P354, DOI 10.1016/j.ijmedinf.2008.11.001; Lugtenberg M, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-54; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; National Institute for Health and Clinical Excellence (NICE), 2009, GUID MAN 2009; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; Redelmeier DA, 1998, NEW ENGL J MED, V338, P1516, DOI 10.1056/NEJM199805213382106; Rubin RR, 1999, DIABETES-METAB RES, V15, P205, DOI 10.1002/(SICI)1520-7560(199905/06)15:3<205::AID-DMRR29>3.0.CO;2-O; Schoen C, 2008, HEALTH AFFAIR, V28, pw1; Schoen C, 2007, HEALTH AFFAIR, V26, pW717, DOI 10.1377/hlthaff.26.6.w717; Schram MT, 2009, CURR DIABETES REV, V5, P112, DOI 10.2174/157339909788166828; The Scottish Intercollegiate Guidelines Network, 2019, SIGN 50 GUID DEV HDB; Tinetti ME, 2004, AM J MED, V116, P179, DOI 10.1016/j.amjmed.2003.09.031; van Weel C, 2006, LANCET, V367, P550, DOI 10.1016/S0140-6736(06)68198-1; Vitry AI, 2008, MED J AUSTRALIA, V189, P360, DOI 10.5694/j.1326-5377.2008.tb02079.x; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269	30	134	135	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25987	10.1371/journal.pone.0025987	http://dx.doi.org/10.1371/journal.pone.0025987			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028802	Green Submitted, Green Published, gold			2022-12-27	WOS:000296510800013
J	Bendavid, E; Seligman, B; Kubo, J				Bendavid, Eran; Seligman, Benjamin; Kubo, Jessica			Comparative Analysis of Old-Age Mortality Estimations in Africa	PLOS ONE			English	Article							UNDER-5 MORTALITY; ADULT MORTALITY; REGIONS; DEATH	Background: Survival to old ages is increasing in many African countries. While demographic tools for estimating mortality up to age 60 have improved greatly, mortality patterns above age 60 rely on models based on little or no demographic data. These estimates are important for social planning and demographic projections. We provide direct estimations of older-age mortality using survey data. Methods: Since 2005, nationally representative household surveys in ten sub-Saharan countries record counts of living and recently deceased household members: Burkina Faso, Cote d'Ivoire, Ethiopia, Namibia, Nigeria, Swaziland, Tanzania, Uganda, Zambia, and Zimbabwe. After accounting for age heaping using multiple imputation, we use this information to estimate probability of death in 5-year intervals ((5)q(x)). We then compare our (5)q(x) estimates to those provided by the World Health Organization (WHO) and the United Nations Population Division (UNPD) to estimate the differences in mortality estimates, especially among individuals older than 60 years old. Findings: We obtained information on 505,827 individuals (18.4% over age 60, 1.64% deceased). WHO and UNPD mortality models match our estimates closely up to age 60 (mean difference in probability of death -1.1%). However, mortality probabilities above age 60 are lower using our estimations than either WHO or UNPD. The mean difference between our sample and the WHO is 5.9% (95% CI 3.8-7.9%) and between our sample is UNPD is 13.5% (95% CI 11.6-15.5%). Regardless of the comparator, the difference in mortality estimations rises monotonically above age 60. Interpretation: Mortality estimations above age 60 in ten African countries exhibit large variations depending on the method of estimation. The observed patterns suggest the possibility that survival in some African countries among adults older than age 60 is better than previously thought. Improving the quality and coverage of vital information in developing countries will become increasingly important with future reductions in mortality.	[Bendavid, Eran; Kubo, Jessica] Stanford Univ, Div Gen Internal Med, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; [Bendavid, Eran] Stanford Univ, Ctr Primary Care & Outcomes Res, Stanford, CA 94305 USA; [Seligman, Benjamin] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Bendavid, E (corresponding author), Stanford Univ, Div Gen Internal Med, Stanford, CA 94305 USA.	ebd@stanford.edu		Seligman, Benjamin/0000-0002-8223-5924	National Institute of Allergy and Infectious Diseases [K01- AI084582]; Center on the Demography and Economics of Health and Aging [P30- AG017253]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K01AI084582] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG017253] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center on the Demography and Economics of Health and Aging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Bendavid is supported by the National Institute of Allergy and Infectious Diseases (K01- AI084582) and by the Center on the Demography and Economics of Health and Aging (P30- AG017253). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, POPUL DEV REV, V27, P365; [Anonymous], 1983, REGIONAL MODEL LIFE; COALE A, 1989, POPUL INDEX, V55, P613, DOI 10.2307/3644567; Demeny Coale AJ., 1966, REGIONAL MODEL LIFE; DUFLO E, 2000, GRANDMOTHERS GRANDDA; Eurostat, 2022, LIF TABL EUR COUNTR; Gakidou E, 2004, INT J EPIDEMIOL, V33, P710, DOI 10.1093/ije/dyh099; Gakidou E, 2006, DEMOGRAPHY, V43, P569, DOI 10.1353/dem.2006.0024; HEITJAN DF, 1990, J AM STAT ASSOC, V85, P304, DOI 10.2307/2289765; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Kautz T, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2841; Lloyd-Sherlock P, 2000, SOC SCI MED, V51, P887, DOI 10.1016/S0277-9536(00)00068-X; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; *MEAS DHS, DHS SURV MAN; Murray CJL, 2007, LANCET, V370, P1040, DOI 10.1016/S0140-6736(07)61478-0; Murray CJL, 2003, POP STUD-J DEMOG, V57, P165, DOI 10.1080/0032472032000097083; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; *ORC MACR, 2010, DEM HLTH SURV; Pullum T. W., 2006, ASSESSMENT AGE DATE; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; Seligman BJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020264; Shisana O., 2009, S AFRICAN NATL HIV P; UNAIDS, 2010, REP GLOB AIDS EP; United Nations Population Division, WORLD POP PROSP 2008; United Nations Population Division, WORLD POP PROSP 2010; *WHO, LIF TABL 2008 2000 1	27	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26607	10.1371/journal.pone.0026607	http://dx.doi.org/10.1371/journal.pone.0026607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841JB	22028921	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500095
J	Filik, R; Barber, E				Filik, Ruth; Barber, Emma			Inner Speech during Silent Reading Reflects the Reader's Regional Accent	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; PHONOLOGICAL CODES; EYE-MOVEMENTS; AUDITORY IMAGERY; MUSICAL IMAGERY; MINDS EAR; ACTIVATION; REPRESENTATION; HEARING; IDENTIFICATION	While reading silently, we often have the subjective experience of inner speech. However, there is currently little evidence regarding whether this inner voice resembles our own voice while we are speaking out loud. To investigate this issue, we compared reading behaviour of Northern and Southern English participants who have differing pronunciations for words like 'glass', in which the vowel duration is short in a Northern accent and long in a Southern accent. Participants' eye movements were monitored while they silently read limericks in which the end words of the first two lines (e. g., glass/class) would be pronounced differently by Northern and Southern participants. The final word of the limerick (e. g., mass/sparse) then either did or did not rhyme, depending on the reader's accent. Results showed disruption to eye movement behaviour when the final word did not rhyme, determined by the reader's accent, suggesting that inner speech resembles our own voice.	[Filik, Ruth; Barber, Emma] Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England	University of Nottingham	Filik, R (corresponding author), Univ Nottingham, Sch Psychol, Nottingham NG7 2RD, England.	ruth.filik@nottingham.ac.uk						Abramson M, 1997, PERCEPT PSYCHOPHYS, V59, P1059, DOI 10.3758/BF03205520; Aleman A, 2005, CEREB CORTEX, V15, P221, DOI 10.1093/cercor/bhh124; Alexander JD, 2008, J EXP PSYCHOL HUMAN, V34, P446, DOI 10.1037/0096-1523.34.2.446; Ashby J, 2006, J EXP PSYCHOL LEARN, V32, P416, DOI 10.1037/0278-7393.32.2.416; Ashby J, 2005, COGNITION, V96, pB89, DOI 10.1016/j.cognition.2004.12.006; Ashby J, 2008, J EXP PSYCHOL HUMAN, V34, P224, DOI 10.1037/0096-1523.34.1.224; Bader M., 1998, REANALYSIS SENTENCE, P1; BERENT I, 1995, PSYCHOL REV, V102, P146, DOI 10.1037/0033-295X.102.1.146; Breen M, 2011, J MEM LANG, V64, P153, DOI 10.1016/j.jml.2010.11.001; Bunzeck N, 2005, NEUROIMAGE, V26, P1119, DOI 10.1016/j.neuroimage.2005.03.013; Corley M, 2011, J EXP PSYCHOL LEARN, V37, P162, DOI 10.1037/a0021321; Drieghe D, 2002, J EXP PSYCHOL LEARN, V28, P951, DOI 10.1037//0278-7393.28.5.951; Eiter BM, 2008, PSYCHOL RES-PSYCH FO, V72, P666, DOI 10.1007/s00426-008-0166-2; Folk JR, 1999, J EXP PSYCHOL LEARN, V25, P892, DOI 10.1037/0278-7393.25.4.892; Ford JM, 2001, AM J PSYCHIAT, V158, P1914, DOI 10.1176/appi.ajp.158.11.1914; Ford JM, 2004, J PSYCHIATR RES, V38, P37, DOI 10.1016/S0022-3956(03)00095-5; Frost R, 1998, PSYCHOL BULL, V123, P71, DOI 10.1037/0033-2909.123.1.71; Halpern AR, 2004, NEUROPSYCHOLOGIA, V42, P1281, DOI 10.1016/j.neuropsychologia.2003.12.017; Halpern AR, 1999, CEREB CORTEX, V9, P697, DOI 10.1093/cercor/9.7.697; Hirose Y, 2003, J PSYCHOLINGUIST RES, V32, P167, DOI 10.1023/A:1022448308035; Hirotani M, 2006, J MEM LANG, V54, P425, DOI 10.1016/j.jml.2005.12.001; Huestegge L, 2010, J EYE MOVEMENT RES, V3; Hwang H, 2009, J PSYCHOLINGUIST RES, V38, P151, DOI 10.1007/s10936-008-9091-1; Inhoff AW, 2004, PSYCHON B REV, V11, P320, DOI 10.3758/BF03196577; KLAPP ST, 1971, J EXP PSYCHOL, V91, P262, DOI 10.1037/h0031852; Klin CM, 2010, PSYCHON B REV, V17, P231, DOI 10.3758/PBR.17.2.231; KOSSLYN SM, 1977, B PSYCHONOMIC SOC, V9, P250, DOI 10.3758/BF03336990; Kraemer DJM, 2005, NATURE, V434, P158, DOI 10.1038/434158a; Kurby CA, 2009, COGNITION, V112, P457, DOI 10.1016/j.cognition.2009.05.007; Lee YA, 1999, J EXP PSYCHOL HUMAN, V25, P948, DOI 10.1037/0096-1523.25.4.948; LEUTHARDT EC, 2011, J NEURAL EN IN PRESS; Lukatela G, 2004, J EXP PSYCHOL HUMAN, V30, P151, DOI 10.1037/0096-1523.30.1.151; MCCUTCHEN D, 1982, J VERB LEARN VERB BE, V21, P672, DOI 10.1016/S0022-5371(82)90870-2; MCCUTCHEN D, 1991, READ RES QUART, V26, P87, DOI 10.2307/747733; McGuire PK, 1996, PSYCHOL MED, V26, P29, DOI 10.1017/S0033291700033699; Oppenheim GM, 2008, COGNITION, V106, P528, DOI 10.1016/j.cognition.2007.02.006; Pei XM, 2011, NEUROIMAGE, V54, P2960, DOI 10.1016/j.neuroimage.2010.10.029; PERFETTI CA, 1991, J MEM LANG, V30, P473, DOI 10.1016/0749-596X(91)90017-E; POLLATSEK A, 1992, J EXP PSYCHOL HUMAN, V18, P148, DOI 10.1037/0096-1523.18.1.148; RAYNER K, 1995, PSYCHOL SCI, V6, P26, DOI 10.1111/j.1467-9280.1995.tb00300.x; Rayner K, 1998, J EXP PSYCHOL LEARN, V24, P476, DOI 10.1037/0278-7393.24.2.476; Rayner K, 1989, LANG COGNITIVE PROC, V4, pSI21, DOI 10.1080/01690968908406362; VANORDEN GC, 1987, MEM COGNITION, V15, P181, DOI 10.3758/BF03197716; Yoo SS, 2001, NEUROREPORT, V12, P3045, DOI 10.1097/00001756-200110080-00013; Zatorre RJ, 1996, J COGNITIVE NEUROSCI, V8, P29, DOI 10.1162/jocn.1996.8.1.29; ZHANG SL, 1993, J EXP PSYCHOL LEARN, V19, P1082, DOI 10.1037/0278-7393.19.5.1082; Ziegler JC, 2000, Q J EXP PSYCHOL-A, V53, P671, DOI 10.1080/027249800410508	47	31	31	2	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25782	10.1371/journal.pone.0025782	http://dx.doi.org/10.1371/journal.pone.0025782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841JB	22039423	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500021
J	Freitas, LM; dos Santos, SL; Rodrigues-Luiz, GF; Mendes, TAO; Rodrigues, TS; Gazzinelli, RT; Teixeira, SMR; Fujiwara, RT; Bartholomeu, DC				Freitas, Leandro M.; dos Santos, Sara Lopes; Rodrigues-Luiz, Gabriela F.; Mendes, Tiago A. O.; Rodrigues, Thiago S.; Gazzinelli, Ricardo T.; Teixeira, Santuza M. R.; Fujiwara, Ricardo T.; Bartholomeu, Daniella C.			Genomic Analyses, Gene Expression and Antigenic Profile of the Trans-Sialidase Superfamily of Trypanosoma cruzi Reveal an Undetected Level of Complexity	PLOS ONE			English	Article							COMPLEMENT REGULATORY PROTEIN; SURFACE PROTEIN; BINDING; FAMILY; IDENTIFICATION; SEQUENCE; DIVERSITY; INFECTION; DOMAIN; FORMS	The protozoan parasite Trypanosoma cruzi is the etiologic agent of Chagas disease, a highly debilitating human pathology that affects millions of people in the Americas. The sequencing of this parasite's genome reveals that trans-sialidase/trans-sialidase-like (TcS), a polymorphic protein family known to be involved in several aspects of T. cruzi biology, is the largest T. cruzi gene family, encoding more than 1,400 genes. Despite the fact that four TcS groups are well characterized and only one of the groups contains active trans-sialidases, all members of the family are annotated in the T. cruzi genome database as trans-sialidase. After performing sequence clustering analysis with all TcS complete genes, we identified four additional groups, demonstrating that the TcS family is even more heterogeneous than previously thought. Interestingly, members of distinct TcS groups show distinctive patterns of chromosome localization. Members of the TcSgroupII, which harbor proteins involved in host cell attachment/invasion, are preferentially located in subtelomeric regions, whereas members of the largest and new TcSgroupV have internal chromosomal locations. Real-time RT-PCR confirms the expression of genes derived from new groups and shows that the pattern of expression is not similar within and between groups. We also performed B-cell epitope prediction on the family and constructed a TcS specific peptide array, which was screened with sera from T. cruzi-infected mice. We demonstrated that all seven groups represented in the array are antigenic. A highly reactive peptide occurs in sixty TcS proteins including members of two new groups and may contribute to the known cross-reactivity of T. cruzi epitopes during infection. Taken together, our results contribute to a better understanding of the real complexity of the TcS family and open new avenues for investigating novel roles of this family during T. cruzi infection.	[Freitas, Leandro M.; dos Santos, Sara Lopes; Rodrigues-Luiz, Gabriela F.; Mendes, Tiago A. O.; Fujiwara, Ricardo T.; Bartholomeu, Daniella C.] Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil; [Rodrigues, Thiago S.] Ctr Fed Educ Tecnol Minas Gerais, Belo Horizonte, MG, Brazil; [Gazzinelli, Ricardo T.; Teixeira, Santuza M. R.] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Freitas, LM (corresponding author), Univ Fed Minas Gerais, Dept Parasitol, Belo Horizonte, MG, Brazil.	daniella@icb.ufmg.br	Fujiwara, Ricardo Toshio/J-7579-2012; Freitas, Leandro/AAK-3005-2020; Mendes, Tiago/AAG-1709-2021; Rodrigues-Luiz, Gabriela Flavia/AAE-4937-2020; TEIXEIRA, SANTUZA MR/I-8137-2013; Bartholomeu, Daniella C./J-4714-2015	Fujiwara, Ricardo Toshio/0000-0002-4713-575X; Freitas, Leandro/0000-0003-4327-2922; Mendes, Tiago/0000-0002-5569-4893; Rodrigues-Luiz, Gabriela Flavia/0000-0003-3838-1008; Bartholomeu, Daniella C./0000-0003-0974-7357; Gazzinelli, Ricardo/0000-0003-2427-7699	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)	Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG), Instituto Nacional de Ciencia e Tecnologia de Vacinas (INCTV), and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atwood JA, 2005, SCIENCE, V309, P473, DOI 10.1126/science.1110289; Azuaje F, 2007, IEEE T NANOBIOSCI, V6, P223, DOI 10.1109/TNB.2007.903482; Azuaje Francisco J, 2007, Kinetoplastid Biol Dis, V6, P6, DOI 10.1186/1475-9292-6-6; Bartholomeu DC, 2002, EXP PARASITOL, V102, P123, DOI 10.1016/S0014-4894(03)00034-1; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Beucher M, 2008, INFECT IMMUN, V76, P750, DOI 10.1128/IAI.01104-07; BRIONES MRS, 1995, J MOL EVOL, V41, P120, DOI 10.1007/BF00170663; BURNS JM, 1992, P NATL ACAD SCI USA, V89, P1239, DOI 10.1073/pnas.89.4.1239; Buschiazzo A, 1997, GLYCOBIOLOGY, V7, P1167, DOI 10.1093/glycob/7.8.1167; Campos PC, 2008, INT J PARASITOL, V38, P1383, DOI 10.1016/j.ijpara.2008.07.001; Cano MIN, 2001, TRENDS PARASITOL, V17, P425, DOI 10.1016/S1471-4922(01)02014-1; Chiurillo MA, 2002, MOL BIOCHEM PARASIT, V120, P305, DOI 10.1016/S0166-6851(02)00005-1; COLLI W, 1993, FASEB J, V7, P1257, DOI 10.1096/fasebj.7.13.8405811; Copley RR, 2001, PROTEIN SCI, V10, P285, DOI 10.1110/ps.31901; Cremona ML, 1999, GLYCOBIOLOGY, V9, P581, DOI 10.1093/glycob/9.6.581; CROSS GAM, 1993, ANNU REV MICROBIOL, V47, P385, DOI 10.1146/annurev.mi.47.100193.002125; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; ENGSTLER M, 1992, MOL BIOCHEM PARASIT, V54, P21, DOI 10.1016/0166-6851(92)90091-W; Fankhauser N, 2005, BIOINFORMATICS, V21, P1846, DOI 10.1093/bioinformatics/bti299; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FRANK R, 1992, TETRAHEDRON, V48, P9217, DOI 10.1016/S0040-4020(01)85612-X; Frasch ACC, 2000, PARASITOL TODAY, V16, P282, DOI 10.1016/S0169-4758(00)01698-7; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; GIORDANO R, 1994, BRAZ J MED BIOL RES, V27, P2315; Grisard EC, 2010, MOL BIOCHEM PARASIT, V174, P18, DOI 10.1016/j.molbiopara.2010.06.008; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Kim D, 2005, GENE, V346, P153, DOI 10.1016/j.gene.2004.10.014; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Magdesian MH, 2007, EXP CELL RES, V313, P210, DOI 10.1016/j.yexcr.2006.10.008; Magdesian MH, 2001, J BIOL CHEM, V276, P19382, DOI 10.1074/jbc.M011474200; Mucci J, 2006, CELL MICROBIOL, V8, P1086, DOI 10.1111/j.1462-5822.2006.00689.x; NORRIS KA, 1991, J IMMUNOL, V147, P2240; Oppezzo P, 2011, BBA-PROTEINS PROTEOM, V1814, P1154, DOI 10.1016/j.bbapap.2011.04.012; Ouaissi A, 1988, Mem Inst Oswaldo Cruz, V83 Suppl 1, P502; Pereira-Chioccola VL, 2000, J CELL SCI, V113, P1299; Pitcovsky TA, 2002, J INFECT DIS, V186, P397, DOI 10.1086/341463; POLLEVICK GD, 1991, MOL BIOCHEM PARASIT, V47, P247, DOI 10.1016/0166-6851(91)90185-9; PREVIATO JO, 1985, MOL BIOCHEM PARASIT, V16, P85, DOI 10.1016/0166-6851(85)90051-9; R Core Team, 2021, R LANGUAGE ENV STAT; Ratier L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003524; ROGGENTIN P, 1989, GLYCOCONJUGATE J, V6, P349, DOI 10.1007/BF01047853; Rubin-de-Celis SSC, 2006, CELL MICROBIOL, V8, P1888, DOI 10.1111/j.1462-5822.2006.00755.x; Santana JM, 1997, BIOCHEM J, V325, P129, DOI 10.1042/bj3250129; SCHENKMAN S, 1994, ANNU REV MICROBIOL, V48, P499, DOI 10.1146/annurev.mi.48.100194.002435; Scherf A, 2001, CURR OPIN MICROBIOL, V4, P409, DOI 10.1016/S1369-5274(00)00227-7; Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134; SOUZA W, 2010, INT J CELL BIOL, P1; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEIXEIRA SMR, 1994, J BIOL CHEM, V269, P20509; Todeschini AR, 2004, J BIOL CHEM, V279, P5323, DOI 10.1074/jbc.M310663200; Todeschini AR, 2000, GLYCOBIOLOGY, V10, P213, DOI 10.1093/glycob/10.2.213; Tonelli RR, 2011, PARASITOLOGY, V138, P481, DOI 10.1017/S0031182010001411; Tonelli RR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000864; Tzelepis F, 2008, J IMMUNOL, V180, P1737, DOI 10.4049/jimmunol.180.3.1737; VANVOORHIS WC, 1989, J EXP MED, V169, P641, DOI 10.1084/jem.169.3.641; VELGE P, 1988, PARASITOLOGY, V97, P255, DOI 10.1017/S0031182000058467; Vercelli CA, 2005, TRANSPL P, V37, P4594, DOI 10.1016/j.transproceed.2005.10.013; Weatherly DB, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-255; WHO, 2002, WHO TECHN REP SER, V912; Yan T, 2005, NUCLEIC ACIDS RES, V33, pW262, DOI 10.1093/nar/gki368	62	63	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25914	10.1371/journal.pone.0025914	http://dx.doi.org/10.1371/journal.pone.0025914			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039427	gold, Green Published, Green Submitted			2022-12-27	WOS:000296507500024
J	Wang, JP; Lee, CK; Akalin, A; Finberg, RW; Levitz, SM				Wang, Jennifer P.; Lee, Chrono K.; Akalin, Ali; Finberg, Robert W.; Levitz, Stuart M.			Contributions of the MyD88-Dependent Receptors IL-18R, IL-1R, and TLR9 to Host Defenses following Pulmonary Challenge with Cryptococcus neoformans	PLOS ONE			English	Article							IFN-GAMMA PRODUCTION; INFECTION; MICE; MYD88; CELLS; TOLL-LIKE-RECEPTOR-4; INTERLEUKIN-12; INVOLVEMENT; MENINGITIS; INDUCTION	Signaling via the adapter protein, MyD88, is important in the host defense against Cryptococcus neoformans infection. While certain Toll-like receptors (TLRs) can enhance the clearance of Cryptococcus, the contributions of MyD88-dependent, TLR-independent pathways have not been fully investigated. We examined the roles of IL-1R and IL-18R in vivo by challenging C57BL/6 mice with a lethal strain of Cryptococcus. We found that the absence of IL-18R, but not IL-1R, causes a shift in the survival curve following pulmonary delivery of a virulent strain of C. neoformans (H99). Specifically, IL-18R-deficient mice have significantly shorter median survival times compared to wild-type mice following infection. Cytokine analysis of lung homogenates revealed that deficiency of IL-IR, IL-18R, or MyD88 is associated with diminished lung levels of IL-1 beta. In order to compare these findings with those related to TLR-deficiency, we studied the effects of TLR9-deficiency and found that deficiency of TLR9 also affects the survival curve of mice following challenge with C. neoformans. Yet the lungs from infected TLR9-deficient mice have robust levels of IL-1 beta. In summary, we found that multiple signaling components can contribute the MyD88-dependent host responses to cryptococcal infection in vivo and each drives distinct pulmonary responses.	[Wang, Jennifer P.; Lee, Chrono K.; Akalin, Ali; Finberg, Robert W.; Levitz, Stuart M.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Wang, JP (corresponding author), Univ Massachusetts, Sch Med, Dept Med, Worcester, MA 01605 USA.	Jennifer.wang@umassmed.edu	Akalin, Ali/GMW-6237-2022; Akalin, Ali/AAH-1266-2019	wang, jennifer/0000-0002-2556-9100	National Institutes of Health [R01 AI025780, P01AI083215, R01 AI092105]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083215, R01AI025780, R01AI092105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding sources include National Institutes of Health grants R01 AI025780 (SL), P01AI083215 (RF), and R01 AI092105 (JW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adachi O, 1998, IMMUNITY, V9, P143, DOI 10.1016/S1074-7613(00)80596-8; Auais A, 2003, AM J PHYSIOL-LUNG C, V285, pL105, DOI 10.1152/ajplung.00004.2003; Bicanic T, 2005, BRIT MED BULL, V72, P99, DOI 10.1093/bmb/ldh043; Biondo C, 2005, EUR J IMMUNOL, V35, P870, DOI 10.1002/eji.200425799; Boulware DR, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000384; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Chen HD, 2001, NAT IMMUNOL, V2, P1067, DOI 10.1038/ni727; Decken K, 1998, INFECT IMMUN, V66, P4994, DOI 10.1128/IAI.66.10.4994-5000.1998; Giles SS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001370; Herring AC, 2002, INFECT IMMUN, V70, P2959, DOI 10.1128/IAI.70.6.2959-2964.2002; Kawakami K, 2000, J IMMUNOL, V165, P941, DOI 10.4049/jimmunol.165.2.941; Kawakami K, 2000, FEMS IMMUNOL MED MIC, V27, P191, DOI 10.1111/j.1574-695X.2000.tb01430.x; Kawakami K, 1997, J IMMUNOL, V159, P5528; Kleinschek MA, 2006, J IMMUNOL, V176, P1098, DOI 10.4049/jimmunol.176.2.1098; McQuiston T, 2010, INFECT IMMUN, V78, P2342, DOI 10.1128/IAI.01140-09; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Nakamura K, 2008, J IMMUNOL, V180, P4067, DOI 10.4049/jimmunol.180.6.4067; Nakamura K, 2006, FEMS IMMUNOL MED MIC, V47, P148, DOI 10.1111/j.1574-695X.2006.00078.x; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; PERFECT JR, 1980, AM J PATHOL, V101, P177; Shoham S, 2001, J IMMUNOL, V166, P4620, DOI 10.4049/jimmunol.166.7.4620; Wozniak KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017204; Yauch LE, 2004, INFECT IMMUN, V72, P5373, DOI 10.1128/IAI.72.9.5373-5382.2004; Zhang YM, 2010, AM J PATHOL, V177, P754, DOI 10.2353/ajpath.2010.091104; Zhang YM, 2009, AM J PATHOL, V175, P2489, DOI 10.2353/ajpath.2009.090530	25	21	24	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26232	10.1371/journal.pone.0026232	http://dx.doi.org/10.1371/journal.pone.0026232			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039448	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500042
J	Abate-Daga, D; Andreu, N; Camacho-Sanchez, J; Alemany, R; Herance, R; Millan, O; Fillat, C				Abate-Daga, Daniel; Andreu, Nuria; Camacho-Sanchez, Juan; Alemany, Ramon; Herance, Raul; Millan, Olga; Fillat, Cristina			Oncolytic Adenoviruses Armed with Thymidine Kinase Can Be Traced by PET Imaging and Show Potent Antitumoural Effects by Ganciclovir Dosing	PLOS ONE			English	Article							REPORTER GENE-EXPRESSION; POSITRON-EMISSION-TOMOGRAPHY; PANCREATIC TUMOR-REGRESSION; EFFECT IN-VIVO; PRECLINICAL MODEL; NONHUMAN-PRIMATES; MOUSE MODELS; THERAPY; CANCER; EFFICACY	Replication-competent adenoviruses armed with thymidine kinase (TK) combine the concepts of virotherapy and suicide gene therapy. Moreover TK-activity can be detected by noninvasive positron emission-computed tomography (PET) imaging, what could potentially facilitate virus monitoring in vivo. Here, we report the generation of a novel oncolytic adenovirus that incorporates the Tat8-TK gene under the control of the Major Late Promoter in a highly selective backbone thus providing selectivity by targeting the retinoblastoma pathway. The selective oncolytic TK virus, termed ICOVIR5-TK-L, showed reduced potency compared to a non-selective counterpart. However the combination of ICOVIR5-TK-L with ganciclovir (GCV) induced a potent antitumoural effect similar to that of wild type adenovirus in a preclinical model of pancreatic cancer. Although the treatment with GCV provoked a reduction in the viral yield, both in vitro and in vivo, a two-cycle treatment of virus and GCV resulted in an enhanced antitumoral response that correlated with high TK-activity, based on microPET measurements. Thus, TK-expressing oncolytic adenoviruses can be traced by PET imaging providing real time information on the activity of the virus and its antitumoral potency can be optimized by GCV dosing.	[Abate-Daga, Daniel; Fillat, Cristina] Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain; [Abate-Daga, Daniel; Andreu, Nuria; Fillat, Cristina] UPF, CRG, Barcelona, Spain; [Andreu, Nuria; Fillat, Cristina] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Barcelona, Spain; [Camacho-Sanchez, Juan; Alemany, Ramon] IDIBELL Catalan Inst Oncol ICO, Gene & Viral Therapy Grp, Barcelona, Spain; [Herance, Raul; Millan, Olga] PRBB Fundacio Privada, Inst Alta Tecnol, Barcelona, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Pompeu Fabra University	Abate-Daga, D (corresponding author), Inst Invest Biomed August Pi i Sunyer IDIBAPS, Barcelona, Spain.	cristina.fillat@crg.es	Fillat, Cristina/ABH-1674-2020; Andreu, Nuria/H-2576-2015	Andreu, Nuria/0000-0003-1999-8483; Abate-Daga, Daniel/0000-0002-2571-0215; Fillat, Cristina/0000-0002-0801-3338; Herance, Jose Raul/0000-0001-7178-3290	Spanish Ministry of Science and Innovation (MICINN) [BIO2005-08682-C03-02/01, BIO2008-04692-C03-02/01]; Fundacion Carolina; Generalitat de Catalunya [01A104]; CIBERER; Instituto de Salud Carlos III [IIS10/00014]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Carolina; Generalitat de Catalunya(Generalitat de Catalunya); CIBERER; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported by the Spanish Ministry of Science and Innovation (MICINN), BIO2005-08682-C03-02/01, BIO2008-04692-C03-02/01 and received partial support from the Generalitat de Catalunya SGR091527. Daniel Abate-Daga was a recipient of a Fundacion Carolina fellowship. Nuria Andreu was partially financed by the Generalitat de Catalunya (01A104). Fillat's group is also partially funded by CIBERER, and by IIS10/00014 from Instituto de Salud Carlos III. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghi M, 2005, ONCOGENE, V24, P7802, DOI 10.1038/sj.onc.1209037; Alauddin MM, 2002, J LABELLED COMPD RAD, V45, P583, DOI 10.1002/jlcr.549; Alauddin MM, 2000, J FLUORINE CHEM, V106, P87, DOI 10.1016/S0022-1139(00)00307-9; Alonso MM, 2007, CANCER RES, V67, P8255, DOI 10.1158/0008-5472.CAN-06-4675; Barton KN, 2008, MOL THER, V16, P1761, DOI 10.1038/mt.2008.172; BERANEK J, 1976, NUCLEIC ACIDS RES, V3, P1387, DOI 10.1093/nar/3.5.1387; BETT AJ, 1993, J VIROL, V67, P5911, DOI 10.1128/JVI.67.10.5911-5921.1993; Carrio M, 1999, GENE THER, V6, P547, DOI 10.1038/sj.gt.3300846; Cascallo M, 2007, MOL THER, V15, P1607, DOI 10.1038/sj.mt.6300239; Cascante A, 2007, GENE THER, V14, P1471, DOI 10.1038/sj.gt.3303008; Cascante A, 2005, HUM GENE THER, V16, P1377, DOI 10.1089/hum.2005.16.1377; Cho SY, 2005, J NUCL MED, V46, P1923; Dmitriev I, 1998, J VIROL, V72, P9706, DOI 10.1128/JVI.72.12.9706-9713.1998; Fontanellas A, 2009, GENE THER, V16, P136, DOI 10.1038/gt.2008.122; Fontanellas A, 2010, MOL THER, V18, P754, DOI 10.1038/mt.2009.312; Freytag SO, 2007, MOL THER, V15, P1600, DOI 10.1038/sj.mt.6300212; Fridlender ZG, 2010, MOL THER, V18, P1947, DOI 10.1038/mt.2010.159; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Gambhir SS, 1999, P NATL ACAD SCI USA, V96, P2333, DOI 10.1073/pnas.96.5.2333; Garcia-Rodriguez L, 2011, GENE THER, V18, P73, DOI 10.1038/gt.2010.114; Hajitou A, 2008, P NATL ACAD SCI USA, V105, P4471, DOI 10.1073/pnas.0712184105; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; HOWELL HG, 1988, J ORG CHEM, V53, P85, DOI 10.1021/jo00236a017; Huch M, 2009, NEOPLASIA, V11, P518, DOI 10.1593/neo.81674; Iyer M, 2001, J NUCL MED, V42, P96; Peerlinck I, 2009, CLIN CANCER RES, V15, P6595, DOI 10.1158/1078-0432.CCR-09-0262; Penuelas I, 2005, GASTROENTEROLOGY, V128, P1787, DOI 10.1053/j.gastro.2005.03.024; Pujal J, 2006, BBA-MOL BASIS DIS, V1762, P73, DOI 10.1016/j.bbadis.2005.08.002; Shibata MA, 2008, MED MOL MORPHOL, V41, P34, DOI 10.1007/s00795-007-0388-1; Soghomonyan S, 2007, NAT PROTOC, V2, P416, DOI 10.1038/nprot.2007.49; Tjuvajev JG, 2002, J NUCL MED, V43, P1072; VILE RG, 1994, CANCER RES, V54, P6228; Villanueva A, 1998, ONCOGENE, V17, P1969, DOI 10.1038/sj.onc.1202118; Xiong ZM, 2006, J NUCL MED, V47, P130	34	26	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26142	10.1371/journal.pone.0026142	http://dx.doi.org/10.1371/journal.pone.0026142			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028820	gold, Green Published, Green Submitted			2022-12-27	WOS:000296186900030
J	Agnani, D; Acharya, P; Martinez, E; Tran, TT; Abraham, F; Tobin, F; Ellens, H; Bentz, J				Agnani, Deep; Acharya, Poulomi; Martinez, Esteban; Thuy Thanh Tran; Abraham, Feby; Tobin, Frank; Ellens, Harma; Bentz, Joe			Fitting the Elementary Rate Constants of the P-gp Transporter Network in the hMDR1-MDCK Confluent Cell Monolayer Using a Particle Swarm Algorithm	PLOS ONE			English	Article							GLYCOPROTEIN-MEDIATED TRANSPORT; DRUG TRANSPORT; ATP HYDROLYSIS; BINDING; PERMEABILITY; PURIFICATION; INHIBITION; MODEL; LINE	P-glycoprotein, a human multidrug resistance transporter, has been extensively studied due to its importance to human health and disease. In order to understand transport kinetics via P-gp, confluent cell monolayers overexpressing P-gp are widely used. The purpose of this study is to obtain the mass action elementary rate constants for P-gp's transport and to functionally characterize members of P-gp's network, i.e., other transporters that transport P-gp substrates in hMDR1-MDCKII confluent cell monolayers and are essential to the net substrate flux. Transport of a range of concentrations of amprenavir, loperamide, quinidine and digoxin across the confluent monolayer of cells was measured in both directions, apical to basolateral and basolateral to apical. We developed a global optimization algorithm using the Particle Swarm method that can simultaneously fit all datasets to yield accurate and exhaustive fits of these elementary rate constants. The statistical sensitivity of the fitted values was determined by using 24 identical replicate fits, yielding simple averages and standard deviations for all of the kinetic parameters, including the efflux active P-gp surface density. Digoxin required additional basolateral and apical transporters, while loperamide required just a basolateral tranporter. The data were better fit by assuming bidirectional transporters, rather than active importers, suggesting that they are not MRP or active OATP transporters. The P-gp efflux rate constants for quinidine and digoxin were about 3-fold smaller than reported ATP hydrolysis rate constants from P-gp proteoliposomes. This suggests a roughly 3: 1 stoichiometry between ATP hydrolysis and P-gp transport for these two drugs. The fitted values of the elementary rate constants for these P-gp substrates support the hypotheses that the selective pressures on P-gp are to maintain a broad substrate range and to keep xenobiotics out of the cytosol, but not out of the apical membrane.	[Agnani, Deep; Acharya, Poulomi; Martinez, Esteban; Bentz, Joe] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Thuy Thanh Tran; Ellens, Harma] GlaxoSmithKline, Preclin Drug Metab & Pharmacokinet, King Of Prussia, PA USA; [Abraham, Feby; Tobin, Frank] GlaxoSmithKline, Sci Comp & Math Modeling, King Of Prussia, PA USA	Drexel University; GlaxoSmithKline; GlaxoSmithKline	Agnani, D (corresponding author), Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA.	bentzj@drexel.edu		Martinez, Esteban/0000-0002-4798-3548				Aanismaa P, 2008, BIOCHEMISTRY-US, V47, P10197, DOI 10.1021/bi800209h; Acharya P, 2008, DRUG METAB DISPOS, V36, P452, DOI 10.1124/dmd.107.017301; Acharya P, 2006, BIOCHEMISTRY-US, V45, P15505, DOI 10.1021/bi060593b; Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200; Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; Bartholome K, 2007, DRUG METAB DISPOS, V35, P1476, DOI 10.1124/dmd.107.015636; Bentz J, 2005, PHARM RES-DORDR, V22, P1667, DOI 10.1007/s11095-005-6627-z; Callaghan R, 1997, BBA-BIOMEMBRANES, V1328, P109, DOI 10.1016/S0005-2736(97)00079-5; Chang C, 2006, ADV DRUG DELIVER REV, V58, P1431, DOI 10.1016/j.addr.2006.09.006; Chang JH, 2005, MOL PHARMACEUT, V2, P428, DOI 10.1021/mp050018m; Doppenschmitt S, 1999, J PHARM SCI, V88, P1067, DOI 10.1021/js980378j; Endres CJ, 2006, EUR J PHARM SCI, V27, P501, DOI 10.1016/j.ejps.2005.11.002; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Ho NFH, 2000, DRUGS PHARM SCI, V102, P219; HORIO M, 1990, BIOCHIM BIOPHYS ACTA, V1027, P116, DOI 10.1016/0005-2736(90)90074-X; Ito S, 1999, AM J PHYSIOL-RENAL, V277, pF84, DOI 10.1152/ajprenal.1999.277.1.F84; Kalvass JC, 2007, PHARM RES-DORDR, V24, P265, DOI 10.1007/s11095-006-9135-x; Kannan P, 2009, CLIN PHARMACOL THER, V86, P368, DOI 10.1038/clpt.2009.138; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Litman T, 1997, BBA-MOL BASIS DIS, V1361, P169, DOI 10.1016/S0925-4439(97)00027-6; Litman T, 2003, J PHARMACOL EXP THER, V307, P846, DOI 10.1124/jpet.103.056960; Loo TW, 2005, J MEMBRANE BIOL, V206, P173, DOI 10.1007/s00232-005-0792-1; Lumen AA, 2011, STRUCTURE FUNCTION B, P241; Lumen AA, 2010, DRUG METAB DISPOS, V38, P260, DOI 10.1124/dmd.109.029843; Modok S, 2004, J LIPID RES, V45, P1910, DOI 10.1194/jlr.M400220-JLR200; Moussatova A, 2008, BBA-BIOMEMBRANES, V1778, P1757, DOI 10.1016/j.bbamem.2008.06.009; Nervi P, 2010, BBA-BIOMEMBRANES, V1798, P515, DOI 10.1016/j.bbamem.2009.11.022; Rautio J, 2006, DRUG METAB DISPOS, V34, P786, DOI 10.1124/dmd.105.008615; Rebbeor JF, 1998, BBA-BIOMEMBRANES, V1369, P85, DOI 10.1016/S0005-2736(97)00185-5; Rosenberg MF, 1997, J BIOL CHEM, V272, P10685; Senior AE, 2000, J EXP BIOL, V203, P35; Shapiro AB, 1997, EUR J BIOCHEM, V250, P130, DOI 10.1111/j.1432-1033.1997.00130.x; Sharom FJ, 2007, DRUG TRANSPORTERS MO; Shirasaka Y, 2008, J PHARM SCI-US, V97, P553, DOI 10.1002/jps.21114; Shitara Y, 2006, EUR J PHARM SCI, V27, P425, DOI 10.1016/j.ejps.2005.12.003; Sun HD, 2008, DRUG METAB DISPOS, V36, P102, DOI 10.1124/dmd.107.015321; Taub ME, 2005, DRUG METAB DISPOS, V33, P1679, DOI 10.1124/dmd.105.005421; Tombline G, 2008, BIOCHEMISTRY-US, V47, P3294, DOI 10.1021/bi7021393; Tran TT, 2004, J PHARM SCI-US, V93, P2108, DOI 10.1002/jps.20105; Tran TT, 2005, BIOPHYS J, V88, P715, DOI 10.1529/biophysj.104.045633; Vaz AIF, 2007, J GLOBAL OPTIM, V39, P197, DOI 10.1007/s10898-007-9133-5	42	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25086	10.1371/journal.pone.0025086	http://dx.doi.org/10.1371/journal.pone.0025086			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028772	gold, Green Submitted, Green Published			2022-12-27	WOS:000296186900005
J	de Andrade, RB; Barlow, J; Louzada, J; Vaz-de-Mello, FZ; Souza, M; Silveira, JM; Cochrane, MA				de Andrade, Rafael Barreto; Barlow, Jos; Louzada, Julio; Vaz-de-Mello, Fernando Zagury; Souza, Mateus; Silveira, Juliana M.; Cochrane, Mark A.			Quantifying Responses of Dung Beetles to Fire Disturbance in Tropical Forests: The Importance of Trapping Method and Seasonality	PLOS ONE			English	Article							RAIN-FOREST; COLEOPTERA SCARABAEIDAE; INSECT CONSERVATION; RECURRENT WILDFIRES; BIODIVERSITY; DIVERSITY; ABUNDANCE; ASSEMBLAGES; COMMUNITY; EXTINCTIONS	Understanding how biodiversity responds to environmental changes is essential to provide the evidence-base that underpins conservation initiatives. The present study provides a standardized comparison between unbaited flight intercept traps (FIT) and baited pitfall traps (BPT) for sampling dung beetles. We examine the effectiveness of the two to assess fire disturbance effects and how trap performance is affected by seasonality. The study was carried out in a transitional forest between Cerrado (Brazilian Savanna) and Amazon Forest. Dung beetles were collected during one wet and one dry sampling season. The two methods sampled different portions of the local beetle assemblage. Both FIT and BPT were sensitive to fire disturbance during the wet season, but only BPT detected community differences during the dry season. Both traps showed similar correlation with environmental factors. Our results indicate that seasonality had a stronger effect than trap type, with BPT more effective and robust under low population numbers, and FIT more sensitive to fine scale heterogeneity patterns. This study shows the strengths and weaknesses of two commonly used methodologies for sampling dung beetles in tropical forests, as well as highlighting the importance of seasonality in shaping the results obtained by both sampling strategies.	[de Andrade, Rafael Barreto; Cochrane, Mark A.] S Dakota State Univ, Brookings, SD 57007 USA; [Barlow, Jos] Univ Lancaster, Lancaster, Lancs, England; [Louzada, Julio; Silveira, Juliana M.] Univ Fed Lavras, Lavras, MG, Brazil; [Vaz-de-Mello, Fernando Zagury; Souza, Mateus] Univ Fed Mato Grosso, Cuiaba, Mato Grosso, Brazil	South Dakota State University; Lancaster University; Universidade Federal de Lavras; Universidade Federal de Mato Grosso	de Andrade, RB (corresponding author), S Dakota State Univ, Brookings, SD 57007 USA.	rb.andrade@ymail.com	Louzada, Julio/F-1265-2010; Vaz-de-Mello, Fernando Z/A-1023-2009; Bioterra Amazonia, Inct/J-9890-2013; Barlow, Jos/E-7861-2014; Barlow, Jos/HGE-9486-2022; Cochrane, Mark A/A-1735-2018	Louzada, Julio/0000-0002-1481-3112; Vaz-de-Mello, Fernando Z/0000-0001-9697-320X; Cochrane, Mark A/0000-0002-4573-568X	Earth Science Division of the NASA Science Mission Directorate [NNX07AF16G]; Fundacao de Amparo a Pesquisa do Estado de Mato Grosso; Conselho Nacional de Pesquisa; Fundacao de Amparo a Pesquisa de Minas Gerais; Engineering and Physical Sciences Research Council [EP/E500811/1] Funding Source: researchfish	Earth Science Division of the NASA Science Mission Directorate; Fundacao de Amparo a Pesquisa do Estado de Mato Grosso(Fundacao de Amparo a Pesquisa do Estado de Mato Grosso (FAPEMAT)); Conselho Nacional de Pesquisa; Fundacao de Amparo a Pesquisa de Minas Gerais(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Biological Diversity Program of the Earth Science Division of the NASA Science Mission Directorate (NNX07AF16G); Fundacao de Amparo a Pesquisa do Estado de Mato Grosso; Conselho Nacional de Pesquisa; Fundacao de Amparo a Pesquisa de Minas Gerais. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andresen E, 2005, BIOTROPICA, V37, P291, DOI 10.1111/j.1744-7429.2005.00039.x; Aragao LEOC, 2010, SCIENCE, V328, P1275, DOI 10.1126/science.1186925; Aragao LEOC, 2008, PHILOS T R SOC B, V363, P1779, DOI 10.1098/rstb.2007.0026; Balch JK, 2008, GLOBAL CHANGE BIOL, V14, P2276, DOI 10.1111/j.1365-2486.2008.01655.x; Barlow J, 2007, P NATL ACAD SCI USA, V104, P18555, DOI 10.1073/pnas.0703333104; Barlow J, 2004, ECOL APPL, V14, P1358, DOI 10.1890/03-5077; Barlow J, 2006, BIODIVERS CONSERV, V15, P985, DOI 10.1007/s10531-004-3952-1; Barlow J, 2007, J APPL ECOL, V44, P1001, DOI 10.1111/j.1365-2664.2007.01347.x; Blanche KR, 2001, ECOL APPL, V11, P86, DOI 10.1890/1051-0761(2001)011[0086:RCDOFI]2.0.CO;2; Canhedo Virginia Luzia, 2006, Arquivos de Zoologia (Sao Paulo), V37, P349; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Cleary DFR, 2004, GLOBAL ECOL BIOGEOGR, V13, P129, DOI 10.1111/j.1466-882X.2004.00074.x; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cochrane MA, 2001, ENVIRONMENT, V43, P28, DOI 10.1080/00139150109604505; Cochrane MA, 2009, GLOBAL CHANGE BIOL, V15, P601, DOI 10.1111/j.1365-2486.2008.01786.x; Colwell RK, 2004, ESTIMATES STAT ESTIM; Davis AJ, 2000, COLEOPTS BULL, V54, P221, DOI 10.1649/0010-065X(2000)054[0221:SRODFB]2.0.CO;2; Davis AJ, 2001, J APPL ECOL, V38, P593, DOI 10.1046/j.1365-2664.2001.00619.x; Dawes-Gromadzki TZ, 2007, AUSTRAL ECOL, V32, P663, DOI 10.1111/j.1442-9993.2007.01752.x; Didham RK, 2010, INSECT CONSERV DIVER, V3, P1, DOI 10.1111/j.1752-4598.2009.00076.x; Dunn RR, 2005, CONSERV BIOL, V19, P1030, DOI 10.1111/j.1523-1739.2005.00078.x; Edmonds W.D., 2004, Folia Heyrovskyana Supplementum, V11, P1; Edmonds W.D., 2010, Insecta Mundi, V0129, P1; Errouissi F, 2004, ENVIRON ENTOMOL, V33, P45, DOI 10.1603/0046-225X-33.1.45; Favila Mario E., 1997, Acta Zoologica Mexicana Nueva Serie, V72, P1; Feer F, 2000, ANN SOC ENTOMOL FR, V36, P29; Filgueiras BKC, 2009, REV BRAS ENTOMOL, V53, P422, DOI 10.1590/S0085-56262009000300017; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gardner TA, 2007, BIOTROPICA, V39, P25, DOI 10.1111/j.1744-7429.2006.00228.x; Gardner TA, 2009, ECOL LETT, V12, P561, DOI 10.1111/j.1461-0248.2009.01294.x; Gill B.D., 1991, P211; Halffter G, 2002, BIOTROPICA, V34, P144, DOI 10.1111/j.1744-7429.2002.tb00250.x; Halffter Gonzalo, 1993, Biology International, V27, P15; Halffter Gonzalo, 2009, Boletin de la SEA, V45, P1; Hanski I., 1991, P305; Flechtmann CAH, 2009, ENTOMOL EXP APPL, V132, P211, DOI 10.1111/j.1570-7458.2009.00885.x; HOWDEN H F, 1981, Contributions of the American Entomological Institute, V18, P1; Hyvarinen E, 2006, EUR J ENTOMOL, V103, P397, DOI 10.14411/eje.2006.054; Ivanauskas NM, 2003, FOREST ECOL MANAG, V184, P239, DOI 10.1016/S0378-1127(03)00156-7; Jacobs CT, 2010, J INSECT CONSERV, V14, P389, DOI 10.1007/s10841-010-9270-x; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Leather SR, 2008, INSECT CONSERV DIVER, V1, P1, DOI 10.1111/j.1752-4598.2007.00009.x; Lee JSH, 2009, RAFFLES B ZOOL, V57, P537; Lindenmayer DB, 2009, CONSERV LETT, V2, P271, DOI 10.1111/j.1755-263X.2009.00080.x; Lopes J, 2011, ZOOLOGIA-CURITIBA, V28, P72, DOI 10.1590/S1984-46702011000100011; Losey JE, 2006, BIOSCIENCE, V56, P311, DOI 10.1641/0006-3568(2006)56[311:TEVOES]2.0.CO;2; Louzada J, 2010, LANDSCAPE ECOL, V25, P631, DOI 10.1007/s10980-010-9448-3; Milhomem MS, 2003, PESQUI AGROPECU BRAS, V38, P1249, DOI 10.1590/S0100-204X2003001100001; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nyeko P, 2009, BIOTROPICA, V41, P476, DOI 10.1111/j.1744-7429.2009.00499.x; PECK S B, 1980, Coleopterists Bulletin, V34, P237; PECK SB, 1982, CAN J ZOOL, V60, P1624, DOI 10.1139/z82-213; PECK SB, 1984, BIOTROPICA, V16, P235, DOI 10.2307/2388057; da Silva NAP, 2011, REV BRAS ENTOMOL, V55, P79, DOI 10.1590/S0085-56262011000100013; Pinheiro F, 2002, AUSTRAL ECOL, V27, P132, DOI 10.1046/j.1442-9993.2002.01165.x; Qie L, 2011, J BIOGEOGR, V38, P792, DOI 10.1111/j.1365-2699.2010.02439.x; RATCLIFFE B C, 1980, Coleopterists Bulletin, V34, P337; Ribeiro MA, 2008, J HERPETOL, V42, P733, DOI 10.1670/07-097R3.1; Ridsdill-Smith J., 1991, P264; Samu F, 2010, COMMUNITY ECOL, V11, P129, DOI 10.1556/ComEc.11.2010.2.1; SAMWAYS MJ, 1993, BIODIVERS CONSERV, V2, P258, DOI 10.1007/BF00056672; Silveira JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012877; Solis Angel, 2004, Giornale Italiano di Entomologia, V11, P1; Vaz-De-Mello FZ, 2008, ZOOTAXA, P1; Vulinec K, 2000, FLA ENTOMOL, V83, P229, DOI 10.2307/3496341; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WOLDA H, 1978, J ANIM ECOL, V47, P369, DOI 10.2307/3789; YOUNG O P, 1981, Coleopterists Bulletin, V35, P427	70	33	36	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26208	10.1371/journal.pone.0026208	http://dx.doi.org/10.1371/journal.pone.0026208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028831	Green Published, Green Accepted, gold			2022-12-27	WOS:000296186900033
J	Hodl, I; Hodl, J; Worman, A; Singer, G; Besemer, K; Battin, TJ				Hoedl, Iris; Hoedl, Josef; Worman, Anders; Singer, Gabriel; Besemer, Katharina; Battin, Tom J.			Voronoi Tessellation Captures Very Early Clustering of Single Primary Cells as Induced by Interactions in Nascent Biofilms	PLOS ONE			English	Article							MICROBIAL BIOFILMS; PSEUDOMONAS-AERUGINOSA; SURFACE; QUORUM; STREAM; COMMUNICATION; HETEROGENEITY; ENVIRONMENT; BACTERIA; ADHESION	Biofilms dominate microbial life in numerous aquatic ecosystems, and in engineered and medical systems, as well. The formation of biofilms is initiated by single primary cells colonizing surfaces from the bulk liquid. The next steps from primary cells towards the first cell clusters as the initial step of biofilm formation remain relatively poorly studied. Clonal growth and random migration of primary cells are traditionally considered as the dominant processes leading to organized microcolonies in laboratory grown monocultures. Using Voronoi tessellation, we show that the spatial distribution of primary cells colonizing initially sterile surfaces from natural streamwater community deviates from uniform randomness already during the very early colonisation. The deviation from uniform randomness increased with colonisation - despite the absence of cell reproduction - and was even more pronounced when the flow of water above biofilms was multidirectional and shear stress elevated. We propose a simple mechanistic model that captures interactions, such as cell-to-cell signalling or chemical surface conditioning, to simulate the observed distribution patterns. Model predictions match empirical observations reasonably well, highlighting the role of biotic interactions even already during very early biofilm formation despite few and distant cells. The transition from single primary cells to clustering accelerated by biotic interactions rather than by reproduction may be particularly advantageous in harsh environments - the rule rather than the exception outside the laboratory.	[Hoedl, Iris; Singer, Gabriel; Besemer, Katharina; Battin, Tom J.] Univ Vienna, Dept Limnol, Vienna, Austria; [Hoedl, Iris; Singer, Gabriel; Besemer, Katharina; Battin, Tom J.] WasserCluster Lunz GmbH, Lunz Am See, Austria; [Worman, Anders] Royal Inst Technol, Dept Land & Water Resources Engn, Stockholm, Sweden	University of Vienna; Royal Institute of Technology	Hodl, I (corresponding author), Univ Vienna, Dept Limnol, Vienna, Austria.	tom.battin@univie.ac.at	Singer, Gabriel/C-6285-2012; BAttin, Tom/H-7971-2012; Worman, Anders/O-8866-2014	Singer, Gabriel/0000-0002-7389-9788; Worman, Anders/0000-0003-2726-6821	Austrian Science Fund [START Y420-B17]; European Science Foundation [ERAS-CT-2003-980409]; Initiativkolleg Symbiosis of the University of Vienna; Austrian Science Fund (FWF) [Y 420] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); European Science Foundation(European Science Foundation (ESF)European Commission); Initiativkolleg Symbiosis of the University of Vienna; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was financially supported by the Austrian Science Fund (START Y420-B17) and the European Science Foundation (COMX, ERAS-CT-2003-980409) grants to TJB and by the Initiativkolleg Symbiosis of the University of Vienna to IH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberghini S, 2009, FEMS MICROBIOL LETT, V292, P149, DOI 10.1111/j.1574-6968.2008.01478.x; Anderson BN, 2007, J BACTERIOL, V189, P1794, DOI 10.1128/JB.00899-06; Banavar JR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068104; Battin TJ, 2003, APPL ENVIRON MICROB, V69, P5443, DOI 10.1128/AEM.69.9.5443-5452.2003; Battin TJ, 2003, APPL ENVIRON MICROB, V67, P799; Berg, 2018, RANDOM WALKS BIOL; Bohn S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.054503; Bos R, 1999, FEMS MICROBIOL REV, V23, P179, DOI 10.1016/S0168-6445(99)00004-2; BOTT TL, 1975, LIMNOL OCEANOGR, V20, P191, DOI 10.4319/lo.1975.20.2.0191; Cho HJ, 2007, PLOS BIOL, V5, P2614, DOI 10.1371/journal.pbio.0050302; Costa LD, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.011913; COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431; Darnton NC, 2007, J BACTERIOL, V189, P1756, DOI 10.1128/JB.01501-06; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; Decho AW, 2011, CHEM REV, V111, P86, DOI 10.1021/cr100311q; Dulla G, 2008, P NATL ACAD SCI USA, V105, P3082, DOI 10.1073/pnas.0711723105; Dusenbery D. B., 2009, LIVING MICROSCALE; Egland PG, 2004, P NATL ACAD SCI USA, V101, P16917, DOI 10.1073/pnas.0407457101; Ferenc JS, 2007, PHYSICA A, V385, P518, DOI 10.1016/j.physa.2007.07.063; FRYMIER PD, 1995, P NATL ACAD SCI USA, V92, P6195, DOI 10.1073/pnas.92.13.6195; Gantner S, 2006, FEMS MICROBIOL ECOL, V56, P188, DOI 10.1111/j.1574-6941.2005.00037.x; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harris HW, 2010, P NATL ACAD SCI USA, V107, P326, DOI 10.1073/pnas.0907468107; Hill J, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.068101; Holland EP, 2007, PLOS COMPUT BIOL, V3, P1979, DOI 10.1371/journal.pcbi.0030200; Hondzo M, 2009, ENVIRON SCI TECHNOL, V43, P764, DOI 10.1021/es801655p; Horswill AR, 2007, ANAL BIOANAL CHEM, V387, P371, DOI 10.1007/s00216-006-0720-y; Houchmandzadeh B, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.078103; Johnson LR, 2008, J THEOR BIOL, V251, P24, DOI 10.1016/j.jtbi.2007.10.039; KENKEL NC, 1989, ECOLOGY, V70, P272, DOI 10.2307/1938433; Keymer JE, 2006, P NATL ACAD SCI USA, V103, P17290, DOI 10.1073/pnas.0607971103; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Kreft JU, 2004, MICROBIOL-SGM, V150, P2751, DOI 10.1099/mic.0.26829-0; Lecuyer S, 2011, BIOPHYS J, V100, P341, DOI 10.1016/j.bpj.2010.11.078; Ledoux H, 2005, DEVELOPMENTS IN SPATIAL DATA HANDLING, P97, DOI 10.1007/3-540-26772-7_8; MAZIA D, 1975, J CELL BIOL, V66, P198, DOI 10.1083/jcb.66.1.198; Mitchell JG, 2006, FEMS MICROBIOL ECOL, V55, P3, DOI 10.1111/j.1574-6941.2005.00003.x; Monds RD, 2009, TRENDS MICROBIOL, V17, P73, DOI 10.1016/j.tim.2008.11.001; Nadell CD, 2008, PLOS BIOL, V6, P171, DOI 10.1371/journal.pbio.0060014; Neu TR, 1996, MICROBIOL REV, V60, P151, DOI 10.1128/MMBR.60.1.151-166.1996; O'Toole GA, 1998, MOL MICROBIOL, V30, P295, DOI 10.1046/j.1365-2958.1998.01062.x; Park S, 2003, P NATL ACAD SCI USA, V100, P13910, DOI 10.1073/pnas.1935975100; Park S, 2003, SCIENCE, V301, P188, DOI 10.1126/science.1079805; Parsek MR, 2005, TRENDS MICROBIOL, V13, P27, DOI 10.1016/j.tim.2004.11.007; PEDLEY TJ, 1992, SCI PROG, V76, P105; Pfeiffer T, 2003, P NATL ACAD SCI USA, V100, P1095, DOI 10.1073/pnas.0335420100; Picioreanu C, 2004, APPL ENVIRON MICROB, V70, P3024, DOI 10.1128/AEM.70.5.3024-3040.2004; Pineda E, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066119; Pineda E, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.040107; Rice AR, 2000, MICROBIAL ECOL, V40, P8, DOI 10.1007/s002480000011; Singer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009988; Smalyukh II, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.030701; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Ulrich S, 2004, LANGMUIR, V20, P1763, DOI 10.1021/la030348i; Volfson D, 2008, P NATL ACAD SCI USA, V105, P15346, DOI 10.1073/pnas.0706805105; Watnick P, 2000, J BACTERIOL, V182, P2675, DOI 10.1128/JB.182.10.2675-2679.2000; WELCH PD, 1967, IEEE T ACOUST SPEECH, VAU15, P70, DOI 10.1109/TAU.1967.1161901	58	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26368	10.1371/journal.pone.0026368	http://dx.doi.org/10.1371/journal.pone.0026368			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028865	Green Published, gold, Green Submitted			2022-12-27	WOS:000296186900055
J	Kritis, A; Pourzitaki, C; Klagas, I; Chourdakis, M; Albani, M				Kritis, Aristidis; Pourzitaki, Chryssa; Klagas, Ioannis; Chourdakis, Michael; Albani, Maria			Proteases Inhibition Assessment on PC12 and NGF Treated Cells after Oxygen and Glucose Deprivation Reveals a Distinct Role for Aspartyl Proteases	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; NERVE GROWTH-FACTOR; OXIDATIVE STRESS; NEURONAL DEATH; MITOCHONDRIAL DYSFUNCTION; HYPOXIA-ISCHEMIA; CATHEPSIN-D; CALPAIN-I; APOPTOSIS; ACTIVATION	Hypoxia is a severe stressful condition and induces cell death leading to neuronal loss both to the developing and adult nervous system. Central theme to cellular death is the activation of different classes of proteases such as caspases calpains and cathepsins. In the present study we investigated the involvement of these proteases, in the hypoxia-induced PC12 cell death. Rat PC12 is a model cell line for experimentation relevant to the nervous system and several protocols have been developed for either lethal hypoxia (oxygen and glucose deprivation OGD) or ischemic preconditioning (IPS). Nerve Growth Factor (NGF) treated PC12 differentiate to a sympathetic phenotype, expressing neurites and excitability. Lethal hypoxia was established by exposing undifferentiated and NGF-treated PC12 cells to a mixture of N(2)/CO(2) (93:5%) in DMEM depleted of glucose and sodium pyruvate for 16 h. The involvement of caspases, calpains and lysosomal cathepsins D and E to the cell death induced by lethal OGD was investigated employing protease specific inhibitors such as z-VAD-fmk for the caspases, MDL28170 for the calpains and pepstatin A for the cathepsins D and E. Our findings show that pepstatin A provides statistically significant protection from cell death of both naive and NGF treated PC12 cells exposed to lethal OGD. We propose that apart from the established processes of apoptosis and necrosis that are integral components of lethal OGD, the activation of cathepsins D and E launches additional cell death pathways in which these proteases are key partners.	[Kritis, Aristidis; Klagas, Ioannis; Albani, Maria] Aristotle Univ Thessaloniki, Physiol Lab, Sch Med, GR-54006 Thessaloniki, Greece; [Pourzitaki, Chryssa; Chourdakis, Michael] Aristotle Univ Thessaloniki, Pharmacol Lab, Sch Med, GR-54006 Thessaloniki, Greece	Aristotle University of Thessaloniki; Aristotle University of Thessaloniki	Kritis, A (corresponding author), Aristotle Univ Thessaloniki, Physiol Lab, Sch Med, GR-54006 Thessaloniki, Greece.	kritis@med.auth.gr	Kritis, Aristeidis/AAG-7474-2019	Kritis, Aristeidis/0000-0002-2067-8842; Chourdakis, Michael/0000-0002-9490-8356	Hellenic Ministry of Education; European Union/European Social Fund	Hellenic Ministry of Education; European Union/European Social Fund(European Social Fund (ESF)European Commission)	The present work was supported by the Hellenic Ministry of Education and the European Union/European Social Fund EPEAEK PYTHGORAS II. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABU RS, 1993, J NEUROSCI METH, V50, P197; Artal-Sanz M, 2005, FEBS LETT, V579, P3287, DOI 10.1016/j.febslet.2005.03.052; Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008; Blomgran R, 2007, J LEUKOCYTE BIOL, V81, P1213, DOI 10.1189/jlb.0506359; Brana C, 1999, EUR J NEUROSCI, V11, P2375, DOI 10.1046/j.1460-9568.1999.00653.x; Broker LE, 2004, CANCER RES, V64, P27, DOI 10.1158/0008-5472.CAN-03-3060; Charlier N, 2002, MOL BRAIN RES, V104, P21, DOI 10.1016/S0169-328X(02)00198-5; Chen J, 1998, J NEUROSCI, V18, P4914; CHOI DW, 1993, RES P ARNMD, V71, P23; Droga-Mazovec G, 2008, J BIOL CHEM, V283, P19140, DOI 10.1074/jbc.M802513200; Evan G, 1998, SCIENCE, V281, P1317, DOI 10.1126/science.281.5381.1317; Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Hillion JA, 2005, J CEREBR BLOOD F MET, V25, P154, DOI 10.1038/sj.jcbfm.9600003; Hol EM, 2008, J MOL NEUROSCI, V34, P23, DOI 10.1007/s12031-007-0013-8; HONG SC, 1994, STROKE, V25, P663, DOI 10.1161/01.STR.25.3.663; HOSSMANN KA, 1994, BRAIN PATHOL, V4, P23; Ivanova S, 2008, METHOD ENZYMOL, V442, P183, DOI 10.1016/S0076-6879(08)01409-2; Koubi D, 2005, NEUROCHEM INT, V46, P73, DOI 10.1016/j.neuint.2004.06.006; Kourtis N, 2009, CELL DEATH DIFFER, V16, P21, DOI 10.1038/cdd.2008.120; Kritis A, 2006, ACTA PHARMACOL SIN, V27, P408; Larsen EC, 2007, NEUROSCIENCE, V146, P946, DOI 10.1016/j.neuroscience.2007.02.022; Liu Y, 2003, J CELL MOL MED, V7, P49, DOI 10.1111/j.1582-4934.2003.tb00202.x; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Minarowska A, 2007, FOLIA HISTOCHEM CYTO, V45, P159; Newcomb-Fernandez JK, 2001, J CEREBR BLOOD F MET, V21, P1281, DOI 10.1097/00004647-200111000-00004; Northington FJ, 2007, NEUROSCIENCE, V149, P822, DOI 10.1016/j.neuroscience.2007.06.060; Northington FJ, 2001, J NEUROSCI, V21, P1931, DOI 10.1523/JNEUROSCI.21-06-01931.2001; Park HK, 2009, NEUROSCI LETT, V451, P16, DOI 10.1016/j.neulet.2008.12.019; Pourzitaki C, 2008, FEBS J, V275, P310; Pourzitaki C., 2008, REV CLIN PHARM PHARM, V22, P304; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Ray SK, 2000, BRAIN RES, V852, P326, DOI 10.1016/S0006-8993(99)02148-4; Sadasivan S, 2006, APOPTOSIS, V11, P1573, DOI 10.1007/s10495-006-7690-6; SIMAN R, 1988, NEURON, V1, P279, DOI 10.1016/0896-6273(88)90076-1; SIMAN R, 1989, J NEUROSCI, V9, P1579; Tabakman R, 2004, J NEUROSCI RES, V75, P499, DOI 10.1002/jnr.20008; Tabakman R, 2002, J NEUROSCI RES, V68, P463, DOI 10.1002/jnr.10228; Tabakman R, 2005, ANN NY ACAD SCI, V1053, P84, DOI 10.1196/annals.1344.008; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Wu LY, 2010, CELL STRESS CHAPERON, V15, P387, DOI 10.1007/s12192-009-0153-6; Yamashima T, 1998, EUR J NEUROSCI, V10, P1723, DOI 10.1046/j.1460-9568.1998.00184.x; Yamashima T, 2000, PROG NEUROBIOL, V62, P273, DOI 10.1016/S0301-0082(00)00006-X; Yamashima T, 2009, PROG NEUROBIOL, V89, P343, DOI 10.1016/j.pneurobio.2009.09.003	45	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25950	10.1371/journal.pone.0025950	http://dx.doi.org/10.1371/journal.pone.0025950			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028798	Green Submitted, gold, Green Published			2022-12-27	WOS:000296186900023
J	Kraemer, S; Vaught, JD; Bock, C; Gold, L; Katilius, E; Keeney, TR; Kim, N; Saccomano, NA; Wilcox, SK; Zichi, D; Sanders, GM				Kraemer, Stephan; Vaught, Jonathan D.; Bock, Christopher; Gold, Larry; Katilius, Evaldas; Keeney, Tracy R.; Kim, Nancy; Saccomano, Nicholas A.; Wilcox, Sheri K.; Zichi, Dom; Sanders, Glenn M.			From SOMAmer-Based Biomarker Discovery to Diagnostic and Clinical Applications: A SOMAmer-Based, Streamlined Multiplex Proteomic Assay	PLOS ONE			English	Article							DNA	Recently, we reported a SOMAmer-based, highly multiplexed assay for the purpose of biomarker identification. To enable seamless transition from highly multiplexed biomarker discovery assays to a format suitable and convenient for diagnostic and life-science applications, we developed a streamlined, plate-based version of the assay. The plate-based version of the assay is robust, sensitive (sub-picomolar), rapid, can be highly multiplexed (upwards of 60 analytes), and fully automated. We demonstrate that quantification by microarray-based hybridization, Luminex bead-based methods, and qPCR are each compatible with our platform, further expanding the breadth of proteomic applications for a wide user community.	[Kraemer, Stephan; Vaught, Jonathan D.; Bock, Christopher; Gold, Larry; Katilius, Evaldas; Keeney, Tracy R.; Kim, Nancy; Saccomano, Nicholas A.; Wilcox, Sheri K.; Zichi, Dom; Sanders, Glenn M.] SomaLogic Inc, Boulder, CO USA; [Gold, Larry] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Kraemer, S (corresponding author), SomaLogic Inc, Boulder, CO USA.	nsaccomano@somalogic.com; gsanders@somalogic.com			SomaLogic, Inc.	SomaLogic, Inc.	This work was funded by SomaLogic, Inc. Study design, data collection and analysis, decision to publish, and preparation of this manuscript were carried out by SomaLogic employees.	Brody E N, 2000, J Biotechnol, V74, P5, DOI 10.1016/S1389-0352(99)00004-5; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Famulok M, 2007, CHEM REV, V107, P3715, DOI 10.1021/cr0306743; GOLD L, 1995, J BIOL CHEM, V270, P13581, DOI 10.1074/jbc.270.23.13581; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Keeney TR, 2009, JALA-J LAB AUTOM, V14, P360, DOI 10.1016/j.jala.2009.05.003; O'Farrell PH, 2008, PROTEOMICS, V8, P4842, DOI 10.1002/pmic.200800719; Ostroff Rachel M, 2010, PLoS One, V5, pe15003, DOI 10.1371/journal.pone.0015003; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Vaught JD, 2010, J AM CHEM SOC, V132, P4141, DOI 10.1021/ja908035g; Zichi D, 2008, CURR OPIN CHEM BIOL, V12, P78, DOI 10.1016/j.cbpa.2008.01.016	11	164	177	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26332	10.1371/journal.pone.0026332	http://dx.doi.org/10.1371/journal.pone.0026332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022604	Green Submitted, gold, Green Published			2022-12-27	WOS:000295984400048
J	Rea, M; Kullmann, S; Veit, R; Casile, A; Braun, C; Belardinelli, MO; Birbaumer, N; Caria, A				Rea, Massimiliano; Kullmann, Stephanie; Veit, Ralf; Casile, Antonino; Braun, Christoph; Belardinelli, Marta Olivetti; Birbaumer, Niels; Caria, Andrea			Effects of Aversive Stimuli on Prospective Memory. An Event-Related fMRI Study	PLOS ONE			English	Article							PREFRONTAL CORTEX; COGNITIVE CONTROL; BRAIN-REGIONS; ATTENTION; EXPRESSION; THREAT; FACE; INVOLVEMENT; PERFORMANCE; MECHANISMS	Prospective memory (PM) describes the ability to execute a previously planned action at the appropriate point in time. Although behavioral studies clearly showed that prospective memory performance is affected by the emotional significance attributed to the intended action, no study so far investigated the brain mechanisms subserving the modulatory effect of emotional salience on PM performance. The general aim of the present study was to explore brain regions involved in prospective memory processes when PM cues are associated with emotional stimuli. In particular, based on the hypothesised critical role of the prefrontal cortex in prospective memory in the presence of emotionally salient stimuli, we expected a stronger involvement of aPFC when the retrieval and execution of the intended action is cued by an aversive stimulus. To this aim BOLD responses of PM trials cued by aversive facial expressions were compared to PM trials cued by neutral facial expressions. Whole brain analysis showed that PM task cued by aversive stimuli is differentially associated with activity in the right lateral prefrontal area (BA 10) and in the left caudate nucleus. Moreover a temporal shift between the response of the caudate nucleus that preceded that of aPFC was observed. These findings suggest that the caudate nucleus might provide an early analysis of the affective properties of the stimuli, whereas the anterior lateral prefrontal cortex (BA10) would be involved in a slower and more deliberative analysis to guide goal-directed behaviour.	[Rea, Massimiliano; Kullmann, Stephanie; Veit, Ralf; Braun, Christoph; Birbaumer, Niels; Caria, Andrea] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Casile, Antonino] Italian Inst Technol, Dept Neurobiol, Boston, MA USA; [Casile, Antonino] Harvard Univ, Sch Med, Boston, MA USA; [Casile, Antonino] Univ Trento, Ist Italiano Tecnol, Ctr Neurosci & Cognit Syst UniTn, Trento, Italy; [Braun, Christoph] Univ Trento, Ctr Mind Brain Sci CiMEC, Trento, Italy; [Belardinelli, Marta Olivetti] Univ Roma La Sapienza, Dept Psychol 1, Rome, Italy; [Birbaumer, Niels] Osped San Camillo, Ist Ricovero & Cura Carattere Sci, Venice, Italy	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Harvard University; Harvard Medical School; Istituto Italiano di Tecnologia - IIT; University of Trento; University of Trento; Sapienza University Rome	Rea, M (corresponding author), Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany.	massimiliano.rea@med.uni-tuebingen.de	Braun, Christoph/J-4160-2014; Olivetti, Marta/T-4540-2017; Veit, Ralf/F-8907-2012; Braun, Christoph/E-4561-2010; Kullmann, Stephanie/Q-3976-2018	Braun, Christoph/0000-0002-7836-4010; Olivetti, Marta/0000-0003-3169-3359; Veit, Ralf/0000-0001-9860-642X; Braun, Christoph/0000-0002-7836-4010; Kullmann, Stephanie/0000-0001-9951-923X; Birbaumer, Niels/0000-0002-6786-5127; Caria, Andrea/0000-0003-2017-7084	Deutsche Forschungsgemeinschaft (DFG) [SFB 437]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG SFB 437). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre GK, 1997, NEUROIMAGE, V5, P199, DOI 10.1006/nimg.1997.0264; ALTGASSEN M, 2011, J CLIN EXPT NEUROPSY, P1; Altgassen M, 2010, Q J EXP PSYCHOL, V63, P1057, DOI 10.1080/17470211003770920; Banich MT, 2009, NEUROSCI BIOBEHAV R, V33, P613, DOI 10.1016/j.neubiorev.2008.09.010; Becerra L, 2001, NEURON, V32, P927, DOI 10.1016/S0896-6273(01)00533-5; Bishop S, 2004, NAT NEUROSCI, V7, P184, DOI 10.1038/nn1173; Braver TS, 2002, NEUROIMAGE, V15, P523, DOI 10.1006/nimg.2001.1019; Bruce V., 1998, EYE BEHOLDER SCI FAC; Burgess P.W., 2005, MEASURING MIND SPEED, P215; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Burgess PW, 2003, NEUROPSYCHOLOGIA, V41, P906, DOI 10.1016/S0028-3932(02)00327-5; Burgess PW, 2000, PSYCHOL RES-PSYCH FO, V63, P279, DOI 10.1007/s004269900006; Buxton R., 2002, INTRO FUNCTIONAL MAG; Carlesimo GA, 2004, J INT NEUROPSYCH SOC, V10, P679, DOI 10.1017/S1355617704105079; Carretie L, 2009, NEUROSCIENCE, V164, P1615, DOI 10.1016/j.neuroscience.2009.09.031; Carretie L, 2009, INT J PSYCHOPHYSIOL, V71, P57, DOI 10.1016/j.ijpsycho.2008.07.006; Christoff K, 2000, PSYCHOBIOLOGY, V28, P168; Christoff K, 2001, NEUROIMAGE, V14, P1136, DOI 10.1006/nimg.2001.0922; Clark-Foos A, 2009, AM J PSYCHOL, V122, P89; COCKBURN J, 1995, CORTEX, V31, P87, DOI 10.1016/S0010-9452(13)80107-4; Cohen AL, 2008, MEM COGNITION, V36, P149, DOI 10.3758/MC.36.1.149; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; den Ouden HEM, 2005, NEUROIMAGE, V28, P787, DOI 10.1016/j.neuroimage.2005.05.001; Depue BE, 2007, SCIENCE, V317, P215, DOI 10.1126/science.1139560; Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015; Einstein GO, 2005, J EXP PSYCHOL GEN, V134, P327, DOI 10.1037/0096-3445.134.3.327; EINSTEIN GO, 1990, J EXP PSYCHOL LEARN, V16, P717, DOI 10.1037/0278-7393.16.4.717; EKMAN P, 1992, COGNITION EMOTION, V6, P169, DOI 10.1080/02699939208411068; Ellis J, 1999, BRIT J PSYCHOL, V90, P9, DOI 10.1348/000712699161233; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Handwerker DA, 2004, NEUROIMAGE, V21, P1639, DOI 10.1016/j.neuroimage.2003.11.029; Harris LM, 1999, MEMORY, V7, P117, DOI 10.1080/741943717; Hayasaka S, 2003, NEUROIMAGE, V20, P2343, DOI 10.1016/j.neuroimage.2003.08.003; Kensinger EA, 2004, COGN AFFECT BEHAV NE, V4, P1, DOI 10.3758/CABN.4.1.1; Kliegel M, 2005, COGNITION EMOTION, V19, P1199, DOI 10.1080/02699930500233820; Kliegel M, 2006, DEV NEUROPSYCHOL, V30, P819, DOI 10.1207/s15326942dn3003_4; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; LeDoux J, 1998, BIOL PSYCHIAT, V44, P1229, DOI 10.1016/S0006-3223(98)00282-0; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liddell BJ, 2005, NEUROIMAGE, V24, P235, DOI 10.1016/j.neuroimage.2004.08.016; Luo Q, 2007, NEUROIMAGE, V34, P839, DOI 10.1016/j.neuroimage.2006.09.023; Marsh RL, 2003, J EXP PSYCHOL LEARN, V29, P861, DOI 10.1037/0278-7393.29.5.861; MARTIN LL, 2001, THEORIES MOOD COGNIT, V8; MEACHAM JA, 1980, J GEN PSYCHOL, V103, P203, DOI 10.1080/00221309.1980.9920999; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Muhlberger A, 2011, SOC COGN AFFECT NEUR, V6, P321, DOI 10.1093/scan/nsq039; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ohman A, 2001, PSYCHOL REV, V108, P483, DOI 10.1037//0033-295X.108.3.483; Ohman A., 2000, HDB PSYCHOPHYSIOLOGY, P533; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Okuda J, 2007, INT J PSYCHOPHYSIOL, V64, P233, DOI 10.1016/j.ijpsycho.2006.09.009; Palermo R, 2007, NEUROPSYCHOLOGIA, V45, P75, DOI 10.1016/j.neuropsychologia.2006.04.025; Ramnani N, 2004, NAT REV NEUROSCI, V5, P184, DOI 10.1038/nrn1343; RENDELL PG, 2010, PROSPECTIVE MEMORY E, P1; Reynolds JR, 2009, CEREB CORTEX, V19, P1208, DOI 10.1093/cercor/bhn164; Rude SS, 1999, COGNITION EMOTION, V13, P267, DOI 10.1080/026999399379276; Schmidt SR, 2004, MEM COGNITION, V32, P443, DOI 10.3758/BF03195837; Sergerie K, 2005, NEUROIMAGE, V24, P580, DOI 10.1016/j.neuroimage.2004.08.051; Simons JS, 2006, NEUROPSYCHOLOGIA, V44, P1388, DOI 10.1016/j.neuropsychologia.2006.01.005; Smith RE, 2003, J EXP PSYCHOL LEARN, V29, P347, DOI 10.1037/0278-7393.29.3.347; Tottenham N, 2009, PSYCHIAT RES, V168, P242, DOI 10.1016/j.psychres.2008.05.006; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Honk J, 2001, COGNITION EMOTION, V15, P279, DOI 10.1080/0269993004200222; Vrticka P, 2009, SOC NEUROSCI-UK, V4, P384, DOI 10.1080/17470910902941793; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; West R, 2005, PSYCHON B REV, V12, P502, DOI 10.3758/BF03193795; West R, 2001, COGNITIVE BRAIN RES, V12, P1, DOI 10.1016/S0926-6410(01)00014-3; Winston JS, 2004, J NEUROPHYSIOL, V92, P1830, DOI 10.1152/jn.00155.2004	70	12	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26290	10.1371/journal.pone.0026290	http://dx.doi.org/10.1371/journal.pone.0026290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022589	gold, Green Published, Green Submitted			2022-12-27	WOS:000295984400043
J	Jornot, L; Cordey, S; Caruso, A; Gerber, C; Vukicevic, M; Tapparel, C; Kaiser, L; Burger, D; Roosnek, E; Lacroix, JS; Rochat, T				Jornot, Lan; Cordey, Samuel; Caruso, Assunta; Gerber, Christine; Vukicevic, Marija; Tapparel, Caroline; Kaiser, Laurent; Burger, Danielle; Roosnek, Eddy; Lacroix, Jean Silvain; Rochat, Thierry			T Lymphocytes Promote the Antiviral and Inflammatory Responses of Airway Epithelial Cells	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; NITRIC-OXIDE; RHINOVIRUS INFECTION; IN-VITRO; IFN-GAMMA; TNF-ALPHA; HUMAN BETA-DEFENSIN-2; CYTOKINE PRODUCTION; EXPRESSION	Hypothesis: T cells modulate the antiviral and inflammatory responses of airway epithelial cells to human rhinoviruses (HRV). Methods: Differentiated primary human nasal epithelial cells (HNEC) grown on collagen-coated filters were exposed apically to HRV14 for 6 h, washed thoroughly and co-cultured with anti-CD3/CD28 activated T cells added in the basolateral compartment for 40 h. Results: HRV14 did not induce IFN gamma, NOS2, CXCL8 and IL-6 in HNEC, but enhanced expression of the T cell attractant CXCL10. On the other hand, HNEC co-cultured with activated T cells produced CXCL10 at a level several orders of magnitude higher than that induced by HRV14. Albeit to a much lower degree, activated T cells also induced CXCL8, IL-6 and NOS2. Anti-IFN gamma antibodies and TNF soluble receptor completely blocked CXCL10 upregulation. Furthermore, a significant correlation was observed between epithelial CXCL10 mRNA expression and the amounts of IFN gamma and TNF secreted by T cells. Likewise, increasing numbers of T cells to a constant number of HNEC in co-cultures resulted in increasing epithelial CXCL10 production, attaining a plateau at high IFN gamma and TNF levels. Hence, HNEC activation by T cells is induced mainly by IFN gamma and/or TNF. Activated T cells also markedly inhibited viral replication in HNEC, partially through activation of the nitric oxide pathway. Conclusion: Cross-talk between T cells and HNEC results in activation of the latter and increases their contribution to airway inflammation and virus clearance.	[Jornot, Lan; Caruso, Assunta; Gerber, Christine; Rochat, Thierry] Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland; [Cordey, Samuel; Tapparel, Caroline; Kaiser, Laurent] Univ Hosp Geneva, Div Infect Dis, Virol Lab, Geneva, Switzerland; [Vukicevic, Marija; Roosnek, Eddy] Univ Hosp Geneva, Div Hematol, Geneva, Switzerland; [Burger, Danielle] Univ Hosp Geneva, Div Immunol & Allergy, Geneva, Switzerland; [Lacroix, Jean Silvain] Univ Hosp Geneva, Rhinol Olfactol Unit, Geneva, Switzerland	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva	Jornot, L (corresponding author), Univ Hosp Geneva, Div Pulm Med, Geneva, Switzerland.	Lan.H.Jornot@hcuge.ch	Cordey, Samuel/C-9240-2018	Cordey, Samuel/0000-0002-2684-5680; Tapparel Vu, Caroline/0000-0002-0411-6567; Kaiser, Laurent/0000-0002-0857-2252	Geneva University Hospitals; Swiss Society for Cystic Fibrosis	Geneva University Hospitals; Swiss Society for Cystic Fibrosis	This work was supported by a research grant from the Geneva University Hospitals and, in part, by a grant from the Swiss Society for Cystic Fibrosis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Chen Y, 2006, AM J RESP CELL MOL, V34, P192, DOI 10.1165/rcmb.2004-0417OC; Clarke DL, 2010, J BIOL CHEM, V285, P29101, DOI 10.1074/jbc.M109.0999952; Cordey S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010588; DeMore JP, 2009, J ALLERGY CLIN IMMUN, V124, P245, DOI 10.1016/j.jaci.2009.05.030; Dreschers S, 2007, CELL MOL LIFE SCI, V64, P181, DOI 10.1007/s00018-006-6266-5; Duits LA, 2003, FEMS IMMUNOL MED MIC, V38, P59, DOI 10.1016/S0928-8244(03)00106-8; Edwards MR, 2007, MOL IMMUNOL, V44, P1587, DOI 10.1016/j.molimm.2006.08.014; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Fleming HE, 1999, AM J RESP CRIT CARE, V160, P100, DOI 10.1164/ajrccm.160.1.9808074; Gern JE, 2000, AM J RESP CRIT CARE, V162, P2226, DOI 10.1164/ajrccm.162.6.2003019; JOHNSTON SL, 1995, AM J RESP CRIT CARE, V152, pS46, DOI 10.1164/ajrccm/152.4_Pt_2.S46; Jornot L, 2008, EUR RESPIR J, V32, P769, DOI 10.1183/09031936.00051608; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Korpi-Steiner NL, 2010, CLIN EXP ALLERGY, V40, P1203, DOI 10.1111/j.1365-2222.2010.03546.x; Lopez-Souza N, 2004, AM J PHYSIOL-LUNG C, V286, pL373, DOI 10.1152/ajplung.00300.2003; Lopez-Souza N, 2009, J ALLERGY CLIN IMMUN, V123, P1384, DOI 10.1016/j.jaci.2009.03.010; Newcomb DC, 2007, AM J PHYSIOL-LUNG C, V293, pL1021, DOI 10.1152/ajplung.00060.2007; Pizzichini MMM, 1998, AM J RESP CRIT CARE, V158, P1178, DOI 10.1164/ajrccm.158.4.9712082; Proud D, 2005, CURR OPIN ALLERGY CL, V5, P37, DOI 10.1097/00130832-200502000-00008; Proud D, 2004, J IMMUNOL, V172, P4637, DOI 10.4049/jimmunol.172.7.4637; Qi XF, 2009, J CELL PHYSIOL, V220, P690, DOI 10.1002/jcp.21815; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saha B, 2010, CYTOKINE, V50, P1, DOI 10.1016/j.cyto.2009.11.021; Sanders SP, 1998, J VIROL, V72, P934, DOI 10.1128/JVI.72.2.934-942.1998; Sanders SP, 2004, J ALLERGY CLIN IMMUN, V113, P697, DOI 10.1016/j.jaci.2004.01.755; Sanders SP, 2001, J ALLERGY CLIN IMMUN, V107, P235, DOI 10.1067/mai.2001.112028; Spurrell JCL, 2005, AM J PHYSIOL-LUNG C, V289, pL85, DOI 10.1152/ajplung.00397.2004; Taima K, 2006, RESPIRATION, V73, P360, DOI 10.1159/000091646; Tapparel C, 2009, J CLIN MICROBIOL, V47, P1742, DOI 10.1128/JCM.02339-08; Turner RB, 1998, CLIN INFECT DIS, V26, P840, DOI 10.1086/513922; Turner RB, 2001, CLIN INFECT DIS, V33, P1865, DOI 10.1086/324347; Wark PAB, 2007, J ALLERGY CLIN IMMUN, V120, P586, DOI 10.1016/j.jaci.2007.04.046; Xu WL, 2006, FREE RADICAL BIO MED, V41, P19, DOI 10.1016/j.freeradbiomed.2006.01.037; Yasuda H, 2006, EUR RESPIR J, V28, P51, DOI 10.1183/09031936.06.00058505	35	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26293	10.1371/journal.pone.0026293	http://dx.doi.org/10.1371/journal.pone.0026293			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022590	Green Published, gold, Green Submitted			2022-12-27	WOS:000295981600048
J	Corin, K; Baaske, P; Ravel, DB; Song, JY; Brown, E; Wang, XQ; Geissler, S; Wienken, CJ; Jerabek-Willemsen, M; Duhr, S; Braun, D; Zhang, SG				Corin, Karolina; Baaske, Philipp; Ravel, Deepali B.; Song, Junyao; Brown, Emily; Wang, Xiaoqiang; Geissler, Sandra; Wienken, Christoph J.; Jerabek-Willemsen, Moran; Duhr, Stefan; Braun, Dieter; Zhang, Shuguang			A Robust and Rapid Method of Producing Soluble, Stable, and Functional G-Protein Coupled Receptors	PLOS ONE			English	Article							CELL-FREE EXPRESSION; MEMBRANE-PROTEINS; HUMAN ENDOTHELIN; BINDING; PURIFICATION; DETERGENTS	Membrane proteins, particularly G-protein coupled receptors (GPCRs), are notoriously difficult to express. Using commercial E. coli cell-free systems with the detergent Brij-35, we could rapidly produce milligram quantities of 13 unique GPCRs. Immunoaffinity purification yielded receptors at >90% purity. Secondary structure analysis using circular dichroism indicated that the purified receptors were properly folded. Microscale thermophoresis, a novel label-free and surface-free detection technique that uses thermal gradients, showed that these receptors bound their ligands. The secondary structure and ligand-binding results from cell-free produced proteins were comparable to those expressed and purified from HEK293 cells. Our study demonstrates that cell-free protein production using commercially available kits and optimal detergents is a robust technology that can be used to produce sufficient GPCRs for biochemical, structural, and functional analyses. This robust and simple method may further stimulate others to study the structure and function of membrane proteins.	[Corin, Karolina; Ravel, Deepali B.; Song, Junyao; Brown, Emily; Wang, Xiaoqiang; Zhang, Shuguang] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [Baaske, Philipp; Geissler, Sandra; Jerabek-Willemsen, Moran; Duhr, Stefan] NanoTemper Technol GmbH, Munich, Germany; [Wang, Xiaoqiang] China Univ Petr E China, Ctr Bioengn & Biotechnol, Qingdao, Shandong, Peoples R China; [Wienken, Christoph J.; Braun, Dieter] Univ Munich, Munich, Germany	Massachusetts Institute of Technology (MIT); China University of Petroleum; University of Munich	Corin, K (corresponding author), MIT, Ctr Biomed Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	shuguang@mit.edu		Zhang, Shuguang/0000-0002-3856-3752; Corin, Karolina/0000-0003-3080-5742	MIT UROP Funding;  [DARPA-HR0011-09-C-0012]	MIT UROP Funding; 	This work is supported by DARPA-HR0011-09-C-0012 and MIT UROP Funding. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Philipp Baaske, Moran Jerabek-Willemsen and Stefan Duhr are employees of NanoTemper Technologies GmbH; these authors contributed to all aspects of the study.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Baaske P, 2010, ANGEW CHEM INT EDIT, V49, P2238, DOI 10.1002/anie.200903998; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Cook BL, 2009, P NATL ACAD SCI USA, V106, P11925, DOI 10.1073/pnas.0811089106; Cook BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002920; DENIAUD A, 2008, BIOCHIM BIOPHYS ACTA, V1798, P1540; Duhr S, 2006, P NATL ACAD SCI USA, V103, P19678, DOI 10.1073/pnas.0603873103; Ishihara G, 2005, PROTEIN EXPRES PURIF, V41, P27, DOI 10.1016/j.pep.2005.01.013; Junge F, 2010, J STRUCT BIOL, V172, P94, DOI 10.1016/j.jsb.2010.05.004; Kai L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012972; Kaiser L, 2008, P NATL ACAD SCI USA, V105, P15726, DOI 10.1073/pnas.0804766105; KAMONCHANOK S, 2008, J PROTEOME RES, V7, P621; Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x; Klammt C, 2004, EUR J BIOCHEM, V271, P568, DOI 10.1111/j.1432-1033.2003.03959.x; Klammt C, 2007, FEBS J, V274, P3257, DOI 10.1111/j.1742-4658.2007.05854.x; Klammt C, 2007, J STRUCT BIOL, V158, P482, DOI 10.1016/j.jsb.2007.01.006; Leck KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015027; Liguori L., 2008, CURR PROTOC PROTEIN, V5, P22; Maslennikov I, 2010, P NATL ACAD SCI USA, V107, P10902, DOI 10.1073/pnas.1001656107; Rasband W., 2006, IMAGEJ; Ren H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004509; Savage DF, 2007, PROTEIN SCI, V16, P966, DOI 10.1110/ps.062696307; Schwarz D, 2008, PROTEOMICS, V8, P3933, DOI 10.1002/pmic.200800171; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Shirokova E, 2008, FASEB J, V22, P1416, DOI 10.1096/fj.07-9233com; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Wang XQ, 2011, P NATL ACAD SCI USA, V108, P9049, DOI 10.1073/pnas.1018185108; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093	28	36	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e23036	10.1371/journal.pone.0023036	http://dx.doi.org/10.1371/journal.pone.0023036			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22039398	Green Published, Green Submitted, gold			2022-12-27	WOS:000296517000001
J	Minge, D; Bahring, R				Minge, Daniel; Baehring, Robert			Acute Alterations of Somatodendritic Action Potential Dynamics in Hippocampal CA1 Pyramidal Cells after Kainate-Induced Status Epilepticus in Mice	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; POTASSIUM CHANNEL SUBUNITS; LONG-LASTING MODIFICATION; PILOCARPINE MODEL; SODIUM CURRENTS; DOWN-REGULATION; AFTER-HYPERPOLARIZATION; CURRENT CONTRIBUTES; ALTERED EXPRESSION; VOLTAGE CLAMP	Pathophysiological remodeling processes at an early stage of an acquired epilepsy are critical but not well understood. Therefore, we examined acute changes in action potential (AP) dynamics immediately following status epilepticus (SE) in mice. SE was induced by intraperitoneal (i.p.) injection of kainate, and behavioral manifestation of SE was monitored for 3-4 h. After this time interval CA1 pyramidal cells were studied ex vivo with whole-cell current-clamp and Ca2+ imaging techniques in a hippocampal slice preparation. Following acute SE both resting potential and firing threshold were modestly depolarized (2-5 mV). No changes were seen in input resistance or membrane time constant, but AP latency was prolonged and AP upstroke velocity reduced following acute SE. All cells showed an increase in AP halfwidth and regular (rather than burst) firing, and in a fraction of cells the notch, typically preceding spike afterdepolarization (ADP), was absent following acute SE. Notably, the typical attenuation of backpropagating action potential (b-AP)-induced Ca2+ signals along the apical dendrite was strengthened following acute SE. The effects of acute SE on the retrograde spread of excitation were mimicked by applying the Kv4 current potentiating drug NS5806. Our data unveil a reduced somatodendritic excitability in hippocampal CA1 pyramidal cells immediately after acute SE with a possible involvement of both Na+ and K+ current components.	[Minge, Daniel; Baehring, Robert] Univ Klinikum Hamburg Eppendorf, Zentrum Expt Med, Inst Zellulare & Integrat Physiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Minge, D (corresponding author), Univ Klinikum Hamburg Eppendorf, Zentrum Expt Med, Inst Zellulare & Integrat Physiol, Hamburg, Germany.	r.baehring@uke.uni-hamburg.de		Bahring, Robert/0000-0002-0406-5958	Deutsche Forschungsgemeinschaft (DFG) [BA 2055/4-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grant BA 2055/4-1 from the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang CW, 2006, J NEUROSCI, V26, P11850, DOI 10.1523/JNEUROSCI.2354-06.2006; Bean BP, 2007, NAT REV NEUROSCI, V8, P451, DOI 10.1038/nrn2148; Beck H, 2008, NAT REV NEUROSCI, V9, P357, DOI 10.1038/nrn2371; Becker AJ, 2008, J NEUROSCI, V28, P13341, DOI 10.1523/JNEUROSCI.1421-08.2008; Ben-Ari Y, 2000, TRENDS NEUROSCI, V23, P580, DOI 10.1016/S0166-2236(00)01659-3; Berger M L, 1986, Adv Exp Med Biol, V203, P199; Bernard C, 2004, SCIENCE, V305, P532, DOI 10.1126/science.1097065; Bischofberger J, 2006, NAT PROTOC, V1, P2075, DOI 10.1038/nprot.2006.312; Calloe K, 2009, CARDIOVASC RES, V81, P686, DOI 10.1093/cvr/cvn339; Chemin J, 2003, EMBO J, V22, P5403, DOI 10.1093/emboj/cdg528; Chen K, 2001, NAT MED, V7, P331, DOI 10.1038/85480; Chen S, 2011, J NEUROPHYSIOL, V105, P117, DOI 10.1152/jn.00184.2010; Chen XX, 2006, J NEUROSCI, V26, P12143, DOI 10.1523/JNEUROSCI.2667-06.2006; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P21, DOI 10.1113/jphysiol.1971.sp009365; CONNOR JA, 1971, J PHYSIOL-LONDON, V213, P31, DOI 10.1113/jphysiol.1971.sp009366; Covolan L, 2000, EPILEPSY RES, V39, P133, DOI 10.1016/S0920-1211(99)00119-9; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; Dichter MA, 2009, ARCH NEUROL-CHICAGO, V66, P443, DOI 10.1001/archneurol.2009.10; Ellerkmann RK, 2003, NEUROSCIENCE, V119, P323, DOI 10.1016/S0306-4522(03)00168-4; Ermolinsky B, 2008, NEUROREPORT, V19, P1291, DOI 10.1097/WNR.0b013e3283094bb6; Francis J, 1997, NEUROSCI LETT, V232, P91, DOI 10.1016/S0304-3940(97)00593-4; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; HajDahmane S, 1997, J NEUROPHYSIOL, V78, P1983, DOI 10.1152/jn.1997.78.4.1983; Hausser M, 2000, SCIENCE, V290, P739, DOI 10.1126/science.290.5492.739; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Hoffman DA, 1997, NATURE, V387, P869, DOI 10.1038/43119; Jerng HH, 2004, MOL CELL NEUROSCI, V27, P343, DOI 10.1016/j.mcn.2004.06.011; Jones-Davis DM, 2003, CURR OPIN PHARMACOL, V3, P12, DOI 10.1016/S1471-4892(02)00015-2; Kaab S, 1998, CIRCULATION, V98, P1383, DOI 10.1161/01.CIR.98.14.1383; Ketelaars SOM, 2001, NEUROSCIENCE, V105, P109, DOI 10.1016/S0306-4522(01)00176-2; Kim J, 2005, J PHYSIOL-LONDON, V569, P41, DOI 10.1113/jphysiol.2005.095042; Krishnan GP, 2011, J NEUROSCI, V31, P8870, DOI 10.1523/JNEUROSCI.6200-10.2011; Loscher W, 2010, PHARMACOL REV, V62, P668, DOI 10.1124/pr.110.003046; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Lugo JN, 2008, J NEUROCHEM, V106, P1929, DOI 10.1111/j.1471-4159.2008.05508.x; Lundby A, 2010, BRIT J PHARMACOL, V160, P2028, DOI 10.1111/j.1476-5381.2010.00859.x; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862; Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552; Magistretti J, 2006, J PHYSIOL-LONDON, V573, P83, DOI 10.1113/jphysiol.2006.106682; Malin SA, 2000, J NEUROSCI, V20, P5191, DOI 10.1523/JNEUROSCI.20-14-05191.2000; Metz AE, 2005, J NEUROSCI, V25, P5763, DOI 10.1523/JNEUROSCI.0624-05.2005; Mitterdorfer J, 2002, J NEUROSCI, V22, P10106; Monaghan MM, 2008, NEUROSCIENCE, V156, P550, DOI 10.1016/j.neuroscience.2008.07.057; Morrison RS, 1996, J NEUROSCI, V16, P1337; Otalora LFP, 2008, BRAIN RES, V1200, P116, DOI 10.1016/j.brainres.2008.01.017; Pedarzani P, 2005, J BIOL CHEM, V280, P41404, DOI 10.1074/jbc.M509610200; Pitkanen A, 2007, EPILEPSIA, V48, P13, DOI 10.1111/j.1528-1167.2007.01063.x; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Remy S, 2010, CURR OPIN NEUROBIOL, V20, P503, DOI 10.1016/j.conb.2010.06.006; Sanabria ERC, 2001, J PHYSIOL-LONDON, V532, P205, DOI 10.1111/j.1469-7793.2001.0205g.x; SERODIO P, 1994, J NEUROPHYSIOL, V72, P1516, DOI 10.1152/jn.1994.72.4.1516; Shah MM, 2004, NEURON, V44, P495, DOI 10.1016/j.neuron.2004.10.011; Shao LR, 1999, J PHYSIOL-LONDON, V521, P135, DOI 10.1111/j.1469-7793.1999.00135.x; Shin M, 2008, NEUROBIOL DIS, V32, P26, DOI 10.1016/j.nbd.2008.06.013; Shruti S, 2008, NEUROBIOL DIS, V30, P323, DOI 10.1016/j.nbd.2008.02.002; Sloviter RS, 2008, EPILEPSIA, V49, P85, DOI 10.1111/j.1528-1167.2008.01931.x; SPERK G, 1994, PROG NEUROBIOL, V42, P1, DOI 10.1016/0301-0082(94)90019-1; Spitzer NC, 2002, CURR OPIN NEUROBIOL, V12, P315, DOI 10.1016/S0959-4388(02)00330-6; STORM JF, 1990, PROG BRAIN RES, V83, P161; STORM JF, 1987, J PHYSIOL-LONDON, V385, P733, DOI 10.1113/jphysiol.1987.sp016517; STORM JF, 1988, NATURE, V336, P379, DOI 10.1038/336379a0; STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0; Su H, 2002, J NEUROSCI, V22, P3645; Su T, 2008, NEUROSCIENCE, V157, P566, DOI 10.1016/j.neuroscience.2008.09.027; Swensen AM, 2003, J NEUROSCI, V23, P9650; TSAUR ML, 1992, NEURON, V8, P1055, DOI 10.1016/0896-6273(92)90127-Y; Vreugdenhil M, 1998, NEUROSCIENCE, V86, P99, DOI 10.1016/S0306-4522(98)00041-4; Waters J, 2005, PROG BIOPHYS MOL BIO, V87, P145, DOI 10.1016/j.pbiomolbio.2004.06.009; Wellmer J, 2002, EUR J NEUROSCI, V16, P259, DOI 10.1046/j.1460-9568.2002.02086.x; Williams SR, 1997, J PHYSIOL-LONDON, V505, P689, DOI 10.1111/j.1469-7793.1997.689ba.x; Yaari Y, 2007, J PHYSIOL-LONDON, V580, P435, DOI 10.1113/jphysiol.2007.127670; YAMADA N, 1991, BRAIN RES, V561, P324, DOI 10.1016/0006-8993(91)91611-4	73	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26664	10.1371/journal.pone.0026664	http://dx.doi.org/10.1371/journal.pone.0026664			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039527	Green Submitted, Green Published, gold			2022-12-27	WOS:000296515200039
J	Sullivan, C; Chen, YY; Shan, Y; Hu, YG; Peng, C; Zhang, HJ; Kong, LH; Li, SG				Sullivan, Con; Chen, Yaoyu; Shan, Yi; Hu, Yiguo; Peng, Cong; Zhang, Haojian; Kong, Linghong; Li, Shaoguang			Functional Ramifications for the Loss of P-Selectin Expression on Hematopoietic and Leukemic Stem Cells	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; MICE; INFLAMMATION	Hematopoiesis is a tightly regulated biological process that relies upon complicated interactions between blood cells and their microenvironment to preserve the homeostatic balance of long-term hematopoietic stem cells (LT-HSCs), short-term HSCs (ST-HSCs), multipotent progenitors (MPPs), and differentiated cells. Adhesion molecules like P-selectin (encoded by the Selp gene) are essential to hematopoiesis, and their dysregulation has been linked to leukemogenesis. Like HSCs, leukemic stem cells (LSCs) depend upon their microenvironments for survival and propagation. P-selectin plays a crucial role in Philadelphia chromosome -positive (Ph(+)) chronic myeloid leukemia (CML). In this paper, we show that cells deficient in P-selectin expression can repopulate the marrow more efficiently than wild type controls. This results from an increase in HSC self-renewal rather than alternative possibilities like increased homing velocity or cell cycle defects. We also show that P-selectin expression on LT-HSCs, but not ST-HSCs and MPPs, increases with aging. In the absence of P-selectin expression, mice at 6 months of age possess increased levels of short-term HSCs and multipotent progenitors. By 11 months of age, there is a shift towards increased levels of long-term HSCs. Recipients of BCR-ABL-transduced bone marrow cells from P-selectin-deficient donors develop a more aggressive CML, with increased percentages of LSCs and progenitors. Taken together, our data reveal that P-selectin expression on HSCs and LSCs has important functional ramifications for both hematopoiesis and leukemogenesis, which is most likely attributable to an intrinsic effect on stem cell self-renewal.	[Sullivan, Con] Maine Inst Human Genet & Hlth, Bangor, ME USA; [Chen, Yaoyu; Shan, Yi; Peng, Cong; Zhang, Haojian; Li, Shaoguang] Univ Massachusetts, Sch Med, Dept Med, Div Hematol Oncol, Worcester, MA USA; [Sullivan, Con; Chen, Yaoyu; Hu, Yiguo; Peng, Cong; Zhang, Haojian; Kong, Linghong; Li, Shaoguang] Jackson Lab, Bar Harbor, ME 04609 USA; [Hu, Yiguo] Dana Farber Canc Inst, Boston, MA 02115 USA	University of Massachusetts System; University of Massachusetts Worcester; Jackson Laboratory; Harvard University; Dana-Farber Cancer Institute	Sullivan, C (corresponding author), Maine Inst Human Genet & Hlth, Bangor, ME USA.	shaoguang.li@umassmed.edu	Zhang, Haojian/H-7897-2013; Peng, Cong/H-2286-2011; Shan, Yi/E-3862-2016	Hu, Yiguo/0000-0002-3973-2140	National Institutes of Health [CA122142, CA114199]; NATIONAL CANCER INSTITUTE [R01CA122142, R01CA114199] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (CA122142,CA114199). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthel SR, 2007, EXPERT OPIN THER TAR, V11, P1473, DOI 10.1517/14728222.11.11.1473; Beerman I, 2010, CURR OPIN IMMUNOL, V22, P500, DOI 10.1016/j.coi.2010.06.007; Chambers SM, 2007, STEM CELL REV, V3, P201, DOI 10.1007/s12015-007-0027-1; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Hu YG, 2004, NAT GENET, V36, P453, DOI 10.1038/ng1343; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Li SG, 1999, J EXP MED, V189, P1399, DOI 10.1084/jem.189.9.1399; Ludwig RJ, 2007, EXPERT OPIN THER TAR, V11, P1103, DOI 10.1517/14728222.11.8.1103; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; MOORE KL, 1995, J CELL BIOL, V128, P661, DOI 10.1083/jcb.128.4.661; Pelletier SD, 2004, BLOOD, V104, P2163, DOI 10.1182/blood-2003-09-3033; Peng C, 2007, BLOOD, V110, P678, DOI 10.1182/blood-2006-10-054098; Peng C, 2010, BLOOD, V115, P626, DOI 10.1182/blood-2009-06-228130; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102	15	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26246	10.1371/journal.pone.0026246	http://dx.doi.org/10.1371/journal.pone.0026246			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039451	Green Published, gold, Green Submitted			2022-12-27	WOS:000296515200007
J	Lebbink, RJ; Lowe, M; Chan, T; Khine, H; Wang, XY; McManus, MT				Lebbink, Robert Jan; Lowe, Maggie; Chan, Theresa; Khine, Htet; Wang, Xiaoyin; McManus, Michael T.			Polymerase II Promoter Strength Determines Efficacy of microRNA Adapted shRNAs	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; MAMMALIAN-CELLS; CAENORHABDITIS-ELEGANS; EXPRESSION VECTORS; INTERFERING RNAS; GENE-EXPRESSION; REGULATORY RNA; HAIRPIN RNAS; C-ELEGANS; SYSTEM	Since the discovery of RNAi and microRNAs more than 10 years ago, much research has focused on the development of systems that usurp microRNA pathways to downregulate gene expression in mammalian cells. One of these systems makes use of endogenous microRNA pri-cursors that are expressed from polymerase II promoters where the mature microRNA sequence is replaced by gene specific duplexes that guide RNAi (shRNA-miRs). Although shRNA-miRs are effective in directing target mRNA knockdown and hence reducing protein expression in many cell types, variability of RNAi efficacy in cell lines has been an issue. Here we show that the choice of the polymerase II promoter used to drive shRNA expression is of critical importance to allow effective mRNA target knockdown. We tested the abundance of shRNA-miRs expressed from five different polymerase II promoters in 6 human cell lines and measured their ability to drive target knockdown. We observed a clear positive correlation between promoter strength, siRNA expression levels, and protein target knockdown. Differences in RNAi from the shRNA-miRs expressed from the various promoters were particularly pronounced in immune cells. Our findings have direct implications for the design of shRNA-directed RNAi experiments and the preferred RNAi system to use for each cell type.	[Lebbink, Robert Jan; Lowe, Maggie; Chan, Theresa; Khine, Htet; Wang, Xiaoyin; McManus, Michael T.] Univ Calif San Francisco, Dept Microbiol & Immunol, Ctr Diabet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lebbink, RJ (corresponding author), Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands.	michael.mcmanus@ucsf.edu	Lebbink, Robert Jan/GNH-5209-2022; mcmanus, michael/AAB-1239-2020	mcmanus, michael/0000-0003-3013-6569; Lebbink, Robert Jan/0000-0002-1981-0420	NIH [RO1GM80783]; Netherlands Organization for Scientific Research (NWO); UCSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080783] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); UCSF; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This work was funded by NIH RO1GM80783 to MTM, a Rubicon grant from The Netherlands Organization for Scientific Research (NWO) to RJL, and a grant from the UCSF Program for Breakthrough Biomedical Research to RJL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An DS, 2000, J VIROL, V74, P1286, DOI 10.1128/JVI.74.3.1286-1295.2000; Boden D, 2004, NUCLEIC ACIDS RES, V32, P1154, DOI 10.1093/nar/gkh278; Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; Chang K, 2006, NAT METHODS, V3, P707, DOI 10.1038/NMETH923; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; Ehlert EM, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-20; Giering JC, 2008, MOL THER, V16, P1630, DOI 10.1038/mt.2008.144; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Ku G, 2008, HUM GENE THER, V19, P17, DOI 10.1089/hum.2007.1226; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Osborn MJ, 2005, MOL THER, V12, P569, DOI 10.1016/j.ymthe.2005.04.013; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Paul CP, 2002, NAT BIOTECHNOL, V20, P505, DOI 10.1038/nbt0502-505; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rossi JJ, 2008, HUM GENE THER, V19, P313, DOI 10.1089/hum.2008.026; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Salmon P, 2000, BLOOD, V96, P3392; Shan ZX, 2009, MOL BIOL REP, V36, P1483, DOI 10.1007/s11033-008-9339-8; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5	35	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26213	10.1371/journal.pone.0026213	http://dx.doi.org/10.1371/journal.pone.0026213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031824	gold, Green Published, Green Submitted			2022-12-27	WOS:000296513200011
J	Alanazi, M; Abduljaleel, Z; Khan, W; Warsy, AS; Elrobh, M; Khan, Z; Al Amri, A; Bazzi, MD				Alanazi, Mohammed; Abduljaleel, Zainularifeen; Khan, Wajahatullah; Warsy, Arjumand S.; Elrobh, Mohamed; Khan, Zahid; Al Amri, Abdullah; Bazzi, Mohammad D.			In Silico Analysis of Single Nucleotide Polymorphism (SNPs) in Human beta-Globin Gene	PLOS ONE			English	Article							STABILITY CHANGES; PROTEIN-STRUCTURE; DATABASE; MUTATIONS; VARIANTS; HEMOGLOBINOPATHIES; SEQUENCE; IMPACT	Single amino acid substitutions in the globin chain are the most common forms of genetic variations that produce hemoglobinopathies- the most widespread inherited disorders worldwide. Several hemoglobinopathies result from homozygosity or compound heterozygosity to beta-globin (HBB) gene mutations, such as that producing sickle cell hemoglobin (HbS), HbC, HbD and HbE. Several of these mutations are deleterious and result in moderate to severe hemolytic anemia, with associated complications, requiring lifelong care and management. Even though many hemoglobinopathies result from single amino acid changes producing similar structural abnormalities, there are functional differences in the generated variants. Using in silico methods, we examined the genetic variations that can alter the expression and function of the HBB gene. Using a sequence homology-based Sorting Intolerant from Tolerant (SIFT) server we have searched for the SNPs, which showed that 200 (80%) non-synonymous polymorphism were found to be deleterious. The structure-based method via PolyPhen server indicated that 135 (40%) non-synonymous polymorphism may modify protein function and structure. The Pupa Suite software showed that the SNPs will have a phenotypic consequence on the structure and function of the altered protein. Structure analysis was performed on the key mutations that occur in the native protein coded by the HBB gene that causes hemoglobinopathies such as: HbC (E -> K), HbD (E -> Q), HbE (E -> K) and HbS (E -> V). Atomic Non-Local Environment Assessment (ANOLEA), Yet Another Scientific Artificial Reality Application (YASARA), CHARMM-GUI webserver for macromolecular dynamics and mechanics, and Normal Mode Analysis, Deformation and Refinement (NOMAD-Ref) of Gromacs server were used to perform molecular dynamics simulations and energy minimization calculations on beta-Chain residue of the HBB gene before and after mutation. Furthermore, in the native and altered protein models, amino acid residues were determined and secondary structures were observed for solvent accessibility to confirm the protein stability. The functional study in this investigation may be a good model for additional future studies.	[Alanazi, Mohammed; Abduljaleel, Zainularifeen; Khan, Wajahatullah; Warsy, Arjumand S.; Elrobh, Mohamed; Khan, Zahid; Al Amri, Abdullah; Bazzi, Mohammad D.] King Saud Univ, Coll Sci, Genome Res Chair Unit, Dept Biochem, Riyadh 11451, Saudi Arabia	King Saud University	Alanazi, M (corresponding author), King Saud Univ, Coll Sci, Genome Res Chair Unit, Dept Biochem, Riyadh 11451, Saudi Arabia.	zarifeen@ksu.edu.sa	Alamri, Abdullah M/C-3108-2012; Warsy, Arjumand/D-5274-2015; Elrobh, Mohamed S/H-5696-2012; Khan, Wajahatullah/J-9574-2012; abduljaleel, zainularifeen/AAE-8036-2021	Alamri, Abdullah M/0000-0002-3045-1350; Warsy, Arjumand/0000-0001-6957-203X; abduljaleel, zainularifeen/0000-0001-9791-1924; , Mohamed/0000-0003-1967-8850	King Saud University [RGP-VPP-081]	King Saud University(King Saud University)	The funding for this research was provided by the Deanship of scientific research at King Saud University (Project No RGP-VPP-081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow-Stewart K, 2007, GENETICS FAMILY MED; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Cartegni L, 2002, NAT REV GENET, V3, P285, DOI 10.1038/nrg775; Cavallo A, 2005, BIOINFORMATICS, V21, P1443, DOI 10.1093/bioinformatics/bti220; Conde L, 2006, NUCLEIC ACIDS RES, V34, pW621, DOI 10.1093/nar/gkl071; Delarue M, 2004, P NATL ACAD SCI USA, V101, P6957, DOI 10.1073/pnas.0400301101; Doss CGP, 2009, NEW BIOTECHNOL, V25, P214, DOI 10.1016/j.nbt.2009.01.004; Driscoll MC, 2007, PEDIATR REV, V28, P259, DOI 10.1542/pir.28-7-259; Fairbrother WG, 2000, MOL CELL BIOL, V20, P6816, DOI 10.1128/MCB.20.18.6816-6825.2000; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Ferrer-Costa C, 2002, J MOL BIOL, V315, P771, DOI 10.1006/jmbi.2001.5255; Fucharoen S, 1997, HEMOGLOBIN, V21, P299, DOI 10.3109/03630269709000664; Gilis D, 1996, J MOL BIOL, V257, P1112, DOI 10.1006/jmbi.1996.0226; Gilis D, 1997, J MOL BIOL, V272, P276, DOI 10.1006/jmbi.1997.1237; Graveley BR, 2000, RNA, V6, P1197, DOI 10.1017/S1355838200000960; Gromiha MM, 2000, NUCLEIC ACIDS RES, V28, P283, DOI 10.1093/nar/28.1.283; Hardison RC, 2002, HUM MUTAT, V19, P225, DOI 10.1002/humu.10044; Hockney R. W., 1981, COMPUTER SIMULATION; Hurst JM, 2009, HUM MUTAT, V30, P616, DOI 10.1002/humu.20898; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Lindahl E, 2006, NUCLEIC ACIDS RES, V34, pW52, DOI 10.1093/nar/gkl082; Livingstone F. B., 1985, FREQUENCIES HEMOGLOB; Massingham T, 2005, GENETICS, V169, P1753, DOI 10.1534/genetics.104.032144; Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665; Ng PC, 2001, GENOME RES, V11, P863, DOI 10.1101/gr.176601; Piel FB, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1104; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Rees DC, 1998, ANN NY ACAD SCI, V850, P334, DOI 10.1111/j.1749-6632.1998.tb10490.x; Reumers J, 2006, BIOINFORMATICS, V22, P2183, DOI 10.1093/bioinformatics/btl348; Rousseau F, 2006, CURR OPIN STRUC BIOL, V16, P118, DOI 10.1016/j.sbi.2006.01.011; Savas S, 2004, CANCER EPIDEM BIOMAR, V13, P801; Sherry ST, 1999, GENOME RES, V9, P677; Venselaar H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-548; Wang Z, 2001, HUM MUTAT, V17, P263, DOI 10.1002/humu.22; Weatherall D.J., 2001, THALASSAEMIA SYNDROM, Vfourth; Xi T, 2004, GENOMICS, V83, P970, DOI 10.1016/j.ygeno.2003.12.016	40	34	36	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25876	10.1371/journal.pone.0025876	http://dx.doi.org/10.1371/journal.pone.0025876			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028795	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800010
J	Bonazzi, VF; Nancarrow, DJ; Stark, MS; Moser, RJ; Boyle, GM; Aoude, LG; Schmidt, C; Hayward, NK				Bonazzi, Vanessa F.; Nancarrow, Derek J.; Stark, Mitchell S.; Moser, Ralf J.; Boyle, Glen M.; Aoude, Lauren G.; Schmidt, Christopher; Hayward, Nicholas K.			Cross-Platform Array Screening Identifies COL1A2, THBS1, TNFRSF10D and UCHL1 as Genes Frequently Silenced by Methylation in Melanoma	PLOS ONE			English	Article							EXPRESSION PROFILING REVEALS; DNA METHYLATION; PROMOTER METHYLATION; TUMOR-SUPPRESSOR; ABERRANT METHYLATION; PGP9.5 METHYLATION; PROGNOSTIC-FACTOR; DECOY RECEPTORS; POOR-PROGNOSIS; MULTIPLE GENES	Epigenetic regulation of tumor suppressor genes (TSGs) has been shown to play a central role in melanomagenesis. By integrating gene expression and methylation array analysis we identified novel candidate genes frequently methylated in melanoma. We validated the methylation status of the most promising genes using highly sensitive Sequenom Epityper assays in a large panel of melanoma cell lines and resected melanomas, and compared the findings with those from cultured melanocytes. We found transcript levels of UCHL1, COL1A2, THBS1 and TNFRSF10D were inversely correlated with promoter methylation. For THBS1 and UCHL1 the effect of this methylation on expression was confirmed at the protein level. Identification of these candidate TSGs and future research designed to understand how their silencing is related to melanoma development will increase our understanding of the etiology of this cancer and may provide tools for its early diagnosis.	[Bonazzi, Vanessa F.; Nancarrow, Derek J.; Stark, Mitchell S.; Aoude, Lauren G.; Hayward, Nicholas K.] Queensland Inst Med Res, Oncogenom Lab, Brisbane, Qld 4006, Australia; [Moser, Ralf J.] Queensland Inst Med Res, SEQUENOM, Asia Pacific Off, Brisbane, Qld 4006, Australia; [Boyle, Glen M.] Queensland Inst Med Res, Drug Discovery Grp, Brisbane, Qld 4006, Australia; [Schmidt, Christopher] Queensland Inst Med Res, Canc Immunotherapy Grp, Brisbane, Qld 4006, Australia	QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute; QIMR Berghofer Medical Research Institute	Bonazzi, VF (corresponding author), Queensland Inst Med Res, Oncogenom Lab, Brisbane, Qld 4006, Australia.	vanessa.bonazzi@qimr.edu.au	hayward, nick/AAV-8802-2020; hayward, nicholas k/C-1367-2015; Stark, Mitchell S/E-3542-2010; Schmidt, Christopher W/A-4353-2009; Stark, Mitchell/K-6794-2019; Boyle, Glen/G-1347-2013; Bonazzi, Vanessa F/R-1676-2018; Aoude, Lauren/C-7484-2014; Stark, Mitchell/K-3874-2019	hayward, nicholas k/0000-0003-4760-1033; Stark, Mitchell S/0000-0002-4510-2161; Schmidt, Christopher W/0000-0002-3955-5076; Stark, Mitchell/0000-0002-4510-2161; Boyle, Glen/0000-0002-1385-529X; Bonazzi, Vanessa F/0000-0002-2574-0334; Aoude, Lauren/0000-0003-1448-3923; 	Cure Cancer Australia [552466]; National Health and Medical Research Council of Australia [442919]	Cure Cancer Australia; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This study was funded by Cure Cancer Australia, grant number 552466. NKH is a recipient of a Senior Principal Research Fellowship from the National Health and Medical Research Council of Australia, grant number 442919. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderton JA, 2008, NEURO-ONCOLOGY, V10, P981, DOI 10.1215/15228517-2008-048; Bauer AP, 2010, NUCLEIC ACIDS RES, V38, P3891, DOI 10.1093/nar/gkq115; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Bonazzi VF, 2009, GENE CHROMOSOME CANC, V48, P10, DOI 10.1002/gcc.20615; Box NF, 2008, PIGM CELL MELANOMA R, V21, P525, DOI 10.1111/j.1755-148X.2008.00495.x; Castellano M, 1997, CANCER RES, V57, P4868; Chiba T, 2005, EUR J CANCER, V41, P1185, DOI 10.1016/j.ejca.2005.02.014; Coolen MW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm662; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrich M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1134; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Gallagher WM, 2005, CARCINOGENESIS, V26, P1856, DOI 10.1093/carcin/bgi152; Ghosh AK, 2004, J BIOL CHEM, V279, P47455, DOI 10.1074/jbc.M403477200; Gonzalez-Gomez P, 2004, INT J MOL MED, V13, P93; Guerrero D, 2008, BJU INT, V102, P747, DOI 10.1111/j.1464-410X.2008.07603.x; Guo W, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/721485; Halaban R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004563; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Isenberg JS, 2009, NAT REV CANCER, V9, P182, DOI 10.1038/nrc2561; Johansson P, 2007, PIGM CELL RES, V20, P216, DOI 10.1111/j.1600-0749.2007.00375.x; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kagara I, 2008, J UROLOGY, V180, P343, DOI 10.1016/j.juro.2008.02.044; Kim JH, 2009, ONCOL REP, V21, P1251, DOI 10.3892/or_00000348; Kim YH, 2006, GENE CHROMOSOME CANC, V45, P781, DOI 10.1002/gcc.20341; Koga Y, 2009, GENOME RES; Lee S, 2004, LAB INVEST, V84, P884, DOI 10.1038/labinvest.3700108; Leonard JH, 2003, PIGM CELL RES, V16, P198, DOI 10.1034/j.1600-0749.2003.00033.x; Li LL, 2010, CLIN CANCER RES, V16, P2949, DOI 10.1158/1078-0432.CCR-09-3178; Liu SH, 2008, PIGM CELL MELANOMA R, V21, P545, DOI 10.1111/j.1755-148X.2008.00484.x; Liu XG, 2005, CANCER RES, V65, P9169, DOI 10.1158/0008-5472.CAN-05-0939; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Loss LA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-305; Mandelker DL, 2005, CANCER RES, V65, P4963, DOI 10.1158/0008-5472.CAN-04-3923; Mizukami H, 2008, ANTICANCER RES, V28, P2697; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Okochi-Takada E, 2006, INT J CANCER, V119, P1338, DOI 10.1002/ijc.22025; Oue N, 2003, ONCOLOGY-BASEL, V64, P423, DOI 10.1159/000070302; Packer LM, 2007, INT J CANCER, V121, P784, DOI 10.1002/ijc.22725; Pavey S, 2004, ONCOGENE, V23, P4060, DOI 10.1038/sj.onc.1207563; Paz MF, 2003, CANCER RES, V63, P1114; Richards HW, 2009, PIGM CELL MELANOMA R, V22, P14, DOI 10.1111/j.1755-148X.2008.00534.x; Rojas A, 2008, INT J CANCER, V123, P14, DOI 10.1002/ijc.23608; Rothhammer T, 2007, PIGM CELL RES, V20, P92, DOI 10.1111/j.1600-0749.2007.00367.x; Schinke C, 2010, MELANOMA RES, V20, P253, DOI 10.1097/CMR.0b013e328338a35a; Sengupta PK, 2003, CANCER RES, V63, P1789; Sheikh MS, 2000, LEUKEMIA, V14, P1509, DOI 10.1038/sj.leu.2401865; Shivapurkar N, 2004, INT J CANCER, V109, P786, DOI 10.1002/ijc.20041; Sjahputera O, 2007, IEEE ACM T COMPUT BI, V4, P176, DOI 10.1109/TCBB.2007.070205; Stark M, 2007, CANCER RES, V67, P2632, DOI 10.1158/0008-5472.CAN-06-4152; Takai D, 2002, P NATL ACAD SCI USA, V99, P3740, DOI 10.1073/pnas.052410099; Tezel E, 2000, CLIN CANCER RES, V6, P4764; Tokumaru Y, 2008, INT J CANCER, V123, P753, DOI 10.1002/ijc.23354; Van der Velden PA, 2003, INT J CANCER, V106, P472, DOI 10.1002/ijc.11262; van Noesel MM, 2002, CANCER RES, V62, P2157; Wang YP, 2005, NEOPLASIA, V7, P748, DOI 10.1593/neo.05289; WEISENBERGER D, 2008, COMPREHENSIVE DNA ME; Yamashita K, 2006, CANCER RES, V66, P3921, DOI 10.1158/0008-5472.CAN-05-1511; Yang QW, 2007, CLIN CANCER RES, V13, P3191, DOI 10.1158/1078-0432.CCR-06-2846; Yang QW, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-286; Yang QW, 2003, CANCER RES, V63, P6299; Yu J, 2008, HEPATOLOGY, V48, P508, DOI 10.1002/hep.22343	63	57	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26121	10.1371/journal.pone.0026121	http://dx.doi.org/10.1371/journal.pone.0026121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028813	gold, Green Published, Green Submitted			2022-12-27	WOS:000296510800018
J	Shah, V; Shah, S; Kambhampati, MS; Ambrose, J; Smith, N; Dowd, SE; McDonnell, KT; Panigrahi, B; Green, T				Shah, Vishal; Shah, Shreya; Kambhampati, Murty S.; Ambrose, Jeffery; Smith, Nyesha; Dowd, Scot E.; McDonnell, Kevin T.; Panigrahi, Bishnu; Green, Timothy			Bacterial and Archaea Community Present in the Pine Barrens Forest of Long Island, NY: Unusually High Percentage of Ammonia Oxidizing Bacteria	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; DIVERSITY; SOIL; PATTERNS	Of the few preserved areas in the northeast of United States, the soil in the Pine Barrens Forests presents a harsh environment for the microorganisms to grow and survive. In the current study we report the use of clustering methods to scientifically select the sampling locations that would represent the entire forest and also report the microbial diversity present in various horizons of the soil. Sixty six sampling locations were selected across the forest and soils were collected from three horizons (sampling depths). The three horizons were 0-10 cm (Horizon O); 11-25 cm (Horizon A) and 26-40 cm (Horizon B). Based on the total microbial substrate utilization pattern and K-means clustering analysis, the soil in the Pine Barrens Forest can be classified into four distinct clusters at each of the three horizons. One soil sample from each of the four clusters were selected and archaeal and bacterial populations within the soil studied using pyrosequencing method. The results show the microbial communities present in each of these clusters are different. Within the microbial communities present, microorganisms involved in nitrogen cycle occupy a major fraction of microbial community in the soil. High level of diversity was observed for nitrogen fixing bacteria. In contrast, Nitrosovibrio and Nitrosocaldus spp are the single bacterial and archaeal population respectively carrying out ammonia oxidation in the soil.	[Shah, Vishal; Shah, Shreya; Panigrahi, Bishnu] Dowling Coll, Dept Biol, Oakdale, NY USA; [Kambhampati, Murty S.; Ambrose, Jeffery; Smith, Nyesha] So Univ New Orleans, Dept Biol, New Orleans, LA USA; [Dowd, Scot E.] Res & Testing Lab, Lubbock, TX USA; [McDonnell, Kevin T.] Dowling Coll, Dept Math & Comp Sci, Oakdale, NY USA; [Green, Timothy] Brookhaven Natl Lab, Upton, NY 11973 USA	Southern University System; Southern University New Orleans; United States Department of Energy (DOE); Brookhaven National Laboratory	Shah, V (corresponding author), Dowling Coll, Dept Biol, Oakdale, NY USA.	ShahV@dowling.edu	Dowd, Scot E/M-5386-2017; Shah, Shreya/HDN-1499-2022	Dowd, Scot E/0000-0002-6296-1427; 	Dowling College; Foundation for Ecological Research in the Northeast; National Science Foundation [HRD-0102620]; Department of Education (DOE) [MSEIP - P120A050086]; DOE Faculty and Student Teams	Dowling College; Foundation for Ecological Research in the Northeast; National Science Foundation(National Science Foundation (NSF)); Department of Education (DOE)(United States Department of Energy (DOE)); DOE Faculty and Student Teams(United States Department of Energy (DOE))	VS thanks Dowling College and Foundation for Ecological Research in the Northeast for the research funding. JA, NS and MK were supported by National Science Foundation (HRD-0102620), Department of Education (DOE) (MSEIP - P120A050086) grants and 2008 DOE Faculty and Student Teams program. KM received support from Dowling College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldenderfer MS., 1984, CLUSTER ANAL; Batcher MS, 2006, MONITORING PROTOCOLS; Boyd HP., 1991, FIELD GUIDE PINE BAR; Callaway TR, 2010, J ANIM SCI, V88, P3977, DOI 10.2527/jas.2010-2900; CHEPLICK GP, 1987, OECOLOGIA, V73, P459, DOI 10.1007/BF00385265; Dillner AM, 2005, ATMOS ENVIRON, V39, P1525, DOI 10.1016/j.atmosenv.2004.11.035; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Francis CA, 2007, ISME J, V1, P19, DOI 10.1038/ismej.2007.8; Garland JL, 1996, SOIL BIOL BIOCHEM, V28, P213, DOI 10.1016/0038-0717(95)00112-3; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Guillen G, 2004, J MARINE SYST, V45, P221, DOI 10.1016/j.jmarsys.2003.11.006; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; He J, 2007, ENVIRON MICROBIOL, V9, P2364, DOI 10.1111/j.1462-2920.2007.01358.x; Hill GT, 2000, APPL SOIL ECOL, V15, P25, DOI 10.1016/S0929-1393(00)00069-X; Joffe JS, 1933, SOIL SCI, V35, P313, DOI 10.1097/00010694-193304000-00007; Kumar N, 2011, PERTURBATION ARCTIC, DOI DOI 10.1016/J.JHAZMAT.2011.04.005; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Markley M. L., 1998, Pine barrens: ecosystem and landscape., P81; McCormick J, 1998, PINE BARRENS ECOSYST, pxxi; Pampulha ME, 2007, J BASIC MICROB, V47, P325, DOI 10.1002/jobm.200610274; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith DM, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-41; Yao B, 2011, INFLUENCE AMMONIUM N, DOI [10.1093/jpe/rtq033, DOI 10.1093/JPE/RTQ033]	27	20	20	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26263	10.1371/journal.pone.0026263	http://dx.doi.org/10.1371/journal.pone.0026263			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028845	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800033
J	Simpson, CR; Buckley, BS; McLernon, DJ; Sheikh, A; Murphy, A; Hannaford, PC				Simpson, Colin R.; Buckley, Brian S.; McLernon, David J.; Sheikh, Aziz; Murphy, Andrew; Hannaford, Philip C.			Five-Year Prognosis in an Incident Cohort of People Presenting with Acute Myocardial Infarction	PLOS ONE			English	Article							GENERAL-PRACTICE; HEART-FAILURE; PRIMARY-CARE; POPULATION; TERM; SURVIVAL; MANAGEMENT; MORTALITY; SCOTLAND; OUTCOMES	Background: Following an AMI, it is important for patients and their physicians to appreciate the subsequent risk of death, and the potential benefits of invasive cardiac procedures and secondary preventive therapy. Studies, to-date, have focused largely on high-risk populations. We wished to determine the risk of death in a population-derived cohort of 2,887 patients after a first acute myocardial infarction (AMI). Methods: Logistic regression and survival analysis were conducted to investigate the effect of different baseline characteristics, pharmacological therapies and revascularization procedures on coronary heart disease (CHD) and all-cause mortality outcomes. Results: Within five years 44.4% of patients died (27.1% short-term [<30 days] and 23.7% longer-term [>= 30 days]). Percutaneous transluminal coronary angioplasty (Adjusted Hazards Ratio (AHR) = 0.49, 95% Confidence Interval (CI) 0.26-0.93), beta-blockers (AHR = 0.58, 95% CI 0.46-0.74) and statins (AHR = 0.60, 95% CI 0.47-0.77) were all associated with significant reductions in longer-term CHD-related mortality. However, not all patients received secondary preventive therapy (8.7%). Diabetes (AHR = 1.83, 95% CI 1.43-2.34), stroke (AHR = 1.73, 95% CI 1.35-2.22), heart failure (AHR = 1.69, 95% CI 1.28-2.22), smoking (AHR = 1.72, 95% CI 1.18-2.51) and obesity (>30 kg/m(2); AHR = 1.39, 95% CI 1.01-1.90) increased the risk of longer-term mortality independent of other risk factors. Conclusions: It is encouraging that the coronary procedure PTCA and pharmacological secondary prevention therapies were found to be strongly associated with an important reduced risk of subsequent death, although not all patients received these interventions. Smoking, being obese and having cardiovascular related disease at baseline were also associated with an increased likelihood of longer-term mortality, independent of other baseline characteristics. Thus, the provision of smoking cessation, advice on diet (for obese patients) and optimal treatment is likely to be crucial for reducing mortality in all patients after AMI.	[Simpson, Colin R.; Sheikh, Aziz] Univ Edinburgh, Sch Med, eHlth Res Grp, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Buckley, Brian S.; Murphy, Andrew] Natl Univ Ireland, Dept Gen Practice, Galway, Ireland; [McLernon, David J.] Univ Aberdeen, Med Stat Team, Sect Populat Hlth, Aberdeen, Scotland; [Hannaford, Philip C.] Univ Aberdeen, Ctr Acad Primary Care, Aberdeen, Scotland	University of Edinburgh; Ollscoil na Gaillimhe-University of Galway; University of Aberdeen; University of Aberdeen	Simpson, CR (corresponding author), Univ Edinburgh, Sch Med, eHlth Res Grp, Ctr Populat Hlth Sci, Teviot Pl, Edinburgh, Midlothian, Scotland.	c.simpson@ed.ac.uk	Hannaford, Philip C/B-7867-2012; Sheikh, Aziz/D-2818-2009; Simpson, Colin/I-3974-2019; Simpson, Colin R/L-7180-2014; McLernon, David/D-5167-2012	Sheikh, Aziz/0000-0001-7022-3056; Simpson, Colin/0000-0002-5194-8083; Simpson, Colin R/0000-0002-5194-8083; McLernon, David/0000-0001-8905-2429; Buckley, Brian/0000-0002-6007-9238; Murphy, Andrew/0000-0001-5549-8246	Chief Scientist Office of the Scottish Government [PDF/08/02]; Chief Scientist Office [PDF/08/02] Funding Source: researchfish	Chief Scientist Office of the Scottish Government; Chief Scientist Office	Colin Simpson was supported by a health services and health of the public post-doctoral fellowship from the Chief Scientist Office of the Scottish Government [PDF/08/02]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Mallah MH, 2006, J AM COLL CARDIOL, V47, P1576, DOI 10.1016/j.jacc.2005.11.073; ALTMAN R, 1994, BMJ-BRIT MED J, V308, P81, DOI 10.1136/bmj.308.6921.81; BARBASH GI, 1993, CIRCULATION, V87, P53, DOI 10.1161/01.CIR.87.1.53; Botkin NF, 2006, AM HEART J, V151, P199, DOI 10.1016/j.ahj.2005.03.016; Buckley B, 2009, BRIT MED J, V339, P438; Capewell S, 2006, HEART, V92, P1563, DOI 10.1136/hrt.2005.085399; Chugh SS, 2008, PROG CARDIOVASC DIS, V51, P213, DOI 10.1016/j.pcad.2008.06.003; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Glynn LG, 2008, BRIT J GEN PRACT, V58, P488, DOI 10.3399/bjgp08X319459; Goodman SG, 2009, AM HEART J, V158, P193, DOI 10.1016/j.ahj.2009.06.003; Harley K, 1996, Health Bull (Edinb), V54, P410; Jhund PS, 2009, CIRCULATION, V119, P515, DOI 10.1161/CIRCULATIONAHA.108.812172; LEHTO S, 1994, J INTERN MED, V236, P291, DOI 10.1111/j.1365-2796.1994.tb00799.x; Lundberg V, 1997, J INTERN MED, V241, P485; Mant J, 2006, BMJ-BRIT MED J, V332, P635, DOI 10.1136/bmj.38758.600116.AE; McAlister FA, 2004, BMJ-BRIT MED J, V328, P1110, DOI 10.1136/bmj.38043.414074.EE; Mueller-Nordhorn J, 2008, EUR HEART J, V29, P1316, DOI 10.1093/eurheartj/ehm604; Rosvall M, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-44; Setoguchi S, 2008, AM J CARDIOL, V101, P1531, DOI 10.1016/j.amjcard.2008.02.033; Tonne C, 2005, CIRCULATION, V111, P3063, DOI 10.1161/CIRCULATIONAHA.104.496174; Whitelaw FG, 1996, BRIT J GEN PRACT, V46, P181; [Writing Group Members Heart Disease and Stroke Statistics-2009 Update], 2011, CIRCULATION, V123, pe18	22	30	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26573	10.1371/journal.pone.0026573	http://dx.doi.org/10.1371/journal.pone.0026573			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028911	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800056
J	Dorji, S; Vernes, K; Rajaratnam, R				Dorji, Sangay; Vernes, Karl; Rajaratnam, Rajanathan			Habitat Correlates of the Red Panda in the Temperate Forests of Bhutan	PLOS ONE			English	Article							AILURUS-FULGENS; SHIFTING CULTIVATION; WOLONG RESERVE; NATIONAL-PARK; CONSERVATION; GIANT; BIODIVERSITY; REGENERATION; SEPARATION; ECOLOGY	Anthropogenic activities and associated global climate change are threatening the biodiversity in the Himalayas against a backdrop of poor knowledge of the region's threatened species. The red panda (Ailurus fulgens) is a threatened mammal confined to the eastern Himalayas, and because of Bhutan's central location in the distributional range of red pandas, its forests are integral to the long-term viability of wild populations. Detailed habitat requirements of the red panda are largely speculative, and there is virtually no ecological information available on this species in Bhutan. Between 2007 and 2009, we established 615 presence/absence plots in a systematic sampling of resident habitat types within Jigme Dorji and Thrumshingla National Parks, Bhutan, to investigate broad and fine-scale red panda habitat associations. Additional locality records of red pandas were obtained from interviewing 664 park residents. Red pandas were generally confined to cool broadleaf and conifer forests from 2,110-4,389 m above sea level (asl), with the majority of records between 2,400-3,700 m asl on south and east-facing slopes. At a finer scale, multivariate analysis revealed that red pandas were strongly associated with old growth Bhutan Fir (Abies densa) forest dominated by a dense cover of Yushania and Arundanaria bamboo with a high density of fallen logs and tree stumps at ground level; a high density of trees, dead snags, and rhododendron shrubs in the mid-storey; and locations that were close to water. Because Bhutan's temperate forests that encompass prime red panda habitat are also integral to human subsistence and socio-economic development, there exists an inadvertent conflict between the needs of people and red pandas. As such, careful sustainable management of Bhutan's temperate forests is necessary if a balance is to be met between the socioeconomic needs of people and the conservation goals for red pandas.	[Dorji, Sangay; Vernes, Karl; Rajaratnam, Rajanathan] Univ New England, Armidale, NSW, Australia	University of New England		kvernes@une.edu.au	Rajaratnam, Rajanathan/U-8690-2019; Vernes, Karl/A-2925-2011; Rajaratnam, Rajanathan/K-2445-2016	Rajaratnam, Rajanathan/0000-0002-5932-7935; Vernes, Karl/0000-0003-1635-9950; Rajaratnam, Rajanathan/0000-0002-5932-7935; Dorji, Sangay/0000-0002-5078-7118	WWF-Bhutan [BU72]; Ugyen Wangchuck Institute of Environmental Conservation, Bhutan; Rotterdam Zoo; WWF [9Z0533.01]; Columbus Zoological Park Association Inc.; University of New England	WWF-Bhutan; Ugyen Wangchuck Institute of Environmental Conservation, Bhutan; Rotterdam Zoo; WWF; Columbus Zoological Park Association Inc.; University of New England	SD was awarded a CEPF (Critical Ecosystem Partnership Fund) Small Grant from WWF-Bhutan (Agreement # BU72) (URL: www.wwfbhutan.org/), and grants from the Ugyen Wangchuck Institute of Environmental Conservation, Bhutan (www.uwice.gov.bt/), and Rotterdam Zoo (www.rotterdamzoo.nl/) to assist with field research and living costs. SD also received a WWF Prince Bernhard Scholarship (Grant Number 9Z0533.01) (URL: www.panda.org) and a grant from the Columbus Zoological Park Association Inc. (www.colszoo.org/) to assist with living costs while writing and analysing data in Australia. A University of New England Research Scholarship (www.une.edu.au) awarded to SD covered tuition fees at the University of New England. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahuguna C.C., 1998, Small Carnivore Conservation, V19, P11; Bhattari S., 2005, ECOSYSTEM PROFILE E, P1; Choudhury A, 2001, ORYX, V35, P250, DOI 10.1046/j.1365-3008.2001.00181.x; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; CURTIS JT, 1971, VEGETATION WISCONSIN; Darabant A, 2007, FOREST ECOL MANAG, V252, P73, DOI 10.1016/j.foreco.2007.06.018; *DEP FOR PARK SERV, 1998, CONS MAN PLAN JIGM D; *DEP FOR PARK SERV, 2008, CONS MAN PLAN THRUMS; Dorjee K., 2014, BHUTAN J RES DEV, V3, P87; DORJI S, ORYX IN PRESS; GITTLEMAN JL, 1988, ETHOLOGY, V79, P13; Glatston A.R, 1994, STATUS SURVEY CONSER; Gratzer G, 1999, CAN J FOREST RES, V29, P1518, DOI 10.1139/cjfr-29-10-1518; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Gyamtsho P., 2000, J BHUTAN STUDIES, V2, P86; Hu J.C., 2004, B BIOL, V39, P7, DOI [10.3969/j.issn.0006-3193.2004.09.003, DOI 10.3969/J.ISSN.0006-3193.2004.09.003]; JOHNSON KG, 1988, J MAMMAL, V69, P552, DOI 10.2307/1381347; Mahato N. K., 2004, Tigerpaper, V31, P7; Mahato N. K., 2005, NEPAL J FORESTRY, V12, P32; MESSERCHMIDT D, 2001, KATHMANDU; MOKTAN MR, 2004, P WORKSH FOR POV RED, P101; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Namgyel U, 2008, CONSERV BIOL, V22, P1349, DOI 10.1111/j.1523-1739.2008.01019.x; OLSON DM, 1998, ANN MISSOURI BOT GAR, V89, P199; Pradhan S, 2001, BIOL CONSERV, V98, P11, DOI 10.1016/S0006-3207(00)00079-3; Pradhan Sunita, 2001, Journal of the Bombay Natural History Society, V98, P224; REID DG, 1991, J ZOOL, V225, P347, DOI 10.1111/j.1469-7998.1991.tb03821.x; Roder W, 2002, MT RES DEV, V22, P368, DOI 10.1659/0276-4741(2002)022[0368:CGITCF]2.0.CO;2; RODER W, 1992, AGROFOREST SYST, V19, P149, DOI 10.1007/BF00138505; *ROYAL GOV BHUT, 2000, REN NAT RES CENS REP; SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0; Stattersfield A.J., 1998, ENDEMIC BIRD AREAS W, V115, P1089, DOI 10.2307/4089533; Vernes K, 2003, AUSTRAL ECOL, V28, P471, DOI 10.1046/j.1442-9993.2003.01303.x; Wangda P, 2006, FOREST ECOL MANAG, V230, P136, DOI 10.1016/j.foreco.2006.04.027; Wei F, 1999, MAMMALIA, V63, P417, DOI 10.1515/mamm.1999.63.4.417; Wei F, 1999, MAMMALIA, V63, P3, DOI 10.1515/mamm.1999.63.1.3; Wei FW, 1999, BIOL CONSERV, V89, P285, DOI 10.1016/S0006-3207(98)00156-6; Wei FW, 2000, J MAMMAL, V81, P448, DOI 10.1644/1545-1542(2000)081<0448:HUASBT>2.0.CO;2; Williams BH., 2003, CONSERV BIOL ASIA, V16, P236; Xu JC, 2009, CONSERV BIOL, V23, P520, DOI 10.1111/j.1523-1739.2009.01237.x; YONZON P, 1991, AMBIO, V20, P285; YONZON PB, 1991, BIOL CONSERV, V57, P1, DOI 10.1016/0006-3207(91)90104-H; Zar J.H., 2010, BIOSTAT ANAL; Zhang ZJ, 2009, ACTA THERIOL, V54, P225, DOI 10.4098/j.at.0001-7051.017.2008; Zhang ZJ, 2006, J WILDLIFE MANAGE, V70, P231, DOI 10.2193/0022-541X(2006)70[231:WMSBGA]2.0.CO;2; Zhou Ben-zhi, 2005, Journal of Forestry Research (Harbin), V16, P143, DOI 10.1007/BF02857909; [No title captured]	47	28	39	3	116	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26483	10.1371/journal.pone.0026483	http://dx.doi.org/10.1371/journal.pone.0026483			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039497	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500075
J	Geiger, K; Leiherer, A; Muendlein, A; Stark, N; Geller-Rhomberg, S; Saely, CH; Wabitsch, M; Fraunberger, P; Drexel, H				Geiger, Kathrin; Leiherer, Andreas; Muendlein, Axel; Stark, Nicole; Geller-Rhomberg, Simone; Saely, Christoph H.; Wabitsch, Martin; Fraunberger, Peter; Drexel, Heinz			Identification of Hypoxia-Induced Genes in Human SGBS Adipocytes by Microarray Analysis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR 1-ALPHA; FOXO TRANSCRIPTION FACTORS; ADIPOSE-TISSUE HYPOXIA; PAS DOMAIN PROTEIN-1; MACROPHAGE INFILTRATION; WD-REPEAT; EXPRESSION; ADRENOMEDULLIN; OBESITY	Hypoxia in adipose tissue is suggested to be involved in the development of a chronic mild inflammation, which in obesity can further lead to insulin resistance. The effect of hypoxia on gene expression in adipocytes appears to play a central role in this inflammatory response observed in obesity. However, the global impact of hypoxia on transcriptional changes in human adipocytes is unclear. Therefore, we compared gene expression profiles of human Simpson-Golabi-Behmel syndrome (SGBS) adipocytes under normoxic or hypoxic conditions to detect hypoxia-responsive genes in adipocytes by using whole human genome microarrays. Microarray analysis showed more than 500 significantly differentially regulated mRNAs after incubation of the cells under low oxygen levels. To gain further insight into the biological processes, hypoxia-regulated genes after 16 hours of hypoxia were classified according to their function. We identified an enrichment of genes involved in important biological processes such as glycolysis, response to hypoxia, regulation of cellular component movement, response to nutrient levels, regulation of cell migration, and transcription regulator activity. Real-time PCR confirmed eight genes to be consistently upregulated in response to 3, 6 and 16 hours of hypoxia. For adipocytes the hypoxia-induced regulation of these genes is shown here for the first time. Moreover in six of these eight genes we identified HIF response elements in the proximal promoters, specific for the HIF transcription factor family members HIF1A and HIF2A. In the present study, we demonstrated that hypoxia has an extensive effect on gene expression of SGBS adipocytes. In addition, the identified hypoxia-regulated genes are likely involved in the regulation of obesity, the incidence of type 2 diabetes, and the metabolic syndrome.	[Geiger, Kathrin; Leiherer, Andreas; Muendlein, Axel; Stark, Nicole; Geller-Rhomberg, Simone; Saely, Christoph H.; Drexel, Heinz] VIVIT, Feldkirch, Austria; [Saely, Christoph H.; Drexel, Heinz] Acad Teaching Hosp Feldkirch, Dept Med & Cardiol, Feldkirch, Austria; [Geiger, Kathrin; Leiherer, Andreas; Muendlein, Axel; Stark, Nicole; Geller-Rhomberg, Simone; Saely, Christoph H.; Drexel, Heinz] Private Univ Principal Liechtenstein, Triesen, Liechtenstein; [Wabitsch, Martin] Univ Ulm, Div Pediat Endocrinol & Diabet, Ulm, Germany; [Leiherer, Andreas; Fraunberger, Peter] Med Cent Labs, Feldkirch, Austria; [Drexel, Heinz] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA	Ulm University; Drexel University	Geiger, K (corresponding author), VIVIT, Feldkirch, Austria.	vivit@lkhf.at	Muendlein, Axel/AAS-5313-2021; Leiherer, Andreas/X-5539-2019	Leiherer, Andreas/0000-0003-3776-5704; Muendlein, Axel/0000-0002-5582-4125	Austrian Science Fund (FWF) [21057]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (FWF, Project 21057). The funding institution had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benita Y, 2009, NUCLEIC ACIDS RES, V37, P4587, DOI 10.1093/nar/gkp425; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boeckle S, 2002, VIROLOGY, V293, P103, DOI 10.1006/viro.2001.1231; Bouloumie A, 1998, CIRC RES, V83, P1059, DOI 10.1161/01.RES.83.10.1059; Bunton DC, 2004, PHARMACOL THERAPEUT, V103, P179, DOI 10.1016/j.pharmthera.2004.07.002; Cancello R, 2005, DIABETES, V54, P2277, DOI 10.2337/diabetes.54.8.2277; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Cormier-Regard S, 1998, J BIOL CHEM, V273, P17787, DOI 10.1074/jbc.273.28.17787; Fain JN, 2004, ENDOCRINOLOGY, V145, P2273, DOI 10.1210/en.2003-1336; Fain JN, 2006, VITAM HORM, V74, P443, DOI 10.1016/S0083-6729(06)74018-3; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Fleischmann E, 2005, OBES SURG, V15, P813, DOI 10.1381/0960892054222867; Foldager CB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-94; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Fruhbeck Gema, 2008, V456, P1, DOI 10.1007/978-1-59745-245-8_1; Furukawa-Hibi Y, 2005, ANTIOXID REDOX SIGN, V7, P752, DOI 10.1089/ars.2005.7.752; Garayoa M, 2000, MOL ENDOCRINOL, V14, P848, DOI 10.1210/me.14.6.848; Gardner LB, 2008, CELL CYCLE, V7, P1916, DOI 10.4161/cc.7.13.6203; Geiger K, 2011, HORM METAB RES, V43, P380, DOI 10.1055/s-0031-1273767; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Halberg N, 2008, ENDOCRIN METAB CLIN, V37, P753, DOI 10.1016/j.ecl.2008.07.002; Halberg N, 2009, MOL CELL BIOL, V29, P4467, DOI 10.1128/MCB.00192-09; Harmancey R, 2007, DIABETES, V56, P553, DOI 10.2337/db06-0857; He Y, 2009, SCIENCE, V325, P866, DOI 10.1126/science.1174443; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Inagaki T, 2009, GENES CELLS, V14, P991, DOI 10.1111/j.1365-2443.2009.01326.x; Isner JM, 1998, AM J CARDIOL, V82, p63S, DOI 10.1016/S0002-9149(98)00764-4; Jeninga EH, 2009, J BIOL CHEM, V284, P26385, DOI 10.1074/jbc.M109.040741; Jin HO, 2007, CELL SIGNAL, V19, P1393, DOI 10.1016/j.cellsig.2006.12.014; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Kinoshita H, 2000, DIABETES CARE, V23, P253, DOI 10.2337/diacare.23.2.253; Kitamuro T, 2000, J NEUROCHEM, V75, P1826, DOI 10.1046/j.1471-4159.2000.0751826.x; Lahnalampi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012991; Le Jan S, 2003, AM J PATHOL, V162, P1521, DOI 10.1016/S0002-9440(10)64285-X; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Liu Y, 2010, GENES CELLS, V15, P315, DOI 10.1111/j.1365-2443.2010.01381.x; Lolmede K, 2003, INT J OBESITY, V27, P1187, DOI 10.1038/sj.ijo.0802407; Marfella R, 2004, DIABETES, V53, P2383, DOI 10.2337/diabetes.53.9.2383; Minchenko O, 2004, FEBS LETT, V576, P14, DOI 10.1016/j.febslet.2004.08.053; Miyazaki K, 2002, J BIOL CHEM, V277, P47014, DOI 10.1074/jbc.M204938200; Miyazawa-Hoshimoto S, 2003, DIABETOLOGIA, V46, P1483, DOI 10.1007/s00125-003-1221-6; Murat A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005947; Nagata D, 1999, KIDNEY INT, V55, P1259, DOI 10.1046/j.1523-1755.1999.00361.x; Nakayama M, 2000, EUR J BIOCHEM, V267, P3559, DOI 10.1046/j.1432-1327.2000.01384.x; Nakayama M, 1998, BIOCHEM BIOPH RES CO, V243, P514, DOI 10.1006/bbrc.1998.8131; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Okar DA, 2004, ADV ENZYME REGUL, V44, P123, DOI 10.1016/j.advenzreg.2003.11.006; Onita T, 2002, CLIN CANCER RES, V8, P471; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pollard PJ, 2008, BIOCHEM J, V416, P387, DOI 10.1042/BJ20081238; Rausch ME, 2008, INT J OBESITY, V32, P451, DOI 10.1038/sj.ijo.0803744; Regazzetti C, 2010, J BIOL CHEM, V285, P5157, DOI 10.1074/jbc.M109.047688; Rocha S, 2007, TRENDS BIOCHEM SCI, V32, P389, DOI 10.1016/j.tibs.2007.06.005; Rohwer N, 2008, CANCER RES, V68, P10113, DOI 10.1158/0008-5472.CAN-08-1839; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosenow A, 2010, J PROTEOME RES, V9, P5389, DOI 10.1021/pr100621g; Sanchez-Elsner T, 2001, J BIOL CHEM, V276, P38527, DOI 10.1074/jbc.M104536200; Sar A, 2009, CELL TISSUE RES, V337, P223, DOI 10.1007/s00441-009-0805-y; Schmidt SF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-152; Semenza GL, 2000, CANCER METAST REV, V19, P59, DOI 10.1023/A:1026544214667; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Shen GM, 2010, FEBS LETT, V584, P4366, DOI 10.1016/j.febslet.2010.09.040; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Sierra-Honigmann MR, 1998, SCIENCE, V281, P1683, DOI 10.1126/science.281.5383.1683; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Srivastava RK, 2010, MOL CELL BIOCHEM, V337, P201, DOI 10.1007/s11010-009-0300-5; Tang TTL, 2003, J BIOL CHEM, V278, P30125, DOI 10.1074/jbc.M302042200; Tateishi K, 2009, NATURE, V458, P757, DOI 10.1038/nature07777; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Trayhurn P, 2001, P NUTR SOC, V60, P329, DOI 10.1079/PNS200194; Tsukahara T, 2009, CANCER SCI, V100, P47, DOI 10.1111/j.1349-7006.2008.00991.x; Vadivel A, 2010, AM J RESP CELL MOL, V43, P152, DOI 10.1165/rcmb.2009-0004OC; Verstraeten VLRM, 2011, HISTOCHEM CELL BIOL, V135, P251, DOI 10.1007/s00418-011-0792-4; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; Wang B, 2007, PFLUG ARCH EUR J PHY, V455, P479, DOI 10.1007/s00424-007-0301-8; Wellmann S, 2008, BIOCHEM BIOPH RES CO, V372, P892, DOI 10.1016/j.bbrc.2008.05.150; Wiesener MS, 1998, BLOOD, V92, P2260, DOI 10.1182/blood.V92.7.2260.2260_2260_2268; Wood IS, 2009, P NUTR SOC, V68, P370, DOI 10.1017/S0029665109990206; Wozniak SE, 2009, DIGEST DIS SCI, V54, P1847, DOI 10.1007/s10620-008-0585-3; Wu Z., 2004, DEP BIOSTATISTICS WO; Xia GB, 2001, CANCER-AM CANCER SOC, V91, P1429, DOI 10.1002/1097-0142(20010415)91:8<1429::AID-CNCR1149>3.0.CO;2-V; Yamada N, 2005, J CLIN ENDOCR METAB, V90, P5841, DOI 10.1210/jc.2005-0991; Ye JP, 2007, AM J PHYSIOL-ENDOC M, V293, pE1118, DOI 10.1152/ajpendo.00435.2007	83	43	43	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26465	10.1371/journal.pone.0026465	http://dx.doi.org/10.1371/journal.pone.0026465			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039494	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500072
J	Kahr, PC; Piccini, I; Fabritz, L; Greber, B; Scholer, H; Scheld, HH; Hoffmeier, A; Brown, NA; Kirchhof, P				Kahr, Peter C.; Piccini, Ilaria; Fabritz, Larissa; Greber, Boris; Schoeler, Hans; Scheld, Hans H.; Hoffmeier, Andreas; Brown, Nigel A.; Kirchhof, Paulus			Systematic Analysis of Gene Expression Differences between Left and Right Atria in Different Mouse Strains and in Human Atrial Tissue	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; FIBRILLATION; PROTEIN; PERSISTENT; MANAGEMENT; GRADIENTS; VARIANTS; RISK	Background: Normal development of the atria requires left-right differentiation during embryonic development. Reduced expression of Pitx2c (paired-like homeodomain transcription factor 2, isoform c), a key regulator of left-right asymmetry, has recently been linked to atrial fibrillation. We therefore systematically studied the molecular composition of left and right atrial tissue in adult murine and human atria. Methods: We compared left and right atrial gene expression in healthy, adult mice of different strains and ages by employing whole genome array analyses on freshly frozen atrial tissue. Selected genes with enriched expression in either atrium were validated by RT-qPCR and Western blot in further animals and in shock-frozen left and right atrial appendages of patients undergoing open heart surgery. Results: We identified 77 genes with preferential expression in one atrium that were common in all strains and age groups analysed. Independent of strain and age, Pitx2c was the gene with the highest enrichment in left atrium, while Bmp10, a member of the TGF beta family, showed highest enrichment in right atrium. These differences were validated by RT-qPCR in murine and human tissue. Western blot showed a 2-fold left-right concentration gradient in PITX2 protein in adult human atria. Several of the genes and gene groups enriched in left atria have a known biological role for maintenance of healthy physiology, specifically the prevention of atrial pathologies involved in atrial fibrillation, including membrane electrophysiology, metabolic cellular function, and regulation of inflammatory processes. Comparison of the array datasets with published array analyses in heterozygous Pitx2c(+/-) atria suggested that approximately half of the genes with left-sided enrichment are regulated by Pitx2c. Conclusions: Our study reveals systematic differences between left and right atrial gene expression and supports the hypothesis that Pitx2c has a functional role in maintaining "leftness" in the atrium in adult murine and human hearts.	[Kahr, Peter C.; Piccini, Ilaria; Fabritz, Larissa; Kirchhof, Paulus] Univ Hosp Munster, Dept Cardiol & Angiol, Munster, Germany; [Kahr, Peter C.; Brown, Nigel A.] St Georges Univ London, Div Biomed Sci, London, England; [Greber, Boris; Schoeler, Hans] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Munster, Germany; [Scheld, Hans H.; Hoffmeier, Andreas] Univ Hosp Munster, Dept Thorac & Cardiovasc Surg, Munster, Germany	University of Munster; St Georges University London; Max Planck Society; University of Munster	Kahr, PC (corresponding author), Univ Hosp Munster, Dept Cardiol & Angiol, Munster, Germany.	p.kirchhof@bham.ac.uk	, HS/AAB-4434-2019; Kirchhof, Paulus/AAT-7074-2021; Stefanadis, Christodoulos/ABH-2232-2020	, HS/0000-0003-2643-5136; Kirchhof, Paulus/0000-0002-1881-0197; Fabritz, Larissa/0000-0002-9241-1733; Stefanadis, Christodoulos/0000-0001-5974-6454; Greber, Boris/0000-0002-9404-7293	Fondation Leducq (ENAFRA); European Union (EUTRAF); Deutsche Forschungsgemeinschaft (DFG) [Fa 413/3-1, C247ACACA56F91B179F7F8456E22B886, 72005176]; Collaborative Research Center (Sonderforschungsbereich) MoBil [SFB 656-A8]	Fondation Leducq (ENAFRA)(Leducq Foundation); European Union (EUTRAF)(European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Collaborative Research Center (Sonderforschungsbereich) MoBil(German Research Foundation (DFG))	This work was supported by Fondation Leducq (ENAFRA, http://www.fondationleducq.org, to PK) and by the European Union (EUTRAF, (http://www.eutraf.eu/, to PK and NB), as well as by Deutsche Forschungsgemeinschaft (DFG, Fa 413/3-1, http://gepris.dfg.de/gepris/OCTOPUS/; jsessionid=C247ACACA56F91B179F7F8456E22B886? module=gepris&task=showDetail&context=projekt&id=72005176, to LF, and Collaborative Research Center (Sonderforschungsbereich) MoBil, SFB 656-A8, http://www.uni-muenster.de/Sfbmobil/projekte/targets/a8.html, to PK and LF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anne W, 2007, J MOL CELL CARDIOL, V43, P148, DOI 10.1016/j.yjmcc.2007.05.010; Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; BOYDEN PA, 1982, AM J CARDIOL, V49, P1896, DOI 10.1016/0002-9149(82)90208-9; Bruchert N, 2008, AM J PHYSIOL-HEART C, V295, pH1539, DOI 10.1152/ajpheart.00515.2008; Brundel BJJM, 2001, J AM COLL CARDIOL, V37, P926, DOI 10.1016/S0735-1097(00)01195-5; Camm AJ, 2010, EUROPACE, V12, P1360, DOI [10.1093/europace/euq350, 10.1093/eurheartj/ehq278]; Campione M, 2001, DEV BIOL, V231, P252, DOI 10.1006/dbio.2000.0133; Chen HY, 2004, IEEE J SEL TOP QUANT, V10, P10, DOI 10.1109/JSTQE.2004.824101; DUSSAULE JC, 1988, CIRCULATION, V78, P276, DOI 10.1161/01.CIR.78.2.276; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Furtado MB, 2008, GENE DEV, V22, P3037, DOI 10.1101/gad.1682108; Gollob MH, 2006, NEW ENGL J MED, V354, P2677, DOI 10.1056/NEJMoa052800; Grote-Wessels S, 2008, CARDIOVASC RES, V79, P464, DOI 10.1093/cvr/cvn113; Gudbjartsson DF, 2007, NATURE, V448, P353, DOI 10.1038/nature06007; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hang CT, 2010, NATURE, V466, P62, DOI 10.1038/nature09130; Jupiter DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001717; Kaab S, 2009, EUR HEART J, V30, P813, DOI 10.1093/eurheartj/ehn578; Kirchhof P, 2007, EUR HEART J, V28, P2803, DOI 10.1093/eurheartj/ehm358; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Li DS, 2001, CIRC RES, V88, P1168, DOI 10.1161/hh1101.091266; Liu CY, 2001, DEVELOPMENT, V128, P2039; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Motoki H, 2009, CIRC J, V73, P1403, DOI 10.1253/circj.CJ-09-0008; Nygren A, 2004, AM J PHYSIOL-HEART C, V287, pH2634, DOI 10.1152/ajpheart.00380.2004; Raya A, 2006, NAT REV GENET, V7, P283, DOI 10.1038/nrg1830; Rozen S, 2000, Methods Mol Biol, V132, P365; Rudolph V, 2010, NAT MED, V16, P470, DOI 10.1038/nm.2124; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sarmast F, 2003, CARDIOVASC RES, V59, P863, DOI 10.1016/S0008-6363(03)00540-6; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Susan-Resiga D, 2011, J BIOL CHEM, V286, P22785, DOI 10.1074/jbc.M111.233577; Tabibiazar R, 2003, CIRC RES, V93, P1193, DOI 10.1161/01.RES.0000103171.42654.DD; TESSARI A, 2008, CIRC RES; Toutouzas K, 2009, AM J MED SCI, V338, P494, DOI 10.1097/MAJ.0b013e3181b271a9; Voigt N, 2010, CIRC-ARRHYTHMIA ELEC, V3, P472, DOI 10.1161/CIRCEP.110.954636; WANG J, 2010, P NATL ACAD SCI US; Wittopper K, 2010, J CLIN INVEST, V120, P617, DOI 10.1172/JCI40545; Xu J, 2004, CIRCULATION, V109, P363, DOI 10.1161/01.CIR.0000109495.02213.52	41	62	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26389	10.1371/journal.pone.0026389	http://dx.doi.org/10.1371/journal.pone.0026389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039477	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000296507500059
J	Zhang, AM; Bandelt, HJ; Jia, XY; Zhang, W; Li, SQ; Yu, DD; Wang, D; Zhuang, XY; Zhang, QJ; Yao, YG				Zhang, A-Mei; Bandelt, Hans-Juergen; Jia, Xiaoyun; Zhang, Wen; Li, Shiqiang; Yu, Dandan; Wang, Dong; Zhuang, Xin-Ying; Zhang, Qingjiong; Yao, Yong-Gang			Is Mitochondrial tRNA(phe) Variant m.593T > C a Synergistically Pathogenic Mutation in Chinese LHON Families with m. 11778G > A?	PLOS ONE			English	Article							HEREDITARY OPTIC NEUROPATHY; TRANSLATIONAL QUALITY-CONTROL; TRANSFER-RNA MUTATIONS; CLINICAL EXPRESSION; DNA; MTDNA; DISEASE; GENOME; GENE; MECHANISM	Mitochondrial transfer RNA (mt-tRNA) mutations have been reported to be associated with a variety of diseases. In a previous paper that studied the mtDNA background effect on clinical expression of Leber's hereditary optic neuropathy (LHON) in 182 Chinese families with m.11778G>A, we found a strikingly high frequency (7/182) of m.593T>C in the mitochondrially encoded tRNA phenylalanine (MT-TF) gene in unrelated LHON patients. To determine the potential role of m.593T>C in LHON, we compared the frequency of this variant in 479 LHON patients with m.11778G>A, 843 patients with clinical features of LHON but without the three known primary mutations, and 2374 Han Chinese from the general populations. The frequency of m.593T>C was higher in LHON patients (14/479) than in suspected LHON subjects (12/843) or in general controls (49/2374), but the difference was not statistically significant. The overall penetrance of LHON in families with both m.11778G>A and m.593T>C (44.6%) was also substantially higher than that of families with only m.11778G>A (32.9%) (P = 0.083). Secondary structure prediction of the MT-TF gene with the wild type or m.593T>C showed that this nucleotide change decreases the free energy. Electrophoretic mobility of the MT-TF genes with the wild type or m.593T>C transcribed in vitro further confirmed the change of secondary structure in the presence of this variant. Although our results could suggest a modest synergistic effect of variant m.593T>C on the LHON causing mutation m.11778G>A, the lack of statistical significance probably due to the relatively small sample size analyzed, makes necessary more studies to confirm this effect.	[Zhang, A-Mei; Zhang, Wen; Yu, Dandan; Wang, Dong; Zhuang, Xin-Ying; Yao, Yong-Gang] Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China; [Zhang, A-Mei; Zhang, Wen; Yu, Dandan; Wang, Dong; Zhuang, Xin-Ying; Yao, Yong-Gang] Kunming Inst Zool, Kunming, Yunnan, Peoples R China; [Jia, Xiaoyun; Li, Shiqiang; Zhang, Qingjiong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Bandelt, Hans-Juergen] Univ Hamburg, Dept Math, Hamburg, Germany; [Zhang, A-Mei; Zhang, Wen; Wang, Dong] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Kunming Institute of Zoology; Sun Yat Sen University; University of Hamburg; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, AM (corresponding author), Chinese Acad Sci, Key Lab Anim Models & Human Dis Mech, Kunming, Yunnan, Peoples R China.	qingjiongzhang@yahoo.com; ygyaozh@gmail.com	Yao, Yong-Gang/AAH-2303-2021; Zhang, Qingjiong/AAR-6331-2021	Yao, Yong-Gang/0000-0002-2955-0693; Zhang, Qingjiong/0000-0001-7508-848X	Ministry of Science and Technology of China [2011CB910900]; National Natural Science Foundation of China [30925021]; National Natural Science Foundation of Yunnan Province [2009CI119]; National Natural Science Foundation of Guangdong Province [2009B091300150]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Yunnan Province; National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This work was supported by the Ministry of Science and Technology of China (2011CB910900), the National Natural Science Foundation of China (30925021), Yunnan Province (2009CI119), and Guangdong Province (2009B091300150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bandelt HJ, 2009, HUM MUTAT, V30, P191, DOI 10.1002/humu.20846; Bandelt HJ, 2000, MOL PHYLOGENET EVOL, V16, P8, DOI 10.1006/mpev.2000.0792; Carelli V, 2004, PROG RETIN EYE RES, V23, P53, DOI 10.1016/j.preteyeres.2003.10.003; Darin N, 2006, NEUROMUSCULAR DISORD, V16, P504, DOI 10.1016/j.nmd.2006.05.010; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Elson JL, 2009, HUM MUTAT, V30, pE984, DOI 10.1002/humu.21113; Fan L, 2011, MITOCHONDRION, V11, P351, DOI 10.1016/j.mito.2010.09.013; Florentz C, 2003, CELL MOL LIFE SCI, V60, P1356, DOI 10.1007/s00018-003-2343-1; GOTO Y, 1990, NATURE, V348, P651, DOI 10.1038/348651a0; Guo LJ, 2005, MITOCHONDRION, V5, P15, DOI 10.1016/j.mito.2004.09.001; Hudson G, 2007, AM J HUM GENET, V81, P228, DOI 10.1086/519394; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Ji YL, 2008, AM J HUM GENET, V83, P760, DOI 10.1016/j.ajhg.2008.11.002; Jia XY, 2006, J HUM GENET, V51, P851, DOI 10.1007/s10038-006-0032-2; Kaewsutthi S, 2011, INVEST OPHTH VIS SCI, V52, P4742, DOI 10.1167/iovs.10-5816; Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102; Kong QP, 2003, AM J HUM GENET, V73, P671, DOI 10.1086/377718; Li PTX, 2008, ANNU REV BIOCHEM, V77, P77, DOI 10.1146/annurev.biochem.77.061206.174353; Ling JQ, 2007, P NATL ACAD SCI USA, V104, P15299, DOI 10.1073/pnas.0704441104; Ling J, 2007, P NATL ACAD SCI USA, V104, P72, DOI 10.1073/pnas.0606272104; Ling JQ, 2009, ANNU REV MICROBIOL, V63, P61, DOI 10.1146/annurev.micro.091208.073210; Lu ZJ, 2009, RNA, V15, P1805, DOI 10.1261/rna.1643609; Mancuso M, 2004, NEUROLOGY, V62, P2119, DOI 10.1212/01.WNL.0000127608.48406.F1; McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014; Neron B, 2009, BIOINFORMATICS, V25, P3005, DOI 10.1093/bioinformatics/btp493; Peng MS, 2010, MOL BIOL EVOL, V27, P2417, DOI 10.1093/molbev/msq131; Roy H, 2004, EMBO J, V23, P4639, DOI 10.1038/sj.emboj.7600474; Salinas T, 2008, TRENDS BIOCHEM SCI, V33, P320, DOI 10.1016/j.tibs.2008.04.010; Scaglia F, 2008, MUSCLE NERVE, V37, P150, DOI 10.1002/mus.20917; Soares P, 2009, AM J HUM GENET, V84, P740, DOI 10.1016/j.ajhg.2009.05.001; Tarassov I, 2007, CELL CYCLE, V6, P2473, DOI 10.4161/cc.6.20.4783; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Wang CY, 2007, INT J CANCER, V121, P1253, DOI 10.1002/ijc.22822; Wang HW, 2008, MUTAT RES-FUND MOL M, V643, P48, DOI 10.1016/j.mrfmmm.2008.06.004; Yao YG, 2006, HUM GENET, V119, P505, DOI 10.1007/s00439-006-0154-9; Yu DD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013426; Yu DD, 2010, NEUROGENETICS, V11, P349, DOI 10.1007/s10048-010-0236-7; Yu-Wai-Man P, 2009, J MED GENET, V46, P145, DOI 10.1136/jmg.2007.054270; Zhang AM, 2010, HUM GENET, V128, P465, DOI 10.1007/s00439-010-0875-7; Zhang Q, 2001, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V18, P441; Zifa E, 2007, RNA BIOL, V4, P38, DOI 10.4161/rna.4.1.4548; Zou Y, 2010, BIOCHEM BIOPH RES CO, V399, P179, DOI 10.1016/j.bbrc.2010.07.051	43	14	33	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26511	10.1371/journal.pone.0026511	http://dx.doi.org/10.1371/journal.pone.0026511			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039503	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500081
J	Zhang, B; Tran, U; Wessely, O				Zhang, Bo; Tran, Uyen; Wessely, Oliver			Expression of Wnt Signaling Components during Xenopus Pronephros Development	PLOS ONE			English	Article							FRIZZLED FAMILY-MEMBER; PLANAR CELL POLARITY; KIDNEY DEVELOPMENT; EPITHELIAL TRANSFORMATION; MORPHOGENETIC MOVEMENTS; METANEPHRIC MESENCHYME; DEVELOPING EYE; GENE; MESODERM; LAEVIS	Background: The formation of the vertebrate kidney is tightly regulated and relies on multiple evolutionarily conserved inductive events. These are present in the complex metanephric kidney of higher vertebrates, but also in the more primitive pronephric kidney functional in the larval stages of amphibians and fish. Wnts have long been viewed as central in this process. Canonical beta-Catenin-dependent Wnt signaling establishes kidney progenitors and non-canonical beta-Cateninin-dependent Wnt signaling participate in the morphogenetic processes that form the highly sophisticated nephron structure. While some individual Wnt signaling components have been studied extensively in the kidney, the overall pathway has not yet been analyzed in depth. Methodology/Principal Findings: Here we report a detailed expression analysis of all Wnt ligands, receptors and several downstream Wnt effectors during pronephros development in Xenopus laevis using in situ hybridization. Out of 19 Wnt ligands, only three, Wnt4, Wnt9a and Wnt11, are specifically expressed in the pronephros. Others such as Wnt8a are present, but in a broader domain comprising adjacent tissues in addition to the kidney. The same paradigm is observed for the Wnt receptors and its downstream signaling components. Fzd1, Fzd4, Fzd6, Fzd7, Fzd8 as well as Celsr1 and Prickle1 show distinct expression domains in the pronephric kidney, whereas the non-traditional Wnt receptors, Ror2 and Ryk, as well as the majority of the effector molecules are rather ubiquitous. In addition to this spatial regulation, the timing of expression is also tightly regulated. In particular, non-canonical Wnt signaling seems to be restricted to later stages of pronephros development. Conclusion/Significance: Together these data suggest a complex cross talk between canonical and non-canonical Wnt signaling is required to establish a functional pronephric kidney.	[Zhang, Bo; Tran, Uyen; Wessely, Oliver] Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA; [Zhang, Bo] Louisiana State Univ, Hlth Sci Ctr, Dept Cell Biol & Anat, New Orleans, LA USA	Cleveland Clinic Foundation; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Zhang, B (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44106 USA.	wesselo@ccf.org			NIH/NIDDK [7RO1DK080745-03]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080745] Funding Source: NIH RePORTER	NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported from NIH/NIDDK (www.niddk.nih.gov/) with the RO1 grant #7RO1DK080745-03 to OW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angers S, 2009, NAT REV MOL CELL BIO, V10, P468, DOI 10.1038/nrm2717; Bang AG, 1999, DEV BIOL, V212, P366, DOI 10.1006/dbio.1999.9319; Brown JD, 2000, DEV GROWTH DIFFER, V42, P347; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Carroll TJ, 1999, DEV GENET, V24, P199, DOI 10.1002/(SICI)1520-6408(1999)24:3/4<199::AID-DVG3>3.0.CO;2-D; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; CHRISTIAN JL, 1991, DEVELOPMENT, V111, P1045; Damianitsch K, 2009, DEV BIOL, V329, P327, DOI 10.1016/j.ydbio.2009.03.004; Deardorf MA, 1999, MECH DEVELOP, V87, P229, DOI 10.1016/S0925-4773(99)00161-6; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Drummond IA, 2005, J AM SOC NEPHROL, V16, P299, DOI 10.1681/ASN.2004090754; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Garriock RJ, 2005, DEV BIOL, V279, P179, DOI 10.1016/j.ydbio.2004.12.013; Garriock RJ, 2007, DEV DYNAM, V236, P1249, DOI 10.1002/dvdy.21156; Goodrich LV, 2011, DEVELOPMENT, V138, P1877, DOI 10.1242/dev.054080; Gray RS, 2009, DEV DYNAM, V238, P2044, DOI 10.1002/dvdy.22028; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Hoppler S, 1996, GENE DEV, V10, P2805, DOI 10.1101/gad.10.21.2805; Itoh K, 1998, MECH DEVELOP, V74, P145, DOI 10.1016/S0925-4773(98)00076-8; Karner CM, 2011, DEVELOPMENT, V138, P1247, DOI 10.1242/dev.057646; Karner CM, 2009, NAT GENET, V41, P793, DOI 10.1038/ng.400; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kispert A, 1998, DEVELOPMENT, V125, P4225; KU M, 1993, DEVELOPMENT, V119, P1161; Lavery DL, 2008, DEV DYNAM, V237, P768, DOI 10.1002/dvdy.21440; Lienkamp S, 2010, P NATL ACAD SCI USA, V107, P20388, DOI 10.1073/pnas.1013070107; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyons JP, 2009, MECH DEVELOP, V126, P142, DOI 10.1016/j.mod.2008.11.007; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Mccoy KE, 2011, DEV DYNAM, V240, P1558, DOI 10.1002/dvdy.22626; MCGREW LL, 1992, DEVELOPMENT, V115, P463; McNeill H, 2009, J AM SOC NEPHROL, V20, P2104, DOI 10.1681/ASN.2008111173; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Merkel CE, 2007, PEDIATR NEPHROL, V22, P1825, DOI 10.1007/s00467-007-0504-4; MOON RT, 1993, DEVELOPMENT, V119, P97; Moriwaki J, 2000, BIOCHEM BIOPH RES CO, V278, P377, DOI 10.1006/bbrc.2000.3808; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; Reversade B, 2005, CELL, V123, P1147, DOI 10.1016/j.cell.2005.08.047; Satow R, 2004, BIOCHEM BIOPH RES CO, V321, P487, DOI 10.1016/j.bbrc.2004.06.166; Saulnier DME, 2002, DEV BIOL, V248, P13, DOI 10.1006/dbio.2002.0712; Saxen L., 1987, ORGANOGENESIS KIDNEY; Shi DL, 2000, MECH DEVELOP, V94, P243, DOI 10.1016/S0925-4773(00)00294-X; Shi DL, 1998, MECH DEVELOP, V70, P35, DOI 10.1016/S0925-4773(97)00166-4; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Smith H. W., 1953, FISH PHILOS; SOKOL SY, 1993, DEVELOPMENT, V118, P1335; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Sumanas S, 2001, MECH DEVELOP, V103, P133, DOI 10.1016/S0925-4773(01)00327-6; Tetelin S, 2010, DEV DYNAM, V239, P148, DOI 10.1002/dvdy.22012; Tour E, 2002, MECH DEVELOP, V110, P3, DOI 10.1016/S0925-4773(01)00591-3; Tran U, 2007, DEV BIOL, V307, P152, DOI 10.1016/j.ydbio.2007.04.030; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Vize P.D., 2003, KIDNEY NORMAL DEV CO; Vize PD, 2003, KIDNEY NORMAL DEV CO, P19, DOI [10.1016/B978-012722441-1/50005-1, DOI 10.1016/B978-012722441-1/50005-1]; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wallingford JB, 2002, MECH DEVELOP, V116, P183, DOI 10.1016/S0925-4773(02)00133-8; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; WESSELY O, 2011, PEDIAT NEPH IN PRESS; Wheeler GN, 1999, MECH DEVELOP, V86, P203, DOI 10.1016/S0925-4773(99)00117-3; White JT, 2010, DEVELOPMENT, V137, P1863, DOI 10.1242/dev.042887; Yin A, 2010, GENE EXPR PATTERNS, V10, P338, DOI 10.1016/j.gep.2010.07.005; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	65	22	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26533	10.1371/journal.pone.0026533	http://dx.doi.org/10.1371/journal.pone.0026533			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028899	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500085
J	Anguissola, S; McCormack, WJ; Morrin, MA; Higgins, WJ; Fox, DM; Worrall, DM				Anguissola, Sergio; McCormack, William J.; Morrin, Michelle A.; Higgins, Wayne J.; Fox, Denise M.; Worrall, D. Margaret			Pigment Epithelium-Derived Factor (PEDF) Interacts with Transportin SR2, and Active Nuclear Import Is Facilitated by a Novel Nuclear Localization Motif	PLOS ONE			English	Article							NEUROTROPHIC ACTIVITY; RS DOMAIN; IDENTIFICATION; SERPIN; PROTEINS; CELLS; ANGIOGENESIS; RECEPTOR; PROLIFERATION; VASCULATURE	PEDF (Pigment epithelium-derived factor) is a non-inhibitory member of the serpin gene family (serpinF1) that displays neurotrophic and anti-angiogenic properties. PEDF contains a secretion signal sequence, but although originally regarded as a secreted extracellular protein, endogenous PEDF is found in the cytoplasm and nucleus of several mammalian cell types. In this study we employed a yeast two-hybrid interaction trap screen to identify transportin-SR2, a member of the importin-beta family of nuclear transport karyopherins, as a putative PEDF binding partner. The interaction was supported in vitro by GST-pulldown and co-immunoprecipitation. Following transfection of HEK293 cells with GFP-tagged PEDF the protein was predominantly localised to the nucleus, suggesting that active import of PEDF occurs. A motif (YxxYRVRS) shared by PEDF and the unrelated transportin-SR2 substrate, RNA binding motif protein 4b, was identified and we investigated its potential as a nuclear localization signal (NLS) sequence. Site-directed mutagenesis of this helix A motif in PEDF resulted in a GFP-tagged mutant protein being excluded from the nucleus, and mutation of two arginine residues (R67, R69) was sufficient to abolish nuclear import and PEDF interaction with transportin-SR2. These results suggest a novel NLS and mechanism for serpinF1 nuclear import, which may be critical for anti-angiogenic and neurotrophic function.	[Anguissola, Sergio; McCormack, William J.; Morrin, Michelle A.; Higgins, Wayne J.; Fox, Denise M.; Worrall, D. Margaret] Univ Coll Dublin, Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland	University College Dublin	Anguissola, S (corresponding author), Univ Coll Dublin, Conway Inst, UCD Sch Biomol & Biomed Sci, Dublin 2, Ireland.	mworrall@ucd.ie		McCormack, William/0000-0003-3748-5729	Irish Cancer Society [CRP08WOR]	Irish Cancer Society	The study was funded by the Irish Cancer Society (Research Grant CRP08WOR) http://www.cancer.ie/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECERRA SP, 1995, J BIOL CHEM, V270, P25992, DOI 10.1074/jbc.270.43.25992; Bernard A, 2009, J BIOL CHEM, V284, P10480, DOI 10.1074/jbc.M809259200; Bilak MM, 2002, J NEUROSCI, V22, P9378; Bird CH, 2001, MOL CELL BIOL, V21, P5396, DOI 10.1128/MCB.21.16.5396-5407.2001; Blacque OE, 2002, J BIOL CHEM, V277, P10783, DOI 10.1074/jbc.M110992200; Cayouette M, 1999, NEUROBIOL DIS, V6, P523, DOI 10.1006/nbdi.1999.0263; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Chuang TL, 1999, J BIOL CHEM, V274, P11194, DOI 10.1074/jbc.274.16.11194; Dawson DW, 1999, SCIENCE, V285, P245, DOI 10.1126/science.285.5425.245; DeRooij KE, 1996, HUM MOL GENET, V5, P1093, DOI 10.1093/hmg/5.8.1093; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Famulla S, 2011, INT J OBESITY, V35, P762, DOI 10.1038/ijo.2010.212; Filleur S, 2005, CANCER RES, V65, P5144, DOI 10.1158/0008-5472.CAN-04-3744; GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Irving JA, 2002, J BIOL CHEM, V277, P13192, DOI 10.1074/jbc.M108460200; Karakousis PC, 2001, MOL VIS, V7, P154; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Kawaguchi T, 2010, CURR MOL MED, V10, P302, DOI 10.2174/156652410791065255; Kawaguchi T, 2010, AM J PATHOL, V176, P168, DOI 10.2353/ajpath.2010.090242; Lai MC, 2003, EMBO J, V22, P1359, DOI 10.1093/emboj/cdg126; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Liu H, 2004, P NATL ACAD SCI USA, V101, P6605, DOI 10.1073/pnas.0308342101; NAIDOO N, 1995, J BIOL CHEM, V270, P14548, DOI 10.1074/jbc.270.24.14548; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Notari L, 2006, J BIOL CHEM, V281, P38022, DOI 10.1074/jbc.M600353200; Olsnes S, 2003, PHYSIOL REV, V83, P163, DOI 10.1152/physrev.00021.2002; PIGNOLO RJ, 1993, J BIOL CHEM, V268, P8949; Sawant S, 2004, BIOCHEM BIOPH RES CO, V325, P408, DOI 10.1016/j.bbrc.2004.10.041; Shibata Y, 2002, MOL CELL BIOL, V22, P6788, DOI 10.1128/MCB.22.19.6788-6796.2002; Simonovic M, 2001, P NATL ACAD SCI USA, V98, P11131, DOI 10.1073/pnas.211268598; STEELE FR, 1993, P NATL ACAD SCI USA, V90, P1526, DOI 10.1073/pnas.90.4.1526; Stewart M, 2001, FEBS LETT, V498, P145, DOI 10.1016/S0014-5793(01)02489-9; Sugita Y, 1997, J NEUROSCI RES, V49, P710, DOI 10.1002/(SICI)1097-4547(19970915)49:6<710::AID-JNR5>3.0.CO;2-A; Tombran-Tink J, 2005, J STRUCT BIOL, V151, P130, DOI 10.1016/j.jsb.2005.05.005; TOMBRANTINK J, 1995, J NEUROSCI, V15, P4992; Truant R, 1999, J BIOL CHEM, V274, P32167, DOI 10.1074/jbc.274.45.32167; Yasui N, 2003, BIOCHEMISTRY-US, V42, P3160, DOI 10.1021/bi0206558; Yun CY, 2003, J BIOL CHEM, V278, P18050, DOI 10.1074/jbc.M211714200	40	22	22	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26234	10.1371/journal.pone.0026234	http://dx.doi.org/10.1371/journal.pone.0026234			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028839	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900037
J	Fu, B; Pitter, MC; Russell, NA				Fu, Bo; Pitter, Mark C.; Russell, Noah A.			A Reconfigurable Real-Time Compressive-Sampling Camera for Biological Applications	PLOS ONE			English	Article							HIGH-SPEED; FRAME RATE; MICROSCOPY; PARAMETERS; SYSTEM; MODE; DYES	Many applications in biology, such as long-term functional imaging of neural and cardiac systems, require continuous highspeed imaging. This is typically not possible, however, using commercially available systems. The frame rate and the recording time of high-speed cameras are limited by the digitization rate and the capacity of on-camera memory. Further restrictions are often imposed by the limited bandwidth of the data link to the host computer. Even if the system bandwidth is not a limiting factor, continuous high-speed acquisition results in very large volumes of data that are difficult to handle, particularly when real-time analysis is required. In response to this issue many cameras allow a predetermined, rectangular region of interest (ROI) to be sampled, however this approach lacks flexibility and is blind to the image region outside of the ROI. We have addressed this problem by building a camera system using a randomly-addressable CMOS sensor. The camera has a low bandwidth, but is able to capture continuous high-speed images of an arbitrarily defined ROI, using most of the available bandwidth, while simultaneously acquiring low-speed, full frame images using the remaining bandwidth. In addition, the camera is able to use the full-frame information to recalculate the positions of targets and update the highspeed ROIs without interrupting acquisition. In this way the camera is capable of imaging moving targets at high-speed while simultaneously imaging the whole frame at a lower speed. We have used this camera system to monitor the heartbeat and blood cell flow of a water flea (Daphnia) at frame rates in excess of 1500 fps.	[Fu, Bo] Univ Nottingham, Inst Biophys Imaging & Opt Sci, Sch Biol, Nottingham NG7 2RD, England; Univ Nottingham, Inst Biophys Imaging & Opt Sci, Sch Elect & Elect Engn, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Fu, B (corresponding author), Univ Nottingham, Inst Biophys Imaging & Opt Sci, Sch Biol, Nottingham NG7 2RD, England.	noah.russell@nottingham.ac.uk		Russell, N/0000-0002-0998-6094	EPSRC (Engineering and Physical Sciences Research Council) [EP/F005512/1, EP/C52389X/1]; Engineering and Physical Sciences Research Council [EP/C52389X/1, EP/F005512/1] Funding Source: researchfish; EPSRC [EP/F005512/1] Funding Source: UKRI	EPSRC (Engineering and Physical Sciences Research Council)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	EPSRC (Engineering and Physical Sciences Research Council) EP/F005512/1 (http://gow.epsrc.ac.uk/ViewGrant.aspx?GrantRef=EP/F005512/1) and EPSRC (Engineering and Physical Sciences Research Council) EP/C52389X/1, (http://gow.epsrc.ac.uk)/ViewGrant.aspx?GrantRef=EP/C52389X/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agronskaia AV, 2003, J PHYS D APPL PHYS, V36, P1655, DOI 10.1088/0022-3727/36/14/301; Bahlmann K, 2007, OPT EXPRESS, V15, P10991, DOI 10.1364/OE.15.010991; Bub G, 2010, NAT METHODS, V7, P209, DOI [10.1038/NMETH.1429, 10.1038/nmeth.1429]; Bullen A, 1997, BIOPHYS J, V73, P477, DOI 10.1016/S0006-3495(97)78086-X; Chan KY, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2536719; Davila AF, 2005, BIOPHYS J, V89, P56, DOI 10.1529/biophysj.104.049346; Efimov IR, 2004, CIRC RES, V95, P21, DOI 10.1161/01.RES.0000130529.18016.35; Graetzel CF, 2010, IEEE T AUTOM SCI ENG, V7, P463, DOI 10.1109/TASE.2009.2031094; Herbin M, 2007, BEHAV BRAIN RES, V181, P173, DOI 10.1016/j.bbr.2007.04.001; Imfeld K, 2008, IEEE T BIO-MED ENG, V55, P2064, DOI 10.1109/TBME.2008.919139; Karimov P, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2804129; Kirugulige MS, 2009, STRAIN, V45, P108, DOI 10.1111/j.1475-1305.2008.00449.x; KITAMURA K, 2007, P SOC PHOTO-OPT INS; KITAMURA K, 2008, P SOC PHOTO-OPT INS; Maccione Alessandro, 2010, Front Neuroeng, V3, P4, DOI 10.3389/fneng.2010.00004; MATSUMOTO K, 1985, JPN J APPL PHYS 2, V24, pL323, DOI 10.1143/JJAP.24.L323; Obaid AL, 2004, J NEUROSCI METH, V134, P179, DOI 10.1016/j.jneumeth.2003.11.011; Pitter MC, 2004, ELECTRON LETT, V40, P1404, DOI 10.1049/el:20046185; POTTER SM, 1997, HIGH SPEED CCD MOVIE, P243; Robucci R, 2008, INT CONF ACOUST SPEE, P5125, DOI 10.1109/ICASSP.2008.4518812	20	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26306	10.1371/journal.pone.0026306	http://dx.doi.org/10.1371/journal.pone.0026306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028852	gold, Green Submitted, Green Published			2022-12-27	WOS:000296186900046
J	Langford-Smith, A; Langford-Smith, KJ; Jones, SA; Wynn, RF; Wraith, JE; Wilkinson, FL; Bigger, BW				Langford-Smith, Alex; Langford-Smith, Kia J.; Jones, Simon A.; Wynn, Robert F.; Wraith, J. E.; Wilkinson, Fiona L.; Bigger, Brian W.			Female Mucopolysaccharidosis IIIA Mice Exhibit Hyperactivity and a Reduced Sense of Danger in the Open Field Test	PLOS ONE			English	Article							ALPHA-N-ACETYLGLUCOSAMINIDASE; MEDIATED GENE-TRANSFER; SYNDROME TYPE-B; MOUSE MODEL; SANFILIPPO-SYNDROME; MPS-IIIA; SLEEP DISTURBANCE; MURINE MODEL; BEHAVIOR; SULFAMIDASE	Reliable behavioural tests in animal models of neurodegenerative diseases allow us to study the natural history of disease and evaluate the efficacy of novel therapies. Mucopolysaccharidosis IIIA (MPS IIIA or Sanfilippo A), is a severe, neurodegenerative lysosomal storage disorder caused by a deficiency in the heparan sulphate catabolising enzyme, sulfamidase. Undegraded heparan sulphate accumulates, resulting in lysosomal enlargement and cellular dysfunction. Patients suffer a progressive loss of motor and cognitive function with severe behavioural manifestations and premature death. There is currently no treatment. A spontaneously occurring mouse model of the disease has been described, that has approximately 3% of normal enzyme activity levels. Behavioural phenotyping of the MPS IIIA mouse has been previously reported, but the results are conflicting and variable, even after full backcrossing to the C57BL/6 background. Therefore we have independently backcrossed the MPS IIIA model onto the C57BL/6J background and evaluated the behaviour of male and female MPS IIIA mice at 4, 6 and 8 months of age using the open field test, elevated plus maze, inverted screen and horizontal bar crossing at the same circadian time point. Using a 60 minute open field, we have demonstrated that female MPS IIIA mice are hyperactive, have a longer path length, display rapid exploratory behaviour and spend less time immobile than WT mice. Female MPS IIIA mice also display a reduced sense of danger and spend more time in the centre of the open field. There were no significant differences found between male WT and MPS IIIA mice and no differences in neuromuscular strength were seen with either sex. The altered natural history of behaviour that we observe in the MPS IIIA mouse will allow more accurate evaluation of novel therapeutics for MPS IIIA and potentially other neurodegenerative disorders.	[Langford-Smith, Alex; Langford-Smith, Kia J.; Wilkinson, Fiona L.; Bigger, Brian W.] Univ Manchester, Fac Med & Human Sci, Sch Biomed, Manchester, Lancs, England; [Jones, Simon A.; Wraith, J. E.] St Marys Hosp, Manchester M13 0JH, Lancs, England; [Wynn, Robert F.] Royal Manchester Childrens Hosp, Blood & Marrow Transplant Unit, Manchester M27 1HA, Lancs, England	University of Manchester; University of Manchester; Royal Manchester Children's Hospital	Langford-Smith, A (corresponding author), Univ Manchester, Fac Med & Human Sci, Sch Biomed, Manchester, Lancs, England.	Brian.Bigger@Manchester.ac.uk	Langford-Smith, Alex/K-7624-2017; Langford-Smith, Alex/H-5249-2011; Langford-Smith, Kia/H-5255-2011; Bigger, Brian/I-3553-2012	Langford-Smith, Alex/0000-0001-7006-0592; Langford-Smith, Alex/0000-0001-7006-0592; Wynn, robert/0000-0002-6046-8428; Wilkinson, Fiona/0000-0002-0358-3489; Bigger, Brian/0000-0002-9708-1112	UK Society for Mucopolysaccharide Diseases; Irish Society for Mucopolysaccharide Diseases; Sanfilippo Children's Research Foundation; Biotechnology and Biological Sciences Research Council	UK Society for Mucopolysaccharide Diseases; Irish Society for Mucopolysaccharide Diseases; Sanfilippo Children's Research Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the UK Society for Mucopolysaccharide Diseases, The Irish Society for Mucopolysaccharide Diseases, The Sanfilippo Children's Research Foundation, and the Biotechnology and Biological Sciences Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfi A, 2011, MOL GENET METAB, V103, P18, DOI 10.1016/j.ymgme.2011.01.015; Arndt SS, 2009, PHYSIOL BEHAV, V97, P385, DOI 10.1016/j.physbeh.2009.03.008; BAX MCO, 1995, ARCH DIS CHILD, V73, P77, DOI 10.1136/adc.73.1.77; Benjamini Y, 2010, NEUROSCI BIOBEHAV R, V34, P1351, DOI 10.1016/j.neubiorev.2010.04.004; Bhaumik M, 1999, GLYCOBIOLOGY, V9, P1389, DOI 10.1093/glycob/9.12.1389; Canal MM, 2010, BEHAV BRAIN RES, V209, P212, DOI 10.1016/j.bbr.2010.01.045; CLEARY MA, 1993, ARCH DIS CHILD, V69, P403, DOI 10.1136/adc.69.3.403; Crawley AC, 2006, BRAIN RES, V1104, P1, DOI 10.1016/j.brainres.2006.05.079; Crawley J. N., 2007, WHATS WRONG MY MOUSE; Cressant A, 2004, J NEUROSCI, V24, P10229, DOI 10.1523/JNEUROSCI.3558-04.2004; Fraldi A, 2007, HUM MOL GENET, V16, P2693, DOI 10.1093/hmg/ddm223; Fraser J, 2005, ARCH DIS CHILD, V90, P1239, DOI 10.1136/adc.2004.065482; Fraser J, 2002, CLIN GENET, V62, P418, DOI 10.1034/j.1399-0004.2002.620512.x; Fu H, 2007, GENE THER, V14, P1065, DOI 10.1038/sj.gt.3302961; Fu HY, 2010, J GENE MED, V12, P624, DOI 10.1002/jgm.1480; Gerlai R, 1996, TRENDS NEUROSCI, V19, P177, DOI 10.1016/S0166-2236(96)20020-7; Gliddon BL, 2004, PEDIATR RES, V56, P65, DOI 10.1203/01.PDR.0000129661.40499.12; Gografe SI, 2009, COMPARATIVE MED, V59, P139; Heldermon CD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000772; Heldermon CD, 2010, MOL THER, V18, P873, DOI 10.1038/mt.2010.17; Hemsley KM, 2008, GENES BRAIN BEHAV, V7, P740, DOI 10.1111/j.1601-183X.2008.00413.x; Hemsley KM, 2007, MOL GENET METAB, V90, P313, DOI 10.1016/j.ymgme.2006.10.005; Hemsley KM, 2009, MOL GENET METAB, V98, P383, DOI 10.1016/j.ymgme.2009.07.013; Hemsley KM, 2009, EUR J NEUROSCI, V29, P1197, DOI 10.1111/j.1460-9568.2009.06666.x; Hemsley KM, 2005, BEHAV BRAIN RES, V158, P191, DOI 10.1016/j.bbr.2004.08.019; Heron B, 2011, AM J MED GENET A, V155A, P58, DOI 10.1002/ajmg.a.33779; Kafkafi N, 2003, BEHAV NEUROSCI, V117, P464, DOI 10.1037/0735-7044.117.3.464; KRESSE H, 1973, BIOCHEM BIOPH RES CO, V54, P1111, DOI 10.1016/0006-291X(73)90807-3; KRESSE H, 1972, J BIOL CHEM, V247, P2164; Lamberty Y, 1996, PHYSIOL BEHAV, V59, P439, DOI 10.1016/0031-9384(96)84912-2; Langford-Smith A, 2011, GENES BRAIN BEHAV, V10, P673, DOI 10.1111/j.1601-183X.2011.00706.x; Langford-Smith K, 2010, MOL GENET METAB, V99, P269, DOI 10.1016/j.ymgme.2009.10.175; Langford-Smith KJ, 2011, J INHERIT METAB DIS, V34, P499, DOI 10.1007/s10545-010-9254-8; Lau AA, 2008, BEHAV BRAIN RES, V191, P130, DOI 10.1016/j.bbr.2008.03.024; Lau AA, 2010, EXP NEUROL, V225, P445, DOI 10.1016/j.expneurol.2010.07.024; Lau AA, 2010, MOL GENET METAB, V100, P168, DOI 10.1016/j.ymgme.2010.02.006; Li HH, 1999, P NATL ACAD SCI USA, V96, P14505, DOI 10.1073/pnas.96.25.14505; Malinowska M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014192; Malinowska M, 2009, MOL GENET METAB, V98, P235, DOI 10.1016/j.ymgme.2009.06.013; Malm G, 2010, ACTA PAEDIATR, V99, P1253, DOI 10.1111/j.1651-2227.2010.01800.x; McGlynn R, 2004, J COMP NEUROL, V480, P415, DOI 10.1002/cne.20355; McIntyre C, 2008, MOL GENET METAB, V93, P411, DOI 10.1016/j.ymgme.2007.11.008; McIntyre C, 2010, J GENE MED, V12, P717, DOI 10.1002/jgm.1489; Meyer A, 2007, PEDIATRICS, V120, pE1255, DOI 10.1542/peds.2007-0282; Roberts ALK, 2007, MOL GENET METAB, V92, P115, DOI 10.1016/j.ymgme.2007.06.016; Savas PS, 2004, MOL GENET METAB, V82, P273, DOI 10.1016/j.ymgme.2004.05.005; SCOTT HS, 1995, NAT GENET, V11, P465, DOI 10.1038/ng1295-465; SIMON P, 1994, BEHAV BRAIN RES, V61, P59, DOI 10.1016/0166-4328(94)90008-6; Valstar MJ, 2008, J INHERIT METAB DIS, V31, P240, DOI 10.1007/s10545-008-0838-5; Valstar MJ, 2010, ANN NEUROL, V68, P876, DOI 10.1002/ana.22092; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x	52	28	28	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25717	10.1371/journal.pone.0025717	http://dx.doi.org/10.1371/journal.pone.0025717			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028789	Green Published, gold, Green Submitted			2022-12-27	WOS:000296186900017
J	Guillemot, V; Tenenhaus, A; Le Brusquet, L; Frouin, V				Guillemot, Vincent; Tenenhaus, Arthur; Le Brusquet, Laurent; Frouin, Vincent			Graph Constrained Discriminant Analysis: A New Method for the Integration of a Graph into a Classification Process	PLOS ONE			English	Article							GENE-EXPRESSION; NETWORKS; INFORMATION; PREDICTION; ALGORITHM; MODELS	Integrating gene regulatory networks (GRNs) into the classification process of DNA microarrays is an important issue in bioinformatics, both because this information has a true biological interest and because it helps in the interpretation of the final classifier. We present a method called graph-constrained discriminant analysis (gCDA), which aims to integrate the information contained in one or several GRNs into a classification procedure. We show that when the integrated graph includes erroneous information, gCDA's performance is only slightly worse, thus showing robustness to misspecifications in the given GRNs. The gCDA framework also allows the classification process to take into account as many a priori graphs as there are classes in the dataset. The gCDA procedure was applied to simulated data and to three publicly available microarray datasets. gCDA shows very interesting performance when compared to state-of-the-art classification methods. The software package gcda, along with the real datasets that were used in this study, are available online: http://biodev.cea.fr/gcda/.	[Guillemot, Vincent; Tenenhaus, Arthur; Frouin, Vincent] IRCM, DSV, Lab Funct Genom CEA, Evry, France; [Guillemot, Vincent; Tenenhaus, Arthur; Le Brusquet, Laurent] Dept Signals & Elect Syst Supelec, Gif Sur Yvette, France	CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Guillemot, V (corresponding author), IRCM, DSV, Lab Funct Genom CEA, Evry, France.	Vincent.Guillemot@ibe.med.uni-muenchen.de; vincent.frouin@cea.fr	Guillemot, Vincent/E-1598-2011; Guillemot, Vincent/AAV-6018-2021	Guillemot, Vincent/0000-0002-7421-0655; 	CEA	CEA(French Atomic Energy Commission)	This work was funded by a CEA - Region Ile de France grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon U, 1999, P NATL ACAD SCI USA, V96, P6745, DOI 10.1073/pnas.96.12.6745; Binder H, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-18; Bradley P. S., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P82; Chandran UR, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-64; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dimitriadou E., 2010, E1071 MISC FUNCTIONS; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; FRIEDMAN JH, 1989, J AM STAT ASSOC, V84, P165, DOI 10.2307/2289860; GUILLEMOT V, 2008, P IEEE INT C BIOINF, P207, DOI DOI 10.1109/BIBMW.2008.4686237; Guo YQ, 2007, BIOSTATISTICS, V8, P86, DOI 10.1093/biostatistics/kxj035; Hand DJ, 2006, STAT SCI, V21, P1, DOI 10.1214/088342306000000060; Hastie Y., 2009, RDA SHRUNKEN CENTROI; Kalisch M, 2007, J MACH LEARN RES, V8, P613; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kramer N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-384; KRAMER N, 2010, PARCOR REGULARIZED E; Lee ES, 2008, CLIN CANCER RES, V14, P7397, DOI 10.1158/1078-0432.CCR-07-4937; Li CY, 2008, BIOINFORMATICS, V24, P1175, DOI 10.1093/bioinformatics/btn081; Mansmann U, 2010, STATISTICAL MODELLING AND REGRESSION STRUCTURES, P249, DOI 10.1007/978-3-7908-2413-1_14; Margolin AA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S1-S7; MCLACHLAN GJ, 2004, ANAL MICROARRAY GENE; MEYER PE, 2010, MINET MUTUAL INFORM; Rapaport F, 2008, BIOINFORMATICS, V24, pI375, DOI 10.1093/bioinformatics/btn188; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175; Schott JR, 2007, COMPUT STAT DATA AN, V51, P6535, DOI 10.1016/j.csda.2007.03.004; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Whittaker J., 1990, GRAPHICAL MODELS APP; Zhang J.D., 2010, KEGGGRAPH KEGGGRAPH; Zhu YN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S21	31	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26146	10.1371/journal.pone.0026146	http://dx.doi.org/10.1371/journal.pone.0026146			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022543	Green Submitted, Green Published, gold			2022-12-27	WOS:000295981600031
J	Scarlett, CJ; Colvin, EK; Pinese, M; Chang, DK; Morey, AL; Musgrove, EA; Pajic, M; Apte, M; Henshall, SM; Sutherland, RL; Kench, JG; Biankin, AV				Scarlett, Christopher J.; Colvin, Emily K.; Pinese, Mark; Chang, David K.; Morey, Adrienne L.; Musgrove, Elizabeth A.; Pajic, Marina; Apte, Minoti; Henshall, Susan M.; Sutherland, Robert L.; Kench, James G.; Biankin, Andrew V.			Recruitment and Activation of Pancreatic Stellate Cells from the Bone Marrow in Pancreatic Cancer: A Model of Tumor-Host Interaction	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; STEM-CELLS; BETA-CELL; IN-VIVO; TUBULAR COMPLEXES; ADULT STEM; REGENERATION; MICE; TRANSPLANTATION; EXPRESSION	Background and Aims: Chronic pancreatitis and pancreatic cancer are characterised by extensive stellate cell mediated fibrosis, and current therapeutic development includes targeting pancreatic cancer stroma and tumor-host interactions. Recent evidence has suggested that circulating bone marrow derived stem cells (BMDC) contribute to solid organs. We aimed to define the role of circulating haematopoietic cells in the normal and diseased pancreas. Methods: Whole bone marrow was harvested from male beta-actin-EGFP donor mice and transplanted into irradiated female recipient C57/BL6 mice. Chronic pancreatitis was induced with repeat injections of caerulein, while carcinogenesis was induced with an intrapancreatic injection of dimethylbenzanthracene (DMBA). Phenotype of engrafted donor-derived cells within the pancreas was assessed by immunohistochemistry, immunofluorescence and in situ hybridisation. Results: GFP positive cells were visible in the exocrine pancreatic epithelia from 3 months post transplantation. These exhibited acinar morphology and were positive for amylase and peanut agglutinin. Mice administered caerulein developed chronic pancreatitis while DMBA mice exhibited precursor lesions and pancreatic cancer. No acinar cells were identified to be donor-derived upon cessation of cerulein treatment, however rare occurrences of bone marrow-derived acinar cells were observed during pancreatic regeneration. Increased recruitment of BMDC was observed within the desmoplastic stroma, contributing to the activated pancreatic stellate cell (PaSC) population in both diseases. Expression of stellate cell markers CELSR3, PBX1 and GFAP was observed in BMD cancer-associated PaSCs, however cancer-associated, but not pancreatitis-associated BMD PaSCs, expressed the cancer PaSC specific marker CELSR3. Conclusions: This study demonstrates that BMDC can incorporate into the pancreas and adopt the differentiated state of the exocrine compartment. BMDC that contribute to the activated PaSC population in chronic pancreatitis and pancreatic cancer have different phenotypes, and may play important roles in these diseases. Further, bone marrow transplantation may provide a useful model for the study of tumor-host interactions in cancer and pancreatitis.	[Scarlett, Christopher J.; Colvin, Emily K.; Pinese, Mark; Chang, David K.; Musgrove, Elizabeth A.; Pajic, Marina; Henshall, Susan M.; Sutherland, Robert L.; Kench, James G.; Biankin, Andrew V.] Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia; [Chang, David K.; Biankin, Andrew V.] Bankstown Hosp, Div Surg, Sydney, NSW, Australia; [Morey, Adrienne L.] St Vincents Hosp, Dept Anat Pathol, Darlinghurst, NSW 2010, Australia; [Apte, Minoti] Univ New S Wales, S Western Sydney Clin Sch, Sydney, NSW, Australia; [Kench, James G.] Royal Prince Alfred Hosp, Dept Anat Pathol, Sydney, NSW, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney; University of New South Wales Sydney; University of Sydney	Scarlett, CJ (corresponding author), Garvan Inst Med Res, Canc Res Program, Sydney, NSW, Australia.	a.biankin@garvan.org.au	Sutherland, Robert L/A-8378-2008; Apte, Minoti/X-2864-2019	Apte, Minoti/0000-0003-0194-8939; Biankin, Andrew/0000-0002-0362-5597; Scarlett, Christopher/0000-0002-4140-7785; Kench, James Geoffrey/0000-0001-8687-4988; Morey, Adrienne/0000-0002-7823-8276; Pinese, Mark/0000-0001-5078-6687; Chang, David/0000-0002-4821-3078; Colvin, Emily/0000-0002-5435-5902; Pajic, Marina/0000-0002-3871-3829	Cancer Institute New South Wales (CINSW); National Health and Medical Research Council (NHMRC) of Australia; Cancer Council New South Wales; St. Vincent's Clinic Foundation; Royal Australian College of Surgeons; Australian Cancer Research Foundation; R. T. Hall Trust	Cancer Institute New South Wales (CINSW); National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council New South Wales(Cancer Council New South Wales); St. Vincent's Clinic Foundation; Royal Australian College of Surgeons; Australian Cancer Research Foundation; R. T. Hall Trust	This work was supported by the Cancer Institute New South Wales (CINSW), the National Health and Medical Research Council (NHMRC) of Australia, The Cancer Council New South Wales, the St. Vincent's Clinic Foundation, the Royal Australian College of Surgeons, the Australian Cancer Research Foundation, and the R. T. Hall Trust. AVB, CJS, DKC, EAM and EKC are supported by fellowships from the CINSW. RLS is a Senior Principal Fellow of the NHMRC and holds the Petre Chair of Breast Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alison MR, 2006, EUR J CANCER, V42, P1247, DOI 10.1016/j.ejca.2006.01.034; Apte MV, 2004, PANCREAS, V29, P179, DOI 10.1097/00006676-200410000-00002; Apte MV, 2003, PANCREAS, V27, P316, DOI 10.1097/00006676-200311000-00008; Apte MV, 1998, GUT, V43, P128, DOI 10.1136/gut.43.1.128; Bachem MG, 2008, LANGENBECK ARCH SURG, V393, P891, DOI 10.1007/s00423-008-0279-5; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Biankin SA, 2007, PATHOLOGY, V39, P247, DOI 10.1080/00313020701230807; Brazelton TR, 2005, STEM CELLS, V23, P1251, DOI 10.1634/stemcells.2005-0149; Cameron JL, 2006, ANN SURG, V244, P10, DOI 10.1097/01.sla.0000217673.04165.ea; Choi JB, 2003, DIABETOLOGIA, V46, P1366, DOI 10.1007/s00125-003-1182-9; DELAPORTE PL, 1991, PANCREAS, V6, P298, DOI 10.1097/00006676-199105000-00007; Desai BM, 2007, J CLIN INVEST, V117, P971, DOI 10.1172/JCI29988; Diaz-Flores L, 2006, HISTOL HISTOPATHOL, V21, P995, DOI 10.14670/HH-21.995; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Erkan M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-88; Gao XD, 2008, BIOCHEM BIOPH RES CO, V371, P132, DOI 10.1016/j.bbrc.2008.04.033; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; Hasegawa Y, 2007, ENDOCRINOLOGY, V148, P2006, DOI 10.1210/en.2006-1351; Herzog EL, 2003, BLOOD, V102, P3483, DOI 10.1182/blood-2003-05-1664; Hess D, 2003, NAT BIOTECHNOL, V21, P763, DOI 10.1038/nbt841; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Ianus A, 2003, J CLIN INVEST, V111, P843, DOI 10.1172/JCI200316502; Jang YY, 2004, NAT CELL BIOL, V6, P532, DOI 10.1038/ncb1132; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jensen JN, 2005, GASTROENTEROLOGY, V128, P728, DOI 10.1053/j.gastro.2004.12.008; Kallifatidis G, 2008, CANCER GENE THER, V15, P231, DOI 10.1038/sj.cgt.7701097; Kimura K, 2007, CANCER SCI, V98, P155, DOI 10.1111/j.1349-7006.2006.00369.x; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Lambert JF, 2003, J EXP MED, V197, P1563, DOI 10.1084/jem.20030031; Lechner A, 2004, DIABETES, V53, P616, DOI 10.2337/diabetes.53.3.616; Marrache F, 2008, GUT, V57, P1113, DOI 10.1136/gut.2007.143271; Mathews V, 2004, DIABETES, V53, P91, DOI 10.2337/diabetes.53.1.91; Minami E, 2005, CIRCULATION, V112, P2951, DOI 10.1161/CIRCULATIONAHA.105.576017; Mothe AJ, 2005, J HISTOCHEM CYTOCHEM, V53, P1215, DOI 10.1369/jhc.5A6639.2005; Neuschwander-Tetri BA, 2000, DIGEST DIS SCI, V45, P665, DOI 10.1023/A:1005423122127; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Omary MB, 2007, J CLIN INVEST, V117, P50, DOI 10.1172/JCI30082; Pan JJ, 2009, ONCOL RES, V17, P339, DOI 10.3727/096504009788428424; Poulsom R, 2002, J PATHOL, V197, P441, DOI 10.1002/path.1176; Schreiber H, 2010, SCIENCE, V330, P761, DOI 10.1126/science.1198345; Sparmann G, 2010, CELL RES, V20, P288, DOI 10.1038/cr.2010.10; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Swenson ES, 2007, STEM CELLS, V25, P2593, DOI 10.1634/stemcells.2007-0241; Swenson ES, 2009, BIOCHEM BIOPH RES CO, V379, P526, DOI 10.1016/j.bbrc.2008.12.104; Taneera J, 2006, DIABETES, V55, P290, DOI 10.2337/diabetes.55.02.06.db05-1212; Toth ZE, 2007, EXP CELL RES, V313, P1943, DOI 10.1016/j.yexcr.2007.02.024; Vonlaufen A, 2008, CANCER RES, V68, P7707, DOI 10.1158/0008-5472.CAN-08-1132; Vonlaufen A, 2008, CANCER RES, V68, P2085, DOI 10.1158/0008-5472.CAN-07-2477; Wang XL, 2006, STEM CELLS, V24, P307, DOI 10.1634/stemcells.2005-0052; Watanabe T, 2009, AM J PHYSIOL-GASTR L, V297, pG1138, DOI 10.1152/ajpgi.00123.2009; WILLEMER S, 1989, DIGEST DIS SCI, V34, P46, DOI 10.1007/BF01536153; Worthley DL, 2009, STEM CELLS, V27, P1463, DOI 10.1002/stem.63	52	49	50	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26088	10.1371/journal.pone.0026088	http://dx.doi.org/10.1371/journal.pone.0026088			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022519	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000295981600030
J	Kunze, A; Valero, A; Zosso, D; Renaud, P				Kunze, Anja; Valero, Ana; Zosso, Dominique; Renaud, Philippe			Synergistic NGF/B27 Gradients Position Synapses Heterogeneously in 3D Micropatterned Neural Cultures	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; IMMOBILIZED CONCENTRATION GRADIENTS; ADULT SENSORY NEURONS; CORTICAL THICKNESS; NEURITE OUTGROWTH; FACTOR-I; HIPPOCAMPAL-NEURONS; INSULIN; RAT; NGF	Native functional brain circuits show different numbers of synapses (synaptic densities) in the cerebral cortex. Until now, different synaptic densities could not be studied in vitro using current cell culture methods for primary neurons. Herein, we present a novel microfluidic based cell culture method that combines 3D micropatterning of hydrogel layers with linear chemical gradient formation. Micropatterned hydrogels were used to encapsulate dissociated cortical neurons in laminar cell layers and neurotrophic factors NGF and B27 were added to influence the formation of synapses. Neurotrophic gradients allowed for the positioning of distinguishable synaptic densities throughout a 3D micropatterned neural culture. NGF and B27 gradients were maintained in the microfluidic device for over two weeks without perfusion pumps by utilizing a refilling procedure. Spatial distribution of synapses was examined with a pre-synaptic marker to determine synaptic densities. From our experiments, we observed that (1) cortical neurons responded only to synergistic NGF/B27 gradients, (2) synaptic density increased proportionally to synergistic NGF/B27 gradients; (3) homogeneous distribution of B27 disturbed cortical neurons in sensing NGF gradients and (4) the cell layer position significantly impacted spatial distribution of synapses.	[Kunze, Anja; Valero, Ana; Renaud, Philippe] Ecole Polytech Fed Lausanne, Microsyst Lab LMIS4, Inst Microengn, Lausanne, Switzerland; [Zosso, Dominique] Ecole Polytech Fed Lausanne, Signal Proc Lab LTS 5, Inst Elect Engn, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Kunze, A (corresponding author), Ecole Polytech Fed Lausanne, Microsyst Lab LMIS4, Inst Microengn, Lausanne, Switzerland.	anja.kunze@epfl.ch	Zosso, Dominique/F-4783-2010; Kunze, Anja/F-8339-2013; Renaud, Philippe/AAQ-6205-2021; Renaud, P/A-6994-2011	Zosso, Dominique/0000-0001-5685-4273; Kunze, Anja/0000-0002-5220-0982; Renaud, Philippe/0000-0001-5199-1252; Renaud, P/0000-0001-5199-1252	Ecole Polytechnique Federale de Lausanne (EPFL)	Ecole Polytechnique Federale de Lausanne (EPFL)	The authors are funded by the Ecole Polytechnique Federale de Lausanne (EPFL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BADOWSKASZALEWS.E, 2011, BRAIN RES IN PRESS; Barnes AP, 2009, ANNU REV NEUROSCI, V32, P347, DOI 10.1146/annurev.neuro.31.060407.125536; Bekheet SH, 2010, TISSUE CELL, V42, P165, DOI 10.1016/j.tice.2010.03.005; BLESCH A, 2009, ENCY NEUROSCIENCE, P1093; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Cao X, 2001, NEUROSCIENCE, V103, P831, DOI 10.1016/S0306-4522(01)00029-X; CELINDA MK, 2009, J NEURAL ENG, V6, P16002; Chen J, 2010, ADV MED SCI-POLAND, V55, P32, DOI 10.2478/v10039-010-0020-9; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Cullen DK, 2010, BRAIN RES, V1359, P44, DOI 10.1016/j.brainres.2010.08.058; Dertinger SKW, 2002, P NATL ACAD SCI USA, V99, P12542, DOI 10.1073/pnas.192457199; FEDOROFF S, 2001, SERUM FREE MEDIA NEU, P255; FERNYHOUGH P, 1993, BRAIN RES, V607, P117, DOI 10.1016/0006-8993(93)91496-F; Fu BM, 1995, AM J PHYSIOL-HEART C, V269, pH2124, DOI 10.1152/ajpheart.1995.269.6.H2124; Hoener MC, 1996, BRAIN RES, V728, P47; HWANG JJ, 1995, MOL CELLS, V5, P501; Im K, 2008, NEUROSCI LETT, V436, P227, DOI 10.1016/j.neulet.2008.03.032; Jones DM, 2003, J NEUROCHEM, V86, P1116, DOI 10.1046/j.1471-4159.2003.01925.x; Kapur TA, 2004, J BIOMED MATER RES A, V68A, P235, DOI 10.1002/jbm.a.10168; Keenan TM, 2010, LAB CHIP, V10, P116, DOI 10.1039/b913494h; Kilinc D, 2011, NEUROTOX RES, V19, P149, DOI 10.1007/s12640-010-9152-8; Kimpinski K, 2001, J NEUROSCI RES, V63, P486, DOI 10.1002/jnr.1043; Kothapalli CR, 2011, LAB CHIP, V11, P497, DOI [10.1039/c0lc00240b, 10.1039/c01c00240b]; KUNZE A, 2011, BIOTECHNOLOGY BIOENG; Kunze A, 2011, BIOMATERIALS, V32, P2088, DOI 10.1016/j.biomaterials.2010.11.047; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; LEHMANN M, 2010, ALZHEIMERS DEMENT, V6, pS447; Li GN, 2008, TISSUE ENG PART B-RE, V14, P33, DOI 10.1089/teb.2007.0181; Ma CHE, 2009, BRAIN RES, V1289, P1, DOI 10.1016/j.brainres.2009.06.093; Markham JA, 2003, NEUROSCIENCE, V116, P71, DOI 10.1016/S0306-4522(02)00554-7; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Millet LJ, 2010, LAB CHIP, V10, P1525, DOI 10.1039/c001552k; Moore K, 2006, TISSUE ENG, V12, P267, DOI 10.1089/ten.2006.12.267; Norman LL, 2009, TISSUE ENG PART B-RE, V15, P291, DOI [10.1089/ten.teb.2009.0114, 10.1089/ten.TEB.2009.0114]; OHSAWA F, 1993, NEUROSCIENCE, V57, P67, DOI 10.1016/0306-4522(93)90112-S; Pautot S, 2008, NAT METHODS, V5, P735, DOI 10.1038/nmeth.1236; RECIOPINTO E, 1988, NEUROCHEM INT, V12, P397, DOI 10.1016/0197-0186(88)90021-6; Rimol LM, 2010, BIOL PSYCHIAT, V68, P41, DOI 10.1016/j.biopsych.2010.03.036; Roy TS, 2002, J PHARMACOL EXP THER, V300, P124, DOI 10.1124/jpet.300.1.124; Russell JW, 1998, J NEUROBIOL, V36, P455, DOI 10.1002/(SICI)1097-4695(19980915)36:4<455::AID-NEU1>3.0.CO;2-V; SHEN K, 2010, COLD SPRING HARBOR P, V2; Sofroniew MV, 2001, ANNU REV NEUROSCI, V24, P1217, DOI 10.1146/annurev.neuro.24.1.1217; SOMOGYI P, 1982, NEUROSCIENCE, V7, P2577, DOI 10.1016/0306-4522(82)90086-0; Stroh M, 2003, BIOPHYS J, V85, P581, DOI 10.1016/S0006-3495(03)74502-0; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644; Taylor AM, 2010, NEURON, V66, P57, DOI 10.1016/j.neuron.2010.03.022; Williams BJ, 2006, PROG NEUROBIOL, V80, P114, DOI 10.1016/j.pneurobio.2006.09.001; Yu LMY, 2008, J NEUROSCI METH, V171, P253, DOI 10.1016/j.jneumeth.2008.03.023; Yu LMY, 2010, BIOMATERIALS, V31, P6987, DOI 10.1016/j.biomaterials.2010.05.070	49	23	22	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26187	10.1371/journal.pone.0026187	http://dx.doi.org/10.1371/journal.pone.0026187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022558	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600043
J	Lagasse, LP; Rimal, RN; Smith, KC; Storey, JD; Rhoades, E; Barnett, DJ; Omer, SB; Links, J				Lagasse, Lisa P.; Rimal, Rajiv N.; Smith, Katherine C.; Storey, J. Douglas; Rhoades, Elizabeth; Barnett, Daniel J.; Omer, Saad B.; Links, Jonathan			How Accessible Was Information about H1N1 Flu? Literacy Assessments of CDC Guidance Documents for Different Audiences	PLOS ONE			English	Article							WORLD-WIDE-WEB; PATIENT EDUCATION MATERIALS; PROSTATE-CANCER; QUALITY; HEALTH	We assessed the literacy level and readability of online communications about H1N1/09 influenza issued by the Centers for Disease Control and Prevention (CDC) during the first month of outbreak. Documents were classified as targeting one of six audiences ranging in technical expertise. Flesch-Kincaid (FK) measure assessed literacy level for each group of documents. ANOVA models tested for differences in FK scores across target audiences and over time. Readability was assessed for documents targeting non-technical audiences using the Suitability Assessment of Materials (SAM). Overall, there was a main-effect by audience, F(5, 82) = 29.72, P<.001, but FK scores did not vary over time, F(2, 82) = .34, P>.05. A time-by-audience interaction was significant, F(10, 82) = 2.11, P<.05. Documents targeting non-technical audiences were found to be text-heavy and densely-formatted. The vocabulary and writing style were found to adequately reflect audience needs. The reading level of CDC guidance documents about H1N1/09 influenza varied appropriately according to the intended audience; sub-optimal formatting and layout may have rendered some text difficult to comprehend.	[Lagasse, Lisa P.; Rimal, Rajiv N.; Smith, Katherine C.; Storey, J. Douglas; Rhoades, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA; [Barnett, Daniel J.; Links, Jonathan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD USA; [Omer, Saad B.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lagasse, LP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA.	llagasse@jhsph.edu	Omer, Saad B/K-1182-2012	Omer, Saad B/0000-0002-5383-3474; Barnett, Daniel/0000-0003-1382-6197	Johns Hopkins Preparedness and Emergency Response Research Center (PERRC) through the Centers for Disease Control [P01TP000288]	Johns Hopkins Preparedness and Emergency Response Research Center (PERRC) through the Centers for Disease Control	This research is funded by the Johns Hopkins Preparedness and Emergency Response Research Center (PERRC) through the Centers for Disease Control grant no. P01TP000288. The funders had no role in the study design, data collection, analysis, decision to publish, or preparation of the manuscript.	BONIME A, 1998, WRITING NEW MEDIA; BRANDT HM, 2005, CANC CONTROL CANC S; CALLAGHAN JD, 2004, EFFECTIVE RISK COMMU; Croft DR, 2002, CHEST, V121, P1301, DOI 10.1378/chest.121.4.1301; D'Alessandro DM, 2001, ARCH PEDIAT ADOL MED, V155, P807, DOI 10.1001/archpedi.155.7.807; DOAK C, 1993, SUITABILITY ASSESSME; Eysenbach G, 2002, JAMA-J AM MED ASSOC, V287, P2691, DOI 10.1001/jama.287.20.2691; Fagerlin A, 2004, ANN INTERN MED, V140, P721, DOI 10.7326/0003-4819-140-9-200405040-00012; Flesh R, 1974, ART READABLE WRITING; FRIEDMAN DB, 2006, INFORM HLTH SOCIAL C, V31, P67; GARRAND T, 2001, WRITING MULTIMEDIA; Hoffmann T, 2006, PATIENT EDUC COUNS, V60, P286, DOI 10.1016/j.pec.2005.06.020; Kaphingst KA, 2006, CANCER CAUSE CONTROL, V17, P147, DOI 10.1007/s10552-005-5116-3; Kirsch I. S., 2002, ADULT LITERACY AM 1; PASSCHEORLOW MK, 2003, JAMA-J AM MED ASSOC, V348, P721; Rimal RN, 2009, B WORLD HEALTH ORGAN, V87, P247, DOI 10.2471/BLT.08.056713; Smith P T, 1998, Clin Nurse Spec, V12, P140, DOI 10.1097/00002800-199807000-00006; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; Wallace LS, 2005, J WOMENS HEALTH, V14, P936, DOI 10.1089/jwh.2005.14.936; Weintraub D, 2004, PATIENT EDUC COUNS, V55, P275, DOI 10.1016/j.pec.2003.10.003; WHO, 2005, WHO HDB JOURN INFL P; Wolf MS, 2006, PATIENT EDUC COUNS, V62, P316, DOI 10.1016/j.pec.2006.06.010; World Health Organization, 2010, PAND H1N1 2009 UPD 1	23	29	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e23583	10.1371/journal.pone.0023583	http://dx.doi.org/10.1371/journal.pone.0023583			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841MS	22039401	Green Published, gold			2022-12-27	WOS:000296517000002
J	Duhoux, FP; Ameye, G; Lambot, V; Herens, C; Lambert, F; Raynaud, S; Wlodarska, I; Michaux, L; Roche-Lestienne, C; Labis, E; Taviaux, S; Chapiro, E; Khac, FN; Struski, S; Dobbelstein, S; Dastugue, N; Lippert, E; Speleman, F; Van Roy, N; De Weer, A; Rack, K; Talmant, P; Richebourg, S; Mugneret, F; Tigaud, I; Mozziconacci, MJ; Laibe, S; Nadal, N; Terre, C; Libouton, JM; Decottignies, A; Vikkula, M; Poirel, HA				Duhoux, Francois P.; Ameye, Genevieve; Lambot, Virginie; Herens, Christian; Lambert, Frederic; Raynaud, Sophie; Wlodarska, Iwona; Michaux, Lucienne; Roche-Lestienne, Catherine; Labis, Elise; Taviaux, Sylvie; Chapiro, Elise; Florence Nguyen Khac; Struski, Stephanie; Dobbelstein, Sophie; Dastugue, Nicole; Lippert, Eric; Speleman, Frank; Van Roy, Nadine; De Weer, An; Rack, Katrina; Talmant, Pascaline; Richebourg, Steven; Mugneret, Francine; Tigaud, Isabelle; Mozziconacci, Marie-Joelle; Laibe, Sophy; Nadal, Nathalie; Terre, Christine; Libouton, Jeanne-Marie; Decottignies, Anabelle; Vikkula, Miikka; Poirel, Helene A.		GFCH; BCG-HO	Refinement of 1p36 Alterations Not Involving PRDM16 in Myeloid and Lymphoid Malignancies	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NON-HODGKINS-LYMPHOMAS; TUMOR-SUPPRESSOR GENE; IN-SITU HYBRIDIZATION; FOLLICULAR LYMPHOMA; COPY NUMBER; CHROMOSOMAL TRANSLOCATIONS; MYELODYSPLASTIC SYNDROME; CYTOGENETIC ANALYSIS; NEUROBLASTOMA	Fluorescence in situ hybridization was performed to characterize 81 cases of myeloid and lymphoid malignancies with cytogenetic 1p36 alterations not affecting the PRDM16 locus. In total, three subgroups were identified: balanced translocations (N = 27) and telomeric rearrangements (N = 15), both mainly observed in myeloid disorders; and unbalanced non-telomeric rearrangements (N = 39), mainly observed in lymphoid proliferations and frequently associated with a highly complex karyotype. The 1p36 rearrangement was isolated in 12 cases, mainly myeloid disorders. The breakpoints on 1p36 were more widely distributed than previously reported, but with identifiable rare breakpoint cluster regions, such as the TP73 locus. We also found novel partner loci on 1p36 for the known multi-partner genes HMGA2 and RUNX1. We precised the common terminal 1p36 deletion, which has been suggested to have an adverse prognosis, in B-cell lymphomas [follicular lymphomas and diffuse large B-cell lymphomas with t(14;18)(q32;q21) as well as follicular lymphomas without t(14;18)]. Intrachromosomal telomeric repetitive sequences were detected in at least half the cases of telomeric rearrangements. It is unclear how the latter rearrangements occurred and whether they represent oncogenic events or result from chromosomal instability during oncogenesis.	[Duhoux, Francois P.; Ameye, Genevieve; Lambot, Virginie; Libouton, Jeanne-Marie; Poirel, Helene A.] Catholic Univ Louvain, Clin Univ St Luc, Ctr Human Genet, B-1200 Brussels, Belgium; [Herens, Christian; Lambert, Frederic] Ctr Hosp Univ, Ctr Genet Humaine, Liege, Belgium; [Raynaud, Sophie] Ctr Hosp Univ, Nice, France; [Wlodarska, Iwona; Michaux, Lucienne] Katholieke Univ Leuven, Ctr Human Genet, Louvain, Belgium; [Roche-Lestienne, Catherine; Labis, Elise] Ctr Hosp Univ, Lille, France; [Taviaux, Sylvie] Hop Arnaud de Villeneuve, Montpellier, France; [Chapiro, Elise; Florence Nguyen Khac] Grp Hosp Pitie Salpetriere, Unite Cytogenet Hematol, F-75634 Paris, France; [Struski, Stephanie; Dobbelstein, Sophie; Dastugue, Nicole] Hop Purpan, Toulouse, France; [Lippert, Eric] Ctr Hosp Univ, Bordeaux, France; [Speleman, Frank; Van Roy, Nadine; De Weer, An] Ghent Univ Hosp, Ctr Med Genet, B-9000 Ghent, Belgium; [Rack, Katrina] Inst Pathol & Genet, Gosselies, Belgium; [Talmant, Pascaline; Richebourg, Steven] Ctr Hosp Univ, Nantes, France; [Mugneret, Francine] Ctr Hosp Univ, Dijon, France; [Tigaud, Isabelle] Ctr Hosp Lyon Sud, Lyon, France; [Mozziconacci, Marie-Joelle; Laibe, Sophy] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Nadal, Nathalie] Ctr Hosp Univ Hop Nord, St Etienne, France; [Terre, Christine] Ctr Hosp Versailles, Versailles, France; [Decottignies, Anabelle; Vikkula, Miikka] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; University of Liege; CHU Nice; KU Leuven; Universite de Lille - ISITE; CHU Lille; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU de Toulouse; CHU Bordeaux; Ghent University; Ghent University Hospital; Nantes Universite; CHU de Nantes; CHU Dijon Bourgogne; CHU Lyon; UNICANCER; Institut Paoli-Calmette (IPC); CHU de St Etienne; Centre Hospitalier de Versailles; UDICE-French Research Universities; Universite Paris Saclay; Universite Catholique Louvain	Duhoux, FP (corresponding author), Catholic Univ Louvain, Clin Univ St Luc, Ctr Human Genet, B-1200 Brussels, Belgium.	helene.antoine-poirel@uclouvain.be	Vikkula, Miikka/Q-1038-2018; speleman, frank/AAR-5184-2020; STRUSKI, stephanie/X-4836-2019	Vikkula, Miikka/0000-0002-6236-338X; speleman, frank/0000-0002-6628-8559; Duhoux, Francois/0000-0002-5429-7888; Roche-Lestienne, Catherine/0000-0002-7998-3817; Nguyen-Khac, Florence/0000-0003-3107-6668	Salus Sanguinis foundation; Maisin foundation; Action de Recherches Concertees (Communaute Francaise de Belgique)	Salus Sanguinis foundation; Maisin foundation; Action de Recherches Concertees (Communaute Francaise de Belgique)	Funding: This work was supported by grants from the Salus Sanguinis and Maisin foundations and the Action de Recherches Concertees (Communaute Francaise de Belgique). FPD is a Fund for Scientific Research (FRS-FNRS) research fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alizadeh AA, 2011, BLOOD; Battaglia A, 2005, BRAIN DEV-JPN, V27, P358, DOI 10.1016/j.braindev.2004.03.011; Caren H, 2007, BRIT J CANCER, V97, P1416, DOI 10.1038/sj.bjc.6604032; Cheung KJJ, 2009, BLOOD, V113, P137, DOI 10.1182/blood-2008-02-140616; Cheung KJJ, 2010, CANCER RES, V70, P9166, DOI 10.1158/0008-5472.CAN-10-2460; Cheung KJJ, 2010, GENE CHROMOSOME CANC, V49, P669, DOI 10.1002/gcc.20780; Cigudosa JC, 1999, GENE CHROMOSOME CANC, V25, P123, DOI 10.1002/(SICI)1098-2264(199906)25:2<123::AID-GCC8>3.0.CO;2-4; Cohen MM, 2009, AM J MED GENET A, V149A, P2629, DOI 10.1002/ajmg.a.33021; Cole KA, 2008, MOL CANCER RES, V6, P735, DOI 10.1158/1541-7786.MCR-07-2102; D'Angelo CS, 2009, HUM GENET, V125, P551, DOI 10.1007/s00439-009-0650-9; Dave BJ, 1999, CLIN CANCER RES, V5, P1401; Dave BJ, 1999, CANCER GENET CYTOGEN, V108, P120, DOI 10.1016/S0165-4608(98)00138-1; DAVIS RJ, 1994, CANCER RES, V54, P2869; Della Peruta M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-61; Duhoux FP, 2010, LEUK RES; ELLMEIER W, 1992, EMBO J, V11, P2563, DOI 10.1002/j.1460-2075.1992.tb05321.x; ENOMOTO H, 1994, ONCOGENE, V9, P2785; Ferrand N, 2010, CANCER RES, V70, P8457, DOI 10.1158/0008-5472.CAN-09-4088; Gajecka M, 2010, AM J MED GENET A, V152A, P3074, DOI 10.1002/ajmg.a.33733; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Hofmann WK, 2001, LEUKEMIA RES, V25, P855, DOI 10.1016/S0145-2126(01)00037-6; Hoglund M, 2004, GENE CHROMOSOME CANC, V39, P195, DOI 10.1002/gcc.10314; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Kang MA, 2009, J CANCER RES CLIN, V135, P761, DOI 10.1007/s00432-008-0510-3; Katzenberger T, 2009, BLOOD, V113, P1053, DOI 10.1182/blood-2008-07-168682; Lahortiga I, 2005, HUM GENET, V116, P476, DOI 10.1007/s00439-005-1268-1; Lestou VS, 2003, GENE CHROMOSOME CANC, V36, P375, DOI 10.1002/gcc.10181; LGSM Shaffer, 2009, ISCN 2009 INT SYSTEM, DOI DOI 10.1007/S00439-009-0726-6; Martinez-Delgado B, 2002, INT J CANCER, V102, P15, DOI 10.1002/ijc.10618; Mayr C, 2006, BLOOD, V107, P742, DOI 10.1182/blood-2005-05-2093; Mitelman F, 1997, NAT GENET, V15, P417, DOI 10.1038/ng0497supp-417; Mochizuki N, 2000, BLOOD, V96, P3209, DOI 10.1182/blood.V96.9.3209.h8003209_3209_3214; Mori N, 2003, BRIT J HAEMATOL, V122, P226, DOI 10.1046/j.1365-2141.2003.04434.x; Nguyen TDT, 2006, GENE CHROMOSOME CANC, V45, P918, DOI 10.1002/gcc.20355; O'Shea D, 2009, BLOOD, V113, P2298, DOI 10.1182/blood-2008-08-174953; Odero MD, 2005, LEUKEMIA, V19, P245, DOI 10.1038/sj.leu.2403605; Odero MD, 2002, GENE CHROMOSOME CANC, V35, P11, DOI 10.1002/gcc.10090; Okawa ER, 2008, ONCOGENE, V27, P803, DOI 10.1038/sj.onc.1210675; Oswald C, 2008, CELL CYCLE, V7, P1726, DOI 10.4161/cc.7.12.6148; Rajgopal A, 2003, CANCER GENET CYTOGEN, V142, P46, DOI 10.1016/S0165-4608(02)00740-9; Ross CW, 2007, CLIN CANCER RES, V13, P4777, DOI 10.1158/1078-0432.CCR-07-0456; Sakai I, 2005, GENE CHROMOSOME CANC, V44, P265, DOI 10.1002/gcc.20241; Schwaenen C, 2009, GENE CHROMOSOME CANC, V48, P39, DOI 10.1002/gcc.20617; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stoffel A, 2004, LEUKEMIA RES, V28, P1341, DOI 10.1016/j.leukres.2004.04.010; Theate I, 2011, ANN ONCOL, V22, P211; Tilman G, 2009, ONCOGENE, V28, P1682, DOI 10.1038/onc.2009.23; Tivnan A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-33; Urashima M, 1996, LEUKEMIA, V10, P1576; Waerner T, 2001, CELL GROWTH DIFFER, V12, P201; WHITE PS, 1993, GENE CHROMOSOME CANC, V7, P102, DOI 10.1002/gcc.2870070207; WHITE PS, 1995, P NATL ACAD SCI USA, V92, P5520, DOI 10.1073/pnas.92.12.5520; Zenz T, 2009, BLOOD, V113, P3801, DOI 10.1182/blood-2008-08-172254	53	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26311	10.1371/journal.pone.0026311	http://dx.doi.org/10.1371/journal.pone.0026311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039459	Green Published, Green Submitted, gold			2022-12-27	WOS:000296513200016
J	Wynn, AN; Rueschhoff, EE; Franks, RG				Wynn, April N.; Rueschhoff, Elizabeth E.; Franks, Robert G.			Transcriptomic Characterization of a Synergistic Genetic Interaction during Carpel Margin Meristem Development in Arabidopsis thaliana	PLOS ONE			English	Article							LEUCINE-RICH REPEAT; OVULE DEVELOPMENT; REGULATORY PROTEINS; FLOWER DEVELOPMENT; ORGAN SIZE; AINTEGUMENTA; EXPRESSION; FAMILY; GYNOECIUM; GROWTH	In flowering plants the gynoecium is the female reproductive structure. In Arabidopsis thaliana ovules initiate within the developing gynoecium from meristematic tissue located along the margins of the floral carpels. When fertilized the ovules will develop into seeds. SEUSS (SEU) and AINTEGUMENTA (ANT) encode transcriptional regulators that are critical for the proper formation of ovules from the carpel margin meristem (CMM). The synergistic loss of ovule initiation observed in the seu ant double mutant suggests that SEU and ANT share overlapping functions during CMM development. However the molecular mechanism underlying this synergistic interaction is unknown. Using the ATH1 transcriptomics platform we identified transcripts that were differentially expressed in seu ant double mutant relative to wild type and single mutant gynoecia. In particular we sought to identify transcripts whose expression was dependent on the coordinated activities of the SEU and ANT gene products. Our analysis identifies a diverse set of transcripts that display altered expression in the seu ant double mutant tissues. The analysis of overrepresented Gene Ontology classifications suggests a preponderance of transcriptional regulators including multiple members of the REPRODUCTIVE MERISTEMS (REM) and GROWTH-REGULATING FACTOR (GRF) families are mis-regulated in the seu ant gynoecia. Our in situ hybridization analyses indicate that many of these genes are preferentially expressed within the developing CMM. This study is the first step toward a detailed description of the transcriptional regulatory hierarchies that control the development of the CMM and ovule initiation. Understanding the regulatory hierarchy controlled by SEU and ANT will clarify the molecular mechanism of the functional redundancy of these two genes and illuminate the developmental and molecular events required for CMM development and ovule initiation.	[Wynn, April N.; Franks, Robert G.] N Carolina State Univ, Dept Genet, Raleigh, NC 27695 USA; [Rueschhoff, Elizabeth E.] Indiana Univ SE, Dept Biol, New Albany, IN 47150 USA	University of North Carolina; North Carolina State University; Indiana University System; Indiana University Southeast	Franks, RG (corresponding author), N Carolina State Univ, Dept Genet, Box 7614, Raleigh, NC 27695 USA.	rgfranks@ncsu.edu		Franks, Robert G./0000-0002-3978-1030	National Science Foundation [NSF IOS 0821896]	National Science Foundation(National Science Foundation (NSF))	Funding: This work is supported by a grant from the National Science Foundation (NSF IOS 0821896). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Ferreira M, 2007, PLANT PHYSIOL, V145, P747, DOI 10.1104/pp.107.104422; Azhakanandam S, 2008, PLANT PHYSIOL, V146, P1165, DOI 10.1104/pp.107.114751; Bao F, 2010, PLANT PHYSIOL, V152, P821, DOI 10.1104/pp.109.146183; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Blazquez MA, 1997, DEVELOPMENT, V124, P3835; Bowman JL, 1999, CURR TOP DEV BIOL, V45, P155, DOI 10.1016/S0070-2153(08)60316-6; Bowman JL, 1999, DEVELOPMENT, V126, P2387; Canales C, 2002, CURR BIOL, V12, P1718, DOI 10.1016/S0960-9822(02)01151-X; Chuang CF, 1999, GENE DEV, V13, P334, DOI 10.1101/gad.13.3.334; Colombo L, 2008, TRENDS PLANT SCI, V13, P444, DOI 10.1016/j.tplants.2008.04.011; Colombo M, 2010, DEV BIOL, V337, P294, DOI 10.1016/j.ydbio.2009.10.043; Conner J, 2000, P NATL ACAD SCI USA, V97, P12902, DOI 10.1073/pnas.230352397; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eshed Y, 2004, DEVELOPMENT, V131, P2997, DOI 10.1242/dev.01186; Franco-Zorrilla JM, 2002, PLANT PHYSIOL, V128, P418, DOI 10.1104/pp.010323; Franks RG, 2002, DEVELOPMENT, V129, P253; Ge XC, 2010, CURR BIOL, V20, pR988, DOI 10.1016/j.cub.2010.09.040; Gomez-Mena C, 2005, DEVELOPMENT, V132, P429, DOI 10.1242/dev.01600; Gonzalez D, 2007, MOL CELL BIOL, V27, P5306, DOI 10.1128/MCB.01912-06; Gregis V, 2006, PLANT CELL, V18, P1373, DOI 10.1105/tpc.106.041798; HILL JP, 1989, CAN J BOT, V67, P2922, DOI 10.1139/b89-375; Horiguchi G, 2005, PLANT J, V43, P68, DOI 10.1111/j.1365-313X.2005.02429.x; Kagi C, 2007, CURR OPIN PLANT BIOL, V10, P633, DOI 10.1016/j.pbi.2007.07.011; KATARI MS, PLANT PHYSL, V152, P500; Kelley DR, 2009, SEX PLANT REPROD, V22, P229, DOI 10.1007/s00497-009-0107-2; Kim JG, 2004, EUR J ENTOMOL, V101, P1; Kim JH, 2003, PLANT J, V36, P94, DOI 10.1046/j.1365-313X.2003.01862.x; Klucher KM, 1996, PLANT CELL, V8, P137, DOI 10.1105/tpc.8.2.137; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krizek BA, 2000, PLANT CELL, V12, P1357, DOI 10.1105/tpc.12.8.1357; Krizek BA, 1999, DEV GENET, V25, P224, DOI 10.1002/(SICI)1520-6408(1999)25:3&lt;224::AID-DVG5&gt;3.0.CO;2-Y; Krizek BA, 2009, PLANT PHYSIOL, V150, P1916, DOI 10.1104/pp.109.141119; Lee BH, 2009, PLANT PHYSIOL, V151, P655, DOI 10.1104/pp.109.141838; Levy YY, 2002, SCIENCE, V297, P243, DOI 10.1126/science.1072147; Liu ZC, 2000, PLANT CELL, V12, P1879, DOI 10.1105/tpc.12.10.1879; Long JA, 1996, NATURE, V379, P66, DOI 10.1038/379066a0; Maier AT, 2009, DEVELOPMENT, V136, P1613, DOI 10.1242/dev.033647; Matias-Hernandez L, 2010, PLANT CELL, V22, P1702, DOI 10.1105/tpc.109.068627; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Mizukami Y, 2000, P NATL ACAD SCI USA, V97, P942, DOI 10.1073/pnas.97.2.942; Nole-Wilson S, 2006, PLANT PHYSIOL, V141, P977, DOI 10.1104/pp.106.076604; Nole-Wilson S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-198; Note-Wilson S, 2010, DEV BIOL, V346, P181, DOI 10.1016/j.ydbio.2010.07.016; Orlando DA, 2009, METHODS MOL BIOL, V553, P57, DOI 10.1007/978-1-60327-563-7_4; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Romanel E, 2011, INT J DEV BIOL, V55, P657, DOI 10.1387/ijdb.113340er; Romanel EAC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005791; Scofield S, 2007, PLANT J, V50, P767, DOI 10.1111/j.1365-313X.2007.03095.x; Sessions A, 1997, DEVELOPMENT, V124, P4481; Shi DQ, 2011, CURR OPIN PLANT BIOL, V14, P74, DOI 10.1016/j.pbi.2010.09.001; Sieber P, 2004, DEV BIOL, V273, P321, DOI 10.1016/j.ydbio.2004.05.037; Siegfried KR, 1999, DEVELOPMENT, V126, P4117; Skinner DJ, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-29; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Sridhar VV, 2006, DEVELOPMENT, V133, P3159, DOI 10.1242/dev.02498; Sridhar VV, 2004, P NATL ACAD SCI USA, V101, P11494, DOI 10.1073/pnas.0403055101; Stepanova AN, 2008, CELL, V133, P177, DOI 10.1016/j.cell.2008.01.047; Swaminathan K, 2008, TRENDS PLANT SCI, V13, P647, DOI 10.1016/j.tplants.2008.09.006; TALBERT PB, 1995, DEVELOPMENT, V121, P2723; Tao Y, 2008, CELL, V133, P164, DOI 10.1016/j.cell.2008.01.049; Trigueros M, 2009, PLANT CELL, V21, P1394, DOI 10.1105/tpc.109.065508; Wellmer F, 2006, PLOS GENET, V2, P1012, DOI 10.1371/journal.pgen.0020117; Woodward AW, 2005, ANN BOT-LONDON, V95, P707, DOI 10.1093/aob/mci083; Yung MH, 1999, PLANT J, V17, P203, DOI 10.1046/j.1365-313X.1999.00359.x; Zhao DZ, 2002, GENE DEV, V16, P2021, DOI 10.1101/gad.997902; Zhong RQ, 1999, PLANT CELL, V11, P2139, DOI 10.1105/tpc.11.11.2139; Zhong RQ, 2004, PLANT CELL PHYSIOL, V45, P369, DOI 10.1093/pcp/pch051	70	35	42	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26231	10.1371/journal.pone.0026231	http://dx.doi.org/10.1371/journal.pone.0026231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031826	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200013
J	Yuan, C; Li, C; Yan, LJ; Jackson, AO; Liu, ZY; Han, CG; Yu, JL; Li, DW				Yuan, Cheng; Li, Cui; Yan, Lijie; Jackson, Andrew O.; Liu, Zhiyong; Han, Chenggui; Yu, Jialin; Li, Dawei			A High Throughput Barley Stripe Mosaic Virus Vector for Virus Induced Gene Silencing in Monocots and Dicots	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; TOBACCO RATTLE VIRUS; TO-CELL MOVEMENT; DISEASE-RESISTANCE; NICOTIANA-BENTHAMIANA; ARABIDOPSIS-THALIANA; FUNCTIONAL GENOMICS; MOLECULAR ANALYSIS; HEXAPLOID WHEAT; CAPSID PROTEIN	Barley stripe mosaic virus (BSMV) is a single-stranded RNA virus with three genome components designated alpha, beta, and gamma. BSMV vectors have previously been shown to be efficient virus induced gene silencing (VIGS) vehicles in barley and wheat and have provided important information about host genes functioning during pathogenesis as well as various aspects of genes functioning in development. To permit more effective use of BSMV VIGS for functional genomics experiments, we have developed an Agrobacterium delivery system for BSMV and have coupled this with a ligation independent cloning (LIC) strategy to mediate efficient cloning of host genes. Infiltrated Nicotiana benthamiana leaves provided excellent sources of virus for secondary BSMV infections and VIGS in cereals. The Agro/LIC BSMV VIGS vectors were able to function in high efficiency down regulation of phytoene desaturase (PDS), magnesium chelatase subunit H (ChlH), and plastid transketolase (TK) gene silencing in N. benthamiana and in the monocots, wheat, barley, and the model grass, Brachypodium distachyon. Suppression of an Arabidopsis orthologue cloned from wheat (TaPMR5) also interfered with wheat powdery mildew (Blumeria graminis f. sp. tritici) infections in a manner similar to that of the A. thaliana PMR5 loss-of-function allele. These results imply that the PMR5 gene has maintained similar functions across monocot and dicot families. Our BSMV VIGS system provides substantial advantages in expense, cloning efficiency, ease of manipulation and ability to apply VIGS for high throughput genomics studies.	[Yuan, Cheng; Li, Cui; Yan, Lijie; Liu, Zhiyong; Han, Chenggui; Yu, Jialin; Li, Dawei] China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Jackson, Andrew O.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA	China Agricultural University; University of California System; University of California Berkeley	Yuan, C (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	Dawei.Li@cau.edu.cn	Li, Dawei/I-8751-2016; Li, Dawei/CAJ-5076-2022	Li, Dawei/0000-0003-4133-1263; Liu liu, Zhiyong zhi yong/0000-0002-6958-5233; Yuan, Cheng/0000-0003-2582-4041	National Basic Research Program (973 program) [2009CB118306]; National Natural Science Foundation of China [30325001]; National Science & Technology Specific Projects of China [2008ZX08009-002]; SKLAB [2008SKLAB06-01]; United States Department of Agriculture [CSREES-2008-35319-19225]	National Basic Research Program (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science & Technology Specific Projects of China; SKLAB; United States Department of Agriculture(United States Department of Agriculture (USDA))	Funding: This work was supported by the National Basic Research Program (973 program, No. 2009CB118306), the National Natural Science Foundation of China (30325001) and the National Science & Technology Specific Projects of China (2008ZX08009-002) to DL, The Project for Extramural Scientists of SKLAB (2008SKLAB06-01) and United States Department of Agriculture Competitive Grant CSREES-2008-35319-19225 to AOJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annamalai P, 2005, VIROLOGY, V338, P96, DOI 10.1016/j.virol.2005.05.013; Baulcombe DC, 1999, CURR OPIN PLANT BIOL, V2, P109, DOI 10.1016/S1369-5266(99)80022-3; Bhullar NK, 2009, P NATL ACAD SCI USA, V106, P9519, DOI 10.1073/pnas.0904152106; Bragg JN, 2004, MOL PLANT PATHOL, V5, P465, DOI [10.1111/j.1364-3703.2004.00246.x, 10.1111/J.1364-3703.2004.00246.X]; Bragg JN, 2008, ENCY VIROLOGY, P459; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; Brueggeman R, 2008, P NATL ACAD SCI USA, V105, P14970, DOI 10.1073/pnas.0807270105; Bruun-Rasmussen M, 2007, MOL PLANT MICROBE IN, V20, P1323, DOI 10.1094/MPMI-20-11-1323; Burch-Smith TM, 2004, PLANT J, V39, P734, DOI 10.1111/j.1365-313X.2004.02158.x; Cakir C, 2010, CROP SCI, V50, pS77, DOI 10.2135/cropsci2009.10.0567; Campbell J., 2010, J BIOTECH RES, V2, P12; Cao AH, 2011, P NATL ACAD SCI USA, V108, P7727, DOI 10.1073/pnas.1016981108; Carpita N., 2000, BIOCH MOL BIOL PLANT, P52; Carrillo-Tripp J, 2006, CURR OPIN PLANT BIOL, V9, P209, DOI 10.1016/j.pbi.2006.01.012; Cloutier S, 2007, PLANT MOL BIOL, V65, P93, DOI 10.1007/s11103-007-9201-8; Consonni C, 2006, NAT GENET, V38, P716, DOI 10.1038/ng1806; Constantin GD, 2004, PLANT J, V40, P622, DOI 10.1111/j.1365-313X.2004.02233.x; Delteil A, 2010, RICE, V3, P56, DOI 10.1007/s12284-009-9035-x; Demircan T, 2010, PLANT CELL TISS ORG, V100, P91, DOI 10.1007/s11240-009-9623-x; Ding XS, 2006, MOL PLANT MICROBE IN, V19, P1229, DOI 10.1094/MPMI-19-1229; DONALD RGK, 1994, PLANT CELL, V6, P1593, DOI 10.1105/tpc.6.11.1593; Dong Y, 2007, PLANT PHYSIOL, V145, P1161, DOI 10.1104/pp.107.107391; Eckardt NA, 2002, PLANT CELL, V14, P1983, DOI 10.1105/tpc.140910; Eichmann R, 2010, MOL PLANT MICROBE IN, V23, P1217, DOI 10.1094/MPMI-23-9-1217; Engler JD, 2005, CURR OPIN BIOTECH, V16, P112, DOI 10.1016/j.copbio.2005.01.009; Goodin MM, 2008, MOL PLANT MICROBE IN, V21, P1015, DOI 10.1094/MPMI-21-8-1015; Gossele V, 2002, PLANT J, V32, P859, DOI 10.1046/j.1365-313X.2002.01471.x; Hein I, 2005, PLANT PHYSIOL, V138, P2155, DOI 10.1104/pp.105.062810; Held MA, 2008, P NATL ACAD SCI USA, V105, P20534, DOI 10.1073/pnas.0809408105; Henkes S, 2001, PLANT CELL, V13, P535, DOI 10.1105/tpc.13.3.535; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Hiriart JB, 2003, MOL PLANT MICROBE IN, V16, P99, DOI 10.1094/MPMI.2003.16.2.99; Holzberg S, 2002, PLANT J, V30, P315, DOI 10.1046/j.1365-313X.2002.01291.x; Hu PS, 2009, MOL PLANT MICROBE IN, V22, P311, DOI 10.1094/MPMI-22-3-0311; Huang CJ, 2009, PLANT BIOTECHNOL J, V7, P254, DOI 10.1111/j.1467-7652.2008.00395.x; Igarashi A, 2009, VIROLOGY, V386, P407, DOI 10.1016/j.virol.2009.01.039; Jackson AO, 2009, ANNU REV PHYTOPATHOL, V47, P385, DOI 10.1146/annurev-phyto-080508-081733; Jackson AO, 1981, HDB PLANT VIRUS INFE, P565; KUMAGAI MH, 1995, P NATL ACAD SCI USA, V92, P1679, DOI 10.1073/pnas.92.5.1679; Lawrence DM, 2001, MOL PLANT PATHOL, V2, P65, DOI 10.1046/j.1364-3703.2001.00052.x; Lawrence DM, 2001, J VIROL, V75, P8712, DOI 10.1128/JVI.75.18.8712-8723.2001; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Loutre C, 2009, PLANT J, V60, P1043, DOI 10.1111/j.1365-313X.2009.04024.x; Maeda K, 2009, MOL PLANT MICROBE IN, V22, P1331, DOI 10.1094/MPMI-22-11-1331; Manning VA, 2010, NEW PHYTOL, V187, P1034, DOI 10.1111/j.1469-8137.2010.03363.x; Meng Y, 2009, PLANT PHYSIOL, V149, P271, DOI 10.1104/pp.108.129031; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Nowara D, 2010, PLANT CELL, V22, P3130, DOI 10.1105/tpc.110.077040; Oikawa A, 2007, J EXP BOT, V58, P2617, DOI 10.1093/jxb/erm109; Pacak A, 2010, PLANT METHODS, V6, DOI 10.1186/1746-4811-6-26; Pavan S, 2010, MOL BREEDING, V25, P1, DOI 10.1007/s11032-009-9323-6; PETTY ITD, 1990, EMBO J, V9, P3453, DOI 10.1002/j.1460-2075.1990.tb07553.x; PETTY ITD, 1989, VIROLOGY, V171, P342, DOI 10.1016/0042-6822(89)90601-6; Pflieger S, 2008, PLANT J, V56, P678, DOI 10.1111/j.1365-313X.2008.03620.x; Pignatta D, 2007, MOL PLANT MICROBE IN, V20, P609, DOI 10.1094/MPMI-20-6-0609; Purkayastha A, 2010, PLANTA, V232, P1531, DOI 10.1007/s00425-010-1273-z; Ratcliff F, 1997, SCIENCE, V276, P1558, DOI 10.1126/science.276.5318.1558; Ratcliff F, 2001, PLANT J, V25, P237, DOI 10.1046/j.0960-7412.2000.00942.x; Renner T, 2009, MOL PLANT, V2, P1084, DOI 10.1093/mp/ssp033; Robertson D, 2004, ANNU REV PLANT BIOL, V55, P495, DOI 10.1146/annurev.arplant.55.031903.141803; Ruiz MT, 1998, PLANT CELL, V10, P937, DOI 10.1105/tpc.10.6.937; Scholthof HB, 1996, ANNU REV PHYTOPATHOL, V34, P299, DOI 10.1146/annurev.phyto.34.1.299; Scofield SR, 2005, PLANT PHYSIOL, V138, P2165, DOI 10.1104/pp.105.061861; Scofield SR, 2009, PLANT PHYSIOL, V149, P152, DOI 10.1104/pp.108.128702; Sindhu A, 2008, P NATL ACAD SCI USA, V105, P1762, DOI 10.1073/pnas.0711406105; Tai YS, 2005, BIOTECHNIQUES, V39, P310, DOI 10.2144/05393BM03; van der Linde K, 2011, NEW PHYTOL, V189, P471, DOI 10.1111/j.1469-8137.2010.03474.x; van Eck L, 2010, PLANT BIOTECHNOL J, V8, P1023, DOI 10.1111/j.1467-7652.2010.00539.x; Vogel J, 2000, P NATL ACAD SCI USA, V97, P1897, DOI 10.1073/pnas.030531997; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Vogel J, 2009, PLANT GENET GENOMICS, V7, P427, DOI 10.1007/978-0-387-77489-3_16; Vogel JP, 2004, PLANT J, V40, P968, DOI 10.1111/j.1365-313X.2004.02264.x; Vorwerk S, 2004, TRENDS PLANT SCI, V9, P203, DOI 10.1016/j.tplants.2004.02.005; Wang GF, 2011, NEW PHYTOL, V191, P418, DOI 10.1111/j.1469-8137.2011.03715.x; Wang XY, 2010, MOL BIOL REP, V37, P967, DOI 10.1007/s11033-009-9766-1; WOLFE KH, 1989, P NATL ACAD SCI USA, V86, P6201, DOI 10.1073/pnas.86.16.6201; Yamagishi N, 2009, PLANT MOL BIOL, V71, P15, DOI 10.1007/s11103-009-9505-y; Yelina NE, 2002, J VIROL, V76, P12981, DOI 10.1128/JVI.76.24.12981-12991.2002; Yin CT, 2011, MOL PLANT MICROBE IN, V24, P554, DOI 10.1094/MPMI-10-10-0229; Zhang CQ, 2010, PLANT PHYSIOL, V153, P52, DOI 10.1104/pp.109.151639; Zhang L, 2009, THEOR APPL GENET, V118, P385, DOI 10.1007/s00122-008-0910-4; Zhou HB, 2007, PLANT J, V52, P420, DOI 10.1111/j.1365-313X.2007.03246.x	82	177	195	4	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26468	10.1371/journal.pone.0026468	http://dx.doi.org/10.1371/journal.pone.0026468			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031834	Green Published, Green Submitted, gold			2022-12-27	WOS:000296513200023
J	Acharya, P; Pallavi, R; Chandran, S; Dandavate, V; Sayeed, SK; Rochani, A; Acharya, J; Middha, S; Kochar, S; Kochar, D; Ghosh, SK; Tatu, U				Acharya, Pragyan; Pallavi, Rani; Chandran, Syama; Dandavate, Vrushali; Sayeed, Syed Khund; Rochani, Ankit; Acharya, Jyoti; Middha, Sheetal; Kochar, Sanjay; Kochar, Dhanpat; Ghosh, Susanta Kumar; Tatu, Utpal			Clinical Proteomics of the Neglected Human Malarial Parasite Plasmodium vivax	PLOS ONE			English	Article							FALCIPARUM LIFE-CYCLE; CRYSTAL-STRUCTURE; BINDING-SITE; PROTEIN; RESISTANCE; INHIBITION; ALDOLASE; IDENTIFICATION; TRANSCRIPTOME; EXPRESSION	Recent reports highlight the severity and the morbidity of disease caused by the long neglected malaria parasite Plasmodium vivax. Due to inherent difficulties in the laboratory-propagation of P. vivax, the biology of this parasite has not been adequately explored. While the proteome of P. falciparum, the causative agent of cerebral malaria, has been extensively explored from several sources, there is limited information on the proteome of P. vivax. We have, for the first time, examined the proteome of P. vivax isolated directly from patients without adaptation to laboratory conditions. We have identified 153 proteins from clinical P. vivax, majority of which do not show homology to any previously known gene products. We also report 29 new proteins that were found to be expressed in P. vivax for the first time. In addition, several proteins previously implicated as anti-malarial targets, were also found in our analysis. Most importantly, we found several unique proteins expressed by P. vivax. This study is an important step in providing insight into physiology of the parasite under clinical settings.	[Acharya, Pragyan; Pallavi, Rani; Chandran, Syama; Dandavate, Vrushali; Sayeed, Syed Khund; Rochani, Ankit; Tatu, Utpal] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India; [Acharya, Jyoti; Middha, Sheetal; Kochar, Sanjay; Kochar, Dhanpat] SP Med Coll, Dept Med, Bikaner, Rajasthan, India; [Ghosh, Susanta Kumar] Natl Inst Malaria Res, Bangalore, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Acharya, P (corresponding author), Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.	tatu@biochem.iisc.ernet.in	Rochani, Ankit/J-8162-2019; Pallavi, Rani/AAR-7824-2020; Khund Sayeed, Syed/AAB-3149-2022	Khund Sayeed, Syed/0000-0002-0404-4233; Tatu, Utpal/0000-0003-0404-8872; Rochani, Ankit/0000-0002-0119-0462	Department of Biotechnology [DBTO201]	Department of Biotechnology	Grant No: DBTO201, "A Systems Biology Approach towards Understanding Severe Malaria with Special Reference to the Transcriptome and Proteome of the Parasite and the Host" funded by Department of Biotechnology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya P, 2009, PROTEOM CLIN APPL, V3, P1314, DOI 10.1002/prca.200900090; Baird J Kevin, 2007, Curr Infect Dis Rep, V9, P39, DOI 10.1007/s11908-007-0021-4; Banumathy G, 2003, J BIOL CHEM, V278, P18336, DOI 10.1074/jbc.M211309200; Becker JVW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-235; Bozdech Z, 2008, P NATL ACAD SCI USA, V105, P16290, DOI 10.1073/pnas.0807404105; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Collins WE, 1996, AM J TROP MED HYG, V55, P243, DOI 10.4269/ajtmh.1996.55.243; Daily JP, 2007, NATURE, V450, P1091, DOI 10.1038/nature06311; Date SV, 2006, GENOME RES, V16, P542, DOI 10.1101/gr.4573206; Dharia NV, 2010, P NATL ACAD SCI USA, V107, P20045, DOI 10.1073/pnas.1003776107; Ersmark K, 2006, BIOORGAN MED CHEM, V14, P2197, DOI 10.1016/j.bmc.2005.11.003; Fernandez-Becerra C, 2009, TRENDS PARASITOL, V25, P44, DOI 10.1016/j.pt.2008.09.012; Florens L, 2002, NATURE, V419, P520, DOI 10.1038/nature01107; Fraser T, 1997, INFECT IMMUN, V65, P2772, DOI 10.1128/IAI.65.7.2772-2777.1997; Fried M, 2007, MOL BIOCHEM PARASIT, V155, P57, DOI 10.1016/j.molbiopara.2007.05.010; Galinski MR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S9; Goh SH, 2007, PHYSIOL GENOMICS, V30, P172, DOI 10.1152/physiolgenomics.00247.2006; Granchi C, 2010, CURR MED CHEM, V17, P672, DOI 10.2174/092986710790416263; Huh AJ, 2011, J KOREAN MED SCI, V26, P42, DOI 10.3346/jkms.2011.26.1.42; ITIN C, 1993, MOL BIOCHEM PARASIT, V58, P135, DOI 10.1016/0166-6851(93)90097-H; Jalah R, 2005, MOL BIOCHEM PARASIT, V142, P158, DOI 10.1016/j.molbiopara.2005.01.020; Joubert F, 2001, PROTEINS, V45, P136, DOI 10.1002/prot.1133; Kim H, 1998, BIOCHEMISTRY-US, V37, P4388, DOI 10.1021/bi972233h; Korsinczky M, 2004, ANTIMICROB AGENTS CH, V48, P2214, DOI 10.1128/AAC.48.6.2214-2222.2004; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Le Roch KG, 2004, GENOME RES, V14, P2308, DOI 10.1101/gr.2523904; LeRoux M, 2009, TRENDS PARASITOL, V25, P474, DOI 10.1016/j.pt.2009.07.005; McGowan S, 2009, P NATL ACAD SCI USA, V106, P2537, DOI 10.1073/pnas.0807398106; Mendis K, 2001, AM J TROP MED HYG, V64, P97, DOI 10.4269/ajtmh.2001.64.97; Pallavi R, 2010, J BIOL CHEM, V285, P37964, DOI 10.1074/jbc.M110.155317; Pesce E. -R, 2010, Infectious Disorders - Drug Targets, V10, P147; PESCE ER, 2009, BIOORGAN MED CHEM, V17, P1527; Price RN, 2009, CURR OPIN INFECT DIS, V22, P430, DOI 10.1097/QCO.0b013e32832f14c1; ROOBSONG W, 2011, J PROTEOMICS    0413; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Trenholme Katharine R., 2010, Infectious Disorders - Drug Targets, V10, P217; Velanker SS, 1997, STRUCTURE, V5, P751, DOI 10.1016/S0969-2126(97)00230-X; Wanidworanun C, 1999, MOL BIOCHEM PARASIT, V102, P91, DOI 10.1016/S0166-6851(99)00087-0; Westenberger SJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000653; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wrenger C, 2005, J BIOL CHEM, V280, P5242, DOI 10.1074/jbc.M412475200	41	37	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26623	10.1371/journal.pone.0026623	http://dx.doi.org/10.1371/journal.pone.0026623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028927	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800062
J	Maan, NS; Maan, S; Nomikou, K; Belaganahalli, MN; Bachanek-Bankowska, K; Mertens, PPC				Maan, Narender S.; Maan, Sushila; Nomikou, Kyriaki; Belaganahalli, Manjunatha N.; Bachanek-Bankowska, Katarzyna; Mertens, Peter P. C.			Serotype Specific Primers and Gel-Based RT-PCR Assays for 'Typing' African Horse Sickness Virus: Identification of Strains from Africa	PLOS ONE			English	Article							EPIZOOTIC HEMORRHAGIC-DISEASE; REAL-TIME PCR; BLUETONGUE VIRUS; HORSESICKNESS-VIRUS; COMPLETE SET; VP2 GENES; SEQUENCE; ORBIVIRUS; AMPLIFICATION; GENOME	African horse sickness is a devastating, transboundary animal disease, that is 'listed' by the Office International des Epizooties (OIE). Although attenuated, inactivated and subunit vaccines have been developed for African horse sickness virus (AHSV), these are serotype-specific and their effective deployment therefore relies on rapid and reliable identification of virus type. AHSV serotype is controlled by the specificity of interactions between neutralising antibodies, and components of the outer-capsid, particularly protein VP2 (encoded by AHSV genome segment 2 (Seg-2)). We report the development and evaluation of novel gel based reverse transcription-PCR (RT-PCR) assays targeting AHSV Seg-2, which can be used to very significantly increase the speed and reliability of detection and identification (compared to virus neutralisation tests) of the nine serotypes of AHSV. Primer sets were designed targeting regions of Seg-2 that are conserved between strains within each of the AHSV serotype (types 1 to 9). These assays were evaluated using multiple AHSV strains from the orbivirus reference collection at IAH (www.reoviridae.org/dsRNA_virus_proteins/ReoID/AHSV-isolates.htm). In each case the Seg-2 primers showed a high level of specificity and failed to cross-amplify the most closely related heterologous AHSV types, or other related orbiviruses (such as bluetongue virus (BTV), or equine encephalosis virus (EEV)). The assays are rapid and sensitive, and can be used to detect and type viral RNA in blood, tissue samples, or cultivated viral suspensions within 24 h. They were used to identify AHSV strains from recent outbreaks in sub-Saharan African countries. These methods also generate cDNAs suitable for sequencing and phylogenetic analyses of Seg-2, identifying distinct virus lineages within each virus-type and helping to identify strain movements/origins. The RT-PCR methods described here provide a robust and versatile tool for rapid and specific detection and identification of AHSV serotypes 1 to 9.	[Maan, Narender S.; Maan, Sushila; Nomikou, Kyriaki; Belaganahalli, Manjunatha N.; Bachanek-Bankowska, Katarzyna; Mertens, Peter P. C.] AFRC, Inst Anim Hlth, Pirbright Lab, Vector Borne Dis Programme, Woking GU24 0NF, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Pirbright Institute	Maan, NS (corresponding author), LLR Univ Vet & Anim Sci, Dept Anim Biotechnol, Hisar, Haryana, India.	peter.mertens@iah.ac.uk	Belaganahalli, Manjunatha N/I-1688-2019; Nomikou, Kyriaki/Q-5555-2016; Nomikou, Kyriaki/P-1840-2018	Belaganahalli, Manjunatha N/0000-0003-3401-5799; Nomikou, Kyriaki/0000-0002-7013-1853; Nomikou, Kyriaki/0000-0002-7013-1853; Mertens, Peter/0000-0002-3438-3738	Biotechnology and Biological Sciences Research Council (BBSRC); European Union (EU) [SANCO/940/2002]; Department for Environment, Food and Rural Affairs (DEFRA) [SE2617]; Commonwealth Scholarship Commission; Institute for Animal Health (IAH)	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (EU)(CGIAREuropean Commission); Department for Environment, Food and Rural Affairs (DEFRA)(Department for Environment, Food & Rural Affairs (DEFRA)); Commonwealth Scholarship Commission; Institute for Animal Health (IAH)	This work was partly funded by Biotechnology and Biological Sciences Research Council (BBSRC) and the European Union (EU) (SANCO/940/2002) awarded to NSM and PM. SM and KN were part of this work funded by the Department for Environment, Food and Rural Affairs (DEFRA)(SE2617). For part of this work, MB was funded by Commonwealth Scholarship Commission (http://cscuk.dfid.gov.uk/), and KB was funded by an Institute for Animal Health (IAH) studentship (http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KA, 1995, VET MICROBIOL, V47, P133, DOI 10.1016/0378-1135(95)00059-J; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; Blacksell SD, 1996, AUST VET J, V73, P33, DOI 10.1111/j.1751-0813.1996.tb09953.x; BURRAGE TG, 1993, VIROLOGY, V196, P799, DOI 10.1006/viro.1993.1537; Castillo-Olivares J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016503; Coetzer JAW, AFRICAN HORSE SICKNE, P1231; DAVIES FG, 1971, RES VET SCI, V12, P181; Diprose JM, 2001, EMBO J, V20, P7229, DOI 10.1093/emboj/20.24.7229; Du Toit R. M., 1944, ONDERSTEPOORT JOUR VET SCI AND ANIMAL INDUST, V19, P7; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; Gouet P, 1999, CELL, V97, P481, DOI 10.1016/S0092-8674(00)80758-8; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; Hess WR, 1988, ARBOVIRUS EPIDEMIOLO, P2; HOWELL P G, 1970, Onderstepoort Journal of Veterinary Research, V37, P59; IWATA H, 1992, VIROLOGY, V191, P251, DOI 10.1016/0042-6822(92)90187-T; JEGGO MH, 1986, RES VET SCI, V40, P386, DOI 10.1016/S0034-5288(18)30556-3; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Koekemoer JJO, 2008, J VIROL METHODS, V154, P104, DOI 10.1016/j.jviromet.2008.08.010; Koekemoer JJO, 2000, J VIROL METHODS, V88, P135, DOI 10.1016/S0166-0934(00)00191-9; Koekemoer JJO, 2004, J VIROL METHODS, V122, P49, DOI 10.1016/j.jviromet.2004.08.002; LAEGREID WW, 1993, VIROLOGY, V195, P836, DOI 10.1006/viro.1993.1440; Lubroth J., 1988, Equine Practice, V10, P26; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; Mellor PS, 2004, VET RES, V35, P445, DOI 10.1051/vetres:2004021; MELLOR PS, 1993, VET RES, V24, P199; MELLOR PS, 2008, ENCY VIROLOGY, P37; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; Mertens PPC, 2011, RNAS PROTEINS DSRNA; NAMP, 2009, NAT ARB MON PROGR NA; NEWSHOLME SJ, 1983, ONDERSTEPOORT J VET, V50, P7; O'Hara RS, 1998, ARCH VIROL, P259; Oura CAL, 2011, EPIDEMIOLOG IN PRESS; Potgieter AC, 2009, J GEN VIROL, V90, P1423, DOI 10.1099/vir.0.009381-0; Potgieter AC, 2003, J GEN VIROL, V84, P1317, DOI 10.1099/vir.0.18919-0; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Rodriguez-Sanchez B, 2008, J VIROL METHODS, V151, P87, DOI 10.1016/j.jviromet.2008.03.029; ROY P, 1994, COMP IMMUNOL MICROB, V17, P243, DOI 10.1016/0147-9571(94)90046-9; Sailleau C, 2000, J GEN VIROL, V81, P831, DOI 10.1099/0022-1317-81-3-831; Stoltz MA, 1996, ONDERSTEPOORT J VET, V63, P57; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDIJK AA, 1982, ONDERSTEPOORT J VET, V49, P227; VANRENSBURG IBJ, 1981, J S AFR VET ASSOC, V52, P323; VREEDE FT, 1994, J GEN VIROL, V75, P3629, DOI 10.1099/0022-1317-75-12-3629; Wilson A, 2009, VET RES, V40, DOI 10.1051/vetres:2008054; World Organization for Animal Health (OIE), 2000, MAN STAND DIAGN TEST, P178; Zientara S, 1998, ARCH VIROL, P317	53	9	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25686	10.1371/journal.pone.0025686	http://dx.doi.org/10.1371/journal.pone.0025686			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028787	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000296510800008
J	Tobin, VA; Douglas, AJ; Leng, G; Ludwig, M				Tobin, Vicky A.; Douglas, Alison J.; Leng, Gareth; Ludwig, Mike			The Involvement of Voltage-Operated Calcium Channels in Somato-Dendritic Oxytocin Release	PLOS ONE			English	Article							RAT SUPRAOPTIC NEURONS; BAG CELL NEURONS; PROTEIN-KINASE-C; MAGNOCELLULAR NEUROSECRETORY-CELLS; GATED ION CHANNELS; CA2+ CHANNELS; NERVE-TERMINALS; AXON TERMINALS; NEUROTRANSMITTER RELEASE; NEUROPEPTIDE RELEASE	Magnocellular neurons of the supraoptic nucleus (SON) secrete oxytocin and vasopressin from axon terminals in the neurohypophysis, but they also release large amounts of peptide from their somata and dendrites, and this can be regulated both by activity-dependent Ca2+ influx and by mobilization of intracellular Ca2+. This somato-dendritic release can also be primed by agents that mobilise intracellular Ca2+, meaning that the extent to which it is activity-dependent, is physiologically labile. We investigated the role of different Ca2+ channels in somato-dendritic release; blocking N-type channels reduced depolarisation-induced oxytocin release from SONs in vitro from adult and post-natal day 8 (PND-8) rats, blocking L-type only had effect in PND-8 rats, while blocking other channel types had no significant effect. When oxytocin release was primed by prior exposure to thapsigargin, both N- and L-type channel blockers reduced release, while P/Q and R-type blockers were ineffective. Using confocal microscopy, we found immunoreactivity for Ca(v)1.2 and 1.3 channel subunits (which both form L-type channels), 2.1 (P/Q type), 2.2 (N-type) and 2.3 (R-type) in the somata and dendrites of both oxytocin and vasopressin neurons, and the intensity of the immunofluorescence signal for different subunits differed between PND-8, adult and lactating rats. Using patch-clamp electrophysiology, the N-type Ca2+ current density increased after thapsigargin treatment, but did not alter the voltage sensitivity of the channel. These results suggest that the expression, location or availability of N-type Ca2+ channels is altered when required for high rates of somato-dendritic peptide release.	[Tobin, Vicky A.; Douglas, Alison J.; Leng, Gareth; Ludwig, Mike] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Tobin, VA (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh, Midlothian, Scotland.	mike.ludwig@ed.ac.uk	Leng, Gareth/C-6688-2011	Leng, Gareth/0000-0002-2388-8466	BBSRC [BB/F019009/1]; MRC [G0700176]; Biotechnology and Biological Sciences Research Council [BB/F019009/1] Funding Source: researchfish; Medical Research Council [G0700176] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the BBSRC (BB/F019009/1) and MRC (G0700176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2000, NAT NEUROSCI, V3, P445, DOI 10.1038/74814; Ahmed MS, 2009, NEURON, V63, P372, DOI 10.1016/j.neuron.2009.07.013; Catterall WA, 2003, PHARMACOL REV, V55, P579, DOI 10.1124/pr.55.4.8; CAZALIS M, 1987, J PHYSIOL-LONDON, V390, P71, DOI 10.1113/jphysiol.1987.sp016687; Chevaleyre V, 2000, J NEUROSCI, V20, P5813, DOI 10.1523/JNEUROSCI.20-15-05813.2000; DISCALAGUENOT D, 1987, NEUROSCI LETT, V76, P209, DOI 10.1016/0304-3940(87)90717-8; DUNLAP K, 1995, TRENDS NEUROSCI, V18, P89, DOI 10.1016/0166-2236(95)93882-X; Fisher TE, 1995, J PHYSIOL-LONDON, V489, P383, DOI 10.1113/jphysiol.1995.sp021059; Fisher TE, 2000, FEBS LETT, V482, P131, DOI 10.1016/S0014-5793(00)02043-3; Fisher TE, 1996, TRENDS NEUROSCI, V19, P440; FISHER TE, 1995, J PHYSIOL-LONDON, V486, P571, DOI 10.1113/jphysiol.1995.sp020835; Fisher TE, 2001, PROG BIOPHYS MOL BIO, V77, P269, DOI 10.1016/S0079-6107(01)00017-7; Foehring RC, 1996, J NEUROPHYSIOL, V76, P977, DOI 10.1152/jn.1996.76.2.977; GUTHRIE PB, 1991, NATURE, V354, P76, DOI 10.1038/354076a0; Huang H, 2002, NEUROSCI LETT, V332, P141, DOI 10.1016/S0304-3940(02)00836-4; Joux N, 2001, J NEUROENDOCRINOL, V13, P638, DOI 10.1046/j.1365-2826.2001.00679.x; KNOX RJ, 1992, NEURON, V8, P883, DOI 10.1016/0896-6273(92)90202-O; Lai MZ, 2005, NAT NEUROSCI, V8, P435, DOI 10.1038/nn1418; LAMBERT RC, 1994, J PHYSIOL-LONDON, V478, P275, DOI 10.1113/jphysiol.1994.sp020249; Landgraf R, 2004, FRONT NEUROENDOCRIN, V25, P150, DOI 10.1016/j.yfrne.2004.05.001; LEMOS JR, 1989, NEURON, V2, P1419, DOI 10.1016/0896-6273(89)90187-6; Leng G, 2008, NEUROCHEM RES, V33, P668, DOI 10.1007/s11064-007-9500-0; LEVINA NN, 1994, J CELL SCI, V107, P127; LLINAS R, 1992, TRENDS NEUROSCI, V15, P351, DOI 10.1016/0166-2236(92)90053-B; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Ludwig M, 2005, J PHYSIOL-LONDON, V564, P515, DOI 10.1113/jphysiol.2005.083931; Ludwig M, 2002, NATURE, V418, P85, DOI 10.1038/nature00822; LUDWIG M, 1992, BRAIN RES, V576, P231, DOI 10.1016/0006-8993(92)90685-3; Ludwig M, 2003, TRENDS NEUROSCI, V26, P255, DOI 10.1016/S0166-2236(03)00072-9; MULLER W, 1991, NATURE, V354, P73, DOI 10.1038/354073a0; Passafaro M, 1996, J BIOL CHEM, V271, P30096, DOI 10.1074/jbc.271.47.30096; POW DV, 1989, NEUROSCIENCE, V32, P435, DOI 10.1016/0306-4522(89)90091-2; Rice ME, 2008, BRAIN RES REV, V58, P303, DOI 10.1016/j.brainresrev.2008.02.004; ROBINSON IM, 1995, P NATL ACAD SCI USA, V92, P2474, DOI 10.1073/pnas.92.7.2474; Rossoni E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000123; Sabatier N, 2003, J NEUROSCI, V23, P10351; Schoppa NE, 2003, TRENDS NEUROSCI, V26, P501, DOI 10.1016/S0166-2236(03)00228-5; Schubert T, 2004, NEUROSCIENCE, V125, P583, DOI 10.1016/j.neuroscience.2004.02.009; SMITH PR, 1995, J MEMBRANE BIOL, V147, P195; STRONG JA, 1987, NATURE, V325, P714, DOI 10.1038/325714a0; Tobin VA, 2004, EUR J NEUROSCI, V19, P2909, DOI 10.1111/j.1460-9568.2004.03388.x; Tobin VA, 2007, J PHYSIOL-LONDON, V582, P1337, DOI 10.1113/jphysiol.2007.132639; TURNER TJ, 1993, P NATL ACAD SCI USA, V90, P9518, DOI 10.1073/pnas.90.20.9518; Ueta Y, 2005, ENDOCRINOLOGY, V146, P406, DOI 10.1210/en.2004-0830; WANG XM, 1993, J NEUROPHYSIOL, V70, P1617, DOI 10.1152/jn.1993.70.4.1617; WANG XM, 1992, J PHYSIOL-LONDON, V445, P181, DOI 10.1113/jphysiol.1992.sp018919; White BH, 1997, J NEUROSCI, V17, P1582; White BH, 1998, J NEUROPHYSIOL, V80, P2514, DOI 10.1152/jn.1998.80.5.2514; Zhang LX, 2000, J NEUROCYTOL, V29, P19, DOI 10.1023/A:1007108012667; Zhang YL, 2008, J NEUROSCI, V28, P2601, DOI 10.1523/JNEUROSCI.4314-07; Zhang Z, 2005, CIRCULATION, V112, P1936, DOI 10.1161/CIRCULATIONAHA.105.540070; Zilberter Y, 2005, NEUROSCIENTIST, V11, P334, DOI 10.1177/1073858405275827	52	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25366	10.1371/journal.pone.0025366	http://dx.doi.org/10.1371/journal.pone.0025366			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028774	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800005
J	Yang, S; Jongejans, E; Yang, S; Bishop, JG				Yang, Suann; Jongejans, Eelke; Yang, Sylvia; Bishop, John G.			The Effect of Consumers and Mutualists of Vaccinium membranaceum at Mount St. Helens: Dependence on Successional Context	PLOS ONE			English	Article							FOOD WEBS; INTERACTION STRENGTH; BIOLOGICAL INVASION; VEGETATION DYNAMICS; PLANT SUCCESSION; HERBIVORES SLOW; MYRICA-FAYA; MECHANISMS; DEMOGRAPHY; COMMUNITY	In contrast to secondary succession, studies of terrestrial primary succession largely ignore the role of biotic interactions, other than plant facilitation and competition, despite the expectation that simplified interaction webs and propagule-dependent demographics may amplify the effects of consumers and mutualists. We investigated whether successional context determined the impact of consumers and mutualists by quantifying their effects on reproduction by the shrub Vaccinium membranaceum in primary and secondary successional sites at Mount St. Helens (Washington, USA), and used simulations to explore the effects of these interactions on colonization. Species interactions differed substantially between sites, and the combined effect of consumers and mutualists was much more strongly negative for primary successional plants. Because greater local control of propagule pressure is expected to increase successional rates, we evaluated the role of dispersal in the context of these interactions. Our simulations showed that even a small local seed source greatly increases population growth rates, thereby balancing strong consumer pressure. The prevalence of strong negative interactions in the primary successional site is a reminder that successional communities will not exhibit the distribution of interaction strengths characteristic of stable communities, and suggests the potential utility of modeling succession as the consequence of interaction strengths.	[Yang, Suann] Washington State Univ, Sch Biol Sci, Pullman, WA 99164 USA; [Jongejans, Eelke] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Expt Plant Ecol, NL-6525 ED Nijmegen, Netherlands; [Yang, Sylvia] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Bishop, John G.] Washington State Univ, Sch Biol Sci, Vancouver, WA USA	Washington State University; Radboud University Nijmegen; University of Washington; University of Washington Seattle; Washington State University	Yang, S (corresponding author), Presbyterian Coll, Clinton, SC USA.	suy14@psu.edu; suy14@psu.edu	Jongejans, Eelke/B-4832-2008	Jongejans, Eelke/0000-0003-1148-7419; Yang, Suann/0000-0001-7985-3011	Mazamas Graduate Student Research Grant; Washington Native Plant Society; WSU; National Science Foundation [DEB-0089843, DEB-0614065]; Netherlands Organisation for Scientific Research [863.08.006]	Mazamas Graduate Student Research Grant; Washington Native Plant Society; WSU; National Science Foundation(National Science Foundation (NSF)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work was partially funded with a Mazamas Graduate Student Research Grant, a Washington Native Plant Society Research Grant, a WSU Betty Higinbotham Travel Award and a National Science Foundation Graduate Research Fellowship to Suann Y, National Science Foundation award DEB-0089843 to JB and National Science Foundation award DEB-0614065 and Netherlands Organisation for Scientific Research veni grant 863.08.006 to EJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2007, FRONT ECOL ENVIRON, V5, P145, DOI 10.1890/1540-9295(2007)5[145:FKGIPA]2.0.CO;2; Albrecht M, 2010, OIKOS, V119, P1610, DOI 10.1111/j.1600-0706.2010.18376.x; Anderson KJ, 2007, AM NAT, V169, P780, DOI 10.1086/516653; Aunapuu M, 2008, AM NAT, V171, P249, DOI 10.1086/524951; Bach CE, 2001, ECOLOGY, V82, P1401, DOI 10.1890/0012-9658(2001)082[1401:LTEOIH]2.0.CO;2; Berlow EL, 2004, J ANIM ECOL, V73, P585, DOI 10.1111/j.0021-8790.2004.00833.x; Bishop JG, 2005, ECOLOGICAL RESPONSES TO THE 1980 ERUPTION OF MOUNT ST. HELENS, P151, DOI 10.1007/0-387-28150-9_11; Bishop JG, 2002, ECOLOGY, V83, P191; Bosch M, 1999, AM J BOT, V86, P871, DOI 10.2307/2656707; BRYANT JP, 1985, ECOLOGY, V66, P1564, DOI 10.2307/1938018; Caswell, 2000, MATRIX POPULATION MO; CHAPIN FS, 1994, ECOL MONOGR, V64, P149, DOI 10.2307/2937039; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Crisafulli CM, 2005, ECOLOGICAL RESPONSES TO THE 1980 ERUPTION OF MOUNT ST. HELENS, P199, DOI 10.1007/0-387-28150-9_14; DAVIDSON DW, 1993, OIKOS, V68, P23, DOI 10.2307/3545305; del Moral R, 2007, J VEG SCI, V18, P479, DOI 10.1111/j.1654-1103.2007.tb02562.x; del Moral R, 2005, PLANT ECOL, V181, P203, DOI 10.1007/s11258-005-6627-4; Del Moral R, 2005, AM J BOT, V92, P27, DOI 10.3732/ajb.92.1.27; Duncan DH, 2004, J ECOL, V92, P977, DOI 10.1111/j.1365-2745.2004.00933.x; Fagan WF, 2005, AM NAT, V166, P669, DOI 10.1086/497621; Fagan WF, 2000, AM NAT, V155, P238, DOI 10.1086/303320; FARRELL TM, 1991, ECOL MONOGR, V61, P95, DOI 10.2307/1943001; Franco M, 2004, ECOLOGY, V85, P531, DOI 10.1890/02-0651; Franklin JF, 2000, SCIENCE, V288, P1183, DOI 10.1126/science.288.5469.1183; Fuller RN, 2003, J VEG SCI, V14, P637, DOI 10.1111/j.1654-1103.2003.tb02195.x; Glenn-Lewin D.C., 1992, PLANT SUCCESSION; Gross T, 2009, SCIENCE, V325, P747, DOI 10.1126/science.1173536; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; Howe HF, 2004, BIOSCIENCE, V54, P651, DOI 10.1641/0006-3568(2004)054[0651:WSDM]2.0.CO;2; Jongejans E, 2006, BASIC APPL ECOL, V7, P71, DOI 10.1016/j.baae.2005.04.004; Kielland K, 1998, OIKOS, V82, P377, DOI 10.2307/3546979; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Laska MS, 1998, ECOLOGY, V79, P461, DOI 10.2307/176946; LUBCHENCO J, 1983, ECOLOGY, V64, P1116, DOI 10.2307/1937822; Marleau JN, 2011, AM NAT, V177, P233, DOI 10.1086/658066; Miles J. D., 1993, PRIMARY SUCCESSION L; MORRIS WF, 1989, ECOLOGY, V70, P697, DOI 10.2307/1940220; Neubert MG, 2000, ECOLOGY, V81, P1613, DOI 10.1890/0012-9658(2000)081[1613:DADCAS]2.0.CO;2; Parker MA, 2006, DIVERS DISTRIB, V12, P563, DOI 10.1111/j.1366-9516.2006.00255.x; Pulido FJ, 2005, ECOSCIENCE, V12, P92, DOI 10.2980/i1195-6860-12-1-92.1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAUSHER MD, 1981, ANIM BEHAV, V29, P1220, DOI 10.1016/S0003-3472(81)80073-5; Rooney N, 2006, NATURE, V442, P265, DOI 10.1038/nature04887; Seeds JD, 2009, PLANT SOIL, V323, P225, DOI 10.1007/s11104-009-9930-3; SILVERTOWN J, 1993, J ECOL, V81, P465, DOI 10.2307/2261525; STRIK B, 1993, PACIFIC NW EXTENSION, V215; Swanson FJ, 2005, ECOLOGICAL RESPONSES TO THE 1980 ERUPTION OF MOUNT ST. HELENS, P27, DOI 10.1007/0-387-28150-9_3; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Thornton IWB, 1996, J BIOGEOGR, V23, P577, DOI 10.1111/j.1365-2699.1996.tb00019.x; Titus JH, 1998, AM J BOT, V85, P370, DOI 10.2307/2446330; Turner MG, 1998, ECOSYSTEMS, V1, P511, DOI 10.1007/s100219900047; Vander Kloet S.P., 1988, GENUS VACCINIUM N AM; Virgo N, 2006, J ANIM ECOL, V75, P377, DOI 10.1111/j.1365-2656.2006.01058.x; VITOUSEK PM, 1989, ECOL MONOGR, V59, P247, DOI 10.2307/1942601; VITOUSEK PM, 1987, SCIENCE, V238, P802, DOI 10.1126/science.238.4828.802; Walker L.R., 2003, PRIMARY SUCCESSION E, DOI 10.1017/cbo9780511615078; WALKER LR, 1987, OIKOS, V50, P131, DOI 10.2307/3565409; WALKER LR, 1986, ECOLOGY, V67, P1508, DOI 10.2307/1939082; Wootton JT, 2005, ANNU REV ECOL EVOL S, V36, P419, DOI 10.1146/annurev.ecolsys.36.091704.175535; Wootton JT, 2002, ECOL RES, V17, P249, DOI 10.1046/j.1440-1703.2002.00484.x; Yang S, 2008, MOL ECOL, V17, P731, DOI [10.1111/j.1365-294X.2007.03625.x, 10.1111/j.1365-294X.2008.03976.x]; Yang S, 2006, VACCINIUM MEMBRANACE	62	5	6	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26094	10.1371/journal.pone.0026094	http://dx.doi.org/10.1371/journal.pone.0026094			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028808	Green Published, gold			2022-12-27	WOS:000296510800016
J	Adelman, ZN; Kilcullen, KA; Koganemaru, R; Anderson, MAE; Anderson, TD; Miller, DM				Adelman, Zach N.; Kilcullen, Kathleen A.; Koganemaru, Reina; Anderson, Michelle A. E.; Anderson, Troy D.; Miller, Dini M.			Deep Sequencing of Pyrethroid-Resistant Bed Bugs Reveals Multiple Mechanisms of Resistance within a Single Population	PLOS ONE			English	Article							SCHIZAPHIS-GRAMINUM HOMOPTERA; INSECTICIDE RESISTANCE; DETOXIFICATION ENZYMES; EVOLUTION	A frightening resurgence of bed bug infestations has occurred over the last 10 years in the U. S. and current chemical methods have been inadequate for controlling this pest due to widespread insecticide resistance. Little is known about the mechanisms of resistance present in U.S. bed bug populations, making it extremely difficult to develop intelligent strategies for their control. We have identified bed bugs collected in Richmond, VA which exhibit both kdr-type (L925I) and metabolic resistance to pyrethroid insecticides. Using LD50 bioassays, we determined that resistance ratios for Richmond strain bed bugs were similar to 5200-fold to the insecticide deltamethrin. To identify metabolic genes potentially involved in the detoxification of pyrethroids, we performed deep-sequencing of the adult bed bug transcriptome, obtaining more than 2.5 million reads on the 454 titanium platform. Following assembly, analysis of newly identified gene transcripts in both Harlan (susceptible) and Richmond (resistant) bed bugs revealed several candidate cytochrome P450 and carboxylesterase genes which were significantly over-expressed in the resistant strain, consistent with the idea of increased metabolic resistance. These data will accelerate efforts to understand the biochemical basis for insecticide resistance in bed bugs, and provide molecular markers to assist in the surveillance of metabolic resistance.	[Adelman, Zach N.; Kilcullen, Kathleen A.; Anderson, Michelle A. E.; Anderson, Troy D.] Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA 24061 USA; [Adelman, Zach N.; Kilcullen, Kathleen A.; Anderson, Michelle A. E.; Anderson, Troy D.] Virginia Tech, Dept Entomol, Blacksburg, VA USA; [Koganemaru, Reina; Miller, Dini M.] Virginia Tech, Dodson Urban Pest Management Lab, Blacksburg, VA USA; [Koganemaru, Reina; Miller, Dini M.] Virginia Tech, Dept Entomol, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Adelman, ZN (corresponding author), Virginia Tech, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.	zachadel@vt.edu		Adelman, Zach/0000-0001-5901-7171; Anderson, Troy/0000-0002-9403-2833; Anderson, Michelle/0000-0003-1510-2942	Fralin Life Science Institute/Virginia Bioinformatics Institute	Fralin Life Science Institute/Virginia Bioinformatics Institute	This work was funded by a grant from the Fralin Life Science Institute/Virginia Bioinformatics Institute to D.M.M. and Z.N.A.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anderson TD, 2004, PESTIC BIOCHEM PHYS, V80, P54, DOI 10.1016/j.pestbp.2004.06.003; Bai XD, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016336, 10.1371/journal.pone.0016368]; BUSVINE JR, 1958, ORGANIZATION, V19, P1041; Claudianos C, 2006, INSECT MOL BIOL, V15, P615, DOI 10.1111/j.1365-2583.2006.00672.x; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FEROZ M, 1969, B ENTOMOL RES, V59, P377, DOI 10.1017/S0007485300003345; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; FEYEREISEN R, 2005, INSECT CYTOCHROME CO, V4; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Francischetti IMB, 2010, J PROTEOME RES, V9, P3820, DOI 10.1021/pr1000169; Karunaratne SHPP, 2007, PESTIC BIOCHEM PHYS, V88, P102, DOI 10.1016/j.pestbp.2006.09.006; LOFGREN CS, 1958, J EC ENTOMOL, V99; Moore DJ, 2006, J ECON ENTOMOL, V99, P2080, DOI 10.1603/0022-0493-99.6.2080; Nelson David R, 2006, Methods Mol Biol, V320, P1; Oakeshott J.G., 2005, COMPREHENSIVE MOL IN, P309, DOI [10.1016/B0-44-451924-6/00073-9, DOI 10.1016/B0-44-451924-6/00073-9]; Polanco Andrea M., 2011, Insects, V2, P173, DOI 10.3390/insects2020173; Potter Michael F., 2011, American Entomologist, V57, P14; Ramsey JS, 2010, INSECT MOL BIOL, V19, P155, DOI 10.1111/j.1365-2583.2009.00973.x; Ranson H, 2002, SCIENCE, V298, P179, DOI 10.1126/science.1076781; Ranson H, 2001, BIOCHEM J, V359, P295, DOI 10.1042/0264-6021:3590295; Romero A., 2009, J EC ENTOMOL, V102; Romero A, 2007, J MED ENTOMOL, V44, P175, DOI 10.1603/0022-2585(2007)44[175:IRITBB]2.0.CO;2; Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Valles SM, 1996, J ECON ENTOMOL, V89, P21, DOI 10.1093/jee/89.1.21; Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2; Zhu F, 2010, ARCH INSECT BIOCHEM, V73, P245, DOI 10.1002/arch.20355; Zhu KY, 1998, PESTIC BIOCHEM PHYS, V62, P135, DOI 10.1006/pest.1998.2376; Zhu KY, 2000, PESTIC BIOCHEM PHYS, V68, P138, DOI 10.1006/pest.2000.2510	30	82	84	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26228	10.1371/journal.pone.0026228	http://dx.doi.org/10.1371/journal.pone.0026228			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039447	gold, Green Submitted, Green Published			2022-12-27	WOS:000296507500041
J	Dennig, A; Shivange, AV; Marienhagen, J; Schwaneberg, U				Dennig, Alexander; Shivange, Amol V.; Marienhagen, Jan; Schwaneberg, Ulrich			OmniChange: The Sequence Independent Method for Simultaneous Site-Saturation of Five Codons	PLOS ONE			English	Article							DIRECTED PROTEIN EVOLUTION; SYNTHETIC BIOLOGY; MUTAGENESIS; PCR; LIBRARIES; ENZYMES; DNA; PERFORMANCE; MUTATIONS; DIVERSITY	Focused mutant library generation methods have been developed to improve mainly "localizable'' enzyme properties such as activity and selectivity. Current multi-site saturation methods are restricted by the gene sequence, require subsequent PCR steps and/or additional enzymatic modifications. Here we report, a multiple site saturation mutagenesis method, OmniChange, which simultaneously and efficiently saturates five independent codons. As proof of principle, five chemically cleaved DNA fragments, each carrying one NNK-degenerated codon, were generated and assembled to full gene length in a one-pot-reaction without additional PCR-amplification or use of restriction enzymes or ligases. Sequencing revealed the presence of up to 27 different codons at individual positions, corresponding to 84.4% of the theoretical diversity offered by NNK-degeneration. OmniChange is absolutely sequence independent, does not require a minimal distance between mutated codons and can be accomplished within a day.	[Dennig, Alexander; Shivange, Amol V.; Marienhagen, Jan; Schwaneberg, Ulrich] Rhein Westfal TH Aachen, Lehrstuhl Biotechnol, Aachen, Germany	RWTH Aachen University	Dennig, A (corresponding author), Rhein Westfal TH Aachen, Lehrstuhl Biotechnol, Aachen, Germany.	u.schwaneberg@biotec.rwth-aachen.de	Dennig, Alexander/D-7362-2012; Shivange, Amol/E-1166-2011; Shivange, Amol V./AAE-9481-2019; Schwaneberg, Ulrich/E-7234-2014; Marienhagen, Jan/E-9593-2011	Shivange, Amol V./0000-0002-4169-2969; Schwaneberg, Ulrich/0000-0003-4026-701X; Marienhagen, Jan/0000-0001-5513-3730	BASF Societas Europaea (BASF SE)	BASF Societas Europaea (BASF SE)	Financial support for this research was provided by BASF Societas Europaea (BASF SE) (http://www.basf.com/group/corporate/en/index). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold F. H., 2003, DIRECTED EVOLUTION L; Blanusa M, 2010, ANAL BIOCHEM, V406, P141, DOI 10.1016/j.ab.2010.07.011; Brouk M, 2010, APPL ENVIRON MICROB, V76, P6397, DOI 10.1128/AEM.00878-10; Brownie J, 1997, NUCLEIC ACIDS RES, V25, P3235, DOI 10.1093/nar/25.16.3235; Chiang L W, 1993, PCR Methods Appl, V2, P210; Chica RA, 2005, CURR OPIN BIOTECH, V16, P378, DOI 10.1016/j.copbio.2005.06.004; ECKSTEIN F, 1989, TRENDS BIOCHEM SCI, V14, P97, DOI 10.1016/0968-0004(89)90130-8; Firth AE, 2008, NUCLEIC ACIDS RES, V36, pW281, DOI 10.1093/nar/gkn226; Garrett JB, 2004, APPL ENVIRON MICROB, V70, P3041, DOI 10.1128/AEM.70.5.3041-3046.2004; GISH G, 1988, SCIENCE, V240, P1520, DOI 10.1126/science.2453926; Hamamatsu N, 2006, PROTEIN ENG DES SEL, V19, P483, DOI 10.1093/protein/gzl034; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63; Herman A, 2007, PROTEIN ENG DES SEL, V20, P219, DOI 10.1093/protein/gzm014; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hogrefe HH, 2002, BIOTECHNIQUES, V33, P1158, DOI 10.2144/02335pf01; INOUE H, 1990, GENE, V96, P23, DOI 10.1016/0378-1119(90)90336-P; Jochens H, 2010, CHEMBIOCHEM, V11, P1861, DOI 10.1002/cbic.201000284; KEGLEREBO DM, 1994, NUCLEIC ACIDS RES, V22, P1593, DOI 10.1093/nar/22.9.1593; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Liang J, 2011, WIRES SYST BIOL MED, V3, P7, DOI 10.1002/wsbm.104; Matsumura I, 2005, BIOMOL ENG, V22, P73, DOI 10.1016/j.bioeng.2004.10.004; Peng RH, 2006, APPL MICROBIOL BIOT, V73, P234, DOI 10.1007/s00253-006-0583-3; Reetz MT, 2008, CHEMBIOCHEM, V9, P1797, DOI 10.1002/cbic.200800298; Reetz MT, 2007, NAT PROTOC, V2, P891, DOI 10.1038/nprot.2007.72; Reetz MT, 2010, J AM CHEM SOC, V132, P9144, DOI 10.1021/ja1030479; Reetz MT, 2006, ANGEW CHEM INT EDIT, V45, P1236, DOI 10.1002/anie.200502746; Reetz MT, 2005, ANGEW CHEM INT EDIT, V44, P4192, DOI 10.1002/anie.200500767; Sambrook J., 1982, MOL CLONING LAB MANU, V1; Seyfang A, 2004, ANAL BIOCHEM, V324, P285, DOI 10.1016/j.ab.2003.10.012; Shen ZY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-143; Shivange AV, 2009, CURR OPIN CHEM BIOL, V13, P19, DOI 10.1016/j.cbpa.2009.01.019; Tabuchi I, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-19; Turner NJ, 2009, NAT CHEM BIOL, V5, P568, DOI 10.1038/nchembio.203; Vroom JA, 2008, BIOTECHNIQUES, V44, P924, DOI 10.2144/000112808; Wang HH, 2010, J MOL CELL BIOL, V2, P178, DOI 10.1093/jmcb/mjq015; Wong TS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh028; Wong TS, 2007, ENVIRON MICROBIOL, V9, P2645, DOI 10.1111/j.1462-2920.2007.01411.x; Yang GY, 2009, CHEMBIOCHEM, V10, P2704, DOI 10.1002/cbic.200900384	38	66	71	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26222	10.1371/journal.pone.0026222	http://dx.doi.org/10.1371/journal.pone.0026222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039444	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500038
J	Yang, SJ; Xiao, X; Meng, XB; Leslie, KK				Yang, Shujie; Xiao, Xue; Meng, Xiangbing; Leslie, Kimberly K.			A Mechanism for Synergy with Combined mTOR and PI3 Kinase Inhibitors	PLOS ONE			English	Article							ENDOMETRIAL CANCER; PTEN EXPRESSION; 3-KINASE/MAMMALIAN TARGET; TRANSLATIONAL CONTROL; AKT PHOSPHORYLATION; ANTITUMOR-ACTIVITY; MAMMALIAN TARGET; IN-VIVO; RAPAMYCIN; PATHWAY	Dysregulation of the mammalian target of rapamycin (mTOR) signaling has been found in many human cancers, particularly those with loss of the tumor suppressor PTEN. However, mTORC1 inhibitors such as temsirolimus have only modest activity when used alone and may induce acquired resistance by activating upstream mTORC2 and Akt. Other tumors that do not depend upon PI3K/Akt/mTOR signaling for survival are primarily resistant. This study tested the hypothesis that the limited clinical efficacy of temsirolimus is due to a compensatory increase in survival signaling pathways downstream of Akt as well as an incomplete block of 4E-BP1-controlled proliferative processes downstream of mTOR. We explored the addition of a PI3K inhibitor to temsirolimus and identified the mechanism of combinatorial synergy. Proliferation assays revealed that BEZ235 (dual PI3K/mTOR inhibitor) or ZSTK474 (pan PI3K inhibitor) combined with temsirolimus synergistically inhibited cell growth compared to cells treated with any of the agents alone. Co-treatment resulted in G0/G1 cell cycle arrest and up-regulation of p27. Cell death occurred through massive autophagy and subsequent apoptosis. While molecular profiling revealed that, in most cases, sensitivity to temsirolimus alone was most marked in cells with high basal phospho-Akt resulting from PTEN inactivation, combining a PI3K inhibitor with temsirolimus prevented compensatory Akt phosphorylation and synergistically enhanced cell death regardless of PTEN status. Another molecular correlate of synergy was the finding that temsirolimus treatment alone blocks downstream S6 kinase signaling, but not 4E-BP1. Adding BEZ235 completely abrogated 4E-BP1 phosphorylation. We conclude that the addition of a PI3K inhibitor overcomes cellular resistance to mTORC1 inhibitors regardless of PTEN status, and thus substantially expands the molecular phenotype of tumors likely to respond.	[Yang, Shujie; Xiao, Xue; Meng, Xiangbing; Leslie, Kimberly K.] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA; [Yang, Shujie; Xiao, Xue; Meng, Xiangbing; Leslie, Kimberly K.] Univ Iowa, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Yang, SJ (corresponding author), Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA.	kimberly-leslie@uiowa.edu		Yang, Shujie/0000-0003-1753-3068; Leslie, Kimberly/0000-0002-2704-8990; meng, xiangbing/0000-0002-9612-6438	NIH [R01CA99908]; Department of Obstetrics and Gynecology; NATIONAL CANCER INSTITUTE [R01CA099908] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Obstetrics and Gynecology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by NIH R01CA99908 to KKL and Department of Obstetrics and Gynecology Research Development Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albitar L, 2007, GYNECOL ONCOL, V106, P52, DOI 10.1016/j.ygyno.2007.02.033; Bansal N, 2009, CANCER CONTROL, V16, P8, DOI 10.1177/107327480901600102; Baumann P, 2009, EXP CELL RES, V315, P485, DOI 10.1016/j.yexcr.2008.11.007; Brachmann SM, 2009, P NATL ACAD SCI USA, V106, P22299, DOI 10.1073/pnas.0905152106; Breuleux M, 2009, MOL CANCER THER, V8, P742, DOI 10.1158/1535-7163.MCT-08-0668; Burris H, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3005; Cheung LWT, 2011, CANCER DISCOV, V1, P170, DOI 10.1158/2159-8290.CD-11-0039; Choo AY, 2008, P NATL ACAD SCI USA, V105, P17414, DOI 10.1073/pnas.0809136105; Dan S, 2009, BIOCHEM BIOPH RES CO, V379, P104, DOI 10.1016/j.bbrc.2008.12.015; Degtyarev M, 2009, AUTOPHAGY, V5, P415, DOI 10.4161/auto.5.3.7827; Delmonte A, 2008, CURR OPIN ONCOL, V20, P554, DOI 10.1097/CCO.0b013e32830b0deb; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Fu L, 2009, CANCER RES, V69, P8967, DOI 10.1158/0008-5472.CAN-09-2190; GARRIDOLAGUNA I, 2010, J CLIN ONCOL, V28; Guertin DA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe24; Gupta M, 2009, BLOOD, V114, P2926, DOI 10.1182/blood-2009-05-220889; Hsieh AC, 2010, CANCER CELL, V17, P249, DOI 10.1016/j.ccr.2010.01.021; Janes MR, 2010, NAT MED, V16, P205, DOI 10.1038/nm.2091; Jin N, 2009, J CLIN ENDOCR METAB, V94, P4107, DOI 10.1210/jc.2009-0662; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kanamori Y, 2001, CLIN CANCER RES, V7, P892; Konecny GE, 2008, BRIT J CANCER, V98, P1076, DOI 10.1038/sj.bjc.6604278; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Marone R, 2009, MOL CANCER RES, V7, P601, DOI 10.1158/1541-7786.MCR-08-0366; Mutter GL, 2000, JNCI-J NATL CANCER I, V92, P924, DOI 10.1093/jnci/92.11.924; Neshat MS, 2001, P NATL ACAD SCI USA, V98, P10314, DOI 10.1073/pnas.171076798; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oda K, 2008, CANCER RES, V68, P8127, DOI 10.1158/0008-5472.CAN-08-0755; Salvesen HB, 2009, P NATL ACAD SCI USA, V106, P4834, DOI 10.1073/pnas.0806514106; Shoji K, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.5074; Shoji K, 2009, BRIT J CANCER, V101, P145, DOI 10.1038/sj.bjc.6605109; Steelman LS, 2008, ONCOGENE, V27, P4086, DOI 10.1038/onc.2008.49; Tashiro H, 1997, CANCER RES, V57, P3935; Terakawa N, 2003, ENDOCR-RELAT CANCER, V10, P203, DOI 10.1677/erc.0.0100203; Wang XR, 2008, CANCER RES, V68, P7409, DOI 10.1158/0008-5472.CAN-08-1522; Wang XR, 2009, EXPERT OPIN THER TAR, V13, P1193, DOI 10.1517/14728220903225008; Werzowa J, 2011, J INVEST DERMATOL, V131, P495, DOI 10.1038/jid.2010.327; Yaguchi SI, 2006, JNCI-J NATL CANCER I, V98, P545, DOI 10.1093/jnci/djj133; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yazbeck VY, 2008, EXP HEMATOL, V36, P443, DOI 10.1016/j.exphem.2007.12.008	43	41	46	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26343	10.1371/journal.pone.0026343	http://dx.doi.org/10.1371/journal.pone.0026343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039466	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500053
J	Rouyar, A; Party, V; Presern, J; Blejec, A; Renou, M				Rouyar, Angela; Party, Virginie; Presern, Janez; Blejec, Andrej; Renou, Michel			A General Odorant Background Affects the Coding of Pheromone Stimulus Intermittency in Specialist Olfactory Receptor Neurones	PLOS ONE			English	Article							TEMPORAL RESOLUTION; RESPONSES; CELLS; PULSES; PLUMES; STIMULATION; LEPIDOPTERA; MECHANISMS; PHYSIOLOGY; BEHAVIOR	In nature the aerial trace of pheromone used by male moths to find a female appears as a train of discontinuous pulses separated by gaps among a complex odorant background constituted of plant volatiles. We investigated the effect of such background odor on behavior and coding of temporal parameters of pheromone pulse trains in the pheromone olfactory receptor neurons of Spodoptera littoralis. Effects of linalool background were tested by measuring walking behavior towards a source of pheromone. While velocity and orientation index did drop when linalool was turned on, both parameters recovered back to pre-background values after 40 s with linalool still present. Photo-ionization detector was used to characterize pulse delivery by our stimulator. The photo-ionization detector signal reached 71% of maximum amplitude at 50 ms pulses and followed the stimulus period at repetition rates up to 10 pulses/s. However, at high pulse rates the concentration of the odorant did not return to base level during inter-pulse intervals. Linalool decreased the intensity and shortened the response of receptor neurons to pulses. High contrast (> 10 dB) in firing rate between pulses and inter-pulse intervals was observed for 1 and 4 pulses/s, both with and without background. Significantly more neurons followed the 4 pulses/s pattern when delivered over linalool; at the same time the information content was preserved almost to the control values. Rapid recovery of behavior shows that change of perceived intensity is more important than absolute stimulus intensity. While decreasing the response intensity, background odor preserved the temporal parameters of the specific signal.	[Rouyar, Angela; Party, Virginie; Renou, Michel] Univ Paris 06, Inst Natl Rech Agron, PISC, UMR1272, Versailles, France; [Presern, Janez; Blejec, Andrej] Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia	INRAE; UDICE-French Research Universities; Sorbonne Universite; National Institute of Biology - Slovenia	Rouyar, A (corresponding author), Univ Paris 06, Inst Natl Rech Agron, PISC, UMR1272, Versailles, France.	michel.renou@versailles.inra.fr	Blejec, Andrej/M-5215-2019; Blejec, Andrej/A-8470-2010; RENOU, Michel/AAT-7340-2021	Blejec, Andrej/0000-0001-7484-6031; Blejec, Andrej/0000-0001-7484-6031; RENOU, Michel/0000-0001-6172-0210	"Sante des Plantes et Environnement" Department of INRA; Proteus project [20221UH]	"Sante des Plantes et Environnement" Department of INRA; Proteus project	This study was supported by a research project from the "Sante des Plantes et Environnement" Department of INRA (http://www4.inra.fr/sante-plantes-environnement). Travel between France and Slovenia was supported by Proteus project 20221UH (http://www.egide.asso.fr/jahia/Jahia/). The funders had no role in study design, data collection, analysis, decision to publish or preparation of the manuscript.	[Anonymous], 2014, PHEROMONES ANIMAL BE; Barrozo RB, 2002, J INSECT PHYSIOL, V48, P825, DOI 10.1016/S0022-1910(02)00109-9; Bau J, 2005, CHEM SENSES, V30, P771, DOI 10.1093/chemse/bji069; Bau J, 2002, J INSECT PHYSIOL, V48, P433, DOI 10.1016/S0022-1910(02)00062-8; Blejec A, 2005, NEUROCOMPUTING, V65, P557, DOI 10.1016/j.neucom.2004.10.103; Carde RT, 2008, J CHEM ECOL, V34, P854, DOI 10.1007/s10886-008-9484-5; DENOTTER CJ, 1978, ENTOMOL EXP APPL, V24, P570, DOI 10.1007/BF02385110; Durand N, 2010, INSECT MOL BIOL, V19, P87, DOI 10.1111/j.1365-2583.2009.00939.x; Durand N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015026; Glynn EF, 2006, BIOINFORMATICS, V22, P310, DOI 10.1093/bioinformatics/bti789; GOMEZ G, 1994, J COMP PHYSIOL A, V174, P803; Hen I, 2004, J NEUROSCI METH, V133, P161, DOI 10.1016/j.jneumeth.2003.10.013; Hillier NK, 2011, CHEM SENSES, V36, P93, DOI 10.1093/chemse/bjq102; Iyengar A, 2010, P NATL ACAD SCI USA, V107, P9855, DOI 10.1073/pnas.1003856107; Jarriault D, 2010, CHEM SENSES, V35, P705, DOI 10.1093/chemse/bjq069; Justus KA, 2005, J NEUROPHYSIOL, V93, P2233, DOI 10.1152/jn.00888.2004; Kaissling KE, 1996, CHEM SENSES, V21, P257, DOI 10.1093/chemse/21.2.257; KAISSLING KE, 1989, J COMP PHYSIOL A, V165, P147, DOI 10.1007/BF00619189; Kaissling KE, 1974, BIOCH SENSORY FUNCTI, P243; Kelling FJ, 2002, MED VET ENTOMOL, V16, P161, DOI 10.1046/j.1365-2915.2002.00359.x; Kodadova B, 1996, J COMP PHYSIOL A, V179, P301, DOI 10.1007/BF00194984; Lei Hong, 2009, Journal of Biology (London), V8, P21, DOI 10.1186/jbiol120; Lemon WC, 1997, J EXP BIOL, V200, P1809; LJUNGBERG H, 1993, J INSECT PHYSIOL, V39, P253, DOI 10.1016/0022-1910(93)90096-A; MAFRANETO A, 1994, NATURE, V369, P142, DOI 10.1038/369142a0; Marion-Poll F., 1995, J NEUROSCI METH, V63, P591, DOI [10.1016/0165-0270(95)00110-7, DOI 10.1016/0165-0270(95)00110-7]; MARIONPOLL F, 1992, J COMP PHYSIOL A, V171, P505, DOI 10.1007/BF00194583; Mustaparta H, 1997, INSECT PHEROMONE RESEARCH, P144; Ochieng SA, 2002, J COMP PHYSIOL A, V188, P325, DOI 10.1007/s00359-002-0308-8; PARTY V, 2009, EUR S INS TAST OLF V, V11; Party V, 2009, CHEM SENSES, V34, P763, DOI 10.1093/chemse/bjp060; Pezier A, 2007, CHEM SENSES, V32, P305, DOI 10.1093/chemse/bjl059; Quero C, 1996, J CHEM ECOL, V22, P1087, DOI 10.1007/BF02027947; RUMBO ER, 1989, J COMP PHYSIOL A, V165, P281, DOI 10.1007/BF00619348; SCHNEIDER D, 1964, Z VERGL PHYSIOL, V48, P632, DOI 10.1007/BF00333745; Vickers NJ, 2006, CHEM SENSES, V31, P155, DOI 10.1093/chemse/bjj011; Vickers NJ, 2000, BIOL BULL, V198, P203, DOI 10.2307/1542524; Zufall F, 2000, CHEM SENSES, V25, P473, DOI 10.1093/chemse/25.4.473	38	26	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26443	10.1371/journal.pone.0026443	http://dx.doi.org/10.1371/journal.pone.0026443			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028879	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900063
J	Bando, SY; Alegro, MC; Amaro, E; Silva, AV; Castro, LHM; Wen, HT; Lima, LD; Brentani, H; Moreira, CA				Bando, Silvia Y.; Alegro, Maryana C.; Amaro, Edson, Jr.; Silva, Alexandre V.; Castro, Luiz H. M.; Wen, Hung-Tzu; Lima, Leandro de A.; Brentani, Helena; Moreira-Filho, Carlos Alberto			Hippocampal CA3 Transcriptome Signature Correlates with Initial Precipitating Injury in Refractory Mesial Temporal Lobe Epilepsy	PLOS ONE			English	Article							FEBRILE SEIZURES; GENE-EXPRESSION; ENDOSOMAL PROTEIN; SOMATOSTATIN; BRAIN; NEUROGENESIS; MODULATION; TEXTURE; TRANSMISSION; RELEASE	Background: Prolonged febrile seizures constitute an initial precipitating injury (IPI) commonly associated with refractory mesial temporal lobe epilepsy (RMTLE). In order to investigate IPI influence on the transcriptional phenotype underlying RMTLE we comparatively analyzed the transcriptomic signatures of CA3 explants surgically obtained from RMTLE patients with (FS) or without (NFS) febrile seizure history. Texture analyses on MRI images of dentate gyrus were conducted in a subset of surgically removed sclerotic hippocampi for identifying IPI-associated histo-radiological alterations. Methodology/Principal Findings: DNA microarray analysis revealed that CA3 global gene expression differed significantly between FS and NFS subgroups. An integrative functional genomics methodology was used for characterizing the relations between GO biological processes themes and constructing transcriptional interaction networks defining the FS and NFS transcriptomic signatures and its major gene-gene links (hubs). Co-expression network analysis showed that: i) CA3 transcriptomic profiles differ according to the IPI; ii) FS distinctive hubs are mostly linked to glutamatergic signalization while NFS hubs predominantly involve GABAergic pathways and neurotransmission modulation. Both networks have relevant hubs related to nervous system development, what is consistent with cell genesis activity in the hippocampus of RMTLE patients. Moreover, two candidate genes for therapeutic targeting came out from this analysis: SSTR1, a relevant common hub in febrile and afebrile transcriptomes, and CHRM3, due to its putative role in epilepsy susceptibility development. MRI texture analysis allowed an overall accuracy of 90% for pixels correctly classified as belonging to FS or NFS groups. Histological examination revealed that granule cell loss was significantly higher in FS hippocampi. Conclusions/Significance: CA3 transcriptional signatures and dentate gyrus morphology fairly correlate with IPI in RMTLE, indicating that FS-RMTLE represents a distinct phenotype. These findings may shed light on the molecular mechanisms underlying refractory epilepsy phenotypes and contribute to the discovery of novel specific drug targets for therapeutic interventions.	[Bando, Silvia Y.; Moreira-Filho, Carlos Alberto] Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil; [Alegro, Maryana C.] Univ Sao Paulo, Escola Politecn, Integrated Syst Lab, Sao Paulo, Brazil; [Amaro, Edson, Jr.] Univ Sao Paulo, Fac Med, Dept Radiol, Sao Paulo, Brazil; [Silva, Alexandre V.] Univ Fed Sao Paulo, Dept Biosci, Sao Paulo, Brazil; [Castro, Luiz H. M.] Univ Sao Paulo, Fac Med, Hosp Clin, Clin Neurol Div, Sao Paulo, Brazil; [Wen, Hung-Tzu] Univ Sao Paulo, Fac Med, Hosp Clin, Epilepsy Surg Grp, Sao Paulo, Brazil; [Lima, Leandro de A.] Hosp Canc AC Camargo, Biotechnol Lab, Sao Paulo, Brazil; [Brentani, Helena] Univ Sao Paulo, Fac Med, Dept Psychiat, Inst Nacl Psiquiatria Desenvolvimento, Sao Paulo, Brazil; [Brentani, Helena] Univ Sao Paulo, Fac Med, Lab Invest Med 23, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade de Sao Paulo; A.C.Camargo Cancer Center; Universidade de Sao Paulo; Universidade de Sao Paulo	Bando, SY (corresponding author), Univ Sao Paulo, Fac Med, Dept Pediat, Sao Paulo, Brazil.	carlos.moreira@icr.usp.br	Castro, Luiz H M/H-9427-2012; moreira-filho, carlos alberto/J-2551-2014; Amaro, Edson/B-6653-2009; Brentani, Helena/G-6839-2011; Silva, Alexandre V/A-2634-2011; Lima, Leandro/F-4132-2012; amaro, edson/GLR-7735-2022	Castro, Luiz H M/0000-0003-1878-8548; moreira-filho, carlos alberto/0000-0003-3433-4714; Amaro, Edson/0000-0002-5889-1382; Brentani, Helena/0000-0001-5192-4682; Silva, Alexandre V/0000-0001-7107-0864; Lima, Leandro/0000-0001-5313-9485; amaro, edson/0000-0002-5889-1382; Bando, Silvia Yumi/0000-0003-3794-2440	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2005/56.446-0]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPq) [475051/2009-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) grant no. 2005/56.446-0 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(CNPq) grant no. 475051/2009-2 to CAM-F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Khalil B, 2007, EPILEPSY RES, V73, P104, DOI 10.1016/j.eplepsyres.2006.08.005; Alberi S, 2005, MOL CELL NEUROSCI, V29, P313, DOI 10.1016/j.mcn.2005.03.011; Arion D, 2006, NEUROBIOL DIS, V22, P374, DOI 10.1016/j.nbd.2005.12.012; Bae EK, 2010, J CLIN NEUROL, V6, P73, DOI 10.3988/jcn.2010.6.2.73; Bant JS, 2010, P NATL ACAD SCI USA, V107, P12357, DOI 10.1073/pnas.1005633107; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Baulac S, 2004, LANCET NEUROL, V3, P421, DOI 10.1016/S1474-4422(04)00808-7; Berg AT, 1999, NEUROLOGY, V53, P1742, DOI 10.1212/WNL.53.8.1742; Cea-del Rio CA, 2010, J NEUROSCI, V30, P6011, DOI 10.1523/JNEUROSCI.5040-09.2010; Cendes F, 2004, CURR OPIN NEUROL, V17, P161, DOI 10.1097/00019052-200404000-00013; Cendes F, 2003, ARQ NEURO-PSIQUIAT, V61, P1; Chemin J, 2002, J PHYSIOL-LONDON, V540, P3, DOI 10.1113/jphysiol.2001.013269; Cho EY, 2009, GENE, V429, P44, DOI 10.1016/j.gene.2008.10.008; Choeiri C, 2005, NEUROSCIENCE, V130, P591, DOI 10.1016/j.neuroscience.2004.09.011; Choi J, 2005, J NEUROSCI, V25, P869, DOI 10.1523/JNEUROSCI.3212-04.2005; CHU A, 1990, PATTERN RECOGN LETT, V11, P415, DOI 10.1016/0167-8655(90)90112-F; Corradini I, 2009, ANN NY ACAD SCI, V1152, P93, DOI 10.1111/j.1749-6632.2008.03995.x; Csaba Z, 2005, J NEUROPATH EXP NEUR, V64, P956, DOI 10.1097/01.jnen.0000186923.50215.50; Diaz E, 2010, EUR J NEUROSCI, V32, P261, DOI 10.1111/j.1460-9568.2010.07357.x; Dube C, 2005, ANN NEUROL, V57, P152, DOI 10.1002/ana.20358; Dube CM, 2007, TRENDS NEUROSCI, V30, P490, DOI 10.1016/j.tins.2007.07.006; Dube CM, 2010, J NEUROSCI, V30, P7484, DOI 10.1523/JNEUROSCI.0551-10.2010; Dube CM, 2009, BRAIN DEV-JPN, V31, P366, DOI 10.1016/j.braindev.2008.11.010; Duvernoy H. M., 1988, HUMAN HIPPOCAMPUS AT; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Ermolinsky B, 2008, NEUROREPORT, V19, P1291, DOI 10.1097/WNR.0b013e3283094bb6; Fiumelli H, 2005, NEURON, V48, P773, DOI 10.1016/j.neuron.2005.10.025; Frank T, 2010, NEURON, V68, P724, DOI 10.1016/j.neuron.2010.10.027; Gasnier B, 2004, PFLUG ARCH EUR J PHY, V447, P756, DOI 10.1007/s00424-003-1091-2; Goetz R, 2009, J BIOL CHEM, V284, P17883, DOI 10.1074/jbc.M109.001842; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Gomez O, 2010, J ANAT, V217, P616, DOI 10.1111/j.1469-7580.2010.01291.x; Goodyer CG, 2004, NEUROSCIENCE, V125, P441, DOI 10.1016/j.neuroscience.2004.02.001; Grigorescu SE, 2002, IEEE T IMAGE PROCESS, V11, P1160, DOI 10.1109/TIP.2002.804262; Hahn A, 2009, BRAIN DEV-JPN, V31, P515, DOI 10.1016/j.braindev.2009.04.012; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hallermann S, 2010, NEURON, V68, P710, DOI 10.1016/j.neuron.2010.10.026; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; Hattiangady B, 2004, NEUROBIOL DIS, V17, P473, DOI 10.1016/j.nbd.2004.08.008; Hattiangady B, 2008, EPILEPSIA, V49, P26, DOI 10.1111/j.1528-1167.2008.01635.x; Heuser K, 2011, SEIZURE-EUR J EPILEP, V20, P163, DOI 10.1016/j.seizure.2010.11.015; Heuser K, 2010, EPILEPSY RES, V88, P55, DOI 10.1016/j.eplepsyres.2009.09.023; Hudson LD, 2011, TRANSGENIC RES, V20, P951, DOI 10.1007/s11248-010-9470-x; Jamali S, 2006, BRAIN, V129, P625, DOI 10.1093/brain/awl001; Kao HT, 1999, J EXP ZOOL, V285, P360, DOI 10.1002/(SICI)1097-010X(19991215)285:4<360::AID-JEZ4>3.3.CO;2-V; Kassner A, 2010, AM J NEURORADIOL, V31, P809, DOI 10.3174/ajnr.A2061; Kerr N, 2010, MOL CELL NEUROSCI, V44, P165, DOI 10.1016/j.mcn.2010.03.005; Khirug S, 2010, J NEUROSCI, V30, P12028, DOI 10.1523/JNEUROSCI.3154-10.2010; Lee SH, 2011, J PHYSIOL-LONDON, V589, P891, DOI 10.1113/jphysiol.2010.198499; Lee TS, 2007, MOL MED, V13, P1, DOI 10.2119/2006-00079.Lee; Ma XM, 2003, J NEUROSCI, V23, P10593; Macdonald RL, 2010, J PHYSIOL-LONDON, V588, P1861, DOI 10.1113/jphysiol.2010.186999; Maeda K, 2001, NEUROL MED-CHIR, V41, P582, DOI 10.2176/nmc.41.582; Majores M, 2007, EPILEPSIA, V48, P4, DOI 10.1111/j.1528-1167.2007.01062.x; Mandai K, 2009, NEURON, V63, P614, DOI 10.1016/j.neuron.2009.07.031; MANJUNATH BS, 1991, IEEE T PATTERN ANAL, V13, P478, DOI 10.1109/34.134046; Mathern GW, 2002, EPILEPSIA, V43, P68, DOI 10.1046/j.1528-1157.43.s.5.28.x; McClelland S, 2011, NEUROSCI LETT, V497, P155, DOI 10.1016/j.neulet.2011.02.032; Meyer AC, 2010, B WORLD HEALTH ORGAN, V88, P260, DOI 10.2471/BLT.09.064147; Morales-Corraliza J, 2010, EPILEPSIA, V51, P1910, DOI 10.1111/j.1528-1167.2010.02680.x; Munoz A, 2007, EPILEPSIA, V48, P663, DOI 10.1111/j.1528-1167.2007.00986.x; Nakayama J, 2009, BRAIN DEV-JPN, V31, P359, DOI 10.1016/j.braindev.2008.11.014; Nielsen JA, 2006, J NEUROSCI, V26, P9881, DOI 10.1523/JNEUROSCI.2246-06.2006; Nielsen JA, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-98; O'Dell C, 2005, PEDIATR NEUROL, V33, P166, DOI 10.1016/j.pediatrneurol.2005.03.005; Ozbas-Gerceker F, 2006, NEUROSCIENCE, V138, P457, DOI 10.1016/j.neuroscience.2005.11.043; Patel YC, 1999, FRONT NEUROENDOCRIN, V20, P157, DOI 10.1006/frne.1999.0183; Perez-Reyes E, 2006, CELL CALCIUM, V40, P89, DOI 10.1016/j.ceca.2006.04.012; Potier S, 2005, EUR J NEUROSCI, V21, P1828, DOI 10.1111/j.1460-9568.2005.04026.x; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sasikala M., 2008, Journal of Medical Engineering & Technology, V32, P198, DOI 10.1080/03091900701455524; Scantlebury MH, 2010, EPILEPSY RES, V89, P27, DOI 10.1016/j.eplepsyres.2009.11.002; Siebzehnrubl FA, 2008, EPILEPSIA, V49, P55, DOI 10.1111/j.1528-1167.2008.01638.x; Singh NA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000649; Stein ELA, 2010, J NEUROCHEM, V113, P42, DOI 10.1111/j.1471-4159.2009.06529.x; Steiner P, 2002, J CELL BIOL, V157, P1197, DOI 10.1083/jcb.200202022; Tallent MK, 2008, MOL CELL ENDOCRINOL, V286, P96, DOI 10.1016/j.mce.2007.12.004; Tallent MK, 1999, J NEUROPHYSIOL, V81, P1626, DOI 10.1152/jn.1999.81.4.1626; Trimbuch T, 2009, CELL, V138, P1222, DOI 10.1016/j.cell.2009.06.050; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Gassen KLI, 2008, EPILEPSIA, V49, P1055, DOI 10.1111/j.1528-1167.2007.01470.x; van Gassen KLI, 2009, EPILEPSIA, V50, P957, DOI 10.1111/j.1528-1167.2008.02015.x; Wang YY, 2010, BRAIN PATHOL, V20, P1, DOI 10.1111/j.1750-3639.2008.00254.x; Watanabe TK, 1996, GENOMICS, V38, P273, DOI 10.1006/geno.1996.0628; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005315; Zacharaki EI, 2009, MAGN RESON MED, V62, P1609, DOI 10.1002/mrm.22147; Zhu L, 2005, J NEUROPHYSIOL, V93, P1557, DOI 10.1152/jn.00616.2004; Zook JM, 2005, MAGN RESON IMAGING, V23, P671, DOI 10.1016/j.mri.2005.04.002	90	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26268	10.1371/journal.pone.0026268	http://dx.doi.org/10.1371/journal.pone.0026268			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022585	Green Published, Green Submitted, gold			2022-12-27	WOS:000295981600044
J	Lodi, A; Ronen, SM				Lodi, Alessia; Ronen, Sabrina M.			Magnetic Resonance Spectroscopy Detectable Metabolomic Fingerprint of Response to Antineoplastic Treatment	PLOS ONE			English	Article							HUMAN PROSTATE-CANCER; DECISION-SUPPORT-SYSTEM; PROTON MR SPECTROSCOPY; HUMAN BREAST-LESIONS; IN-VIVO; CELL-METABOLISM; CHOLINE KINASE; BRAIN-TUMORS; INHIBITION; PHOSPHOCHOLINE	Targeted therapeutic approaches are increasingly being implemented in the clinic, but early detection of response frequently presents a challenge as many new therapies lead to inhibition of tumor growth rather than tumor shrinkage. Development of novel non-invasive methods to monitor response to treatment is therefore needed. Magnetic resonance spectroscopy (MRS) and magnetic resonance spectroscopic imaging are non-invasive imaging methods that can be employed to monitor metabolism, and previous studies indicate that these methods can be useful for monitoring the metabolic consequences of treatment that are associated with early drug target modulation. However, single-metabolite biomarkers are often not specific to a particular therapy. Here we used an unbiased 1H MRS-based metabolomics approach to investigate the overall metabolic consequences of treatment with the phosphoinositide 3-kinase inhibitor LY294002 and the heat shock protein 90 inhibitor 17AAG in prostate and breast cancer cell lines. LY294002 treatment resulted in decreased intracellular lactate, alanine fumarate, phosphocholine and glutathione. Following 17AAG treatment, decreased intracellular lactate, alanine, fumarate and glutamine were also observed but phosphocholine accumulated in every case. Furthermore, citrate, which is typically observed in normal prostate tissue but not in tumors, increased following 17AAG treatment in prostate cells. This approach is likely to provide further information about the complex interactions between signaling and metabolic pathways. It also highlights the potential of MRS-based metabolomics to identify metabolic signatures that can specifically inform on molecular drug action.	[Lodi, Alessia; Ronen, Sabrina M.] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Lodi, A (corresponding author), Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA.	sabrina.ronen@ucsf.edu			National Institutes of Health (NIH) [RO1 CA130819]; NATIONAL CANCER INSTITUTE [R01CA130819] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health (NIH; www.nih.gov) grant RO1 CA130819. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Saffar NMS, 2010, CANCER RES, V70, P5507, DOI 10.1158/0008-5472.CAN-09-4476; Albers MJ, 2008, CANCER RES, V68, P8607, DOI 10.1158/0008-5472.CAN-08-0749; Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; Bathen TF, 2010, CANCER RES, V70, P6692, DOI 10.1158/0008-5472.CAN-10-0437; Beloueche-Babari M, 2006, MOL CANCER THER, V5, P187, DOI 10.1158/1535-7163.MCT-03-0220; Beloueche-Babari M, 2009, MOL CANCER THER, V8, P1305, DOI 10.1158/1535-7163.MCT-09-0039; Brandes AH, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2729; Cao MD, 2012, NMR BIOMED, V25, P369, DOI 10.1002/nbm.1762; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Cheng LL, 2005, CANCER RES, V65, P3030, DOI 10.1158/0008-5472.CAN-04-4106; Chung YL, 2003, J NATL CANCER I, V95, P1624, DOI 10.1093/jnci/djg084; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Dafni H, 2010, CANCER RES, V70, P7400, DOI 10.1158/0008-5472.CAN-10-0883; Day SE, 2007, NAT MED, V13, P1382, DOI 10.1038/nm1650; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Elstrom RL, 2004, CANCER RES, V64, P3892, DOI 10.1158/0008-5472.CAN-03-2904; Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823; Glunde K, 2006, MOL PHARMACEUT, V3, P496, DOI 10.1021/mp060067e; Goetz MP, 2003, ANN ONCOL, V14, P1169, DOI 10.1093/annonc/mdg316; Gunther UL, 2000, J MAGN RESON, V145, P201, DOI 10.1006/jmre.2000.2071; Heath Elisabeth I, 2005, Clin Prostate Cancer, V4, P138, DOI 10.3816/CGC.2005.n.024; Holmes E, 2008, NATURE, V453, P396, DOI 10.1038/nature06882; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Isaacs JS, 2005, CANCER CELL, V8, P143, DOI 10.1016/j.ccr.2005.06.017; Jacobs MA, 2004, J MAGN RESON IMAGING, V19, P68, DOI 10.1002/jmri.10427; Jagannathan NR, 1998, NMR BIOMED, V11, P414, DOI 10.1002/(SICI)1099-1492(199812)11:8<414::AID-NBM537>3.0.CO;2-W; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Jordan NF, 2005, NMR BIOMED, V18, P430, DOI 10.1002/nbm.977; Kaelin WG, 2010, NATURE, V465, P562, DOI 10.1038/465562a; Koul D, 2010, NEURO-ONCOLOGY, V12, P559, DOI 10.1093/neuonc/nop058; Kurhanewicz J, 1996, RADIOLOGY, V198, P795, DOI 10.1148/radiology.198.3.8628874; Le HC, 2009, MAGN RESON MED, V62, P1112, DOI 10.1002/mrm.22137; Lodi A, 2011, ACS CHEM BIOL, V6, P169, DOI 10.1021/cb900300j; Mori N, 2004, MOL IMAGING, V3, P319, DOI 10.1162/1535350042973517; Nakagami K, 1999, JPN J CANCER RES, V90, P419, DOI 10.1111/j.1349-7006.1999.tb00764.x; Parsons HM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-234; Peet AC, 2007, NMR BIOMED, V20, P692, DOI 10.1002/nbm.1181; Perez-Ruiz A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-581; Regan PL, 2011, INT J ONCOL, V38, P105, DOI 10.3892/ijo_00000829; Roebuck JR, 1998, RADIOLOGY, V209, P269, DOI 10.1148/radiology.209.1.9769842; Romanska HM, 2009, NEOPLASIA, V11, P1301, DOI 10.1593/neo.09850; Ronen SM, 2001, BRIT J CANCER, V84, P691, DOI 10.1054/bjoc.2000.1663; ROSS B, 1994, MAGN RESON QUART, V10, P191; Sankaranarayanapillai M, 2008, MOL IMAGING, V7, P92, DOI 10.2310/7290.2008.0011; Schnackenberg LK, 2009, METABOLOME ANAL STRA, P159; Seth P, 2011, NEOPLASIA, V13, P60, DOI 10.1593/neo.101020; Sitter B, 2004, MAGN RESON MATER PHY, V16, P174, DOI 10.1007/s10334-003-0025-5; Solit DB, 2007, CLIN CANCER RES, V13, P1775, DOI 10.1158/1078-0432.CCR-06-1863; Stroobants S, 2003, EUR J CANCER, V39, P2012, DOI 10.1016/S0959-8049(03)00073-X; SU JS, 2011, NMR BIOMED; Tate AR, 2006, NMR BIOMED, V19, P411, DOI 10.1002/nbm.1016; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251; Tiziani S, 2009, NEOPLASIA, V11, P269, DOI 10.1593/neo.81396; Van den Abbeele AD, 2008, PET CLIN, V3, P77, DOI 10.1016/j.cpet.2008.08.001; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Ward CS, 2010, CANCER RES, V70, P1296, DOI 10.1158/0008-5472.CAN-09-2251; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yeung DKW, 2001, RADIOLOGY, V220, P40, DOI 10.1148/radiology.220.1.r01jl0240	60	34	35	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26155	10.1371/journal.pone.0026155	http://dx.doi.org/10.1371/journal.pone.0026155			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022547	Green Published, gold, Green Submitted			2022-12-27	WOS:000295976000077
J	Na, B; Huang, ZM; Wang, Q; Qi, ZX; Tian, YJ; Lu, CC; Yu, JW; Hanes, MA; Kakar, S; Huang, EJ; Ou, JHJ; Liu, LM; Yen, TSB				Na, Bing; Huang, Zhiming; Wang, Qian; Qi, Zhongxia; Tian, Yongjun; Lu, Cheng-Chan; Yu, Jingwei; Hanes, Martha A.; Kakar, Sanjay; Huang, Eric J.; Ou, J. -H. James; Liu, Limin; Yen, T. S. Benedict			Transgenic Expression of Entire Hepatitis B Virus in Mice Induces Hepatocarcinogenesis Independent of Chronic Liver Injury	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; LARGE SURFACE PROTEIN; HEPATOCELLULAR-CARCINOMA; ENDOPLASMIC-RETICULUM; X-PROTEIN; ER STRESS; TRANSCRIPTION FACTOR; TUMOR-GROWTH; S-PROMOTER; CYCLIN D1	Hepatocellular carcinoma (HCC), the third leading cause of cancer deaths worldwide, is most commonly caused by chronic hepatitis B virus (HBV) infection. However, whether HBV plays any direct role in carcinogenesis, other than indirectly causing chronic liver injury by inciting the host immune response, remains unclear. We have established two independent transgenic mouse lines expressing the complete genome of a mutant HBV ("preS2 mutant") that is found at much higher frequencies in people with HCC than those without. The transgenic mice show evidence of stress in the endoplasmic reticulum (ER) and overexpression of cyclin D1 in hepatocytes. These mice do not show any evidence of chronic liver injury, but by 2 years of age a majority of the male mice develop hepatocellular neoplasms, including HCC. Unexpectedly, we also found a significant increase in hepatocarcinogenesis independent of necroinflammation in a transgenic line expressing the entire wildtype HBV. As in the mutant HBV mice, HCC was found only in aged-2-year-old-mice of the wildtype HBV line. The karyotype in all the three transgenic lines appears normal and none of the integration sites of the HBV transgene in the mice is near an oncogene or tumor suppressor gene. The significant increase of HCC incidence in all the three transgenic lines-expressing either mutant or wildtype HBV-therefore argues strongly that in absence of chronic necroinflammation, HBV can contribute directly to the development of HCC.	[Na, Bing; Huang, Zhiming; Wang, Qian; Kakar, Sanjay; Huang, Eric J.; Yen, T. S. Benedict] Vet Adm Med Ctr, Pathol Serv, San Francisco, CA 94121 USA; [Na, Bing; Liu, Limin] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Qi, Zhongxia; Yu, Jingwei] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Tian, Yongjun; Ou, J. -H. James] Univ So Calif, Dept Mol Microbiol & Immunol, Los Angeles, CA USA; [Lu, Cheng-Chan] Natl Cheng Kung Univ, Coll Med, Dept Pathol, Tainan 70101, Taiwan; [Hanes, Martha A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Lab Anim Resources, San Antonio, TX 78229 USA; [Kakar, Sanjay; Huang, Eric J.; Yen, T. S. Benedict] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Southern California; National Cheng Kung University; University of Texas System; University of Texas Health San Antonio; University of California System; University of California San Francisco	Na, B (corresponding author), Vet Adm Med Ctr, Pathol Serv, San Francisco, CA 94121 USA.	Limin.Liu@ucsf.edu	Huang, Eric J./AAH-7997-2019; Tian, Yongjun/F-8007-2011	Huang, Eric J./0000-0002-5381-3801; 	US National Institutes of Health [R01CA55578, R01AI060559, R01CA122359, P30DK26743, P01CA123328]; Taiwan National Science Council [NSC88-2314-B-006-053, NSC89-2314-B-006-026]; NATIONAL CANCER INSTITUTE [P01CA123328, R01CA122359, R01CA055578] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060559] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Taiwan National Science Council(Ministry of Science and Technology, Taiwan); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the US National Institutes of Health (R01CA55578 to TSBY, R01AI060559 to JHJO, R01CA122359 to LL, P30DK26743 to the University of California, San Francisco Liver Center, and P01CA123328 to TSBY, JHJO, and LL) and from the Taiwan National Science Council (NSC88-2314-B-006-053 and NSC89-2314-B-006-026 to CCL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan AL, 2001, J BIOL CHEM, V276, P27272, DOI 10.1074/jbc.M103196200; [Anonymous], 1972, J Hered, V63, P69; ARAKI K, 1991, JPN J CANCER RES, V82, P235, DOI 10.1111/j.1349-7006.1991.tb01834.x; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Block TM, 2003, ONCOGENE, V22, P5093, DOI 10.1038/sj.onc.1206557; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; BRUSS V, 1991, P NATL ACAD SCI USA, V88, P1059, DOI 10.1073/pnas.88.3.1059; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; CHISARI FV, 1989, CELL, V59, P1145, DOI 10.1016/0092-8674(89)90770-8; CHISARI FV, 1987, P NATL ACAD SCI USA, V84, P6909, DOI 10.1073/pnas.84.19.6909; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Deane NG, 2001, CANCER RES, V61, P5389; Edamoto Y, 2003, INT J CANCER, V106, P334, DOI 10.1002/ijc.11254; Elchuri S, 2005, ONCOGENE, V24, P367, DOI 10.1038/sj.onc.1208207; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Fan YF, 2000, J GASTROEN HEPATOL, V15, P519, DOI 10.1046/j.1440-1746.2000.02187.x; FERNHOLZ D, 1993, VIROLOGY, V194, P137, DOI 10.1006/viro.1993.1243; Foo NC, 2002, HEPATOLOGY, V36, P1400, DOI 10.1053/jhep.2002.36819; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; GUIDOTTI LG, 1995, J VIROL, V69, P6158, DOI 10.1128/JVI.69.10.6158-6169.1995; Huang ZM, 2005, MOL CELL BIOL, V25, P7522, DOI 10.1128/MCB.25.17.7522-7533.2005; HUANG ZM, 1993, J VIROL, V67, P7032, DOI 10.1128/JVI.67.12.7032-7040.1993; Huy TTT, 2003, J CLIN MICROBIOL, V41, P5449, DOI 10.1128/JCM.41.12.5449-5455.2003; Jamora C, 1996, P NATL ACAD SCI USA, V93, P7690, DOI 10.1073/pnas.93.15.7690; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; KOIKE K, 1994, HEPATOLOGY, V19, P810, DOI 10.1002/hep.1840190403; LEE TH, 1990, J VIROL, V64, P5939, DOI 10.1128/JVI.64.12.5939-5947.1990; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Nagy Andras, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.prot4706; Nakamoto Y, 1998, J EXP MED, V188, P341, DOI 10.1084/jem.188.2.341; Raimondo G, 2004, J HEPATOL, V40, P515, DOI 10.1016/j.jhep.2003.11.025; Reifenberg K, 1997, J HEPATOL, V26, P119, DOI 10.1016/S0168-8278(97)80018-9; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Seeger C., 2007, FIELDS VIROLOGY, V1, P2977; Tai PC, 2002, VIROLOGY, V292, P44, DOI 10.1006/viro.2001.1239; TSUKUMA H, 1993, NEW ENGL J MED, V328, P1797, DOI 10.1056/NEJM199306243282501; Turturro A, 2002, J GERONTOL A-BIOL, V57, pB379, DOI 10.1093/gerona/57.11.B379; Wei W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000328; Xu ZC, 1996, J VIROL, V70, P133, DOI 10.1128/JVI.70.1.133-140.1996; Xu ZC, 1997, J VIROL, V71, P7387, DOI 10.1128/JVI.71.10.7387-7392.1997; Xu ZM, 2002, J VIROL, V76, P2579, DOI 10.1128/JVI.76.5.2579-2584.2002; Xu ZR, 2005, P NATL ACAD SCI USA, V102, P4120, DOI 10.1073/pnas.0500660102; Yergeau DA, 2007, NAT PROTOC, V2, P2975, DOI 10.1038/nprot.2007.428; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zheng YY, 2007, HEPATOLOGY, V45, P16, DOI 10.1002/hep.21445; ZHOU DX, 1991, MOL CELL BIOL, V11, P1353, DOI 10.1128/MCB.11.3.1353; ZHOU DX, 1990, J BIOL CHEM, V265, P20731	49	30	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26240	10.1371/journal.pone.0026240	http://dx.doi.org/10.1371/journal.pone.0026240			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022578	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000091
J	Kim, SK; Yun, SJ; Kim, J; Lee, OJ; Bae, SC; Kim, WJ				Kim, Seon-Kyu; Yun, Seok-Joong; Kim, Jiyeon; Lee, Ok-Jun; Bae, Suk-Chul; Kim, Wun-Jae			Identification of Gene Expression Signature Modulated by Nicotinamide in a Mouse Bladder Cancer Model	PLOS ONE			English	Article							URINARY-BLADDER; NIACIN; CARCINOGENESIS; CARCINOMA; PROFILES; TUMORS; N-BUTYL-N-(4-HYDROXYBUTYL)NITROSAMINE; EPIDEMIOLOGY; OCCUPATION; DIAGNOSIS	Background: Urinary bladder cancer is often a result of exposure to chemical carcinogens such as cigarette smoking. Because of histological similarity, chemically-induced rodent cancer model was largely used for human bladder cancer studies. Previous investigations have suggested that nicotinamide, water-soluble vitamin B3, may play a key role in cancer prevention through its activities in cellular repair. However, to date, evidence towards identifying the genetic alterations of nicotinamide in cancer prevention has not been provided. Here, we search for the molecular signatures of cancer prevention by nicotinamide using a N-butyl-N-(4-hydroxybutyl)-nitrosamine (BBN)-induced urinary bladder cancer model in mice. Methodology/Principal Findings: Via microarray gene expression profiling of 20 mice and 233 human bladder samples, we performed various statistical analyses and immunohistochemical staining for validation. The expression patterns of 893 genes associated with nicotinamide activity in cancer prevention were identified by microarray data analysis. Gene network analyses of these 893 genes revealed that the Myc and its associated genes may be the most important regulator of bladder cancer prevention, and the gene expression signature correlated well with protein expression data. Comparison of gene expression between human and mouse revealed that BBN-induced mouse bladder cancers exhibited gene expression profiles that were more similar to those of invasive human bladder cancers than to those of non-invasive human bladder cancers. Conclusions/Significance: This study demonstrates that nicotinamide plays an important role as a chemo-preventive and therapeutic agent in bladder cancer through the regulation of the Myc oncogenic signature. Nicotinamide may represent a promising therapeutic modality in patients with muscle-invasive bladder cancer.	[Kim, Seon-Kyu; Yun, Seok-Joong; Kim, Wun-Jae] Chungbuk Natl Univ, Dept Urol, Coll Med, Chonju, South Korea; [Kim, Seon-Kyu; Yun, Seok-Joong; Kim, Wun-Jae] Chungbuk Natl Univ, Chungbuk Biomed Sci Ctr BK21, Sch Med, Chonju, South Korea; [Kim, Jiyeon] Duke Univ, Sch Med, Dept Pharmacol & Canc Biol, Durham, NC USA; [Lee, Ok-Jun] Chungbuk Natl Univ, Dept Pathol, Coll Med, Chonju, South Korea; [Bae, Suk-Chul] Chungbuk Natl Univ, Dept Biochem, Coll Med, Chonju, South Korea	Chungbuk National University; Chungbuk National University; Duke University; Chungbuk National University; Chungbuk National University	Kim, SK (corresponding author), Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea.	wjkim@chungbuk.ac.kr		Kim, Seon-Kyu/0000-0002-4176-5187; Yun, Seok-Joong/0000-0001-7737-4746	National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2011-0001042, R16-2003-002-01001-02006]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2011-0001042 and R16-2003-002-01001-02006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baffa R, 2006, J EXP CLIN CANC RES, V25, P145; Chen JL, 2009, J CEREBR BLOOD F MET, V29, P911, DOI 10.1038/jcbfm.2009.11; COLE P, 1972, CANCER, V29, P1250, DOI 10.1002/1097-0142(197205)29:5<1250::AID-CNCR2820290518>3.0.CO;2-T; DRUCKREY H., 1964, Z KREBSFORSCH, V66, P280, DOI 10.1007/BF00524156; Dudoit S, 2002, J AM STAT ASSOC, V97, P77, DOI 10.1198/016214502753479248; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; GRUBBS CJ, 1977, SCIENCE, V198, P743, DOI 10.1126/science.910158; Grubbs CJ, 2000, CANCER RES, V60, P5599; Gurujeyalakshmi G, 2000, J PHARMACOL EXP THER, V293, P82; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Hoskin PJ, 2010, J CLIN ONCOL, V28, P4912, DOI 10.1200/JCO.2010.28.4950; HOWE GR, 1980, JNCI-J NATL CANCER I, V64, P701; JACOBSON EL, 1993, J INTERN MED, V233, P59, DOI 10.1111/j.1365-2796.1993.tb00649.x; JACOBSON EL, 1995, BIOCHIMIE, V77, P394, DOI 10.1016/0300-9084(96)88152-1; Jin YH, 2004, J BIOL CHEM, V279, P29409, DOI 10.1074/jbc.M313120200; KIM WJ, 2011, J UROLOGY; Kirkland JB, 2009, MOL CANCER THER, V8, P725, DOI 10.1158/1535-7163.MCT-09-0042; Kirkland JB, 2003, NUTR CANCER, V46, P110, DOI 10.1207/S15327914NC4602_02; Lam SH, 2006, NAT BIOTECHNOL, V24, P73, DOI 10.1038/nbt1169; Lee CWL, 2010, CANCER RES, V70, P4243, DOI 10.1158/0008-5472.CAN-09-3805; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lee JS, 2010, J CLIN ONCOL, V28, P2660, DOI 10.1200/JCO.2009.25.0977; Marshall GM, 2010, ONCOGENE, V29, P5957, DOI 10.1038/onc.2010.332; MATANOSKI GM, 1981, EPIDEMIOL REV, V3, P203, DOI 10.1093/oxfordjournals.epirev.a036234; OHTANI M, 1986, CANCER RES, V46, P2001; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Radmacher MD, 2002, J COMPUT BIOL, V9, P505, DOI 10.1089/106652702760138592; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Schultz L, 2010, CANCER-AM CANCER SOC, V116, P5517, DOI 10.1002/cncr.25502; Shah GM, 2005, AM J GASTROENTEROL, V100, P2307, DOI 10.1111/j.1572-0241.2005.00268.x; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Williams PD, 2008, NEOPLASIA, V10, P838, DOI 10.1593/neo.08432; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wu BJ, 2010, ARTERIOSCL THROM VAS, V30, P968, DOI 10.1161/ATVBAHA.109.201129; WYNDER EL, 1977, CANCER-AM CANCER SOC, V40, P1246, DOI 10.1002/1097-0142(197709)40:3<1246::AID-CNCR2820400340>3.0.CO;2-5; Yao RS, 2004, NEOPLASIA, V6, P569, DOI 10.1593/neo.04223; Yao RS, 2007, NEOPLASIA, V9, P207, DOI 10.1593/neo.06814	41	29	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26131	10.1371/journal.pone.0026131	http://dx.doi.org/10.1371/journal.pone.0026131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028816	Green Published, gold			2022-12-27	WOS:000295971700042
J	Li, DJ; Lanigan, G; Humphreys, J				Li, Dejun; Lanigan, Gary; Humphreys, James			Measured and Simulated Nitrous Oxide Emissions from Ryegrass- and Ryegrass/White Clover-Based Grasslands in a Moist Temperate Climate	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; CLAY-LOAM SOIL; SPATIAL VARIABILITY; MANAGED GRASSLANDS; GRAZED GRASSLANDS; RAINFALL EVENTS; N2O EMISSIONS; DAIRY-COWS; DENITRIFICATION; PASTURES	There is uncertainty about the potential reduction of soil nitrous oxide (N2O) emission when fertilizer nitrogen (FN) is partially or completely replaced by biological N fixation (BNF) in temperate grassland. The objectives of this study were to 1) investigate the changes in N2O emissions when BNF is used to replace FN in permanent grassland, and 2) evaluate the applicability of the process-based model DNDC to simulate N2O emissions from Irish grasslands. Three grazing treatments were: (i) ryegrass (Lolium perenne) grasslands receiving 226 kg FN ha(-1) yr(-1) (GG+FN), (ii) ryegrass/white clover (Trifolium repens) grasslands receiving 58 kg FN ha(-1) yr(-1) (GWC+FN) applied in spring, and (iii) ryegrass/white clover grasslands receiving no FN (GWC-FN). Two background treatments, un-grazed swards with ryegrass only (G-B) or ryegrass/white clover (WC-B), did not receive slurry or FN and the herbage was harvested by mowing. There was no significant difference in ;annual N2O emissions between G-B (2.38 +/- 0.12 kg N ha(-1) yr(-1) (mean +/- SE)) and WC-B (2.45 +/- 0.85 kg N ha(-1) yr(-1)), indicating that N2O emission due to BNF itself and clover residual decomposition from permanent ryegrass/clover grassland was negligible. N2O emissions were 7.82 +/- 1.67, 6.35 +/- 1.14 and 6.54 +/- 1.70 kg N ha(-1) yr(-1), respectively, from GG+FN, GWC+FN and GWC-FN. N2O fluxes simulated by DNDC agreed well with the measured values with significant correlation between simulated and measured daily fluxes for the three grazing treatments, but the simulation did not agree very well for the background treatments. DNDC overestimated annual emission by 61% for GG+FN, and underestimated by 45% for GWC-FN, but simulated very well for GWC+FN. Both the measured and simulated results supported that there was a clear reduction of N2O emissions when FN was replaced by BNF.	[Li, Dejun; Humphreys, James] TEAGASC, Livestock Syst Res Dept, Fermoy, County Cork, Ireland; [Li, Dejun] Univ Coll Dublin, UCD Sch Agr Food Sci & Vet Med, Dublin 2, Ireland; [Lanigan, Gary] TEAGASC, Environm Soils & Land Use Res Dept, Johnstown Castle, County Wexford, Ireland	Teagasc; University College Dublin; Teagasc	Li, DJ (corresponding author), Univ Oklahoma, Dept Bot & Microbiol, Norman, OK 73019 USA.	dejunl@gmail.com	Lanigan, Gary J/C-6864-2012	Lanigan, Gary J/0000-0003-0813-3097	Irish Department of Agriculture, Fisheries and Food Research [RSF 07 516, RSF 07 511]	Irish Department of Agriculture, Fisheries and Food Research	This work was financially supported by the Irish Department of Agriculture, Fisheries and Food Research Stimulus Fund (RSF 07 516, RSF 07 511) under the National Development Plan 2007-2013 (http://www.agriculture.gov.ie/research/researchstimulusfundrsf/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla M, 2010, ATMOS ENVIRON, V44, P2961, DOI 10.1016/j.atmosenv.2010.05.018; Abdalla M, 2009, SOIL USE MANAGE, V25, P376, DOI 10.1111/j.1475-2743.2009.00237.x; Abdalla M, 2009, GEODERMA, V151, P327, DOI 10.1016/j.geoderma.2009.04.021; [Anonymous], 2006, IPCC 2006 GUIDELINES; [Anonymous], 2009, FAO STAT YB; Carter MS, 2006, NUTR CYCL AGROECOSYS, V74, P13, DOI 10.1007/s10705-005-4111-0; Dalal RC, 2003, AUST J SOIL RES, V41, P165, DOI 10.1071/SR02064; Davies DA, 1996, OCCASIONAL S BRIT GR, P72; *EEA, 2006, ANN EUR COMM GREENH; Flechard CR, 2007, AGR ECOSYST ENVIRON, V121, P135, DOI 10.1016/j.agee.2006.12.024; Garcia-Montiel DC, 2003, BIOGEOCHEMISTRY, V64, P319, DOI 10.1023/A:1024968802018; Giltrap DL, 2010, AGR ECOSYST ENVIRON, V136, P292, DOI 10.1016/j.agee.2009.06.014; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; Hsieh CI, 2005, NUTR CYCL AGROECOSYS, V73, P15, DOI 10.1007/s10705-005-7129-4; Humphreys J, 2008, GRASS FORAGE SCI, V63, P467, DOI 10.1111/j.1365-2494.2008.00660.x; Humphreys J, 2009, IRISH J AGR FOOD RES, V48, P189; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311, DOI 10.2136/sssaj1981.03615995004500020017x; Hyde BP, 2006, NUTR CYCL AGROECOSYS, V75, P187, DOI 10.1007/s10705-006-9026-x; Jarvis SC, 1996, GRASS FORAGE SCI, V51, P21, DOI 10.1111/j.1365-2494.1996.tb02034.x; Keogh B, 2010, P 23 GEN M EUR GRASS, P907; Kim DG, 2010, NUTR CYCL AGROECOSYS, V88, P397, DOI 10.1007/s10705-010-9365-5; Klumpp K, 2010, PLANT SOIL, DOI [10.1007/s11104-11010-10526-11108, DOI 10.1007/S11104-11010-10526-11108]; Lampe C, 2006, SOIL BIOL BIOCHEM, V38, P2602, DOI 10.1016/j.soilbio.2006.03.016; Leahy P, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021161; Ledgard S, 2009, IRISH J AGR FOOD RES, V48, P209; Ledgard SF, 2001, PLANT SOIL, V229, P177, DOI 10.1023/A:1004833804002; Ledgard SF, 1999, J AGR SCI-CAMBRIDGE, V132, P215, DOI 10.1017/S002185969800625X; LI CS, 1992, J GEOPHYS RES-ATMOS, V97, P9759, DOI 10.1029/92JD00509; Li Y, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002392; Ludwig B, 2011, J PLANT NUTR SOIL SC, V174, P350, DOI 10.1002/jpln.201000040; McGettigan M., 2010, IRELAND NATL INVENTO; Metz ORDB, 2007, CLIMATE CHANGE 2007; Nyfeler D, 2011, AGR ECOSYST ENVIRON, V140, P155, DOI 10.1016/j.agee.2010.11.022; Olesen JE, 2006, AGR ECOSYST ENVIRON, V112, P207, DOI 10.1016/j.agee.2005.08.022; Parkin TB, 2008, J ENVIRON QUAL, V37, P1390, DOI 10.2134/jeq2007.0333; Phelan P, 2011, AGR RES FORUM; Ravishankara AR, 2009, SCIENCE, V326, P123, DOI 10.1126/science.1176985; Rochette P, 2005, NUTR CYCL AGROECOSYS, V73, P171, DOI 10.1007/s10705-005-0357-9; Rochon JJ, 2004, GRASS FORAGE SCI, V59, P197, DOI 10.1111/j.1365-2494.2004.00423.x; RUZJEREZ BE, 1994, SOIL BIOL BIOCHEM, V26, P29, DOI 10.1016/0038-0717(94)90192-9; Saggar S, 2004, NUTR CYCL AGROECOSYS, V68, P243, DOI 10.1023/B:FRES.0000019463.92440.a3; Saggar S, 2007, AGR ECOSYST ENVIRON, V119, P205, DOI 10.1016/j.agee.2006.07.010; Saxton KE, 2006, SOIL SCI SOC AM J, V70, P1569, DOI 10.2136/sssaj2005.0117; Schils RLM, 2006, GLOBAL CHANGE BIOL, V12, P382, DOI 10.1111/j.1365-2486.2005.01090.x; Simek M, 2004, SOIL BIOL BIOCHEM, V36, P9, DOI 10.1016/j.soilbio.2003.08.010; Solomon S., 2007, PHYS SCI BASIS WORKI; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Turner DA, 2008, PLANT SOIL, V309, P77, DOI 10.1007/s11104-008-9639-8; USEPA, 2006, GLOB ANTHR NON GREEN; Velthof GL, 1996, PLANT SOIL, V181, P263, DOI 10.1007/BF00012061; Velthof GL, 1996, SOIL BIOL BIOCHEM, V28, P1215, DOI 10.1016/0038-0717(96)00129-0; Velthof GL, 1998, ENVIRON POLLUT, V102, P173, DOI 10.1016/S0269-7491(98)80030-4; Virkajarvi P, 2010, AGR ECOSYST ENVIRON, V137, P59, DOI 10.1016/j.agee.2009.12.015; Weng ES, 2008, J GEOPHYS RES-BIOGEO, V113, DOI 10.1029/2007JG000539; Williams DL, 1999, SOIL BIOL BIOCHEM, V31, P779, DOI 10.1016/S0038-0717(98)00186-2; WMO, 2009, STAT GREENH GAS ATM; Wrage N, 2001, SOIL BIOL BIOCHEM, V33, P1723, DOI 10.1016/S0038-0717(01)00096-7; Xu-Ri, 2003, PLANT SOIL, V255, P513, DOI 10.1023/A:1026076914167; Zhang F, 2010, BIOGEOSCIENCES, V7, P2039, DOI 10.5194/bg-7-2039-2010	59	36	36	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26176	10.1371/journal.pone.0026176	http://dx.doi.org/10.1371/journal.pone.0026176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028829	Green Submitted, gold, Green Published			2022-12-27	WOS:000295971700046
J	Dawson, LF; Valiente, E; Donahue, EH; Birchenough, G; Wren, BW				Dawson, Lisa F.; Valiente, Esmeralda; Donahue, Elizabeth H.; Birchenough, George; Wren, Brendan W.			Hypervirulent Clostridium difficile PCR-Ribotypes Exhibit Resistance to Widely Used Disinfectants	PLOS ONE			English	Article							ANTIBIOTIC-ASSOCIATED COLITIS; INFECTION; EPIDEMIOLOGY; BIOCIDE; CONTAMINATION; ENVIRONMENT; DIARRHEA; STRAINS; TRICLOSAN; MORTALITY	The increased prevalence of Clostridium difficile infection (CDI) has coincided with enhanced transmissibility and severity of disease, which is often linked to two distinct clonal lineages designated PCR-ribotype 027 and 017 responsible for CDI outbreaks in the USA, Europe and Asia. We assessed sporulation and susceptibility of three PCR-ribotypes; 012, 017 and 027 to four classes of disinfectants; chlorine releasing agents (CRAs), peroxygens, quaternary ammonium compounds (QAC) and biguanides. The 017 PCR-ribotype, showed the highest sporulation frequency under these test conditions. The oxidizing biocides and CRAs were the most efficacious in decontamination of C. difficile vegetative cells and spores, the efficacy of the CRAs were concentration dependent irrespective of PCR-ribotype. However, there were differences observed in the susceptibility of the PCR-ribotypes, independent of the concentrations tested for Virkon (R), Newgenn (R), Proceine 40 (R) and Hibiscrub (R). Whereas, for Steri7 (R) and Biocleanse (R) the difference observed between the disinfectants were dependent on both PCR-ribotype and concentration. The oxidizing agent Perasafe (R) was consistently efficacious across all three PCR ribotypes at varying concentrations; with a consistent five Log10 reduction in spore titre. The PCR-ribotype and concentration dependent differences in the efficacy of the disinfectants in this study indicate that disinfectant choice is a factor for llimiting the survival and transmission of C. difficile spores in healthcare settings.	[Dawson, Lisa F.; Valiente, Esmeralda; Donahue, Elizabeth H.; Birchenough, George; Wren, Brendan W.] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England	University of London; London School of Hygiene & Tropical Medicine	Dawson, LF (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	Brendan.Wren@lshtm.ac.uk			Wellcome Trust [WT086418MA]; Marie Curie Grant [PIEF-GA-2009-252207]; MRC [G1000214] Funding Source: UKRI; Medical Research Council [G1000214] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Marie Curie Grant(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Funding came from Wellcome Trust Grant number WT086418MA and Marie Curie Grant number PIEF-GA-2009-252207. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT JG, 1994, CLIN INFECT DIS, V18, pS265, DOI 10.1093/clinids/18.Supplement_4.S265; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS4, DOI 10.1086/521865; Best EL, 2010, CLIN INFECT DIS, V50, P1450, DOI 10.1086/652648; Block SS, 1991, DISINFECTION STERILI, V4th, P167; CERAGIOLI M, 2010, APPL ENV MICROBIOL; Clements ACA, 2010, LANCET INFECT DIS, V10, P395, DOI 10.1016/S1473-3099(10)70080-3; Dingle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019993; DRUDY D, 2006, J ANTIMICROB CHEMOTH; FEKETY R, 1981, AM J MED, V70, P906, DOI 10.1016/0002-9343(81)90553-2; Fraise AP, 2002, J ANTIMICROB CHEMOTH, V49, P11, DOI 10.1093/jac/49.1.11; Goorhuis A, 2008, CLIN INFECT DIS, V47, P1162, DOI 10.1086/592257; He M, 2010, P NATL ACAD SCI USA, V107, P7527, DOI 10.1073/pnas.0914322107; Hota B, 2004, CLIN INFECT DIS, V39, P1182, DOI 10.1086/424667; Hubert B, 2007, CLIN INFECT DIS, V44, P238, DOI 10.1086/510391; KIM KH, 1981, J INFECT DIS, V143, P42, DOI 10.1093/infdis/143.1.42; Kuijper EJ, 2007, CURR OPIN INFECT DIS, V20, P376; KULIKOVSKY A, 1975, J APPL BACTERIOL, V38, P39, DOI 10.1111/j.1365-2672.1975.tb00498.x; Lawley TD, 2010, APPL ENVIRON MICROB, V76, P6895, DOI 10.1128/AEM.00718-10; Levy SB, 2000, PEDIATR INFECT DIS J, V19, pS120, DOI 10.1097/00006454-200010001-00008; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; MALAMOULADAS H, 1983, J CLIN PATHOL, V36, P88, DOI 10.1136/jcp.36.1.88; McBain AJ, 2003, APPL ENVIRON MICROB, V69, P4770, DOI 10.1128/AEM.69.8.4770-4776.2003; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; McMurry LM, 1998, FEMS MICROBIOL LETT, V166, P305, DOI 10.1016/S0378-1097(98)00347-4; MULLIGAN ME, 1984, ANTIMICROB AGENTS CH, V26, P343, DOI 10.1128/AAC.26.3.343; MULLIGAN ME, 1980, AM J CLIN NUTR, V33, P2533, DOI 10.1093/ajcn/33.11.2533; NY O, 2011, LANCET, V377, P1407; ONEILL G, 1993, EPIDEMIOL INFECT, V111, P257, DOI 10.1017/S095026880005696X; Pepin J, 2005, CAN MED ASSOC J, V173, P1037, DOI 10.1503/cmaj.050978; Russell AD, 2003, LANCET INFECT DIS, V3, P794, DOI 10.1016/S1473-3099(03)00833-8; Russell AD, 1999, J MED MICROBIOL, V48, P613, DOI 10.1099/00222615-48-7-613; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; Schweizer HP, 2001, FEMS MICROBIOL LETT, V202, P1, DOI 10.1111/j.1574-6968.2001.tb10772.x; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Settle CD, 2008, LANCET, V371, P810, DOI 10.1016/S0140-6736(08)60373-6; Shapey S, 2008, J HOSP INFECT, V70, P136, DOI 10.1016/j.jhin.2008.06.008; Spigaglia P, 2008, J MED MICROBIOL, V57, P784, DOI 10.1099/jmm.0.47738-0; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; Stabler RA, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r102; Thomas L, 2005, J APPL MICROBIOL, V98, P533, DOI 10.1111/j.1365-2672.2004.02402.x; Vrtis Mary C, 2008, Home Healthc Nurse, V26, P563, DOI 10.1097/01.NHH.0000338518.64238.07; VRTIS MC, 2008, HOME HEALTHC NURSE, V26, P570; Wilcox MH, 2003, J HOSP INFECT, V54, P109, DOI 10.1016/S0195-6701(02)00400-0; WUST J, 1982, J CLIN MICROBIOL, V16, P1096	44	49	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e25754	10.1371/journal.pone.0025754	http://dx.doi.org/10.1371/journal.pone.0025754			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22039420	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000296517000010
J	Dahm, T; Neshat-Doost, HT; Golden, AM; Horn, E; Hagger, M; Dalgleish, T				Dahm, Theresa; Neshat-Doost, Hamid Taher; Golden, Ann-Marie; Horn, Elizabeth; Hagger, Martin; Dalgleish, Tim			Age Shall Not Weary Us: Deleterious Effects of Self-Regulation Depletion Are Specific to Younger Adults	PLOS ONE			English	Article							AUTOBIOGRAPHICAL MEMORY SPECIFICITY; EXECUTIVE CONTROL; REDUCED SPECIFICITY; EMOTION REGULATION; PREFRONTAL CORTEX; STRENGTH MODEL; SYSTEM	Self-regulation depletion (SRD), or ego-depletion, refers to decrements in self-regulation performance immediately following a different self-regulation-demanding activity. There are now over a hundred studies reporting SRD across a broad range of tasks and conditions. However, most studies have used young student samples. Because prefrontal brain regions thought to subserve self-regulation do not fully mature until 25 years of age, it is possible that SRD effects are confined to younger populations and are attenuated or disappear in older samples. We investigated this using the Stroop color task as an SRD induction and an autobiographical memory task as the outcome measure. We found that younger participants (<25 years) were susceptible to depletion effects, but found no support for such effects in an older group (40-65 years). This suggests that the widely-reported phenomenon of SRD has important developmental boundary conditions casting doubt on claims that it represents a general feature of human cognition.	[Dahm, Theresa; Golden, Ann-Marie; Horn, Elizabeth; Dalgleish, Tim] MRC, Cognit & Brain Sci Unit, Cambridge, England; [Neshat-Doost, Hamid Taher] Univ Isfahan, Esfahan, Iran; [Hagger, Martin] Univ Nottingham, Nottingham NG7 2RD, England	University of Isfahan; University of Nottingham	Dahm, T (corresponding author), MRC, Cognit & Brain Sci Unit, Cambridge, England.	tim.dalgleish@mrc-cbu.cam.ac.uk	Dalgleish, Tim/E-8341-2010; Doost, Hamid Taher Neshat/AAD-9380-2019; Hagger, Martin S./G-5211-2012	Dalgleish, Tim/0000-0002-7304-2231; Doost, Hamid Taher Neshat/0000-0001-6368-0769; Hagger, Martin S./0000-0002-2685-1546	 [U.1055.02.002.00001.01]; Medical Research Council [MC_U105579215] Funding Source: researchfish	; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Grant: U.1055.02.002.00001.01, Ethics: Cambridge Local Research Ethics Committee No. 4: CAM REC 4 NO: 11/H0305/001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A.T., 1996, PSYCHOL ASSESS, V10, DOI [10.1037/t00742-000, DOI 10.1037/T00742-000]; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Dalgleish T, 2008, J ABNORM PSYCHOL, V117, P236, DOI 10.1037/0021-843X.117.1.236; Dalgleish T, 2007, J EXP PSYCHOL GEN, V136, P23, DOI 10.1037/0096-3445.136.1.23; DeWall CN, 2007, J EXP SOC PSYCHOL, V43, P62, DOI 10.1016/j.jesp.2005.12.005; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Gailhot MT, 2007, J EXP SOC PSYCHOL, V43, P894, DOI 10.1016/j.jesp.2006.10.011; GOEL V, 1995, NEUROPSYCHOLOGIA, V33, P623, DOI 10.1016/0028-3932(95)90866-P; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; Jones D, 2010, SCIENCE, V328, P1627, DOI 10.1126/science.328.5986.1627; Konishi S, 2003, J NEUROSCI, V23, P7776; Lewis MD, 2006, J COGNITIVE NEUROSCI, V18, P430, DOI 10.1162/089892906775990633; Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037/0033-295X.106.1.3; Muraven M, 2002, PSYCHOL ADDICT BEHAV, V16, P113, DOI 10.1037//0893-164X.16.2.113; Neshat-Doost HT, 2008, EMOTION, V8, P731, DOI 10.1037/a0013507; Oaten M, 2007, J ECON PSYCHOL, V28, P487, DOI 10.1016/j.joep.2006.11.003; Schmeichel BJ, 2007, J EXP PSYCHOL GEN, V136, P241, DOI 10.1037/0096-3445.136.2.241; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122	21	22	22	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26351	10.1371/journal.pone.0026351	http://dx.doi.org/10.1371/journal.pone.0026351			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039469	Green Published, gold, Green Submitted			2022-12-27	WOS:000296515200015
J	Ljungqvist, MG; Nielsen, ME; Ersboll, BK; Frosch, S				Ljungqvist, Martin Georg; Nielsen, Michael Engelbrecht; Ersboll, Bjarne Kjaer; Frosch, Stina			Image Analysis of Pellet Size for a Control System in Industrial Feed Production	PLOS ONE			English	Article							FOOD PARTICLE-SIZE; GROWTH; GRANULOMETRY	When producing aquaculture fish feed pellets, the size of the output product is of immense importance. As the production method cannot produce pellets of constant and uniform size using constant machine settings, there is a demand for size control. Fish fed with feed pellets of improper size are prone to not grow as expected, which is undesirable to the aquaculture industry. In this paper an image analysis method is proposed for automatic size-monitoring of pellets. This is called granulometry and the method used here is based on the mathematical morphological opening operation. In the proposed method, no image object segmentation is needed. The results show that it is possible to extract a general size distribution from an image of piled disordered pellets representing both length and diameter of the pellets in combination as an area.	[Ljungqvist, Martin Georg; Ersboll, Bjarne Kjaer] Tech Univ Denmark, Dept Informat & Math Modelling, DK-2800 Lyngby, Denmark; [Ljungqvist, Martin Georg; Nielsen, Michael Engelbrecht; Frosch, Stina] Tech Univ Denmark, Div Ind Food Res, Natl Food Inst, DK-2800 Lyngby, Denmark	Technical University of Denmark; Technical University of Denmark	Ljungqvist, MG (corresponding author), Tech Univ Denmark, Dept Informat & Math Modelling, DK-2800 Lyngby, Denmark.	malj@imm.dtu.dk; sfro@food.dtu.dk	Nielsen, Michael Canova Engelbrecht/L-4911-2019	Nielsen, Michael Canova Engelbrecht/0000-0001-5044-4441; Ersboll, Bjarne Kjaer/0000-0003-1262-7890; Ljungqvist, Martin/0000-0002-0115-869X	BioMar A/S; EU [214505.10]	BioMar A/S; EU(European Commission)	Funding: The work presented has received funding from BioMar A/S and the EU under the Seventh Framework Programme FP7/2007-2013 under grant agreement number 214505.10. http://biomar.com/. http://epp.eurostat.ec.europa.eu/portal/page/portal/research_methodology/research/seventh_framework. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS R, 1993, CVGIP-GRAPH MODEL IM, V55, P325, DOI 10.1006/cgip.1993.1024; Angulo J, 2008, I S BIOMED IMAGING, P360, DOI 10.1109/ISBI.2008.4541007; Azaza MS, 2010, AQUACULTURE, V309, P193, DOI 10.1016/j.aquaculture.2010.09.026; Clemmensen LH, 2010, MACH VISION APPL, V21, P959, DOI 10.1007/s00138-009-0193-z; Devaux MF, 2008, POSTHARVEST BIOL TEC, V47, P199, DOI 10.1016/j.postharvbio.2007.06.017; FOSTER M, 1995, AQUACULT ENG, V14, P251, DOI 10.1016/0144-8609(94)00006-M; JAGERSAND M, 1995, FIFTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, PROCEEDINGS, P195, DOI 10.1109/ICCV.1995.466786; Jones R, 1996, PATTERN RECOGN LETT, V17, P1057, DOI 10.1016/0167-8655(96)00066-9; Lassoued N, 2007, FOOD RES INT, V40, P1087, DOI 10.1016/j.foodres.2007.06.004; Lindeberg T, 1998, INT J COMPUT VISION, V30, P79, DOI 10.1023/A:1008045108935; Lindeberg T, 1996, CERN REPORT, V96, P27; Lindeberg T., 1999, HDB COMPUTER VISION, P239; MARAGOS P, 1989, IEEE T PATTERN ANAL, V11, P701, DOI 10.1109/34.192465; Matheron G, 2002, MATHEMATICAL MORPHOLOGY, PROCEEDINGS, P1; Matheron G., 1975, RANDOM SETS INTEGRAL; Montgomery DC, 2005, INTRO STAT QUALITY E; Morales-Hernandez LA, 2010, J MATER PROCESS TECH, V210, P335, DOI 10.1016/j.jmatprotec.2009.09.020; Parsonage KD, 2001, THESIS U BRIT COLUMB; Serra J, 1983, IMAGE ANAL MATH MORP; TABACHEK JAL, 1988, AQUACULTURE, V71, P319, DOI 10.1016/0044-8486(88)90201-3; Vincent L, 1994, COMP IMAG VIS, V2, P265; Vincent L., 2000, PROC 11 ANN S S AFRI, P119; Wang X, 2006, INT C SIGN PROC P, V8; WANKOWSKI JWJ, 1979, J FISH BIOL, V14, P351, DOI 10.1111/j.1095-8649.1979.tb03530.x; Zadorozny A, 2002, INT C VIS INT, V15, P433	25	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26492	10.1371/journal.pone.0026492	http://dx.doi.org/10.1371/journal.pone.0026492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031836	Green Published, Green Submitted, gold			2022-12-27	WOS:000296513200025
J	Carrancio, S; Blanco, B; Romo, C; Muntion, S; Lopez-Holgado, N; Blanco, JF; Brinon, JG; San Miguel, JF; Sanchez-Guijo, FM; del Canizo, MC				Carrancio, Soraya; Blanco, Belen; Romo, Carlos; Muntion, Sandra; Lopez-Holgado, Natalia; Blanco, Juan F.; Brinon, Jesus G.; San Miguel, Jesus F.; Sanchez-Guijo, Fermin M.; Consuelo del Canizo, M.			Bone Marrow Mesenchymal Stem Cells for Improving Hematopoietic Function: An In Vitro and In Vivo Model. Part 2: Effect on Bone Marrow Microenvironment	PLOS ONE			English	Article							STROMAL CELLS; PERIPHERAL-BLOOD; TRANSPLANTATION; ENGRAFTMENT; EXPANSION; COTRANSPLANTATION; MOBILIZATION; RECOVERY; LEUKEMIA; FAILURE	The aim of the present study was to determine how mesenchymal stem cells (MSC) could improve bone marrow (BM) stroma function after damage, both in vitro and in vivo. Human MSC from 20 healthy donors were isolated and expanded. Mobilized selected CD34(+) progenitor cells were obtained from 20 HSCT donors. For in vitro study, long-term bone marrow cultures (LTBMC) were performed using a etoposide damaged stromal model to test MSC effect in stromal confluence, capability of MSC to lodge in stromal layer as well as some molecules (SDF1, osteopontin,) involved in hematopoietic niche maintenance were analyzed. For the in vivo model, 64 NOD/SCID recipients were transplanted with CD34(+) cells administered either by intravenous (IV) or intrabone (IB) route, with or without BM derived MSC. MSC lodgement within the BM niche was assessed by FISH analysis and the expression of SDF1 and osteopontin by immunohistochemistry. In vivo study showed that when the stromal damage was severe, TP-MSC could lodge in the etoposide-treated BM stroma, as shown by FISH analysis. Osteopontin and SDF1 were differently expressed in damaged stroma and their expression restored after TP-MSC addition. Human in vivo MSC lodgement was observed within BM niche by FISH, but MSC only were detected and not in the contralateral femurs. Human MSC were located around blood vessels in the subendoestal region of femurs and expressed SDF1 and osteopontin. In summary, our data show that MSC can restore BM stromal function and also engraft when a higher stromal damage was done. Interestingly, MSC were detected locally where they were administered but not in the contralateral femur.	[Carrancio, Soraya; Blanco, Belen; Romo, Carlos; Muntion, Sandra; Lopez-Holgado, Natalia; San Miguel, Jesus F.; Sanchez-Guijo, Fermin M.; Consuelo del Canizo, M.] Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain; [Carrancio, Soraya; Blanco, Belen; Romo, Carlos; Muntion, Sandra; Lopez-Holgado, Natalia; San Miguel, Jesus F.; Sanchez-Guijo, Fermin M.; Consuelo del Canizo, M.] ISCIII, Ctr Red Med Regenerat & Terapia Celular Castilla, Castilla Y Leon, Spain; [Carrancio, Soraya; Blanco, Belen; Romo, Carlos; Muntion, Sandra; Lopez-Holgado, Natalia; San Miguel, Jesus F.; Sanchez-Guijo, Fermin M.; Consuelo del Canizo, M.] ISCIII, Red Nacl Terapia Celular Tercel, Castilla Y Leon, Spain; [Carrancio, Soraya; Blanco, Belen; Romo, Carlos; San Miguel, Jesus F.; Consuelo del Canizo, M.] Univ Salamanca, CSIC, Ctr Invest Canc, IBMCC, E-37008 Salamanca, Spain; [Blanco, Juan F.] Hosp Univ Salamanca, Serv Traumatol, Salamanca, Spain; [Brinon, Jesus G.] Univ Salamanca, Dept Biol Celular & Patol, E-37008 Salamanca, Spain	University of Salamanca; Instituto de Salud Carlos III; Instituto de Salud Carlos III; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; University of Salamanca; University of Salamanca	Carrancio, S (corresponding author), Hosp Univ Salamanca, Serv Hematol, Salamanca, Spain.	concarol@usal.es	San-Miguel, Jesús F./V-8977-2018; Blanco, Belén/S-5796-2018; Sanchez-Guijo, Fermin/D-8542-2018; Blanco, Belén/GRX-4894-2022; Blanco, Juan F/AAI-5787-2021; Brinon, Jesus G./L-7316-2014	San-Miguel, Jesús F./0000-0002-9183-4857; Sanchez-Guijo, Fermin/0000-0002-7076-7739; Blanco, Juan F/0000-0001-7803-9149; Brinon, Jesus G./0000-0002-3503-0539; Muntion Olave, Sandra/0000-0001-7164-0767	Consejeria de Educacion de Castilla y Leon [HUS003A10-2]; Gerencia Regional de Salud de Castilla y Leon [GRS/222/A/08]; Fondo de Investigaciones Sanitarias (ISCIII), Ministerio de Sanidad, Spain [PS09/01530]; Junta de Castilla y Leon (FPI) [EDU/1878/2006]; Fondo de Investigaciones Sanitarias (FIS) from the Instituto de Salud Carlos III [CD06/00042]	Consejeria de Educacion de Castilla y Leon; Gerencia Regional de Salud de Castilla y Leon; Fondo de Investigaciones Sanitarias (ISCIII), Ministerio de Sanidad, Spain(Instituto de Salud Carlos IIISpanish Government); Junta de Castilla y Leon (FPI)(Junta de Castilla y LeonSpanish Government); Fondo de Investigaciones Sanitarias (FIS) from the Instituto de Salud Carlos III(Instituto de Salud Carlos III)	This study was supported in part by a grant from Consejeria de Educacion de Castilla y Leon (ref: HUS003A10-2), Gerencia Regional de Salud de Castilla y Leon (ref: GRS/222/A/08) and Fondo de Investigaciones Sanitarias (ISCIII) (ref: PS09/01530), Ministerio de Sanidad, Spain. S. C. was supported by Junta de Castilla y Leon (FPI Grant EDU/1878/2006). B. B. was supported by Fondo de Investigaciones Sanitarias (FIS) from the Instituto de Salud Carlos III (ref. CD06/00042). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball LM, 2007, BLOOD, V110, P2764, DOI 10.1182/blood-2007-04-087056; Baron F, 2010, BIOL BLOOD MARROW TR, V16, P838, DOI 10.1016/j.bbmt.2010.01.011; Bartsch K, 2009, TRANSPLANTATION, V87, P217, DOI 10.1097/TP.0b013e3181938998; Blanco B, 2006, BLOOD, V107, P3575, DOI 10.1182/blood-2005-05-2118; Burt RK, 2008, J AUTOIMMUN, V30, P116, DOI 10.1016/j.jaut.2007.12.010; BUTLER WT, 1989, CONNECT TISSUE RES, V23, P123, DOI 10.3109/03008208909002412; Carrancio S, 2008, EXP HEMATOL, V36, P1014, DOI 10.1016/j.exphem.2008.03.012; Carrancio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026241; Clutter SD, 2006, EXP HEMATOL, V34, P1522, DOI 10.1016/j.exphem.2006.06.021; del Canizo MC, 2003, HAEMATOLOGICA, V88, P402; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Fujita S, 2008, CELL TRANSPLANT, V17, P1169, DOI 10.3727/096368908787236611; Gabert J, 2003, LEUKEMIA, V17, P2318, DOI 10.1038/sj.leu.2403135; Garcia-Gomez I, 2010, EXPERT OPIN BIOL TH, V10, P1453, DOI 10.1517/14712598.2010.519333; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Gibson L F, 1997, Biol Blood Marrow Transplant, V3, P122; Gomez C, 2007, J NEUROCHEM, V100, P924, DOI 10.1111/j.1471-4159.2006.04229.x; Grassinger J, 2009, BLOOD, V114, P49, DOI 10.1182/blood-2009-01-197988; Guezguez B, 2008, CURR OPIN ORGAN TRAN, V13, P44, DOI 10.1097/MOT.0b013e3282f42486; Gutierrez NC, 2004, BLOOD, V104, P2661, DOI 10.1182/blood-2004-04-1319; HESSELTON RM, 1995, J INFECT DIS, V172, P974, DOI 10.1093/infdis/172.4.974; Hiwase SD, 2009, STEM CELLS, V27, P2293, DOI 10.1002/stem.157; Horvat-Karajz K, 2009, LASER SURG MED, V41, P463, DOI 10.1002/lsm.20791; Ikehara S, 2005, ANN NY ACAD SCI, V1051, P626, DOI 10.1196/annals.1361.107; Janczewska S, 2003, CELL TRANSPLANT, V12, P399, DOI 10.3727/000000003108746948; Jing DH, 2010, HAEMATOL-HEMATOL J, V95, P542, DOI 10.3324/haematol.2009.010736; Jones CV, 2009, FUTURE ONCOL, V5, P559, DOI 10.2217/FON.09.20; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kemp K, 2010, ANN HEMATOL, V89, P701, DOI 10.1007/s00277-009-0896-2; Koestenbauer S, 2009, CELL TRANSPLANT, V18, P1059, DOI 10.3727/096368909X471288; Lopez-Holgado N, 2005, HAEMATOLOGICA, V90, P353; Meuleman N, 2009, STEM CELLS DEV, V18, P1247, DOI 10.1089/scd.2009.0029; Mishima S, 2010, EUR J HAEMATOL  0105; Mishima S, 2010, EUR J HAEMATOL, V84, P538, DOI 10.1111/j.1600-0609.2010.01419.x; Myers KC, 2009, BIOL BLOOD MARROW TR, V15, P279, DOI 10.1016/j.bbmt.2008.11.037; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Ramirez PA, 2010, BONE MARROW TRANSPL, V45, P1127, DOI 10.1038/bmt.2010.39; Renstrom J, 2010, CHEM-BIOL INTERACT, V184, P7, DOI 10.1016/j.cbi.2009.11.012; Rettig MP, 2009, METHOD ENZYMOL, V460, P57, DOI 10.1016/S0076-6879(09)05203-3; Spyridonidis A, 2005, STEM CELLS DEV, V14, P213, DOI 10.1089/scd.2005.14.213; Sumitomo A, 2010, MOL CELL BIOL, V30, P4818, DOI 10.1128/MCB.01348-09; Trouche E, 2010, CELL TRANSPLANT, V19, P1623, DOI 10.3727/096368910X514297; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; van Velthoven CTJ, 2010, PEDIATR RES, V68, P419, DOI 10.1203/PDR.0b013e3181f1c289; Villaron EM, 2004, HAEMATOLOGICA, V89, P1421	46	34	40	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26241	10.1371/journal.pone.0026241	http://dx.doi.org/10.1371/journal.pone.0026241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028841	Green Published, gold			2022-12-27	WOS:000296510800030
J	Sohn, JW; Yu, WJ; Lee, D; Shin, HS; Lee, SH; Ho, WK				Sohn, Jong-Woo; Yu, Weon-Jin; Lee, Doyun; Shin, Hee-Sup; Lee, Suk-Ho; Ho, Won-Kyung			Cyclic ADP Ribose-Dependent Ca2+ Release by Group I Metabotropic Glutamate Receptors in Acutely Dissociated Rat Hippocampal Neurons	PLOS ONE			English	Article							CA1 PYRAMIDAL NEURONS; LONG-TERM DEPRESSION; BACKPROPAGATING ACTION-POTENTIALS; SEA-URCHIN EGGS; MOLECULAR CHARACTERIZATION; RYANODINE RECEPTOR; CALCIUM RELEASE; CADP-RIBOSE; EXCITABILITY; MODULATION	Group I metabotropic glutamate receptors (group I mGluRs; mGluR1 and mGluR5) exert diverse effects on neuronal and synaptic functions, many of which are regulated by intracellular Ca2+. In this study, we characterized the cellular mechanisms underlying Ca2+ mobilization induced by (RS)-3,5-dihydroxyphenylglycine (DHPG; a specific group I mGluR agonist) in the somata of acutely dissociated rat hippocampal neurons using microfluorometry. We found that DHPG activates mGluR5 to mobilize intracellular Ca2+ from ryanodine-sensitive stores via cyclic adenosine diphosphate ribose (cADPR), while the PLC/IP3 signaling pathway was not involved in Ca2+ mobilization. The application of glutamate, which depolarized the membrane potential by 28.5 +/- 4.9 mV (n = 4), led to transient Ca2+ mobilization by mGluR5 and Ca2+ influx through L-type Ca2+ channels. We found no evidence that mGluR5-mediated Ca2+ release and Ca2+ influx through L-type Ca2+ channels interact to generate supralinear Ca2+ transients. Our study provides novel insights into the mechanisms of intracellular Ca2+ mobilization by mGluR5 in the somata of hippocampal neurons.	[Sohn, Jong-Woo; Yu, Weon-Jin; Lee, Doyun; Lee, Suk-Ho; Ho, Won-Kyung] Seoul Natl Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Sohn, Jong-Woo; Yu, Weon-Jin; Lee, Doyun; Lee, Suk-Ho; Ho, Won-Kyung] Seoul Natl Univ, Coll Med, Biomembrane Plast Res Ctr, Seoul, South Korea; [Shin, Hee-Sup] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Institute of Science & Technology (KIST)	Sohn, JW (corresponding author), Univ Texas SW Med Ctr Dallas, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA.	wonkyung@snu.ac.kr	Lee, Suk-Ho/D-6344-2012; Lee, Doyun/AAK-5369-2020; Sohn, Jong Woo/D-6700-2014; Ho, Won-Kyung/J-2798-2012	Lee, Doyun/0000-0002-9968-9113; Lee, Suk-Ho/0000-0003-4117-5619	Korean Ministry of Education, Science, and Technology [2010-0029394, R32-10084]	Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the Korean Ministry of Education, Science, and Technology [SRC program (2010-0029394) and WCU Neurocytomics program (R32-10084) to W.K.H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augustine GJ, 2003, NEURON, V40, P331, DOI 10.1016/S0896-6273(03)00639-1; BANNISTER NJ, 1995, J COMP NEUROL, V360, P161, DOI 10.1002/cne.903600112; Barnes SJ, 2010, J NEUROSCI, V30, P12996, DOI 10.1523/JNEUROSCI.1847-10.2010; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; Bloodgood BL, 2008, J PHYSIOL-LONDON, V586, P1475, DOI 10.1113/jphysiol.2007.148353; Brager DH, 2007, J NEUROSCI, V27, P13926, DOI 10.1523/JNEUROSCI.3520-07.2007; Chuang SC, 2001, J NEUROSCI, V21, P6387, DOI 10.1523/JNEUROSCI.21-16-06387.2001; Churaman D, 2008, CELL SIGNAL, V20, P2347, DOI 10.1016/j.cellsig.2008.09.005; Churamani D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000797; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; D'Ascenzo M, 2009, J PHYSIOL-LONDON, V587, P3233, DOI 10.1113/jphysiol.2009.172593; Fakler B, 2008, NEURON, V59, P873, DOI 10.1016/j.neuron.2008.09.001; Finkbeiner S, 1998, J NEUROBIOL, V37, P171, DOI 10.1002/(SICI)1097-4695(199810)37:1<171::AID-NEU13>3.0.CO;2-H; GALIONE A, 1991, SCIENCE, V253, P1143, DOI 10.1126/science.1909457; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; Guse AH, 2005, FEBS J, V272, P4590, DOI 10.1111/j.1742-4658.2005.04863.x; Hardingham GE, 2001, NAT NEUROSCI, V4, P565, DOI 10.1038/88380; Hashii M, 2000, BIOCHEM J, V345, P207, DOI 10.1042/0264-6021:3450207; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Higashida H, 2003, J NEUROCHEM, V85, P1148, DOI 10.1046/j.1471-4159.2003.01751.x; Ireland DR, 2004, J NEUROPHYSIOL, V92, P2811, DOI 10.1152/jn.01236.2003; Ireland DR, 2002, J NEUROPHYSIOL, V88, P107, DOI 10.1152/jn.2002.88.1.107; Jo J, 2008, NEURON, V60, P1095, DOI 10.1016/j.neuron.2008.10.050; Kim D, 1997, NATURE, V389, P290, DOI 10.1038/38508; Kleppisch T, 2001, J NEUROSCI, V21, P4943, DOI 10.1523/JNEUROSCI.21-14-04943.2001; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Krause M, 2002, J NEUROSCI, V22, P666, DOI 10.1523/JNEUROSCI.22-03-00666.2002; Lee D, 2007, J NEUROSCI, V27, P13603, DOI 10.1523/JNEUROSCI.3985-07.2007; Lee HC, 2004, CURR MOL MED, V4, P227, DOI 10.2174/1566524043360753; LEE HC, 1993, SCIENCE, V261, P352, DOI 10.1126/science.8392749; Lee SH, 2000, J PHYSIOL-LONDON, V525, P405, DOI 10.1111/j.1469-7793.2000.t01-3-00405.x; Lopatina O, 2010, NEUROPHARMACOLOGY, V58, P50, DOI 10.1016/j.neuropharm.2009.06.012; Luscher C, 2010, NEURON, V65, P445, DOI 10.1016/j.neuron.2010.01.016; Maejima T, 2005, J NEUROSCI, V25, P6826, DOI 10.1523/JNEUROSCI.0945-05.2005; Malavasi F, 2008, PHYSIOL REV, V88, P841, DOI 10.1152/physrev.00035.2007; MCPHERSON PS, 1991, NEURON, V7, P17, DOI 10.1016/0896-6273(91)90070-G; MESZAROS LG, 1993, NATURE, V364, P76, DOI 10.1038/364076a0; Morgan AJ, 2008, METHODS, V46, P194, DOI 10.1016/j.ymeth.2008.09.013; Morikawa H, 2003, J NEUROSCI, V23, P149; Mushtaq M, 2011, J BIOL CHEM, V286, P12952, DOI 10.1074/jbc.M110.207100; Nakamura T, 2002, J PHYSIOL-LONDON, V543, P465, DOI 10.1113/jphysiol.2002.020362; Nakamura T, 2000, J NEUROSCI, V20, P8365, DOI 10.1523/JNEUROSCI.20-22-08365.2000; Nakamura T, 1999, NEURON, V24, P727, DOI 10.1016/S0896-6273(00)81125-3; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Ogunbayo OA, 2011, J BIOL CHEM, V286, P9136, DOI 10.1074/jbc.M110.202002; Rae MG, 2004, NEUROPHARMACOLOGY, V46, P1057, DOI 10.1016/j.neuropharm.2004.02.002; Rae MG, 2000, J NEUROSCI, V20, P8628; Reyes-Harde M, 1999, J NEUROPHYSIOL, V82, P1569, DOI 10.1152/jn.1999.82.3.1569; Sethi JK, 1996, BIOCHEM J, V319, P613, DOI 10.1042/bj3190613; Sidiropoulou K, 2009, NAT NEUROSCI, V12, P190, DOI 10.1038/nn.2245; Sohn JW, 2007, J PHYSIOL-LONDON, V580, P411, DOI 10.1113/jphysiol.2006.125914; Sourdet V, 2003, J NEUROSCI, V23, P10238; Topolnik L, 2009, J NEUROSCI, V29, P4658, DOI 10.1523/JNEUROSCI.0493-09.2009; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Xu JH, 2007, CURR OPIN NEUROBIOL, V17, P352, DOI 10.1016/j.conb.2007.04.005; Young SR, 2004, J PHYSIOL-LONDON, V554, P371, DOI 10.1113/jphysiol.2003.051847; Yue JB, 2009, J BIOL CHEM, V284, P29335, DOI 10.1074/jbc.M109.049767; Zheng J, 2010, CELL CALCIUM, V47, P449, DOI 10.1016/j.ceca.2010.03.006	58	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26625	10.1371/journal.pone.0026625	http://dx.doi.org/10.1371/journal.pone.0026625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028929	Green Submitted, Green Published, gold			2022-12-27	WOS:000296510800063
J	Wang, XH; Kang, GH; Campan, M; Weisenberger, DJ; Long, TI; Cozen, W; Bernstein, L; Wu, AH; Siegmund, KD; Shibata, D; Laird, PW				Wang, Xinhui; Kang, Gyeong Hoon; Campan, Mihaela; Weisenberger, Daniel J.; Long, Tiffany I.; Cozen, Wendy; Bernstein, Leslie; Wu, Anna H.; Siegmund, Kimberly D.; Shibata, Darryl; Laird, Peter W.			Epigenetic Subgroups of Esophageal and Gastric Adenocarcinoma with Differential GATA5 DNA Methylation Associated with Clinical and Lifestyle Factors	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; UNITED-STATES; BARRETTS-ESOPHAGUS; CANCER; GENES; PATTERNS; RISK; CARCINOMA; PROFILES; CARCINOGENESIS	Background: Adenocarcinomas located near the gastroesophageal junction have unclear etiology and are difficult to classify. We used DNA methylation analysis to identify subtype-specific markers and new subgroups of gastroesophageal adenocarcinomas, and studied their association with epidemiological risk factors and clinical outcomes. Methodology/Principal Findings: We used logistic regression models and unsupervised hierarchical cluster analysis of 74 DNA methylation markers on 45 tumor samples (44 patients) of esophageal and gastric adenocarcinomas obtained from a population-based case-control study to uncover epigenetic markers and cluster groups of gastroesophageal adenocarcinomas. No distinct epigenetic differences were evident between subtypes of gastric and esophageal cancers. However, we identified two gastroesophageal adenocarcinoma subclusters based on DNA methylation profiles. Group membership was best predicted by GATA5 DNA methylation status. We analyzed the associations between these two epigenetic groups and exposure using logistic regression, and the associations with survival time using Cox regression in a larger set of 317 tumor samples (278 patients). There were more males with esophageal and gastric cardia cancers in Cluster Group 1 characterized by higher GATA5 DNA methylation values (all p < 0.05). This group also showed associations of borderline statistical significance with having ever smoked (p-value = 0.07), high body mass index (p-value = 0.06), and symptoms of gastroesophageal reflux (p-value = 0.07). Subjects in cluster Group 1 showed better survival than those in Group 2 after adjusting for tumor differentiation grade, but this was not found to be independent of tumor stage. Conclusions/Significance: DNA methylation profiling can be used in population-based studies to identify epigenetic subclasses of gastroesophageal adenocarcinomas and class-specific DNA methylation markers that can be linked to epidemiological data and clinical outcome. Two new epigenetic subgroups of gastroesophageal adenocarcinomas were identified that differ to some extent in their survival rates, risk factors of exposure, and GATA5 DNA methylation.	[Wang, Xinhui; Cozen, Wendy; Wu, Anna H.; Siegmund, Kimberly D.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Campan, Mihaela; Long, Tiffany I.; Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Kang, Gyeong Hoon] Seoul Natl Univ, Coll Med, Dept Pathol, Canc Res Inst, Seoul 151, South Korea; [Bernstein, Leslie] City Hope Natl Med Ctr, Div Populat Sci, Duarte, CA 91010 USA; [Shibata, Darryl] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA; [Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Weisenberger, Daniel J.; Laird, Peter W.] Univ So Calif, Epigenome Ctr, Los Angeles, CA USA; [Weisenberger, Daniel J.; Laird, Peter W.] USC Norris Comprehens Canc Ctr, Los Angeles, CA USA	University of Southern California; University of Southern California; Seoul National University (SNU); City of Hope; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Wang, XH (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	plaird@usc.edu	Kang, Gyeong Hoon/F-1051-2010; Laird, Peter W/G-8683-2012; Weisenberger, Daniel/AAA-8314-2020	Kang, Gyeong Hoon/0000-0003-2380-6675; Laird, Peter W/0000-0001-9117-3641; Weisenberger, Daniel/0000-0001-8303-2603	US National Cancer Institute (NCI) [5R01 CA 001815]; California Tobacco Related Research Program [3RT-0122, 10RT-0251]; California Department of Health Services; NCI's Division of Cancer Prevention and Control Surveillance [N01 CN 25403]; DIVISION OF CANCER PREVENTION AND CONTROL [N01CN025403] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA001815] Funding Source: NIH RePORTER	US National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); California Tobacco Related Research Program; California Department of Health Services; NCI's Division of Cancer Prevention and Control Surveillance; DIVISION OF CANCER PREVENTION AND CONTROL(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by US National Cancer Institute (NCI) grant 5R01 CA 001815 (P.W. Laird), and California Tobacco Related Research Program grant 3RT-0122 and 10RT-0251 (A.H. Wu). Incident cancer cases for this study were collected by the University of Southern California Center Surveillance Program (CSP), which is supported under subcontract by the California Department of Health Services. The CSP is also part of the NCI's Division of Cancer Prevention and Control Surveillance, Epidemiology and End Results Program, under contract number N01 CN 25403. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiyama Y, 2003, MOL CELL BIOL, V23, P8429, DOI 10.1128/MCB.23.23.8429-8439.2003; Alvarez H, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001356; Arasaradnam RP, 2008, EPIGENETICS-US, V3, P193, DOI 10.4161/epi.3.4.6508; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown LM, 2008, J NATL CANCER I, V100, P1184, DOI 10.1093/jnci/djn211; Crane SJ, 2007, AM J GASTROENTEROL, V102, P1596, DOI 10.1111/j.1572-0241.2007.01234.x; DeMeester SR, 2000, ANN SURG, V231, P303, DOI 10.1097/00000658-200003000-00003; DEVESA SS, 1987, J NATL CANCER I, V79, P701; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Eads CA, 2001, CANCER RES, V61, P3410; Eads CA, 2000, CANCER RES, V60, P5021; Eads CA, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.8.e32; Fu BJ, 2007, CANCER BIOL THER, V6, P1546, DOI 10.4161/cbt.6.10.4708; Furniss CS, 2008, CANCER EPIDEM BIOMAR, V17, P966, DOI 10.1158/1055-9965.EPI-07-2775; Guo MZ, 2006, INT J CANCER, V119, P2078, DOI 10.1002/ijc.22092; Guo MZ, 2004, CLIN CANCER RES, V10, P7917, DOI 10.1158/1078-0432.CCR-04-1140; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kang GH, 2008, LAB INVEST, V88, P161, DOI 10.1038/labinvest.3700707; Kawakami K, 2000, J NATL CANCER I, V92, P1805, DOI 10.1093/jnci/92.22.1805; Kimmons Joel E, 2006, MedGenMed, V8, P59; Lagarde SM, 2006, J CLIN ONCOL, V24, P4347, DOI 10.1200/JCO.2005.04.9445; Lagergren J, 2006, LANCET ONCOL, V7, P347, DOI 10.1016/S1470-2045(06)70660-X; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Laird PW, 2003, NAT REV CANCER, V3, P253, DOI 10.1038/nrc1045; Leng S, 2008, CANCER RES, V68, P3049, DOI 10.1158/0008-5472.CAN-07-6344; Lyon CM, 2007, RADIAT RES, V168, P409, DOI 10.1667/RR0825.1; MACDONALD WC, 1987, CANCER, V60, P1094, DOI 10.1002/1097-0142(19870901)60:5<1094::AID-CNCR2820600529>3.0.CO;2-4; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Sato F, 2006, CANCER-AM CANCER SOC, V106, P483, DOI 10.1002/cncr.21657; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Siewert JR, 1998, BRIT J SURG, V85, P1457; SPECHLER SJ, 1986, NEW ENGL J MED, V315, P362, DOI 10.1056/NEJM198608073150605; Wakana K, 2006, CANCER LETT, V241, P281, DOI 10.1016/j.canlet.2005.10.039; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987; Widschwendter M, 2004, CANCER RES, V64, P3807, DOI 10.1158/0008-5472.CAN-03-3852; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wu AH, 2001, CANCER CAUSE CONTROL, V12, P721, DOI 10.1023/A:1011290704728; Wu HY, 2009, CANCER EPIDEM BIOMAR, V18, P1945, DOI 10.1158/1055-9965.EPI-09-0250; Yamamoto E, 2011, DIGESTION, V83, P241, DOI 10.1159/000320453	42	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25985	10.1371/journal.pone.0025985	http://dx.doi.org/10.1371/journal.pone.0025985			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028801	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800012
J	Chen, MQ; Zhang, JB; Li, N; Qian, ZP; Zhu, MQ; Li, Q; Zheng, JM; Wang, XY; Shi, GF				Chen, Mingquan; Zhang, Jianbin; Li, Ning; Qian, Zhiping; Zhu, Mengqi; Li, Qian; Zheng, Jianming; Wang, Xinyu; Shi, Guangfeng			Promoter Hypermethylation Mediated Downregulation of FBP1 in Human Hepatocellular Carcinoma and Colon Cancer	PLOS ONE			English	Article							DAMAGE; GENES; DNA	FBP1, fructose-1,6-bisphosphatase-1, a gluconeogenesis regulatory enzyme, catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate and inorganic phosphate. The mechanism that it functions to antagonize glycolysis and was epigenetically inactivated through NF-kappaB pathway in gastric cancer has been reported. However, its role in the liver carcinogenesis still remains unknown. Here, we investigated the expression and DNA methylation of FBP1 in primary HCC and colon tumor. FBP1 was lowly expressed in 80% (8/10) human hepatocellular carcinoma, 66.7% (6/9) liver cancer cell lines and 100% (6/6) colon cancer cell lines, but was higher in paired adjacent non-tumor tissues and immortalized normal cell lines, which was well correlated with its promoter methylation status. Methylation was further detected in primary HCCs, gastric and colon tumor tissues, but none or occasionally in paired adjacent non-tumor tissues. Detailed methylation analysis of 29 CpG sites at a 327-bp promoter region by bisulfite genomic sequencing confirmed its methylation. FBP1 silencing could be reversed by chemical demethylation treatment with 5-aza-2'-deoxycytidine (Aza), indicating direct epigenetic silencing. Restoring FBP1 expression in low expressed cells significantly inhibited cell growth and colony formation ability through the induction of G2-M phase cell cycle arrest. Moreover, the observed effects coincided with an increase in reactive oxygen species (ROS) generation. In summary, epigenetic inactivation of FBP1 is also common in human liver and colon cancer. FBP1 appears to be a functional tumor suppressor involved in the liver and colon carcinogenesis.	[Chen, Mingquan; Li, Ning; Qian, Zhiping; Zhu, Mengqi; Li, Qian; Zheng, Jianming; Wang, Xinyu; Shi, Guangfeng] Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China; [Zhang, Jianbin] Zhejiang Univ, Sch Med, Inst Immunol, Hangzhou 310003, Zhejiang, Peoples R China	Fudan University; Zhejiang University	Chen, MQ (corresponding author), Fudan Univ, Huashan Hosp, Dept Infect Dis, Shanghai 200433, Peoples R China.	gfshi@shmu.edu.cn			Major Science and Technology Special Project of China Eleventh Five-Year Plan [2008ZX1002-004]; Chinese State Basic Research Foundation [2007CB512904]; Shanghai Sci and Tech Research Program [08JC1403900]; program for Outstanding Medical Academic Leader of Shanghai [08GWD19]	Major Science and Technology Special Project of China Eleventh Five-Year Plan; Chinese State Basic Research Foundation; Shanghai Sci and Tech Research Program; program for Outstanding Medical Academic Leader of Shanghai	This work was supported by grants from Major Science and Technology Special Project of China Eleventh Five-Year Plan (No. 2008ZX1002-004), the Chinese State Basic Research Foundation Grant (2007CB512904), Shanghai Sci and Tech Research Program (08JC1403900), and the program for Outstanding Medical Academic Leader of Shanghai (08GWD19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aykin-Burns N, 2009, BIOCHEM J, V418, P29, DOI 10.1042/BJ20081258; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Berndtsson M, 2007, INT J CANCER, V120, P175, DOI 10.1002/ijc.22132; Bigl M, 2008, BIOCHEM BIOPH RES CO, V377, P720, DOI 10.1016/j.bbrc.2008.10.045; Cabello CM, 2007, CURR OPIN INVEST DR, V8, P1022; Eruslanov E, 2010, METHODS MOL BIOL, V594, P57, DOI 10.1007/978-1-60761-411-1_4; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Fruehauf JP, 2007, CLIN CANCER RES, V13, P789, DOI 10.1158/1078-0432.CCR-06-2082; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kitanovic A, 2006, MUTAT RES-FUND MOL M, V594, P135, DOI 10.1016/j.mrfmmm.2005.08.005; Liu X, 2010, ONCOGENE, V29, P442, DOI 10.1038/onc.2009.332; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957	13	102	112	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25564	10.1371/journal.pone.0025564	http://dx.doi.org/10.1371/journal.pone.0025564			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039417	Green Submitted, gold, Green Published			2022-12-27	WOS:000296507500015
J	Meng, QL; Guo, HK; Hou, SP; Jiang, ZX; Kijlstra, A; Yang, PZ				Meng, Qianli; Guo, Haike; Hou, Shengping; Jiang, Zhengxuan; Kijlstra, Aize; Yang, Peizeng			Lack of an Association of PD-1 and Its Ligand Genes with Behcet's Disease in a Chinese Han Population	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; PDCD1 GENE; RHEUMATOID-ARTHRITIS; REGULATORY POLYMORPHISM; NO EVIDENCE; SILK ROAD; SUSCEPTIBILITY; HAPLOTYPE; MANIFESTATIONS; HLA-B51	Background: Behcet's disease is a chronic, multi-systemic autoimmune disease. Programmed cell death 1 (PD-1) gene is one of non-human leucocyte antigen genes. It has been demonstrated to be associated with several autoimmune diseases. However, only a few studies have addressed the association of ligand genes of PD-1, PD-L1 and PD-L2 with autoimmune disease. The purpose of this study was to analyze the potential association of the PD-1 and its ligand genes with Behcet's disease in a Chinese Han population. Methodology/Principal Findings: Four single-nucleotide polymorphism (SNPs) rs2227981 and rs10204525 of PD-1, rs1970000 of PD-L1 and rs7854303 of PD-L2 were genotyped in 405 Behcet's patients and 414 age-, sex-, ethnic-matched healthy controls using polymerase chain reaction-restriction fragment length polymorphism assay. The results revealed that there were no significant differences in the genotype and allele frequencies of PD-1 rs2227981 and rs10204525 between the Behcet's patients and controls. A similar result was found for PD-L1 rs1970000 versus healthy controls. Only the C allele and the CC genotype of PD-L2 rs7854303 were identified in patients and controls. Stratification analysis based on gender and clinical findings did not show any associations between PD-1 or its ligand polymorphisms and Behcet's disease. Conclusions/Significance: None of the currently studied SNPs, PD-1 rs2227981 and rs10204525, PD-L1 rs1970000 and PD-L2 rs7854303, are associated with the susceptibility to Behcet's disease in a Chinese Han population. More studies are needed to confirm these findings in Behcet's patients with other ethnic backgrounds.	[Meng, Qianli; Guo, Haike] Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Eye Inst, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Hou, Shengping; Jiang, Zhengxuan; Yang, Peizeng] Chongqing Med Univ, Affiliated Hosp 1, Chongqing Key Lab Ophthalmol, Chongqing, Peoples R China; [Kijlstra, Aize] Univ Hosp Maastricht, Dept Ophthalmol, Eye Res Inst Maastricht, Maastricht, Netherlands	Guangdong Academy of Medical Sciences & Guangdong General Hospital; Chongqing Medical University; Maastricht University; Maastricht University Medical Centre (MUMC)	Meng, QL (corresponding author), Guangdong Acad Med Sci, Guangdong Gen Hosp, Guangdong Eye Inst, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China.	peizengycum@126.com	Hou, Shengping/E-5250-2013; Yang, Peizeng/C-6336-2013		Fund for National Natural Science Foundation [30901653]; Natural Science Foundation of Guangdong Province [7301447]; Project of Medical Science and Technology of Chongqing; Health Bureau of Chongqing; Chongqing Key Laboratory of Ophthalmology (CSTC) [2008CA5003]; Natural Science Foundation of Chongqing (CSTC) [2009BA5037]; Natural Science Foundation [30910103912]; Chongqing Municipality; Fund for PAR-EU Scholars Program and National Basic Research	Fund for National Natural Science Foundation; Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Project of Medical Science and Technology of Chongqing; Health Bureau of Chongqing; Chongqing Key Laboratory of Ophthalmology (CSTC)(Natural Science Foundation Project of CQ CSTC); Natural Science Foundation of Chongqing (CSTC)(Natural Science Foundation of ChongqingNatural Science Foundation Project of CQ CSTC); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chongqing Municipality; Fund for PAR-EU Scholars Program and National Basic Research	This work was supported by Fund for National Natural Science Foundation (30901653), Natural Science Foundation of Guangdong Province (7301447), Project of Medical Science and Technology of Chongqing, Key Project of Health Bureau of Chongqing, Chongqing Key Laboratory of Ophthalmology (CSTC, 2008CA5003), Key Project of Natural Science Foundation of Chongqing (CSTC, 2009BA5037), Natural Science Foundation Major International (Regional) Joint Research Project (30910103912), Program for the Training of a Hundred Outstanding S&T Leaders of Chongqing Municipality and Fund for PAR-EU Scholars Program and National Basic Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson AK, 2007, GENES IMMUN, V8, P69, DOI 10.1038/sj.gene.6364360; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Chou WC, 1999, BIOTECHNOL BIOENG, V65, P160, DOI 10.1002/(SICI)1097-0290(19991020)65:2<160::AID-BIT5>3.0.CO;2-U; Cohen R, 2002, ANN RHEUM DIS, V61, P157, DOI 10.1136/ard.61.2.157; Direskeneli H, 2006, RHEUMATOLOGY, V45, P1461, DOI 10.1093/rheumatology/kel329; Fawwaz S, 2007, DIABETIC MED, V24, P1473, DOI 10.1111/j.1464-5491.2007.02297.x; Ferreiros-Vidal I, 2007, GENES IMMUN, V8, P138, DOI 10.1038/sj.gene.6364370; Ferreiros-Vidal I, 2004, ARTHRITIS RHEUM-US, V50, P2590, DOI 10.1002/art.20436; Gul Ahmet, 2005, Current Drug Targets - Inflammation and Allergy, V4, P81, DOI 10.2174/1568010053622894; Hayashi M, 2008, EUR J ENDOCRINOL, V158, P817, DOI 10.1530/EJE-07-0649; Hou SP, 2008, CLIN IMMUNOL, V129, P170, DOI 10.1016/j.clim.2008.06.006; Iwamoto T, 2007, J HUM GENET, V52, P557, DOI 10.1007/s10038-007-0145-2; Jiang ZX, 2010, ANN RHEUM DIS, V69, P1325, DOI 10.1136/ard.2009.119420; Keino H, 2007, BRIT J OPHTHALMOL, V91, P1573, DOI 10.1136/bjo.2007.124875; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Kong EKP, 2005, ARTHRITIS RHEUM-US, V52, P1058, DOI 10.1002/art.20966; Kroner A, 2005, ANN NEUROL, V58, P50, DOI 10.1002/ana.20514; Lee SH, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2071; Lin SC, 2004, ARTHRITIS RHEUM-US, V50, P770, DOI 10.1002/art.20040; Meng QL, 2006, INVEST OPHTH VIS SCI, V47, P4444, DOI 10.1167/iovs.06-0201; Meng QL, 2009, MOL VIS, V15, P386; Mizuki N, 2002, TISSUE ANTIGENS, V60, P396, DOI 10.1034/j.1399-0039.2002.600506.x; Newby PR, 2007, CLIN ENDOCRINOL, V67, P125, DOI 10.1111/j.1365-2265.2007.02848.x; Ni RH, 2007, HUM GENET, V121, P223, DOI 10.1007/s00439-006-0309-8; Nielsen C, 2003, TISSUE ANTIGENS, V62, P492, DOI 10.1046/j.1399-0039.2003.00136.x; Nishimura H, 2001, SCIENCE, V291, P319, DOI 10.1126/science.291.5502.319; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Okazaki T, 2001, P NATL ACAD SCI USA, V98, P13866, DOI 10.1073/pnas.231486598; Park K, 2006, J KOREAN MED SCI, V21, P596, DOI 10.3346/jkms.2006.21.4.596; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Sakane T, 1999, NEW ENGL J MED, V341, P1284, DOI 10.1056/NEJM199910213411707; Sanghera DK, 2004, HUM GENET, V115, P393, DOI 10.1007/s00439-004-1172-0; SILMAN AJ, 1990, LANCET, V335, P1078; Thorburn CM, 2007, GENES IMMUN, V8, P279, DOI 10.1038/sj.gene.6364383; Velazquez-Cruz R, 2007, EUR J HUM GENET, V15, P336, DOI 10.1038/sj.ejhg.5201767; Verity DH, 1999, TISSUE ANTIGENS, V54, P213, DOI 10.1034/j.1399-0039.1999.540301.x; Wang SC, 2007, J RHEUMATOL, V34, P721; Wang SC, 2006, J CLIN IMMUNOL, V26, P506, DOI 10.1007/s10875-006-9048-9; Yabuki K, 1999, INVEST OPHTH VIS SCI, V40, P1921; Yang PZ, 2008, OPHTHALMOLOGY, V115, P312, DOI 10.1016/j.ophtha.2007.04.056	40	11	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25345	10.1371/journal.pone.0025345	http://dx.doi.org/10.1371/journal.pone.0025345			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039410	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500010
J	Mitha, F; Herodotou, H; Borisov, N; Jiang, C; Yoder, J; Owzar, K				Mitha, Faheem; Herodotou, Herodotos; Borisov, Nedyalko; Jiang, Chen; Yoder, Josh; Owzar, Kouros			SNPpy - Database Management for SNP Data from Genome Wide Association Studies	PLOS ONE			English	Article							GENOTYPE IMPUTATION; INFERENCE	Background: We describe SNPpy, a hybrid script database system using the Python SQLAlchemy library coupled with the PostgreSQL database to manage genotype data from Genome-Wide Association Studies (GWAS). This system makes it possible to merge study data with HapMap data and merge across studies for meta-analyses, including data filtering based on the values of phenotype and Single-Nucleotide Polymorphism (SNP) data. SNPpy and its dependencies are open source software. Results: The current version of SNPpy offers utility functions to import genotype and annotation data from two commercial platforms. We use these to import data from two GWAS studies and the HapMap Project. We then export these individual datasets to standard data format files that can be imported into statistical software for downstream analyses. Conclusions: By leveraging the power of relational databases, SNPpy offers integrated management and manipulation of genotype and phenotype data from GWAS studies. The analysis of these studies requires merging across GWAS datasets as well as patient and marker selection. To this end, SNPpy enables the user to filter the data and output the results as standardized GWAS file formats. It does low level and flexible data validation, including validation of patient data. SNPpy is a practical and extensible solution for investigators who seek to deploy central management of their GWAS data.	[Mitha, Faheem; Jiang, Chen; Yoder, Josh; Owzar, Kouros] Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27706 USA; [Herodotou, Herodotos; Borisov, Nedyalko] Duke Univ, Dept Comp Sci, Durham, NC 27706 USA	Duke University; Duke University	Mitha, F (corresponding author), Duke Univ, Dept Biostat & Bioinformat, Durham, NC 27706 USA.	faheem@faheem.info		Herodotou, Herodotos/0000-0002-8717-1691	National Cancer Institute [P01CA142538, CA33601]; PAAR-Pharmacogenomics of Anticancer Agents Research Group; National Institute Of General Medical Sciences [U01GM061393]; NATIONAL CANCER INSTITUTE [U10CA033601, P01CA142538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM061393] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PAAR-Pharmacogenomics of Anticancer Agents Research Group; National Institute Of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by Award Number P01CA142538 (KO) and Award Number CA33601 (FM, CJ, JY, KO) from the National Cancer Institute and the PAAR-Pharmacogenomics of Anticancer Agents Research Group and Award Number U01GM061393 (KO) from the National Institute Of General Medical Sciences. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], GLU GENOTYPE LIB UTI; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Conway JE, 2009, PL R POSTGRESQL LOAD; Fong C, 2010, BIOINFORMATICS, V26, P560, DOI 10.1093/bioinformatics/btp714; Halperin E, 2009, NAT BIOTECHNOL, V27, P349, DOI 10.1038/nbt0409-349; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Orro A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S2-S13; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795	13	8	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e24982	10.1371/journal.pone.0024982	http://dx.doi.org/10.1371/journal.pone.0024982			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039405	Green Submitted, gold, Green Published			2022-12-27	WOS:000296507500006
J	Fields, DM; Durif, CMF; Bjelland, RM; Shema, SD; Skiftesvik, AB; Browman, HI				Fields, David M.; Durif, Caroline M. F.; Bjelland, Reidun M.; Shema, Steven D.; Skiftesvik, Anne B.; Browman, Howard I.			Grazing Rates of Calanus finmarchicus on Thalassiosira weissflogii Cultured under Different Levels of Ultraviolet Radiation	PLOS ONE			English	Article							COPEPOD ACARTIA-TONSA; SOLAR UV-RADIATION; EGG-PRODUCTION; B RADIATION; ACID-COMPOSITION; NORTH-ATLANTIC; FECAL PELLETS; FOOD QUALITY; MARINE; PHYTOPLANKTON	UVB alters photosynthetic rate, fatty acid profiles and morphological characteristics of phytoplankton. Copepods, important grazers of primary production, select algal cells based upon their size, morphological traits, nutritional status, and motility. We investigated the grazing rates of the copepod Calanus finmarchicus on the diatom Thalassiosira weissflogii cultured under 3 levels of ultraviolet radiation (UVR): photosynthetically active radiation (PAR) only (4 kJ-m(-2)/day), and PAR supplemented with UVR radiation at two intensities (24 kJ-m(-2)/day and 48 kJ-m(-2)/day). There was no significant difference in grazing rates between the PAR only treatment and the lower UVR treatment. However, grazing rates were significantly (similar to 66%) higher for copepods feeding on cells treated with the higher level of UVR. These results suggest that a short-term increase in UVR exposure results in a significant increase in the grazing rate of copepods and, thereby, potentially alters the flow rate of organic matter through this component of the ecosystem.	[Fields, David M.; Shema, Steven D.] Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA; [Durif, Caroline M. F.; Bjelland, Reidun M.; Skiftesvik, Anne B.; Browman, Howard I.] Inst Marine Res, Austevoll Res Stn, Storebo, Norway	Bigelow Laboratory for Ocean Sciences; Institute of Marine Research - Norway	Fields, DM (corresponding author), Bigelow Lab Ocean Sci, W Boothbay Harbor, ME USA.	dfields@bigelow.org	Skiftesvik, Anne Berit/M-1266-2013; Browman, Howard/B-4441-2009; Browman, Howard/CAA-2802-2022; Durif, Caroline/A-6406-2011	Skiftesvik, Anne Berit/0000-0002-7754-5661; Browman, Howard/0000-0002-6282-7316; Browman, Howard/0000-0002-6282-7316; Fields, David/0000-0002-8291-912X	Norwegian Institute of Marine Research; Research Council of Norway [178731/S40]; NSF [0648346]	Norwegian Institute of Marine Research; Research Council of Norway(Research Council of Norway); NSF(National Science Foundation (NSF))	This research was supported by the Norwegian Institute of Marine Research (Sensory Biology and Behaviour Project to HIB) and the Research Council of Norway project "Cascading effects of climate change and UV envirotoxins on the nutritional quality of the food base in marine ecosystems" (Project # 178731/S40 to HIB). Additional funding was provided by NSF (# 0648346 awarded to DMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrady A, 2009, PHOTOCH PHOTOBIO SCI, V8, P13, DOI 10.1039/b820432m; Bancroft BA, 2008, CONSERV BIOL, V22, P987, DOI 10.1111/j.1523-1739.2008.00966.x; Bancroft BA, 2007, ECOL LETT, V10, P332, DOI 10.1111/j.1461-0248.2007.01022.x; Beardall J, 2009, PHOTOCH PHOTOBIO SCI, V8, P1257, DOI 10.1039/b9pp00034h; Behrenfeld MJ, 2006, NATURE, V444, P752, DOI 10.1038/nature05317; BERGGREEN U, 1988, MAR BIOL, V99, P341, DOI 10.1007/BF02112126; Bundy MH, 1998, J PLANKTON RES, V20, P2129, DOI 10.1093/plankt/20.11.2129; Cabrera S, 1997, J PLANKTON RES, V19, P1565, DOI 10.1093/plankt/19.11.1565; Conover DO, 1988, FISHERIES, V13, P58; Cury P, 2003, RESPONSIBLE FISHERIES IN THE MARINE ECOSYSTEM, P103, DOI 10.1079/9780851996332.0103; De Lange HJ, 2003, HYDROBIOLOGIA, V491, P133, DOI 10.1023/A:1024485320677; De Lange HJ, 2003, FRESHWATER BIOL, V48, P678, DOI 10.1046/j.1365-2427.2003.01036.x; DEMOTT WR, 1991, J PLANKTON RES, V13, P1203, DOI 10.1093/plankt/13.6.1203; DONAGHAY PL, 1979, MAR BIOL, V52, P137, DOI 10.1007/BF00390421; DOWNS JN, 1985, LIMNOL OCEANOGR, V30, P1024, DOI 10.4319/lo.1985.30.5.1024; Fauchot J, 2000, J PHYCOL, V36, P484, DOI 10.1046/j.1529-8817.2000.99011.x; Fields DM, 1996, INTERACTION CALANOID, P353; FROST BW, 1972, LIMNOL OCEANOGR, V17, P805, DOI 10.4319/lo.1972.17.6.0805; GOES JI, 1994, MAR ECOL PROG SER, V114, P259, DOI 10.3354/meps114259; Gonçalves Rodrigo J, 2010, Ecol. austral, V20, P129; Guisande C, 1999, LIMNOL OCEANOGR, V44, P691, DOI 10.4319/lo.1999.44.3.0691; Hader DP, 2011, PHOTOCH PHOTOBIO SCI, V10, P242, DOI 10.1039/c0pp90036b; Hargreaves BR, 2003, COMP SER PHOTOCHEM, V1, P59; Helbling EW, 2003, MAR ECOL PROG SER, V259, P59, DOI 10.3354/meps259059; Helbling EW, 2003, UV EFFECTS AQUATIC O, p[XXI, 575]; Hessen DO, 1997, FRESHWATER BIOL, V38, P513, DOI 10.1046/j.1365-2427.1997.00223.x; HESSEN DO, 1992, AM NAT, V140, P799, DOI 10.1086/285441; HONJO S, 1978, J MAR RES, V36, P45; INFANTE A, 1985, LIMNOL OCEANOGR, V30, P1046, DOI 10.4319/lo.1985.30.5.1046; Jonasdottir SH, 2002, MAR BIOL, V140, P1195, DOI 10.1007/s00227-002-0782-0; JONASDOTTIR SH, 1995, MAR ECOL PROG SER, V119, P87, DOI 10.3354/meps119087; Kjeldstad B, 2003, MAR ECOL PROG SER, V256, P1, DOI 10.3354/meps256001; Kleppel GS, 1998, ESTUARIES, V21, P328, DOI 10.2307/1352479; Kouwenberg JHM, 2007, J EXP MAR BIOL ECOL, V341, P239, DOI 10.1016/j.jembe.2006.10.047; Leu E, 2007, LIMNOL OCEANOGR, V52, P787, DOI 10.4319/lo.2007.52.2.0787; Leu E, 2006, J EXP MAR BIOL ECOL, V337, P65, DOI 10.1016/j.jembe.2006.06.005; Madronich S, 1998, J PHOTOCH PHOTOBIO B, V46, P5, DOI 10.1016/S1011-1344(98)00182-1; McKenzie RL, 2011, PHOTOCH PHOTOBIO SCI, V10, P182, DOI 10.1039/c0pp90034f; MULLIN MM, 1963, LIMNOL OCEANOGR, V8, P239, DOI 10.4319/lo.1963.8.2.0239; Nahon S, 2010, J EXP MAR BIOL ECOL, V383, P164, DOI 10.1016/j.jembe.2009.12.006; PAFFENHOFER GA, 1984, MAR BIOL, V80, P323, DOI 10.1007/BF00392828; PENRY DL, 1991, LIMNOL OCEANOGR, V36, P147, DOI 10.4319/lo.1991.36.1.0147; Petzold TJ, 1988, CHARACTERIZATION MER; Planque B, 2000, ICES J MAR SCI, V57, P1528, DOI 10.1006/jmsc.2000.0970; Pond D, 1996, MAR ECOL PROG SER, V143, P45, DOI 10.3354/meps143045; Santas R, 1996, PHOTOCHEM PHOTOBIOL, V64, P435, DOI 10.1111/j.1751-1097.1996.tb03088.x; Shick JM, 2002, ANNU REV PHYSIOL, V64, P223, DOI 10.1146/annurev.physiol.64.081501.155802; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Steemann Nielsen E., 1964, J CONS INT EXPLOR ME, V29, P130; STERNER RW, 1994, ANNU REV ECOL SYST, V25, P1, DOI 10.1146/annurev.es.25.110194.000245; Swaim Zachary T., 2009, Endangered Species Research, V6, P259, DOI 10.3354/esr00163; Tedetti M, 2006, PHOTOCHEM PHOTOBIOL, V82, P389, DOI 10.1562/2005-11-09-IR-733; VANDONK E, 1995, HYDROBIOLOGIA, V307, P147, DOI 10.1007/BF00032006; VANDONK E, 1993, OECOLOGIA, V93, P508, DOI 10.1007/BF00328958; Von Elert E, 2000, FRESHWATER BIOL, V45, P189, DOI 10.1046/j.1365-2427.2000.00671.x; Worrest R. C., 1986, EFFECTS CHANGES STRA, P175; Wu HY, 2009, FUNCT PLANT BIOL, V36, P137, DOI 10.1071/FP08172; Zudaire L, 2001, J PHOTOCH PHOTOBIO B, V62, P26, DOI 10.1016/S1011-1344(01)00150-6	58	9	10	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26333	10.1371/journal.pone.0026333	http://dx.doi.org/10.1371/journal.pone.0026333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028858	gold, Green Published, Green Submitted			2022-12-27	WOS:000296186900051
J	Geng, H; Law, PPY; Ng, MCY; Li, T; Liang, LY; Ge, TF; Wong, KB; Liang, C; Ma, RC; So, WY; Chan, JCN; Ho, YY				Geng, Hua; Law, Peggy P. Y.; Ng, Maggie C. Y.; Li, Ting; Liang, Li-Yun; Ge, Tian-Fang; Wong, Kam-Bo; Liang, Chun; Ma, Ronald C.; So, Wing-Yee; Chan, Juliana C. N.; Ho, Yuan-Yuan			APOE Genotype-Function Relationship: Evidence of -491 A/T Promoter Polymorphism Modifying Transcription Control but Not Type 2 Diabetes Risk	PLOS ONE			English	Article							PLASMA APOLIPOPROTEIN-E; GENE REGULATORY REGION; HONG-KONG CHINESE; ALZHEIMERS-DISEASE; PROTEIN; STRESS; ATF4; DYSLIPIDEMIA; METAANALYSIS; APOPTOSIS	Background: The apolipoprotein E gene (APOE) coding polymorphism modifies the risks of Alzheimer's disease, type 2 diabetes, and coronary heart disease. Aside from the coding variants, single nucleotide polymorphism (SNP) of the APOE promoter has also been shown to modify the risk of Alzheimer's disease. Methodology/Principal Findings: In this study we investigate the genotype-function relationship of APOE promoter polymorphism at molecular level and at physiological level: i.e., in transcription control of the gene and in the risk of type 2 diabetes. In molecular studies, the effect of the APOE -491A/T (rs449647) polymorphism on gene transcription was accessed by dual-luciferase reporter gene assays. The 2491 A to T substitution decreased the activity (p<0.05) of the cloned APOE promoter (-1017 to +406). Using the -501 to -481 nucleotide sequence of the APOE promoter as a 'bait' to screen the human brain cDNA library by yeast one-hybrid system yielded ATF4, an endoplasmic reticulum stress response gene, as one of the interacting factors. Electrophoretic-mobility-shift assays (EMSA) and chromatin immuno-precipitation (ChIP) analyses further substantiated the physical interaction between ATF4 and the APOE promoter. Over-expression of ATF4 stimulated APOE expression whereas siRNA against ATF4 suppressed the expression of the gene. However, interaction between APOE promoter and ATF4 was not 2491A/T-specific. At physiological level, the genotype-function relationship of APOE promoter polymorphism was studied in type 2 diabetes. In 630 cases and 595 controls, three APOE promoter SNPs -491A/T, -219G/T (rs405509), and + 113G/C (rs440446) were genotyped and tested for association with type 2 diabetes in Hong Kong Chinese. No SNP or haplotype association with type 2 diabetes was detected. Conclusions/Significance: At molecular level, polymorphism 2491A/T and ATF4 elicit independent control of APOE gene expression. At physiological level, no genotype-risk association was detected between the studied APOE promoter SNPs and type 2 diabetes in Hong Kong Chinese.	[Geng, Hua; Law, Peggy P. Y.; Li, Ting; Liang, Li-Yun; Ge, Tian-Fang; Wong, Kam-Bo; Ho, Yuan-Yuan] Chinese Univ Hong Kong, Dept Biochem, Shatin, Hong Kong, Peoples R China; [Ng, Maggie C. Y.; Ma, Ronald C.; So, Wing-Yee; Chan, Juliana C. N.] Chinese Univ Hong Kong, Dept Med & Therapeut, Prince Wales Hosp, Shatin, Hong Kong, Peoples R China; [Liang, Chun] Hong Kong Univ Sci & Technol, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Ho, Yuan-Yuan] Columbia Univ, Dept Biostat, Genet Complex Disorder Program, New York, NY USA; [Ho, Yuan-Yuan] Columbia Univ, Dept Psychiat, Genet Complex Disorder Program, New York, NY USA	Chinese University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Hong Kong University of Science & Technology; Columbia University; Columbia University	Geng, H (corresponding author), Tianjin Med Univ, Res Ctr Basic Med Sci, Tianjin, Peoples R China.	yyh2@columbia.edu	Wong, Kam-Bo/G-4258-2013; Ma, Ronald/C-2788-2009; Chan, Juliana/B-7918-2016; Wong, Kam-Bo/AAU-9364-2021	Wong, Kam-Bo/0000-0002-6984-5373; Ma, Ronald/0000-0002-1227-803X; Chan, Juliana/0000-0003-1325-1194; Wong, Kam-Bo/0000-0002-6984-5373	Faculty of Medicine, The Chinese University of Hong Kong [2041183]; National Institute of Mental Health, USA [T32-MH-65213]; Division of Statistical Genetics, Department of Biostatistics, Columbia University, New York; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065213] Funding Source: NIH RePORTER	Faculty of Medicine, The Chinese University of Hong Kong(Chinese University of Hong Kong); National Institute of Mental Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Division of Statistical Genetics, Department of Biostatistics, Columbia University, New York; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This project was partially supported by the following grants: 1) Direct Grant (No. 2041183), Faculty of Medicine, The Chinese University of Hong Kong. 2) T32-MH-65213, National Institute of Mental Health, USA. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the support of the Division of Statistical Genetics, Department of Biostatistics, Columbia University, New York.	Ameri K, 2008, INT J BIOCHEM CELL B, V40, P14, DOI 10.1016/j.biocel.2007.01.020; Anthopoulos PG, 2010, MOL GENET METAB, V100, P283, DOI 10.1016/j.ymgme.2010.03.008; Aparicio Oscar, 2005, Curr Protoc Mol Biol, VChapter 21, DOI 10.1002/0471142727.mb2103s69; Artiga MJ, 1998, FEBS LETT, V421, P105, DOI 10.1016/S0014-5793(97)01543-3; Bullido MJ, 1998, NAT GENET, V18, P69, DOI 10.1038/ng0198-69; Chahil TJ, 2006, ENDOCRIN METAB CLIN, V35, P491, DOI 10.1016/j.ecl.2006.06.002; Cheung YY, 2004, ACTA CRYSTALLOGR D, V60, P1308, DOI 10.1107/S0907444904010996; Corbo RM, 2001, CLIN CHEM LAB MED, V39, P2, DOI 10.1515/CCLM.2001.002; Fawcett TW, 1999, BIOCHEM J, V339, P135, DOI 10.1042/0264-6021:3390135; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hosoi T, 2010, CLIN SCI, V118, P19, DOI 10.1042/CS20080680; Krauss RM, 2004, MED CLIN N AM, V88, P897, DOI 10.1016/j.mcna.2004.04.004; Lassot I, 2005, J BIOL CHEM, V280, P41537, DOI 10.1074/jbc.M505294200; Laws SM, 1999, NEUROREPORT, V10, P879, DOI 10.1097/00001756-199903170-00038; Laws SM, 2003, J NEUROCHEM, V84, P1215, DOI 10.1046/j.1471-4159.2003.01615.x; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lipson KL, 2006, CURR MOL MED, V6, P71, DOI 10.2174/156652406775574613; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Malhotra A, 2007, DIABETES, V56, P890, DOI 10.2337/db06-1057; Maloney B, 2010, AM J MED GENET B, V153B, P185, DOI 10.1002/ajmg.b.30973; Ng MCY, 2004, DIABETES, V53, P2676, DOI 10.2337/diabetes.53.10.2676; Rutkowski DT, 2003, DEV CELL, V4, P442, DOI 10.1016/S1534-5807(03)00100-X; Scacchi R, 2001, DEMENT GERIATR COGN, V12, P63, DOI 10.1159/000051237; Seo J, 2009, DIABETES, V58, P2565, DOI 10.2337/db09-0335; Tan KCB, 2006, DIABETES-METAB RES, V22, P307, DOI 10.1002/dmrr.616; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; van Vliet P, 2007, ANN NY ACAD SCI, V1100, P140, DOI 10.1196/annals.1395.012; Yang X, 2007, DIABETES CARE, V30, P65, DOI 10.2337/dc06-1273; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhou JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017324	30	4	4	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e24669	10.1371/journal.pone.0024669	http://dx.doi.org/10.1371/journal.pone.0024669			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028770	Green Published, gold, Green Submitted			2022-12-27	WOS:000296186900003
J	Regala, RP; Justilien, V; Walsh, MP; Weems, C; Khoor, A; Murray, NR; Fields, AP				Regala, Roderick P.; Justilien, Verline; Walsh, Michael P.; Weems, Capella; Khoor, Andras; Murray, Nicole R.; Fields, Alan P.			Matrix Metalloproteinase-10 Promotes Kras-Mediated Bronchio-Alveolar Stem Cell Expansion and Lung Cancer Formation	PLOS ONE			English	Article							GENE-EXPRESSION PROFILES; TUMOR-INITIATING CELLS; BREAST-TUMORS; MOUSE MODEL; IN-SITU; IDENTIFICATION; PROGRESSION; ADENOCARCINOMA; MICRODISSECTION; PROLIFERATION	Matrix metalloproteinase 10 (MMP-10; stromelysin 2) is a member of a large family of structurally related matrix metalloproteinases, many of which have been implicated in tumor progression, invasion and metastasis. We recently identified Mmp10 as a gene that is highly induced in tumor-initiating lung bronchioalveolar stem cells (BASCs) upon activation of oncogenic Kras in a mouse model of lung adenocarcinoma. However, the potential role of Mmp10 in lung tumorigenesis has not been addressed. Here, we demonstrate that Mmp10 is overexpressed in lung tumors induced by either the smoke carcinogen urethane or oncogenic Kras. In addition, we report a significant reduction in lung tumor number and size after urethane exposure or genetic activation of oncogenic Kras in Mmp10 null (Mmp10(-/-)) mice. This inhibitory effect is reflected in a defect in the ability of Mmp10-deficient BASCs to expand and undergo transformation in response to urethane or oncogenic Kras in vivo and in vitro, demonstrating a role for Mmp10 in the tumor-initiating activity of Kras-transformed lung stem cells. To determine the potential relevance of MMP10 in human cancer we analyzed Mmp10 expression in publicly-available gene expression profiles of human cancers. Our analysis reveals that MMP10 is highly overexpressed in human lung tumors. Gene set enhancement analysis (GSEA) demonstrates that elevated MMP10 expression correlates with both cancer stem cell and tumor metastasis genomic signatures in human lung cancer. Finally, Mmp10 is elevated in many human tumor types suggesting a widespread role for Mmp10 in human malignancy. We conclude that Mmp10 plays an important role in lung tumor initiation via maintenance of a highly tumorigenic, cancer-initiating, stem-like cell population, and that Mmp10 expression is associated with stem-like, highly metastatic genotypes in human lung cancers. These results indicate that Mmp10 may represent a novel therapeutic approach to target lung cancer stem cells.	[Regala, Roderick P.; Justilien, Verline; Walsh, Michael P.; Weems, Capella; Murray, Nicole R.; Fields, Alan P.] Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA; [Khoor, Andras] Mayo Clin, Coll Med, Dept Pathol, Jacksonville, FL 32224 USA	Mayo Clinic; Mayo Clinic	Regala, RP (corresponding author), Mayo Clin, Coll Med, Dept Canc Biol, Jacksonville, FL 32224 USA.	fields.alan@mayo.edu	Pillay, Nischalan/F-9536-2012		National Cancer Institute [R01 CA081436-13, R21 CA151250-01, CA115160]; V Foundation for Cancer Research; James and Esther King Biomedical Research Program [1KG-05-33971]; NIH from the NCI; NATIONAL CANCER INSTITUTE [R21CA151250, R01CA081436, F32CA115160] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); V Foundation for Cancer Research; James and Esther King Biomedical Research Program; NIH from the NCI; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from National Cancer Institute (R01 CA081436-13 and R21 CA151250-01), the V Foundation for Cancer Research, and the James and Esther King Biomedical Research Program (1KG-05-33971) to APF; a Ruth A. Kirschstein Postdoctoral Fellowship Award CA115160 from the NCI (RPR); and a NIH Research Supplement to Promote Diversity in Health-related Research Award from the NCI (VJ). Alan P. Fields is the Monica Flynn Jacoby Professor of Cancer Research, an endowment that provides partial support for his research program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Baty F, 2010, AM J RESP CRIT CARE, V181, P181, DOI 10.1164/rccm.200812-1807OC; Becker M, 2005, MOL CANCER THER, V4, P151; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BOLSTAD BM, PREPROCESSCORE COLLE; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bose S, 2009, J PATHOL, V217, P345, DOI 10.1002/path.2487; Cho NH, 2004, ONCOGENE, V23, P845, DOI 10.1038/sj.onc.1207140; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Cromer A, 2004, ONCOGENE, V23, P2484, DOI 10.1038/sj.onc.1207345; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Dazard JE, 2003, ONCOGENE, V22, P2993, DOI 10.1038/sj.onc.1206537; Dehan E, 2007, LUNG CANCER, V56, P175, DOI 10.1016/j.lungcan.2006.12.010; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Fang D, 2005, CANCER RES, V65, P9328, DOI 10.1158/0008-5472.CAN-05-1343; Farmer P, 2005, ONCOGENE, V24, P4660, DOI 10.1038/sj.onc.1208561; Frederick LA, 2008, ONCOGENE, V27, P4841, DOI 10.1038/onc.2008.119; Gal H, 2006, LEUKEMIA, V20, P2147, DOI 10.1038/sj.leu.2404401; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Giangreco A, 2007, AM J RESP CRIT CARE, V175, P547, DOI 10.1164/rccm.200607-984PP; Gill JH, 2004, NEOPLASIA, V6, P777, DOI 10.1593/neo.04283; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; Gyorffy B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005645; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Huper G, 2007, CANCER RES, V67, P2990, DOI 10.1158/0008-5472.CAN-06-4065; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jiang TY, 2009, CANCER RES, V69, P845, DOI 10.1158/0008-5472.CAN-08-2762; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kelly-Spratt KS, 2009, ONCOGENE, V28, P3652, DOI 10.1038/onc.2009.226; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kim WJ, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-3; Kommagani R, 2006, ONCOGENE, V25, P3745, DOI 10.1038/sj.onc.1209412; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Kupershmidt I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013066; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; MALKINSON AM, 1985, J NATL CANCER I, V75, P971, DOI 10.1093/jnci/75.5.971; Matsuyama T, 2010, INT J CANCER, V127, P2292, DOI 10.1002/ijc.25256; McGarvey KM, 2008, CANCER RES, V68, P5753, DOI 10.1158/0008-5472.CAN-08-0700; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Pyeon D, 2007, CANCER RES, V67, P4605, DOI 10.1158/0008-5472.CAN-06-3619; R Core Team, 2021, R LANGUAGE ENV STAT; Regala RP, 2009, CANCER RES, V69, P7603, DOI 10.1158/0008-5472.CAN-09-2066; Regala RP, 2005, CANCER RES, V65, P8905, DOI 10.1158/0008-5472.CAN-05-2372; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Riker AI, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-13; Rosty C, 2005, ONCOGENE, V24, P7094, DOI 10.1038/sj.onc.1208854; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Sawey ET, 2008, CELL CYCLE, V7, P566, DOI 10.4161/cc.7.5.5531; Sawey ET, 2007, P NATL ACAD SCI USA, V104, P19327, DOI 10.1073/pnas.0705953104; Schuetz CS, 2006, CANCER RES, V66, P5278, DOI 10.1158/0008-5472.CAN-05-4610; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Sengupta S, 2006, CANCER RES, V66, P7999, DOI 10.1158/0008-5472.CAN-05-4399; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Su H, 2011, CLIN CANCER RES, V17, P2955, DOI 10.1158/1078-0432.CCR-10-2724; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeuchi T, 2006, J CLIN ONCOL, V24, P1679, DOI 10.1200/JCO.2005.03.8224; Tirino V, 2009, EUR J CARDIO-THORAC, V36, P446, DOI 10.1016/j.ejcts.2009.03.063; Tomida S, 2009, J CLIN ONCOL, V27, P2793, DOI 10.1200/JCO.2008.19.7053; Turashvili G, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-55; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Uva P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-135; Vecchi M, 2007, ONCOGENE, V26, P4284, DOI 10.1038/sj.onc.1210208; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wrage M, 2009, CLIN CANCER RES, V15, P1566, DOI 10.1158/1078-0432.CCR-08-2188; Yang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002220; Ye H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-69; Yu K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000129; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353	85	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26439	10.1371/journal.pone.0026439	http://dx.doi.org/10.1371/journal.pone.0026439			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022614	gold, Green Published, Green Submitted			2022-12-27	WOS:000295984400058
J	Zou, JF; Hong, GN; Guo, XW; Zhang, L; Yao, C; Wang, J; Guo, Z				Zou, Jinfeng; Hong, Guini; Guo, Xinwu; Zhang, Lin; Yao, Chen; Wang, Jing; Guo, Zheng			Reproducible Cancer Biomarker Discovery in SELDI-TOF MS Using Different Pre-Processing Algorithms	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; MASS-SPECTROMETRY DATA; BREAST-CANCER; PROTEIN PROFILES; MICROARRAY DATA; SAMPLE-SIZE; SERUM; PROTEOMICS; NORMALIZATION; POWER	Background: There has been much interest in differentiating diseased and normal samples using biomarkers derived from mass spectrometry (MS) studies. However, biomarker identification for specific diseases has been hindered by irreproducibility. Specifically, a peak profile extracted from a dataset for biomarker identification depends on a data preprocessing algorithm. Until now, no widely accepted agreement has been reached. Results: In this paper, we investigated the consistency of biomarker identification using differentially expressed (DE) peaks from peak profiles produced by three widely used average spectrum-dependent pre-processing algorithms based on SELDI-TOF MS data for prostate and breast cancers. Our results revealed two important factors that affect the consistency of DE peak identification using different algorithms. One factor is that some DE peaks selected from one peak profile were not detected as peaks in other profiles, and the second factor is that the statistical power of identifying DE peaks in large peak profiles with many peaks may be low due to the large scale of the tests and small number of samples. Furthermore, we demonstrated that the DE peak detection power in large profiles could be improved by the stratified false discovery rate (FDR) control approach and that the reproducibility of DE peak detection could thereby be increased. Conclusions: Comparing and evaluating pre-processing algorithms in terms of reproducibility can elucidate the relationship among different algorithms and also help in selecting a pre-processing algorithm. The DE peaks selected from small peak profiles with few peaks for a dataset tend to be reproducibly detected in large peak profiles, which suggests that a suitable pre-processing algorithm should be able to produce peaks sufficient for identifying useful and reproducible biomarkers.	[Zou, Jinfeng; Hong, Guini; Zhang, Lin; Yao, Chen; Wang, Jing; Guo, Zheng] Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China; [Guo, Xinwu; Guo, Zheng] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China	University of Electronic Science & Technology of China; Harbin Medical University	Zou, JF (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci, Bioinformat Ctr, Chengdu 610054, Peoples R China.	guoz@ems.hrbmu.edu.cn	Wang, Jing/B-5420-2014	Wang, Jing/0000-0002-8128-9920	National Natural Science Foundation of China [30970668, 81071646, 91029717]; Excellent Youth Foundation of Heilongjiang Province [JC200808]; Natural Science Foundation of Heilongjiang Province of China [QC2010012]; Heilongjiang Provincial Education Department [11541156]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Heilongjiang Province; Natural Science Foundation of Heilongjiang Province of China(Natural Science Foundation of Heilongjiang Province); Heilongjiang Provincial Education Department	This work was supported by the National Natural Science Foundation of China (30970668, 81071646, 91029717) (http://www.nsfc.gov.cn/Portal0/default106.htm), Excellent Youth Foundation of Heilongjiang Province (JC200808)(http://jj.hljkj.cn/qn/), Natural Science Foundation of Heilongjiang Province of China (QC2010012) (http://jj.hljkj.cn/zr/index.htm), and the Scientific Research Fund of Heilongjiang Provincial Education Department (11541156). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BL, 2002, CANCER RES, V62, P3609; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Baggerly KA, 2004, BIOINFORMATICS, V20, P777, DOI 10.1093/bioinformatics/btg484; Bell AW, 2009, NAT METHODS, V6, P423, DOI [10.1038/NMETH.1333, 10.1038/nmeth.1333]; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caffrey RE, 2010, METHODS MOL BIOL, V641, P167, DOI 10.1007/978-1-60761-711-2_10; Callesen AK, 2008, J PROTEOME RES, V7, P1395, DOI 10.1021/pr800115f; Carvajal-Rodriguez A, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-209; Carvalho PC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-316; Cho William C. S., 2007, Genomics Proteomics & Bioinformatics, V5, P77, DOI 10.1016/S1672-0229(07)60018-7; Cho William Chi-shing, 2006, Sheng Wu Gong Cheng Xue Bao, V22, P871; Coombes K. R., 2007, PREPROCESSING MASS S; Cruz-Marcelo A, 2008, BIOINFORMATICS, V24, P2129, DOI 10.1093/bioinformatics/btn398; De Bock M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/906082; Diamandis EP, 2004, J NATL CANCER I, V96, P353, DOI 10.1093/jnci/djh056; Diao L, 2011, CANCER INFORM, V10, P45, DOI 10.4137/CIN.S6438; Dijkstra M, 2009, PROTEOMICS, V9, P3869, DOI 10.1002/pmic.200701064; Du P, 2006, BIOINFORMATICS, V22, P2059, DOI 10.1093/bioinformatics/btl355; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Emanuele VA, 2009, PROTEOMICS, V9, P1754, DOI 10.1002/pmic.200701171; Esteva FJ, 2005, BREAST CANCER RES, V7, pR436, DOI 10.1186/bcr1020; Fortin T, 2009, MOL CELL PROTEOMICS, V8, P1006, DOI 10.1074/mcp.M800238-MCP200; Froebel Julia, 2010, Archives of Physiology and Biochemistry, V116, P174, DOI 10.3109/13813455.2010.501082; Gong X, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-76; Hanash SM, 2008, NATURE, V452, P571, DOI 10.1038/nature06916; Hogan JM, 2006, OMICS, V10, P152, DOI 10.1089/omi.2006.10.152; Huang Baisong, 2007, BMC Proc, V1 Suppl 1, pS142; Klebanov L, 2006, STAT APPL GENET MOL, V5; Kristina G, 2009, LAB CHIP, V9, P1014, DOI 10.1039/b815503h; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Lee MLT, 2002, STAT MED, V21, P3543, DOI 10.1002/sim.1335; Li C, 2008, HUM HERED, V65, P129, DOI 10.1159/000109730; Li JN, 2005, CLIN CANCER RES, V11, P8312, DOI 10.1158/1078-0432.CCR-05-1538; Li X, 2005, STAT BIOL HEALTH, P91; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Mathelin C, 2006, BREAST CANCER RES TR, V96, P83, DOI 10.1007/s10549-005-9046-2; Mead JA, 2009, PROTEOMICS, V9, P861, DOI 10.1002/pmic.200800553; Meuleman W, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-88; Poon TCW, 2007, EXPERT REV PROTEOMIC, V4, P51, DOI 10.1586/14789450.4.1.51; Pusztai L, 2004, CANCER, V100, P1814, DOI 10.1002/cncr.20203; Qiu X, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-120; Ransohoff DF, 2005, J NATL CANCER I, V97, P315, DOI 10.1093/jnci/dji054; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Rocke DM, 2009, BIOINFORMATICS, V25, P701, DOI 10.1093/bioinformatics/btp038; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sanders ME, 2008, J PROTEOME RES, V7, P1500, DOI 10.1021/pr7008109; SAUVE AC, 2004, 2004 P GEN SIGN PROC; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Song HJ, 2009, ACTA PHARMACOL SIN, V30, P1550, DOI 10.1038/aps.2009.140; Sun L, 2006, GENET EPIDEMIOL, V30, P519, DOI 10.1002/gepi.20164; Swinkels DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002706; Timms JF, 2007, CLIN CHEM, V53, P645, DOI 10.1373/clinchem.2006.080101; Truntzer C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-434; Tuck MK, 2009, J PROTEOME RES, V8, P113, DOI 10.1021/pr800545q; Wang J, 2011, MOL BIOSYST, V7, P1158, DOI 10.1039/c0mb00211a; Wong JWH, 2005, BIOINFORMATICS, V21, P2088, DOI 10.1093/bioinformatics/bti300; Wu ST, 2009, BIOINFORMATICS: TOOLS AND APPLICATIONS, P225, DOI 10.1007/978-0-387-92738-1_11; Yasui Y, 2003, BIOSTATISTICS, V4, P449, DOI 10.1093/biostatistics/4.3.449; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365	61	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26294	10.1371/journal.pone.0026294	http://dx.doi.org/10.1371/journal.pone.0026294			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022591	Green Published, gold, Green Submitted			2022-12-27	WOS:000295981600049
J	Santucci, N; D'Attilio, L; Kovalevski, L; Bozza, V; Besedovsky, H; del Rey, A; Bay, ML; Bottasso, O				Santucci, Natalia; D'Attilio, Luciano; Kovalevski, Leandro; Bozza, Veronica; Besedovsky, Hugo; del Rey, Adriana; Luisa Bay, Maria; Bottasso, Oscar			A Multifaceted Analysis of Immune-Endocrine-Metabolic Alterations in Patients with Pulmonary Tuberculosis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; LEPTIN CONCENTRATIONS; INFLAMMATORY MARKERS; GAMMA PRODUCTION; NERVOUS-SYSTEM; PLASMA LEPTIN; FAT MASS; WEIGHT; NEUROENDOCRINE; RESPONSES	Our study investigated the circulating levels of factors involved in immune-inflammatory-endocrine-metabolic responses in patients with tuberculosis with the aim of uncovering a relation between certain immune and hormonal patterns, their clinical status and in vitro immune response. The concentration of leptin, adiponectin, IL-6, IL-1 beta, ghrelin, C-reactive protein (CRP), cortisol and dehydroepiandrosterone (DHEA), and the in vitro immune response (lymphoproliferation and IFN-gamma production) was evaluated in 53 patients with active untreated tuberculosis, 27 household contacts and 25 healthy controls, without significant age-or sex-related differences. Patients had a lower body mass index (BMI), reduced levels of leptin and DHEA, and increased concentrations of CRP, IL-6, cortisol, IL-1 beta and nearly significant adiponectin values than household contacts and controls. Within tuberculosis patients the BMI and leptin levels were positively correlated and decreased with increasing disease severity, whereas higher concentrations of IL-6, CRP, IL-1 beta, cortisol, and ghrelin were seen in cases with moderate to severe tuberculosis. Household contacts had lower DHEA and higher IL-6 levels than controls. Group classification by means of discriminant analysis and the k-nearest neighbor method showed that tuberculosis patients were clearly different from the other groups, having higher levels of CRP and lower DHEA concentration and BMI. Furthermore, plasma leptin levels were positively associated with the basal in vitro IFN-gamma production and the ConA-driven proliferation of cells from tuberculosis patients. Present alterations in the communication between the neuro-endocrine and immune systems in tuberculosis may contribute to disease worsening.	[Santucci, Natalia; D'Attilio, Luciano; Bozza, Veronica; Luisa Bay, Maria; Bottasso, Oscar] Univ Nacl Rosario, Inst Inmunol, Fac Ciencias Med, RA-2000 Rosario, Santa Fe, Argentina; [Kovalevski, Leandro] Univ Nacl Rosario, Inst Invest Teor & Aplicadas, Escuela Estadist, Fac Ciencias Econ & Estadist, RA-2000 Rosario, Santa Fe, Argentina; [Besedovsky, Hugo; del Rey, Adriana] Inst Physiol & Pathophysiol, Marburg, Germany	National University of Rosario; National University of Rosario	Santucci, N (corresponding author), Univ Nacl Rosario, Inst Inmunol, Fac Ciencias Med, RA-2000 Rosario, Santa Fe, Argentina.	bottasso@uolsinectis.com.ar	Santucci, Natalia Estefanía/AAE-2602-2022	Santucci, Natalia Estefanía/0000-0002-2440-2296	FONCYT [BID 1728/OC-AR PID 160]; Fundacion Florencio Fiorini	FONCYT(FONCyT); Fundacion Florencio Fiorini	This work was supported by grants from FONCYT (BID 1728/OC-AR PID 160) and Fundacion Florencio Fiorini. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson TW., 2003, INTRO MULTIVARIATE S, V3; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; Baccan GC, 2011, BRAIN BEHAV IMMUN, V25, P548, DOI 10.1016/j.bbi.2010.12.009; Bahceci M, 2007, J ENDOCRINOL INVEST, V30, P210, DOI 10.1007/BF03347427; Besedovsky HO, 1996, ENDOCR REV, V17, P64, DOI 10.1210/er.17.1.64; BOTTASSO O, 2000, NEUROIMMUNOMODULAT, V16, P68; Bottasso Oscar, 2010, Current Immunology Reviews, V6, P314; Bozza VV, 2007, SCAND J IMMUNOL, V66, P97, DOI 10.1111/j.1365-3083.2007.01952.x; Bozza V, 2009, ANN NY ACAD SCI, V1153, P247, DOI 10.1111/j.1749-6632.2008.03976.x; Breen RAM, 2008, INT J TUBERC LUNG D, V12, P44; Cardona PJ, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/868246; Choi CM, 2007, INT J TUBERC LUNG D, V11, P233; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; DALLMAN MF, 1993, FRONT NEUROENDOCRIN, V14, P303, DOI 10.1006/frne.1993.1010; Dannenberg Arthur M. Jr., 1994, P459; del Rey A, 2007, BRAIN BEHAV IMMUN, V21, P171, DOI 10.1016/j.bbi.2006.06.005; Dillon Joseph S., 2005, Current Drug Targets - Inflammation and Allergy, V4, P377, DOI 10.2174/1568010054022079; FAREBEE SH, 1970, ADV TUBER RES, V7, P29; FIX E, 1989, INT STAT REV, V57, P238, DOI 10.2307/1403797; Flynn JL, 2004, TUBERCULOSIS, V84, P93, DOI 10.1016/j.tube.2003.08.010; Grange JM, 2011, TUBERCULOSIS, V91, P179, DOI 10.1016/j.tube.2010.12.004; Hernandez-Pando R, 2005, J INFECT DIS, V191, P299, DOI 10.1086/426453; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Kellendonk C, 2002, ENDOCRINOLOGY, V143, P2333, DOI 10.1210/en.143.6.2333; Kim JH, 2010, CLIN NUTR, V29, P512, DOI 10.1016/j.clnu.2010.01.008; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Langhans W, 2000, NUTRITION, V16, P996, DOI 10.1016/S0899-9007(00)00421-4; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Lorenzi T, 2009, CYTOKINE GROWTH F R, V20, P137, DOI 10.1016/j.cytogfr.2009.02.003; Luheshi GN, 1999, P NATL ACAD SCI USA, V96, P7047, DOI 10.1073/pnas.96.12.7047; MAFFEI M, 1995, NAT MED, V1, P1155, DOI 10.1038/nm1195-1155; Mahuad C, 2007, NEUROIMMUNOMODULAT, V14, P193, DOI 10.1159/000110646; Martin SS, 2008, J AM COLL CARDIOL, V52, P1201, DOI 10.1016/j.jacc.2008.05.060; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Ota K, 2009, ANN NY ACAD SCI, V1153, P82, DOI 10.1111/j.1749-6632.2008.03981.x; Perez AR, 2011, J NEUROIMMUNOL, V235, P84, DOI 10.1016/j.jneuroim.2011.03.010; Raso GM, 2002, BRIT J PHARMACOL, V137, P799, DOI 10.1038/sj.bjp.0704903; Ribeiro F, 2007, BIOGERONTOLOGY, V8, P209, DOI 10.1007/s10522-006-9069-z; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; Santucci N, 2010, NEUROIMMUNOMODULAT, V17, P184, DOI 10.1159/000258719; Schleicher GK, 2005, EUR RESPIR J, V25, P688, DOI 10.1183/09031936.05.00067604; Schwenk A, 2003, AM J CLIN NUTR, V77, P392, DOI 10.1093/ajcn/77.2.392; Stenlof K, 2003, J CLIN ENDOCR METAB, V88, P4379, DOI 10.1210/jc.2002-021733; Straub RH, 2011, BRAIN BEHAV IMMUN, V25, P1, DOI 10.1016/j.bbi.2010.08.002; Straub RH, 2003, FASEB J, V17, P2176, DOI 10.1096/fj.03-0433hyp; Taub DD, 2008, VITAM HORM, V77, P325, DOI 10.1016/S0083-6729(06)77014-5; van Crevel R, 2002, J CLIN ENDOCR METAB, V87, P758, DOI 10.1210/jc.87.2.758; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Yuksel I, 2003, ENDOCR RES, V29, P257, DOI 10.1081/ERC-120025033	52	43	44	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26363	10.1371/journal.pone.0026363	http://dx.doi.org/10.1371/journal.pone.0026363			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022605	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600050
J	Egan, K; Crowley, D; Smyth, P; O'Toole, S; Spillane, C; Martin, C; Gallagher, M; Canney, A; Norris, L; Conlon, N; McEvoy, L; Ffrench, B; Stordal, B; Keegan, H; Finn, S; McEneaney, V; Laios, A; Ducree, J; Dunne, E; Smith, L; Berndt, M; Sheils, O; Kenny, D; O'Leary, J				Egan, Karl; Crowley, Darragh; Smyth, Paul; O'Toole, Sharon; Spillane, Cathy; Martin, Cara; Gallagher, Michael; Canney, Aoife; Norris, Lucy; Conlon, Niamh; McEvoy, Lynda; Ffrench, Brendan; Stordal, Britta; Keegan, Helen; Finn, Stephen; McEneaney, Victoria; Laios, Alex; Ducree, Jens; Dunne, Eimear; Smith, Leila; Berndt, Michael; Sheils, Orla; Kenny, Dermot; O'Leary, John			Platelet Adhesion and Degranulation Induce Pro-Survival and Pro-Angiogenic Signalling in Ovarian Cancer Cells	PLOS ONE			English	Article							GLYCOPROTEIN IB-ALPHA; EXPERIMENTAL LUNG METASTASIS; TUMOR-CELLS; DIMERIC BETA(2)-GLYCOPROTEIN-I; KALLIKREIN GENES; GROWTH-FACTOR; ACTIVATION; RECEPTORS; B7-H1; OVEREXPRESSION	Thrombosis is common in ovarian cancer. However, the interaction of platelets with ovarian cancer cells has not been critically examined. To address this, we investigated platelet interactions in a range of ovarian cancer cell lines with different metastatic potentials [HIO-80, 59M, SK-OV-3, A2780, A2780cis]. Platelets adhered to ovarian cancer cells with the most significant adhesion to the 59M cell line. Ovarian cancer cells induced platelet activation [P-selectin expression] in a dose dependent manner, with the most significant activation seen in response to the 59M cell line. The platelet antagonists [cangrelor, MRS2179, and apyrase] inhibited 59M cell induced activation suggesting a P2Y12 and P2Y1 receptor mediated mechanism of platelet activation dependent on the release of ADP by 59M cells. A2780 and 59M cells potentiated PAR-1, PAR-4, and TxA2 receptor mediated platelet activation, but had no effect on ADP, epinephrine, or collagen induced activation. Analysis of gene expression changes in ovarian cancer cells following treatment with washed platelets or platelet releasate showed a subtle but valid upregulation of anti-apoptotic, anti-autophagy pro-angiogenic, pro-cell cycle and metabolic genes. Thus, ovarian cancer cells with different metastatic potential adhere and activate platelets differentially while both platelets and platelet releasate mediate pro-survival and pro-angiogenic signals in ovarian cancer cells.	[Egan, Karl; Dunne, Eimear; Berndt, Michael; Kenny, Dermot] Royal Coll Surgeons Ireland, Dublin 2, Ireland; [Crowley, Darragh; Smyth, Paul; O'Toole, Sharon; Spillane, Cathy; Martin, Cara; Gallagher, Michael; Canney, Aoife; Conlon, Niamh; McEvoy, Lynda; Ffrench, Brendan; Stordal, Britta; Keegan, Helen; Finn, Stephen; McEneaney, Victoria; Laios, Alex; Sheils, Orla; O'Leary, John] Trinity Coll Dublin, Dept Histopathol, Dublin, Ireland; [O'Toole, Sharon; Norris, Lucy; Laios, Alex] Trinity Coll Dublin, Dept Obstet & Gynaecol, Dublin, Ireland; [Ducree, Jens; Berndt, Michael; Kenny, Dermot] Dublin City Univ, Biomed Diagnost Inst, Dublin 9, Ireland; [Smith, Leila] Fluidigm Corp Europe, Amsterdam, Netherlands	Royal College of Surgeons - Ireland; Trinity College Dublin; Trinity College Dublin; Dublin City University	Egan, K (corresponding author), Royal Coll Surgeons Ireland, Dublin 2, Ireland.	olearyjj@tcd.ie	Laios, Alexandros/AAN-9433-2020; Norris, Lucy/B-8904-2009; Sheils, Orla Sheils M/B-8461-2015; Ducrée, Jens/M-4264-2014; Ducrée, Jens/AAL-4994-2021; Dunne, Eimear/AGX-1949-2022; Kenny, Dermot/C-3898-2012; Norris, Lucy/AAJ-2747-2020; Finn, Stephen/V-3236-2019; Berndt, Michael C/D-5580-2012; Dunne, Eimear/C-6785-2012; Ducrée, Jens/P-3756-2019; Laios, Alex/AAD-7618-2020	Laios, Alexandros/0000-0002-4870-7393; Norris, Lucy/0000-0001-7862-3230; Sheils, Orla Sheils M/0000-0002-4493-9496; Ducrée, Jens/0000-0002-0366-1897; Dunne, Eimear/0000-0001-9862-1398; Kenny, Dermot/0000-0001-5548-3263; Norris, Lucy/0000-0001-7862-3230; Finn, Stephen/0000-0002-8628-5814; Dunne, Eimear/0000-0001-9862-1398; Ducrée, Jens/0000-0002-0366-1897; Martin, Cara/0000-0001-8411-8564; Gallagher, Michael/0000-0003-1636-2404; Egan, Karl/0000-0001-5828-0365; Ffrench, Brendan/0000-0002-5647-3734; o toole, sharon/0000-0002-9260-3225; O'Leary, John/0000-0001-7311-9326	Science Foundation Ireland [SFI] as part of the Biomedical Diagnostics Institute [BDI-2 Centre for Science Excellence and Technology (CSET)]; National Biophotonics and Imaging Platform, Ireland; Irish Government; Health Research Board (Ireland); Emer Casey Foundation, Ireland	Science Foundation Ireland [SFI] as part of the Biomedical Diagnostics Institute [BDI-2 Centre for Science Excellence and Technology (CSET)](Science Foundation Ireland); National Biophotonics and Imaging Platform, Ireland; Irish Government; Health Research Board (Ireland); Emer Casey Foundation, Ireland	This research was supported by a grant from Science Foundation Ireland [SFI] as part of the Biomedical Diagnostics Institute [BDI-2 Centre for Science Excellence and Technology (CSET)]. KE is supported through the National Biophotonics and Imaging Platform, Ireland, and funded by the Irish Government's Programme for Research in Third Level Institutions, Cycle 4, National Development Plan 2007-2013. DC is supported by the Health Research Board (Ireland) Scholars Programme: Molecular Medicine - From Genes to Function. BF and LMcE are supported by the Emer Casey Foundation, Ireland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AITOKALLIOTALLBERG AM, 1988, CANCER RES, V48, P2396; Aktas B, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2333; Avgeris M, 2010, BIOL CHEM, V391, P505, DOI 10.1515/BC.2010.056; Azuma T, 2008, BLOOD, V111, P3635, DOI 10.1182/blood-2007-11-123141; Bambace NM, 2010, PLATELETS, V21, P85, DOI 10.3109/09537100903470298; Bonnomet A, 2010, J MAMMARY GLAND BIOL, V15, P261, DOI 10.1007/s10911-010-9174-0; Braun S, 2001, J CLIN ONCOL, V19, P368, DOI 10.1200/JCO.2001.19.2.368; Camerer E, 2004, BLOOD, V104, P397, DOI 10.1182/blood-2004-02-0434; Chandler LA, 1998, INT J CANCER, V78, P106, DOI 10.1002/(SICI)1097-0215(19980925)78:1<106::AID-IJC17>3.0.CO;2-9; Choi SY, 2007, CELL DEATH DIFFER, V14, P597, DOI 10.1038/sj.cdd.4402020; Coppinger JA, 2007, BLOOD, V109, P4786, DOI 10.1182/blood-2006-07-038539; Croucher DR, 2008, NAT REV CANCER, V8, P535, DOI 10.1038/nrc2400; Deng L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.9; Dong HD, 2003, J MOL MED, V81, P281, DOI 10.1007/s00109-003-0430-2; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; DVORETSKY PM, 1988, HUM PATHOL, V19, P57, DOI 10.1016/S0046-8177(88)80316-2; Edwards RJ, 2007, NAT CHEM BIOL, V3, P108, DOI 10.1038/nchembio854; GASIC GJ, 1968, P NATL ACAD SCI USA, V61, P46, DOI 10.1073/pnas.61.1.46; Gungor T, 2009, ARCH GYNECOL OBSTET, V279, P53, DOI 10.1007/s00404-008-0673-9; Holmes CE, 2009, CLIN EXP METASTAS, V26, P653, DOI 10.1007/s10585-009-9264-9; Holschneider CH, 2000, SEMIN SURG ONCOL, V19, P3, DOI 10.1002/1098-2388(200007/08)19:1<3::AID-SSU2>3.0.CO;2-S; Iodice S, 2008, J THROMB HAEMOST, V6, P781, DOI 10.1111/j.1538-7836.2008.02928.x; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Jain S, 2009, J THROMB HAEMOST, V7, P1713, DOI 10.1111/j.1538-7836.2009.03559.x; Jain S, 2007, P NATL ACAD SCI USA, V104, P9024, DOI 10.1073/pnas.0700625104; Kim YJ, 1998, P NATL ACAD SCI USA, V95, P9325, DOI 10.1073/pnas.95.16.9325; Landen CN, 2008, J CLIN ONCOL, V26, P995, DOI 10.1200/JCO.2006.07.9970; Levitan N, 1999, MEDICINE, V78, P285, DOI 10.1097/00005792-199909000-00001; Maloney JP, 1998, AM J PHYSIOL-HEART C, V275, pH1054, DOI 10.1152/ajpheart.1998.275.3.H1054; Medina C, 2006, J PHARMACOL EXP THER, V317, P739, DOI 10.1124/jpet.105.098384; Miesbach W, 2009, CLIN REV ALLERG IMMU, V36, P91, DOI 10.1007/s12016-008-8101-2; Minami SS, 2010, FASEB J, V24, P58, DOI 10.1096/fj.09-138123; Mullenders J, 2010, MOL CANCER RES, V8, P592, DOI 10.1158/1541-7786.MCR-09-0386; Naora H, 2005, NAT REV CANCER, V5, P355, DOI 10.1038/nrc1611; Nieswandt B, 1999, CANCER RES, V59, P1295; Nylander S, 2004, BRIT J PHARMACOL, V142, P1325, DOI 10.1038/sj.bjp.0705885; Pennings MTT, 2007, J THROMB HAEMOST, V5, P369, DOI 10.1111/j.1538-7836.2007.02310.x; PHILIPPE C, 1993, AM J PATHOL, V143, P1713; Prezas P, 2006, BIOL CHEM, V387, P807, DOI 10.1515/BC.2006.102; Schlumbrecht MP, 2011, MODERN PATHOL, V24, P453, DOI 10.1038/modpathol.2010.211; Stevens Joanne M, 2004, Methods Mol Biol, V272, P145; Thomson S, 2011, CLIN EXP METASTAS, V28, P137, DOI 10.1007/s10585-010-9367-3; Uluckan O, 2008, J CELL BIOCHEM, V104, P1311, DOI 10.1002/jcb.21709; Urbanus RT, 2008, J THROMB HAEMOST, V6, P1405, DOI 10.1111/j.1538-7836.2008.03021.x; White TC, 2008, J THROMB HAEMOST, V6, P995, DOI 10.1111/j.1538-7836.2008.02979.x; White-Adams TC, 2009, ARTERIOSCL THROM VAS, V29, P1602, DOI 10.1161/ATVBAHA.109.187393; Yanagie Hironobu, 2010, Gan To Kagaku Ryoho, V37, P2052; Yang WL, 2004, CANCER RES, V64, P1534, DOI 10.1158/0008-5472.CAN-03-2928; Yousef GM, 2003, CANCER RES, V63, P2223; Zhang J, 2010, PROG MOL BIOL TRANSL, V95, P31, DOI 10.1016/B978-0-12-385071-3.00003-4; Zhang LQ, 2011, MOL BIOL CELL, V22, P128, DOI 10.1091/mbc.E10-06-0556; Zhang T, 2010, CANCER IMMUNOL IMMUN, V59, P1097, DOI 10.1007/s00262-010-0836-y	52	120	126	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26125	10.1371/journal.pone.0026125	http://dx.doi.org/10.1371/journal.pone.0026125			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022533	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000295976000071
J	Girardet, C; Bonnet, MS; Jdir, R; Sadoud, M; Thirion, S; Tardivel, C; Roux, J; Lebrun, B; Wanaverbecq, N; Mounien, L; Trouslard, J; Jean, A; Dallaporta, M; Troadec, JD				Girardet, Clemence; Bonnet, Marion S.; Jdir, Rajae; Sadoud, Medhi; Thirion, Sylvie; Tardivel, Catherine; Roux, Julien; Lebrun, Bruno; Wanaverbecq, Nicolas; Mounien, Lourdes; Trouslard, Jerome; Jean, Andre; Dallaporta, Michel; Troadec, Jean-Denis			The Food-Contaminant Deoxynivalenol Modifies Eating by Targeting Anorexigenic Neurocircuitry	PLOS ONE			English	Article							NERVOUS-SYSTEM CONTROL; TISSUE DISTRIBUTION; ORAL-EXPOSURE; VAGUS NERVE; BODY-WEIGHT; MEAL SIZE; MICE; RAT; NESFATIN-1; MYCOTOXINS	Physiological regulations of energy balance and body weight imply highly adaptive mechanisms which match caloric intake to caloric expenditure. In the central nervous system, the regulation of appetite relies on complex neurocircuitry which disturbance may alter energy balance and result in anorexia or obesity. Deoxynivalenol (DON), a trichothecene, is one of the most abundant mycotoxins found on contaminated cereals and its stability during processing and cooking explains its widespread presence in human food. DON has been implicated in acute and chronic illnesses in both humans and farm animals including weight loss. Here, we provide the first demonstration that DON reduced feeding behavior and modified satiation and satiety by interfering with central neuronal networks dedicated to food intake regulation. Moreover, our results strongly suggest that during intoxication, DON reaches the brain where it modifies anorexigenic balance. In view of the widespread human exposure to DON, the present results may lead to reconsider the potential consequences of chronic DON consumption on human eating disorders.	[Girardet, Clemence; Bonnet, Marion S.; Jdir, Rajae; Sadoud, Medhi; Lebrun, Bruno; Wanaverbecq, Nicolas; Mounien, Lourdes; Trouslard, Jerome; Jean, Andre; Dallaporta, Michel; Troadec, Jean-Denis] Univ Paul Cezanne, Marseille, France; [Girardet, Clemence; Bonnet, Marion S.; Tardivel, Catherine; Lebrun, Bruno; Wanaverbecq, Nicolas; Mounien, Lourdes; Trouslard, Jerome; Jean, Andre; Dallaporta, Michel; Troadec, Jean-Denis] INRA USC 2027, Marseille, France; [Girardet, Clemence; Bonnet, Marion S.; Thirion, Sylvie; Tardivel, Catherine; Lebrun, Bruno; Wanaverbecq, Nicolas; Mounien, Lourdes; Trouslard, Jerome; Jean, Andre; Dallaporta, Michel; Troadec, Jean-Denis] CNRS UMR 6231, Ctr Rech Neurobiol Neurophysiol Marseille, Dept Physiol Neurovegetat, Marseille, France; [Thirion, Sylvie] Univ Aix Marseille 2, Marseille, France; [Roux, Julien] Biomeostasis, Contract Res Org, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; INRAE; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Girardet, C (corresponding author), Univ Paul Cezanne, Marseille, France.	j-d.troadec@univ-cezanne.fr	Girardet, Clemence/GQQ-0627-2022; troadec, jean denis/V-1412-2017	Thirion, Sylvie/0000-0001-5361-8275; Girardet, Clemence/0000-0002-0302-3350; Mounien, Lourdes/0000-0002-9221-5783; Wanaverbecq, Nicolas/0000-0001-5486-2771; Troadec, jean denis/0000-0003-0346-6247	Aix-Marseille University; Centre National de la Recherche Scientifique (CNRS); Institut National de la Recherche Agronomique (INRA)	Aix-Marseille University; Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Recherche Agronomique (INRA)	This work was supported by the Aix-Marseille University, the Centre National de la Recherche Scientifique (CNRS) and the Institut National de la Recherche Agronomique (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNOLD DL, 1986, FOOD CHEM TOXICOL, V24, P935, DOI 10.1016/0278-6915(86)90321-2; Benoit S, 2000, HORM BEHAV, V37, P299, DOI 10.1006/hbeh.2000.1588; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Bonnet MS, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-27; Bretz M, 2006, J AGR FOOD CHEM, V54, P6445, DOI 10.1021/jf061008g; Bryden WL, 2007, ASIA PAC J CLIN NUTR, V16, P95; Fan W, 1997, NATURE, V385, P165, DOI 10.1038/385165a0; Flannery BM, 2011, FOOD CHEM TOXICOL, V49, P1863, DOI 10.1016/j.fct.2011.05.004; Flynn MC, 1998, AM J PHYSIOL-REG I, V275, pR174, DOI 10.1152/ajpregu.1998.275.1.R174; Garfield AS, 2009, TRENDS ENDOCRIN MET, V20, P203, DOI 10.1016/j.tem.2009.02.002; Girardet C, 2011, TOX SCI IN PRESS; Goebel M, 2009, NEUROSCI LETT, V452, P241, DOI 10.1016/j.neulet.2009.01.064; Hermann GE, 2001, AM J PHYSIOL-REG I, V280, pR289, DOI 10.1152/ajpregu.2001.280.1.R289; HSIAO S, 1983, PEPTIDES, V4, P15, DOI 10.1016/0196-9781(83)90158-4; Kohno D, 2008, ENDOCRINOLOGY, V149, P1295, DOI 10.1210/en.2007-1276; Kurokawa M, 2000, PHYSIOL BEHAV, V70, P105, DOI 10.1016/S0031-9384(00)00226-2; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Lombaert GA, 2003, FOOD ADDIT CONTAM A, V20, P494, DOI 10.1080/0265203031000094645; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Oh-I S, 2006, NATURE, V443, P709, DOI 10.1038/nature05162; Pecchi E, 2006, PHYSIOL GENOMICS, V25, P485, DOI 10.1152/physiolgenomics.00306.2005; Pecchi E, 2008, J NEUROIMMUNOL, V199, P104, DOI 10.1016/j.jneuroim.2008.05.012; Pecchi E, 2007, J COMP NEUROL, V501, P353, DOI 10.1002/cne.21259; Pestka JJ, 2008, FOOD CHEM TOXICOL, V46, P2826, DOI 10.1016/j.fct.2008.05.016; Pestka JJ, 2008, TOXICOL LETT, V178, P83, DOI 10.1016/j.toxlet.2008.02.005; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Porter MH, 1998, PHYSIOL BEHAV, V64, P581, DOI 10.1016/S0031-9384(98)00082-1; Prelusky Dan B., 1993, Natural Toxins, V1, P296, DOI 10.1002/nt.2620010508; ROTTER BA, 1992, J TOXICOL ENV HEALTH, V37, P329, DOI 10.1080/15287399209531673; Schothorst RC, 2004, TOXICOL LETT, V153, P133, DOI 10.1016/j.toxlet.2004.04.045; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shimizu H, 2009, ENDOCRINOLOGY, V150, P662, DOI 10.1210/en.2008-0598; Shimizu H, 2009, PEPTIDES, V30, P995, DOI 10.1016/j.peptides.2009.01.002; Timofeeva E, 2005, EUR J NEUROSCI, V22, P1489, DOI 10.1111/j.1460-9568.2005.04330.x; van Kol SWM, 2011, TOXICOL APPL PHARM, V250, P299, DOI 10.1016/j.taap.2010.11.001; VANDERWEELE DA, 1994, PHYSIOL BEHAV, V56, P619, DOI 10.1016/0031-9384(94)90310-7; WEST DB, 1987, APPETITE, V8, P221, DOI 10.1016/0195-6663(87)90021-3; Wolf-Hall CE, 1999, J FOOD PROTECT, V62, P962, DOI 10.4315/0362-028X-62.8.962; Yamamoto K, 2002, METHOD FIND EXP CLIN, V24, P135, DOI 10.1358/mf.2002.24.3.802297; Zheng HY, 2005, AM J PHYSIOL-REG I, V289, pR247, DOI 10.1152/ajpregu.00869.2004	41	63	64	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26134	10.1371/journal.pone.0026134	http://dx.doi.org/10.1371/journal.pone.0026134			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022538	Green Published, gold			2022-12-27	WOS:000295976000073
J	Torres-Benito, L; Neher, MF; Cano, R; Ruiz, R; Tabares, L				Torres-Benito, Laura; Neher, Margret Feodora; Cano, Raquel; Ruiz, Rocio; Tabares, Lucia			SMN Requirement for Synaptic Vesicle, Active Zone and Microtubule Postnatal Organization in Motor Nerve Terminals	PLOS ONE			English	Article							SPINAL MUSCULAR-ATROPHY; MOUSE MODELS; NEUROMUSCULAR-JUNCTION; NEURON PROTEIN; RIBONUCLEOPROTEIN BIOGENESIS; MITOCHONDRIAL DYSFUNCTION; SINGLE NUCLEOTIDE; DETERMINING GENE; MESSENGER-RNA; GROWTH CONES	Low levels of the Survival Motor Neuron (SMN) protein produce Spinal Muscular Atrophy (SMA), a severe monogenetic disease in infants characterized by muscle weakness and impaired synaptic transmission. We report here severe structural and functional alterations in the organization of the organelles and the cytoskeleton of motor nerve terminals in a mouse model of SMA. The decrease in SMN levels resulted in the clustering of synaptic vesicles (SVs) and Active Zones (AZs), reduction in the size of the readily releasable pool (RRP), and the recycling pool (RP) of synaptic vesicles, a decrease in active mitochondria and limiting of neurofilament and microtubule maturation. We propose that SMN is essential for the normal postnatal maturation of motor nerve terminals and that SMN deficiency disrupts the presynaptic organization leading to neurodegeneration.	[Torres-Benito, Laura; Neher, Margret Feodora; Cano, Raquel; Ruiz, Rocio; Tabares, Lucia] Univ Seville, Sch Med, Dept Physiol & Med Biophys, Seville, Spain	University of Sevilla	Torres-Benito, L (corresponding author), Univ Seville, Sch Med, Dept Physiol & Med Biophys, Seville, Spain.	ltabares@us.es	Ruiz, Rocio/B-9306-2013; Torres-Benito, Laura/X-5491-2019; Tabares, Lucia/K-8768-2015	Ruiz, Rocio/0000-0001-5142-9972; Tabares, Lucia/0000-0002-4027-4044; Cano, Raquel/0000-0002-5927-5725	Spanish Ministry of Science and Innovation [BFU2010-21648]; Junta de Andalucia [P09-CVI-4862]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Junta de Andalucia(Junta de Andalucia)	The financial support of the following research grants is gratefully acknowledged: FUNDAME (Gename Project), Spanish Ministry of Science and Innovation BFU2010-21648, and Junta de Andalucia P09-CVI-4862. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acsadi G, 2009, J NEUROSCI RES, V87, P2748, DOI 10.1002/jnr.22106; Beattie CE, 2007, J CHILD NEUROL, V22, P995, DOI 10.1177/0883073807305671; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Burghes AHM, 2009, NAT REV NEUROSCI, V10, P597, DOI 10.1038/nrn2670; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Chada SR, 2004, CURR BIOL, V14, P1272, DOI 10.1016/j.cub.2004.07.027; Cheever TR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017768; Chen J, 2011, J NEUROSCI, V31, P512, DOI 10.1523/JNEUROSCI.3771-10.2011; Cifuentes-Diaz C, 2002, HUM MOL GENET, V11, P1439, DOI 10.1093/hmg/11.12.1439; Crawford TO, 1996, NEUROBIOL DIS, V3, P97, DOI 10.1006/nbdi.1996.0010; DECAMILLI P, 1990, ANNU REV CELL BIOL, V6, P433, DOI 10.1146/annurev.cellbio.6.1.433; Dieck ST, 1998, J CELL BIOL, V142, P499, DOI 10.1083/jcb.142.2.499; Dillon C, 2005, ANNU REV NEUROSCI, V28, P25, DOI 10.1146/annurev.neuro.28.061604.135757; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; Fan L, 2002, HUM MOL GENET, V11, P1605, DOI 10.1093/hmg/11.14.1605; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; GENNARELLI M, 1995, BIOCHEM BIOPH RES CO, V213, P342, DOI 10.1006/bbrc.1995.2135; Glinka M, 2010, HUM MOL GENET, V19, P1951, DOI 10.1093/hmg/ddq073; GREENGARD P, 1993, SCIENCE, V259, P780, DOI 10.1126/science.8430330; Hao LT, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-24; Hervias I, 2006, MUSCLE NERVE, V33, P598, DOI 10.1002/mus.20489; HIROKAWA N, 1989, J CELL BIOL, V108, P111, DOI 10.1083/jcb.108.1.111; Jablonka S, 2004, J NEUROBIOL, V58, P272, DOI 10.1002/neu.10313; Jablonka S, 2001, HUM MOL GENET, V10, P497, DOI 10.1093/hmg/10.5.497; Jablonka S, 2007, J CELL BIOL, V179, P139, DOI 10.1083/jcb.200703187; Kariya S, 2008, HUM MOL GENET, V17, P2552, DOI 10.1093/hmg/ddn156; Kariya S, 2009, NEUROSCI LETT, V449, P246, DOI 10.1016/j.neulet.2008.10.107; Kong LL, 2009, J NEUROSCI, V29, P842, DOI 10.1523/JNEUROSCI.4434-08.2009; Le TT, 2005, HUM MOL GENET, V14, P845, DOI 10.1093/hmg/ddi078; Lee YI, 2011, DEV BIOL, V356, P432, DOI 10.1016/j.ydbio.2011.05.667; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Ling KKY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015457; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; McGovern VL, 2008, HUM MOL GENET, V17, P2900, DOI 10.1093/hmg/ddn189; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Mentis GZ, 2011, NEURON, V69, P453, DOI 10.1016/j.neuron.2010.12.032; Minin AA, 2006, J CELL SCI, V119, P659, DOI 10.1242/jcs.02762; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Murray LM, 2008, HUM MOL GENET, V17, P949, DOI 10.1093/hmg/ddm367; Nguyen DM, 2006, CANCER J, V12, P257, DOI 10.1097/00130404-200607000-00004; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Norgren N, 2003, BRAIN RES, V987, P25, DOI 10.1016/S0006-8993(03)03219-0; Oprea GE, 2008, SCIENCE, V320, P524, DOI 10.1126/science.1155085; Pagliardini S, 2000, HUM MOL GENET, V9, P47, DOI 10.1093/hmg/9.1.47; Park GH, 2010, J NEUROSCI, V30, P12005, DOI 10.1523/JNEUROSCI.2208-10.2010; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Perkins GA, 2010, J NEUROSCI, V30, P1015, DOI 10.1523/JNEUROSCI.1517-09.2010; Peter CJ, 2011, HUM MOL GENET; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Ranganathan S, 2009, HUM MOL GENET, V18, P27, DOI 10.1093/hmg/ddn310; Reynolds IJ, 2004, J BIOENERG BIOMEMBR, V36, P283, DOI 10.1023/B:JOBB.0000041754.78313.c2; Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; Ruiz R, 2008, EUR J NEUROSCI, V27, P3118, DOI 10.1111/j.1460-9568.2008.06301.x; Ruiz R, 2011, J NEUROSCI, V31, P2000, DOI 10.1523/JNEUROSCI.4663-10.2011; Ruiz R, 2010, J NEUROSCI, V30, P849, DOI 10.1523/JNEUROSCI.4496-09.2010; Shupliakov O, 2002, P NATL ACAD SCI USA, V99, P14476, DOI 10.1073/pnas.212381799; Torres-Benito L, 2011, DEV NEUROBIOL; Wan LL, 2005, MOL CELL BIOL, V25, P5543, DOI 10.1128/MCB.25.13.5543-5551.2005; Wen HL, 2010, HUM MOL GENET, V19, P1766, DOI 10.1093/hmg/ddq058; Wimmer VC, 2006, J NEUROSCI, V26, P109, DOI 10.1523/JNEUROSCI.3268-05.2006; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; WULF E, 1979, P NATL ACAD SCI USA, V76, P4498, DOI 10.1073/pnas.76.9.4498; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031	72	59	61	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26164	10.1371/journal.pone.0026164	http://dx.doi.org/10.1371/journal.pone.0026164			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022549	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000078
J	Luo, GPS; Ibrahim, AS; French, SW; Edwards, JE; Fu, Y				Luo, Guanpingsheng; Ibrahim, Ashraf S.; French, Samuel W.; Edwards, John E., Jr.; Fu, Yue			Active and Passive Immunization with rHyr1p-N Protects Mice against Hematogenously Disseminated Candidiasis	PLOS ONE			English	Article							INFLUENZAE TYPE-B; HUMAN-IMMUNODEFICIENCY-VIRUS; BETA-GLUCAN ANTIBODIES; N-TERMINAL DOMAIN; IMPROVES SURVIVAL; ALBICANS; VACCINE; CONJUGATE; ALS1P; IMMUNOGENICITY	We previously reported that Candida albicans cell surface protein Hyr1 encodes a phagocyte killing resistance factor and active vaccination with a recombinant N-terminus of Hyr1 protein (rHyr1p-N), significantly protects immunocompetent mice from disseminated candidiasis. Here we report the marked efficacy of rHyr1p-N vaccine on improving the survival and reducing the fungal burden of disseminated candidiasis in both immunocompetent and immunocompromised mice using the FDA-approved adjuvant, alum. Importantly, we also show that pooled rabbit anti-Hyr1p polyclonal antibodies raised against 8 different peptide regions of rHyr1p-N protected mice in a hematogenously disseminated candidiasis model, raising the possibility of developing a successful passive immunotherapy strategy to treat this disease. Our data suggest that the rabbit anti-Hyr1p antibodies directly neutralized the Hyr1p virulence function, rather than enhanced opsonophagocytosis for subsequent killing by neutrophil in vitro. Finally, the rHyr1p-N vaccine was protective against non-albicans Candida spp. These preclinical data demonstrate that rHyr1p-N is likely to be a novel target for developing both active and passive immunization strategies against Candida infections.	[Luo, Guanpingsheng; Ibrahim, Ashraf S.; Edwards, John E., Jr.; Fu, Yue] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA 90509 USA; [Ibrahim, Ashraf S.; French, Samuel W.; Edwards, John E., Jr.; Fu, Yue] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [French, Samuel W.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Dept Pathol, Torrance, CA 90509 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute	Luo, GPS (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Div Infect Dis, Torrance, CA 90509 USA.	yfu@labiomed.org			Public Health Service [R01 AI19990, AI063382, R21 AI066010, R03 AI083251, R01 AI063503, R21 AI082414]; NovaDigm Therapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063382, R21AI082414, R21AI066010, R03AI083251, R01AI019990, R01AI063503] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NovaDigm Therapeutics, Inc.; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Public Health Service grants R01 AI19990 and AI063382 to JEE and R21 AI066010 and R03 AI083251 to YF. ASI is supported by Public Health Service grant R01 AI063503 and R21 AI082414. NovaDigm Therapeutics, Inc. partially provided financial support for these studies. ASI, JEE, and YF did have a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The Public Health Service had no role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bailey DA, 1996, J BACTERIOL, V178, P5353, DOI 10.1128/jb.178.18.5353-5360.1996; Chokephaibulkit K, 2004, VACCINE, V22, P2018, DOI 10.1016/j.vaccine.2003.10.033; d'Enfert C, 2005, NUCLEIC ACIDS RES, V33, pD353, DOI 10.1093/nar/gki124; Davis D, 2000, INFECT IMMUN, V68, P5953, DOI 10.1128/IAI.68.10.5953-5959.2000; Dockrell DH, 1999, VACCINE, V17, P2779, DOI 10.1016/S0264-410X(99)00089-4; Dos Santos SD, 2004, AIDS RES HUM RETROV, V20, P493, DOI 10.1089/088922204323087732; Fu Y, 2008, EUKARYOT CELL, V7, P483, DOI 10.1128/EC.00445-07; Groll AH, 1998, ADV PHARMACOL, V44, P343, DOI 10.1016/S1054-3589(08)60129-5; Gudlaugsson O, 2003, CLIN INFECT DIS, V37, P1172, DOI 10.1086/378745; Ibrahim AS, 2006, INFECT IMMUN, V74, P3039, DOI 10.1128/IAI.74.5.3039-3041.2006; Ibrahim AS, 2005, INFECT IMMUN, V73, P999, DOI 10.1128/IAI.73.2.999-1005.2005; King JC, 1996, PEDIATR INFECT DIS J, V15, P192, DOI 10.1097/00006454-199603000-00003; Kullberg BJ, 2002, EUR J MED RES, V7, P183; Kumamoto CA, 2005, CELL MICROBIOL, V7, P1546, DOI 10.1111/j.1462-5822.2005.00616.x; Lin L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000703; Luo G, 2010, J INFECT DIS, V201, P1718, DOI 10.1086/652407; Matthews RC, 2003, ANTIMICROB AGENTS CH, V47, P2208, DOI 10.1128/AAC.47.7.2208-2216.2003; Neely MN, 2000, EUR J CLIN MICROBIOL, V19, P897, DOI 10.1007/s100960000395; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Nucci Marcio, 1995, Revista do Instituto de Medicina Tropical de Sao Paulo, V37, P397, DOI 10.1590/S0036-46651995000500004; Pappas PG, 2003, CLIN INFECT DIS, V37, P634, DOI 10.1086/376906; Phan QT, 2007, PLOS BIOL, V5, P543, DOI 10.1371/journal.pbio.0050064; Pietrella D, 2010, VACCINE, V28, P1717, DOI 10.1016/j.vaccine.2009.12.021; Sheppard DC, 2004, ANTIMICROB AGENTS CH, V48, P1908, DOI 10.1128/AAC.48.5.1908-1911.2004; Spellberg BJ, 2006, J INFECT DIS, V194, P256, DOI 10.1086/504691; Spellberg BJ, 2005, INFECT IMMUN, V73, P6191, DOI 10.1128/IAI.73.9.6191-6193.2005; Spellberg BJ, 2005, J LEUKOCYTE BIOL, V78, P338, DOI 10.1189/jlb.0205072; Spellberg BJ, 2006, CLIN INFECT DIS, V42, P244, DOI 10.1086/499057; Spellberg B, 2008, J INFECT DIS, V197, P967, DOI 10.1086/529204; Torosantucci A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005392; Wisplinghoff H, 2004, CLIN INFECT DIS, V39, P309, DOI 10.1086/421946; Xin H, 2008, P NATL ACAD SCI USA, V105, P13526, DOI 10.1073/pnas.0803195105	32	37	46	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25909	10.1371/journal.pone.0025909	http://dx.doi.org/10.1371/journal.pone.0025909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028796	Green Published, Green Submitted, gold			2022-12-27	WOS:000295971700024
J	Costa, SM; Yorio, AP; Goncalves, AJS; Vidale, MM; Costa, ECB; Mohana-Borges, R; Motta, MA; Freire, MS; Alves, AMB				Costa, Simone M.; Yorio, Anna Paula; Goncalves, Antonio J. S.; Vidale, Mariana M.; Costa, Emmerson C. B.; Mohana-Borges, Ronaldo; Motta, Marcia A.; Freire, Marcos S.; Alves, Ada M. B.			Induction of a Protective Response in Mice by the Dengue Virus NS3 Protein Using DNA Vaccines	PLOS ONE			English	Article							T-CELL RESPONSES; ACTIVATOR SIGNAL SEQUENCE; HEMORRHAGIC-FEVER; NONSTRUCTURAL PROTEIN-3; MONOCLONAL-ANTIBODIES; JAPANESE ENCEPHALITIS; IMMUNE-RESPONSES; DRUG DESIGN; TYPE-2; IMMUNIZATION	The dengue non-structural 3 (NS3) is a multifunctional protein, containing a serino-protease domain, located at the N-terminal portion, and helicase, NTPase and RTPase domains present in the C-terminal region. This protein is considered the main target for CD4+ and CD8+ T cell responses during dengue infection, which may be involved in protection. However, few studies have been undertaken evaluating the use of this protein as a protective antigen against dengue, as well as other flavivirus. In the present work, we investigate the protective efficacy of DNA vaccines based on the NS3 protein from DENV2. Different recombinant plasmids were constructed, encoding either the full-length NS3 protein or only its functional domains (protease and helicase), fused or not to a signal peptide (t-PA). The recombinant proteins were successfully expressed in transfected BHK-21 cells, and only plasmids encoding the t-PA signal sequence mediated protein secretion. Balb/c mice were immunized with the different DNA vaccines and challenged with a lethal dose of DENV2. Most animals immunized with plasmids encoding the full-length NS3 or the helicase domain survived challenge, regardless of the presence of the t-PA. However, some mice presented clinical signs of infection with high morbidity (hind leg paralysis and hunched posture), mainly in animal groups immunized with the DNA vaccines based on the helicase domain. On the other hand, inoculation with plasmids encoding the protease domain did not induce any protection, since mortality and morbidity rates in these mouse groups were similar to those detected in the control animals. The cellular immune response was analyzed by ELISPOT with a specific-CD8+ T cell NS3 peptide. Results revealed that the DNA vaccines based on the full-length protein induced the production of INF-gamma, thus suggesting the involvement of this branch of the immune system in the protection.	[Costa, Simone M.; Yorio, Anna Paula; Goncalves, Antonio J. S.; Vidale, Mariana M.; Alves, Ada M. B.] Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil; [Costa, Emmerson C. B.; Mohana-Borges, Ronaldo] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Genom Estrutural, BR-21941 Rio De Janeiro, Brazil; [Motta, Marcia A.; Freire, Marcos S.] Fundacao Oswaldo Cruz Fdn, Inst Tecnol Imunobiol, Lab Tecnol Virol, Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Costa, SM (corresponding author), Fundacao Oswaldo Cruz, Inst Oswaldo Cruz, Lab Biotecnol & Fisiol Infeccoes Virais, Rio De Janeiro, Brazil.	ada@ioc.fiocruz.br	Borges, Ronaldo S Mohana/C-5575-2013	Mohana Borges, Ronaldo/0000-0002-1796-475X	Fundacao Oswaldo Cruz (FIOCRUZ); Instituto Oswaldo Cruz (IOC)/FIOCRUZ; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq/FAPERJ	Fundacao Oswaldo Cruz (FIOCRUZ); Instituto Oswaldo Cruz (IOC)/FIOCRUZ; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq/FAPERJ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Funding: This work was supported by Programa de Desenvolvimento Tecnologico em Insumos para Saude (PDTIS)/Fundacao Oswaldo Cruz (FIOCRUZ), Instituto Oswaldo Cruz (IOC)/FIOCRUZ, Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and Programa de apoio a Nucleos de Excelencia (PRONEX)-CNPq/FAPERJ grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves AMB, 1999, BRAZ J MED BIOL RES, V32, P223, DOI 10.1590/S0100-879X1999000200011; Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07; AZEVEDO AS, 2011, PLOS ONE IN PRESS; Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790; Bartelma G, 2002, VIROLOGY, V299, P122, DOI 10.1006/viro.2002.1504; Beaumier CM, 2008, J INFECT DIS, V197, P608, DOI 10.1086/526790; Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009; Brinton MA, 1998, CLIN DIAGN VIROL, V10, P129, DOI 10.1016/S0928-0197(98)00039-7; CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245; Cheng HJ, 2009, MOL IMMUNOL, V47, P398, DOI 10.1016/j.molimm.2009.08.033; Costa SM, 2007, VIROLOGY, V358, P413, DOI 10.1016/j.virol.2006.08.052; Costa SM, 2006, VACCINE, V24, P195, DOI 10.1016/j.vaccine.2005.07.059; Cui TA, 1998, VIROLOGY, V246, P409, DOI 10.1006/viro.1998.9213; Dmitriev IP, 1996, J BIOTECHNOL, V44, P97, DOI 10.1016/0168-1656(95)00141-7; Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Falconar AKI, 2007, CLIN VACCINE IMMUNOL, V14, P493, DOI 10.1128/CVI.00371-06; FALGOUT B, 1993, J VIROL, V67, P2034, DOI 10.1128/JVI.67.4.2034-2042.1993; FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991; FALGOUT B, 1990, J VIROL, V64, P4356, DOI 10.1128/JVI.64.9.4356-4363.1990; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793; GUZMAN MG, 1990, AM J TROP MED HYG, V42, P179, DOI 10.4269/ajtmh.1990.42.179; HALSTEAD SB, 1970, YALE J BIOL MED, V42, P276; HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0; Hu DM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-47; IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7; KAUFMAN BM, 1987, AM J TROP MED HYG, V36, P427, DOI 10.4269/ajtmh.1987.36.427; Konishi E, 2003, VACCINE, V21, P3675, DOI 10.1016/S0264-410X(03)00382-7; Kurane I, 2007, COMP IMMUNOL MICROB, V30, P329, DOI 10.1016/j.cimid.2007.05.010; Lazaro-Olan L, 2008, VECTOR-BORNE ZOONOT, V8, P69, DOI 10.1089/vbz.2007.0117; Li HT, 1999, J VIROL, V73, P3108, DOI 10.1128/JVI.73.4.3108-3116.1999; Lin CF, 2008, LAB INVEST, V88, P1079, DOI 10.1038/labinvest.2008.70; LINDENBACH BD, 2001, FIELDS VIROLOGY, P991; Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232; Luo MC, 2008, J VIROL METHODS, V154, P121, DOI 10.1016/j.jviromet.2008.08.011; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638; Mangada MM, 2005, J IMMUNOL, V175, P2676, DOI 10.4049/jimmunol.175.4.2676; Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x; Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887; Morozova OV, 1999, VIRAL IMMUNOL, V12, P277, DOI 10.1089/vim.1999.12.277; Murrell S, 2011, BIOTECHNOL ADV, V29, P239, DOI 10.1016/j.biotechadv.2010.11.008; Niyomrattanakit P, 2004, J VIROL, V78, P13708, DOI 10.1128/JVI.78.24.13708-13716.2004; Qi RF, 2008, ACTA BIOCH BIOPH SIN, V40, P91, DOI 10.1111/j.1745-7270.2008.00382.x; Rau H, 2006, VET RES, V37, P155, DOI 10.1051/vetres:2005049; Rothman AL, 2004, J CLIN INVEST, V113, P946, DOI [10.1172/JCI200421512, 10.1172/JCI21512]; Rothman AL, 1996, J VIROL, V70, P6540, DOI 10.1128/JVI.70.10.6540-6546.1996; Sambrook J., 2002, MOL CLONING LAB MANU; Sampath A, 2006, J VIROL, V80, P6686, DOI 10.1128/JVI.02215-05; SCHLESINGER JJ, 1993, VIROLOGY, V192, P132, DOI 10.1006/viro.1993.1015; SCHLESINGER JJ, 1987, J GEN VIROL, V68, P853, DOI 10.1099/0022-1317-68-3-853; Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823; TAN CHC, 1990, J GEN VIROL, V71, P745, DOI 10.1099/0022-1317-71-3-745; Valdes K, 2000, CLIN DIAGN LAB IMMUN, V7, P856, DOI 10.1128/CDLI.7.5.856-857.2000; Valle RPC, 1998, J VIROL, V72, P624, DOI 10.1128/JVI.72.1.624-632.1998; Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003; Webster DP, 2009, LANCET INFECT DIS, V9, P678, DOI 10.1016/S1473-3099(09)70254-3; Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690; WHO/TDR, 2009, DENG GUID DIAGN TREA; Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005; Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974; Young NJ, 2005, PREV VET MED, V72, P115, DOI 10.1016/j.prevetmed.2005.08.013; Zivna I, 2002, J IMMUNOL, V168, P5959, DOI 10.4049/jimmunol.168.11.5959	64	32	34	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e25685	10.1371/journal.pone.0025685	http://dx.doi.org/10.1371/journal.pone.0025685			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031819	gold, Green Published, Green Submitted			2022-12-27	WOS:000296513200006
J	Maillard, P; Walic, M; Meuleman, P; Roohvand, F; Huby, T; Le Goff, W; Leroux-Roels, G; Pecheur, EI; Budkowska, A				Maillard, Patrick; Walic, Marine; Meuleman, Philip; Roohvand, Farzin; Huby, Thierry; Le Goff, Wilfried; Leroux-Roels, Geert; Pecheur, Eve-Isabelle; Budkowska, Agata			Lipoprotein Lipase Inhibits Hepatitis C Virus (HCV) Infection by Blocking Virus Cell Entry	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; VIRION-ASSOCIATED CHOLESTEROL; UPA-SCID MOUSE; APOLIPOPROTEIN-B; HUMAN HEPATOCYTES; HUMAN LIVER; RICH LIPOPROTEINS; BUOYANT DENSITY; BINDING; ASSOCIATION	A distinctive feature of HCV is that its life cycle depends on lipoprotein metabolism. Viral morphogenesis and secretion follow the very low-density lipoprotein (VLDL) biogenesis pathway and, consequently, infectious HCV in the serum is associated with triglyceride-rich lipoproteins (TRL). Lipoprotein lipase (LPL) hydrolyzes TRL within chylomicrons and VLDL but, independently of its catalytic activity, it has a bridging activity, mediating the hepatic uptake of chylomicrons and VLDL remnants. We previously showed that exogenously added LPL increases HCV binding to hepatoma cells by acting as a bridge between virus-associated lipoproteins and cell surface heparan sulfate, while simultaneously decreasing infection levels. We show here that LPL efficiently inhibits cell infection with two HCV strains produced in hepatoma cells or in primary human hepatocytes transplanted into uPA-SCID mice with fully functional human ApoB-lipoprotein profiles. Viruses produced in vitro or in vivo were separated on iodixanol gradients into low and higher density populations, and the infection of Huh 7.5 cells by both virus populations was inhibited by LPL. The effect of LPL depended on its enzymatic activity. However, the lipase inhibitor tetrahydrolipstatin restored only a minor part of HCV infectivity, suggesting an important role of the LPL bridging function in the inhibition of infection. We followed HCV cell entry by immunoelectron microscopy with anti-envelope and anti-core antibodies. These analyses demonstrated the internalization of virus particles into hepatoma cells and their presence in intracellular vesicles and associated with lipid droplets. In the presence of LPL, HCV was retained at the cell surface. We conclude that LPL efficiently inhibits HCV infection by acting on TRL associated with HCV particles through mechanisms involving its lipolytic function, but mostly its bridging function. These mechanisms lead to immobilization of the virus at the cell surface. HCV-associated lipoproteins may therefore be a promising target for the development of new therapeutic approaches.	[Maillard, Patrick; Walic, Marine; Roohvand, Farzin; Budkowska, Agata] Inst Pasteur, Dept Virol, Unite Hepacivirus & Immunite Innee, Paris, France; [Maillard, Patrick; Walic, Marine; Roohvand, Farzin; Budkowska, Agata] CNRS, URA3015, Paris, France; [Walic, Marine] Univ Paris Diderot, Paris, France; [Meuleman, Philip; Leroux-Roels, Geert] Ghent Univ & Hosp, Ctr Vaccinol, Ghent, Belgium; [Roohvand, Farzin] Pasteur Inst Iran, Hepatitis & AIDS Dept, Tehran, Iran; [Huby, Thierry; Le Goff, Wilfried] INSERM, UMRS939, Paris, France; [Pecheur, Eve-Isabelle] Univ Lyon 1, F-69365 Lyon, France; [Pecheur, Eve-Isabelle] CNRS, UMR5086, Lyon, France; [Pecheur, Eve-Isabelle] IBCP, Lyon, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Ghent University; Ghent University Hospital; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS)	Maillard, P (corresponding author), Inst Pasteur, Dept Virol, Unite Hepacivirus & Immunite Innee, Paris, France.	agata.budkowska@pasteur.fr	Le Goff, Wilfried/N-6326-2017; HUBY, Thierry/N-4820-2019; Huby, Thierry/E-6768-2017; Roohvand, Farzin/K-8931-2018; Meuleman, Philip/H-2899-2013; Le Goff, Wilfried/N-7593-2019	Le Goff, Wilfried/0000-0002-7611-9644; HUBY, Thierry/0000-0001-6634-551X; Huby, Thierry/0000-0001-6634-551X; Roohvand, Farzin/0000-0002-9597-3555; Meuleman, Philip/0000-0001-6821-234X; Le Goff, Wilfried/0000-0002-7611-9644; Pecheur, Eve/0000-0002-8613-862X	Agence nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS); Ghent University (CRA) [01G00507]; Belgian state [IUAP: P6/36-HEPRO]; Research Foundation - Flanders [31500910]	Agence nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); Ghent University (CRA)(Ghent University); Belgian state; Research Foundation - Flanders(FWO)	This work was supported by a grant from Agence nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS), and from the Ghent University (CRA n<SUP>o</SUP> 01G00507), the Belgian state (IUAP: P6/36-HEPRO) and the The Research Foundation - Flanders (31500910. MW was granted a fellowship from ANRS and Pasteur-Weizmann, FR a fellowship from ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Aizaki H, 2008, J VIROL, V82, P5715, DOI 10.1128/JVI.02530-07; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andre P, 2005, SEMIN LIVER DIS, V25, P93, DOI 10.1055/s-2005-864785; Andreo U, 2007, CELL MICROBIOL, V9, P2445, DOI 10.1111/j.1462-5822.2007.00972.x; Bartenschlager R, 2010, J HEPATOL, V53, P583, DOI 10.1016/j.jhep.2010.04.015; Barth H, 2006, J VIROL, V80, P10579, DOI 10.1128/JVI.00941-06; Bassendine MF, 2011, J HEPATOL IN PRESS; Beigneux AP, 2009, J LIPID RES, V50, pS57, DOI 10.1194/jlr.R800030-JLR200; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; BERRYMAN DE, 1995, J BIOL CHEM, V270, P24525, DOI 10.1074/jbc.270.41.24525; Boren J, 2001, J BIOL CHEM, V276, P26916, DOI 10.1074/jbc.M011090200; BRADLEY D, 1991, J MED VIROL, V34, P206, DOI 10.1002/jmv.1890340315; BRADLEY DW, 1990, GASTROENTEROLOGY, V99, P1054, DOI 10.1016/0016-5085(90)90626-C; BRADLEY WA, 1984, J BIOL CHEM, V259, P4728; Bukh J, 2006, P NATL ACAD SCI USA, V103, P3500, DOI 10.1073/pnas.0600551103; Bukh J, 2010, J INFECT DIS, V201, P1381, DOI 10.1086/651579; Burlone ME, 2009, J GEN VIROL, V90, P1055, DOI 10.1099/vir.0.008300-0; Casaroli-Marano RP, 1998, J LIPID RES, V39, P789; Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; Cooper AD, 1997, J LIPID RES, V38, P2173; Cribier B, 1998, ARCH VIROL, V143, P375, DOI 10.1007/s007050050293; Dallinga-Thie GM, 2010, ATHEROSCLEROSIS, V211, P1, DOI 10.1016/j.atherosclerosis.2009.12.027; Ehrhardt M, 2011, HEPATOLOGY, V54, P1112, DOI 10.1002/hep.24366; Felmlee DJ, 2010, GASTROENTEROLOGY, V139, P1774, DOI 10.1053/j.gastro.2010.07.047; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Fuki IV, 1997, J CLIN INVEST, V100, P1611, DOI 10.1172/JCI119685; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gastaminza P, 2006, J VIROL, V80, P11074, DOI 10.1128/JVI.01150-06; Gustafsson M, 2007, CIRC RES, V101, P777, DOI 10.1161/CIRCRESAHA.107.149666; Haberstroh A, 2008, GASTROENTEROLOGY, V135, P1719, DOI 10.1053/j.gastro.2008.07.018; Haid S, 2009, J BIOL CHEM, V284, P17657, DOI 10.1074/jbc.M109.014647; Heeren J, 2002, J MOL MED-JMM, V80, P576, DOI 10.1007/s00109-002-0351-5; Hishiki T, 2010, J VIROL, V84, P12048, DOI 10.1128/JVI.01063-10; Hu LH, 2008, J LIPID RES, V49, P1553, DOI 10.1194/jlr.M800130-JLR200; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Icard V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004233; Jones DM, 2010, J BIOL CHEM, V285, P22732, DOI 10.1074/jbc.R110.133017; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Keam SJ, 2008, DRUGS, V68, P1273, DOI 10.2165/00003495-200868090-00006; Khalil MF, 2004, ARTERIOSCL THROM VAS, V24, P2211, DOI 10.1161/01.ATV.0000147163.54024.70; Koutsoudakis G, 2007, J VIROL, V81, P588, DOI 10.1128/JVI.01534-06; Lindenbach BD, 2006, P NATL ACAD SCI USA, V103, P3805, DOI 10.1073/pnas.0511218103; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; LOOKENE A, 1994, EUR J BIOCHEM, V222, P395, DOI 10.1111/j.1432-1033.1994.tb18878.x; Maillard P, 2001, J VIROL, V75, P8240, DOI 10.1128/JVI.75.17.8240-8250.2001; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; MARCEL YL, 1988, ARTERIOSCLEROSIS, V8, P832, DOI 10.1161/01.ATV.8.6.832; Mead JR, 2002, J MOL MED, V80, P753, DOI 10.1007/s00109-002-0384-9; Meex SJR, 2011, J LIPID RES, V52, P152, DOI 10.1194/jlr.D008888; Merkel M, 1998, P NATL ACAD SCI USA, V95, P13841, DOI 10.1073/pnas.95.23.13841; Meuleman P, 2005, HEPATOLOGY, V41, P847, DOI 10.1002/hep.20657; Meuleman P, 2008, ANTIVIR RES, V80, P231, DOI 10.1016/j.antiviral.2008.07.006; Milosavljevic D, 2003, BBA-MOL CELL BIOL L, V1631, P51, DOI 10.1016/S1388-1981(02)00355-4; Molina S, 2007, J HEPATOL, V46, P411, DOI 10.1016/j.jhep.2006.09.024; Nahmias Y, 2008, HEPATOLOGY, V47, P1437, DOI 10.1002/hep.22197; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Owen DM, 2009, VIROLOGY, V394, P99, DOI 10.1016/j.virol.2009.08.037; Pawlotsky JM, 2006, HEPATOLOGY, V43, pS207, DOI 10.1002/hep.21064; Petit JM, 2003, AM J GASTROENTEROL, V98, P1150, DOI 10.1016/S0002-9270(03)00106-0; Piver E, 2010, INT J BIOCHEM CELL B, V42, P869, DOI 10.1016/j.biocel.2010.01.005; Podevin P, 2010, GASTROENTEROLOGY, V139, P1355, DOI 10.1053/j.gastro.2010.06.058; RAISONNIER A, 1995, COMP BIOCHEM PHYS B, V111, P385, DOI 10.1016/0305-0491(95)00006-T; Sabahi A, 2010, VIROLOGY, V407, P110, DOI 10.1016/j.virol.2010.07.026; Salinelli S, 1996, J BIOL CHEM, V271, P21906, DOI 10.1074/jbc.271.36.21906; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shimizu Y, 2010, VIROLOGY, V407, P152, DOI 10.1016/j.virol.2010.08.011; Steenbergen RHG, 2010, AM J PHYSIOL-GASTR L, V299, pG844, DOI 10.1152/ajpgi.00200.2010; Tao WY, 2009, VIROLOGY, V395, P67, DOI 10.1016/j.virol.2009.09.006; THOMSSEN R, 1992, MED MICROBIOL IMMUN, V181, P293, DOI 10.1007/BF00198849; Thomssen R, 2002, MED MICROBIOL IMMUN, V191, P17, DOI 10.1007/s00430-001-0106-x; Von Hahn T, 2007, GASTROENTEROLOGY, V132, P667, DOI 10.1053/j.gastro.2006.12.008; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Williams KJ, 2008, J CLIN INVEST, V118, P3247, DOI 10.1172/JCI35206; Yamamoto M, 2011, J GEN VIROL, V92, P2082, DOI 10.1099/vir.0.032391-0; Ye J, 2007, PLOS PATHOG, V3, P1017, DOI 10.1371/journal.ppat.0030108; Zheng CY, 2006, ARTERIOSCL THROM VAS, V26, P891, DOI 10.1161/01.ATV.0000203512.01007.3d; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	80	37	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26637	10.1371/journal.pone.0026637	http://dx.doi.org/10.1371/journal.pone.0026637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039521	gold, Green Published			2022-12-27	WOS:000296513200035
J	Moura, DS; Sultan, S; Georgin-Lavialle, S; Pillet, N; Montestruc, F; Gineste, P; Barete, S; Damaj, G; Moussy, A; Lortholary, O; Hermine, O				Moura, Daniela Silva; Sultan, Serge; Georgin-Lavialle, Sophie; Pillet, Nathalie; Montestruc, Francois; Gineste, Paul; Barete, Stephane; Damaj, Gandhi; Moussy, Alain; Lortholary, Olivier; Hermine, Olivier			Depression in Patients with Mastocytosis: Prevalence, Features and Effects of Masitinib Therapy	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING HORMONE; PROTEIN-TYROSINE KINASE; MAST-CELL DEGRANULATION; BLOOD-BRAIN-BARRIER; IMMUNE GATE; HAMILTON; CANCER; STRESS; KIT; PERMEABILITY	Depression in patients with mastocytosis is often reported but its prevalence and characteristics are not precisely described. In addition, the impact of therapies targeting mast cells proliferation, differentiation and degranulation on psychic symptoms of depression have never been investigated. Our objective was to determine the prevalence and to describe features of depression in a large cohort of mastocytosis patients (n = 288) and to investigate the therapeutic impact of the protein kinase inhibitor masitinib in depression symptoms. The description of depression was based on the analysis of a database with Hamilton scores using Principal Component Analysis (PCA). Efficacy of masitinib therapy was evaluated using non parametric Wilcoxon test for paired data within a three months period (n = 35). Our results show that patients with indolent mastocytosis present an elevated prevalence of depression (64%). Depression was moderate in 56% but severe in 8% of cases. Core symptoms (such as psychic anxiety, depressed mood, work and interests) characterized depression in mastocytosis patients. Masitinib therapy was associated with significant improvement (67% of the cases) of overall depression, with 75% of recovery cases. Global Quality of Life slightly improved after masitinib therapy and did not predicted depression improvement. In conclusion, depression is very frequent in mastocytosis patients and masitinib therapy is associated with the reduction its psychic experiences. We conclude that depression in mastocytosis may originate from processes related to mast cells activation. Masitinib could therefore be a useful treatment for mastocytosis patients with depression and anxiety symptoms.	[Moura, Daniela Silva; Georgin-Lavialle, Sophie; Hermine, Olivier] Univ Paris 05, Hop Necker Enfants Malad, Serv Hematol, Ctr Reference Mastocytoses, Paris, France; [Moura, Daniela Silva; Sultan, Serge] Univ Paris 05, Lab Psychopathol & Proc Sante EA 4057, IUPDP Inst Psychol, Paris, France; [Sultan, Serge] Univ Montreal, Ctr Rech, CHU St Justine, Montreal, PQ, Canada; [Georgin-Lavialle, Sophie; Hermine, Olivier] Univ Paris 05, Hop Necker Enfants Malad, CNRS, UMR 8147, Paris, France; [Pillet, Nathalie; Montestruc, Francois; Gineste, Paul; Moussy, Alain; Hermine, Olivier] AB Sci SA, Paris, France; [Barete, Stephane] Univ Paris 06, Hop Tenon, Dept Dermatol, Ctr Reference Mastocytoses, Paris, France; [Damaj, Gandhi] Univ Jules Vernes Picardie, CHU Amiens, Serv Hematol, Amiens, France; [Moussy, Alain; Hermine, Olivier] AFIRMM, Paris, France; [Lortholary, Olivier] Univ Paris 05, Hop Necker Enfants Malad, Serv Malad Infect & Trop, Ctr Reference Mastocytoses, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Moura, DS (corresponding author), Univ Paris 05, Hop Necker Enfants Malad, Serv Hematol, Ctr Reference Mastocytoses, Paris, France.	ohermine@gmail.com	Hermine, Olivier/Q-7072-2018	Hermine, Olivier/0000-0003-2574-3874	Canceropole Ile-de-France; AFIRMM; Fondation de la recherche medicale; AB Science; Institut National du Cancer	Canceropole Ile-de-France(Region Ile-de-France); AFIRMM; Fondation de la recherche medicale(Fondation pour la Recherche Medicale); AB Science; Institut National du Cancer(Institut National du Cancer (INCA) France)	Funding: This research was funded by grants from the Canceropole Ile-de-France (Appel d'offre SHS 2009), the AFIRMM and the Fondation de la recherche medicale. In addition, part of this study was supported by AB Science, by grants from the Institut National du Cancer (2009, 2010 and 2011-SHS program) and start-up budgets from the CHU Sainte-Justine (Montreal, Qc). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addolorato G, 1998, HEPATO-GASTROENTEROL, V45, P1559; Amsterdam JD, 2010, J CLIN PSYCHOPHARM, V30, P306, DOI 10.1097/JCP.0b013e3181da5300; Bech P, 2005, AM J PSYCHIAT, V162, P2396, DOI 10.1176/appi.ajp.162.12.2396; Bellamy F, 2009, VET RES COMMUN, V33, P831, DOI 10.1007/s11259-009-9231-6; Bienenstock J, 2002, REV FR ALLERGOL, V42, P11, DOI 10.1016/S0335-7457(01)00124-1; BIENENSTOCK J, 1987, INT ARCH ALLER A IMM, V82, P238, DOI 10.1159/000234197; BJORDAL K, 1992, ACTA ONCOL, V31, P311, DOI 10.3109/02841869209108178; Black PH, 2002, BRAIN BEHAV IMMUN, V16, P622, DOI 10.1016/S0889-1591(02)00021-1; Bodemer C, 2010, J INVEST DERMATOL, V130, P804, DOI 10.1038/jid.2009.281; BOGOUSSLAVSKY J, 1991, ACTA NEUROL SCAND, V83, P309, DOI 10.1111/j.1600-0404.1991.tb04708.x; Boncoraglio GB, 2005, NEUROLOGY, V65, P332, DOI 10.1212/01.wnl.0000168897.35545.61; Brintzenhofe-Szoc KM, 2009, PSYCHOSOMATICS, V50, P383, DOI 10.1176/appi.psy.50.4.383; CAMPBELL DJ, 1966, NATURE, V210, P756, DOI 10.1038/210756b0; Cirulli F, 1998, BRAIN BEHAV IMMUN, V12, P123, DOI 10.1006/brbi.1998.0505; Costa-Pinto FA, 2007, BRAIN BEHAV IMMUN, V21, P783, DOI 10.1016/j.bbi.2007.01.002; Cowen PJ, 2010, PSYCHOL MED, V40, P1, DOI 10.1017/S0033291709005558; Dantzer R, 2008, PSYCHONEUROENDOCRINO, V33, P18, DOI 10.1016/j.psyneuen.2007.10.008; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; Dubreuil P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007258; ECLANCHER F, 1972, CR SOC BIOL, V166, P439; Esposito P, 2002, J PHARMACOL EXP THER, V303, P1061, DOI 10.1124/jpet.102.038497; Esposito P, 2001, BRAIN RES, V888, P117, DOI 10.1016/S0006-8993(00)03026-2; GUELFI JD, 1981, ANN MED-PSYCHOL, V139, P199; Hahn KA, 2008, J VET INTERN MED, V22, P1301, DOI 10.1111/j.1939-1676.2008.0190.x; Hermine O, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002266; Horny HP, 2002, INT ARCH ALLERGY IMM, V127, P115, DOI 10.1159/000048180; Krack P, 2010, TRENDS NEUROSCI, V33, P474, DOI 10.1016/j.tins.2010.07.002; Lai CH, 2010, J CLIN PSYCHOPHARM, V31, P39; Lanternier F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001906; Laugsand EA, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-104; Lennartsson J, 2005, STEM CELLS, V23, P16, DOI 10.1634/stemcells.2004-0117; LENNERT K, 1979, HISTOPATHOLOGY, V3, P349, DOI 10.1111/j.1365-2559.1979.tb03017.x; Letard S, 2008, MOL CANCER RES, V6, P1137, DOI 10.1158/1541-7786.MCR-08-0067; Martens EJ, 2010, PSYCHOL MED, V40, P807, DOI 10.1017/S0033291709990997; Matsumoto I, 2001, J EXP MED, V194, P71, DOI 10.1084/jem.194.1.71; Metcalfe DD, 1991, J INVEST DERMATOL, V96, p2S; Moller HJ, 2001, EUR ARCH PSY CLIN N, V251, P13; Nautiyal KM, 2008, P NATL ACAD SCI USA, V105, P18053, DOI 10.1073/pnas.0809479105; Ng WXD, 2009, NEUROSCI BIOBEHAV R, V33, P336, DOI 10.1016/j.neubiorev.2008.10.001; Pardanani A, 2006, BEST PRACT RES CL HA, V19, P595, DOI 10.1016/j.beha.2005.07.010; Paul C, 2010, AM J HEMATOL, V85, P921, DOI 10.1002/ajh.21894; Paus R, 2006, TRENDS IMMUNOL, V27, P32, DOI 10.1016/j.it.2005.10.002; Pehlivanidis C, 2002, J CLIN PSYCHOPHARM, V22, P221, DOI 10.1097/00004714-200204000-00019; Price JL, 2010, NEUROPSYCHOPHARMACOL, V35, P192, DOI 10.1038/npp.2009.104; Reynolds WM, 1995, PSYCHOL ASSESSMENT, V7, P472; ROGERS MP, 1986, PSYCHOSOM MED, V48, P437, DOI 10.1097/00006842-198607000-00006; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V338, P1307, DOI 10.1016/j.bbrc.2005.09.150; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Schramm A, 2004, J NEUROL, V251, P1270, DOI 10.1007/s00415-004-0505-1; Shafer AB, 2006, J CLIN PSYCHOL, V62, P123, DOI 10.1002/jclp.20213; Stiefel F, 2001, SUPPORT CARE CANCER, V9, P477, DOI 10.1007/s005200100244; Sultan S, 2003, DIABETES METAB, V29, pS21; Sultan S, 2010, J AFFECT DISORDERS, V123, P332, DOI 10.1016/j.jad.2009.09.022; Tadic A, 2010, J AFFECT DISORDERS, V120, P86, DOI 10.1016/j.jad.2009.04.014; Tamborini E, 2010, NEURO-ONCOLOGY, V12, P776, DOI 10.1093/neuonc/noq003; Temuryants N. A., 2001, Biofizika, V46, P901; Testa U, 2008, DRUG FUTURE, V33, P161, DOI 10.1358/dof.2008.033.02.1164207; Theoharides TC, 2004, J NEUROIMMUNOL, V146, P1, DOI 10.1016/j.jneuroim.2003.10.041; THEOHARIDES TC, 1995, ENDOCRINOLOGY, V136, P5745, DOI 10.1210/en.136.12.5745; THEOHARIDES TC, 1990, LIFE SCI, V46, P607, DOI 10.1016/0024-3205(90)90129-F; Theoharides TC, 2009, INT J IMMUNOPATH PH, V22, P859, DOI 10.1177/039463200902200401; Trevisan G, 2000, J EUR ACAD DERMATOL, V14, P119, DOI 10.1046/j.1468-3083.2000.00018.x; Valent P, 2007, EUR J CLIN INVEST, V37, P435, DOI 10.1111/j.1365-2362.2007.01807.x; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Valent P, 2003, HEMATOL ONCOL CLIN N, V17, P1227, DOI 10.1016/S0889-8588(03)00089-3; Valent P, 2001, WHO CLASSIFICATION T, P291; Williams JBW, 2001, EUR ARCH PSY CLIN N, V251, P6, DOI 10.1007/BF03035120	67	52	54	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26375	10.1371/journal.pone.0026375	http://dx.doi.org/10.1371/journal.pone.0026375			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031830	Green Published, Green Submitted, gold			2022-12-27	WOS:000296513200019
J	Gomez, JMD				Diaz Gomez, Juan Manuel			Estimating Ancestral Ranges: Testing Methods with a Clade of Neotropical Lizards (Iguania: Liolaemidae)	PLOS ONE			English	Article							AREAS; EVOLUTION; VICARIANCE; BIOGEOGRAPHY; COLEOPTERA; DISPERSAL	Establishing the ancestral ranges of distribution of a monophyletic clade, called the ancestral area, is one of the central objectives of historical biogeography. In this study, I used three common methodologies to establish the ancestral area of an important clade of Neotropical lizards, the family Liolaemidae. The methods used were: Fitch optimization, Weighted Ancestral Area Analysis and Dispersal-Vicariance Analysis (DIVA). A main difference from previous studies is that the areas used in the analysis are defined based on actual distributions of the species of Liolaemidae, instead of areas defined arbitrarilyor based on other taxa. The ancestral area of Liolaemidae found by Fitch optimization is Prepuna on Argentina, Central Chile and Coastal Peru. Weighted Ancestral Area Analysis found Central Chile, Coquimbo, Payunia, Austral Patagonia and Coastal Peru. Dispersal-Vicariance analysis found an ancestral area that includes almost all the areas occupied by Liolaemidae, except Atacama, Coquimbo and Austral Patagonia. The results can be resumed on two opposing hypothesis: a restricted ancestral area for the ancestor of Liolaemidae in Central Chile and Patagonia, or a widespread ancestor distributed along the Andes. Some limitations of the methods were identified, for example the excessive importance of plesiomorphic areas in the cladograms.	Univ Nacl Salta, Catedra Diversidad Biol 4, Fac Ciencias Nat, CONICET IBIGEO, Salta, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gomez, JMD (corresponding author), Univ Nacl Salta, Catedra Diversidad Biol 4, Fac Ciencias Nat, CONICET IBIGEO, Salta, Argentina.	jmdiaz@unsa.edu.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo de Investigacion de la Universidad Nacional de Salta (CIUNSa) [1783]	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Consejo de Investigacion de la Universidad Nacional de Salta (CIUNSa)	The work was funded by the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET - www.conicet.gob.ar), in form of a doctoral fellowship to the author, and the Consejo de Investigacion de la Universidad Nacional de Salta (CIUNSa), Proyecto N<SUP>o</SUP> 1783. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala CS, 2007, ZOOTAXA, P1; Abdala CS, 2008, HERPETOLOGICA, V64, P458, DOI 10.1655/08-022R1.1; Albino AM, 1998, 7 C ARG PAL BIOESTR; [Anonymous], [No title captured]; Baez A.M, 1979, MUSEUM NATURAL HIST, V7, P309; BREMER K, 1992, SYST BIOL, V41, P436, DOI 10.2307/2992585; Brown J. H., 1998, BIOGEOGRAPHY; Carine MA, 2009, J BIOGEOGR, V36, P593, DOI 10.1111/j.1365-2699.2008.02016.x; Cei J, 1986, MUSEO REGIONALE SCI, VIV; Cei J.M., 1979, University of Kansas Museum of Natural History Monograph, P309; Cei J. M., 1993, MUSEO REGIONALE SCI, VXIV, P949; Cei JM, 1975, PAYUNIA PAESSAGIO VU, V6, P1121; Crisci-V. Jorge, 2001, Caldasia, V23, P21; Crisp MD, 2005, TRENDS ECOL EVOL, V20, P122, DOI 10.1016/j.tree.2004.11.010; DEMUIZON C, 1983, GEOBIOS-LYON, V16, P747, DOI 10.1016/S0016-6995(83)80091-6; Díaz Gómez Juan Manuel, 2006, Pap. Avulsos Zool. (São Paulo), V46, P261, DOI 10.1590/S0031-10492006002400001; Diaz Gomez Juan Manuel, 2007, South American Journal of Herpetology, V2, P59; Gomez JMD, 2009, ZOOL SCR, V38, P1, DOI 10.1111/j.1463-6409.2008.00357.x; Donadio O. E., 1983, CIRCULAR INFORM ASOC, V11, P5; Donoso-Barros R., 1966, REPTILES CHILE; Drovetski SV, 2003, J BIOGEOGR, V30, P1173, DOI 10.1046/j.1365-2699.2003.00920.x; Ebach MC, 1999, CLADISTICS, V15, P387, DOI 10.1111/j.1096-0031.1999.tb00275.x; Espinoza RE, 2004, P NATL ACAD SCI USA, V101, P16819, DOI 10.1073/pnas.0401226101; ESTES R, 1973, SCIENCE, V180, P748, DOI 10.1126/science.180.4087.748; Etheridge Richard, 1995, American Museum Novitates, V3142, P1; Flores GE, 2001, J NEW YORK ENTOMOL S, V109, P309, DOI 10.1664/0028-7199(2001)109[0309:CABAOT]2.0.CO;2; FROST D R, 1989, University of Kansas Museum of Natural History Miscellaneous Publication, P1; Frost DR, 2001, MOL PHYLOGENET EVOL, V21, P352, DOI 10.1006/mpev.2001.1015; Goloboff P.A., 2003, TREE ANAL USING NEW; Hausdorf B, 1998, SYST BIOL, V47, P445, DOI 10.1080/106351598260815; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; Hovenkamp P, 1997, CLADISTICS, V13, P67, DOI 10.1111/j.1096-0031.1997.tb00241.x; Humphries C. J., 1986, CLADISTIC BIOGEOGRAP; Kodandaramaiah U, 2010, J BIOGEOGR, V37, P3, DOI 10.1111/j.1365-2699.2009.02221.x; Krell FT, 2004, SYST ENTOMOL, V29, P279, DOI 10.1111/j.0307-6970.2004.00262.x; Laurent R.F., 1992, Breviora, V494, P1; Laurent R.F, 1985, CUAD HERPETOL, V1, P1; LAURENT RF, 1983, B ASOCIACION HERPETO, V1, P16; Lobo F, 2001, HERPETOL J, V11, P137; Lobo F, 2005, ACTA ZOOLOGICA LILLO, V49, P67; Lobo Fernando, 2005, Pap. Avulsos Zool. (São Paulo), V45, P143, DOI 10.1590/S0031-10492005001300001; Lobo F, 2010, ZOOTAXA, P1; Morrone J.J., 1996, NEOTROPICA, V42, P104; MORRONE JJ, 1994, SYST BIOL, V43, P438, DOI 10.2307/2413679; MORRONE JJ, 1994, GLOBAL ECOL BIOGEOGR, V4, P188, DOI 10.2307/2997650; Morrone Juan J., 2002, Revista de la Sociedad Entomologica Argentina, V61, P1; Nelson G., 1981, SYSTEMATICS BIOGEORA; Pereyra E. A., 1992, THESIS U CHILE; Ree RH, 2005, EVOLUTION, V59, P257; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Roig-Juuent S., 2001, INTRO BIOGEOGRAFIA L, P257; ROIGJUNENT S, 2002, PROYECTO RED IBEROAM, V2, P247; RONQUIST F, 1994, SYST BIOL, V43, P267, DOI 10.2307/2413467; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2001, EVOLUTION, V55, P2503; Santos CMD, 2007, J BIOGEOGR, V34, P1470, DOI 10.1111/j.1365-2699.2007.01723.x; Schulte JA, 2000, BIOL J LINN SOC, V69, P75, DOI 10.1006/bijl.1999.0346; Schulte JA, 2003, HERPETOLOGICA, V59, P399, DOI 10.1655/02-48; Scolaro Jose A., 2003, Historia Natural (Corrientes), V2, P73; SIMPSON B B, 1975, Paleobiology, V1, P273; Szumik CA, 2002, SYST BIOL, V51, P806, DOI 10.1080/10635150290102483; Szumik CA, 2004, SYST BIOL, V53, P968, DOI 10.1080/10635150490888859; TAYLOR DW, 1991, PALAEOGEOGR PALAEOCL, V88, P69, DOI 10.1016/0031-0182(91)90015-J; VUILLEUMIER SB, 1971, SCIENCE, V173, P771, DOI 10.1126/science.173.3999.771; Young-Downey A. R., 1998, THESIS U MIAMI CORAL; [No title captured]	66	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26412	10.1371/journal.pone.0026412	http://dx.doi.org/10.1371/journal.pone.0026412			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028873	Green Published, gold			2022-12-27	WOS:000296510800041
J	Wong, HEE; Li, MS; Kroll, JS; Hibberd, ML; Langford, PR				Wong, Hazel En En; Li, Ming-Shi; Kroll, J. Simon; Hibberd, Martin L.; Langford, Paul R.			Genome Wide Expression Profiling Reveals Suppression of Host Defence Responses during Colonisation by Neisseria meningitides but not N. lactamica	PLOS ONE			English	Article							EPITHELIAL-CELL RESPONSES; GENE-EXPRESSION; MENINGOCOCCAL DISEASE; ENDOTHELIAL-CELLS; PSEUDOMONAS-AERUGINOSA; SECRETED PROTEINS; IDENTIFICATION; MODULATION; INHIBITION; SEQUENCE	Both Neisseria meningitidis and the closely related bacterium Neisseria lactamica colonise human nasopharyngeal mucosal surface, but only N. meningitidis invades the bloodstream to cause potentially life-threatening meningitis and septicaemia. We have hypothesised that the two neisserial species differentially modulate host respiratory epithelial cell gene expression reflecting their disease potential. Confluent monolayers of 16HBE14 human bronchial epithelial cells were exposed to live and/or dead N. meningitidis (including capsule and pili mutants) and N. lactamica, and their transcriptomes were compared using whole genome microarrays. Changes in expression of selected genes were subsequently validated using Q-RT-PCR and ELISAs. Live N. meningitidis and N. lactamica induced genes involved in host energy production processes suggesting that both bacterial species utilise host resources. N. meningitidis infection was associated with down-regulation of host defence genes. N. lactamica, relative to N. meningitidis, initiates up-regulation of proinflammatory genes. Bacterial secreted proteins alone induced some of the changes observed. The results suggest N. meningitidis and N. lactamica differentially regulate host respiratory epithelial cell gene expression through colonisation and/or protein secretion, and that this may contribute to subsequent clinical outcomes associated with these bacteria.	[Wong, Hazel En En; Hibberd, Martin L.] Genome Inst Singapore, Singapore, Singapore; [Wong, Hazel En En; Li, Ming-Shi; Kroll, J. Simon; Langford, Paul R.] Univ London Imperial Coll Sci Technol & Med, Paediat Sect, London, England	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Imperial College London	Wong, HEE (corresponding author), Genome Inst Singapore, Singapore, Singapore.	p.langford@imperial.ac.uk	Langford, Paul R/B-9092-2008; Hibberd, Martin L/D-5050-2009; Langford, Paul/AAU-4189-2020	Langford, Paul R/0000-0002-6368-4724; Langford, Paul/0000-0002-6368-4724; Hibberd, Martin/0000-0001-8587-1849	Agency for Science, Technology and Research, Singapore (A*-Star); George John and Sheilah Livanos Charitable Trust	Agency for Science, Technology and Research, Singapore (A*-Star)(Agency for Science Technology & Research (A*STAR)); George John and Sheilah Livanos Charitable Trust	HEEW and MLH are funded by the Agency for Science, Technology and Research, Singapore (A*-Star), while MSL, JSK, and PRL are funded by the George John and Sheilah Livanos Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baart GJE, 2010, MICROBIOL-SGM, V156, P530, DOI 10.1099/mic.0.031641-0; Beisswenger C, 2007, J BIOL CHEM, V282, P28700, DOI 10.1074/jbc.M703576200; Bennett JS, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-652; Bergman P, 2005, CELL MICROBIOL, V7, P1009, DOI 10.1111/j.1462-5822.2005.00530.x; BLAKE MS, 1989, J EXP MED, V170, P1727, DOI 10.1084/jem.170.5.1727; Bonnah RA, 2004, CELL MICROBIOL, V6, P473, DOI 10.1111/j.1462-5822.2004.00376.x; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Chamot-Rooke J, 2011, SCIENCE, V331, P778, DOI 10.1126/science.1200729; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Dietrich G, 2003, J BACTERIOL, V185, P155, DOI 10.1128/JB.185.1.155-164.2003; Evans CM, 2011, CLIN INFECT DIS, V52, P70, DOI 10.1093/cid/ciq065; Exley RM, 2009, INFECT IMMUN, V77, P45, DOI 10.1128/IAI.00968-08; Fiorentino L, 2000, MOL CELL BIOL, V20, P7735, DOI 10.1128/MCB.20.20.7735-7750.2000; Fowler MI, 2006, INFECT IMMUN, V74, P6467, DOI 10.1128/IAI.00644-06; GOLD R, 1978, J INFECT DIS, V137, P112, DOI 10.1093/infdis/137.2.112; Gorringe AR, 2009, CLIN VACCINE IMMUNOL, V16, P1113, DOI 10.1128/CVI.00118-09; Grifantini R, 2002, ANN NY ACAD SCI, V975, P202, DOI 10.1111/j.1749-6632.2002.tb05953.x; Grifantini R, 2002, NAT BIOTECHNOL, V20, P914, DOI 10.1038/nbt728; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; Hammerschmidt S, 1996, EMBO J, V15, P192, DOI 10.1002/j.1460-2075.1996.tb00347.x; Hartman AL, 2008, J VIROL, V82, P5348, DOI 10.1128/JVI.00215-08; Higashimoto Y, 2005, RESPIRATION, V72, P629, DOI 10.1159/000089579; Hooper LV, 1999, P NATL ACAD SCI USA, V96, P9833, DOI 10.1073/pnas.96.17.9833; Li MS, 2009, MED MICROBIOL IMMUN, V198, P57, DOI 10.1007/s00430-008-0105-2; Linhartova I, 2006, FEMS MICROBIOL LETT, V263, P109, DOI 10.1111/j.1574-6968.2006.00407.x; Liu XP, 2010, INFECT IMMUN, V78, P5314, DOI 10.1128/IAI.00681-10; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; McNeil LK, 2007, NUCLEIC ACIDS RES, V35, pD347, DOI 10.1093/nar/gkl947; Meyer-Hoffert U, 2003, EXP DERMATOL, V12, P418, DOI 10.1034/j.1600-0625.2002.120409.x; Monick MM, 2005, J BIOL CHEM, V280, P2147, DOI 10.1074/jbc.M408745200; Mukhopadhyay TK, 2005, BIOTECHNOL APPL BIOC, V41, P175; Mukhopadhyay TK, 2008, THESIS U LONDON; O'Dwyer CA, 2004, INFECT IMMUN, V72, P6511, DOI 10.1128/IAI.72.11.6511-6518.2004; O'Grady E, 2007, NAT REV MICROBIOL, V5, P337, DOI 10.1038/nrmicro1641; OLSEN SF, 1991, EPIDEMIOL INFECT, V106, P445, DOI 10.1017/S0950268800067492; Pathan N, 2004, LANCET, V363, P203, DOI 10.1016/S0140-6736(03)15326-3; Plant L, 2004, CELL MICROBIOL, V6, P663, DOI 10.1111/j.1462-5822.2004.00393.x; Pujol C, 1997, INFECT IMMUN, V65, P4836, DOI 10.1128/IAI.65.11.4836-4842.1997; Read RC, 1996, INFECT IMMUN, V64, P3210, DOI 10.1128/IAI.64.8.3210-3217.1996; Reigstad CS, 2007, J BIOL CHEM, V282, P21259, DOI 10.1074/jbc.M611502200; Robinson K, 2004, CELL MICROBIOL, V6, P927, DOI 10.1111/j.1462-5822.2004.00410.x; Schneider MC, 2007, TRENDS MICROBIOL, V15, P233, DOI 10.1016/j.tim.2007.03.005; Schneider MC, 2006, J IMMUNOL, V176, P7566, DOI 10.4049/jimmunol.176.12.7566; Schneider MC, 2009, NATURE, V458, P890, DOI 10.1038/nature07769; Schubert-Unkmeir A, 2007, INFECT IMMUN, V75, P899, DOI 10.1128/IAI.01508-06; Schubert-Unkmeir A, 2009, EXPERT REV MOL DIAGN, V9, P833, DOI 10.1586/ERM.09.68; Serruto D, 2004, J BIOTECHNOL, V113, P15, DOI 10.1016/j.jbiotec.2004.03.024; Simpson AJ, 1999, FEBS LETT, V452, P309, DOI 10.1016/S0014-5793(99)00670-5; Tettelin H, 2000, SCIENCE, V287, P1809, DOI 10.1126/science.287.5459.1809; Tezera L, 2010, CELL MICROBIOL; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uronen-Hansson H, 2004, CELL MICROBIOL, V6, P625, DOI 10.1111/j.1462-5822.2004.00387.x; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; van Ulsen P, 2006, FEMS MICROBIOL REV, V30, P292, DOI 10.1111/j.1574-6976.2006.00013.x; Vaughan TE, 2006, VACCINE, V24, P5277, DOI 10.1016/j.vaccine.2006.03.013; VIRJI M, 1993, MOL MICROBIOL, V10, P1013, DOI 10.1111/j.1365-2958.1993.tb00972.x; Virji M, 1995, MOL MICROBIOL, V18, P741, DOI 10.1111/j.1365-2958.1995.mmi_18040741.x; Virji M, 1996, TRENDS MICROBIOL, V4, P466, DOI 10.1016/S0966-842X(97)82905-8; VIRJI M, 1991, MOL MICROBIOL, V5, P1831, DOI 10.1111/j.1365-2958.1991.tb00807.x; Vos JB, 2005, PHYSIOL GENOMICS, V21, P324, DOI 10.1152/physiolgenomics.00289.2004; Wells DB, 2001, INFECT IMMUN, V69, P2718, DOI 10.1128/IAI.69.4.2718-2722.2001; WICK M, 1995, EXP CELL RES, V219, P527, DOI 10.1006/excr.1995.1261; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhou LM, 2004, RESP PHYSIOL NEUROBI, V140, P89, DOI 10.1016/j.resp.2003.12.003	66	9	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26130	10.1371/journal.pone.0026130	http://dx.doi.org/10.1371/journal.pone.0026130			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028815	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000296510800019
J	Zhang, JY; Zhang, XL; Wu, C; Lu, DS; Guo, G; Mao, XH; Zhang, Y; Wang, DC; Li, DF; Zou, QM				Zhang, Jinyong; Zhang, Xiaoli; Wu, Chao; Lu, Dongshui; Guo, Gang; Mao, Xuhu; Zhang, Ying; Wang, Da-Cheng; Li, Defeng; Zou, Quanming			Expression, Purification and Characterization of Arginase from Helicobacter pylori in Its Apo Form	PLOS ONE			English	Article							BINUCLEAR MANGANESE CLUSTER; HUMAN LIVER; INFECTION; INHIBITION; PATHOGENESIS; SUPERFAMILY; ACTIVATION; ESCAPE; ENZYME; IONS	Arginase, a manganese-dependent enzyme that widely distributed in almost all creatures, is a urea cycle enzyme that catalyzes the hydrolysis of L-arginine to generate L-ornithine and urea. Compared with the well-studied arginases from animals and yeast, only a few eubacterial arginases have been characterized, such as those from H. pylori and B. anthracis. However, these enzymes used for arginase activity assay were all expressed with LB medium, as low concentration of Mn2+ was detectable in the medium, protein obtained were partially Mn2+ bonded, which may affect the results of arginase activity assay. In the present study, H. pylori arginase (RocF) was expressed in a Mn2+ and Co2+ free minimal medium, the resulting protein was purified through affinity and gel filtration chromatography and the apo-form of RocF was confirmed by flame photometry analysis. Gel filtration indicates that the enzyme exists as monomer in solution, which was unique as compared with homologous enzymes. Arginase activity assay revealed that apo-RocF had an acidic pH optimum of 6.4 and exhibited metal preference of Co2+>Ni2+>Mn2+. We also confirmed that heat-activation and reducing regents have significant impact on arginase activity of RocF, and inhibits S-(2-boronoethyl)-L-Cysteine (BEC) and N omega-hydroxy-nor-Arginine (nor-NOHA) inhibit the activity of RocF in a dose-dependent manner.	[Zhang, Jinyong; Zhang, Xiaoli; Wu, Chao; Lu, Dongshui; Guo, Gang; Mao, Xuhu; Zou, Quanming] Third Mil Med Univ, Dept Clin Microbiol & Immunol, Coll Med Lab, Chongqing, Peoples R China; [Zhang, Ying; Wang, Da-Cheng; Li, Defeng] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China	Army Medical University; Chinese Academy of Sciences; Institute of Biophysics, CAS	Zhang, JY (corresponding author), Third Mil Med Univ, Dept Clin Microbiol & Immunol, Coll Med Lab, Chongqing, Peoples R China.	lidefeng@moon.ibp.ac.cn; qmzou2007@163.com		Zhang, Jinyong/0000-0001-9622-5834	National Science Foundation of China [31000336]; National Basic Research Program of China [2011CB910304, 2011CB91103]; Chinese Academy of Sciences [KSCXZ-EW-J-3]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by funding from the National Science Foundation of China (31000336), the grants from National Basic Research Program of China (2011CB910304, 2011CB91103) and the Chinese Academy of Sciences (KSCXZ-EW-J-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldari CT, 2005, TRENDS IMMUNOL, V26, P199, DOI 10.1016/j.it.2005.01.007; Bewley MC, 1999, STRUCT FOLD DES, V7, P435, DOI 10.1016/S0969-2126(99)80056-2; Cama E, 2004, BIOCHEMISTRY-US, V43, P8987, DOI 10.1021/bi0491705; CARVAJAL N, 1995, COMP BIOCHEM PHYS B, V112, P153, DOI 10.1016/0305-0491(95)00027-6; Chaput C, 2006, PLOS PATHOG, V2, P844, DOI 10.1371/journal.ppat.0020097; Cheng Y, 2005, J BIOL CHEM, V280, P22492, DOI 10.1074/jbc.C500122200; Di Costanzo L, 2005, P NATL ACAD SCI USA, V102, P13058, DOI 10.1073/pnas.0504027102; Di Costanzo L, 2010, ARCH BIOCHEM BIOPHYS, V496, P101, DOI 10.1016/j.abb.2010.02.004; Gobert AP, 2001, P NATL ACAD SCI USA, V98, P13844, DOI 10.1073/pnas.241443798; HIRSCHKOLB H, 1970, COMP BIOCHEM PHYSIOL, V37, P345, DOI 10.1016/0010-406X(70)90563-3; Hovey JG, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-26; IKEMOTO M, 1990, BIOCHEM J, V270, P697, DOI 10.1042/bj2700697; Kanyo ZF, 1996, NATURE, V383, P554, DOI 10.1038/383554a0; Kao JY, 2010, GASTROENTEROLOGY, V138, P1046, DOI 10.1053/j.gastro.2009.11.043; KUHN NJ, 1995, ARCH BIOCHEM BIOPHYS, V320, P24, DOI 10.1006/abbi.1995.1338; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; McGee DJ, 2006, J BIOL CHEM, V281, P3290, DOI 10.1074/jbc.M506139200; McGee DJ, 2004, EUR J BIOCHEM, V271, P1952, DOI 10.1111/j.1432-1033.2004.04105.x; McGee DJ, 1999, J BACTERIOL, V181, P7314, DOI 10.1128/JB.181.23.7314-7322.1999; Mendz GL, 1998, BBA-PROTEIN STRUCT M, V1388, P465, DOI 10.1016/S0167-4838(98)00207-6; Molnar B, 2010, DIGEST DIS, V28, P604, DOI 10.1159/000320060; MUSZYNSKA G, 1972, ACTA BIOCHIM POL, V19, P109; Shishova EY, 2009, BIOCHEMISTRY-US, V48, P121, DOI 10.1021/bi801911v; Srivastava A, 2010, IUBMB LIFE, V62, P906, DOI 10.1002/iub.401; Srivastava A, 2010, BIOCHEM BIOPH RES CO, V395, P348, DOI 10.1016/j.bbrc.2010.04.014; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Tormanen CD, 2001, J ENZYM INHIB, V16, P443, DOI 10.1080/14756360109162393; Viator Ryan J., 2008, BMC Biochemistry, V9, P15, DOI 10.1186/1471-2091-9-15; Walker J M, 1994, Methods Mol Biol, V32, P5; Ye WM, 2004, JNCI-J NATL CANCER I, V96, P388, DOI 10.1093/jnci/djh057; Yuan JP, 2009, CELL MOL IMMUNOL, V6, P191, DOI 10.1038/cmi.2009.26; Zabaleta J, 2004, J IMMUNOL, V173, P586, DOI 10.4049/jimmunol.173.1.586; Zhang JY, 2011, ACTA CRYSTALLOGR F, V67, P707, DOI 10.1107/S1744309111014242	33	14	15	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26205	10.1371/journal.pone.0026205	http://dx.doi.org/10.1371/journal.pone.0026205			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028830	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800025
J	Andersson, K; Norman, D; Werdelin, L				Andersson, Ki; Norman, David; Werdelin, Lars			Sabretoothed Carnivores and the Killing of Large Prey	PLOS ONE			English	Article							LEOPARD NEOFELIS-NEBULOSA; LION PANTHERA-LEO; LATE MIOCENE; MORPHOLOGY; MACHAIRODONTINAE; PREFERENCES; EVOLUTION; ORIGINS; FELIDAE; MAMMALS	Sabre-like canines clearly have the potential to inflict grievous wounds leading to massive blood loss and rapid death. Hypotheses concerning sabretooth killing modes include attack to soft parts such as the belly or throat, where biting deep is essential to generate strikes reaching major blood vessels. Sabretoothed carnivorans are widely interpreted as hunters of larger and more powerful prey than that of their present-day nonsabretoothed relatives. However, the precise functional advantage of the sabretooth bite, particularly in relation to prey size, is unknown. Here, we present a new point-to-point bite model and show that, for sabretooths, depth of the killing bite decreases dramatically with increasing prey size. The extended gape of sabretooths only results in considerable increase in bite depth when biting into prey with a radius of less than similar to 10 cm. For sabretooths, this size-reversed functional advantage suggests predation on species within a similar size range to those attacked by present-day carnivorans, rather than "megaherbivores" as previously believed. The development of the sabretooth condition appears to represent a shift in function and killing behaviour, rather than one in predator-prey relations. Furthermore, our results demonstrate how sabretoothed carnivorans are likely to have evolved along a functionally continuous trajectory: beginning as an extension of a jaw-powered killing bite, as adopted by present-day pantherine cats, followed by neck-powered biting and thereafter shifting to neck-powered shear-biting. We anticipate this new insight to be a starting point for detailed study of the evolution of pathways that encompass extreme specialisation, for example, understanding how neck-powered biting shifts into shear-biting and its significance for predator-prey interactions. We also expect that our model for point-to-point biting and bite depth estimations will yield new insights into the behaviours of a broad range of extinct predators including therocephalians (gorgonopsian + cynodont, sabretoothed mammal-like reptiles), sauropterygians (marine reptiles) and theropod dinosaurs.	[Andersson, Ki; Norman, David] Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England; [Andersson, Ki; Werdelin, Lars] Swedish Museum Nat Hist, Dept Palaeozool, S-10405 Stockholm, Sweden	University of Cambridge; Swedish Museum of Natural History	Andersson, K (corresponding author), Univ Cambridge, Dept Earth Sci, Cambridge CB2 3EQ, England.	andersson.ki@gmail.com			Swedish Research Council [623-2004-2206]	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The study was funded by a postdoctoral stipend (no: 623-2004-2206) to KA from the Swedish Research Council and a research grant to LW from the Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKERSTEN W, 1985, LOS ANGELES COUNTY M, V356, P1; Anton M, 1999, J VERTEBR PALEONTOL, V19, P771, DOI 10.1080/02724634.1999.10011190; ANTON M, 2004, SOCIETY, V140, P207; Bohlin B., 1940, B GEOL I U UPPSALA, V28, P156; BRAMBLE DM, 1978, PALEOBIOLOGY, V4, P271, DOI 10.1017/S009483730000600X; Bryant Harold N., 1996, P283; BRYANT HN, 1987, NATURE, V325, P488, DOI 10.1038/325488a0; Carbone C, 1999, NATURE, V402, P286, DOI 10.1038/46266; Carbone C, 2005, J ZOOL, V266, P153, DOI 10.1017/s0952836905006710; CHRISTIANSEN P, 2011, ZOOLOGICAL J LINNEAN; Christiansen P, 2008, J MAMM EVOL, V15, P155, DOI 10.1007/s10914-007-9069-z; Christiansen P, 2006, J MORPHOL, V267, P1186, DOI 10.1002/jmor.10468; DIAMOND JM, 1986, NATURE, V322, P773, DOI 10.1038/322773a0; EMERSON SB, 1980, PALEOBIOLOGY, V6, P295, DOI 10.1017/S0094837300006813; Evans G.L., 1961, B TEX MEM MUS, V2, P7; Ewer, 1998, CARNIVORES; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hayward MW, 2005, J ZOOL, V267, P309, DOI 10.1017/S0952836905007508; HERRING SW, 1974, AM NAT, V108, P561, DOI 10.1086/282934; KEMP TS, 2005, ORIGIN EVOLUTION MAM; KITCHENER A., 1991, NATURAL HIST WILD CA; Lewis ME, 1997, J HUM EVOL, V32, P257, DOI 10.1006/jhev.1996.0103; MARTIN L D, 1980, Transactions of the Nebraska Academy of Sciences, V8, P141; Martin LD, 2000, NATURWISSENSCHAFTEN, V87, P41, DOI 10.1007/s001140050007; Matthew WD, 1910, B AM MUS NAT HIST, V28, P289; RADINSKY LB, 1981, BIOL J LINN SOC, V15, P369, DOI 10.1111/j.1095-8312.1981.tb00770.x; Radloff FGT, 2004, J ANIM ECOL, V73, P410, DOI 10.1111/j.0021-8790.2004.00817.x; Salesa MJ, 2010, J ANAT, V216, P381, DOI 10.1111/j.1469-7580.2009.01178.x; Salesa MJ, 2005, ZOOL J LINN SOC-LOND, V144, P363, DOI 10.1111/j.1096-3642.2005.00174.x; SALESA MJ, 2006, J ZOOLOGY LONDON, V268, P2543; SCHULTZ C B, 1970, Bulletin of the University of Nebraska State Museum, V9, P1; SIMPSON GEORGE GAYLORD, 1941, AMER MUS NOVITATES, V1130, P1; Slater GJ, 2008, PALEOBIOLOGY, V34, P403, DOI 10.1666/07061.1; TURNBULL WD, 1970, FIELDIANA GEOLOGY, V18, P149; Turner A., 1997, BIG CATS THEIR FOSSI; VANVALKENBURGH B, 1988, PALEOBIOLOGY, V14, P155, DOI 10.1017/S0094837300011891; Werdelin L, 2010, BIOL CONSERVATION WI, P59	37	28	29	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e24971	10.1371/journal.pone.0024971	http://dx.doi.org/10.1371/journal.pone.0024971			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039403	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500004
J	Kobayashi, S; Takebe, T; Zheng, YW; Mizuno, M; Yabuki, Y; Maegawa, J; Taniguchi, H				Kobayashi, Shinji; Takebe, Takanori; Zheng, Yun-Wen; Mizuno, Mitsuru; Yabuki, Yuichiro; Maegawa, Jiro; Taniguchi, Hideki			Presence of Cartilage Stem/Progenitor Cells in Adult Mice Auricular Perichondrium	PLOS ONE			English	Article							LABEL-RETAINING CELLS; STEM-CELLS; ARTICULAR CHONDROCYTES; EXTRACELLULAR-MATRIX; INTEGRIN EXPRESSION; COSTAL CARTILAGE; IN-VITRO; RECONSTRUCTION; TISSUE; CD44	Background: Based on evidence from several other tissues, cartilage stem/progenitor cells in the auricular cartilage presumably contribute to tissue development or homeostasis of the auricle. However, no definitive studies have identified or characterized a stem/progenitor population in mice auricle. Methodology/Principal Findings: The 5-bromo-2'-deoxyuridine (BrdU) label-retaining technique was used to label dividing cells in fetal mice. Observations one year following the labeling revealed that label-retaining cells (LRCs) were present specifically in auricular perichondrium at a rate of 0.08 +/- 0.06%, but LRCs were not present in chondrium. Furthermore, LRCs were successfully isolated and cultivated from auricular cartilage. Immunocytochemical analyses showed that LRCs express CD44 and integrin-alpha(5). These LRCs, putative stem/progenitor cells, possess clonogenicity and chondrogenic capability in vitro. Conclusions/Significance: We have identified a population of putative cartilage stem/progenitor cells in the auricular perichondrium of mice. Further characterization and utilization of the cell population should improve our understanding of basic cartilage biology and lead to advances in cartilage tissue engineering and novel therapeutic strategies for patients with craniofacial defects, including long-term tissue restoration.	[Kobayashi, Shinji; Takebe, Takanori; Zheng, Yun-Wen; Mizuno, Mitsuru; Taniguchi, Hideki] Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, Kanagawa, Japan; [Yabuki, Yuichiro; Maegawa, Jiro] Yokohama City Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Kanazawa Ku, Kanagawa, Japan; [Taniguchi, Hideki] Yokohama City Univ, Adv Med Res Ctr, Kanagawa, Japan; [Kobayashi, Shinji] Kanagawa Childrens Med Ctr, Dept Plast & Reconstruct Surg, Minami Ku, Yokohama, Kanagawa, Japan	Yokohama City University; Yokohama City University; Yokohama City University	Kobayashi, S (corresponding author), Yokohama City Univ, Grad Sch Med, Dept Regenerat Med, Kanazawa Ku, Kanagawa, Japan.	zoukisai@yokohama-cu.ac.jp	Mitsuru, Mizuno/K-3962-2017; Zheng, Yun-Wen/R-2874-2019	Mitsuru, Mizuno/0000-0002-4410-3621; Zheng, Yun-Wen/0000-0001-9002-3190	Ministry of Education, Science and Culture [20592101]; Health and Labour Sciences Research Grants Research on intractable disease [2011-164]; Yokohama City University, Japan [19-15]	Ministry of Education, Science and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health and Labour Sciences Research Grants Research on intractable disease; Yokohama City University, Japan	This work was supported by grant from Grant-in-aid for Developmental Scientific Research, The Ministry of Education, Science and Culture (No. 20592101) and Health and Labour Sciences Research Grants Research on intractable disease (No. 2011-164). This work was also supported by the grant for Research and Development Project (No. 19-15) of Yokohama City University, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Bairati A, 1996, TISSUE CELL, V28, P455, DOI 10.1016/S0040-8166(96)80031-0; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Bickenbach JR, 1998, EXP CELL RES, V244, P184, DOI 10.1006/excr.1998.4163; Brandl C, 2009, EXP EYE RES, V89, P209, DOI 10.1016/j.exer.2009.03.009; CHOW G, 1995, J BIOL CHEM, V270, P27734, DOI 10.1074/jbc.270.46.27734; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Duvillie B, 2003, DIABETES, V52, P2035, DOI 10.2337/diabetes.52.8.2035; ENGKVIST O, 1979, SCAND J PLAST RECONS, V13, P371, DOI 10.3109/02844317909013085; EnomotoIwamoto M, 1997, J BONE MINER RES, V12, P1124, DOI 10.1359/jbmr.1997.12.7.1124; Hausler G, 2002, CALCIFIED TISSUE INT, V71, P212, DOI 10.1007/s00223-001-2083-x; HOLMVALL K, 1995, EXP CELL RES, V221, P496, DOI 10.1006/excr.1995.1401; Homandberg GA, 2002, OSTEOARTHR CARTILAGE, V10, P938, DOI 10.1053/joca.2002.0854; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Ito M, 2002, J INVEST DERMATOL, V119, P1310, DOI 10.1046/j.1523-1747.2002.19644.x; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Kawanabe Y, 2007, PLAST RECONSTR SURG, V119, P308, DOI 10.1097/01.prs.0000244880.12256.7c; Kawanabe Y, 2006, PLAST RECONSTR SURG, V117, P2011, DOI 10.1097/01.prs.0000210015.28620.1c; Kim SJ, 2003, YONSEI MED J, V44, P493, DOI 10.3349/ymj.2003.44.3.493; Knudson W, 2002, CELL MOL LIFE SCI, V59, P36, DOI 10.1007/s00018-002-8403-0; Nakamura H, 2005, J HISTOCHEM CYTOCHEM, V53, P113, DOI 10.1369/jhc.4A6354.2005; Nishimura K, 1999, ARTHRITIS RHEUM, V42, P2631, DOI 10.1002/1529-0131(199912)42:12<2631::AID-ANR18>3.0.CO;2-H; PELTOMAKI T, 1992, J ANAT, V181, P259; SALTER DM, 1995, J HISTOCHEM CYTOCHEM, V43, P447, DOI 10.1177/43.4.7897185; Shirasawa S, 2006, J CELL BIOCHEM, V97, P84, DOI 10.1002/jcb.20546; Szotek PP, 2008, P NATL ACAD SCI USA, V105, P12469, DOI 10.1073/pnas.0805012105; Tavella S, 1997, J CELL SCI, V110, P2261; Togo T, 2006, LAB INVEST, V86, P445, DOI 10.1038/labinvest.3700409; VANDERMEULEN JCH, 1984, PLAST RECONSTR SURG, V74, P687, DOI 10.1097/00006534-198411000-00018; WU LJ, 1994, SCIENCE, V264, P572, DOI 10.1126/science.8160014; Yanaga H, 2006, PLAST RECONSTR SURG, V117, P2019, DOI 10.1097/01.prs.0000210662.12267.de; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	33	27	32	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26393	10.1371/journal.pone.0026393	http://dx.doi.org/10.1371/journal.pone.0026393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039478	gold, Green Published, Green Submitted			2022-12-27	WOS:000296507500060
J	Neri, P; Tokoro, S; Kobayashi, R; Sugiyama, T; Umeda, K; Shimizu, T; Tsuji, T; Kodama, Y; Oguma, K; Mori, H				Neri, Paola; Tokoro, Shunji; Kobayashi, Ryo; Sugiyama, Tsuyoshi; Umeda, Kouji; Shimizu, Takeshi; Tsuji, Takao; Kodama, Yoshikatsu; Oguma, Keiji; Mori, Hiroshi			Specific Egg Yolk Immunoglobulin as a New Preventive Approach for Shiga-Toxin-Mediated Diseases	PLOS ONE			English	Article							ESCHERICHIA-COLI O157-H7; HEMOLYTIC-UREMIC SYNDROME; HUMAN MONOCLONAL-ANTIBODY; CARBOHYDRATE LIGANDS; ANTIBIOTIC-TREATMENT; EPITHELIAL-CELLS; VERO TOXIN; B-SUBUNIT; IN-VITRO; MICE	Shiga toxins (Stxs) are involved in the development of severe systemic complications associated with enterohemorrhagic Escherichia coli (EHEC) infection. Various neutralizing agents against Stxs are under investigation for management of EHEC infection. In this study, we immunized chickens with formalin-inactivated Stx-1 or Stx-2, and obtained immunoglobulin Y (IgY) from the egg yolk. Anti-Stx-1 IgY and anti-Stx-2 IgY recognized the corresponding Stx A subunit and polymeric but not monomeric B subunit. Anti-Stx-1 IgY and anti-Stx-2 IgY suppressed the cytotoxicity of Stx-1 and Stx-2 to HeLa 229 cells, without cross-suppressive activity. The suppressive activity of these IgY was abrogated by pre-incubation with the corresponding recombinant B subunit, which suggests that the antibodies directed to the polymeric B subunits were predominantly involved in the suppression. In vivo, the intraperitoneal or intravenous administration of these IgY rescued mice from death caused by intraperitoneal injection of the corresponding toxin at a lethal dose. Moreover, oral administration of anti-Stx-2 IgY reduced the mortality of mice infected intestinally with EHEC O157:H7. Our results therefore suggest that anti-Stx IgY antibodies may be considered as preventive agents for Stx-mediated diseases in EHEC infection.	[Neri, Paola; Tokoro, Shunji; Kobayashi, Ryo; Sugiyama, Tsuyoshi; Mori, Hiroshi] Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Gifu, Japan; [Umeda, Kouji; Kodama, Yoshikatsu] GHEN Corp, Immunol Res Inst, Gifu, Japan; [Shimizu, Takeshi] Chiba Univ, Grad Sch Med, Dept Mol Infectiol, Chiba, Japan; [Tsuji, Takao] Fujita Hlth Univ, Sch Med, Dept Microbiol, Aichi, Japan; [Oguma, Keiji] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Bacteriol, Okayama 7008530, Japan	Gifu Pharmaceutical University; Chiba University; Fujita Health University; Okayama University	Neri, P (corresponding author), Gifu Pharmaceut Univ, Dept Biopharmaceut Sci, Gifu, Japan.	morih@gifu-pu.ac.jp			Grants-in-Aid for Scientific Research [21590497] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Acheson DWK, 1996, INFECT IMMUN, V64, P3294, DOI 10.1128/IAI.64.8.3294-3300.1996; Amaral JA, 2002, RES VET SCI, V72, P229, DOI 10.1053/rvsc.2002.0551; Boerlin P, 1999, J CLIN MICROBIOL, V37, P497, DOI 10.1128/JCM.37.3.497-503.1999; Cook SR, 2005, CAN J ANIM SCI, V85, P291, DOI 10.4141/A04-076; Dohi H, 2002, ORG LETT, V4, P355, DOI 10.1021/ol017135+; DOWNES FP, 1988, INFECT IMMUN, V56, P1926, DOI 10.1128/IAI.56.8.1926-1933.1988; ENDO Y, 1988, EUR J BIOCHEM, V171, P45, DOI 10.1111/j.1432-1033.1988.tb13756.x; Ergonul Z, 2003, J INFECT DIS, V187, P154, DOI 10.1086/345861; Flagler MJ, 2007, INFECT IMMUN, V75, P760, DOI 10.1128/IAI.01594-06; GENTRY MK, 1980, J CLIN MICROBIOL, V12, P361, DOI 10.1128/JCM.12.3.361-366.1980; Girard F, 2006, FEMS IMMUNOL MED MIC, V46, P340, DOI 10.1111/j.1574-695X.2005.00030.x; HEAD SC, 1988, FEMS MICROBIOL LETT, V51, P211, DOI 10.1111/j.1574-6968.1988.tb02999.x; Hurley BP, 1999, INFECT IMMUN, V67, P6670; JACKSON MP, 1987, FEMS MICROBIOL LETT, V44, P109, DOI 10.1016/0378-1097(87)90210-2; Jeong KI, 2010, J INFECT DIS, V201, P1081, DOI 10.1086/651198; KARMALI MA, 1985, J INFECT DIS, V151, P775, DOI 10.1093/infdis/151.5.775; Kitov PI, 2000, NATURE, V403, P669, DOI 10.1038/35001095; Kiyokawa N, 1998, J INFECT DIS, V178, P178, DOI 10.1086/515592; Krautz-Peterson G, 2008, INFECT IMMUN, V76, P1931, DOI 10.1128/IAI.01282-07; LINDBERG AA, 1987, J BIOL CHEM, V262, P1779; LINDGREN SW, 1994, INFECT IMMUN, V62, P623, DOI 10.1128/IAI.62.2.623-631.1994; LINGWOOD CA, 1987, J BIOL CHEM, V262, P8834; Mine Yoshinori, 2002, Journal of Medicinal Food, V5, P159, DOI 10.1089/10966200260398198; Mukherjee J, 2002, INFECT IMMUN, V70, P5896, DOI 10.1128/IAI.70.10.5896-5899.2002; Mulvey GL, 2003, J INFECT DIS, V187, P640, DOI 10.1086/373996; Nagano K, 2003, J PHARMACOL SCI, V91, P219; Nagano K, 2003, MICROBIOL IMMUNOL, V47, P125, DOI 10.1111/j.1348-0421.2003.tb02795.x; Nakajima H, 2001, J BIOL CHEM, V276, P42915, DOI 10.1074/jbc.M106015200; Nakajima H, 2001, PROTEIN EXPRES PURIF, V22, P267, DOI 10.1006/prep.2001.1449; Neri P, 2007, BIOL PHARM BULL, V30, P1697, DOI 10.1248/bpb.30.1697; Neri P, 2007, MICROBIOL IMMUNOL, V51, P581, DOI 10.1111/j.1348-0421.2007.tb03944.x; Nishikawa K, 2005, J INFECT DIS, V191, P2097, DOI 10.1086/430388; OBRIEN AD, 1983, INFECT IMMUN, V40, P675, DOI 10.1128/IAI.40.2.675-683.1983; OBRIEN AD, 1992, CURR TOP MICROBIOL, V180, P65; OSTROFF SM, 1989, J INFECT DIS, V160, P994, DOI 10.1093/infdis/160.6.994; OSTROFF SM, 1989, JAMA-J AM MED ASSOC, V262, P355, DOI 10.1001/jama.262.3.355; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Reilly RM, 1997, CLIN PHARMACOKINET, V32, P313, DOI 10.2165/00003088-199732040-00004; SAXENA SK, 1989, J BIOL CHEM, V264, P596; Sheoran AS, 2005, INFECT IMMUN, V73, P4607, DOI 10.1128/IAI.73.8.4607-4613.2005; Shimizu K, 2003, MICROB PATHOGENESIS, V35, P1, DOI 10.1016/S0882-4010(03)00065-2; Shimizu T, 2007, MICROB PATHOGENESIS, V43, P88, DOI 10.1016/j.micpath.2007.04.003; Shimizu T, 2007, INFECT IMMUN, V75, P2189, DOI 10.1128/IAI.01546-06; Shin JH, 2002, CLIN DIAGN LAB IMMUN, V9, P1061, DOI 10.1128/CDLI.9.5.1061-1066.2002; Smith MJ, 2006, VACCINE, V24, P4122, DOI 10.1016/j.vaccine.2006.02.035; STROCKBINE NA, 1986, INFECT IMMUN, V53, P135, DOI 10.1128/IAI.53.1.135-140.1986; TESH VL, 1993, INFECT IMMUN, V61, P3392, DOI 10.1128/IAI.61.8.3392-3402.1993; Tsuji T, 2008, VACCINE, V26, P469, DOI 10.1016/j.vaccine.2007.11.038; Uzawa H, 2007, CHEMBIOCHEM, V8, P2117, DOI 10.1002/cbic.200700439; Wang Q, 2010, CAN J MICROBIOL, V56, P1003, DOI 10.1139/W10-087; Watanabe M, 2004, J INFECT DIS, V189, P360, DOI 10.1086/381124; Wen SX, 2006, VACCINE, V24, P1142, DOI 10.1016/j.vaccine.2005.08.094; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601; Yamagami S, 2001, J INFECT DIS, V184, P738, DOI 10.1086/323082; Yoh M, 1997, EPIDEMIOL INFECT, V119, P101, DOI 10.1017/S0950268897007541; Yokoyama H, 1998, VACCINE, V16, P388, DOI 10.1016/S0264-410X(97)80916-4; Yokoyama S, 2001, J CLIN BIOCHEM NUTR, V30, P33; YUTSUDO T, 1987, MICROB PATHOGENESIS, V3, P21, DOI 10.1016/0882-4010(87)90034-9; Zhang XP, 2000, J INFECT DIS, V181, P664, DOI 10.1086/315239; Zumbrun SD, 2010, INFECT IMMUN, V78, P4488, DOI 10.1128/IAI.00620-10	60	17	20	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26526	10.1371/journal.pone.0026526	http://dx.doi.org/10.1371/journal.pone.0026526			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028896	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500083
J	Oostindjer, M; Bolhuis, JE; Simon, K; van den Brand, H; Kemp, B				Oostindjer, Marije; Bolhuis, J. Elizabeth; Simon, Kristina; van den Brand, Henry; Kemp, Bas			Perinatal Flavour Learning and Adaptation to Being Weaned: All the Pig Needs Is Smell	PLOS ONE			English	Article							TRANSNATAL OLFACTORY CONTINUITY; FULL-TERM NEWBORNS; AMNIOTIC-FLUID; MOTHERS MILK; FEEDING PREFERENCES; DOMESTIC RUMINANTS; HUMAN AMYGDALA; FAMILIAR ODOR; GROWING PIGS; IN-UTERO	Perinatal flavour learning through the maternal diet is known to enhance flavour preference and acceptance of flavoured food in many species, yet still little is known about the mechanism underlying perinatal flavour learning. Previously we found positive effects of perinatal flavour learning on food intake, growth and behaviour of piglets postweaning, but no increased preference for the flavour. This suggests that flavour learning in pigs works through a reduction of weaning stress by the presence of the familiar flavour instead. The aim of this study was to investigate whether perinatal flavour learning reduces stress at weaning, and whether the effect is stronger when the familiar flavour is present in the food. Sows were offered an anethol-flavoured diet (Flavour treatment) or control diet (Control treatment) during late gestation and lactation. Flavour and Control piglets were provided with anethol either in their food (Food treatment) or in the air (Air treatment) after weaning. Preweaning and postweaning treatments did not affect food intake, preference or growth in the first two weeks postweaning but flavour treatment reduced the latency to eat (24 versus 35 hours, P = 0.02) and within-pen variation in growth (SD within-pen: 0.7 versus 1.2 kg, P < 0.001). Salivary cortisol levels tended to be lower four and seven hours postweaning for Flavour piglets compared to Control piglets (4 hours: 2.5 versus 3.0 ng/ml, P = 0.05, 7 hours: 3.1 versus 3.4 ng/ml, P = 0.08). Flavour piglets played more and showed less damaging behaviours than Control piglets, indicating that the familiar flavour reduced stress around weaning. Few interaction effects were found between preweaning and postweaning treatment, and no effects of postweaning treatment. We conclude that in the newly weaned pig, perinatal flavour learning results in a reduction of stress when the familiar flavour is present, regardless of providing the flavour in the food or in the air.	[Oostindjer, Marije; Bolhuis, J. Elizabeth; Simon, Kristina; van den Brand, Henry; Kemp, Bas] Wageningen Univ, Wageningen Inst Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands	Wageningen University & Research	Oostindjer, M (corresponding author), Wageningen Univ, Wageningen Inst Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands.	marije.oostindjer@wur.nl	Bolhuis, J. Elizabeth/P-7978-2015	Bolhuis, J. Elizabeth/0000-0002-5172-7635; Oostindjer, Marije/0000-0002-0997-0041	Science and Technology Foundation of the Netherlands Organization for Scientific Research (NWO-STW) [07722]; Product Boards for Livestock and Meat (PVV); Product Board Animal Feed (PDV); Lucta S.A.; Nutreco Nederland B.V.; Verbakel B.V.; Nutreco B.V.	Science and Technology Foundation of the Netherlands Organization for Scientific Research (NWO-STW)(Netherlands Organization for Scientific Research (NWO)); Product Boards for Livestock and Meat (PVV); Product Board Animal Feed (PDV); Lucta S.A.; Nutreco Nederland B.V.; Verbakel B.V.; Nutreco B.V.	This work was supported by the Science and Technology Foundation of the Netherlands Organization for Scientific Research (NWO-STW, grant number 07722), with co-financers Product Boards for Livestock and Meat (PVV), Product Board Animal Feed (PDV), Lucta S.A., Nutreco Nederland B.V., and Verbakel B.V. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: The work was co-financed by three commercial funders: Lucta S.A., Verbakel B.V. and Nutreco B.V. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Arias C, 2007, DEV PSYCHOBIOL, V49, P139, DOI 10.1002/dev.20205; Becques A, 2010, CHEM SENSES, V35, P41, DOI 10.1093/chemse/bjp080; BILKO A, 1994, PHYSIOL BEHAV, V56, P907, DOI 10.1016/0031-9384(94)90322-0; Birch LL, 1998, P NUTR SOC, V57, P617, DOI 10.1079/PNS19980090; Bolhuis JE, 2009, VOLUNTARY FEED INTAKE IN PIGS, P37; Bolhuis JE, 2003, PHYSIOL BEHAV, V79, P289, DOI 10.1016/S0031-9384(03)00090-8; Botermans JAM, 2000, ACTA AGR SCAND A-AN, V50, P237, DOI 10.1080/090647000750069430; BRAKE SC, 1981, SCIENCE, V211, P506, DOI 10.1126/science.7192882; Buchanan TW, 2003, LEARN MEMORY, V10, P319, DOI 10.1101/lm.62303; Burritt EA, 1997, APPL ANIM BEHAV SCI, V54, P317, DOI 10.1016/S0168-1591(97)00005-1; Chaloupkova H, 2007, J ANIM SCI, V85, P1741, DOI 10.2527/jas.2006-504; CHESLER P, 1969, SCIENCE, V166, P901, DOI 10.1126/science.166.3907.901; Chu S, 2000, COGNITION, V75, pB41, DOI 10.1016/S0010-0277(00)00065-2; Chu S, 2000, CHEM SENSES, V25, P111, DOI 10.1093/chemse/25.1.111; Coureaud G, 2002, DEV PSYCHOBIOL, V40, P372, DOI 10.1002/dev.10038; Dudink S, 2006, APPL ANIM BEHAV SCI, V101, P86, DOI 10.1016/j.applanim.2005.12.008; Dunshea FR, 2001, ASIAN AUSTRAL J ANIM, V14, P1610, DOI 10.5713/ajas.2001.1610; DYBKJAER L, 1992, APPL ANIM BEHAV SCI, V35, P135, DOI 10.1016/0168-1591(92)90004-U; El-Haddad MA, 2005, J MATERN-FETAL NEO M, V18, P123, DOI 10.1080/14767050500233860; Epple G, 1999, DEV PSYCHOBIOL, V35, P103, DOI 10.1002/(SICI)1098-2302(199909)35:2<103::AID-DEV3>3.0.CO;2-4; Forestell CA, 2007, PEDIATRICS, V120, P1247, DOI 10.1542/peds.2007-0858; Galef BG, 2001, ANIM BEHAV, V61, P3, DOI 10.1006/anbe.2000.1557; GALEF BG, 1972, J COMP PHYSIOL PSYCH, V78, P213, DOI 10.1037/h0032186; Goubet N, 2007, J DEV BEHAV PEDIATR, V28, P189, DOI 10.1097/dbp.0b013e31802d0b8d; Guiraudie-Capraz G, 2005, CHEM SENSES, V30, P241, DOI 10.1093/chemse/bji020; Hausner H., 2009, e-SPEN, V4, pe231; Hausner H, 2008, PHYSIOL BEHAV, V95, P118, DOI 10.1016/j.physbeh.2008.05.007; Hepper PG, 2006, CHEM SENSES, V31, P207, DOI 10.1093/chemse/bjj020; HEPPER PG, 1992, Q J EXP PSYCHOL-B, V44B, P179; HEPPER PG, 1988, ANIM BEHAV, V36, P935, DOI 10.1016/S0003-3472(88)80177-5; Herz RS, 2002, OLFACTION, TASTE, AND COGNITION, P160, DOI 10.1017/CBO9780511546389.016; Herz RS, 2004, INT J COMP PSYCHOL, P17; HESSING MJC, 1993, APPL ANIM BEHAV SCI, V37, P285, DOI 10.1016/0168-1591(93)90118-9; Hudson R, 1999, SCHWEIZ MED WSCHR, V129, P176; Jones RB, 2002, ANIM BEHAV, V63, P659, DOI 10.1006/anbe.2001.1943; JONES RB, 1985, PHYSIOL BEHAV, V34, P917, DOI 10.1016/0031-9384(85)90014-9; Launchbaugh KL, 1997, APPL ANIM BEHAV SCI, V54, P327, DOI 10.1016/S0168-1591(96)01194-X; Macri S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001015; Marlier L, 1998, DEV PSYCHOBIOL, V33, P133, DOI 10.1002/(SICI)1098-2302(199809)33:2<133::AID-DEV4>3.0.CO;2-K; MCGAUGH JL, 1993, BEHAV BRAIN RES, V58, P81, DOI 10.1016/0166-4328(93)90092-5; MENNELLA JA, 1995, CHEM SENSES, V20, P207, DOI 10.1093/chemse/20.2.207; Mennella JA, 1999, DEV PSYCHOBIOL, V35, P197, DOI 10.1002/(SICI)1098-2302(199911)35:3&lt;197::AID-DEV4&gt;3.0.CO;2-J; Mennella JA, 2001, PEDIATRICS, V107, part. no., DOI 10.1542/peds.107.6.e88; Mennella JA, 1998, CHEM SENSES, V23, P11, DOI 10.1093/chemse/23.1.11; Mennella JA, 2009, AM J CLIN NUTR, V90, p780S, DOI 10.3945/ajcn.2009.27462O; Nicolaidis S, 2008, METABOLISM, V57, pS22, DOI 10.1016/j.metabol.2008.07.004; Oostindjer M, 2010, PHYSIOL BEHAV, V99, P579, DOI 10.1016/j.physbeh.2010.01.031; Oostindjer M, 2009, CHEM SENSES, V34, P775, DOI 10.1093/chemse/bjp063; PROVENZA FD, 1987, APPL ANIM BEHAV SCI, V18, P211, DOI 10.1016/0168-1591(87)90218-8; Rattaz C, 2005, J DEV BEHAV PEDIATR, V26, P86, DOI 10.1097/00004703-200504000-00003; Ruis MAW, 1997, PHYSIOL BEHAV, V62, P623, DOI 10.1016/S0031-9384(97)00177-7; SCHAAL B, 1995, BEHAVIOUR, V132, P351, DOI 10.1163/156853995X00603; SCHAAL B, 1995, BIOL NEONATE, V67, P397; Schaal B, 2000, CHEM SENSES, V25, P729, DOI 10.1093/chemse/25.6.729; Sevelinges Y, 2009, BEHAV BRAIN RES, V198, P313, DOI 10.1016/j.bbr.2008.11.003; Simitzis PE, 2008, PHYSIOL BEHAV, V93, P529, DOI 10.1016/j.physbeh.2007.10.013; Sneddon H, 1998, PHYSIOL BEHAV, V64, P133, DOI 10.1016/S0031-9384(98)00037-7; Sullivan RM, 1998, BIOL NEONATE, V74, P402, DOI 10.1159/000014061; Todrank J, 2011, P ROY SOC B-BIOL SCI, V278, P1949, DOI 10.1098/rspb.2010.2314; Varendi H, 1998, EARLY HUM DEV, V51, P47, DOI 10.1016/S0378-3782(97)00082-0; Villalba JJ, 2000, J ANIM SCI, V78, P3060; Weary DM, 1997, APPL ANIM BEHAV SCI, V53, P249, DOI 10.1016/S0168-1591(96)01173-2; Wells DL, 2006, ANIM BEHAV, V72, P681, DOI 10.1016/j.anbehav.2005.12.008; Willander J, 2006, PSYCHON B REV, V13, P240, DOI 10.3758/BF03193837; Winston JS, 2005, J NEUROSCI, V25, P8903, DOI 10.1523/JNEUROSCI.1569-05.2005; WUENSCH KL, 1978, J GEN PSYCHOL, V99, P163, DOI 10.1080/00221309.1978.9710501	66	30	30	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25318	10.1371/journal.pone.0025318	http://dx.doi.org/10.1371/journal.pone.0025318			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039409	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500009
J	Scotti, C; Olivieri, C; Boeri, L; Canzonieri, C; Ornati, F; Buscarini, E; Pagella, F; Danesino, C				Scotti, Claudia; Olivieri, Carla; Boeri, Laura; Canzonieri, Cecilia; Ornati, Federica; Buscarini, Elisabetta; Pagella, Fabio; Danesino, Cesare			Bioinformatic Analysis of Pathogenic Missense Mutations of Activin Receptor Like Kinase 1 Ectodomain	PLOS ONE			English	Article							PROTEIN-STRUCTURE PREDICTION; MULTIPLE SEQUENCE ALIGNMENT; HEREDITARY HEMORRHAGIC TELANGIECTASIA; TRANSMEMBRANE CONDUCTANCE REGULATOR; SUPPORT VECTOR MACHINES; TGF-BETA; STRUCTURAL BASIS; CYSTIC-FIBROSIS; STABILITY CHANGES; CRYSTAL-STRUCTURE	Activin A receptor, type II-like kinase 1 (also called ALK1), is a serine-threonine kinase predominantly expressed on endothelial cells surface. Mutations in its ACVRL1 encoding gene (12q11-14) cause type 2 Hereditary Haemorrhagic Telangiectasia (HHT2), an autosomal dominant multisystem vascular dysplasia. The study of the structural effects of mutations is crucial to understand their pathogenic mechanism. However, while an X-ray structure of ALK1 intracellular domain has recently become available (PDB ID: 3MY0), structure determination of ALK1 ectodomain (ALK1(EC)) has been elusive so far. We here describe the building of a homology model for ALK1(EC), followed by an extensive bioinformatic analysis, based on a set of 38 methods, of the effect of missense mutations at the sequence and structural level. ALK1(EC) potential interaction mode with its ligand BMP9 was then predicted combining modelling and docking data. The calculated model of the ALK1(EC) allowed mapping and a preliminary characterization of HHT2 associated mutations. Major structural changes and loss of stability of the protein were predicted for several mutations, while others were found to interfere mainly with binding to BMP9 or other interactors, like Endoglin (CD105), whose encoding ENG gene (9q34) mutations are known to cause type 1 HHT. This study gives a preliminary insight into the potential structure of ALK1(EC) and into the structural effects of HHT2 associated mutations, which can be useful to predict the potential effect of each single mutation, to devise new biological experiments and to interpret the biological significance of new mutations, private mutations, or non-synonymous polymorphisms.	[Scotti, Claudia] Univ Pavia, Dept Expt Med, Sect Gen Pathol, I-27100 Pavia, Italy; [Olivieri, Carla; Boeri, Laura; Canzonieri, Cecilia; Ornati, Federica; Danesino, Cesare] Univ Pavia, Dept Human & Hereditary Pathol, Sect Gen Biol & Med Genet, I-27100 Pavia, Italy; [Buscarini, Elisabetta] Maggiore Hosp, Dept Gastroenterol, Crema, Italy; [Pagella, Fabio] Fdn IRCCS Policlin San Matteo, Dept Otorhinolaryngol, ENT Unit, Pavia, Italy	University of Pavia; University of Pavia; IRCCS Fondazione San Matteo	Scotti, C (corresponding author), Univ Pavia, Dept Expt Med, Sect Gen Pathol, Via Palestro 3, I-27100 Pavia, Italy.	claudia.scotti@unipv.it	Scotti, Claudia/AAM-3372-2021; Scotti, Claudia/A-7126-2012; Olivieri, Carla/D-8525-2011	Scotti, Claudia/0000-0002-5790-1833; Olivieri, Carla/0000-0001-5812-3175; Ornati, Federica/0000-0002-6299-7761	Italian HHT Patients' Association "Fondazione Italiana Onilde Carini per la Teleangectasia Emorragica Ereditaria"	Italian HHT Patients' Association "Fondazione Italiana Onilde Carini per la Teleangectasia Emorragica Ereditaria"	This work has been performed with the financial support of the Italian HHT Patients' Association "Fondazione Italiana Onilde Carini per la Teleangectasia Emorragica Ereditaria". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Bates G, 2003, LANCET, V361, P1642, DOI 10.1016/S0140-6736(03)13304-1; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Bilandzic M, 2011, MOL CELL ENDOCRINOL, V339, P180, DOI 10.1016/j.mce.2011.04.014; Bone LJ, 1997, NEUROBIOL DIS, V4, P221, DOI 10.1006/nbdi.1997.0152; Bross P, 1999, HUM MUTAT, V14, P186, DOI 10.1002/(SICI)1098-1004(1999)14:3<186::AID-HUMU2>3.0.CO;2-J; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Bujnicki JM, 2003, CURR PROTEIN PEPT SC, V4, P327, DOI 10.2174/1389203033487072; Capriotti E, 2006, BIOINFORMATICS, V22, P2729, DOI 10.1093/bioinformatics/btl423; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cheng JL, 2006, PROTEINS, V62, P1125, DOI 10.1002/prot.20810; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Conchillo-Sole O, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-65; Corradini E, 2009, CYTOKINE GROWTH F R, V20, P389, DOI 10.1016/j.cytogfr.2009.10.008; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; David L, 2009, CYTOKINE GROWTH F R, V20, P203, DOI 10.1016/j.cytogfr.2009.05.001; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dosztanyi Z, 1997, J MOL BIOL, V272, P597, DOI 10.1006/jmbi.1997.1242; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2003, BIOINFORMATICS, V19, P899, DOI 10.1093/bioinformatics/btg110; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; FINN RD, NUCL ACIDS RES, V38, pD211; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Godzik Adam, 2003, Methods Biochem Anal, V44, P525; Govani FS, 2009, EUR J HUM GENET, V17, P860, DOI 10.1038/ejhg.2009.35; Grateau G, 2005, M S-MED SCI, V21, P627, DOI 10.1051/medsci/2005216-7627; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Groppe J, 2008, MOL CELL, V29, P157, DOI 10.1016/j.molcel.2007.11.039; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Haigis MC, 2010, MOL CELL, V40, P333, DOI 10.1016/j.molcel.2010.10.002; Higa RH, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-107; Higgins DG, 1996, METHOD ENZYMOL, V266, P383; Huang LT, 2007, BIOINFORMATICS, V23, P1292, DOI 10.1093/bioinformatics/btm100; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kirsch T, 2000, NAT STRUCT BIOL, V7, P492; Kosinski J, 2003, PROTEINS, V53, P369, DOI 10.1002/prot.10545; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557; Kwasigroch JM, 2002, BIOINFORMATICS, V18, P1701, DOI 10.1093/bioinformatics/18.12.1701; Lappalainen I, 2002, PROTEIN ENG, V15, P1005, DOI 10.1093/protein/15.12.1005; Lappalainen I, 2000, BIOCHEM BIOPH RES CO, V269, P124, DOI 10.1006/bbrc.2000.2146; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li, 1999, Genome Inform Ser Workshop Genome Inform, V10, P30; Lin SJ, 2006, REPRODUCTION, V132, P179, DOI 10.1530/rep.1.01072; Linding R, 2004, J MOL BIOL, V342, P345, DOI 10.1016/j.jmb.2004.06.088; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Magyar C, 2005, NUCLEIC ACIDS RES, V33, pW303, DOI 10.1093/nar/gki409; Mahadeva R, 1998, THORAX, V53, P1022, DOI 10.1136/thx.53.12.1022; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Miller MP, 2001, HUM MOL GENET, V10, P2319, DOI 10.1093/hmg/10.21.2319; Mooney SD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-24; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Olivieri C, 2007, J HUM GENET, V52, P820, DOI 10.1007/s10038-007-0187-5; Parthiban V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-54; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; PENG I, 2010, MULTIPLE TEMPL UNPUB; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Ricard N, 2010, BLOOD, V116, P1604, DOI 10.1182/blood-2010-03-276881; Rodriguez R, 1998, BIOINFORMATICS, V14, P523, DOI 10.1093/bioinformatics/14.6.523; Rong SB, 2000, MOL MED, V6, P155, DOI 10.1007/BF03402111; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Runker AE, 2003, J NEUROSCI, V23, P277; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Scheufler C, 1999, J MOL BIOL, V287, P103, DOI 10.1006/jmbi.1999.2590; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shen B, 2004, PROTEIN ENG DES SEL, V17, P267, DOI 10.1093/protein/gzh030; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shimizu K, 2007, BIOINFORMATICS, V23, P2337, DOI 10.1093/bioinformatics/btm330; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; THOMAS PJ, 1991, SCIENCE, V251, P555, DOI 10.1126/science.1703660; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Thusberg J, 2006, HUM MUTAT, V27, P1230, DOI 10.1002/humu.20407; Tramontano A, 1998, METHODS, V14, P293, DOI 10.1006/meth.1998.0585; Trovato A, 2007, PROTEIN ENG DES SEL, V20, P521, DOI 10.1093/protein/gzm042; van Meeteren LA, 2011, CURR PHARM BIOTECHNO; Vitkup D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-11-r72; Vullo A, 2006, NUCLEIC ACIDS RES, V34, pW164, DOI 10.1093/nar/gkl166; Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606; Wallner B, 2005, BIOINFORMATICS, V21, P4248, DOI 10.1093/bioinformatics/bti702; Wallner B, 2003, PROTEINS, V53, P534, DOI 10.1002/prot.10536; Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803; WARD CL, 1994, J BIOL CHEM, V269, P25710; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Westhead DR, 1998, CURR OPIN BIOTECH, V9, P383, DOI 10.1016/S0958-1669(98)80012-8; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Winn MD, ACTA CRYSTALLOGR D, V67, P235; XU Y, 2006, COMPUTATIONAL METHOD, V1, P389; XU Y, 2006, COMPUTATIONAL METHOD, V2, P389; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466; Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002	104	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26431	10.1371/journal.pone.0026431	http://dx.doi.org/10.1371/journal.pone.0026431			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028876	gold, Green Published			2022-12-27	WOS:000296186900061
J	Morioka, M; Parameswaran, H; Naruse, K; Kondo, M; Sokabe, M; Hasegawa, Y; Suki, B; Ito, S				Morioka, Masataka; Parameswaran, Harikrishnan; Naruse, Keiji; Kondo, Masashi; Sokabe, Masahiro; Hasegawa, Yoshinori; Suki, Bela; Ito, Satoru			Microtubule Dynamics Regulate Cyclic Stretch-Induced Cell Alignment in Human Airway Smooth Muscle Cells	PLOS ONE			English	Article							CULTURED ENDOTHELIAL-CELLS; EXTERNALLY APPLIED STRAIN; MECHANICAL STRETCH; LIVING CELLS; ACTIN-FILAMENTS; FOCAL ADHESIONS; STRESS FIBERS; REORIENTATION; ORIENTATION; MODEL	Microtubules are structural components of the cytoskeleton that determine cell shape, polarity, and motility in cooperation with the actin filaments. In order to determine the role of microtubules in cell alignment, human airway smooth muscle cells were exposed to cyclic uniaxial stretch. Human airway smooth muscle cells, cultured on type I collagen-coated elastic silicone membranes, were stretched uniaxially (20% in strain, 30 cycles/min) for 2 h. The population of airway smooth muscle cells which were originally oriented randomly aligned near perpendicular to the stretch axis in a time-dependent manner. However, when the cells treated with microtubule disruptors, nocodazole and colchicine, were subjected to the same cyclic uniaxial stretch, the cells failed to align. Lack of alignment was also observed for airway smooth muscle cells treated with a microtubule stabilizer, paclitaxel. To understand the intracellular mechanisms involved, we developed a computational model in which microtubule polymerization and attachment to focal adhesions were regulated by the preexisting tensile stress, pre-stress, on actin stress fibers. We demonstrate that microtubules play a central role in cell reorientation when cells experience cyclic uniaxial stretching. Our findings further suggest that cell alignment and cytoskeletal reorganization in response to cyclic stretch results from the ability of the microtubule-stress fiber assembly to maintain a homeostatic strain on the stress fiber at focal adhesions. The mechanism of stretch-induced alignment we uncovered is likely involved in various airway functions as well as in the pathophysiology of airway remodeling in asthma.	[Morioka, Masataka; Kondo, Masashi; Hasegawa, Yoshinori; Ito, Satoru] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan; [Sokabe, Masahiro] Nagoya Univ, Grad Sch Med, Dept Physiol, Nagoya, Aichi 4648601, Japan; [Naruse, Keiji] Okayama Univ, Grad Sch Med, Dept Cardiovasc Physiol, Okayama 7008530, Japan; [Parameswaran, Harikrishnan; Suki, Bela] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Nagoya University; Nagoya University; Okayama University; Boston University	Morioka, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan.	itori@med.nagoya-u.ac.jp	NARUSE, Keiji/B-1620-2011; Sokabe, Masahiro/I-1565-2012; Kondo, Masashi/I-7378-2014; Parameswaran, Harikrishnan/D-9839-2012; Ito, Satoru/AAT-5219-2020; Hasegawa, Yoshinori/I-1277-2012	Ito, Satoru/0000-0001-7885-4653; naruse, keiji/0000-0003-4100-6444; Parameswaran, Harikrishnan/0000-0002-5324-5517	Ministry of Education, Culture, Sports, Science, and Technology of Japan [19689017, 22890837]; National Heart, Lung, and Blood Institute [HL098976]; MENICON; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098976] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MENICON; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Grant-in-Aid for Young Scientists A #19689017 and for Scientific Research C #22890837 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to S. I.) and by National Heart, Lung, and Blood Institute Grant HL098976 (to B. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; K.N. has served on the STREX Advisory Board for up to $ 1,000. He has received a grant from MENICON for $1,001-$5,000, and a sponsored grant from the National Institutes of Health for $5,001-$10,000. He has a patent pending with STREX for a stretch machine, and owns stock in the amount of $10,001-$50,000. None of the other authors have a financial relationship with a commercial entity that has an interest in the subject of this manuscript. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; BATES JHT, 1990, J APPL PHYSIOL, V69, P995, DOI 10.1152/jappl.1990.69.3.995; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Brangwynne CP, 2006, J CELL BIOL, V173, P733, DOI 10.1083/jcb.200601060; Costa KD, 2002, CELL MOTIL CYTOSKEL, V52, P266, DOI 10.1002/cm.10056; DARTSCH PC, 1989, BASIC RES CARDIOL, V84, P268, DOI 10.1007/BF01907974; De R, 2007, NAT PHYS, V3, P655, DOI 10.1038/nphys680; Fredberg JJ, 2006, ANNU REV PHYSIOL, V68, P507, DOI 10.1146/annurev.physiol.68.072304.114110; Fung Y. C., 1977, 1 COURSE CONTINUUM M; Gierke S, 2010, METHOD CELL BIOL, V97, P15, DOI 10.1016/S0091-679X(10)97002-7; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Goldyn AM, 2010, CYTOSKELETON, V67, P241, DOI 10.1002/cm.20439; Goldyn AM, 2009, J CELL SCI, V122, P3644, DOI 10.1242/jcs.054866; Hasaneen NA, 2005, FASEB J, V19, P1507, DOI 10.1096/fj.04-3350fje; Hawkins T, 2010, J BIOMECH, V43, P23, DOI 10.1016/j.jbiomech.2009.09.005; Hayakawa K, 2000, ZOOL SCI, V17, P617, DOI 10.2108/zsj.15.617; Hayakawa K, 2001, EXP CELL RES, V268, P104, DOI 10.1006/excr.2001.5270; Hsu HJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004853; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Ito S, 2006, AM J PHYSIOL-LUNG C, V290, pL1227, DOI 10.1152/ajplung.00299.2005; Ito S, 2008, AM J RESP CELL MOL, V38, P407, DOI 10.1165/rcmb.2007-0259OC; Ito S, 2006, EUR J PHARMACOL, V552, P135, DOI 10.1016/j.ejphar.2006.08.067; Ito S, 2010, AM J RESP CELL MOL, V43, P26, DOI 10.1165/rcmb.2009-0073OC; Iwaki M, 2009, BIOCHEM BIOPH RES CO, V389, P531, DOI 10.1016/j.bbrc.2009.09.020; Jungbauer S, 2008, BIOPHYS J, V95, P3470, DOI 10.1529/biophysj.107.128611; Kadi A, 1998, BIOCHEM BIOPH RES CO, V246, P690, DOI 10.1006/bbrc.1998.8536; Kaunas R, 2005, P NATL ACAD SCI USA, V102, P15895, DOI 10.1073/pnas.0506041102; Kaunas R, 2009, J THEOR BIOL, V257, P320, DOI 10.1016/j.jtbi.2008.11.024; Kaverina I, 1998, J CELL BIOL, V142, P181, DOI 10.1083/jcb.142.1.181; Kaverina I, 1999, J CELL BIOL, V146, P1033, DOI 10.1083/jcb.146.5.1033; Kaverina I, 2002, J CELL SCI, V115, P2283; KOLODNEY MS, 1995, P NATL ACAD SCI USA, V92, P10252, DOI 10.1073/pnas.92.22.10252; Kueh HY, 2009, SCIENCE, V325, P960, DOI 10.1126/science.1168823; Kumar A, 2003, J BIOL CHEM, V278, P18868, DOI 10.1074/jbc.M212777200; Lei M, 1997, J APPL PHYSIOL, V82, P70, DOI 10.1152/jappl.1997.82.1.70; Malek AM, 1996, J CELL SCI, V109, P713; Maurin B, 2008, J BIOMECH, V41, P2036, DOI 10.1016/j.jbiomech.2008.03.011; Naruse K, 1998, AM J PHYSIOL-HEART C, V274, pH1532; Naruse K, 1998, ONCOGENE, V17, P455, DOI 10.1038/sj.onc.1201950; OAKLEY C, 1993, J CELL SCI, V106, P343; Paul RJ, 2000, AM J PHYSIOL-HEART C, V279, pH2493, DOI 10.1152/ajpheart.2000.279.5.H2493; Pirentis AP, 2011, CELL MOL BIOENG, V4, P67, DOI 10.1007/s12195-010-0152-9; Putnam AJ, 1998, J CELL SCI, V111, P3379; Putnam AJ, 2001, AM J PHYSIOL-CELL PH, V280, pC556, DOI 10.1152/ajpcell.2001.280.3.C556; Rhee S, 2007, P NATL ACAD SCI USA, V104, P5425, DOI 10.1073/pnas.0608030104; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Smiley-Jewell SM, 2002, J APPL PHYSIOL, V93, P1506, DOI 10.1152/japplphysiol.01109.2001; Smith PG, 2003, AM J RESP CELL MOL, V28, P436, DOI 10.1165/rcmb.4754; Smith PG, 2003, AM J PHYSIOL-LUNG C, V285, pL456, DOI 10.1152/ajplung.00329.2002; Smith PG, 1997, EXP CELL RES, V232, P127, DOI 10.1006/excr.1997.3492; Stamenovic D, 2005, ACTA BIOMATER, V1, P255, DOI 10.1016/j.actbio.2005.01.004; Stamenovic D, 2005, J BIOMECH, V38, P1728, DOI 10.1016/j.jbiomech.2004.07.016; Stamenovic D, 2002, AM J PHYSIOL-CELL PH, V282, pC617, DOI 10.1152/ajpcell.00271.2001; Stamenovic D, 2008, RESP PHYSIOL NEUROBI, V163, P25, DOI 10.1016/j.resp.2008.02.009; Stamenovic D, 2009, CELL MOL BIOENG, V2, P475, DOI 10.1007/s12195-009-0093-3; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Tschumperlin DJ, 2006, ANNU REV PHYSIOL, V68, P563, DOI 10.1146/annurev.physiol.68.072304.113102; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang HC, 1995, J BIOMECH, V28, P1543, DOI 10.1016/0021-9290(95)00101-8; Wang N, 2001, P NATL ACAD SCI USA, V98, P7765, DOI 10.1073/pnas.141199598	60	53	54	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26384	10.1371/journal.pone.0026384	http://dx.doi.org/10.1371/journal.pone.0026384			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022610	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400052
J	Tkachuk, A; Kim, M; Kravchuk, O; Savitsky, M				Tkachuk, Artem; Kim, Maria; Kravchuk, Oksana; Savitsky, Mikhail			A New Powerful Method for Site-Specific Transgene Stabilization Based on Chromosomal Double-Strand Break Repair	PLOS ONE			English	Article							POST-INTEGRATION BEHAVIOR; ZINC-FINGER NUCLEASES; MEXICAN FRUIT-FLY; HOMOLOGOUS RECOMBINATION; DROSOPHILA-MELANOGASTER; GENOMIC INTEGRATION; PHI-C31 INTEGRASE; MAMMALIAN-CELLS; PHAGE PHI-C31; AEDES-AEGYPTI	Transgenic insects are a promising tool in sterile insect techniques and population replacement strategies. Such transgenic insects can be created using nonautonomous transposons, which cannot be transferred without a transposase source. In biocontrol procedures where large numbers of insects are released, there is increased risk of transgene remobilization caused by external transposase sources that can alter the characteristics of the transgenic organisms lead horizontal transgene transfer to other species. Here we describe a novel, effective method for transgene stabilization based on the introduction of directed double-strand breaks (DSB) into a genome-integrated sequence and their subsequent repair by the single-strand annealing (SSA) pathway. Due to the construct's organization, the repair pathway is predictable, such that all transposon and marker sequences can be deleted, while preserving integration of exogenous DNA in the genome. The exceptional conservation of DNA repair pathways makes this method suitable for a broad range of organisms.	[Tkachuk, Artem; Kim, Maria; Kravchuk, Oksana; Savitsky, Mikhail] Russian Acad Sci, Inst Gene Biol, Grp Telomere Biol, Moscow, Russia; [Savitsky, Mikhail] Univ Oslo, Ctr Med Studies, Moscow, Russia	Russian Academy of Sciences; Institute of Gene Biology (IGB) of Russian Academy of Sciences	Tkachuk, A (corresponding author), Russian Acad Sci, Inst Gene Biol, Grp Telomere Biol, Moscow, Russia.	msavitsky@gmail.com	Tkachuk, Artem/AAU-1208-2021; Savitsky, Mikhail/AAC-7631-2022; Kravchuk, Oksana/B-9624-2014	Kravchuk, Oksana/0000-0002-8363-6666; Savitsky, Mikhail/0000-0002-4735-5517; Tkachuk, Artem/0000-0003-3262-4873	Russian Academy of Sciences; Center for Medical Studies, Oslo University; Federal Program "Scientific and scientific-pedagogical personnel of innovative Russia [P597, P274]	Russian Academy of Sciences(Russian Academy of Sciences); Center for Medical Studies, Oslo University; Federal Program "Scientific and scientific-pedagogical personnel of innovative Russia	This work was supported by the Molecular and Cellular Biology Program of the Russian Academy of Sciences, the Young Scientists Support Program of the Russian Academy of Sciences (to M. K.), a stipend from the Center for Medical Studies, Oslo University (to M. S.) and Federal Program "Scientific and scientific-pedagogical personnel of innovative Russia 2009-2013" (state contracts P597 and P274). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Atkinson PW, 2008, ADV EXP MED BIOL, V627, P60; Bateman JR, 2006, GENETICS, V173, P769, DOI 10.1534/genetics.106.056945; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; COLLEAUX L, 1986, CELL, V44, P521, DOI 10.1016/0092-8674(86)90262-X; Condon KC, 2007, INSECT MOL BIOL, V16, P573, DOI 10.1111/j.1365-2583.2007.00752.x; Dafa'alla TH, 2006, NAT BIOTECHNOL, V24, P820, DOI 10.1038/nbt1221; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Groth AC, 2000, P NATL ACAD SCI USA, V97, P5995, DOI 10.1073/pnas.090527097; Handler AM, 2004, NAT BIOTECHNOL, V22, P1150, DOI 10.1038/nbt1002; Handler AM, 2004, INSECT BIOCHEM MOLEC, V34, P121, DOI 10.1016/j.ibmb.2003.08.005; Hay BA, 2010, J INSECT PHYSIOL, V56, P1402, DOI 10.1016/j.jinsphys.2010.05.022; Horn C, 2005, P NATL ACAD SCI USA, V102, P12483, DOI 10.1073/pnas.0504305102; Horn C, 2000, DEV GENES EVOL, V210, P623, DOI 10.1007/s004270000111; Horn C, 2000, DEV GENES EVOL, V210, P630, DOI 10.1007/s004270000110; Kappeler M, 2008, NUCLEIC ACIDS RES, V36, P6907, DOI 10.1093/nar/gkn793; Lozovsky ER, 2002, GENETICS, V160, P527; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nimmo DD, 2006, INSECT MOL BIOL, V15, P129, DOI 10.1111/j.1365-2583.2006.00615.x; O'Brochta DA, 2003, J EXP BIOL, V206, P3823, DOI 10.1242/jeb.00638; O'Brochta DA, 2008, ADV EXP MED BIOL, V627, P1, DOI 10.1007/978-0-387-78225-6_1; Olivares EC, 2002, NAT BIOTECHNOL, V20, P1124, DOI 10.1038/nbt753; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Preston CR, 2006, GENETICS, V172, P1055, DOI 10.1534/genetics.105.050138; Preston CR, 2002, GENETICS, V161, P711; PUCHTA H, 1993, NUCLEIC ACIDS RES, V21, P5034, DOI 10.1093/nar/21.22.5034; Robinson GE, 2011, SCIENCE, V331, P1386, DOI 10.1126/science.331.6023.1386; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Rong YS, 2003, GENETICS, V165, P1831; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Meza JS, 2011, GENETICA, V139, P53, DOI 10.1007/s10709-010-9484-6; Scali C, 2007, MOL GENET GENOMICS, V278, P575, DOI 10.1007/s00438-007-0274-5; Schetelig MF, 2011, GENETICA, V139, P71, DOI 10.1007/s10709-010-9494-4; Schetelig MF, 2009, P NATL ACAD SCI USA, V106, P18171, DOI 10.1073/pnas.0907264106; Sethuraman N, 2007, INSECT BIOCHEM MOLEC, V37, P941, DOI 10.1016/j.ibmb.2007.05.004; Sigrist CJA, 1997, GENETICS, V147, P209; Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870; THOMPSON AJ, 1992, GENE, V119, P247, DOI 10.1016/0378-1119(92)90278-W; Thyagarajan B, 2001, MOL CELL BIOL, V21, P3926, DOI 10.1128/MCB.21.12.3926-3934.2001; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; Venken KJT, 2009, NAT METHODS, V6, P431, DOI [10.1038/NMETH.1331, 10.1038/nmeth.1331]; Wilson R, 2003, INSECT BIOCHEM MOLEC, V33, P853, DOI 10.1016/S0965-1748(03)00044-4; Wimmer EA, 2003, NAT REV GENET, V4, P225, DOI 10.1038/nrg1021	44	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26422	10.1371/journal.pone.0026422	http://dx.doi.org/10.1371/journal.pone.0026422			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022613	Green Published, Green Submitted, gold			2022-12-27	WOS:000295984400057
J	Uyeda, TQP; Iwadate, Y; Umeki, N; Nagasaki, A; Yumura, S				Uyeda, Taro Q. P.; Iwadate, Yoshiaki; Umeki, Nobuhisa; Nagasaki, Akira; Yumura, Shigehiko			Stretching Actin Filaments within Cells Enhances their Affinity for the Myosin II Motor Domain	PLOS ONE			English	Article							HEAVY-CHAIN GENE; LABELED F-ACTIN; DEPOLYMERIZING FACTOR; KINETIC-ANALYSIS; DIFFERENTIAL REGULATION; CONFORMATIONAL-CHANGE; CORTICAL FLOW; DICTYOSTELIUM; DYNAMICS; LOCALIZATION	To test the hypothesis that the myosin II motor domain (S1) preferentially binds to specific subsets of actin filaments in vivo, we expressed GFP-fused S1 with mutations that enhanced its affinity for actin in Dictyostelium cells. Consistent with the hypothesis, the GFP-S1 mutants were localized along specific portions of the cell cortex. Comparison with rhodamine-phalloidin staining in fixed cells demonstrated that the GFP-S1 probes preferentially bound to actin filaments in the rear cortex and cleavage furrows, where actin filaments are stretched by interaction with endogenous myosin II filaments. The GFP-S1 probes were similarly enriched in the cortex stretched passively by traction forces in the absence of myosin II or by external forces using a microcapillary. The preferential binding of GFP-S1 mutants to stretched actin filaments did not depend on cortexillin I or PTEN, two proteins previously implicated in the recruitment of myosin II filaments to stretched cortex. These results suggested that it is the stretching of the actin filaments itself that increases their affinity for the myosin II motor domain. In contrast, the GFP-fused myosin I motor domain did not localize to stretched actin filaments, which suggests different preferences of the motor domains for different structures of actin filaments play a role in distinct intracellular localizations of myosin I and II. We propose a scheme in which the stretching of actin filaments, the preferential binding of myosin II filaments to stretched actin filaments, and myosin II-dependent contraction form a positive feedback loop that contributes to the stabilization of cell polarity and to the responsiveness of the cells to external mechanical stimuli.	[Uyeda, Taro Q. P.; Umeki, Nobuhisa; Nagasaki, Akira] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan; [Uyeda, Taro Q. P.] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo, Japan; [Iwadate, Yoshiaki; Yumura, Shigehiko] Yamaguchi Univ, Dept Funct Mol Biol, Grad Sch Med, Yamaguchi, Japan; [Iwadate, Yoshiaki] Japan Sci & Technol Agcy JST, Precursory Res Embryon Sci & Technol PRESTO, Kawaguchi, Saitama, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Yamaguchi University; Japan Science & Technology Agency (JST)	Uyeda, TQP (corresponding author), Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan.	t-uyeda@aist.go.jp	yumura, shigehiko/E-8672-2013; Nagasaki, Akira/M-4892-2018	yumura, shigehiko/0000-0001-8249-0100; Nagasaki, Akira/0000-0002-1468-4592; Iwadate, Yoshiaki/0000-0002-5300-4393	Ministry of Education, Culture, Sports, Science and Technology, Japan	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid to Y.I. and T.U. from the Ministry of Education, Culture, Sports, Science and Technology, Japan (http://www.mext.go.jp/english/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Aizawa H, 1997, J CELL SCI, V110, P2333; ANDO T, 1985, J BIOL CHEM, V260, P2321; Asano Y, 2004, CELL MOTIL CYTOSKEL, V59, P17, DOI 10.1002/cm.20015; Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; BEMENT WM, 1995, CELL MOTIL CYTOSKEL, V31, P87, DOI 10.1002/cm.970310202; BRETSCHER A, 1991, ANNU REV CELL BIOL, V7, P337, DOI 10.1146/annurev.cb.07.110191.002005; Chhabra ES, 2007, NAT CELL BIOL, V9, P1110, DOI 10.1038/ncb1007-1110; DeBiasio RL, 1996, MOL BIOL CELL, V7, P1259, DOI 10.1091/mbc.7.8.1259; DELOZANNE A, 1987, SCIENCE, V236, P1086, DOI 10.1126/science.3576222; Doyle T, 1996, P NATL ACAD SCI USA, V93, P3886, DOI 10.1073/pnas.93.9.3886; Effler JC, 2007, CELL CYCLE, V6, P30, DOI 10.4161/cc.6.1.3674; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; EGELMAN EH, 1982, NATURE, V298, P131, DOI 10.1038/298131a0; Faix J, 1996, CELL, V86, P631, DOI 10.1016/S0092-8674(00)80136-1; FANNING AS, 1994, CELL MOTIL CYTOSKEL, V29, P29, DOI 10.1002/cm.970290104; Fujii T, 2010, NATURE, V467, P724, DOI 10.1038/nature09372; FUJIME S, 1971, J MOL BIOL, V62, P251, DOI 10.1016/0022-2836(71)90144-6; FUKUI Y, 1989, NATURE, V341, P328, DOI 10.1038/341328a0; Galkin VE, 2005, J MOL BIOL, V346, P565, DOI 10.1016/j.jmb.2004.11.078; Galkin VE, 2001, J CELL BIOL, V153, P75, DOI 10.1083/jcb.153.1.75; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P1318, DOI 10.1038/nsmb.1930; Galkin VE, 2010, NAT STRUCT MOL BIOL, V17, P614, DOI 10.1038/nsmb.1789; HAMMER JA, 1994, J CELL BIOL, V127, P1779, DOI 10.1083/jcb.127.6.1779; Hanein D, 1997, J CELL BIOL, V139, P387, DOI 10.1083/jcb.139.2.387; HAWKINS M, 1993, BIOCHEMISTRY-US, V32, P9985, DOI 10.1021/bi00089a014; HAYAKAWA K, 2011, J CELL BIOL IN PRESS; HAYDEN SM, 1993, BIOCHEMISTRY-US, V32, P9994, DOI 10.1021/bi00089a015; HIBBERD MG, 1986, ANNU REV BIOPHYS BIO, V15, P119; Hild G, 2010, CYTOSKELETON, V67, P609, DOI 10.1002/cm.20473; Hodgkinson JL, 1997, J MOL BIOL, V273, P150, DOI 10.1006/jmbi.1997.1307; Janetopoulos C, 2005, DEV CELL, V8, P467, DOI 10.1016/j.devcel.2005.02.010; Kee YS, 2008, CURR BIOL, V18, pR860, DOI 10.1016/j.cub.2008.07.071; Kinose F, 1996, J CELL BIOL, V134, P895, DOI 10.1083/jcb.134.4.895; KNECHT DA, 1987, SCIENCE, V236, P1081, DOI 10.1126/science.3576221; Kovar DR, 2011, TRENDS CELL BIOL, V21, P177, DOI 10.1016/j.tcb.2010.11.001; Kozuka J, 2006, NAT CHEM BIOL, V2, P83, DOI 10.1038/nchembio763; Kuhn TB, 2008, ADV EXP MED BIOL, V644, P232; Laakso JM, 2008, SCIENCE, V321, P133, DOI 10.1126/science.1159419; Liu X, 2000, BIOCHEM BIOPH RES CO, V271, P75, DOI 10.1006/bbrc.2000.2582; Lord M, 2005, MOL BIOL CELL, V16, P5346, DOI 10.1091/mbc.E05-07-0601; LOSCALZO J, 1975, P NATL ACAD SCI USA, V72, P3412, DOI 10.1073/pnas.72.9.3412; LYMN RW, 1979, ANNU REV BIOPHYS BIO, V8, P145, DOI 10.1146/annurev.bb.08.060179.001045; Marshall TW, 2009, J CELL SCI, V122, P3061, DOI 10.1242/jcs.051482; Martin C, 2008, ADV EXP MED BIOL, V644, P187; Matsushita S, 2011, J BIOMECH, V44, P1776, DOI 10.1016/j.jbiomech.2011.04.012; McGough A, 1998, CURR OPIN STRUC BIOL, V8, P166, DOI 10.1016/S0959-440X(98)80034-1; McGough A, 1997, J CELL BIOL, V138, P771, DOI 10.1083/jcb.138.4.771; Merkel R, 2000, BIOPHYS J, V79, P707, DOI 10.1016/S0006-3495(00)76329-6; MIKI M, 1982, BIOCHEMISTRY-US, V21, P3661, DOI 10.1021/bi00258a021; Moores SL, 1996, P NATL ACAD SCI USA, V93, P443, DOI 10.1073/pnas.93.1.443; Naqvi NI, 1999, EMBO J, V18, P854, DOI 10.1093/emboj/18.4.854; Oda T, 2010, STRUCTURE, V18, P761, DOI 10.1016/j.str.2010.05.009; OOSAWA F, 1973, COLD SPRING HARB SYM, V37, P277, DOI 10.1101/SQB.1973.037.01.038; Orlova A, 1997, J MOL BIOL, V265, P469, DOI 10.1006/jmbi.1996.0761; ORLOVA A, 1995, J MOL BIOL, V245, P598, DOI 10.1006/jmbi.1994.0049; Ostap EM, 2008, ADV EXP MED BIOL, V644, P273; Patterson B, 1997, J BIOL CHEM, V272, P27612, DOI 10.1074/jbc.272.44.27612; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Pramanik MK, 2009, GENES CELLS, V14, P821, DOI 10.1111/j.1365-2443.2009.01312.x; Puchner EM, 2008, P NATL ACAD SCI USA, V105, P13385, DOI 10.1073/pnas.0805034105; Ren YX, 2009, CURR BIOL, V19, P1421, DOI 10.1016/j.cub.2009.07.018; Ressad F, 1998, J BIOL CHEM, V273, P20894, DOI 10.1074/jbc.273.33.20894; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; RUPPEL KM, 1994, J BIOL CHEM, V269, P18773; Sabry JH, 1997, MOL BIOL CELL, V8, P2605, DOI 10.1091/mbc.8.12.2605; Sawada Y, 2002, J CELL BIOL, V156, P609, DOI 10.1083/jcb.200110068; Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044; Schmid MF, 2004, NATURE, V431, P104, DOI 10.1038/nature02881; SCHROEDER TE, 1988, ZOOL SCI, V5, P713; Sharma S, 2011, NANO LETT, V11, P825, DOI 10.1021/nl104159v; Shimozawa T, 2009, BIOPHYS J, V96, P1036, DOI 10.1016/j.bpj.2008.09.056; Skau CT, 2010, CURR BIOL, V20, P1415, DOI 10.1016/j.cub.2010.06.020; SUSSMAN M, 1987, DICTYOSTELIUM DISCOI, P9; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Tang NY, 2001, CURR BIOL, V11, P1131, DOI 10.1016/S0960-9822(01)00320-7; TAWADA K, 1969, BIOCHIM BIOPHYS ACTA, V172, P311, DOI 10.1016/0005-2728(69)90073-5; THOMAS DD, 1979, J MOL BIOL, V132, P257, DOI 10.1016/0022-2836(79)90259-6; Tokuraku K, 2009, J MOL BIOL, V386, P149, DOI 10.1016/j.jmb.2008.12.008; Tsaturyan AK, 2005, BIOPHYS J, V88, P1902, DOI 10.1529/biophysj.104.050047; Tsujioka M, 2004, EMBO J, V23, P2216, DOI 10.1038/sj.emboj.7600238; Uehara R, 2010, CURR BIOL, V20, P1080, DOI 10.1016/j.cub.2010.04.058; Uyeda TQP, 2002, J MUSCLE RES CELL M, V23, P685, DOI 10.1023/A:1024463325335; Uyeda TQP, 2000, CELL STRUCT FUNCT, V25, P1; Verkhovsky AB, 1999, CURR BIOL, V9, P11, DOI 10.1016/S0960-9822(99)80042-6; WAKABAYASHI K, 1994, BIOPHYS J, V67, P2422, DOI 10.1016/S0006-3495(94)80729-5; Washington RW, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-10; Westphal M, 1997, CURR BIOL, V7, P176, DOI 10.1016/S0960-9822(97)70088-5; Yonemura S, 2010, NAT CELL BIOL, V12, P533, DOI 10.1038/ncb2055; Yumura S, 2005, MOL BIOL CELL, V16, P4256, DOI 10.1091/mbc.E05-03-0219; YUMURA S, 1984, J CELL BIOL, V99, P894, DOI 10.1083/jcb.99.3.894; Yumura S, 2003, INT REV CYTOL, V224, P173, DOI 10.1016/S0074-7696(05)24005-6; Yumura S, 2001, J CELL BIOL, V154, P137, DOI 10.1083/jcb.200011013; Yumura S, 2008, TRAFFIC, V9, P2089, DOI 10.1111/j.1600-0854.2008.00837.x; Zang JH, 1998, P NATL ACAD SCI USA, V95, P13652, DOI 10.1073/pnas.95.23.13652	94	111	113	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26200	10.1371/journal.pone.0026200	http://dx.doi.org/10.1371/journal.pone.0026200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022566	Green Published, gold			2022-12-27	WOS:000295978600045
J	Badiola, N; de Oliveira, RM; Herrera, F; Guardia-Laguarta, C; Goncalves, SA; Pera, M; Suarez-Calvet, M; Clarimon, J; Outeiro, TF; Lleo, A				Badiola, Nahuai; de Oliveira, Rita Machado; Herrera, Federico; Guardia-Laguarta, Cristina; Goncalves, Susana A.; Pera, Marta; Suarez-Calvet, Marc; Clarimon, Jordi; Outeiro, Tiago Fleming; Lleo, Alberto			Tau Enhances alpha-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; FAMILIAL PARKINSONS-DISEASE; LEWY BODY DEMENTIA; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; FRONTOTEMPORAL DEMENTIA; DOWNS-SYNDROME; BODIES; INCLUSIONS; HYPERPHOSPHORYLATION	Background: The simultaneous accumulation of different misfolded proteins in the central nervous system is a common feature in many neurodegenerative diseases. In most cases, co-occurrence of abnormal deposited proteins is observed in different brain regions and cell populations, but, in some instances, the proteins can be found in the same cellular aggregates. Co-occurrence of tau and alpha-synuclein (alpha-syn) aggregates has been described in neurodegenerative disorders with primary deposition of alpha-syn, such as Parkinson's disease and dementia with Lewy bodies. Although it is known that tau and alpha-syn have pathological synergistic effects on their mutual fibrillization, the underlying biological effects remain unclear. Methodology/Principal Findings: We used different cell models of synucleinopathy to investigate the effects of tau on alpha-syn aggregation. Using confocal microscopy and FRET-based techniques we observed that tau colocalized and interacted with alpha-syn aggregates. We also found that tau overexpression changed the pattern of alpha-syn aggregation, reducing the size and increasing the number of aggregates. This shift was accompanied by an increase in the levels of insoluble alpha-syn. Furthermore, co-transfection of tau increased secreted alpha-syn and cytotoxicity. Conclusions/Significance: Our data suggest that tau enhances alpha-syn aggregation and toxicity and disrupts alpha-syn inclusion formation. This pathological synergistic effect between tau and syn may amplify the deleterious process and spread the damage in neurodegenerative diseases that show co-occurrence of both pathologies.	[Badiola, Nahuai; Guardia-Laguarta, Cristina; Pera, Marta; Suarez-Calvet, Marc; Clarimon, Jordi; Lleo, Alberto] Hosp Santa Creu & Sant Pau, Inst Invest Biomed St Pau, Barcelona, Spain; [Badiola, Nahuai; Guardia-Laguarta, Cristina; Pera, Marta; Suarez-Calvet, Marc; Clarimon, Jordi; Lleo, Alberto] CIBERNED, Madrid, Spain; [de Oliveira, Rita Machado; Herrera, Federico; Goncalves, Susana A.; Outeiro, Tiago Fleming] Inst Mol Med, Cell & Mol Neurosci Unit, Lisbon, Portugal; [Outeiro, Tiago Fleming] Univ Lisbon, Fac Med, P-1699 Lisbon, Portugal	Hospital of Santa Creu i Sant Pau; CIBERNED; Universidade de Lisboa; Universidade de Lisboa	Badiola, N (corresponding author), Hosp Santa Creu & Sant Pau, Inst Invest Biomed St Pau, Barcelona, Spain.	alleo@santpau.es	Outeiro, Tiago/M-8106-2019; Badiola, Nahuai/C-6526-2011; Lleó, Alberto/K-5783-2019; Herrera, Federico/F-2261-2011; Outeiro, Tiago F/C-1067-2008; Suárez-Calvet, Marc/W-8633-2019; de Oliveira, Rita M/E-9696-2015; Outeiro, Tiago/L-7351-2019; Goncalves, Susana/B-4663-2015	Badiola, Nahuai/0000-0001-9488-5628; Herrera, Federico/0000-0002-9596-9353; Outeiro, Tiago F/0000-0003-1679-1727; de Oliveira, Rita M/0000-0002-0970-4501; Outeiro, Tiago/0000-0003-1679-1727; Goncalves, Susana/0000-0002-8025-2624; Hempsall, Ann-Maree/0000-0001-8610-0106; Guardia-Laguarta, Cristina/0000-0003-0811-9068; Pera, Marta/0000-0003-4317-6623; Suarez-Calvet, Marc/0000-0002-2993-569X; Clarimon, Jordi/0000-0002-6824-6942	Ministerio de Ciencia e Innovacion [FISPI071137]; Fundacio Marato TV3 [072610]; Centro Investigacion Biomedica en Red Enfermedades Neurodegenerativas (CIBERNED); Marie Curie International Reintegration Grant (Neurofold); EMBO; Fundacao para a Ciencia e a Tecnologia [SFRH/BPD/41416/2007, SFRH/BPD/63530/2009]	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Fundacio Marato TV3; Centro Investigacion Biomedica en Red Enfermedades Neurodegenerativas (CIBERNED); Marie Curie International Reintegration Grant (Neurofold)(European Commission); EMBO(European Molecular Biology Organization (EMBO)); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by grants from the Ministerio de Ciencia e Innovacion (FISPI071137), the Fundacio Marato TV3 (072610) and Centro Investigacion Biomedica en Red Enfermedades Neurodegenerativas (CIBERNED) to AL. TFO is supported by a Marie Curie International Reintegration Grant (Neurofold) and an EMBO Installation Grant. RMO and FH are supported by the Fundacao para a Ciencia e a Tecnologia (SFRH/BPD/41416/2007 and SFRH/BPD/63530/2009, respectively). The funders (including CIBERNED) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badiola N, 2010, CNS NEUROL DISORD-DR, V9, P727, DOI 10.2174/187152710793237403; Berezovska O, 2005, J NEUROSCI, V25, P3009, DOI 10.1523/JNEUROSCI.0364-05.2005; Berezovska O, 2003, J NEUROSCI, V23, P4560; Cabin DE, 2002, J NEUROSCI, V22, P8797; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Clarimon J, 2009, J NEUROPATH EXP NEUR, V68, P73, DOI 10.1097/NEN.0b013e3181927577; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; Desplats P, 2009, P NATL ACAD SCI USA, V106, P13010, DOI 10.1073/pnas.0903691106; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Duda JE, 2002, ACTA NEUROPATHOL, V104, P7, DOI 10.1007/s00401-002-0563-3; Duka T, 2006, FASEB J, V20, P2302, DOI 10.1096/fj.06-6092com; Duka T, 2006, NEUROTOX RES, V10, P1, DOI 10.1007/BF03033329; Duka T, 2009, FASEB J, V23, P2820, DOI 10.1096/fj.08-120410; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Forman MS, 2002, AM J PATHOL, V160, P1725, DOI 10.1016/S0002-9440(10)61119-4; GALLOWAY PG, 1988, J NEUROPATH EXP NEUR, V47, P654, DOI 10.1097/00005072-198811000-00008; Galpern WR, 2006, ANN NEUROL, V59, P449, DOI 10.1002/ana.20819; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Guardia-Laguarta C, 2009, J NEUROCHEM, V110, P220, DOI 10.1111/j.1471-4159.2009.06126.x; Hamilton RL, 2000, BRAIN PATHOL, V10, P378; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Iseki E, 1999, NEUROSCI LETT, V265, P9, DOI 10.1016/S0304-3940(99)00178-0; Ishizawa T, 2003, J NEUROPATH EXP NEUR, V62, P389, DOI 10.1093/jnen/62.4.389; Jensen PH, 1999, J BIOL CHEM, V274, P25481, DOI 10.1074/jbc.274.36.25481; Judkins AR, 2002, ACTA NEUROPATHOL, V103, P526, DOI 10.1007/s00401-001-0483-7; Klucken J, 2004, J BIOL CHEM, V279, P25497, DOI 10.1074/jbc.M400255200; Kramer ML, 2007, J NEUROSCI, V27, P1405, DOI 10.1523/JNEUROSCI.4564-06.2007; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; Lee SJ, 2010, NAT REV NEUROL, V6, P702, DOI 10.1038/nrneurol.2010.145; Lippa CF, 1998, AM J PATHOL, V153, P1365, DOI 10.1016/S0002-9440(10)65722-7; Lippa CF, 1999, ANN NEUROL, V45, P353, DOI 10.1002/1531-8249(199903)45:3<353::AID-ANA11>3.0.CO;2-4; Lleo A, 2004, NAT MED, V10, P1065, DOI 10.1038/nm1112; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; McLean PJ, 2001, NEUROSCIENCE, V104, P901, DOI 10.1016/S0306-4522(01)00113-0; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Outeiro TF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001867; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; RAGHAVAN R, 1993, CAN J NEUROL SCI, V20, P48, DOI 10.1017/S0317167100047405; Schmidt ML, 1996, ACTA NEUROPATHOL, V91, P475, DOI 10.1007/s004010050454; Seto-Salvia N, 2011, ARCH NEUROL-CHICAGO, V68, P359, DOI 10.1001/archneurol.2011.17; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Terni B, 2007, ACTA NEUROPATHOL, V113, P403, DOI 10.1007/s00401-006-0192-3; Waxman EA, 2011, J NEUROSCI, V31, P7604, DOI 10.1523/JNEUROSCI.0297-11.2011; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Wilhelmsen KC, 2004, ARCH NEUROL-CHICAGO, V61, P398, DOI 10.1001/archneur.61.3.398; Williams-Gray CH, 2009, BRAIN, V132, P2958, DOI 10.1093/brain/awp245; Wills J, 2010, EXP NEUROL, V225, P210, DOI 10.1016/j.expneurol.2010.06.017; Yancopoulou D, 2005, J NEUROPATH EXP NEUR, V64, P245, DOI 10.1093/jnen/64.3.245; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	57	100	103	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26609	10.1371/journal.pone.0026609	http://dx.doi.org/10.1371/journal.pone.0026609			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039514	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200029
J	Francou, B; Bouligand, J; Voican, A; Amazit, L; Trabado, S; Fagart, J; Meduri, G; Brailly-Tabard, S; Chanson, P; Lecomte, P; Guiochon-Mantel, A; Young, J				Francou, Bruno; Bouligand, Jerome; Voican, Adela; Amazit, Larbi; Trabado, Severine; Fagart, Jerome; Meduri, Geri; Brailly-Tabard, Sylvie; Chanson, Philippe; Lecomte, Pierre; Guiochon-Mantel, Anne; Young, Jacques			Normosmic Congenital Hypogonadotropic Hypogonadism Due to TAC3/TACR3 Mutations: Characterization of Neuroendocrine Phenotypes and Novel Mutations	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; NEUROKININ-B; ARCUATE NUCLEUS; KISSPEPTIN NEURONS; TACR3 MUTATIONS; ALPHA-SUBUNIT; DYNORPHIN-A; RECEPTOR; SECRETION; BETA	Context: TAC3/TACR3 mutations have been reported in normosmic congenital hypogonadotropic hypogonadism (nCHH) (OMIM #146110). In the absence of animal models, studies of human neuroendocrine phenotypes associated with neurokinin B and NK3R receptor dysfunction can help to decipher the pathophysiology of this signaling pathway. Objective: To evaluate the prevalence of TAC3/TACR3 mutations, characterize novel TACR3 mutations and to analyze neuroendocrine profiles in nCHH caused by deleterious TAC3/TACR3 biallelic mutations. Results: From a cohort of 352 CHH, we selected 173 nCHH patients and identified nine patients carrying TAC3 or TACR3 variants (5.2%). We describe here 7 of these TACR3 variants (1 frameshift and 2 nonsense deleterious mutations and 4 missense variants) found in 5 subjects. Modeling and functional studies of the latter demonstrated the deleterious consequence of one missense mutation (Tyr267Asn) probably caused by the misfolding of the mutated NK3R protein. We found a statistically significant (p<0.0001) higher mean FSH/LH ratio in 11 nCHH patients with TAC3/TACR3 biallelic mutations than in 47 nCHH patients with either biallelic mutations in KISS1R, GNRHR, or with no identified mutations and than in 50 Kallmann patients with mutations in KAL1, FGFR1 or PROK2/PROKR2. Three patients with TAC3/TACR3 biallelic mutations had an apulsatile LH profile but low-frequency alpha-subunit pulses. Pulsatile GnRH administration increased alpha-subunit pulsatile frequency and reduced the FSH/LH ratio. Conclusion: The gonadotropin axis dysfunction associated with nCHH due to TAC3/TACR3 mutations is related to a low GnRH pulsatile frequency leading to a low frequency of alpha-subunit pulses and to an elevated FSH/LH ratio. This ratio might be useful for pre-screening nCHH patients for TAC3/TACR3 mutations.	[Francou, Bruno; Bouligand, Jerome; Voican, Adela; Amazit, Larbi; Trabado, Severine; Brailly-Tabard, Sylvie; Chanson, Philippe; Guiochon-Mantel, Anne; Young, Jacques] Univ Paris 11, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France; [Francou, Bruno; Bouligand, Jerome; Trabado, Severine; Meduri, Geri; Brailly-Tabard, Sylvie; Guiochon-Mantel, Anne] Hop Bicetre, Assistance Publ Hop Paris, Serv Genet Mol Pharmacogenet & Hormonol, Le Kremlin Bicetre, France; [Francou, Bruno; Bouligand, Jerome; Voican, Adela; Amazit, Larbi; Trabado, Severine; Fagart, Jerome; Meduri, Geri; Brailly-Tabard, Sylvie; Chanson, Philippe; Guiochon-Mantel, Anne; Young, Jacques] INSERM, U693, IFR93, F-94275 Le Kremlin Bicetre, France; [Voican, Adela] Univ Med & Farm, Craiova, Romania; [Chanson, Philippe; Young, Jacques] Serv Endocrinol & Malad Reprod, Le Kremlin Bicetre, France; [Chanson, Philippe; Young, Jacques] Ctr Reference Malad Endocriniennes Rares Croissan, Le Kremlin Bicetre, France; [Lecomte, Pierre] Hop Bretonneau, Serv Endocrinol, Tours, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Medicine & Pharmacy of Craiova; CHU Tours	Francou, B (corresponding author), Univ Paris 11, Fac Med Paris Sud, UMR S693, Le Kremlin Bicetre, France.	anne.mantel@bct.aphp.fr	Francou, Bruno/AAX-7301-2020; Guiochon-Mantel, Anne S/S-8408-2018; Chanson, Philippe/F-8511-2013; Francou, Bruno/B-8156-2015; BOULIGAND, Jérôme/S-5716-2018; Young, Jacques/T-2976-2018; Fagart, Jerome/S-4581-2018; Young, Jacques/N-5251-2019	Francou, Bruno/0000-0002-3903-2320; Guiochon-Mantel, Anne S/0000-0003-1737-1409; Chanson, Philippe/0000-0001-5096-5722; Young, Jacques/0000-0001-9286-5631; Fagart, Jerome/0000-0002-7965-0553; Young, Jacques/0000-0001-9286-5631; Trabado, Severine/0000-0002-1925-1999	Paris-Sud 11 University; INSERM ANR [KalGenopath 09-GENO-017]; PHRC HYPOPROTEO [P081212]; Fondation pour la Recherche Medicale	Paris-Sud 11 University; INSERM ANR(Institut National de la Sante et de la Recherche Medicale (Inserm)French National Research Agency (ANR)); PHRC HYPOPROTEO; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	Funding: This work was supported in part by grants from Paris-Sud 11 University (Bonus Qualite Recherche 2009), INSERM ANR KalGenopath 09-GENO-017, PHRC HYPOPROTEO P081212 and Fondation pour la Recherche Medicale. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amazit L, 2007, MOL CELL BIOL, V27, P6913, DOI 10.1128/MCB.01695-06; Amstalden M, 2010, J NEUROENDOCRINOL, V22, P1, DOI 10.1111/j.1365-2826.2009.01930.x; Bouligand J, 2009, NEW ENGL J MED, V360, P2742, DOI 10.1056/NEJMoa0900136; Brioude F, 2010, EUR J ENDOCRINOL, V162, P835, DOI 10.1530/EJE-10-0083; Burke MC, 2006, J COMP NEUROL, V498, P712, DOI 10.1002/cne.21086; Chanson P, 1997, J CLIN ENDOCR METAB, V82, P1397, DOI 10.1210/jc.82.5.1397; Ciccone NA, 2009, CURR OPIN ENDOCRINOL, V16, P321, DOI 10.1097/MED.0b013e32832d88fb; Ciccone NA, 2010, MOL CELL BIOL, V30, P1028, DOI 10.1128/MCB.00848-09; Conn PM, 2009, MOL CELL ENDOCRINOL, V299, P137, DOI 10.1016/j.mce.2008.10.051; Corander MP, 2010, J NEUROENDOCRINOL, V22, P181, DOI 10.1111/j.1365-2826.2009.01951.x; Crowley WF, 1994, GLYCOPROTEIN HORMONE, P253; De Luca F, 2008, EUR J ENDOCRINOL, V158, P921, DOI 10.1530/EJE-07-0494; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; deRoux N, 1997, NEW ENGL J MED, V337, P1597, DOI 10.1056/NEJM199711273372205; Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122; Dode C, 2006, PLOS GENET, V2, P1648, DOI 10.1371/journal.pgen.0020175; Duarte CR, 2006, CELL TISSUE RES, V323, P43, DOI 10.1007/s00441-005-0027-x; Eswar N, 2006, CURR PROTOC BIOINFOR, V50, P291; Fukami M, 2010, HORM RES PAEDIAT, V73, P477, DOI 10.1159/000313373; Gianetti E, 2010, J CLIN ENDOCR METAB, V95, P2857, DOI 10.1210/jc.2009-2320; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; Goze C, 2010, EUR J PHARMACOL, V643, P153, DOI 10.1016/j.ejphar.2010.06.018; Guran T, 2009, J CLIN ENDOCR METAB, V94, P3633, DOI 10.1210/jc.2009-0551; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Latronico AC, 2009, NAT GENET, V41, P269, DOI 10.1038/ng0309-269; Luan XH, 2007, EUR J ENDOCRINOL, V157, P113, DOI 10.1530/EJE-07-0061; Navarro VM, 2011, AM J PHYSIOL-ENDOC M, V300, pE202, DOI 10.1152/ajpendo.00517.2010; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; Pascual-Le Tallec L, 2003, MOL ENDOCRINOL, V17, P2529, DOI 10.1210/me.2003-0299; Pitteloud N, 2002, J CLIN ENDOCR METAB, V87, P4128, DOI 10.1210/jc.2002-020518; Ramaswamy S, 2010, ENDOCRINOLOGY, V151, P4494, DOI 10.1210/en.2010-0223; Rance NE, 2010, BRAIN RES, V1364, P116, DOI 10.1016/j.brainres.2010.08.059; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Salenave S, 2008, J CLIN ENDOCR METAB, V93, P758, DOI 10.1210/jc.2007-1168; Sandoval-Guzman T, 2004, BRAIN RES, V1026, P307, DOI 10.1016/j.brainres.2004.08.026; Schmidlin F, 2003, AM J PHYSIOL-CELL PH, V285, pC945, DOI 10.1152/ajpcell.00541.2002; Siuciak JA, 2007, PSYCHOPHARMACOLOGY, V194, P185, DOI 10.1007/s00213-007-0828-6; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; WHITCOMB RW, 1990, J CLIN ENDOCR METAB, V70, P1654, DOI 10.1210/jcem-70-6-1654; WINTERS SJ, 1988, J CLIN ENDOCR METAB, V66, P338, DOI 10.1210/jcem-66-2-338; Young J, 2010, J CLIN ENDOCR METAB, V95, P2287, DOI 10.1210/jc.2009-2600	42	59	60	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e25614	10.1371/journal.pone.0025614	http://dx.doi.org/10.1371/journal.pone.0025614			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031817	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200004
J	Koorem, K; Price, JN; Moora, M				Koorem, Kadri; Price, Jodi N.; Moora, Mari			Species-Specific Effects of Woody Litter on Seedling Emergence and Growth of Herbaceous Plants	PLOS ONE			English	Article							TREE LEAF LITTER; UNDERSTORY VEGETATION; DECOMPOSITION RATES; BOREONEMORAL FOREST; DECIDUOUS WOODLAND; TEMPERATE FORESTS; SOIL QUALITY; OAK STANDS; RICHNESS; DIVERSITY	The effect of litter on seedling establishment can influence species richness in plant communities. The effect of litter depends on amount, and also on litter type, but relatively little is known about the species-specific effects of litter. We conducted a factorial greenhouse experiment to examine the effect of litter type, using two woody species that commonly co-occur in boreonemoral forest-evergreen spruce (Picea abies), deciduous hazel (Corylus avellana), and a mixture of the two species-and litter amount-shallow (4 mm), deep (12 mm) and leachate-on seedling emergence and biomass of three understorey species. The effect of litter amount on seedling emergence was highly dependent on litter type; while spruce needle litter had a significant negative effect that increased with depth, seedling emergence in the presence of hazel broadleaf litter did not differ from control pots containing no litter. Mixed litter of both species also had a negative effect on seedling emergence that was intermediate compared to the single-species treatments. Spruce litter had a marginally positive (shallow) or neutral effect (deep) on seedling biomass, while hazel and mixed litter treatments had significant positive effects on biomass that increased with depth. We found non-additive effects of litter mixtures on seedling biomass indicating that high quality hazel litter can reduce the negative effects of spruce. Hazel litter does not inhibit seedling emergence; it increases seedling growth, and creates better conditions for seedling growth in mixtures by reducing the suppressive effect of spruce litter, having a positive effect on understorey species richness.	[Koorem, Kadri; Price, Jodi N.; Moora, Mari] Univ Tartu, Dept Bot, Inst Ecol & Earth Sci, EE-50090 Tartu, Estonia	University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Koorem, K (corresponding author), Univ Tartu, Dept Bot, Inst Ecol & Earth Sci, Ulikooli 18, EE-50090 Tartu, Estonia.	kadri.koorem@ut.ee	Price, Jodi/J-6534-2012; Moora, Mari/D-1961-2009	Moora, Mari/0000-0002-4819-7506; Koorem, Kadri/0000-0002-3376-9372	Estonian Science Foundation [7371, SF0180098s08]; Centre of Excellence FIBIR; MOBILITAS post doctoral grant [MJD47]	Estonian Science Foundation; Centre of Excellence FIBIR; MOBILITAS post doctoral grant	The project was supported by Estonian Science Foundation grants 7371, SF0180098s08 (University of Tartu), by the European Regional Development Fund (Centre of Excellence FIBIR) and by MOBILITAS post doctoral grant (MJD47). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aavik T, 2009, ANN BOT FENN, V46, P326, DOI 10.5735/085.046.0408; Aerts R, 1997, OIKOS, V79, P439, DOI 10.2307/3546886; Augusto L, 2003, ANN FOREST SCI, V60, P823, DOI 10.1051/forest:2003077; Barbier S, 2008, FOREST ECOL MANAG, V254, P1, DOI 10.1016/j.foreco.2007.09.038; Binkley D, 1998, BIOGEOCHEMISTRY, V42, P89, DOI 10.1023/A:1005948126251; BOSY JL, 1995, FUNCT ECOL, V9, P635, DOI 10.2307/2390155; Cornwell WK, 2008, ECOL LETT, V11, P1065, DOI 10.1111/j.1461-0248.2008.01219.x; Donath TW, 2008, J ECOL, V96, P272, DOI 10.1111/j.1365-2745.2007.01338.x; Donath TW, 2010, PLANT ECOL, V207, P257, DOI 10.1007/s11258-009-9670-8; Eckstein RL, 2005, J ECOL, V93, P807, DOI 10.1111/j.1365-2745.2005.01015.x; FACELLI JM, 1991, ECOLOGY, V72, P1024, DOI 10.2307/1940602; FACELLI JM, 1991, BOT REV, V57, P1, DOI 10.1007/BF02858763; Goldberg DE, 1999, ECOLOGY, V80, P1118, DOI 10.2307/177059; GRUBB PJ, 1977, BIOL REV, V52, P107, DOI 10.1111/j.1469-185X.1977.tb01347.x; Hoorens B, 2010, OECOLOGIA, V162, P479, DOI 10.1007/s00442-009-1454-2; Janisova M, 2007, ANN BOT FENN, V44, P256; Jogar U, 2008, RESTOR ECOL, V16, P382, DOI 10.1111/j.1526-100X.2008.00435.x; Jonsson M, 2008, OIKOS, V117, P1674, DOI 10.1111/j.1600-0706.2008.16810.x; Kooijman AM, 2010, FUNCT ECOL, V24, P469, DOI 10.1111/j.1365-2435.2009.01640.x; Koorem K, 2010, FOREST ECOL MANAG, V260, P1407, DOI 10.1016/j.foreco.2010.07.043; Kostel-Hughes F, 2005, J TORREY BOT SOC, V132, P50, DOI 10.3159/1095-5674(2005)132[50:EOLLDO]2.0.CO;2; Li W, 2009, ECOL RES, V24, P761, DOI 10.1007/s11284-008-0546-5; Molder A, 2008, FOREST ECOL MANAG, V256, P272, DOI 10.1016/j.foreco.2008.04.012; Mohr D, 2005, GEODERMA, V129, P45, DOI 10.1016/j.geoderma.2004.12.029; Mohr D, 2005, ANN FOREST SCI, V62, P23, DOI 10.1051/forest:2004090; Moora M, 2007, FOREST ECOL MANAG, V250, P64, DOI 10.1016/j.foreco.2007.03.010; Nilsson MC, 1999, OIKOS, V86, P16, DOI 10.2307/3546566; Quested H, 2006, FUNCT ECOL, V20, P522, DOI 10.1111/j.1365-2435.2006.01131.x; Quested HM, 2003, OECOLOGIA, V135, P606, DOI 10.1007/s00442-003-1225-4; Richards AE, 2010, TREE PHYSIOL, V30, P1192, DOI 10.1093/treephys/tpq035; Royal Botanical Gardens KEW, 2008, SEED INF DAT SID VER; Ruprecht E, 2010, J VEG SCI, V21, P1069, DOI 10.1111/j.1654-1103.2010.01206.x; Saetre P, 1999, ECOGRAPHY, V22, P183, DOI 10.1111/j.1600-0587.1999.tb00467.x; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; SYDES C, 1981, J ECOL, V69, P249, DOI 10.2307/2259829; SYDES C, 1981, J ECOL, V69, P237, DOI 10.2307/2259828; Tinya F, 2009, PLANT ECOL, V204, P69, DOI 10.1007/s11258-008-9566-z; van Oijen D, 2005, APPL VEG SCI, V8, P155, DOI 10.1658/1402-2001(2005)008[0155:EOTSCO]2.0.CO;2; Vogt DR, 2010, AM NAT, V175, P73, DOI 10.1086/648556; Wulf M, 2009, J VEG SCI, V20, P517, DOI 10.1111/j.1654-1103.2009.05713.x; Xiong SJ, 1999, J ECOL, V87, P984, DOI 10.1046/j.1365-2745.1999.00414.x; Zobel M, 2007, FOREST ECOL MANAG, V250, P71, DOI 10.1016/j.foreco.2007.03.011	42	22	25	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26505	10.1371/journal.pone.0026505	http://dx.doi.org/10.1371/journal.pone.0026505			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028890	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800047
J	Wu, CH; Chen, SY; Shortreed, MR; Kreitinger, GM; Yuan, Y; Frey, BL; Zhang, Y; Mirza, S; Cirillo, LA; Olivier, M; Smith, LM				Wu, Cheng-Hsien; Chen, Siyuan; Shortreed, Michael R.; Kreitinger, Gloria M.; Yuan, Yuan; Frey, Brian L.; Zhang, Yi; Mirza, Shama; Cirillo, Lisa A.; Olivier, Michael; Smith, Lloyd M.			Sequence-Specific Capture of Protein-DNA Complexes for Mass Spectrometric Protein Identification	PLOS ONE			English	Article							FORMALDEHYDE CROSS-LINKING; CHROMATIN IMMUNOPRECIPITATION; TELOMERIC HETEROCHROMATIN; TRANSCRIPTION FACTORS; BINDING PROTEINS; GENOME; HISTONE; GENE; OLIGONUCLEOTIDES; ASSOCIATION	The regulation of gene transcription is fundamental to the existence of complex multicellular organisms such as humans. Although it is widely recognized that much of gene regulation is controlled by gene-specific protein-DNA interactions, there presently exists little in the way of tools to identify proteins that interact with the genome at locations of interest. We have developed a novel strategy to address this problem, which we refer to as GENECAPP, for Global ExoNuclease-based Enrichment of Chromatin-Associated Proteins for Proteomics. In this approach, formaldehyde cross-linking is employed to covalently link DNA to its associated proteins; subsequent fragmentation of the DNA, followed by exonuclease digestion, produces a single-stranded region of the DNA that enables sequence-specific hybridization capture of the protein-DNA complex on a solid support. Mass spectrometric (MS) analysis of the captured proteins is then used for their identification and/or quantification. We show here the development and optimization of GENECAPP for an in vitro model system, comprised of the murine insulin-like growth factor-binding protein 1 (IGFBP1) promoter region and FoxO1, a member of the forkhead rhabdomyosarcoma (FoxO) subfamily of transcription factors, which binds specifically to the IGFBP1 promoter. This novel strategy provides a powerful tool for studies of protein-DNA and protein-protein interactions.	[Wu, Cheng-Hsien; Chen, Siyuan; Shortreed, Michael R.; Kreitinger, Gloria M.; Yuan, Yuan; Frey, Brian L.; Smith, Lloyd M.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA; [Wu, Cheng-Hsien; Smith, Lloyd M.] Univ Wisconsin, Program Cellular & Mol Biol, Madison, WI USA; [Zhang, Yi; Mirza, Shama; Olivier, Michael] Med Coll Wisconsin, Biotechnol & Bioengn Ctr, Milwaukee, WI 53226 USA; [Mirza, Shama] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Cirillo, Lisa A.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA; [Olivier, Michael] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Smith, Lloyd M.] Genome Ctr Wisconsin, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Wu, CH (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.	smith@chem.wisc.edu	Frey, Brian L/M-5035-2015; SHORTREED, MICHAEL/A-8371-2018; Chen, Siyuan/C-6163-2012	Frey, Brian L/0000-0002-0397-7269; SHORTREED, MICHAEL/0000-0003-4626-0863; 	Wisconsin Center of Excellence in Genomics Science through the National Human Genome Research Institute, National Institutes of Health [1P50HG004952]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004952] Funding Source: NIH RePORTER	Wisconsin Center of Excellence in Genomics Science through the National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Wisconsin Center of Excellence in Genomics Science through the National Human Genome Research Institute, National Institutes of Health [1P50HG004952]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Boyd KE, 1998, P NATL ACAD SCI USA, V95, P13887, DOI 10.1073/pnas.95.23.13887; Butala M, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp043; Cirillo LA, 2007, J MOL BIOL, V366, P720, DOI 10.1016/j.jmb.2006.11.087; DEDON PC, 1991, MOL CELL BIOL, V11, P1729, DOI 10.1128/MCB.11.3.1729; Dejardin J, 2009, CELL, V136, P175, DOI 10.1016/j.cell.2008.11.045; Farnham PJ, 2009, NAT REV GENET, V10, P605, DOI 10.1038/nrg2636; Griffin TJ, 2001, J BIOL CHEM, V276, P45497, DOI 10.1074/jbc.R100014200; GUO Z, 1994, NUCLEIC ACIDS RES, V22, P5456, DOI 10.1093/nar/22.24.5456; Hatta M, 2007, J BIOL CHEM, V282, P35583, DOI 10.1074/jbc.M704735200; Hecht A, 1999, METHOD ENZYMOL, V304, P399; Hecht A, 1996, NATURE, V383, P92, DOI 10.1038/383092a0; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; Himeda CL, 2004, MOL CELL BIOL, V24, P2132, DOI 10.1128/MCB.24.5.2132-2143.2004; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; JACKSON V, 1978, CELL, V15, P945, DOI 10.1016/0092-8674(78)90278-7; JOHNSON DS, 2007, GENOME WIDE MAPPING; KATZHENDLER J, 1989, TETRAHEDRON, V45, P2777, DOI 10.1016/S0040-4020(01)80108-3; Kim TH, 2006, ANNU REV GENOM HUM G, V7, P81, DOI 10.1146/annurev.genom.7.080505.115634; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Lieb JD, 2001, NAT GENET, V28, P327, DOI 10.1038/ng569; Little J W, 1981, Gene Amplif Anal, V2, P135; Lockett MR, 2008, LANGMUIR, V24, P69, DOI 10.1021/la702493u; McGall GH, 1997, J AM CHEM SOC, V119, P5081, DOI 10.1021/ja964427a; Mittler G, 2009, GENOME RES, V19, P284, DOI 10.1101/gr.081711.108; Nordhoff E, 1999, NAT BIOTECHNOL, V17, P884, DOI 10.1038/12873; ORLANDO V, 1993, CELL, V75, P1187, DOI 10.1016/0092-8674(93)90328-N; Orlando V, 1997, METHODS, V11, P205, DOI 10.1006/meth.1996.0407; Ren B, 2000, SCIENCE, V290, P2306, DOI 10.1126/science.290.5500.2306; Richmond KE, 2004, NUCLEIC ACIDS RES, V32, P5011, DOI 10.1093/nar/gkh793; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rogers S G, 1980, Methods Enzymol, V65, P201; ROGERS SG, 1980, GENE, V11, P187, DOI 10.1016/0378-1119(80)90059-1; Rundlett SE, 1998, NATURE, V392, P831, DOI 10.1038/33952; Singh-Gasson S, 1999, NAT BIOTECHNOL, V17, P974, DOI 10.1038/13664; Smith LM, 2011, ANALYST, V136, P3060, DOI 10.1039/c1an15037e; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; SOLOMON MJ, 1988, CELL, V53, P937, DOI 10.1016/S0092-8674(88)90469-2; Stead JA, 2006, MOL CELL PROTEOMICS, V5, P1697, DOI 10.1074/mcp.T600027-MCP200; StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83; Sutherland BW, 2008, J MASS SPECTROM, V43, P699, DOI 10.1002/jms.1415; THOMAS KR, 1978, J BIOL CHEM, V253, P424	43	21	21	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26217	10.1371/journal.pone.0026217	http://dx.doi.org/10.1371/journal.pone.0026217			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028835	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800026
J	Pappalardo, F; Forero, IM; Pennisi, M; Palazon, A; Melero, I; Motta, S				Pappalardo, Francesco; Martinez Forero, Ivan; Pennisi, Marzio; Palazon, Asis; Melero, Ignacio; Motta, Santo			SimB16: Modeling Induced Immune System Response against B16-Melanoma	PLOS ONE			English	Article							IMMUNOSTIMULATORY MONOCLONAL-ANTIBODIES; CANCER; EFFICACY; CD137; IMMUNOTHERAPY; EXPRESSION; CELLS	Immunological therapy of progressive tumors requires not only activation and expansion of tumor specific cytotoxic T lymphocytes (CTLs), but also an efficient effector phase including migration of CTLs in the tumor tissue followed by conjugation and killing of target cells. We report the application of an agent-based model to recapitulate both the effect of a specific immunotherapy strategy against B16-melanoma in mice and the tumor progression in a generic tissue section. A comparison of the in silico results with the in vivo experiments shows excellent agreement. We therefore use the model to predict a critical role for CD137 expression on tumor vessel endothelium for successful therapy and other mechanistic aspects. Experimental results are fully compatible with the model predictions. The biologically oriented in silico model derived in this work will be used to predict treatment failure or success in other pre-clinical conditions eventually leading new promising in vivo experiments.	[Pappalardo, Francesco; Pennisi, Marzio; Motta, Santo] Univ Catania, Catania, Italy; [Martinez Forero, Ivan; Palazon, Asis; Melero, Ignacio] CIMA, Pamplona, Spain; [Martinez Forero, Ivan; Palazon, Asis; Melero, Ignacio] CUN Univ Navarra Pamplona, Pamplona, Spain	University of Catania; University of Navarra	Pappalardo, F (corresponding author), Univ Catania, Catania, Italy.	imelero@unav.es	Palazon, Asis/ABI-1748-2020; Pennisi, Marzio/AAC-7947-2019; Melero, Ignacio/T-7600-2019; Pappalardo, Francesco/C-5832-2011; Pennisi, Marzio/G-4618-2015	Palazon, Asis/0000-0002-7172-7229; Pennisi, Marzio/0000-0003-0231-7653; Melero, Ignacio/0000-0002-1360-348X; Pappalardo, Francesco/0000-0003-1668-3320; Pennisi, Marzio/0000-0003-0231-7653; Joyce, Melinda/0000-0002-2791-5425; Motta, Santo/0000-0003-3533-2972	MEC/MICINN [SAF2005-03131, SAF2008- 03294]; Departamento de Educacion de Navarra (Beca Ortiz de Landazuri), Redes Tematicas de Investigacion Cooperativa RETIC [RD06/0020/0065]; Fondo de Investigacion Sanitaria [FIS PI060932]; European Commission; Fundacion Mutua Madrilena; FIS; UTE	MEC/MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Departamento de Educacion de Navarra (Beca Ortiz de Landazuri), Redes Tematicas de Investigacion Cooperativa RETIC; Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); European Commission(European CommissionEuropean Commission Joint Research Centre); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); FIS(Instituto de Salud Carlos III); UTE	Financial support was from MEC/MICINN (SAF2005-03131 and SAF2008- 03294), Departamento de Educacion de Navarra (Beca Ortiz de Landazuri), Redes Tematicas de Investigacion Cooperativa RETIC (RD06/0020/0065), Fondo de Investigacion Sanitaria (FIS PI060932), European Commission 7th Framework Program (ENCITE) and SUDOE-IMMUNONET, Fundacion Mutua Madrilena, and "UTE for project FIMA''. AP receives a scholarship from FIS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldazzi V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-387; Broll K, 2001, AM J CLIN PATHOL, V115, P543, DOI 10.1309/E343-KMYX-W3Y2-10KY; Castiglione F, 2007, BIOINFORMATICS, V23, P3350, DOI 10.1093/bioinformatics/btm408; Dubrot J, 2010, CANCER IMMUNOL IMMUN, V59, P1223, DOI 10.1007/s00262-010-0846-9; Halling-Brown M, 2010, PHILOS T R SOC A, V368, P2799, DOI 10.1098/rsta.2010.0067; Ito F, 2004, CANCER RES, V64, P8411, DOI 10.1158/0008-5472.CAN-04-0590; May KF, 2002, CANCER RES, V62, P3459; Melero I, 1997, NAT MED, V3, P682, DOI 10.1038/nm0697-682; Melero I, 2008, TRENDS PHARMACOL SCI, V29, P383, DOI 10.1016/j.tips.2008.05.005; Melero I, 2007, NAT REV CANCER, V7, P95, DOI 10.1038/nrc2051; Melero I, 2009, CLIN CANCER RES, V15, P1507, DOI 10.1158/1078-0432.CCR-08-2931; Melief CJM, 2008, IMMUNITY, V29, P372, DOI 10.1016/j.immuni.2008.08.004; Morgan RA, 2006, SCIENCE, V314, P126, DOI 10.1126/science.1129003; Motta Santo, 2005, Immunome Res, V1, P5, DOI 10.1186/1745-7580-1-5; Olofsson PS, 2008, CIRCULATION, V117, P1292, DOI 10.1161/CIRCULATIONAHA.107.699173; Palazon A, 2011, CANCER RES, V71, P801, DOI 10.1158/0008-5472.CAN-10-1733; Palladini A, 2010, CANCER RES, V70, P7755, DOI 10.1158/0008-5472.CAN-10-0701; Pappalardo F, 2006, LECT NOTES ARTIF INT, V3849, P223; Pappalardo F, 2008, BIOINFORMATICS, V24, P1715, DOI 10.1093/bioinformatics/btn306; Pappalardo Francesco, 2010, Immunome Res, V6, P1, DOI 10.1186/1745-7580-6-1; Pappalardo F, 2010, BIOTECHNOL ADV, V28, P82, DOI 10.1016/j.biotechadv.2009.10.001; Pappalardo F, 2009, BRIEF BIOINFORM, V10, P330, DOI 10.1093/bib/bbp014; Pennisi M, 2008, BIOINFORMATICS, V24, P1740, DOI 10.1093/bioinformatics/btn260; Pennisi M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S13; Perez-Gracia JL, 2009, IMMUNOTHERAPY-UK, V1, P845, DOI 10.2217/IMT.09.51; Rosenberg SA, 2008, NAT REV CANCER, V8, P299, DOI 10.1038/nrc2355; Tirapu I, 2006, CANCER RES, V66, P2442, DOI 10.1158/0008-5472.CAN-05-1681; Tirapu I, 2004, INT J CANCER, V110, P51, DOI 10.1002/ijc.20093	28	41	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26523	10.1371/journal.pone.0026523	http://dx.doi.org/10.1371/journal.pone.0026523			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028894	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500082
J	Pfeilschifter, W; Spitzer, D; Pfeilschifter, J; Steinmetz, H; Foerch, C				Pfeilschifter, Waltraud; Spitzer, Daniel; Pfeilschifter, Josef; Steinmetz, Helmuth; Foerch, Christian			Warfarin Anticoagulation Exacerbates the Risk of Hemorrhagic Transformation after rt-PA Treatment in Experimental Stroke: Therapeutic Potential of PCC	PLOS ONE			English	Article							ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; INTRACEREBRAL HEMORRHAGE; RAPID REVERSAL; THROMBOLYSIS; GUIDELINE; OUTCOMES; MODEL	Background: Oral anticoagulant therapy (OAT) with warfarin is the standard of stroke prevention in patients with atrial fibrillation. Approximately 30% of patients with cardioembolic strokes are on OAT at the time of symptom onset. We investigated whether warfarin exacerbates the risk of thrombolysis-associated hemorrhagic transformation (HT) in a mouse model of ischemic stroke. Methods: 62 C57BL/6 mice were used for this study. To achieve effective anticoagulation, warfarin was administered orally. We performed right middle cerebral artery occlusion (MCAO) for 3 h and assessed functional deficit and HT blood volume after 24 h. Results: In non-anticoagulated mice, treatment with rt-PA (10 mg/kg i.v.) after 3 h MCAO led to a 5-fold higher degree of HT compared to vehicle-treated controls (4.0 +/- 0.5 mu l vs. 0.8 +/- 0.1, p<0.001). Mice on warfarin revealed larger amounts of HT after rt-PA treatment in comparison to non-anticoagulated mice (9.2 +/- 3.2 mu l vs. 2.8 +/- 1.0, p<0.05). The rapid reversal of anticoagulation by means of prothrombin complex concentrates (PCC, 100 IU/kg) at the end of the 3 h MCAO period, but prior to rt-PA administration, neutralized the exacerbated risk of HT as compared to sham-treated controls (3.8 +/- 0.7 mu l vs. 15.0 +/- 3.8, p<0.001). Conclusion: In view of the vastly increased risk of HT, it seems to be justified to withhold tPA therapy in effectively anticoagulated patients with acute ischemic stroke. The rapid reversal of anticoagulation with PCC prior to tPA application reduces the risk attributed to warfarin pretreatment and may constitute an interesting therapeutic option.	[Pfeilschifter, Waltraud; Spitzer, Daniel; Steinmetz, Helmuth; Foerch, Christian] Goethe Univ Hosp, Dept Neurol, Frankfurt, Germany; [Pfeilschifter, Josef] Goethe Univ Hosp, Dept Gen Pharmacol & Toxicol, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Pfeilschifter, W (corresponding author), Goethe Univ Hosp, Dept Neurol, Frankfurt, Germany.	w.pfeilschifter@med.uni-frankfurt.de	Pfeilschifter, Waltraud/K-6134-2012; Spitzer, Daniel/GQO-7467-2022	Pfeilschifter, Waltraud/0000-0001-6935-8842; 	Medical Faculty of the Goethe-University (Patenschaftsmodell)	Medical Faculty of the Goethe-University (Patenschaftsmodell)	W. Pfeilschifter was supported by a stipend of the Medical Faculty of the Goethe-University (Patenschaftsmodell). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; *BRYST MYERS SQUIB, PRESCR INF COUM WARF; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Collen D., 1994, MOL BASIS BLOOD DIS, P662; Czech B, 2009, BIOCHEM BIOPH RES CO, V389, P251, DOI 10.1016/j.bbrc.2009.08.142; Foerch C, 2009, J CEREBR BLOOD F MET, V29, P1015, DOI 10.1038/jcbfm.2009.27; Foerch C, 2008, STROKE, V39, P3397, DOI 10.1161/STROKEAHA.108.517482; *GEN, PRESCR INF ACT ALT; Janjua N, 2007, NEUROCRIT CARE, V7, P152, DOI 10.1007/s12028-007-0027-7; Kim YD, 2010, J NEUROL SCI, V298, P101, DOI 10.1016/j.jns.2010.07.025; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; Montaner J, 2003, CIRCULATION, V107, P598, DOI 10.1161/01.CIR.0000046451.38849.90; O'Donnell M, 2006, LANCET NEUROL, V5, P749, DOI 10.1016/S1474-4422(06)70536-1; Pabinger I, 2008, J THROMB HAEMOST, V6, P622, DOI 10.1111/j.1538-7836.2008.02904.x; Pfeilschifter W, 2011, STROKE, V42, P1116, DOI 10.1161/STROKEAHA.110.604652; Prabhakaran S, 2010, ARCH NEUROL-CHICAGO, V67, P1414, DOI 10.1001/archneurol.2010.288; Prabhakaran S, 2010, ARCH NEUROL-CHICAGO, V67, P559, DOI 10.1001/archneurol.2010.25; Preston FE, 2002, BRIT J HAEMATOL, V116, P619, DOI 10.1046/j.0007-1048.2001.03295.x; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Warach S, 2004, STROKE, V35, P2659, DOI 10.1161/01.STR.0000144051.32131.09; A PRIORI SAMPLE SIZE; GRUBBS TEST OUTLIERS	22	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26087	10.1371/journal.pone.0026087	http://dx.doi.org/10.1371/journal.pone.0026087			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039437	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500031
J	Zhang, C; Tang, WJ; Li, Y; Yang, F; Dowd, DR; MacDonald, PN				Zhang, Chi; Tang, Wanjin; Li, Yang; Yang, Fan; Dowd, Diane R.; MacDonald, Paul N.			Osteoblast-Specific Transcription Factor Osterix Increases Vitamin D Receptor Gene Expression in Osteoblasts	PLOS ONE			English	Article							BONE-FORMATION; MEDIATED TRANSCRIPTION; DIFFERENTIATION; RICKETS; PROTEIN; CELLS; MICE; 1,25-DIHYDROXYVITAMIN-D; HOMEOSTASIS; ALOPECIA	Osterix (Osx) is an osteoblast-specific transcription factor required for osteoblast differentiation from mesenchymal stem cells. In Osx knock-out mice, no bone formation occurs. The vitamin D receptor (VDR) is a member of the nuclear hormone receptor superfamily that regulates target gene transcription to ensure appropriate control of calcium homeostasis and bone development. Here, we provide several lines of evidence that show that the VDR gene is a target for transcriptional regulation by Osx in osteoblasts. For example, calvaria obtained from Osx-null embryos displayed dramatic reductions in VDR expression compared to wild-type calvaria. Stable overexpression of Osx stimulated VDR expression in C2C12 mesenchymal cells. Inhibition of Osx expression by siRNA led to downregulation of VDR. In contrast, Osx levels remained unchanged in osteoblasts in VDR-null mice. Mechanistic approaches using transient transfection assays showed that Osx directly activated a 1 kb fragment of the VDR promoter in a dose-dependent manner. To define the region of the VDR promoter that was responsive to Osx, a series of VDR promoter deletion mutants were examined and the minimal Osx-responsive region was refined to the proximal 120 bp of the VDR promoter. Additional point mutants were used to identify two GC-rich regions that were responsible for VDR promoter activation by Osx. Chromatin immunoprecipitation assays demonstrated that endogenous Osx was associated with the native VDR promoter in primary osteoblasts in vivo. Cumulatively, these data strongly support a direct regulatory role for Osx in VDR gene expression. They further provide new insight into potential mechanisms and pathways that Osx controls in osteoblasts and during the process of osteoblastic cell differentiation.	[Zhang, Chi; Tang, Wanjin; Li, Yang; Yang, Fan] Univ Texas SW Med Ctr Dallas, Texas Scottish Rite Hosp Children, Bone Res Lab, Dallas, TX 75390 USA; [Zhang, Chi] Univ Texas SW Med Ctr Dallas, Dept Orthoped Surg, Dallas, TX 75390 USA; [Zhang, Chi] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Dowd, Diane R.; MacDonald, Paul N.] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA	Texas Scottish Rite Hospital for Children; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University	Zhang, C (corresponding author), Univ Texas SW Med Ctr Dallas, Texas Scottish Rite Hosp Children, Bone Res Lab, Dallas, TX 75390 USA.	Chi5.Zhang@utsouthwestern.edu	Zhang, Chi/K-4467-2012		Arthritis Foundation; Texas Scottish Rite Hospital for Children; NIH [RO1-DK53980]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053980] Funding Source: NIH RePORTER	Arthritis Foundation; Texas Scottish Rite Hospital for Children; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study is supported by Arthritis Foundation (http://www.arthritis.org) and Texas Scottish Rite Hospital for Children (http://www.tsrh.org). This work is also supported by NIH Grant RO1-DK53980 (to PNM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldock PA, 2006, J BONE MINER RES, V21, P1618, DOI 10.1359/JBMR.060714; BALSAN S, 1986, J CLIN INVEST, V77, P1661, DOI 10.1172/JCI112483; Ellison TI, 2007, J BIOL CHEM, V282, P10953, DOI 10.1074/jbc.M609717200; Gardiner EM, 2000, FASEB J, V14, P1908, DOI 10.1096/fj.99-1075com; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Horwood NJ, 1998, ENDOCRINOLOGY, V139, P4743, DOI 10.1210/en.139.11.4743; Jehan F, 1997, P NATL ACAD SCI USA, V94, P10138, DOI 10.1073/pnas.94.19.10138; Kim S, 2006, MOL CELL BIOL, V26, P6469, DOI 10.1128/MCB.00353-06; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; LIAN J, 1989, P NATL ACAD SCI USA, V86, P1143, DOI 10.1073/pnas.86.4.1143; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; OWEN TA, 1991, ENDOCRINOLOGY, V128, P1496, DOI 10.1210/endo-128-3-1496; PRINCE CW, 1987, COLLAGEN REL RES, V7, P305; RITCHIE HH, 1989, P NATL ACAD SCI USA, V86, P9783, DOI 10.1073/pnas.86.24.9783; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sooy K, 2005, J CELL BIOCHEM, V94, P81, DOI 10.1002/jcb.20313; St-Arnaud R, 2008, ARCH BIOCHEM BIOPHYS, V473, P225, DOI 10.1016/j.abb.2008.03.038; St-Jacques B, 1999, GENE DEV, V13, P2072, DOI 10.1101/gad.13.16.2072; Tanaka H, 2004, J STEROID BIOCHEM, V89-90, P343, DOI 10.1016/j.jsbmb.2004.03.021; Tang WJ, 2011, J BIOL CHEM, V286, P32995, DOI 10.1074/jbc.M111.244236; Yang F, 2010, BIOCHEM BIOPH RES CO, V400, P684, DOI 10.1016/j.bbrc.2010.08.128; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391; Zhang C, 2001, J BIOL CHEM, V276, P40614, DOI 10.1074/jbc.M106263200; Zhang C, 2003, J BIOL CHEM, V278, P35325, DOI 10.1074/jbc.M305191200; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang C, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-37	29	28	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26504	10.1371/journal.pone.0026504	http://dx.doi.org/10.1371/journal.pone.0026504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028889	Green Submitted, gold, Green Published			2022-12-27	WOS:000296186900070
J	Dong, YW; Yu, SS; Wang, QL; Dong, SL				Dong, Yun-wei; Yu, Shan-shan; Wang, Qing-lin; Dong, Shuang-lin			Physiological Responses in a Variable Environment: Relationships between Metabolism, Hsp and Thermotolerance in an Intertidal-Subtidal Species	PLOS ONE			English	Article							APOSTICHOPUS-JAPONICUS SELENKA; SEA-CUCUMBER; OXYGEN-CONSUMPTION; CLIMATE-CHANGE; GROWTH; ADAPTATION; PERFORMANCE; STRESS	Physiological responses to temperature reflect the evolutionary adaptations of organisms to their thermal environment and the capability of animals to tolerate thermal stress. Contrary to conventional metabolism theory, increasing environmental temperatures have been shown to reduce metabolic rate in rocky-eulittoral-fringe species inhabiting highly variable environments, possibly as a strategy for energy conservation. To study the physiological adaptations of an intertidal-subtidal species to the extreme and unpredictable heat stress of the intertidal zone, oxygen consumption rate and heat shock protein expression were quantified in the sea cucumber Apostichopus japonicus. Using simulate natural temperatures, the relationship between temperature, physiological performance (oxygen consumption and heat shock proteins) and thermotolerance were assessed. Depression of oxygen consumption rate and upregulation of heat shock protein genes (hsps) occurred in sequence when ambient temperature was increased from 24 to 30 degrees C. Large-scale mortality of the sea cucumber occurred when temperatures rose beyond 30 degrees C, suggesting that the upregulation of heat shock proteins and mortality are closely related to the depression of aerobic metabolism, a phenomenon that is in line with the concept of oxygen-and capacity-limited thermal tolerance (OCLTT). The physiologically-related thermotolerance of this sea cucumber should be an adaptation to its local environment.	[Dong, Yun-wei] Xiamen Univ, Coll Oceanog & Environm Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian Province, Peoples R China; [Yu, Shan-shan; Wang, Qing-lin; Dong, Shuang-lin] Ocean Univ China, Coll Fisheries, Minist Educ, Key Lab Mariculture, Qingdao, Shandong, Peoples R China	Xiamen University; Ocean University of China	Dong, YW (corresponding author), Xiamen Univ, Coll Oceanog & Environm Sci, State Key Lab Marine Environm Sci, Xiamen, Fujian Province, Peoples R China.	dongyw@xmu.edu.cn	HUANG, Shuiying/C-3117-2014; Dong, Yunwei/C-4617-2011; han, guodong/H-3404-2011	Dong, Yunwei/0000-0003-4550-2322; 	Natural Science Foundation for Distinguished Young Scholars of Fujian Province, China [2011J06017]; Chinese National Science Foundation [30400333]; National Key Technologies R&D Program of China [2006BAD09A01]; Reward Research Foundation for Talented Young and Middle Aged Scientists of Shandong, China [BS2009NY019]	Natural Science Foundation for Distinguished Young Scholars of Fujian Province, China; Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); National Key Technologies R&D Program of China(National Key Technology R&D Program); Reward Research Foundation for Talented Young and Middle Aged Scientists of Shandong, China	This work was supported by the Natural Science Foundation for Distinguished Young Scholars of Fujian Province, China (2011J06017), Chinese National Science Foundation (30400333), National Key Technologies R&D Program of China (2006BAD09A01), Reward Research Foundation for Talented Young and Middle Aged Scientists of Shandong, China (BS2009NY019). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], FAUNA CASINI PHYLUM; Dong YW, 2011, MAR BIOL, V158, P1223, DOI 10.1007/s00227-011-1642-6; Dong YW, 2008, FISHERIES SCI, V74, P573, DOI 10.1111/j.1444-2906.2008.01560.x; Dong YW, 2008, AQUACULTURE, V276, P179, DOI 10.1016/j.aquaculture.2008.01.028; Dong Yunwei, 2007, Journal of Ocean University of China, V6, P275, DOI 10.1007/s11802-007-0275-3; Dong YW, 2008, AQUACULTURE, V275, P329, DOI 10.1016/j.aquaculture.2007.12.006; Dong YW, 2006, AQUAC RES, V37, P1327, DOI 10.1111/j.1365-2109.2006.01570.x; Dong YW, 2006, AQUACULTURE, V255, P514, DOI 10.1016/j.aquaculture.2005.12.013; DONG YW, 2005, FISH SCI CHINA, V1, P33; Hamano T., 1989, Suisan Zoshoku, V37, P179; Ji TT, 2008, AQUACULTURE, V283, P180, DOI 10.1016/j.aquaculture.2008.07.006; Li Bao-Quan, 2002, Oceanologia et Limnologia Sinica, V33, P182; Marshall DJ, 2011, P ROY SOC B-BIOL SCI, V278, P281, DOI 10.1098/rspb.2010.1414; MARSHALL DJ, 2011, J EXP BIOL IN PRESS, DOI DOI 10.1242/JEB.059899.; Meng XL, 2009, AQUACULTURE, V294, P314, DOI 10.1016/j.aquaculture.2009.06.015; OMORI M, 1984, METHODS MARINE ZOOPL, P173; Portner HO, 2007, SCIENCE, V315, P95, DOI 10.1126/science.1135471; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Portner HO, 2002, COMP BIOCHEM PHYS A, V132, P739, DOI 10.1016/S1095-6433(02)00045-4; Portner HO, 2006, PHYSIOL BIOCHEM ZOOL, V79, P295, DOI 10.1086/499986; Portner HO, 2001, CONT SHELF RES, V21, P1975, DOI 10.1016/S0278-4343(01)00038-3; Portner HO, 1998, COLD OCEAN PHYSL, P88, DOI DOI 10.1017/CBO9780511661723.005; Portner HO, 2000, ANTARCTIC ECOSYSTEMS, P109; Seebacher F, 2003, P ROY SOC B-BIOL SCI, V270, pS50, DOI 10.1098/rsbl.2003.0007; Sloan N. A., 1984, ECHINODERMATA, P109, DOI 10.1201/9781003079224-14; Somero GN, 2010, J EXP BIOL, V213, P912, DOI 10.1242/jeb.037473; SOMERO GN, 2011, AM PHYSL SOC REGULAT, DOI DOI 10.1152/AJPREGU.00719.2010; Terblanche JS, 2006, J EXP BIOL, V209, P1064, DOI 10.1242/jeb.02129; Yamana Y, 2009, FISHERIES SCI, V75, P585, DOI 10.1007/s12562-009-0076-2; Yang HS, 2006, J EXP MAR BIOL ECOL, V330, P505, DOI 10.1016/j.jembe.2005.09.010; YUSUKE Y, 2006, J NATL FISH U, V54, P111	31	28	29	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26446	10.1371/journal.pone.0026446	http://dx.doi.org/10.1371/journal.pone.0026446			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022615	Green Submitted, Green Published, gold			2022-12-27	WOS:000295984400059
J	Papes, S; Ladich, F				Papes, Sandra; Ladich, Friedrich			Effects of Temperature on Sound Production and Auditory Abilities in the Striped Raphael Catfish Platydoras armatulus (Family Doradidae)	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; NERVE-FIBER RESPONSE; TEMPORAL RESOLUTION; SONIC MUSCLE; INNER-EAR; DEPENDENCE; HEARING; BEHAVIOR; GOLDFISH; FROG	Background: Sound production and hearing sensitivity of ectothermic animals are affected by the ambient temperature. This is the first study investigating the influence of temperature on both sound production and on hearing abilities in a fish species, namely the neotropical Striped Raphael catfish Platydoras armatulus. Methodology/Principal Findings: Doradid catfishes produce stridulation sounds by rubbing the pectoral spines in the shoulder girdle and drumming sounds by an elastic spring mechanism which vibrates the swimbladder. Eight fish were acclimated for at least three weeks to 22 degrees, then to 30 degrees and again to 22 degrees C. Sounds were recorded in distress situations when fish were hand-held. The stridulation sounds became shorter at the higher temperature, whereas pulse number, maximum pulse period and sound pressure level did not change with temperature. The dominant frequency increased when the temperature was raised to 30 degrees C and the minimum pulse period became longer when the temperature decreased again. The fundamental frequency of drumming sounds increased at the higher temperature. Using the auditory evoked potential (AEP) recording technique, the hearing thresholds were tested at six different frequencies from 0.1 to 4 kHz. The temporal resolution was determined by analyzing the minimum resolvable click period (0.3-5 ms). The hearing sensitivity was higher at the higher temperature and differences were more pronounced at higher frequencies. In general, latencies of AEPs in response to single clicks became shorter at the higher temperature, whereas temporal resolution in response to double-clicks did not change. Conclusions/Significance: These data indicate that sound characteristics as well as hearing abilities are affected by temperatures in fishes. Constraints imposed on hearing sensitivity at different temperatures cannot be compensated even by longer acclimation periods. These changes in sound production and detection suggest that acoustic orientation and communication are affected by temperature changes in the neotropical catfish P. armatulus.	[Papes, Sandra; Ladich, Friedrich] Univ Vienna, Dept Behav Biol, Vienna, Austria	University of Vienna	Papes, S (corresponding author), Univ Vienna, Dept Behav Biol, Vienna, Austria.	friedrich.ladich@univie.ac.at			Austrian Science Fund (FWF) [P22319-B17]; Austrian Science Fund (FWF) [P 22319] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This research was supported by the Austrian Science Fund (FWF; grant P22319-B17 to Friedrich Ladich). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amorim MCP, 2006, J FISH BIOL, V69, P1892, DOI 10.1111/j.1095-8649.2006.01247.x; Amorim M. Clara P., 2005, Acta Zoologica Sinica, V51, P1013; Amoser S., 2006, J ACOUST SOC AM, V120, P3056; Andersson E, 2003, FISH PHYSIOL BIOCHEM, V28, P411, DOI 10.1023/B:FISH.0000030608.76252.22; Bellgraph BJ, 2010, J THERM BIOL, V35, P6, DOI 10.1016/j.jtherbio.2009.10.001; BENNETT AF, 1985, J EXP BIOL, V115, P333; BRAWN VM, 1960, BEHAVIOUR, V18, P239; BRENOWITZ EA, 1985, BRAIN RES, V359, P364, DOI 10.1016/0006-8993(85)91452-0; Connaughton MA, 2000, J EXP BIOL, V203, P1503; Connaughton MA, 2004, J EXP BIOL, V207, P1643, DOI 10.1242/jeb.00928; COSSINS AR, 1977, J COMP PHYSIOL, V120, P109, DOI 10.1007/BF00619309; Domingues PM, 2002, AQUACULT INT, V10, P207, DOI 10.1023/A:1022148802078; EATOCK RA, 1981, J COMP PHYSIOL, V142, P219, DOI 10.1007/BF00605740; EGERT D, 1995, HEARING RES, V84, P72, DOI 10.1016/0378-5955(95)00019-Z; Fay R, 2009, INTEGR ZOOL, V4, P26, DOI 10.1111/j.1749-4877.2008.00132.x; Fay RR, 2000, HEARING RES, V149, P1, DOI 10.1016/S0378-5955(00)00168-4; FAY RR, 1992, HEARING RES, V58, P9, DOI 10.1016/0378-5955(92)90003-6; Feher JJ, 1998, J MUSCLE RES CELL M, V19, P661, DOI 10.1023/A:1005333215172; Fine ML, 2003, CATFISHES, VOLS 1-2, P249; Fine ML, 1997, COPEIA, P777, DOI 10.2307/1447295; Fonseca PJ, 2007, J EXP BIOL, V210, P1834, DOI 10.1242/jeb.001495; Franz A, 2002, J COMP PHYSIOL A, V188, P261, DOI 10.1007/s00359-002-0298-6; Heyd A, 2000, REV SUISSE ZOOL, V107, P165, DOI 10.5962/bhl.part.80125; HUBL L, 1977, BEHAV PROCESS, V2, P305, DOI 10.1016/0376-6357(77)90001-8; Itoi S, 2003, FISH PHYSIOL BIOCHEM, V29, P237, DOI 10.1023/B:FISH.0000045721.26261.a4; JOHANSEN PH, 1985, CAN J ZOOL, V63, P1211, DOI 10.1139/z85-181; Jones EA, 2008, J EXP BIOL, V211, P1386, DOI 10.1242/jeb.014688; Kaatz I.M., 1999, BEHAV MORPHOLOGICAL; Kaatz IM, 2010, CURR ZOOL, V56, P73, DOI 10.1093/czoolo/56.1.73; KASTBERGER G, 1981, ZOOL JAHRB ALLG ZOOL, V85, P393; Kasumyan A.O., 2008, J ICHTHYOL, V48, P981, DOI [10.1134/S0032945208110039, DOI 10.1134/S0032945208110039]; Kenyon TN, 1998, J COMP PHYSIOL A, V182, P307, DOI 10.1007/s003590050181; Ladich F, 2011, ENCYCLOPEDIA OF FISH PHYSIOLOGY: FROM GENOME TO ENVIRONMENT, VOLS 1-3, P321; Ladich F, 2004, SPR HDB AUD, V22, P95, DOI 10.1007/978-1-4419-8957-4_4; Ladich F, 2001, ANAT REC, V263, P297, DOI 10.1002/ar.1105; Ladich F., 1992, Bioacoustics, V4, P131; Ladich Friedrich, 2006, P3; Ladich Friedrich, 2003, P173, DOI 10.1007/978-0-387-22628-6_9; Ladich F, 2009, COMP BIOCHEM PHYS A, V154, P341, DOI 10.1016/j.cbpa.2009.07.004; Ladich Friedrich, 1997, Bioacoustics, V8, P185; Long GR, 1996, HEARING RES, V98, P22, DOI 10.1016/0378-5955(96)00057-3; Lugli M, 1996, J FISH BIOL, V49, P648; Mann DA, 2009, T AM FISH SOC, V138, P1000, DOI 10.1577/T08-052.1; Maruska KP, 2009, ENVIRON BIOL FISH, V84, P325, DOI 10.1007/s10641-009-9446-y; Muller J., 1842, ARCH ANATOMIE PHYSL, V1842, P307; Myrberg A.A. Jr, 1978, P137; Navarro I, 2002, FISH PHYSIOL BIOCHEM, V27, P205, DOI 10.1023/B:FISH.0000032726.78074.04; OLDFIELD BP, 1988, HEARING RES, V35, P151, DOI 10.1016/0378-5955(88)90114-1; Parmentier E, 2010, J EXP BIOL, V213, P1107, DOI 10.1242/jeb.039461; Pfeiffer W., 1965, Zeitschrift fuer Morphologie und Oekologie der Tiere, V54, P669, DOI 10.1007/BF00429936; PIORSKI NM, 1999, COMMUN MUS CIENE TEC, P19; Pruzsinszky I, 1998, ENVIRON BIOL FISH, V53, P183, DOI 10.1023/A:1007413108550; RATNASABAPATHI D, 1992, AGGRESSIVE BEHAV, V18, P365, DOI 10.1002/1098-2337(1992)18:5<365::AID-AB2480180506>3.0.CO;2-E; Salem MA, 1998, ARCH HISTOL CYTOL, V61, P179, DOI 10.1679/aohc.61.179; SIEGMUND R, 1977, EXPERIENTIA, V33, P1607, DOI 10.1007/BF01934025; SMOLDERS JWT, 1984, J COMP PHYSIOL, V155, P19, DOI 10.1007/BF00610927; Tavolga WN, 1960, ANIMAL SOUNDS COMMUN, P93; TORRICELLI P, 1990, Bioacoustics, V2, P261; vanDijk P, 1997, HEARING RES, V114, P243, DOI 10.1016/S0378-5955(97)00169-X; VANHEEL WHD, 1956, EXPERIENTIA, V12, P75; WALKOWIAK W, 1980, BEHAV PROCESS, V5, P363, DOI 10.1016/0376-6357(80)90019-4; Wysocki LE, 2005, HEARING RES, V201, P27, DOI 10.1016/j.heares.2004.08.015; Wysocki LE, 2002, HEARING RES, V169, P36, DOI 10.1016/S0378-5955(02)00336-2; WYSOCKI LE, 2006, J ACOUST SOC AM, V120, P3056; Wysocki LE, 2009, J EXP BIOL, V212, P3091, DOI 10.1242/jeb.033274	65	30	31	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26479	10.1371/journal.pone.0026479	http://dx.doi.org/10.1371/journal.pone.0026479			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022618	Green Published, gold			2022-12-27	WOS:000295984400062
J	Wang, CH; Eng, HL; Lin, KH; Chang, CH; Hsieh, CA; Lin, YL; Lin, TM				Wang, Chiou-Huey; Eng, Hock-Liew; Lin, Kuei-Hsiang; Chang, Cheng-Hsien; Hsieh, Chi-An; Lin, Yen-Li; Lin, Tsun-Mei			TLR7 and TLR8 Gene Variations and Susceptibility to Hepatitis C Virus Infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PLASMACYTOID DENDRITIC CELLS; HCV-INFECTION; IMMUNE-RESPONSES; ALPHA PRODUCTION; EXPRESSION; AGONISTS; POLYMORPHISM	Toll-like receptors (TLRs) play pivotal roles in the innate immune system and control inflammatory responses and adaptive immunity. We previously evaluated associations between TLR7 and TLR8 gene SNPs and susceptibility to hepatitis C virus (HCV) infection. Our results suggested that TLR7IVS2-151G and TLR8-129G alleles were present at higher frequency in males of an HCV-infected group as compared to a control group (24.1% vs. 14.4%, p = 0.028; 17.6% vs. 6.8%, p = 0.004, respectively). Based upon their recognition of single stranded viral RNA, this suggested that TLR7 and TLR8 played a significant role in anti-HCV immune responses. Here, we studied the functional effects of these polymorphisms by analyzing the mRNA expressions of TLR7 and TLR8 and cytokine production induced ex vivo by TLR7- and TLR8-specific agonists using whole blood of subjects with different genotypes. The percentage of CD14+ cells from those with an AG haplotype that expressed TLR7 and TLR8 was significantly lower, but higher in intensity compared to cells from those with GG and AC haplotypes. Cells from those with an AG haplotype produced more IFN-alpha and less amounts of pro-inflammatory cytokines upon stimulation. This suggests that variations in TLR7 and TLR8 genes might impair immune responses during HCV infection.	[Wang, Chiou-Huey] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan; [Lin, Kuei-Hsiang] Kaohsiung Med Univ, Dept Clin Lab, Sch Med, Coll Med, Kaohsiung, Taiwan; [Chang, Cheng-Hsien] Kaohsiung Med Univ, Dept Ophthalmol, Kaohsiung, Taiwan; [Wang, Chiou-Huey; Lin, Yen-Li; Lin, Tsun-Mei] I SHOU Univ, Dept Lab Med, E Da Hosp, Kaohsiung, Taiwan; [Lin, Tsun-Mei] I SHOU Univ, Dept Med Res, E Da Hosp, Kaohsiung, Taiwan; [Eng, Hock-Liew] Chang Gung Univ, Dept Pathol, Chang Gung Mem Hosp, Kaohsiung Med Ctr,Coll Med, Kaohsiung, Taiwan; [Hsieh, Chi-An; Lin, Tsun-Mei] Natl Cheng Kung Univ, Dept Med Lab Sci & Biotechnol, Tainan 70101, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; E-Da Hospital; I Shou University; E-Da Hospital; I Shou University; Chang Gung Memorial Hospital; Chang Gung University; National Cheng Kung University	Wang, CH (corresponding author), Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan.	ltmei@mail.ncku.edu.tw			National Science Council [NSC 96-2320-B-650-001-MY3]; E-DA Hospital [EDAHT-98002]	National Science Council(Ministry of Science and Technology, Taiwan); E-DA Hospital	This work was supported by the National Science Council [NSC 96-2320-B-650-001-MY3], E-DA Hospital [EDAHT-98002]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal S, 2007, BIOCHEM SOC T, V35, P1461, DOI 10.1042/BST0351461; Askar E, 2010, J MED VIROL, V82, P1859, DOI 10.1002/jmv.21893; Beignon AS, 2005, J CLIN INVEST, V115, P3265, DOI 10.1172/JCI26032; Beutler B, 2006, ANNU REV IMMUNOL, V24, P353, DOI 10.1146/annurev.immunol.24.021605.090552; Cheng PL, 2007, TRANSL RES, V150, P311, DOI 10.1016/j.trsl.2007.03.010; Chuang TH, 2000, EUR CYTOKINE NETW, V11, P372; Colonna M, 2002, CURR OPIN IMMUNOL, V14, P373, DOI 10.1016/S0952-7915(02)00349-7; Du X, 2000, EUR CYTOKINE NETW, V11, P362; Eng HL, 2004, GENES IMMUN, V5, P426, DOI 10.1038/sj.gene.6364100; Georgel P, 2010, TRENDS MOL MED, V16, P277, DOI 10.1016/j.molmed.2010.04.003; Gorden KB, 2005, J IMMUNOL, V174, P1259, DOI 10.4049/jimmunol.174.3.1259; He YL, 2006, WORLD J GASTROENTERO, V12, P4788; Honda K, 2005, INT IMMUNOL, V17, P1367, DOI 10.1093/intimm/dxh318; Horsmans Y, 2005, HEPATOLOGY, V42, P724, DOI 10.1002/hep.20839; Huang WS, 2005, HEPATO-GASTROENTEROL, V52, P893; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jarrossay D, 2001, EUR J IMMUNOL, V31, P3388, DOI 10.1002/1521-4141(200111)31:11<3388::AID-IMMU3388>3.0.CO;2-Q; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kontorinis Nickolas, 2004, Rev Gastroenterol Disord, V4 Suppl 1, pS39; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Libri NA, 2009, J VIRAL HEPATITIS, V16, P315, DOI 10.1111/j.1365-2893.2008.01011.x; Lu SN, 2004, J VIRAL HEPATITIS, V11, P563, DOI 10.1111/j.1365-2893.2004.00533.x; Marotta F, 2007, J GASTROEN HEPATOL, V22, P697, DOI 10.1111/j.1440-1746.2007.04937.x; Mozer-Lisewska I, 2010, ARCH IMMUNOL THER EX, V58, P295, DOI 10.1007/s00005-010-0087-9; O'Neill LAJ, 2004, SCIENCE, V303, P1481, DOI 10.1126/science.1096113; Oh DY, 2008, J INFECT DIS, V198, P701, DOI 10.1086/590431; Osterlund P, 2005, J VIROL, V79, P9608, DOI 10.1128/JVI.79.15.9608-9617.2005; Powell EE, 2000, HEPATOLOGY, V31, P828, DOI 10.1053/he.2000.6253; Rauch A, 2009, PHARMACOGENOMICS, V10, P1819, DOI 10.2217/PGS.09.121; Sato K, 2007, J GASTROEN HEPATOL, V22, P1627, DOI 10.1111/j.1440-1746.2006.04783.x; Schott E, 2007, J HEPATOL, V47, P203, DOI 10.1016/j.jhep.2007.03.021; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Thomas A, 2007, ANTIMICROB AGENTS CH, V51, P2969, DOI 10.1128/AAC.00268-07; Wieland SF, 2005, J VIROL, V79, P9369, DOI 10.1128/JVI.79.15.9369-9380.2005	34	51	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26235	10.1371/journal.pone.0026235	http://dx.doi.org/10.1371/journal.pone.0026235			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022576	gold, Green Submitted, Green Published			2022-12-27	WOS:000295978600046
J	Poisot, T; Verneau, O; Desdevises, Y				Poisot, Timothee; Verneau, Olivier; Desdevises, Yves			Morphological and Molecular Evolution Are Not Linked in Lamellodiscus (Plathyhelminthes, Monogenea)	PLOS ONE			English	Article							GYRODACTYLUS-SALARIS MALMBERG; OPISTHAPTORAL HARD PARTS; N. SP MONOGENEA; HOST-SPECIFICITY; DIPLODUS-SARGUS; BODY-SIZE; DIPLECTANIDAE; TELEOSTEI; PARASITES; PHYLOGENY	Lamellodiscus Johnston & Tiegs 1922 (Monogenea, Diplectanidae) is a genus of common parasites on the gills of sparid fishes. Here we show that this genus is probably undergoing a fast molecular diversification, as reflected by the important genetic variability observed within three molecular markers (partial nuclear 18S rDNA, Internal Transcribed Spacer 1, and mitonchondrial Cytochrome Oxidase I). Using an updated phylogeny of this genus, we show that molecular and morphological evolution are weakly correlated, and that most of the morphologically defined taxonomical units are not consistent with the molecular data. We suggest that Lamellodiscus morphology is probably constrained by strong environmental (host-induced) pressure, and discuss why this result can apply to other taxa. Genetic variability within nuclear 18S and mitochondrial COI genes are compared for several monogenean genera, as this measure may reflect the level of diversification within a genus. Overall our results suggest that cryptic speciation events may occur within Lamellodiscus, and discuss the links between morphological and molecular evolution.	[Poisot, Timothee; Desdevises, Yves] Univ Paris 06, UMR 7232, Observ Oceanol, Banyuls Sur Mer, France; [Poisot, Timothee; Desdevises, Yves] CNRS, UMR 7232, Observ Oceanol, Banyuls Sur Mer, France; [Verneau, Olivier] Univ Perpignan Via Domitia, Ctr Format & Rech Environm Mediterraneens, CNRS, UPVD,UMR 5110, Perpignan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite Perpignan Via Domitia	Poisot, T (corresponding author), Univ Paris 06, UMR 7232, Observ Oceanol, Banyuls Sur Mer, France.	tpoisot@um2.fr	Desdevises, Yves/H-5334-2019; Desdevises, Yves/AAH-2097-2019; Desdevises, Yves/D-5528-2011	Desdevises, Yves/0000-0001-9774-0336; Desdevises, Yves/0000-0001-9774-0336; Poisot, Timothee/0000-0002-0735-5184				Amine F, 2007, PARASITE, V14, P281, DOI 10.1051/parasite/2007144281; Amine F, 2006, SYST PARASITOL, V64, P37, DOI 10.1007/s11230-005-9016-4; Amine F, 2006, PARASITE, V13, P45, DOI 10.1051/parasite/2006131045; Amine F, 2005, SYST PARASITOL, V1922, P187; Amine F, 2007, ACTA PARASITOL, V52, P305, DOI 10.2478/s11686-007-0052-x; Bakke TA, 2002, INT J PARASITOL, V32, P281, DOI 10.1016/S0020-7519(01)00331-9; Beaumont M, 2001, MOL ECOL, V10, P319, DOI 10.1046/j.1365-294x.2001.01196.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bradley RD, 2001, J MAMMAL, V82, P960, DOI 10.1644/1545-1542(2001)082<0960:ATOTGS>2.0.CO;2; BROWN JM, 1994, MOL BIOL EVOL, V11, P128; Bueno-Silva M, 2011, INT J PARASITOL, V41, P657, DOI 10.1016/j.ijpara.2011.01.002; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Davidova M, 2005, PARASITOL RES, V95, P398, DOI 10.1007/s00436-005-1311-0; DEQUEIROZ K, 1988, CLADISTICS, V4, P317, DOI 10.1111/j.1096-0031.1988.tb00518.x; Desdevises Y, 2002, EVOLUTION, V56, P2459, DOI 10.1111/j.0014-3820.2002.tb00171.x; Desdevises Y, 2000, INT J PARASITOL, V30, P741, DOI 10.1016/S0020-7519(00)00051-5; Desdevises Y, 2002, BIOL J LINN SOC, V77, P431, DOI 10.1046/j.1095-8312.2002.00114.x; Desdevises Y, 2001, INT J PARASITOL, V31, P205, DOI 10.1016/S0020-7519(00)00163-6; Diamanka A, 2011, FOLIA PARASIT, V58, P17, DOI 10.14411/fp.2011.002; Donoghue Michael J., 1994, P393; Ellis JT, 1999, PARASITOLOGY, V118, P357, DOI 10.1017/S0031182098003801; ERGENS R, 1985, FOLIA PARASIT, V32, P377; Euzet L, 1993, 2 INT S MON MONTP SE; FENCHEL T, 1993, OIKOS, V68, P375, DOI 10.2307/3544855; Garcia-Robledo C, 2011, J ANIM ECOL, V80, P976, DOI 10.1111/j.1365-2656.2011.01843.x; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hansen H, 2007, TRENDS PARASITOL, V23, P363, DOI 10.1016/j.pt.2007.06.007; Hansen H, 2007, PARASITOL RES, V100, P1389, DOI 10.1007/s00436-006-0423-5; Harrison G, 1992, ENDLESS FORMS SPECIE, P19; Havermans C, 2010, MOL PHYLOGENET EVOL, V55, P202, DOI 10.1016/j.ympev.2009.10.025; Hay JM, 2008, TRENDS GENET, V24, P106, DOI 10.1016/j.tig.2007.12.002; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Huyse T, 2008, GENE, V417, P27, DOI 10.1016/j.gene.2008.03.008; Justine JL, 2010, SYST PARASITOL, V75, P159, DOI 10.1007/s11230-009-9224-4; Kaci-Chaouchi T, 2008, PARASITOLOGY, V135, P607, DOI 10.1017/S003118200800437X; Laurent P, 2006, MOL PHYLOGENET EVOL, V38, P241, DOI 10.1016/j.ympev.2005.08.013; Libby E, 2011, P ROY SOC B-BIOL SCI, V278, P3574, DOI 10.1098/rspb.2011.0146; Littlewood DTJ, 1997, INT J PARASITOL, V27, P1289, DOI 10.1016/S0020-7519(97)00086-6; LUCKOW M, 1995, SYST BOT, V20, P589, DOI 10.2307/2419812; Lymbery AJ, 1996, PARASITOL TODAY, V12, P486, DOI 10.1016/S0169-4758(96)10071-5; MARZLUFF JM, 1991, ECOLOGY, V72, P428, DOI 10.2307/2937185; Matejusova I, 2002, SYST PARASITOL, V53, P39, DOI 10.1023/A:1019945921143; Matsubayashi KW, 2011, J EVOLUTION BIOL, V24, P1421, DOI 10.1111/j.1420-9101.2011.02274.x; MAURER BA, 1992, EVOLUTION, V46, P939, DOI 10.1111/j.1558-5646.1992.tb00611.x; MO TA, 1993, SYST PARASITOL, V26, P225, DOI 10.1007/BF00009730; MO TA, 1991, SYST PARASITOL, V20, P11, DOI 10.1007/BF00009707; Morand S, 2002, INT J PARASITOL, V32, P111, DOI 10.1016/S0020-7519(01)00347-2; Neifar L, 2004, ZOOSYSTEMA, V26, P365; Olstad K, 2006, PARASITOLOGY, V133, P33, DOI 10.1017/S0031182006009966; Omland KE, 1997, EVOLUTION, V51, P1381, DOI [10.1111/j.1558-5646.1997.tb01461.x, 10.2307/2411190]; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Park JK, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-11; Perkins EM, 2009, MOL PHYLOGENET EVOL, V52, P705, DOI 10.1016/j.ympev.2009.05.008; Pleijel F, 2000, P ROY SOC B-BIOL SCI, V267, P627, DOI 10.1098/rspb.2000.1048; Poisot T, 2011, ECOL LETT, V14, P841, DOI 10.1111/j.1461-0248.2011.01645.x; Poisot T, 2010, BIOL J LINN SOC, V99, P559, DOI 10.1111/j.1095-8312.2009.01381.x; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Poulin R, 1996, CAN J ZOOL, V74, P726, DOI 10.1139/z96-082; Poulin R, 2000, Q REV BIOL, V75, P277, DOI 10.1086/393500; R Core Team, 2021, R LANGUAGE ENV STAT; Rambault A, 2007, TRACER V1 4; Rohde K, 2005, MARINE PARASITOLOGY, P1; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Shinn AP, 2001, J FISH DIS, V24, P83, DOI 10.1046/j.1365-2761.2001.00272.x; Simkova A, 2004, EVOLUTION, V58, P1001, DOI 10.1111/j.0014-3820.2004.tb00434.x; Soller R, 2000, MAR BIOL, V136, P29, DOI 10.1007/s002270050004; Swofford D. L, 2002, PAUP PHYLOGENETIC AN; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Talbot SL, 1996, MOL PHYLOGENET EVOL, V5, P477, DOI 10.1006/mpev.1996.0044; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Verneau O, 2011, PARASITOLOGY, V138, P1778, DOI 10.1017/S0031182011000333; Verneau O, 2002, P ROY SOC B-BIOL SCI, V269, P535, DOI 10.1098/rspb.2001.1899; Verneau O, 1997, MOL BIOL EVOL, V14, P630, DOI 10.1093/oxfordjournals.molbev.a025802; Vignon M, 2011, BIOL J LINN SOC, V102, P694, DOI 10.1111/j.1095-8312.2010.01607.x; Vrba ES, 1987, EVOL ECOL, V1, P283, DOI 10.1007/BF02071554	75	23	26	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26252	10.1371/journal.pone.0026252	http://dx.doi.org/10.1371/journal.pone.0026252			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022582	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000093
J	Kallio, S; Hyona, J; Revonsuo, A; Sikka, P; Nummenmaa, L				Kallio, Sakari; Hyona, Jukka; Revonsuo, Antti; Sikka, Pilleriin; Nummenmaa, Lauri			The Existence of a Hypnotic State Revealed by Eye Movements	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; HYPNOSIS	Hypnosis has had a long and controversial history in psychology, psychiatry and neurology, but the basic nature of hypnotic phenomena still remains unclear. Different theoretical approaches disagree as to whether or not hypnosis may involve an altered mental state. So far, a hypnotic state has never been convincingly demonstrated, if the criteria for the state are that it involves some objectively measurable and replicable behavioural or physiological phenomena that cannot be faked or simulated by non-hypnotized control subjects. We present a detailed case study of a highly hypnotizable subject who reliably shows a range of changes in both automatic and volitional eye movements when given a hypnotic induction. These changes correspond well with the phenomenon referred to as the "trance stare" in the hypnosis literature. Our results show that this 'trance stare' is associated with large and objective changes in the optokinetic reflex, the pupillary reflex and programming a saccade to a single target. Control subjects could not imitate these changes voluntarily. For the majority of people, hypnotic induction brings about states resembling normal focused attention or mental imagery. Our data nevertheless highlight that in some cases hypnosis may involve a special state, which qualitatively differs from the normal state of consciousness.	[Kallio, Sakari; Revonsuo, Antti; Sikka, Pilleriin] Univ Skovde, Sch Humanities & Informat, Skovde, Sweden; [Kallio, Sakari; Revonsuo, Antti; Sikka, Pilleriin] Univ Turku, Ctr Cognit Neurosci, Turku, Finland; [Kallio, Sakari; Hyona, Jukka; Revonsuo, Antti; Sikka, Pilleriin] Univ Turku, Dept Psychol, Turku, Finland; [Nummenmaa, Lauri] Aalto Univ, Sch Sci, Low Temp Lab, Brain Res Unit, Espoo, Finland; [Nummenmaa, Lauri] Aalto Univ, Sch Sci, Dept Biomed Engn & Computat Sci, Espoo, Finland; [Nummenmaa, Lauri] Univ Turku, Turku PET Ctr, Turku, Finland	University of Skovde; University of Turku; University of Turku; Aalto University; Aalto University; University of Turku	Kallio, S (corresponding author), Univ Skovde, Sch Humanities & Informat, Skovde, Sweden.	sakari.kallio@his.se	Hyönä, Jukka/K-5280-2019; Nummenmaa, Lauri/G-6910-2012	Hyönä, Jukka/0000-0002-5950-3361; Nummenmaa, Lauri/0000-0002-2497-9757; Lauwereyns, Jan/0000-0003-0551-2550; Sikka, Pilleriin/0000-0002-1926-6138	Signe and Ane Gyllenberg Foundation; Academy of Finland; Aalto University [121031]	Signe and Ane Gyllenberg Foundation; Academy of Finland(Academy of Finland); Aalto University	This study was supported by the Signe and Ane Gyllenberg Foundation (http://www.gyllenberg-foundation.fi/en/foundation/) (S. K. and P. S.), the Academy of Finland and by the aivoAALTO Grant (121031) from Aalto University (L.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON TJ, 1994, BRAIN, V117, P1073, DOI 10.1093/brain/117.5.1073; Capgras J., 1923, B SOC CLIN MED MENT, V11, P6; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; DIETRICH M, 2009, ANN NY ACAD SCI, V1664, P282; Egner T, 2005, NEUROIMAGE, V27, P969, DOI 10.1016/j.neuroimage.2005.05.002; Findlay JM, 1999, BEHAV BRAIN SCI, V22, P661, DOI 10.1017/S0140525X99002150; Fingelkurts AA, 2007, CONT HYPNOSIS, V24, P3, DOI DOI 10.1002/CH.327; Fingelkurts AA, 2007, NEUROPSYCHOLOGIA, V45, P1452, DOI 10.1016/j.neuropsychologia.2006.11.018; Gauld A., 1992, HIST HYPNOTISM; Gruzelier J., 2005, CONT HYPN, V22, P1; HEINZE HJ, 1994, NATURE, V372, P543, DOI 10.1038/372543a0; Hilgard E. R., 1965, HYPNOTIC SUSCEPTIBIL; Hubbard EM, 2005, NEURON, V48, P509, DOI 10.1016/j.neuron.2005.10.012; HUERTA MF, 1990, J COMP NEUROL, V293, P299, DOI 10.1002/cne.902930211; Ilg UJ, 1997, PROG NEUROBIOL, V53, P293, DOI 10.1016/S0301-0082(97)00039-7; Kallio S, 1999, NEUROREPORT, V10, P3579, DOI 10.1097/00001756-199911260-00021; Kallio S., 2005, CONT HYPNOSIS, V22, P46, DOI DOI 10.1002/(ISSN)1557-0711; Kallio S., 2003, CONT HYPNOSIS, V20, P111, DOI [10.1002/ch.273, DOI 10.1002/CH.273]; KIRSCH I, 1995, AM PSYCHOL, V50, P846, DOI 10.1037/0003-066X.50.10.846; LILIENFELD SO, 2009, 50 GREAT MYTHS POP P; LINDSAY S, 1993, INT J CLIN EXP HYP, V41, P92, DOI 10.1080/00207149308414540; Maquet P, 1999, BIOL PSYCHIAT, V45, P327, DOI 10.1016/S0006-3223(97)00546-5; McGeown WJ, 2009, CONSCIOUS COGN, V18, P848, DOI 10.1016/j.concog.2009.09.001; NOREIKA V, 2011, INT J CLIN IN PRESS; Oakley DA, 2009, TRENDS COGN SCI, V13, P264, DOI 10.1016/j.tics.2009.03.004; PAUS T, 1993, J NEUROPHYSIOL, V70, P453, DOI 10.1152/jn.1993.70.2.453; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Rainville P, 2002, J COGNITIVE NEUROSCI, V14, P887, DOI 10.1162/089892902760191117; Shor R. E., 1962, HARVARD GROUP SCALE; TADA T, 1990, PERCEPT MOTOR SKILL, V71, P832; WEITZENHOFFER A M, 1969, American Journal of Clinical Hypnosis, V11, P221; WEITZENHOFFER A M, 1971, American Journal of Clinical Hypnosis, V14, P102; Weitzenhoffer A. M., 2000, PRACTICE HYPNOTISM; WEITZENHOFFER AM, 1969, PERCEPT MOTOR SKILL, V28, P671, DOI 10.2466/pms.1969.28.2.671; Weitzenhoffer AM, 1962, STANFORD HYPNOTIC SU, V27; Weitzenhoffer AM, 1980, AM J CLIN HYPN, V44, P69	36	15	15	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26374	10.1371/journal.pone.0026374	http://dx.doi.org/10.1371/journal.pone.0026374			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039474	Green Published, gold			2022-12-27	WOS:000296515200016
J	Zhang, HL; Zhang, A; Guo, CF; Shi, CZ; Zhang, Y; Liu, Q; Sparatore, A; Wang, CQ				Zhang, Huili; Zhang, Alian; Guo, Changfa; Shi, Chunzhi; Zhang, Yang; Liu, Qing; Sparatore, Anna; Wang, Changqian			S-diclofenac Protects against Doxorubicin-Induced Cardiomyopathy in Mice via Ameliorating Cardiac Gap Junction Remodeling	PLOS ONE			English	Article							PROGENITOR-CELL FUNCTION; HYDROGEN-SULFIDE; ACUTE-PANCREATITIS; LUNG INJURY; CONNEXIN43; ISCHEMIA; CARDIOTOXICITY; ANTHRACYCLINES; ACTIVATION; SEQUENCE	Hydrogen sulfide (H2S), as a novel gaseous mediator, plays important roles in mammalian cardiovascular tissues. In the present study, we investigated the cardioprotective effect of S-diclofenac (2-[(2,6-dichlorophenyl)amino] benzeneacetic acid 4-(3H-1,2,dithiol-3-thione-5-yl) phenyl ester), a novel H2S-releasing derivative of diclofenac, in a murine model of doxorubicin-induced cardiomyopathy. After a single dose injection of doxorubicin (15 mg/kg, i.p.), male C57BL/6J mice were given daily treatment of S-diclofenac (25 and 50 mu mol/kg, i.p.), diclofenac (25 and 50 mu mol/kg, i.p.), NaHS (50 mu mol/kg, i.p.), or same volume of vehicle. The cardioprotective effect of S-diclofenac was observed after 14 days. It showed that S-diclofenac, but not diclofenac, dose-dependently inhibited the doxorubicin-induced downregulation of cardiac gap junction proteins (connexin 43 and connexin 45) and thus reversed the remodeling of gap junctions in hearts. It also dose-dependently suppressed doxorubicin-induced activation of JNK in hearts. Furthermore, S-diclofenac produced a dose-dependent anti-inflammatory and anti-oxidative effect in this model. As a result, S-diclofenac significantly attenuated doxorubicin-related cardiac injury and cardiac dysfunction, and improved the survival rate of mice with doxorubicin-induced cardiomyopathy. These effects of S-diclofenac were mimicked in large part by NaHS. Therefore, we propose that H2S released from S-diclofenac in vivo contributes to the protective effect in doxorubicin-induced cardiomyopathy. These data also provide evidence for a critical role of H2S in the pathogenesis of doxorubicin-induced cardiomyopathy.	[Zhang, Huili; Zhang, Alian; Shi, Chunzhi; Zhang, Yang; Liu, Qing; Wang, Changqian] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China; [Guo, Changfa] Fudan Univ, Zhongshan Hosp, Dept Cardiac Surg, Shanghai 200433, Peoples R China; [Sparatore, Anna] Univ Milan, Dipartimento Sci Farmaceut Pietro Pratesi, Milan, Italy	Shanghai Jiao Tong University; Fudan University; University of Milan	Zhang, HL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Cardiol, Shanghai 200030, Peoples R China.	huili.zhang815@gmail.com; changqianwang@hotmail.com	zhang, hui/GXH-6098-2022; Sparatore, Anna/J-8634-2015; Zhang, Hui/HHN-8494-2022	Sparatore, Anna/0000-0003-2135-2649; 	National Natural Science Foundation of China [30900522]; Shanghai Pujiang Program [09PJ1407000]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Pujiang Program(Shanghai Pujiang Program); Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	This work was supported by the National Natural Science Foundation of China grant (Grant No. 30900522) www.nsfc.gov.cn, the Shanghai Pujiang Program (Grant No. 09PJ1407000) www.stcsm.gov.cn, and the Scientific Research Foundation for the Returned Overseas Chinese Scholars, Ministry of Education of China www.cscse.edu.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldridge D, 2001, BIOSCIENCE REP, V21, P683, DOI 10.1023/A:1014777111259; Bass SE, 2009, CLIN CANCER RES, V15, P1964, DOI 10.1158/1078-0432.CCR-08-1870; Beardslee MA, 2000, CIRC RES, V87, P656, DOI 10.1161/01.RES.87.8.656; Bhatia M, 2005, FASEB J, V19, P623, DOI 10.1096/fj.04-3023fje; Bhatia M, 2008, SHOCK, V29, P84, DOI 10.1097/shk.0b013e31806ec26; De Angelis A, 2010, CIRCULATION, V121, P276, DOI 10.1161/CIRCULATIONAHA.109.895771; Desplantez T, 2007, J MEMBRANE BIOL, V218, P13, DOI 10.1007/s00232-007-9046-8; Fiorucci S, 2005, GASTROENTEROLOGY, V129, P1210, DOI 10.1053/j.gastro.2005.07.060; Geimonen E, 1996, J BIOL CHEM, V271, P23667, DOI 10.1074/jbc.271.39.23667; Hrdina R, 2000, Acta Medica (Hradec Kralove), V43, P75; Huang CQ, 2010, CIRCULATION, V121, P675, DOI 10.1161/CIRCULATIONAHA.109.902221; Jones RL, 2006, EXPERT OPIN DRUG SAF, V5, P791, DOI 10.1517/14740338.5.6.791; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; LABARCA C, 1980, ANAL BIOCHEM, V102, P344, DOI 10.1016/0003-2697(80)90165-7; Li L, 2007, FREE RADICAL BIO MED, V42, P706, DOI 10.1016/j.freeradbiomed.2006.12.011; LING L, 2005, FASEB J, V19, P1196; Lowicka E, 2007, PHARMACOL REP, V59, P4; LUKE RA, 1991, J CLIN INVEST, V87, P1594, DOI 10.1172/JCI115173; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Petrich BG, 2002, CIRC RES, V91, P640, DOI 10.1161/01.RES.0000035854.11082.01; Rossoni G, 2008, BRIT J PHARMACOL, V153, P100, DOI 10.1038/sj.bjp.0707540; Saffitz JE, 2000, AM J PHYSIOL-HEART C, V278, pH1662, DOI 10.1152/ajpheart.2000.278.5.H1662; Schulz R, 2003, FASEB J, V17, P1355, DOI 10.1096/fj.02-0975fje; Sidhapuriwala J, 2007, EUR J PHARMACOL, V569, P149, DOI 10.1016/j.ejphar.2007.05.003; Singal PK, 1997, FASEB J, V11, P931, DOI 10.1096/fasebj.11.12.9337145; Su YW, 2009, CIRC J, V73, P741, DOI 10.1253/circj.CJ-08-0636; Teunissen BEJ, 2004, CARDIOVASC RES, V62, P246, DOI 10.1016/j.cardiores.2003.12.011; Wallace JL, 2007, GASTROENTEROLOGY, V132, P261, DOI 10.1053/j.gastro.2006.11.042; Whiteman M, 2006, BIOCHEM BIOPH RES CO, V343, P303, DOI 10.1016/j.bbrc.2006.02.154; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Wouters KA, 2005, BRIT J HAEMATOL, V131, P561, DOI 10.1111/j.1365-2141.2005.05759.x; Zanardo RCO, 2006, FASEB J, V20, P2118, DOI 10.1096/fj.06-6270fje; Zhang HL, 2007, AM J PHYSIOL-LUNG C, V292, pL960, DOI 10.1152/ajplung.00388.2006; Zhao WM, 2001, EMBO J, V20, P6008, DOI 10.1093/emboj/20.21.6008	35	9	10	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26441	10.1371/journal.pone.0026441	http://dx.doi.org/10.1371/journal.pone.0026441			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039489	gold, Green Published, Green Submitted			2022-12-27	WOS:000296515200019
J	Dumont, M; Massot, S; Doutriaux, MP; Gratias, A				Dumont, Marilyn; Massot, Sophie; Doutriaux, Marie-Pascale; Gratias, Ariane			Characterization of Brca2-Deficient Plants Excludes the Role of NHEJ and SSA in the Meiotic Chromosomal Defect Phenotype	PLOS ONE			English	Article							HUMAN BRCA2 PROTEIN; DNA BREAK REPAIR; ARABIDOPSIS MUTANTS; NUCLEAR ABNORMALITIES; DEFICIENT PLANTS; TELOMERE LENGTH; LIGASE-IV; GENE; RAD51; RECOMBINATION	In somatic cells, three major pathways are involved in the repair of DNA double-strand breaks (DBS): Non-Homologous End Joining (NHEJ), Single-Strand Annealing (SSA) and Homologous Recombination (HR). In somatic and meiotic HR, DNA DSB are 59 to 39 resected, producing long 39 single-stranded DNA extensions. Brca2 is essential to load the Rad51 recombinase onto these 39 overhangs. The resulting nucleofilament can thus invade a homologous DNA sequence to copy and restore the original genetic information. In Arabidopsis, the inactivation of Brca2 specifically during meiosis by an RNAi approach results in aberrant chromosome aggregates, chromosomal fragmentation and missegregation leading to a sterility phenotype. We had previously suggested that such chromosomal behaviour could be due to NHEJ. In this study, we show that knock-out plants affected in both BRCA2 genes show the same meiotic phenotype as the RNAi-inactivated plants. Moreover, it is demonstrated that during meiosis, neither NHEJ nor SSA compensate for HR deficiency in BRCA2-inactivated plants. The role of the plant-specific DNA Ligase6 is also excluded. The possible mechanism(s) involved in the formation of these aberrant chromosomal bridges in the absence of HR during meiosis are discussed.	[Dumont, Marilyn; Massot, Sophie; Doutriaux, Marie-Pascale; Gratias, Ariane] Univ Paris 11, CNRS, UMR8618, Inst Biol Plantes, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Dumont, M (corresponding author), Univ Paris 11, CNRS, UMR8618, Inst Biol Plantes, F-91405 Orsay, France.	ariane.gratias-weill@u-psud.fr			Centre National de la Recherche Scientifique; Universite Paris Sud-11; French Ministere de L'Enseignement Superieur et de la Recherche	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite Paris Sud-11; French Ministere de L'Enseignement Superieur et de la Recherche	This work was supported by the Centre National de la Recherche Scientifique and the Universite Paris Sud-11. M. D. is the recipient of a French Ministere de L'Enseignement Superieur et de la Recherche doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe K, 2009, J EXP BOT, V60, P2751, DOI 10.1093/jxb/erp135; Andreuzza S, 2010, DEVELOPMENT, V137, P73, DOI 10.1242/dev.041020; Bonatto D, 2005, BRAZ J MED BIOL RES, V38, P321, DOI 10.1590/S0100-879X2005000300002; Bundock P, 2002, NUCLEIC ACIDS RES, V30, P3395, DOI 10.1093/nar/gkf445; Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470; Charbonnel C, 2011, DNA REPAIR IN PRESS; Charbonnel C, 2010, PLANT J, V64, P280, DOI 10.1111/j.1365-313X.2010.04331.x; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cole F, 2010, GENE DEV, V24, P1201, DOI 10.1101/gad.1944710; Couteau F, 1999, PLANT CELL, V11, P1623, DOI 10.1105/tpc.11.9.1623; Daley JM, 2005, ANNU REV GENET, V39, P431, DOI 10.1146/annurev.genet.39.073003.113340; Dray E, 2006, PLANT PHYSIOL, V140, P1059, DOI 10.1104/pp.105.075838; Dubest S, 2004, PLANT J, V39, P334, DOI 10.1111/j.1365-313X.2004.02136.x; Dubest S, 2002, EMBO REP, V3, P1049, DOI 10.1093/embo-reports/kvf211; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; Fidantsef AL, 2000, PLANT PHYSIOL, V124, P579, DOI 10.1104/pp.124.2.579; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Friesner J, 2003, PLANT J, V34, P427, DOI 10.1046/j.1365-313X.2003.01738.x; Gallego ME, 2003, PLANT J, V35, P557, DOI 10.1046/j.1365-313X.2003.01827.x; Hartsuiker E, 2009, MOL CELL BIOL, V29, P1671, DOI 10.1128/MCB.01182-08; Heacock ML, 2007, NUCLEIC ACIDS RES, V35, P6490, DOI 10.1093/nar/gkm472; Hefner E, 2003, J EXP BOT, V54, P669, DOI 10.1093/jxb/erg069; Helliwell C, 2003, METHODS, V30, P289, DOI 10.1016/S1046-2023(03)00036-7; Jasin M, 2002, ONCOGENE, V21, P8981, DOI 10.1038/sj.onc.1206176; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kojic M, 2002, MOL CELL, V10, P683, DOI 10.1016/S1097-2765(02)00632-9; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Martin JS, 2005, MOL CELL BIOL, V25, P3127, DOI 10.1128/MCB.25.8.3127-3139.2005; MCWHIR J, 1993, NAT GENET, V5, P217, DOI 10.1038/ng1193-217; Milman N, 2009, MOL CELL BIOL, V29, P5998, DOI 10.1128/MCB.01127-09; Neale MJ, 2005, NATURE, V436, P1053, DOI 10.1038/nature03872; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Preuss SB, 1999, MOL GEN GENET, V261, P623, DOI 10.1007/s004380050004; Riha K, 2002, EMBO J, V21, P2819, DOI 10.1093/emboj/21.11.2819; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Sharan SK, 1997, NATURE, V386, P804, DOI 10.1038/386804a0; Siaud N, 2004, EMBO J, V23, P1392, DOI 10.1038/sj.emboj.7600146; Tamura K, 2002, PLANT J, V29, P771, DOI 10.1046/j.1365-313X.2002.01258.x; Tanaka S, 2010, BIOCHEM BIOPH RES CO, V396, P289, DOI 10.1016/j.bbrc.2010.04.082; Tarsounas M, 2004, PHILOS T R SOC B, V359, P87, DOI 10.1098/rstb.2003.1368; Thorslund T, 2007, EMBO J, V26, P2915, DOI 10.1038/sj.emboj.7601739; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Tian M, 2004, MOL CELL BIOL, V24, P1200, DOI 10.1128/MCB.24.3.1200-1205.2004; Timson DJ, 2000, MUTAT RES-DNA REPAIR, V460, P301, DOI 10.1016/S0921-8777(00)00033-1; van Attikum H, 2003, NUCLEIC ACIDS RES, V31, P4247, DOI 10.1093/nar/gkg458; Wang S, 2010, P NATL ACAD SCI USA, V107, P22716, DOI 10.1073/pnas.1005978107; Wang YK, 2010, PLANT MOL BIOL, V74, P453, DOI 10.1007/s11103-010-9685-5; Waterworth WM, 2010, PLANT J, V63, P848, DOI 10.1111/j.1365-313X.2010.04285.x; Waterworth WM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-79; Weeda G, 1997, CURR BIOL, V7, P427, DOI 10.1016/S0960-9822(06)00190-4; West CE, 2000, PLANT J, V24, P67, DOI 10.1046/j.1365-313x.2000.00856.x; West CE, 2002, PLANT J, V31, P517, DOI 10.1046/j.1365-313X.2002.01370.x; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wong AKC, 1997, J BIOL CHEM, V272, P31941, DOI 10.1074/jbc.272.51.31941; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yu VPCC, 2000, GENE DEV, V14, P1400	57	4	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26696	10.1371/journal.pone.0026696	http://dx.doi.org/10.1371/journal.pone.0026696			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039535	Green Submitted, Green Published, gold			2022-12-27	WOS:000296513200044
J	Drozd, M; Gangaiah, D; Liu, Z; Rajashekara, G				Drozd, Mary; Gangaiah, Dharanesh; Liu, Zhe; Rajashekara, Gireesh			Contribution of TAT System Translocated PhoX to Campylobacter jejuni Phosphate Metabolism and Resilience to Environmental Stresses	PLOS ONE			English	Article							PSEUDOMONAS-FLUORESCENS PF0-1; BIOFILM FORMATION; INORGANIC POLYPHOSPHATE; ALKALINE-PHOSPHATASE; REGULON; EXPRESSION; PROTEIN; SURVIVAL; COLI; HOMEOSTASIS	Campylobacter jejuni is a common gastrointestinal pathogen that colonizes food animals; it is transmitted via fecal contamination of food, and infections in immune-compromised people are more likely to result in serious long-term illness. Environmental phosphate is likely an important sensor of environmental fitness and the ability to obtain extracellular phosphate is central to the bacteria's core metabolic responses. PhoX is the sole alkaline phosphatase in C. jejuni, a substrate of the TAT transport system. Alkaline phosphatases mediate the hydrolytic removal of inorganic phosphate (Pi) from phospho-organic compounds and thereby contribute significantly to the polyphosphate kinase 1 (ppk1) mediated formation of poly P, a molecule that regulates bacterial response to stresses and virulence. Similarly, deletion of the tatC gene, a key component of the TAT system, results in diverse phenotypes in C. jejuni including reduced stress tolerance and in vivo colonization. Therefore, here we investigated the contribution of phoX in poly P synthesis and in TAT-system mediated responses. The phoX deletion mutant showed significant decrease (P<0.05) in poly P accumulation in stationary phase compared to the wild-type, suggesting that PhoX is a major contributor to the inorganic phosphate pool in the cell which is essential for poly P synthesis. The phoX deletion is sufficient for a nutrient stress defect similar to the defect previously described for the Delta tatC mutant. Additionally, the phoX deletion mutant has increased resistance to certain antimicrobials. The Delta phoX mutant was also moderately defective in invasion and intracellular survival within human intestinal epithelial cells as well as in chicken colonization. Further, the Delta phoX mutant produced increased biofilm that can be rescued with 1 mM inorganic phosphate. The qRT-PCR of the Delta phoX mutant revealed transcriptional changes that suggest potential mechanisms for the increased biofilm phenotype.	[Drozd, Mary; Gangaiah, Dharanesh; Liu, Zhe; Rajashekara, Gireesh] Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA	Ohio State University	Drozd, M (corresponding author), Ohio State Univ, Ohio Agr Res & Dev Ctr, Food Anim Hlth Res Program, Dept Vet Prevent Med, Wooster, OH 44691 USA.	rajashekara.2@osu.edu	Drozd, Mary/AAC-4533-2021; Rajashekara, Gireesh/E-3913-2011		United States Department of Agriculture [2007-35201-18414]; Ohio Agricultural Research and Development Center, The Ohio State University	United States Department of Agriculture(United States Department of Agriculture (USDA)); Ohio Agricultural Research and Development Center, The Ohio State University(Ohio State University)	The research in Dr. Rajashekara's lab is supported by the United States Department of Agriculture grant 2007-35201-18414 and by the SEEDS grant from Ohio Agricultural Research and Development Center, The Ohio State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; BRICKMAN E, 1975, J MOL BIOL, V96, P307, DOI 10.1016/0022-2836(75)90350-2; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; Candon HL, 2007, J BACTERIOL, V189, P8099, DOI 10.1128/JB.01037-07; Centers for Disease Control and Prevention Centers for Disease Control and Prevention Division of Foodborne Bacterial and Mycotic Diseases National Center for Zoonotic Vector-Borne and Enteric Diseases, 2010, CAMP TECHN INF; Chaveerach P, 2003, APPL ENVIRON MICROB, V69, P711, DOI 10.1128/AEM.69.1.711-714.2003; Crushell E, 2004, PEDIATR RES, V55, P3, DOI 10.1203/01.PDR.0000099794.06260.71; Danhorn T, 2004, J BACTERIOL, V186, P4492, DOI 10.1128/JB.186.14.4492-4501.2004; De Buck E, 2008, TRENDS MICROBIOL, V16, P442, DOI 10.1016/j.tim.2008.06.004; Fields JA, 2008, J BACTERIOL, V192, P2182; Gangaiah D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012142; Gangaiah D, 2009, APPL ENVIRON MICROB, V75, P7838, DOI 10.1128/AEM.01603-09; Garenaux A, 2008, RES MICROBIOL, V159, P718, DOI 10.1016/j.resmic.2008.08.001; Gillespie IA, 2008, EPIDEMIOL INFECT, V136, P1717, DOI 10.1017/S0950268808000319; Greig JD, 2009, INT J FOOD MICROBIOL, V130, P77, DOI 10.1016/j.ijfoodmicro.2008.12.031; Hall SJ, 2008, J BACTERIOL, V190, P8075, DOI 10.1128/JB.00821-08; Hartley LE, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-13; Hitchcock A, 2010, MICROBIOL-SGM, V156, P2994, DOI 10.1099/mic.0.042788-0; Hwang S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022300; Karatan E, 2009, MICROBIOL MOL BIOL R, V73, P310, DOI 10.1128/MMBR.00041-08; Karlyshev AV, 2005, APPL ENVIRON MICROB, V71, P4004, DOI 10.1128/AEM.71.7.4004-4013.2005; Kemper Alex R, 2002, Eff Clin Pract, V5, P84; Kim SK, 2000, J BACTERIOL, V182, P5596, DOI 10.1128/JB.182.19.5596-5599.2000; Kopecko DJ, 2001, TRENDS MICROBIOL, V9, P389, DOI 10.1016/S0966-842X(01)02107-2; KORLATH JA, 1985, J INFECT DIS, V152, P592, DOI 10.1093/infdis/152.3.592; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kuramitsu HK, 2005, J PERIODONTOL, V76, P2047, DOI 10.1902/jop.2005.76.11-S.2047; Lamarche MG, 2008, FEMS MICROBIOL REV, V32, P461, DOI 10.1111/j.1574-6976.2008.00101.x; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; McLennan MK, 2008, J BACTERIOL, V190, P1097, DOI 10.1128/JB.00516-07; Mendz GL, 2005, ARCH MICROBIOL, V183, P113, DOI 10.1007/s00203-004-0752-7; Monds RD, 2001, MOL MICROBIOL, V42, P415, DOI 10.1046/j.1365-2958.2001.02641.x; Monds RD, 2007, MOL MICROBIOL, V63, P656, DOI 10.1111/j.1365-2958.2006.05539.x; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Naito M, 2010, J BACTERIOL, V192, P2182, DOI 10.1128/JB.01222-09; Newell DG, INT J FOOD MICROB S1, V139, pS3; Pichereau V, 2000, INT J FOOD MICROBIOL, V55, P19, DOI 10.1016/S0168-1605(00)00208-7; Pigrau C, 1997, CLIN INFECT DIS, V25, P1414, DOI 10.1086/516127; Pratt JT, 2009, J BACTERIOL, V191, P6632, DOI 10.1128/JB.00708-09; Rajashekara G, 2009, FOODBORNE PATHOG DIS, V6, P935, DOI 10.1089/fpd.2009.0298; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; Rashid MH, 2000, J BACTERIOL, V182, P225, DOI 10.1128/JB.182.1.225-227.2000; Romeo T, 2008, CURRENT TOPICS MICRO; Salloway S, 1996, INFECT IMMUN, V64, P2945, DOI 10.1128/IAI.64.8.2945-2949.1996; Sambrook J., 2001, MOL CLONING LAB MANU; Scharff R.L., 2010, PRODUCE SAFETY PROJE; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sebastian M, 2009, ISME J, V3, P563, DOI 10.1038/ismej.2009.10; Silby MW, 2009, APPL ENVIRON MICROB, V75, P3872, DOI 10.1128/AEM.00017-09; Spira B, 1998, MOL GEN GENET, V257, P469, DOI 10.1007/s004380050671; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; Sultan SZ, 2010, FEMS MICROBIOL LETT, V302, P22, DOI 10.1111/j.1574-6968.2009.01837.x; Taschner NP, 2004, MICROBIOL-SGM, V150, P2985, DOI 10.1099/mic.0.27124-0; Vaishnava S, 2007, CELL HOST MICROBE, V2, P365, DOI 10.1016/j.chom.2007.11.004; van Mourik A, 2008, MICROBIOL-SGM, V154, P584, DOI 10.1099/mic.0.2007/012120-0; VanBogelen RA, 1996, J BACTERIOL, V178, P4344, DOI 10.1128/jb.178.15.4344-4366.1996; Vincent G. K., 2010, CURRENT POPULATION R, VP25, P1; Wosten MMSM, 2006, MOL MICROBIOL, V62, P278, DOI 10.1111/j.1365-2958.2006.05372.x; Yen MR, 2002, ARCH MICROBIOL, V177, P441, DOI 10.1007/s00203-002-0408-4; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718; Yuan ZC, 2005, MOL MICROBIOL, V58, P877, DOI 10.1111/j.1365-2958.2005.04874.x; Zaheer R, 2009, ENVIRON MICROBIOL, V11, P1572, DOI 10.1111/j.1462-2920.2009.01885.x	62	13	14	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26336	10.1371/journal.pone.0026336	http://dx.doi.org/10.1371/journal.pone.0026336			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028859	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800035
J	Li, FW; Kuo, LY; Rothfels, CJ; Ebihara, A; Chiou, WL; Windham, MD; Pryer, KM				Li, Fay-Wei; Kuo, Li-Yaung; Rothfels, Carl J.; Ebihara, Atsushi; Chiou, Wen-Liang; Windham, Michael D.; Pryer, Kathleen M.			rbcL and matK Earn Two Thumbs Up as the Core DNA Barcode for Ferns	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; CHLOROPLAST GENOME; EVOLUTION; HYMENOPHYLLACEAE; GAMETOPHYTES; PHYLOGENY; CLASSIFICATION; IDENTIFICATION; DISCRIMINATE; POSITION	Background: DNA barcoding will revolutionize our understanding of fern ecology, most especially because the accurate identification of the independent but cryptic gametophyte phase of the fern's life history-an endeavor previously impossible-will finally be feasible. In this study, we assess the discriminatory power of the core plant DNA barcode (rbcL and matK), as well as alternatively proposed fern barcodes (trnH-psbA and trnL-F), across all major fern lineages. We also present plastid barcode data for two genera in the hyperdiverse polypod clade-Deparia (Woodsiaceae) and the Cheilanthes marginata group (currently being segregated as a new genus of Pteridaceae)-to further evaluate the resolving power of these loci. Principal Findings: Our results clearly demonstrate the value of matK data, previously unavailable in ferns because of difficulties in amplification due to a major rearrangement of the plastid genome. With its high sequence variation, matK complements rbcL to provide a two-locus barcode with strong resolving power. With sequence variation comparable to matK, trnL-F appears to be a suitable alternative barcode region in ferns, and perhaps should be added to the core barcode region if universal primer development for matK fails. In contrast, trnH-psbA shows dramatically reduced sequence variation for the majority of ferns. This is likely due to the translocation of this segment of the plastid genome into the inverted repeat regions, which are known to have a highly constrained substitution rate. Conclusions: Our study provides the first endorsement of the two-locus barcode (rbcL+matK) in ferns, and favors trnL-F over trnH-psbA as a potential back-up locus. Future work should focus on gathering more fern matK sequence data to facilitate universal primer development.	[Li, Fay-Wei; Rothfels, Carl J.; Windham, Michael D.; Pryer, Kathleen M.] Duke Univ, Dept Biol, Durham, NC 27710 USA; [Kuo, Li-Yaung] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan; [Ebihara, Atsushi] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan; [Chiou, Wen-Liang] Taiwan Forestry Res Inst, Div Bot Garden, Taipei, Taiwan	Duke University; National Taiwan University; National Museum of Nature and Science	Li, FW (corresponding author), Duke Univ, Dept Biol, Durham, NC 27710 USA.	fl43@duke.edu	Pryer, Kathleen M./ABF-4908-2020; Pryer, Kathleen/X-4635-2019	Pryer, Kathleen M./0000-0002-9776-6736; Rothfels, Carl/0000-0002-6605-1770; Li, Fay-Wei/0000-0002-0076-0152	National Science Foundation [DEB-0717398]	National Science Foundation(National Science Foundation (NSF))	A National Science Foundation (www.nsf.gov) grant #DEB-0717398 to KMP and MDW (co-authors). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIRKY CW, 1992, GENETICS, V130, P677; BOWMAN CM, 1983, THEOR APPL GENET, V65, P247, DOI 10.1007/BF00308076; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; CURTIS SE, 1984, MOL BIOL EVOL, V1, P291; Dassler CL, 2001, BRITTONIA, V53, P352, DOI 10.1007/BF02812705; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; Duffy AM, 2009, GENE, V438, P17, DOI 10.1016/j.gene.2009.02.006; Ebihara A, 2008, AM J BOT, V95, P1645, DOI 10.3732/ajb.0800122; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Ebihara A, 2009, MOL ECOL, V18, P4904, DOI 10.1111/j.1365-294X.2009.04406.x; FARRAR DR, 1967, SCIENCE, V155, P1266, DOI 10.1126/science.155.3767.1266; Fazekas AJ, 2009, MOL ECOL RESOUR, V9, P130, DOI 10.1111/j.1755-0998.2009.02652.x; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Gureyeva II, 2003, PTERIDOLOGY IN THE NEW MILLENNIUM, P341; Hilu KW, 2003, AM J BOT, V90, P1758, DOI 10.3732/ajb.90.12.1758; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hollingsworth PM, 2009, P NATL ACAD SCI USA, V106, P12794, DOI 10.1073/pnas.0905845106; JOHNSON LA, 1995, ANN MO BOT GARD, V82, P149, DOI 10.2307/2399875; Katoh K, 2008, BRIEF BIOINFORM, V9, P286, DOI 10.1093/bib/bbn013; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuo LY, 2011, MOL PHYLOGENET EVOL, V59, P556, DOI 10.1016/j.ympev.2011.03.010; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Li FW, 2010, MOL ECOL RESOUR, V10, P92, DOI 10.1111/j.1755-0998.2009.02745.x; Li FW, 2009, PLANT SYST EVOL, V281, P77, DOI 10.1007/s00606-009-0188-2; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu Y, 2010, J SYST EVOL, V48, P36, DOI 10.1111/j.1759-6831.2009.00063.x; Ma XY, 2010, BIOL PHARM BULL, V33, P1919, DOI 10.1248/bpb.33.1919; Mickel JT, 2004, MEMOIR NEW YORK BOT, V88, P176; Newmaster S G, 2008, Mol Ecol Resour, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nitta JH, 2008, TAXON, V57, P725, DOI 10.1002/tax.573006; PALMER JD, 1983, MOL GEN GENET, V190, P13, DOI 10.1007/BF00330318; Perry AS, 2002, J MOL EVOL, V55, P501, DOI 10.1007/s00239-002-2333-y; Piredda R, 2011, MOL ECOL RESOUR, V11, P72, DOI 10.1111/j.1755-0998.2010.02900.x; Pryer KM, 2010, MOL ECOL RESOUR, V10, P979, DOI 10.1111/j.1755-0998.2010.02858.x; Pryer KM, 2004, AM J BOT, V91, P1582, DOI 10.3732/ajb.91.10.1582; Pryer KM, 2001, AM J BOT, V88, P1118, DOI 10.2307/2657095; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Rothfels CJ, IN PRESS; Roy S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013674; Rumsey F. J., 1998, Watsonia, V22, P1; Schneider H, 2006, MOL ECOL NOTES, V6, P989, DOI 10.1111/j.1471-8286.2006.01424.x; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Spooner DM, 2009, AM J BOT, V96, P1177, DOI 10.3732/ajb.0800246; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Swofford DL, 2002, PAUP PHYLOGENETIC AN; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tate JA, 2003, SYST BOT, V28, P723; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Van den Heede CJ, 2003, AM J BOT, V90, P481, DOI 10.3732/ajb.90.3.481; Wang CN, 2004, SYST BOT, V29, P407, DOI 10.1600/036364404774195593; Watkins JE, 2007, AM J BOT, V94, P701, DOI 10.3732/ajb.94.4.701; Wheeler TJ, 2007, BIOINFORMATICS, V23, pI559, DOI 10.1093/bioinformatics/btm226; Wolf PG, 2010, GENOME, V53, P731, DOI [10.1139/G10-061, 10.1139/g10-061]; Wolf PG, 2003, DNA RES, V10, P59, DOI 10.1093/dnares/10.2.59; WOLF PG, 1994, MOL PHYLOGENET EVOL, V3, P383, DOI 10.1006/mpev.1994.1044; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Yao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013102; Zhao ZL, 2007, PLANTA MED, V73, P1230, DOI 10.1055/s-2007-981588	62	69	83	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26597	10.1371/journal.pone.0026597	http://dx.doi.org/10.1371/journal.pone.0026597			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028918	gold, Green Published, Green Submitted			2022-12-27	WOS:000296510800059
J	Bystrom, J; Wray, JA; Sugden, MC; Holness, MJ; Swales, KE; Warner, TD; Edin, ML; Zeldin, DC; Gilroy, DW; Bishop-Bailey, D				Bystrom, Jonas; Wray, Jessica A.; Sugden, Mary C.; Holness, Mark J.; Swales, Karen E.; Warner, Timothy D.; Edin, Matthew L.; Zeldin, Darryl C.; Gilroy, Derek W.; Bishop-Bailey, David			Endogenous Epoxygenases Are Modulators of Monocyte/Macrophage Activity	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; KAPPA-B ACTIVITY; ENDOTHELIAL-CELLS; LAMINAR-FLOW; IN-VITRO; CYTOCHROME-P450; ACID; EXPRESSION; CYP2J2; GAMMA	Background: Arachidonic acid is metabolized through three major metabolic pathways, the cyclooxygenase, lipoxygenase and CYP450 enzyme systems. Unlike cyclooxygenase and lipoxygenases, the role of CYP450 epoxygenases in monocyte/macrophage-mediated responses is not known. Methodology/Principal Findings: When transfected in vitro, CYP2J2 is an efficient activator of anti-inflammatory pathways through the nuclear receptor peroxisome proliferator-activated receptor (PPAR) alpha. Human monocytes and macrophages contain PPAR alpha and here we show they express the epoxygenases CYP2J2 and CYP2C8. Inhibition of constitutive monocyte epoxygenases using the epoxygenase inhibitor SKF525A induces cyclooxygenase (COX)-2 expression and activity, and the release of TNF alpha, and can be reversed by either add back of the endogenous epoxygenase products and PPAR alpha ligand 11,12-epoxyeicosatrienoic acid (EET) or the addition of the selective synthetic PPAR alpha ligand GW7647. In alternatively activated (IL-4-treated) monocytes, in contrast to classically activated cells, epoxygenase inhibition decreased TNF alpha release. Epoxygenases can be pro-inflammatory via superoxide anion production. The suppression of TNF alpha by SKF525A in the presence of IL-4 was associated with a reduction in superoxide anion generation and reproduced by the superoxide dismutase MnCl2. Similar to these acute activation studies, in monocyte derived macrophages, epoxygenase inhibition elevates M1 macrophage TNF alpha mRNA and further decreases M2 macrophage TNF alpha. Conclusions/Significance: In conclusion, epoxygenase activity represents an important endogenous pathway which limits monocyte activation. Moreover endogenous epoxygenases are immuno-modulators regulating monocyte/macrophage activation depending on the underlying activation state.	[Bystrom, Jonas; Wray, Jessica A.; Swales, Karen E.; Warner, Timothy D.; Bishop-Bailey, David] Queen Mary Univ London, William Harvey Res Inst, London, England; [Sugden, Mary C.; Holness, Mark J.] Queen Mary Univ London, Blizzard Inst Cell & Mol Sci, London, England; [Edin, Matthew L.; Zeldin, Darryl C.] NIEHS, Div Intramural Res, NIH, Res Triangle Pk, NC 27709 USA; [Gilroy, Derek W.] UCL, Div Med, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of London; University College London	Bystrom, J (corresponding author), Queen Mary Univ London, William Harvey Res Inst, London, England.	d.bishop-bailey@qmul.ac.uk	Gilroy, Derek W/C-2588-2009; Gilroy, Derek/AAP-7227-2020; Zeldin, Darryl C/Y-7091-2018; Warner, Timothy D/A-1980-2009; Edin, Matthew/AAI-1934-2019	Gilroy, Derek/0000-0003-3476-0844; Zeldin, Darryl C/0000-0002-2087-7307; Warner, Timothy D/0000-0003-3988-4408; Edin, Matthew/0000-0002-7042-500X; Bishop-Bailey, David/0000-0003-2455-596X	British Heart Foundation [FS/04/075, BS/02/002, PG/08/070/25464]; Wellcome Trust [074361/Z/04/Z]; National Institutes of Health, NIEHS; European Community [LSHM-CT-2004-0050333]; National Institute of Health Research; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025034] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health, NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); European Community(European Commission); National Institute of Health Research(National Institute for Health Research (NIHR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was partly funded by grants from the British Heart Foundation (FS/04/075; BS/02/002; PG/08/070/25464), the Wellcome Trust (074361/Z/04/Z) and the Intramural Research Programs of the National Institutes of Health, NIEHS (to DZ), and European Community FP6 funding (LSHM-CT-2004-0050333). Derek Gilroy holds a Wellcome Trust Senior Fellowship. This work forms part of the research themes contributing to the translational research portfolio of Barts and the London Cardiovascular Biomedical Research Unit which is supported and funded by the National Institute of Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON SL, 1990, J IMMUNOL, V144, P625; BAIN B, 1972, TRANSPLANT P, V4, P163; BHASKARAN G, 1992, J LEUKOCYTE BIOL, V52, P218, DOI 10.1002/jlb.52.2.218; Bishop-Bailey D, 2000, BRIT J PHARMACOL, V129, P823, DOI 10.1038/sj.bjp.0703149; Bishop-Bailey D, 2003, PROSTAG OTH LIPID M, V71, P1, DOI 10.1016/S0090-6980(03)00003-0; Bishop-Bailey D, 2002, CIRC RES, V91, P210, DOI 10.1161/01.RES.0000029080.15742.85; Brown PJ, 2001, BIOORG MED CHEM LETT, V11, P1225, DOI 10.1016/S0960-894X(01)00188-3; Campbell W.B., PFLUGERS ARCH, V459, P881; Capdevila JH, 2000, J LIPID RES, V41, P163; CHEN C, J PHARM EXP THER, V336, P344; Deng Y., FASEB J, V25, P703; DENG Y, FASEB J; Donato MT, 1998, J PHARMACOL EXP THER, V284, P760; DONNELLY RP, 1993, J IMMUNOL, V151, P5603; Fleming I, 2001, CIRC RES, V88, P44, DOI 10.1161/01.RES.88.1.44; Harrington LS, 2004, EUR J PHARMACOL, V506, P165, DOI 10.1016/j.ejphar.2004.09.062; HARRINGTON LS, BIOCH BIOPHYS RES CO, V408, P511; Kaipainen A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000260; KONKEL A, BIOCH BIOPHYS ACTA, V1814, P210; Lee CR, 2007, PHARMACOGENET GENOM, V17, P349, DOI 10.1097/FPC.0b013e32809913ea; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Liu Y, 2004, CIRCULATION, V110, P1128, DOI 10.1161/01.CIR.0000139850.08365.EC; MacKenzie A, 1999, BRIT J PHARMACOL, V127, P1159, DOI 10.1038/sj.bjp.0702670; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Spiecker M, 2004, CIRCULATION, V110, P2132, DOI 10.1161/01.CIR.0000143832.91812.60; Spiecker M, 2005, ARCH BIOCHEM BIOPHYS, V433, P413, DOI 10.1016/j.abb.2004.10.009; Sun JX, 2002, CIRC RES, V90, P1020, DOI 10.1161/01.RES.0000017727.35930.33; Thieu VT, 2007, J LEUKOCYTE BIOL, V82, P370, DOI 10.1189/jlb.1106707; Werner K, 2002, PROSTAG LEUKOTR ESS, V67, P397, DOI 10.1054/plef.2002.0449; Wray J, 2008, EXP PHYSIOL, V93, P148, DOI 10.1113/expphysiol.2007.038612; Wray JA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007421; Wu S, 1996, J BIOL CHEM, V271, P3460; Yang BC, 2001, MOL PHARMACOL, V60, P310, DOI 10.1124/mol.60.2.310; Yang WQ, 2008, J PHARMACOL EXP THER, V324, P1019, DOI 10.1124/jpet.107.129577; Zaric J, 2005, J BIOL CHEM, V280, P1077, DOI 10.1074/jbc.M410006200; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200	41	64	67	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26591	10.1371/journal.pone.0026591	http://dx.doi.org/10.1371/journal.pone.0026591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028915	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500092
J	Fowler, ZL; Shah, K; Panepinto, JC; Jacobs, A; Koffas, MAG				Fowler, Zachary L.; Shah, Karan; Panepinto, John C.; Jacobs, Amy; Koffas, Mattheos A. G.			Development of Non-Natural Flavanones as Antimicrobial Agents	PLOS ONE			English	Article							NATURAL-PRODUCTS; ESCHERICHIA-COLI; PUMP INHIBITORS; DERIVATIVES; SUSCEPTIBILITY; BIOSYNTHESIS; PERSPECTIVES; FLAVONOIDS; CHALCONES; TRENDS	With growing concerns over multidrug resistance microorganisms, particularly strains of bacteria and fungi, evolving to become resistant to the antimicrobial agents used against them, the identification of new molecular targets becomes paramount for novel treatment options. Recently, the use of new treatments containing multiple active ingredients has been shown to increase the effectiveness of existing molecules for some infections, often with these added compounds enabling the transport of a toxic molecule into the infecting species. Flavonoids are among the most abundant plant secondary metabolites and have been shown to have natural abilities as microbial deterrents and anti-infection agents in plants. Combining these ideas we first sought to investigate the potency of natural flavonoids in the presence of efflux pump inhibitors to limit Escherichia coli growth. Then we used the natural flavonoid scaffold to synthesize non-natural flavanone molecules and further evaluate their antimicrobial efficacy on Escherichia coli, Bacillus subtilis and the fungal pathogens Cryptococcus neoformans and Aspergillus fumigatus. Of those screened, we identified the synthetic molecule 4-chloro-flavanone as the most potent antimicrobial compound with a MIC value of 70 mu g/mL in E. coli when combined with the inhibitor Phe-Arg-beta-naphthylamide, and MICs of 30 mu g/mL in S. cerevesiae and 30 mu g/mL in C. neoformans when used alone. Through this study we have demonstrated that combinatorial synthesis of non-natural flavonones can identify novel antimicrobial agents with activity against bacteria and fungi but with minimal toxicity to human cells.	[Fowler, Zachary L.] Praxair Inc, BioPharma Res & Dev, Burr Ridge, IL USA; [Shah, Karan] SUNY Buffalo, Dept Chem & Biol Engn, Buffalo, NY 14260 USA; [Panepinto, John C.; Jacobs, Amy] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Koffas, Mattheos A. G.] Rensalear Polytech Inst, Dept Chem Engn, Troy, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Fowler, ZL (corresponding author), Praxair Inc, BioPharma Res & Dev, Burr Ridge, IL USA.	koffam@rpi.edu		Koffas, Mattheos/0000-0002-1405-0565	University at Buffalo, the State University of New York	University at Buffalo, the State University of New York	Funds were provided from the Dean of Engineering, University at Buffalo, the State University of New York. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arif T, 2009, J ASIAN NAT PROD RES, V11, P621, DOI 10.1080/10286020902942350; BALL PR, 1977, BIOCHEM BIOPH RES CO, V77, P1500, DOI 10.1016/S0006-291X(77)80148-4; Bavaresco L, 2008, J AGR FOOD CHEM, V56, P2085, DOI 10.1021/jf073456+; Cazarolli LH, 2008, MINI-REV MED CHEM, V8, P1429, DOI 10.2174/138955708786369564; Chemier Joseph A., 2009, V76, P151; Chemler JA, 2007, ORG LETT, V9, P1855, DOI 10.1021/ol0703736; Chen ZH, 2010, EUR J MED CHEM, V45, P5739, DOI 10.1016/j.ejmech.2010.09.031; Cowan MM, 1999, CLIN MICROBIOL REV, V12, P564, DOI 10.1128/CMR.12.4.564; Forkmann G, 2001, CURR OPIN BIOTECH, V12, P155, DOI 10.1016/S0958-1669(00)00192-0; Fowler ZL, 2011, YEAST, V28, P181, DOI 10.1002/yea.1829; Fowler ZL, 2009, APPL ENVIRON MICROB, V75, P5831, DOI 10.1128/AEM.00270-09; Fowler ZL, 2009, APPL MICROBIOL BIOT, V83, P799, DOI 10.1007/s00253-009-2039-z; Ghani SBA, 2008, BIOORG MED CHEM LETT, V18, P518, DOI 10.1016/j.bmcl.2007.11.081; Hannula M, 2008, J MED MICROBIOL, V57, P851, DOI 10.1099/jmm.0.47823-0; Harborne JB, 2000, PHYTOCHEMISTRY, V55, P481, DOI 10.1016/S0031-9422(00)00235-1; Jakobsen A, 2005, J CLIN ONCOL, V23, P1365, DOI 10.1200/JCO.2005.06.219; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kaefer CM, 2008, J NUTR BIOCHEM, V19, P347, DOI 10.1016/j.jnutbio.2007.11.003; Lombardino JG, 2004, NAT REV DRUG DISCOV, V3, P853, DOI 10.1038/nrd1523; Moorthy NSHN, 2006, CHEM PHARM BULL, V54, P1384, DOI 10.1248/cpb.54.1384; Nowakowska Z, 2007, EUR J MED CHEM, V42, P125, DOI 10.1016/j.ejmech.2006.09.019; Rusin A, 2010, ACTA BIOCHIM POL, V57, P23; Saleem M, 2010, NAT PROD REP, V27, P238, DOI 10.1039/b916096e; Schumacher A, 2006, J ANTIMICROB CHEMOTH, V57, P344, DOI 10.1093/jac/dki446; SELIK RM, 1995, ANN INTERN MED, V123, P933, DOI 10.7326/0003-4819-123-12-199512150-00006; Sivakumar PM, 2010, CHEM BIOL DRUG DES, V76, P407, DOI 10.1111/j.1747-0285.2010.01020.x; Sobolev VS, 2009, J AGR FOOD CHEM, V57, P62, DOI 10.1021/jf802891v; Srinivas NR, 2010, XENOBIOTICA, V40, P357, DOI 10.3109/00498251003663724; Suzuki K, 2010, CHEM REC, V10, P291, DOI 10.1002/tcr.201000030; Tegos G, 2002, ANTIMICROB AGENTS CH, V46, P3133, DOI 10.1128/AAC.46.10.3133-3141.2002; Vooturi SK, 2010, CURR MED CHEM, V17, P2292, DOI 10.2174/092986710791331059; Yaipakdee P, 2001, PHYTOCHEMISTRY, V57, P341, DOI 10.1016/S0031-9422(01)00075-9; Zhou H, 2008, CURR OPIN BIOTECH, V19, P590, DOI 10.1016/j.copbio.2008.10.012; Zhu XD, 2004, FEMS YEAST RES, V5, P1, DOI 10.1016/j.femsyr.2004.04.004	34	27	28	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25681	10.1371/journal.pone.0025681	http://dx.doi.org/10.1371/journal.pone.0025681			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039419	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500017
J	Idikio, HA				Idikio, Halliday A.			Galectin-3 and Beclin1/Atg6 Genes In Human Cancers: Using cDNA Tissue Panel, qRT-PCR, and Logistic Regression Model to Identify Cancer Cell Biomarkers	PLOS ONE			English	Article							HUMAN BREAST-CARCINOMA; REAL-TIME PCR; INDUCED APOPTOSIS; MAMMALIAN TARGET; RIP KINASES; AUTOPHAGY; EXPRESSION; INHIBITION; DEATH; PROGRESSION	Background: Cancer biomarkers are sought to support cancer diagnosis, predict cancer patient response to treatment and survival. Identifying reliable biomarkers for predicting cancer treatment response needs understanding of all aspects of cancer cell death and survival. Galectin-3 and Beclin1 are involved in two coordinated pathways of programmed cell death, apoptosis and autophagy and are linked to necroptosis/necrosis. The aim of the study was to quantify galectin-3 and Beclin1 mRNA in human cancer tissue cDNA panels and determine their utility as biomarkers of cancer cell survival. Methods and Results: A panel of 96 cDNAs from eight (8) different normal and cancer tissue types were used for quantitative real-time polymerase chain reaction (qRT-PCR) using ABI7900HT. Miner2.0, a web-based 4- and 3-parameter logistic regression software was used to derive individual well polymerase chain reaction efficiencies (E) and cycle threshold (Ct) values. Miner software derived formula was used to calculate mRNA levels and then fold changes. The ratios of cancer to normal tissue levels of galectin-3 and Beclin1 were calculated (using the mean for each tissue type). Relative mRNA expressions for galectin-3 were higher than for Beclin1 in all tissue (normal and cancer) types. In cancer tissues, breast, kidney, thyroid and prostate had the highest galectin-3 mRNA levels compared to normal tissues. High levels of Beclin1 mRNA levels were in liver and prostate cancers when compared to normal tissues. Breast, kidney and thyroid cancers had high galectin-3 levels and low Beclin1 levels. Conclusion: Galectin-3 expression patterns in normal and cancer tissues support its reported roles in human cancer. Beclin1 expression pattern supports its roles in cancer cell survival and in treatment response. qRT-PCR analysis method used may enable high throughput studies to generate molecular biomarker sets for diagnosis and predicting cancer treatment response.	Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada	University of Alberta	Idikio, HA (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.	hidikio@ualberta.ca						Abida WM, 2008, CANCER RES, V68, P352, DOI 10.1158/0008-5472.CAN-07-2069; Ahmed H, 2009, TRANSL ONCOL, V2, P146, DOI 10.1593/tlo.09118; Akahani S, 1997, CANCER RES, V57, P5272; Akdemir F, 2006, DEVELOPMENT, V133, P1457, DOI 10.1242/dev.02332; Amaravadi RK, 2007, CLIN CANCER RES, V13, P7271, DOI 10.1158/1078-0432.CCR-07-1595; Apel A, 2008, CANCER RES, V68, P1485, DOI 10.1158/0008-5472.CAN-07-0562; Bartolazzi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003768; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cao C, 2006, CANCER RES, V66, P10040, DOI 10.1158/0008-5472.CAN-06-0802; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chiariotti L, 2002, GLYCOCONJUGATE J, V19, P441, DOI 10.1023/B:GLYC.0000014073.23096.3a; CRIOLLO A, 2007, CELL DEATH DIFFERENT, V14; Declercq W, 2009, CELL, V138, P229, DOI 10.1016/j.cell.2009.07.006; Ding ZB, 2008, CANCER RES, V68, P9167, DOI 10.1158/0008-5472.CAN-08-1573; Ellerhorst J, 1999, UROL RES, V27, P362, DOI 10.1007/s002400050164; Ellerhorst JA, 2002, PROSTATE, V50, P64, DOI 10.1002/pros.10033; Finley DJ, 2004, ANN SURG, V240, P425, DOI 10.1097/01.sla.0000137128.64978.bc; Fukumori T, 2006, CANCER RES, V66, P3114, DOI 10.1158/0008-5472.CAN-05-3750; Fukumori T, 2007, DRUG RESIST UPDATE, V10, P101, DOI 10.1016/j.drup.2007.04.001; Galluzzi L, 2009, J MOL CELL BIOL, V1, P8, DOI 10.1093/jmcb/mjp007; Glinsky VV, 2009, NEOPLASIA, V11, P901, DOI 10.1593/neo.09594; GOLDSTEIN P, 2007, EMBO REP, V8, P829; Grassadonia A, 2002, GLYCOCONJUGATE J, V19, P551, DOI 10.1023/B:GLYC.0000014085.00706.d4; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Hsu DK, 2002, GLYCOCONJUGATE J, V19, P507, DOI 10.1023/B:GLYC.0000014080.95829.52; Idikio H, 1998, INT J ONCOL, V12, P1287; Jiang W, 2007, J NATL CANCER I, V99, P1036, DOI 10.1093/jnci/djm022; Jin SK, 2007, AUTOPHAGY, V3, P28, DOI 10.4161/auto.3269; John S, 2008, CANCER RES, V68, P7855, DOI 10.1158/0008-5472.CAN-07-5875; Kihara A, 2001, EMBO REP, V2, P330, DOI 10.1093/embo-reports/kve061; Kim KW, 2006, J BIOL CHEM, V281, P36883, DOI 10.1074/jbc.M607094200; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Lambert LA, 2008, CANCER RES, V68, P7966, DOI 10.1158/0008-5472.CAN-08-1333; Lavra L, 2009, J PATHOL, V218, P66, DOI 10.1002/path.2510; Levine B, 2008, NAT CELL BIOL, V10, P637, DOI 10.1038/ncb0608-637; Liang XH, 2001, CANCER RES, V61, P3443; Lin CL, 2009, MOL CANCER RES, V7, P1655, DOI 10.1158/1541-7786.MCR-09-0274; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu FT, 2002, BBA-GEN SUBJECTS, V1572, P263, DOI 10.1016/S0304-4165(02)00313-6; Lu Z, 2008, J CLIN INVEST, V118, P3917, DOI 10.1172/JCI35512; Ludwig JA, 2005, NAT REV CANCER, V5, P845, DOI 10.1038/nrc1739; Maiuri MC, 2009, CELL DEATH DIFFER, V16, P87, DOI 10.1038/cdd.2008.131; Maiuri MC, 2007, NAT REV MOL CELL BIO, V8, P741, DOI 10.1038/nrm2239; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Matsuda Y, 2008, HEPATOL RES, V38, P1098, DOI 10.1111/j.1872-034X.2008.00387.x; Merseburger AS, 2008, PROSTATE, V68, P72, DOI 10.1002/pros.20688; Moon BK, 2001, AM J PATHOL, V159, P1055, DOI 10.1016/S0002-9440(10)61780-4; Mourad-Zeidan AA, 2008, AM J PATHOL, V173, P1839, DOI 10.2353/ajpath.2008.080380; Nakahara S, 2005, APOPTOSIS, V10, P267, DOI 10.1007/s10495-005-0801-y; Nakahara S, 2006, CANCER RES, V66, P9995, DOI 10.1158/0008-5472.CAN-06-1772; Nangia-Makker P, 2010, INT J CANCER, V127, P2530, DOI 10.1002/ijc.25254; Oka N, 2005, CANCER RES, V65, P7546, DOI 10.1158/0008-5472.CAN-05-1197; Okada H, 2004, NAT REV CANCER, V4, P592, DOI 10.1038/nrc1412; Paglin S, 2001, CANCER RES, V61, P439; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2006, CANCER RES, V66, P2885, DOI 10.1158/0008-5472.CAN-05-4412; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Rutledge RG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh177; Rutledge RG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009731; Rutledge RG, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-96; Rutledge RG, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-47; Sakaki M, 2010, J MED INVESTIG, V57, P152, DOI 10.2152/jmi.57.152; Sato K, 2007, CANCER RES, V67, P9677, DOI 10.1158/0008-5472.CAN-07-1462; Sawyers CL, 2008, NATURE, V452, P548, DOI 10.1038/nature06913; Shalom-Feuerstein R, 2005, CANCER RES, V65, P7292, DOI 10.1158/0008-5472.CAN-05-0775; Shekhar MPV, 2004, AM J PATHOL, V165, P1931, DOI 10.1016/S0002-9440(10)63245-2; Shimura T, 2005, CANCER RES, V65, P3535, DOI 10.1158/0008-5472.CAN-05-0104; SUN Q, 2008, PNAS, V196, P19211; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Taube SE, 2009, JNCI-J NATL CANCER I, V101, P1453, DOI 10.1093/jnci/djp334; Thijssen VL, 2008, AM J PATHOL, V172, P545, DOI 10.2353/ajpath.2008.070938; Thorburn A, 2008, APOPTOSIS, V13, P1, DOI 10.1007/s10495-007-0154-9; Turcotte S, 2008, CANCER CELL, V14, P90, DOI 10.1016/j.ccr.2008.06.004; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Vandenabeele P, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3115re4; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wang Y, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.79; Wang Y, 2009, AM J PATHOL, V174, P1515, DOI 10.2353/ajpath.2009.080816; XU XC, 1995, AM J PATHOL, V147, P815; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Young AN, 2001, AM J PATHOL, V158, P1639, DOI 10.1016/S0002-9440(10)64120-X; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zeng XH, 2007, CLIN CANCER RES, V13, P1315, DOI 10.1158/1078-0432.CCR-06-1517; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhao S, 2005, J COMPUT BIOL, V12, P1047, DOI 10.1089/cmb.2005.12.1047	92	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26150	10.1371/journal.pone.0026150	http://dx.doi.org/10.1371/journal.pone.0026150			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039439	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500033
J	Pappalardo, AM; Guarino, F; Reina, S; Messina, A; De Pinto, V				Pappalardo, Anna Maria; Guarino, Francesca; Reina, Simona; Messina, Angela; De Pinto, Vito			Geographically Widespread Swordfish Barcode Stock Identification: A Case Study of Its Application	PLOS ONE			English	Article							GLOBAL POPULATION-STRUCTURE; DNA CONTROL REGION; XIPHIAS GLADIUS L; VARIABILITY; PHYLOGENIES; EVOLUTION; GENETICS; PROGRAM; NUCLEAR; FISHES	Background: The swordfish (Xiphias gladius) is a cosmopolitan large pelagic fish inhabiting tempered and tropical waters and it is a target species for fisheries all around the world. The present study investigated the ability of COI barcoding to reliably identify swordfish and particularly specific stocks of this commercially important species. Methodology: We applied the classical DNA barcoding technology, upon a 682 bp segment of COI, and compared swordfish sequences from different geographical sources (Atlantic, Indian Oceans and Mediterranean Sea). The sequences of the 5' hyper-variable fragment of the control region (5'dloop), were also used to validate the efficacy of COI as a stock-specific marker. Case Report: This information was successfully applied to the discrimination of unknown samples from the market, detecting in some cases mislabeled seafood products. Conclusions: The NJ distance-based phenogram (K2P model) obtained with COI sequences allowed us to correlate the swordfish haplotypes to the different geographical stocks. Similar results were obtained with 5'dloop. Our preliminary data in swordfish Xiphias gladius confirm that Cytochrome Oxidase I can be proposed as an efficient species-specific marker that has also the potential to assign geographical provenance. This information might speed the samples analysis in commercial application of barcoding.	[Pappalardo, Anna Maria; Guarino, Francesca; Reina, Simona; Messina, Angela; De Pinto, Vito] Univ Catania, Sect Biochem & Mol Biol, Dept Biol Geol & Environm Sci, Natl Inst Biomembranes & Biosyst,Sect Catania, Catania, Italy	University of Catania	Pappalardo, AM (corresponding author), Univ Catania, Sect Biochem & Mol Biol, Dept Biol Geol & Environm Sci, Natl Inst Biomembranes & Biosyst,Sect Catania, Catania, Italy.	mess@unict.it; vdpbiofa@unict.it	Pappalardo, Anna Maria/AAD-3410-2019; De Pinto, Vito/AAC-2634-2019; Messina, Angela/ABC-9518-2020	GUARINO, Francesca Maria/0000-0002-0704-7333; MESSINA, Angela Anna/0000-0002-5745-9846; De Pinto, Vito/0000-0001-5513-2906	University of Catania PRA	University of Catania PRA	Authors acknowledge funding from University of Catania PRA 2007-2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avise JC, 2000, PHYLOGEOGRAPHY HIST, DOI 10.2307/j.ctv1nzfgj7; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bremer JRA, 2006, B MAR SCI, V79, P493; Bremer JRA, 1996, J EXP MAR BIOL ECOL, V197, P295, DOI 10.1016/0022-0981(95)00164-6; Bremer JRA, 2005, MOL PHYLOGENET EVOL, V36, P169, DOI 10.1016/j.ympev.2004.12.011; BREMER JRA, 1995, CAN J FISH AQUAT SCI, V52, P1720, DOI 10.1139/f95-764; Caccone A, 1996, INSECT MOL BIOL, V5, P51, DOI 10.1111/j.1365-2583.1996.tb00040.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chow S, 1997, MAR BIOL, V127, P359, DOI 10.1007/s002270050022; Chow S, 2000, J FISH BIOL, V56, P1087, DOI 10.1006/jfbi.2000.1229; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Costa FO., 2007, GENOMICS SOC POLICY, V3, P29; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Greig T.W., 1999, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V49, P476; GrijalvaChon JM, 1996, FISH B-NOAA, V94, P589; GRIJALVACHON JM, 1994, MAR ECOL PROG SER, V115, P15, DOI 10.3354/meps115015; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hogg ID, 2004, CAN J ZOOL, V82, P749, DOI [10.1139/z04-041, 10.1139/Z04-041]; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; KOTOULAS G, 1995, MOL ECOL, V4, P473, DOI 10.1111/j.1365-294X.1995.tb00241.x; Lu CP, 2006, ZOOL STUD, V45, P269; MAGOULAS A, 1993, ICCAT COIL VOL SCI P, V40, P26; NEI M, 1981, GENETICS, V97, P145; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Pujolar JM, 2002, J EXP MAR BIOL ECOL, V276, P19, DOI 10.1016/S0022-0981(02)00245-9; Reeb CA, 2000, MAR BIOL, V136, P1123, DOI 10.1007/s002270000291; Rosel PE, 1996, MAR BIOL, V125, P11, DOI 10.1007/BF00350756; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Smith PJ, 2008, J FISH BIOL, V72, P464, DOI 10.1111/j.1095-8649.2007.01745.x; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teletchea F, 2009, REV FISH BIOL FISHER, V19, P265, DOI 10.1007/s11160-009-9107-4; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ward RD, 2009, J FISH BIOL, V74, P329, DOI 10.1111/j.1095-8649.2008.02080.x; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; WARD RD, 2001, POPULATION STRUCTURE; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; Wong EHK, 2009, MOL ECOL RESOUR, V9, P243, DOI 10.1111/j.1755-0998.2009.02653.x; Zhang DX, 1996, TRENDS ECOL EVOL, V11, P247, DOI 10.1016/0169-5347(96)10031-8	42	26	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25516	10.1371/journal.pone.0025516	http://dx.doi.org/10.1371/journal.pone.0025516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039414	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500012
J	Samaha, AN; Minogianis, EA; Nachar, W				Samaha, Anne-Noel; Minogianis, Ellie-Anna; Nachar, Walid			Cues Paired with either Rapid or Slower Self-Administered Cocaine Injections Acquire Similar Conditioned Rewarding Properties	PLOS ONE			English	Article							INTRAVENOUS COCAINE; ATTENTIONAL BIAS; D-AMPHETAMINE; DELIVERY; ACQUISITION; RATS; SENSITIZATION; REINSTATEMENT; STIMULUS; ALTERS	The faster drugs of abuse reach the brain, the more addictive they can be. It is not known why this is. Environmental stimuli associated with drugs can promote the development and persistence of addiction by invigorating and precipitating drug-seeking behaviour. We determined, therefore, whether cues associated with the self-administration of rapidly delivered cocaine (injected intravenously over 5 versus 90 seconds) would acquire greater conditioned rewarding properties, as assessed by the performance of an operant response reinforced solely by the cues. Rats nose-poked for intravenous cocaine infusions delivered either over 5 or 90 seconds. Discrete visual cues accompanied each infusion. The rats could then press a lever to obtain the cues-now a conditioned reward-or an inactive lever. Rats in both the 5- and 90-second groups pressed more on the active versus inactive lever following extensive (24 sessions) but not following limited (3 sessions) self-administration training. There were no group differences in this behaviour. Following withdrawal from cocaine self-administration, lever discrimination progressively abated in both groups and was lost by withdrawal day 30. However, the rewarding properties of the cues were not "forgotten" because on withdrawal days 32-33, amphetamine selectively enhanced active-lever pressing, and did so to a similar extent in both groups. Thus, cues paired with rapid or slower cocaine delivery acquire similar conditioned rewarding properties. We conclude, therefore, that the rapid delivery of cocaine to the brain promotes addiction by mechanisms that might not involve a greater ability of drug cues to control behaviour.	[Samaha, Anne-Noel; Minogianis, Ellie-Anna; Nachar, Walid] Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada; [Samaha, Anne-Noel] Univ Montreal, Fac Med, CNS Res Grp, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Samaha, AN (corresponding author), Univ Montreal, Fac Med, Dept Pharmacol, Montreal, PQ H3C 3J7, Canada.	Anna.samaha@umontreal.ca			Canadian Institutes of Health Research [97841]; Fonds de la Recherche en Sante du Quebec [16193]; Canada Foundation for Innovation [24326]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	This research was supported by an operating grant from the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html) to ANS (Grant No. 97841), a salary award from the Fonds de la Recherche en Sante du Quebec (http://www.frsq.gouv.qc.ca/en/index.shtml) to ANS (Grant No. 16193) and an infrastructure grant from the Canada Foundation for Innovation (http://www.innovation.ca/en) to ANS (Grant No. 24326). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu ME, 2001, PSYCHOPHARMACOLOGY, V154, P76, DOI 10.1007/s002130000624; Arroyo M, 1998, PSYCHOPHARMACOLOGY, V140, P331, DOI 10.1007/s002130050774; BALSTER RL, 1973, J EXP ANAL BEHAV, V20, P119, DOI 10.1901/jeab.1973.20-119; BEDARD AM, 2011, CHRONIC TREATMENT TY; Brown PL, 2005, PSYCHOPHARMACOLOGY, V181, P299, DOI 10.1007/s00213-005-2244-0; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Carroll ME, 1997, PSYCHOPHARMACOLOGY, V129, P206, DOI 10.1007/s002130050182; Chen CY, 2004, PSYCHOPHARMACOLOGY, V172, P78, DOI 10.1007/s00213-003-1624-6; Crombag HS, 2008, PHARMACOL BIOCHEM BE, V90, P797, DOI 10.1016/j.pbb.2008.06.003; DEWIT H, 1981, PSYCHOPHARMACOLOGY, V75, P134, DOI 10.1007/BF00432175; DEWIT H, 1993, PSYCHOPHARMACOLOGY, V112, P324, DOI 10.1007/BF02244928; Di Ciano P, 2004, NEUROPHARMACOLOGY, V47, P202, DOI 10.1016/j.neuropharm.2004.06.005; Di Ciano P, 2008, NEUROPSYCHOPHARMACOL, V33, P1426, DOI 10.1038/sj.npp.1301542; DICKINSON A, 1987, Q J EXP PSYCHOL-B, V39, P201; DICKINSON A, 1978, ANNU REV PSYCHOL, V29, P587, DOI 10.1146/annurev.ps.29.020178.003103; DMELLO GD, 1977, BRIT J PHARMACOL, V61, P415, DOI 10.1111/j.1476-5381.1977.tb08434.x; Duka T, 2004, PSYCHOPHARMACOLOGY, V176, P353, DOI 10.1007/s00213-004-1906-7; EHRMAN RN, 1992, PSYCHOPHARMACOLOGY, V107, P523, DOI 10.1007/BF02245266; Ferrario CR, 2008, BRAIN RES, V1209, P151, DOI 10.1016/j.brainres.2008.02.081; Field M, 2008, DRUG ALCOHOL DEPEN, V97, P1, DOI 10.1016/j.drugalcdep.2008.03.030; GAWIN FH, 1988, NEW ENGL J MED, V318, P1173, DOI 10.1056/NEJM198805053181806; GORELICK DA, 1992, AM J DRUG ALCOHOL AB, V18, P13, DOI 10.3109/00952999209001607; GOSSOP M, 1992, BRIT J ADDICT, V87, P1527; GOSSOP M, 1994, BRIT J PSYCHIAT, V164, P660, DOI 10.1192/bjp.164.5.660; Hatsukami DK, 1996, JAMA-J AM MED ASSOC, V276, P1580; HENNINGFIELD JE, 1993, J CONSULT CLIN PSYCH, V61, P743, DOI 10.1037/0022-006X.61.5.743; JAVAID JI, 1978, SCIENCE, V202, P227, DOI 10.1126/science.694530; Jones R T, 1990, NIDA Res Monogr, V99, P30; KATO S, 1987, PHARMACOL BIOCHEM BE, V28, P407; KELLEHER ROGER T., 1962, JOUR EXPTL ANALYSIS BEHAVIOR, V5, P543, DOI 10.1901/jeab.1962.5-s543; LEVINE DG, 1974, AM J PSYCHIAT, V131, P297, DOI 10.1176/ajp.131.3.297; Liu Y, 2005, EUR J NEUROSCI, V22, P195, DOI 10.1111/j.1460-9568.2005.04195.x; LOVIBOND PF, 1983, J EXP PSYCHOL ANIM B, V9, P225, DOI 10.1037/0097-7403.9.3.225; Mackintosh N. J., 1974, PSYCHOL ANIMAL LEARN; Nelson RA, 2006, DRUG ALCOHOL DEPEN, V82, P19, DOI 10.1016/j.drugalcdep.2005.08.004; O'Brien MS, 2005, NEUROPSYCHOPHARMACOL, V30, P1006, DOI 10.1038/sj.npp.1300681; OBRIEN CP, 1992, ANN NY ACAD SCI, V654, P400, DOI 10.1111/j.1749-6632.1992.tb25984.x; Panlilio LV, 1996, PSYCHOPHARMACOLOGY, V125, P202, DOI 10.1007/BF02247329; Panlilio LV, 1998, PSYCHOPHARMACOLOGY, V137, P253, DOI 10.1007/s002130050618; PORRINO LJ, 1993, PSYCHOPHARMACOLOGY, V112, P343, DOI 10.1007/BF02244931; RESCORLA RA, 1967, PSYCHOL REV, V74, P151, DOI 10.1037/h0024475; ROBBINS TW, 1983, PSYCHOPHARMACOLOGY, V80, P113, DOI 10.1007/BF00427952; ROBBINS TW, 1978, PSYCHOPHARMACOLOGY, V58, P79, DOI 10.1007/BF00426794; Robinson TE, 2009, BIOL PSYCHIAT, V65, P869, DOI 10.1016/j.biopsych.2008.09.006; Samaha AN, 2004, J NEUROSCI, V24, P6362, DOI 10.1523/JNEUROSCI.1205-04.2004; Samaha AN, 2005, BIOL PSYCHIAT, V57, P351, DOI 10.1016/j.biopsych.2004.11.040; Samaha AN, 2005, TRENDS PHARMACOL SCI, V26, P82, DOI 10.1016/j.tips.2004.12.007; Samaha AN, 2002, J NEUROSCI, V22, P3244, DOI 10.1523/JNEUROSCI.22-08-03244.2002; Saunders BT, 2010, BIOL PSYCHIAT, V67, P730, DOI 10.1016/j.biopsych.2009.11.015; Schindler CW, 2011, PHARMACOL BIOCHEM BE, V99, P301, DOI 10.1016/j.pbb.2011.05.005; Schoenmakers T, 2008, PSYCHOPHARMACOLOGY, V197, P169, DOI 10.1007/s00213-007-1023-5; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Uslaner JM, 2006, BEHAV BRAIN RES, V169, P320, DOI 10.1016/j.bbr.2006.02.001; Wakabayashi KT, 2010, J NEUROSCI, V30, P11346, DOI 10.1523/JNEUROSCI.2524-10.2010; Wise RA, 2011, NAT REV NEUROSCI, V12, DOI 10.1038/nrn3043-c2; Wise RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002846	56	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26481	10.1371/journal.pone.0026481	http://dx.doi.org/10.1371/journal.pone.0026481			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039496	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500074
J	Smith, KB; Oxley, D; Hibbing, MV; Alford, JR; Hibbing, JR				Smith, Kevin B.; Oxley, Douglas; Hibbing, Matthew V.; Alford, John R.; Hibbing, John R.			Disgust Sensitivity and the Neurophysiology of Left-Right Political Orientations	PLOS ONE			English	Article							ANTERIOR INSULA; GENDER; REPRESENTATION; CONSERVATIVES; PERSONALITY; ATTITUDES; RESPONSES; OXYTOCIN; VARY	Disgust has been described as the most primitive and central of emotions. Thus, it is not surprising that it shapes behaviors in a variety of organisms and in a variety of contexts-including homo sapien politics. People who believe they would be bothered by a range of hypothetical disgusting situations display an increased likelihood of displaying right-of-center rather than left-of-center political orientations. Given its primal nature and essential value in avoiding pathogens disgust likely has an effect even without registering in conscious beliefs. In this article, we demonstrate that individuals with marked involuntary physiological responses to disgusting images, such as of a man eating a large mouthful of writhing worms, are more likely to self-identify as conservative and, especially, to oppose gay marriage than are individuals with more muted physiological responses to the same images. This relationship holds even when controlling for the degree to which respondents believe themselves to be disgust sensitive and suggests that people's physiological predispositions help to shape their political orientations.	[Smith, Kevin B.; Hibbing, John R.] Univ Nebraska, Dept Polit Sci, Lincoln, NE 68583 USA; [Oxley, Douglas] Texas A&M Univ, Dept Polit Sci, College Stn, TX 77843 USA; [Hibbing, Matthew V.] Univ Calif Merced, Sch Social Sci Humanities & Arts, Merced, CA USA; [Alford, John R.] Rice Univ, Dept Polit Sci, Houston, TX USA	University of Nebraska System; University of Nebraska Lincoln; Texas A&M University System; Texas A&M University College Station; University of California System; University of California Merced; Rice University	Smith, KB (corresponding author), Univ Nebraska, Dept Polit Sci, Lincoln, NE 68583 USA.	ksmith1@unl.edu	Hibbing, Matthew/AAF-3930-2020; Alford, John R/A-2561-2009	Oxley, Douglas/0000-0003-2258-2112; Alford, John/0000-0003-1866-8271	National Science Foundation [BCS-0826828]	National Science Foundation(National Science Foundation (NSF))	Funding was provided by the National Science Foundation's Human and Social Dynamics Competition (BCS-0826828). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford JR, 2005, AM POLIT SCI REV, V99, P153, DOI 10.1017/S0003055405051579; Amodio DM, 2007, NAT NEUROSCI, V10, P1246, DOI 10.1038/nn1979; Bargh JA, 1999, AM PSYCHOL, V54, P462, DOI 10.1037/0003-066x.54.7.462; Bell E, 2009, CAN J POLIT SCI, V42, P855, DOI 10.1017/S0008423909990060; Borg JS, 2008, J COGNITIVE NEUROSCI, V20, P1529, DOI 10.1162/jocn.2008.20109; Bouchard TJ, 2003, J NEUROBIOL, V54, P4, DOI 10.1002/neu.10160; BRADER T, 2005, CAMPAIGNING HEARTS M; Bradley M. M., 2000, HDB PSYCHOPHYSIOLOGY; Caprara GV, 2006, POLIT PSYCHOL, V27, P1, DOI 10.1111/j.1467-9221.2006.00447.x; Carney DR, 2008, POLIT PSYCHOL, V29, P807, DOI 10.1111/j.1467-9221.2008.00668.x; CONVERSE PE, 1964, IDEOLOGY DISCONTENT; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Critchley HD, 2000, J NEUROSCI, V20, P3033; Dawson ME, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P159, DOI 10.1017/cbo9780511546396.007; Fowler JH, 2008, AM POLIT SCI REV, V102, P233, DOI 10.1017/S0003055408080209; Galdi S, 2008, SCIENCE, V321, P1100, DOI 10.1126/science.1160769; Graham J, 2009, J PERS SOC PSYCHOL, V96, P1029, DOI 10.1037/a0015141; GRANBERG D, 1991, AM J POLIT SCI, V35, P448, DOI 10.2307/2111370; Haidt J, 2001, J APPL SOC PSYCHOL, V31, P191, DOI 10.1111/j.1559-1816.2001.tb02489.x; Haidt J., 2007, SOCIAL JUSTICE RES, V20, P98, DOI [DOI 10.1007/S11211-007-0034-Z, 10.1007/s11211-007-0034-z]; HAMM AO, 2003, HDB AFFECTIVE SCI; Harrison NA, 2010, J NEUROSCI, V30, P12878, DOI 10.1523/JNEUROSCI.1725-10.2010; Hatemi PK, 2009, J POLIT, V71, P262, DOI 10.1017/S0022381608090178; HELZER E, 2011, PSYCH SCI IN PRESS, V22; Inbar Y, 2009, COGNITION EMOTION, V23, P714, DOI 10.1080/02699930802110007; Jabbi M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002939; JAMES W, 1894, PSYCHOL REV, V1, P516; Johnson DDP, 2006, P ROY SOC B-BIOL SCI, V273, P2513, DOI 10.1098/rspb.2006.3606; Jost JT, 2003, PSYCHOL BULL, V129, P339, DOI 10.1037/0033-2909.129.3.339; Kanai R, 2011, CURR BIOL, V21, pR106, DOI [10.1016/j.cub.2010.12.009, 10.1016/j.cub.2011.03.017]; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Lang P.J., 2008, INT AFFECTIVE PICTUR; Lieberman MD, 2003, POLIT PSYCHOL, V24, P681, DOI 10.1046/j.1467-9221.2003.00347.x; Lodge M, 2005, POLIT PSYCHOL, V26, P455, DOI 10.1111/j.1467-9221.2005.00426.x; Lodge M., 2000, ELEMENTS REASON COGN, P183, DOI DOI 10.1017/CBO9780511805813.009; MADSEN D, 1985, AM POLIT SCI REV, V79, P448, DOI 10.2307/1956659; Marcus G.E., 2000, AFFECTIVE INTELLIGEN; MARTIN NG, 1986, P NATL ACAD SCI USA, V83, P4364, DOI 10.1073/pnas.83.12.4364; Mataix-Cols D, 2008, EUR J NEUROSCI, V27, P3050, DOI 10.1111/j.1460-9568.2008.06311.x; McDermott R., 2004, PERSPECT POLIT, V2, P691, DOI DOI 10.1017/S1537592704040459; MILLER A, 2007, DEV PSYCHOPHYSIOLOGY, P367; Mondak JJ, 2010, AM POLIT SCI REV, V104, P85, DOI 10.1017/S0003055409990359; NEUBERG SL, 2010, NEUROSCI BIOBEHAV R, V35, P989; Olatunji BO, 2008, J RES PERS, V42, P1243, DOI 10.1016/j.jrp.2008.03.009; Oxley DR, 2008, SCIENCE, V321, P1667, DOI 10.1126/science.1157627; Rohrmann S, 2008, J PSYCHOPHYSIOL, V22, P65, DOI 10.1027/0269-8803.22.2.65; Rozin P., 2000, HDB EMOTIONS, P637; Rutchick AM, 2010, POLIT PSYCHOL, V31, P209, DOI 10.1111/j.1467-9221.2009.00749.x; Schell AM, 2002, PSYCHOPHYSIOLOGY, V39, P124, DOI 10.1017/S0048577201392028; Schirmer A, 2005, NEUROREPORT, V16, P635, DOI 10.1097/00001756-200504250-00024; Schwartz SH, 2010, POLIT PSYCHOL, V31, P421, DOI 10.1111/j.1467-9221.2010.00764.x; Vigil JM, 2010, GROUP PROCESS INTERG, V13, P547, DOI 10.1177/1368430209356930; Wegner D., 2002, ILLUSION CONSCIOUS W; Westen D., 2007, PUBLIC AFFAIRS; WILLIAMSON PC, 2011, HUMAN ILLNESSES; WILSON GD, 1968, BRIT J SOC CLIN PSYC, V7, P264; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151; Zak PJ, 2005, HORM BEHAV, V48, P522, DOI 10.1016/j.yhbeh.2005.07.009; Zaller J. R., 1992, NATURE ORIGINS MASS, DOI DOI 10.1017/CBO9780511818691	59	121	122	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25552	10.1371/journal.pone.0025552	http://dx.doi.org/10.1371/journal.pone.0025552			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841JB	22039415	gold, Green Published			2022-12-27	WOS:000296507500013
J	Bender, N; Allemann, N; Marek, D; Vollenweider, P; Waeber, G; Mooser, V; Egger, M; Bochud, M				Bender, Nicole; Allemann, Noemi; Marek, Diana; Vollenweider, Peter; Waeber, Gerard; Mooser, Vincent; Egger, Matthias; Bochud, Murielle			Association between Variants of the Leptin Receptor Gene (LEPR) and Overweight: A Systematic Review and an Analysis of the CoLaus Study	PLOS ONE			English	Review							BODY-MASS INDEX; GLN223ARG POLYMORPHISM; NO ASSOCIATION; OBESITY; LOCI; FAT; EPIDEMIOLOGY; METAANALYSIS; ADIPOSITY; REVEALS	Background: Three non-synonymous single nucleotide polymorphisms (Q223R, K109R and K656N) of the leptin receptor gene (LEPR) have been tested for association with obesity-related outcomes in multiple studies, showing inconclusive results. We performed a systematic review and meta-analysis on the association of the three LEPR variants with BMI. In addition, we analysed 15 SNPs within the LEPR gene in the CoLaus study, assessing the interaction of the variants with sex. Methodology/Principal Findings: We searched electronic databases, including population-based studies that investigated the association between LEPR variants Q223R, K109R and K656N and obesity-related phenotypes in healthy, unrelated subjects. We furthermore performed meta-analyses of the genotype and allele frequencies in case-control studies. Results were stratified by SNP and by potential effect modifiers. CoLaus data were analysed by logistic and linear regressions and tested for interaction with sex. The meta-analysis of published data did not show an overall association between any of the tested LEPR variants and overweight. However, the choice of a BMI cut-off value to distinguish cases from controls was crucial to explain heterogeneity in Q223R. Differences in allele frequencies across ethnic groups are compatible with natural selection of derived alleles in Q223R and K109R and of the ancient allele in K656N in Asians. In CoLaus, the rs10128072, rs3790438 and rs3790437 variants showed interaction with sex for their association with overweight, waist circumference and fat mass in linear regressions. Conclusions: Our systematic review and analysis of primary data from the CoLaus study did not show an overall association between LEPR SNPs and overweight. Most studies were underpowered to detect small effect sizes. A potential effect modification by sex, population stratification, as well as the role of natural selection should be addressed in future genetic association studies.	[Bender, Nicole; Allemann, Noemi; Egger, Matthias] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Bender, Nicole] Univ Witwatersrand, Inst Human Evolut, Johannesburg, South Africa; [Marek, Diana] Univ Lausanne, Swiss Inst Bioinformat, Dept Med Genet, Lausanne, Switzerland; [Vollenweider, Peter; Waeber, Gerard] CHU Vaudois, Dept Med, Lausanne, Switzerland; [Mooser, Vincent] GlaxoSmithKline, Philadelphia, PA USA; [Bochud, Murielle] Univ Lausanne, Inst Social & Prevent Med, Ctr Hosp Univ Vaudois, Lausanne, Switzerland	University of Bern; University of Witwatersrand; Swiss Institute of Bioinformatics; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); GlaxoSmithKline; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Bender, N (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	nbender@ispm.unibe.ch	Bochud, Murielle/A-3981-2010; Colaus, PsyColaus/K-6607-2013; Bender, Nicole/C-2237-2009	Bochud, Murielle/0000-0002-5727-0218; Bender, Nicole/0000-0002-3838-587X; Egger, Matthias/0000-0001-7462-5132; Waeber, Gerard/0000-0003-4193-788X	GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation [33CSCO-122661, 3200BO-111361/2, 3100AO-116323/1]; Swiss School of Public Health Plus	GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss School of Public Health Plus	The CoLaus study was supported by GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (33CSCO-122661, 3200BO-111361/2, 3100AO-116323/1). Dr. Bochud is supported by the Swiss School of Public Health Plus. The Faculty of Biology and Medicine of Lausanne, the Swiss National Science Foundation, and the Swiss School of Public Health Plus had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Vincent Mooser is an employee of GlaxoSmithKline, Philadelphia and helped perform the experiments; therefore, GlaxoSmithKline had a role in data collection.	Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Ben Ali S, 2009, ARCH MED RES, V40, P186, DOI 10.1016/j.arcmed.2009.02.008; Bienertova-Vasku J, 2008, NUTR NEUROSCI, V11, P2, DOI 10.1179/147683008X301379; Capelli C, 2001, AM J HUM GENET, V68, P432, DOI 10.1086/318205; Chagnon YC, 1999, INT J OBESITY, V23, P278, DOI 10.1038/sj.ijo.0800809; Chakravarthy MV, 2004, J APPL PHYSIOL, V96, P3, DOI 10.1152/japplphysiol.00757.2003; Chang JG, 2002, J HUM GENET, V47, P60, DOI 10.1007/s100380200001; Constantin A, 2010, BIOCHEM BIOPH RES CO, V391, P282, DOI 10.1016/j.bbrc.2009.11.050; Currat M, 2005, P ROY SOC B-BIOL SCI, V272, P679, DOI 10.1098/rspb.2004.2999; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; de Krom M, 2007, DIABETES, V56, P276, DOI 10.2337/db06-0473; Duarte SFP, 2007, GENET MOL RES, V6, P1035; Dulloo AG, 2002, FEBS LETT, V515, P109, DOI 10.1016/S0014-5793(02)02449-3; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Endo K, 2000, INT J OBESITY, V24, P443, DOI 10.1038/sj.ijo.0801177; Firmann M, 2008, BMC CARDIOVASC DISOR, V8, DOI 10.1186/1471-2261-8-6; Friedlander Y, 2010, ANN HUM GENET, V74, P387, DOI 10.1111/j.1469-1809.2010.00596.x; Fuller DQ, 2009, SCIENCE, V323, P1607, DOI 10.1126/science.1166605; Furusawa T, 2010, HUM GENET, V127, P287, DOI 10.1007/s00439-009-0768-9; Gepts P., 2004, Plant Breeding Reviews, V24, P1, DOI 10.1002/9780470650288.ch1; Gotoda T, 1997, HUM MOL GENET, V6, P869, DOI 10.1093/hmg/6.6.869; Guizar-Mendoza JM, 2005, J HUM HYPERTENS, V19, P341, DOI 10.1038/sj.jhh.1001824; Hancock AM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040032; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Heid IM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000694; Heo M, 2002, INT J OBESITY, V26, P640, DOI 10.1038/sj.ijo.0801990; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioannidis JPA, 2008, INT J EPIDEMIOL, V37, P120, DOI 10.1093/ije/dym159; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Kagawa Y, 2003, Asia Pac J Public Health, V15 Suppl, pS10, DOI 10.1177/101053950301500S04; Kagawa Y, 2002, BIOCHEM BIOPH RES CO, V295, P207, DOI 10.1016/S0006-291X(02)00680-0; Lappalainen T, 2010, EUR J HUM GENET, V18, P471, DOI 10.1038/ejhg.2009.184; Li SX, 2008, CURR OPIN LIPIDOL, V19, P113, DOI 10.1097/MOL.0b013e3282f6a7f3; LITTLE J, 2006, HUGENET HUGE REV HDB; Little J, 2009, J CLIN EPIDEMIOL, V62, P597, DOI 10.1016/j.jclinepi.2008.12.004; Magi R, 2010, GENET EPIDEMIOL, V34, P846, DOI 10.1002/gepi.20540; Mammes O, 2001, EUR J CLIN INVEST, V31, P398, DOI 10.1046/j.1365-2362.2001.00843.x; Marchini J, 2004, NAT GENET, V36, P512, DOI 10.1038/ng1337; Masuo K, 2008, HYPERTENS RES, V31, P1093, DOI 10.1291/hypres.31.1093; Mattevi VS, 2002, INT J OBESITY, V26, P1179, DOI 10.1038/sj.ijo.0802067; MELTON T, 1995, AM J HUM GENET, V57, P403; Mergen H, 2007, ENDOCR J, V54, P89, DOI 10.1507/endocrj.K06-023; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Muller MJ, 2010, OBES REV, V11, P612, DOI 10.1111/j.1467-789X.2010.00734.x; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Okada T, 2010, ACTA PAEDIATR, V99, P1213, DOI 10.1111/j.1651-2227.2010.01778.x; Okorodudu DO, 2010, INT J OBESITY, V34, P791, DOI 10.1038/ijo.2010.5; Paracchini V, 2005, AM J EPIDEMIOL, V162, P101, DOI 10.1093/aje/kwi174; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; POND C, 1987, NEW SCI, V114, P62; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Portoles O, 2006, EUR J EPIDEMIOL, V21, P605, DOI 10.1007/s10654-006-9045-6; Pyrzak B, 2009, EUR J MED RES, V14, P201, DOI 10.1186/2047-783X-14-S4-201; Qu YC, 2007, OBES RES CLIN PRACT, V1, P261, DOI 10.1016/j.orcp.2007.10.002; Riestra P, 2010, ACTA PAEDIATR, V99, P1527, DOI 10.1111/j.1651-2227.2010.01877.x; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosmond R, 2000, J CLIN ENDOCR METAB, V85, P3126, DOI 10.1210/jc.85.9.3126; Sebro R, 2010, GENET EPIDEMIOL, V34, P674, DOI 10.1002/gepi.20528; Silver K, 1997, DIABETES, V46, P1898, DOI 10.2337/diab.46.11.1898; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang TN, 2006, OBESITY, V14, P183, DOI 10.1038/oby.2006.23; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; World Health Organization, 2000, WHO TECHN REP SER, V894, DOI DOI 10.1007/978-0-387-71799-9_454; Yang WJ, 2007, EPIDEMIOL REV, V29, P49, DOI 10.1093/epirev/mxm004; Yiannakouris N, 2001, J CLIN ENDOCR METAB, V86, P4434, DOI 10.1210/jc.86.9.4434	68	55	58	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26157	10.1371/journal.pone.0026157	http://dx.doi.org/10.1371/journal.pone.0026157			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028824	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900031
J	Kajiro, M; Tsuchiya, M; Kawabe, Y; Furumai, R; Iwasaki, N; Hayashi, Y; Katano, M; Nakajima, Y; Goto, N; Watanabe, T; Murayama, A; Oishi, H; Ema, M; Takahashi, S; Kishimoto, H; Yanagisawa, J				Kajiro, Masashi; Tsuchiya, Mai; Kawabe, Yoh-ichi; Furumai, Ryohei; Iwasaki, Naoya; Hayashi, Yuki; Katano, Miyuki; Nakajima, Yuka; Goto, Natsuka; Watanabe, Tatsuya; Murayama, Akiko; Oishi, Hisashi; Ema, Masatsugu; Takahashi, Satoru; Kishimoto, Hiroyuki; Yanagisawa, Junn			The E3 Ubiquitin Ligase Activity of Trip12 Is Essential for Mouse Embryogenesis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; N-MYC EXPRESSION; CONTRASTING PATTERNS; THYROID-HORMONE; HECT FAMILY; C-MYC; CANCER; RECEPTOR; SUBUNIT; CELLS	Protein ubiquitination is a post-translational protein modification that regulates many biological conditions [1,2,3,4]. Trip12 is a HECT-type E3 ubiquitin ligase that ubiquitinates ARF and APP-BP1 [5,6]. However, the significance of Trip12 in vivo is largely unknown. Here we show that the ubiquitin ligase activity of Trip12 is indispensable for mouse embryogenesis. A homozygous mutation in Trip12 (Trip12(mt/mt)) that disrupts the ubiquitin ligase activity resulted in embryonic lethality in the middle stage of development. Trip12(mt/mt) embryos exhibited growth arrest and increased expression of the negative cell cycle regulator p16 [7,8,9,10]. In contrast, Trip12(mt/mt) ES cells were viable. They had decreased proliferation, but maintained both the undifferentiated state and the ability to differentiate. Trip12(mt/mt) ES cells had increased levels of the BAF57 protein (a component of the SWI/SNF chromatin remodeling complex) and altered gene expression patterns. These data suggest that Trip12 is involved in global gene expression and plays an important role in mouse development.	[Kajiro, Masashi; Tsuchiya, Mai; Iwasaki, Naoya; Hayashi, Yuki; Nakajima, Yuka; Goto, Natsuka; Watanabe, Tatsuya; Murayama, Akiko; Kishimoto, Hiroyuki; Yanagisawa, Junn] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Kawabe, Yoh-ichi; Furumai, Ryohei; Katano, Miyuki; Nakajima, Yuka; Murayama, Akiko; Kishimoto, Hiroyuki; Yanagisawa, Junn] Univ Tsukuba, Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki, Japan; [Oishi, Hisashi; Ema, Masatsugu; Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan	University of Tsukuba; University of Tsukuba; University of Tsukuba	Kajiro, M (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan.	junny@agbi.tsukuba.ac.jp	Furumai, Ryohei/L-2220-2013	Ema, Masatsugu/0000-0003-0645-6183	Nuclear System to Decipher Operation [17064005]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [MPB2]	Nuclear System to Decipher Operation; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by a Nuclear System to Decipher Operation Code (DECODE) (ID: 17064005), and Targeted Proteins Research Program (TPRP) (ID: MPB2) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernassola F, 2008, CANCER CELL, V14, P10, DOI 10.1016/j.ccr.2008.06.001; Canepa ET, 2007, IUBMB LIFE, V59, P419, DOI 10.1080/15216540701488358; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; DOWNS KM, 1989, GENE DEV, V3, P860, DOI 10.1101/gad.3.6.860; Garcia-Pedrero JM, 2006, J BIOL CHEM, V281, P22656, DOI 10.1074/jbc.M602561200; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Hah N, 2010, CANCER RES, V70, P4402, DOI 10.1158/0008-5472.CAN-09-2767; HARRIS LL, 1992, DEVELOPMENT, V115, P813; Harte MT, 2010, CANCER RES, V70, P2538, DOI 10.1158/0008-5472.CAN-09-2089; Heimeier RA, 2008, MOL ENDOCRINOL, V22, P1065, DOI 10.1210/me.2007-0492; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Keppler BR, 2010, J BIOL CHEM, V285, P35665, DOI 10.1074/jbc.M110.173997; Kitagawa K, 2009, CANCER SCI, V100, P1374, DOI 10.1111/j.1349-7006.2009.01196.x; Lai DZ, 2009, P NATL ACAD SCI USA, V106, P1169, DOI 10.1073/pnas.0811274106; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Liu SH, 2006, MOL CELL BIOL, V26, P3835, DOI 10.1128/MCB.26.10.3835-3841.2006; NOBORI T, 1994, NATURE, V368, P753, DOI 10.1038/368753a0; Park Y, 2008, BIOCHEM BIOPH RES CO, V374, P294, DOI 10.1016/j.bbrc.2008.07.019; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Ruas M, 1998, BBA-REV CANCER, V1378, pF115, DOI 10.1016/S0304-419X(98)00017-1; Shabek N, 2010, CELL CYCLE, V9, P523, DOI 10.4161/cc.9.3.11152; Wang L, 2005, MOL CELL BIOL, V25, P7953, DOI 10.1128/MCB.25.18.7953-7965.2005; Weissman B, 2009, CANCER RES, V69, P8223, DOI 10.1158/0008-5472.CAN-09-2166; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Yokomizo T, 2007, EMBO J, V26, P184, DOI 10.1038/sj.emboj.7601480	31	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25871	10.1371/journal.pone.0025871	http://dx.doi.org/10.1371/journal.pone.0025871			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028794	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900021
J	Liu, LT; Huang, B; Li, CQ; Zhuang, Y; Wang, J; Zhou, Y				Liu, Lan-Tao; Huang, Bo; Li, Chang-Qing; Zhuang, Ying; Wang, Jian; Zhou, Yue			Characteristics of Stem Cells Derived from the Degenerated Human Intervertebral Disc Cartilage Endplate	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; BONE-MARROW; EXTRACELLULAR-MATRIX; BACK-PAIN; DIFFERENTIATION; TISSUES; CHONDROCYTES; THERAPY; SOX9; CALCIFICATION	Mesenchymal stem cells (MSCs) derived from adult tissues are an important candidate for cell-based therapies and regenerative medicine due to their multipotential differentiation capability. MSCs have been identified in many adult tissues but have not reported in the human intervertebral disc cartilage endplate (CEP). The initial purpose of this study was to determine whether MSCs exist in the degenerated human CEP. Next, the morphology, proliferation capacity, cell cycle, cell surface epitope profile and differentiation capacity of these CEP-derived stem cells (CESCs) were compared with bone-marrow MSCs (BM-MSCs). Lastly, whether CESCs are a suitable candidate for BM-MSCs was evaluated. Isolated cells from degenerated human CEP were seeded in an agarose suspension culture system to screen the proliferative cell clusters. Cell clusters were chosen and expanded in vitro and were compared with BM-MSCs derived from the same patient. The morphology, proliferation rate, cell cycle, immunophenotype and stem cell gene expression of the CESCs were similar to BM-MSCs. In addition, the CESCs could be induced into osteoblasts, adipocytes, chondrocytes, and are superior to BM-MSCs in terms of osteogenesis and chondrogenesis. This study is first to demonstrate the presence of stem cells in the human degenerated CEP. These results may improve our understanding of intervertebral disc (IVD) pathophysiology and the degeneration process, and could provide cell candidates for cell-based regenerative medicine and tissue engineering.	[Liu, Lan-Tao; Huang, Bo; Li, Chang-Qing; Zhuang, Ying; Wang, Jian; Zhou, Yue] Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China	Army Medical University	Liu, LT (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Orthoped, Chongqing, Peoples R China.	younglee881@163.com; happyzhou@vip.163.com			National Natural Science Foundation of China [81071498, 81071496, 81101364]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81071498, 81071496 and 81101364). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson GBJ, 1999, LANCET, V354, P581, DOI 10.1016/S0140-6736(99)01312-4; Ariga K, 2001, SPINE, V26, P2414, DOI 10.1097/00007632-200111150-00004; Bajada S, 2008, J TISSUE ENG REGEN M, V2, P169, DOI 10.1002/term.83; Battie MC, 2006, J BONE JOINT SURG AM, V88A, P3, DOI 10.2106/JBJS.E.01313; Benneker LM, 2005, SPINE, V30, P167, DOI 10.1097/01.brs.0000150833.93248.09; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bilic G, 2008, CELL TRANSPLANT, V17, P955, DOI 10.3727/096368908786576507; Blanco JF, 2010, SPINE, V35, P2259, DOI 10.1097/BRS.0b013e3181cb8828; Carlin R, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-8; Cortes F, 1999, BLOOD, V93, P826, DOI 10.1182/blood.V93.3.826.403k28_826_837; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fang BJ, 2009, BIOTECHNOL LETT, V31, P929, DOI 10.1007/s10529-009-9968-6; Freemont AJ, 2009, RHEUMATOLOGY, V48, P5, DOI 10.1093/rheumatology/ken396; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gruber HE, 2005, SPINE, V30, P625, DOI 10.1097/01.brs.0000155420.01444.c6; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hattori S, 2007, BIOCHEM BIOPH RES CO, V358, P99, DOI 10.1016/j.bbrc.2007.04.142; Higuchi C, 2002, J BONE MINER RES, V17, P1785, DOI 10.1359/jbmr.2002.17.10.1785; HOLM S, 1981, CONNECT TISSUE RES, V8, P101, DOI 10.3109/03008208109152130; Huang B, 2010, J BIOMED MATER RES B, V92B, P322, DOI 10.1002/jbm.b.31518; Jackson WM, 2009, J ORTHOP RES, V27, P1645, DOI 10.1002/jor.20924; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Li FC, 2010, MED HYPOTHESES, V75, P169, DOI 10.1016/j.mehy.2010.02.012; Lian JB, 1998, J CELL BIOCHEM, P62, DOI 10.1002/(SICI)1097-4644(1998)72:30/31+<62::AID-JCB10>3.0.CO;2-S; Mayer H, 2005, J CELL BIOCHEM, V95, P827, DOI 10.1002/jcb.20462; Murdoch AD, 2007, STEM CELLS, V25, P2786, DOI 10.1634/stemcells.2007-0374; Musina RA, 2005, B EXP BIOL MED+, V139, P504, DOI 10.1007/s10517-005-0331-1; Okazaki R, 2002, ENDOCRINOLOGY, V143, P2349, DOI 10.1210/en.143.6.2349; Paul R, 2003, SPINE, V28, P755, DOI 10.1097/00007632-200304150-00006; PEARCE RH, 1987, J ORTHOP RES, V5, P198, DOI 10.1002/jor.1100050206; Peng BG, 2001, CHINESE MED J-PEKING, V114, P308; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rajasekaran S, 2008, EUR SPINE J, V17, P626, DOI 10.1007/s00586-008-0645-6; Rajasekaran S, 2004, SPINE, V29, P2654, DOI 10.1097/01.brs.0000148014.15210.64; Rebelatto CK, 2008, EXP BIOL MED, V233, P901, DOI 10.3181/0712-RM-356; REEMS JA, 1995, BLOOD, V85, P1480, DOI 10.1182/blood.V85.6.1480.bloodjournal8561480; Risbud MV, 2007, SPINE, V32, P2537, DOI 10.1097/BRS.0b013e318158dea6; Roberts S, 1996, SPINE, V21, P415, DOI 10.1097/00007632-199602150-00003; Sakaguchi Y, 2005, ARTHRITIS RHEUM-US, V52, P2521, DOI 10.1002/art.21212; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Smith LJ, 2011, DIS MODEL MECH, V4, P31, DOI 10.1242/dmm.006403; Stokes IAF, 2004, SPINE, V29, P2724, DOI 10.1097/01.brs.0000146049.52152.da; Thornemo M, 2005, CELLS TISSUES ORGANS, V180, P141, DOI 10.1159/000088242; Urban JPG, 2004, SPINE, V29, P2700, DOI 10.1097/01.brs.0000146499.97948.52; Urban JPG, 2003, ARTHRITIS RES THER, V5, P120, DOI 10.1186/ar629; Zhang LM, 2010, BIOTECHNOL LETT, V32, P1339, DOI 10.1007/s10529-010-0293-x	47	131	153	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26285	10.1371/journal.pone.0026285	http://dx.doi.org/10.1371/journal.pone.0026285			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028847	gold, Green Published			2022-12-27	WOS:000296186900041
J	Bainbridge, JM; Potts, T; O'Higgins, TG				Bainbridge, John Michael; Potts, Tavis; O'Higgins, Tim Gerard			Rapid Policy Network Mapping: A New Method for Understanding Governance Structures for Implementation of Marine Environmental Policy	PLOS ONE			English	Article							MANAGEMENT	Understanding the relationships and dependencies in the development and implementation of environmental policy is essential to the effective management of the marine environment. A new method of policy network analysis called 'Rapid Policy Network Mapping' was developed that delivers an insight for both technical and non-technical users into the lifecycle, relationships and dependencies of policy development. The method was applied to the Marine Strategy Framework Directive and the Water Framework Directive in the UK. These case studies highlight the environmental policy challenges to protect the UK's marine coastal environment and they identify differences in the styles of policy implementation between the devolved authorities of the UK. Rapid Policy Network Mapping provides an opportunity to create a collaborative policy data environment with a relatively small investment. As a tool for civil society it should assist in their ability to understand and influence policy making and implementation.	[Bainbridge, John Michael; Potts, Tavis; O'Higgins, Tim Gerard] Scottish Assoc Marine Sci, Ctr Coastal & Oceans Governance, Oban, Argyll, Scotland	UHI Millennium Institute	Bainbridge, JM (corresponding author), Scottish Assoc Marine Sci, Ctr Coastal & Oceans Governance, Oban, Argyll, Scotland.	john.bainbridge@sams.ac.uk	O'Higgins, Tim/G-6717-2015	O'Higgins, Tim/0000-0003-1274-4480; Potts, Tavis/0000-0001-7652-8854	European Community [226675]; Natural Environment Research Council [dml010007] Funding Source: researchfish; NERC [dml010007] Funding Source: UKRI	European Community(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The research leading to these results has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement number 226675. The KnowSeas project is affiliated with LOICZ and LWEC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EC HUM WELL BEING WE; Atkinson R., 2001, ACCESSING HIDDEN HAR; Borja A, 2010, MAR POLLUT BULL, V60, P2175, DOI 10.1016/j.marpolbul.2010.09.026; Bots P. W. G., 1999, P 32 HAW INT C SYST; Bryman A., 2004, HDB DATA ANAL, DOI DOI 10.4135/9781848608184.N22; Cairney P., 2009, PUBLIC POLICY ADMIN, V24, P355, DOI DOI 10.1177/0952076709340508; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Crowder L, 2008, MAR POLICY, V32, P772, DOI 10.1016/j.marpol.2008.03.012; *DEP ENV FOOD RUR, 2007, SEA CHANG; *DIR GEN MAR AFF F, 2009, SOC STUD FIELD INT M; Douvere F, 2007, MAR POLICY, V31, P182, DOI 10.1016/j.marpol.2006.07.003; *ENV AG, 2007, 2 CONS DOC WAT LIF L; *EUR COMM, 2009, SEC20091343 EUR COMM; European Commission, 2007, INT MAR POL EUR UN; Farquharson K., 2005, INT J SOC RES METHOD, V8, P345, DOI [10.1080/1364557042000203116, DOI 10.1080/1364557042000203116]; Fowler JH, 2009, P NATL ACAD SCI USA, V106, P1720, DOI 10.1073/pnas.0806746106; Friedman B. L., 2006, OXFORD HDB PUBLIC PO, P482; Garcia S., 2003, 443 FAO; Gilliland PM, 2008, MAR POLICY, V32, P787, DOI 10.1016/j.marpol.2008.03.022; Greenaway J, 2007, PUBLIC ADMIN, V85, P717, DOI 10.1111/j.1467-9299.2007.00661.x; Hanneman R.A., 2005, INTRO SOCIAL NETWORK; Lawton JH, 2007, J APPL ECOL, V44, P465, DOI 10.1111/j.1365-2664.2007.01315.x; Leifeld P., 2010, PREPRINTS M PLANCK I; LEIFELD P, 2008, M PLANCK I LECT; Leith MS, 2010, PARLIAMENT AFF, V63, P286, DOI 10.1093/pa/gsp032; Lipsky Michael, 1980, STREET LEVEL DEMOCRA; MARSDEN PV, 1984, SOC FORCES, V63, P482, DOI 10.2307/2579058; McArther S., 2008, ASIAN J PUBLIC AFFAI, V2, P55; Mikkelsen M., 2006, POLICY STUD-UK, V27, P17, DOI [10.1080/01442870500499868, DOI 10.1080/01442870500499868]; Monge P. R., 2003, THEORIES COMMUNICATI, P141; Osterblom H, 2010, MAR POLICY, V34, P1290, DOI 10.1016/j.marpol.2010.05.007; PETERSON J, 2003, POLITICAL SCI SERIES; Rhodes RAW, 2007, ORGAN STUD, V28, P1243, DOI 10.1177/0170840607076586; ROTH E, 2010, P LITT C 20 IN PRESS; *SCOTT GOV, 2008, SCOTT GOV STAK SURV; Smith H, 2011, J COAST CONSERV, V15, P291, DOI 10.1007/s11852-010-0098-z; Steunenberg B, 2009, J EUR PUBLIC POLICY, V16, P951, DOI 10.1080/13501760903226625; Tallis H, 2010, MAR POLICY, V34, P340, DOI 10.1016/j.marpol.2009.08.003; Wasserman S., 1994, STRUCTURAL ANAL SOCI, DOI 10.1017/CBO9780511815478	39	20	20	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26149	10.1371/journal.pone.0026149	http://dx.doi.org/10.1371/journal.pone.0026149			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834RQ	22022545	gold, Green Submitted, Green Published			2022-12-27	WOS:000295981600032
J	Hornoy, B; Tarayre, M; Herve, M; Gigord, L; Atlan, A				Hornoy, Benjamin; Tarayre, Michele; Herve, Maxime; Gigord, Luc; Atlan, Anne			Invasive Plants and Enemy Release: Evolution of Trait Means and Trait Correlations in Ulex europaeus	PLOS ONE			English	Article							INCREASED COMPETITIVE ABILITY; APION-ULICIS FORST; INTRODUCED POPULATIONS; FLOWERING PHENOLOGY; SEED PREDATION; BIOTIC INTERACTIONS; NEW-ZEALAND; HYPOTHESIS; SELECTION; GORSE	Several hypotheses that attempt to explain invasive processes are based on the fact that plants have been introduced without their natural enemies. Among them, the EICA (Evolution of Increased Competitive Ability) hypothesis is the most influential. It states that, due to enemy release, exotic plants evolve a shift in resource allocation from defence to reproduction or growth. In the native range of the invasive species Ulex europaeus, traits involved in reproduction and growth have been shown to be highly variable and genetically correlated. Thus, in order to explore the joint evolution of life history traits and susceptibility to seed predation in this species, we investigated changes in both trait means and trait correlations. To do so, we compared plants from native and invaded regions grown in a common garden. According to the expectations of the EICA hypothesis, we observed an increase in seedling height. However, there was little change in other trait means. By contrast, correlations exhibited a clear pattern: the correlations between life history traits and infestation rate by seed predators were always weaker in the invaded range than in the native range. In U. europaeus, the role of enemy release in shaping life history traits thus appeared to imply trait correlations rather than trait means. In the invaded regions studied, the correlations involving infestation rates and key life history traits such as flowering phenology, growth and pod density were reduced, enabling more independent evolution of these key traits and potentially facilitating local adaptation to a wide range of environments. These results led us to hypothesise that a relaxation of genetic correlations may be implied in the expansion of invasive species.	[Hornoy, Benjamin; Tarayre, Michele; Atlan, Anne] Univ Rennes 1, CNRS, Rennes, France; [Herve, Maxime] Univ Rennes 1, BIO3P, Inst Natl Rech Agron Agrocampus Ouest, Rennes, France; [Gigord, Luc] Conservatoire Bot Natl Mascarin, St Leu, Reunion, France	Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; INRAE; Institut Agro; Agrocampus Ouest; Universite de Rennes	Hornoy, B (corresponding author), Univ Rennes 1, CNRS, Rennes, France.	anne.atlan@univ-rennes1.fr			CNRS (Centre National de la Recherche Scientifique); CNRS (Centre National de la Recherche Scientifique)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS))	This work was supported by an ATIP (Action Thematique et Incitative sur Programme) grant of the CNRS (Centre National de la Recherche Scientifique). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AF, 2009, P ROY SOC B-BIOL SCI, V276, P1183, DOI 10.1098/rspb.2008.1671; Alexander JM, 2010, OIKOS, V119, P1377, DOI 10.1111/j.1600-0706.2009.17977.x; Alexander JM, 2009, ECOLOGY, V90, P612, DOI 10.1890/08-0453.1; Alpert Peter, 2000, Perspectives in Plant Ecology Evolution and Systematics, V3, P52, DOI 10.1078/1433-8319-00004; [Anonymous], 2010, R LANG ENV STAT COMP; Atlan A, 2010, J EVOLUTION BIOL, V23, P362, DOI 10.1111/j.1420-9101.2009.01908.x; Barat M, 2008, ECOL ENTOMOL, V33, P328, DOI 10.1111/j.1365-2311.2007.00968.x; Barat M, 2007, ENTOMOL EXP APPL, V124, P167, DOI 10.1111/j.1570-7458.2007.00565.x; Biere A, 1996, EVOLUTION, V50, P1098, DOI [10.1111/j.1558-5646.1996.tb02350.x, 10.2307/2410650]; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Blows MW, 2005, ECOLOGY, V86, P1371, DOI 10.1890/04-1209; Blumenthal DM, 2007, ECOLOGY, V88, P2758, DOI 10.1890/06-2115.1; Bossdorf O, 2005, OECOLOGIA, V144, P1, DOI 10.1007/s00442-005-0070-z; Bowman G, 2008, PLANT ECOL, V197, P197, DOI 10.1007/s11258-007-9370-1; Buckley YM, 2003, ECOLOGY, V84, P1434, DOI 10.1890/0012-9658(2003)084[1434:AIBAGS]2.0.CO;2; Callaway RM, 2004, FRONT ECOL ENVIRON, V2, P436, DOI 10.1890/1540-9295(2004)002[0436:NWISAT]2.0.CO;2; CHATER E. H., 1931, BULL ENT RES, V22, P225, DOI 10.1017/S0007485300035197; Davies WM, 1928, ANN APPL BIOL, V15, P263, DOI 10.1111/j.1744-7348.1928.tb07051.x; Elzinga JA, 2007, TRENDS ECOL EVOL, V22, P432, DOI 10.1016/j.tree.2007.05.006; Etterson JR, 2001, SCIENCE, V294, P151, DOI 10.1126/science.1063656; Falconer D. S., 1996, INTRO QUANTITATIVE G; Futuyma D. J., 2005, EVOLUTION; Gilchrist GW, 2007, GENETICA, V129, P127, DOI 10.1007/s10709-006-9009-5; Herrera J, 1999, INT J PLANT SCI, V160, P887, DOI 10.1086/314183; Hilker M, 2002, ENTOMOL EXP APPL, V104, P181, DOI 10.1023/A:1021232319226; Hill RL, 2002, BIOL CONTROL, V25, P173, DOI 10.1016/S1049-9644(02)00057-9; HILL RL, 1991, NEW ZEAL J ZOOL, V18, P37, DOI 10.1080/03014223.1991.10757946; Huang W, 2010, J ECOL, V98, P1157, DOI 10.1111/j.1365-2745.2010.01704.x; Johnson MTJ, 2009, J EVOLUTION BIOL, V22, P1295, DOI 10.1111/j.1420-9101.2009.01747.x; Joshi J, 2005, ECOL LETT, V8, P704, DOI 10.1111/j.1461-0248.2005.00769.x; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kollmann J, 2004, DIVERS DISTRIB, V10, P377, DOI 10.1111/j.1366-9516.2004.00126.x; Lahti DC, 2009, TRENDS ECOL EVOL, V24, P487, DOI 10.1016/j.tree.2009.03.010; Lee CE, 2008, EVOL APPL, V1, P427, DOI 10.1111/j.1752-4571.2008.00039.x; Leger EA, 2003, ECOL LETT, V6, P257, DOI 10.1046/j.1461-0248.2003.00423.x; Leimu R, 2002, OIKOS, V98, P229, DOI 10.1034/j.1600-0706.2002.980205.x; Levin DA, 2004, NEW PHYTOL, V161, P91, DOI 10.1046/j.1469-8137.2003.00921.x; Liu H, 2006, BIOL INVASIONS, V8, P1535, DOI 10.1007/s10530-005-5845-y; Lowe S., 2000, ENCY BIOL INVASIONS; Lynch M., 1998, GENETICS ANAL QUANTI; Markin G.P., 1996, NEWSLETTER HAWAIIAN, V35, P45; Maron JL, 2004, ECOLOGY, V85, P3243, DOI 10.1890/04-0297; Metcalf CJE, 2009, EVOL ECOL, V23, P893, DOI 10.1007/s10682-008-9279-8; MILLENER L. H., 1962, NEW PHYTOL, V61, P119, DOI 10.1111/j.1469-8137.1962.tb06280.x; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Montague JL, 2008, J EVOLUTION BIOL, V21, P234, DOI 10.1111/j.1420-9101.2007.01456.x; Monty A, 2009, OECOLOGIA, V159, P305, DOI 10.1007/s00442-008-1228-2; Muller-Scharer H, 2004, GENETICS, EVOLUTION AND BIOLOGICAL CONTROL, P137, DOI 10.1079/9780851997353.0137; Norghauer JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018790; Orians CM, 2010, ANNU REV ENTOMOL, V55, P439, DOI 10.1146/annurev-ento-112408-085333; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Ridenour WM, 2008, ECOL MONOGR, V78, P369, DOI 10.1890/06-1926.1; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Roff D, 2000, HEREDITY, V84, P135, DOI 10.1046/j.1365-2540.2000.00695.x; Roff Derek, 2002, pi; Sinervo B, 2002, HEREDITY, V89, P329, DOI 10.1038/sj.hdy.6800148; Stastny M, 2005, J ECOL, V93, P27, DOI 10.1111/j.1365-2745.2004.00962.x; Tarayre M, 2007, EVOL ECOL, V21, P395, DOI 10.1007/s10682-006-9109-9; Treier UA, 2009, ECOLOGY, V90, P1366, DOI 10.1890/08-0420.1; Walsh B, 2009, ANNU REV ECOL EVOL S, V40, P41, DOI 10.1146/annurev.ecolsys.110308.120232; Wolfe LM, 2004, ECOL LETT, V7, P813, DOI 10.1111/j.1461-0248.2004.00649.x; Zou JW, 2008, BIOL INVASIONS, V10, P291, DOI 10.1007/s10530-007-9130-0; [No title captured]; [No title captured]	65	35	35	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26275	10.1371/journal.pone.0026275	http://dx.doi.org/10.1371/journal.pone.0026275			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022588	gold, Green Published			2022-12-27	WOS:000295981600046
J	Dzialak, MR; Olson, CV; Harju, SM; Webb, SL; Mudd, JP; Winstead, JB; Hayden-Wing, LD				Dzialak, Matthew R.; Olson, Chad V.; Harju, Seth M.; Webb, Stephen L.; Mudd, James P.; Winstead, Jeffrey B.; Hayden-Wing, L. D.			Identifying and Prioritizing Greater Sage-Grouse Nesting and Brood-Rearing Habitat for Conservation in Human-Modified Landscapes	PLOS ONE			English	Article							RESOURCE SELECTION FUNCTIONS; FEMALE SPRUCE GROUSE; ENERGY DEVELOPMENT; CENTROCERCUS-UROPHASIANUS; SPATIAL-PATTERN; MONO COUNTY; PREDATION; SURVIVAL; MOVEMENTS; FIDELITY	Background: Balancing animal conservation and human use of the landscape is an ongoing scientific and practical challenge throughout the world. We investigated reproductive success in female greater sage-grouse (Centrocercus urophasianus) relative to seasonal patterns of resource selection, with the larger goal of developing a spatially-explicit framework for managing human activity and sage-grouse conservation at the landscape level. Methodology/Principal Findings: We integrated field-observation, Global Positioning Systems telemetry, and statistical modeling to quantify the spatial pattern of occurrence and risk during nesting and brood-rearing. We linked occurrence and risk models to provide spatially-explicit indices of habitat-performance relationships. As part of the analysis, we offer novel biological information on resource selection during egg-laying, incubation, and night. The spatial pattern of occurrence during all reproductive phases was driven largely by selection or avoidance of terrain features and vegetation, with little variation explained by anthropogenic features. Specifically, sage-grouse consistently avoided rough terrain, selected for moderate shrub cover at the patch level (within 90 m(2)), and selected for mesic habitat in mid and late brood-rearing phases. In contrast, risk of nest and brood failure was structured by proximity to anthropogenic features including natural gas wells and human-created mesic areas, as well as vegetation features such as shrub cover. Conclusions/Significance: Risk in this and perhaps other human-modified landscapes is a top-down (i.e., human-mediated) process that would most effectively be minimized by developing a better understanding of specific mechanisms (e.g., predator subsidization) driving observed patterns, and using habitat-performance indices such as those developed herein for spatially-explicit guidance of conservation intervention. Working under the hypothesis that industrial activity structures risk by enhancing predator abundance or effectiveness, we offer specific recommendations for maintaining high-performance habitat and reducing low-performance habitat, particularly relative to the nesting phase, by managing key high-risk anthropogenic features such as industrial infrastructure and water developments.	[Dzialak, Matthew R.; Olson, Chad V.; Harju, Seth M.; Webb, Stephen L.; Mudd, James P.; Winstead, Jeffrey B.; Hayden-Wing, L. D.] Hayden Wing Associates LLC, Nat Resource Consultants, Laramie, WY USA		Dzialak, MR (corresponding author), Hayden Wing Associates LLC, Nat Resource Consultants, Laramie, WY USA.	matt@haydenwing.com	Webb, Stephen L./B-6473-2009	Webb, Stephen L./0000-0001-6034-5164	ConocoPhillips Company; Encana Corporation; Noble Energy	ConocoPhillips Company; Encana Corporation; Noble Energy	This study was funded by ConocoPhillips Company, Encana Corporation and Noble Energy. Hayden-Wing Associates LLC provided in-kind contributions to support travel costs associated with dissemination of this work and the materials associated with data collection and analysis including: Radio-telemetry equipment, GPS devices and statistical analysis software. The authors are employed by Hayden-Wing Associates LLC and, therefore, played a role in the study. The other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; Aldridge CL, 2002, J WILDLIFE MANAGE, V66, P433, DOI 10.2307/3803176; Allison P. D., 1995, SURVIVAL ANAL USING; Arthur SM, 1996, ECOLOGY, V77, P215, DOI 10.2307/2265671; BERRY JD, 1985, J WILDLIFE MANAGE, V49, P237, DOI 10.2307/3801877; Boyce MS, 2003, ECOSCIENCE, V10, P421, DOI 10.1080/11956860.2003.11682790; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Bui TVD, 2010, CONDOR, V112, P65, DOI 10.1525/cond.2010.090132; Coates PS, 2010, J WILDLIFE MANAGE, V74, P240, DOI 10.2193/2009-047; Compton BW, 2002, ECOLOGY, V83, P833, DOI 10.1890/0012-9658(2002)083[0833:HSBWTC]2.0.CO;2; Connelly J.W., 2004, CONSERVATION ASSESSM; Connelly JW, 1997, WILDLIFE BIOL, V3, P229, DOI 10.2981/wlb.1997.028; Connelly JW, 2000, WILDLIFE SOC B, V28, P967; Conway CJ, 2000, EVOLUTION, V54, P670; Cooper AB, 1999, ECOLOGY, V80, P566, DOI 10.1890/0012-9658(1999)080[0566:TAODCM]2.0.CO;2; COX DR, 1972, J R STAT SOC B, V34, P187; Crunden C. W., 1963, Journal of Wildlife Management, V27, P846, DOI 10.2307/3798498; Darlington R. B., 1990, REGRESSION LINEAR MO; Delibes M, 2001, AM NAT, V158, P277, DOI 10.1086/321319; Doherty KE, 2008, J WILDLIFE MANAGE, V72, P187, DOI 10.2193/2006-454; Doherty KE, 2010, J WILDLIFE MANAGE, V74, P1544, DOI 10.2193/2009-043; Doherty KE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010339; DRUT MS, 1994, GREAT BASIN NAT, V54, P170; Duchesne T, 2010, J ANIM ECOL, V79, P548, DOI 10.1111/j.1365-2656.2010.01670.x; DUNN PO, 1986, J WILDLIFE MANAGE, V50, P228, DOI 10.2307/3801903; Dzialak MR, 2011, LANDSCAPE ECOL, V26, P775, DOI 10.1007/s10980-011-9607-1; FISCHER RA, 1993, CONDOR, V95, P1038, DOI 10.2307/1369442; Forester JD, 2009, ECOLOGY, V90, P3554, DOI 10.1890/08-0874.1; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Gompper ME, 2008, ANIM CONSERV, V11, P13, DOI 10.1111/j.1469-1795.2008.00160.x; GREGG MA, 1994, J WILDLIFE MANAGE, V58, P162, DOI 10.2307/3809563; Hamilton L. C., 1992, REGRESSION GRAPHICS; Harju SM, 2010, J WILDLIFE MANAGE, V74, P437, DOI 10.2193/2008-289; HERZOG PW, 1978, J WILDLIFE MANAGE, V42, P632, DOI 10.2307/3800829; Hjermann DO, 2000, ECOLOGY, V81, P1462, DOI 10.1890/0012-9658(2000)081[1462:AHSIAW]2.0.CO;2; Holloran MJ, 2010, J WILDLIFE MANAGE, V74, P65, DOI 10.2193/2008-291; HOMER CG, 2010, PROVISIONAL REMOTE S; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Jimenez JE, 2001, WILDLIFE SOC B, V29, P62; Johnson CJ, 2004, J APPL ECOL, V41, P238, DOI 10.1111/j.0021-8901.2004.00899.x; JOHNSTON G, 2003, P 28 ANN SAS US GROU; Jones R. E., 1963, Journal of Wildlife Management, V27, P757, DOI 10.2307/3798492; KENNEDY B, 1989, CAN J ECON, V22, P383, DOI 10.2307/135675; Kiesecker JM, 2010, FRONT ECOL ENVIRON, V8, P261, DOI 10.1890/090005; KLEBENOW DA, 1969, J WILDLIFE MANAGE, V33, P649, DOI 10.2307/3799390; KLOTT JH, 1990, J WILDLIFE MANAGE, V54, P84, DOI 10.2307/3808905; Kolada EJ, 2009, J WILDLIFE MANAGE, V73, P1341, DOI 10.2193/2008-339; Kolada EJ, 2009, J WILDLIFE MANAGE, V73, P1333, DOI 10.2193/2008-338; Kristan WB, 2003, ECOLOGY, V84, P2432, DOI 10.1890/02-0448; KUHFELD WF, 2000, TS621 SAS I; Langholz B, 2007, COMPUT STAT DATA AN, V51, P3737, DOI 10.1016/j.csda.2006.12.028; Liebezeit JR, 2009, ECOL APPL, V19, P1628, DOI 10.1890/08-1661.1; Manly B.F.J., 2002, RESOURCE SELECTION A; Manzer DL, 2005, J WILDLIFE MANAGE, V69, P110, DOI 10.2193/0022-541X(2005)069&lt;0110:RGNSAC&gt;2.0.CO;2; MCCOURT KH, 1973, AUK, V90, P619, DOI 10.2307/4084160; McCune B, 2002, J VEG SCI, V13, P603, DOI 10.1111/j.1654-1103.2002.tb02087.x; McDonald TL, 2006, J WILDLIFE MANAGE, V70, P375, DOI 10.2193/0022-541X(2006)70[375:DMIWSE]2.0.CO;2; McLoughlin PD, 2005, J ANIM ECOL, V74, P701, DOI 10.1111/j.1365-2656.2005.00967.x; McLoughlin PD, 2006, P ROY SOC B-BIOL SCI, V273, P1449, DOI 10.1098/rspb.2006.3486; Mery F, 2010, EVOL ECOL, V24, P571, DOI 10.1007/s10682-009-9336-y; Moynahan BJ, 2007, J WILDLIFE MANAGE, V71, P1773, DOI 10.2193/2005-386; Nielsen SE, 2006, BIOL CONSERV, V130, P217, DOI 10.1016/j.biocon.2005.12.016; Part T, 2007, J ORNITHOL, V148, pS327, DOI 10.1007/s10336-007-0226-1; Patten MA, 2010, ECOL APPL, V20, P2148, DOI 10.1890/09-2370.1; Patterson R.L., 1952, SAGE GROUSE WYOMING; Rand TA, 2006, ECOL LETT, V9, P603, DOI 10.1111/j.1461-0248.2006.00911.x; Rodewald AD, 2011, ECOL APPL, V21, P936, DOI 10.1890/10-0863.1; Rosenberg DK, 1999, J WILDLIFE MANAGE, V63, P1028, DOI 10.2307/3802818; Sargeant AB, 1998, INTERPRETING EVIDENC; SAS Institute, 2009, SAS STAT 9 2 US GUID; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; SCHLADWEILER P, 1968, J WILDLIFE MANAGE, V32, P426, DOI 10.2307/3798993; Schroeder M.A., 1999, Birds of North America, V425, P1; Schroeder MA, 2003, WILDLIFE BIOL, V9, P291, DOI 10.2981/wlb.2003.017; Schroeder MA, 2001, WILDLIFE SOC B, V29, P24; SMITH T, 2003, P 28 ANN SAS US GROU, P254; *STAT WY, 2008, STAT WYOM EX DEP EX; Stephens SE, 2005, ECOL APPL, V15, P2137, DOI 10.1890/04-1162; Thompson KM, 2006, WEST N AM NATURALIST, V66, P332, DOI 10.3398/1527-0904(2006)66[332:EBHUAP]2.0.CO;2; *US DEP INT, 2008, VERN FIELD OFF REC D; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; *VIS LEARN SYST IN, 2008, FEAT AN 4 2 ARCGIS; WAKKINEN WL, 1992, WILDLIFE SOC B, V20, P425; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529; WALLESTAD RO, 1971, J WILDLIFE MANAGE, V35, P129, DOI 10.2307/3799881; Wegge P, 2007, WILDLIFE BIOL, V13, P87, DOI 10.2981/0909-6396(2007)13[87:GSTPNI]2.0.CO;2; *WY GAM FISH DEP, 2003, WYOM GREAT SAG GROUS; Zar J. H., 1996, BIOSTATISTICAL ANAL; 2010, FED REG, V75, P13910	90	54	55	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26273	10.1371/journal.pone.0026273	http://dx.doi.org/10.1371/journal.pone.0026273			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022587	Green Published, Green Submitted, gold			2022-12-27	WOS:000295978600048
J	Buhling, F; Kouadio, M; Chwieralski, CE; Kern, U; Hohlfeld, JM; Klemm, N; Friedrichs, N; Roth, W; Deussing, JM; Peters, C; Reinheckel, T				Buehling, Frank; Kouadio, Martin; Chwieralski, Caroline E.; Kern, Ursula; Hohlfeld, Jens M.; Klemm, Nicole; Friedrichs, Nicole; Roth, Wera; Deussing, Jan M.; Peters, Christoph; Reinheckel, Thomas			Gene Targeting of the Cysteine Peptidase Cathepsin H Impairs Lung Surfactant in Mice	PLOS ONE			English	Article							PULMONARY SURFACTANT; MINI-CHAIN; PROTEIN-B; SUBSTRATE-SPECIFICITY; ENDOPEPTIDASE; CELLS; AMINOPEPTIDASE; DISEASE; DYSFUNCTION; DEFICIENT	Background: The 11 human cysteine cathepsins are proteases mainly located in the endolysosomal compartment of all cells and within the exocytosis pathways of some secretory cell types. Cathepsin H (Ctsh) has amino-and endopeptidase activities. In vitro studies have demonstrated Ctsh involvement in the processing and secretion of the pulmonary surfactant protein B (SP-B). Furthermore, Ctsh is highly expressed in the secretory organelles of alveolar type II pneumocytes where the surfactant proteins are processed. Methodology/Principal Findings: Hence, we generated Ctsh null mice by gene targeting in embryonic stem cells to investigate the role of this protease in surfactant processing in vivo. The targeting construct contains a beta-galactosidase (lacZ) reporter enabling the visualisation of Ctsh expression sites. Ctsh-deficiency was verified by northern blot, western blot, and measurement of the Ctsh aminopeptidase activity. Ctsh(-/-) mice show no gross phenotype and their development is normal without growth retardation. Broncho-alveolar lavage (BAL) from Ctsh(-/-) mice contained lower levels of SP-B indicating reduced SP-B secretion. The BAL phospholipid concentration was not different in Ctsh(+/+) and Ctsh(-/-) mice, but measurement of surface tension by pulsating bubble surfactometry revealed an impairment of the tension reducing function of lung surfactant of Ctsh(-/-) mice. Conclusions/Significance: We conclude that cathepsin H is involved in the SP-B production and reduced SP-B levels impair the physical properties of the lung surfactant. However, Ctsh defiency does not reproduce the severe phenotype of SP-B deficient mice. Hence, other proteases of the secretory pathway of type II pneumocytes, i.e. cathepsins C or E, are still able to produce surfactant of sufficient quality in absence of Ctsh.	[Buehling, Frank] Carl Thiem Klinikum, Inst Lab Med, Cottbus, Germany; [Kouadio, Martin; Kern, Ursula; Klemm, Nicole; Friedrichs, Nicole; Roth, Wera; Deussing, Jan M.; Peters, Christoph; Reinheckel, Thomas] Univ Freiburg, Inst Mol Med & Cell Res, Freiburg, Germany; [Chwieralski, Caroline E.] Otto Von Guericke Univ, Magdeburg, Germany; [Kern, Ursula] Univ Freiburg, Fac Biol, Freiburg, Germany; [Kern, Ursula] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, Freiburg, Germany; [Hohlfeld, Jens M.] Fraunhofer Inst Toxicol & Expt Med, Div Immunol Allergol & Airway Res, Hannover, Germany; [Peters, Christoph; Reinheckel, Thomas] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, Freiburg, Germany	University of Freiburg; Otto von Guericke University; University of Freiburg; University of Freiburg; Fraunhofer Gesellschaft; University of Freiburg	Buhling, F (corresponding author), Carl Thiem Klinikum, Inst Lab Med, Cottbus, Germany.	thomas.reinheckel@uniklinik-freiburg.de	Deussing, Jan M/ABB-5993-2021; Reinheckel, Thomas/AAL-9761-2021	Reinheckel, Thomas/0000-0001-9866-9105; Hohlfeld, Jens/0000-0003-2646-6186; Deussing, Jan/0000-0002-9329-5252	Deutsche Forschungsgemeinschaft (DFG) [RE 1584/3-1, BU 1152/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) grants RE 1584/3-1 and BU 1152/1-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht S, 2010, CELL PHYSIOL BIOCHEM, V25, P81, DOI 10.1159/000272053; BAUDYS M, 1991, BIOMED BIOCHIM ACTA, V50, P569; Brasch F, 2002, AM J RESP CELL MOL, V26, P659, DOI 10.1165/ajrcmb.26.6.4744; Brix K, 2008, BIOCHIMIE, V90, P194, DOI 10.1016/j.biochi.2007.07.024; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; D'Angelo ME, 2010, J BIOL CHEM, V285, P20514, DOI 10.1074/jbc.M109.094573; Dodt J, 2003, BIOL CHEM, V384, P1327, DOI 10.1515/BC.2003.149; ENHORNING G, 1977, J APPL PHYSIOL, V43, P198, DOI 10.1152/jappl.1977.43.2.198; Gocheva V, 2010, BIOL CHEM, V391, P937, DOI 10.1515/BC.2010.080; Guncar G, 1998, STRUCTURE, V6, P51; Guttentag S, 2003, AM J RESP CELL MOL, V28, P69, DOI 10.1165/rcmb.2002-0111OC; Hagemann S, 2004, EUR J CELL BIOL, V83, P775, DOI 10.1078/0171-9335-00404; Hohlfeld JM, 1999, AM J RESP CRIT CARE, V159, P1803, DOI 10.1164/ajrccm.159.6.9806145; KIRSCHKE H, 1977, ACTA BIOL MED GER, V36, P185; KOGA H, 1992, CHEM PHARM BULL, V40, P965; Lu JI, 2007, J BIOL CHEM, V282, P22176, DOI 10.1074/jbc.M700063200; Nogee LM, 2004, ANNU REV PHYSIOL, V66, P601, DOI 10.1146/annurev.physiol.66.032102.134711; Puzer L, 2004, ARCH BIOCHEM BIOPHYS, V430, P274, DOI 10.1016/j.abb.2004.07.006; Rawlings ND, 2010, NUCLEIC ACIDS RES, V38, pD227, DOI 10.1093/nar/gkp971; Reiser J, 2010, J CLIN INVEST, V120, P3421, DOI 10.1172/JCI42918; SAFTIG P, 1995, EMBO J, V14, P3599, DOI 10.1002/j.1460-2075.1995.tb00029.x; Tedelind S, 2010, BIOL CHEM, V391, P923, DOI 10.1515/BC.2010.109; Tokieda K, 1997, AM J PHYSIOL-LUNG C, V273, pL875, DOI 10.1152/ajplung.1997.273.4.L875; Ueno T, 2004, J BIOL CHEM, V279, P16178, DOI 10.1074/jbc.M312029200; Vasiljeva O, 2003, BIOCHEMISTRY-US, V42, P13522, DOI 10.1021/bi035355k; Vasiljeva O, 2007, CURR PHARM DESIGN, V13, P387, DOI 10.2174/138161207780162962; WASANO K, 1994, HISTOCHEMISTRY, V102, P329, DOI 10.1007/BF00268903; WEAVER TE, 1992, AM J PHYSIOL, V263, pL95, DOI 10.1152/ajplung.1992.263.1.L95	28	26	26	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26247	10.1371/journal.pone.0026247	http://dx.doi.org/10.1371/journal.pone.0026247			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022579	gold, Green Submitted, Green Published			2022-12-27	WOS:000295976000092
J	Chen, WS; Li, ZY; Hu, JY; Zhang, ZH; Chen, LL; Chen, YX; Liu, ZG				Chen, Wensheng; Li, Zhiyuan; Hu, Jiaoyue; Zhang, Zhenhao; Chen, Lelei; Chen, Yongxiong; Liu, Zuguo			Corneal Alternations Induced by Topical Application of Benzalkonium Chloride in Rabbit	PLOS ONE			English	Article							LIMBAL BASAL EPITHELIUM; BARRIER FUNCTION; TIGHT JUNCTIONS; LANGERHANS CELLS; OCULAR SURFACE; CUTTING EDGE; IN-VIVO; DRY EYE; ENDOTHELIUM; GATIFLOXACIN	Benzalkonium chloride (BAC) is the most common preservative in ophthalmic preparations. Here, we investigated the corneal alternations in rabbits following exposure to BAC. Twenty-four adult male New Zealand albino rabbits were randomly divided into three groups. BAC at 0.01%, 0.05%, or 0.1% was applied twice daily to one eye each of rabbits for 4 days. The contralateral untreated eyes were used as control. Aqueous tear production and fluorescein staining scores of BAC-treated eyes were compared with those of controls. The structure of the central cornea was examined by in vivo confocal microscopy. Expression of mucin-5 subtype AC (MUC5AC) in conjunctiva was detected by immunostainig on cryosections. Corneal barrier function was assessed in terms of permeability to carboxy fluorescein (CF). The distribution and expression of ZO-1, a known marker of tight junction, and reorganization of the perijunctional actomyosin ring (PAMR) were examined by immunofluorescence analysis. Although there were no significant differences between control and BAC-treated eyes in Schirmer scores, corneal fluorescein scores and the number of conjunctival MUC5AC staining cells, in vivo confocal microscopy revealed significant epithelial and stromal defects in all BAC-treated corneas. Moreover, BAC at 0.1% resulted in significant increases in central corneal thickness and endothelial CF permeability, compared with those in control eyes, and endothelial cell damage with dislocation of ZO-1 and disruption of PAMR. Topical application of BAC can quickly impair the whole cornea without occurrence of dry eye. A high concentration of BAC breaks down the barrier integrity of corneal endothelium, concomitant with the disruption of PAMR and remodeling of apical junctional complex in vivo.	[Chen, Wensheng] Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China; Xiamen Univ, Affiliated Xiamen Eye Ctr, Xiamen, Fujian, Peoples R China	Xiamen University; Xiamen University	Chen, WS (corresponding author), Xiamen Univ, Inst Eye, Xiamen, Fujian, Peoples R China.	cwensheng@hotmail.com; zuguoliu@xmu.edu.cn	li, zhiyuan/HGD-9581-2022		National Basic Research Program of China (Project 973) [2011CB504606]; National Natural Science Foundation of China, Beijing, China [30973249, 81100638]; Natural Science Foundation of Fujian Province, China [2009J01201]; Technological innovation platform program of Fujian Province, China [2009J1013]	National Basic Research Program of China (Project 973)(National Basic Research Program of China); National Natural Science Foundation of China, Beijing, China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province); Technological innovation platform program of Fujian Province, China	This work was supported by the National Basic Research Program of China (Project 973) Grant 2011CB504606; National Natural Science Foundation of China, Beijing, China (grant no: 30973249; 81100638); and Natural Science Foundation of Fujian Province, China (grant no: 2009J01201); Technological innovation platform program of Fujian Province, China (grant no: 2009J1013). The funders had no role in study design, data collection and analysis, decision on publish, or preparation of the manuscript.	Ban Y, 2003, EXP EYE RES, V76, P663, DOI 10.1016/S0014-4835(03)00054-X; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; Bourne WM, 2003, EYE, V17, P912, DOI 10.1038/sj.eye.6700559; Chen WS, 2007, CORNEA, V26, P1101, DOI 10.1097/ICO.0b013e318123771e; Chen WS, 2007, EXP EYE RES, V84, P626, DOI 10.1016/j.exer.2006.11.006; Chen WS, 2010, CORNEA, V29, P73, DOI 10.1097/ICO.0b013e3181ac9f92; Chinnery HR, 2008, J IMMUNOL, V180, P5779, DOI 10.4049/jimmunol.180.9.5779; CRONE C, 1982, BRAIN RES, V241, P49, DOI 10.1016/0006-8993(82)91227-6; Edelhauser HF, 2006, INVEST OPHTH VIS SCI, V47, P1755, DOI 10.1167/iovs.05-1139; Hutcheon AEK, 2007, EXP EYE RES, V84, P32, DOI 10.1016/j.exer.2006.08.011; Kimura K, 2008, INVEST OPHTH VIS SCI, V49, P565, DOI 10.1167/iovs.07-0419; Kusano M, 2010, CORNEA, V29, P80, DOI 10.1097/ICO.0b013e3181a3c3e6; Labbe A, 2006, J OCUL PHARMACOL TH, V22, P267, DOI 10.1089/jop.2006.22.267; Lemp Michael A., 1995, CLAO Journal, V21, P221; Liang H, 2008, BRIT J OPHTHALMOL, V92, P1275, DOI 10.1136/bjo.2008.138768; Lin H, 2010, INVEST OPHTH VIS SCI, V51, P122, DOI 10.1167/iovs.09-3629; Mandell KJ, 2006, INVEST OPHTH VIS SCI, V47, P2408, DOI 10.1167/iovs.05-0745; Nakamura T, 2010, BIOL PHARM BULL, V33, P107, DOI 10.1248/bpb.33.107; Onfelt B, 2004, J IMMUNOL, V173, P1511, DOI 10.4049/jimmunol.173.3.1511; Pauly A, 2007, INVEST OPHTH VIS SCI, V48, P5473, DOI 10.1167/iovs.06-0728; Pauly A, 2009, INVEST OPHTH VIS SCI, V50, P1644, DOI 10.1167/iovs.08-2992; Pisella PJ, 2000, OPHTHALMIC RES, V32, P3, DOI 10.1159/000055579; Ramachandran C, 2010, INVEST OPHTH VIS SCI, V51, P2139, DOI 10.1167/iovs.09-4421; Rathore MS, 2006, AAPS PHARMSCITECH, V7; Riley MV, 1998, INVEST OPHTH VIS SCI, V39, P2076; Romanowski EG, 2008, J OCUL PHARMACOL TH, V24, P380, DOI 10.1089/jop.2008.0017; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Shivanna M, 2010, INVEST OPHTH VIS SCI, V51, P1575, DOI 10.1167/iovs.09-4343; Srinivas SP, 2010, OPTOMETRY VISION SCI, V87, P239, DOI 10.1097/OPX.0b013e3181d39464; SRINIVAS SP, 2010, OPTOMETRY VISION SCI, V84, pE239; Swan K. C., 1944, AM J OPHTHALMOL, V27, P1118; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Xiong C, 2008, INVEST OPHTH VIS SCI, V49, P1850, DOI 10.1167/iovs.07-0720; Yi X, 2000, INVEST OPHTH VIS SCI, V41, P4093	34	43	52	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26103	10.1371/journal.pone.0026103	http://dx.doi.org/10.1371/journal.pone.0026103			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022526	Green Published, gold, Green Submitted			2022-12-27	WOS:000295976000068
J	Sharma, D; Smits, BMG; Eichelberg, MR; Meilahn, AL; Muelbl, MJ; Haag, JD; Gould, MN				Sharma, Deepak; Smits, Bart M. G.; Eichelberg, Mark R.; Meilahn, Amanda L.; Muelbl, Matthew J.; Haag, Jill D.; Gould, Michael N.			Quantification of Epithelial Cell Differentiation in Mammary Glands and Carcinomas from DMBA- and MNU-Exposed Rats	PLOS ONE			English	Article							FOCAL ADHESION KINASE; SEXUALLY IMMATURE RATS; NITROSO-N-METHYLUREA; STEM-CELLS; BREAST-CANCER; SIGNAL-TRANSDUCTION; IN-VIVO; CARCINOGENESIS; TUMORIGENESIS; 1-METHYL-1-NITROSOUREA	Rat mammary carcinogenesis models have been used extensively to study breast cancer initiation, progression, prevention, and intervention. Nevertheless, quantitative molecular data on epithelial cell differentiation in mammary glands of untreated and carcinogen-exposed rats is limited. Here, we describe the characterization of rat mammary epithelial cells (RMECs) by multicolor flow cytometry using antibodies against cell surface proteins CD24, CD29, CD31, CD45, CD49f, CD61, Peanut Lectin, and Thy-1, intracellular proteins CK14, CK19, and FAK, along with phalloidin and Hoechst staining. We identified the luminal and basal/myoepithelial populations and actively dividing RMECs. In inbred rats susceptible to mammary carcinoma development, we quantified the changes in differentiation of the RMEC populations at 1, 2, and 4 weeks after exposure to mammary carcinogens DMBA and MNU. DMBA exposure did not alter the percentage of basal or luminal cells, but upregulated CD49f (Integrin alpha 6) expression and increased cell cycle activity. MNU exposure resulted in a temporary disruption of the luminal/basal ratio and no CD49f upregulation. When comparing DMBA-or MNU-induced mammary carcinomas, the RMEC differentiation profiles are indistinguishable. The carcinomas compared with mammary glands from untreated rats, showed upregulation of CD29 (Integrin beta 1) and CD49f expression, increased FAK (focal adhesion kinase) activation especially in the CD29hi population, and decreased CD61 (Integrin beta 3) expression. This study provides quantitative insight into the protein expression phenotypes underlying RMEC differentiation. The results highlight distinct RMEC differentiation etiologies of DMBA and MNU exposure, while the resulting carcinomas have similar RMEC differentiation profiles. The methodology and data will enhance rat mammary carcinogenesis models in the study of the role of epithelial cell differentiation in breast cancer.	[Sharma, Deepak; Smits, Bart M. G.; Eichelberg, Mark R.; Meilahn, Amanda L.; Muelbl, Matthew J.; Haag, Jill D.; Gould, Michael N.] Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sharma, D (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, Dept Oncol, Sch Med & Publ Hlth, 1400 Univ Ave, Madison, WI 53706 USA.	bsmits@wisc.edu	Gould, Michael N/C-7414-2014	Sharma, Deepak/0000-0002-7529-5574	National Institutes of Health [CA123272, CA077494]; National Institute of Environmental Health Sciences [ES019466]; NATIONAL CANCER INSTITUTE [R01CA123272, R01CA077494] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES019466] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants [CA123272] and [CA077494], and National Institute of Environmental Health Sciences grant [ES019466]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariazi JL, 2005, MOL CARCINOGEN, V43, P155, DOI 10.1002/mc.20104; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; CLIFTON KH, 1986, CANCER RES, V46, P2390; DUNDAS SR, 1991, J CELL SCI, V100, P459; GUAN JL, 1992, NATURE, V358, P690, DOI 10.1038/358690a0; Guan JL, 2010, IUBMB LIFE, V62, P268, DOI 10.1002/iub.303; GUGLIOTTA P, 1988, J HISTOCHEM CYTOCHEM, V36, P659, DOI 10.1177/36.6.3367051; GULLINO PM, 1975, J NATL CANCER I, V54, P401; HUGGINS C, 1961, NATURE, V189, P204, DOI 10.1038/189204a0; KIM ND, 1993, EXP CELL RES, V207, P74, DOI 10.1006/excr.1993.1165; KORNBERG LJ, 1991, P NATL ACAD SCI USA, V88, P8392, DOI 10.1073/pnas.88.19.8392; Lahlou H, 2007, P NATL ACAD SCI USA, V104, P20302, DOI 10.1073/pnas.0710091104; Li N, 2005, EMBO J, V24, P1942, DOI 10.1038/sj.emboj.7600674; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; MILLER JA, 1970, CANCER RES, V30, P559; NANDI S, 1995, P NATL ACAD SCI USA, V92, P3650, DOI 10.1073/pnas.92.9.3650; Papaconstantinou AD, 2006, INT J CANCER, V118, P17, DOI 10.1002/ijc.21247; RUDLAND PS, 1982, J NATL CANCER I, V68, P799; RUDLAND PS, 1991, J HISTOCHEM CYTOCHEM, V39, P1257, DOI 10.1177/39.9.1918944; RUDLAND PS, 1988, J CELL SCI, P95; RUSSO IH, 1978, J NATL CANCER I, V61, P1439; Russo J, 1996, BREAST CANCER RES TR, V39, P7, DOI 10.1007/BF01806074; RUSSO J, 1990, LAB INVEST, V62, P244; Samuelson DJ, 2007, P NATL ACAD SCI USA, V104, P6299, DOI 10.1073/pnas.0701687104; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shan L, 2005, CARCINOGENESIS, V26, P503, DOI 10.1093/carcin/bgh330; Singh M, 2000, LAB INVEST, V80, P221, DOI 10.1038/labinvest.3780025; Smits BMG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2933; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; THOMPSON HJ, 1995, CARCINOGENESIS, V16, P2407, DOI 10.1093/carcin/16.10.2407; Thompson HJ, 1998, CARCINOGENESIS, V19, P383, DOI 10.1093/carcin/19.3.383; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; White DE, 2004, CANCER CELL, V6, P159, DOI 10.1016/j.ccr.2004.06.025; ZARBL H, 1985, NATURE, V315, P382, DOI 10.1038/315382a0; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	36	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26145	10.1371/journal.pone.0026145	http://dx.doi.org/10.1371/journal.pone.0026145			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022542	Green Published, gold, Green Submitted			2022-12-27	WOS:000295976000075
J	Hu, Y; Ma, DX; Shan, NN; Zhu, YY; Liu, XG; Zhang, L; Yu, S; Ji, CY; Hou, M				Hu, Yu; Ma, Dao-xin; Shan, Ning-ning; Zhu, Yuan-yuan; Liu, Xin-guang; Zhang, Lei; Yu, Shuang; Ji, Chun-yan; Hou, Ming			Increased Number of Tc17 and Correlation with Th17 Cells in Patients with Immune Thrombocytopenia	PLOS ONE			English	Article							T-CELLS; ROR-GAMMA; PURPURA; DIFFERENTIATION; PATHOPHYSIOLOGY; PROFILE; IL-17	Background: IL-17-secreting CD8+ T cells (Tc17 subset) have recently been defined as a subpopulation of effector T cells implicated in the pathogenesis of autoimmune diseases. The role of Tc17 and correlation with Th17 cells in the pathophysiology of immune thrombocytopenia (ITP) remain unsettled. Design and Methods: We studied 47 ITP patients (20 newly-diagnosed and 27 with complete response) and 34 healthy controls. IL-17-producing CD3+CD8+ cells (Tc17) and IL-17-producing CD3+CD8- cells (Th17) were evaluated by flow cytometry and expressed as a percentage of the total number of CD3+ cells. Specific anti-platelet glycoprotein (GP) GPIIb/IIIa and/or GPIb/IX autoantibodies were measured by modified monoclonal antibody specific immobilization of platelet antigens. Peripheral blood mononuclear cells of ITP patients were isolated, incubated in the presence of 0, 0.25, 0.5, or 1 mu mol/L of dexamethasone for 72 h, and collected to detect Tc17 and Th17 cells by flow cytometric analysis. Results: IL-17 was expressed on CD3+CD8- and CD3+ CD8+ T cells. The percentages of Tc17 and Th17 cells in newly-diagnosed patients were significantly elevated compared to controls, and Tc17 was decreased after clinical treatment. The Th17:Tc17 ratio was significantly lower in newly-diagnosed patients compared with controls, and was increased in patients who had complete response. There was a significantly positive correlation between Tc17 and Th17 cells in the control group, but not in the ITP patients. A positive correlation existed between Tc17 and the CD8:CD4 ratio, as well as CD8+ cells in patients with ITP. The frequencies of Tc17 were marginally higher in autoantibody-negative patients than autoantibody-positive patients. Moreover, both Tc17 and Th17 cell percentages decreased as the concentration of dexamethasone in the culture media increased in ITP patients. Conclusions: Tc17 and the Th17 subset are involved in the immunopathology of ITP. Blocking the abnormally increased number of Tc17 may be a reasonable therapeutic strategy for ITP.	[Hu, Yu; Ma, Dao-xin; Zhu, Yuan-yuan; Liu, Xin-guang; Yu, Shuang; Ji, Chun-yan; Hou, Ming] Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Shan, Ning-ning] Shandong Univ, Prov Hosp, Dept Hematol, Jinan 250100, Peoples R China; [Zhang, Lei] Shandong Univ, Qilu Hosp, Dept Orthoped, Jinan 250100, Peoples R China	Shandong University; Shandong University; Shandong University	Ma, DX (corresponding author), Shandong Univ, Qilu Hosp, Dept Hematol, Jinan 250100, Peoples R China.	daoxinma@hotmail.com			National Natural Science Foundation [30600680, 81070396, 81070407, 81170515]; Shandong Technological Development Project [2005BS03022, Q 2008C 07, BS2009SW014]; Scientific Research Foundation for the Returned Overseas Chinese Scholars; State Education Ministry (SRF); Independent Innovation Foundation of Shandong University (IIFSDU) [2009TS063, 2009TS071, 21300070613233]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shandong Technological Development Project; Scientific Research Foundation for the Returned Overseas Chinese Scholars(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Education Ministry (SRF); Independent Innovation Foundation of Shandong University (IIFSDU)	This study was partially supported by research funding from the National Natural Science Foundation (30600680, 81070396, 81070407, 81170515), the Shandong Technological Development Project (2005BS03022, Q 2008C 07, and BS2009SW014), the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (SRF for ROCS, SEM), and Independent Innovation Foundation of Shandong University (IIFSDU; 2009TS063, 2009TS071, and 21300070613233). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chi LJ, 2010, J PERIPHER NERV SYST, V15, P345, DOI 10.1111/j.1529-8027.2010.00294.x; Chow L, 2010, BLOOD, V115, P1247, DOI 10.1182/blood-2009-09-244772; Garcia-Hernandez MD, 2010, J IMMUNOL, V184, P4215, DOI 10.4049/jimmunol.0902995; Hamada H, 2009, J IMMUNOL, V182, P3469, DOI 10.4049/jimmunol.0801814; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Henriques A, 2010, CELL IMMUNOL, V264, P97, DOI 10.1016/j.cellimm.2010.05.004; Hou M, 2003, EUR J HAEMATOL, V70, P353, DOI 10.1034/j.1600-0609.2003.00076.x; Huber M, 2009, EUR J IMMUNOL, V39, P1716, DOI 10.1002/eji.200939412; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kagami S, 2010, J INVEST DERMATOL, V130, P1373, DOI 10.1038/jid.2009.399; Kondo T, 2009, J IMMUNOL, V182, P1794, DOI 10.4049/jimmunol.0801347; Ma DX, 2008, ANN HEMATOL, V87, P899, DOI 10.1007/s00277-008-0535-3; Nicoletti F, 2009, CLIN EXP IMMUNOL, V155, P28, DOI 10.1111/j.1365-2249.2008.03780.x; Olsson B, 2003, NAT MED, V9, P1123, DOI 10.1038/nm921; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Rodeghiero F, 2009, BLOOD, V113, P2386, DOI 10.1182/blood-2008-07-162503; Sakakura M, 2007, THROMB RES, V120, P187, DOI 10.1016/j.thromres.2006.09.008; Semple JW, 2002, BLOOD REV, V16, P9, DOI 10.1054/blre.2001.0172; Semple JW, 1996, BLOOD, V87, P4245, DOI 10.1182/blood.V87.10.4245.bloodjournal87104245; Stasi R, 2008, THROMB HAEMOSTASIS, V99, P4, DOI 10.1160/TH07-08-0513; SYRJALA H, 1991, CLIN EXP IMMUNOL, V83, P326; Yang XXO, 2008, IMMUNITY, V28, P29, DOI 10.1016/j.immuni.2007.11.016; Zhang JB, 2009, HAEMATOL-HEMATOL J, V94, P1326, DOI 10.3324/haematol.2009.007823; Zhao XY, 2011, EUR J IMMUNOL, V41, P514, DOI 10.1002/eji.201040793; Zhao Y, 2009, BRIT J DERMATOL, V161, P1301, DOI 10.1111/j.1365-2133.2009.09400.x; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488; Zhu XJ, 2010, J CLIN IMMUNOL, V30, P253, DOI 10.1007/s10875-009-9353-1	27	43	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26522	10.1371/journal.pone.0026522	http://dx.doi.org/10.1371/journal.pone.0026522			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039505	Green Published, gold, Green Submitted			2022-12-27	WOS:000296515200023
J	Marcelin, G; DuBois, R; Rubrum, A; Russell, CJ; McElhaney, JE; Webby, RJ				Marcelin, Glendie; DuBois, Rebecca; Rubrum, Adam; Russell, Charles J.; McElhaney, Janet E.; Webby, Richard J.			A Contributing Role for Anti-Neuraminidase Antibodies on Immunity to Pandemic H1N1 2009 Influenza A Virus	PLOS ONE			English	Article							HELPER T-CELLS; IMMUNOLOGICAL RESPONSE; ANTIGENIC-COMPETITION; UNPRIMED POPULATIONS; EXTRACELLULAR DOMAIN; VIRAL HEMAGGLUTININ; PROTECTIVE IMMUNITY; CROSS-PROTECTION; PRIOR EXPERIENCE; VACCINE	Background: Exposure to contemporary seasonal influenza A viruses affords partial immunity to pandemic H1N1 2009 influenza A virus (pH1N1) infection. The impact of antibodies to the neuraminidase (NA) of seasonal influenza A viruses to cross-immunity against pH1N1 infection is unknown. Methods and Results: Antibodies to the NA of different seasonal H1N1 influenza strains were tested for cross-reactivity against A/California/04/09 (pH1N1). A panel of reverse genetic (rg) recombinant viruses was generated containing 7 genes of the H1N1 influenza strain A/Puerto Rico/08/34 (PR8) and the NA gene of either the pandemic H1N1 2009 strain (pH1N1) or one of the following contemporary seasonal H1N1 strains: A/Solomon/03/06 (rg Solomon) or A/Brisbane/59/07 (rg Brisbane). Convalescent sera collected from mice infected with recombinant viruses were measured for cross-reactive antibodies to pH1N1 via Hemagglutinin Inhibition (HI) or Enzyme-Linked Immunosorbent Assay (ELISA). The ectodomain of a recombinant NA protein from the pH1N1 strain (pNA-ecto) was expressed, purified and used in ELISA to measure cross-reactive antibodies. Analysis of sera from elderly humans immunized with trivalent split-inactivated influenza (TIV) seasonal vaccines prior to 2009 revealed considerable cross-reactivity to pNA-ecto. High titers of cross-reactive antibodies were detected in mice inoculated with either rg Solomon or rg Brisbane. Convalescent sera from mice inoculated with recombinant viruses were used to immunize naive recipient Balb/c mice by passive transfer prior to challenge with pH1N1. Mice receiving rg California sera were better protected than animals receiving rg Solomon or rg Brisbane sera. Conclusions: The NA of contemporary seasonal H1N1 influenza strains induces a cross-reactive antibody response to pH1N1 that correlates with reduced lethality from pH1N1 challenge, albeit less efficiently than anti-pH1N1 NA antibodies. These findings demonstrate that seasonal NA antibodies contribute to but are not sufficient for cross-reactive immunity to pH1N1.	[Marcelin, Glendie; DuBois, Rebecca; Rubrum, Adam; Russell, Charles J.; Webby, Richard J.] St Jude Childrens Hosp, Div Virol, Dept Infect Dis, Memphis, TN 38105 USA; [DuBois, Rebecca] St Jude Childrens Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [McElhaney, Janet E.] Univ Connecticut, Sch Med, Dept Immunol, Ctr Immunotherapy Canc & Infect Dis, Farmington, CT USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Connecticut	Webby, RJ (corresponding author), St Jude Childrens Hosp, Div Virol, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.	richard.webby@stjude.org	Russell, Charles/AAU-6006-2020; Russell, Charles/K-4824-2013; Webby, Richard J/N-5657-2018	Russell, Charles/0000-0001-5683-3990; Russell, Charles/0000-0001-5683-3990; DuBois, Rebecca/0000-0003-4185-5673	National Institute of Allergy and Infectious Diseases [HHSN266200700005C]; Centers of Excellence for Influenza Research and Surveillance [HHSN266200700005C]; American Lebanese Syrian Associated Charities	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Centers of Excellence for Influenza Research and Surveillance; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC))	This study was supported by the National Institute of Allergy and Infectious Diseases (contract number HHSN266200700005C), Centers of Excellence for Influenza Research and Surveillance (contract number HHSN266200700005C) and the American Lebanese Syrian Associated Charities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMERDING D, 1982, J INFECT DIS, V145, P320, DOI 10.1093/infdis/145.3.320; Boon ACM, 2010, J VIROL, V84, P7662, DOI 10.1128/JVI.02444-09; Bragstad K, 2011, INFLUENZA OTHER RESP, V5, P13, DOI 10.1111/j.1750-2659.2010.00177.x; Brecht H, 1971, Virology, V46, P337; Carrat F, 2007, VACCINE, V25, P6852, DOI 10.1016/j.vaccine.2007.07.027; Cate TR, 2010, VACCINE, V28, P2076, DOI 10.1016/j.vaccine.2009.12.041; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen Z, 2000, VACCINE, V18, P3214, DOI 10.1016/S0264-410X(00)00149-3; Chi CY, 2010, CLIN VACCINE IMMUNOL, V17, P1958, DOI 10.1128/CVI.00212-10; Cowling BJ, 2010, CLIN INFECT DIS, V51, P1370, DOI 10.1086/657311; Cox NJ, 1999, LANCET, V354, P1277, DOI 10.1016/S0140-6736(99)01241-6; De Groot AS, 2009, VACCINE, V27, P5740, DOI 10.1016/j.vaccine.2009.07.040; ELLEBEDY AH, 2010, VACCINE; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; HANCOCK EJ, 1986, J INFECT DIS, V154, P1031, DOI 10.1093/infdis/154.6.1031; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; HOLMES KT, 1982, EUR J IMMUNOL, V12, P523, DOI 10.1002/eji.1830120614; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598; JOHANSSON BE, 1987, P NATL ACAD SCI USA, V84, P6869, DOI 10.1073/pnas.84.19.6869; JOHANSSON BE, 1987, J IMMUNOL, V139, P2015; JOHANSSON BE, 1993, VACCINE, V11, P1037, DOI 10.1016/0264-410X(93)90130-P; JOHANSSON BE, 1994, P NATL ACAD SCI USA, V91, P2358, DOI 10.1073/pnas.91.6.2358; Johansson BE, 1998, VACCINE, V16, P1009, DOI 10.1016/S0264-410X(97)00279-X; JOHANSSON BE, 1989, J VIROL, V63, P1239, DOI 10.1128/JVI.63.3.1239-1246.1989; JOHANSSON BE, 1987, J IMMUNOL, V139, P2010; Kayamuro H, 2010, J VIROL, V84, P12703, DOI 10.1128/JVI.01182-10; KENDAL AP, 1977, J INFECT DIS, V136, pS415, DOI 10.1093/infdis/136.Supplement_3.S415; KENDAL AP, 1980, INFECT IMMUN, V29, P966; KILBOURNE ED, 1968, J VIROL, V2, P281, DOI 10.1128/JVI.2.4.281-288.1968; Koerner I, 2007, J VIROL, V81, P2025, DOI 10.1128/JVI.01718-06; Laurie KL, 2010, J INFECT DIS, V202, P1011, DOI 10.1086/656188; Lee VJ, 2010, VACCINE, V28, P6852, DOI 10.1016/j.vaccine.2010.08.031; Li Q, 2010, NAT STRUCT MOL BIOL, V17, P1266, DOI 10.1038/nsmb.1909; Lipatov AS, 2006, J INFECT DIS, V194, P1040, DOI 10.1086/507709; Marcelin G, 2010, J INFECT DIS, V202, P1634, DOI 10.1086/657084; McCullers JA, 2010, CLIN INFECT DIS, V50, P1487, DOI 10.1086/652441; Mordstein M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000151; Neirynck S, 1999, NAT MED, V5, P1157, DOI 10.1038/13484; Pascua PNQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008431; Pearce MB, 2011, VACCINE, V29, P2887, DOI 10.1016/j.vaccine.2011.02.014; Powers DC, 1996, CLIN DIAGN LAB IMMUN, V3, P511, DOI 10.1128/CDLI.3.5.511-516.1996; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sandbulte MR, 2007, PLOS MED, V4, P265, DOI 10.1371/journal.pmed.0040059; Sandbulte MR, 2009, INFLUENZA OTHER RESP, V3, P233, DOI 10.1111/j.1750-2659.2009.00094.x; Scheible K, 2011, VACCINE, V29, P2159, DOI 10.1016/j.vaccine.2010.12.073; Song JM, 2011, P NATL ACAD SCI USA, V108, P757, DOI 10.1073/pnas.1012199108; Steel J, 2010, J VIROL, V84, P21, DOI 10.1128/JVI.01732-09; Subbramanian RA, 2010, HUM IMMUNOL, V71, P957, DOI 10.1016/j.humimm.2010.07.005; Sun K, 2011, J IMMUNOL, V186, P987, DOI 10.4049/jimmunol.1002664; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; WEBSTER RG, 1967, J IMMUNOL, V99, P49; Xing Z, 2009, EMERG INFECT DIS, V15, P1847, DOI 10.3201/eid1511.090685; Xu XJ, 2008, J VIROL, V82, P10493, DOI 10.1128/JVI.00959-08	56	54	55	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26335	10.1371/journal.pone.0026335	http://dx.doi.org/10.1371/journal.pone.0026335			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039464	Green Submitted, Green Published, gold			2022-12-27	WOS:000296515200013
J	Bansal, N; Kadamb, R; Mittal, S; Vig, L; Sharma, R; Dwarakanath, BS; Saluja, D				Bansal, Nidhi; Kadamb, Rama; Mittal, Shilpi; Vig, Leena; Sharma, Raisha; Dwarakanath, Bilikere S.; Saluja, Daman			Tumor Suppressor Protein p53 Recruits Human Sin3B/HDAC1 Complex for Down-Regulation of Its Target Promoters in Response to Genotoxic Stress	PLOS ONE			English	Article							ALPHA-FETOPROTEIN GENE; CELL-CYCLE ARREST; TRANSCRIPTIONAL REPRESSION; HISTONE DEACETYLASE; BINDING-SITE; CHROMATIN MODIFICATIONS; FUNCTIONAL DOMAIN; INDUCED APOPTOSIS; DNA-BINDING; LYSINE 9	Master regulator protein p53, popularly known as the "guardian of genome" is the hub for regulation of diverse cellular pathways. Depending on the cell type and severity of DNA damage, p53 protein mediates cell cycle arrest or apoptosis, besides activating DNA repair, which is apparently achieved by regulation of its target genes, as well as direct interaction with other proteins. p53 is known to repress target genes via multiple mechanisms one of which is via recruitment of chromatin remodelling Sin3/HDAC1/2 complex. Sin3 proteins (Sin3A and Sin3B) regulate gene expression at the chromatin-level by serving as an anchor onto which the core Sin3/HDAC complex is assembled. The Sin3/HDAC co-repressor complex can be recruited by a large number of DNA-binding transcription factors. Sin3A has been closely linked to p53 while Sin3B is considered to be a close associate of E2Fs. The theme of this study was to establish the role of Sin3B in p53-mediated gene repression. We demonstrate a direct protein-protein interaction between human p53 and Sin3B (hSin3B). Amino acids 1-399 of hSin3B protein are involved in its interaction with N-terminal region (amino acids 1-108) of p53. Genotoxic stress induced by Adriamycin treatment increases the levels of hSin3B that is recruited to the promoters of p53-target genes (HSPA8, MAD1 and CRYZ). More importantly recruitment of hSin3B and repression of the three p53-target promoters upon Adriamycin treatment were observed only in p53(+/+) cell lines. Additionally an increased tri-methylation of the H3K9 residue at the promoters of HSPA8 and CRYZ was also observed following Adriamycin treatment. The present study highlights for the first time the essential role of Sin3B as an important associate of p53 in mediating the cellular responses to stress and in the transcriptional repression of genes encoding for heat shock proteins or proteins involved in regulation of cell cycle and apoptosis.	[Bansal, Nidhi; Kadamb, Rama; Mittal, Shilpi; Vig, Leena; Sharma, Raisha; Saluja, Daman] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India; [Dwarakanath, Bilikere S.] Inst Nucl Med & Allied Sci, Delhi, India	University of Delhi; Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS)	Bansal, N (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	dsalujach59@gmail.com	Kadamb, Rama/AAE-7233-2022	Kadamb, Rama/0000-0002-0157-2305; Dwarakanath, Bilikere S./0000-0001-6988-2601; Bansal, Nidhi/0000-0001-6502-3930	Department of Science and Technology [R/SO/BB- 55/2004]; Council of Scientific and Industrial Research, Government of India [37/1431/10/EMRII]; Council of Scientific and Industrial Research; University Grants Commission; Indian Council of Medical Research	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR))	This work was supported by grants from Department of Science and Technology (R/SO/BB- 55/2004) and Council of Scientific and Industrial Research (37/1431/10/EMRII), Government of India to Prof. Daman Saluja. The research fellowships of the authors were funded by Council of Scientific and Industrial Research (authors NB and RK), University Grants Commission (author SM) and Indian Council of Medical Research (author LV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakura S, 2001, J BIOL CHEM, V276, P14649, DOI 10.1074/jbc.M100200200; AYER DE, 1995, CELL, V80, P767, DOI 10.1016/0092-8674(95)90355-0; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; BARRANCO SC, 1973, CANCER RES, V33, P11; Ceribelli M, 2006, CELL CYCLE, V5, P1102, DOI 10.4161/cc.5.10.2777; Chun ACS, 2003, J BIOL CHEM, V278, P37439, DOI 10.1074/jbc.M307185200; Crosby ME, 2004, J ENVIRON PATHOL TOX, V23, P67, DOI 10.1615/JEnvPathToxOncol.v23.i1.70; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; FUNK WD, 1992, MOL CELL BIOL, V12, P2866, DOI 10.1128/MCB.12.6.2866; Giaccia AJ, 1998, GENE DEV, V12, P2973, DOI 10.1101/gad.12.19.2973; Grandinetti KB, 2008, CELL CYCLE, V7, P1550, DOI 10.4161/cc.7.11.6052; Grandinetti KB, 2009, CANCER RES, V69, P6430, DOI 10.1158/0008-5472.CAN-09-0537; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Im HJ, 2002, J BIOL CHEM, V277, P14612, DOI 10.1074/jbc.M109414200; Imbriano C, 2005, MOL CELL BIOL, V25, P3737, DOI 10.1128/MCB.25.9.3737-3751.2005; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Koumenis C, 2001, MOL CELL BIOL, V21, P1297, DOI 10.1128/MCB.21.4.1297-1310.2001; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Laptenko O, 2006, CELL DEATH DIFFER, V13, P951, DOI 10.1038/sj.cdd.4401916; Lapucci A, 2010, FASEB J, V24, P1852, DOI 10.1096/fj.09-140459; Lee KC, 1999, MOL CELL BIOL, V19, P1279; Lee TKW, 2002, CANCER CHEMOTH PHARM, V49, P78, DOI 10.1007/s00280-001-0376-4; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Mirza A, 2003, ONCOGENE, V22, P3645, DOI 10.1038/sj.onc.1206477; Murphy M, 1999, GENE DEV, V13, P2490, DOI 10.1101/gad.13.19.2490; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Nguyen TT, 2005, MOL CELL BIOL, V25, P2147, DOI 10.1128/MCB.25.6.2147-2157.2005; Osheroff N, 1994, Adv Pharmacol, V29B, P105; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Ryan KM, 1998, MOL CELL BIOL, V18, P3692, DOI 10.1128/MCB.18.7.3692; Sakamuro D, 1997, ONCOGENE, V15, P887, DOI 10.1038/sj.onc.1201263; Siu WY, 1999, FEBS LETT, V461, P299, DOI 10.1016/S0014-5793(99)01481-7; Soutoglou E, 2002, SCIENCE, V295, P1901, DOI 10.1126/science.1068356; Venot C, 1998, EMBO J, V17, P4668, DOI 10.1093/emboj/17.16.4668; Walker KK, 1996, P NATL ACAD SCI USA, V93, P15335, DOI 10.1073/pnas.93.26.15335; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; Wu YL, 2001, ONCOGENE, V20, P240, DOI 10.1038/sj.onc.1204067; Xu Y, 2008, J BIOL CHEM, V283, P1243, DOI 10.1074/jbc.M707180200; Yamane K, 2006, CELL, V125, P483, DOI 10.1016/j.cell.2006.03.027; Yang L, 2003, BIOCHEM J, V369, P651, DOI 10.1042/BJ20020854; Zhang Y, 2004, J BIOL CHEM, V279, P42545, DOI 10.1074/jbc.M314213200; Zilfou JT, 2001, MOL CELL BIOL, V21, P3974, DOI 10.1128/MCB.21.12.3974-3985.2001	49	31	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26156	10.1371/journal.pone.0026156	http://dx.doi.org/10.1371/journal.pone.0026156			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028823	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800021
J	Kassa, FA; Shio, MT; Bellemare, MJ; Faye, B; Ndao, M; Olivier, M				Kassa, Fikregabrail Aberra; Shio, Marina Tiemi; Bellemare, Marie-Josee; Faye, Babacar; Ndao, Momar; Olivier, Martin			New Inflammation-Related Biomarkers during Malaria Infection	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; CEREBRAL MALARIA; UNCOMPLICATED MALARIA; COMPLEMENT ACTIVATION; CHILDREN; HEMOZOIN; SEVERITY; PROTEINS; PIGMENT; IL-10	Malaria is one of the most prevalent infectious diseases worldwide with more than 250 million cases and one million deaths each year. One of the well-characterized malarial-related molecules is hemozoin (HZ), which is a dark-brown crystal formed by the parasite and released into the host during the burst of infected red blood cells. HZ has a stimulatory effect on the host immune system such as its ability to induce pro-inflammatory mediators responsible for some of the malaria related clinical symptoms such as fever. However, the host serum proteins interacting with malarial HZ as well as how this interaction modifies its recognition by phagocytes remained elusive. In the actual study, using proteomic liquid chromatographic mass spectrometry (LC-MS/MS) and immunochemical approaches, we compared the serum protein profiles of malaria patients and healthy individuals. Particularly, we utilized the malarial HZ itself to capture serum proteins capable to bind to HZ, enabling us to identify several proteins such as apolipoprotein E (ApoE), serum amyloid A (SAA), gelsolin, complement factor H and fibrinogen that were found to differ among healthy and malaria individual. Of particular interest is LPS binding protein (LBP), which is reported herein for the first time in the context of malaria. LBP is usually produced during innate inflammatory response to gram-negative bacterial infections. The exact role of these biomarkers and acute phase responses in malaria in general and HZ in particular remains to be investigated. The identification of these inflammation-related biomarkers in malaria paves the way to potentially utilize them as diagnostic and therapeutic targets.	[Kassa, Fikregabrail Aberra; Shio, Marina Tiemi; Bellemare, Marie-Josee; Olivier, Martin] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Kassa, Fikregabrail Aberra; Shio, Marina Tiemi; Bellemare, Marie-Josee; Ndao, Momar; Olivier, Martin] McGill Univ, Ctr Study Host Resistance, Res Inst, Ctr Hlth, Montreal, PQ, Canada; [Faye, Babacar] Cheikh Anta Diop Univ, Fac Med, Dept Parasitol & Mycol, Dakar, Senegal; [Ndao, Momar] Montreal Gen Hosp, Natl Reference Ctr Parasitol, Montreal, PQ H3G 1A4, Canada	McGill University; McGill University; University Cheikh Anta Diop Dakar; McGill University	Kassa, FA (corresponding author), McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada.	martin.olivier@mcgill.ca	Shio, Marina Tiemi/E-6466-2019	Shio, Marina Tiemi/0000-0002-2494-6816	Canadian Institute of Health Research; Burroughs Wellcome Fund; Research Institute of the McGill University Health Center and Faculty of Medicine	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Research Institute of the McGill University Health Center and Faculty of Medicine	This study is supported by operating grants from the Canadian Institute of Health Research to M.O. M.O. is a Canadian Institute of Health Research Investigator and a Burroughs Wellcome Fund Fellow. F. A. K. is recipient of fellowships from the Research Institute of the McGill University Health Center and Faculty of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAM C, 1981, INFECT IMMUN, V31, P530, DOI 10.1128/IAI.31.2.530-535.1981; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Bellemare MJ, 2009, J PHYS CHEM B, V113, P8391, DOI 10.1021/jp8104375; Conroy AL, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-295; Francis SE, 1997, ANNU REV MICROBIOL, V51, P97, DOI 10.1146/annurev.micro.51.1.97; GILLESPIE SH, 1991, J CLIN PATHOL, V44, P228, DOI 10.1136/jcp.44.3.228; GREENWOOD BM, 1974, CLIN EXP IMMUNOL, V18, P267; JAKOBSEN PH, 1994, IMMUNOLOGY, V83, P665; Jaramillo M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006957; Kabyemela ER, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-26; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Lovegrove FE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004912; Lyke KE, 2004, INFECT IMMUN, V72, P5630, DOI 10.1128/IAI.72.10.5630-5637.2004; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Nesvizhskii AI, 2004, DRUG DISCOV TODAY, V9, P173, DOI 10.1016/S1359-6446(03)02978-7; Parroche P, 2007, P NATL ACAD SCI USA, V104, P1919, DOI 10.1073/pnas.0608745104; PHANUPHAK P, 1985, CLIN EXP IMMUNOL, V59, P571; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; SALE FO, 2005, EUR J HAEMATOL, V74, P324; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shio MT, 2010, MICROBES INFECT, V12, P889, DOI 10.1016/j.micinf.2010.07.001; SRICHAIKUL T, 1975, LANCET, V1, P770; TAYLOR TE, 1993, Q J MED, V86, P99; Trampuz A, 2003, CRIT CARE, V7, P315, DOI 10.1186/cc2183; Urieli-Shoval S, 2000, CURR OPIN HEMATOL, V7, P64, DOI 10.1097/00062752-200001000-00012; Wenisch C, 1997, CLIN IMMUNOL IMMUNOP, V85, P166, DOI 10.1006/clin.1997.4417; Yeo TW, 2008, P NATL ACAD SCI USA, V105, P17097, DOI 10.1073/pnas.0805782105	27	36	36	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26495	10.1371/journal.pone.0026495	http://dx.doi.org/10.1371/journal.pone.0026495			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028888	gold, Green Published, Green Submitted			2022-12-27	WOS:000296510800046
J	Niwayama, S; Kassar, AS; Zhao, T; Sutton, RB; Altenberg, GA				Niwayama, Satomi; Kassar, Abdullatif S.; Zhao, Tian; Sutton, Roger B.; Altenberg, Guillermo A.			A Pyrene Maleimide with a Flexible Linker for Sampling of Longer Inter-Thiol Distances by Excimer Formation	PLOS ONE			English	Article							ESCHERICHIA-COLI; LACTOSE PERMEASE; PROXIMITY RELATIONSHIPS; FLUORESCENT-PROBE; VIRUS MEMBRANE; DYNAMICS; BINDING; FUSION; DOMAIN	Pyrene-containing compounds are commonly used in a number of fluorescence-based applications because they can form excited-state dimers (excimers) by stacking interaction between excited-state and ground-state monomers. Their usefulness arises from the facts that excimer formation requires close proximity between the pyrenes and that the excimer emission spectrum is very different from that of the monomers. One of many applications is to assess proximity between specific sites of macromolecules labeled with pyrenes. This has been done using pyrene maleimide, a reagent that reacts with reduced thiols of cysteines, but its use for structural studies of proteins has been rather limited. This is because the introduction of two cysteines at sufficiently close distance from each other to obtain excimer fluorescence upon labeling with pyrene maleimide requires detailed knowledge of the protein structure or extensive site-directed mutagenesis trials. We synthesized and tested a new compound with a 4-carbon methylene linker placed between the maleimide and the pyrene (pyrene-4-maleimide), with the aim of increasing the sampling distance for excimer formation and making the use of excimer fluorescence simpler and more widespread. We tested the new compound on thiol-modified oligonucleotides and showed that it can detect proximity between thiols beyond the reach of pyrene maleimide. Based on its spectroscopic and chemical properties, we suggest that pyrene-4-maleimide is an excellent probe to assess proximities between cysteines in proteins and thiols in other macromolecules, as well as to follow conformational changes.	[Niwayama, Satomi; Zhao, Tian] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Kassar, Abdullatif S.; Sutton, Roger B.; Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys, Lubbock, TX USA; [Kassar, Abdullatif S.; Sutton, Roger B.; Altenberg, Guillermo A.] Texas Tech Hlth Sci Ctr, Ctr Membrane Prot Res, Lubbock, TX USA	Texas Tech University System; Texas Tech University; Texas Tech University System; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University Health Science Center	Niwayama, S (corresponding author), Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA.	g.altenberg@ttuhsc.edu	Niwayama, Satomi/O-1598-2015; Zhao, Tian/AAM-9541-2021	Niwayama, Satomi/0000-0001-6385-5274; Altenberg, Guillermo/0000-0002-8932-740X	National Institutes of Health [R01GM79629, 3R01GM079629-03S1]; Cancer Prevention & Research Institute of Texas [RP101073]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Prevention & Research Institute of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants from the National Institutes of Health (R01GM79629 and 3R01GM079629-03S1) and Cancer Prevention & Research Institute of Texas (RP101073). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BETCHERLANGE SL, 1978, J BIOL CHEM, V253, P3757; Boens N, 2007, ANAL CHEM, V79, P2137, DOI 10.1021/ac062160k; Boschek CB, 2008, BIOCHEMISTRY-US, V47, P1640, DOI 10.1021/bi701987n; Conlon P, 2008, J AM CHEM SOC, V130, P336, DOI 10.1021/ja076411y; GRACEFFA P, 1980, J BIOL CHEM, V255, P1296; JUNG K, 1994, BIOCHEMISTRY-US, V33, P3980, DOI 10.1021/bi00179a026; JUNG K, 1993, BIOCHEMISTRY-US, V32, P12273, DOI 10.1021/bi00097a001; Karuppannan S, 2011, CHEM-ASIAN J, V6, P964, DOI 10.1002/asia.201000724; Lehrer SS, 1997, METHOD ENZYMOL, V278, P286; Liou YM, 2007, BBA-PROTEINS PROTEOM, V1774, P466, DOI 10.1016/j.bbapap.2007.01.004; Liou YM, 2003, EUR J BIOCHEM, V270, P3092, DOI 10.1046/j.1432-1033.2003.03700.x; Moesker B, 2010, J GEN VIROL, V91, P389, DOI 10.1099/vir.0.015255-0; PAL R, 1988, BIOCHEMISTRY-US, V27, P30, DOI 10.1021/bi00401a006; Patel AB, 2010, BIOCHEMISTRY-US, V49, P1766, DOI 10.1021/bi901902e; Pearson JT, 2005, ARCH BIOCHEM BIOPHYS, V436, P397, DOI 10.1016/j.abb.2005.02.008; Santra MK, 2006, PHOTOCHEM PHOTOBIOL, V82, P480, DOI 10.1562/2005-09-26-RA-698; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; WALKER MA, 1995, J ORG CHEM, V60, P5352, DOI 10.1021/jo00121a070; WELTMAN JK, 1973, J BIOL CHEM, V248, P3173; West JM, 2004, J BIOL CHEM, V279, P945, DOI 10.1074/jbc.M304018200; Wu CC, 2010, BIOSENS BIOELECTRON, V25, P2232, DOI 10.1016/j.bios.2010.02.030; Wu CC, 2009, J BIOMED NANOTECHNOL, V5, P495, DOI 10.1166/jbn.2009.1074; Xu Z, 2009, J AM CHEM SOC, V131, P15528, DOI 10.1021/ja906855a; Zhao M, 1999, BIOCHEMISTRY-US, V38, P7407, DOI 10.1021/bi9906524	24	10	13	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26691	10.1371/journal.pone.0026691	http://dx.doi.org/10.1371/journal.pone.0026691			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028936	Green Submitted, gold, Green Published			2022-12-27	WOS:000296510800065
J	Belda-Ferre, P; Cabrera-Rubio, R; Moya, A; Mira, A				Belda-Ferre, Pedro; Cabrera-Rubio, Raul; Moya, Andres; Mira, Alex			Mining Virulence Genes Using Metagenomics	PLOS ONE			English	Article							WEB-BASED RESOURCE; SPECIES DEFINITION; GENOME SEQUENCE; ISLANDS; PATHOGENOMICS; PROKARYOTES; MICROBIOME; DIVERSITY	When a bacterial genome is compared to the metagenome of an environment it inhabits, most genes recruit at high sequence identity. In free-living bacteria (for instance marine bacteria compared against the ocean metagenome) certain genomic regions are totally absent in recruitment plots, representing therefore genes unique to individual bacterial isolates. We show that these Metagenomic Islands (MIs) are also visible in bacteria living in human hosts when their genomes are compared to sequences from the human microbiome, despite the compartmentalized structure of human-related environments such as the gut. From an applied point of view, MIs of human pathogens (e. g. those identified in enterohaemorragic Escherichia coli against the gut metagenome or in pathogenic Neisseria meningitidis against the oral metagenome) include virulence genes that appear to be absent in related strains or species present in the microbiome of healthy individuals. We propose that this strategy (i.e. recruitment analysis of pathogenic bacteria against the metagenome of healthy subjects) can be used to detect pathogenicity regions in species where the genes involved in virulence are poorly characterized. Using this approach, we detect well-known pathogenicity islands and identify new potential virulence genes in several human pathogens.	[Belda-Ferre, Pedro; Cabrera-Rubio, Raul; Moya, Andres; Mira, Alex] Univ Valencia, Joint Unit Res Genom & Hlth, Ctr Publ Hlth Res, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Moya, Andres] Ctr Invest Biomed Red Especializado Epidemiol & S, Madrid, Spain	University of Valencia	Belda-Ferre, P (corresponding author), Univ Valencia, Joint Unit Res Genom & Hlth, Ctr Publ Hlth Res, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain.	mira_ale@gva.es	Mira, Alex/A-7244-2010; Belda-Ferre, Pedro/E-7699-2013; Belda-Ferre, Pedro/C-9825-2010; Moya, Andrés/A-8190-2008; Cabrera-Rubio, Raúl/K-3720-2014	Belda-Ferre, Pedro/0000-0001-6532-1161; Moya, Andrés/0000-0002-2867-1119; Mira, Alex/0000-0002-9127-3877	Spanish Ministerio De Ciencia E Innovacion [SAF2009-13032-C02-01, SAF2009-13032-C02-02]; EXPLORA program [BIO2008-03419-E]; Consolider-Ingenio program [MICROGEN CSD2009-00006]	Spanish Ministerio De Ciencia E Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); EXPLORA program; Consolider-Ingenio program(Spanish Government)	This work was funded by the following projects from the Spanish Ministerio De Ciencia E Innovacion: SAF2009-13032-C02-01 and SAF2009-13032-C02-02 from the I+D program, BIO2008-03419-E from the EXPLORA program and MICROGEN CSD2009-00006 from the Consolider-Ingenio program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bik EM, 2010, ISME J, V4, P962, DOI 10.1038/ismej.2010.30; Chaudhuri RR, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000529; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; Coleman ML, 2006, SCIENCE, V311, P1768, DOI 10.1126/science.1122050; Cuadros-Orellana S, 2007, ISME J, V1, P235, DOI 10.1038/ismej.2007.35; Fan X, 2007, J BIOL CHEM, V282, P35143, DOI 10.1074/jbc.M706296200; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gomez-Alvarez V, 2009, ISME J, V3, P1314, DOI 10.1038/ismej.2009.72; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Haley BJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-154; Ivars-Martinez E, 2008, ISME J, V2, P1194, DOI 10.1038/ismej.2008.74; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Mira A, 2002, MOL BIOL EVOL, V19, P1350, DOI 10.1093/oxfordjournals.molbev.a004196; Pasic L, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-570; Perna NT, 2001, NATURE, V409, P529, DOI 10.1038/35054089; Richter M, 2009, P NATL ACAD SCI USA, V106, P19126, DOI 10.1073/pnas.0906412106; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Xie G, 2010, MOL ORAL MICROBIOL, V25, P391, DOI 10.1111/j.2041-1014.2010.00587.x; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951; Yoon SH, 2007, NUCLEIC ACIDS RES, V35, pD395, DOI 10.1093/nar/gkl790; Zaura E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-259; Zhang JR, 1999, MOL MICROBIOL, V31, P1477, DOI 10.1046/j.1365-2958.1999.01291.x; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	26	12	12	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e24975	10.1371/journal.pone.0024975	http://dx.doi.org/10.1371/journal.pone.0024975			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039404	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500005
J	Sanchez, CJ; Hinojosa, CA; Shivshankar, P; Hyams, C; Camberlein, E; Brown, JS; Orihuela, CJ				Sanchez, Carlos J.; Hinojosa, Cecilia A.; Shivshankar, Pooja; Hyams, Catherine; Camberlein, Emilie; Brown, Jeremy S.; Orihuela, Carlos J.			Changes in Capsular Serotype Alter the Surface Exposure of Pneumococcal Adhesins and Impact Virulence	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE ADHESIN; COMPLEMENT DEPOSITION; EPITHELIAL-CELLS; CONJUGATE VACCINE; BINDING-PROTEIN; MULTIPLEX PCR; POLYSACCHARIDE; DISEASE; MICE; PSPA	We examined the contribution of serotype on Streptococcus pneumoniae adhesion and virulence during respiratory tract infection using a panel of isogenic TIGR4 (serotype 4) mutants expressing the capsule types 6A (+6A), 7F (+7F) and 23F (+23F) as well as a deleted and restored serotype 4 (+4) control strain. Immunoblots, bacterial capture assays with immobilized antibody, and measurement of mean fluorescent intensity by flow cytometry following incubation of bacteria with antibody, all determined that the surface accessibility, but not total protein levels, of the virulence determinants Pneumococcal surface protein A (PspA), Choline binding protein A (CbpA), and Pneumococcal serine-rich repeat protein (PsrP) changed with serotype. In vitro, bacterial adhesion to Detroit 562 pharyngeal or A549 lung epithelial cells was modestly but significantly altered for +6A, +7F and +23F. In a mouse model of nasopharyngeal colonization, the number of +6A, +7F, and +23F pneumococci in the nasopharynx was reduced 10 to 100-fold versus +4; notably, only mice challenged with +4 developed bacteremia. Intratracheal challenge of mice confirmed that capsule switch strains were highly attenuated for virulence. Compared to +4, the +6A, +7F, and +23F strains were rapidly cleared from the lungs and were not detected in the blood. In mice challenged intraperitoneally, a marked reduction in bacterial blood titers was observed for those challenged with +6A and +7F versus +4 and +23F was undetectable. These findings show that serotype impacts the accessibility of surface adhesins and, in particular, affects virulence within the respiratory tract. They highlight the complex interplay between capsule and protein virulence determinants.	[Sanchez, Carlos J.; Hinojosa, Cecilia A.; Shivshankar, Pooja; Orihuela, Carlos J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA; [Hyams, Catherine; Camberlein, Emilie; Brown, Jeremy S.] Royal Free & Univ Coll Med Sch, Rayne Inst, Ctr Resp Res, Dept Med, London WC1E 6BT, England	University of Texas System; University of Texas Health San Antonio; University of London; King's College London; University College London	Sanchez, CJ (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	orihuela@uthscsa.edu	Hyams, Catherine/AAH-1721-2019	Hyams, Catherine/0000-0003-3923-1773; Brown, Jeremy/0000-0002-5650-5361	United States National Institutes of Health, National Institute of Dental and Craniofacial [DE14318]; Astor Foundation; Glaxo Smith Kline through University College London, MB; United Kingdom Medical Research Council; United States National Institutes of Health, National Institute of Allergy and Infectious Diseases [AI078972]; United Kingdom Department of Health, National Institute for Health Research Biomedical Research Centre; U.S. National Institutes of Health, National Cancer Institute [CA54174, UL1 RR025767]; Glaxo Smith Kline through University College London, MD; MRC [G0700829] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000149] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025767] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014318] Funding Source: NIH RePORTER; Medical Research Council [G0700829] Funding Source: researchfish	United States National Institutes of Health, National Institute of Dental and Craniofacial(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Astor Foundation; Glaxo Smith Kline through University College London, MB; United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United States National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); United Kingdom Department of Health, National Institute for Health Research Biomedical Research Centre(National Institute for Health Research (NIHR)); U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Glaxo Smith Kline through University College London, MD; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Dr. Sanchez is supported through the United States National Institutes of Health, National Institute of Dental and Craniofacial Research grant DE14318 for the Craniofacial Oral-Biology Student Training in Academic Research (COSTAR) program. Dr. Hinojosa was supported by the Astor Foundation and Glaxo Smith Kline through the University College London, MB, PhD program. Dr. Camberlein was supported by the United Kingdom Medical Research Council. Dr. Orihuela is supported by United States National Institutes of Health, National Institute of Allergy and Infectious Diseases grant AI078972. For work at University College London Hospitals/University College London a proportion of funding was obtained from the United Kingdom Department of Health, National Institute for Health Research Biomedical Research Centre's funding scheme. The University of Texas Health Science Center Flow Cytometry Core Facility is supported by U.S. National Institutes of Health, National Cancer Institute grant CA54174 and UL1 RR025767. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Dr. Hinojosa was supported by an unrestricted educational grant from Glaxo Smith Kline through the University College London, MD, PhD program. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials. All other authors have declared that no competing interests exist.	Abeyta M, 2003, INFECT IMMUN, V71, P218, DOI 10.1128/IAI.71.1.218-225.2003; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; BRILES DE, 1992, INFECT IMMUN, V60, P111, DOI 10.1128/IAI.60.1.111-116.1992; Brito DA, 2003, J CLIN MICROBIOL, V41, P2378, DOI 10.1128/JCM.41.6.2378-2384.2003; Daniely D, 2006, CLIN EXP IMMUNOL, V144, P254, DOI 10.1111/j.1365-2249.2006.03047.x; Dave S, 2001, INFECT IMMUN, V69, P3435, DOI 10.1128/IAI.69.5.3435-3437.2001; De Angelis G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021269; Hammerschmidt S, 2005, INFECT IMMUN, V73, P4653, DOI 10.1128/IAI.73.8.4653-4667.2005; Hilleringmann M, 2009, EMBO J, V28, P3921, DOI 10.1038/emboj.2009.360; Holmes AR, 2001, MOL MICROBIOL, V41, P1395, DOI 10.1046/j.1365-2958.2001.02610.x; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Hyams C, 2010, INFECT IMMUN, V78, P716, DOI 10.1128/IAI.01056-09; Iannelli F, 2004, INFECT IMMUN, V72, P3077, DOI 10.1128/IAI.72.5.3077-3080.2004; Imai S, 2011, CLIN MICROBIOL INFEC, V17, P1409, DOI 10.1111/j.1469-0691.2010.03446.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; KELLY T, 1994, INFECT IMMUN, V62, P1813, DOI 10.1128/IAI.62.5.1813-1819.1994; Kim JO, 1999, INFECT IMMUN, V67, P2327, DOI 10.1128/IAI.67.5.2327-2333.1999; Kim JO, 1998, J INFECT DIS, V177, P368, DOI 10.1086/514205; Kline KA, 2009, CELL HOST MICROBE, V5, P580, DOI 10.1016/j.chom.2009.05.011; Lexau CA, 2005, JAMA-J AM MED ASSOC, V294, P2043, DOI 10.1001/jama.294.16.2043; Lu PJ, 2010, AM J PREV MED, V39, P287, DOI 10.1016/j.amepre.2010.06.004; Lysenko ES, 2010, CURR BIOL, V20, P1222, DOI 10.1016/j.cub.2010.05.051; Mann B, 2006, INFECT IMMUN, V74, P821, DOI 10.1128/IAI.74.2.821-829.2006; Melin M, 2010, INFECT IMMUN, V78, P5252, DOI 10.1128/IAI.00739-10; Melin M, 2010, INFECT IMMUN, V78, P5262, DOI 10.1128/IAI.00740-10; Melin M, 2009, INFECT IMMUN, V77, P676, DOI 10.1128/IAI.01186-08; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; Munoz-Almagro C, 2010, CLIN VACCINE IMMUNOL, V17, P1672, DOI 10.1128/CVI.00271-10; Munoz-Elias EJ, 2008, INFECT IMMUN, V76, P5049, DOI 10.1128/IAI.00425-08; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Nuorti J Pekka, 2010, MMWR Recomm Rep, V59, P1; Obert C, 2006, INFECT IMMUN, V74, P4766, DOI 10.1128/IAI.00316-06; Orihuela CJ, 2009, J CLIN INVEST, V119, P1638, DOI 10.1172/JCI36759; Orihuela CJ, 2004, J INFECT DIS, V190, P1661, DOI 10.1086/424596; Pai R, 2006, J CLIN MICROBIOL, V44, P124, DOI 10.1128/JCM.44.1.124-131.2006; Paterson GK, 2010, MOL MICROBIOL, V77, P1, DOI 10.1111/j.1365-2958.2010.07190.x; Quin LR, 2007, INFECT IMMUN, V75, P2067, DOI 10.1128/IAI.01727-06; Ren B, 2003, INFECT IMMUN, V71, P75, DOI 10.1128/IAI.71.1.75-85.2003; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; Sanchez CJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001044; Sandgren A, 2004, J INFECT DIS, V189, P785, DOI 10.1086/381686; Shivshankar P, 2009, MOL MICROBIOL, V73, P663, DOI 10.1111/j.1365-2958.2009.06796.x; Sleeman KL, 2006, J INFECT DIS, V194, P682, DOI 10.1086/505710; Talbot UM, 1996, INFECT IMMUN, V64, P3772, DOI 10.1128/IAI.64.9.3772-3777.1996; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Wartha F, 2007, CELL MICROBIOL, V9, P1162, DOI 10.1111/j.1462-5822.2006.00857.x; *WHO, 1999, WKLY EPIDEMIOL REC, V74, P177; Yuste J, 2005, J IMMUNOL, V175, P1813, DOI 10.4049/jimmunol.175.3.1813; Yuste J, 2010, INFECT IMMUN, V78, P283, DOI 10.1128/IAI.00541-09; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	51	46	48	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26587	10.1371/journal.pone.0026587	http://dx.doi.org/10.1371/journal.pone.0026587			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028914	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500091
J	Heather, LC; Howell, NJ; Emmanuel, Y; Cole, MA; Frenneaux, MP; Pagano, D; Clarke, K				Heather, Lisa C.; Howell, Neil J.; Emmanuel, Yaso; Cole, Mark A.; Frenneaux, Michael P.; Pagano, Domenico; Clarke, Kieran			Changes in Cardiac Substrate Transporters and Metabolic Proteins Mirror the Metabolic Shift in Patients with Aortic Stenosis	PLOS ONE			English	Article							FATTY-ACID TRANSPORT; FAILING HUMAN HEART; IDIOPATHIC DILATED CARDIOMYOPATHY; GENE-EXPRESSION; RAT-HEART; CD36 DEFICIENCY; SKELETAL-MUSCLE; BINDING-PROTEIN; FAT/CD36; MYOCYTES	In the hypertrophied human heart, fatty acid metabolism is decreased and glucose utilisation is increased. We hypothesized that the sarcolemmal and mitochondrial proteins involved in these key metabolic pathways would mirror these changes, providing a mechanism to account for the modified metabolic flux measured in the human heart. Echocardiography was performed to assess in vivo hypertrophy and aortic valve impairment in patients with aortic stenosis (n = 18). Cardiac biopsies were obtained during valve replacement surgery, and used for western blotting to measure metabolic protein levels. Protein levels of the predominant fatty acid transporter, fatty acid translocase (FAT/CD36) correlated negatively with levels of the glucose transporters, GLUT1 and GLUT4. The decrease in FAT/CD36 was accompanied by decreases in the fatty acid binding proteins, FABPpm and H-FABP, the beta-oxidation protein medium chain acyl-coenzyme A dehydrogenase, the Krebs cycle protein alpha-ketoglutarate dehydrogenase and the oxidative phosphorylation protein ATP synthase. FAT/CD36 and complex I of the electron transport chain were downregulated, whereas the glucose transporter GLUT4 was upregulated with increasing left ventricular mass index, a measure of cardiac hypertrophy. In conclusion, coordinated downregulation of sequential steps involved in fatty acid and oxidative metabolism occur in the human heart, accompanied by upregulation of the glucose transporters. The profile of the substrate transporters and metabolic proteins mirror the metabolic shift from fatty acid to glucose utilisation that occurs in vivo in the human heart.	[Heather, Lisa C.; Emmanuel, Yaso; Cole, Mark A.; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Cardiac Metab Res Grp, Oxford, England; [Howell, Neil J.; Pagano, Domenico] Univ Hosp NHS Fdn Trust, Dept Cardiothorac Surg, Birmingham, W Midlands, England; [Frenneaux, Michael P.] Univ Aberdeen, Inst Med Sci, Aberdeen, Scotland	University of Oxford; University of Aberdeen	Heather, LC (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Cardiac Metab Res Grp, Oxford, England.	Lisa.Heather@dpag.ox.ac.uk		Howell, Neil/0000-0003-2851-089X; Heather, Lisa/0000-0002-7246-1338; Cole, Mark/0000-0002-0727-7833	British Heart Foundation [RG/07/004/22659]; British Heart Foundation [PG/08/076/25549, PS/02/002/14893] Funding Source: researchfish	British Heart Foundation(British Heart Foundation); British Heart Foundation(British Heart Foundation)	The work was supported by the British Heart Foundation (grant number RG/07/004/22659). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; BING RJ, 1954, AM J MED, V16, P504, DOI 10.1016/0002-9343(54)90365-4; Bonen A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1740, DOI 10.1152/ajpendo.00579.2006; Chabowski A, 2006, AM J PHYSIOL-ENDOC M, V291, pE675, DOI 10.1152/ajpendo.00096.2006; Coort SLM, 2004, DIABETES, V53, P1655, DOI 10.2337/diabetes.53.7.1655; Davila-Roman VG, 2002, J AM COLL CARDIOL, V40, P271, DOI 10.1016/S0735-1097(02)01967-8; de las Fuentes L, 2003, HYPERTENSION, V41, P83, DOI 10.1161/01.HYP.0000047668.48494.39; Fabris R, 2001, DIABETES, V50, P601, DOI 10.2337/diabetes.50.3.601; Garcia-Martinez C, 2005, AM J PHYSIOL-CELL PH, V288, pC1264, DOI 10.1152/ajpcell.00271.2004; Garnier A, 2009, CIRC-HEART FAIL, V2, P342, DOI 10.1161/CIRCHEARTFAILURE.108.812099; Gimeno RE, 2003, J BIOL CHEM, V278, P16039, DOI 10.1074/jbc.M211412200; Goikoetxea MJ, 2006, CARDIOVASC RES, V69, P899, DOI 10.1016/j.cardiores.2005.11.016; HARMON CM, 1991, J MEMBRANE BIOL, V121, P261, DOI 10.1007/BF01951559; Heather LC, 2006, CARDIOVASC RES, V72, P430, DOI 10.1016/j.cardiores.2006.08.020; Irie H, 2003, P NATL ACAD SCI USA, V100, P6819, DOI 10.1073/pnas.1132094100; Luiken JJFP, 1999, J LIPID RES, V40, P1007; Neglia D, 2007, AM J PHYSIOL-HEART C, V293, pH3270, DOI 10.1152/ajpheart.00887.2007; OFFNER GD, 1986, J BIOL CHEM, V261, P5584; Opie L.H., 2004, HEART PHYSL CELL CIR, DOI 10.1161/01.CIR.0000143724.99618.; Otsuka Y, 2002, CIRC J, V66, P41, DOI 10.1253/circj.66.41; Razeghi P, 2002, CARDIOLOGY, V97, P203, DOI 10.1159/000063122; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Sack MN, 1996, CIRCULATION, V94, P2837, DOI 10.1161/01.CIR.94.11.2837; Scheubel RJ, 2002, J AM COLL CARDIOL, V40, P2174, DOI 10.1016/S0735-1097(02)02600-1; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Sharov VG, 2000, J MOL CELL CARDIOL, V32, P2361, DOI 10.1006/jmcc.2000.1266; SLOT JW, 1991, P NATL ACAD SCI USA, V88, P7815, DOI 10.1073/pnas.88.17.7815; SORRENTINO D, 1988, J CLIN INVEST, V82, P928, DOI 10.1172/JCI113700; Taegtmeyer H, 2004, ANN NY ACAD SCI, V1015, P202, DOI 10.1196/annals.1302.017; Tanaka T, 1997, J MOL CELL CARDIOL, V29, P121, DOI 10.1006/jmcc.1996.0257; VANDERVUSSE GJ, 1992, PHYSIOL REV, V72, P881, DOI 10.1152/physrev.1992.72.4.881; Yang J, 2007, CIRC RES, V100, P1208, DOI 10.1161/01.RES.0000264104.25265.b6; Zorzano A, 1997, AM J CARDIOL, V80, pA65, DOI 10.1016/S0002-9149(97)00459-1	33	30	30	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26326	10.1371/journal.pone.0026326	http://dx.doi.org/10.1371/journal.pone.0026326			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028857	gold, Green Submitted, Green Published			2022-12-27	WOS:000296186900050
J	Pierron, D; Opazo, JC; Heiske, M; Papper, Z; Uddin, M; Chand, G; Wildman, DE; Romero, R; Goodman, M; Grossman, LI				Pierron, Denis; Opazo, Juan C.; Heiske, Margit; Papper, Zack; Uddin, Monica; Chand, Gopi; Wildman, Derek E.; Romero, Roberto; Goodman, Morris; Grossman, Lawrence I.			Silencing, Positive Selection and Parallel Evolution: Busy History of Primate Cytochromes c	PLOS ONE			English	Article							PHOSPHORYLATED IN-VIVO; MOLECULAR EVOLUTION; ANTHROPOID PRIMATES; OXIDASE SUBUNIT; ADAPTIVE EVOLUTION; LIKELIHOOD METHOD; DIVERGENCE TIME; HOX CLUSTERS; BINDING-SITE; MITOCHONDRIAL	Cytochrome c (cyt c) participates in two crucial cellular processes, energy production and apoptosis, and unsurprisingly is a highly conserved protein. However, previous studies have reported for the primate lineage (i) loss of the paralogous testis isoform, (ii) an acceleration and then a deceleration of the amino acid replacement rate of the cyt c somatic isoform, and (iii) atypical biochemical behavior of human cyt c. To gain insight into the cause of these major evolutionary events, we have retraced the history of cyt c loci among primates. For testis cyt c, all primate sequences examined carry the same nonsense mutation, which suggests that silencing occurred before the primates diversified. For somatic cyt c, maximum parsimony, maximum likelihood, and Bayesian phylogenetic analyses yielded the same tree topology. The evolutionary analyses show that a fast accumulation of non-synonymous mutations (suggesting positive selection) occurred specifically on the anthropoid lineage root and then continued in parallel on the early catarrhini and platyrrhini stems. Analysis of evolutionary changes using the 3D structure suggests they are focused on the respiratory chain rather than on apoptosis or other cyt c functions. In agreement with previous biochemical studies, our results suggest that silencing of the cyt c testis isoform could be linked with the decrease of primate reproduction rate. Finally, the evolution of cyt c in the two sister anthropoid groups leads us to propose that somatic cyt c evolution may be related both to COX evolution and to the convergent brain and body mass enlargement in these two anthropoid clades.	[Pierron, Denis; Opazo, Juan C.; Papper, Zack; Uddin, Monica; Chand, Gopi; Wildman, Derek E.; Romero, Roberto; Goodman, Morris; Grossman, Lawrence I.] Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48202 USA; [Pierron, Denis; Chand, Gopi; Wildman, Derek E.; Romero, Roberto] NICHD, Perinatol Res Branch, NIH, Bethesda, MD USA; [Pierron, Denis; Chand, Gopi; Wildman, Derek E.; Romero, Roberto] NICHD, Perinatol Res Branch, NIH, Detroit, MI USA; [Opazo, Juan C.] Univ Austral Chile, Fac Ciencias, Inst Ecol & Evoluc, Valdivia, Chile; [Heiske, Margit] Univ Victor Segalen Bordeaux 2, INSERM, Lab Physiopathol Mitochondriale, Bordeaux, France; [Uddin, Monica] Univ Michigan, Sch Publ Hlth, Ann Arbor, MI 48109 USA; [Wildman, Derek E.] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Goodman, Morris] Wayne State Univ, Sch Med, Dept Anat & Cell Biol, Detroit, MI 48201 USA	Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Universidad Austral de Chile; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Michigan System; University of Michigan; Wayne State University; Wayne State University	Pierron, D (corresponding author), Wayne State Univ, Sch Med, Ctr Mol Med & Genet, Detroit, MI 48202 USA.	lgrossman@wayne.edu	Opazo, Juan C./A-9363-2009; Romero, Roberto/A-5268-2019	Opazo, Juan C./0000-0001-7938-4083; Romero, Roberto/0000-0002-4448-5121; Wildman, Derek/0000-0002-6374-5136	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Institutes of Health [GM65580]; Department of Health and Human Services; National Science Foundation [BCS-0550209, BCS0827546, BCS 9910679]; Wayne State Research Excellence fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM065580] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Health and Human Services; National Science Foundation(National Science Foundation (NSF)); Wayne State Research Excellence fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Perinatology Research Branch, Division of Intramural Research, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Department of Health and Human Services, by NIH GM65580, and by the National Science Foundation (grants BCS-0550209, BCS0827546 and BCS 9910679) and the Wayne State Research Excellence fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BABA ML, 1981, J MOL EVOL, V17, P197, DOI 10.1007/BF01732758; Bergman NM, 2004, AM J SCI, V304, P397, DOI 10.2475/ajs.304.5.397; Bielawski JP, 2004, J MOL EVOL, V59, P121, DOI 10.1007/s00239-004-2597-8; CRAIG DB, 1991, BIOCHEM J, V279, P781, DOI 10.1042/bj2790781; CZELUSNIAK J, 1982, NATURE, V298, P297, DOI 10.1038/298297a0; de Magalhaes JP, 2009, J EVOLUTION BIOL, V22, P1770, DOI 10.1111/j.1420-9101.2009.01783.x; Doan JW, 2005, J BIOENERG BIOMEMBR, V37, P35, DOI 10.1007/s10863-005-4121-2; Doan JW, 2004, MOL PHYLOGENET EVOL, V33, P944, DOI 10.1016/j.ympev.2004.07.016; Falkowski PG, 2005, SCIENCE, V309, P2202, DOI 10.1126/science.1116047; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; Goldberg A, 2003, P NATL ACAD SCI USA, V100, P5873, DOI 10.1073/pnas.0931463100; Goldenberg O, 2009, NUCLEIC ACIDS RES, V37, pD323, DOI 10.1093/nar/gkn822; Grossman LI, 2001, MOL PHYLOGENET EVOL, V18, P26, DOI 10.1006/mpev.2000.0890; Grossman LI, 2004, TRENDS GENET, V20, P578, DOI 10.1016/j.tig.2004.09.002; HENNIG B, 1975, EUR J BIOCHEM, V55, P167, DOI 10.1111/j.1432-1033.1975.tb02149.x; Hoegg S, 2005, TRENDS GENET, V21, P421, DOI 10.1016/j.tig.2005.06.004; Huttemann M, 2011, MITOCHONDRION, V11, P369, DOI 10.1016/j.mito.2011.01.010; Kalanxhi E, 2007, BIOCHEM J, V407, P179, DOI 10.1042/BJ20070459; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kishino H, 2001, MOL BIOL EVOL, V18, P352, DOI 10.1093/oxfordjournals.molbev.a003811; Lee I, 2006, BIOCHEMISTRY-US, V45, P9121, DOI 10.1021/bi060585v; Lee TS, 2006, EVOL BIOINFORM, V2, P321; Liu Z, 2006, P NATL ACAD SCI USA, V103, P8965, DOI 10.1073/pnas.0603327103; Lynch VJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000349; Mishmar D, 2006, GENE, V378, P11, DOI 10.1016/j.gene.2006.03.015; Narisawa S, 2002, MOL CELL BIOL, V22, P5554, DOI 10.1128/MCB.22.15.5554-5562.2002; OSHEROFF N, 1983, J BIOL CHEM, V258, P5731; Patriarca A, 2009, BIOCHEMISTRY-US, V48, P3279, DOI 10.1021/bi801837e; Ray DA, 2005, MOL PHYLOGENET EVOL, V35, P117, DOI 10.1016/j.ympev.2004.10.023; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Roberts VA, 1999, J BIOL CHEM, V274, P38051, DOI 10.1074/jbc.274.53.38051; Rodriguez-Roldan V, 2006, BIOCHEM BIOPH RES CO, V346, P1108, DOI 10.1016/j.bbrc.2006.06.022; Ruta M, 2003, BIOL REV, V78, P251, DOI 10.1017/S1464793102006103; Schmidt TR, 2005, P NATL ACAD SCI USA, V102, P6379, DOI 10.1073/pnas.0409714102; Schmidt TR, 2001, MOL BIOL EVOL, V18, P563, DOI 10.1093/oxfordjournals.molbev.a003836; Solmaz SRN, 2008, J BIOL CHEM, V283, P17542, DOI 10.1074/jbc.M710126200; Sundstrom G, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-254; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Thorne JL, 2002, SYST BIOL, V51, P689, DOI 10.1080/10635150290102456; Uddin M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-8; VANKUILENBURG ABP, 1992, EUR J BIOCHEM, V205, P1145; Wildman DE, 2002, MOL BIOL EVOL, V19, P1812, DOI 10.1093/oxfordjournals.molbev.a004005; Williams BA, 2010, P NATL ACAD SCI USA, V107, P4797, DOI 10.1073/pnas.0908320107; Wu W, 2000, MOL PHYLOGENET EVOL, V17, P294, DOI 10.1006/mpev.2000.0833; Wu W, 1997, J MOL EVOL, V44, P477, DOI 10.1007/PL00006172; Yang ZH, 2002, CURR OPIN GENET DEV, V12, P688, DOI 10.1016/S0959-437X(02)00348-9; Ying TL, 2009, J BIOENERG BIOMEMBR, V41, P251, DOI 10.1007/s10863-009-9223-9; Yu H, 2008, BBA-BIOENERGETICS, V1777, P1066, DOI 10.1016/j.bbabio.2008.04.023; Yu TN, 2001, J BIOL CHEM, V276, P13034, DOI 10.1074/jbc.M009773200; Yuasa K, 2000, J BIOL CHEM, V275, P31469, DOI 10.1074/jbc.M003041200; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang ZL, 2003, GENE, V312, P61, DOI 10.1016/S0378-1119(03)00579-1	52	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26269	10.1371/journal.pone.0026269	http://dx.doi.org/10.1371/journal.pone.0026269			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028846	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900040
J	Nieto, PS; Valdez, DJ; Acosta-Rodriguez, VA; Guido, ME				Nieto, Paula S.; Valdez, Diego J.; Acosta-Rodriguez, Victoria A.; Guido, Mario E.			Expression of Novel Opsins and Intrinsic Light Responses in the Mammalian Retinal Ganglion Cell Line RGC-5. Presence of OPN5 in the Rat Retina	PLOS ONE			English	Article							HAMSTER SUPRACHIASMATIC NUCLEUS; COUPLED RECEPTOR OPSIN; EARLY GENE-EXPRESSION; C-FOS-GENE; G-PROTEIN; PIGMENT-EPITHELIUM; CIRCADIAN REGULATION; PHOTOTRANSDUCTION CASCADE; AMPHIBIAN MELANOPHORES; SIGNALING PATHWAY	The vertebrate retina is known to contain three classes of photoreceptor cells: cones and rods responsible for vision, and intrinsically photoresponsive retinal ganglion cells (RGCs) involved in diverse non-visual functions such as photic entrainment of daily rhythms and pupillary light responses. In this paper we investigated the potential intrinsic photoresponsiveness of the rat RGC line, RGC-5, by testing for the presence of visual and non-visual opsins and assessing expression of the immediate-early gene protein c-Fos and changes in intracellular Ca2+ mobilization in response to brief light pulses. Cultured RGC-5 cells express a number of photopigment mRNAs such as retinal G protein coupled receptor (RGR), encephalopsin/panopsin (Opn3), neuropsin (Opn5) and cone opsin (Opn1mw) but not melanopsin (Opn4) or rhodopsin. Opn5 immunoreactivity was observed in RGC-5 cells and in the inner retina of rat, mainly localized in the ganglion cell layer (GCL). Furthermore, white light pulses of different intensities and durations elicited changes both in intracellular Ca2+ levels and in the induction of c-Fos protein in RGC-5 cell cultures. The results demonstrate that RGC-5 cells expressing diverse putative functional photopigments display intrinsic photosensitivity which accounts for the photic induction of c-Fos protein and changes in intracellular Ca2+ mobilization. The presence of Opn5 in the GCL of the rat retina suggests the existence of a novel type of photoreceptor cell.	[Nieto, Paula S.; Valdez, Diego J.; Acosta-Rodriguez, Victoria A.; Guido, Mario E.] Univ Nacl Cordoba, Fac Ciencias Quim, CIQUIBIC CONICET, Dept Quim Biol, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Nieto, PS (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, CIQUIBIC CONICET, Dept Quim Biol, RA-5000 Cordoba, Argentina.	mguido@fcq.unc.edu.ar		Acosta-Rodriguez, Victoria/0000-0002-4818-0667; Valdez, Diego Javier/0000-0002-4467-6761	Agencia Nacional de Promocion Cientifica y Tecnica [967, 898]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas de la Republica Argentina (CONICET); Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SeCyT-UNC); Fundacion Florencio Fiorini; Ministry of Sciences and Technology of Cordoba	Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnologicas de la Republica Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SeCyT-UNC)(Secretaria de Ciencia y Tecnologia (SECYT)); Fundacion Florencio Fiorini; Ministry of Sciences and Technology of Cordoba	This work was supported by Agencia Nacional de Promocion Cientifica y Tecnica (FONCyT, PICT 2004 No 967 and PICT 2006 No 898), Consejo Nacional de Investigaciones Cientificas y Tecnologicas de la Republica Argentina (CONICET), Secretaria de Ciencia y Tecnologia de la Universidad Nacional de Cordoba (SeCyT-UNC), Fundacion Florencio Fiorini and Ministry of Sciences and Technology of Cordoba. MEG is a fellow of the John Simon Guggenheim Memorial Foundation, 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2007, MOL VIS, V13, P1311; AGRAWAL DK, CURR ALLERGY ASTHMA, V10, P39; Allen AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015063; Arendt D, 2003, INT J DEV BIOL, V47, P563; Bailey MJ, 2004, INVEST OPHTH VIS SCI, V45, P769, DOI 10.1167/iovs.03-1125; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Berson DM, 2007, PFLUG ARCH EUR J PHY, V454, P849, DOI 10.1007/s00424-007-0242-2; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Blackshaw S, 1997, J NEUROSCI, V17, P8074; Blackshaw S, 1999, J NEUROSCI, V19, P3681; BUSCHER M, 1988, ONCOGENE, V3, P301; Caputto BL, 2000, NEUROCHEM RES, V25, P153, DOI 10.1023/A:1007508020173; Chen P, 2001, NAT GENET, V28, P256, DOI 10.1038/90089; Chen P, 2001, J BIOL CHEM, V276, P21098, DOI 10.1074/jbc.M010441200; Cheng N, 2009, NATURE, V460, P899, DOI 10.1038/nature08175; Contin MA, 2006, FASEB J, V20, P2648, DOI 10.1096/fj.06-6133fje; Contin MA, 2010, INVEST OPHTH VIS SCI, V51, P5491, DOI 10.1167/iovs.10-5643; DAVIES WL, 2010, EXP EYE RES; Duran C, 2010, ANNU REV PHYSIOL, V72, P95, DOI 10.1146/annurev-physiol-021909-135811; FOSTER RG, 1991, J COMP PHYSIOL A, V169, P39, DOI 10.1007/BF00198171; FOSTER RG, 2003, NOVART FDN SYMP, V253, P102; FOSTER RG, 2003, NOVART FDN SYMP, V253, P23; Foster RG, 2007, CURR BIOL, V17, pR746, DOI 10.1016/j.cub.2007.07.007; Foster Russell G., 2003, Novartis Foundation Symposium, V253, P3; Graham DM, 2008, J NEUROPHYSIOL, V99, P2522, DOI 10.1152/jn.01066.2007; Guido ME, 2010, PROG NEUROBIOL, V92, P484, DOI 10.1016/j.pneurobio.2010.08.005; Guido ME, 1999, NEUROSCIENCE, V90, P555, DOI 10.1016/S0306-4522(98)00467-9; Guido ME, 1996, J NEUROSCI RES, V43, P93, DOI 10.1002/jnr.490430112; Halford S, 2001, CYTOGENET CELL GENET, V95, P234, DOI 10.1159/000059351; Halford S, 2001, GENOMICS, V72, P203, DOI 10.1006/geno.2001.6469; Hao WS, 1996, BIOCHEMISTRY-US, V35, P6251, DOI 10.1021/bi952420k; Hao WS, 1999, J BIOL CHEM, V274, P6085, DOI 10.1074/jbc.274.10.6085; Hartwick ATE, 2007, J NEUROSCI, V27, P13468, DOI 10.1523/JNEUROSCI.3626-07.2007; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Hazlerigg DG, 2006, TRENDS ENDOCRIN MET, V17, P83, DOI 10.1016/j.tem.2006.02.004; IMAKI J, 1995, MOL BRAIN RES, V30, P48, DOI 10.1016/0169-328X(94)00270-O; Isoldi MC, 2005, P NATL ACAD SCI USA, V102, P1217, DOI 10.1073/pnas.0409252102; Iuvone PM, 2005, PROG RETIN EYE RES, V24, P433, DOI 10.1016/j.preteyeres.2005.01.003; JIANG M, 1993, INVEST OPHTH VIS SCI, V34, P3669; KACZMAREK L, 2002, IMMEDIATE EARLY GENE; Kasper G, 2002, GENE, V295, P27, DOI 10.1016/S0378-1119(02)00799-0; KORNHAUSER JM, 1990, NEURON, V5, P127, DOI 10.1016/0896-6273(90)90303-W; Koyanagi M, 2005, CURR BIOL, V15, P1065, DOI 10.1016/j.cub.2005.04.063; Koyanagi M, 2008, PHOTOCHEM PHOTOBIOL, V84, P1024, DOI 10.1111/j.1751-1097.2008.00369.x; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kunzelmann K, 2009, CELL CALCIUM, V46, P233, DOI 10.1016/j.ceca.2009.09.003; Li ZZ, 1999, PHOTOCHEM PHOTOBIOL, V69, P500, DOI 10.1562/0031-8655(1999)069<0500:DORTPF>2.3.CO;2; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; Lupi D, 1999, NEUROSCIENCE, V89, P363, DOI 10.1016/S0306-4522(98)00353-4; Maeda A, 2009, J BIOL CHEM, V284, P15173, DOI 10.1074/jbc.M900322200; Maeda T, 2003, J NEUROCHEM, V85, P944, DOI 10.1046/j.1471-4159.2003.01741.x; Meijer JH, 2003, J BIOL RHYTHM, V18, P235, DOI 10.1177/0748730403253370; Melyan Z, 2005, NATURE, V433, P741, DOI 10.1038/nature03344; Moorhouse AJ, 2004, BRAIN RES, V1003, P205, DOI 10.1016/j.brainres.2004.01.027; Nakane Y, 2010, P NATL ACAD SCI USA, V107, P15264, DOI 10.1073/pnas.1006393107; Nickle B, 2007, CELL MOL LIFE SCI, V64, P2917, DOI 10.1007/s00018-007-7253-1; Nieto PS, 2010, NEUROCHEM INT, V57, P216, DOI 10.1016/j.neuint.2010.05.013; Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121; Panda S, 2002, SCIENCE, V298, P2213, DOI 10.1126/science.1076848; PANDEY S, 1994, EXP EYE RES, V58, P605, DOI 10.1006/exer.1994.1055; Peirson SN, 2009, PHILOS T R SOC B, V364, P2849, DOI 10.1098/rstb.2009.0050; Pickard GE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004984; Provencio I, 2000, J NEUROSCI, V20, P600, DOI 10.1523/JNEUROSCI.20-02-00600.2000; Provencio I, 1998, P NATL ACAD SCI USA, V95, P340, DOI 10.1073/pnas.95.1.340; Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345; Radu RA, 2008, J BIOL CHEM, V283, P19730, DOI 10.1074/jbc.M801288200; Rollag MD, 2000, METHOD ENZYMOL, V316, P291; ROLLAG MD, 1996, J EXPT ZOOLOGY, P20; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; RUSAK B, 2002, IMMEDIATE EARLY GENE; SAGAR SM, 1990, MOL BRAIN RES, V7, P17, DOI 10.1016/0169-328X(90)90068-O; SCHREIBER M, 1995, EMBO J, V14, P5338, DOI 10.1002/j.1460-2075.1995.tb00218.x; Sekaran S, 2003, CURR BIOL, V13, P1290, DOI 10.1016/S0960-9822(03)00510-4; Semo M, 2003, EUR J NEUROSCI, V17, P1793, DOI 10.1046/j.1460-9568.2003.02616.x; Semo M, 2007, EUR J NEUROSCI, V25, P2296, DOI 10.1111/j.1460-9568.2007.05461.x; Sernagor E, 2005, CURR BIOL, V15, pR556, DOI 10.1016/j.cub.2005.07.004; Tarttelin EE, 2003, FEBS LETT, V554, P410, DOI 10.1016/S0014-5793(03)01212-2; Terakita A, 2008, J NEUROCHEM, V105, P883, DOI 10.1111/j.1471-4159.2007.05184.x; TESSIERLAVIGNE M, 1991, PRINCIPLES NEURAL SC; Tosini G, 2000, P NATL ACAD SCI USA, V97, P11540, DOI 10.1073/pnas.210248297; Uchida K, 1999, MOL VIS, V5, pU1; Valdez DJ, 2009, FASEB J, V23, P1186, DOI 10.1096/fj.08-117085; VICENTE NBD, 2007, J PHISICS, V90; Warren EJ, 2006, EUR J NEUROSCI, V23, P2477, DOI 10.1111/j.1460-9568.2006.04777.x; Wenzel A, 2005, J BIOL CHEM, V280, P29874, DOI 10.1074/jbc.M503603200; White JH, 2008, HUM MOL GENET, V17, P1890, DOI 10.1093/hmg/ddn087; Wood JPM, 2008, MOL VIS, V14, P334; WOOD JP, 2010, INVEST OPHTHALMOL VI; Yamashita T, 2010, P NATL ACAD SCI USA, V107, P22084, DOI 10.1073/pnas.1012498107; YOSHIDA K, 1993, NEURON, V10, P1049, DOI 10.1016/0896-6273(93)90053-T	93	26	26	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26417	10.1371/journal.pone.0026417	http://dx.doi.org/10.1371/journal.pone.0026417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022612	Green Published, gold, Green Submitted			2022-12-27	WOS:000295984400056
J	Kamiyama, H; Kakoki, K; Yoshii, H; Iwao, M; Igawa, T; Sakai, H; Hayashi, H; Matsuyama, T; Yamamoto, N; Kubo, Y				Kamiyama, Haruka; Kakoki, Katsura; Yoshii, Hiroaki; Iwao, Masatomo; Igawa, Tsukasa; Sakai, Hideki; Hayashi, Hideki; Matsuyama, Toshifumi; Yamamoto, Naoki; Kubo, Yoshinao			Infection of XC Cells by MLVs and Ebola Virus Is Endosome-Dependent but Acidification-Independent	PLOS ONE			English	Article							MURINE LEUKEMIA-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; R-PEPTIDE; SYNCYTIUM FORMATION; RETROVIRUS RECEPTOR; TYPE-1 INFECTION; ENVELOPE PROTEIN; SURFACE RECEPTOR; MEMBRANE-FUSION; VIRAL ENTRY	Inhibitors of endosome acidification or cathepsin proteases attenuated infections mediated by envelope proteins of xenotropic murine leukemia virus-related virus (XMRV) and Ebola virus, as well as ecotropic, amphotropic, polytropic, and xenotropic murine leukemia viruses (MLVs), indicating that infections by these viruses occur through acidic endosomes and require cathepsin proteases in the susceptible cells such as TE671 cells. However, as previously shown, the endosome acidification inhibitors did not inhibit these viral infections in XC cells. It is generally accepted that the ecotropic MLV infection in XC cells occurs at the plasma membrane. Because cathepsin proteases are activated by low pH in acidic endosomes, the acidification inhibitors may inhibit the viral infections by suppressing cathepsin protease activation. The acidification inhibitors attenuated the activities of cathepsin proteases B and L in TE671 cells, but not in XC cells. Processing of cathepsin protease L was suppressed by the acidification inhibitor in NIH3T3 cells, but again not in XC cells. These results indicate that cathepsin proteases are activated without endosome acidification in XC cells. Treatment with an endocytosis inhibitor or knockdown of dynamin 2 expression by siRNAs suppressed MLV infections in all examined cells including XC cells. Furthermore, endosomal cathepsin proteases were required for these viral infections in XC cells as other susceptible cells. These results suggest that infections of XC cells by the MLVs and Ebola virus occur through endosomes and pH-independent cathepsin activation induces pH-independent infection in XC cells.	[Kamiyama, Haruka; Kakoki, Katsura; Yoshii, Hiroaki; Yamamoto, Naoki; Kubo, Yoshinao] Nagasaki Univ, Global COE Program, Inst Trop Med, Dept AIDS Res, Nagasaki 852, Japan; [Kamiyama, Haruka; Iwao, Masatomo] Nagasaki Univ, Grad Sch Sci & Technol, Nagasaki 852, Japan; [Kakoki, Katsura; Igawa, Tsukasa; Sakai, Hideki] Nagasaki Univ, Grad Sch Biomed Sci, Dept Urol, Nagasaki 852, Japan; [Hayashi, Hideki; Matsuyama, Toshifumi; Kubo, Yoshinao] Nagasaki Univ, Grad Sch Biomed Sci, Div Cytokine Signaling, Nagasaki 852, Japan; [Yamamoto, Naoki] Natl Univ Singapore, Dept Microbiol, Singapore 117548, Singapore	Nagasaki University; Nagasaki University; Nagasaki University; Nagasaki University; National University of Singapore	Kamiyama, H (corresponding author), Nagasaki Univ, Global COE Program, Inst Trop Med, Dept AIDS Res, Nagasaki 852, Japan.	yoshinao@nagasaki-u.ac.jp	Hideki, Hayashi/AAW-9081-2021	Hayashi, Hideki/0000-0003-4585-6542	NEKKEN Research Found of Nagasaki University; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [22590416, 09J07637] Funding Source: KAKEN	NEKKEN Research Found of Nagasaki University; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by the NEKKEN Research Found 2008 of Nagasaki University, and by the Japan Society for the Promotion of Science. H. Kamiyama is a special research fellow of the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI A, 1984, J VIROL, V50, P813, DOI 10.1128/JVI.50.3.813-821.1984; ALBRITTON LM, 1989, CELL, V57, P659, DOI 10.1016/0092-8674(89)90134-7; ANDERSEN KB, 1994, J VIROL, V68, P3175, DOI 10.1128/JVI.68.5.3175-3182.1994; Battini JL, 1999, P NATL ACAD SCI USA, V96, P1385, DOI 10.1073/pnas.96.4.1385; Caglic D, 2007, J BIOL CHEM, V282, P33076, DOI 10.1074/jbc.M705761200; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Chang LJ, 1999, GENE THER, V6, P715, DOI 10.1038/sj.gt.3300895; COSSET FL, 1995, J VIROL, V69, P7430, DOI 10.1128/JVI.69.12.7430-7436.1995; Cureton DK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000394; Fredericksen BL, 2002, J VIROL, V76, P11440, DOI 10.1128/JVI.76.22.11440-11446.2002; HARTLEY JW, 1976, J VIROL, V19, P19, DOI 10.1128/JVI.19.1.19-25.1976; Iwakuma T, 1999, VIROLOGY, V261, P120, DOI 10.1006/viro.1999.9850; JONES JS, 1993, J VIROL, V67, P67, DOI 10.1128/JVI.67.1.67-74.1993; Kanbe K, 1999, VIROLOGY, V265, P264, DOI 10.1006/viro.1999.0036; Katen LJ, 2001, J VIROL, V75, P5018, DOI 10.1128/JVI.75.11.5018-5026.2001; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Kizhatil K, 1997, J VIROL, V71, P7145, DOI 10.1128/JVI.71.10.7145-7156.1997; Kubo Y, 2007, ARCH VIROL, V152, P2169, DOI 10.1007/s00705-007-1054-6; Kubo Y, 2003, J GEN VIROL, V84, P2253, DOI 10.1099/vir.0.19126-0; Kubo Y, 2003, J VIROL, V77, P7510, DOI 10.1128/JVI.77.13.7510-7516.2003; Kubo Y, 2008, VIROLOGY, V375, P130, DOI 10.1016/j.virol.2008.01.047; Kumar P, 2007, J VIROL, V81, P10506, DOI 10.1128/JVI.02853-06; Lavillette D, 2001, J VIROL, V75, P3685, DOI 10.1128/JVI.75.8.3685-3695.2001; LEIBOVITCH SA, 1984, BIOCHEM BIOPH RES CO, V119, P630, DOI 10.1016/S0006-291X(84)80296-X; MCCLURE MO, 1990, J GEN VIROL, V71, P767, DOI 10.1099/0022-1317-71-4-767; MCCOY MS, 1983, NATURE, V302, P79, DOI 10.1038/302079a0; MILLER DG, 1994, P NATL ACAD SCI USA, V91, P78, DOI 10.1073/pnas.91.1.78; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; RAGHEB JA, 1994, J VIROL, V68, P3220, DOI 10.1128/JVI.68.5.3220-3231.1994; REIN A, 1994, J VIROL, V68, P1773, DOI 10.1128/JVI.68.3.1773-1781.1994; ROMMERSKIRCH W, 1988, NUCLEIC ACIDS RES, V16, P941, DOI 10.1093/nar/16.3.941; ROWE WP, 1970, VIROLOGY, V42, P1136, DOI 10.1016/0042-6822(70)90362-4; Song BD, 2004, J BIOL CHEM, V279, P40431, DOI 10.1074/jbc.M407007200; STEIN BS, 1987, CELL, V49, P659, DOI 10.1016/0092-8674(87)90542-3; SVOBODA J, 1960, NATURE, V186, P980, DOI 10.1038/186980b0; Tailor CS, 1999, P NATL ACAD SCI USA, V96, P927, DOI 10.1073/pnas.96.3.927; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; VANZEIJL M, 1994, P NATL ACAD SCI USA, V91, P1168, DOI 10.1073/pnas.91.3.1168; Wei BDL, 2005, J VIROL, V79, P5705, DOI 10.1128/JVI.79.9.5705-5712.2005; WILSON CA, 1992, J VIROL, V66, P7262, DOI 10.1128/JVI.66.12.7262-7269.1992; Yang YL, 1999, NAT GENET, V21, P216, DOI 10.1038/6005; Yoshii H, 2008, J GEN VIROL, V89, P297, DOI 10.1099/vir.0.83430-0; Yoshii H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019352; Yoshii H, 2009, VIROLOGY, V394, P227, DOI 10.1016/j.virol.2009.08.045	47	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26180	10.1371/journal.pone.0026180	http://dx.doi.org/10.1371/journal.pone.0026180			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022555	gold, Green Submitted, Green Published			2022-12-27	WOS:000295976000081
J	Leontieva, OV; Demidenko, ZN; Gudkov, AV; Blagosklonny, MV				Leontieva, Olga V.; Demidenko, Zoya N.; Gudkov, Andrei V.; Blagosklonny, Mikhail V.			Elimination of Proliferating Cells Unmasks the Shift from Senescence to Quiescence Caused by Rapamycin	PLOS ONE			English	Article							GROWTH ARREST; TUMOR-CELLS; CYCLE; P53; MTOR; LEADS	Background: Depending on cellular context, p53-inducing agents (such as nutlin-3a) cause different outcomes including reversible quiescence and irreversible senescence. Inhibition of mTOR shifts the balance from senescence to quiescence. In cell lines with incomplete responses to p53, this shift may be difficult to document because of a high proportion of proliferating cells contaminating arrested (quiescent and senescent) cells. This problem also complicates the study of senescence caused by minimal levels of p21 that are capable to arrest a few cells. Methodology: During induction of senescence by low levels of endogenous p53 and ectopic p21, cells were co-treated with nocodazole, which eliminated proliferating cells. As a result, only senescent and quiescent cells remained. Results and Discussion: This approach revealed that rapamycin efficiently converted nutlin-induced-senescence into quiescence. In the presence of rapamycin, nutlin-arrested MCF-7 cells retained the proliferative potential and small/lean morphology. Using this approach, we also unmasked senescence in cells arrested by low levels of ectopic p21, capable to arrest only a small proportion of HT1080-p21-9 cells. When p21 did cause arrest, mTOR caused senescent phenotype. Rapamycin and high concentrations of nutlin-3a, which inhibit the mTOR pathway in these particular cells, suppressed senescence, ensuring quiescence instead. Thus, p21 causes senescence passively, just by causing arrest, while still active mTOR drives senescent phenotype.	[Leontieva, Olga V.; Demidenko, Zoya N.; Gudkov, Andrei V.; Blagosklonny, Mikhail V.] Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA	Roswell Park Cancer Institute	Leontieva, OV (corresponding author), Roswell Pk Canc Inst, Dept Cell Stress Biol, Buffalo, NY 14263 USA.	blagosklonny@oncotarget.com		Gudkov, Andrei/0000-0003-2548-0154				Apontes P, 2011, ONCOTARGET, V2, P222, DOI 10.18632/oncotarget.248; Blagosklonny MV, 2011, CELL CYCLE, V10, P2295, DOI 10.4161/cc.10.14.16819; Blagosklonny MV, 2011, AGING-US, V3, P94, DOI 10.18632/aging.100281; Blagosklonny MV, 2003, EMBO REP, V4, P358, DOI 10.1038/sj.embor.embor806; Chang BD, 1999, CANCER RES, V59, P3761; Chang BD, 2000, ONCOGENE, V19, P2165, DOI 10.1038/sj.onc.1203573; Chang BD, 1999, ONCOGENE, V18, P4808, DOI 10.1038/sj.onc.1203078; Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919; Demidenko ZN, 2010, P NATL ACAD SCI USA, V107, P9660, DOI 10.1073/pnas.1002298107; Demidenko ZN, 2009, CELL CYCLE, V8, P1888, DOI 10.4161/cc.8.12.8606; Itahana K, 2002, J BIOL CHEM, V277, P18206, DOI 10.1074/jbc.M201028200; Itahana Koji, 2007, Methods Mol Biol, V371, P21; Korotchkina LG, 2010, AGING-US, V2, P344, DOI 10.18632/aging.100160; Leontieva OV, 2010, AGING-US, V2, P924, DOI 10.18632/aging.100265; Leontieva OV, 2010, CELL CYCLE, V9, P4323, DOI 10.4161/cc.9.21.13584; Pani G, 2011, CELL CYCLE, V10, P2450, DOI 10.4161/cc.10.15.16886; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909	17	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26126	10.1371/journal.pone.0026126	http://dx.doi.org/10.1371/journal.pone.0026126			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022534	Green Published, gold, Green Submitted			2022-12-27	WOS:000295973200040
J	Hopkins, RC; Sun, JS; Jenney, FE; Chandrayan, SK; McTernan, PM; Adams, MWW				Hopkins, R. Christopher; Sun, Junsong; Jenney, Francis E., Jr.; Chandrayan, Sanjeev K.; McTernan, Patrick M.; Adams, Michael W. W.			Homologous Expression of a Subcomplex of Pyrococcus furiosus Hydrogenase that Interacts with Pyruvate Ferredoxin Oxidoreductase	PLOS ONE			English	Article							ARCHAEON; AGMATINE; ENZYMES; RNA	furiosus Hydrogen gas is an attractive alternative fuel as it is carbon neutral and has higher energy content per unit mass than fossil fuels. The biological enzyme responsible for utilizing molecular hydrogen is hydrogenase, a heteromeric metalloenzyme requiring a complex maturation process to assemble its O-2-sensitive dinuclear-catalytic site containing nickel and iron atoms. To facilitate their utility in applied processes, it is essential that tools are available to engineer hydrogenases to tailor catalytic activity and electron carrier specificity, and decrease oxygen sensitivity using standard molecular biology techniques. As a model system we are using hydrogen-producing Pyrococcus furiosus, which grows optimally at 100 degrees C. We have taken advantage of a recently developed genetic system that allows markerless chromosomal integrations via homologous recombination. We have combined a new gene marker system with a highly-expressed constitutive promoter to enable high-level homologous expression of an engineered form of the cytoplasmic NADP-dependent hydrogenase (SHI) of P. furiosus. In a step towards obtaining 'minimal' hydrogenases, we have successfully produced the heterodimeric form of SHI that contains only two of the four subunits found in the native heterotetrameric enzyme. The heterodimeric form is highly active (150 units mg(-1) in H-2 production using the artificial electron donor methyl viologen) and thermostable (t(1/2) similar to 0.5 hour at 90 degrees C). Moreover, the heterodimer does not use NADPH and instead can directly utilize reductant supplied by pyruvate ferredoxin oxidoreductase from P. furiosus. The SHI heterodimer and POR therefore represent a two-enzyme system that oxidizes pyruvate and produces H-2 in vitro without the need for an intermediate electron carrier.	[Hopkins, R. Christopher; Sun, Junsong; Jenney, Francis E., Jr.; Chandrayan, Sanjeev K.; McTernan, Patrick M.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Hopkins, RC (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	adams@bmb.uga.edu	McTernan, Patrick/HGV-0762-2022; CHANDRAYAN, SANJEEV/M-1662-2016	CHANDRAYAN, SANJEEV/0000-0003-2219-4654; Jenney, Francis/0000-0002-1667-6924; Adams, Michael/0000-0002-9796-5014	Chemical Sciences, Geosciences and Biosciences Division, Office of 307 Basic Energy Sciences, Office of Science, U.S. Department of Energy [DE-FG05-95ER20175, DE-FG02-306 05ER15710]	Chemical Sciences, Geosciences and Biosciences Division, Office of 307 Basic Energy Sciences, Office of Science, U.S. Department of Energy(United States Department of Energy (DOE))	This research was supported by grants (DE-FG05-95ER20175 and DE-FG02-306 05ER15710) from the Chemical Sciences, Geosciences and Biosciences Division, Office of 307 Basic Energy Sciences, Office of Science, U.S. Department of Energy (http://science.energy.gov/bes/csgb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong FA, 2009, CHEM SOC REV, V38, P36, DOI 10.1039/b801144n; BRYANT FO, 1989, J BIOL CHEM, V264, P5070; Charon MH, 1999, CURR OPIN STRUC BIOL, V9, P663, DOI 10.1016/S0959-440X(99)00027-5; Dorian JP, 2006, ENERG POLICY, V34, P1984, DOI 10.1016/j.enpol.2005.03.010; Edwards PP, 2007, PHILOS T R SOC A, V365, P1043, DOI 10.1098/rsta.2006.1965; FIALA G, 1986, ARCH MICROBIOL, V145, P56, DOI 10.1007/BF00413027; Fontecilla-Camps JC, 2007, CHEM REV, V107, P4273, DOI 10.1021/cr050195z; Fukuda W, 2008, FEMS MICROBIOL LETT, V287, P113, DOI 10.1111/j.1574-6968.2008.01303.x; Grzeszik C, 1997, ARCH MICROBIOL, V167, P172, DOI 10.1007/s002030050431; Ikeuchi Y, 2010, NAT CHEM BIOL, V6, P277, DOI [10.1038/NCHEMBIO.323, 10.1038/nchembio.323]; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Lipscomb GL, 2011, APPL ENVIRON MICROB, V77, P2232, DOI 10.1128/AEM.02624-10; Ma KS, 2000, J BACTERIOL, V182, P1864, DOI 10.1128/JB.182.7.1864-1871.2000; Ma KS, 2001, METHOD ENZYMOL, V331, P208; McKinlay JB, 2010, CURR OPIN BIOTECH, V21, P244, DOI 10.1016/j.copbio.2010.02.012; Pfromm PH, 2011, BIORESOURCE TECHNOL, V102, P1185, DOI 10.1016/j.biortech.2010.09.050; Sambrook J., 2001, MOL CLONING LAB MANU; Santangelo TJ, 2010, APPL ENVIRON MICROB, V76, P1044, DOI 10.1128/AEM.02497-09; Sapra R, 2000, J BACTERIOL, V182, P3423, DOI 10.1128/JB.182.12.3423-3428.2000; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Schut GJ, 2003, J BACTERIOL, V185, P3935, DOI 10.1128/JB.185.13.3935-3947.2003; Sigfusson TI, 2007, PHILOS T R SOC A, V365, P1025, DOI 10.1098/rsta.2006.1960; Silva PJ, 2000, EUR J BIOCHEM, V267, P6541, DOI 10.1046/j.1432-1327.2000.01745.x; Stephenson M, 1931, BIOCHEM J, V25, P205, DOI 10.1042/bj0250205; Sun JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010526; Thore S, 2003, J BIOL CHEM, V278, P1239, DOI 10.1074/jbc.M207685200; Verhagen MFJM, 2001, METHOD ENZYMOL, V330, P25; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vignais PM, 2004, CURR ISSUES MOL BIOL, V6, P159; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Wackett LP, 2010, CURR OPIN B IN PRESS	31	24	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26569	10.1371/journal.pone.0026569	http://dx.doi.org/10.1371/journal.pone.0026569			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039508	Green Submitted, gold, Green Published			2022-12-27	WOS:000296515200026
J	Long, MA; Rossi, FMV				Long, Michael A.; Rossi, Fabio M. V.			Targeted Cell Fusion Facilitates Stable Heterokaryon Generation In Vitro and In Vivo	PLOS ONE			English	Article							ONCOLYTIC MEASLES VIRUSES; SKELETAL-MUSCLE; MYOBLAST TRANSPLANTATION; SATELLITE CELLS; EXPRESSION; ANTIBODY; SPECIFICITY; HEPATOCYTES; ACTIVATION; INDUCTION	Induced cell fusion has enabled several important discoveries, including the phenomenon of nuclear reprogramming and may yet be applied as a novel therapy for degenerative diseases. However, existing fusogens lack the efficiency required to enable investigation of the epigenetic modifications underlying nuclear reprogramming and the specificity required for clinical application. Here we present a chimeric measles hemagglutinin, H alpha 7, which specifically and efficiently mediates the fusion of diverse cell types with skeletal muscle both in vitro and in vivo. When compared directly to polyethylene glycol, H alpha 7 consistently generated a substantial increase in heterokaryon yield and exhibited insignificant levels of toxicity. Moreover, this increased fusion efficiency enabled detection of chromatin modifications associated with nuclear reprogramming following H alpha 7-mediated fusion of human fibroblasts and mouse myotubes. Finally, H alpha 7 was also capable of increasing the contribution of transplanted fibroblasts to skeletal muscle repair in vivo, suggesting that this strategy could be used for therapeutic gene delivery.	[Long, Michael A.; Rossi, Fabio M. V.] Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada	University of British Columbia	Long, MA (corresponding author), Univ British Columbia, Biomed Res Ctr, Vancouver, BC, Canada.	fabio@brc.ubc.ca	Rossi, Fabio MV/B-5587-2013	Rossi, Fabio MV/0000-0002-0368-2620	Jesse's Journey; Stem Cell Network; Muscular Dystrophy Canada	Jesse's Journey; Stem Cell Network; Muscular Dystrophy Canada(Muscular Dystrophy Association)	This research was supported by a research grant from Jesse's Journey (www.jessesjourney.com). MAL was supported by training grants from the Stem Cell Network (www.stemcellnetwork.ca) and Muscular Dystrophy Canada (www.muscle.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen C, 2008, MOL THER, V16, P1556, DOI 10.1038/mt.2008.152; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; ALVAREZERVITI L, NAT BIOTECHNOL, V29, P341; Blanco-Bose WE, 2001, EXP CELL RES, V265, P212, DOI 10.1006/excr.2001.5191; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1983, P NATL ACAD SCI-BIOL, V80, P4856, DOI 10.1073/pnas.80.15.4856; Bouchentouf M, 2006, NEUROMUSCULAR DISORD, V16, P518, DOI 10.1016/j.nmd.2006.06.003; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; CHIU CP, 1985, CELL, V40, P417, DOI 10.1016/0092-8674(85)90155-2; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Gong JL, 1997, NAT MED, V3, P558, DOI 10.1038/nm0597-558; Hallak LK, 2005, CANCER RES, V65, P5292, DOI 10.1158/0008-5472.CAN-04-2879; Held PK, 2006, MOL THER, V13, P49, DOI 10.1016/j.ymthe.2005.09.004; Iankov ID, 2007, MOL THER, V15, P114, DOI 10.1038/sj.mt.6300020; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KUDRYAVTSEV BN, 1993, VIRCHOWS ARCH B, V64, P387, DOI 10.1007/BF02915139; LIPTON BH, 1979, SCIENCE, V205, P1292, DOI 10.1126/science.472747; Nakamura T, 2004, NAT BIOTECHNOL, V22, P331, DOI 10.1038/nbt942; Navaratnarajah CK, 2011, NAT STRUCT MOL BIOL, V18, P128, DOI 10.1038/nsmb.1967; OKADA Y, 1962, EXP CELL RES, V26, P98, DOI 10.1016/0014-4827(62)90205-7; Olivetti G, 1996, J MOL CELL CARDIOL, V28, P1463, DOI 10.1006/jmcc.1996.0137; Palermo A, 2009, FASEB J, V23, P1431, DOI 10.1096/fj.08-122903; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Peng KW, 2003, BLOOD, V101, P2557, DOI 10.1182/blood-2002-07-2195; Plant DR, 2006, MUSCLE NERVE, V34, P577, DOI 10.1002/mus.20616; Pomerantz JH, 2009, J CELL SCI, V122, P1045, DOI 10.1242/jcs.041376; PONTECORVO G, 1975, SOMAT CELL GENET, V1, P397, DOI 10.1007/BF01538671; Relvas JB, 1997, BASIC APPL MYOL, V7, P211; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Schneider U, 2000, J VIROL, V74, P9928, DOI 10.1128/JVI.74.21.9928-9936.2000; SCHUT TCB, 1993, BIOPHYS J, V65, P568, DOI 10.1016/S0006-3495(93)81128-7; Skelley AM, 2009, NAT METHODS, V6, P147, DOI [10.1038/NMETH.1290, 10.1038/nmeth.1290]; Skuk D, 1999, EXP NEUROL, V155, P22, DOI 10.1006/exnr.1998.6973; Stromberg A, 2000, P NATL ACAD SCI USA, V97, P7, DOI 10.1073/pnas.97.1.7; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Terranova R, 2006, J CELL SCI, V119, P2065, DOI 10.1242/jcs.02945; Wang X, 2003, NATURE, V422, P897, DOI 10.1038/nature01531; Warthin AS, 1931, ARCH PATHOL, V11, P864; WILD TF, 1991, J GEN VIROL, V72, P439, DOI 10.1099/0022-1317-72-2-439; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Zhang F, 2007, P NATL ACAD SCI USA, V104, P4395, DOI 10.1073/pnas.0700181104; ZIMMERMANN U, 1982, J MEMBRANE BIOL, V67, P165, DOI 10.1007/BF01868659	43	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26381	10.1371/journal.pone.0026381	http://dx.doi.org/10.1371/journal.pone.0026381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039476	gold, Green Published, Green Submitted			2022-12-27	WOS:000296515200018
J	Abdel-Motal, UM; Sarkis, PTN; Han, T; Pudney, J; Anderson, DJ; Zhu, Q; Marasco, WA				Abdel-Motal, Ussama M.; Sarkis, Phuong T. N.; Han, Thomas; Pudney, Jeffery; Anderson, Deborah J.; Zhu, Quan; Marasco, Wayne A.			Anti-gp120 Minibody Gene Transfer to Female Genital Epithelial Cells Protects against HIV-1 Virus Challenge In Vitro	PLOS ONE			English	Article							LEUKOCYTE PROTEASE INHIBITOR; IMMUNODEFICIENCY-VIRUS; ADENOASSOCIATED VIRUS; MONOCLONAL-ANTIBODY; VAGINAL EPITHELIUM; LONG-TERM; EXPRESSION; VECTOR; NEUTRALIZATION; TRANSDUCTION	Background: Although cervico-vaginal epithelial cells of the female lower genital tract provide the initial defense system against HIV-1 infection, the protection is sometimes incomplete. Thus, enhancing anti-HIV-1 humoral immunity at the mucosal cell surface by local expression of anti-HIV-1 broadly neutralizing antibodies (BnAb) that block HIV-1 entry would provide an important new intervention that could slow the spread of HIV/AIDS. Methods and Findings: This study tested the hypothesis that adeno-associated virus (AAV)-BnAb gene transfer to cervico-vaginal epithelial cells will lead to protection against HIV-1. Accordingly, a recombinant AAV vector that encodes human b12 anti-HIV gp120 BnAb as a single-chain variable fragment Fc fusion (scFvFc), or "minibody'' was constructed. The secreted b12 minibody was shown to be biologically functional in binding to virus envelope protein, neutralizing HIV-1 and importantly, blocking transfer and infectivity of HIV-1(bal) in an organotypic human vaginal epithelial cell (VEC) model. Furthermore, cervico-vaginal epithelial stem cells were found to be efficiently transduced by the optimal AAV serotype mediated expression of GFP. Conclusion: This study provides the foundation for a novel microbicide strategy to protect against sexual transmission of HIV-1 by AAV transfer of broadly neutralizing antibody genes to cervico-vaginal epithelial stem cells that could replenish b12 BnAb secreting cells through multiple menstrual cycles.	[Abdel-Motal, Ussama M.; Sarkis, Phuong T. N.; Han, Thomas; Zhu, Quan; Marasco, Wayne A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Pudney, Jeffery; Anderson, Deborah J.] Boston Univ, Sch Med, Dept Obstet & Gynecol, Boston, MA 02118 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Boston University	Abdel-Motal, UM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS, 44 Binney St, Boston, MA 02115 USA.	wayne_marasco@dfci.harvard.edu		Anderson, Deborah/0000-0002-2848-7290; Pudney, Jeffrey/0000-0001-8121-8586	National Institutes of Health (NIH) [AI079767]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, R21AI079767, R33AI079767] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was supported by the National Institutes of Health (NIH) grant AI079767 to Dr. Marasco. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Blaskewicz CD, 2011, BIOL REPROD, V85, P97, DOI 10.1095/biolreprod.110.090423; Bobardt MD, 2003, IMMUNITY, V18, P27, DOI 10.1016/S1074-7613(02)00504-6; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bobardt MD, 2010, ANTIMICROB AGENTS CH, V54, P2753, DOI 10.1128/AAC.01606-09; Bosch A, 2000, MOL THER, V1, P63, DOI 10.1006/mthe.1999.0005; Brantly ML, 2009, P NATL ACAD SCI USA, V106, P16363, DOI 10.1073/pnas.0904514106; BURTON DR, 1994, SCIENCE, V266, P1024, DOI 10.1126/science.7973652; Cole AM, 2008, AM J REPROD IMMUNOL, V59, P27, DOI 10.1111/j.1600-0897.2007.00561.x; de Parseval A, 2005, J BIOL CHEM, V280, P39493, DOI 10.1074/jbc.M504233200; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; FLOTTE TR, 1993, P NATL ACAD SCI USA, V90, P10613, DOI 10.1073/pnas.90.22.10613; Ghosh M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011366; Halbert CL, 2001, J VIROL, V75, P6615, DOI 10.1128/JVI.75.14.6615-6624.2001; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kaushic C, 2010, AM J REPROD IMMUNOL, V63, P566, DOI 10.1111/j.1600-0897.2010.00843.x; King AE, 2000, MOL HUM REPROD, V6, P191, DOI 10.1093/molehr/6.2.191; Klein JS, 2009, P NATL ACAD SCI USA, V106, P7385, DOI 10.1073/pnas.0811427106; Koup RA, 2001, CURR PROTOC IMMUNOL; Labrijn AF, 2003, J VIROL, V77, P10557, DOI 10.1128/JVI.77.19.10557-10565.2003; Livingston JB, 1998, INFECT IMMUN, V66, P322, DOI 10.1128/IAI.66.1.322-329.1998; Mantis NJ, 2007, J IMMUNOL, V179, P3144, DOI 10.4049/jimmunol.179.5.3144; Marasco WA, 2005, NAT BIOTECHNOL, V23, P551, DOI 10.1038/nbt0505-551; Martens JE, 2004, ANTICANCER RES, V24, P771; Nakai H, 1998, BLOOD, V91, P4600, DOI 10.1182/blood.V91.12.4600.412k22_4600_4607; Novak RM, 2007, CLIN VACCINE IMMUNOL, V14, P1102, DOI 10.1128/CVI.00386-06; Parren PWHI, 2001, J VIROL, V75, P8340, DOI 10.1128/JVI.75.17.8340-8347.2001; Poonia B, 2006, J ENDOCRINOL, V190, P829, DOI 10.1677/joe.1.06873; Schmidt M, 2008, J VIROL, V82, P1399, DOI 10.1128/JVI.02012-07; Tomescu C, 2011, CLIN EXP IMMUNOL, V164, P158, DOI 10.1111/j.1365-2249.2011.04379.x; Veazey RS, 2003, NAT MED, V9, P343, DOI 10.1038/nm833; Walker LM, 2010, CURR OPIN IMMUNOL, V22, P358, DOI 10.1016/j.coi.2010.02.012; Warrington KH, 2006, HUM GENET, V119, P571, DOI 10.1007/s00439-006-0165-6; Weber M, 2003, MOL THER, V7, P774, DOI 10.1016/S1525-0016(03)00098-4; Wu ZW, 2003, J INFECT DIS, V188, P1473, DOI 10.1086/379248; Xiao WD, 1998, J VIROL, V72, P10222, DOI 10.1128/JVI.72.12.10222-10226.1998	39	26	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26473	10.1371/journal.pone.0026473	http://dx.doi.org/10.1371/journal.pone.0026473			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031835	gold, Green Published, Green Submitted			2022-12-27	WOS:000296513200024
J	Arjomandi, M; Frelinger, J; Donde, A; Wong, H; Yellamilli, A; Raymond, W				Arjomandi, Mehrdad; Frelinger, Jessica; Donde, Aneesh; Wong, Hofer; Yellamilli, Amritha; Raymond, Wilfred			Secreted Osteopontin Is Highly Polymerized in Human Airways and Fragmented in Asthmatic Airway Secretions	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; POSTTRANSLATIONAL MODIFICATIONS; STRUCTURAL REQUIREMENTS; INTEGRIN ALPHA-9-BETA-1; NEUTROPHIL INFILTRATION; TISSUE TRANSGLUTAMINASE; BOVINE OSTEOPONTIN; DEFICIENT MICE; CROSS-LINKING; MURINE MODEL	Background: Osteopontin (OPN) is a member of the small integrin-binding ligand N-linked glycoprotein (SIBLING) family and a cytokine with diverse biologic roles. OPN undergoes extensive post-translational modifications, including polymerization and proteolytic fragmentation, which alters its biologic activity. Recent studies suggest that OPN may contribute to the pathogenesis of asthma. Methodology: To determine whether secreted OPN (sOPN) is polymerized in human airways and whether it is qualitatively different in asthma, we used immunoblotting to examine sOPN in bronchoalveolar lavage (BAL) fluid samples from 12 healthy and 21 asthmatic subjects (and in sputum samples from 27 healthy and 21 asthmatic subjects). All asthmatic subjects had mild to moderate asthma and abstained from corticosteroids during the study. Furthermore, we examined the relationship between airway sOPN and cellular inflammation. Principal Findings: We found that sOPN in BAL fluid and sputum exists in polymeric, monomeric, and cleaved forms, with most of it in polymeric form. Compared to healthy subjects, asthmatic subjects had proportionately less polymeric sOPN and more monomeric and cleaved sOPN. Polymeric sOPN in BAL fluid was associated with increased alveolar macrophage counts in airways in all subjects. Conclusions: These results suggest that sOPN in human airways (1) undergoes extensive post-translational modification by polymerization and proteolytic fragmentation, (2) is more fragmented and less polymerized in subjects with mild to moderate asthma, and (3) may contribute to recruitment or survival of alveolar macrophages.	[Arjomandi, Mehrdad; Frelinger, Jessica] Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA; [Arjomandi, Mehrdad; Frelinger, Jessica; Donde, Aneesh; Wong, Hofer; Yellamilli, Amritha] Univ Calif San Francisco, Dept Med, Human Exposure Lab, San Francisco, CA USA; [Raymond, Wilfred] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Med, San Francisco, CA 94143 USA; [Arjomandi, Mehrdad; Frelinger, Jessica; Raymond, Wilfred] San Francisco VA Med Ctr, Pulm Res Grp, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center	Arjomandi, M (corresponding author), Univ Calif San Francisco, Dept Med, Div Pulm & Crit Care Med, San Francisco, CA 94143 USA.	mehrdad.arjomandi@ucsf.edu	Arjomandi, Mehrdad/ABB-4327-2021	Arjomandi, Mehrdad/0000-0002-0116-9217	National Institutes of Health (NIH) [K23 HL083099, NIH P01 HL024136]; NIH/NCRR/OD [KL2 RR024130]; Northern California Institute for Research and Education; University of California San Francisco Cardiovascular Research Institute; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR024130] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL083099, P01HL024136] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR/OD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Northern California Institute for Research and Education; University of California San Francisco Cardiovascular Research Institute(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding: This work was supported by National Institutes of Health (NIH) K23 HL083099, NIH P01 HL024136, NIH/NCRR/OD UCSF-CTSI Grant Number KL2 RR024130, Northern California Institute for Research and Education, and University of California San Francisco Cardiovascular Research Institute Faculty Development Funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apte UM, 2005, TOXICOL APPL PHARM, V207, P25, DOI 10.1016/j.taap.2004.12.018; Arjomandi M, 2005, CHEST, V128, P416, DOI 10.1378/chest.128.1.416; ARJOMANDI M, 2009, AM J RESP CRIT CARE, V175, pA1393; ARJOMANDI M, 2011, PEDIAT ALLE IN PRESS; Ashkar S, 2000, SCIENCE, V287, P860, DOI 10.1126/science.287.5454.860; Banerjee A, 2006, J PATHOL, V208, P473, DOI 10.1002/path.1917; Barry ST, 2000, EXP CELL RES, V258, P342, DOI 10.1006/excr.2000.4941; Bayless KJ, 2001, J BIOL CHEM, V276, P13483, DOI 10.1074/jbc.M011392200; BENINATI S, 1994, J BIOCHEM-TOKYO, V115, P675, DOI 10.1093/oxfordjournals.jbchem.a124395; Burdo TH, 2007, J LEUKOCYTE BIOL, V81, P1504, DOI 10.1189/jlb.1106711; Chabas D, 2001, SCIENCE, V294, P1731, DOI 10.1126/science.1062960; Christensen B, 2005, BIOCHEM J, V390, P285, DOI 10.1042/BJ20050341; Christensen B, 2008, BIOCHEM J, V411, P53, DOI 10.1042/BJ20071021; DELIMPOURA V, THORAX, V65, P782; Delimpoura V, 2010, THORAX, V65, P782, DOI 10.1136/thx.2010.138552; Frenzel DF, 2011, EXPERT REV CLIN IMMU, V7, P93, DOI 10.1586/ECI.10.82; Giachelli CM, 1998, AM J PATHOL, V152, P353; GIACHELLI CM, 1993, J CLIN INVEST, V92, P1686, DOI 10.1172/JCI116755; Hallstrand TS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008583; HALLSTRAND TS, PLOS ONE, V5, pE8583; Higashikawa F, 2007, FEBS LETT, V581, P2697, DOI 10.1016/j.febslet.2007.05.018; Holgate ST, 1997, CIBA F SYMP, V206, P5; Kaartinen MT, 2007, J HISTOCHEM CYTOCHEM, V55, P375, DOI 10.1369/jhc.6A7087.2006; Kaartinen MT, 2002, J BONE MINER RES, V17, P2161, DOI 10.1359/jbmr.2002.17.12.2161; Kaartinen MT, 1999, J BIOL CHEM, V274, P1729, DOI 10.1074/jbc.274.3.1729; KANNER RE, 1994, AM J RESP CRIT CARE, V150, P956, DOI 10.1164/ajrccm.150.4.7921469; KIEFER MC, 1989, NUCLEIC ACIDS RES, V17, P3306, DOI 10.1093/nar/17.8.3306; Koh A, 2007, IMMUNOLOGY, V122, P466, DOI 10.1111/j.1365-2567.2007.02682.x; Kohan M, 2007, CLIN EXP ALLERGY, V37, P1444, DOI 10.1111/j.1365-2222.2007.02801.x; KOHAN M, 2009, AM J RESP CELL MOL B; LAFFON A, 1991, J CLIN INVEST, V88, P546, DOI 10.1172/JCI115338; Lee JL, 2007, CANCER RES, V67, P2089, DOI 10.1158/0008-5472.CAN-06-3625; Liaw L, 1998, J CLIN INVEST, V101, P1468; Marcinkiewicz C, 2000, J BIOL CHEM, V275, P31930, DOI 10.1074/jbc.M003209200; Marcondes MCG, 2008, CELL IMMUNOL, V254, P56, DOI 10.1016/j.cellimm.2008.06.012; MIYAZAKI Y, 1990, J BIOL CHEM, V265, P14432; NISHIMICHI N, J BIOL CHEM, V286, P11170; Nishimichi N, 2009, J BIOL CHEM, V284, P14769, DOI 10.1074/jbc.M901515200; O'Regan A, 2003, CYTOKINE GROWTH F R, V14, P479, DOI 10.1016/S1359-6101(03)00055-8; O'Regan AW, 1999, J IMMUNOL, V162, P1024; Ohshima S, 2002, J RHEUMATOL, V29, P2061; Ohshima S, 2002, ARTHRITIS RHEUM, V46, P1094, DOI 10.1002/art.10143; Okamoto H, 2007, MOL CELL BIOCHEM, V300, P1, DOI 10.1007/s11010-006-9368-3; PATARCA R, 1993, CRIT REV IMMUNOL, V13, P225; PRINCE CW, 1991, BIOCHEM BIOPH RES CO, V177, P1205, DOI 10.1016/0006-291X(91)90669-X; PUXEDDU I, ALLERGY, V65, P168; Qin C, 2004, CRIT REV ORAL BIOL M, V15, P126, DOI 10.1177/154411130401500302; Rittling SR, 1999, EXP NEPHROL, V7, P103; Rollo EE, 1996, J LEUKOCYTE BIOL, V60, P397, DOI 10.1002/jlb.60.3.397; Rollo EE, 1996, IMMUNOLOGY, V88, P642, DOI 10.1046/j.1365-2567.1996.d01-691.x; Sakata M, 2001, J RHEUMATOL, V28, P1492; SAMITAS K, EUR RESP J; Seiffge D, 1996, J RHEUMATOL, V23, P2086; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Simoes DCM, 2009, AM J RESP CRIT CARE, V179, P894, DOI 10.1164/rccm.200807-1081OC; SINGH K, 1990, J BIOL CHEM, V265, P18696; Smith LL, 1998, EXP CELL RES, V242, P351, DOI 10.1006/excr.1998.4108; Sodek J, 2000, CRIT REV ORAL BIOL M, V11, P279, DOI 10.1177/10454411000110030101; SORENSEN ES, 1994, BIOCHEM BIOPH RES CO, V198, P200, DOI 10.1006/bbrc.1994.1028; SORENSEN ES, 1994, BIOCHEM J, V304, P13, DOI 10.1042/bj3040013; Takahashi A, 2009, CLIN EXP ALLERGY, V39, P1152, DOI 10.1111/j.1365-2222.2009.03249.x; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; Trueblood NA, 2001, CIRC RES, V88, P1080, DOI 10.1161/hh1001.090842; Weber Georg F., 1996, Cytokine and Growth Factor Reviews, V7, P241, DOI 10.1016/S1359-6101(96)00030-5; Weber GF, 2002, J LEUKOCYTE BIOL, V72, P752; Xanthou G, 2007, NAT MED, V13, P570, DOI 10.1038/nm1580; Yamamoto N, 2003, J CLIN INVEST, V112, P181, DOI 10.1172/JCI200317778; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Zohar R, 1997, J CELL PHYSIOL, V170, P88	69	10	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e25678	10.1371/journal.pone.0025678	http://dx.doi.org/10.1371/journal.pone.0025678			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031818	Green Submitted, gold, Green Published			2022-12-27	WOS:000296513200005
J	Kita, A; Sakurai, Y; Myers, DR; Rounsevell, R; Huang, JN; Seok, TJ; Yu, K; Wu, MC; Fletcher, DA; Lam, WA				Kita, Ashley; Sakurai, Yumiko; Myers, David R.; Rounsevell, Ross; Huang, James N.; Seok, Tae Joon; Yu, Kyoungsik; Wu, Ming C.; Fletcher, Daniel A.; Lam, Wilbur A.			Microenvironmental Geometry Guides Platelet Adhesion and Spreading: A Quantitative Analysis at the Single Cell Level	PLOS ONE			English	Article							ACTIVATION; GENERATION; FIBRINOGEN; DYNAMICS; COLLAGEN	To activate clot formation and maintain hemostasis, platelets adhere and spread onto sites of vascular injury. Although this process is well-characterized biochemically, how the physical and spatial cues in the microenvironment affect platelet adhesion and spreading remain unclear. In this study, we applied deep UV photolithography and protein micro/nanostamping to quantitatively investigate and characterize the spatial guidance of platelet spreading at the single cell level and with nanoscale resolution. Platelets adhered to and spread only onto micropatterned collagen or fibrinogen surfaces and followed the microenvironmental geometry with high fidelity and with single micron precision. Using micropatterned lines of different widths, we determined that platelets are able to conform to micropatterned stripes as thin as 0.6 mu m and adopt a maximum aspect ratio of 19 on those protein patterns. Interestingly, platelets were also able to span and spread over non-patterned regions of up to 5 mu m, a length consistent with that of maximally extended filopodia. This process appears to be mediated by platelet filopodia that are sensitive to spatial cues. Finally, we observed that microenvironmental geometry directly affects platelet biology, such as the spatial organization and distribution of the platelet actin cytoskeleton. Our data demonstrate that platelet spreading is a finely-tuned and spatially-guided process in which spatial cues directly influence the biological aspects of how clot formation is regulated.	[Kita, Ashley; Sakurai, Yumiko; Myers, David R.; Lam, Wilbur A.] Emory Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, Atlanta, GA 30322 USA; [Kita, Ashley; Sakurai, Yumiko; Myers, David R.; Lam, Wilbur A.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Kita, Ashley; Sakurai, Yumiko; Myers, David R.; Lam, Wilbur A.] Emory Univ, Sch Med, Winship Canc Ctr, Atlanta, GA 30322 USA; [Kita, Ashley; Rounsevell, Ross; Fletcher, Daniel A.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Huang, James N.] Univ Calif San Francisco, Dept Pediat, Div Pediat Hematol Oncol, San Francisco, CA USA; [Seok, Tae Joon; Wu, Ming C.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Yu, Kyoungsik] Korea Adv Inst Sci & Technol, Dept Elect Engn, Taejon 305701, South Korea; [Fletcher, Daniel A.] Univ Calif Berkeley, Grad Grp Biophys, Berkeley, CA 94720 USA	Emory University; University System of Georgia; Georgia Institute of Technology; Emory University; University of California System; University of California Berkeley; University of California System; University of California San Francisco; University of California System; University of California Berkeley; Korea Advanced Institute of Science & Technology (KAIST); University of California System; University of California Berkeley	Kita, A (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Pediat Hematol Oncol, Atlanta, GA 30322 USA.	wilbur.lam@emory.edu	Yu, Kyoungsik/C-2078-2011; Wu, Ming C/J-9906-2012; Huang, James/W-5976-2019; Kita, Ashley/GPT-0506-2022; Myers, David Richard/G-7542-2017	Wu, Ming C/0000-0003-4808-6686; Myers, David Richard/0000-0001-9659-3274	National Institutes of Health (NIH) [K08-HL093360]; UCSF REAC; NIH Nanomedicine Development Center [PN2EY018244, PN2EY018228]; Center for Endothelial Cell Biology of Children's Healthcare of Atlanta; National Science Foundation (NSF); NATIONAL EYE INSTITUTE [PN2EY018244, PN2EY018228] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL093360] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UCSF REAC; NIH Nanomedicine Development Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Center for Endothelial Cell Biology of Children's Healthcare of Atlanta; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Financial support for this work was provided by a K08-HL093360 National Institutes of Health (NIH) grant, a UCSF REAC award, an NIH Nanomedicine Development Center Award PN2EY018244, and Center for Endothelial Cell Biology of Children's Healthcare of Atlanta funding to W. A. L., an NIH Nanomedicine Development Center PN2EY018228 to M. C. W., and a National Science Foundation (NSF) CAREER Award to D. A. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirkhosravi A, 2002, BLOOD COAGUL FIBRIN, V13, P505, DOI 10.1097/00001721-200209000-00005; Basabe-Desmonts L, 2010, LANGMUIR, V26, P14700, DOI 10.1021/la9039682; Briede JJ, 2001, THROMB HAEMOSTASIS, V85, P509, DOI 10.1055/s-0037-1615613; Corum LE, 2011, LANGMUIR, V27, P8316, DOI 10.1021/la201064d; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; Inoue O, 2006, BLOOD, V107, P1405, DOI 10.1182/blood-2005-06-2406; Jirouskova M, 2007, BLOOD, V109, P5260, DOI 10.1182/blood-2006-10-054015; Kehrel B, 1998, BLOOD, V91, P491; Lam WA, 2011, NAT MATER, V10, P61, DOI 10.1038/NMAT2903; Loncar Robert, 2007, Thromb J, V5, P2, DOI 10.1186/1477-9560-5-2; Medalia O, 2007, CURR BIOL, V17, P79, DOI 10.1016/j.cub.2006.11.022; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Rivera J, 2009, HAEMATOL-HEMATOL J, V94, P700, DOI 10.3324/haematol.2008.003178; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Von Philipsborn AC, 2006, NAT PROTOC, V1, P1322, DOI 10.1038/nprot.2006.251	15	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26437	10.1371/journal.pone.0026437	http://dx.doi.org/10.1371/journal.pone.0026437			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028878	gold, Green Submitted, Green Published			2022-12-27	WOS:000296510800043
J	Lee, C; Linkenauger, SA; Bakdash, JZ; Joy-Gaba, JA; Profitt, DR				Lee, Charles; Linkenauger, Sally A.; Bakdash, Jonathan Z.; Joy-Gaba, Jennifer A.; Profitt, Dennis R.			Putting Like a Pro: The Role of Positive Contagion in Golf Performance and Perception	PLOS ONE			English	Article							SIZE; OBJECTS	Many amateur athletes believe that using a professional athlete's equipment can improve their performance. Such equipment can be said to be affected with positive contagion, which refers to the belief of transference of beneficial properties between animate persons/objects to previously neutral objects. In this experiment, positive contagion was induced by telling participants in one group that a putter previously belonged to a professional golfer. The effect of positive contagion was examined for perception and performance in a golf putting task. Individuals who believed they were using the professional golfer's putter perceived the size of the golf hole to be larger than golfers without such a belief and also had better performance, sinking more putts. These results provide empirical support for anecdotes, which allege that using objects with positive contagion can improve performance, and further suggest perception can be modulated by positive contagion.	[Lee, Charles; Joy-Gaba, Jennifer A.; Profitt, Dennis R.] Univ Virginia, Dept Psychol, Charlottesville, VA 22903 USA; [Linkenauger, Sally A.] Max Planck Inst Biol Cybernet, Tubingen, Germany; [Bakdash, Jonathan Z.] Univ Utah, Dept Psychol, Salt Lake City, UT 84112 USA	University of Virginia; Max Planck Society; Utah System of Higher Education; University of Utah	Lee, C (corresponding author), Univ Virginia, Dept Psychol, Gilmer Hall, Charlottesville, VA 22903 USA.	sally.linkenauger@tuebingen.mpg.de	Bakdash, Jonathan/ABI-7594-2020	Bakdash, Jonathan/0000-0002-1409-4779; Linkenauger, Sally/0000-0002-6056-0187	University of Virginia College of Arts and Sciences	University of Virginia College of Arts and Sciences	This research was supported by a Small Research and Travel Grant from the University of Virginia College of Arts and Sciences to CL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariely Daniel, 2008, PREDICTABLY IRRATION; Beauchamp MR, 2002, J SPORT SCI, V20, P697, DOI 10.1080/026404102320219400; Canal-Bruland R, 2009, PSYCHON B REV, V16, P1100, DOI 10.3758/PBR.16.6.1100; Crum AJ, 2007, PSYCHOL SCI, V18, P165, DOI 10.1111/j.1467-9280.2007.01867.x; DAMISCH L, 2007, THESIS U KOLN; Dijksterhuis A, 1998, J PERS SOC PSYCHOL, V75, P862, DOI 10.1037/0022-3514.75.4.862; FELTZ DL, 1983, J SPORT PSYCHOL, V5, P25, DOI 10.1123/jsp.5.1.25; Herrigel E., 1953, ZEN ART ARCHERY; KAHNEMAN D, 1990, J POLIT ECON, V98, P1325, DOI 10.1086/261737; LOEWENSTEIN G, 1994, J BEHAV DECIS MAKING, V7, P157, DOI 10.1002/bdm.3960070302; Moerman DE, 2002, ANN INTERN MED, V136, P471, DOI 10.7326/0003-4819-136-6-200203190-00011; ROZIN P, 1986, J PERS SOC PSYCHOL, V50, P703, DOI 10.1037/0022-3514.50.4.703; SCHULTZ J, 2002, MIKE; Wesp R, 2004, PERCEPT PSYCHOPHYS, V66, P1261, DOI 10.3758/BF03194996; Witt JK, 2008, PSYCHON B REV, V15, P581, DOI 10.3758/PBR.15.3.581; Witt JK, 2005, PSYCHOL SCI, V16, P937, DOI 10.1111/j.1467-9280.2005.01640.x	16	40	41	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26016	10.1371/journal.pone.0026016	http://dx.doi.org/10.1371/journal.pone.0026016			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028804	Green Submitted, gold, Green Accepted, Green Published			2022-12-27	WOS:000296510800014
J	Callahan, JE; Munro, CL; Kitten, T				Callahan, Jill E.; Munro, Cindy L.; Kitten, Todd			The Streptococcus sanguinis Competence Regulon Is Not Required for Infective Endocarditis Virulence in a Rabbit Model	PLOS ONE			English	Article							SIGNATURE-TAGGED MUTAGENESIS; REGULATORY SYSTEM; PNEUMONIAE VIRULENCE; ADDITIVE ATTENUATION; GENETIC COMPETENCE; IDENTIFICATION; GORDONII; PEPTIDE; GENOME; MUTANS	Streptococcus sanguinis is an important component of dental plaque and a leading cause of infective endocarditis. Genetic competence in S. sanguinis requires a quorum sensing system encoded by the early comCDE genes, as well as late genes controlled by the alternative sigma factor, ComX. Previous studies of Streptococcus pneumoniae and Streptococcus mutans have identified functions for the >100-gene com regulon in addition to DNA uptake, including virulence. We investigated this possibility in S. sanguinis. Strains deleted for the comCDE or comX master regulatory genes were created. Using a rabbit endocarditis model in conjunction with a variety of virulence assays, we determined that both mutants possessed infectivity equivalent to that of a virulent control strain, and that measures of disease were similar in rabbits infected with each strain. These results suggest that the com regulon is not required for S. sanguinis infective endocarditis virulence in this model. We propose that the different roles of the S. sanguinis, S. pneumoniae, and S. mutans com regulons in virulence can be understood in relation to the pathogenic mechanisms employed by each species.	[Callahan, Jill E.; Kitten, Todd] Virginia Commonwealth Univ, VCU Philips Inst Oral & Craniofacial Mol Biol, Richmond, VA USA; [Callahan, Jill E.; Kitten, Todd] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Munro, Cindy L.] Virginia Commonwealth Univ, Dept Adult Hlth Nursing, Richmond, VA 23298 USA; [Kitten, Todd] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Callahan, JE (corresponding author), St Peters Coll, Dept Biol, Jersey City, NJ USA.	tkitten@vcu.edu	Kitten, Todd/O-6531-2014	Kitten, Todd/0000-0001-6097-7583	Hazel Thorpe and George Gay Carman Trust [C-VCU-07]; NIDCR, National Institutes of Health [F31DE020963]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F31DE020963] Funding Source: NIH RePORTER	Hazel Thorpe and George Gay Carman Trust; NIDCR, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grant C-VCU-07 from the Hazel Thorpe and George Gay Carman Trust. JEC received additional support from grant F31DE020963 from the NIDCR, National Institutes of Health (www.nidcr.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartilson M, 2001, MOL MICROBIOL, V39, P126, DOI 10.1046/j.1365-2958.2001.02218.x; Bashore TM, 2006, CURR PROB CARDIOLOGY, V31, P274, DOI 10.1016/j.cpcardiol.2005.12.001; Berry AM, 2000, INFECT IMMUN, V68, P133, DOI 10.1128/IAI.68.1.133-140.2000; Das S, 2009, J BACTERIOL, V191, P4166, DOI 10.1128/JB.01739-08; Di Filippo S, 2006, HEART, V92, P1490, DOI 10.1136/hrt.2005.085332; Donati C, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r107; DURACK DT, 1973, BRIT J EXP PATHOL, V54, P142; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; Forner L, 2006, J CLIN PERIODONTOL, V33, P401, DOI 10.1111/j.1600-051X.2006.00924.x; Ge XC, 2008, INFECT IMMUN, V76, P2551, DOI 10.1128/IAI.00338-08; Guiral S, 2005, P NATL ACAD SCI USA, V102, P8710, DOI 10.1073/pnas.0500879102; GUNTHEROTH WG, 1984, AM J CARDIOL, V54, P797, DOI 10.1016/S0002-9149(84)80211-8; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Havarstein LS, 1997, J BACTERIOL, V179, P6589, DOI 10.1128/jb.179.21.6589-6594.1997; Havarstein LS, 2006, MOL MICROBIOL, V59, P1297, DOI 10.1111/j.1365-2958.2005.05021.x; Hensel M, 1998, ELECTROPHORESIS, V19, P608, DOI 10.1002/elps.1150190425; HERZBERG MC, 1992, INFECT IMMUN, V60, P4809, DOI 10.1128/IAI.60.11.4809-4818.1992; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Johnsborg O, 2009, FEMS MICROBIOL REV, V33, P627, DOI 10.1111/j.1574-6976.2009.00167.x; KILIAN M, 1989, INT J SYST BACTERIOL, V39, P471, DOI 10.1099/00207713-39-4-471; Kowalko JE, 2008, INFECT IMMUN, V76, P3131, DOI 10.1128/IAI.01696-07; Lau GW, 2001, MOL MICROBIOL, V40, P555, DOI 10.1046/j.1365-2958.2001.02335.x; Li YH, 2008, MICROBIOL-SGM, V154, P3256, DOI 10.1099/mic.0.2008/019455-0; LOWRANCE JH, 1990, J CLIN INVEST, V86, P7, DOI 10.1172/JCI114717; Martin B, 2000, MOL MICROBIOL, V38, P867, DOI 10.1046/j.1365-2958.2000.02187.x; Martin B, 2006, TRENDS MICROBIOL, V14, P339, DOI 10.1016/j.tim.2006.06.007; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; Moreillon P, 2004, LANCET, V363, P139, DOI 10.1016/S0140-6736(03)15266-X; Okinaga T, 2010, MOL ORAL MICROBIOL, V25, P165, DOI 10.1111/j.2041-1014.2010.00574.x; Okinaga T, 2010, J BACTERIOL, V192, P1844, DOI 10.1128/JB.01667-09; Paik S, 2005, INFECT IMMUN, V73, P6064, DOI 10.1128/IAI.73.9.6064-6074.2005; Perry JA, 2009, MOL MICROBIOL, V72, P905, DOI 10.1111/j.1365-2958.2009.06693.x; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Rodriguez AM, 2011, MOL ORAL MICROBIOL, V26, P99, DOI 10.1111/j.2041-1014.2011.00606.x; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Takahashi Y, 2006, INFECT IMMUN, V74, P740, DOI 10.1128/IAI.74.1.740-743.2006; Turner LS, 2009, INFECT IMMUN, V77, P4966, DOI 10.1128/IAI.00760-09; Turner LS, 2009, MICROBIOL-SGM, V155, P2573, DOI 10.1099/mic.0.024513-0; Vickerman MM, 2007, J BACTERIOL, V189, P7799, DOI 10.1128/JB.01023-07; Xiong YQ, 2008, MICROB PATHOGENESIS, V45, P297, DOI 10.1016/j.micpath.2008.06.004; Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06; Zhu L, 2011, MOL ORAL MICROBIOL, V26, P117, DOI 10.1111/j.2041-1014.2010.00602.x	43	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26403	10.1371/journal.pone.0026403	http://dx.doi.org/10.1371/journal.pone.0026403			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039480	gold, Green Published, Green Submitted			2022-12-27	WOS:000296507500062
J	Li, BY; Qing, LT; Yan, JQ; Kong, QZ				Li, Baiya; Qing, Liuting; Yan, Jianqun; Kong, Qingzhong			Instability of the Octarepeat Region of the Human Prion Protein Gene	PLOS ONE			English	Article							DNA MISMATCH REPAIR; OCTAPEPTIDE REPEAT INSERTIONS; TRANSGENIC MICE; MICROSATELLITE INSTABILITY; DISEASE PATHOGENESIS; COPPER HOMEOSTASIS; SOMATIC EXPANSION; INVERTED REPEATS; IRON UPTAKE; CAG REPEAT	Prion diseases are a family of unique fatal transmissible neurodegenerative diseases that affect humans and many animals. Sporadic Creutzfeldt-Jakob disease (sCJD) is the most common prion disease in humans, accounting for 85-90% of all human prion cases, and exhibits a high degree of diversity in phenotypes. The etiology of sCJD remains to be elucidated. The human prion protein gene has an octapeptide repeat region (octarepeats) that normally contains 5 repeats of 24-27 bp (1 nonapeptide and 4 octapeptide coding sequences). An increase of the octarepeat numbers to six or more or a decrease of the octarepeat number to three is linked to genetic prion diseases with heterogeneous phenotypes in humans. Here we report that the human octarepeat region is prone to either contraction or expansion when subjected to PCR amplification in vitro using Taq or Pwo polymerase and when replicated in wild type E. coli cells. Octarepeat insertion mutants were even less stable, and the mutation rate for the wild type octarepeats was much higher when replicated in DNA mismatch repair-deficient E. coli cells. All observed octarepeat mutants resulting from DNA replication in E. coli were contained in head-to-head plasmid dimers and DNA mfold analysis (http://mfold.rna.albany.edu/?q = mfold/DNA-Folding-Form) indicates that both DNA strands of the octarepeat region would likely form multiple stable hairpin structures, suggesting that the octarepeat sequence may form stable hairpin structures during DNA replication or repair to cause octarepeat instability. These results provide the first evidence supporting a somatic octarepeat mutation-based model for human sCJD etiology: 1) the instability of the octarepeat region leads to accumulation of somatic octarepeat mutations in brain cells during development and aging, 2) this instability is augmented by compromised DNA mismatch repair in aged cells, and 3) eventually some of the octarepeat mutation-containing brain cells start spontaneous de novo prion formation and replication to initiate sCJD.	[Li, Baiya; Yan, Jianqun] Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Sch Med, Xian 710049, Shaanxi, Peoples R China; [Li, Baiya; Qing, Liuting; Kong, Qingzhong] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Xi'an Jiaotong University; Case Western Reserve University	Li, BY (corresponding author), Xi An Jiao Tong Univ, Dept Physiol & Pathophysiol, Sch Med, Xian 710049, Shaanxi, Peoples R China.	qxk2@case.edu			National Institutes of Health [R01 NS052319]; Creutzfeldt-Jakob Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052319] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Creutzfeldt-Jakob Disease Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	These studies were supported by National Institutes of Health R01 NS052319 and the Creutzfeldt-Jakob Disease Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzualde A, 2010, AM J MED GENET B, V153B, P1283, DOI 10.1002/ajmg.b.31099; Atarashi R, 2003, J BIOL CHEM, V278, P28944, DOI 10.1074/jbc.M303655200; Beck JA, 2004, HUM MOL GENET, V13, P1219, DOI 10.1093/hmg/ddh134; Ben Yehuda A, 2000, MECH AGEING DEV, V121, P173; Biasini E, 2008, J NEUROCHEM, V104, P1293, DOI 10.1111/j.1471-4159.2007.05082.x; Bois P, 1997, HUM MOL GENET, V6, P1565, DOI 10.1093/hmg/6.9.1565; Bois PRJ, 2003, GENOMICS, V81, P349, DOI 10.1016/S0888-7543(03)00021-1; Botta A, 2008, J MED GENET, V45, P639, DOI 10.1136/jmg.2008.058909; Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200; Brooks PJ, 2002, MUTAT RES-FUND MOL M, V509, P93, DOI 10.1016/S0027-5107(02)00222-1; Brouwer JR, 2009, BIOESSAYS, V31, P71, DOI 10.1002/bies.080122; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Brown DR, 2003, J NEUROCHEM, V87, P377, DOI 10.1046/j.1471-4159.2003.02046.x; Brown LR, 2003, J NEUROCHEM, V87, P353, DOI 10.1046/j.1471-4159.2003.01996.x; BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504; Buard J, 2000, GENOMICS, V65, P95, DOI 10.1006/geno.2000.6161; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Choi CJ, 2006, NEUROTOXICOLOGY, V27, P777, DOI 10.1016/j.neuro.2006.06.004; Coolbaugh-Murphy MI, 2005, MECH AGEING DEV, V126, P1051, DOI 10.1016/j.mad.2005.06.005; Croes EA, 2004, J NEUROL NEUROSUR PS, V75, P1166, DOI 10.1136/jnnp.2003.020198; DEROOIJ KE, 1995, HUM GENET, V95, P270, DOI 10.1007/BF00225192; DIFIGLIA M, 1995, NEURON, V14, P1075, DOI 10.1016/0896-6273(95)90346-1; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Felton KEA, 2007, CLIN GENET, V71, P483, DOI 10.1111/j.1399-0004.2007.00803.x; Gaggelli E, 2006, CHEM REV, V106, P1995, DOI 10.1021/cr040410w; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; GOLDFARB LG, 1991, P NATL ACAD SCI USA, V88, P10926, DOI 10.1073/pnas.88.23.10926; Gonitel R, 2008, P NATL ACAD SCI USA, V105, P3467, DOI 10.1073/pnas.0800048105; Gorbunova V, 2007, NUCLEIC ACIDS RES, V35, P7466, DOI 10.1093/nar/gkm756; Hardwick RJ, 2009, MOL BIOL EVOL, V26, P2647, DOI 10.1093/molbev/msp182; Harris TJR, 2010, NAT REV CLIN ONCOL, V7, P251, DOI 10.1038/nrclinonc.2010.41; Hiraga C, 2009, BIOCHEM BIOPH RES CO, V382, P715, DOI 10.1016/j.bbrc.2009.03.093; Hsieh P, 2008, MECH AGEING DEV, V129, P391, DOI 10.1016/j.mad.2008.02.012; Imam SZ, 2006, NEUROBIOL AGING, V27, P1129, DOI 10.1016/j.neurobiolaging.2005.06.002; Kaliman P, 2008, CELL SIGNAL, V20, P1935, DOI 10.1016/j.cellsig.2008.05.005; Kennedy L, 2003, HUM MOL GENET, V12, P3359, DOI 10.1093/hmg/ddg352; Kiaris H, 1996, ATHEROSCLEROSIS, V125, P47, DOI 10.1016/0021-9150(96)05841-8; Kong Qingzhong, 2004, VVolume 41, P673; Larsson NG, 2010, ANNU REV BIOCHEM, V79, P683, DOI 10.1146/annurev-biochem-060408-093701; Lin CT, 1997, NUCLEIC ACIDS RES, V25, P3009, DOI 10.1093/nar/25.15.3009; Lin CT, 2001, NUCLEIC ACIDS RES, V29, P3529, DOI 10.1093/nar/29.17.3529; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Metzgar D, 2002, GENOME RES, V12, P408, DOI 10.1101/gr.198602; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; Moore RA, 2006, PROTEIN SCI, V15, P609, DOI 10.1110/ps.051822606; Neri S, 2008, REJUV RES, V11, P565, DOI 10.1089/rej.2007.0639; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Poulogiannis G, 2010, HISTOPATHOLOGY, V56, P167, DOI 10.1111/j.1365-2559.2009.03392.x; Priola SA, 1998, J BIOL CHEM, V273, P11980, DOI 10.1074/jbc.273.19.11980; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; SCHAAPER RM, 1991, GENETICS, V129, P317; Seznec H, 2000, HUM MOL GENET, V9, P1185, DOI 10.1093/hmg/9.8.1185; Simpson AJG, 1997, ADV CANCER RES, V71, P209, DOI 10.1016/S0065-230X(08)60100-1; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006115; Singh A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000336; Singh A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004468; Sumudhu W, 2001, CURR BIOL, V11, P519, DOI 10.1016/S0960-9822(01)00147-6; Swami M, 2009, HUM MOL GENET, V18, P3039, DOI 10.1093/hmg/ddp242; TELENIUS H, 1994, NAT GENET, V6, P409, DOI 10.1038/ng0494-409; Varela-Nallar L, 2006, BIOL RES, V39, P39, DOI 10.4067/S0716-97602006000100005; Vassallo N, 2003, J NEUROCHEM, V86, P538, DOI 10.1046/j.1471-4159.2003.01882.x; Wallace DC, 2010, ENVIRON MOL MUTAGEN, V51, P440, DOI 10.1002/em.20586; Yin SM, 2006, J BIOL CHEM, V281, P10698, DOI 10.1074/jbc.M511819200; Yu SL, 2008, FEBS J, V275, P5564, DOI 10.1111/j.1742-4658.2008.06680.x; Yu SL, 2007, BIOCHEM J, V403, P343, DOI 10.1042/BJ20061592; Zou WQ, 2010, ANN NEUROL, V68, P162, DOI 10.1002/ana.22094	68	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26635	10.1371/journal.pone.0026635	http://dx.doi.org/10.1371/journal.pone.0026635			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028931	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500102
J	Smeds, L; Kunstner, A				Smeds, Linnea; Kunstner, Axel			CONDETRI - A Content Dependent Read Trimmer for Illumina Data	PLOS ONE			English	Article							SEQUENCING ERRORS; QUALITY; GENOMES	During the last few years, DNA and RNA sequencing have started to play an increasingly important role in biological and medical applications, especially due to the greater amount of sequencing data yielded from the new sequencing machines and the enormous decrease in sequencing costs. Particularly, Illumina/Solexa sequencing has had an increasing impact on gathering data from model and non-model organisms. However, accurate and easy to use tools for quality filtering have not yet been established. We present CONDETRI, a method for content dependent read trimming for next generation sequencing data using quality scores of each individual base. The main focus of the method is to remove sequencing errors from reads so that sequencing reads can be standardized. Another aspect of the method is to incorporate read trimming in next-generation sequencing data processing and analysis pipelines. It can process single-end and paired-end sequence data of arbitrary length and it is independent from sequencing coverage and user interaction. CONDETRI is able to trim and remove reads with low quality scores to save computational time and memory usage during de novo assemblies. Low coverage or large genome sequencing projects will especially gain from trimming reads. The method can easily be incorporated into preprocessing and analysis pipelines for Illumina data.	[Smeds, Linnea; Kunstner, Axel] Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Uppsala, Sweden	Uppsala University	Smeds, L (corresponding author), Uppsala Univ, Dept Evolutionary Biol, Evolutionary Biol Ctr, Uppsala, Sweden.	axel.kunstner@ebc.uu.se		Smeds, Linnea/0000-0002-8415-9259; Kunstner, Axel/0000-0003-0692-2105	Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	The Swedish Research Council through a grant to Hans Ellegren financially supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DOHM JC, 2007, GENOME RES; Dohm JC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn425; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; *ICGC, 2004, NATURE, V432, P717; Ilie L, 2011, BIOINFORMATICS, V27, P295, DOI 10.1093/bioinformatics/btq653; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Kozarewa I, 2009, NAT METHODS, V6, P291, DOI [10.1038/nmeth.1311, 10.1038/NMETH.1311]; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Miller JR, 2010, GENOMICS, V95, P315, DOI 10.1016/j.ygeno.2010.03.001; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Ratan A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-130; Salmela L, 2010, BIOINFORMATICS, V26, P1284, DOI 10.1093/bioinformatics/btq151; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scheibye-Alsing K, 2009, COMPUT BIOL CHEM, V33, P121, DOI 10.1016/j.compbiolchem.2008.11.003; Schroder J, 2009, BIOINFORMATICS, V25, P2157, DOI 10.1093/bioinformatics/btp379; Ye L, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r31; ZERBINO D, 2008, GENOME RES	25	174	176	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26314	10.1371/journal.pone.0026314	http://dx.doi.org/10.1371/journal.pone.0026314			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039460	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500049
J	Burdina, AO; Klosterman, SM; Shtessel, L; Ahmed, S; Richmond, JE				Burdina, Anna O.; Klosterman, Susan M.; Shtessel, Ludmila; Ahmed, Shawn; Richmond, Janet E.			In Vivo Analysis of Conserved C. elegans Tomosyn Domains	PLOS ONE			English	Article							SNARE COMPLEX-FORMATION; NEUROTRANSMITTER RELEASE; REGULATES EXOCYTOSIS; FUSION; IDENTIFICATION; MEMBRANE; PROTEINS; UNC-13; CELLS; FORMS	Neurosecretion is critically dependent on the assembly of a macromolecular complex between the SNARE proteins syntaxin, SNAP-25 and synaptobrevin. Evidence indicates that the binding of tomosyn to syntaxin and SNAP-25 interferes with this assembly, thereby negatively regulating both synaptic transmission and peptide release. Tomosyn has two conserved domains: an N-terminal encompassing multiple WD40 repeats predicted to form two beta-propeller structures and a C-terminal SNARE-binding motif. To assess the function of each domain, we performed an in vivo analysis of the N- and C-terminal domains of C. elegans tomosyn (TOM-1) in a tom-1 mutant background. We verified that both truncated TOM-1 constructs were transcribed at levels comparable to rescuing full-length TOM-1, were of the predicted size, and localized to synapses. Unlike full-length TOM-1, expression of the N- or C-terminal domains alone was unable to restore inhibitory control of synaptic transmission in tom-1 mutants. Similarly, co-expression of both domains failed to restore TOM-1 function. In addition, neither the N-nor C-terminal domain inhibited release when expressed in a wild-type background. Based on these results, we conclude that the ability of tomosyn to regulate neurotransmitter release in vivo depends on the physical integrity of the protein, indicating that both N- and C-terminal domains are necessary but not sufficient for effective inhibition of release in vivo.	[Burdina, Anna O.; Klosterman, Susan M.; Richmond, Janet E.] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Shtessel, Ludmila; Ahmed, Shawn] Univ N Carolina, Dept Biol, Chapel Hill, NC USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of North Carolina; University of North Carolina Chapel Hill	Burdina, AO (corresponding author), Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA.	jer@uic.edu			National Institutes of Health [RO1 MH073156]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073156] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by National Institutes of Health Grant RO1 MH073156. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashery U, 2009, TRENDS NEUROSCI, V32, P275, DOI 10.1016/j.tins.2009.01.004; Constable JRL, 2005, J BIOL CHEM, V280, P31615, DOI 10.1074/jbc.M505858200; Dybbs M, 2005, PLOS GENET, V1, P6, DOI 10.1371/journal.pgen.0010002; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fujita Y, 1998, NEURON, V20, P905, DOI 10.1016/S0896-6273(00)80472-9; Gladycheva SE, 2007, J BIOL CHEM, V282, P22887, DOI 10.1074/jbc.M701787200; Gracheva EO, 2006, PLOS BIOL, V4, P1426, DOI 10.1371/journal.pbio.0040261; Groffen AJA, 2005, J NEUROCHEM, V92, P554, DOI 10.1111/j.1471-4159.2004.02890.x; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; Hatsuzawa K, 2003, J BIOL CHEM, V278, P31159, DOI 10.1074/jbc.M305500200; Hattendorf DA, 2007, NATURE, V446, P567, DOI 10.1038/nature05635; HORZ HP, MONITORING MICROBIAL; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Masuda ES, 1998, NEURON, V21, P479, DOI 10.1016/S0896-6273(00)80559-0; McEwen JM, 2006, NEURON, V51, P303, DOI 10.1016/j.neuron.2006.06.025; Pobbati AV, 2004, J BIOL CHEM, V279, P47192, DOI 10.1074/jbc.M408767200; Richmond JE, 1999, NAT NEUROSCI, V2, P959, DOI 10.1038/12160; Sakisaka T, 2008, J CELL BIOL, V183, P323, DOI 10.1083/jcb.200805150; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; YAMAMOTO Y, J BIOL CHEM, V285, P40943; Yamamoto Y, 2009, J BIOL CHEM, V284, P12480, DOI 10.1074/jbc.M807182200; Yizhar O, 2007, J NEUROCHEM, V103, P604, DOI 10.1111/j.1471-4159.2007.04791.x; Yokoyama S, 1999, BIOCHEM BIOPH RES CO, V256, P218, DOI 10.1006/bbrc.1999.0300; Zhang W, 2006, DIABETES, V55, P574, DOI 10.2337/diabetes.55.03.06.db05-0015; Zheng Q, 2011, DEVELOPMENT, V138, P87, DOI 10.1242/dev.055350	27	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26185	10.1371/journal.pone.0026185	http://dx.doi.org/10.1371/journal.pone.0026185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022557	gold, Green Submitted, Green Published			2022-12-27	WOS:000295981600034
J	Liu, XF; Xu, XK; Small, M; Tse, CK				Liu, Xiao Fan; Xu, Xiao-Ke; Small, Michael; Tse, Chi K.			Attack Resilience of the Evolving Scientific Collaboration Network	PLOS ONE			English	Article								Stationary complex networks have been extensively studied in the last ten years. However, many natural systems are known to be continuously evolving at the local ("microscopic") level. Understanding the response to targeted attacks of an evolving network may shed light on both how to design robust systems and finding effective attack strategies. In this paper we study empirically the response to targeted attacks of the scientific collaboration networks. First we show that scientific collaboration network is a complex system which evolves intensively at the local level - fewer than 20% of scientific collaborations last more than one year. Then, we investigate the impact of the sudden death of eminent scientists on the evolution of the collaboration networks of their former collaborators. We observe in particular that the sudden death, which is equivalent to the removal of the center of the egocentric network of the eminent scientist, does not affect the topological evolution of the residual network. Nonetheless, removal of the eminent hub node is exactly the strategy one would adopt for an effective targeted attack on a stationary network. Hence, we use this evolving collaboration network as an experimental model for attack on an evolving complex network. We find that such attacks are ineffectual, and infer that the scientific collaboration network is the trace of knowledge propagation on a larger underlying social network. The redundancy of the underlying structure in fact acts as a protection mechanism against such network attacks.	[Liu, Xiao Fan; Xu, Xiao-Ke; Small, Michael; Tse, Chi K.] Hong Kong Polytech Univ, Dept Elect & Informat Engn, Kowloon, Hong Kong, Peoples R China; [Xu, Xiao-Ke] Qingdao Technol Univ, Sch Commun & Elect Engn, Qingdao, Peoples R China	Hong Kong Polytechnic University; Qingdao University of Technology	Liu, XF (corresponding author), Hong Kong Polytech Univ, Dept Elect & Informat Engn, Kowloon, Hong Kong, Peoples R China.	xfliu@eie.polyu.edu.hk	xu, xiaoke/GPX-3060-2022; Liu, Xiao Fan/I-6403-2015; LIU, Xiao Fan/E-8139-2010; Small, Michael/C-9807-2010; xu, xiaoke/GQY-8278-2022; Xu, xiaoke/AAS-3266-2021	xu, xiaoke/0000-0002-9148-3145; Liu, Xiao Fan/0000-0001-8342-4623; LIU, Xiao Fan/0000-0001-8342-4623; Small, Michael/0000-0001-5378-1582; xu, xiaoke/0000-0002-9148-3145; Xu, xiaoke/0000-0002-9148-3145	PolyU Postdoctoral Fellowships Scheme [G-YX4A]; Research Grants Council of Hong Kong [BQ19H]; National Natural Science Foundation of China [61004104, 60802066]	PolyU Postdoctoral Fellowships Scheme; Research Grants Council of Hong Kong(Hong Kong Research Grants Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	XKX was supported by the PolyU Postdoctoral Fellowships Scheme (G-YX4A) and the Research Grants Council of Hong Kong (BQ19H). XKX also acknowledges the National Natural Science Foundation of China (61004104, 60802066). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.025103; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Azoulay P, 2010, Q J ECON, V125, P549, DOI 10.1162/qjec.2010.125.2.549; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Gautreau A, 2009, P NATL ACAD SCI USA, V106, P8847, DOI 10.1073/pnas.0811113106; Gross T, 2008, J R SOC INTERFACE, V5, P259, DOI 10.1098/rsif.2007.1229; Grujic J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013749; Guimera R, 2007, NAT PHYS, V3, P63, DOI 10.1038/nphys489; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026107; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Jin EM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.046132; Kumpula JM, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.228701; Lee D, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.026112; LIU XF, 2011, INT J BIFUR IN PRESS; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Schneider CM, 2011, P NATL ACAD SCI USA, V108, P3838, DOI 10.1073/pnas.1009440108; ZACHARY WW, 1977, J ANTHROPOL RES, V33, P452, DOI 10.1086/jar.33.4.3629752	20	11	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26271	10.1371/journal.pone.0026271	http://dx.doi.org/10.1371/journal.pone.0026271			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022586	gold, Green Published, Green Submitted			2022-12-27	WOS:000295981600045
J	Prole, DL; Taylor, CW				Prole, David L.; Taylor, Colin W.			Identification of Intracellular and Plasma Membrane Calcium Channel Homologues in Pathogenic Parasites	PLOS ONE			English	Article							INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; BLOOD FLUKE SCHISTOSOMA; OPERATED CA2+ ENTRY; MUSCLE RYANODINE RECEPTOR; SURFACE ANION CHANNEL; VOLTAGE-GATED SODIUM; PLASMODIUM-FALCIPARUM; TRYPANOSOMA-CRUZI; LEISHMANIA-DONOVANI; GENOME SEQUENCE	Ca2+ channels regulate many crucial processes within cells and their abnormal activity can be damaging to cell survival, suggesting that they might represent attractive therapeutic targets in pathogenic organisms. Parasitic diseases such as malaria, leishmaniasis, trypanosomiasis and schistosomiasis are responsible for millions of deaths each year worldwide. The genomes of many pathogenic parasites have recently been sequenced, opening the way for rational design of targeted therapies. We analyzed genomes of pathogenic protozoan parasites as well as the genome of Schistosoma mansoni, and show the existence within them of genes encoding homologues of mammalian intracellular Ca2+ release channels: inositol 1,4,5-trisphosphate receptors (IP(3)Rs), ryanodine receptors (RyRs), two-pore Ca2+ channels (TPCs) and intracellular transient receptor potential (Trp) channels. The genomes of Trypanosoma, Leishmania and S. mansoni parasites encode IP3R/RyR and Trp channel homologues, and that of S. mansoni additionally encodes a TPC homologue. In contrast, apicomplexan parasites lack genes encoding IP3R/RyR homologues and possess only genes encoding TPC and Trp channel homologues (Toxoplasma gondii) or Trp channel homologues alone. The genomes of parasites also encode homologues of mammalian Ca2+ influx channels, including voltage-gated Ca2+ channels and plasma membrane Trp channels. The genome of S. mansoni also encodes Orai Ca2+ channel and STIM Ca2+ sensor homologues, suggesting that store-operated Ca2+ entry may occur in this parasite. Many anti-parasitic agents alter parasite Ca2+ homeostasis and some are known modulators of mammalian Ca2+ channels, suggesting that parasite Ca2+ channel homologues might be the targets of some current anti-parasitic drugs. Differences between human and parasite Ca2+ channels suggest that pathogen-specific targeting of these channels may be an attractive therapeutic prospect.	[Prole, David L.; Taylor, Colin W.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1QJ, England	University of Cambridge	Prole, DL (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1QJ, England.	dp350@cam.ac.uk	Taylor, Colin/G-2447-2010	Taylor, Colin/0000-0001-7771-1044; Prole, David/0000-0003-2782-6665	St. John's College, Cambridge; Wellcome Trust	St. John's College, Cambridge; Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a Meres Senior Research Associateship from St. John's College, Cambridge (to DLP) and by the Wellcome Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen MS, 2004, SCIENCE, V304, P441, DOI 10.1126/science.1094786; Agboh KC, 2004, J BIOL CHEM, V279, P41650, DOI 10.1074/jbc.M408203200; Alonso PL, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000406; Arnaiz O, 2007, NUCLEIC ACIDS RES, V35, pD439, DOI 10.1093/nar/gkl777; Arnou B, 2011, BIOCHEM SOC T, V39, P823, DOI 10.1042/BST0390823; Aurrecoechea C, 2007, NUCLEIC ACIDS RES, V35, pD427, DOI 10.1093/nar/gkl880; Bankier AT, 2003, GENOME RES, V13, P1787, DOI 10.1101/gr.1555203; Baughman JM, 2011, NATURE, V476, P341, DOI 10.1038/nature10234; BELDE PJM, 1993, FEBS LETT, V323, P113, DOI 10.1016/0014-5793(93)81460-H; Bentley GN, 2007, PARASITOLOGY, V134, P833, DOI 10.1017/S0031182006002162; Bentley GN, 2004, GENE, V329, P27, DOI 10.1016/j.gene.2003.12.009; Beraldo FH, 2007, J PINEAL RES, V43, P360, DOI 10.1111/j.1600-079X.2007.00486.x; Bernsel A, 2009, NUCLEIC ACIDS RES, V37, pW465, DOI 10.1093/nar/gkp363; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Berriman M, 2009, NATURE, V460, P352, DOI 10.1038/nature08160; Biel M, 1996, TRENDS CARDIOVAS MED, V6, P274, DOI 10.1016/S1050-1738(96)00105-3; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Brayton KA, 2007, PLOS PATHOG, V3, P1401, DOI 10.1371/journal.ppat.0030148; Cai XJ, 2008, MOL BIOL EVOL, V25, P1357, DOI 10.1093/molbev/msn077; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; CASEMORE D. P., 1997, CRYPTOSPORIDIUM CRYP, P65; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Chen SRW, 2002, BIOPHYS J, V82, P2436, DOI 10.1016/S0006-3495(02)75587-2; Cheng KT, 2011, ADV EXP MED BIOL, V704, P435, DOI 10.1007/978-94-007-0265-3_24; Cheng XP, 2010, FEBS LETT, V584, P2013, DOI 10.1016/j.febslet.2009.12.056; Chenik M, 2005, PARASITOL RES, V98, P5, DOI 10.1007/s00436-005-0012-z; Chini EN, 2005, BIOCHEM J, V389, P269, DOI 10.1042/BJ20041971; CLARKSON AB, 1982, SCIENCE, V216, P1321, DOI 10.1126/science.6805075; Cudmore Sarah L, 2010, J Infect Public Health, V3, P47, DOI 10.1016/j.jiph.2010.01.003; Das R, 2008, APOPTOSIS, V13, P867, DOI 10.1007/s10495-008-0224-7; Day TA, 2000, PARASITOLOGY, V120, P417, DOI 10.1017/S0031182099005594; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Docampo R, 2003, PARASITOL RES, V90, pS10, DOI 10.1007/s00436-002-0752-y; Docampo R, 2001, MOL BIOCHEM PARASIT, V114, P151, DOI 10.1016/S0166-6851(01)00246-8; DOCAMPO R, 1993, MOL BIOCHEM PARASIT, V59, P305, DOI 10.1016/0166-6851(93)90228-P; Dong XP, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1037; Dong XP, 2010, J NEUROCHEM, V113, P313, DOI 10.1111/j.1471-4159.2010.06626.x; Eckstein-Ludwig U, 2003, NATURE, V424, P957, DOI 10.1038/nature01813; El-Sayed NM, 2005, SCIENCE, V309, P404, DOI 10.1126/science.1112181; Fang JM, 2006, BIOCHEM J, V394, P417, DOI 10.1042/BJ20051393; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Fischer M, 1997, FEBS LETT, V419, P259, DOI 10.1016/S0014-5793(97)01466-X; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Franzen O, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000560; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; Furuichi T, 2001, PLANT CELL PHYSIOL, V42, P900, DOI 10.1093/pcp/pce145; Furuya T, 2000, J BIOL CHEM, V275, P6428, DOI 10.1074/jbc.275.9.6428; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gardner MJ, 2002, NATURE, V419, P531, DOI 10.1038/nature01094; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gazarini ML, 2007, MEM I OSWALDO CRUZ, V102, P329, DOI 10.1590/S0074-02762007000300012; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Giamarchi A, 2006, EMBO REP, V7, P787, DOI 10.1038/sj.embor.7400745; Greenberg RM, 2005, PARASITOLOGY, V131, pS97, DOI 10.1017/S0031182005008346; Greenberg RM, 2005, INT J PARASITOL, V35, P1, DOI 10.1016/j.ijpara.2004.09.004; Gupta S, 2006, EXP PARASITOL, V113, P161, DOI 10.1016/j.exppara.2005.12.020; Hall N, 2002, NATURE, V419, P527, DOI 10.1038/nature01095; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hohenegger M, 1996, MOL PHARMACOL, V50, P1443; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jerlstrom-Hultqvist J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-543; Jones ML, 2009, MOL BIOCHEM PARASIT, V168, P55, DOI 10.1016/j.molbiopara.2009.06.007; Kang MS, 2005, MOL PHARMACOL, V68, P34, DOI 10.1124/mol.104.010553; Klauke N, 2000, J MEMBRANE BIOL, V174, P141, DOI 10.1007/s002320001039; Kohn AB, 2001, PARASITOLOGY, V123, P489, DOI 10.1017/S0031182001008691; Kohn AB, 2001, J BIOL CHEM, V276, P36873, DOI 10.1074/jbc.C100273200; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Koulen P, 2002, NAT CELL BIOL, V4, P191, DOI 10.1038/ncb754; Kulkarni MM, 2009, J BIOL CHEM, V284, P15496, DOI 10.1074/jbc.M809079200; Ladenburger EM, 2006, J CELL SCI, V119, P3705, DOI 10.1242/jcs.03075; Lalle Marco, 2010, Infectious Disorders - Drug Targets, V10, P283; Lange I, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000278; Laurentino EC, 2004, MOL BIOCHEM PARASIT, V137, P81, DOI 10.1016/j.molbiopara.2004.05.001; LEY V, 1988, J EXP MED, V168, P649, DOI 10.1084/jem.168.2.649; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Lisk G, 2006, EUKARYOT CELL, V5, P1882, DOI 10.1128/EC.00212-06; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Lorenzi H, 2008, ANNOTATION TOXOPLASM; Lovett JL, 2002, J BIOL CHEM, V277, P25870, DOI 10.1074/jbc.M202553200; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Martins VD, 2010, J BIOL CHEM, V285, P30906, DOI 10.1074/jbc.M110.142190; McArthur AG, 2000, FEMS MICROBIOL LETT, V189, P271, DOI 10.1111/j.1574-6968.2000.tb09242.x; McGeary RP, 2008, MINI-REV MED CHEM, V8, P1384, DOI 10.2174/138955708786369573; Mendonca-Silva DL, 2006, PARASITOLOGY, V133, P67, DOI 10.1017/S0031182006000023; Mendoza M, 2008, PARASITOLOGY, V135, P1303, DOI 10.1017/S0031182008004903; Misra UK, 1997, J CELL BIOCHEM, V64, P225, DOI 10.1002/(SICI)1097-4644(199702)64:2<225::AID-JCB6>3.0.CO;2-Z; Montell Craig, 2005, Sci STKE, V2005, pre3, DOI 10.1126/stke.2722005re3; Moreno SNJ, 2009, J EUKARYOT MICROBIOL, V56, P208, DOI 10.1111/j.1550-7408.2009.00404.x; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; MORENO SNJ, 1992, MOL BIOCHEM PARASIT, V52, P251, DOI 10.1016/0166-6851(92)90057-Q; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Naderer T, 2011, MOL MICROBIOL, V80, P471, DOI 10.1111/j.1365-2958.2011.07584.x; Nagamune Kisaburo, 2008, V47, P70; Nogi T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000464; O'Neill PM, 2010, MOLECULES, V15, P1705, DOI 10.3390/molecules15031705; Paidhungat M, 1997, MOL CELL BIOL, V17, P6339, DOI 10.1128/MCB.17.11.6339; Palmer CP, 2001, P NATL ACAD SCI USA, V98, P7801, DOI 10.1073/pnas.141036198; Passos APD, 1998, BIOCHEM BIOPH RES CO, V245, P155, DOI 10.1006/bbrc.1998.8338; Paul-Pletzer K, 2002, J BIOL CHEM, V277, P34918, DOI 10.1074/jbc.M205487200; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Peiter E, 2005, NATURE, V434, P404, DOI 10.1038/nature03381; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Petri ET, 2010, P NATL ACAD SCI USA, V107, P9176, DOI 10.1073/pnas.0912295107; PHILOSOPH H, 1989, J BIOL CHEM, V264, P10420; Ponting CP, 2000, TRENDS BIOCHEM SCI, V25, P48; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prasad A, 2001, MOL CELL BIOCHEM, V224, P39, DOI 10.1023/A:1011965109446; Raabe AC, 2011, CELL MICROBIOL, V13, P955, DOI 10.1111/j.1462-5822.2011.01591.x; RAHA S, 1994, MOL BIOCHEM PARASIT, V65, P63, DOI 10.1016/0166-6851(94)90115-5; Ramos IB, 2010, BIOCHEM J, V429, P485, DOI 10.1042/BJ20091956; Ranatunga KM, 2005, MOL PHARMACOL, V68, P840, DOI 10.1124/mol.105.012807; Reimao JQ, 2010, BIOORGAN MED CHEM, V18, P8044, DOI 10.1016/j.bmc.2010.09.015; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; Rohloff P, 2003, MOL BIOCHEM PARASIT, V126, P219, DOI 10.1016/S0166-6851(02)00277-3; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Salido GM, 2009, BBA-MOL CELL RES, V1793, P223, DOI 10.1016/j.bbamcr.2008.11.001; SARKAR D, 1995, FEBS LETT, V375, P83, DOI 10.1016/0014-5793(95)01161-7; Sattelle David B., 2008, Invertebrate Neuroscience, V8, P107, DOI 10.1007/s10158-008-0076-4; SCHEIBEL LW, 1987, P NATL ACAD SCI USA, V84, P7310, DOI 10.1073/pnas.84.20.7310; Serrano-Martin X, 2009, ANTIMICROB AGENTS CH, V53, P1403, DOI 10.1128/AAC.01215-08; Sibley LD, 2011, IMMUNOL REV, V240, P72, DOI 10.1111/j.1600-065X.2010.00990.x; Sitsapesan R, 1996, J MEMBRANE BIOL, V153, P93, DOI 10.1007/s002329900113; Smyth JT, 2006, BBA-MOL CELL RES, V1763, P1147, DOI 10.1016/j.bbamcr.2006.08.050; Taylor CW, 2009, BIOCHEMISTRY-US, V48, P12062, DOI 10.1021/bi901739t; Tempone AG, 2009, PARASITOL RES, V105, P499, DOI 10.1007/s00436-009-1427-8; Tsiokas L, 2009, AM J PHYSIOL-RENAL, V297, pF1, DOI 10.1152/ajprenal.90277.2008; Valderramos SG, 2010, ANTIMICROB AGENTS CH, V54, P3842, DOI 10.1128/AAC.00121-10; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495; Wiser MF, 2011, PROTOZOA AND HUMAN DISEASE, P1; Wolstenholme AJ, 2011, ADV EXP MED BIOL, V704, P359, DOI 10.1007/978-94-007-0265-3_20; Xu P, 2004, NATURE, V431, P1107, DOI 10.1038/nature02977; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoshikawa F, 1996, J BIOL CHEM, V271, P18277, DOI 10.1074/jbc.271.30.18277; YU FH, 2004, SCI STKE; Zhou YB, 2010, P NATL ACAD SCI USA, V107, P4896, DOI 10.1073/pnas.1001169107	148	84	87	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26218	10.1371/journal.pone.0026218	http://dx.doi.org/10.1371/journal.pone.0026218			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022573	Green Published, gold, Green Submitted			2022-12-27	WOS:000295981600040
J	Cook, D; Sanchez-Carbente, MD; Lachance, C; Radzioch, D; Tremblay, S; Khandjian, EW; DesGroseillers, L; Murai, KK				Cook, Denise; Sanchez-Carbente, Maria del Rayo; Lachance, Claude; Radzioch, Danuta; Tremblay, Sandra; Khandjian, Edouard W.; DesGroseillers, Luc; Murai, Keith K.			Fragile X Related Protein 1 Clusters with Ribosomes and Messenger RNAs at a Subset of Dendritic Spines in the Mouse Hippocampus	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; ACTIVITY-DEPENDENT TRAFFICKING; MAMMALIAN STRESS GRANULES; SYNAPTIC PLASTICITY; BINDING PROTEINS; NEURONS; FXR1; FMRP; TRANSLATION; LOCALIZATION	The formation and storage of memories in neuronal networks relies on new protein synthesis, which can occur locally at synapses using translational machinery present in dendrites and at spines. These new proteins support long-lasting changes in synapse strength and size in response to high levels of synaptic activity. To ensure that proteins are made at the appropriate time and location to enable these synaptic changes, messenger RNA (mRNA) translation is tightly controlled by dendritic RNA-binding proteins. Fragile X Related Protein 1 (FXR1P) is an RNA-binding protein with high homology to Fragile X Mental Retardation Protein (FMRP) and is known to repress and activate mRNA translation in non-neuronal cells. However, unlike FMRP, very little is known about the role of FXR1P in the central nervous system. To understand if FXR1P is positioned to regulate local mRNA translation in dendrites and at synapses, we investigated the expression and targeting of FXR1P in developing hippocampal neurons in vivo and in vitro. We found that FXR1P was highly expressed during hippocampal development and co-localized with ribosomes and mRNAs in the dendrite and at a subset of spines in mouse hippocampal neurons. Our data indicate that FXR1P is properly positioned to control local protein synthesis in the dendrite and at synapses in the central nervous system.	[Cook, Denise; Murai, Keith K.] McGill Univ, Ctr Res Neurosci, Montreal Gen Hosp, Dept Neurol & Neurosurg,Res Inst,Hlth Ctr, Montreal, PQ H3A 2T5, Canada; [Sanchez-Carbente, Maria del Rayo; DesGroseillers, Luc] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada; [Lachance, Claude; Radzioch, Danuta] McGill Univ, Div Expt Med, Dept Med, Montreal, PQ H3A 2T5, Canada; [Tremblay, Sandra; Khandjian, Edouard W.] Univ Laval, Ctr Rech Robert Giffard, Quebec City, PQ, Canada	McGill University; Universite de Montreal; McGill University; Laval University	Cook, D (corresponding author), McGill Univ, Ctr Res Neurosci, Montreal Gen Hosp, Dept Neurol & Neurosurg,Res Inst,Hlth Ctr, Montreal, PQ H3A 2T5, Canada.	keith.murai@mcgill.ca	Lachance, Claude/A-4214-2012; del Rayo Sánchez, Maria/AAG-3615-2020	Lachance, Claude/0000-0002-1974-1787; del Rayo Sánchez, Maria/0000-0001-9586-3033; Radzioch, Danuta/0000-0002-1601-2757; Cook, Denise/0000-0002-8837-1492	Canadian Institutes of Health Research, Canadian Foundation for Innovation; National Institutes of Health (USA) [1R21DA026053-01]; Frederick Banting and Charles Best CIHR; FRSQ; Canadian Institutes of Health Research; NSERC; Consejo Nacional de Ciencia y Tecnologia (CONACYT); NATIONAL INSTITUTE ON DRUG ABUSE [R21DA026053] Funding Source: NIH RePORTER	Canadian Institutes of Health Research, Canadian Foundation for Innovation(Canada Foundation for InnovationCanadian Institutes of Health Research (CIHR)); National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frederick Banting and Charles Best CIHR(Canadian Institutes of Health Research (CIHR)); FRSQ(Fonds de la Recherche en Sante du Quebec); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Canadian Institutes of Health Research, Canada Research Chairs Program, Canadian Foundation for Innovation and the National Institutes of Health grant 1R21DA026053-01 (USA) (K.K.M.). D.C. was supported through a Frederick Banting and Charles Best CIHR Doctoral Research Award and an FRSQ Doctoral Award. L.D.G. was funded by the Canadian Institutes of Health Research, E.W. K. by the NSERC, and M.d.R.S-C. received a postdoctoral fellowship from Consejo Nacional de Ciencia y Tecnologia (CONACYT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakalu G, 2001, NEURON, V30, P489, DOI 10.1016/S0896-6273(01)00295-1; Antar LN, 2005, GENES BRAIN BEHAV, V4, P350, DOI 10.1111/j.1601-183X.2005.00128.x; Bakker CE, 2000, EXP CELL RES, V258, P162, DOI 10.1006/excr.2000.4932; Bardoni Barbara, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010751; Bassell GJ, 1998, J NEUROSCI, V18, P251; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Darnell JC, 2009, HUM MOL GENET, V18, P3164, DOI 10.1093/hmg/ddp255; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Garnon J, 2005, J BIOL CHEM, V280, P5750, DOI 10.1074/jbc.M401988200; Gessert S, 2010, DEV BIOL, V341, P222, DOI 10.1016/j.ydbio.2010.02.031; Govindarajan A, 2011, NEURON, V69, P132, DOI 10.1016/j.neuron.2010.12.008; Haber M, 2006, J NEUROSCI, V26, P8881, DOI 10.1523/JNEUROSCI.1302-06.2006; HARRELL FE, 2003, HMISC S FUNCTION LIB; Huber KM, 2002, P NATL ACAD SCI USA, V99, P7746, DOI 10.1073/pnas.122205699; Huber KM, 2000, SCIENCE, V288, P1254, DOI 10.1126/science.288.5469.1254; Huot ME, 2001, HUM MOL GENET, V10, P2803, DOI 10.1093/hmg/10.24.2803; Jacobs T, 2007, J NEUROSCI, V27, P8604, DOI 10.1523/JNEUROSCI.0765-07.2007; Job C, 2001, P NATL ACAD SCI USA, V98, P13037, DOI 10.1073/pnas.231485698; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kao DI, 2010, P NATL ACAD SCI USA, V107, P15601, DOI 10.1073/pnas.1010564107; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Khandjian EW, 1998, HUM MOL GENET, V7, P2121, DOI 10.1093/hmg/7.13.2121; Khandjian EW, 2004, P NATL ACAD SCI USA, V101, P13357, DOI 10.1073/pnas.0405398101; Knowles RB, 1996, J NEUROSCI, V16, P7812; KOSIK KS, 2002, SCI STKE, pPE16; Krichevsky AM, 2001, NEURON, V32, P683, DOI 10.1016/S0896-6273(01)00508-6; Levenga J, 2009, NEUROBIOL DIS, V35, P241, DOI 10.1016/j.nbd.2009.05.004; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; LO DC, 2001, CURR PROTOC NEUROSCI, V15, pCH3; MATESIC DF, 1994, J NEUROCHEM, V63, P1012; Mazroui R, 2003, HUM MOL GENET, V12, P3087, DOI 10.1093/hmg/ddg335; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; Mientjes EJ, 2004, HUM MOL GENET, V13, P1291, DOI 10.1093/hmg/ddh150; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; Ostroff LE, 2002, NEURON, V35, P535, DOI 10.1016/S0896-6273(02)00785-7; Say E, 2010, MOL CELL, V38, P236, DOI 10.1016/j.molcel.2010.04.004; SIOMI MC, 1995, EMBO J, V14, P2401, DOI 10.1002/j.1460-2075.1995.tb07237.x; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Sossin WS, 2006, TRAFFIC, V7, P1581, DOI 10.1111/j.1600-0854.2006.00500.x; Spencer CM, 2006, HUM MOL GENET, V15, P1984, DOI 10.1093/hmg/ddl121; STEWARD O, 1985, J NEUROSCI RES, V13, P75, DOI 10.1002/jnr.490130106; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; STEWARD O, 1982, J NEUROSCI, V2, P284; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Tamanini F, 1999, BIOCHEM J, V343, P517, DOI 10.1042/0264-6021:3430517; Tamanini F, 1997, HUM MOL GENET, V6, P1315, DOI 10.1093/hmg/6.8.1315; Team R. D. C, 2011, R LANG ENV STAT COMP; Tiruchinapalli DM, 2003, J NEUROSCI, V23, P3251; TORRE ER, 1992, J NEUROSCI, V12, P762; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang DO, 2010, TRENDS NEUROSCI, V33, P173, DOI 10.1016/j.tins.2010.01.005; Wells DG, 2006, J NEUROSCI, V26, P7135, DOI 10.1523/JNEUROSCI.1795-06.2006; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Zeitelhofer M, 2008, J NEUROSCI, V28, P7555, DOI 10.1523/JNEUROSCI.0104-08.2008; Zhang J, 2008, AM J HUM GENET, V83, P43, DOI 10.1016/j.ajhg.2008.06.003; Zhang J, 2009, J NEUROPHYSIOL, V101, P2572, DOI 10.1152/jn.90558.2008; ZHANG Y, 1995, EMBO J, V14, P5358, DOI 10.1002/j.1460-2075.1995.tb00220.x; ZINCHUK V, 2008, CURR PROTOC CELL BIO, V19, pCH4; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054	67	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26120	10.1371/journal.pone.0026120	http://dx.doi.org/10.1371/journal.pone.0026120			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022532	Green Published, gold, Green Submitted			2022-12-27	WOS:000295973200039
J	Ji, JP; Kinders, RJ; Zhang, YP; Rubinstein, L; Kummar, S; Parchment, RE; Tomaszewski, JE; Doroshow, JH				Ji, Jiuping; Kinders, Robert J.; Zhang, Yiping; Rubinstein, Larry; Kummar, Shivaani; Parchment, Ralph E.; Tomaszewski, Joseph E.; Doroshow, James H.			Ribose) Polymerase Inhibitor ABT-888 in Human Peripheral Blood Mononuclear Cells	PLOS ONE			English	Article							0 CLINICAL-TRIAL; POLY(ADP-RIBOSE) POLYMERASE; DRUG DEVELOPMENT; PARP INHIBITORS; BIOMARKERS; EXPRESSION; TUMORS; ASSAY	Background: Poly(ADP-ribose) polymerase (PARP) facilitates DNA repair and PARP inhibitors may potentiate the effect of DNA-damaging chemotherapeutic agents in patients with cancer. Collection of peripheral blood mononuclear cells (PBMCs) as a surrogate tissue to monitor PARP inhibitor pharmacodynamic effects has several advantages over tumor biopsy collection, including minimally invasive sample collection and the ability to collect multiple samples for longitudinal assessment of drug effect. Methodology/Principal Findings: Using our previously validated immunoassay for measuring poly(ADP-ribose) (PAR), a product of PARP, in tumor biopsies, we validated a method to quantify PAR levels in PBMCs to monitor the pharmacodynamic effects of the PARP inhibitor ABT-888 in clinical trials. The inter-individual variation in PAR levels was large. No significant difference (P = 0.67) was measured between median baseline PAR levels in 144 healthy volunteers (131.7 pg/1 x 10(7) PBMCs [interquartile range, 79.5-241.6]) and 49 patients with cancer (149.2 pg/1610 7 PBMCs [interquartile range, 83.2-249.3]). In addition, PAR levels monitored in healthy volunteers over 3 weeks had considerable intra-and inter-individual variation (range, 44-1073 pg PAR/1 x 10(7) PBMCs). As a pharmacodynamic model, we quantified changes in PAR levels in human PBMCs treated ex vivo with clinically relevant concentrations of ABT-888. Of 40 healthy volunteer PBMC samples treated with ABT-888, 47.5% had greater than 50% PAR reduction compared to vehicle-treated controls. Considerable inter-sample heterogeneity in PAR levels was measured, and several ABT-888-insensitive samples were identified. Conclusions/Significance: Our results emphasize the importance of using a validated method to measure PAR levels, and support further investigation into the role of PARP in PBMCs. To this end, the PAR immunoassay has been validated for use with PBMCs and incorporated into clinical trials to assess PBMCs as a potential pharmacodynamic surrogate for tumor biopsies in clinical trials of PARP inhibitors.	[Ji, Jiuping; Zhang, Yiping] NCI, Natl Clin Target Validat Lab, Frederick, MD 21701 USA; [Kinders, Robert J.; Parchment, Ralph E.] NCI, Lab Human Toxicol & Pharmacol, Appl Dev Res Support Directorate, SAIC Frederick Inc, Frederick, MD 21701 USA; [Rubinstein, Larry; Kummar, Shivaani; Tomaszewski, Joseph E.; Doroshow, James H.] NCI, Div Canc Treatment & Diag, Bethesda, MD 20892 USA; [Kummar, Shivaani; Doroshow, James H.] NCI, Ctr Canc Res, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ji, JP (corresponding author), NCI, Natl Clin Target Validat Lab, Frederick, MD 21701 USA.	jijiupi@mail.nih.gov		Rubinstein, Lawrence/0000-0002-9720-9737	National Cancer Institute, National Institutes of Health [HHSN261200800001E]; National Institutes of Health (NIH) National Cancer Institute, Center for Cancer Research; NATIONAL CANCER INSTITUTE [ZIABC011078] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (NIH) National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US Government. This research was supported in part by the Intramural Research Program of the National Institutes of Health (NIH) National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ame JC, 2004, BIOESSAYS, V26, P882, DOI 10.1002/bies.20085; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Curtin Nicola J., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S146239940500904X; DCTD, DCTD RES RES BIOM; Donawho CK, 2007, CLIN CANCER RES, V13, P2728, DOI 10.1158/1078-0432.CCR-06-3039; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Findlay JWA, 2000, J PHARMACEUT BIOMED, V21, P1249, DOI 10.1016/S0731-7085(99)00244-7; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Jagtap P, 2005, NAT REV DRUG DISCOV, V4, P421, DOI 10.1038/nrd1718; Kinders RJ, 2008, CLIN CANCER RES, V14, P6877, DOI 10.1158/1078-0432.CCR-08-0214; Kummar S, 2007, NAT REV CANCER, V7, P131, DOI 10.1038/nrc2066; Kummar S, 2009, J CLIN ONCOL, V27, P2705, DOI 10.1200/JCO.2008.19.7681; Kunzmann Andrea, 2006, Immun Ageing, V3, P8, DOI 10.1186/1742-4933-3-8; Liu X, 2008, ANAL BIOCHEM, V381, P240, DOI 10.1016/j.ab.2008.07.007; Ossovskaya V, 2010, GENES CANC, V1, P812, DOI 10.1177/1947601910383418; Park JW, 2004, CLIN CANCER RES, V10, P3885, DOI 10.1158/1078-0432.CCR-03-0785; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Rubinstein LV, 2010, STAT MED, V29, P1072, DOI 10.1002/sim.3840; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Zaremba T, 2009, BRIT J CANCER, V101, P256, DOI 10.1038/sj.bjc.6605166; Zaremba T, 2011, BIOCHEM J, V436, P671, DOI 10.1042/BJ20101723	21	40	40	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e26152	10.1371/journal.pone.0026152	http://dx.doi.org/10.1371/journal.pone.0026152			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028822	Green Published, gold, Green Submitted			2022-12-27	WOS:000295971700045
J	Todorova, D; Sabatier, F; Doria, E; Lyonnet, L; Coponat, HV; Robert, S; Despoix, N; Legris, T; Moal, V; Loundou, A; Morange, S; Berland, Y; George, FD; Burtey, S; Paul, P				Todorova, Dilyana; Sabatier, Florence; Doria, Evelyne; Lyonnet, Luc; Coponat, Henri Vacher; Robert, Stephane; Despoix, Nicolas; Legris, Tristan; Moal, Valerie; Loundou, Anderson; Morange, Sophie; Berland, Yvon; George, Francoise Dignat; Burtey, Stephane; Paul, Pascale			Fractalkine Expression Induces Endothelial Progenitor Cell Lysis by Natural Killer Cells	PLOS ONE			English	Article							RENAL-ALLOGRAFT REJECTION; INTERSTITIAL FIBROSIS; RECEPTOR CX(3)CR1; VASCULAR REPAIR; CD34(+) CELLS; IFN-GAMMA; NK CELLS; KIDNEY; INJURY; CHEMOKINE	Background: Circulating CD34(+) cells, a population that includes endothelial progenitors, participate in the maintenance of endothelial integrity. Better understanding of the mechanisms that regulate their survival is crucial to improve their regenerative activity in cardiovascular and renal diseases. Chemokine-receptor cross talk is critical in regulating cell homeostasis. We hypothesized that cell surface expression of the chemokine fractalkine (FKN) could target progenitor cell injury by Natural Killer (NK) cells, thereby limiting their availability for vascular repair. Methodology/Principal Findings: We show that CD34(+)-derived Endothelial Colony Forming Cells (ECFC) can express FKN in response to TNF-alpha and IFN-gamma inflammatory cytokines and that FKN expression by ECFC stimulates NK cell adhesion, NK cell-mediated ECFC lysis and microparticles release in vitro. The specific involvement of membrane FKN in these processes was demonstrated using FKN-transfected ECFC and anti-FKN blocking antibody. FKN expression was also evidenced on circulating CD34(+) progenitor cells and was detected at higher frequency in kidney transplant recipients, when compared to healthy controls. The proportion of CD34(+) cells expressing FKN was identified as an independent variable inversely correlated to CD34(+) progenitor cell count. We further showed that treatment of CD34(+) circulating cells isolated from adult blood donors with transplant serum or TNF-alpha/IFN-gamma can induce FKN expression. Conclusions: Our data highlights a novel mechanism by which FKN expression on CD34(+) progenitor cells may target their NK cell mediated killing and participate to their immune depletion in transplant recipients. Considering the numerous diseased contexts shown to promote FKN expression, our data identify FKN as a hallmark of altered progenitor cell homeostasis with potential implications in better evaluation of vascular repair in patients.	[Todorova, Dilyana; Sabatier, Florence; Robert, Stephane; Despoix, Nicolas; George, Francoise Dignat; Burtey, Stephane; Paul, Pascale] Aix Marseille Univ, INSERM, UMR S 608, Lab Physiopathol Endothelium, F-13005 Marseille, France; [Doria, Evelyne; Lyonnet, Luc; George, Francoise Dignat; Paul, Pascale] CHU Concept, Assistance Publ Hop Marseille, Hematol Lab, Marseille, France; [Coponat, Henri Vacher; Legris, Tristan; Moal, Valerie; Berland, Yvon; Burtey, Stephane] Hop Conception, Assistance Publ Hop Marseille, Ctr Nephrol & Transplantat Renale, Marseille, France; [Loundou, Anderson] Assistance Publ Hop Marseille, DRRC, Unite Aide Methodol Rech Clin & Epidemiol, Marseille, France; [Morange, Sophie; Berland, Yvon] Hop Conception, Ctr Invest Clin, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Todorova, D (corresponding author), Aix Marseille Univ, INSERM, UMR S 608, Lab Physiopathol Endothelium, F-13005 Marseille, France.	pascale.paul@univmed.fr	DIGNAT-GEORGE, Françoise/R-1129-2016; PAUL, Pascale/AAI-1772-2020; PAUL, Pascale/R-1484-2016; Burtey, Stéphane/S-2433-2019	DIGNAT-GEORGE, Françoise/0000-0001-7006-4462; PAUL, Pascale/0000-0002-6734-4479; PAUL, Pascale/0000-0002-6734-4479; Burtey, Stéphane/0000-0003-1813-7884	Institut National de la Sante et de la Recherche Medicale (INSERM); Aix-Marseille University; L'institut National Du Cancer (INCa); la Direction de l'Hospitalisation et de l'Organisation des Soins (DHOS) [FEG CO8-17, ID 2008-A00604-51]	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Aix-Marseille University; L'institut National Du Cancer (INCa)(Institut National du Cancer (INCA) France); la Direction de l'Hospitalisation et de l'Organisation des Soins (DHOS)	This work was supported by Institut National de la Sante et de la Recherche Medicale (INSERM) and Aix-Marseille University. Evaluation of blood samples was supported on the basis of a translational research grant funded by Institut National de la Sante et de la Recherche Medicale (INSERM), L'institut National Du Cancer (INCa) and la Direction de l'Hospitalisation et de l'Organisation des Soins (DHOS) (Appel a Projet 2008, Acronym FEG CO8-17, ID 2008-A00604-51). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Bobryshev YV, 2005, ATHEROSCLEROSIS, V180, P423, DOI 10.1016/j.atherosclerosis.2005.01.046; Bompais H, 2004, BLOOD, V103, P2577, DOI 10.1182/blood-2003-08-2770; D'Haese JG, 2010, EXPERT OPIN THER TAR, V14, P207, DOI 10.1517/14728220903540265; de Groot K, 2005, TRANSPLANTATION, V79, P941, DOI 10.1097/00007890-200504270-00012; Delorme B, 2005, THROMB HAEMOSTASIS, V94, P1270, DOI 10.1160/TH05-07-0499; Dignat-George F, 2011, ARTERIOSCL THROM VAS, V31, P27, DOI 10.1161/ATVBAHA.110.218123; Fadini GP, 2006, EUR HEART J, V27, P2247, DOI 10.1093/eurheartj/ehl198; Fadini GP, 2009, ATHEROSCLEROSIS, V207, P213, DOI 10.1016/j.atherosclerosis.2009.03.040; Farris AB, 2011, AM J TRANSPLANT, V11, P1464, DOI 10.1111/j.1600-6143.2011.03572.x; Furuichi K, 2006, AM J PATHOL, V169, P372, DOI 10.2353/ajpath.2006.060043; Grimm PC, 2001, NEW ENGL J MED, V345, P93, DOI 10.1056/NEJM200107123450203; Haskell CA, 2001, J CLIN INVEST, V108, P679, DOI 10.1172/JCI12976; Hidalgo LG, 2010, AM J TRANSPLANT, V10, P1812, DOI 10.1111/j.1600-6143.2010.03201.x; Hoffmann U, 2010, TRANSPL IMMUNOL, V23, P204, DOI 10.1016/j.trim.2010.06.006; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Jie KE, 2010, NEPHROL DIAL TRANSPL, V25, P1875, DOI 10.1093/ndt/gfp749; Jourde-Chiche N, 2009, J THROMB HAEMOST, V7, P1576, DOI 10.1111/j.1538-7836.2009.03540.x; Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009; Kitchens WH, 2006, TRANSPLANTATION, V81, P811, DOI 10.1097/01.tp.0000202844.33794.0e; KUTUKCULER N, 1995, TRANSPLANT INT, V8, P45, DOI 10.1007/BF00366710; Lacroix R, 2007, BLOOD, V110, P2432, DOI 10.1182/blood-2007-02-069997; Lagaaij EL, 2001, LANCET, V357, P33, DOI 10.1016/S0140-6736(00)03569-8; Lau TT, 2011, EXPERT OPIN BIOL TH, V11, P189, DOI 10.1517/14712598.2011.546338; Lavergne M, 2011, CELL PROLIFERAT, V44, P44, DOI 10.1111/j.1365-2184.2010.00722.x; Osto E, 2011, J HEART LUNG TRANSPL, V30, P70, DOI 10.1016/j.healun.2010.07.004; Quyyumi AA, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.025; Ravet S, 2007, BLOOD, V109, P4296, DOI 10.1182/blood-2006-08-040238; Robinson LA, 2000, J IMMUNOL, V165, P6067, DOI 10.4049/jimmunol.165.11.6067; Romo N, 2011, ARTERIOSCL THROM VAS, V31, P2314, DOI 10.1161/ATVBAHA.111.233288; Scandling JD, 2008, NEW ENGL J MED, V358, P362, DOI 10.1056/NEJMoa074191; Schmidt-Lucke C, 2005, CIRCULATION, V111, P2981, DOI 10.1161/CIRCULATIONAHA.104.504340; Shimizu A, 2000, CLIN TRANSPLANT, V14, P6, DOI 10.1034/j.1399-0012.2000.0140s3006.x; Shimizu K, 2011, HYPERTENS RES, V34, P747, DOI 10.1038/hr.2011.23; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Tongers J, 2007, J AM SOC NEPHROL, V18, P2843, DOI 10.1681/ASN.2007050597; Umehara H, 2004, ARTERIOSCL THROM VAS, V24, P34, DOI 10.1161/01.ATV.0000095360.62479.1F; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Werner N, 2005, NEW ENGL J MED, V353, P999, DOI 10.1056/NEJMoa043814; Whitman SC, 2004, ARTERIOSCL THROM VAS, V24, P1049, DOI 10.1161/01.ATV.0000124923.95545.2c; Yoneda O, 2000, J IMMUNOL, V164, P4055, DOI 10.4049/jimmunol.164.8.4055; Yoneda O, 2003, EUR J IMMUNOL, V33, P53, DOI 10.1002/immu.200390007; Zampetaki A, 2008, CARDIOVASC RES, V78, P413, DOI 10.1093/cvr/cvn081	43	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26663	10.1371/journal.pone.0026663	http://dx.doi.org/10.1371/journal.pone.0026663			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039526	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200038
J	Diaz-Sylvester, PL; Porta, M; Copello, JA				Diaz-Sylvester, Paula L.; Porta, Maura; Copello, Julio A.			Modulation of Cardiac Ryanodine Receptor Channels by Alkaline Earth Cations	PLOS ONE			English	Article							CALCIUM-RELEASE CHANNELS; RETICULUM LUMENAL CA2+; SARCOPLASMIC-RETICULUM; SKELETAL-MUSCLE; LUMINAL CA2+; DIVALENT-CATIONS; VENTRICULAR MYOCYTES; INACTIVATION SITES; CYTOSOLIC CA2+; SINGLE-CHANNEL	Cardiac ryanodine receptor (RyR2) function is modulated by Ca2+ and Mg2+. To better characterize Ca2+ and Mg2+ binding sites involved in RyR2 regulation, the effects of cytosolic and luminal earth alkaline divalent cations (M2+: Mg2+, Ca2+, Sr2+, Ba2+) were studied on RyR2 from pig ventricle reconstituted in bilayers. RyR2 were activated by M2+ binding to high affinity activating sites at the cytosolic channel surface, specific for Ca2+ or Sr2+. This activation was interfered by Mg2+ and Ba2+ acting at low affinity M2+-unspecific binding sites. When testing the effects of luminal M2+ as current carriers, all M2+ increased maximal RyR2 open probability (compared to Cs+), suggesting the existence of low affinity activating M2+-unspecific sites at the luminal surface. Responses to M2+ vary from channel to channel (heterogeneity). However, with luminal Ba2+ or Mg2+, RyR2 were less sensitive to cytosolic Ca2+ and caffeine-mediated activation, openings were shorter and voltage-dependence was more marked (compared to RyR2 with luminal Ca2+ or Sr2+). Kinetics of RyR2 with mixtures of luminal Ba2+/Ca2+ and additive action of luminal plus cytosolic Ba2+ or Mg2+ suggest luminal M2+ differentially act on luminal sites rather than accessing cytosolic sites through the pore. This suggests the presence of additional luminal activating Ca2+/Sr2+-specific sites, which stabilize high Po mode (less voltage-dependent) and increase RyR2 sensitivity to cytosolic Ca2+ activation. In summary, RyR2 luminal and cytosolic surfaces have at least two sets of M2+ binding sites (specific for Ca2+ and unspecific for Ca2+/Mg2+) that dynamically modulate channel activity and gating status, depending on SR voltage.	[Diaz-Sylvester, Paula L.; Copello, Julio A.] So Illinois Sch Med, Dept Pharmacol, Springfield, IL USA; [Porta, Maura] Midwestern Univ, Dept Physiol, Downers Grove, IL 60515 USA	Southern Illinois University System; Southern Illinois University; Midwestern University	Diaz-Sylvester, PL (corresponding author), So Illinois Sch Med, Dept Pharmacol, Springfield, IL USA.	jcopello@siumed.edu		Diaz-Sylvester, Paula/0000-0002-1531-1958	National Institutes of Health [R01 GM078665]; Bernie L. Eskridge Heart Disease Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078665] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bernie L. Eskridge Heart Disease Research Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (R01 GM078665 to JAC) and by the Bernie L. Eskridge Heart Disease Research Fund (to JAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON K, 1989, J BIOL CHEM, V264, P1329; Armisen R, 1996, AM J PHYSIOL-CELL PH, V271, pC144, DOI 10.1152/ajpcell.1996.271.1.C144; Beard NA, 2005, BIOPHYS J, V88, P3444, DOI 10.1529/biophysj.104.051441; Bers DM, 2001, EXCITATION CONTRACTI; Carafoli E, 1999, CALCIUM CELLULAR REG, Vxiii; Chakrapani S, 2011, NAT STRUCT MOL BIOL, V18, P67, DOI 10.1038/nsmb.1968; CHAMBERLAIN BK, 1983, J BIOL CHEM, V258, P6602; Ching LL, 2000, CIRC RES, V87, P201, DOI 10.1161/01.RES.87.3.201; CHU A, 1993, J MEMBRANE BIOL, V135, P49; Copello JA, 2002, J MEMBRANE BIOL, V187, P51, DOI 10.1007/s00232-001-0150-x; Copello JA, 1997, BIOPHYS J, V73, P141, DOI 10.1016/S0006-3495(97)78055-X; CORONADO R, 1994, AM J PHYSIOL, V266, pC1485, DOI 10.1152/ajpcell.1994.266.6.C1485; Diaz-Sylvester P, 2010, BIOPHYSICAL J, V98; Diaz-Sylvester PL, 2002, BIOPHYS J, V82, p74A; FABIATO A, 1985, J GEN PHYSIOL, V85, P247, DOI 10.1085/jgp.85.2.247; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Gaburjakova J, 2006, J MEMBRANE BIOL, V212, P17, DOI 10.1007/s00232-006-7018-z; HOLMBERG SRM, 1990, BIOCHIM BIOPHYS ACTA, V1022, P187, DOI 10.1016/0005-2736(90)90113-3; Hu XF, 2003, BIOCHEMISTRY-US, V42, P5515, DOI 10.1021/bi034016o; Jiang D, 2007, P NATL ACAD SCI USA, V104, P18309, DOI 10.1073/pnas.0706573104; Lancaster B, 2000, J PHYSIOL-LONDON, V522, P231, DOI 10.1111/j.1469-7793.2000.t01-1-00231.x; Laver DR, 2008, J GEN PHYSIOL, V132, P429, DOI 10.1085/jgp.200810001; Laver DR, 2007, CLIN EXP PHARMACOL P, V34, P889, DOI 10.1111/j.1440-1681.2007.04708.x; Laver DR, 1997, J MEMBRANE BIOL, V156, P213, DOI 10.1007/s002329900202; LAVER DR, 1995, J MEMBRANE BIOL, V147, P7; Liu W, 1998, AM J PHYSIOL-CELL PH, V274, pC120, DOI 10.1152/ajpcell.1998.274.1.C120; Liu YW, 2010, J GEN PHYSIOL, V135, P15, DOI 10.1085/jgp.200910273; Lukyanenko V, 1996, PFLUG ARCH EUR J PHY, V432, P1047, DOI 10.1007/s004240050233; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; McHugh JM, 2004, AM J PHYSIOL-CELL PH, V286, pC342, DOI 10.1152/ajpcell.00270.2003; Mead-Savery FC, 2009, BIOPHYS J, V96, P1374, DOI 10.1016/j.bpj.2008.10.054; Meissner G, 2004, CELL CALCIUM, V35, P621, DOI 10.1016/j.ceca.2004.01.015; Porta M, 2004, BIOPHYS J, V86, p241A; Porta M, 2011, BIOPHYS J, V100, P931, DOI 10.1016/j.bpj.2011.01.017; Ramachandran S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000367; Rosales RA, 2004, J GEN PHYSIOL, V123, P533, DOI 10.1085/jgp.200308868; ROUSSEAU E, 1986, BIOPHYS J, V50, P1009, DOI 10.1016/S0006-3495(86)83543-3; ROUSSEAU E, 1992, CAN J PHYSIOL PHARM, V70, P394, DOI 10.1139/y92-049; Shelley C, 2010, J GEN PHYSIOL, V135, P461, DOI 10.1085/jgp.200910331; Sitsapesan R, 1997, J MEMBRANE BIOL, V159, P179, DOI 10.1007/s002329900281; Sitsapesan R, 1999, STRUCTURE FUNCTION R; Sitsapesan R, 1998, STRUCTURE FUNCTION R, Vxvii; STERN MD, 1992, CELL CALCIUM, V13, P183, DOI 10.1016/0143-4160(92)90046-U; Tripathy A, 1996, BIOPHYS J, V70, P2600, DOI 10.1016/S0006-3495(96)79831-4; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Xu L, 1998, BIOPHYS J, V75, P2302, DOI 10.1016/S0006-3495(98)77674-X; Zahradnikova A, 1995, BIOPHYS J, V69, P1780, DOI 10.1016/S0006-3495(95)80048-2; Zoghbi ME, 2004, CELL CALCIUM, V36, P119, DOI 10.1016/j.ceca.2004.01.023	48	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26693	10.1371/journal.pone.0026693	http://dx.doi.org/10.1371/journal.pone.0026693			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039534	Green Submitted, gold, Green Published			2022-12-27	WOS:000296513200043
J	Hock, K; Fefferman, NH				Hock, Karlo; Fefferman, Nina H.			Violating Social Norms when Choosing Friends: How Rule-Breakers Affect Social Networks	PLOS ONE			English	Article							PUNISHMENT; EVOLUTION; COOPERATION; CENTRALITY; CONVENTIONS; EMERGENCE; DYNAMICS	Social networks rely on basic rules of conduct to yield functioning societies in both human and animal populations. As individuals follow established rules, their behavioral decisions shape the social network and give it structure. Using dynamic, self-organizing social network models we demonstrate that defying conventions in a social system can affect multiple levels of social and organizational success independently. Such actions primarily affect actors' own positions within the network, but individuals can also affect the overall structure of a network even without immediately affecting themselves or others. These results indicate that defying the established social norms can help individuals to change the properties of a social system via seemingly neutral behaviors, highlighting the power of rule-breaking behavior to transform convention-based societies, even before direct impacts on individuals can be measured.	[Hock, Karlo; Fefferman, Nina H.] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA; [Fefferman, Nina H.] Rutgers State Univ, DIMACS, Piscataway, NJ 08903 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Hock, K (corresponding author), Rutgers State Univ, Dept Ecol Evolut & Nat Resources, New Brunswick, NJ 08903 USA.	hock@aesop.rutgers.edu	Fefferman, Nina/AAQ-7378-2021	Fefferman, Nina/0000-0003-0233-1404; Hock, Karlo/0000-0001-7858-1130				Borgatti SP, 2005, SOC NETWORKS, V27, P55, DOI 10.1016/j.socnet.2004.11.008; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Brandt H, 2006, P NATL ACAD SCI USA, V103, P495, DOI 10.1073/pnas.0507229103; Brass DJ, 2004, ACAD MANAGE J, V47, P795, DOI 10.2307/20159624; Camazine S., 2001, SELF ORG BIOL SYSTEM, DOI DOI 10.1515/9780691212920; Carrington P. J., 2005, MODELS METHODS SOCIA; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Delgado J, 2002, ARTIF INTELL, V141, P171, DOI 10.1016/S0004-3702(02)00262-X; DREWS C, 1993, BEHAVIOUR, V125, P283, DOI 10.1163/156853993X00290; Everett MG, 1999, J MATH SOCIOL, V23, P181, DOI 10.1080/0022250X.1999.9990219; Fefferman NH, 2007, ANN ZOOL FENN, V44, P58; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fewell JH, 2003, SCIENCE, V301, P1867, DOI 10.1126/science.1088945; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Flack JC, 2005, P ROY SOC B-BIOL SCI, V272, P1091, DOI 10.1098/rspb.2004.3019; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Godfrey SS, 2009, BEHAV ECOL SOCIOBIOL, V63, P1045, DOI 10.1007/s00265-009-0730-9; GRAFEN A, 1987, ANIM BEHAV, V35, P462, DOI 10.1016/S0003-3472(87)80271-3; Helbing D, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000758; Hilbe C, 2010, P ROY SOC B-BIOL SCI, V277, P2427, DOI 10.1098/rspb.2010.0065; Hock K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015789; Hock K, 2007, MAR FRESHW BEHAV PHY, V40, P151, DOI 10.1080/10236240701505056; Hock K, 2009, BEHAVIOUR, V146, P69, DOI 10.1163/156853908X390931; Kelling G.L., 1982, ATLANTIC, V249, P29, DOI DOI 10.4135/9781412959193.n281; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; Lusseau D, 2007, EVOL ECOL, V21, P357, DOI 10.1007/s10682-006-9105-0; Madden JR, 2009, BEHAV ECOL SOCIOBIOL, V64, P81, DOI 10.1007/s00265-009-0820-8; Maynard Smith J., 1982, pi; McDonald DB, 2007, P NATL ACAD SCI USA, V104, P10910, DOI 10.1073/pnas.0701159104; Naug D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1719, DOI 10.1007/s00265-008-0600-x; Pacheco JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.258103; Parrish JK, 2002, BIOL BULL-US, V202, P296, DOI 10.2307/1543482; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Poncela J, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/8/083031; Proulx SR, 2005, TRENDS ECOL EVOL, V20, P345, DOI 10.1016/j.tree.2005.04.004; Rand DG, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1442; Rand DG, 2009, SCIENCE, V325, P1272, DOI 10.1126/science.1177418; Shoham Y, 1997, ARTIF INTELL, V94, P139, DOI 10.1016/S0004-3702(97)00028-3; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Sih A, 2005, BEHAVIOUR, V142, P1417, DOI 10.1163/156853905774539454; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; Sparrowe RT, 2001, ACAD MANAGE J, V44, P316, DOI 10.2307/3069458; Szolnoki A, 2010, EPL-EUROPHYS LETT, V92, DOI 10.1209/0295-5075/92/38003; Szolnoki A, 2008, EPL-EUROPHYS LETT, V84, DOI 10.1209/0295-5075/84/50007; Szolnoki A, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036101; Szolnoki A, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/30007; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Whiten A, 2005, NATURE, V437, P52, DOI 10.1038/nature04023; Williams R, 2006, BIOL LETTERS, V2, P497, DOI 10.1098/rsbl.2006.0510; Wilson D. S, 1998, GAME THEORY ANIMAL B, P261; Wittemyer G, 2005, ANIM BEHAV, V69, P1357, DOI 10.1016/j.anbehav.2004.08.018	54	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26652	10.1371/journal.pone.0026652	http://dx.doi.org/10.1371/journal.pone.0026652			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841LG	22039524	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200037
J	Lebarbenchon, C; Yang, M; Keeler, SP; Ramakrishnan, MA; Brown, JD; Stallknecht, DE; Sreevatsan, S				Lebarbenchon, Camille; Yang, My; Keeler, Shamus P.; Ramakrishnan, Muthannan A.; Brown, Justin D.; Stallknecht, David E.; Sreevatsan, Srinand			Viral Replication, Persistence in Water and Genetic Characterization of Two Influenza A Viruses Isolated from Surface Lake Water	PLOS ONE			English	Article							AVIAN INFLUENZA; BORNE TRANSMISSION; SEQUENCES; DYNAMICS; DUCKS; PCR; AMPLIFICATION; INFECTIVITY; TEMPERATURE; RESERVOIRS	Water-borne transmission has been suggested as an important transmission mechanism for Influenza A (IA) viruses in wild duck populations; however, relatively few studies have attempted to detect IA viruses from aquatic habitats. Water-isolated viruses have rarely been genetically characterized and evaluation for persistence in water and infectivity in natural hosts has never been documented. In this study, we focused on two IA viruses (H3N8 and H4N6 subtypes) isolated from surface lake water in Minnesota, USA. We investigated the relative prevalence of the two virus subtypes in wild duck populations at the sampling site and their genetic relatedness to IA viruses isolated in wild waterbirds in North America. Viral persistence under different laboratory conditions (temperature and pH) and replication in experimentally infected Mallards (Anas platyrhynchos) were also characterized. Both viruses were the most prevalent subtype one year following their isolation in lake water. The viruses persisted in water for an extended time period at constant temperature (several weeks) but infectivity rapidly reduced under multiple freeze-thaw cycles. Furthermore, the two isolates efficiently replicated in Mallards. The complete genome characterization supported that these isolates originated from genetic reassortments with other IA viruses circulating in wild duck populations during the year of sampling. Based on phylogenetic analyses, we couldn't identify genetically similar viruses in duck populations in the years following their isolation from lake water. Our study supports the role for water-borne transmission for IA viruses but also highlights that additional field and experimental studies are required to support inter-annual persistence in aquatic habitats.	[Lebarbenchon, Camille; Keeler, Shamus P.; Brown, Justin D.; Stallknecht, David E.] Univ Georgia, Coll Vet Med, SE Cooperat Wildlife Dis Study, Dept Populat Hlth, Athens, GA 30602 USA; [Yang, My; Ramakrishnan, Muthannan A.; Sreevatsan, Srinand] Univ Minnesota, Coll Vet Med, St Paul, MN 55108 USA	University System of Georgia; University of Georgia; University of Minnesota System; University of Minnesota Twin Cities	Lebarbenchon, C (corresponding author), Univ Georgia, Coll Vet Med, SE Cooperat Wildlife Dis Study, Dept Populat Hlth, Athens, GA 30602 USA.	cleb@uga.edu	Keeler, Shamus/A-3237-2013; Lebarbenchon, Camille/H-7245-2013; Sreevatsan, Srinand/V-6808-2019; Keeler, Shamus/ABC-1774-2020; Ramakrishnan, Muthannan Andavar/Y-3338-2019; Lebarbenchon, Camille/GLQ-7287-2022	Lebarbenchon, Camille/0000-0002-0922-7573; Sreevatsan, Srinand/0000-0002-5162-2403; Keeler, Shamus/0000-0002-1301-0852; Lebarbenchon, Camille/0000-0002-0922-7573; Ramakrishnan, Muthannan Andavar/0000-0001-7789-328X	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services [HHSN266200700007C]; Center of Disease Control [1U19CI0004501]; Fondation pour la Recherche Medicale; CLINICAL CENTER [Z01CL000045] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center of Disease Control; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); CLINICAL CENTER	This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health (NIH), Department of Health and Human Services, under Contract No. HHSN266200700007C. The 2006 data were collected under Cooperative Agreement 1U19CI0004501 with the Center of Disease Control. CL was supported by a 'Fondation pour la Recherche Medicale' post-doctoral fellowship during this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Brandley MC, 2005, SYST BIOL, V54, P373, DOI 10.1080/10635150590946808; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Costa TP, 2010, AVIAN DIS, V54, P581, DOI 10.1637/8692-031309-ResNote.1; Das A, 2009, J VET DIAGN INVEST, V21, P771, DOI 10.1177/104063870902100603; Domanska-Blicharz K, 2010, AVIAN DIS, V54, P734, DOI 10.1637/8786-040109-ResNote.1; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Faust C, 2009, P ROY SOC B-BIOL SCI, V276, P3727, DOI 10.1098/rspb.2009.0572; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; HALVORSON D, 1983, AVIAN DIS, V27, P77, DOI 10.2307/1590374; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Krasnitz M, 2008, J VIROL, V82, P8947, DOI 10.1128/JVI.00101-08; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; MARKWELL DD, 1982, APPL ENVIRON MICROB, V43, P110, DOI 10.1128/AEM.43.1.110-115.1982; Nazir J, 2010, AVIAN DIS, V54, P720, DOI 10.1637/8754-033109-ResNote.1; R Core Team, 2020, R LANG ENV STAT COMP; Ramakrishnan MA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007105; Rambaut A., 2007, TRACER V1 5; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; REED L. J., 1938, AMER JOUR HYG, V27, P493; Roche B, 2009, INFECT GENET EVOL, V9, P800, DOI 10.1016/j.meegid.2009.04.009; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; SIVANANDAN V, 1991, AVIAN DIS, V35, P974, DOI 10.2307/1591638; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stallknecht DE, 2010, AVIAN DIS, V54, P461, DOI 10.1637/8760-033109-Reg.1; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Stumpf P, 2010, AVIAN DIS, V54, P1183, DOI 10.1637/9162-111709-Reg.1; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; Swayne D. E., 2008, LAB MANUAL ISOLATION, P128; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; Wilcox BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024010; Zarkov IS, 2006, REV MED VET-TOULOUSE, V157, P471; Zhang HB, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-42; Zhang HB, 2011, ARCH VIROL, V156, P95, DOI 10.1007/s00705-010-0836-4; Zhou B, 2009, J VIROL, V83, P10309, DOI 10.1128/JVI.01109-09	44	49	50	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26566	10.1371/journal.pone.0026566	http://dx.doi.org/10.1371/journal.pone.0026566			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028909	gold, Green Submitted, Green Published			2022-12-27	WOS:000296510800054
J	Angiuoli, SV; White, JR; Matalka, M; White, O; Fricke, WF				Angiuoli, Samuel V.; White, James R.; Matalka, Malcolm; White, Owen; Fricke, W. Florian			Resources and Costs for Microbial Sequence Analysis Evaluated Using Virtual Machines and Cloud Computing	PLOS ONE			English	Article							PROTEIN FAMILIES; RNA GENES; ANNOTATION; MEDICINE; DATABASE; SOFTWARE; DNA	Background: The widespread popularity of genomic applications is threatened by the "bioinformatics bottleneck'' resulting from uncertainty about the cost and infrastructure needed to meet increasing demands for next-generation sequence analysis. Cloud computing services have been discussed as potential new bioinformatics support systems but have not been evaluated thoroughly. Results: We present benchmark costs and runtimes for common microbial genomics applications, including 16S rRNA analysis, microbial whole-genome shotgun (WGS) sequence assembly and annotation, WGS metagenomics and large-scale BLAST. Sequence dataset types and sizes were selected to correspond to outputs typically generated by small-to midsize facilities equipped with 454 and Illumina platforms, except for WGS metagenomics where sampling of Illumina data was used. Automated analysis pipelines, as implemented in the CloVR virtual machine, were used in order to guarantee transparency, reproducibility and portability across different operating systems, including the commercial Amazon Elastic Compute Cloud (EC2), which was used to attach real dollar costs to each analysis type. We found considerable differences in computational requirements, runtimes and costs associated with different microbial genomics applications. While all 16S analyses completed on a single-CPU desktop in under three hours, microbial genome and metagenome analyses utilized multi-CPU support of up to 120 CPUs on Amazon EC2, where each analysis completed in under 24 hours for less than $60. Representative datasets were used to estimate maximum data throughput on different cluster sizes and to compare costs between EC2 and comparable local grid servers. Conclusions: Although bioinformatics requirements for microbial genomics depend on dataset characteristics and the analysis protocols applied, our results suggests that smaller sequencing facilities (up to three Roche/454 or one Illumina GAIIx sequencer) invested in 16S rRNA amplicon sequencing, microbial single-genome and metagenomics WGS projects can achieve cost-efficient bioinformatics support using CloVR in combination with Amazon EC2 as an alternative to local computing centers.	[Angiuoli, Samuel V.; White, James R.; Matalka, Malcolm; White, Owen; Fricke, W. Florian] Univ Maryland, IGS, Baltimore, MD 21201 USA; [Angiuoli, Samuel V.] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland College Park	Angiuoli, SV (corresponding author), Univ Maryland, IGS, Baltimore, MD 21201 USA.	angiuoli@umiacs.umd.edu; wffricke@som.umaryland.edu	Angiuoli, Samuel V/H-7340-2014	Fricke, W. Florian/0000-0003-1586-0962; Angiuoli, Samuel/0000-0001-9525-4350	National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH), ARRA [RC2 HG005597-01]; National Science Foundation (NSF) [0949201]; Amazon Web Services in Education Research Grants program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005597] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH), ARRA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Human Genome Research Institute (NHGRI)); National Science Foundation (NSF)(National Science Foundation (NSF)); Amazon Web Services in Education Research Grants program; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research was supported by funds from the National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH), ARRA under Grant No. RC2 HG005597-01, the National Science Foundation (NSF), under Grant No. 0949201 and the Amazon Web Services in Education Research Grants program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bailey RC, 2010, NAT CHEM BIOL, V6, P857, DOI 10.1038/nchembio.488; Bateman A, 2009, BIOINFORMATICS, V25, P1475, DOI 10.1093/bioinformatics/btp274; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Dudley JT, 2010, NAT BIOTECHNOL, V28, P1181, DOI 10.1038/nbt1110-1181; Dudley JT, 2010, GENOME MED, V2, DOI 10.1186/gm172; Eddy Sean R, 2009, Genome Inform, V23, P205; Field D, 2006, NAT BIOTECHNOL, V24, P801, DOI 10.1038/nbt0706-801; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; GALENS K, 2011, NATURE PRECEDING; Galens K, 2011, STAND GENOMIC SCI, V4, P244, DOI 10.4056/sigs.1223234; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Guttmacher AE, 2010, NAT REV GENET, V11, P161, DOI 10.1038/nrg2735; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; KOENIG JE, 2010, P NATL ACAD SCI US; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Langmead B, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r83; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r134; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Noguchi H, 2006, NUCLEIC ACIDS RES, V34, P5623, DOI 10.1093/nar/gkl723; Orvis J, 2010, BIOINFORMATICS, V26, P1488, DOI 10.1093/bioinformatics/btq167; Pruitt KD, 2009, NUCLEIC ACIDS RES, V37, pD32, DOI 10.1093/nar/gkn721; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; RAVEL J, 2010, P NATL ACAD SCI US; Rusk N, 2011, NAT METHODS, V8, P44, DOI 10.1038/NMETH.F.330; Schatz MC, 2010, NAT BIOTECHNOL, V28, P691, DOI 10.1038/nbt0710-691; Schatz MC, 2009, BIOINFORMATICS, V25, P1363, DOI 10.1093/bioinformatics/btp236; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Stewart AC, 2009, BIOINFORMATICS, V25, P962, DOI 10.1093/bioinformatics/btp097; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; WHITE JR, 2011, NATURE PRECEDING; White JR, 2011, NATURE PRECEDINGS; Wilkening J, 2009, USING CLOUDS METAGEN; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	48	50	52	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26624	10.1371/journal.pone.0026624	http://dx.doi.org/10.1371/journal.pone.0026624			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028928	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500100
J	Ji, HK; Wu, G; Zhan, XC; Nolan, A; Koh, C; De Marzo, A; Doan, HM; Fan, JS; Cheadle, C; Fallahi, M; Cleveland, JL; Dang, CV; Zeller, KI				Ji, Hongkai; Wu, George; Zhan, Xiangcan; Nolan, Alexandra; Koh, Cheryl; De Marzo, Angelo; Hoang Mai Doan; Fan, Jinshui; Cheadle, Christopher; Fallahi, Mohammad; Cleveland, John L.; Dang, Chi V.; Zeller, Karen I.			Cell-Type Independent MYC Target Genes Reveal a Primordial Signature Involved in Biomass Accumulation	PLOS ONE			English	Article							PROTEIN-KINASE-A; C-MYC; TRANSCRIPTIONAL NETWORK; RIBOSOME BIOGENESIS; GENOMIC TARGETS; STEM-CELLS; RNA; DIFFERENTIATION; EXPRESSION; CYCLE	The functions of key oncogenic transcription factors independent of context have not been fully delineated despite our richer understanding of the genetic alterations in human cancers. The MYC oncogene, which produces the Myc transcription factor, is frequently altered in human cancer and is a major regulatory hub for many cancers. In this regard, we sought to unravel the primordial signature of Myc function by using high-throughput genomic approaches to identify the cell-type independent core Myc target gene signature. Using a model of human B lymphoma cells bearing inducible MYC, we identified a stringent set of direct Myc target genes via chromatin immunoprecipitation (ChIP), global nuclear run-on assay, and changes in mRNA levels. We also identified direct Myc targets in human embryonic stem cells (ESCs). We further document that a Myc core signature (MCS) set of target genes is shared in mouse and human ESCs as well as in four other human cancer cell types. Remarkably, the expression of the MCS correlates with MYC expression in a cell-type independent manner across 8,129 microarray samples, which include 312 cell and tissue types. Furthermore, the expression of the MCS is elevated in vivo in Em-Myc transgenic murine lymphoma cells as compared with premalignant or normal B lymphocytes. Expression of the MCS in human B cell lymphomas, acute leukemia, lung cancers or Ewing sarcomas has the highest correlation with MYC expression. Annotation of this gene signature reveals Myc's primordial function in RNA processing, ribosome biogenesis and biomass accumulation as its key roles in cancer and stem cells.	[Ji, Hongkai; Wu, George] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Zhan, Xiangcan] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Zhan, Xiangcan] Kennedy Krieger Inst, Hugo W Moser Res Inst, Baltimore, MD USA; [Nolan, Alexandra; Hoang Mai Doan; Fan, Jinshui; Cheadle, Christopher; Zeller, Karen I.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Koh, Cheryl; De Marzo, Angelo] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Fallahi, Mohammad; Cleveland, John L.] Scripps Res Inst, Dept Canc Biol, Jupiter, FL USA; [Dang, Chi V.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Kennedy Krieger Institute; Johns Hopkins University; Johns Hopkins University; Scripps Research Institute; University of Pennsylvania; Pennsylvania Medicine	Ji, HK (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA.	hji@jhsph.edu; dangvchi@exchange.upenn.edu; kzeller@jhmi.edu	Dang, Chi/Y-3375-2019	Dang, Chi/0000-0002-4031-2522	NIH [R01CA57341, CA076379, DK44158, R01HG005220]; Maryland Stem Cell Research Fund [007-MSCRFE-0167-00, 2008-MSCRFE-0156-00]; State of Florida; NATIONAL CANCER INSTITUTE [R01CA057341, R01CA076379] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG005220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044158] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Fund; State of Florida; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants R01CA57341 to CVD, Maryland Stem Cell Research Fund grants 2007-MSCRFE-0167-00 (KIZ) and 2008-MSCRFE-0156-00 (CVD) and NIH grants CA076379 and DK44158 to JLC, and by monies from the State of Florida to Scripps Florida to JLC. HJ is partially supported by NIH grant R01HG005220. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altucci L, 2005, CANCER RES, V65, P8754, DOI 10.1158/0008-5472.CAN-04-3569; Arabi A, 2005, NAT CELL BIOL, V7, P303, DOI 10.1038/ncb1225; Barna M, 2008, NATURE, V456, P971, DOI 10.1038/nature07449; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Berta MA, 2010, EMBO MOL MED, V2, P16, DOI 10.1002/emmm.200900047; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brown SJ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-442; Carrour TL, 2010, OPEN BIOINFORMATICS, V4, P5, DOI [10.2174/1875036201004010005, DOI 10.2174/1875036201004010005]; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Egle A, 2004, P NATL ACAD SCI USA, V101, P6164, DOI 10.1073/pnas.0401471101; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Eischen CM, 1999, GENE DEV, V13, P2658, DOI 10.1101/gad.13.20.2658; Fan JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009691; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Grandori C, 2005, NAT CELL BIOL, V7, P311, DOI 10.1038/ncb1224; Greasley PJ, 2000, NUCLEIC ACIDS RES, V28, P446, DOI 10.1093/nar/28.2.446; Hartl M, 2010, P NATL ACAD SCI USA, V107, P4051, DOI 10.1073/pnas.0911060107; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3; Kapur K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r82; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Koh CM, 2011, AM J PATHOL, V178, P1824, DOI 10.1016/j.ajpath.2010.12.040; Kurosawa H, 2007, J BIOSCI BIOENG, V103, P389, DOI 10.1263/jbb.103.389; Laurenti E, 2009, CURR OPIN CELL BIOL, V21, P844, DOI 10.1016/j.ceb.2009.09.006; Lempiainen H, 2009, CURR OPIN CELL BIOL, V21, P855, DOI 10.1016/j.ceb.2009.09.002; Li L, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-7; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Lippman SI, 2009, P NATL ACAD SCI USA, V106, P19928, DOI 10.1073/pnas.0907027106; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nilsson JA, 2005, CANCER CELL, V7, P433, DOI 10.1016/j.ccr.2005.03.036; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Park JR, 2008, PEDIATR CLIN N AM, V55, P97, DOI 10.1016/j.pcl.2007.10.014; Patel JH, 2004, NAT REV CANCER, V4, P562, DOI 10.1038/nrc1393; PLOTON D, 1986, HISTOCHEM J, V18, P5, DOI 10.1007/BF01676192; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; ROSENBLOOM KR, NUCL ACIDS RES, V38, pD620; Ruggero D, 2009, CANCER RES, V69, P8839, DOI 10.1158/0008-5472.CAN-09-1970; Schlosser I, 2003, NUCLEIC ACIDS RES, V31, P6148, DOI 10.1093/nar/gkg794; SHEINESS D, 1979, J VIROL, V31, P514, DOI 10.1128/JVI.31.2.514-521.1979; Shim H, 1998, P NATL ACAD SCI USA, V95, P1511, DOI 10.1073/pnas.95.4.1511; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Yustein JT, 2010, P NATL ACAD SCI USA, V107, P3534, DOI 10.1073/pnas.0901230107; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	62	116	117	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26057	10.1371/journal.pone.0026057	http://dx.doi.org/10.1371/journal.pone.0026057			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039435	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500030
J	Wang, J; Wu, YX; Ren, GP; Guo, QH; Liu, JQ; Lascoux, M				Wang, Juan; Wu, Yuxia; Ren, Guangpeng; Guo, Qiuhong; Liu, Jianquan; Lascoux, Martin			Genetic Differentiation and Delimitation between Ecologically Diverged Populus euphratica and P. pruinosa	PLOS ONE			English	Article							POPULATION-STRUCTURE; DNA VARIATION; CHLOROPLAST; NUCLEAR; POPLAR; INTROGRESSION; HYBRIDIZATION; MITOCHONDRIAL; RATES; FLOW	Background: The fixed genetic differences between ecologically divergent species were found to change greatly depending on the markers examined. With such species it is difficult to differentiate between shared ancestral polymorphisms and past introgressions between the diverging species. In order to disentangle these possibilities and provide a further case for DNA barcoding of plants, we examine genetic differentiation between two ecologically divergent poplar species, Populus euphratica Oliver and P. pruinosa Schrenk using three different types of genetic marker. Methodology/Principal Findings: We genotyped 290 individuals from 29 allopatric and sympatric populations, using chloroplast (cp) DNA, nuclear (nr) ITS sequences and eight simple sequence repeat (SSR) loci. Three major cpDNA haplotypes were widely shared between the two species and between-species cpDNA differentiation (FCT) was very low, even lower than among single species populations. The average SSR FCT values were higher. Bayesian clustering analysis of all loci allowed a clear delineation of the two species. Gene flow, determined by examining all SSR loci, was obvious but only slightly asymmetrical. However, the two species were almost fixed for two different nrITS genotypes that had the highest FCT, although a few introgressed individuals were detected both in allopatric and sympatric populations. Conclusions: The two species shared numerous ancestral polymorphisms at cpDNA and a few SSR loci. Both ITS and a combination of nuclear SSR data could be used to differentiate between the two species. Introgressions and gene flow were obvious between the two species either during or after their divergence. Our findings underscore the complex genetic differentiations between ecologically diverged species and highlight the importance of nuclear DNA (especially ITS) differentiation for delimiting closely related plant species.	[Wang, Juan; Wu, Yuxia; Ren, Guangpeng; Guo, Qiuhong; Liu, Jianquan] Lanzhou Univ, State Key Lab Grassland Farming Syst, Mol Ecol Grp, Lanzhou 730000, Gansu, Peoples R China; [Lascoux, Martin] Chinese Acad Sci, CAS MPG Partner Inst Computat Biol, Lab Evolutionary Genom, Shanghai, Peoples R China; [Lascoux, Martin] Uppsala Univ, Evolutionary Biol Ctr, Program Evolutionary Funct Genom, Uppsala, Sweden	Lanzhou University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Uppsala University	Wang, J (corresponding author), Lanzhou Univ, State Key Lab Grassland Farming Syst, Mol Ecol Grp, Lanzhou 730000, Gansu, Peoples R China.	liujq@nwipb.ac.cn	Ren, Guangpeng/HHC-4750-2022	Ren, Guangpeng/0000-0002-4052-9115; Lascoux, Martin/0000-0003-1699-9042	Natural Science Foundation of China [30725004, 30430560]; National Key Project for Basic Research	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project for Basic Research(National Basic Research Program of China)	This research was supported by grants from the Natural Science Foundation of China (Grant numbers 30725004, 30430560) and the National Key Project for Basic Research to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; ML is part of the Evoltree Network of Excellence and would like to thank the Chinese Academy of Sciences for granting him a Visiting Professorship in 2010-2011 and HL his hospitality in Shanghai.	Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Bai WN, 2010, NEW PHYTOL, V188, P892, DOI 10.1111/j.1469-8137.2010.03407.x; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Currat M, 2008, EVOLUTION, V62, P1908, DOI 10.1111/j.1558-5646.2008.00413.x; Dasmahapatra KK, 2006, HEREDITY, V97, P254, DOI 10.1038/sj.hdy.6800858; Dickmann D, 2008, POPLARS WILLOWS WORL; Ding MQ, 2010, PLANT MOL BIOL, V73, P251, DOI 10.1007/s11103-010-9612-9; Doyle J. J., 1987, PHYTOCHEM B, P11; Drouin G, 2008, MOL PHYLOGENET EVOL, V49, P827, DOI 10.1016/j.ympev.2008.09.009; DU FK, 2011, NEW PHYTOL IN PRESS; Edwards CE, 2008, MOL ECOL, V17, P5157, DOI 10.1111/j.1365-294X.2008.03985.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Hamilton MB, 1999, MOL ECOL, V8, P521; Hamzeh M, 2007, CAN J BOT, V85, P1227, DOI 10.1139/B07-105; Hoelzer GA, 1997, EVOLUTION, V51, P622, DOI 10.1111/j.1558-5646.1997.tb02451.x; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Kikuchi R, 2010, NEW PHYTOL, V188, P879, DOI 10.1111/j.1469-8137.2010.03398.x; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lepais O, 2009, MOL ECOL, V18, P2228, DOI 10.1111/j.1365-294X.2009.04137.x; Lexer C, 2005, MOL ECOL, V14, P1045, DOI 10.1111/j.1365-294X.2005.02469.x; Li Li, 2006, Forestry Studies in China, V8, P10, DOI 10.1007/s11632-006-0002-y; Liu PX, 2007, J INTEGR PLANT BIOL, V49, P150, DOI 10.1111/j.1744-7909.2007.00425.x; MA C, 1997, FOREST ECOL MANAG, V93, P56; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; McKinnon GE, 2010, MOL ECOL, V19, P1367, DOI 10.1111/j.1365-294X.2010.04579.x; McKinnon GE, 2004, PHILOS T R SOC B, V359, P275, DOI 10.1098/rstb.2003.1391; McKinnon GE, 2001, EVOLUTION, V55, P703, DOI 10.1554/0014-3820(2001)055[0703:CSITTE]2.0.CO;2; Mims MC, 2010, MOL ECOL, V19, P940, DOI 10.1111/j.1365-294X.2010.04529.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Okumura S, 2006, TRANSGENIC RES, V15, P637, DOI 10.1007/s11248-006-9009-3; Ottow EA, 2005, PLANT PHYSIOL, V139, P1762, DOI 10.1104/pp.105.069971; Palme AE, 2004, MOL ECOL, V13, P167, DOI 10.1046/j.1365-294X.2003.02034.x; Pennisi E, 2007, SCIENCE, V318, P190, DOI 10.1126/science.318.5848.190; Petit RJ, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P23, DOI 10.1007/1-4020-4904-8_2; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Petit RJ, 2002, FOREST ECOL MANAG, V156, P115, DOI 10.1016/S0378-1127(01)00638-7; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Polezhaeva MA, 2010, MOL ECOL, V19, P1239, DOI 10.1111/j.1365-294X.2010.04552.x; Pons O, 1996, GENETICS, V144, P1237; Pritchard JK, 2000, GENETICS, V155, P945; Qiu Q, 2011, TREE PHYSIOL, V31, P452, DOI 10.1093/treephys/tpr015; Raymond M, 1995, EVOLUTION, V49, P1280, DOI 10.1111/j.1558-5646.1995.tb04456.x; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rottenberg A, 2000, CAN J FOREST RES, V30, P482, DOI 10.1139/cjfr-30-3-482; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Schemske DW, 2010, AM NAT, V176, pS4, DOI 10.1086/657060; Schluter D, 2009, SCIENCE, V323, P737, DOI 10.1126/science.1160006; Schnittler M, 2010, EVOL ECOL, V24, P1417, DOI 10.1007/s10682-010-9389-y; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOLLEFSRUD MM, 2008, THESIS OSLO U; WANG J, 2011, ANN FOR SCI; WANG J, 2011, HEREDITY IN PRESS; Wang RG, 2008, TREE PHYSIOL, V28, P947, DOI 10.1093/treephys/28.6.947; Wang RG, 2007, TREES-STRUCT FUNCT, V21, P581, DOI 10.1007/s00468-007-0154-y; WANG SJ, 1995, EUPHRATES POPLAR FOR, P12; Wang XR, 1999, AM J BOT, V86, P1742, DOI 10.2307/2656672; Weisgerber H, 2001, FOREST CHRON, V77, P227, DOI 10.5558/tfc77227-2; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; White TJ., 1990, PCR PROTOCOLS GUIDE, P315; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wright S, 1943, GENETICS, V28, P139; WRIGHT S, 1943, GENETICS, V28, P515; Wu YX, 2008, MOL ECOL RESOUR, V8, P1142, DOI 10.1111/j.1755-0998.2008.02202.x; Wu YX, 2007, PLANT MOL BIOL, V65, P1, DOI 10.1007/s11103-007-9170-y; Zhang F, 2007, PLANT CELL ENVIRON, V30, P775, DOI 10.1111/j.1365-3040.2007.01667.x; Zhang H, 2003, J ARID ENVIRON, V55, P545, DOI 10.1016/S0140-1963(02)00283-5; Zhou YF, 2010, EVOLUTION, V64, P2342, DOI 10.1111/j.1558-5646.2010.00988.x	72	38	45	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26530	10.1371/journal.pone.0026530	http://dx.doi.org/10.1371/journal.pone.0026530			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028897	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500084
J	Zhao, T; Krokene, P; Hu, J; Christiansen, E; Bjorklund, N; Langstrom, B; Solheim, H; Borg-Karlson, AK				Zhao, Tao; Krokene, Paal; Hu, Jiang; Christiansen, Erik; Bjorklund, Niklas; Langstrom, Bo; Solheim, Halvor; Borg-Karlson, Anna-Karin			Induced Terpene Accumulation in Norway Spruce Inhibits Bark Beetle Colonization in a Dose-Dependent Manner	PLOS ONE			English	Article							MOUNTAIN PINE-BEETLE; METHYL JASMONATE; PICEA-ABIES; CERATOCYSTIS-POLONICA; INDUCED RESPONSES; FUNGAL-INFECTION; MONOTERPENE CONCENTRATIONS; ENANTIOMERIC COMPOSITION; DISEASE RESISTANCE; CHEMICAL DEFENSES	Background: Tree-killing bark beetles (Coleoptera, Scolytinae) are among the most economically and ecologically important forest pests in the northern hemisphere. Induction of terpenoid-based oleoresin has long been considered important in conifer defense against bark beetles, but it has been difficult to demonstrate a direct correlation between terpene levels and resistance to bark beetle colonization. Methods: To test for inhibitory effects of induced terpenes on colonization by the spruce bark beetle Ips typographus (L.) we inoculated 20 mature Norway spruce Picea abies (L.) Karsten trees with a virulent fungus associated with the beetle, Ceratocystis polonica (Siem.) C. Moreau, and investigated induced terpene levels and beetle colonization in the bark. Results: Fungal inoculation induced very strong and highly variable terpene accumulation 35 days after inoculation. Trees with high induced terpene levels (n = 7) had only 4.9% as many beetle attacks (5.1 vs. 103.5 attacks m(-2)) and 2.6% as much gallery length (0.029 m m(-2) vs. 1.11 m m(-2)) as trees with low terpene levels (n = 6). There was a highly significant rank correlation between terpene levels at day 35 and beetle colonization in individual trees. The relationship between induced terpene levels and beetle colonization was not linear but thresholded: above a low threshold concentration of similar to 100 mg terpene g(-1) dry phloem trees suffered only moderate beetle colonization, and above a high threshold of similar to 200 mg terpene g(-1) dry phloem trees were virtually unattacked. Conclusion/Significance: This is the first study demonstrating a dose-dependent relationship between induced terpenes and tree resistance to bark beetle colonization under field conditions, indicating that terpene induction may be instrumental in tree resistance. This knowledge could be useful for developing management strategies that decrease the impact of tree-killing bark beetles.	[Zhao, Tao; Hu, Jiang; Borg-Karlson, Anna-Karin] Royal Inst Technol, Ecol Chem Grp, Dept Chem, Stockholm, Sweden; [Krokene, Paal; Christiansen, Erik; Solheim, Halvor] Norwegian Forest & Landscape Inst, As, Norway; [Bjorklund, Niklas; Langstrom, Bo] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Royal Institute of Technology; The Norwegian Forest & Landscape Institute; Swedish University of Agricultural Sciences	Zhao, T (corresponding author), Royal Inst Technol, Ecol Chem Grp, Dept Chem, Stockholm, Sweden.	akbk@kth.se	Solheim, Halvor/N-9691-2013; Björklund, Niklas/J-7812-2015; Krokene, Paal/A-1835-2008; Bjørklund, Geir/B-7319-2014; Björklund, Niklas/F-2220-2011	Solheim, Halvor/0000-0002-6808-1615; Björklund, Niklas/0000-0001-8526-407X; Krokene, Paal/0000-0002-7205-0715; Bjørklund, Geir/0000-0003-2632-3935; Björklund, Niklas/0000-0001-8526-407X; Zhao, Tao/0000-0001-5909-2841	FORMAS (The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning); Swedish University of Agriculture Sciences; Norwegian Forest and Landscape Institute	FORMAS (The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning)(Swedish Research Council Formas); Swedish University of Agriculture Sciences; Norwegian Forest and Landscape Institute	This study was supported by FORMAS (The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning), the Swedish University of Agriculture Sciences and Norwegian Forest and Landscape Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AS, 2009, CAN J FOREST RES, V39, P1133, DOI 10.1139/X09-034; Bakke A., 1983, Meddelelser fra Norsk Institutt for Skogforskning, V38, P1; BORGKARLSON AK, 1993, ACTA CHEM SCAND, V47, P138, DOI 10.3891/acta.chem.scand.47-0138; BRIGNOLAS F, 1995, PLANT PHYSIOL, V109, P821, DOI 10.1104/pp.109.3.821; Christiansen E, 1999, TREE PHYSIOL, V19, P399; Christiansen E., 1988, P479; COOK SP, 1988, J ENTOMOL SCI, V23, P287, DOI 10.18474/0749-8004-23.3.287; Erbilgin N, 2003, AGR FOREST ENTOMOL, V5, P269, DOI 10.1046/j.1461-9563.2003.00186.x; Erbilgin N, 2006, OECOLOGIA, V148, P426, DOI 10.1007/s00442-006-0394-3; Erbilgin N, 2009, AGR FOREST ENTOMOL, V11, P255, DOI 10.1111/j.1461-9563.2009.00435.x; Faldt J, 2006, J CHEM ECOL, V32, P1779, DOI 10.1007/s10886-006-9109-9; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Franceschi VR, 2002, AM J BOT, V89, P578, DOI 10.3732/ajb.89.4.578; Jost RW, 2008, J WOOD CHEM TECHNOL, V28, P37, DOI 10.1080/02773810801916407; Kane JM, 2010, OECOLOGIA, V164, P601, DOI 10.1007/s00442-010-1683-4; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; Klepzig KD, 2009, ENVIRON ENTOMOL, V38, P67, DOI 10.1603/022.038.0109; Klepzig KD, 1996, J CHEM ECOL, V22, P1367, DOI 10.1007/BF02027719; Klepzig KD, 2005, TREE PHYSIOL, V25, P681, DOI 10.1093/treephys/25.6.681; KLIMETZEK D, 1980, EXPERIENTIA, V36, P1343, DOI 10.1007/BF01960087; Kopper BJ, 2005, ENVIRON ENTOMOL, V34, P486, DOI 10.1603/0046-225X-34.2.486; Krokene P, 1996, CAN J FOREST RES, V26, P2115, DOI 10.1139/x26-240; Krokene P, 1998, PHYTOPATHOLOGY, V88, P39, DOI 10.1094/PHYTO.1998.88.1.39; Krokene P, 2003, TREE PHYSIOL, V23, P191, DOI 10.1093/treephys/23.3.191; Krokene P, 2001, PLANT PATHOL, V50, P230, DOI 10.1046/j.1365-3059.2001.00559.x; Krokene P, 1999, PLANT PHYSIOL, V121, P565, DOI 10.1104/pp.121.2.565; Krokene P, 2000, EUR J PLANT PATHOL, V106, P537, DOI 10.1023/A:1008776002248; Krokene P, 2008, TREE PHYSIOL, V28, P29, DOI 10.1093/treephys/28.1.29; Krokene Paal, 2008, P147, DOI 10.1007/978-1-4020-8182-8_7; Lieutier F, 1995, J APPL ENTOMOL, V119, P591, DOI 10.1111/j.1439-0418.1995.tb01341.x; Miller DR, 2000, CAN ENTOMOL, V132, P183, DOI 10.4039/Ent132183-2; Nagy NE, 2000, AM J BOT, V87, P302, DOI 10.2307/2656626; Nagy NE, 2004, TREE PHYSIOL, V24, P505, DOI 10.1093/treephys/24.5.505; Phillips MA, 1999, TRENDS PLANT SCI, V4, P184, DOI 10.1016/S1360-1385(99)01401-6; Raffa KF, 2008, BIOSCIENCE, V58, P501, DOI 10.1641/B580607; RAFFA KF, 1983, CAN ENTOMOL, V115, P723, DOI 10.4039/Ent115723-7; RAFFA KF, 1982, ENVIRON ENTOMOL, V11, P486, DOI 10.1093/ee/11.2.486; RAFFA KF, 1983, ECOL MONOGR, V53, P27, DOI 10.2307/1942586; RAFFA KF, 1982, CAN ENTOMOL, V114, P797, DOI 10.4039/Ent114797-9; RAFFA KF, 1995, OECOLOGIA, V102, P285, DOI 10.1007/BF00329795; Sandnes A, 2002, SCAND J FOREST RES, V17, P522, DOI 10.1080/02827580260417170; Seybold Steven J., 2006, Phytochemistry Reviews, V5, P143, DOI 10.1007/s11101-006-9002-8; Smith RH, 1965, J ECON ENTOMOL, P58; SOLHEIM H, 1992, EUR J FOREST PATHOL, V22, P136; SOLHEIM H, 1992, CAN J BOT, V70, P1, DOI 10.1139/b92-001; SOLHEIM H, 1991, MYCOL RES, V95, P1387, DOI 10.1016/S0953-7562(09)80390-0; Viiri H, 2001, TREES-STRUCT FUNCT, V15, P112, DOI 10.1007/s004680000082; Zeneli G, 2006, TREE PHYSIOL, V26, P977, DOI 10.1093/treephys/26.8.977; Zhao T, 2010, PHYTOCHEMISTRY, V71, P1332, DOI 10.1016/j.phytochem.2010.05.017	49	57	57	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26649	10.1371/journal.pone.0026649	http://dx.doi.org/10.1371/journal.pone.0026649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028932	gold, Green Submitted, Green Accepted, Green Published			2022-12-27	WOS:000296507500103
J	Chan, LN; Fiji, HDG; Watanabe, M; Kwon, O; Tamanoi, F				Chan, Lai N.; Fiji, Hannah D. G.; Watanabe, Masaru; Kwon, Ohyun; Tamanoi, Fuyuhiko			Identification and Characterization of Mechanism of Action of P61-E7, a Novel Phosphine Catalysis-Based Inhibitor of Geranylgeranyltransferase-I	PLOS ONE			English	Article							HIGHLY FUNCTIONALIZED TETRAHYDROPYRIDINES; FARNESYLTRANSFERASE INHIBITORS; 4+2 ANNULATION; GROWTH; CELLS; RAS; APOPTOSIS; TRANSFORMATION; ALLENOATES; CANCER	Small molecule inhibitors of protein geranylgeranyltransferase-I (GGTase-I) provide a promising type of anticancer drugs. Here, we first report the identification of a novel tetrahydropyridine scaffold compound, P61-E7, and define effects of this compound on pancreatic cancer cells. P61-E7 was identified from a library of allenoate-derived compounds made through phosphine-catalyzed annulation reactions. P61-E7 inhibits protein geranylgeranylation and blocks membrane association of geranylgeranylated proteins. P61-E7 is effective at inhibiting both cell proliferation and cell cycle progression, and it induces high p21(CIP1/WAF1) level in human cancer cells. P61-E7 also increases p27(Kip1) protein level and inhibits phosphorylation of p27(Kip1) on Thr187. We also report that P61-E7 treatment of Panc-1 cells causes cell rounding, disrupts actin cytoskeleton organization, abolishes focal adhesion assembly and inhibits anchorage independent growth. Because the cellular effects observed pointed to the involvement of RhoA, a geranylgeranylated small GTPase protein shown to influence a number of cellular processes including actin stress fiber organization, cell adhesion and cell proliferation, we have evaluated the significance of the inhibition of RhoA geranylgeranylation on the cellular effects of inhibitors of GGTase-I (GGTIs). Stable expression of farnesylated RhoA mutant (RhoA-F) results in partial resistance to the anti-proliferative effect of P61-E7 and prevents induction of p21(CIP1/WAF1) and p27(Kip1) by P61-E7 in Panc-1 cells. Moreover, stable expression of RhoA-F rescues Panc-1 cells from cell rounding and inhibition of focal adhesion formation caused by P61-E7. Taken together, these findings suggest that P61-E7 is a promising GGTI compound and that RhoA is an important target of P61-E7 in Panc-1 pancreatic cancer cells.	[Chan, Lai N.; Watanabe, Masaru; Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Chan, Lai N.; Kwon, Ohyun; Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Fiji, Hannah D. G.; Kwon, Ohyun] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Chan, LN (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	fuyut@microbio.ucla.edu			National Institutes of Health (NIH) [CA41996, GM071779, GM081282, GM07185]; NATIONAL CANCER INSTITUTE [R01CA041996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071779, P41GM081282, T32GM007185] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health (NIH) grants CA41996, GM071779, GM081282 and GM07185. The funders had no role in study design, data collection and analysis, decision to publish. or preparation of the manuscript.	Adnane J, 1998, MOL CELL BIOL, V18, P6962, DOI 10.1128/MCB.18.12.6962; Allal C, 2000, J BIOL CHEM, V275, P31001, DOI 10.1074/jbc.M005264200; Allal C, 2002, CELL CYCLE, V1, P430, DOI 10.4161/cc.1.6.272; Andrews IP, 2011, ORG SYNTH, V88, P138, DOI 10.15227/orgsyn.088.0138; Castellano S, 2007, J AM CHEM SOC, V129, P5843, DOI 10.1021/ja070274n; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Creech GS, 2008, TETRAHEDRON, V64, P6935, DOI 10.1016/j.tet.2008.04.075; Creech GS, 2008, ORG LETT, V10, P429, DOI 10.1021/ol702462w; Croft DR, 2006, MOL CELL BIOL, V26, P4612, DOI 10.1128/MCB.02061-05; Dan HC, 2004, ONCOGENE, V23, P706, DOI 10.1038/sj.onc.1207171; Falsetti SC, 2007, MOL CELL BIOL, V27, P8003, DOI 10.1128/MCB.00057-07; Gau CL, 2005, MOL CANCER THER, V4, P918, DOI 10.1158/1535-7163.MCT-04-0347; Guo HC, 2009, J AM CHEM SOC, V131, P6318, DOI 10.1021/ja8097349; Hakem A, 2005, GENE DEV, V19, P1974, DOI 10.1101/gad.1310805; Hirai A, 1997, J BIOL CHEM, V272, P13; Hu WM, 1999, J BIOL CHEM, V274, P3396, DOI 10.1074/jbc.274.6.3396; Joyce PL, 2003, CANCER RES, V63, P7959; Kato-Stankiewicz J, 2002, P NATL ACAD SCI USA, V99, P14398, DOI 10.1073/pnas.222222699; Kazi A, 2009, MOL CELL BIOL, V29, P2254, DOI 10.1128/MCB.01029-08; LERNER EC, 1995, J BIOL CHEM, V270, P26770, DOI 10.1074/jbc.270.45.26770; Lim KH, 2005, CANCER CELL, V7, P533, DOI 10.1016/j.ccr.2005.04.030; Lim KH, 2006, CURR BIOL, V16, P2385, DOI 10.1016/j.cub.2006.10.023; Lu J, 2009, MOL CANCER THER, V8, P1218, DOI 10.1158/1535-7163.MCT-08-1122; Lu K, 2009, ORG SYNTH, V86, P212, DOI 10.15227/orgsyn.086.0212; Miquel K, 1997, CANCER RES, V57, P1846; Olson MF, 1998, NATURE, V394, P295, DOI 10.1038/28425; Peterson YK, 2006, J BIOL CHEM, V281, P12445, DOI 10.1074/jbc.M600168200; Peterson YK, 2009, J MED CHEM, V52, P4210, DOI 10.1021/jm8013772; Sarma KD, 2006, EUR J ORG CHEM, P3730, DOI DOI 10.1002/EJ0C.200600153; Sebti SM, 2004, SEMIN ONCOL, V31, P28, DOI 10.1053/j.seminoncol.2003.12.012; Sjogren AKM, 2007, J CLIN INVEST, V117, P1294, DOI 10.1172/JCI30868; Sun JZ, 2003, CANCER RES, V63, P8922; Sun JZ, 1999, CANCER RES, V59, P4919; Sun JZ, 1998, ONCOGENE, V16, P1467, DOI 10.1038/sj.onc.1201656; Sung JZ, 1999, J BIOL CHEM, V274, P6930; Tamanoi F., 2001, ENZYMES, V21; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Tran YS, 2007, J AM CHEM SOC, V129, P12632, DOI 10.1021/ja0752181; Vasudevan A, 1999, J MED CHEM, V42, P1333, DOI 10.1021/jm9900873; Watanabe M, 2008, J BIOL CHEM, V283, P9571, DOI 10.1074/jbc.M706229200; Wittchen Erika S, 2011, Small GTPases, V2, P65; Zhu XF, 2005, TETRAHEDRON, V61, P6276, DOI 10.1016/j.tet.2005.03.104; Zhu XF, 2005, ORG LETT, V7, P2977, DOI 10.1021/ol050946j; Zhu XF, 2005, ORG LETT, V7, P1387, DOI 10.1021/ol050203y; Zhu XF, 2003, J AM CHEM SOC, V125, P4716, DOI 10.1021/ja0344009	45	17	17	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26135	10.1371/journal.pone.0026135	http://dx.doi.org/10.1371/journal.pone.0026135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028818	Green Submitted, gold, Green Published			2022-12-27	WOS:000296186900029
J	Lammers, B; Zhao, Y; Hoekstra, M; Hildebrand, RB; Ye, D; Meurs, I; Van Berkel, TJC; Van Eck, M				Lammers, Bart; Zhao, Ying; Hoekstra, Menno; Hildebrand, Reeni B.; Ye, Dan; Meurs, Illiana; Van Berkel, Theo J. C.; Van Eck, Miranda			Augmented Atherogenesis in LDL Receptor Deficient Mice Lacking Both Macrophage ABCA1 and ApoE	PLOS ONE			English	Article							ATP-BINDING CASSETTE; ATHEROSCLEROTIC LESION DEVELOPMENT; HIGH-DENSITY-LIPOPROTEINS; APOLIPOPROTEIN-E; CHOLESTEROL EFFLUX; LIPID-ACCUMULATION; ABCG1; EXPRESSION; EXTRACTION; SECRETION	Aim: ABCA1 protects against atherosclerosis by facilitating cholesterol efflux from macrophage foam cells in the arterial wall to extracellular apolipoprotein (apo) A-I. In contrast to apoA-I, apoE is secreted by macrophages and can, like apoA-I, induce ABCA1-mediated cholesterol efflux. Yet, the combined effect of macrophage ABCA1 and apoE on lesion development is unexplored. Methods and Results: LDL receptor knockout (KO) mice were transplanted with bone marrow from ABCA1/apoE double KO (dKO) mice, their respective single KO's, and wild-type (WT) controls and were challenged with a high-fat/high-cholesterol diet for 9 weeks. In vitro cholesterol efflux experiments showed no differences between ABCA1 KO and dKO macrophages. The serum non-HDL/HDL ratio in dKO transplanted mice was 1.7-fold and 2.4-fold (p<0.01) increased compared to WT and ABCA1 KO transplanted mice, respectively. The atherosclerotic lesion area in dKO transplanted animals (650 +/- 94x10(3) mu m(2)), however, was 1.9-fold (p<0.01) and 1.6-fold (p<0.01) increased compared to single knockouts (ABCA1 KO: 341 +/- 20x10(3) mu m(2); apoE KO: 402 +/- 78x10(3) mu m(2), respectively) and 3.1-fold increased (p<0.001) compared to WT (211 +/- 20x10(3) mu m(2)). When normalized for serum cholesterol exposure, macrophage ABCA1 and apoE independently protected against atherosclerotic lesion development (p<0.001). Moreover, hepatic expression levels of TNF alpha and IL-6 were highly induced in dKO transplanted animals (3.0-fold; p<0.05, and 4.3-fold; p<0.001, respectively). In agreement, serum IL-6 levels were also enhanced in ABCA1 KO transplanted mice (p<0.05) and even further enhanced in dKO transplanted animals (3.1-fold as compared to ABCA1 KO transplanted animals; p<0.05). Conclusions: Combined deletion of macrophage ABCA1 and apoE results in a defect in cholesterol efflux and, compared to ABCA1 KO transplanted mice, elevated serum total cholesterol levels. Importantly, these mice also suffer from enhanced systemic and hepatic inflammation, together resulting in the observed augmented atherosclerotic lesion development.	[Lammers, Bart; Zhao, Ying; Hoekstra, Menno; Hildebrand, Reeni B.; Ye, Dan; Meurs, Illiana; Van Berkel, Theo J. C.; Van Eck, Miranda] Leiden Univ, Gorlaeus Labs, Div Biopharmaceut, Leiden Amsterdam Ctr Drug Res, NL-2300 RA Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Lammers, B (corresponding author), Leiden Univ, Gorlaeus Labs, Div Biopharmaceut, Leiden Amsterdam Ctr Drug Res, POB 9502, NL-2300 RA Leiden, Netherlands.	b.lammers@lacdr.leidenuniv.nl	Van Berkel, Theo/ABD-7677-2021; Zhao, Ying/C-3916-2011; Zhao, Ying/AAS-7970-2021	Hoekstra, Menno/0000-0001-7463-2893; van Eck, Miranda/0000-0003-3936-3194	Netherlands Heart Foundation [2005B002, 2008T070, 2007T056]; Netherlands Organization for Scientific Research [917.66.301]; Top Institute Pharma [T2-110]	Netherlands Heart Foundation(Netherlands Heart Foundation); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Top Institute Pharma	This work was supported by The Netherlands Heart Foundation, Grant numbers 2005B002 (B. L.), and 2008T070 (M. H.); The Netherlands Organization for Scientific Research (VIDI Grant number 917.66.301 (I.M., M.V.E.)), and Top Institute Pharma (TIPharma grant number T2-110; M.H., T.V.B.). M.V.E. is an Established Investigator of the Netherlands Heart Foundation (Grant number 2007T056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boisvert WA, 1999, J LIPID RES, V40, P806; Castelli W P, 1992, Ann Epidemiol, V2, P23, DOI 10.1016/1047-2797(92)90033-M; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; ECKEL RH, 1989, NEW ENGL J MED, V320, P1060; Fazio S, 1997, P NATL ACAD SCI USA, V94, P4647, DOI 10.1073/pnas.94.9.4647; Getz GS, 2006, ARTERIOSCL THROM VAS, V26, P242, DOI 10.1161/01.ATV.0000201071.49029.17; Holewijn S, 2010, J INTERN MED, V268, P567, DOI 10.1111/j.1365-2796.2010.02277.x; Huang ZH, 2001, ARTERIOSCL THROM VAS, V21, P2019, DOI 10.1161/hq1201.100242; Jessup W, 2006, CURR OPIN LIPIDOL, V17, P247, DOI 10.1097/01.mol.0000226116.35555.eb; Keidar S, 2001, ARTERIOSCL THROM VAS, V21, P1464, DOI 10.1161/hq0901.095547; Kennedy MA, 2005, CELL METAB, V1, P121, DOI 10.1016/j.cmet.2005.01.002; Lammers B, 2009, ATHEROSCLEROSIS, V205, P420, DOI 10.1016/j.atherosclerosis.2009.01.017; Lin CY, 2001, J LIPID RES, V42, P1125; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Oram JF, 2000, J BIOL CHEM, V275, P34508, DOI 10.1074/jbc.M006738200; Out R, 2008, ARTERIOSCL THROM VAS, V28, P258, DOI 10.1161/ATVBAHA.107.156935; Out R, 2006, ARTERIOSCL THROM VAS, V26, P2295, DOI 10.1161/01.ATV.0000237629.29842.4c; REDGRAVE TG, 1975, ANAL BIOCHEM, V65, P42, DOI 10.1016/0003-2697(75)90488-1; Santamarina-Fojo S, 2000, P NATL ACAD SCI USA, V97, P7987, DOI 10.1073/pnas.97.14.7987; Shi WB, 2004, BIOCHEM BIOPH RES CO, V317, P223, DOI 10.1016/j.bbrc.2004.03.037; SWEETNAM PM, 1994, CIRCULATION, V90, P769, DOI 10.1161/01.CIR.90.2.769; Takeda N, 2006, ARTERIOSCL THROM VAS, V26, P1177, DOI 10.1161/01.ATV.0000214296.94849.1c; Van Eck M, 2000, ATHEROSCLEROSIS, V150, P71, DOI 10.1016/S0021-9150(99)00372-X; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; von Eckardstein A, 2001, ARTERIOSCL THROM VAS, V21, P13, DOI 10.1161/01.ATV.21.1.13; Von Eckardstein A, 2001, FASEB J, V15, P1555, DOI 10.1096/fj.00-0798com; Wang N, 2004, P NATL ACAD SCI USA, V101, P9774, DOI 10.1073/pnas.0403506101; ZANOTTI I, ARTERIOSCLER THROMB, V31, P74	31	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26095	10.1371/journal.pone.0026095	http://dx.doi.org/10.1371/journal.pone.0026095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022523	Green Published, gold			2022-12-27	WOS:000295973200035
J	Ito, K; Igarashi, M; Miyazaki, Y; Murakami, T; Iida, S; Kida, H; Takada, A				Ito, Kimihito; Igarashi, Manabu; Miyazaki, Yutaka; Murakami, Teiji; Iida, Syaka; Kida, Hiroshi; Takada, Ayato			Gnarled-Trunk Evolutionary Model of Influenza A Virus Hemagglutinin	PLOS ONE			English	Article							AMINO-ACID CHANGES; POSITIVE SELECTION; GENETIC EVOLUTION; ANTIGENIC DRIFT; H3N2; EPIDEMIC; VACCINE; DETERMINANTS; VARIANTS; CLUSTERS	Human influenza A viruses undergo antigenic changes with gradual accumulation of amino acid substitutions on the hemagglutinin (HA) molecule. A strong antigenic mismatch between vaccine and epidemic strains often requires the replacement of influenza vaccines worldwide. To establish a practical model enabling us to predict the future direction of the influenza virus evolution, relative distances of amino acid sequences among past epidemic strains were analyzed by multidimensional scaling (MDS). We found that human influenza viruses have evolved along a gnarled evolutionary pathway with an approximately constant curvature in the MDS-constructed 3D space. The gnarled pathway indicated that evolution on the trunk favored multiple substitutions at the same amino acid positions on HA. The constant curvature was reasonably explained by assuming that the rate of amino acid substitutions varied from one position to another according to a gamma distribution. Furthermore, we utilized the estimated parameters of the gamma distribution to predict the amino acid substitutions on HA in subsequent years. Retrospective prediction tests for 12 years from 1997 to 2009 showed that 70% of actual amino acid substitutions were correctly predicted, and that 45% of predicted amino acid substitutions have been actually observed. Although it remains unsolved how to predict the exact timing of antigenic changes, the present results suggest that our model may have the potential to recognize emerging epidemic strains.	[Ito, Kimihito; Igarashi, Manabu; Murakami, Teiji; Iida, Syaka; Kida, Hiroshi; Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Ito, Kimihito] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan; [Miyazaki, Yutaka] Osaka Univ Econ & Law, Fac Liberal Arts & Sci, Yao, Japan; [Kida, Hiroshi] Hokkaido Univ, Dept Dis Control, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] OIE Reference Lab Highly Pathogen Avian Influenza, Sapporo, Hokkaido, Japan; [Kida, Hiroshi] Japan Sci & Technol Agcy, SORST, Saitama, Japan; [Takada, Ayato] Univ Zambia, Sch Vet Med, Lusaka, Zambia	Hokkaido University; Japan Science & Technology Agency (JST); Hokkaido University; Japan Science & Technology Agency (JST); University of Zambia	Ito, K (corresponding author), Hokkaido Univ, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan.	atakada@czc.hokudai.ac.jp	Igarashi, Manabu/F-6871-2012; Takada, Ayato/A-6679-2012; Ito, Kimihito/E-9975-2012; Kida, Hiroshi/F-7244-2012	Ito, Kimihito/0000-0003-4986-1795; 	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This project was supported by the Program of Founding Research Centers for Emerging and Reemerging Infectious Diseases, the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID), the Global COE Program, Grants-in-Aid, all from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan, and PRESTO and SORST from Japan Science and Technology Agency (JST) Basic Research Programs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Borg I, 2010, MODERN MULTIDIMENSIO; BOTH GW, 1983, J VIROL, V48, P52, DOI 10.1128/JVI.48.1.52-60.1983; Bush RM, 1999, MOL BIOL EVOL, V16, P1457, DOI 10.1093/oxfordjournals.molbev.a026057; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Cox NJ, 1995, SEMIN VIROL, V6, P359, DOI 10.1016/S1044-5773(05)80013-7; de Jong JC, 2000, J MED VIROL, V61, P94, DOI 10.1002/(SICI)1096-9071(200005)61:1&lt;94::AID-JMV15&gt;3.0.CO;2-C; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Ferguson NM, 2002, NAT MED, V8, P562, DOI 10.1038/nm0602-562; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; FITCH WM, 1991, P NATL ACAD SCI USA, V88, P4270, DOI 10.1073/pnas.88.10.4270; Fitch WM, 1997, P NATL ACAD SCI USA, V94, P7712, DOI 10.1073/pnas.94.15.7712; Gupta V, 2006, VACCINE, V24, P3881, DOI 10.1016/j.vaccine.2006.01.010; He JK, 2010, PROTEIN ENG DES SEL, V23, P935, DOI 10.1093/protein/gzq078; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kryazhimskiy S, 2008, P ROY SOC B-BIOL SCI, V275, P2455, DOI 10.1098/rspb.2008.0521; Lavenu A, 2006, EPIDEMIOL INFECT, V134, P514, DOI 10.1017/S0950268805005686; LAVER WG, 1981, J MOL BIOL, V145, P339, DOI 10.1016/0022-2836(81)90209-6; Liao YC, 2008, BIOINFORMATICS, V24, P505, DOI 10.1093/bioinformatics/btm638; Nakajima K, 2003, J VIROL, V77, P10088, DOI 10.1128/JVI.77.18.10088-10098.2003; NEI M, 1976, P NATL ACAD SCI USA, V73, P4164, DOI 10.1073/pnas.73.11.4164; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; OTA T, 1994, J MOL EVOL, V38, P642; Palese P., 2007, FIELDS VIROLOGY, P1647; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Suzuki Y, 2004, MOL BIOL EVOL, V21, P2352, DOI 10.1093/molbev/msh249; Tokuriki N, 2009, NATURE, V459, P668, DOI 10.1038/nature08009; Treanor J, 2004, NEW ENGL J MED, V351, P2037, DOI 10.1056/NEJMp048290; WEBSTER RG, 1980, VIROLOGY, V104, P139, DOI 10.1016/0042-6822(80)90372-4; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691	40	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2011	6	10							e25953	10.1371/journal.pone.0025953	http://dx.doi.org/10.1371/journal.pone.0025953			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OO	22028800	Green Published, gold			2022-12-27	WOS:000295971700027
J	Hansen, B; Oturai, AB; Harbo, HF; Celius, EG; Nissen, KK; Laska, MJ; Sondergaard, HB; Petersen, T; Nexo, BA				Hansen, Bettina; Oturai, Annette B.; Harbo, Hanne F.; Celius, Elisabeth G.; Nissen, Kari K.; Laska, Magdalena J.; Sondergaard, Helle B.; Petersen, Thor; Nexo, Bjorn A.			Genetic Association of Multiple Sclerosis with the Marker rs391745 near the Endogenous Retroviral Locus HERV-Fc1: Analysis of Disease Subtypes	PLOS ONE			English	Article							RISK	We have previously described the occurrence of multiple sclerosis (MS) to be associated with human endogenous retroviruses, specifically the X-linked viral locus HERV-Fc1. The aim of this study was to investigate a possible association of the HERV-Fc1 locus with subtypes of MS. MS patients are generally subdivided into three categories: Remitting/Relapsing and Secondary Progressive, which together constitute Bout Onset MS, and Primary Progressive. In this study of 1181 MS patients and 1886 controls we found that Bout Onset MS was associated with the C-allele of the marker rs391745 near the HERV-Fc1 locus (p = 0.003), while primary progressive disease was not. The ability to see genetic differences between subtypes of MS near this gene speaks for the involvement of the virus HERV-Fc1 locus in modifying the disease course of MS.	[Hansen, Bettina; Nissen, Kari K.; Laska, Magdalena J.; Nexo, Bjorn A.] Aarhus Univ, Dept Biomed, Aarhus C, Denmark; [Oturai, Annette B.; Sondergaard, Helle B.] Rigshosp, Dept Neurol, Copenhagen Univ Hosp, Danish Multiple Sclerosis Ctr, DK-2100 Copenhagen, Denmark; [Harbo, Hanne F.; Celius, Elisabeth G.] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Harbo, Hanne F.] Univ Oslo, Inst Clin Med, Oslo, Norway; [Petersen, Thor] Aarhus Univ Hosp, DK-8000 Aarhus, Denmark	Aarhus University; Rigshospitalet; University of Copenhagen; University of Oslo; University of Oslo; Aarhus University	Hansen, B (corresponding author), Aarhus Univ, Dept Biomed, Aarhus C, Denmark.	nexo@humgen.au.dk	Celius, Elisabeth Gulowsen/S-1387-2019	Celius, Elisabeth Gulowsen/0000-0002-9127-6488; Laska, Magdalena Janina/0000-0001-5188-3446; Sondergaard, Helle Bach/0000-0001-9435-0658; Petersen, Thor/0000-0001-5633-2600	Lundbeck Foundation; Danish Multiple Sclerosis Society; Warwara Larsen's Foundation; Norwegian Research Council; South-East Regional Norwegian Health Authorities; Odd Fellow MS Society; Oslo MS Society	Lundbeck Foundation(Lundbeckfonden); Danish Multiple Sclerosis Society; Warwara Larsen's Foundation; Norwegian Research Council(Research Council of NorwayEuropean Commission); South-East Regional Norwegian Health Authorities; Odd Fellow MS Society; Oslo MS Society	This work was supported by The Lundbeck Foundation, The Danish Multiple Sclerosis Society and Warwara Larsen's Foundation. The Norwegian Bone Marrow Registry is acknowledged for recruitment of the Norwegian control samples. The Norwegian part of the study was supported by grants from the Norwegian Research Council, South-East Regional Norwegian Health Authorities, Odd Fellow MS Society and Oslo MS Society to the Oslo MS Genetics group. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascherio A, 2007, ANN NEUROL, V61, P288, DOI 10.1002/ana.21117; Benit L, 2003, VIROLOGY, V312, P159, DOI 10.1016/S0042-6822(03)00163-6; Christensen T, 2005, REV MED VIROL, V15, P179, DOI 10.1002/rmv.465; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; GARDNER MB, 1993, GENETICA, V91, P199, DOI 10.1007/BF01435998; Johnson R T, 1975, Adv Neurol, V13, P1; LASKA MJ, 2011, PATHOGENESIS M UNPUB; Miller DH, 2007, LANCET NEUROL, V6, P903, DOI 10.1016/S1474-4422(07)70243-0; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Nexo BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016652; Pepin M, 1998, VET RES, V29, P341; Perron H, 1997, P NATL ACAD SCI USA, V94, P7583, DOI 10.1073/pnas.94.14.7583; POSER CM, 1983, ANN NEUROL, V13, P227, DOI 10.1002/ana.410130302; Sawcer S, 2008, LANCET NEUROL, V7, P567, DOI 10.1016/S1474-4422(08)70122-4; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Zink MC, 2002, J NEUROVIROL, V8, P42, DOI 10.1080/13550280290101076	16	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e26438	10.1371/journal.pone.0026438	http://dx.doi.org/10.1371/journal.pone.0026438			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22039488	gold, Green Published, Green Submitted			2022-12-27	WOS:000296517000019
J	Fouks, B; Lattorff, HMG				Fouks, Bertrand; Lattorff, H. Michael G.			Recognition and Avoidance of Contaminated Flowers by Foraging Bumblebees (Bombus terrestris)	PLOS ONE			English	Article							HOST-PARASITE INTERACTIONS; EVOLUTIONARY ECOLOGY; GENETIC DIVERSITY; BEES; BEHAVIOR; INFORMATION; CONSTANCY; WORKERS; CONSEQUENCES; POLLINATORS	Bumblebee colonies are founded by a single-mated queen. Due to this life history trait, bumblebees are more susceptible to parasites and diseases than polyandrous and/or polygynous social insects. A greater resistance towards parasites is shown when the genetic variability within a colony is increased. The parasite resistance may be divided into different levels regarding the step of the parasite infection (e. g. parasite uptake, parasite intake, parasite's establishment in the nest, parasite transmission). We investigate the prophylactic behaviour of bumblebees. Bumblebees were observed during their foraging flights on two artificial flowers; one of these was contaminated by Crithidia bombi, a naturally occurring gut parasite of bumblebees (in a control experiment the non-specific pathogen Escherichia coli was used). For C. bombi, bumblebees were preferentially observed feeding on the non-contaminated flower. Whereas for E. coli, the number of visits between flowers was the same, bumblebees spent more time feeding on the non-contaminated flower. These results demonstrate the ability of bumblebees to recognise the contamination of food sources. In addition, bumblebees have a stronger preference for the non-contaminated flower when C. bombi is present in the other flower than with E. coli which might be explained as an adaptive behaviour of bumblebees towards this specific gut parasite. It seems that the more specific the parasite is, the more it reduces the reward of the flower.	[Fouks, Bertrand; Lattorff, H. Michael G.] Univ Halle Wittenberg, Inst Biol, Halle, Germany	Martin Luther University Halle Wittenberg	Fouks, B (corresponding author), Univ Halle Wittenberg, Inst Biol, Halle, Germany.	bertrand.fouks@zoologie.uni-halle.de	Fouks, Bertrand/AAG-2921-2022; Lattorff, Michael/F-6287-2010; Fouks, Bertrand/AFK-4155-2022	Fouks, Bertrand/0000-0002-3675-3499; Lattorff, Michael/0000-0002-8603-6332; Fouks, Bertrand/0000-0002-3675-3499	Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research) [FKZ: 0315126]	Bundesministerium fur Bildung und Forschung (Federal Ministry of Education and Research)(Federal Ministry of Education & Research (BMBF))	Bundesministerium fur Bildung und Forschung grant (Federal Ministry of Education and Research) (FKZ: 0315126 to HMGL) URL: http://www.bmbf.de/en/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott KR, 2006, CAN J ZOOL, V84, P1240, DOI 10.1139/Z06-117; Alford DV, 1975, BUMBLEBEES; Alghamdi A, 2008, BIOL LETTERS, V4, P479, DOI 10.1098/rsbl.2008.0331; Anfora G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018903; Baer B, 2001, EVOLUTION, V55, P1639, DOI 10.1111/j.0014-3820.2001.tb00683.x; Baer B, 1999, NATURE, V397, P151, DOI 10.1038/16451; Baer B, 2003, ECOL LETT, V6, P106, DOI 10.1046/j.1461-0248.2003.00411.x; Bar-Shai N, 2011, BEHAV ECOL, V22, P317, DOI 10.1093/beheco/arq206; Bates D., 2008, LME4 LINEAR MIXED EF; Bell G, 1982, MASTERPIECE NATURE E; Biernaskie JM, 2007, P ROY SOC B-BIOL SCI, V274, P2595, DOI 10.1098/rspb.2007.0705; Biernaskie JM, 2009, AM NAT, V174, P413, DOI 10.1086/603629; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Birmingham AL, 2004, CAN J ZOOL, V82, P1843, DOI 10.1139/Z04-181; Blarer A, 2002, ETHOLOGY, V108, P341, DOI 10.1046/j.1439-0310.2002.00778.x; Bonsall MB, 2004, PHYSIOL ENTOMOL, V29, P223, DOI 10.1111/j.0307-6962.2004.00389.x; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Christe P, 1996, ANIM BEHAV, V52, P1087, DOI 10.1006/anbe.1996.0256; Crawley MJ, 2005, STAT INTRO USING R; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; Dornhaus A, 2005, BEHAV ECOL, V16, P661, DOI 10.1093/beheco/ari040; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; Durisko Z, 2011, ETHOLOGY, V117, P49, DOI 10.1111/j.1439-0310.2010.01842.x; Durrer Stephan, 1994, Proceedings of the Royal Society of London Series B Biological Sciences, V258, P299, DOI 10.1098/rspb.1994.0176; Ebert Dieter, 1996, Trends in Ecology and Evolution, V11, P79, DOI 10.1016/0169-5347(96)81047-0; Erler S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018126; Fankhauser R, 2008, EUR J WILDLIFE RES, V54, P88, DOI 10.1007/s10344-007-0115-1; Goulson D, 2000, J CHEM ECOL, V26, P2897, DOI 10.1023/A:1026406330348; Goulson D, 2001, J INSECT BEHAV, V14, P669, DOI 10.1023/A:1012231419067; Goulson Dave, 1999, Perspectives in Plant Ecology Evolution and Systematics, V2, P185, DOI 10.1078/1433-8319-00070; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Hughes WOH, 2004, EVOLUTION, V58, P1251, DOI 10.1111/j.0014-3820.2004.tb01704.x; Ings TC, 2005, OECOLOGIA, V144, P508, DOI 10.1007/s00442-005-0081-9; Jordan CY, 2006, AM NAT, V167, P496, DOI 10.1086/501142; Kawaguchi LG, 2006, FUNCT ECOL, V20, P239, DOI 10.1111/j.1365-2435.2006.01086.x; Keasar T, 1997, ISRAEL J PLANT SCI, V45, P223, DOI 10.1080/07929978.1997.10676686; Kunze J, 2001, BEHAV ECOL, V12, P447, DOI 10.1093/beheco/12.4.447; Leadbeater E, 2009, BIOL LETTERS, V5, P310, DOI 10.1098/rsbl.2008.0692; Lefebvre D, 2007, BEHAV ECOL SOCIOBIOL, V61, P1707, DOI 10.1007/s00265-007-0402-6; Liersch S, 1998, P ROY SOC B-BIOL SCI, V265, P221, DOI 10.1098/rspb.1998.0285; LIVELY CM, 1990, NATURE, V344, P864, DOI 10.1038/344864a0; Lopez-Vaamonde C, 2004, NATURE, V430, P557, DOI 10.1038/nature02769; Otterstatter MC, 2005, BEHAV ECOL SOCIOBIOL, V58, P383, DOI 10.1007/s00265-005-0945-3; Otto SP, 2004, SCIENCE, V304, P1018, DOI 10.1126/science.1094072; Popp M, 2011, J EUKARYOT MICROBIOL, V58, P7, DOI 10.1111/j.1550-7408.2010.00514.x; R Team Core Development, 2008, R LANG ENV STAT COMP; Raine NE, 2008, P R SOC B, V275, P803, DOI 10.1098/rspb.2007.1652; Raine NE, 2007, NATURWISSENSCHAFTEN, V94, P459, DOI 10.1007/s00114-006-0184-0; Raine NE, 2007, ENTOMOL GEN, V29, P179; Renner MA, 2008, INSECT SOC, V55, P417, DOI 10.1007/s00040-008-1021-6; Riddell C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007621; Riveros AJ, 2009, NATURWISSENSCHAFTEN, V96, P851, DOI 10.1007/s00114-009-0532-y; Salathe M, 2008, EVOLUTION, V62, P295, DOI 10.1111/j.1558-5646.2007.00265.x; Saleh N, 2007, ARTHROPOD-PLANT INTE, V1, P119, DOI 10.1007/s11829-007-9011-6; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schmid-Hempel P, 2001, NATURWISSENSCHAFTEN, V88, P147, DOI 10.1007/s001140100222; Schmid-Hempel R, 2000, INSECT SOC, V47, P36, DOI 10.1007/s000400050006; SCHMIDHEMPEL P, 1998, PARASITES SOCIAL INS; SHYKOFF JA, 1991, P ROY SOC B-BIOL SCI, V243, P55; Spaethe J, 2002, INSECT SOC, V49, P142, DOI 10.1007/s00040-002-8293-z; Tarpy DR, 2006, NATURWISSENSCHAFTEN, V93, P195, DOI 10.1007/s00114-006-0091-4; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507; Worden BD, 2005, BIOL LETT-UK, V1, P504, DOI 10.1098/rsbl.2005.0368	65	42	42	0	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26328	10.1371/journal.pone.0026328	http://dx.doi.org/10.1371/journal.pone.0026328			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039462	Green Submitted, gold, Green Published			2022-12-27	WOS:000296515200011
J	Sibley, CR; Wood, MJA				Sibley, Christopher R.; Wood, Matthew J. A.			Identification of Allele-Specific RNAi Effectors Targeting Genetic Forms of Parkinson's Disease	PLOS ONE			English	Article							ALPHA-SYNUCLEIN MUTATIONS; SECONDARY STRUCTURE; IN-VIVO; TRANSGENIC MICE; LRRK2; SIRNA; DEGRADATION; DYSFUNCTION; TOXICITY; STRATEGY	Parkinson's disease (PD) is a progressive neurological disorder affecting an estimated 5-10 million people worldwide. Recent evidence has implicated several genes that directly cause or increase susceptibility to PD. As well as advancing understanding of the genetic aetiology of PD these findings suggest new ways to modify the disease course, in some cases through genetic manipulation. Here we generated a 'walk-through' series of RNA Pol III-expressed shRNAs targeting both the alpha-synuclein A30P and LRRK2 G2019S PD-associated mutations. Allele-specific discrimination of the alpha-synuclein A30P mutation was achieved with alignments at position 10, 13 and 14 in two model systems, including a heterozygous model mimicking the disease setting, whilst 5'RACE was used to confirm stated alignments. Discrimination of the most common PD-linked LRRK2 G2019S mutation was assessed in hemizygous dual-luciferase assays and showed that alignment of the mutation opposite position 4 of the antisense species produced robust discrimination of alleles at all time points studied. Discrimination at this position was subsequently confirmed using siRNAs, where up to 10-fold discrimination was seen. The results suggest that RNAi-mediated silencing of PD-associated autosomal dominant genes could be a novel therapeutic approach for the treatment of the relevant clinical cases of PD in future.	[Sibley, Christopher R.; Wood, Matthew J. A.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Sibley, Christopher R.] MRC, Mol Biol Lab, Cambridge CB2 2QH, England	University of Oxford; MRC Laboratory Molecular Biology	Sibley, CR (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	matthew.wood@dpag.ox.ac.uk	Wood, Matthew/HDN-1469-2022	Wood, Matthew/0000-0002-5436-6011; Sibley, Christopher/0000-0002-8286-4683	Medical Research Council; Parkinson's UK; MRC [G0900887, MC_U105185858] Funding Source: UKRI; Medical Research Council [MC_U105185858, G0900887] Funding Source: researchfish; Parkinson&quot;s UK [G-0503, G-0904] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Parkinson's UK(Parkinson's UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK)	Funding: This work was supported a Medical Research Council Studentship (CRS). This work was supported by a research grants from Parkinson's UK to MJAW. A free gift of an siRNA was provided by Novartis Pharmaceuticals with nothing in exchange. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeliovich A, 2000, NEURON, V25, P239, DOI 10.1016/S0896-6273(00)80886-7; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Ding HL, 2003, AGING CELL, V2, P209, DOI 10.1046/j.1474-9728.2003.00054.x; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; Giasson BI, 2008, NEUROSIGNALS, V16, P99, DOI 10.1159/000109764; Gomez-Isla T, 2003, NEUROBIOL AGING, V24, P245, DOI 10.1016/S0197-4580(02)00091-X; Gorbatyuk OS, 2010, MOL THER, V18, P1450, DOI 10.1038/mt.2010.115; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Heale BSE, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni026; Hickerson RP, 2008, J INVEST DERMATOL, V128, P594, DOI 10.1038/sj.jid.5701060; Holen T, 2005, NUCLEIC ACIDS RES, V33, P4704, DOI 10.1093/nar/gki785; Kachergus J, 2005, AM J HUM GENET, V76, P672, DOI 10.1086/429256; Kanda S, 2000, NEUROSCIENCE, V97, P279, DOI 10.1016/S0306-4522(00)00077-4; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kubodera T, 2005, OLIGONUCLEOTIDES, V15, P298, DOI 10.1089/oli.2005.15.298; Lashuel HA, 2002, J MOL BIOL, V322, P1089, DOI 10.1016/S0022-2836(02)00735-0; Lesage S, 2009, HUM MOL GENET, V18, pR48, DOI 10.1093/hmg/ddp012; McBride JL, 2008, P NATL ACAD SCI USA, V105, P5868, DOI 10.1073/pnas.0801775105; Miller VM, 2004, NUCLEIC ACIDS RES, V32, P661, DOI 10.1093/nar/gkh208; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Nonaka T, 2009, BIOCHEMISTRY-US, V48, P8014, DOI 10.1021/bi900619j; Ohnishi Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002248; Pandey N, 2006, EXP NEUROL, V197, P515, DOI 10.1016/j.expneurol.2005.10.019; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Rathke-Hartlieb S, 2001, J NEUROCHEM, V77, P1181, DOI 10.1046/j.1471-4159.2001.00366.x; Sapru MK, 2006, EXP NEUROL, V198, P382, DOI 10.1016/j.expneurol.2005.12.024; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Scholefield J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007232; Schwarz DS, 2006, PLOS GENET, V2, P1307, DOI 10.1371/journal.pgen.0020140; Shao Y, 2007, RNA, V13, P1631, DOI 10.1261/rna.546207; Sibley CR, 2010, MOL THER, V18, P466, DOI 10.1038/mt.2009.306; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Strazewski P, 1999, RNA, V5, P1490, DOI 10.1017/S1355838299991586; Tong YR, 2010, P NATL ACAD SCI USA, V107, P9879, DOI 10.1073/pnas.1004676107; Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001; WANG JJ, 2011, NEUROSCI LETT, DOI DOI 10.1016/J.NEULET.2011.04.064; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008; Yue ZY, 2009, FEBS J, V276, P6445, DOI 10.1111/j.1742-4658.2009.07343.x; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhou H, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S1-S9	46	14	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26194	10.1371/journal.pone.0026194	http://dx.doi.org/10.1371/journal.pone.0026194			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031823	gold, Green Published, Green Submitted			2022-12-27	WOS:000296513200010
J	Beekman, R; Valkhof, M; Erkeland, SJ; Taskesen, E; Rockova, V; Peeters, JK; Valk, PJM; Lowenberg, B; Touw, IP				Beekman, Renee; Valkhof, Marijke; Erkeland, Stefan J.; Taskesen, Erdogan; Rockova, Veronika; Peeters, Justine K.; Valk, Peter J. M.; Lowenberg, Bob; Touw, Ivo P.			Retroviral Integration Mutagenesis in Mice and Comparative Analysis in Human AML Identify Reduced PTP4A3 Expression as a Prognostic Indicator	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; INSERTIONAL MUTAGENESIS; PRL-3 EXPRESSION; TILING-ARRAYS; CANCER; GENES; CELLS; IDENTIFICATION; METHYLATION; NETWORKS	Acute myeloid leukemia (AML) results from multiple genetic and epigenetic aberrations, many of which remain unidentified. Frequent loss of large chromosomal regions marks haplo-insufficiency as one of the major mechanisms contributing to leukemogenesis. However, which haplo-insufficient genes (HIGs) are involved in leukemogenesis is largely unknown and powerful experimental strategies aimed at their identification are currently lacking. Here, we present a new approach to discover HIGs, using retroviral integration mutagenesis in mice in which methylated viral integration sites and neighbouring genes were identified. In total we mapped 6 genes which are flanked by methylated viral integration sites (mVIS). Three of these, i.e., Lrmp, Hcls1 and Prkrir, were up regulated and one, i.e., Ptp4a3, was down regulated in the affected tumor. Next, we investigated the role of PTP4A3 in human AML and we show that PTP4A3 expression is a negative prognostic indicator, independent of other prognostic parameters. In conclusion, our novel strategy has identified PTP4A3 to potentially have a role in AML, on one hand as a candidate HIG contributing to leukemogenesis in mice and on the other hand as a prognostic indicator in human AML.	[Beekman, Renee; Valkhof, Marijke; Erkeland, Stefan J.; Taskesen, Erdogan; Rockova, Veronika; Peeters, Justine K.; Valk, Peter J. M.; Lowenberg, Bob; Touw, Ivo P.] Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands; [Rockova, Veronika] Erasmus Univ, Dept Biostat, Med Ctr, NL-3000 DR Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Beekman, R (corresponding author), Erasmus Univ, Dept Hematol, Med Ctr, Rotterdam, Netherlands.	i.touw@erasmusmc.nl	Valk, Peter/AAX-2823-2020; Beekman, Renée/AAF-2088-2020; Taskesen, Erdogan/N-4983-2015	Beekman, Renée/0000-0001-7081-7874; Taskesen, Erdogan/0000-0002-3430-9618; Erkeland, Stefan/0000-0002-1019-7957	Center for Translational Molecular Medicine (CTMM); Netherlands Genomics Initiative (NGI); Dutch Cancer Society (KWF Kankerbestrijding)	Center for Translational Molecular Medicine (CTMM); Netherlands Genomics Initiative (NGI); Dutch Cancer Society (KWF Kankerbestrijding)(KWF Kankerbestrijding)	This research is supported by the Center for Translational Molecular Medicine (www.ctmm.nl, CTMM), the Netherlands Genomics Initiative (NGI) and the Dutch Cancer Society (www.kwfkankerbestrijding.nl, KWF Kankerbestrijding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak S, 2008, MOL CELL, V30, P303, DOI 10.1016/j.molcel.2008.04.002; Broyl A, 2010, BLOOD, V116, P2543, DOI 10.1182/blood-2009-12-261032; Erkeland SJ, 2004, J VIROL, V78, P1971, DOI 10.1128/JVI.78.4.1971-1980.2004; Fagerli UM, 2008, BLOOD, V111, P806, DOI 10.1182/blood-2007-07-101139; Hao RT, 2010, J CANCER RES CLIN, V136, P1349, DOI 10.1007/s00432-010-0786-y; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Juric D, 2007, J CLIN ONCOL, V25, P1341, DOI 10.1200/JCO.2006.09.3534; Kool J, 2009, NAT REV CANCER, V9, P389, DOI 10.1038/nrc2647; Laurent C, 2011, CANCER RES, V71, P666, DOI 10.1158/0008-5472.CAN-10-0605; Lorincz MC, 2000, MOL CELL BIOL, V20, P842, DOI 10.1128/MCB.20.3.842-850.2000; Lowenberg Bob, 2008, Hematology Am Soc Hematol Educ Program, P1, DOI 10.1182/asheducation-2008.1.1; Min SH, 2010, LIFE SCI, V86, P66, DOI 10.1016/j.lfs.2009.11.010; Mollevi DG, 2008, BRIT J CANCER, V99, P1718, DOI 10.1038/sj.bjc.6604747; Pfeifer D, 2009, J CANCER RES CLIN, V135, P1583, DOI 10.1007/s00432-009-0606-4; Suzuki T, 2002, NAT GENET, V32, P166, DOI 10.1038/ng949; Suzuki T, 2006, EMBO J, V25, P3422, DOI 10.1038/sj.emboj.7601215; Swerdlow S. H., WHO CLASSIFICATION T; Swindle CS, 2004, J BIOL CHEM, V279, P34, DOI 10.1074/jbc.M309128200; Taskesen E, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-275; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; Verhaak RGW, 2009, HAEMATOL-HEMATOL J, V94, P131, DOI 10.3324/haematol.13299; Voisin W, 2006, J VIROL, V80, P4026, DOI 10.1128/JVI.80.8.4026-4037.2006; Wang HH, 2007, CANCER RES, V67, P2922, DOI 10.1158/0008-5472.CAN-06-3598; Wang Z, 2009, J CANCER RES CLIN, V135, P1041, DOI 10.1007/s00432-008-0541-9; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Wouters BJ, 2009, BLOOD, V113, P291, DOI 10.1182/blood-2008-04-153239; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yao SY, 2004, MOL THER, V10, P27, DOI 10.1016/j.ymthe.2004.04.007; Zhao WB, 2008, INT J MOL MED, V22, P187, DOI 10.3892/ijmm_00000007; Zhou JB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019798	31	16	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26537	10.1371/journal.pone.0026537	http://dx.doi.org/10.1371/journal.pone.0026537			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028901	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800052
J	Antonioni, A; Tomassini, M				Antonioni, Alberto; Tomassini, Marco			Network Fluctuations Hinder Cooperation in Evolutionary Games	PLOS ONE			English	Article							PRISONERS-DILEMMA GAME; EMPIRICAL-ANALYSIS; SOCIAL DILEMMAS; EMERGENCE; DYNAMICS	In this paper we study the influence of random network fluctuations on the behavior of evolutionary games on Barabasi-Albert networks. This network class has been shown to promote cooperation on social dilemmas such as the Prisoner's Dilemma and the Snowdrift games when the population network is fixed. Here we introduce exogenous random fluctuations of the network links through several noise models, and we investigate the evolutionary dynamics comparing them with the known static network case. The results we obtain show that even a moderate amount of random noise on the network links causes a significant loss of cooperation, to the point that cooperation vanishes altogether in the Prisoner's Dilemma when the noise rate is the same as the agents' strategy revision rate. The results appear to be robust since they are essentially the same whatever the type of the exogenous noise. Besides, it turns out that random network noise is more important than strategy noise in suppressing cooperation. Thus, even in the more favorable situation of accumulated payoff in which links have no cost, the mere presence of random external network fluctuations act as a powerful limitation to the attainment of high levels of cooperation.	[Antonioni, Alberto; Tomassini, Marco] Univ Lausanne, Dept Informat Syst, Fac Business & Econ, Lausanne, Switzerland	University of Lausanne	Antonioni, A (corresponding author), Univ Lausanne, Dept Informat Syst, Fac Business & Econ, Lausanne, Switzerland.	alberto.antonioni@unil.ch	Antonioni, Alberto/U-6497-2018; Tomassini, Marco/D-6312-2013; Antonioni, Alberto/B-9686-2014	Antonioni, Alberto/0000-0002-5788-3348; Antonioni, Alberto/0000-0002-5788-3348	Swiss National Scientific Foundation [200021-132802/1]; University of Lausanne	Swiss National Scientific Foundation(Swiss National Science Foundation (SNSF)); University of Lausanne	Project partially funded by the Swiss National Scientific Foundation under grant n. 200021-132802/1 (http://www.snf.ch/F/Pages/default.aspx). The rest of the salary of A. Antonioni is paid by the University of Lausanne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; [Anonymous], 1995, EVOLUTIONARY GAME TH; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Eguiluz VM, 2005, AM J SOCIOL, V110, P977, DOI 10.1086/428716; Hauert C, 2004, NATURE, V428, P643, DOI 10.1038/nature02360; Jackson MO, 2008, SOCIAL AND ECONOMIC NETWORKS, P1; Kossinets G, 2006, SCIENCE, V311, P88, DOI 10.1126/science.1116869; Leskovec J., 2007, ACM T KNOWLEDGE DISC, V1; Lozano S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001892; Luthi L, 2008, PHYSICA A, V387, P955, DOI 10.1016/j.physa.2007.09.046; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Masuda N, 2007, P R SOC B, V274, P1815, DOI 10.1098/rspb.2007.0294; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; Pena J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016110; Perc M, 2010, BIOSYSTEMS, V99, P109, DOI 10.1016/j.biosystems.2009.10.003; Pestelacci Enea, 2008, Biological Theory, V3, P139, DOI 10.1162/biot.2008.3.2.139; Poncela J, 2010, INT J BIFURCAT CHAOS, V20, P849, DOI 10.1142/S0218127410026137; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Roca CP, 2009, EUR PHYS J B, V71, P587, DOI 10.1140/epjb/e2009-00189-0; Roca CP, 2009, PHYS LIFE REV, V6, P208, DOI 10.1016/j.plrev.2009.08.001; Santos FC, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098104; Santos FC, 2006, P NATL ACAD SCI USA, V103, P3490, DOI 10.1073/pnas.0508201103; Santos FC, 2006, PLOS COMPUT BIOL, V2, P1284, DOI 10.1371/journal.pcbi.0020140; Szabo G, 2007, PHYS REP, V446, P97, DOI 10.1016/j.physrep.2007.04.004; Szolnoki A, 2008, PHYSICA A, V387, P2075, DOI 10.1016/j.physa.2007.11.021; Tomassini M, 2007, INT J MOD PHYS C, V18, P1173, DOI 10.1142/S0129183107011212; Tomassini M, 2007, PHYSICA A, V385, P750, DOI 10.1016/j.physa.2007.07.028; Wu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011187; Zimmermann MG, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.065102	32	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25555	10.1371/journal.pone.0025555	http://dx.doi.org/10.1371/journal.pone.0025555			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039416	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500014
J	Bailey, JR; Probert, CSJ; Cogan, TA				Bailey, Jennifer R.; Probert, Christopher S. J.; Cogan, Tristan A.			Identification and Characterisation of an Iron-Responsive Candidate Probiotic	PLOS ONE			English	Article							PLACEBO-CONTROLLED TRIAL; LACTIC-ACID BACTERIA; INFLAMMATORY-BOWEL-DISEASE; STRAIN NISSLE 1917; ESCHERICHIA-COLI; ULCERATIVE-COLITIS; T-CELLS; EPITHELIAL-CELLS; ATOPIC DISEASE; DOUBLE-BLIND	Background: Iron is an essential cofactor in almost all biological systems. The lactic acid bacteria (LAB), frequently employed as probiotics, are unusual in having little or no requirement for iron. Iron in the human body is sequestered by transferrins and lactoferrin, limiting bacterial growth. An increase in the availability of iron in the intestine by bleeding, surgery, or under stress leads to an increase in the growth and virulence of many pathogens. Under these high iron conditions, LAB are rapidly out-competed; for the levels of probiotic bacteria to be maintained under high iron conditions they must be able to respond by increasing growth rate to compete with the normal flora. Despite this, iron-responsive genera are poorly characterised as probiotics. Methodology/Principal Findings: Here, we show that a panel of probiotics are not able to respond to increased iron availability, and identify an isolate of Streptococcus thermophilus that can increase growth rate in response to increased iron availability. The isolate of S. thermophilus selected was able to reduce epithelial cell death as well as NF-kappa B signalling and IL-8 production triggered by pathogens. It was capable of crossing an epithelial cell barrier in conjunction with E. coli and downregulating Th1 and Th17 responses in primary human intestinal leukocytes. Conclusions/Significance: We propose that an inability to compete with potential pathogens under conditions of high iron availability such as stress and trauma may contribute to the lack of efficacy of many LAB-based probiotics in treating disease. Therefore, we offer an alternative paradigm which considers that probiotics should be able to be competitive during periods of intestinal bleeding, trauma or stress.	[Bailey, Jennifer R.; Cogan, Tristan A.] Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England; [Probert, Christopher S. J.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England	University of Bristol; University of Bristol	Bailey, JR (corresponding author), Univ Bristol, Sch Vet Sci, Bristol BS18 7DU, Avon, England.	tristan.cogan@bristol.ac.uk	Bailey, Jennifer/H-5856-2013	Probert, Christopher/0000-0003-4550-0239				Abrahamsson TR, 2007, J ALLERGY CLIN IMMUN, V119, P1174, DOI 10.1016/j.jaci.2007.01.007; Anukam KC, 2008, J CLIN GASTROENTEROL, V42, P239, DOI 10.1097/MCG.0b013e31802c7465; ARCHIBALD F, 1986, CRC CR REV MICROBIOL, V13, P63, DOI 10.3109/10408418609108735; Bibiloni R, 2005, AM J GASTROENTEROL, V100, P1539, DOI 10.1111/j.1572-0241.2005.41794.x; BRUYNEEL B, 1989, BIOTECHNOL LETT, V11, P401, DOI 10.1007/BF01089472; Burke JP, 2007, AM J GASTROENTEROL, V102, P439, DOI 10.1111/j.1572-0241.2006.01010.x; de Chambrun GP, 2008, CURR OPIN GASTROEN, V24, P440, DOI 10.1097/MOG.0b013e3283023be5; Food and Agriculture Organization of the United Nations World Health Organization, 2001, REP JOINT FAO WHO EX; Freestone PP, 2002, SHOCK, V18, P465, DOI 10.1097/00024382-200211000-00014; Freestone PPE, 1999, FEMS MICROBIOL LETT, V172, P53, DOI 10.1111/j.1574-6968.1999.tb13449.x; Furet JP, 2004, INT J FOOD MICROBIOL, V97, P197, DOI 10.1016/j.ijfoodmicro.2004.04.020; Gronbach K, 2010, INFECT IMMUN, V78, P3036, DOI 10.1128/IAI.00218-10; Hafez M, 2010, INFECT IMMUN, V78, P2153, DOI 10.1128/IAI.01406-09; Haller D, 2010, J NUTR, V140, p690S, DOI 10.3945/jn.109.113746; Hickson M, 2007, BMJ-BRIT MED J, V335, P80, DOI 10.1136/bmj.39231.599815.55; Hoffmann M, 2008, J NUTR, V138, P1684, DOI 10.1093/jn/138.9.1684; Imbert M, 1998, CURR MICROBIOL, V37, P64, DOI 10.1007/s002849900339; Inman CF, 2005, J IMMUNOL METHODS, V302, P156, DOI 10.1016/j.jim.2005.05.005; Isolauri E, 2000, CLIN EXP ALLERGY, V30, P1604, DOI 10.1046/j.1365-2222.2000.00943.x; Ivory K, 2008, CLIN EXP ALLERGY, V38, P1282, DOI 10.1111/j.1365-2222.2008.03025.x; Kalliomaki M, 2003, LANCET, V361, P1869, DOI 10.1016/S0140-6736(03)13490-3; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kalliomaki M, 2007, J ALLERGY CLIN IMMUN, V119, P1019, DOI 10.1016/j.jaci.2006.12.608; Kwon HK, 2010, P NATL ACAD SCI USA, V107, P2159, DOI 10.1073/pnas.0904055107; Majamaa H, 1997, J ALLERGY CLIN IMMUN, V99, P179, DOI 10.1016/S0091-6749(97)70093-9; McFarland Lynne V, 2007, Travel Med Infect Dis, V5, P97, DOI 10.1016/j.tmaid.2005.10.003; Metchnikoff E., 1907, PROLONGATION LIFE OP; Pagnini C, 2010, P NATL ACAD SCI USA, V107, P454, DOI 10.1073/pnas.0910307107; PANDEY A, 1994, APPL MICROBIOL BIOT, V40, P735, DOI [10.1007/BF00173337, 10.1007/s002530050058]; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; Rodriguez C, 2010, WORLD J GASTROENTERO, V16, P1622, DOI 10.3748/wjg.v16.i13.1622; Roselli M, 2009, INFLAMM BOWEL DIS, V15, P1526, DOI 10.1002/ibd.20961; Sandrini SM, 2010, J BACTERIOL, V192, P587, DOI 10.1128/JB.01028-09; Singh Udai P., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P111, DOI 10.2174/187153007780832109; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stallmach A, 2001, EUR J IMMUNOL, V31, P1228, DOI 10.1002/1521-4141(200104)31:4<1228::AID-IMMU1228>3.0.CO;2-K; Sturm A, 2004, J IMMUNOL, V173, P3889, DOI 10.4049/jimmunol.173.6.3889; Subramanian S, 2008, INFLAMM BOWEL DIS, V14, P162, DOI 10.1002/ibd.20296; Szajewska H, 2007, ALIMENT PHARM THER, V25, P871, DOI 10.1111/j.1365-2036.2007.03282.x; Tursi A, 2004, MED SCI MONITOR, V10, pPI126; van Baarlen P, 2009, P NATL ACAD SCI USA, V106, P2371, DOI 10.1073/pnas.0809919106; Venturi A, 1999, ALIMENT PHARM THER, V13, P1103; West CE, 2009, PEDIATR ALLERGY IMMU, V20, P430, DOI 10.1111/j.1399-3038.2009.00745.x; WOOLDRIDGE KG, 1993, FEMS MICROBIOL REV, V12, P325, DOI 10.1016/0168-6445(93)90011-W	44	20	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26507	10.1371/journal.pone.0026507	http://dx.doi.org/10.1371/journal.pone.0026507			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039501	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500079
J	Bian, YN; Zhou, W; Zhao, YC; Li, XP; Geng, W; Hao, RX; Yang, Q; Huang, WD				Bian, Yingnan; Zhou, Wei; Zhao, Yingchun; Li, Xiaoping; Geng, Wei; Hao, Ruixin; Yang, Qing; Huang, Weida			High-Dose siRNAs Upregulate Mouse Eri-1 at both Transcription and Posttranscription Levels	PLOS ONE			English	Article							GENE-EXPRESSION; HISTONE DEACETYLASE; PROMOTER ACTIVITY; SIGNAL TRANSDUCER; INTERFERING RNAS; MESSENGER-RNA; DNA-BINDING; IN-VIVO; C-JUN; EPITHELIAL-CELLS	The eri-1 gene encodes a 3' exonuclease that can negatively regulate RNA interference via siRNase activity. High-dose siRNAs (hd-siRNAs) can enhance Eri-1 expression, which in return degrade siRNAs and greatly reduces RNAi efficiency. Here we report that hd-siRNAs induce mouse Eri-1 (meri-1) expression through the recruitment of Sp1, Ets-1, and STAT3 to the meri-1 promoter and the formation of an Sp1-Ets-1-STAT3 complex. In addition, hd-siRNAs also abolish the 3' untranslated region (UTR) mediated posttranscriptional repression of meri-1. Our findings demonstrate the molecular mechanism underlying the upregulation of meri-1 by hd-siRNA.	[Bian, Yingnan; Zhou, Wei; Zhao, Yingchun; Li, Xiaoping; Geng, Wei; Hao, Ruixin; Yang, Qing; Huang, Weida] Fudan Univ, Sch Life Sci, Dept Biochem, Shanghai 200433, Peoples R China; [Huang, Weida] Chinese Acad Sci, Shanghai Adv Res Inst, Lab Synthet Biol, Ctr Nanomed, Shanghai, Peoples R China	Fudan University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS	Bian, YN (corresponding author), Fudan Univ, Sch Life Sci, Dept Biochem, Shanghai 200433, Peoples R China.	whuang@fudan.edu.cn		Zhou, Wei/0000-0003-3742-2592	Shanghai Leading Academic Discipline Project [B111]; NSF of China [50533010]	Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project); NSF of China(National Natural Science Foundation of China (NSFC))	This study was supported by Shanghai Leading Academic Discipline Project (Project Number: B111, http://www.shmec.gov.cn/) and NSF of China (No. 50533010, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2009, ANN NY ACAD SCI, V1171, P59, DOI 10.1111/j.1749-6632.2009.04911.x; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; BERGER J, 1988, GENE, V66, P1, DOI 10.1016/0378-1119(88)90219-3; Black AR, 1999, J BIOL CHEM, V274, P1207, DOI 10.1074/jbc.274.3.1207; Bouwman P, 2002, MOL CELL ENDOCRINOL, V195, P27, DOI 10.1016/S0303-7207(02)00221-6; Burgyan Jozsef, 2008, V451, P69, DOI 10.1007/978-1-59745-102-4_5; Caldenhoven E, 1996, J BIOL CHEM, V271, P13221, DOI 10.1074/jbc.271.22.13221; Campillos M, 2003, NUCLEIC ACIDS RES, V31, P3063, DOI 10.1093/nar/gkg435; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Chen BK, 2000, P NATL ACAD SCI USA, V97, P10406, DOI 10.1073/pnas.180321497; Diamond DA, 1999, J BIOL CHEM, V274, P16959, DOI 10.1074/jbc.274.24.16959; Dittmer Jurgen, 2003, Mol Cancer, V2, P29, DOI 10.1186/1476-4598-2-29; Dominski Z, 2003, MOL CELL, V12, P295, DOI 10.1016/S1097-2765(03)00278-8; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; DYER RB, 1995, NUCLEIC ACIDS RES, V23, P3345; Emiliani S, 1998, P NATL ACAD SCI USA, V95, P2795, DOI 10.1073/pnas.95.6.2795; Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fischer SEJ, 2008, NATURE, V455, P491, DOI 10.1038/nature07274; Fujimoto E, 2005, ONCOGENE, V24, P3684, DOI 10.1038/sj.onc.1208430; Gess B, 2008, J NEUROSCI RES, V86, P797, DOI 10.1002/jnr.21528; Greenwel P, 1997, J BIOL CHEM, V272, P19738, DOI 10.1074/jbc.272.32.19738; Hong J, 2005, BIOCHEM J, V390, P675, DOI 10.1042/BJ20050647; Hong J, 2007, BIOCHEM BIOPH RES CO, V361, P373, DOI 10.1016/j.bbrc.2007.07.003; Hong J, 2006, BIOCHEM BIOPH RES CO, V348, P600, DOI 10.1016/j.bbrc.2006.07.107; Huang WQ, 2005, J BIOL CHEM, V280, P10047, DOI 10.1074/jbc.M408680200; Hung JJ, 2006, MOL CELL BIOL, V26, P1770, DOI 10.1128/MCB.26.5.1770-1785.2006; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Kardassis D, 1999, J BIOL CHEM, V274, P29572, DOI 10.1074/jbc.274.41.29572; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Kim KR, 2000, ONCOGENE, V19, P1764, DOI 10.1038/sj.onc.1203502; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kiryu-Seo S, 2008, J BIOL CHEM, V283, P6988, DOI 10.1074/jbc.M707514200; Krainc D, 1998, J BIOL CHEM, V273, P26218, DOI 10.1074/jbc.273.40.26218; KUMAR P, 2010, J BIOL CHEM; Lee C, 2008, CANCER RES, V68, P8661, DOI 10.1158/0008-5472.CAN-08-1082; LEGGETT RW, 1995, J BIOL CHEM, V270, P25879, DOI 10.1074/jbc.270.43.25879; Leslie K, 2006, CANCER RES, V66, P2544, DOI 10.1158/0008-5472.CAN-05-2203; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li RZ, 2000, ONCOGENE, V19, P6514, DOI 10.1038/sj.onc.1204035; Lin SB, 2006, MOL ENDOCRINOL, V20, P3376, DOI 10.1210/me.2006-0177; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Liu L, 2005, P NATL ACAD SCI USA, V102, P8150, DOI 10.1073/pnas.0501643102; Loeffler S, 2005, INT J CANCER, V115, P202, DOI 10.1002/ijc.20871; LZEL MH, 2010, J BIOL CHEM, V285, P6364; Marinescu VD, 2005, NUCLEIC ACIDS RES, V33, pD91, DOI 10.1093/nar/gki103; Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Nakajima K, 1996, EMBO J, V15, P3651, DOI 10.1002/j.1460-2075.1996.tb00734.x; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Persengiev SP, 2004, RNA, V10, P12, DOI 10.1261/rna5160904; Petersohn D, 1996, EUR J BIOCHEM, V239, P827, DOI 10.1111/j.1432-1033.1996.0827u.x; Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Pushparaj PN, 2008, J DENT RES, V87, P992, DOI 10.1177/154405910808701109; Pushparaj PN, 2008, INT J BIOCHEM CELL B, V40, P1817, DOI 10.1016/j.biocel.2008.01.015; Qian ZK, 2005, WORLD J GASTROENTERO, V11, P1297, DOI 10.3748/wjg.v11.i9.1297; Ray S, 2008, NUCLEIC ACIDS RES, V36, P4510, DOI 10.1093/nar/gkn419; Rozen S, 2000, Methods Mol Biol, V132, P365; Ryu H, 2003, J NEUROSCI, V23, P3597; Ryu H, 2003, P NATL ACAD SCI USA, V100, P4281, DOI 10.1073/pnas.0737363100; Santiago FS, 2004, CIRC RES, V95, P479, DOI 10.1161/01.RES.0000141135.36279.67; Schnur N, 2007, BBA-MOL CELL BIOL L, V1771, P1271, DOI 10.1016/j.bbalip.2007.08.003; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Shimizu R, 2010, LEUKEMIA, V24, P1760, DOI 10.1038/leu.2010.157; SIOUD M, 2006, J BIOMED BIOTECHNOL, V2, P4; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Sliva K, 2006, VIROLOGY, V351, P218, DOI 10.1016/j.virol.2006.03.014; Sternson SM, 2001, ORG LETT, V3, P4239, DOI 10.1021/ol016915f; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Suzuki T, 2000, GENES CELLS, V5, P29, DOI 10.1046/j.1365-2443.2000.00302.x; Tapias A, 2008, CELL CYCLE, V7, P2856, DOI 10.4161/cc.7.18.6671; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tong L, 2006, INVEST OPHTH VIS SCI, V47, P4295, DOI 10.1167/iovs.06-0412; Torigoe T, 2005, J BIOL CHEM, V280, P1179, DOI 10.1074/jbc.M410499200; Verger A, 2002, BIOESSAYS, V24, P362, DOI 10.1002/bies.10068; Waby JS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-275; Xuan BQ, 2005, MOL BIOTECHNOL, V31, P203, DOI 10.1385/MB:31:3:203; Yan GZ, 1997, J NEUROSCI, V17, P6122; Yang SL, 2009, ONCOGENE, V28, P1320, DOI 10.1038/onc.2008.475; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Yoshida T, 2005, CANCER RES, V65, P5662, DOI 10.1158/0008-5472.CAN-05-0693; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang XC, 2004, J BIOL CHEM, V279, P10677, DOI 10.1074/jbc.M312941200; Zheng ZM, 2005, ANN NY ACAD SCI, V1058, P105, DOI 10.1196/annals.1359.019	94	7	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26466	10.1371/journal.pone.0026466	http://dx.doi.org/10.1371/journal.pone.0026466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039495	gold, Green Published, Green Submitted			2022-12-27	WOS:000296507500073
J	El-Osta, H; Falchook, G; Tsimberidou, A; Hong, D; Naing, A; Kim, K; Wen, SJ; Janku, F; Kurzrock, R				El-Osta, Hazem; Falchook, Gerald; Tsimberidou, Apostolia; Hong, David; Naing, Aung; Kim, Kevin; Wen, Sijin; Janku, Filip; Kurzrock, Razelle			BRAF Mutations in Advanced Cancers: Clinical Characteristics and Outcomes	PLOS ONE			English	Article							COLORECTAL-CANCER; MELANOMA PATIENTS; KRAS; VALIDATION	Background: Oncogenic BRAF mutations have been found in diverse malignancies and activate RAF/MEK/ERK signaling, a critical pathway of tumorigenesis. We examined the clinical characteristics and outcomes of patients with mutant (mut) BRAF advanced cancer referred to phase 1 clinic. Methods: We reviewed the records of 80 consecutive patients with mutBRAF advanced malignancies and 149 with wild-type (wt) BRAF (matched by tumor type) referred to the Clinical Center for Targeted Therapy and analyzed their outcome. Results: Of 80 patients with mutBRAF advanced cancer, 56 had melanoma, 10 colorectal, 11 papillary thyroid, 2 ovarian and 1 esophageal cancer. Mutations in codon 600 were found in 77 patients (62, V600E; 13, V600K; 1, V600R; 1, unreported). Multivariate analysis showed less soft tissue (Odds ratio (OR) = 0.39, 95%CI: 0.20-0.77, P = 0.007), lung (OR = 0.38, 95%CI: 0.19-0.73, p = 0.004) and retroperitoneal metastases (OR = 0.34, 95%CI: 0.13-0.86, p = 0.024) and more brain metastases (OR = 2.05, 95%CI: 1.02-4.11, P = 0.043) in patients with mutBRAF versus wtBRAF. Comparing to the corresponding wtBRAF, mutBRAF melanoma patients had insignificant trend to longer median survival from diagnosis (131 vs. 78 months, p = 0.14), while mutBRAF colorectal cancer patients had an insignificant trend to shorter median survival from diagnosis (48 vs. 53 months, p = 0.22). In melanoma, V600K mutations in comparison to other BRAF mutations were associated with more frequent brain (75% vs. 36.3%, p = 0.02) and lung metastases (91.6% vs. 47.7%, p = 0.007), and shorter time from diagnosis to metastasis and to death (19 vs. 53 months, p = 0.046 and 78 vs. 322 months, p = 0.024 respectively). Treatment with RAF/MEK targeting agents (Hazard ratio (HR) = 0.16, 95%CI: 0.03-0.89, p = 0.037) and any decrease in tumor size after referral (HR = 0.07, 95%CI: 0.015-0.35, p = 0.001) correlated with longer survival in mutBRAF patients. Conclusions: BRAF appears to be a druggable mutation that also defines subgroups of patients with phenotypic overlap, albeit with differences that correlate with histology or site of mutation.	[El-Osta, Hazem; Falchook, Gerald; Tsimberidou, Apostolia; Hong, David; Naing, Aung; Janku, Filip; Kurzrock, Razelle] Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA; [Kim, Kevin] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Wen, Sijin] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	El-Osta, H (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Invest Canc Therapeut, Phase Clin Trials Program 1, Houston, TX 77030 USA.	rkurzroc@mdanderson.org	Janku, Filip/ABB-9136-2020; Kurzrock, Razelle/AAU-9782-2020	Tsimberidou, Apostolia M./0000-0003-2713-233X; Wen, Sijin/0000-0002-6955-2917; Naing, Aung/0000-0002-4803-8513	National Center for Research Resources, National Institutes of Health Roadmap for Medical Research [RR024148]; GlaxoSmithKline; AstraZeneca; Genentech; Bayer; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	National Center for Research Resources, National Institutes of Health Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); GlaxoSmithKline(GlaxoSmithKline); AstraZeneca(AstraZeneca); Genentech(Roche HoldingGenentech); Bayer(Bayer AG); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported in part by Grant Number RR024148 from the National Center for Research Resources, a component of the National Institutes of Health Roadmap for Medical Research. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.; Dr Razelle Kurzrock received commercial research grants from GlaxoSmithKline, AstraZeneca, Genentech and Bayer. Dr Gerald Falchook received commercial research grant from GlaxoSmithKline. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Arkenau HT, 2009, J CLIN ONCOL, V27, P2692, DOI 10.1200/JCO.2008.19.5081; Balch CM, 2001, J CLIN ONCOL, V19, P3622, DOI 10.1200/JCO.2001.19.16.3622; Chang David Z, 2004, J Transl Med, V2, P46, DOI 10.1186/1479-5876-2-46; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; De Roock W, 2010, LANCET ONCOL, V11, P753, DOI 10.1016/S1470-2045(10)70130-3; Eberhard DA, 2005, J CLIN ONCOL, V23, P5900, DOI 10.1200/JCO.2005.02.857; Flaherty KT, 2010, CANCER-AM CANCER SOC, V116, P4902, DOI 10.1002/cncr.25261; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fugazzola L, 2006, ENDOCR-RELAT CANCER, V13, P455, DOI 10.1677/erc.1.01086; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Houben Roland, 2004, J Carcinog, V3, P6, DOI 10.1186/1477-3163-3-6; INFANTE JR, 2010, J CLIN ONCOL S, V28, pS15; JOSEPH RW, 2010, J CLIN ONCOL S, V28, pS15; Jovanovic B, 2010, J INVEST DERMATOL, V130, P618, DOI 10.1038/jid.2009.287; Kefford RF, 2010, J CLIN ONCOL S, V28, p15s; Kumar R, 2003, CLIN CANCER RES, V9, P3362; LINOT B, 2010, 2010 GASTR CANC S; Long GV, 2010, J CLIN ONCOL, V28, p15s; Loupakis F, 2009, BRIT J CANCER, V101, P715, DOI 10.1038/sj.bjc.6605177; Nosho K, 2008, NEOPLASIA, V10, P534, DOI 10.1593/neo.08336; Richman SD, 2009, J CLIN ONCOL, V27, P5931, DOI 10.1200/JCO.2009.22.4295; Rubinstein JC, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-67; Sakr RA, 2010, APPL IMMUNOHISTO M M, V18, P371, DOI 10.1097/PAI.0b013e3181d50bd5; Scoggins CR, 2006, ANN SURG, V243, P693, DOI 10.1097/01.sla.0000216771.81362.6b; Sensi M, 2006, ONCOGENE, V25, P3357, DOI 10.1038/sj.onc.1209379; Shinozaki M, 2004, CLIN CANCER RES, V10, P1753, DOI 10.1158/1078-0432.CCR-1169-3; SOUGKLAKOS I, 2010, 2010 GASTR CANC S; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tie J, 2011, INT J CANCER, V128, P2075, DOI 10.1002/ijc.25555; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Tran B, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.15_suppl.3592; Xing MZ, 2005, J CLIN ENDOCR METAB, V90, P6373, DOI 10.1210/jc.2005-0987; Zlobec I, 2010, INT J CANCER, V127, P367, DOI 10.1002/ijc.25042; Zuo Z, 2009, MODERN PATHOL, V22, P1023, DOI 10.1038/modpathol.2009.59	36	67	71	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25806	10.1371/journal.pone.0025806	http://dx.doi.org/10.1371/journal.pone.0025806			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039425	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500023
J	Fluge, O; Bruland, O; Risa, K; Storstein, A; Kristoffersen, EK; Sapkota, D; Naess, H; Dahl, O; Nyland, H; Mella, O				Fluge, Oystein; Bruland, Ove; Risa, Kristin; Storstein, Anette; Kristoffersen, Einar K.; Sapkota, Dipak; Naess, Halvor; Dahl, Olav; Nyland, Harald; Mella, Olav			Benefit from B-Lymphocyte Depletion Using the Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome. A Double-Blind and Placebo-Controlled Study	PLOS ONE			English	Article							RETROVIRUS; CELLS; XMRV; INFECTION; BLOOD	Background: Chronic fatigue syndrome (CFS) is a disease of unknown aetiology. Major CFS symptom relief during cancer chemotherapy in a patient with synchronous CFS and lymphoma spurred a pilot study of B-lymphocyte depletion using the anti-CD20 antibody Rituximab, which demonstrated significant clinical response in three CFS patients. Methods and Findings: In this double-blind, placebo-controlled phase II study (NCT00848692), 30 CFS patients were randomised to either Rituximab 500 mg/m(2) or saline, given twice two weeks apart, with follow-up for 12 months. Xenotropic murine leukemia virus-related virus (XMRV) was not detected in any of the patients. The responses generally affected all CFS symptoms. Major or moderate overall response, defined as lasting improvements in self-reported Fatigue score during follow-up, was seen in 10 out of 15 patients (67%) in the Rituximab group and in two out of 15 patients (13%) in the Placebo group (p = 0.003). Mean response duration within the follow-up period for the 10 responders to Rituximab was 25 weeks (range 8-44). Four Rituximab patients had clinical response durations past the study period. General linear models for repeated measures of Fatigue scores during follow-up showed a significant interaction between time and intervention group (p = 0.018 for self-reported, and p = 0.024 for physician-assessed), with differences between the Rituximab and Placebo groups between 6-10 months after intervention. The primary end-point, defined as effect on self-reported Fatigue score 3 months after intervention, was negative. There were no serious adverse events. Two patients in the Rituximab group with pre-existing psoriasis experienced moderate psoriasis worsening. Conclusion: The delayed responses starting from 2-7 months after Rituximab treatment, in spite of rapid B-cell depletion, suggests that CFS is an autoimmune disease and may be consistent with the gradual elimination of autoantibodies preceding clinical responses. The present findings will impact future research efforts in CFS.	[Fluge, Oystein; Bruland, Ove; Risa, Kristin; Sapkota, Dipak; Dahl, Olav; Mella, Olav] Haukeland Hosp, Dept Oncol & Med Phys, N-5021 Bergen, Norway; [Bruland, Ove] Haukeland Hosp, Dept Med Genet & Mol Med, N-5021 Bergen, Norway; [Storstein, Anette; Naess, Halvor; Nyland, Harald] Haukeland Hosp, Dept Neurol, N-5021 Bergen, Norway; [Kristoffersen, Einar K.] Haukeland Hosp, Dept Immunol & Transfus Med, N-5021 Bergen, Norway; [Kristoffersen, Einar K.] Univ Bergen, Gade Inst, Bergen, Norway; [Dahl, Olav; Mella, Olav] Univ Bergen, Sect Oncol, Inst Internal Med, Bergen, Norway	University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen	Fluge, O (corresponding author), Haukeland Hosp, Dept Oncol & Med Phys, N-5021 Bergen, Norway.	oystein.fluge@gmail.com		Sapkota, Dipak/0000-0003-0061-825X	Helse Vest grant [911557]; legacy of Torstein Hereid	Helse Vest grant; legacy of Torstein Hereid	The work received financial support from Helse Vest grant no 911557, and also from the legacy of Torstein Hereid. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspler AL, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-44; Blacker CVR, 2004, JAMA-J AM MED ASSOC, V292, P1195, DOI 10.1001/jama.292.10.1195; Blank M, 2007, CLIN REV ALLERG IMMU, V32, P111; Broderick G, 2010, BRAIN BEHAV IMMUN, V24, P1209, DOI 10.1016/j.bbi.2010.04.012; Capelli E, 2010, INT J IMMUNOPATH PH, V23, P981, DOI 10.1177/039463201002300402; Carruthers BM, 2003, J CHRONIC FATIGUE SY, V11, P7, DOI [DOI 10.1300/J092V11N01_02, 10.1300/J092v11n01_02]; Carson KR, 2009, BLOOD, V113, P4834, DOI 10.1182/blood-2008-10-186999; Cooper N, 2010, BRIT J HAEMATOL, V149, P3, DOI 10.1111/j.1365-2141.2010.08076.x; Covelli M, 2010, REUMATISMO, V62, P101, DOI 10.4081/reumatismo.2010.101; Devanur LD, 2006, J CLIN VIROL, V37, P139, DOI 10.1016/j.jcv.2006.08.013; Fluge O, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-28; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Gurcan HM, 2009, INT IMMUNOPHARMACOL, V9, P10, DOI 10.1016/j.intimp.2008.10.004; Kessel A, 2008, CLIN REV ALLERG IMMU, V34, P74, DOI 10.1007/s12016-008-8074-1; Knox K, 2011, SCIENCE, V333, P94, DOI 10.1126/science.1204963; Kogelnik AM, 2006, J CLIN VIROL, V37, pS33, DOI 10.1016/S1386-6532(06)70009-9; Lerner AM., 2010, VIRUS ADAPT TREAT, V2, P47; Lo SC, 2010, P NATL ACAD SCI USA, V107, P15874, DOI 10.1073/pnas.1006901107; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Nacul LC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-91; Naess H, 2010, IN VIVO, V24, P185; Ortega-Hernandez OD, 2009, ANN NY ACAD SCI, V1173, P600, DOI 10.1111/j.1749-6632.2009.04799.x; Pace TWW, 2011, BRAIN BEHAV IMMUN, V25, P6, DOI 10.1016/j.bbi.2010.10.003; Paprotka T, 2011, SCIENCE, V333, P97, DOI 10.1126/science.1205292; Rizzi M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010838; Sanz I, 2010, NAT REV RHEUMATOL, V6, P326, DOI 10.1038/nrrheum.2010.68; Satterfield BC, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-12; Shin CH, 2011, J VIROL, V85, P7195, DOI 10.1128/JVI.00693-11; Skowera A, 2004, CLIN EXP IMMUNOL, V135, P294, DOI 10.1111/j.1365-2249.2004.02354.x; Townsend MJ, 2010, IMMUNOL REV, V237, P264, DOI 10.1111/j.1600-065X.2010.00945.x	30	120	127	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26358	10.1371/journal.pone.0026358	http://dx.doi.org/10.1371/journal.pone.0026358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039471	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500056
J	Geberzahn, N; Gahr, M				Geberzahn, Nicole; Gahr, Manfred			Undirected (Solitary) Birdsong in Female and Male Blue-Capped Cordon-Bleus (Uraeginthus cyanocephalus) and Its Endocrine Correlates	PLOS ONE			English	Article							STARLINGS STURNUS-VULGARIS; FINCHES TAENIOPYGIA-GUTTATA; WHITE-CROWNED SPARROWS; NEW-WORLD BLACKBIRDS; SEX-ROLE REVERSAL; ZEBRA FINCHES; EUROPEAN STARLINGS; SONG SYSTEM; BASAL GANGLIA; TESTOSTERONE	Background: Birdsong is a popular model system in research areas such as vocal communication, neuroethology or neuroendocrinology of behaviour. As most research has been conducted on species with male-only song production, the hormone-dependency of male song is well established. However, female singing and its mechanisms are poorly understood. Methodology/Principal Findings: We characterised the song and its endocrine correlates of blue-capped cordon-bleus (Uraeginthus cyanocephalus), a species in which both sexes sing. Like other estrildids, they produce directed song during courtship and undirected (or solitary) song in isolation, i.e. when the mate is not visible or absent. We compare solitary song of blue-capped cordon-bleus to published descriptions of the song of its relative, the zebra finch (Taeniopygia guttata). Solitary song of cordon-bleus shared some overall song features with that of zebra finches but differed in spectro-temporal song features, sequential stereotypy and sequential organisation. The song of cordon-bleus was dimorphic with respect to the larger size of syllable repertoires, the higher song duration and the lower variability of pitch goodness (measuring the pureness of harmonic sounds) in males. However, in both sexes the overall plasma testosterone concentrations were low (ca. 300 pg/ml) and did not correlate with the sexually dimorphic song motor pattern. Despite such low concentrations, the increase in the rate of solitary song coincided with an increase in the level of testosterone. Furthermore, the latency to start singing after the separation from the mate was related to hormone levels. Conclusions/Significance: Our findings suggest that the occurrence of solitary song but not its motor pattern might be under the control of testosterone in female and male cordon-bleus.	[Geberzahn, Nicole; Gahr, Manfred] Max Planck Inst Ornithol, Dept Behav Neurobiol, Seewiesen, Germany	Max Planck Society	Geberzahn, N (corresponding author), Univ Paris 11, CNRS, CNPS, UMR 8195, F-91405 Orsay, France.	nicole.geberzahn@u-psud.fr			Max Planck Society; The European Research Network in Neurosciences CNRS-MPG (GDRE CNRS - MPG Neurosciences)	Max Planck Society(Max Planck SocietyFoundation CELLEX); The European Research Network in Neurosciences CNRS-MPG (GDRE CNRS - MPG Neurosciences)	The study was financed by the Max Planck Society. The European Research Network in Neurosciences CNRS-MPG (GDRE CNRS - MPG Neurosciences) funded NG while working on the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bortz JLG., 1990, VERTEILUNGSFREIE MET, DOI 10.1007/978-3-662-22593-6; Bottjer SW, 2010, NAT NEUROSCI, V13, P153, DOI 10.1038/nn.2472; Brenowitz Eliot A., 1996, P285; Brunton DH, 2006, J ETHOL, V24, P17, DOI 10.1007/s10164-005-0155-5; Canoine V, 2007, DEV NEUROBIOL, V67, P57, DOI 10.1002/dneu.20296; Cheng MF, 2008, HORM BEHAV, V53, P1, DOI 10.1016/j.yhbeh.2007.08.007; COONEY R, 1995, ANIM BEHAV, V49, P1635, DOI 10.1016/0003-3472(95)90086-1; CUNNINGHAM MA, 1983, BEHAV ECOL SOCIOBIOL, V13, P259, DOI 10.1007/BF00299673; Cynx J, 2005, HORM BEHAV, V47, P446, DOI 10.1016/j.yhbeh.2004.11.018; De Ridder E, 2002, AUK, V119, P487, DOI 10.1642/0004-8038(2002)119[0487:SALTEO]2.0.CO;2; Fusani L, 2003, J NEUROBIOL, V54, P370, DOI 10.1002/neu.10141; Gahr M, 1997, BRAIN RES BULL, V44, P509, DOI 10.1016/S0361-9230(97)00233-5; GAHR M, 1986, ETHOLOGY, V72, P123; Gahr M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003073; Garamszegi LZ, 2008, AM NAT, V172, P533, DOI 10.1086/590955; Garamszegi LZ, 2005, HORM BEHAV, V47, P389, DOI 10.1016/j.yhbeh.2004.11.008; Geberzahn N, 2003, P ROY SOC B-BIOL SCI, V270, P1085, DOI 10.1098/rspb.2003.2340; Geberzahn N, 2010, BEHAV ECOL, V21, P1147, DOI 10.1093/beheco/arq122; Geberzahn N, 2009, BEHAV ECOL SOCIOBIOL, V64, P193, DOI 10.1007/s00265-009-0836-0; Goodwin, 1982, ESTRILDID FINCHES WO; Goymann W, 2004, AM NAT, V164, P327, DOI 10.1086/422856; Goymann W, 2006, HORM BEHAV, V49, P644, DOI 10.1016/j.yhbeh.2005.12.006; GURNEY ME, 1980, SCIENCE, V208, P1380, DOI 10.1126/science.208.4450.1380; GURNEY ME, 1981, J NEUROSCI, V1, P658; Harrison C. J. O., 1962, Journal fuer Ornithologie, V103, P369, DOI 10.1007/BF01676599; Hartog TE, 2009, J NEUROSCI, V29, P15511, DOI 10.1523/JNEUROSCI.2564-09.2009; HAUSBERGER M, 1995, ETHOLOGY, V99, P193; HAUSBERGER M, 1995, J COMP PSYCHOL, V109, P222, DOI 10.1037/0735-7036.109.3.222; HAUSBERGER M, 1991, ETHOL ECOL EVOL, V3, P337, DOI 10.1080/08927014.1991.9525362; Helekar SA, 2003, BEHAV NEUROSCI, V117, P939, DOI 10.1037/0735-7044.117.5.939; Hessler NA, 1999, NAT NEUROSCI, V2, P209, DOI 10.1038/6306; Hile AG, 2000, ANIM BEHAV, V59, P1209, DOI 10.1006/anbe.1999.1438; Holveck MJ, 2007, ANIM BEHAV, V74, P297, DOI 10.1016/j.anbehav.2006.08.016; Illes AE, 2009, P ROY SOC B-BIOL SCI, V276, P981, DOI 10.1098/rspb.2008.1445; IMMELMANN K, 1968, Journal fuer Ornithologie, V109, P284, DOI 10.1007/BF01678374; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Jawor JM, 2007, AUK, V124, P331, DOI 10.1642/0004-8038(2007)124[331:TINCCC]2.0.CO;2; Kao MH, 2006, J NEUROPHYSIOL, V96, P1441, DOI 10.1152/jn.01138.2005; KERN MD, 1972, CONDOR, V74, P204, DOI 10.2307/1366289; KRINER E, 1991, ETHOLOGY, V87, P37; LANGMORE NE, 2000, T ROYAL NORWEGIAN SO, P00389; Leadbeater E, 2005, ANIM BEHAV, V70, P909, DOI 10.1016/j.anbehav.2005.02.007; Leitner S, 2001, BEHAVIOUR, V138, P885, DOI 10.1163/156853901753172700; Logue DM, 2007, BEHAVIOUR, V144, P331, DOI 10.1163/156853907780425749; McGraw KJ, 2006, PHYSIOL BEHAV, V88, P347, DOI 10.1016/j.physbeh.2006.04.003; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Pavlova D, 2005, CONDOR, V107, P559, DOI 10.1650/0010-5422(2005)107[0559:FSIESS]2.0.CO;2; POHLAPEL G, 1984, Z TIERPSYCHOL, V64, P330; Price JJ, 2008, CONDOR, V110, P387, DOI 10.1525/cond.2008.8430; Price JJ, 2009, BEHAV ECOL, V20, P967, DOI 10.1093/beheco/arp085; Price JJ, 2009, P ROY SOC B-BIOL SCI, V276, P1971, DOI 10.1098/rspb.2008.1626; PROEVE V, 1978, Zeitschrift fuer Tierpsychologie, V48, P47; PROVE E, 1982, HORM BEHAV, V16, P121, DOI 10.1016/0018-506X(82)90013-7; Pytte CL, 2007, DEV NEUROBIOL, V67, P1699, DOI 10.1002/dneu.20520; Remage-Healey L, 2004, J NEUROSCI, V24, P5892, DOI 10.1523/JNEUROSCI.1220-04.2004; Remage-Healey L, 2008, NAT NEUROSCI, V11, P1327, DOI 10.1038/nn.2200; Riebel K, 2005, TRENDS ECOL EVOL, V20, P419, DOI 10.1016/j.tree.2005.04.024; Riebel K, 2003, ADV STUD BEHAV, V33, P49, DOI 10.1016/S0065-3454(03)33002-5; SCHARFF C, 1991, J NEUROSCI, V11, P2896; Siegel S, 1988, NONPARAMETRIC STAT B, V2; SIMPSON HB, 1991, J NEUROBIOL, V22, P755, DOI 10.1002/neu.480220710; Slater PJB, 2004, J AVIAN BIOL, V35, P289, DOI 10.1111/j.0908-8857.2004.03392.x; SOSSINKA R, 1980, Z TIERPSYCHOL, V53, P123; Sturdy CB, 1999, J COMP PSYCHOL, V113, P194, DOI 10.1037/0735-7036.113.2.194; Stutchbury B.J.M., 2001, BEHAV ECOLOGY TROPIC; Tchernichovski O, 2000, ANIM BEHAV, V59, P1167, DOI 10.1006/anbe.1999.1416; Tchernichovski O, 2004, ANN NY ACAD SCI, V1016, P348, DOI 10.1196/annals.1298.031; Voigt C, 2006, BEHAVIOUR, V143, P159, DOI 10.1163/156853906775900739; Voigt C, 2007, DEV NEUROBIOL, V67, P1560, DOI 10.1002/dneu.20528; WALTERS MJ, 1991, ANIM BEHAV, V42, P445, DOI 10.1016/S0003-3472(05)80043-0; Wikelski Martin, 2001, Trends in Ecology and Evolution, V16, P479, DOI 10.1016/S0169-5347(01)02279-0; Yamaguchi A, 1998, CONDOR, V100, P504, DOI 10.2307/1369716; ZANN R, 1996, ZEBRA FINCH; [No title captured]; [No title captured]; [No title captured]	77	17	18	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26485	10.1371/journal.pone.0026485	http://dx.doi.org/10.1371/journal.pone.0026485			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039498	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500076
J	Gruendler, TOJ; Ullsperger, M; Huster, RJ				Gruendler, Theo O. J.; Ullsperger, Markus; Huster, Rene J.			Event-Related Potential Correlates of Performance-Monitoring in a Lateralized Time-Estimation Task	PLOS ONE			English	Article							ERROR-RELATED NEGATIVITY; ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; OBSESSIVE-COMPULSIVE DISORDER; ENHANCED COGNITIVE CONTROL; STOP-SIGNAL PARADIGM; RESPONSE-INHIBITION; TOURETTE-SYNDROME; BRAIN POTENTIALS; EXTERNAL INFORMATION	Performance-monitoring as a key function of cognitive control covers a wide range of diverse processes to enable goal directed behavior and to avoid maladjustments. Several event-related brain potentials (ERP) are associated with performance-monitoring, but their conceptual background differs. For example, the feedback-related negativity (FRN) is associated with unexpected performance feedback and might serve as a teaching signal for adaptational processes, whereas the error-related negativity (ERN) is associated with error commission and subsequent behavioral adaptation. The N2 is visible in the EEG when the participant successfully inhibits a response following a cue and thereby adapts to a given stop-signal. Here, we present an innovative paradigm to concurrently study these different performance-monitoring-related ERPs. In 24 participants a tactile time-estimation task interspersed with infrequent stop-signal trials reliably elicited all three ERPs. Sensory input and motor output were completely lateralized, in order to estimate any hemispheric processing preferences for the different aspects of performance monitoring associated with these ERPs. In accordance with the literature our data suggest augmented inhibitory capabilities in the right hemisphere given that stop-trial performance was significantly better with left-as compared to right-hand stop-signals. In line with this, the N2 scalp distribution was generally shifted to the right in addition to an ipsilateral shift in relation to the response hand. Other than that, task lateralization affected neither behavior related to error and feedback processing nor ERN or FRN. Comparing the ERP topographies using the Global Map Dissimilarity index, a large topographic overlap was found between all considered components. With an evenly distributed set of trials and a split-half reliability for all ERP components >=.85 the task is well suited to efficiently study N2, ERN, and FRN concurrently which might prove useful for group comparisons, especially in clinical populations.	[Gruendler, Theo O. J.; Ullsperger, Markus] Max Planck Inst Neurol Res, Cologne, Germany; [Ullsperger, Markus] Radboud Univ Nijmegen, NL-6525 ED Nijmegen, Netherlands; [Huster, Rene J.] Carl von Ossietzky Univ Oldenburg, Inst Psychol, Expt Psychol Lab, D-2900 Oldenburg, Germany	Max Planck Society; Radboud University Nijmegen; Carl von Ossietzky Universitat Oldenburg	Gruendler, TOJ (corresponding author), Max Planck Inst Neurol Res, Cologne, Germany.	theo@gruendler.de	Ullsperger, Markus/E-2797-2010; Gruendler, Theo OJ/H-4486-2012; Ullsperger, Markus/I-4760-2019	Ullsperger, Markus/0000-0003-3970-1982; Gruendler, Theo OJ/0000-0002-5631-7352; Ullsperger, Markus/0000-0003-3970-1982				Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Baker TE, 2011, BIOL PSYCHOL, V87, P25, DOI 10.1016/j.biopsycho.2011.01.010; Baym CL, 2008, BRAIN, V131, P165, DOI 10.1093/brain/awm278; Bush G, 1998, HUM BRAIN MAPP, V6, P270, DOI 10.1002/(SICI)1097-0193(1998)6:4<270::AID-HBM6>3.0.CO;2-0; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Cavanagh JF, 2010, NEUROPSYCHOLOGIA, V48, P2098, DOI 10.1016/j.neuropsychologia.2010.03.031; Charron S, 2010, SCIENCE, V328, P360, DOI 10.1126/science.1183614; Danielmeier C, 2011, J NEUROSCI, V31, P1780, DOI 10.1523/JNEUROSCI.4299-10.2011; Danielmeier C, 2009, PSYCHOPHYSIOLOGY, V46, P1288, DOI 10.1111/j.1469-8986.2009.00860.x; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; DEHAENE S, 1994, PSYCHOL SCI; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eichele H, 2010, CHILD NEUROPSYCHOL, V16, P162, DOI 10.1080/09297040903150182; Endrass T, 2008, NEUROPSYCHOLOGIA, V46, P1877, DOI 10.1016/j.neuropsychologia.2007.12.001; Enriquez-Geppert S, 2010, NEUROIMAGE, V51, P877, DOI 10.1016/j.neuroimage.2010.02.043; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; FISSENI HJ, 1997, LEHRBUCH PSYCHOL; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Fornito A, 2004, CEREB CORTEX, V14, P424, DOI 10.1093/cercor/bhh004; Fornito A, 2006, SCHIZOPHR RES, V88, P192, DOI 10.1016/j.schres.2006.06.034; Gehring WJ, 2000, PSYCHOL SCI, V11, P1, DOI 10.1111/1467-9280.00206; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gentsch A, 2009, NEUROIMAGE, V47, P2023, DOI 10.1016/j.neuroimage.2009.05.064; Grundler TOJ, 2009, NEUROPSYCHOLOGIA, V47, P1978, DOI 10.1016/j.neuropsychologia.2009.03.010; Heldmann M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-33; HELMSTADTER GC, 1964, PRINCIPLES PSYCHOL M, P248; Hochman EY, 2009, LATERALITY, V14, P618, DOI 10.1080/13576500902823463; Hochman EY, 2004, BRAIN COGNITION, V55, P314, DOI 10.1016/j.bandc.2004.02.030; Holroyd CB, 1998, NEUROSCI LETT, V242, P65, DOI 10.1016/S0304-3940(98)00035-4; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Holroyd CB, 2008, PSYCHOPHYSIOLOGY, V45, P688, DOI 10.1111/j.1469-8986.2008.00668.x; Holroyd CB, 2008, CORTEX, V44, P548, DOI 10.1016/j.cortex.2007.08.013; Holroyd CB, 2007, PSYCHOPHYSIOLOGY, V44, P913, DOI 10.1111/j.1469-8986.2007.00561.x; Hugdahl K, 2000, ACTA PSYCHOL, V105, P211, DOI 10.1016/S0001-6918(00)00062-7; Huster RJ, 2011, NEUROIMAGE, V56, P1588, DOI 10.1016/j.neuroimage.2011.03.039; Huster RJ, 2010, HUM BRAIN MAPP, V31, P1260, DOI 10.1002/hbm.20933; Huster RJ, 2011, BRAIN STRUCT FUNCT, V215, P225, DOI 10.1007/s00429-010-0289-2; Huster RJ, 2009, HUM BRAIN MAPP, V30, P1279, DOI 10.1002/hbm.20594; Jackson GM, 2007, EXP BRAIN RES, V182, P357, DOI 10.1007/s00221-007-0999-8; King JA, 2010, J NEUROSCI, V30, P12759, DOI 10.1523/JNEUROSCI.3274-10.2010; Kline RB, 2004, SIGNIFICANCE TESTING, P325; Koenig T, 2009, ELECT NEUROIMAGING, P25, DOI DOI 10.1017/CBO9780511596889; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; LEHMANN D, 1980, ELECTROEN CLIN NEURO, V48, P609, DOI 10.1016/0013-4694(80)90419-8; Liotti M, 2005, CORTEX, V41, P377, DOI 10.1016/S0010-9452(08)70274-0; Lutcke H, 2008, CEREB CORTEX, V18, P508, DOI 10.1093/cercor/bhm090; Manly BFJ., 2017, RANDOMIZATION MONTE, DOI 10.1201/9781315273075; Masaki H, 2001, NEUROREPORT, V12, P1851, DOI 10.1097/00001756-200107030-00018; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Mueller SC, 2006, CURR BIOL, V16, P570, DOI 10.1016/j.cub.2006.01.064; Muller SV, 2005, CLIN NEUROPHYSIOL, V116, P63, DOI 10.1016/j.clinph.2004.07.009; Murray MM, 2008, BRAIN TOPOGR, V20, P249, DOI 10.1007/s10548-008-0054-5; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nieuwenhuis S, 2002, COGN AFFECT BEHAV NE, V2, P19, DOI 10.3758/CABN.2.1.19; Ocklenburg S, 2011, NEUROIMAGE, V55, P1771, DOI 10.1016/j.neuroimage.2011.01.035; Oliveira FTP, 2007, J COGNITIVE NEUROSCI, V19, P1994, DOI 10.1162/jocn.2007.19.12.1994; Olvet DM, 2009, BRAIN RES, V1284, P89, DOI 10.1016/j.brainres.2009.05.079; PERRIN F, 1990, J CLIN NEUROPHYSIOL, V7, P498, DOI 10.1097/00004691-199010000-00005; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Peterson BS, 1998, ARCH GEN PSYCHIAT, V55, P326, DOI 10.1001/archpsyc.55.4.326; Pliszka SR, 2000, BIOL PSYCHIAT, V48, P238, DOI 10.1016/S0006-3223(00)00890-8; Ramautar JR, 2006, BIOL PSYCHOL, V72, P96, DOI 10.1016/j.biopsycho.2005.08.001; Ramautar JR, 2004, BRAIN COGNITION, V56, P234, DOI 10.1016/j.bandc.2004.07.002; Ridderinkhof KR, 2004, SCIENCE, V306, P443, DOI 10.1126/science.1100301; Riesel A, 2011, AM J PSYCHIAT, V168, P317, DOI 10.1176/appi.ajp.2010.10030416; Rosenthal R, 1994, HDB RES SYNTHESIS, P231; Schmajuk M, 2006, NEUROPSYCHOLOGIA, V44, P384, DOI 10.1016/j.neuropsychologia.2005.06.005; Swann N, 2009, J NEUROSCI, V29, P12675, DOI 10.1523/JNEUROSCI.3359-09.2009; Ullsperger M, 2006, INT J PSYCHOPHYSIOL, V59, P59, DOI 10.1016/j.ijpsycho.2005.06.010; van Gaal S, 2011, J COGNITIVE NEUROSCI, V23, P91, DOI 10.1162/jocn.2010.21431; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Van 't Ent D, 1999, CLIN NEUROPHYSIOL, V110, P1058, DOI 10.1016/S1388-2457(98)00036-4; Vogt BA, 2003, EUR J NEUROSCI, V18, P3134, DOI 10.1111/j.1460-9568.2003.03034.x; WAGNER M, 2007, INT C SER, P185; Westerhausen R, 2008, NEUROSCI BIOBEHAV R, V32, P1044, DOI 10.1016/j.neubiorev.2008.04.005; Yeung N, 2006, J NEUROSCI, V26, P1429, DOI 10.1523/JNEUROSCI.3109-05.2006; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; Yordanova J, 2004, NEUROIMAGE, V22, P590, DOI 10.1016/j.neuroimage.2004.01.040; ZAIDEL E, 1990, NEUROBIOLOGY HIGHER	83	55	55	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25591	10.1371/journal.pone.0025591	http://dx.doi.org/10.1371/journal.pone.0025591			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841JB	22039418	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500016
J	Pascoe, S; Wilcox, C; Donlan, CJ				Pascoe, Sean; Wilcox, Chris; Donlan, C. Josh			Biodiversity Offsets: A Cost-Effective Interim Solution to Seabird Bycatch in Fisheries?	PLOS ONE			English	Article							FLESH-FOOTED SHEARWATERS; COMPENSATORY MITIGATION; MARINE BYCATCH; LONGLINE FISHERIES; ECONOMIC-BENEFITS; CONSERVATION; MANAGEMENT; AUSTRALIA; DISCOUNT; ISLANDS	The concept of biodiversity offsets is well established as an approach to environmental management. The concept has been suggested for environmental management in fisheries, particularly in relation to the substantial numbers of non-target species-seabirds in particular-caught and killed as incidental bycatch during fishing activities. Substantial areas of fisheries are being closed to protect these species at great cost to the fishing industry. However, other actions may be taken to offset the impact of fishing on these populations at lower cost to the fishing industry. This idea, however, has attracted severe criticism largely as it does not address the underlying externality problems created by the fishing sector, namely seabird fishing mortality. In this paper, we re-examine the potential role of compensatory mitigation as a fisheries management tool, although from the perspective of being an interim management measure while more long-lasting solutions to the problem are found. We re-model an example previously examined by both proponents and opponents of the approach, namely the cost effectiveness of rodent control relative to fishery area closures for the conservation of a seabird population adversely affected by an Australian tuna fishery. We find that, in the example being examined, invasive rodent eradication is at least 10 times more cost effective than area closures. We conclude that, while this does not solve the actual bycatch problem, it may provide breathing space for both the seabird species and the industry to find longer term means of reducing bycatch.	[Pascoe, Sean] CSIRO Marine & Atmospher Res, Brisbane, Qld, Australia; [Wilcox, Chris] CSIRO Marine & Atmospher Res, Hobart, Tas, Australia; [Donlan, C. Josh] Adv Conservat Strategies, Midway, UT USA; [Donlan, C. Josh] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Cornell University	Pascoe, S (corresponding author), CSIRO Marine & Atmospher Res, Brisbane, Qld, Australia.	sean.pascoe@csiro.au	Wilcox, Chris/A-3585-2010; Pascoe, Sean/D-9710-2011	Wilcox, Chris/0000-0002-5983-657X; Pascoe, Sean/0000-0001-6581-2649	National Center for Ecological Analysis and Synthesis; NSF [DEB-0553768]; University of California Santa Barbara; State of California; Australian Government	National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California Santa Barbara(University of California System); State of California; Australian Government(Australian GovernmentCGIAR)	This work was conducted as a part of the 'Exploring Compensatory Mitigation and Markets as Mechanisms for Resolving Fisheries Bycatch and Biodiversity Conservation Conflicts' Working Group supported by the National Center for Ecological Analysis and Synthesis, a Center funded by NSF (Grant #DEB-0553768), the University of California Santa Barbara, and the State of California. Support for SP and CW has been provided through the Commonwealth Environment Research Facilities (CERF) program, an Australian Government initiative supporting world class, public good research. The CERF Marine Biodiversity Hub is a collaborative partnership between the University of Tasmania, CSIRO Wealth from Oceans Flagship, Geoscience Australia, Australian Institute of Marine Science and Museum Victoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARES, 2010, AUSTR FISH STAT 2009; *AFMA, 2008, AUSTR TUN BILLF LONG; Asche F, 2001, ENVIRON RESOUR ECON, V19, P403, DOI 10.1023/A:1011631714874; ATKINSON IAE, 1985, CONSERVATION ISLAND, P35; Baker GB, 2005, BIOL CONSERV, V126, P306, DOI 10.1016/j.biocon.2005.06.001; Baker GB, 2002, EMU, V102, P71, DOI 10.1071/MU01036; Botsford LW, 1997, SCIENCE, V277, P509, DOI 10.1126/science.277.5325.509; Brothers N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012491; Brothers NP, 1999, FAO FISHERIES CIRCUL; CLARK CW, 1973, SCIENCE, V181, P630, DOI 10.1126/science.181.4100.630; Cox TA, 2007, CONSERV BIOL, V21, P1155, DOI 10.1111/j.1523-1739.2007.00772.x; Cullen R, 2005, ECOL ECON, V53, P311, DOI 10.1016/j.ecolecon.2004.09.014; Dasgupta P, 2008, J RISK UNCERTAINTY, V37, P141, DOI 10.1007/s11166-008-9049-6; *DEP ENV CLIM CHAN, 2009, MONT ISL SEAB HAB RE; Doak D, 2007, FRONT ECOL ENVIRON, V5, P350, DOI 10.1890/1540-9295(2007)5[350:CMFMBW]2.0.CO;2; Donlan CJ, 2008, BIOL INVASIONS, V10, P1053, DOI 10.1007/s10530-007-9183-0; Eiswerth ME, 2009, ECOL ECON, V68, P2129, DOI 10.1016/j.ecolecon.2009.02.009; *ENV AUSTR, 1998, THREAT AB PLAN INC C; FAO, 2004, STAT WORLD FISH AQ 2; Finkelstein M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002480; FISHER AC, 1975, Q J ECON, V89, P358, DOI 10.2307/1885257; Gilman E, 2005, FISH FISH, V6, P35, DOI 10.1111/j.1467-2679.2005.00175.x; Groombridge B., 1992, GLOBAL BIODIVERSITY; Haraden J, 2004, ENVIRON RESOUR ECON, V28, P451, DOI 10.1023/B:EARE.0000036773.77566.3d; Hilborn R, 2005, PHILOS T R SOC B, V360, P47, DOI 10.1098/rstb.2004.1569; Horowitz JK, 2002, ENVIRON RESOUR ECON, V21, P241, DOI 10.1023/A:1014592629514; Huang H, 2007, J ENVIRON MANAGE, V84, P523, DOI 10.1016/j.jenvman.2006.07.008; Hughey KFD, 2003, CONSERV BIOL, V17, P93, DOI 10.1046/j.1523-1739.2003.01317.x; Igual JM, 2006, ANIM CONSERV, V9, P59, DOI 10.1111/j.1469-1795.2005.00005.x; LANE N, 2005, DOMINION POST   0507; Lavers JL, 2010, BIOL INVASIONS, V12, P3839, DOI 10.1007/s10530-010-9776-x; Lewison RL, 2004, TRENDS ECOL EVOL, V19, P598, DOI 10.1016/j.tree.2004.09.004; Long JL, 2003, INTRO MAMMALS WORLD; Loomis JB, 1996, ECOL ECON, V18, P197, DOI 10.1016/0921-8009(96)00029-8; Lucchetti A, 2010, REV FISH BIOL FISHER, V20, P141, DOI 10.1007/s11160-009-9126-1; MacPhee R.D.E., 1999, P333; Igual JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004826; MARTIN G, 2005, SAN FRANCISCO C 0805; Martins TLF, 2006, ANIM CONSERV, V9, P439, DOI 10.1111/j.1469-1795.2006.00058.x; MONTGOMERY CA, 1994, J ENVIRON ECON MANAG, V26, P111, DOI 10.1006/jeem.1994.1007; NAGY KA, 1987, ECOL MONOGR, V57, P111, DOI 10.2307/1942620; Nogales M, 2004, CONSERV BIOL, V18, P310, DOI 10.1111/j.1523-1739.2004.00442.x; Norton DA, 2009, ENVIRON MANAGE, V43, P698, DOI 10.1007/s00267-008-9192-5; PARKES J, 2004, LC030464 LANDC RES; Pascoe S, 2010, INT REV ENVIRON RESO, V4, P123, DOI 10.1561/101.00000032; Priddel D, 2006, BIOL CONSERV, V128, P412, DOI 10.1016/j.biocon.2005.10.007; Priddel D, 2007, FRONT ECOL ENVIRON, V5, P407, DOI 10.1890/i1540-9295-5-8-407.1; Punt AE, 2011, FISH RES, V109, P201, DOI 10.1016/j.fishres.2011.02.006; Schippers P, 2009, POPUL ECOL, V51, P459, DOI 10.1007/s10144-009-0159-z; Spotila JR, 2000, NATURE, V405, P529, DOI 10.1038/35014729; Stapp P, 2002, J APPL ECOL, V39, P831, DOI 10.1046/j.1365-2664.2002.00754.x; ten Kate K., 2004, BIODIVERSITY OFFSETS; Thalmann SJ, 2009, J WILDLIFE MANAGE, V73, P399, DOI 10.2193/2007-461; Vieira S., 2010, IMPACT STRUCTURAL AD; Watzold F, 2005, BIOL CONSERV, V123, P327, DOI 10.1016/j.biocon.2004.12.001; Weitzman ML, 1998, J ENVIRON ECON MANAG, V36, P201, DOI 10.1006/jeem.1998.1052; WEITZMAN ML, 1994, J ENVIRON ECON MANAG, V26, P200, DOI 10.1006/jeem.1994.1012; WILCOX C, 2010, PREDICTING IMPACT HO; Wilcox C, 2007, FRONT ECOL ENVIRON, V5, P325, DOI 10.1890/1540-9295(2007)5[325:CMAAST]2.0.CO;2; Zydelis R, 2009, CONSERV BIOL, V23, P608, DOI 10.1111/j.1523-1739.2009.01172.x; 2006, FEDERAL AGENCY CUTS	61	20	21	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25762	10.1371/journal.pone.0025762	http://dx.doi.org/10.1371/journal.pone.0025762			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841JB	22039422	Green Published, gold			2022-12-27	WOS:000296507500019
J	Aguirre, J; Buldu, JM; Stich, M; Manrubia, SC				Aguirre, Jacobo; Buldu, Javier M.; Stich, Michael; Manrubia, Susanna C.			Topological Structure of the Space of Phenotypes: The Case of RNA Neutral Networks	PLOS ONE			English	Article							SEQUENCE STRUCTURE MAPS; SMALL-WORLD; EXHAUSTIVE ENUMERATION; SECONDARY; ORGANIZATION; REPERTOIRE; PREDICTION; STABILITY; EVOLUTION; DYNAMICS	The evolution and adaptation of molecular populations is constrained by the diversity accessible through mutational processes. RNA is a paradigmatic example of biopolymer where genotype (sequence) and phenotype (approximated by the secondary structure fold) are identified in a single molecule. The extreme redundancy of the genotype-phenotype map leads to large ensembles of RNA sequences that fold into the same secondary structure and can be connected through single-point mutations. These ensembles define neutral networks of phenotypes in sequence space. Here we analyze the topological properties of neutral networks formed by 12-nucleotides RNA sequences, obtained through the exhaustive folding of sequence space. A total of 4 12 sequences fragments into 645 subnetworks that correspond to 57 different secondary structures. The topological analysis reveals that each subnetwork is far from being random: it has a degree distribution with a well-defined average and a small dispersion, a high clustering coefficient, and an average shortest path between nodes close to its minimum possible value, i.e. the Hamming distance between sequences. RNA neutral networks are assortative due to the correlation in the composition of neighboring sequences, a feature that together with the symmetries inherent to the folding process explains the existence of communities. Several topological relationships can be analytically derived attending to structural restrictions and generic properties of the folding process. The average degree of these phenotypic networks grows logarithmically with their size, such that abundant phenotypes have the additional advantage of being more robust to mutations. This property prevents fragmentation of neutral networks and thus enhances the navigability of sequence space. In summary, RNA neutral networks show unique topological properties, unknown to other networks previously described.	[Aguirre, Jacobo; Stich, Michael; Manrubia, Susanna C.] CSIC INTA, Ctr Astrobiol, Madrid, Spain; [Buldu, Javier M.] Univ Rey Juan Carlos, Complex Syst Grp, Madrid, Spain; [Buldu, Javier M.] UPM Campus Montegancedo, Ctr Biomed Technol, Lab Biol Networks, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Astrobiologia (INTA); Universidad Rey Juan Carlos; Universidad Politecnica de Madrid	Aguirre, J (corresponding author), CSIC INTA, Ctr Astrobiol, Madrid, Spain.	scmanrubia@cab.inta-csic.es	Manrubia, Susanna/K-4501-2014; Buldu, Javier Martin/R-8167-2018; Buldu, Javier/N-5422-2014; Aguirre, Jacobo/K-5855-2014	Manrubia, Susanna/0000-0003-0134-2785; Buldu, Javier/0000-0002-9345-599X; Aguirre, Jacobo/0000-0003-2196-5103	Spanish Ministry of Science and Innovation [FIS08-05273, FIS09-07072]; Comunidad de Madrid [MODELICO-CM S2009ESP-1691]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid)	This work was supported by the Spanish Ministry of Science and Innovation, grants FIS08-05273 and FIS09-07072; and Comunidad de Madrid, R&D Program of activities, grant MODELICO-CM S2009ESP-1691. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre J, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066112; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Bagler G, 2007, BIOINFORMATICS, V23, P1760, DOI 10.1093/bioinformatics/btm257; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bollobas B., 1985, RANDOM GRAPHS; Buldu JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019584; Casella DA, 2005, IEEE C EVOL COMPUTAT, P2499; Cowperthwaite MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000110; Diaz-Guilera A, 2009, INT J BIFURCAT CHAOS, V19, P687, DOI 10.1142/S0218127409023044; Duch J, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.027104; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; FONTANA W, 1993, BIOPOLYMERS, V33, P1389, DOI 10.1002/bip.360330909; Fontana W, 1998, J THEOR BIOL, V194, P491, DOI 10.1006/jtbi.1998.0771; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Gan HH, 2003, NUCLEIC ACIDS RES, V31, P2926, DOI 10.1093/nar/gkg365; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Gruner W, 1996, MONATSH CHEM, V127, P355, DOI 10.1007/BF00810881; Gruner W, 1996, MONATSH CHEM, V127, P375, DOI 10.1007/BF00810882; Guelzim N, 2002, NAT GENET, V31, P60, DOI 10.1038/ng873; Gursoy A, 2008, BIOCHEM SOC T, V36, P1398, DOI 10.1042/BST0361398; Higgs PG, 1998, GENETICA, V102-3, P91, DOI 10.1023/A:1017059530664; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Huxham M, 1996, OIKOS, V76, P284, DOI 10.2307/3546201; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Jorg T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-464; Kautz WH, 1958, IRE T ELECT COMPUTER, V7, P177, DOI DOI 10.1109/TEC.1958.5222529; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Montoya JM, 2002, J THEOR BIOL, V214, P405, DOI 10.1006/jtbi.2001.2460; Montoya JM, 2006, NATURE, V442, P259, DOI 10.1038/nature04927; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Penrose M., 2003, RANDOM GEOMETRIC GRA; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reidys C, 1997, B MATH BIOL, V59, P339, DOI 10.1016/S0092-8240(96)00089-4; Reidys C, 2001, B MATH BIOL, V63, P57, DOI 10.1006/bulm.2000.0206; SCHUSTER P, 1994, P ROY SOC B-BIOL SCI, V255, P279, DOI 10.1098/rspb.1994.0040; Schuster P, 2006, REP PROG PHYS, V69, P1419, DOI 10.1088/0034-4885/69/5/R04; Schuster Peter, 2003, P163; Stich M, 2008, J THEOR BIOL, V252, P750, DOI 10.1016/j.jtbi.2008.02.018; Stich M, 2011, J THEOR BIOL, V280, P117, DOI 10.1016/j.jtbi.2011.03.010; Tanaka R, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.168101; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; Wagner A, 2001, P ROY SOC B-BIOL SCI, V268, P1803, DOI 10.1098/rspb.2001.1711; Wagner A, 2001, MOL BIOL EVOL, V18, P1283, DOI 10.1093/oxfordjournals.molbev.a003913; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wuchty S, 1999, BIOPOLYMERS, V49, P145, DOI 10.1002/(SICI)1097-0282(199902)49:2<145::AID-BIP4>3.3.CO;2-7; Wuchty Stefan, 2006, P165; Yook SH, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.045105; Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636	60	52	52	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26324	10.1371/journal.pone.0026324	http://dx.doi.org/10.1371/journal.pone.0026324			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028856	Green Published, Green Accepted, gold			2022-12-27	WOS:000296186900049
J	Kaeffer, B; Legrand, A; Moyon, T; Frondas-Chauty, A; Billard, H; Guzman-Quevedo, O; Darmaun, D; Roze, JC				Kaeffer, Bertrand; Legrand, Arnaud; Moyon, Thomas; Frondas-Chauty, Anne; Billard, Helene; Guzman-Quevedo, Omar; Darmaun, Dominique; Roze, Jean-Christophe			Non-Invasive Exploration of Neonatal Gastric Epithelium by Using Exfoliated Epithelial Cells	PLOS ONE			English	Article							PREMATURE-INFANTS; UP-REGULATION; STEM-CELLS; EXPRESSION; AUTOPHAGY; MECHANISMS; APOPTOSIS; STOMACH; DEFENSE; STOOL	Background & Aims: In preterm infants, exfoliated gastric epithelial cells can be retrieved from aspirates sampled through the naso-gastric feeding tube. Our aims were to determine (1) whether the recovery of exfoliated cells is feasible at any time from birth through the removal of the nasogastric tube, (2) whether they can be grown in culture in vitro, and (3) whether the physiological state of exfoliated cells expressing H+/K+-ATPases reflects that of their counterparts remaining in situ at the surface of the gastric epithelium in neonatal rat pups. Methods: In infants, gastric fluid aspirates were collected weekly after birth or every 3 hours over 24-h periods, and related to clinical parameters (Biocollection PROG/09/18). In rat pups submitted to a single fasting/refeeding cycle, we explored circadian exfoliation with the cellular counter-parts in the gland. All samples were analyzed by confocal imaging and Enzyme-Linked Immunosorbent Assay. Results: Epithelial cells were identified by microscopy using membrane-bound anti-H+/K+ ATPases antibody, assessed for nucleus integrity, and the expression of selected proteins (autophagy, circadian clock). On 34 infants, the H+/K+ -ATPase-positive cells were consistently found quiescent, regardless of gestational age and feeding schedule from day-5 of life to the day of removal of the naso-gastric tube. By logistic regression analysis, we did find a positive correlation between the intensity of exfoliation (cellular loss per sample) and the postnatal age (p, 0.001). The H+/K+ ATPase-positive cells established in culture retained the expression of a biomarker of progenitor status (Pouf5F1-Oct4). In rat pups, the expression pattern of Survivin in H+/K+ ATPase-positive exfoliated cells paralleled that observed in cells remaining at the surface of the gastric gland. Conclusions: Tracking parietal cells can improve clinical monitoring and understanding of the autophagic death via the phosphatidylinositol 3-kinase/Akt/survivin pathway.	[Kaeffer, Bertrand; Moyon, Thomas; Billard, Helene; Guzman-Quevedo, Omar; Darmaun, Dominique] INRA, UMR 1280, F-44026 Nantes, France; [Legrand, Arnaud; Frondas-Chauty, Anne; Darmaun, Dominique; Roze, Jean-Christophe] Univ Nantes, Hosp Mother & Child, Nantes, France	INRAE; Nantes Universite; CHU de Nantes	Kaeffer, B (corresponding author), INRA, UMR 1280, F-44026 Nantes, France.	Bertrand.Kaeffer@univ-nantes.fr	Quevedo, omar Guzman/AAG-6327-2020; Rozé, Jean-Christophe/AAS-1314-2021; Darmaun, Dominique/X-8453-2018; roze, jean christophe/B-5433-2012; Guzman Quevedo, Omar/ABU-5276-2022	Quevedo, omar Guzman/0000-0003-1358-1783; Darmaun, Dominique/0000-0002-0366-3227; Guzman Quevedo, Omar/0000-0003-1358-1783; Roze, Jean-Christophe/0000-0003-3367-512X; MOYON, Thomas/0000-0002-8308-8719; BILLARD, HELENE/0000-0002-1183-2959; Kaeffer, Bertrand/0000-0003-2459-5072	Departement Alimentation Humaine (Inra, France) [ANSSD-2008]; Region Pays de la Loire, France [PremaCol-2008]	Departement Alimentation Humaine (Inra, France); Region Pays de la Loire, France(Region Pays de la Loire)	The authors are grateful for receiving financial support from ANSSD-2008 Departement Alimentation Humaine (Inra, France); and PremaCol-2008 (Region Pays de la Loire, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama F, 2008, HISTOCHEM CELL BIOL, V129, P785, DOI 10.1007/s00418-008-0403-1; Bandaletova T, 2002, APMIS, V110, P239, DOI 10.1034/j.1600-0463.2002.100306.x; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Chapkin RS, 2010, AM J PHYSIOL-GASTR L, V298, pG582, DOI 10.1152/ajpgi.00004.2010; Chen A, 2010, J MATERN-FETAL NEO M, V23, P1172, DOI 10.3109/14767051003677947; Chiou SK, 2003, BIOCHEM BIOPH RES CO, V305, P374, DOI 10.1016/S0006-291X(03)00724-1; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dimaline R, 2007, EXP PHYSIOL, V92, P591, DOI 10.1113/expphysiol.2006.036483; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Fung C, 2008, MOL BIOL CELL, V19, P797, DOI 10.1091/mbc.E07-10-1092; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Godlewski MM, 2007, J PHYSIOL PHARMACOL, V58, P97; Green CB, 2008, CELL, V134, P728, DOI 10.1016/j.cell.2008.08.022; Kaeffer B, 2007, PEDIATR RES, V62, P564, DOI 10.1203/PDR.0b013e318155a402; Kitazawa H, 2004, J BIOL CHEM, V279, P42867, DOI 10.1074/jbc.M408047200; Laine L, 2008, GASTROENTEROLOGY, V135, P41, DOI 10.1053/j.gastro.2008.05.030; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Liu Z, 2006, ONCOGENE, V25, P7680, DOI 10.1038/sj.onc.1209753; Lock R, 2008, CURR OPIN CELL BIOL, V20, P583, DOI 10.1016/j.ceb.2008.05.002; Martinet W, 2006, AUTOPHAGY, V2, P55, DOI 10.4161/auto.2217; Nomura S, 1998, DEV BIOL, V204, P124, DOI 10.1006/dbio.1998.9055; Orozco-Solis R, 2011, INT J OBESITY, V35, P990, DOI 10.1038/ijo.2010.223; Petrovic S, 2003, AM J PHYSIOL-GASTR L, V284, pG1093, DOI 10.1152/ajpgi.00454.2002; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Rivkees SA, 2004, PEDIATRICS, V113, P833, DOI 10.1542/peds.113.4.833; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Sachdeva UM, 2008, AUTOPHAGY, V4, P581, DOI 10.4161/auto.6141; Sawaguchi A, 2004, J HISTOCHEM CYTOCHEM, V52, P77, DOI 10.1177/002215540405200108; Tarnawski A, 2007, GASTROENTEROLOGY, V133, P1938, DOI 10.1053/j.gastro.2007.08.037; Trosko JE, 2006, ANN NY ACAD SCI, V1089, P36, DOI 10.1196/annals.1386.018	30	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25562	10.1371/journal.pone.0025562	http://dx.doi.org/10.1371/journal.pone.0025562			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028779	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900008
J	Pham, LL; Garot, C; Brue, T; Brauner, R				Luu-Ly Pham; Garot, Christelle; Brue, Thierry; Brauner, Raja			Clinical, Biological and Genetic Analysis of 8 Cases of Congenital Isolated Adrenocorticotrophic Hormone (ACTH) Deficiency	PLOS ONE			English	Article							TPIT GENE; ADRENAL INSUFFICIENCY; EARLY-ONSET; MUTATIONS; OBESITY; DEATH	Background: Congenital isolated adrenocorticotrophic hormone (ACTH) deficiency may be rare, but it could be an underestimated cause of neonatal death. Our objective was to shorten the time between first symptoms and diagnosis. Methods: This single-centre retrospective case-cohort study was carried out on eight consecutive patients. Results: Two had the neonatal form and 6 the late onset form. Six were admitted to an intensive care unit at least once for seizures with hypoglycemia, major hypothermia, fever, and/or collapsus. The 2 neonatal cases presented with hypoglycemia and in a state of "apparent death" at birth or hypothermia (29 degrees C) at 6 days. All 6 late onset cases had also been admitted to an emergency department 1-3 times, but had left hospital incorrectly diagnosed. Their first symptoms were noted at 3-12.3 years, and they were diagnosed at 3.3-14.4 years. All had hypoglycemia, and 4 had had seizures. The presenting symptoms were vomiting and/or abdominal pain, asthenia, irritability, difficulty with physical activities, and anorexia. The school performance of 4 deteriorated. Two underwent psychotherapy and treatment for depression, which was stopped when Hydrocortisone (R) replacement therapy began. The plasma concentrations in spontaneous hypoglycemia were: ACTH<5 to 17.1 pg/mL, with concomitant cortisol <3.5 to 37 ng/mL. The plasma dehydroepiandrosterone sulfate (DHAS) concentrations were low in the 7 evaluated. The coding sequence of TPIT was normal in all. Conclusion: Several unexplained symptoms in a child, mainly gastro-intestinal symptoms and seizures due to hypoglycemia, may indicate ACTH deficiency. A low or normal basal plasma ACTH despite concomitant low cortisol at 8 a. m. and/or in spontaneous hypoglycemia, associated with low DHAS, in a patient not given corticosteroids is highly suggestive of ACTH deficiency. The isolated character of ACTH deficiency must be confirmed by determining the other hypothalamic-pituitary functions, and Hydrocortisone (R) replacement therapy initiated in emergency.	[Luu-Ly Pham; Garot, Christelle; Brauner, Raja] Univ Paris 05, Sorbonne Paris Cite, France; [Luu-Ly Pham; Garot, Christelle; Brauner, Raja] Hop Bicetre, AP HP, Unite Endocrinol Pediat, Le Kremlin Bicetre, France; [Brue, Thierry] CHU Timone, AP HP, Ctr Reference Malad Rares Origine Hypophysaire, Marseille, France; [Brue, Thierry] Univ Aix Marseille 2, Marseille, France	UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UDICE-French Research Universities; Aix-Marseille Universite	Pham, LL (corresponding author), Univ Paris 05, Sorbonne Paris Cite, France.	raja.brauner@wanadoo.fr	Brue, Thierry/AAI-2328-2019; Brue, Thierry/P-6571-2019	Brue, Thierry/0000-0001-8482-6691; Brue, Thierry/0000-0001-8482-6691				ADAN L, 1994, J CLIN ENDOCR METAB, V78, P478, DOI 10.1210/jc.78.2.478; Bremer AA, 2008, J PEDIATR ENDOCR MET, V21, P799; FOREST MG, 1992, FUNCTIONAL ENDOCRINO, P248; Jackson RS, 1997, NAT GENET, V16, P303, DOI 10.1038/ng0797-303; Krude H, 1998, NAT GENET, V19, P155, DOI 10.1038/509; Louvel M, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-29; MCEACHERN R, 2011, J CLIN ENDOCRIN 0713; Metherell LA, 2004, EUR J ENDOCRINOL, V151, P463, DOI 10.1530/eje.0.1510463; Nasrallah MP, 2003, J CLIN ENDOCR METAB, V88, P5293, DOI 10.1210/jc.2003-030449; Nozue H, 2007, PEDIATR INT, V49, P522, DOI 10.1111/j.1442-200X.2007.02417.x; Shulman DI, 2007, PEDIATRICS, V119, pE484, DOI 10.1542/peds.2006-1612; STEINBERG A, 1954, J CLIN ENDOCR METAB, V14, P1519, DOI 10.1210/jcem-14-12-1519; Vallette-Kasic S, 2005, J CLIN ENDOCR METAB, V90, P1323, DOI 10.1210/jc.2004-1300; Vallette-Kasic S, 2007, J CLIN ENDOCR METAB, V92, P3991, DOI 10.1210/jc.2007-0284; Weintrob N, 2006, PEDIATRICS, V117, pE322, DOI 10.1542/peds.2005-1973	15	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26516	10.1371/journal.pone.0026516	http://dx.doi.org/10.1371/journal.pone.0026516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028893	Green Published, gold, Green Submitted			2022-12-27	WOS:000296186900071
J	Streicher, S; Boyles, JG; Oosthuizen, MK; Bennett, NC				Streicher, Sonja; Boyles, Justin G.; Oosthuizen, Maria K.; Bennett, Nigel C.			Body Temperature Patterns and Rhythmicity in Free-Ranging Subterranean Damaraland Mole-Rats, Fukomys damarensis	PLOS ONE			English	Article							CRYPTOMYS-DAMARENSIS; LOCOMOTOR-ACTIVITY; ENERGY AVAILABILITY; CIRCADIAN-RHYTHMS; TORPOR; ENERGETICS; RODENTIA; BATHYERGIDAE; SOLITARY; HETEROTHERMY	Body temperature (T-b) is an important physiological component that affects endotherms from the cellular to whole organism level, but measurements of T-b in the field have been noticeably skewed towards heterothermic species and seasonal comparisons are largely lacking. Thus, we investigated patterns of T-b patterns in a homeothermic, free-ranging small mammal, the Damaraland mole-rat (Fukomys damarensis) during both the summer and winter. Variation in T-b was significantly greater during winter than summer, and greater among males than females. Interestingly, body mass had only a small effect on variation in T-b and there was no consistent pattern relating ambient temperature to variation in T-b. Generally speaking, it appears that variation in T-b patterns varies between seasons in much the same way as in heterothermic species, just to a lesser degree. Both cosinor analysis and Fast Fourier Transform analysis revealed substantial individual variation in T-b rhythms, even within a single colony. Some individuals had no T-b rhythms, while others appeared to exhibit multiple rhythms. These data corroborate previous laboratory work showing multiplicity of rhythms in mole-rats and suggest the variation seen in the laboratory is a true indicator of the variation seen in the wild.	[Streicher, Sonja; Boyles, Justin G.; Oosthuizen, Maria K.; Bennett, Nigel C.] Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Bennett, Nigel C.] King Saud Univ, Dept Zool, Riyadh, Saudi Arabia	University of Pretoria; King Saud University	Streicher, S (corresponding author), Univ Pretoria, Mammal Res Inst, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa.	jgboyles@zoology.up.ac.za	Oosthuizen, Maria/U-7276-2019; Boyles, Justin G/A-5152-2010; Oosthuizen, Maria Kathleen/K-7923-2012; Bennett, Nigel/E-4238-2010	Oosthuizen, Maria Kathleen/0000-0001-6305-8283; Bennett, Nigel/0000-0001-9748-2947	NRF; Claude Leon Postdoctoral Research Fellowship; DST-NRF	NRF; Claude Leon Postdoctoral Research Fellowship; DST-NRF(Department of Science & Technology (India))	SS was supported by a NRF Chair bursary during this research. JGB was supported by a Claude Leon Postdoctoral Research Fellowship. The research was supported by a core grant to NCB via the DST-NRF South African research Chair of Mammal Behavioural Ecology and Physiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angilletta Michael J Jr, 2010, Front Biosci (Elite Ed), V2, P861; Angilletta MJ, 2010, PHYSIOL BIOCHEM ZOOL, V83, P197, DOI 10.1086/648567; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; [Anonymous], 2006, SAS MIXED MODELS; Arnold W, 2004, AM J PHYSIOL-REG I, V286, pR174, DOI 10.1152/ajpregu.00593.2002; ASCHOFF J, 1983, J THERM BIOL, V8, P143, DOI 10.1016/0306-4565(83)90094-3; Barclay RMR, 2001, CAN J ZOOL, V79, P1885, DOI 10.1139/cjz-79-10-1885; BENNETT NC, 1988, J MAMMAL, V69, P293, DOI 10.2307/1381379; Bennett NC, 1996, P ROY SOC B-BIOL SCI, V263, P1599, DOI 10.1098/rspb.1996.0234; BENNETT NC, 1990, J ZOOL, V220, P225, DOI 10.1111/j.1469-7998.1990.tb04305.x; BENNETT NC, 1994, OECOLOGIA, V97, P222, DOI 10.1007/BF00323153; BENNETT NC, 1988, S AFR J ZOOL, V23, P189; BENNETT NC, 1992, J ARID ENVIRON, V23, P189, DOI 10.1016/S0140-1963(18)30530-5; Bennett NC, 2009, AFR ZOOL, V44, P263, DOI 10.3377/004.044.0214; Boyles JG, J EXP ZOO A IN PRESS; Boyles JG, 2007, J EXP BIOL, V210, P4345, DOI 10.1242/jeb.007294; Boyles JG, 2011, PHYSIOL BIOCHEM ZOOL, V84, P115, DOI 10.1086/656724; Brown CM, 1996, J THERM BIOL, V21, P227, DOI 10.1016/0306-4565(96)00006-X; BUFFENSTEIN R, 1991, J THERM BIOL, V16, P227, DOI 10.1016/0306-4565(91)90030-6; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; FANNING FD, 1980, AUST J ZOOL, V28, P229, DOI 10.1071/ZO9800229; Geiser F, 2007, J COMP PHYSIOL B, V177, P495, DOI 10.1007/s00360-007-0147-6; Glanville EJ, 2010, COMP BIOCHEM PHYS A, V155, P383, DOI 10.1016/j.cbpa.2009.12.008; Goldman BD, 1997, J BIOL RHYTHM, V12, P348, DOI 10.1177/074873049701200407; Hart L, 2004, PHYSIOL BEHAV, V82, P563, DOI 10.1016/j.physbeh.2004.05.008; Hetem RS, 2009, COMP BIOCHEM PHYS A, V152, P379, DOI 10.1016/j.cbpa.2008.11.011; Hilmer S, 2010, J THERM BIOL, V35, P270, DOI 10.1016/j.jtherbio.2010.06.002; HISLOP MS, 1994, J THERM BIOL, V19, P25, DOI 10.1016/0306-4565(94)90006-X; Humphries MM, 2003, PHYSIOL BIOCHEM ZOOL, V76, P165, DOI 10.1086/367950; JACOBS DS, 1991, J ZOOL, V224, P553, DOI 10.1111/j.1469-7998.1991.tb03785.x; JARVIS JUM, 1993, BEHAV ECOL SOCIOBIOL, V33, P253, DOI 10.1007/BF02027122; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kotze J, 2008, PHYSIOL BEHAV, V93, P215, DOI 10.1016/j.physbeh.2007.08.016; LABYAK SE, 1995, PHYSIOL BEHAV, V58, P573, DOI 10.1016/0031-9384(95)00096-2; Landry-Cuerrier M, 2008, ECOLOGY, V89, P3306, DOI 10.1890/08-0121.1; LOVEGROVE BG, 1994, AUST J ZOOL, V42, P65, DOI 10.1071/ZO9940065; LOVEGROVE BG, 1986, OECOLOGIA, V69, P551, DOI 10.1007/BF00410361; Lovegrove BG, 1996, PHYSIOL BEHAV, V60, P991; Martinez GS, 2002, BRAIN RES, V955, P1, DOI 10.1016/S0006-8993(02)03264-X; McKechnie AE, 2007, J AVIAN BIOL, V38, P261, DOI 10.1111/j.2007.0908-8857.04116.x; MCNAB BK, 1979, ECOLOGY, V60, P1010, DOI 10.2307/1936869; MINORS DS, 1989, BIOL RHYTHMS CLIN PR, P272; Oosthuizen MK, 2003, J BIOL RHYTHM, V18, P481, DOI 10.1177/0748730403259109; Pereira ME, 2002, J MAMMAL, V83, P467, DOI 10.1644/1545-1542(2002)083<0467:TOHIEG>2.0.CO;2; Racinais S, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01204.x; REFINETTI R, 1992, J EXP ZOOL, V263, P453, DOI 10.1002/jez.1402630413; Refinetti R, 1999, J THERM BIOL, V24, P477, DOI 10.1016/S0306-4565(99)00077-7; Refinetti R, 1997, ANN NY ACAD SCI, V813, P63, DOI 10.1111/j.1749-6632.1997.tb51673.x; Roper TJ, 2001, J ZOOL, V254, P101, DOI 10.1017/S0952836901000590; Scantlebury M, 2006, NATURE, V440, P795, DOI 10.1038/nature04578; Schabenberger O, 2000, AM STAT, V54, P210, DOI 10.2307/2685592; SCHMIDTNIELSEN K, 1957, AM J PHYSIOL, V188, P103, DOI 10.1152/ajplegacy.1956.188.1.103; Signer C, 2011, FUNCT ECOL, V25, P537, DOI 10.1111/j.1365-2435.2010.01806.x; Smit B, J BIOL RHYT IN PRESS; Smit B, 2010, PHYSIOL BIOCHEM ZOOL, V83, P149, DOI 10.1086/605457; Stawski C, 2010, J EXP BIOL, V213, P393, DOI 10.1242/jeb.038224; Venables WN., 2002, MODERN APPL STAT S 4; Warnecke L, 2007, J THERM BIOL, V32, P72, DOI 10.1016/j.jtherbio.2006.10.003; Willis CKR, 2007, PHYSIOL BIOCHEM ZOOL, V80, P643, DOI 10.1086/521085; Withers PC, 2000, AUST J ZOOL, V48, P241, DOI 10.1071/ZO99073; Wooden KM, 2004, J EXP BIOL, V207, P41, DOI 10.1242/jeb.00717; Zelova J, 2007, COMP BIOCHEM PHYS A, V147, P412, DOI 10.1016/j.cbpa.2007.01.002	62	24	24	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26346	10.1371/journal.pone.0026346	http://dx.doi.org/10.1371/journal.pone.0026346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028861	gold, Green Published			2022-12-27	WOS:000296186900052
J	Yang, YH; Zhou, H; Binmadi, NO; Proia, P; Basile, JR				Yang, Ying-Hua; Zhou, Hua; Binmadi, Nada O.; Proia, Patrizia; Basile, John R.			Plexin-B1 Activates NF-kappa B and IL-8 to Promote a Pro-Angiogenic Response in Endothelial Cells	PLOS ONE			English	Article							RHO; SEMAPHORINS; CARCINOMA; SEMA4D; GROWTH; AKT; RECEPTOR; BINDING; TARGET; CANCER	Background: The semaphorins and their receptors, the plexins, are proteins related to c-Met and the scatter factors that have been implicated in an expanding signal transduction network involving co-receptors, RhoA and Ras activation and deactivation, and phosphorylation events. Our previous work has demonstrated that Semaphorin 4D (Sema4D) acts through its receptor, Plexin-B1, on endothelial cells to promote angiogenesis in a RhoA and Akt-dependent manner. Since NF-kappa B has been linked to promotion of angiogenesis and can be activated by Akt in some contexts, we wanted to examine NF-kappa B in Sema4D treated cells to determine if there was biological significance for the pro-angiogenic phenotype observed in endothelium. Methods/Principal Findings: Using RNA interference techniques, gel shifts and NF-kappa B reporter assays, we demonstrated NF kappa B translocation to the nucleus in Sema4D treated endothelial cells occurring downstream of Plexin-B1. This response was necessary for endothelial cell migration and capillary tube formation and protected endothelial cells against apoptosis as well, but had no effect on cell proliferation. We dissected Plexin-B1 signaling with chimeric receptor constructs and discovered that the ability to activate NF-kappa B was dependent upon Plexin-B1 acting through Rho and Akt, but did not involve its role as a Ras inhibitor. Indeed, inhibition of Rho by C3 toxin and Akt by LY294002 blocked Sema4D-mediated endothelial cell migration and tubulogenesis. We also observed that Sema4D treatment of endothelial cells induced production of the NF-kappa B downstream target IL-8, a response necessary for angiogenesis. Finally, we could show through co-immunofluorescence for p65 and CD31 that Sema4D produced by tumor xenografts in nude mice activated NF-kappa B in vessels of the tumor stroma. Conclusion/Significance: These findings provide evidence that Sema4D/Plexin-B1-mediated NF-kappa B activation and IL-8 production is critical in the generation a pro-angiogenic phenotype in endothelial cells and suggests a new therapeutic target for the anti-angiogenic treatment of some cancers.	[Yang, Ying-Hua; Zhou, Hua; Binmadi, Nada O.; Proia, Patrizia; Basile, John R.] Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA; [Proia, Patrizia] Univ Palermo, Dept Sports Sci DISMOT, Palermo, Italy; [Basile, John R.] Marlene & Stuart Greenebaum Canc Ctr, Baltimore, MD USA	University System of Maryland; University of Maryland Baltimore; University of Palermo; University System of Maryland; University of Maryland Baltimore	Yang, YH (corresponding author), Univ Maryland, Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD 21201 USA.	jbasile@umaryland.edu			National Cancer Institute [R01 CA133162]; King Abdulaziz University in Jeddah, Saudi Arabia; NATIONAL CANCER INSTITUTE [R01CA133162] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); King Abdulaziz University in Jeddah, Saudi Arabia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute (R01 CA133162 to JRB) and a scholarship to NOB from the King Abdulaziz University in Jeddah, Saudi Arabia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Malak NA, 2008, BLOOD, V111, P4145, DOI 10.1182/blood-2007-08-110338; Ahmed ST, 2009, BIOCHEM BIOPH RES CO, V378, P821, DOI 10.1016/j.bbrc.2008.11.147; Amornphimoltham P, 2004, CLIN CANCER RES, V10, P4029, DOI 10.1158/1078-0432.CCR-03-0249; Aurora AB, 2010, BLOOD, V116, P475, DOI 10.1182/blood-2009-07-232132; Basile JR, 2007, J BIOL CHEM, V282, P34888, DOI 10.1074/jbc.M705467200; Basile JR, 2006, P NATL ACAD SCI USA, V103, P9017, DOI 10.1073/pnas.0508825103; Basile JR, 2005, MOL CELL BIOL, V25, P6889, DOI 10.1128/MCB.25.16.6889-6898.2005; Basile JR, 2004, CANCER RES, V64, P5212, DOI 10.1158/0008-5472.CAN-04-0126; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Catalano A, 2009, CANCER RES, V69, P1485, DOI 10.1158/0008-5472.CAN-08-3659; Ch'ng ES, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-251; Chen Fei, 2002, Current Drug Targets - Inflammation and Allergy, V1, P137, DOI 10.2174/1568010023344706; Conrotto P, 2005, BLOOD, V105, P4321, DOI 10.1182/blood-2004-07-2885; Giordano S, 2002, NAT CELL BIOL, V4, P720, DOI 10.1038/ncb843; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hannon Gregory J, 2004, Methods Mol Biol, V257, P255, DOI 10.1385/1-59259-750-5:255; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Karin M, 2005, NAT REV IMMUNOL, V5, P749, DOI 10.1038/nri1703; KOLODKIN AL, 1993, CELL, V75, P1389, DOI 10.1016/0092-8674(93)90625-Z; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Luqman S, 2010, PHYTOTHER RES, V24, P949, DOI 10.1002/ptr.3171; Martin D, 2008, ONCOGENE, V27, P1844, DOI [10.1038/sj.onc.1210817, 10.1038/onc.2009.351]; Masuda K, 2004, GENES CELLS, V9, P821, DOI 10.1111/j.1365-2443.2004.00766.x; Neufeld G, 2005, FRONT BIOSCI-LANDMRK, V10, P751, DOI 10.2741/1569; OHTA K, 1995, NEURON, V14, P1189, DOI 10.1016/0896-6273(95)90266-X; Oinuma I, 2004, SCIENCE, V305, P862, DOI 10.1126/science.1097545; Ozes ON, 1999, NATURE, V401, P82; Perrot V, 2002, J BIOL CHEM, V277, P43115, DOI 10.1074/jbc.M206005200; Rao SK, 2010, J BIOL CHEM, V285, P32512, DOI 10.1074/jbc.M110.150490; Rice J, 2006, J VASC RES, V43, P422, DOI 10.1159/000094884; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Sakamoto K, 2009, CLIN CANCER RES, V15, P2248, DOI 10.1158/1078-0432.CCR-08-1383; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Sultana H, 2010, J EXP MED, V207, P1727, DOI 10.1084/jem.20100276; Sun QM, 2009, J BIOL CHEM, V284, P32066, DOI 10.1074/jbc.M109.057166; Swiercz JM, 2002, NEURON, V35, P51, DOI 10.1016/S0896-6273(02)00750-X; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tong Y, 2007, J BIOL CHEM, V282, P37215, DOI 10.1074/jbc.M703800200; Vikis HG, 2002, GENE DEV, V16, P836, DOI 10.1101/gad.966402; Yang YH, 2006, J PHARMACOL EXP THER, V318, P547, DOI 10.1124/jpet.106.102467	41	10	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25826	10.1371/journal.pone.0025826	http://dx.doi.org/10.1371/journal.pone.0025826			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028792	Green Submitted, gold, Green Published			2022-12-27	WOS:000296186900020
J	Britton, JR; Pegg, J; Williams, CF				Britton, J. Robert; Pegg, Josephine; Williams, Chris F.			Pathological and Ecological Host Consequences of Infection by an Introduced Fish Parasite	PLOS ONE			English	Article							BOTHRIOCEPHALUS-ACHEILOGNATHI YAMAGUTI; LIFE-HISTORY TRAITS; CYPRINUS-CARPIO; CLIMATE-CHANGE; GROWTH; RESPONSES; TAPEWORM; DISEASES; RIVER	The infection consequences of the introduced cestode fish parasite Bothriocephalus acheilognathi were studied in a cohort of wild, young-of-the-year common carp Cyprinus carpio that lacked co-evolution with the parasite. Within the cohort, parasite prevalence was 42% and parasite burdens were up to 12% body weight. Pathological changes within the intestinal tract of parasitized carp included distension of the gut wall, epithelial compression and degeneration, pressure necrosis and varied inflammatory changes. These were most pronounced in regions containing the largest proportion of mature proglottids. Although the body lengths of parasitized and non-parasitized fish were not significantly different, parasitized fish were of lower body condition and reduced weight compared to non-parasitized conspecifics. Stable isotope analysis (delta N-15 and delta C-13) revealed trophic impacts associated with infection, particularly for delta N-15 where values for parasitized fish were significantly reduced as their parasite burden increased. In a controlled aquarium environment where the fish were fed ad libitum on an identical food source, there was no significant difference in values of delta N-15 and delta N-13 between parasitized and non-parasitized fish. The growth consequences remained, however, with parasitized fish growing significantly slower than non-parasitized fish, with their feeding rate (items s(-1)) also significantly lower. Thus, infection by an introduced parasite had multiple pathological, ecological and trophic impacts on a host with no experience of the parasite.	[Britton, J. Robert; Pegg, Josephine] Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England; [Williams, Chris F.] Environm Agcy, Brampton, Cambs, England	Bournemouth University	Britton, JR (corresponding author), Bournemouth Univ, Sch Appl Sci, Ctr Conservat Ecol & Environm Change, Poole BH12 5BB, Dorset, England.	rbritton@bournemouth.ac.uk	Britton, Robert/B-5040-2009; Britton, Robert/AAO-6673-2020	Britton, Robert/0000-0003-1853-3086; Britton, Robert/0000-0003-1853-3086; Pegg, Josephine/0000-0001-6364-4741	Fisheries Society of the British Isles; Bournemouth University; Environment Agency of England and Wales	Fisheries Society of the British Isles; Bournemouth University; Environment Agency of England and Wales	Funding for the study was received through a grant from the Fisheries Society of the British Isles (www.fsbi.co.uk), with support from Bournemouth University and the Environment Agency of England and Wales. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2000, MICROBES INFECT, V2, P891, DOI 10.1016/S1286-4579(00)00389-0; Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; ANDREWS C, 1981, J FISH DIS, V4, P89, DOI 10.1111/j.1365-2761.1981.tb01113.x; Arnott SA, 2000, P ROY SOC B-BIOL SCI, V267, P657, DOI 10.1098/rspb.2000.1052; Bauer O. N., 1973, Diseases of pond fishes.; Blanchet S, 2010, EVOL ECOL, V24, P1129, DOI 10.1007/s10682-010-9353-x; Blanchet S, 2009, TRENDS PARASITOL, V25, P364, DOI 10.1016/j.pt.2009.05.005; Britton JR, 2010, FRESHWATER BIOL, V55, P1130, DOI 10.1111/j.1365-2427.2010.02396.x; Christe P, 1996, BEHAV ECOL, V7, P127, DOI 10.1093/beheco/7.2.127; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Daszak P, 1999, TRENDS ECOL EVOL, V14, P279, DOI 10.1016/S0169-5347(99)01665-1; DUBININA MN, 1964, KEY PARASITES FRESHW, P480; Edwards SV, 1998, TRENDS ECOL EVOL, V13, P305, DOI 10.1016/S0169-5347(98)01416-5; FERNANDEZDELGADO C, 1990, HYDROBIOLOGIA, V206, P19, DOI 10.1007/BF00018966; Gozlan RE, 2010, J FISH BIOL, V76, P751, DOI 10.1111/j.1095-8649.2010.02566.x; Gozlan RE, 2006, MICROBES INFECT, V8, P1358, DOI 10.1016/j.micinf.2005.12.010; Grey J, 2006, POL J ECOL, V54, P563; HECKMANN RA, 1987, J PARASITOL, V73, P226, DOI 10.2307/3282373; Heckmann Richard A., 2000, Proceedings of Parasitology, V29, P1; Hoffman G.L., 1984, P233; HOOLE D, 1994, J FISH DIS, V17, P623, DOI 10.1111/j.1365-2761.1994.tb00260.x; Hoole D., 1994, P119; Huber SK, 2008, BIOL CONSERV, V141, P601, DOI 10.1016/j.biocon.2007.11.012; Khan TA, 2003, HYDROBIOLOGIA, V506, P465, DOI 10.1023/B:HYDR.0000008558.48008.63; Koop JAH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019706; MICHALAKIS Y, 1994, PARASITE, V1, P291, DOI 10.1051/parasite/1994014291; MINCHELLA DJ, 1991, TRENDS ECOL EVOL, V6, P250, DOI 10.1016/0169-5347(91)90071-5; MINERVINI R, 1985, RIV IT PISCIC ITTIOP, V20, P27; Murray AG, 2005, PREV VET MED, V67, P223, DOI 10.1016/j.prevetmed.2004.10.012; Norton J, 2005, PARASITOLOGY, V130, P679, DOI 10.1017/S0031182004007139; Pagan I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000124; Peeler EJ, 2011, BIOL INVASIONS, V13, P1291, DOI 10.1007/s10530-010-9890-9; Pegg J, 2011, ECOL FRESHW FISH, V20, P598, DOI 10.1111/j.1600-0633.2011.00509.x; Penczykowski RM, 2011, FRESHWATER BIOL, V56, P689, DOI 10.1111/j.1365-2427.2010.02499.x; Perrin N, 1996, OIKOS, V75, P317, DOI 10.2307/3546256; Phares K, 1996, INT J PARASITOL, V26, P575, DOI 10.1016/0020-7519(96)00025-2; Poulin R, 1998, J PARASITOL, V84, P1050, DOI 10.2307/3284645; Power AG, 2004, AM NAT, V164, pS79, DOI 10.1086/424610; Rosenblum EB, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000550; SALGADOMALDONAD.G, 1993, ANALES I BIOL U NACL, V57, P213; Scholz T., 1992, Parassitologia (Rome), V34, P155; Sorci G, 1997, P ROY SOC B-BIOL SCI, V264, P285, DOI 10.1098/rspb.1997.0040; Sorensen RE, 1998, OECOLOGIA, V115, P188, DOI 10.1007/s004420050507; Taraschewski H, 2006, J HELMINTHOL, V80, P99, DOI 10.1079/JOH2006364; Vercken E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001229; XIANGHUA L, 2007, CURRENT ZOOLOGY, V53, P470; FISHERIES AGR DEP 20	47	33	38	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26365	10.1371/journal.pone.0026365	http://dx.doi.org/10.1371/journal.pone.0026365			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022606	Green Published, gold, Green Accepted			2022-12-27	WOS:000295984400051
J	Kaer, K; Branovets, J; Hallikma, A; Nigumann, P; Speek, M				Kaer, Kristel; Branovets, Jelena; Hallikma, Anni; Nigumann, Pilvi; Speek, Mart			Intronic L1 Retrotransposons and Nested Genes Cause Transcriptional Interference by Inducing Intron Retention, Exonization and Cryptic Polyadenylation	PLOS ONE			English	Article							NONCODING RNAS; ANTISENSE PROMOTER; MESSENGER-RNA; EXPRESSION; ELONGATION; PATTERNS; BINDING; LONG; CIS; IDENTIFICATION	Background: Transcriptional interference has been recently recognized as an unexpectedly complex and mostly negative regulation of genes. Despite a relatively few studies that emerged in recent years, it has been demonstrated that a readthrough transcription derived from one gene can influence the transcription of another overlapping or nested gene. However, the molecular effects resulting from this interaction are largely unknown. Methodology/Principal Findings: Using in silico chromosome walking, we searched for prematurely terminated transcripts bearing signatures of intron retention or exonization of intronic sequence at their 3' ends upstream to human L1 retrotransposons, protein-coding and noncoding nested genes. We demonstrate that transcriptional interference induced by intronic L1s (or other repeated DNAs) and nested genes could be characterized by intron retention, forced exonization and cryptic polyadenylation. These molecular effects were revealed from the analysis of endogenous transcripts derived from different cell lines and tissues and confirmed by the expression of three minigenes in cell culture. While intron retention and exonization were comparably observed in introns upstream to L1s, forced exonization was preferentially detected in nested genes. Transcriptional interference induced by L1 or nested genes was dependent on the presence or absence of cryptic splice sites, affected the inclusion or exclusion of the upstream exon and the use of cryptic polyadenylation signals. Conclusions/Significance: Our results suggest that transcriptional interference induced by intronic L1s and nested genes could influence the transcription of the large number of genes in normal as well as in tumor tissues. Therefore, this type of interference could have a major impact on the regulation of the host gene expression.	[Kaer, Kristel; Branovets, Jelena; Hallikma, Anni; Nigumann, Pilvi; Speek, Mart] Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia	Tallinn University of Technology	Kaer, K (corresponding author), Tallinn Univ Technol, Dept Gene Technol, Tallinn, Estonia.	mart.speek@ttu.ee	Branovets, Jelena/AAF-7977-2020	Branovets, Jelena/0000-0001-7970-8543	Estonian Science Foundation [ETF8381]; Estonian Ministry of Education and Research [SF0140143s08]	Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	This work was supported by grants from the Estonian Science Foundation (ETF8381) and the Estonian Ministry of Education and Research (SF0140143s08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assis R, 2008, TRENDS GENET, V24, P475, DOI 10.1016/j.tig.2008.08.003; BECKER KG, 1993, HUM MOL GENET, V2, P1697, DOI 10.1093/hmg/2.10.1697; Belancio VP, 2006, NUCLEIC ACIDS RES, V34, P1512, DOI 10.1093/nar/gkl027; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Brouha B, 2003, P NATL ACAD SCI USA, V100, P5280, DOI 10.1073/pnas.0831042100; Callen BP, 2004, MOL CELL, V14, P647, DOI 10.1016/j.molcel.2004.05.010; Celniker SE, 2009, NATURE, V459, P927, DOI 10.1038/459927a; Chavez S, 2001, MOL CELL BIOL, V21, P7054, DOI 10.1128/MCB.21.20.7054-7064.2001; Chen JC, 2006, HUM MOL GENET, V15, P2146, DOI 10.1093/hmg/ddl138; CHURCH DM, 1994, NAT GENET, V6, P98, DOI 10.1038/ng0194-98; Crampton N, 2006, NUCLEIC ACIDS RES, V34, P5416, DOI 10.1093/nar/gkl668; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Dodd IB, 2002, MOL MICROBIOL, V45, P697, DOI 10.1046/j.1365-2958.2002.03038.x; Druker R, 2004, NUCLEIC ACIDS RES, V32, P5800, DOI 10.1093/nar/gkh914; EPERON LP, 1988, CELL, V54, P393, DOI 10.1016/0092-8674(88)90202-4; Eszterhas SK, 2002, MOL CELL BIOL, V22, P469, DOI 10.1128/MCB.22.2.469-479.2002; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Gal-Mark N, 2008, NUCLEIC ACIDS RES, V36, P2012, DOI 10.1093/nar/gkn024; Gibson CW, 2005, GENE, V350, P15, DOI 10.1016/j.gene.2004.12.045; Goldman SR, 2009, SCIENCE, V324, P927, DOI 10.1126/science.1169237; Greger IH, 1998, NUCLEIC ACIDS RES, V26, P1294, DOI 10.1093/nar/26.5.1294; Han JS, 2004, NATURE, V429, P314, DOI 10.1038/nature02535; Han JS, 2004, NATURE, V429, P268, DOI 10.1038/nature02536; Han YF, 2008, CELL HOST MICROBE, V4, P134, DOI 10.1016/j.chom.2008.06.008; Hongay CF, 2006, CELL, V127, P735, DOI 10.1016/j.cell.2006.09.038; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khan H, 2006, GENOME RES, V16, P78, DOI 10.1101/gr.4001406; Kimberland ML, 1999, HUM MOL GENET, V8, P1557, DOI 10.1093/hmg/8.8.1557; Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5; Kumar A, 2009, EUKARYOT CELL, V8, P1321, DOI 10.1128/EC.00143-09; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leupin O, 2005, EMBO REP, V6, P956, DOI 10.1038/sj.embor.7400502; Lev-Maor G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000204; Liu F, 2003, GENE, V315, P71, DOI 10.1016/S0378-1119(03)00732-7; Macia A, 2011, MOL CELL BIOL, V31, P300, DOI 10.1128/MCB.00561-10; Maquat LE, 2004, NAT REV MOL CELL BIO, V5, P89, DOI 10.1038/nrm1310; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Matlik K, 2006, J BIOMED BIOTECHNOL, DOI 10.1155/JBB/2006/71753; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mazo A, 2007, J CELL SCI, V120, P2755, DOI 10.1242/jcs.007633; MINAKAMI R, 1992, NUCLEIC ACIDS RES, V20, P3139, DOI 10.1093/nar/20.12.3139; Muotri AR, 2005, NATURE, V435, P903, DOI 10.1038/nature03663; Nakaya HI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r43; Naville M, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r97; Nigumann P, 2002, GENOMICS, V79, P628, DOI 10.1006/geno.2002.6758; Ostertag EM, 2001, ANNU REV GENET, V35, P501, DOI 10.1146/annurev.genet.35.102401.091032; Padidam M, 2001, BIOTECHNIQUES, V31, P328, DOI 10.2144/01312st04; Perepelitsa-Belancio V, 2003, NAT GENET, V35, P363, DOI 10.1038/ng1269; Petrakis TG, 2005, J BIOL CHEM, V280, P19454, DOI 10.1074/jbc.M413373200; Petruk S, 2007, RNA BIOL, V4, P1; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Piehler A, 2002, BIOCHEM BIOPH RES CO, V295, P408, DOI 10.1016/S0006-291X(02)00659-9; Prescott EM, 2002, P NATL ACAD SCI USA, V99, P8796, DOI 10.1073/pnas.132270899; PROUDFOOT NJ, 1986, NATURE, V322, P562, DOI 10.1038/322562a0; Rangwala SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r100; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Sambrook J., 2001, MOL CLONING LAB MANU; Shearwin KE, 2005, TRENDS GENET, V21, P339, DOI 10.1016/j.tig.2005.04.009; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Speek M, 2001, MOL CELL BIOL, V21, P1973, DOI 10.1128/MCB.21.6.1973-1985.2001; Steinhoff C, 2004, MOL GENET GENOMICS, V270, P394, DOI 10.1007/s00438-003-0931-2; SWERGOLD GD, 1990, MOL CELL BIOL, V10, P6718, DOI 10.1128/MCB.10.12.6718; Tabaska JE, 1999, GENE, V231, P77, DOI 10.1016/S0378-1119(99)00104-3; Tchenio T, 2000, NUCLEIC ACIDS RES, V28, P411, DOI 10.1093/nar/28.2.411; Trinklein ND, 2004, GENOME RES, V14, P62, DOI 10.1101/gr.1982804; Ustyugova SV, 2006, GENETICA, V128, P261, DOI 10.1007/s10709-005-5967-2; Vihma H, 2008, GENOMICS, V92, P279, DOI 10.1016/j.ygeno.2008.06.011; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Yang N, 2003, NUCLEIC ACIDS RES, V31, P4929, DOI 10.1093/nar/gkg663; Yang ZY, 1998, J BIOL CHEM, V273, P891, DOI 10.1074/jbc.273.2.891; Yu P, 2005, GENOMICS, V86, P414, DOI 10.1016/j.ygeno.2005.06.008; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002046	74	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26099	10.1371/journal.pone.0026099	http://dx.doi.org/10.1371/journal.pone.0026099			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022525	Green Submitted, gold, Green Published			2022-12-27	WOS:000295978600040
J	Smee, DF; Wong, MH; Russell, A; Ennis, J; Turner, JD				Smee, Donald F.; Wong, Min-Hui; Russell, Andrew; Ennis, Jane; Turner, Jeffrey D.			Therapy and Long-Term Prophylaxis of Vaccinia Virus Respiratory Infections in Mice with an Adenovirus-Vectored Interferon Alpha (mDEF201)	PLOS ONE			English	Article							EQUINE ENCEPHALITIS-VIRUS; CONSENSUS INTERFERON; SMALLPOX VACCINEE; RHESUS-MONKEYS; ANIMAL-MODELS; PATHOGENESIS; PREVENTION	An adenovirus 5 vector encoding for mouse interferon alpha, subtype 5 (mDEF201) was evaluated for efficacy against lethal vaccinia virus (WR strain) respiratory infections in mice. mDEF201 was administered as a single intranasal treatment either prophylactically or therapeutically at doses of 10(6) to 10(8) plaque forming units/mouse. When the prophylactic treatment was given at 56 days prior to infection, it protected 90% of animals from death (100% protection for treatments given between 1-49 days pre-infection), with minimal weight loss occurring during infection. Surviving animals re-challenged with virus 22 days after the primary infection were protected from death, indicating that mDEF201 did not compromise the immune response against the initial infection. Post-exposure therapy was given between 6-24 h after vaccinia virus exposure and protection was afforded by a 10(8) dose of mDEF201 given at 24 h, whereas a 10(7) dose was effective up to 12 h. Comparisons were made of the ability of mDEF201, given either 28 or 1 day prior to infection, to inhibit tissue virus titers and lung infection parameters. Lung, liver, and spleen virus titers were inhibited to nearly the same extent by either treatment, as were lung weights and lung hemorrhage scores (indicators of pneumonitis). Lung virus titers were significantly (>100-fold) lower than in the placebo group, and the other infection parameters in mDEF201 treated mice were nearly at baseline. In contrast, viral titers and lung infection parameters were high in the placebo group on day 5 of the infection. These results demonstrate the long-acting prophylactic and treatment capacity of mDEF201 to combat vaccinia virus infections.	[Smee, Donald F.; Wong, Min-Hui; Russell, Andrew] Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA; [Ennis, Jane; Turner, Jeffrey D.] Defyrus Inc, Toronto, ON, Canada	Utah System of Higher Education; Utah State University	Smee, DF (corresponding author), Utah State Univ, Dept Anim Dairy & Vet Sci, Inst Antiviral Res, Logan, UT 84322 USA.	don.smee@usu.edu			Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA [N01-AI-30063]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030063] Funding Source: NIH RePORTER	Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by contract N01-AI-30063 (awarded to Southern Research Institute, Birmingham, Alabama, USA) from the Virology Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, USA. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bray M, 2003, ANTIVIR RES, V58, P101, DOI 10.1016/S0166-3542(03)00008-1; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P532; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Du Y, 2008, BIOPHARM DRUG DISPOS, V29, P481, DOI 10.1002/bdd.630; Hutson TE, 2003, CLIN CANCER RES, V9, P1354; Jahrling PB, 2005, CURR MOL MED, V5, P817, DOI 10.2174/156652405774962326; Jordan R, 2009, ANTIMICROB AGENTS CH, V53, P1817, DOI 10.1128/AAC.01596-08; Julander JG, 2011, ANTIMICROB AGENTS CH, V55, P2067, DOI 10.1128/AAC.01635-10; Kumaki Y, 2011, ANTIVIR RES, V89, P75, DOI 10.1016/j.antiviral.2010.11.007; Lanier R, 2010, VIRUSES-BASEL, V2, P2740, DOI 10.3390/v2122740; Liu G, 2004, FEMS IMMUNOL MED MIC, V40, P201, DOI 10.1016/S0928-8244(03)00358-4; NEWMANNHAEFELIN D, 1975, INFECT IMMUN, V12, P148; O'Brien L, 2009, J GEN VIROL, V90, P874, DOI 10.1099/vir.0.006833-0; Perdiguero B, 2009, J INTERF CYTOK RES, V29, P581, DOI 10.1089/jir.2009.0073; RADWANSKI E, 1987, J CLIN PHARMACOL, V27, P432, DOI 10.1002/j.1552-4604.1987.tb03044.x; Smee DF, 2003, ANTIVIR RES, V57, P41, DOI 10.1016/S0166-3542(02)00199-7; Smee DF, 2001, ANTIVIR RES, V52, P55, DOI 10.1016/S0166-3542(01)00159-0; Smee Donald F., 2008, Antiviral Chemistry & Chemotherapy, V19, P115; Vora S, 2008, CLIN INFECT DIS, V46, P1555, DOI 10.1086/587668; WEIMAR W, 1980, J GEN VIROL, V48, P25, DOI 10.1099/0022-1317-48-1-25; Wu JQH, 2007, VIROLOGY, V369, P206, DOI 10.1016/j.virol.2007.07.024	21	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26330	10.1371/journal.pone.0026330	http://dx.doi.org/10.1371/journal.pone.0026330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022603	Green Submitted, Green Published, gold			2022-12-27	WOS:000295978600049
J	Homan, EJ; Bremel, RD				Homan, E. Jane; Bremel, Robert D.			Patterns of Predicted T-Cell Epitopes Associated with Antigenic Drift in Influenza H3N2 Hemagglutinin	PLOS ONE			English	Article							MHC CLASS-II; A VIRUS NUCLEOPROTEIN; B-CELL; ANTIBODY-RESPONSES; INFECTION; EVOLUTION; MICE; VACCINE; IMMUNODOMINANCE; LYMPHOCYTES	Antigenic drift allowing escape from neutralizing antibodies is an important feature of transmission and survival of influenza viruses in host populations. Antigenic drift has been studied in particular detail for influenza A H3N2 and well defined antigenic clusters of this virus documented. We examine how host immunogenetics contributes to determination of the antibody spectrum, and hence the immune pressure bringing about antigenic drift. Using uTOPE (TM) bioinformatics analysis of predicted MHC binding, based on amino acid physical property principal components, we examined the binding affinity of all 9-mer and 15-mer peptides within the hemagglutinin 1 (HA1) of 447 H3N2 virus isolates to 35 MHC-I and 14 MHC-II alleles. We provide a comprehensive map of predicted MHC-I and MHC-II binding affinity for a broad array of HLA alleles for the H3N2 influenza HA1 protein. Each HLA allele exhibited a characteristic predicted binding pattern. Cluster analysis for each HLA allele shows that patterns based on predicted MHC binding mirror those described based on antibody binding. A single amino acid mutation or position displacement can result in a marked difference in MHC binding and hence potential T-helper function. We assessed the impact of individual amino acid changes in HA1 sequences between 10 virus isolates from 1968-2002, representative of antigenic clusters, to understand the changes in MHC binding over time. Gain and loss of predicted high affinity MHC-II binding sites with cluster transitions were documented. Predicted high affinity MHC-II binding sites were adjacent to antibody binding sites. We conclude that host MHC diversity may have a major determinant role in the antigenic drift of influenza A H3N2.	[Homan, E. Jane; Bremel, Robert D.] IoGenet LLC, Madison, WI USA		Homan, EJ (corresponding author), IoGenet LLC, Madison, WI USA.	jane_homan@iogenetics.com		Homan, Jane/0000-0002-2685-8852				Albright FS, 2008, J INFECT DIS, V197, P18, DOI 10.1086/524064; Babon JAB, 2009, HUM IMMUNOL, V70, P711, DOI 10.1016/j.humimm.2009.06.004; BARNETT BC, 1990, IMMUNOLOGY, V70, P48; BARNETT BC, 1989, EUR J IMMUNOL, V19, P515, DOI 10.1002/eji.1830190316; Batista FD, 2001, NATURE, V411, P489, DOI 10.1038/35078099; Baumgartner CK, 2010, J IMMUNOL, V184, P573, DOI 10.4049/jimmunol.0902107; Bedford T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000918; Belz GT, 2002, J VIROL, V76, P12388, DOI 10.1128/JVI.76.23.12388-12393.2002; Berkhoff EGM, 2004, J VIROL, V78, P5216, DOI 10.1128/JVI.78.10.5216-5222.2004; Berkhoff EGM, 2007, VIRUS RES, V126, P282, DOI 10.1016/j.virusres.2007.02.018; Boon ACM, 2002, J VIROL, V76, P2567, DOI 10.1128/JVI.76.5.2567-2572.2002; BOTH GW, 1983, J VIROL, V48, P52, DOI 10.1128/JVI.48.1.52-60.1983; Bremel Robert D, 2010, Immunome Res, V6, P7, DOI 10.1186/1745-7580-6-7; Bremel Robert D, 2010, Immunome Res, V6, P8, DOI 10.1186/1745-7580-6-8; Bush RM, 1999, SCIENCE, V286, P1921, DOI 10.1126/science.286.5446.1921; Cagigi A, 2010, LANCET INFECT DIS, V10, P499, DOI 10.1016/S1473-3099(10)70117-1; Chi XS, 2005, J CLIN MICROBIOL, V43, P6130, DOI 10.1128/JCM.43.12.6130-6132.2005; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Crowe SR, 2006, VACCINE, V24, P457, DOI 10.1016/j.vaccine.2005.07.096; Crowe SR, 2003, J EXP MED, V198, P399, DOI 10.1084/jem.20022151; DECAMPOSLIMA PO, 1993, SCIENCE, V260, P98, DOI 10.1126/science.7682013; Desmet J, 2005, PROTEINS, V58, P53, DOI 10.1002/prot.20302; Ferguson NM, 2002, NAT MED, V8, P562, DOI 10.1038/nm0602-562; Gelder CM, 2002, J INFECT DIS, V185, P114, DOI 10.1086/338014; Gerhard W, 2001, CURR TOP MICROBIOL, V260, P171; Gerhard W, 1997, IMMUNOL REV, V159, P95, DOI 10.1111/j.1600-065X.1997.tb01009.x; Gianfrani C, 2000, HUM IMMUNOL, V61, P438, DOI 10.1016/S0198-8859(00)00105-1; Giannella M, 2011, CLIN MICROBIOL INFEC, V17, P1160, DOI 10.1111/j.1469-0691.2010.03399.x; Greenbaum J, 2011, IMMUNOGENETICS, V63, P325, DOI 10.1007/s00251-011-0513-0; HAMILTONEASTON A, 1995, J VIROL, V69, P6359, DOI 10.1128/JVI.69.10.6359-6366.1995; HIOE CE, 1990, J VIROL, V64, P6246, DOI 10.1128/JVI.64.12.6246-6251.1990; HORIMOTO T, 1994, J VIROL, V68, P3120, DOI 10.1128/JVI.68.5.3120-3128.1994; Iqbal M, 2009, PHILOS T R SOC B, V364, P2739, DOI 10.1098/rstb.2009.0088; JOHNSON NL, 1949, BIOMETRIKA, V36, P149, DOI 10.1093/biomet/36.1-2.149; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; LEBIUSH M, 1981, J HYG-CAMBRIDGE, V87, P139, DOI 10.1017/S002217240006931X; Lee MS, 2004, EMERG INFECT DIS, V10, P1385, DOI 10.3201/eid1008.040107; Li CC, 2010, EMERG INFECT DIS, V16, P1265, DOI 10.3201/eid1608.091918; Lund O, 2005, IMMUNOLOGICAL BIOINF; MARUYAMA N, 2004, GERIATR GERONTOL INT, V4, P234; MCMICHAEL AJ, 1986, J GEN VIROL, V67, P719, DOI 10.1099/0022-1317-67-4-719; Mozdzanowska K, 2005, J VIROL, V79, P5943, DOI 10.1128/JVI.79.10.5943-5951.2005; Mozdzanowska K, 1997, VIROLOGY, V239, P217, DOI 10.1006/viro.1997.8882; Murcia PR, 2010, J VIROL, V84, P6943, DOI 10.1128/JVI.00112-10; Nimmerjahn F, 2004, J GEN VIROL, V85, P2347, DOI 10.1099/vir.0.79958-0; Pham DT, 2005, P I MECH ENG C-J MEC, V219, P103, DOI 10.1243/095440605X8298; Pinsky BA, 2010, EMERG INFECT DIS, V16, P1165, DOI 10.3201/eid1607.091248; Plotkin JB, 2002, P NATL ACAD SCI USA, V99, P6263, DOI 10.1073/pnas.082110799; Poland GA, 2008, VACCINE, V26, pD35, DOI 10.1016/j.vaccine.2008.07.065; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Richards KA, 2007, J VIROL, V81, P7608, DOI 10.1128/JVI.02834-06; Roti M, 2008, J IMMUNOL, V180, P1758, DOI 10.4049/jimmunol.180.3.1758; RUBEN FL, 1988, J LAB CLIN MED, V112, P595; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; SAS Institute Inc, 2010, JMP 9 MOD MULT METH; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; SCHERLE PA, 1992, J IMMUNOL, V148, P212; Sette A, 2008, IMMUNITY, V28, P847, DOI 10.1016/j.immuni.2008.04.018; Smith DJ, 2003, VACCINE, V21, P1758, DOI 10.1016/S0264-410X(03)00068-9; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Tewari MK, 2005, NAT IMMUNOL, V6, P287, DOI 10.1038/ni1171; Thomas PG, 2006, EMERG INFECT DIS, V12, P48, DOI 10.3201/eid1201.051237; Tong JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009291; Topham DJ, 1998, J VIROL, V72, P882, DOI 10.1128/JVI.72.1.882-885.1998; Tscherne DM, 2011, J CLIN INVEST, V121, P6, DOI 10.1172/JCI44947; VANOOSTEN AR, 2010, PLOS ONE, V5, DOI DOI 10.1371/JOURNAL.PONE.0012902; Voeten JTM, 2000, J VIROL, V74, P6800, DOI 10.1128/JVI.74.15.6800-6807.2000; WILEY DC, 1981, NATURE, V289, P373, DOI 10.1038/289373a0; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	71	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26711	10.1371/journal.pone.0026711	http://dx.doi.org/10.1371/journal.pone.0026711			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039539	gold, Green Published, Green Submitted			2022-12-27	WOS:000296515200045
J	Przybycien-Szymanska, MM; Mott, NN; Pak, TR				Przybycien-Szymanska, Magdalena M.; Mott, Natasha N.; Pak, Toni R.			Alcohol Dysregulates Corticotropin-Releasing-Hormone (CRH) Promoter Activity by Interfering with the Negative Glucocorticoid Response Element (nGRE)	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; INTRACELLULAR CAMP LEVELS; GENE-EXPRESSION; ADRENOCORTICAL AXIS; HYPOTHALAMIC CELLS; GENDER-DIFFERENCE; BETA-ENDORPHIN; ETHANOL; INCREASES; STRESS	EtOH exposure in male rats increases corticotropin-releasing hormone (CRH) mRNA in the paraventricular nucleus of the hypothalamus (PVN), a brain region responsible for coordinating stress and anxiety responses. In this study we identified the molecular mechanisms involved in mediating these effects by examining the direct effects of EtOH on CRH promoter activity in a neuronal cell line derived from the PVN (IVB). In addition, we investigated the potential interactions of EtOH and glucocorticoids on the CRH promoter by concomitantly treating cells with EtOH and the glucocorticoid receptor (GR) antagonist RU486, and by sequentially deleting GR binding sites within glucocorticoid response element (GRE) on the CRH promoter. Cells were transiently transfected with a firefly luciferase reporter construct containing 2.5 kb of the rat wild type (WT) or mutated CRH promoter. Our results showed that EtOH treatment induced a biphasic response in CRH promoter activity. EtOH exposure for 0.5 h significantly decreased promoter activity compared to vehicle treated controls, whereas promoter activity was significantly increased after 2.0 h of EtOH exposure. Treatment with RU486, or deletion of the GR binding sites 1 and 2 within the GRE, abolished the EtOH-induced increase in the promoter activity, however did not affect EtOH-induced decrease in CRH promoter activity at an earlier time point. Overall, our data suggest that alcohol exposure directly regulates CRH promoter activity by interfering with the normal feedback mechanisms of glucocorticoids mediated by GR signaling at the GRE site of the CRH promoter.	[Przybycien-Szymanska, Magdalena M.; Mott, Natasha N.; Pak, Toni R.] Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL USA	Loyola University Chicago	Przybycien-Szymanska, MM (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Cell & Mol Physiol, Maywood, IL USA.	tpak@lumc.edu			National Institutes of Health (NIH) [R21 AA018398, T32 AA013527]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013527, R21AA018398] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	Supported by National Institutes of Health (NIH) R21 AA018398 and NIH T32 AA013527. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blevins T, 1997, J NEUROCHEM, V69, P2345; Boyadjieva N, 1999, BRAIN RES, V824, P112, DOI 10.1016/S0006-8993(99)01170-1; Boyadjieva NI, 1997, ALCOHOL CLIN EXP RES, V21, P1005, DOI 10.1111/j.1530-0277.1997.tb04245.x; Druse MJ, 2006, BRAIN RES, V1092, P79, DOI 10.1016/j.brainres.2006.02.065; Figueiredo HF, 2003, ENDOCRINOLOGY, V144, P5249, DOI 10.1210/en.2003-0713; Goujon E, 1997, PSYCHONEUROENDOCRINO, V22, pS75, DOI 10.1016/S0306-4530(97)00009-7; King BR, 2002, MOL CELL ENDOCRINOL, V194, P19, DOI 10.1016/S0303-7207(02)00218-6; Lee JH, 2009, BRAIN RES, V1249, P54, DOI 10.1016/j.brainres.2008.10.013; Li ZQ, 2005, MOL CELL NEUROSCI, V29, P345, DOI 10.1016/j.mcn.2005.04.002; Little HJ, 2008, NEUROSCIENCE, V156, P1017, DOI 10.1016/j.neuroscience.2008.08.029; McAlhany RE, 1999, ALCOHOL CLIN EXP RES, V23, P1691, DOI 10.1111/j.1530-0277.1999.tb04062.x; Morsink MC, 2006, J NEUROENDOCRINOL, V18, P239, DOI 10.1111/j.1365-2826.2006.01413.x; Ogilvie KM, 1997, BRAIN RES, V744, P83, DOI 10.1016/S0006-8993(96)01082-7; Ogilvie KM, 1996, ALCOHOL CLIN EXP RES, V20, P255, DOI 10.1111/j.1530-0277.1996.tb01637.x; Ogilvie KM, 1997, BRAIN RES, V766, P19, DOI 10.1016/S0006-8993(97)00525-8; Ostrander MM, 2006, ENDOCRINOLOGY, V147, P2008, DOI 10.1210/en.2005-1041; Papadimitriou A, 2009, NEUROIMMUNOMODULAT, V16, P265, DOI 10.1159/000216184; PICKERING C, BASIC CLIN PHARM TOX, V106, P472; Przybycien-Szymanska MM, 2009, AM J PHYSL ENDOCRINO; RIVIER C, 1993, ALCOHOL CLIN EXP RES, V17, P854, DOI 10.1111/j.1530-0277.1993.tb00853.x; Roy A, 2002, J PHARMACOL EXP THER, V301, P774, DOI 10.1124/jpet.301.2.774; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schulkin J, 1998, PSYCHONEUROENDOCRINO, V23, P219, DOI 10.1016/S0306-4530(97)00099-1; SPENCER RL, 1990, NEUROENDOCRINOLOGY, V52, P481, DOI 10.1159/000125632	24	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26647	10.1371/journal.pone.0026647	http://dx.doi.org/10.1371/journal.pone.0026647			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039522	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200036
J	Carvalho, SM; Kloosterman, TG; Kuipers, OP; Neves, AR				Carvalho, Sandra M.; Kloosterman, Tomas G.; Kuipers, Oscar P.; Neves, Ana Rute			CcpA Ensures Optimal Metabolic Fitness of Streptococcus pneumoniae	PLOS ONE			English	Article							CARBON CATABOLITE REPRESSION; VIRULENCE GENE-EXPRESSION; LACTIC-ACID BACTERIA; LACTOCOCCUS-LACTIS; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; GLYCOLYTIC FLUX; SUBSP CREMORIS; PROTEIN CCPA; SYSTEM	In Gram-positive bacteria, the transcriptional regulator CcpA is at the core of catabolite control mechanisms. In the human pathogen Streptococcus pneumoniae, links between CcpA and virulence have been established, but its role as a master regulator in different nutritional environments remains to be elucidated. Thus, we performed whole-transcriptome and metabolic analyses of S. pneumoniae D39 and its isogenic ccpA mutant during growth on glucose or galactose, rapidly and slowly metabolized carbohydrates presumably encountered by the bacterium in different host niches. CcpA affected the expression of up to 19% of the genome covering multiple cellular processes, including virulence, regulatory networks and central metabolism. Its prevalent function as a repressor was observed on glucose, but unexpectedly also on galactose. Carbohydrate-dependent CcpA regulation was also observed, as for the tagatose 6-phosphate pathway genes, which were activated by galactose and repressed by glucose. Metabolite analyses revealed that two pathways for galactose catabolism are functionally active, despite repression of the Leloir genes by CcpA. Surprisingly, galactose-induced mixed-acid fermentation apparently required CcpA, since genes involved in this type of metabolism were mostly under CcpA-repression. These findings indicate that the role of CcpA extends beyond transcriptional regulation, which seemingly is overlaid by other regulatory mechanisms. In agreement, CcpA influenced the level of many intracellular metabolites potentially involved in metabolic regulation. Our data strengthen the view that a true understanding of cell physiology demands thorough analyses at different cellular levels. Moreover, integration of transcriptional and metabolic data uncovered a link between CcpA and the association of surface molecules ( e. g. capsule) to the cell wall. Hence, CcpA may play a key role in mediating the interaction of S. pneumoniae with its host. Overall, our results support the hypothesis that S. pneumoniae optimizes basic metabolic processes, likely enhancing in vivo fitness, in a CcpA-mediated manner.	[Carvalho, Sandra M.; Neves, Ana Rute] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Kloosterman, Tomas G.; Kuipers, Oscar P.] Univ Groningen, Dept Mol Genet, Groningen Biomol Sci & Biotechnol Inst, Groningen, Netherlands	Universidade Nova de Lisboa; University of Groningen	Carvalho, SM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	arn@itqb.unl.pt	Neves, Ana/B-9476-2008; Kuipers, Oscar/B-6752-2009	Neves, Ana/0000-0003-4896-9585; Kuipers, Oscar/0000-0001-5596-7735; Carvalho, Sandra/0000-0002-3144-411X	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/35947/2007]; EU [HEALTH-F3-2009-222983]; Fundacao para a Ciencia e a Tecnologia, Portugal (FCT); FEDER [PTDC/BIA-MIC/099963/2008, PTDC/SAU-MII/100964/2008, PEst-OE/EQB/LA0004/2011]; Programa Operacional Ciencia e Inovacao (POCTI); FCT	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); EU(European Commission); Fundacao para a Ciencia e a Tecnologia, Portugal (FCT)(Portuguese Foundation for Science and Technology); FEDER(European Commission); Programa Operacional Ciencia e Inovacao (POCTI); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	S. M. Carvalho was supported by a Fundacao para a Ciencia e a Tecnologia (FCT) Ph.D. grant (SFRH/BD/35947/2007). T. G. Kloosterman is supported by the EU-funded Pneumopath project HEALTH-F3-2009-222983. This work was supported by Fundacao para a Ciencia e a Tecnologia, Portugal (FCT) and FEDER, projects PTDC/BIA-MIC/099963/2008 and PTDC/SAU-MII/100964/2008 and through grant PEst-OE/EQB/LA0004/2011. The NMR spectrometers are part of the National NMR Network (REDE/1517/RMN/2005), supported by "Programa Operacional Ciencia e Inovacao (POCTI) 2010'' and FCT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2008, J BACTERIOL, V190, P2340, DOI 10.1128/JB.01237-07; Andersen HW, 2001, J BACTERIOL, V183, P3458, DOI 10.1128/JB.183.11.3458-3467.2001; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Baerends RJS, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-5-r37; Bergmann S, 2006, MICROBIOL-SGM, V152, P295, DOI 10.1099/mic.0.28610-0; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; Chiang C, 2011, J BACTERIOL, V193, P52, DOI 10.1128/JB.01656-09; Dalia AB, 2010, INFECT IMMUN, V78, P2108, DOI 10.1128/IAI.01125-09; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Garrigues C, 1997, J BACTERIOL, V179, P5282, DOI 10.1128/jb.179.17.5282-5287.1997; GASSON MJ, 1983, A VAN LEEUW J MICROB, V49, P275, DOI 10.1007/BF00399503; Giammarinaro P, 2002, INFECT IMMUN, V70, P5454, DOI 10.1128/IAI.70.10.5454-5461.2002; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Halfmann A, 2007, MOL MICROBIOL, V66, P110, DOI 10.1111/j.1365-2958.2007.05900.x; Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x; Heinemann M, 2010, CURR OPIN MICROBIOL, V13, P337, DOI 10.1016/j.mib.2010.02.005; Hendriksen WT, 2008, J BACTERIOL, V190, P590, DOI 10.1128/JB.00917-07; Hendriksen WT, 2007, J BACTERIOL, V189, P1382, DOI 10.1128/JB.01144-06; Holo H, 1995, Methods Mol Biol, V47, P195; IWAMI Y, 1985, INFECT IMMUN, V50, P378, DOI 10.1128/IAI.50.2.378-381.1985; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; JOHANSEN E, 1992, PLASMID, V27, P200, DOI 10.1016/0147-619X(92)90022-3; Johnston JW, 2006, INFECT IMMUN, V74, P1171, DOI 10.1128/IAI.74.2.1171-1180.2006; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kaufman GE, 2007, J BACTERIOL, V189, P5183, DOI 10.1128/JB.00449-07; Kietzman CC, 2010, INFECT IMMUN, V78, P241, DOI 10.1128/IAI.00746-09; King SJ, 2010, MOL ORAL MICROBIOL, V25, P15, DOI 10.1111/j.2041-1014.2009.00564.x; Kloosterman TG, 2006, MICROBIOL-SGM, V152, P351, DOI 10.1099/mic.0.28521-0; Kloosterman TG, 2008, J BACTERIOL, V190, P5382, DOI 10.1128/JB.00307-08; Kloosterman TG, 2006, J BIOL CHEM, V281, P25097, DOI 10.1074/jbc.M601661200; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lulko AT, 2007, J MOL MICROB BIOTECH, V12, P82, DOI 10.1159/000096463; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; McCluskey J, 2004, MOL MICROBIOL, V51, P1661, DOI 10.1111/j.1365-2958.2003.03917.x; McKessar SJ, 2007, J BACTERIOL, V189, P1342, DOI 10.1128/JB.01170-06; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Morona JK, 2006, P NATL ACAD SCI USA, V103, P8505, DOI 10.1073/pnas.0602148103; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Neves AR, 2010, APPL ENVIRON MICROB, V76, P7048, DOI 10.1128/AEM.01195-10; Neves AR, 2002, J BIOL CHEM, V277, P28088, DOI 10.1074/jbc.M202573200; Philips BJ, 2003, INTENS CARE MED, V29, P2204, DOI 10.1007/s00134-003-1961-2; Ramos A, 2001, APPL ENVIRON MICROB, V67, P33, DOI 10.1128/AEM.67.1.33-41.2001; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Shelburne SA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000817; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Singh KD, 2008, J BACTERIOL, V190, P7275, DOI 10.1128/JB.00848-08; Song JH, 2005, MOL CELLS, V19, P365; Standish AJ, 2007, J BACTERIOL, V189, P5591, DOI 10.1128/JB.00335-07; THEVELEIN JM, 1995, TRENDS BIOCHEM SCI, V20, P3, DOI 10.1016/S0968-0004(00)88938-0; van Opijnen T, 2009, NAT METHODS, V6, P767, DOI [10.1038/NMETH.1377, 10.1038/nmeth.1377]; YAMADA T, 1975, J BACTERIOL, V124, P55, DOI 10.1128/JB.124.1.55-61.1975; Yesilkaya H, 2000, INFECT IMMUN, V68, P2819, DOI 10.1128/IAI.68.5.2819-2826.2000; Yesilkaya H, 2008, FEMS MICROBIOL LETT, V278, P231, DOI 10.1111/j.1574-6968.2007.01003.x; Yesilkaya H, 2009, INFECT IMMUN, V77, P5418, DOI 10.1128/IAI.00178-09; Zeng L, 2010, MOL MICROBIOL, V75, P1145, DOI 10.1111/j.1365-2958.2009.07029.x; Zheng LY, 2011, APPL ENVIRON MICROB, V77, P4318, DOI 10.1128/AEM.00309-11; Zomer AL, 2007, J BACTERIOL, V189, P1366, DOI 10.1128/JB.01013-06	61	95	97	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26707	10.1371/journal.pone.0026707	http://dx.doi.org/10.1371/journal.pone.0026707			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039538	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200046
J	Lai, Y; Adhikarakunnathu, S; Bhardwaj, K; Ranjith-Kumar, CT; Wen, YH; Jordan, JL; Wu, LH; Dragnea, B; Mateo, LS; Kao, CC				Lai, Yvonne; Adhikarakunnathu, Sreedevi; Bhardwaj, Kanchan; Ranjith-Kumar, C. T.; Wen, Yahong; Jordan, Jarrat L.; Wu, Linda H.; Dragnea, Bogdan; Mateo, Lani San; Kao, C. Cheng			LL37 and Cationic Peptides Enhance TLR3 Signaling by Viral Double-stranded RNAs	PLOS ONE			English	Article							TOLL-LIKE RECEPTOR-3; RESPIRATORY EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; NF-KAPPA-B; ANTIMICROBIAL PEPTIDES; RIG-I; CATHELICIDIN LL-37; DENDRITIC CELLS; HOST-DEFENSE; VITAMIN-D	Background: Toll-like Receptor 3 (TLR3) detects viral dsRNA during viral infection. However, most natural viral dsRNAs are poor activators of TLR3 in cell-based systems, leading us to hypothesize that TLR3 needs additional factors to be activated by viral dsRNAs. The anti-microbial peptide LL37 is the only known human member of the cathelicidin family of antimicrobial peptides. LL37 complexes with bacterial lipopolysaccharide (LPS) to prevent activation of TLR4, binds to ssDNA to modulate TLR9 and ssRNA to modulate TLR7 and 8. It synergizes with TLR2/1, TLR3 and TLR5 agonists to increase IL8 and IL6 production. This work seeks to determine whether LL37 enhances viral dsRNA recognition by TLR3. Methodology/Principal Findings: Using a human bronchial epithelial cell line (BEAS2B) and human embryonic kidney cells (HEK 293T) transiently transfected with TLR3, we found that LL37 enhanced poly(I:C)-induced TLR3 signaling and enabled the recognition of viral dsRNAs by TLR3. The presence of LL37 also increased the cytokine response to rhinovirus infection in BEAS2B cells and in activated human peripheral blood mononuclear cells. Confocal microscopy determined that LL37 could co-localize with TLR3. Electron microscopy showed that LL37 and poly(I:C) individually formed globular structures, but a complex of the two formed filamentous structures. To separate the effects of LL37 on TLR3 and TLR4, other peptides that bind RNA and transport the complex into cells were tested and found to activate TLR3 signaling in response to dsRNAs, but had no effect on TLR4 signaling. This is the first demonstration that LL37 and other RNA-binding peptides with cell penetrating motifs can activate TLR3 signaling and facilitate the recognition of viral ligands. Conclusions/Significance: LL37 and several cell-penetrating peptides can enhance signaling by TLR3 and enable TLR3 to respond to viral dsRNA.	[Lai, Yvonne; Bhardwaj, Kanchan; Ranjith-Kumar, C. T.; Wen, Yahong; Kao, C. Cheng] Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA; [Dragnea, Bogdan] Indiana Univ, Dept Chem, Bloomington, IN USA; [Adhikarakunnathu, Sreedevi; Jordan, Jarrat L.; Wu, Linda H.; Mateo, Lani San] Centocor Res & Dev Inc, Discovery Res, Radnor, PA USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Johnson & Johnson; Johnson & Johnson USA	Lai, Y (corresponding author), Indiana Univ, Dept Mol & Cellular Biochem, Bloomington, IN 47405 USA.	yylai@indiana.edu	Mackie, Ken/E-3384-2013; Bhardwaj, Kanchan/CAH-2291-2022; Kumar CT, Ranjith/J-5701-2016	Bhardwaj, Kanchan/0000-0002-7331-7717; Jordan, Jarrat/0000-0002-0699-3774	Centocor Inc.; National Institutes of Health [RAI075015A]; Centocor; Division Of Chemistry [0832651] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI075015] Funding Source: NIH RePORTER	Centocor Inc.(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Centocor; Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by a grant to C. K. by Centocor Inc. Students in the laboratory are partially supported by National Institutes of Health grant RAI075015A to study protein-RNA interaction. No patent is involved in this project. While authors S. A., J.J., L. W., L. M. are employees of Centocor Research and Development, funding from Centocor had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Bucki R, 2010, ARCH IMMUNOL THER EX, V58, P15, DOI 10.1007/s00005-009-0057-2; Busse WW, 2010, LANCET, V376, P826, DOI 10.1016/S0140-6736(10)61380-3; Chen Christiane I-U, 2004, J Cyst Fibros, V3, P45, DOI 10.1016/j.jcf.2003.12.008; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Duffy KE, 2007, CELL IMMUNOL, V248, P103, DOI 10.1016/j.cellimm.2007.10.002; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Filewod NCJ, 2009, FEMS IMMUNOL MED MIC, V56, P233, DOI 10.1111/j.1574-695X.2009.00571.x; Futaki S, 2003, J MOL RECOGNIT, V16, P260, DOI 10.1002/jmr.635; Ganguly D, 2009, J EXP MED, V206, P1983, DOI 10.1084/jem.20090480; Gaudreault E, 2008, J IMMUNOL, V180, P6211, DOI 10.4049/jimmunol.180.9.6211; Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200; Gilliet M, 2008, CURR OPIN IMMUNOL, V20, P401, DOI 10.1016/j.coi.2008.06.008; Golec M, 2009, ANN AGR ENV MED, V16, P289; Gombart AF, 2009, FUTURE MICROBIOL, V4, P1151, DOI 10.2217/FMB.09.87; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hennessy EJ, 2010, NAT REV DRUG DISCOV, V9, P293, DOI 10.1038/nrd3203; Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005; Homma T, 2004, AM J RESP CELL MOL, V31, P463, DOI 10.1165/rcmb.2004-0161OC; Howell MD, 2004, J IMMUNOL, V172, P1763, DOI 10.4049/jimmunol.172.3.1763; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kato A, 2004, J IMMUNOL, V172, P6185, DOI 10.4049/jimmunol.172.10.6185; Kato A, 2007, CURR OPIN IMMUNOL, V19, P711, DOI 10.1016/j.coi.2007.08.004; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kumar H, 2009, BIOCHEM J, V420, P1, DOI 10.1042/BJ20090272; Kuznetsov YG, 2005, J MOL BIOL, V347, P41, DOI 10.1016/j.jmb.2005.01.006; LAI Y, 2011, PLOS ONE IN PRESS; Lancaster GI, 2005, J PHYSIOL-LONDON, V563, P945, DOI 10.1113/jphysiol.2004.081224; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lang KS, 2005, NAT MED, V11, P138, DOI 10.1038/nm1176; Lau YE, 2005, INFECT IMMUN, V73, P583, DOI 10.1128/IAI.73.1.583-591.2005; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Matsukura S, 2006, CLIN EXP ALLERGY, V36, P1049, DOI 10.1111/j.1365-2222.2006.02530.x; Mendez-Samperio P, 2010, PEPTIDES, V31, P1791, DOI 10.1016/j.peptides.2010.06.016; Murakami M, 2004, J IMMUNOL, V172, P3070, DOI 10.4049/jimmunol.172.5.3070; Murray LA, 2008, AM J RESP CRIT CARE, V178, P1227, DOI 10.1164/rccm.200807-1020OC; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Nijnik A, 2009, CURR OPIN HEMATOL, V16, P41, DOI 10.1097/MOH.0b013e32831ac517; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Pistolic J, 2009, J INNATE IMMUN, V1, P254, DOI 10.1159/000171533; Potena Alfredo, 2007, Int J Chron Obstruct Pulmon Dis, V2, P477; Qi XP, 2011, MOL PLANT MICROBE IN, V24, P25, DOI 10.1094/MPMI-07-10-0147; Ranjith-Kumar CT, 2008, MOL CELL BIOL, V28, P4507, DOI 10.1128/MCB.00308-08; Ranjith-Kumar CT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012878; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Scott MG, 2007, NAT BIOTECHNOL, V25, P465, DOI 10.1038/nbt1288; Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178; Starner TD, 2005, J IMMUNOL, V174, P1608, DOI 10.4049/jimmunol.174.3.1608; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43; Sun JC, 2006, J BIOL CHEM, V281, P11144, DOI 10.1074/jbc.M510442200; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Teng F, 2010, CELL IMMUNOL, V260, P98, DOI 10.1016/j.cellimm.2009.09.008; Tjabringa GS, 2005, PULM PHARMACOL THER, V18, P321, DOI 10.1016/j.pupt.2005.01.001; van Duin D, 2006, TRENDS IMMUNOL, V27, P49, DOI 10.1016/j.it.2005.11.005; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wan M, 2007, FASEB J, V21, P2897, DOI 10.1096/fj.06-7974com; Wang TT, 2004, J IMMUNOL, V173, P2909, DOI 10.4049/jimmunol.173.5.2909; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zanetti M, 2000, ADV EXP MED BIOL, V479, P203; Zhang SY, 2007, SCIENCE, V317, P1522, DOI 10.1126/science.1139522	66	80	83	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26632	10.1371/journal.pone.0026632	http://dx.doi.org/10.1371/journal.pone.0026632			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039520	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200034
J	Negrete, R; Hervera, A; Leanez, S; Martin-Campos, JM; Pol, O				Negrete, Roger; Hervera, Arnau; Leanez, Sergi; Martin-Campos, Jesus M.; Pol, Olga			The Antinociceptive Effects of JWH-015 in Chronic Inflammatory Pain Are Produced by Nitric Oxide-cGMP-PKG-KATP Pathway Activation Mediated by Opioids	PLOS ONE			English	Article							MECHANICALLY-EVOKED-RESPONSES; SENSITIVE GUANYLYL CYCLASE; CB2 RECEPTORS SUPPRESSES; NEUROPATHIC PAIN; PERIPHERAL ANTINOCICEPTION; ANALGESIC ACTIVITY; DORSAL-HORN; AGONIST; INHIBITION; EXPRESSION	Background: Cannabinoid 2 receptor (CB2R) agonists attenuate inflammatory pain but the precise mechanism implicated in these effects is not completely elucidated. We investigated if the peripheral nitric oxide-cGMP-protein kinase G (PKG)-ATPsensitive K(+) (KATP) channels signaling pathway triggered by the neuronal nitric oxide synthase (NOS1) and modulated by opioids, participates in the local antinociceptive effects produced by a CB2R agonist (JWH-015) during chronic inflammatory pain. Methodology/Principal Findings: In wild type (WT) and NOS1 knockout (NOS1-KO) mice, at 10 days after the subplantar administration of complete Freund's adjuvant (CFA), we evaluated the antiallodynic (von Frey filaments) and antihyperalgesic (plantar test) effects produced by the subplantar administration of JWH-015 and the reversion of their effects by the local co-administration with CB2R (AM630), peripheral opioid receptor (naloxone methiodide, NX-ME) or CB1R (AM251) antagonists. Expression of CB2R and NOS1 as well as the antinociceptive effects produced by a high dose of JWH-015 combined with different doses of selective L-guanylate cyclase (ODQ) or PKG (Rp-8-pCPT-cGMPs) inhibitors or a KATP channel blocker (glibenclamide), were also assessed. Results show that the local administration of JWH-015 dose-dependently inhibited the mechanical and thermal hypersensitivity induced by CFA which effects were completely reversed by the local co-administration of AM630 or NX-ME, but not AM251. Inflammatory pain increased the paw expression of CB2R and the dorsal root ganglia transcription of NOS1. Moreover, the antinociceptive effects of JWH-015 were absent in NOS1-KO mice and diminished by their co-administration with ODQ, Rp-8-pCPT-cGMPs or glibenclamide. Conclusions/Significance: These data indicate that the peripheral antinociceptive effects of JWH-015 during chronic inflammatory pain are mainly produced by the local activation of the nitric oxide-cGMP-PKG-KATP signaling pathway, triggered by NOS1 and mediated by endogenous opioids. These findings suggest that the activation of this pathway might be an interesting therapeutic target for the treatment of chronic inflammatory pain with cannabinoids.	[Negrete, Roger; Hervera, Arnau; Leanez, Sergi; Pol, Olga] Univ Autonoma Barcelona, Grp Neurofarmacol Mol, Inst Recerca, Hosp Sta Creu & St Pau, E-08193 Barcelona, Spain; [Negrete, Roger; Hervera, Arnau; Leanez, Sergi; Pol, Olga] Univ Autonoma Barcelona, Inst Neurociencies, E-08193 Barcelona, Spain; [Martin-Campos, Jesus M.] Hosp Sta Creu & St Pau, Inst Recerca, Grp Bioquim, Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Negrete, R (corresponding author), Univ Autonoma Barcelona, Grp Neurofarmacol Mol, Inst Recerca, Hosp Sta Creu & St Pau, E-08193 Barcelona, Spain.	opol@santpau.es	Pol, Olga/C-9194-2011; Martín-Campos, Jesús M./AAQ-5478-2021; Pol, Olga/O-2146-2019; abad, Arnau Hervera/V-5435-2017; Martín-Campos, Jesús Maria/AGJ-2586-2022	Pol, Olga/0000-0002-4621-8457; abad, Arnau Hervera/0000-0001-8362-369X; Martín-Campos, Jesús Maria/0000-0003-0414-037X	Fondo de Investigacion Sanitaria, Madrid [PS0900968]; Fundacio La Marato de TV3 Barcelona, Spain [070810]	Fondo de Investigacion Sanitaria, Madrid; Fundacio La Marato de TV3 Barcelona, Spain	This work was supported by Fondo de Investigacion Sanitaria, Madrid (http://www.isciii.es/htdocs/investigacion/Fondo_lineas.jsp) [Grant: PS0900968] and the Fundacio La Marato de TV3 Barcelona (http://www.fundaciomaratotv3.cat/) [Grant: 070810], Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chu YC, 2005, PAIN, V119, P113, DOI 10.1016/j.pain.2005.09.024; Cunha TM, 2010, P NATL ACAD SCI USA, V107, P4442, DOI 10.1073/pnas.0914733107; Curto-Reyes V, 2010, BRIT J PHARMACOL, V160, P561, DOI 10.1111/j.1476-5381.2009.00629.x; Elmes SJR, 2004, EUR J NEUROSCI, V20, P2311, DOI 10.1111/j.1460-9568.2004.03690.x; FERREIRA SH, 1991, EUR J PHARMACOL, V201, P121, DOI 10.1016/0014-2999(91)90333-L; Fox A, 2001, PAIN, V92, P91, DOI 10.1016/S0304-3959(00)00474-7; GARTHWAITE J, 1995, MOL PHARMACOL, V48, P184; Gutierrez T, 2007, BRIT J PHARMACOL, V150, P153, DOI 10.1038/sj.bjp.0706984; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Hervera A, 2010, J PHARMACOL EXP THER, V334, P887, DOI 10.1124/jpet.110.167585; Hervera A, 2009, N-S ARCH PHARMACOL, V380, P345, DOI 10.1007/s00210-009-0436-6; Hsieh GC, 2011, BRIT J PHARMACOL, V162, P428, DOI 10.1111/j.1476-5381.2010.01046.x; Ibrahim MM, 2005, P NATL ACAD SCI USA, V102, P3093, DOI 10.1073/pnas.0409888102; Infante C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2208; Jones JD, 2008, NEUROPHARMACOLOGY, V54, P23, DOI 10.1016/j.neuropharm.2007.06.027; LARSON AA, 1986, PHARMACOL BIOCHEM BE, V24, P49, DOI 10.1016/0091-3057(86)90043-2; Leanez S, 2009, EUR J PHARMACOL, V602, P41, DOI 10.1016/j.ejphar.2008.11.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Reis GML, 2009, LIFE SCI, V85, P351, DOI 10.1016/j.lfs.2009.06.012; Malan TP, 2001, PAIN, V93, P239, DOI 10.1016/S0304-3959(01)00321-9; Menendez L, 2007, NEUROPHARMACOLOGY, V53, P71, DOI 10.1016/j.neuropharm.2007.04.011; Nackley AG, 2004, J NEUROPHYSIOL, V92, P3562, DOI 10.1152/jn.00886.2003; Pacheco DF, 2005, EUR J PHARMACOL, V512, P23, DOI 10.1016/j.ejphar.2005.02.018; Pol O, 2007, CURR MED CHEM, V14, P1945; Quartilho A, 2003, ANESTHESIOLOGY, V99, P955, DOI 10.1097/00000542-200310000-00031; Schmidtko A, 2009, TRENDS NEUROSCI, V32, P339, DOI 10.1016/j.tins.2009.01.010; Sokal DM, 2003, NEUROPHARMACOLOGY, V45, P404, DOI 10.1016/S0028-3908(03)00195-3; WESTON AH, 1991, Z KARDIOL, V80, P1; Yao BB, 2008, BRIT J PHARMACOL, V153, P390, DOI 10.1038/sj.bjp.0707568	31	25	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26688	10.1371/journal.pone.0026688	http://dx.doi.org/10.1371/journal.pone.0026688			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031841	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200042
J	Strecker, JK; Minnerup, J; Gess, B; Ringelstein, EB; Schabitz, WR; Schilling, M				Strecker, Jan-Kolja; Minnerup, Jens; Gess, Burkhard; Ringelstein, E. Bernd; Schaebitz, Wolf-Ruediger; Schilling, Matthias			Monocyte Chemoattractant Protein-1-Deficiency Impairs the Expression of IL-6, IL-1 beta and G-CSF after Transient Focal Ischemia in Mice	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; COLONY-STIMULATING FACTOR; BRAIN-DAMAGE; STROKE; PROTEIN-1; RECRUITMENT; ACTIVATION; RECEPTOR; MODEL; INTERLEUKIN-1-BETA	Monocyte chemoattractant protein-1 (MCP-1), a chemokine secreted by neurons and astrocytes following stroke is known to aggravate ischemia-related damage. Previous studies revealed that MCP-1-deficient mice develop smaller infarcts and have an improved neurological outcome, whereas mice overexpressing MCP-1 show worsened brain damage and impaired neurological function. The aim of the present study was to elucidate the molecular background of the enhanced recovery in MCP-1-deficient mice after stroke. For this purpose, we (1) performed expression analyses on crucial post-stroke related inflammatory genes in MCP-1-deficient mice compared to wildtype controls, (2) analyzed a possible impact of MCP-1 on astrocyte activation (3) investigated the cellular origin of respective inflammatory cytokines and (4) analyzed the impact of MCP-1 secretion on the migration of both neutrophil granulocytes and T-cells. Here we report that MCP-1-deficiency leads to a shift towards a less inflammatory state following experimental occlusion of the middle cerebral artery including an impaired induction of interleukin-6, interleukin-1 beta and granulocyte-colony stimulating factor expression as well as a subsequent diminished influx of hematogenous cells. Additionally, MCP-1-deficient mice developed smaller infarcts 36 hours after experimental stroke. Investigations revealed no differences in transcription of tumor necrosis factor-a and astrogliosis 12 and 36 hours after onset of ischemia. These novel results help to understand post ischemic, inflammatory mechanisms and might give further arguments towards therapeutical interventions by modulation of MCP-1 expression in post stroke inflammation.	[Strecker, Jan-Kolja; Minnerup, Jens; Gess, Burkhard; Ringelstein, E. Bernd; Schaebitz, Wolf-Ruediger; Schilling, Matthias] Univ Munster, Dept Neurol, D-4400 Munster, Germany; [Schaebitz, Wolf-Ruediger] Evangel Krankenhaus, Dept Neurol, Bielefeld, Germany	University of Munster	Strecker, JK (corresponding author), Univ Munster, Dept Neurol, D-4400 Munster, Germany.	strecker.jan@gmx.de			Innovative Medical Research of the University of Munster Medical School [SC 520 501]	Innovative Medical Research of the University of Munster Medical School	Funding: This work was supported by the Innovative Medical Research of the University of Munster Medical School (IMF grant nr: SC 520 501, http://campus.unimuenster.de/3856.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acalovschi D, 2003, STROKE, V34, P1864, DOI 10.1161/01.STR.0000079815.38626.44; Bowen KK, 2006, NEUROCHEM INT, V49, P127, DOI 10.1016/j.neuint.2006.02.011; Buck BH, 2008, STROKE, V39, P355, DOI 10.1161/STROKEAHA.107.490128; Che XM, 2001, BRAIN RES, V902, P171, DOI 10.1016/S0006-8993(01)02328-9; Chen Y, 2003, J CEREBR BLOOD F MET, V23, P748, DOI 10.1097/01.WCB.0000071885.63724.20; Clark WM, 2000, STROKE, V31, P1715, DOI 10.1161/01.STR.31.7.1715; Deng YY, 2009, GLIA, V57, P604, DOI 10.1002/glia.20790; Gautier S, 2009, BRIT J PHARMACOL, V156, P673, DOI 10.1111/j.1476-5381.2009.00068.x; Gee JM, 2007, STROKE, V38, P783, DOI 10.1161/01.STR.0000248425.59176.7b; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Gibson CL, 2005, J CEREBR BLOOD F MET, V25, P431, DOI 10.1038/sj.jcbfm.9600033; Gibson CL, 2005, J NEUROPATH EXP NEUR, V64, P763, DOI 10.1097/01.jnen.0000179196.10032.dd; Gibson CL, 2010, J CEREBR BLOOD F MET, V30, P739, DOI 10.1038/jcbfm.2010.12; Haile WB, 2010, J CEREBR BLOOD F MET, V30, P1147, DOI 10.1038/jcbfm.2009.280; Hata R, 1998, J CEREBR BLOOD F MET, V18, P367, DOI 10.1097/00004647-199804000-00004; Hata R, 2000, J CEREBR BLOOD F MET, V20, P306, DOI 10.1097/00004647-200002000-00012; Hughes PM, 2002, J CEREBR BLOOD F MET, V22, P308, DOI 10.1097/00004647-200203000-00008; Kriz J, 2009, ACTA NEUROPATHOL, V117, P497, DOI 10.1007/s00401-009-0496-1; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Lin N, 2009, NEUROSURGERY, V65, pN13, DOI 10.1227/01.NEU.0000345343.04287.23; Loddick SA, 1996, J CEREBR BLOOD F MET, V16, P932, DOI 10.1097/00004647-199609000-00017; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; McColl BW, 2007, J NEUROSCI, V27, P4403, DOI 10.1523/JNEUROSCI.5376-06.2007; Minnerup Jens, 2009, Exp Transl Stroke Med, V1, P2, DOI 10.1186/2040-7378-1-2; Montaner J, 2003, J CEREBR BLOOD F MET, V23, P1403, DOI 10.1097/01.WCB.0000100044.07481.97; Murikinati S, 2010, FASEB J, V24, P788, DOI 10.1096/fj.09-141275; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Potula HSK, 2009, J BIOL CHEM, V284, P31142, DOI 10.1074/jbc.M109.012526; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Schilling M, 2009, NEUROSCIENCE, V161, P806, DOI 10.1016/j.neuroscience.2009.04.025; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Sevimli S, 2009, EXP NEUROL, V217, P328, DOI 10.1016/j.expneurol.2009.03.018; Shin JA, 2009, J NEUROIMMUNOL, V217, P14, DOI 10.1016/j.jneuroim.2009.06.001; Touzani O, 2002, J NEUROSCI, V22, P38, DOI 10.1523/JNEUROSCI.22-01-00038.2002; Watanabe S, 2004, AM J NEPHROL, V24, P387, DOI 10.1159/000079706; Yamashita T, 2005, J NEUROCHEM, V94, P459, DOI 10.1111/j.1471-4159.2005.03227.x; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046	39	45	47	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e25863	10.1371/journal.pone.0025863	http://dx.doi.org/10.1371/journal.pone.0025863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031820	Green Submitted, Green Published, gold			2022-12-27	WOS:000296513200007
J	Wang, P; Chen, SD; Guo, Y; Xiong, ZZ; Hu, FP; Zhu, DM; Zhang, YY				Wang, Peng; Chen, Shudan; Guo, Yan; Xiong, Zizhong; Hu, Fupin; Zhu, Demei; Zhang, Yingyuan			Occurrence of False Positive Results for the Detection of Carbapenemases in Carbapenemase-Negative Escherichia coli and Klebsiella pneumoniae Isolates	PLOS ONE			English	Article							BETA-LACTAMASE; ACID	Adequate detection of the production of carbapenemase in Enterobacteriaceae isolates is crucial for infection control measures and the appropriate choice of antimicrobial therapy. In this study, we investigated the frequency of false positive results for the detection of carbapenemases in carbapenemase-negative Escherichia coli and Klebsiella pneumoniae clinical isolates by the modified Hodge test (MHT). Three hundred and one E. coli and K. pneumoniae clinical isolates were investigated. All produced extended spectrum beta-lactamases (ESBLs) but were susceptible to carbapenems. Antimicrobial susceptibility testing was performed by the disk diffusion and agar dilution methods. The MHT was performed using the standard inoculum of test organisms recommended by the CLSI. Genes that encoded ESBLs and carbapenemases were identified by PCR and DNA sequencing. Among the 301 clinical isolates, none of the isolates conformed to the criteria for carbapenemase screening recommended by the CLSI. The susceptibility rates for imipenem, meropenem, and ertapenem all were 100.0%, 100.0%, and 100.0%, respectively. Of the 301 E. coli and K. pneumoniae isolates, none produced carbapenemase. The MHT gave a positive result for 3.3% (10/301) of the isolates. False positive results can occur when the MHT is used to detect carbapenemase in ESBL-producing isolates and clinical laboratories must be aware of this fact.	[Wang, Peng; Chen, Shudan; Guo, Yan; Hu, Fupin; Zhu, Demei; Zhang, Yingyuan] Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai 200433, Peoples R China; [Chen, Shudan] Fudan Univ, State Key Lab Genet Engn, Inst Genet, Sch Life Sci, Shanghai 200433, Peoples R China; [Xiong, Zizhong] Anhui Med Univ, Affiliated Hosp 1, Dept Infect Dis, Hefei, Peoples R China	Fudan University; Fudan University; Anhui Medical University	Wang, P (corresponding author), Fudan Univ, Huashan Hosp, Inst Antibiot, Shanghai 200433, Peoples R China.	hufupin@163.com	Hu, Fupin/AAR-8314-2020		Shanghai Municipal Natural Science Foundation [11ZR1404700]	Shanghai Municipal Natural Science Foundation	Funding: This work was supported by Shanghai Municipal Natural Science Foundation (No. 11ZR1404700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KF, 2007, J CLIN MICROBIOL, V45, P2723, DOI 10.1128/JCM.00015-07; [Anonymous], 2010, M100S20 CLIN LAB STA; Bell JM, 2007, J CLIN MICROBIOL, V45, P1478, DOI 10.1128/JCM.02470-06; Carvalhaes CG, 2010, J ANTIMICROB CHEMOTH, V65, P249, DOI 10.1093/jac/dkp431; Chen SD, 2011, ANTIMICROB AGENTS CH, V55, P2493, DOI 10.1128/AAC.00047-11; Girlich D, 2008, J ANTIMICROB CHEMOTH, V62, P1155, DOI 10.1093/jac/dkn317; Giske CG, 2011, CLIN MICROBIOL INFEC, V17, P552, DOI 10.1111/j.1469-0691.2010.03294.x; Hirsch EB, 2010, J ANTIMICROB CHEMOTH, V65, P1119, DOI 10.1093/jac/dkq108; HOSAKA M, 1995, ANTIMICROB AGENTS CH, V39, P1731, DOI 10.1128/AAC.39.8.1731; Landman D, 2005, J CLIN MICROBIOL, V43, P5639, DOI 10.1128/JCM.43.11.5639-5641.2005; Lee K, 2003, J CLIN MICROBIOL, V41, P4623, DOI 10.1128/JCM.41.10.4623-4629.2003; Lledo W, 2009, JAMA-J AM MED ASSOC, V301, P1979; Munoz-Price LS, 2009, CLIN INFECT DIS, V49, P1739, DOI 10.1086/648078; Pasteran F, 2009, J CLIN MICROBIOL, V47, P1631, DOI 10.1128/JCM.00130-09; Patrick RM, 2007, MANUAL CLIN MICROBIO, P1250; Stuart JC, 2010, INT J ANTIMICROB AG, V36, P205, DOI 10.1016/j.ijantimicag.2010.05.014; Tsakris A, 2008, J ANTIMICROB CHEMOTH, V62, P1257, DOI 10.1093/jac/dkn364; Tsakris A, 2009, J CLIN MICROBIOL, V47, P3420, DOI 10.1128/JCM.01314-09; Tsakris A, 2009, J CLIN MICROBIOL, V47, P362, DOI 10.1128/JCM.01922-08; Woodford N, 2006, J ANTIMICROB CHEMOTH, V57, P154, DOI 10.1093/jac/dki412; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001	21	28	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26356	10.1371/journal.pone.0026356	http://dx.doi.org/10.1371/journal.pone.0026356			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031829	gold, Green Published, Green Submitted			2022-12-27	WOS:000296513200018
J	Brown, PH; Balbo, A; Zhao, HY; Ebel, C; Schuck, P				Brown, Patrick H.; Balbo, Andrea; Zhao, Huaying; Ebel, Christine; Schuck, Peter			Density Contrast Sedimentation Velocity for the Determination of Protein Partial-Specific Volumes	PLOS ONE			English	Article							HEAVY-OXYGEN WATER; ANALYTICAL ULTRACENTRIFUGATION; MEMBRANE-PROTEINS; DIFFERENTIAL SEDIMENTATION; SOLVENT INTERACTIONS; PHYSICAL PROPERTIES; NEUTRON-SCATTERING; DETERGENT BINDING; MACROMOLECULES; EQUILIBRIUM	The partial-specific volume of proteins is an important thermodynamic parameter required for the interpretation of data in several biophysical disciplines. Building on recent advances in the use of density variation sedimentation velocity analytical ultracentrifugation for the determination of macromolecular partial-specific volumes, we have explored a direct global modeling approach describing the sedimentation boundaries in different solvents with a joint differential sedimentation coefficient distribution. This takes full advantage of the influence of different macromolecular buoyancy on both the spread and the velocity of the sedimentation boundary. It should lend itself well to the study of interacting macromolecules and/or heterogeneous samples in microgram quantities. Model applications to three protein samples studied in either H2O, or isotopically enriched H-2 O-18 mixtures, indicate that partial-specific volumes can be determined with a statistical precision of better than 0.5%, provided signal/noise ratios of 50-100 can be achieved in the measurement of the macromolecular sedimentation velocity profiles. The approach is implemented in the global modeling software SEDPHAT.	[Brown, Patrick H.; Zhao, Huaying; Schuck, Peter] Natl Inst Biomed Imaging & Bioengn, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD 20892 USA; [Ebel, Christine] Univ Grenoble 1, Inst Biol Struct, Grenoble, France; [Ebel, Christine] CNRS, Grenoble, France; [Ebel, Christine] Commisariat Energie Atom, Grenoble, France	National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CEA	Brown, PH (corresponding author), Natl Inst Biomed Imaging & Bioengn, Dynam Macromol Assembly Sect, Lab Cellular Imaging & Macromol Biophys, NIH, Bethesda, MD 20892 USA.	schuckp@mail.nih.gov	Zhao, Huaying/F-5716-2012; Schuck, Peter/AAA-6888-2020	Schuck, Peter/0000-0002-8859-6966; Ebel, Christine/0000-0002-6912-500X	NIBIB, National Institutes of Health, Bethesda, Maryland, U.S.A; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000051] Funding Source: NIH RePORTER	NIBIB, National Institutes of Health, Bethesda, Maryland, U.S.A(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This study was funded by the intramural research program of the NIBIB, National Institutes of Health, Bethesda, Maryland, U.S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon S, 2011, METHODS; ARAKAWA T, 1986, J BIOCHEM-TOKYO, V100, P1471, DOI 10.1093/oxfordjournals.jbchem.a121853; Arnold MS, 2008, ACS NANO, V2, P2291, DOI 10.1021/nn800512t; Bevington PR., 2002, DATA REDUCTION ERROR; Brown PH, 2008, COMPUT PHYS COMMUN, V178, P105, DOI 10.1016/j.cpc.2007.08.012; Brown PH, 2009, EUR BIOPHYS J BIOPHY, V38, P1079, DOI 10.1007/s00249-009-0514-1; Brown Patrick H, 2008, Curr Protoc Immunol, VChapter 18, DOI 10.1002/0471142735.im1815s81; CASASSA EF, 1964, ADV PROTEIN CHEM, V19, P287, DOI 10.1016/S0065-3233(08)60191-6; Center RJ, 2001, P NATL ACAD SCI USA, V98, P14877, DOI 10.1073/pnas.261573898; CHENG PY, 1955, J POLYM SCI, V16, P19, DOI 10.1002/pol.1955.120168102; Cohn E. J., 1943, PROTEINS AMINO ACIDS, P370; Correia JJ, 2000, METHOD ENZYMOL, V321, P81; Dam J, 2004, METHOD ENZYMOL, V384, P185; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P45; Ebel C, 2002, BIOCHEMISTRY-US, V41, P13234, DOI 10.1021/bi0258290; Ebel C, 2000, BIOPHYS J, V78, P385, DOI 10.1016/S0006-3495(00)76601-X; Ebel C, 2011, METHODS; EBEL C, 2007, PROTEIN INTERACTIONS, P255; EDELSTEIN SJ, 1967, J BIOL CHEM, V242, P306; Eisenberg H, 2003, PROTEIN SCI, V12, P2647, DOI 10.1110/ps.0235803; EISENBERG H, 1981, J MOL BIOL, V150, P537, DOI 10.1016/0022-2836(81)90379-X; Eisenberg H, 1992, Biochem Soc Symp, V58, P113; Eisenberg H, 2000, BIOPHYS CHEM, V88, P1, DOI 10.1016/S0301-4622(00)00205-2; EISENBERG H, 1981, Q REV BIOPHYS, V14, P142, DOI 10.1017/S0033583500002237; Eisenberg H, 1990, NUMERICAL DATA FUNCT; Eisenberg H, 1976, BIOL MACROMOLECULES; Elder J P, 1979, Methods Enzymol, V61, P12; Errington N, 2003, EUR BIOPHYS J BIOPHY, V32, P511, DOI 10.1007/s00249-003-0315-x; GAGEN WL, 1966, BIOCHEMISTRY-US, V5, P2553, DOI 10.1021/bi00872a010; GEKKO K, 1981, BIOCHEMISTRY-US, V20, P4667, DOI 10.1021/bi00519a023; Gohon Y, 2004, ANAL BIOCHEM, V334, P318, DOI 10.1016/j.ab.2004.07.033; Gohon Y, 2008, BIOPHYS J, V94, P3523, DOI 10.1529/biophysj.107.121848; HARPAZ Y, 1994, STRUCTURE, V2, P641, DOI 10.1016/S0969-2126(00)00065-4; Hellman LM, 2010, EUR BIOPHYS J BIOPHY, V39, P389, DOI 10.1007/s00249-009-0411-7; HENDERSO.RF, 1970, J BIOL CHEM, V245, P3733; Heredia KL, 2007, ORG BIOMOL CHEM, V5, P45, DOI 10.1039/b612355d; Howlett G.J., 1992, ANAL ULTRACENTRIFUGA, P470; Howlett GJ, 2006, CURR OPIN CHEM BIOL, V10, P430, DOI 10.1016/j.cbpa.2006.08.017; Hunter M J, 1978, Methods Enzymol, V48, P23; INOUE H, 1968, J AM CHEM SOC, V90, P1890, DOI 10.1021/ja01009a037; Jones G, 1936, J CHEM PHYS, V4, P30, DOI 10.1063/1.1749743; JOSSANG T, 1988, J PROTEIN CHEM, V7, P165, DOI 10.1007/BF01025246; Kratky O, 1973, Methods Enzymol, V27, P98; KUDISH AI, 1972, J CHEM SOC FARAD T 1, V68, P2041, DOI 10.1039/f19726802041; Kudish AI, 1973, JCS F1, V68, P1504; Lamm O., 1929, ARK MAT ASTR FYS, V21B, P1; Le Maire M, 2008, NAT PROTOC, V3, P1782, DOI 10.1038/nprot.2008.177; Lebowitz J, 2003, PROTEIN SCI, V12, P2649; Lee J C, 1979, Methods Enzymol, V61, P26; LUSTIG A, 1991, BIOCHIM BIOPHYS ACTA, V1115, P89, DOI 10.1016/0304-4165(91)90016-A; MARTIN WG, 1956, CAN J CHEM, V34, P809, DOI 10.1139/v56-104; MARTIN WG, 1959, CAN J CHEM, V37, P1662, DOI 10.1139/v59-241; MATSUNAGA N, 1983, J PHYS CHEM REF DATA, V12, P933, DOI 10.1063/1.555694; Mayer G, 1999, PROG COLL POL SCI S, V113, P176; MCMEEKIN TL, 1952, SCIENCE, V116, P142, DOI 10.1126/science.116.3006.142; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Noy D, 2003, ANAL BIOCHEM, V320, P185, DOI 10.1016/S0003-2697(03)00347-6; Nury H, 2008, BIOCHEMISTRY-US, V47, P12319, DOI 10.1021/bi801053m; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Page M, 2002, PROTEIN PROTOCOLS HD, P987; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; PHILLIPS DL, 1962, J ACM, V9, P84, DOI 10.1145/321105.321114; REYNOLDS JA, 1976, P NATL ACAD SCI USA, V73, P4467, DOI 10.1073/pnas.73.12.4467; Salvay AG, 2007, J BIOL PHYS, V33, P399, DOI 10.1007/s10867-008-9058-3; SCHACHMAN HK, 1949, J AM CHEM SOC, V71, P536, DOI 10.1021/ja01170a047; Schilling K, 1999, PROG COLL POL SCI S, V113, P50; SCHUBERT D, 1991, PROG COLL POL SCI S, V86, P12, DOI 10.1007/BFb0115002; Schuck P, 1999, BIOPHYS J, V76, P2288, DOI 10.1016/S0006-3495(99)77384-4; Schuck P, 2004, BIOPHYS CHEM, V108, P187, DOI 10.1016/j.bpc.2003.10.016; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schuck P, 2009, EUR BIOPHYS J; Schuck P, 2010, BIOPHYS J, V98, P2741, DOI 10.1016/j.bpj.2010.03.004; Schuck P, 2010, ANAL BIOCHEM, V401, P280, DOI 10.1016/j.ab.2010.02.037; Schuck P, 2010, BIOPHYS J, V98, P2005, DOI 10.1016/j.bpj.2009.12.4336; Shu JY, 2008, BIOMACROMOLECULES, V9, P2111, DOI 10.1021/bm800113g; STECKEL F, 1963, T FARADAY SOC, V59, P331, DOI 10.1039/tf9635900331; STOTHART PH, 1984, BIOCHEM J, V219, P1049, DOI 10.1042/bj2191049; Svedberg T, 1940, ULTRAZENTRIFUGE; Svedberg T, 1940, THE ULTRACENTRIFUGE; TARDIEU A, 1981, BIOCHEMISTRY-US, V20, P4399, DOI 10.1021/bi00518a026; TEWARI UJ, 1975, IMMUNOCHEMISTRY, V12, P925, DOI 10.1016/0019-2791(75)90254-2; TZIATZIOS C, 1994, Z NATURFORSCH C, V49, P220; Veronese FM, 2001, BIOMATERIALS, V22, P405, DOI 10.1016/S0142-9612(00)00193-9; Wandrey C, 2010, METHODS; ZACCAI G, 1983, ANNU REV BIOPHYS BIO, V12, P139, DOI 10.1146/annurev.bb.12.060183.001035; Zhao H, 2011, BIOPHYS J IN PRESS; Zhao H, 2011, METHODS	88	28	28	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26221	10.1371/journal.pone.0026221	http://dx.doi.org/10.1371/journal.pone.0026221			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028836	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800027
J	Moorwood, C; Lozynska, O; Suri, N; Napper, AD; Diamond, SL; Khurana, TS				Moorwood, Catherine; Lozynska, Olga; Suri, Neha; Napper, Andrew D.; Diamond, Scott L.; Khurana, Tejvir S.			Drug Discovery for Duchenne Muscular Dystrophy via Utrophin Promoter Activation Screening	PLOS ONE			English	Article							CELL-BASED ASSAY; SKELETAL-MUSCLE; MDX MICE; RHEUMATOID-ARTHRITIS; PROTEIN; EXPRESSION; GENE; TRANSCRIPTION; ACCUMULATION; MECHANISM	Background: Duchenne muscular dystrophy (DMD) is a devastating muscle wasting disease caused by mutations in dystrophin, a muscle cytoskeletal protein. Utrophin is a homologue of dystrophin that can functionally compensate for its absence when expressed at increased levels in the myofibre, as shown by studies in dystrophin-deficient mice. Utrophin upregulation is therefore a promising therapeutic approach for DMD. The use of a small, drug-like molecule to achieve utrophin upregulation offers obvious advantages in terms of delivery and bioavailability. Furthermore, much of the time and expense involved in the development of a new drug can be eliminated by screening molecules that are already approved for clinical use. Methodology/Principal Findings: We developed and validated a cell-based, high-throughput screening assay for utrophin promoter activation, and used it to screen the Prestwick Chemical Library of marketed drugs and natural compounds. Initial screening produced 20 hit molecules, 14 of which exhibited dose-dependent activation of the utrophin promoter and were confirmed as hits. Independent validation demonstrated that one of these compounds, nabumetone, is able to upregulate endogenous utrophin mRNA and protein, in C2C12 muscle cells. Conclusions/Significance: We have developed a cell-based, high-throughput screening utrophin promoter assay. Using this assay, we identified and validated a utrophin promoter-activating drug, nabumetone, for which pharmacokinetics and safety in humans are already well described, and which represents a lead compound for utrophin upregulation as a therapy for DMD.	[Moorwood, Catherine; Suri, Neha; Khurana, Tejvir S.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA; [Moorwood, Catherine; Suri, Neha; Khurana, Tejvir S.] Univ Penn, Sch Med, Penn Muscle Inst, Philadelphia, PA 19104 USA; [Lozynska, Olga; Napper, Andrew D.; Diamond, Scott L.] Univ Penn, Penn Ctr Mol Discovery, Inst Med & Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine	Moorwood, C (corresponding author), Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA.	tsk@mail.med.upenn.edu		Moorwood, Catherine/0000-0002-0589-861X	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health [5R01AR048871-07]; Charley's Fund; Penn Medicine Institute for Translational Medicine and Therapeutics; University of Pennsylvania; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048871] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Charley's Fund; Penn Medicine Institute for Translational Medicine and Therapeutics; University of Pennsylvania; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was funded in part by grants to TSK from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health (Grant number 5R01AR048871-07), Charley's Fund and Penn Medicine Institute for Translational Medicine and Therapeutics and to SLD from the Chemical Biology In Translation Program in Translational Medicine and Therapeutics (University of Pennsylvania). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aartsma-Rus A, 2009, THEORETIC APPLICABIL, P293; Amenta AR, BIGLYCAN RECRUITS UT, P762; ARAHATA K, 1984, ANN NEUROL, V16, P193, DOI 10.1002/ana.410160206; Ashburn TT, 2004, NAT REV DRUG DISCOV, V3, P673, DOI 10.1038/nrd1468; Auld DS, 2008, ACS CHEM BIOL, V3, P463, DOI 10.1021/cb8000793; Baby SM, 2010, DIFFERENTIAL EXPRESS, P323; Barton ER, 2005, MUSCLE NERVE, V32, P751, DOI 10.1002/mus.20425; BODENSTEINER JB, 1978, NEUROLOGY, V28, P439, DOI 10.1212/WNL.28.5.439; Bombardier C, 2000, NEW ENGL J MED, V343, P1520, DOI 10.1056/NEJM200011233432103; Bresalier RS, 2005, CARDIOVASCULAR EVENT, P1092; Burton EA, 1999, P NATL ACAD SCI USA, V96, P14025, DOI 10.1073/pnas.96.24.14025; Chaubourt E, 1999, NEUROBIOL DIS, V6, P499, DOI 10.1006/nbdi.1999.0256; Chen YW, 2005, NEUROLOGY, V65, P826, DOI 10.1212/01.wnl.0000173836.09176.c4; Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a; Di L, 2003, CURR OPIN CHEM BIOL, V7, P402, DOI 10.1016/S1367-5931(03)00055-3; DiMasi JA, 2001, CLIN PHARMACOL THER, V69, P297, DOI 10.1067/mcp.2001.115446; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Emery AEH, 2003, DUCHENNE MUSCULAR DY; Engel A., 2004, MYOLOGY BASIC CLIN; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; Gilbert T, 1999, HUM GENE THER, V10, P1299, DOI 10.1089/10430349950017987; Gramolini AO, 2001, J CELL BIOL, V154, P1173, DOI 10.1083/jcb.200101108; Gramolini AO, 2001, AM J PHYSIOL-CELL PH, V281, pC1300, DOI 10.1152/ajpcell.2001.281.4.C1300; Hedner T, 2004, DRUGS, V64, P2315, DOI 10.2165/00003495-200464200-00004; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoffman EP, 2007, SKIPPING PERSONALIZE, P2719; Ji DB, 2008, BIOL PHARM BULL, V31, P2255, DOI 10.1248/bpb.31.2255; Jiang N, 2005, ACTA PHARMACOL SIN, V26, P1181, DOI 10.1111/j.1745-7254.2005.00199.x; Khurana T S, 1991, Neuromuscul Disord, V1, P185, DOI 10.1016/0960-8966(91)90023-L; KHURANA TS, 1990, J BIOL CHEM, V265, P16717; Khurana TS, 1999, MOL BIOL CELL, V10, P2075, DOI 10.1091/mbc.10.6.2075; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; Kohler M, 2009, J NEUROL NEUROSUR PS, V80, P320, DOI 10.1136/jnnp.2007.141721; Krag TOB, 2004, P NATL ACAD SCI USA, V101, P13856, DOI 10.1073/pnas.0405972101; LANEUVILLE O, 1994, J PHARMACOL EXP THER, V271, P927; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; LOVE DR, 1991, P NATL ACAD SCI USA, V88, P3243, DOI 10.1073/pnas.88.8.3243; Lu YF, 2008, J BIOL CHEM, V283, P34720, DOI 10.1074/jbc.M804518200; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; MCDOUALL RM, 1990, J NEUROL SCI, V99, P199, DOI 10.1016/0022-510X(90)90156-H; Miura P, 2005, J BIOL CHEM, V280, P32997, DOI 10.1074/jbc.M503994200; Nguyen T M, 1991, J Cell Biol, V115, P1695, DOI 10.1083/jcb.115.6.1695; OHLENDIECK K, 1991, NEURON, V7, P499, DOI 10.1016/0896-6273(91)90301-F; Reichert JM, 2003, NAT REV DRUG DISCOV, V2, P695, DOI 10.1038/nrd1178; Rodova M, 2004, NEUROSCI LETT, V363, P163, DOI 10.1016/j.neulet.2004.04.001; Rosenberg MI, 2006, J CELL BIOL, V175, P77, DOI 10.1083/jcb.200603039; Rothstein JD, 2005, NATURE, V433, P73, DOI 10.1038/nature03180; Schulman SP, 2006, L ARGININE THERAPY A, P58; Solomon SD, 2005, CARDIOVASCULAR RISK, P1071; Sonnemann KJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000083; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; Tobinick EL, 2009, DRUG NEWS PERSPECT, V22, P119, DOI 10.1358/dnp.2009.22.2.1303818; U. S. National Library of Medicine NIoH, 2010, DRUGS SUPPL L ARG; Voisin V, 2005, NEUROBIOL DIS, V20, P123, DOI 10.1016/j.nbd.2005.02.010; Weir AP, 2002, J BIOL CHEM, V277, P45285, DOI 10.1074/jbc.M205177200; Welch EM, 2007, NATURE, V447, P87, DOI 10.1038/nature05756; WROGEMANN K, 1976, LANCET, V1, P672; Xu ZL, 2004, ACTA PHARMACOL SIN, V25, P1165; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	63	50	50	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26169	10.1371/journal.pone.0026169	http://dx.doi.org/10.1371/journal.pone.0026169			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028826	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800023
J	Reilly, JE; Hanson, HH; Fernandez-Monreal, M; Wearne, SL; Hof, PR; Phillips, GR				Reilly, James E.; Hanson, Hugo H.; Fernandez-Monreal, Monica; Wearne, Susan L.; Hof, Patrick R.; Phillips, Greg R.			Characterization of MSB Synapses in Dissociated Hippocampal Culture with Simultaneous Pre- and Postsynaptic Live Microscopy	PLOS ONE			English	Article							NEOCORTEX IN-VIVO; DENDRITIC SPINES; ADULT-RATS; 3-DIMENSIONAL STRUCTURE; PRESYNAPTIC TERMINALS; GAMMA-PROTOCADHERINS; MULTIPLE SYNAPSES; PYRAMIDAL CELLS; DENTATE GYRUS; NEURONS	Multisynaptic boutons (MSBs) are presynaptic boutons in contact with multiple postsynaptic partners. Although MSB synapses have been studied with static imaging techniques such as electron microscopy (EM), the dynamics of individual MSB synapses have not been directly evaluated. It is known that the number of MSB synapses increases with synaptogenesis and plasticity but the formation, behavior, and fate of individual MSB synapses remains largely unknown. To address this, we developed a means of live imaging MSB synapses to observe them directly over time. With time lapse confocal microscopy of GFP-filled dendrites in contact with VAMP2-DsRed-labeled boutons, we recorded both MSBs and their contacting spines hourly over 15 or more hours. Our live microscopy showed that, compared to spines contacting single synaptic boutons (SSBs), MSB-contacting spines exhibit elevated dynamic behavior. These results are consistent with the idea that MSBs serve as intermediates in synaptic development and plasticity.	[Reilly, James E.; Hanson, Hugo H.; Fernandez-Monreal, Monica; Wearne, Susan L.; Hof, Patrick R.; Phillips, Greg R.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Wearne, Susan L.; Hof, Patrick R.] Mt Sinai Sch Med, Computat Neurobiol & Imaging Ctr, New York, NY USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Reilly, JE (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	greg.phillips@mssm.edu	Monreal, Monica Fernandez/P-6685-2019; Fernandez-Monreal, Mónica/I-7954-2012	Monreal, Monica Fernandez/0000-0001-7278-448X; Fernandez-Monreal, Mónica/0000-0001-7278-448X	National Institutes of Health [NS051238, MH071818]; Irma T. Hirschl Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051238] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Irma T. Hirschl Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS051238 and an Irma T. Hirschl Award, both to GRP. PRH was supported by NIH MH071818. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen S, 2007, MOL CELL NEUROSCI, V36, P472, DOI 10.1016/j.mcn.2007.08.004; Dunaevsky A, 2001, NAT NEUROSCI, V4, P685, DOI 10.1038/89460; Federmeier KD, 2002, NEUROSCI LETT, V332, P180, DOI 10.1016/S0304-3940(02)00759-0; Fernandez-Monreal M, 2010, EUR J NEUROSCI, V32, P921, DOI 10.1111/j.1460-9568.2010.07386.x; Fernandez-Monreal M, 2009, MOL CELL NEUROSCI, V40, P344, DOI 10.1016/j.mcn.2008.12.002; Fiala JC, 1998, J NEUROSCI, V18, P8900; FIELD PM, 1980, BRAIN RES, V189, P103, DOI 10.1016/0006-8993(80)90010-4; Geinisman Y, 2001, J NEUROSCI, V21, P5568, DOI 10.1523/JNEUROSCI.21-15-05568.2001; Hanson HH, 2010, MICROSC MICROANAL, V16, P747, DOI 10.1017/S1431927610094092; Hanson HH, 2010, J BIOL CHEM, V285, P20982, DOI 10.1074/jbc.M109.092031; HARRIS KM, 1995, TRENDS NEUROSCI, V18, P365, DOI 10.1016/0166-2236(95)93930-V; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Jones TA, 1999, J COMP NEUROL, V414, P57; Jones TA, 1997, NEUROBIOL LEARN MEM, V68, P13, DOI 10.1006/nlme.1997.3774; Kirov SA, 1999, J NEUROSCI, V19, P2876; Knott GW, 2006, NAT NEUROSCI, V9, P1117, DOI 10.1038/nn1747; Konur S, 2004, MOL CELL NEUROSCI, V27, P427, DOI 10.1016/j.mcn.2004.07.005; Korkotian E, 2001, J NEUROSCI, V21, P6115, DOI 10.1523/JNEUROSCI.21-16-06115.2001; MATTHEWS DA, 1976, BRAIN RES, V115, P23, DOI 10.1016/0006-8993(76)90820-9; Nagerl UV, 2007, J NEUROSCI, V27, P8149, DOI 10.1523/JNEUROSCI.0511-07.2007; Nicholson DA, 2009, J COMP NEUROL, V512, P399, DOI 10.1002/cne.21896; RAISMAN G, 1973, BRAIN RES, V50, P241, DOI 10.1016/0006-8993(73)90729-4; Rodriguez A, 2006, NAT PROTOC, V1, P2152, DOI 10.1038/nprot.2006.313; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Sabo SL, 2006, J NEUROSCI, V26, P10813, DOI 10.1523/JNEUROSCI.2052-06.2006; Shepherd GMG, 1998, J NEUROSCI, V18, P8300; Sorra KE, 1998, J COMP NEUROL, V398, P225; SORRA KE, 1993, J NEUROSCI, V13, P3736; STEWARD O, 1988, J COMP NEUROL, V267, P203, DOI 10.1002/cne.902670205; Toni N, 1999, NATURE, V402, P421, DOI 10.1038/46574; Toni N, 2007, NAT NEUROSCI, V10, P727, DOI 10.1038/nn1908; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Woolley CS, 1996, J COMP NEUROL, V373, P108; Yankova M, 2001, P NATL ACAD SCI USA, V98, P3525, DOI 10.1073/pnas.051624598; Yasumatsu N, 2008, J NEUROSCI, V28, P13592, DOI 10.1523/JNEUROSCI.0603-08.2008; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26478	10.1371/journal.pone.0026478	http://dx.doi.org/10.1371/journal.pone.0026478			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028887	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800045
J	Zhao, LD; Guo, WW; Lin, C; Li, LX; Sun, JH; Wu, N; Ren, LL; Li, XX; Liu, HZ; Young, WY; Gao, WQ; Yang, SM				Zhao, Li-Dong; Guo, Wei-Wei; Lin, Chang; Li, Li-Xian; Sun, Jian-He; Wu, Nan; Ren, Li-Li; Li, Xin-Xin; Liu, Hui-Zhan; Young, Wie-Yen; Gao, Wei-Qiang; Yang, Shi-Ming			Effects of DAPT and Atoh1 Overexpression on Hair Cell Production and Hair Bundle Orientation in Cultured Organ of Corti from Neonatal Rats	PLOS ONE			English	Article							MAMMALIAN INNER-EAR; PROSENSORY PATCHES; REGENERATION; COCHLEA; CHICK; REPLACEMENT; INHIBITION; MATH1; DIFFERENTIATION; EXPRESSION	Background: In mammals, hair cells do not undergo spontaneous regeneration when they are damaged and result in permanent hearing loss. Previous studies in cultured Organ of Corti dissected from neonatal animals have shown that both DAPT (r-secretase inhibitor in the Notch signal pathway) treatment and Atoh1 overexpression can induce supernumerary hair cells. The effects of simultaneous DAPT treatment and Atoh1 over expression in the cells of cultured Organ of Corti from neonatal rats are still obscure. Principal Findings: In this study, we set out to investigate the interaction of DAPT treatment and Atoh1 overexpression as well as culture time and the location of basilar fragment isolated form neonatal rat inner ear. Our results showed that DAPT treatment induced more hair cells in the apical turn, while Atoh1 overexpression induced more extra hair cells in the middle turn of the cultured Organ of Corti. When used together, their effects are additive but not synergistic. In addition, the induction of supernumerary hair cells by both DAPT and Atoh1 overexpression is dependent on the treatment time and the location of the cochlear tissue. Moreover, DAPT treatment causes dramatic changes in the orientation of the stereociliary bundles of hair cells, whereas Atoh1 overexpression didn't induce drastic change of the polarity of stereociliary bundles. Conclusions/Significance: Taken together, these results suggest that DAPT treatment are much more potent in inducing supernumerary hair cells than Atoh1 overexpression and that the new hair cells mainly come from the trans-differentiation of supporting cells around hair cells. The orientation change of stereociliary bundle of hair cells may be attributed to the insertion of the newly formed hair cells. The immature hair bundles on the newly formed hair cells may also contribute to the overall chaos of the stereociliary bundle of the sensory epithelia.	[Zhao, Li-Dong; Guo, Wei-Wei; Li, Li-Xian; Sun, Jian-He; Wu, Nan; Ren, Li-Li; Li, Xin-Xin; Liu, Hui-Zhan; Young, Wie-Yen; Yang, Shi-Ming] Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Inst Otolaryngol, Beijing, Peoples R China; [Lin, Chang; Li, Li-Xian] Fujian Med Univ, Affiliated Hosp 1, Dept Otolaryngol Head & Neck Surg, Fuzhou, Peoples R China; [Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Sch Med, Renji MedX Clin Stem Cell Res Ctr, Renji Hosp, Shanghai 200030, Peoples R China; [Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Med Res Inst X, Shanghai 200030, Peoples R China; [Gao, Wei-Qiang] Shanghai Jiao Tong Univ, Sch Med, Shanghai Canc Inst, Renji Hosp, Shanghai 200030, Peoples R China	Chinese People's Liberation Army General Hospital; Fujian Medical University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhao, LD (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Otolaryngol Head & Neck Surg, Inst Otolaryngol, Beijing, Peoples R China.	weiqgao@yahoo.com; yangsm301@263.net	Gao, Wei/GXH-0380-2022; , sunjhe/S-5843-2019	Zhao, Lidong/0000-0002-0810-0941	Major State Basic Research Development Program of China (973) [2011CBA01000]; National Hi-Tech Research and Development Program of China (863) [2007AA02Z150]; National Natural Science Foundation of China [30871398, 30730040, 30628030]; National Basic Research Program of China [2012CB966800]; K. C. Wong endowment fund	Major State Basic Research Development Program of China (973)(National Basic Research Program of China); National Hi-Tech Research and Development Program of China (863)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); K. C. Wong endowment fund	This work was supported by grants from the Major State Basic Research Development Program of China (973) (#2011CBA01000), National Hi-Tech Research and Development Program of China (863) (#2007AA02Z150) to S-MY, and the National Natural Science Foundation of China (#30871398, 30730040, 30628030) to S-MY. National Basic Research Program of China (Grant No. 2012CB966800) to W-QG and K. C. Wong endowment fund (to W-QG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The URL of the funder's website is as following: http://www.nsfc.gov.cn/Portal0/default124.htm.	ABDOUH A, 1994, BRAIN RES, V660, P181, DOI 10.1016/0006-8993(94)91288-2; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; CORWIN JT, 1991, ANNU REV NEUROSCI, V14, P301, DOI 10.1146/annurev.neuro.14.1.301; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; Doetzlhofer A, 2009, DEV CELL, V16, P58, DOI 10.1016/j.devcel.2008.11.008; Duncan LJ, 2006, J COMP NEUROL, V499, P691, DOI 10.1002/cne.21114; Gale JE, 2002, J NEUROBIOL, V50, P81, DOI 10.1002/neu.10002; Hartman BH, 2009, JARO-J ASSOC RES OTO, V10, P321, DOI 10.1007/s10162-009-0162-2; Hori R, 2007, NEUROREPORT, V18, P1911, DOI 10.1097/WNR.0b013e3282f213e0; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Jones JE, 1996, J NEUROSCI, V16, P649; KELLEY MW, 1995, J NEUROSCI, V15, P3013; Kelly M, 2007, INT J DEV BIOL, P13; Kiernan AE, 2005, DEVELOPMENT, V132, P4353, DOI 10.1242/dev.02002; Kiernan AE, 2001, P NATL ACAD SCI USA, V98, P3873, DOI 10.1073/pnas.071496998; Kiernan AE, 2006, PLOS GENET, V2, P27, DOI 10.1371/journal.pgen.0020004; Lanford PJ, 1999, NAT GENET, V21, P289, DOI 10.1038/6804; LEWIS J, 1991, CIBA F SYMP, V160, P25, DOI 10.4171/RMI/104; RAPHAEL Y, 1991, CELL MOTIL CYTOSKEL, V18, P215, DOI 10.1002/cm.970180307; RAPHAEL Y, 1992, J NEUROCYTOL, V21, P663, DOI 10.1007/BF01191727; Sobkowicz HM, 1997, INT J DEV NEUROSCI, V15, P463, DOI 10.1016/S0736-5748(96)00104-9; Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js; Stone JS, 1999, J NEUROCYTOL, V28, P863, DOI 10.1023/A:1007022205821; STONE JS, 1994, J COMP NEUROL, V341, P50, DOI 10.1002/cne.903410106; Takebayashi S, 2007, DEV BIOL, V307, P165, DOI 10.1016/j.ydbio.2007.04.035; Taylor RR, 2008, JARO-J ASSOC RES OTO, V9, P44, DOI 10.1007/s10162-007-0105-8; Woods C, 2004, NAT NEUROSCI, V7, P1310, DOI 10.1038/nn1349; Wu WJ, 2001, HEARING RES, V158, P165, DOI 10.1016/S0378-5955(01)00303-3; Yamamoto N, 2006, J MOL MED, V84, P37, DOI 10.1007/s00109-005-0706-9; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zheng JL, 1999, J NEUROSCI, V19, P2161; Zine A, 2000, DEVELOPMENT, V127, P3373	33	25	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e23729	10.1371/journal.pone.0023729	http://dx.doi.org/10.1371/journal.pone.0023729			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028767	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800002
J	Bharatham, N; Chi, SW; Yoon, HS				Bharatham, Nagakumar; Chi, Seung-Wook; Yoon, Ho Sup			Molecular Basis of Bcl-X-L-p53 Interaction: Insights from Molecular Dynamics Simulations	PLOS ONE			English	Article							BCL-2 PROTEIN FAMILY; IN-VIVO; INDUCE APOPTOSIS; X-L; BH3-ONLY PROTEINS; NUCLEIC-ACIDS; CELL-SURVIVAL; P53; MDM2; COMPLEX	Bcl-X-L, an antiapoptotic Bcl-2 family protein, plays a central role in the regulation of the apoptotic pathway. Heterodimerization of the antiapoptotic Bcl-2 family proteins with the proapoptotic family members such as Bad, Bak, Bim and Bid is a crucial step in the apoptotic regulation. In addition to these conventional binding partners, recent evidences reveal that the Bcl-2 family proteins also interact with noncanonical binding partners such as p53. Our previous NMR studies showed that Bcl-X-L: BH3 peptide and Bcl-X-L: SN15 peptide (a peptide derived from residues S15-N29 of p53) complex structures share similar modes of bindings. To further elucidate the molecular basis of the interactions, here we have employed molecular dynamics simulations coupled with MM/PBSA approach. Bcl-XL and other Bcl-2 family proteins have 4 hydrophobic pockets (p1-p4), which are occupied by four systematically spaced hydrophobic residues (h1-h4) of the proapoptotic Bad and Bak BH3 peptides. We observed that three conserved hydrophobic residues (F19, W23 and L26) of p53 (SN15) peptide anchor into three hydrophobic pockets (p2-p4) of Bcl-X-L in a similar manner as BH3 peptide. Our results provide insights into the novel molecular recognition by Bcl-X-L with p53.	[Bharatham, Nagakumar; Yoon, Ho Sup] Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore, Singapore; [Chi, Seung-Wook] KRIBB, Med Prote Res Ctr, Taejon, South Korea	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Bharatham, N (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Div Struct Biol & Biochem, Singapore, Singapore.	hsyoon@ntu.edu.sg	Yoon, Ho Sup/A-2193-2011	Yoon, Ho Sup/0000-0002-8243-3904	Ministry of Education Singapore [AcRF Tier 2 ARC 4/04]; Nanyang Technological University [RG161/06]; Ministry of Health Singapore [NMRC/1177/2008]	Ministry of Education Singapore(Ministry of Education, Singapore); Nanyang Technological University(Nanyang Technological University); Ministry of Health Singapore(Ministry of Health-Singapore)	This study was supported by Ministry of Education Singapore Grant AcRF Tier 2 ARC 4/04, Nanyang Technological University Grant RG161/06, and Ministry of Health Singapore Grant NMRC/1177/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JM, 2001, TRENDS BIOCHEM SCI, V26, P61, DOI 10.1016/S0968-0004(00)01740-0; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Bottger A, 1997, J MOL BIOL, V269, P744, DOI 10.1006/jmbi.1997.1078; CASE DA, 1994, CURR OPIN STRUC BIOL, V4, P285, DOI 10.1016/S0959-440X(94)90321-2; CASE DA, 2004, AMBER9; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; El-Deiry WS, 1998, SEMIN CANCER BIOL, V8, P345, DOI 10.1006/scbi.1998.0097; Ha JH, 2011, J AM CHEM SOC, V133, P1244, DOI 10.1021/ja109521f; Harris CC, 1996, CARCINOGENESIS, V17, P1187, DOI 10.1093/carcin/17.6.1187; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang P, 2006, MOL CELL BIOL, V26, P9071, DOI 10.1128/MCB.01025-06; JOSEPH TL, 2010, CELL CYCLE, V9; Kokontis JM, 2001, ONCOGENE, V20, P659, DOI 10.1038/sj.onc.1204139; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Kutzki O, 2002, J AM CHEM SOC, V124, P11838, DOI 10.1021/ja026861k; Lama D, 2008, PROTEINS, V73, P492, DOI 10.1002/prot.22075; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Lee H, 2000, J BIOL CHEM, V275, P29426, DOI 10.1074/jbc.M003107200; Lee HJ, 2007, CELL CYCLE, V6, P2604, DOI 10.4161/cc.6.21.4923; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Minn AJ, 1998, ADV IMMUNOL, V70, P245, DOI 10.1016/S0065-2776(08)60388-0; Moroy G, 2009, J BIOL CHEM, V284, P17499, DOI 10.1074/jbc.M805542200; Naski N, 2009, CELL CYCLE, V8, P31, DOI 10.4161/cc.8.1.7326; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pazgiera M, 2009, P NATL ACAD SCI USA, V106, P4665, DOI 10.1073/pnas.0900947106; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Petros AM, 2004, BBA-MOL CELL RES, V1644, P83, DOI 10.1016/j.bbamcr.2003.08.012; Phan J, 2010, J BIOL CHEM, V285, P2174, DOI 10.1074/jbc.M109.073056; Popowicz GM, 2010, CELL CYCLE, V9, P1104, DOI 10.4161/cc.9.6.10956; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schon O, 2002, J MOL BIOL, V323, P491, DOI 10.1016/S0022-2836(02)00852-5; Shimizu H, 2002, J BIOL CHEM, V277, P28446, DOI 10.1074/jbc.M202296200; Skommer J, 2007, LEUKEMIA RES, V31, P277, DOI 10.1016/j.leukres.2006.06.027; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Talos F, 2005, CANCER RES, V65, P9971, DOI 10.1158/0008-5472.CAN-05-1084; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsui V, 2000, J AM CHEM SOC, V122, P2489, DOI 10.1021/ja9939385; van der Spoel D., 2005, GROMACS USER MANUAL; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wahl GM, 2006, CELL DEATH DIFFER, V13, P973, DOI 10.1038/sj.cdd.4401911; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Xu HB, 2006, BIOCHEM BIOPH RES CO, V341, P938, DOI 10.1016/j.bbrc.2005.12.227; Xu HB, 2009, BIOCHEMISTRY-US, V48, P12159, DOI 10.1021/bi901188s; Yin H, 2005, J AM CHEM SOC, V127, P10191, DOI 10.1021/ja050122x; Zhong HZ, 2005, PROTEINS, V58, P222, DOI 10.1002/prot.20275; Zondlo SC, 2006, BIOCHEMISTRY-US, V45, P11945, DOI 10.1021/bi060309g; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	67	28	28	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26014	10.1371/journal.pone.0026014	http://dx.doi.org/10.1371/journal.pone.0026014			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039431	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500027
J	Luo, ZJ; Xu, XP; Gu, PL; Lonard, D; Gunaratne, PH; Cooney, AJ; Azencott, R				Luo, Zijun; Xu, Xuping; Gu, Peili; Lonard, David; Gunaratne, Preethi H.; Cooney, Austin J.; Azencott, Robert			miRNA Regulatory Circuits in ES Cells Differentiation: A Chemical Kinetics Modeling Approach	PLOS ONE			English	Article							MICRORNAS; OCT4; IDENTIFICATION; FEEDBACK; LOOPS	MicroRNAs (miRNAs) play an important role in gene regulation for Embryonic Stem cells (ES cells), where they either down-regulate target mRNA genes by degradation or repress protein expression of these mRNA genes by inhibiting translation. Well known tables TargetScan and miRanda may predict quite long lists of potential miRNAs inhibitors for each mRNA gene, and one of our goals was to strongly narrow down the list of mRNA targets potentially repressed by a known large list of 400 miRNAs. Our paper focuses on algorithmic analysis of ES cells microarray data to reliably detect repressive interactions between miRNAs and mRNAs. We model, by chemical kinetics equations, the interaction architectures implementing the two basic silencing processes of miRNAs, namely "direct degradation" or "translation inhibition" of targeted mRNAs. For each pair (M, G) of potentially interacting miRMA gene M and mRNA gene G, we parameterize our associated kinetic equations by optimizing their fit with microarray data. When this fit is high enough, we validate the pair (M, G) as a highly probable repressive interaction. This approach leads to the computation of a highly selective and drastically reduced list of repressive pairs (M, G) involved in ES cells differentiation.	[Luo, Zijun; Azencott, Robert] Univ Houston, Dept Math, Houston, TX 77204 USA; [Xu, Xuping; Gu, Peili; Lonard, David; Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Gunaratne, Preethi H.] Univ Houston, Dept Biol & Biochem, Houston, TX USA	University of Houston System; University of Houston; Baylor College of Medicine; University of Houston System; University of Houston	Luo, ZJ (corresponding author), Univ Houston, Dept Math, Houston, TX 77204 USA.	boluomiduo1@gmail.com			National Institute for General Medicine [P01-GM081627-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081627] Funding Source: NIH RePORTER	National Institute for General Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a grant from the National Institute for General Medicine (P01-GM081627-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Azencott R, 2008, C MOD AN BIOL NETW U; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cohen SM, 2006, GENE DEV, V20, P2769, DOI 10.1101/gad.1484606; Goutsias J, 2007, CURR PHARM DESIGN, V13, P1415, DOI 10.2174/138161207780765945; Goutsias J, 2004, BIOPHYS J, V86, P1922, DOI 10.1016/S0006-3495(04)74257-5; Gregory P., 2005, BAYESIAN LOGICAL DAT; Gu P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002548; Kugler P, 2009, J PHYS CHEM A, V113, P2775, DOI 10.1021/jp808792u; Luo Z, 2010, THESIS U HOUSTON; Marson A, 2008, CELL, V10, P1016; Miller L, 2010, QUANTIFYING W BLOTS; Periwal V, 2008, AM J PHYSIOL-REG I, V295, pR1089, DOI 10.1152/ajpregu.90426.2008; Saxe JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004467; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200	19	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e23263	10.1371/journal.pone.0023263	http://dx.doi.org/10.1371/journal.pone.0023263			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039400	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500002
J	Li, M; Song, Y; Cho, N; Chang, JM; Koo, HR; Yi, A; Kim, H; Park, S; Moon, WK				Li, Mulan; Song, Yonghyun; Cho, Nariya; Chang, Jung Min; Koo, Hye Ryoung; Yi, Ann; Kim, Hyeonjin; Park, Sunghyouk; Moon, Woo Kyung			An HR-MAS MR Metabolomics Study on Breast Tissues Obtained with Core Needle Biopsy	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; NMR-SPECTROSCOPY; CANCER TISSUE; IDENTIFICATION; METABOLISM; DIAGNOSIS; DISEASE; CLASSIFICATION; PREDICTION; BIOFLUIDS	Background: Much research has been devoted to the development of new breast cancer diagnostic measures, including those involving high-resolution magic angle spinning (HR-MAS) magnetic resonance (MR) spectroscopic techniques. Previous HR-MAS MR results have been obtained from post-surgery samples, which limits their direct clinical applicability. Methodology/Principal Findings: In the present study, we performed HR-MAS MR spectroscopic studies on 31 breast tissue samples (13 cancer and 18 non-cancer) obtained by percutaneous core needle biopsy. We showed that cancer and non-cancer samples can be discriminated very well with Orthogonal Projections to Latent Structure-Discriminant Analysis (OPLS-DA) multivariate model on the MR spectra. A subsequent blind test showed 69% sensitivity and 94% specificity in the prediction of the cancer status. A spectral analysis showed that in cancer cells, taurine-and choline-containing compounds are elevated. Our approach, additionally, could predict the progesterone receptor statuses of the cancer patients. Conclusions/Significance: HR-MAS MR metabolomics on intact breast tissues obtained by core needle biopsy may have a potential to be used as a complement to the current diagnostic and prognostic measures for breast cancers.	[Li, Mulan; Cho, Nariya; Chang, Jung Min; Koo, Hye Ryoung; Yi, Ann; Kim, Hyeonjin; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Song, Yonghyun; Park, Sunghyouk] Inha Univ, Dept Biochem, Coll Med, Inchon, South Korea; [Song, Yonghyun; Park, Sunghyouk] Inha Univ, Ctr Adv Med Educ, Coll Med, Inchon, South Korea	Seoul National University (SNU); Inha University; Inha University	Li, M (corresponding author), Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea.	spark@inha.ac.kr; moonwk@snu.ac.kr	Kim, Hyeonjin/J-2751-2012; Moon, Woo Kyung/J-2755-2012; Kim, Hyeonjin/M-3761-2019; Cho, Nariya/J-5663-2012	Chang, Jung Min/0000-0001-5726-9797	NRF; Ministry Of Education, Science and Technology [20090080219, 2010-0005189]; Ministry of Health & Welfare, Republic of Korea [A01185]; Innovative Research Institute for Cell Therapy, Republic of Korea [A062260]; National Research Foundation of Korea (NRF); Ministry for Health & Welfare, Republic of Korea [A092006]	NRF; Ministry Of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Innovative Research Institute for Cell Therapy, Republic of Korea; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry for Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the Mid-career Researcher Program through NRF grant funded by the Ministry Of Education, Science and Technology (No. 20090080219), by a grant from the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (A01185), and by a grant (A062260) from the Innovative Research Institute for Cell Therapy, Republic of Korea. This research was also supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0005189), and a grant of the Korea Healthcare technology R&D Project, Ministry for Health & Welfare, Republic of Korea (A092006) to SP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bathen TF, 2007, BREAST CANCER RES TR, V104, P181, DOI 10.1007/s10549-006-9400-z; Bathen TF, 2010, CANCER RES, V70, P6692, DOI 10.1158/0008-5472.CAN-10-0437; Beckonert O, 2003, NMR BIOMED, V16, P1, DOI 10.1002/nbm.797; Beckonert O, 2010, NAT PROTOC, V5, P1019, DOI 10.1038/nprot.2010.45; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Burns MA, 2004, TECHNOL CANCER RES T, V3, P591, DOI 10.1177/153303460400300609; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; Cecil KM, 2001, BREAST CANCER RES TR, V68, P45, DOI 10.1023/A:1017911211090; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Cheng LL, 1998, J MAGN RESON, V135, P194, DOI 10.1006/jmre.1998.1578; Clayton TA, 2009, P NATL ACAD SCI USA, V106, P14728, DOI 10.1073/pnas.0904489106; Clayton TA, 2006, NATURE, V440, P1073, DOI 10.1038/nature04648; Defeo EM, 2010, TECHNOL CANCER RES T, V9, P381, DOI 10.1177/153303461000900407; Giskeodegard GF, 2010, J PROTEOME RES, V9, P972, DOI 10.1021/pr9008783; Gribbestad IS, 1999, ANTICANCER RES, V19, P1737; Holmes E, 2006, J PROTEOME RES, V5, P1313, DOI 10.1021/pr050399w; Kang J, 2008, J AGR FOOD CHEM, V56, P11589, DOI 10.1021/jf802088a; Katz-Brull R, 2002, CANCER RES, V62, P1966; Kwon HN, 2011, KIDNEY INT, V79, P529, DOI 10.1038/ki.2010.440; Larsen TO, 2005, NAT PROD REP, V22, P672, DOI 10.1039/b404943h; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Martinez-Granados B, 2011, INT J MOL MED, V27, P111, DOI 10.3892/ijmm.2010.563; Mountford CE, 2001, BRIT J SURG, V88, P1234, DOI 10.1046/j.0007-1323.2001.01864.x; NEGENDANK W, 1992, NMR BIOMED, V5, P303, DOI 10.1002/nbm.1940050518; Rocha CM, 2010, J PROTEOME RES, V9, P319, DOI 10.1021/pr9006574; Roebuck JR, 1998, RADIOLOGY, V209, P269, DOI 10.1148/radiology.209.1.9769842; Sands CJ, 2009, ANAL CHEM, V81, P6458, DOI 10.1021/ac900828p; SINGER S, 1995, CANCER RES, V55, P5140; Sitter B, 2002, NMR BIOMED, V15, P327, DOI 10.1002/nbm.775; Sitter B, 2006, NMR BIOMED, V19, P30, DOI 10.1002/nbm.992; Sitter B, 2010, NMR BIOMED, V23, P424, DOI 10.1002/nbm.1478; Swanson MG, 2003, MAGN RESON MED, V50, P944, DOI 10.1002/mrm.10614; Thomas MA, 2009, NMR BIOMED, V22, P77, DOI 10.1002/nbm.1310; Ting YLT, 1996, ANTICANCER RES, V16, P1381; Wen H, 2010, J HEPATOL, V52, P228, DOI 10.1016/j.jhep.2009.11.002; Wiklund S, 2008, ANAL CHEM, V80, P115, DOI 10.1021/ac0713510	36	55	57	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25563	10.1371/journal.pone.0025563	http://dx.doi.org/10.1371/journal.pone.0025563			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028780	Green Submitted, Green Published, gold			2022-12-27	WOS:000296186900009
J	Zhang, Y; Thomas, GL; Swat, M; Shirinifard, A; Glazier, JA				Zhang, Ying; Thomas, Gilberto L.; Swat, Maciej; Shirinifard, Abbas; Glazier, James A.			Computer Simulations of Cell Sorting Due to Differential Adhesion	PLOS ONE			English	Article							HOMOPHILIC CADHERIN ADHESION; N-CADHERIN; ACTIN CYTOSKELETON; FORCE MEASUREMENTS; MEDIATED ADHESION; STRUCTURAL BASIS; WOUND CLOSURE; CHICK LIMB; MORPHOGENESIS; SPECIFICITY	The actions of cell adhesion molecules, in particular, cadherins during embryonic development and morphogenesis more generally, regulate many aspects of cellular interactions, regulation and signaling. Often, a gradient of cadherin expression levels drives collective and relative cell motions generating macroscopic cell sorting. Computer simulations of cell sorting have focused on the interactions of cells with only a few discrete adhesion levels between cells, ignoring biologically observed continuous variations in expression levels and possible nonlinearities in molecular binding. In this paper, we present three models relating the surface density of cadherins to the net intercellular adhesion and interfacial tension for both discrete and continuous levels of cadherin expression. We then use then the Glazier-Graner-Hogeweg (GGH) model to investigate how variations in the distribution of the number of cadherins per cell and in the choice of binding model affect cell sorting. We find that an aggregate with a continuous variation in the level of a single type of cadherin molecule sorts more slowly than one with two levels. The rate of sorting increases strongly with the interfacial tension, which depends both on the maximum difference in number of cadherins per cell and on the binding model. Our approach helps connect signaling at the molecular level to tissue-level morphogenesis.	[Zhang, Ying] NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA; [Thomas, Gilberto L.] Univ Fed Rio Grande do Sul, Inst Fis, Porto Alegre, RS, Brazil; [Swat, Maciej; Shirinifard, Abbas; Glazier, James A.] Indiana Univ, Biocomplex Inst, Bloomington, IN USA; [Swat, Maciej; Shirinifard, Abbas; Glazier, James A.] Indiana Univ, Dept Phys, Bloomington, IN 47405 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Universidade Federal do Rio Grande do Sul; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Zhang, Y (corresponding author), NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA.	zhangy14@mail.nih.gov	Thomas, Gilberto L/H-8944-2012; Zhang, Ying/Q-6956-2016; Thomas, Gilberto L/AAW-4072-2020	Zhang, Ying/0000-0002-8045-3821; Thomas, Gilberto L/0000-0003-0317-6186; Glazier, James Alexander/0000-0003-3634-190X	Indiana University; Biocomplexity Institute at Indiana University; National Institutes of Health [NIGMS R01-GM76692, R01-GM077138]; EPA; Brazilian agencies Conselho Nacional de Pesquisa e Desenvolvimento (CNPq); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) [PRONEX-10/0008-0]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077138, R01GM076692] Funding Source: NIH RePORTER	Indiana University; Biocomplexity Institute at Indiana University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EPA(United States Environmental Protection Agency); Brazilian agencies Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge support from Indiana University and The Biocomplexity Institute at Indiana University and National Institutes of Health grants NIGMS R01-GM76692 and R01-GM077138 and The EPA grant "Texas-Indiana Virtual STAR Center.'' GLT acknowledges support from the Brazilian agencies Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) and Fundacao de Amparo a Pesquisa do Estado do Rio Grande do Sul (FAPERGS) under the grant PRONEX-10/0008-0. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CL, 1998, CURR OPIN CELL BIOL, V10, P572, DOI 10.1016/S0955-0674(98)80031-8; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Angres B, 1996, J CELL BIOL, V134, P549, DOI 10.1083/jcb.134.2.549; ARMSTRONG PB, 1971, ROUX ARCH DEV BIOL, V168, P125, DOI 10.1007/BF00581804; Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697; BEHRENS J, 1985, J CELL BIOL, V101, P1307, DOI 10.1083/jcb.101.4.1307; BEMENT WM, 1993, J CELL BIOL, V121, P565, DOI 10.1083/jcb.121.3.565; Berx G, 2001, BREAST CANCER RES, V3, P289, DOI 10.1186/bcr309; Beysens DA, 2000, P NATL ACAD SCI USA, V97, P9467, DOI 10.1073/pnas.97.17.9467; BITZUR S, 1994, DEV DYNAM, V201, P121, DOI 10.1002/aja.1002010204; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; Chen CP, 2005, P NATL ACAD SCI USA, V102, P8531, DOI 10.1073/pnas.0503319102; Chu YS, 2004, J CELL BIOL, V167, P1183, DOI 10.1083/jcb.200403043; Dan D, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.041909; Foty RA, 2005, DEV BIOL, V278, P255, DOI 10.1016/j.ydbio.2004.11.012; Frenkel J., 1945, J PHYS, V9, P385; FRIEDLANDER DR, 1989, P NATL ACAD SCI USA, V86, P7043, DOI 10.1073/pnas.86.18.7043; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Glazier JA, SINGLE CELL BASED MO, P79; Glazier JA, 2008, CURR TOP DEV BIOL, V81, P205, DOI 10.1016/S0070-2153(07)81007-6; Godt D, 1998, NATURE, V395, P387, DOI 10.1038/26493; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Horikawa K, 1999, DEV BIOL, V215, P182, DOI 10.1006/dbio.1999.9463; Linask KK, 1998, DEV BIOL, V202, P85, DOI 10.1006/dbio.1998.9025; Lorger M, 2006, J CELL SCI, V119, P3385, DOI 10.1242/jcs.03027; Maree AFM, 2001, P NATL ACAD SCI USA, V98, P3879, DOI 10.1073/pnas.061535198; Merks RMH, 2005, PHYSICA A, V352, P113, DOI 10.1016/j.physa.2004.12.028; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Mombach JCM, 1996, PHYS REV LETT, V76, P3032, DOI 10.1103/PhysRevLett.76.3032; Niessen CM, 2002, J CELL BIOL, V156, P389, DOI 10.1083/jcb.200108040; Omi M, 2002, DEV BIOL, V250, P292, DOI 10.1006/dbio.2002.0804; Panorchan P, 2006, J CELL SCI, V119, P66, DOI 10.1242/jcs.02719; Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738; Poplawski NJ, 2007, PHYSICA A, V373, P521, DOI 10.1016/j.physa.2006.05.028; Prakasam AK, 2006, P NATL ACAD SCI USA, V103, P15434, DOI 10.1073/pnas.0606701103; Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Rieu JP, 2000, BIOPHYS J, V79, P1903, DOI 10.1016/S0006-3495(00)76440-X; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Sivasankar S, 1999, P NATL ACAD SCI USA, V96, P11820, DOI 10.1073/pnas.96.21.11820; STEINBERG MS, 1963, SCIENCE, V141, P401, DOI 10.1126/science.141.3579.401; STEINBERG MS, 1994, P NATL ACAD SCI USA, V91, P206, DOI 10.1073/pnas.91.1.206; STEINBERG MS, 1972, J CELL BIOL, V55, P606, DOI 10.1083/jcb.55.3.606; Steinhaus H., 1957, B ACAD POL SCI, V4, P801; Takeichi M, 1993, CURR OPIN CELL BIOL, V5, P806, DOI 10.1016/0955-0674(93)90029-P; von der Hardt S, 2007, CURR BIOL, V17, P475, DOI 10.1016/j.cub.2007.02.013; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P7467, DOI 10.1073/pnas.0902859106; Xu X, 2001, J CELL BIOL, V154, P217, DOI 10.1083/jcb.200105047; Yajima H, 1999, DEV DYNAM, V216, P274, DOI 10.1002/(SICI)1097-0177(199911)216:3<274::AID-DVDY6>3.3.CO;2-J; Zajac M, 2000, PHYS REV LETT, V85, P2022, DOI 10.1103/PhysRevLett.85.2022; Zeng W, 2004, PHYSICA A, V341, P482, DOI 10.1016/j.physa.2004.03.089; Zhu B, 2003, BIOPHYS J, V84, P4033, DOI 10.1016/S0006-3495(03)75129-7	55	27	27	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e24999	10.1371/journal.pone.0024999	http://dx.doi.org/10.1371/journal.pone.0024999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028771	Green Published, gold			2022-12-27	WOS:000296186900004
J	Ali, BR; Ben-Rebeh, I; John, A; Akawi, NA; Milhem, RM; Al-Shehhi, NA; Al-Ameri, MM; Al-Shamisi, SA; Al-Gazali, L				Ali, Bassam R.; Ben-Rebeh, Imen; John, Anne; Akawi, Nadia A.; Milhem, Reham M.; Al-Shehhi, Nouf A.; Al-Ameri, Mouza M.; Al-Shamisi, Shamma A.; Al-Gazali, Lihadh			Endoplasmic Reticulum Quality Control Is Involved in the Mechanism of Endoglin-Mediated Hereditary Haemorrhagic Telangiectasia	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN-MISFOLDING DISEASES; BETA-BINDING-PROTEIN; TGF-BETA; INTRACELLULAR-TRANSPORT; ENDOTHELIAL-CELLS; ROBINOW-SYNDROME; TRAFFIC JAMS; MUTATIONS; ER	Hereditary haemorrhagic telangiectasia (HHT) is an autosomal dominant genetic condition affecting the vascular system and is characterised by epistaxis, arteriovenous malformations and mucocutaneous and gastrointestinal telangiectases. This disorder affects approximately 1 in 8,000 people worldwide. Significant morbidity is associated with this condition in affected individuals, and anaemia can be a consequence of repeated haemorrhages from telangiectasia in the gut and nose. In the majority of the cases reported, the condition is caused by mutations in either ACVRL1 or endoglin genes, which encode components of the TGF-beta signalling pathway. Numerous missense mutations in endoglin have been reported as causative defects for HHT but the exact underlying cellular mechanisms caused by these mutations have not been fully established despite data supporting a role for the endoplasmic reticulum (ER) quality control machinery. For this reason, we examined the subcellular trafficking of twenty-five endoglin disease-causing missense mutations. The mutant proteins were expressed in HeLa and HEK293 cell lines, and their subcellular localizations were established by confocal fluorescence microscopy alongside the analysis of their N-glycosylation profiles. ER quality control was found to be responsible in eight (L32R, V49F, C53R, V125D, A160D, P165L, I271N and A308D) out of eleven mutants located on the orphan extracellular domain in addition to two (C363Y and C382W) out of thirteen mutants in the Zona Pellucida (ZP) domain. In addition, a single intracellular domain missense mutant was examined and found to traffic predominantly to the plasma membrane. These findings support the notion of the involvement of the ER's quality control in the mechanism of a significant number, but not all, missense endoglin mutants found in HHT type 1 patients. Other mechanisms including loss of interactions with signalling partners as well as adverse effects on functional residues are likely to be the cause of the mutant proteins' loss of function.	[Ali, Bassam R.; Ben-Rebeh, Imen; John, Anne; Akawi, Nadia A.; Milhem, Reham M.; Al-Shehhi, Nouf A.; Al-Ameri, Mouza M.; Al-Shamisi, Shamma A.] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates; [Al-Gazali, Lihadh] United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Paediat, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University	Ali, BR (corresponding author), United Arab Emirates Univ, Fac Med & Hlth Sci, Dept Pathol, Al Ain, U Arab Emirates.	bassam.ali@uaeu.ac.ae	Akawi, Nadia/AAX-2650-2020; Ali, Bassam/J-7014-2012	Akawi, Nadia/0000-0001-6311-7028; Ali, Bassam R/0000-0003-1306-6618; Milhem, Reham/0000-0002-1587-6502	United Arab Emirates University [NRF-RSA-1108-00439]	United Arab Emirates University	This project has been funded by the United Arab Emirates University NRF-RSA-1108-00439 grant to B. R. A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2006, J MED GENET, V43, P97, DOI 10.1136/jmg.2005.030833; ABDULLA SA, 2005, HUM MUTAT, V25, P320; Ali BR, 2007, HUM GENET, V122, P389, DOI 10.1007/s00439-007-0409-0; Ali BR, 2010, HUM MOL GENET, V19, P2239, DOI 10.1093/hmg/ddq103; Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Aridor M, 2002, TRAFFIC, V3, P781, DOI 10.1034/j.1600-0854.2002.31103.x; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Aridor M, 2007, ADV DRUG DELIVER REV, V59, P759, DOI 10.1016/j.addr.2007.06.002; Assar O, 1991, LARYNGOSCOPE, V101, P977; Bernabeu C, 2010, J APPL BIOMED, V8, P169, DOI 10.2478/v10136-009-0020-x; BIDEAU A, 1992, ANN HUM BIOL, V19, P233, DOI 10.1080/03014469200002112; Brown CR, 1996, CELL STRESS CHAPERON, V1, P117, DOI 10.1379/1466-1268(1996)001<0117:CCCTMP>2.3.CO;2; Chen Y, 2005, HUM MOL GENET, V14, P2559, DOI 10.1093/hmg/ddi259; Cohen FE, 2003, NATURE, V426, P905, DOI 10.1038/nature02265; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Dupuis-Girod S, 2010, J THROMB HAEMOST, V8, P1447, DOI 10.1111/j.1538-7836.2010.03860.x; Fan JQ, 1999, NAT MED, V5, P112, DOI 10.1038/4801; Fernandez-L Africa, 2006, Hum Mutat, V27, P295; Fontalba A, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-75; GOUGOS A, 1990, J BIOL CHEM, V265, P8361; Govani FS, 2009, EUR J HUM GENET, V17, P860, DOI 10.1038/ejhg.2009.35; GUTTMACHER AE, 1995, NEW ENGL J MED, V333, P918, DOI 10.1056/NEJM199510053331407; Hume AN, 2009, HUM MOL GENET, V18, P267, DOI 10.1093/hmg/ddn354; Karabegovic A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022079; Kjeldsen AD, 1999, J INTERN MED, V245, P31, DOI 10.1046/j.1365-2796.1999.00398.x; LASTRES P, 1994, BIOCHEM J, V301, P765, DOI 10.1042/bj3010765; Lebrin F, 2004, EMBO J, V23, P4018, DOI 10.1038/sj.emboj.7600386; Llorca O, 2007, J MOL BIOL, V365, P694, DOI 10.1016/j.jmb.2006.10.015; Maattanen P, 2010, SEMIN CELL DEV BIOL, V21, P500, DOI 10.1016/j.semcdb.2010.03.006; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2000, GENE DEV, V14, P627; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; McDonald J, 2011, CLIN GENET, V79, P335, DOI 10.1111/j.1399-0004.2010.01596.x; Paquet ME, 2001, HUM MOL GENET, V10, P1347, DOI 10.1093/hmg/10.13.1347; Pece N, 1997, J CLIN INVEST, V100, P2568, DOI 10.1172/JCI119800; Pece-Barbara N, 1999, HUM MOL GENET, V8, P2171, DOI 10.1093/hmg/8.12.2171; Romisch K, 2004, TRAFFIC, V5, P815, DOI 10.1111/j.1600-0854.2004.00231.x; Sato S, 1996, J BIOL CHEM, V271, P635, DOI 10.1074/jbc.271.2.635; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Shovlin CL, 2000, AM J MED GENET, V91, P66, DOI 10.1002/(SICI)1096-8628(20000306)91:1<66::AID-AJMG12>3.0.CO;2-P; Shovlin CL, 1997, AM J HUM GENET, V61, P68, DOI 10.1086/513906; Shovlin CL, 2010, BLOOD REV, V24, P203, DOI 10.1016/j.blre.2010.07.001; Welch WJ, 2004, SEMIN CELL DEV BIOL, V15, P31, DOI 10.1016/j.semcdb.2003.12.011	46	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26206	10.1371/journal.pone.0026206	http://dx.doi.org/10.1371/journal.pone.0026206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022569	Green Submitted, gold, Green Published			2022-12-27	WOS:000295981600039
J	Choi, YH; Jit, M; Gay, N; Andrews, N; Waight, PA; Melegaro, A; George, R; Miller, E				Choi, Yoon Hong; Jit, Mark; Gay, Nigel; Andrews, Nick; Waight, Pauline A.; Melegaro, Alessia; George, Robert; Miller, Elizabeth			7-Valent Pneumococcal Conjugate Vaccination in England and Wales: Is It Still Beneficial Despite High Levels of Serotype Replacement?	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; TRANSMISSION PARAMETERS; COST-EFFECTIVENESS; CARRIAGE; VACCINES; MODELS	Background: The UK introduced the 7-valent pneumococcal conjugate vaccine (PCV7) into the national vaccination program in September 2006. Previous modelling assumed that the likely impact of PCV7 on invasive pneumococcal disease (IPD) would be similar to the US experience with PCV7. However, recent surveillance data show a more rapid replacement of PCV7 IPD cases by non-PCV7 IPD cases than was seen in the US. Methods and Findings: A previous model of pneumococcal vaccination was re-parameterised using data on vaccine coverage and IPD from England and Wales between 2006 and 2009. Disease incidence was adjusted for the increasing trend in reported IPD cases prior to vaccination. Using this data we estimated that individuals carrying PCV7 serotypes have much higher protection (96%; 95% CI 72%-100%) against acquisition of NVT carriage than the 15% previously estimated from US data, which leads to greater replacement. However, even with this level of replacement, the annual number of IPD cases may be 560 (95% CI, -100 to 1230) lower ten years after vaccine introduction compared to what it may have been without vaccination. A particularly marked fall of 39% in children under 15 years by 2015/6 is predicted. Conclusion: Our model suggests that PCV7 vaccination could result in a decrease in overall invasive pneumococcal disease, particularly in children, even in an environment of rapid replacement with non-PCV7 serotypes within 5 years of vaccine introduction at high coverage.	[Choi, Yoon Hong; Waight, Pauline A.; Miller, Elizabeth] Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England; [Choi, Yoon Hong; Jit, Mark] Hlth Protect Agcy, Modelling & Econ Unit, London, England; [Gay, Nigel] Fu Consulting, Hungerford, Berks, England; [Andrews, Nick] Hlth Protect Agcy, Stat Unit, London, England; [Melegaro, Alessia] Bocconi Univ, DONDENA Ctr Res Social Dynam, Milan, Italy; [George, Robert] Hlth Protect Agcy, Resp & Syst Infect Lab, London, England	Health Protection Agency; Health Protection Agency; Health Protection Agency; Bocconi University; Health Protection Agency	Choi, YH (corresponding author), Hlth Protect Agcy, Immunisat Hepatitis & Blood Safety Dept, London, England.	yoon.choi@hpa.org.uk	Jit, Mark/HDM-7797-2022; Choi, Yoon Hong/AAY-1740-2020	Choi, Yoon Hong/0000-0001-5561-4366; Jit, Mark/0000-0001-6658-8255; Melegaro, Alessia/0000-0003-2221-8898	Pfizer Vaccines	Pfizer Vaccines	The authors have read the journal's policy and have the following conflicts: RG has declared that he has received funding from Wyeth (now Pfizer Vaccines) to support conference attendance which was not for the purpose of this study. RG, EM and NA have declared that they have been a member of the Department of Health's Joint Committee on Vaccines and Immunisations Committee Sub-committee on pneumococcal vaccines. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	ANDERSON RM, 1983, J HYG-CAMBRIDGE, V90, P259, DOI 10.1017/S002217240002893X; [Anonymous], 2010, Wkly Epidemiol Rec, V85, P434; Black S, 2010, PEDIATR INFECT DIS J, V29, P301, DOI 10.1097/INF.0b013e3181c391fb; Cauchemez S, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-14; Choi YH, 2010, VACCINE, V28, P4091, DOI 10.1016/j.vaccine.2009.09.125; Dagan R, 2003, PEDIATR INFECT DIS J, V22, P532, DOI 10.1097/00006454-200306000-00009; Flasche S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001017; GRATTEN M, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P501; Hussain M, 2005, EPIDEMIOL INFECT, V133, P891, DOI 10.1017/S0950268805004012; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Johnson HL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000348; Lipsitch M, 1999, EMERG INFECT DIS, V5, P336, DOI 10.3201/eid0503.990304; Lipsitch M, 2009, EPIDEMICS-NETH, V1, P2, DOI 10.1016/j.epidem.2008.07.001; Melegaro A, 2004, VACCINE, V22, P4203, DOI 10.1016/j.vaccine.2004.05.003; Melegaro A, 2004, EPIDEMIOL INFECT, V132, P433, DOI 10.1017/S0950268804001980; Melegaro A, 2007, AM J EPIDEMIOL, V166, P228, DOI 10.1093/aje/kwm076; Melegaro A, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-90; Miller E, 2011, LANCET INFECT DIS, V11, P760, DOI 10.1016/S1473-3099(11)70090-1; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Pilishvili T, 2010, J INFECT DIS, V201, P32, DOI 10.1086/648593; Ridda I, 2010, VACCINE, V28, P3902, DOI 10.1016/j.vaccine.2010.03.073; Trotter CL, 2010, J INFECTION, V60, P200, DOI 10.1016/j.jinf.2009.12.008; Turner P, 2011, J CLIN MICROBIOL, V49, P1784, DOI 10.1128/JCM.00157-11; van Hoek AJ, 2009, VACCINE, V27, P1454, DOI 10.1016/j.vaccine.2008.12.024; Weinbergera D.M., 2011, LANCET, V378, P1962, DOI [10.1016/S0140-6736(10)62225-8, DOI 10.1016/S0140-6736(10)62225-8]; *WHO, 2011, M STRAT ADV GROUP EX, V86, P1	26	48	48	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26190	10.1371/journal.pone.0026190	http://dx.doi.org/10.1371/journal.pone.0026190			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022559	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000295981600035
J	Tu, JG; Guo, J; Zhang, AD; Zhang, WT; Zhao, ZZ; Zhou, HB; Liu, C; Chen, HC; Jin, ML				Tu, Jiagang; Guo, Jing; Zhang, Anding; Zhang, Wenting; Zhao, Zongzheng; Zhou, Hongbo; Liu, Cheng; Chen, Huanchun; Jin, Meilin			Effects of the C-Terminal Truncation in NS1 Protein of the 2009 Pandemic H1N1 Influenza Virus on Host Gene Expression	PLOS ONE			English	Article							A-VIRUS; INFECTED-CELLS; ACTIVATION; BINDING; VIRULENCE; P85-BETA; MOTIF	The 2009 pandemic H1N1 influenza virus encodes an NS1 protein with 11 amino acids (aa) truncation at the C-terminus. The C-terminal tail of influenza virus NS1 protein constitutes a nucleolar localization signal (NoLS) and is the binding domain of the cellular pre-mRNA processing protein, poly(A)-binding protein II (PABII). Here, our studies showed that the C-terminal-truncated NS1 of the 2009 pandemic virus was inefficient at blocking host gene expression, extension of the truncated NS1 to its full length increased the inhibition of host gene expression. Mechanistically, this increased inhibition of host gene expression by the full-length NS1 was not associated with nucleolar localization, but was due to the restoration of NS1's binding capacity to PABII. Furthermore, in vitro and in vivo characterization of two recombinant viruses encoding either the C-terminal 11-aa truncated or full-length NS1 of the 2009 pandemic virus showed that the C-terminal 11-aa truncation in NS1 did not significantly alter virus replication, but increased virus pathogenicity in mice.	[Tu, Jiagang; Guo, Jing; Zhang, Anding; Zhang, Wenting; Zhao, Zongzheng; Zhou, Hongbo; Liu, Cheng; Chen, Huanchun; Jin, Meilin] Huazhong Agr Univ, Coll Vet Med, Natl Key Lab Agr Microbiol, Unit Anim Infect Dis, Wuhan, Peoples R China	Huazhong Agricultural University	Tu, JG (corresponding author), Huazhong Agr Univ, Coll Vet Med, Natl Key Lab Agr Microbiol, Unit Anim Infect Dis, Wuhan, Peoples R China.	jml8328@126.com			National Basic Research Program of China (program 973) [2011CB505004 1/4 CE2010CB534002]; National Transgenic Major Program [2009ZX08009-141B]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0726]	National Basic Research Program of China (program 973)(National Basic Research Program of China); National Transgenic Major Program; Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT))	This work was supported by National Basic Research Program of China (program 973, grant 2011CB5050041/4CE2010CB534002), the National Transgenic Major Program (2009ZX08009-141B), and Program for Changjiang Scholars and Innovative Research Team in University (IRT0726). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Dundon WG, 2009, VIRUSES-BASEL, V1, P1057, DOI 10.3390/v1031057; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2008, J BIOL CHEM, V283, P1372, DOI 10.1074/jbc.M708862200; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hale BG, 2010, J GEN VIROL, V91, P1737, DOI 10.1099/vir.0.020925-0; Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10; Hale BG, 2010, P NATL ACAD SCI USA, V107, P1954, DOI 10.1073/pnas.0910715107; Han H, 2010, J GEN VIROL, V91, P2907, DOI 10.1099/vir.0.024943-0; Heikkinen LS, 2008, J BIOL CHEM, V283, P5719, DOI 10.1074/jbc.M707195200; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jackson D, 2008, P NATL ACAD SCI USA, V105, P4381, DOI 10.1073/pnas.0800482105; Li R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-556; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Li YZ, 2001, RNA, V7, P920, DOI 10.1017/S1355838201010226; Liu HB, 2010, J VIROL, V84, P11164, DOI 10.1128/JVI.01278-10; Ludwig S, 2002, J VIROL, V76, P11166, DOI 10.1128/JVI.76.21.11166-11171.2002; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Ozawa M, 2011, J VIROL, V85, P4596, DOI 10.1128/JVI.00029-11; Peiris JSM, 2009, J CLIN VIROL, V45, P169, DOI 10.1016/j.jcv.2009.06.006; Ramos I, 2011, J VIROL, V85, P4421, DOI 10.1128/JVI.02356-10; Soubies SM, 2010, J VIROL, V84, P6733, DOI 10.1128/JVI.02427-09; Talon J, 2000, J VIROL, V74, P7989, DOI 10.1128/JVI.74.17.7989-7996.2000; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; Zhou HB, 2010, J INFECT DIS, V202, P1338, DOI 10.1086/656536; Zielecki F, 2010, J VIROL, V84, P10708, DOI 10.1128/JVI.00610-10	30	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26175	10.1371/journal.pone.0026175	http://dx.doi.org/10.1371/journal.pone.0026175			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022552	gold, Green Submitted, Green Published			2022-12-27	WOS:000295976000080
J	Gowen, BB; Ennis, J; Russell, A; Sefing, EJ; Wong, MH; Turner, J				Gowen, Brian B.; Ennis, Jane; Russell, Andrew; Sefing, Eric J.; Wong, Min-Hui; Turner, Jeffrey			Use of Recombinant Adenovirus Vectored Consensus IFN-alpha to Avert Severe Arenavirus Infection	PLOS ONE			English	Article							ARGENTINE HEMORRHAGIC-FEVER; EQUINE ENCEPHALITIS-VIRUS; I INTERFERON INDUCTION; LASSA FEVER; POSTEXPOSURE PROPHYLAXIS; RIBAVIRIN; THERAPY; INHIBITION; RESPONSES; HAMSTERS	Several arenaviruses can cause viral hemorrhagic fever, a severe disease with case-fatality rates in hospitalized individuals ranging from 15-30%. Because of limited prophylaxis and treatment options, new medical countermeasures are needed for these viruses classified by the National Institutes of Allergy and Infectious Diseases (NIAID) as top priority biodefense Category A pathogens. Recombinant consensus interferon alpha (cIFN-alpha) is a licensed protein with broad clinical appeal. However, while cIFN-alpha has great therapeutic value, its utility for biodefense applications is hindered by its short in vivo half-life, mode and frequency of administration, and costly production. To address these limitations, we describe the use of DEF201, a replication-deficient adenovirus vector that drives the expression of cIFN-alpha, for pre- and post-exposure prophylaxis of acute arenaviral infection modeled in hamsters. Intranasal administration of DEF201 24 h prior to challenge with Pichinde virus (PICV) was highly effective at protecting animals from mortality and preventing viral replication and liver-associated disease. A significant protective effect was still observed with a single dosing of DEF201 given two weeks prior to PICV challenge. DEF201 was also efficacious when administered as a treatment 24 to 48 h post-virus exposure. The protective effect of DEF201 was largely attributed to the expression of cIFN-alpha, as dosing with a control empty vector adenovirus did not protect hamsters from lethal PICV challenge. Effective countermeasures that are highly stable, easily administered, and elicit long lasting protective immunity are much needed for arena and other viral infections. The DEF201 technology has the potential to address all of these issues and may serve as a broad-spectrum antiviral to enhance host defense against a number of viral pathogens.	[Gowen, Brian B.; Russell, Andrew; Sefing, Eric J.; Wong, Min-Hui] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA; [Gowen, Brian B.; Russell, Andrew; Sefing, Eric J.; Wong, Min-Hui] Utah State Univ, Dept Anim Dairy & Vet Sci, Logan, UT 84322 USA; [Ennis, Jane; Turner, Jeffrey] Defyrus Inc, Toronto, ON, Canada	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University	Gowen, BB (corresponding author), Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA.	brian.gowen@usu.edu			National Institutes of Health [AI30063, HHSN272201000039I, AI065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030063, U54AI065357] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by funding from the National Institutes of Health (AI30063, HHSN272201000039I, and AI065357). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbink P, 2007, J VIROL, V81, P4654, DOI 10.1128/JVI.02696-06; Baize S, 2009, J VIROL, V83, P5890, DOI 10.1128/JVI.01948-08; BARRY M, 1995, NEW ENGL J MED, V333, P294, DOI 10.1056/NEJM199508033330505; Bausch DG, 2010, CLIN INFECT DIS, V51, P1435, DOI 10.1086/657315; Bell SJ, 2008, BIOCONJUGATE CHEM, V19, P299, DOI 10.1021/bc070131q; Brassard DL, 2002, J LEUKOCYTE BIOL, V71, P565; Buchmeier MJ, 2001, FIELDS VIROLOGY, P1635; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; de Manzione N, 1998, CLIN INFECT DIS, V26, P308, DOI 10.1086/516299; Enria DA, 2008, ANTIVIR RES, V78, P132, DOI 10.1016/j.antiviral.2007.10.010; Fan L, 2010, J VIROL, V84, P1785, DOI 10.1128/JVI.01362-09; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Gowen BB, 2005, ANTIMICROB AGENTS CH, V49, P2378, DOI 10.1128/AAC.49.6.2378-2386.2005; Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002; Gowen Brian B., 2006, Antiviral Chemistry & Chemotherapy, V17, P175; Gowen BB, 2007, ANTIMICROB AGENTS CH, V51, P3168, DOI 10.1128/AAC.00356-07; Hadi CM, 2010, EMERG INFECT DIS, V16, P2009, DOI 10.3201/eid1612.100994; Julander JG, 2011, ANTIMICROB AGENTS CH, V55, P2067, DOI 10.1128/AAC.01635-10; Khan SH, 2008, ANTIVIR RES, V78, P103, DOI 10.1016/j.antiviral.2007.11.003; Kilgore PE, 1997, CLIN INFECT DIS, V24, P718, DOI 10.1093/clind/24.4.718; Kumaki Y, 2011, ANTIVIR RES, V89, P75, DOI 10.1016/j.antiviral.2010.11.007; MAIZTEGUI JI, 1979, LANCET, V2, P1216; Marq JB, 2011, J BIOL CHEM, V286, P6108, DOI 10.1074/jbc.M110.186262; Martinez-Sobrido L, 2007, J VIROL, V81, P12696, DOI 10.1128/JVI.00882-07; Martinez-Sobrido L, 2006, J VIROL, V80, P9192, DOI 10.1128/JVI.00555-06; MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104; *NIAID, 2002, COUNT BIOT RES AG NA; O'Brien L, 2009, J GEN VIROL, V90, P874, DOI 10.1099/vir.0.006833-0; Pannetier D, 2004, J VIROL, V78, P10516, DOI 10.1128/JVI.78.19.10516-10524.2004; Paweska JT, 2009, EMERG INFECT DIS, V15, P1598, DOI 10.3201/eid1510.090211; REED L. J., 1938, AMER JOUR HYG, V27, P493; Shayakhmetov DM, 2010, MOL THER, V18, P1422, DOI 10.1038/mt.2010.124; Wu JQH, 2007, VIROLOGY, V369, P206, DOI 10.1016/j.virol.2007.07.024	33	12	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26072	10.1371/journal.pone.0026072	http://dx.doi.org/10.1371/journal.pone.0026072			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039436	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200006
J	Stavrum, R; Stavrum, AK; Valvatne, H; Riley, LW; Ulvestad, E; Jonassen, I; Assmus, J; Doherty, TM; Grewal, HMS				Stavrum, Ruth; Stavrum, Anne-Kristin; Valvatne, Havard; Riley, Lee W.; Ulvestad, Elling; Jonassen, Inge; Assmus, Joerg; Doherty, T. Mark; Grewal, Harleen M. S.			Modulation of Transcriptional and Inflammatory Responses in Murine Macrophages by the Mycobacterium tuberculosis Mammalian Cell Entry (Mce) 1 Complex	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEINS; GENE-EXPRESSION; DENDRITIC CELLS; MICROARRAY DATA; ACTIVATION; SYSTEM; INDUCTION; INFECTION; VIRULENCE; BACTERIAL	The outcome of many infections depends on the initial interactions between agent and host. Aiming at elucidating the effect of the M. tuberculosis Mce1 protein complex on host transcriptional and immunological responses to infection with M. tuberculosis, RNA from murine macrophages at 15, 30, 60 min, 4 and 10 hrs post-infection with M. tuberculosis H37Rv or Delta-mce1 H37Rv was analyzed by whole-genome microarrays and RT-QPCR. Immunological responses were measured using a 23-plex cytokine assay. Compared to uninfected controls, 524 versus 64 genes were up-regulated by 15 min post H37Rv- and Delta-mce1 H37Rv-infection, respectively. By 15 min post-H37Rv infection, a decline of 17 cytokines combined with up-regulation of Ccl24 (26.5-fold), Clec4a2 (23.2-fold) and Pparc (10.5-fold) indicated an anti-inflammatory response initiated by IL-13. Down-regulation of Il13ra1 combined with up-regulation of Il12b (30.2-fold), suggested switch to a pro-inflammatory response by 4 hrs post H37Rv-infection. Whereas no significant change in cytokine concentration or transcription was observed during the first hour post Delta-mce1 H37Rv-infection, a significant decline of IL-1b, IL-9, IL-13, Eotaxin and GM-CSF combined with increased transcription of Il12b (25.1-fold) and Inb1 (17.9-fold) by 4 hrs, indicated a pro-inflammatory response. The balance between pro-and anti-inflammatory responses during the early stages of infection may have significant bearing on outcome.	[Stavrum, Ruth; Valvatne, Havard; Ulvestad, Elling; Grewal, Harleen M. S.] Univ Bergen, Gade Inst, Microbiol & Immunol Sect, Bergen, Norway; [Stavrum, Anne-Kristin] Haukeland Hosp, Ctr Med Genet & Mol Med, N-5021 Bergen, Norway; [Stavrum, Anne-Kristin; Jonassen, Inge] Univ Bergen, Dept Informat, N-5008 Bergen, Norway; [Riley, Lee W.] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA; [Ulvestad, Elling; Grewal, Harleen M. S.] Haukeland Hosp, Dept Microbiol, N-5021 Bergen, Norway; [Jonassen, Inge] Uni Res AS, Uni Comp, Computat Biol Unit, Bergen, Norway; [Assmus, Joerg] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway; [Doherty, T. Mark] Statens Serum Inst, DK-2300 Copenhagen, Denmark	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of California System; University of California Berkeley; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital; Statens Serum Institut	Stavrum, R (corresponding author), Univ Bergen, Gade Inst, Microbiol & Immunol Sect, Bergen, Norway.	Ruth.Stavrum@Gades.uib.no	Grewal, Harleen/ABC-5831-2020; Jonassen, Inge/AAC-7035-2020	Jonassen, Inge/0000-0003-4110-0748	Western Regional Health Authority; Norwegian Research Council; University of Bergen	Western Regional Health Authority; Norwegian Research Council(Research Council of NorwayEuropean Commission); University of Bergen	This study was funded by the Western Regional Health Authority, the Norwegian Research Council and the University of Bergen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARRUDA S, 1993, SCIENCE, V261, P1454, DOI 10.1126/science.8367727; Beltan E, 2000, MICROB PATHOGENESIS, V28, P313, DOI 10.1006/mpat.1999.0345; Bo TH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh026; Bouchonnet F, 2002, INFECT IMMUN, V70, P3020, DOI 10.1128/IAI.70.6.3020-3025.2002; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Cantrell SA, 2005, STRUCTURAL FUNCTIONA; Casali N, 2006, J BACTERIOL, V188, P441, DOI 10.1128/JB.188.2.441-449.2006; Casali N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-60; Deretic V, 2005, TRENDS IMMUNOL, V26, P523, DOI 10.1016/j.it.2005.08.003; DiRusso CC, 2004, J BIOL CHEM, V279, P49563, DOI 10.1074/jbc.R400026200; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; Dunphy KY, 2010, J INFECT DIS, V201, P1232, DOI 10.1086/651452; Dysvik B, 2001, BIOINFORMATICS, V17, P369, DOI 10.1093/bioinformatics/17.4.369; Falcone V, 1994, FEMS IMMUNOLOGY MED, V8, P7; Fellenberg K, 2001, P NATL ACAD SCI USA, V98, P10781, DOI 10.1073/pnas.181597298; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001; Freeman S, 2006, J INTERF CYTOK RES, V26, P27, DOI 10.1089/jir.2006.26.27; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Garcia-Perez BE, 2003, MICROB PATHOGENESIS, V35, P49, DOI 10.1016/S0882-4010(03)00089-5; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Howard AD, 1999, CLIN EXP IMMUNOL, V115, P428; Joshi SM, 2006, P NATL ACAD SCI USA, V103, P11760, DOI 10.1073/pnas.0603179103; Korf JE, 2006, AM J RESP CRIT CARE, V174, P152, DOI 10.1164/rccm.200507-1175OC; Mah N, 2010, MICROBIOL-SGM, V156, P2506, DOI 10.1099/mic.0.040089-0; Malik AN, 2005, LANCET INFECT DIS, V5, P174, DOI 10.1016/S1473-3099(05)01310-1; Manca C, 2004, INFECT IMMUN, V72, P5511, DOI 10.1128/IAI.72.9.5511-5514.2004; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Meyer-Wentrup F, 2008, BLOOD, V111, P4245, DOI 10.1182/blood-2007-03-081398; Meyer-Wentrup F, 2009, J LEUKOCYTE BIOL, V85, P518, DOI 10.1189/jlb.0608352; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Pajon R, 2006, TUBERCULOSIS, V86, P290, DOI 10.1016/j.tube.2006.01.005; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; SCHWAB JH, 1975, BACTERIOL REV, V39, P121, DOI 10.1128/MMBR.39.2.121-143.1975; Shimono N, 2003, P NATL ACAD SCI USA, V100, P15918, DOI 10.1073/pnas.2433882100; Simmons DP, 2010, J IMMUNOL, V185, P2405, DOI 10.4049/jimmunol.0904005; Song H, 2008, TUBERCULOSIS, V88, P526, DOI 10.1016/j.tube.2008.02.004; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Wassie L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001522; Wright K, 1997, J BIOL CHEM, V272, P12626, DOI 10.1074/jbc.272.19.12626; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; Zahrt TC, 2001, P NATL ACAD SCI USA, V98, P12706, DOI 10.1073/pnas.221272198	48	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26295	10.1371/journal.pone.0026295	http://dx.doi.org/10.1371/journal.pone.0026295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039457	Green Published, gold			2022-12-27	WOS:000296515200010
J	Maan, S; Maan, NS; Nomikou, K; Veronesi, E; Bachanek-Bankowska, K; Belaganahalli, MN; Attoui, H; Mertens, PPC				Maan, Sushila; Maan, Narender S.; Nomikou, Kyriaki; Veronesi, Eva; Bachanek-Bankowska, Katarzyna; Belaganahalli, Manjunatha N.; Attoui, Houssam; Mertens, Peter P. C.			Complete Genome Characterisation of a Novel 26th Bluetongue Virus Serotype from Kuwait	PLOS ONE			English	Article							COMPLETE NUCLEOTIDE-SEQUENCE; AFRICAN HORSE SICKNESS; RT-PCR ASSAY; PHYLOGENETIC ANALYSIS; PURIFYING SELECTION; POSITIVE SELECTION; MULTIPLE ALIGNMENT; FAMILY REOVIRIDAE; ANALYSIS TOOLS; ORBIVIRUS	Bluetongue virus is the "type'' species of the genus Orbivirus, family Reoviridae. Twenty four distinct bluetongue virus (BTV) serotypes have been recognized for decades, any of which is thought to be capable of causing "bluetongue'' (BT), an insect-borne disease of ruminants. However, two further BTV serotypes, BTV-25 (Toggenburg orbivirus, from Switzerland) and BTV-26 (from Kuwait) have recently been identified in goats and sheep, respectively. The BTV genome is composed of ten segments of linear dsRNA, encoding 7 virus-structural proteins (VP1 to VP7) and four distinct non-structural (NS) proteins (NS1 to NS4). We report the entire BTV-26 genome sequence (isolate KUW2010/02) and comparisons to other orbiviruses. Highest identity levels were consistently detected with other BTV strains, identifying KUW2010/02 as BTV. The outer-core protein and major BTV serogroup-specific antigen "VP7'' showed 98% aa sequence identity with BTV-25, indicating a common ancestry. However, higher level of variation in the nucleotide sequence of Seg-7 (81.2% identity) suggests strong conservation pressures on the protein of these two strains, and that they diverged a long time ago. Comparisons of Seg-2, encoding major outer-capsid component and cell-attachment protein "VP2'' identified KUW2010/02 as 26th BTV, within a 12th Seg-2 nucleotype [nucleotype L]. Comparisons of Seg-6, encoding the smaller outer capsid protein VP5, also showed levels of nt/aa variation consistent with identification of KUW2010/02 as BTV-26 (within a 9th Seg-6 nucleotype - nucleotype I). Sequence data for Seg-2 of KUW2010/02 were used to design four sets of oligonucleotide primers for use in BTV-26, type-specific RT-PCR assays. Analyses of other more conserved genome segments placed KUW2010/02 and BTV-25/SWI2008/01 closer to each other than to other "eastern'' or "western'' BTV strains, but as representatives of two novel and distinct geographic groups (topotypes). Our analyses indicate that all of the BTV genome segments have evolved under strong purifying selection.	[Maan, Sushila; Maan, Narender S.; Nomikou, Kyriaki; Veronesi, Eva; Bachanek-Bankowska, Katarzyna; Belaganahalli, Manjunatha N.; Attoui, Houssam; Mertens, Peter P. C.] Inst Anim Hlth, Vector Borne Dis Programme, Woking, Surrey, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Maan, S (corresponding author), Inst Anim Hlth, Vector Borne Dis Programme, Woking, Surrey, England.	peter.mertens@iah.ac.uk	Belaganahalli, Manjunatha N/I-1688-2019; Nomikou, Kyriaki/P-1840-2018; Nomikou, Kyriaki/Q-5555-2016	Belaganahalli, Manjunatha N/0000-0003-3401-5799; Nomikou, Kyriaki/0000-0002-7013-1853; Nomikou, Kyriaki/0000-0002-7013-1853; Attoui, Houssam/0000-0001-9639-9981; Mertens, Peter/0000-0002-3438-3738; Veronesi, Eva/0000-0003-3411-7891	Department for Environment, Food and Rural Affairs (Defra) [SE2617]; Wellcome BTV Programme; Biotechnology and Biological Sciences Research Council (BBSRC); European Union (EU) [SANCO/940/2002]; Commonwealth Scholarship Commission; Institute for Animal Health (IAH)	Department for Environment, Food and Rural Affairs (Defra)(Department for Environment, Food & Rural Affairs (DEFRA)); Wellcome BTV Programme; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Union (EU)(CGIAREuropean Commission); Commonwealth Scholarship Commission; Institute for Animal Health (IAH)	Funding: This work was partly funded by the Department for Environment, Food and Rural Affairs (Defra)(SE2617) awarded to SM and EV; KN was involved in this study and is funded by Wellcome BTV Programme grant (http://www.wellcome.ac.uk/). NSM, PCM and HA were part of this work, funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the European Union (EU) (SANCO/940/2002) and Defra. For part of this work, MB was funded by Commonwealth Scholarship Commission (http://cscuk.dfid.gov.uk/), and KB was funded by an Institute for Animal Health (IAH) studentship (http://www.bbsrc.ac.uk/). No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER KA, 1994, AM J TROP MED HYG, V51, P568, DOI 10.4269/ajtmh.1994.51.568; Anisimova M, 2001, MOL BIOL EVOL, V18, P1585, DOI 10.1093/oxfordjournals.molbev.a003945; Anthony S, 2007, J VIROL METHODS, V141, P188, DOI 10.1016/j.jviromet.2006.12.013; Attoui H, 2000, J VIROL METHODS, V89, P147, DOI 10.1016/S0166-0934(00)00212-3; Attoui H, 2006, J GEN VIROL, V87, P1375, DOI 10.1099/vir.0.81584-0; Attoui H, 2005, J GEN VIROL, V86, P3409, DOI 10.1099/vir.0.81258-0; Attoui H, 2009, BIOL ANIM INFECT, P23, DOI 10.1016/B978-012369368-6.50007-1; Attoui H, 2009, VIROLOGY, V394, P298, DOI 10.1016/j.virol.2009.08.032; Balasuriya UBR, 2008, VET MICROBIOL, V126, P91, DOI 10.1016/j.vetmic.2007.07.006; Belhouchet M, 2010, J GEN VIROL, V91, P2985, DOI 10.1099/vir.0.024760-0; Carpi G, 2010, J MOL EVOL, V70, P583, DOI 10.1007/s00239-010-9354-y; Coffey LL, 2008, P NATL ACAD SCI USA, V105, P6970, DOI 10.1073/pnas.0712130105; Darpel KE, 2007, VET REC, V161, P253, DOI 10.1136/vr.161.8.253; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Firth AE, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-48; Gibbs A., 1995, MOL BASIS VIRUS EVOL, P76; GOULD AR, 1987, VIRUS RES, V7, P169, DOI 10.1016/0168-1702(87)90078-5; Grimes JM, 1998, NATURE, V395, P470, DOI 10.1038/26694; GUMM ID, 1982, ARCH VIROL, V72, P83, DOI 10.1007/BF01314453; Hofmann MA, 2008, EMERG INFECT DIS, V14, P1855, DOI 10.3201/eid1412.080818; HOWERTH EW, 1988, AM J VET RES, V49, P1906; Huismans H, 2004, Vet Ital, V40, P417; HUISMANS H, 1981, ONDERSTEPOORT J VET, V48, P51; HUISMANS H, 1987, J VIROL, V61, P3589, DOI 10.1128/JVI.61.11.3589-3595.1987; HUISMANS H, 1979, VIROLOGY, V92, P397, DOI 10.1016/0042-6822(79)90144-2; Jerzak G, 2005, J GEN VIROL, V86, P2175, DOI 10.1099/vir.0.81015-0; Johnson DJ, 2007, P ANN C AM ASS VET L; Katoh K, 2009, METHODS MOL BIOL, V537, P39, DOI 10.1007/978-1-59745-251-9_3; Lee F, 2011, VET MICROBIOL, V148, P140, DOI 10.1016/j.vetmic.2010.08.016; Maan S, 2007, J GEN VIROL, V88, P621, DOI 10.1099/vir.0.82456-0; Maan S, 2008, VIROLOGY, V377, P308, DOI 10.1016/j.virol.2008.04.028; Maan S, 2007, J VIROL METHODS, V143, P132, DOI 10.1016/j.jviromet.2007.02.016; Maan S, 2011, EMERG INFECT DIS, V17, P886, DOI 10.3201/eid1705.101742; Maan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010323; MacLachlan NJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010007; MACLACHLAN NJ, 1994, COMP IMMUNOL MICROB, V17, P197, DOI 10.1016/0147-9571(94)90043-4; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Mertens PPC, 2007, J GEN VIROL, V88, P2811, DOI 10.1099/vir.0.83023-0; MERTENS PPC, 1984, VIROLOGY, V135, P207, DOI 10.1016/0042-6822(84)90131-4; MERTENS PPC, 1989, VIROLOGY, V170, P561, DOI 10.1016/0042-6822(89)90447-9; Mertens PPC., 2005, VIRUS TAXONOMY, P466; Mertens PPC, 2011, RNAS PROTEINS DSRNA; Meyer G, 2009, EMERG INFECT DIS, V15, P608, DOI 10.3201/eid1504.081514; Nomikou K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006437; Orru G, 2006, J VIROL METHODS, V137, P34, DOI 10.1016/j.jviromet.2006.05.028; Planzer J, 2011, RES VET SCI; Posada D, 2002, J MOL EVOL, V54, P396, DOI 10.1007/s00239-001-0034-9; PRITCHARD LI, 1995, VIRUS RES, V35, P247, DOI 10.1016/0168-1702(94)00072-K; Purse BV, 2008, REV SCI TECH OIE, V27, P427, DOI 10.20506/rst.27.2.1801; Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090; Quan M, 2008, J GEN VIROL, V89, P1159, DOI 10.1099/vir.0.83502-0; ROY P, 1992, J GEN VIROL, V73, P3051, DOI 10.1099/0022-1317-73-12-3051; ROY P, 1989, VIRUS RES, V13, P179, DOI 10.1016/0168-1702(89)90015-4; Roy P, 2008, CELL BIOCHEM BIOPHYS, V50, P143, DOI 10.1007/s12013-008-9009-4; Ruiz-Fons F, 2008, EMERG INFECT DIS, V14, P951, DOI 10.3201/eid1406.071586; Shaw AE, 2007, J VIROL METHODS, V145, P115, DOI 10.1016/j.jviromet.2007.05.014; Suzuki Y, 1999, MOL BIOL EVOL, V16, P1315, DOI 10.1093/oxfordjournals.molbev.a026042; Tamura K, 2011, MOL BIOL EVOL; Thevasagayam JA, 1996, J VIROL METHODS, V56, P49, DOI 10.1016/0166-0934(95)01910-3; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toussaint JF, 2007, J VIROL METHODS, V140, P115, DOI 10.1016/j.jviromet.2006.11.007; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Wilson AJ, 2009, PHILOS T R SOC B, V364, P2669, DOI 10.1098/rstb.2009.0091; Woelk CH, 2002, MOL BIOL EVOL, V19, P2333, DOI 10.1093/oxfordjournals.molbev.a004059	64	131	151	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26147	10.1371/journal.pone.0026147	http://dx.doi.org/10.1371/journal.pone.0026147			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031822	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000296513200009
J	Thuesen, PA; Ebner, BC; Larson, H; Keith, P; Silcock, RM; Prince, J; Russell, DJ				Thuesen, Paul A.; Ebner, Brendan C.; Larson, Helen; Keith, Philippe; Silcock, Rebecca M.; Prince, Jason; Russell, David J.			Amphidromy Links a Newly Documented Fish Community of Continental Australian Streams, to Oceanic Islands of the West Pacific	PLOS ONE			English	Article							FRESH-WATER FISH; REPRODUCTIVE-BIOLOGY; ASSEMBLAGE STRUCTURE; GOBIIDAE; MANAGEMENT; GOBY; SICYDIINAE; STARVATION; DISPERSAL; ECOLOGY	Background: Indo-Pacific high island streams experience extreme hydrological variation, and are characterised by freshwater fish species with an amphidromous life history. Amphidromy is a likely adaptation for colonisation of island streams following stochastic events that lead to local extirpation. In the Wet Tropics of north-eastern Australia, steep coastal mountain streams share similar physical characteristics to island systems. These streams are poorly surveyed, but may provide suitable habitat for amphidromous species. However, due to their ephemeral nature, common non-diadromous freshwater species of continental Australia are unlikely to persist. Consequently, we hypothesise that coastal Wet Tropics streams are faunally more similar, to distant Pacific island communities, than to nearby faunas of large continental rivers. Methods/Principal Findings: Surveys of coastal Wet Tropics streams recorded 26 species, 10 of which are first records for Australia, with three species undescribed. This fish community is unique in an Australian context in that it contains mostly amphidromous species, including sicydiine gobies of the genera Sicyopterus, Sicyopus, Smilosicyopus and Stiphodon. Species presence/absence data of coastal Wet Tropics streams were compared to both Wet Tropics river networks and Pacific island faunas. ANOSIM indicated the fish fauna of north-eastern Australian coastal streams were more similar to distant Pacific islands (R = 0.76), than to nearby continental rivers (R = 0.98). Main Conclusions/Significance: Coastal Wet Tropics streams are faunally more similar to distant Pacific islands (79% of species shared), than to nearby continental fauna due to two factors. First, coastal Wet Tropics streams lack many non-diadromous freshwater fish which are common in nearby large rivers. Second, many amphidromous species found in coastal Wet Tropics streams and Indo-Pacific islands remain absent from large rivers of the Wet Tropics. The evolutionary and conservation significance of this newly discovered Australian fauna requires clarification in the context of the wider amphidromous fish community of the Pacific.	[Thuesen, Paul A.; Silcock, Rebecca M.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia; [Thuesen, Paul A.; Russell, David J.] Dept Employment Econ Dev & Innovat, Cairns, Qld, Australia; [Ebner, Brendan C.] Griffith Univ, Australian Rivers Inst, Nathan, Qld 4111, Australia; [Larson, Helen] Museum & Art Gallery No Terr, Darwin, NT, Australia; [Keith, Philippe] Museum Natl Hist Nat, Lab Ichtyol, F-75231 Paris, France; [Prince, Jason] The Patch, Melbourne, Vic, Australia	James Cook University; Griffith University; Northern Territory Government; Museum National d'Histoire Naturelle (MNHN)	Thuesen, PA (corresponding author), James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld, Australia.	paul.thuesen@gmail.com	Ebner, Brendan C/J-3759-2014	Ebner, Brendan C/0000-0001-8808-4998	W.V. Scott Charitable Trust	W.V. Scott Charitable Trust	This research was partially funded through a grant to B.C. Ebner via the W.V. Scott Charitable Trust. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Remaining expenses were covered by Thuesen and Ebner. As authors of this study, these funders played role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen G.R., 2002, FIELD GUIDE FRESHWAT; Allen G.R., 2008, FRESHWATER FISHES FL; Amarasinghe U.S., 2006, FAUNA SRI LANKA STAT, P113; [Anonymous], 2007, FISH ATL N AUSTR; Barbee NC, 2002, INT VER THEOR ANGEW, V28, P739; Bell K.N.I., 1999, Naga, V22, P30; Blob RW, 2007, J ZOOL, V273, P200, DOI 10.1111/j.1469-7998.2007.00315.x; Boseto David, 2007, South Pacific Journal of Natural Science, V25, P16, DOI 10.1071/SP07003; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; CHAPPELL J, 1986, NATURE, V324, P137, DOI 10.1038/324137a0; Clarke KR, 2001, PRIMER USER MANUAL T; COATES D, 1993, ENVIRON BIOL FISH, V38, P345, DOI 10.1007/BF00007528; Cook BD, 2008, MOL ECOL, V17, P1066, DOI 10.1111/j.1365-294X.2007.03637.x; Cook BD, 2009, J N AM BENTHOL SOC, V28, P709, DOI 10.1899/09-008.1; Cook BD, 2010, J BIOGEOGR, V37, P270, DOI 10.1111/j.1365-2699.2009.02215.x; Craig DA, 2003, BIOSCIENCE, V53, P1079, DOI 10.1641/0006-3568(2003)053[1079:GDORWH]2.0.CO;2; Crandall ED, 2010, HEREDITY, V104, P563, DOI 10.1038/hdy.2009.138; Ebner B, 2010, AUST J ZOOL, V58, P1; Fitzsimons JM, 2002, ENVIRON BIOL FISH, V65, P123; Harrison Ian J., 1993, Ichthyological Exploration of Freshwaters, V4, P201; Hoareau TB, 2007, MAR ECOL PROG SER, V333, P303, DOI 10.3354/meps333303; Hope Geoff, 1996, P165; Iguchi K, 1999, J FISH BIOL, V54, P705, DOI 10.1111/j.1095-8649.1999.tb02027.x; IWATA A., 1997, CIRCUMSTANCES ENDANG, P155; Jenkins AP, 2010, AQUAT CONSERV, V20, P224, DOI 10.1002/aqc.1086; Jenkins AP, 2007, FRESHWATER FISHES TE, P1; Johnson TB, 2005, J GREAT LAKES RES, V31, P78, DOI 10.1016/S0380-1330(05)70239-2; Keith P, 2008, MAR FRESHWATER RES, V59, P876, DOI 10.1071/MF08116; Keith P, 2011, MAR BIOL, V158, P311, DOI 10.1007/s00227-010-1560-z; Keith P, 2003, J FISH BIOL, V63, P831, DOI 10.1046/j.1095-8649.2003.00197.x; Kottelat M., 1996, World Bank Technical Paper; Lindstrom D. P., 1998, THESIS U MICHIGAN AN; Lord C, 2010, ECOL FRESHW FISH, V19, P26, DOI 10.1111/j.1600-0633.2009.00386.x; Lord C, 2008, ENVIRON BIOL FISH, V83, P169, DOI 10.1007/s10641-007-9311-9; MACIOLEK JA, 1980, PROG FISH CULT, V42, P57, DOI 10.1577/1548-8659(1980)42[57:EITIS]2.0.CO;2; March JG, 2003, BIOSCIENCE, V53, P1069, DOI 10.1641/0006-3568(2003)053[1069:DTISPS]2.0.CO;2; Marquet G., 2003, ATLAS POISSONS CRUST; McDowall RM, 2007, FISH FISH, V8, P1, DOI 10.1111/j.1467-2979.2007.00232.x; McDowall R. M., 1997, Micronesica, V30, P3; McDowall RM, 2010, REV FISH BIOL FISHER, V20, P87, DOI 10.1007/s11160-009-9125-2; McDowall RM, 2009, REV FISH BIOL FISHER, V19, P1, DOI 10.1007/s11160-008-9085-y; McDowall RM, 2003, J BIOGEOGR, V30, P703, DOI 10.1046/j.1365-2699.2003.00851.x; Moriyama A, 1998, ENVIRON BIOL FISH, V52, P321, DOI 10.1023/A:1007333302864; Nip Tony H.M., 2010, Journal of Threatened Taxa, V2, P1237; PARENTI L R, 1991, Australian Systematic Botany, V4, P137, DOI 10.1071/SB9910137; Pusey B., 2004, FRESHWATER FISHES N, DOI DOI 10.1071/9780643092082; Pusey BJ, 2003, MAR FRESHWATER RES, V54, P1, DOI 10.1071/MF02041; Pusey BJ, 1996, MAR FRESHWATER RES, V47, P563, DOI 10.1071/MF9960563; Rayner TS, 2008, MAR FRESHWATER RES, V59, P97, DOI 10.1071/MF07129; Reynolds James B., 1996, P221; Russell DJ, 2003, MAR FRESHWATER RES, V54, P813, DOI 10.1071/MF02046; Russell DJ, 1996, QI96008 QUEENSL DEP; Russell DJ, 1993, QI93056 QUEENSL DEP, P1; RYAN PA, 1991, NEW ZEAL J ZOOL, V18, P25, DOI 10.1080/03014223.1991.10757944; THUESEN P., 2004, ANGFA NEWS, V19, P4; Thuesen PA, 2011, MAR FRESHWATER RES, V62, P110, DOI 10.1071/MF10057; Thuesen PA, 2004, THESIS J COOK U CAIR; Unmack PJ, 2001, J BIOGEOGR, V28, P1053, DOI 10.1046/j.1365-2699.2001.00615.x; Valade P, 2001, THESIS U LA REUNION; Way CM, 1998, ENVIRON BIOL FISH, V51, P53, DOI 10.1023/A:1007305917443; Williams MAJ, 1984, ARID AUSTR, P59; Woolfe KJ, 1998, GEOLOGY, V26, P75, DOI 10.1130/0091-7613(1998)026<0075:LRNNIT>2.3.CO;2; Yamasaki N, 2006, ICHTHYOL RES, V53, P13, DOI 10.1007/s10228-005-0307-1; Yokoi Ken-ichi, 2005, Japanese Journal of Ichthyology, V52, P31	64	47	50	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26685	10.1371/journal.pone.0026685	http://dx.doi.org/10.1371/journal.pone.0026685			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039530	gold, Green Published, Green Accepted			2022-12-27	WOS:000296513200040
J	Knubel, CP; Martinez, FF; Rodriguez, EVA; Altamirano, A; Rivarola, HW; Lujan, CD; Fretes, RE; Cervi, L; Motran, CC				Knubel, Carolina P.; Martinez, Fernando F.; Acosta Rodriguez, Eva V.; Altamirano, Andres; Rivarola, Hector W.; Diaz Lujan, Cintia; Fretes, Ricardo E.; Cervi, Laura; Motran, Claudia C.			3-Hydroxy Kynurenine Treatment Controls T. cruzi Replication and the Inflammatory Pathology Preventing the Clinical Symptoms of Chronic Chagas Disease	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; ARYL-HYDROCARBON RECEPTOR; RIBOSOMAL P PROTEINS; C-TERMINAL REGION; TRYPANOSOMA-CRUZI; IMMUNE-RESPONSE; TGF-BETA; INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN CATABOLISM; PARASITE PERSISTENCE	Background: 3-Hydroxy Kynurenine (3-HK) administration during the acute phase of Trypanosoma. cruzi infection decreases the parasitemia of lethally infected mice and improves their survival. However, due to the fact that the treatment with 3-HK is unable to eradicate the parasite, together with the known proapoptotic and immunoregulatory properties of 3-HK and their downstream catabolites, it is possible that the 3-HK treatment is effective during the acute phase of the infection by controlling the parasite replication, but at the same time suppressed the protective T cell response before pathogen clearance worsening the chronic phase of the infection. Therefore, in the present study, we investigated the effect of 3-HK treatment on the development of chronic Chagas' disease. Principal Findings: In the present study, we treated mice infected with T. cruzi with 3-HK at day five post infection during 5 consecutive days and investigated the effect of this treatment on the development of chronic Chagas disease. Cardiac functional (electrocardiogram) and histopathological studies were done at 60 dpi. 3-HK treatment markedly reduced the incidence and the severity of the electrocardiogram alterations and the inflammatory infiltrates and fibrosis in heart and skeletal muscle. 3-HK treatment modulated the immune response at the acute phase of the infection impairing the Th1- and Th2-type specific response and inducing TGF-beta-secreting cells promoting the emergence of regulatory T cells and long-term specific IFN-gamma secreting cells. 3-HK in vitro induced regulatory phenotype in T cells from T. cruzi acutely infected mice. Conclusions: Our results show that the early 3-HK treatment was effective in reducing the cardiac lesions as well as altering the pattern of the immune response in experimental Chagas' disease. Thus, we propose 3-HK as a novel therapeutic treatment able to control both the parasite replication and the inflammatory response.	[Knubel, Carolina P.; Martinez, Fernando F.; Acosta Rodriguez, Eva V.; Altamirano, Andres; Cervi, Laura; Motran, Claudia C.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, RA-5000 Cordoba, Argentina; [Rivarola, Hector W.] Univ Nacl Cordoba, Fac Ciencias Med, Catedra Fis Biomed, RA-5000 Cordoba, Argentina; [Diaz Lujan, Cintia; Fretes, Ricardo E.] Univ Nacl Cordoba, Fac Med, Inst Biol Celular, RA-5000 Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; National University of Cordoba	Knubel, CP (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Ctr Invest Bioquim Clin & Inmunol CIBICI CONICET, Ciudad Univ, RA-5000 Cordoba, Argentina.	cmotran@fcq.unc.edu.ar	Oliveira, Claudia DL/G-8618-2011; Motran, Claudia/U-9106-2019	Motran, Claudia/0000-0002-8088-3901; Acosta Rodriguez, Eva/0000-0001-5871-2391	Consejo Nacional de Investigaciones Cientificas y Tecnicas from Argentina (CONICET); Agencia Nacional de Promocion Cientifica y Tecnica [PICT 25511]; Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba; Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba; CONICET (Argentina)	Consejo Nacional de Investigaciones Cientificas y Tecnicas from Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnica(ANPCyT); Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba(Secretaria de Ciencia y Tecnologia (SECYT)); CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas from Argentina (CONICET), Agencia Nacional de Promocion Cientifica y Tecnica (PICT 25511), Ministerio de Ciencia y Tecnologia de la Provincia de Cordoba and Secretaria de Ciencia y Tecnica, Universidad Nacional de Cordoba (grants to CCM). The work of CPK and FFM was supported by CONICET fellowships (Argentina). The funding bodies had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRADE S G, 1987, Memorias do Instituto Oswaldo Cruz, V82, P59, DOI 10.1590/S0074-02761987000100010; Bilate AMB, 2008, REV INST MED TROP SP, V50, P67, DOI 10.1590/S0036-46652008000200001; BURLEIGH BA, 1995, ANNU REV MICROBIOL, V49, P175, DOI 10.1146/annurev.mi.49.100195.001135; Bustamante JM, 2008, NAT MED, V14, P542, DOI 10.1038/nm1744; BYRNE GI, 1986, INFECT IMMUN, V53, P347, DOI 10.1128/IAI.53.2.347-351.1986; CamargO E. P., 1964, Revista do Instituto de Medicina Tropical de Sao Paulo, V6, P93; Cazorla SI, 2008, INFECT IMMUN, V76, P324, DOI 10.1128/IAI.01163-07; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Ecco G, 2009, GENE, V448, P1, DOI 10.1016/j.gene.2009.08.007; Elizari MV, 1999, MEDICINA-BUENOS AIRE, V59, P25; Fallarino F, 2006, J IMMUNOL, V176, P6752, DOI 10.4049/jimmunol.176.11.6752; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; GEA S, 1992, REV I MED TROP, V34, P389, DOI 10.1590/S0036-46651992000500003; Giordanengo L, 2000, MUSCLE NERVE, V23, P1407, DOI 10.1002/1097-4598(200009)23:9<1407::AID-MUS12>3.3.CO;2-V; Giordanengo L, 2000, EUR J IMMUNOL, V30, P3181, DOI 10.1002/1521-4141(200011)30:11&lt;3181::AID-IMMU3181&gt;3.0.CO;2-A; Gorelik L, 2002, J EXP MED, V195, P1499, DOI 10.1084/jem.20012076; Guerri-Guttenberg RA, 2008, EUR HEART J, V29, P2587, DOI 10.1093/eurheartj/ehn424; Guinazu N, 2004, MICROBES INFECT, V6, P1250, DOI 10.1016/j.micinf.2004.07.010; HASSANAIN HH, 1993, J BIOL CHEM, V268, P5077; HOFT DF, 1993, J IMMUNOL, V151, P7038; Hoft DF, 2000, INFECT IMMUN, V68, P197, DOI 10.1128/IAI.68.1.197-204.2000; Huss DJ, 2010, J IMMUNOL, V184, P5628, DOI 10.4049/jimmunol.1000288; Kaplan D, 1997, P NATL ACAD SCI USA, V94, P10301, DOI 10.1073/pnas.94.19.10301; KEHRL JH, 1986, J EXP MED, V163, P1037, DOI 10.1084/jem.163.5.1037; Kierszenbaum F, 2005, TRENDS PARASITOL, V21, P513, DOI 10.1016/j.pt.2005.08.013; Kotner J, 2007, INFECT IMMUN, V75, P861, DOI 10.1128/IAI.01500-06; KROWCZYNSKA AM, 1989, NUCLEIC ACIDS RES, V17, P6408, DOI 10.1093/nar/17.15.6408; LAGUENS RP, 1981, MEDICINA-BUENOS AIRE, V41, P35; LEVIN MJ, 1990, MEM I OSWALDO CRUZ, V85, P539, DOI 10.1590/S0074-02761990000400028; Mariano FS, 2008, MICROBES INFECT, V10, P825, DOI 10.1016/j.micinf.2008.04.009; Mellor A, 2005, BIOCHEM BIOPH RES CO, V338, P20, DOI 10.1016/j.bbrc.2005.08.232; Mellor AL, 2004, NAT REV IMMUNOL, V4, P762, DOI 10.1038/nri1457; Mezrich JD, 2010, J IMMUNOL, V185, P3190, DOI 10.4049/jimmunol.0903670; Millar AE, 1999, J IMMUNOL, V162, P6092; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Motran CC, 1999, CLIN IMMUNOL, V91, P17, DOI 10.1006/clim.1998.4678; Motran CC, 1998, EXP PARASITOL, V88, P223, DOI 10.1006/expr.1998.4255; Motran CC, 2000, CLIN IMMUNOL, V97, P89, DOI 10.1006/clim.2000.4919; Munn DH, 2005, IMMUNITY, V22, P633, DOI 10.1016/j.immuni.2005.03.013; Nguyen NT, 2010, P NATL ACAD SCI USA, V107, P19961, DOI 10.1073/pnas.1014465107; Knubel CP, 2010, FASEB J, V24, P2689, DOI 10.1096/fj.09-150920; PFEFFERKORN ER, 1984, P NATL ACAD SCI-BIOL, V81, P908, DOI 10.1073/pnas.81.3.908; Piron M, 2007, ACTA TROP, V103, P195, DOI 10.1016/j.actatropica.2007.05.019; Prata A, 2001, Lancet Infect Dis, V1, P92, DOI 10.1016/S1473-3099(01)00065-2; RICH BE, 1987, MOL CELL BIOL, V7, P4065, DOI 10.1128/MCB.7.11.4065; Rigato PO, 2011, INFECT IMMUN, V79, P2120, DOI 10.1128/IAI.01190-10; Roggero E, 2002, CLIN EXP IMMUNOL, V128, P421, DOI 10.1046/j.1365-2249.2002.01874.x; ROSENBAUM MB, 1964, PROG CARDIOVASC DIS, V7, P199, DOI 10.1016/S0033-0620(64)80020-7; SADIGURSKY M, 1986, BRAZ J MED BIOL RES, V19, P379; Sakaguchi S, 2007, SCIENCE, V317, P627, DOI 10.1126/science.1142331; Sales-Junior PA, 2008, MICROBES INFECT, V10, P680, DOI 10.1016/j.micinf.2008.03.008; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; SILVA JS, 1991, J EXP MED, V174, P539, DOI 10.1084/jem.174.3.539; SZAPIEL SV, 1979, AM REV RESPIR DIS, V120, P893; Tarleton RL, 2007, PLOS MED, V4, P1852, DOI 10.1371/journal.pmed.0040332; Tarleton RL, 2001, INT J PARASITOL, V31, P550, DOI 10.1016/S0020-7519(01)00158-8; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; VAZQUEZ MP, 1992, NUCLEIC ACIDS RES, V20, P2599, DOI 10.1093/nar/20.10.2599; Viotti R, 2007, EXPERT REV ANTI-INFE, V5, P717, DOI 10.1586/14787210.5.4.717; Viotti R, 2006, ANN INTERN MED, V144, P724, DOI 10.7326/0003-4819-144-10-200605160-00006; Waghabi MC, 2007, ANTIMICROB AGENTS CH, V51, P2905, DOI 10.1128/AAC.00022-07; Wehrens XHT, 2000, CARDIOVASC RES, V45, P231, DOI 10.1016/S0008-6363(99)00335-1; Zhang L, 1999, J INFECT DIS, V180, P480, DOI 10.1086/314889; Zheng SG, 2002, J IMMUNOL, V169, P4183, DOI 10.4049/jimmunol.169.8.4183; Zuniga E, 2000, CLIN EXP IMMUNOL, V119, P507, DOI 10.1046/j.1365-2249.2000.01150.x	66	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26550	10.1371/journal.pone.0026550	http://dx.doi.org/10.1371/journal.pone.0026550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028903	gold, Green Submitted, Green Published			2022-12-27	WOS:000296507500087
J	Mafham, M; Emberson, J; Landray, MJ; Wen, CP; Baigent, C				Mafham, Marion; Emberson, Jonathan; Landray, Martin J.; Wen, Chi-Pang; Baigent, Colin			Estimated Glomerular Filtration Rate and the Risk of Major Vascular Events and All-Cause Mortality: A Meta-Analysis	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR-DISEASE; SERUM CREATININE; GENERAL-POPULATION; ASSOCIATION; DYSFUNCTION; HEALTH; HYPERTENSION; INFLAMMATION; COMBINATION	Background: Lower estimated glomerular filtration rate (eGFR) has been associated with an increased risk of major vascular events (MVEs) and death, but differences in methodology make between-study comparisons difficult. We used a novel method to summarise the published results. Methods and Findings: Studies assessing the relationship between baseline eGFR and subsequent MVEs or all cause mortality were identified using Pubmed. Those which involved at least 500 individuals, planned at least 1 year of follow-up, reported age and sex adjusted relative risks, and provided the mean eGFR in each category (or sufficient information to allow its estimation) were included. To take account of differences in underlying risk between studies, proportional within-study differences in eGFR (rather than absolute eGFR values) were related to risk. Fifty studies (2 million participants) assessing MVEs and 67 studies (5 million participants) assessing all cause mortality were eligible. There was an inverse relationship between lower eGFR and the risk of MVEs and of death. In studies among people without prior vascular disease, a 30% lower eGFR level was on average associated with a 29% (SE 0.2%) increase in the risk of a MVE and a 31% (SE 0.2%) increase in the risk of death from any cause. In studies among people with prior vascular disease, these estimates were 26% (SE 1.0%) and 23% (SE 0.2%) respectively. While there was substantial statistical heterogeneity between the results of individual studies, a 30% lower eGFR was consistently associated with a 20-30% higher risk of both outcomes, irrespective of prior history of vascular disease or study design. Conclusions: Lower eGFR was consistently associated with a moderate increase in the risk of death and MVEs. If these relationships are causal and continuous, then around one fifth of vascular events among those over 70 years might be attributable to renal impairment.	[Mafham, Marion; Emberson, Jonathan; Landray, Martin J.; Baigent, Colin] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Mafham, Marion; Emberson, Jonathan; Landray, Martin J.; Baigent, Colin] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England; [Wen, Chi-Pang] Natl Hlth Res Inst, Ctr Hlth Policy Res & Dev, Zhunan, Taiwan	University of Oxford; University of Oxford; National Health Research Institutes - Taiwan	Mafham, M (corresponding author), Univ Oxford, Clin Trial Serv Unit, Oxford, England.	colin.baigent@ctsu.ox.ac.uk		Emberson, Jonathan/0000-0001-7792-9422; Landray, Martin/0000-0001-6646-827X	British Heart Foundation Centre of Research Excellence, Oxford [RE/08/04]; MRC [MC_U137686857] Funding Source: UKRI; Medical Research Council [MC_U137686857] Funding Source: researchfish	British Heart Foundation Centre of Research Excellence, Oxford; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JE acknowledges support from the British Heart Foundation Centre of Research Excellence, Oxford (RE/08/04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Coresh J, 2002, AM J KIDNEY DIS, V39, P920, DOI 10.1053/ajkd.2002.32765; Coresh J, 2005, J AM SOC NEPHROL, V16, P180, DOI 10.1681/ASN.2004070539; Deo R, 2008, AM HEART J, V155, P62, DOI 10.1016/j.ahj.2007.08.012; Di Angelantonio E, 2007, PLOS MED, V4, P1497, DOI 10.1371/journal.pmed.0040270; DUFFY SW, 1989, STAT MED, V8, P1529, DOI 10.1002/sim.4780081213; Foley RN, 1998, AM J KIDNEY DIS, V32, pS112, DOI 10.1053/ajkd.1998.v32.pm9820470; Fried LF, 2005, J AM SOC NEPHROL, V16, P3728, DOI 10.1681/ASN.2005040384; Garg AX, 2008, TRANSPLANTATION, V86, P399, DOI 10.1097/TP.0b013e31817ba9e3; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Irie F, 2006, KIDNEY INT, V69, P1264, DOI 10.1038/sj.ki.5000284; Knight EL, 2004, J AM SOC NEPHROL, V15, P1897, DOI 10.1097/01.asn.0000128966.55133.69; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; Mielniczuk LM, 2008, AM HEART J, V155, P725, DOI 10.1016/j.ahj.2007.11.031; Muntner P, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133745; Nickolas TL, 2008, STROKE, V39, P2876, DOI 10.1161/STROKEAHA.107.513713; Ninomiya T, 2005, KIDNEY INT, V68, P228, DOI 10.1111/j.1523-1755.2005.00397.x; O'Hare AM, 2006, J AM SOC NEPHROL, V17, P846, DOI 10.1681/ASN.2005090986; Plummer M, 2004, STAT MED, V23, P93, DOI 10.1002/sim.1485; Rahman M, 2006, ANN INTERN MED, V144, P172, DOI 10.7326/0003-4819-144-3-200602070-00005; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Tonelli M, 2004, CIRCULATION, V110, P1557, DOI 10.1161/01.CIR.0000143892.84582.60; *US REN DAT SYST, 2008, USRDS 2008 ANN DAT R, V2; Vanholder R, 2005, NEPHROL DIAL TRANSPL, V20, P1048, DOI 10.1093/ndt/gfh813; Wannamethee SG, 2006, EUR HEART J, V27, P2975, DOI 10.1093/eurheartj/ehl402; Weiner DE, 2004, AM J KIDNEY DIS, V44, P198, DOI 10.1053/j.ajkd.2004.04.024; Weiner DE, 2004, J AM SOC NEPHROL, V15, P1307, DOI 10.1097/01.ASN.0000123691.46138.E2; Wen CP, 2008, LANCET, V371, P2173, DOI 10.1016/S0140-6736(08)60952-6; Wright RS, 2002, ANN INTERN MED, V137, P563, DOI 10.7326/0003-4819-137-7-200210010-00007	34	59	60	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25920	10.1371/journal.pone.0025920	http://dx.doi.org/10.1371/journal.pone.0025920			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039429	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500025
J	Norris, SL; Holmer, HK; Ogden, LA; Burda, BU				Norris, Susan L.; Holmer, Haley K.; Ogden, Lauren A.; Burda, Brittany U.			Conflict of Interest in Clinical Practice Guideline Development: A Systematic Review	PLOS ONE			English	Review							PHARMACEUTICAL-INDUSTRY; RANDOMIZED-TRIAL; FINANCIAL TIES; PHYSICIANS; DISCLOSURE; MANAGEMENT; COMPANIES; QUALITY; AUTHORS; DEBATE	Background: There is an emerging literature on the existence and effect of industry relationships on physician and researcher behavior. Much less is known, however, about the effects of these relationships and other conflicts of interest (COI) on clinical practice guideline (CPG) development and recommendations. We performed a systematic review of the prevalence of COI and its effect on CPG recommendations. Methodology/Principal Findings: We searched Medline (1980 to March, 2011) for studies that examined the effect of COI on CPG development and/or recommendations. Data synthesis was qualitative. Twelve studies fulfilled inclusion criteria; 9 were conducted in the US. All studies reported on financial relationships of CPG authors with the pharmaceutical industry; 1 study also examined relationships with diagnostic testing and insurance companies. The majority of guidelines had authors with industry affiliations, including consultancies (authors with relationship, range 6-80%); research support (4-78%); equity/stock ownership (2-17%); or any COI (56-87%). Four studies reported multiple types of financial interactions for individual authors (number of types per author: range 2 to 10 or more). Data on the effect of COI on CPG recommendations were confined to case studies wherein authors with specific financial ties appeared to benefit from the related CPG recommendations. In a single study, few authors believed that their relationships influenced their recommendations. No studies reported on intellectual COI in CPGs. Conclusions/Significance: There are limited data describing the high prevalence of COI among CPG authors, and only case studies of the effect of COI on CPG recommendations. Further research is needed to explore this potential source of bias.	[Norris, Susan L.; Holmer, Haley K.; Ogden, Lauren A.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Burda, Brittany U.] Kaiser Permanente Ctr Hlth Res, Portland, OR USA	Oregon Health & Science University; Kaiser Permanente	Norris, SL (corresponding author), Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA.	norriss@ohsu.edu		Holmer, Haley/0000-0003-4198-8708	Agency for Healthcare Research and Quality [1R01HS018500-01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS018500] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Funded by the Agency for Healthcare Research and Quality, Grant Number: 1R01HS018500-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert JS, 2004, J AM COLL CARDIOL, V44, P1724, DOI 10.1016/j.jacc.2004.08.038; Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; [Anonymous], 2017, NATION; Association of American Medical Colleges, 2010, INT PAT REC PHYS FIN; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Buchan HA, 2010, MED J AUSTRALIA, V192, P490, DOI 10.5694/j.1326-5377.2010.tb03604.x; Campbell EG, 2010, NEW ENGLAND J M 0714, P1; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; Campbell EG, 2010, ARCH INTERN MED, V170, P667, DOI 10.1001/archinternmed.2010.27; Chaudhry S, 2002, BRIT MED J, V325, P1391, DOI 10.1136/bmj.325.7377.1391; Choudhry NK, 2002, JAMA-J AM MED ASSOC, V287, P612, DOI 10.1001/jama.287.5.612; CHREN MM, 1994, JAMA-J AM MED ASSOC, V271, P684, DOI 10.1001/jama.271.9.684; Cosgrove L, 2006, PSYCHOTHER PSYCHOSOM, V75, P154, DOI 10.1159/000091772; Cosgrove L, 2009, NEW ENGL J MED, V360, P2035, DOI 10.1056/NEJMc0810237; Cosgrove L, 2009, PSYCHOTHER PSYCHOSOM, V78, P228, DOI 10.1159/000214444; Coyne DW, 2007, CLIN J AM SOC NEPHRO, V2, P3, DOI 10.2215/CJN.02170606; Davis DA, 1997, CAN MED ASSOC J, V157, P408; Deeks J, 2003, EVALUATING NONRANDOM, V7; Drazen JM, 2009, LANCET, V374, P1395, DOI 10.1016/S0140-6736(09)61796-7; Field MJ, 2009, CONFLICT INTEREST ME, P414; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; GUYATT G, 1992, JAMA-J AM MED ASSOC, V268, P2420, DOI 10.1001/jama.1992.03490170092032; Guyatt G, 2010, ANN INTERN MED, V152, P738, DOI 10.7326/0003-4819-152-11-201006010-00254; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Hietanen P, 2009, ANN ONCOL, V20, P1749, DOI 10.1093/annonc/mdp399; Holloway RG, 2008, NEUROLOGY, V71, P57, DOI 10.1212/01.wnl.0000316319.19159.c3; Insel TR, 2010, JAMA-J AM MED ASSOC, V303, P1192, DOI 10.1001/jama.2010.317; Institute of Medicine, 2010, STAND DEV TRUSTW CLI; International Committee of Medical Journal Editors, 2010, UN DISCL FORM POT CO; Johnson L, 2009, J MED ETHICS, V35, P283, DOI 10.1136/jme.2008.026526; Krimsky S, 1998, JAMA-J AM MED ASSOC, V280, P225, DOI 10.1001/jama.280.3.225; Kuehn BM, 2010, JAMA-J AM MED ASSOC, V303, P2237, DOI 10.1001/jama.2010.724; Laupacis A, 2006, CAN MED ASSOC J, V174, P335, DOI 10.1503/cmaj.051622; Lederer ED, 2007, CLIN J AM SOC NEPHRO, V2, P207, DOI 10.2215/CJN.04471206; Levinsky NG, 2002, NEW ENGL J MED, V347, P759, DOI 10.1056/NEJMsb020853; Lexchin J, 2003, BMJ-BRIT MED J, V326, P1167, DOI 10.1136/bmj.326.7400.1167; Licurse A, 2010, ARCH INTERN MED, V170, P675, DOI 10.1001/archinternmed.2010.39; Lo B, 2009, COMMITTEE CONFLICT I, p1 ; Lugtenberg M, 2009, QUAL SAF HEALTH CARE, V18, P385, DOI 10.1136/qshc.2008.028043; Okike K, 2009, NEW ENGL J MED, V361, P1466, DOI 10.1056/NEJMsa0807160; Papanikolaou G N, 2001, BMC Med Res Methodol, V1, P3, DOI 10.1186/1471-2288-1-3; Schroter S, 2004, BRIT MED J, V328, P742, DOI 10.1136/bmj.38035.705185.F6; Silverman GK, 2010, J MED ETHICS, V36, P265, DOI 10.1136/jme.2009.034496; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Taylor R, 2005, NATURE, V437, P1070, DOI 10.1038/4371070a; THOMPSON DF, 1993, NEW ENGL J MED, V329, P573, DOI 10.1056/NEJM199308193290812; Tricoci P, 2009, JAMA-J AM MED ASSOC, V301, P831, DOI 10.1001/jama.2009.205; van der Sanden WJM, 2005, EUR J ORAL SCI, V113, P349, DOI 10.1111/j.1600-0722.2005.00232.x; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527	49	148	157	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25153	10.1371/journal.pone.0025153	http://dx.doi.org/10.1371/journal.pone.0025153			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	841JB	22039406	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500007
J	Poritz, MA; Blaschke, AJ; Byington, CL; Meyers, L; Nilsson, K; Jones, DE; Thatcher, SA; Robbins, T; Lingenfelter, B; Amiott, E; Herbener, A; Daly, J; Dobrowolski, SF; David, HFT; Ririe, KM				Poritz, Mark A.; Blaschke, Anne J.; Byington, Carrie L.; Meyers, Lindsay; Nilsson, Kody; Jones, David E.; Thatcher, Stephanie A.; Robbins, Thomas; Lingenfelter, Beth; Amiott, Elizabeth; Herbener, Amy; Daly, Judy; Dobrowolski, Steven F.; David, H. -F. Teng; Ririe, Kirk M.			FilmArray, an Automated Nested Multiplex PCR System for Multi-Pathogen Detection: Development and Application to Respiratory Tract Infection	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; ANTIBIOTIC-RESISTANCE GENES; ACID AMPLIFICATION TESTS; CLINICAL MICROBIOLOGY; CHLAMYDOPHILA-PNEUMONIAE; MYCOPLASMA-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; BORDETELLA-PERTUSSIS; MOLECULAR DIAGNOSIS	The ideal clinical diagnostic system should deliver rapid, sensitive, specific and reproducible results while minimizing the requirements for specialized laboratory facilities and skilled technicians. We describe an integrated diagnostic platform, the "FilmArray'', which fully automates the detection and identification of multiple organisms from a single sample in about one hour. An unprocessed biologic/clinical sample is subjected to nucleic acid purification, reverse transcription, a high-order nested multiplex polymerase chain reaction and amplicon melt curve analysis. Biochemical reactions are enclosed in a disposable pouch, minimizing the PCR contamination risk. FilmArray has the potential to detect greater than 100 different nucleic acid targets at one time. These features make the system well-suited for molecular detection of infectious agents. Validation of the FilmArray technology was achieved through development of a panel of assays capable of identifying 21 common viral and bacterial respiratory pathogens. Initial testing of the system using both cultured organisms and clinical nasal aspirates obtained from children demonstrated an analytical and clinical sensitivity and specificity comparable to existing diagnostic platforms. We demonstrate that automated identification of pathogens from their corresponding target amplicon(s) can be accomplished by analysis of the DNA melting curve of the amplicon.	[Poritz, Mark A.; Meyers, Lindsay; Nilsson, Kody; Jones, David E.; Thatcher, Stephanie A.; Robbins, Thomas; Lingenfelter, Beth; Amiott, Elizabeth; Dobrowolski, Steven F.; David, H. -F. Teng; Ririe, Kirk M.] Idaho Technol Inc, Salt Lake City, UT USA; [Blaschke, Anne J.; Byington, Carrie L.; Herbener, Amy] Univ Utah, Sch Med, Dept Pediat, Salt Lake City, UT USA; [Daly, Judy] Univ Utah, Primary Childrens Med Ctr, Salt Lake City, UT USA; [Daly, Judy] Univ Utah, Dept Pathol, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Poritz, MA (corresponding author), Idaho Technol Inc, Salt Lake City, UT USA.	mark_poritz@idahotech.com	Poritz, Mark/AAH-4426-2021; Blaschke, Anne/GOJ-7946-2022	Poritz, Mark/0000-0002-5060-0560; Byington, Carrie/0000-0002-7350-9495	National Institutes of Health: National Institute of Allergy and Infectious Diseases [1R43 AI063695-01, U01 AI061611, U01 AI074419, 1K23-AI079401-01A1]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K24HD047249]; Edna Benning Society; United States Air Force Surgeon General; Idaho Technology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K24HD047249] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074419, R43AI063695, U01AI061611, K23AI079401] Funding Source: NIH RePORTER	National Institutes of Health: National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Edna Benning Society; United States Air Force Surgeon General; Idaho Technology; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health: National Institute of Allergy and Infectious Diseases: 1R43 AI063695-01 (SFD), U01 AI061611 (MAP, AJB, CLB), U01 AI074419 (SFD and CLB), 1K23-AI079401-01A1 (AJB) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development: K24HD047249 (CLB); the H. A. and Edna Benning Society (CLB); the United States Air Force Surgeon General; and by funds from Idaho Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archimbaud C, 2009, J MED VIROL, V81, P42, DOI 10.1002/jmv.21330; Auroux PA, 2004, LAB CHIP, V4, P534, DOI 10.1039/b408850f; BALDINO F, 1989, METHOD ENZYMOL, V168, P761; Barenfanger J, 2000, J CLIN MICROBIOL, V38, P2824, DOI 10.1128/JCM.38.8.2824-2828.2000; Belak S, 2001, Expert Rev Mol Diagn, V1, P434; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Byington CL, 2002, ARCH PEDIAT ADOL MED, V156, P1230, DOI 10.1001/archpedi.156.12.1230; Byington CL, 2002, PEDIATR INFECT DIS J, V21, P996, DOI 10.1097/00006454-200211000-00004; Charles PGP, 2008, CURR OPIN PULM MED, V14, P176, DOI 10.1097/MCP.0b013e3282f7642f; Chen L, 2007, LAB CHIP, V7, P1413, DOI 10.1039/b708362a; Chia JH, 2005, J CLIN MICROBIOL, V43, P4486, DOI 10.1128/JCM.43.9.4486-4491.2005; Choi SM, 2003, J KOREAN MED SCI, V18, P631, DOI 10.3346/jkms.2003.18.5.631; Cockerill FR, 2003, ARCH PATHOL LAB MED, V127, P1112; Colom K, 2003, FEMS MICROBIOL LETT, V223, P147, DOI 10.1016/S0378-1097(03)00306-9; DEAR P, 2004, PCR TECHNOLOGY CURRE, P245; Dundas NE, 2011, J MOL DIAGN, V13, P175, DOI 10.1016/j.jmoldx.2010.09.003; Ecker DJ, 2005, P NATL ACAD SCI USA, V102, P8012, DOI 10.1073/pnas.0409920102; Endimiani A, 2011, CLIN INFECT DIS, V52, pS373, DOI 10.1093/cid/cir054; Espy MJ, 2006, CLIN MICROBIOL REV, V19, P165, DOI 10.1128/CMR.19.1.165-256.2006; Falsey AR, 2007, ARCH INTERN MED, V167, P354, DOI 10.1001/archinte.167.4.ioi60207; Forbes BA, 2003, ARCH PATHOL LAB MED, V127, P1106; Fox JD, 2007, J CLIN VIROL, V40, pS15, DOI 10.1016/S1386-6532(07)70005-7; Fox JD, 2007, J CLIN VIROL, V40, pS24, DOI 10.1016/S1386-6532(07)70006-9; Ginevra C, 2005, J CLIN MICROBIOL, V43, P3247, DOI 10.1128/JCM.43.7.3247-3254.2005; Hatchette TF, 2009, CAN J PUBLIC HEALTH, V100, P204, DOI 10.1007/BF03405541; Henrickson KJ, 2004, PEDIATR INFECT DIS J, V23, pS6, DOI 10.1097/01.inf.0000108187.63151.ea; Kang JH, 2008, LAB CHIP, V8, P176, DOI 10.1039/b712672g; Kehl SC, 2001, J CLIN MICROBIOL, V39, P1696, DOI 10.1128/JCM.39.5.1696-1701.2001; Khanna M, 2005, J CLIN MICROBIOL, V43, P565, DOI 10.1128/JCM.43.2.565-571.2005; Kim SR, 2009, J VIROL METHODS, V156, P111, DOI 10.1016/j.jviromet.2008.11.007; Kodani M, 2011, J CLIN MICROBIOL, V49, P2175, DOI 10.1128/JCM.02270-10; KORGENSKI EK, 2007, EPIDEMIOLOGY CLIN FI; Kosters K, 2002, J CLIN MICROBIOL, V40, P1719, DOI 10.1128/JCM.40.5.1719-1722.2002; Lam WY, 2007, J CLIN MICROBIOL, V45, P3631, DOI 10.1128/JCM.00280-07; LASSAUNIERE R, 2010, J VIROL METHODS; Lee WM, 2007, J CLIN MICROBIOL, V45, P2626, DOI 10.1128/JCM.02501-06; Lessa FC, 2009, J INFECT DIS, V200, P1759, DOI 10.1086/647987; Li H, 2007, J CLIN MICROBIOL, V45, P2105, DOI 10.1128/JCM.00210-07; Lieberman D, 2002, DIAGN MICR INFEC DIS, V42, P21, DOI 10.1016/S0732-8893(01)00324-8; Lopez MM, 2003, INT MICROBIOL, V6, P233, DOI 10.1007/s10123-003-0143-y; Mackay IM, 2004, CLIN MICROBIOL INFEC, V10, P190, DOI 10.1111/j.1198-743X.2004.00722.x; Mahony J, 2007, J CLIN MICROBIOL, V45, P2965, DOI 10.1128/JCM.02436-06; Mahony JB, 2008, CLIN MICROBIOL REV, V21, P716, DOI 10.1128/CMR.00037-07; MAHONY JB, 2009, J CLIN MICROBIOL; Marshall DJ, 2007, J CLIN MICROBIOL, V45, P3875, DOI 10.1128/JCM.00838-07; Martineau F, 2000, J ANTIMICROB CHEMOTH, V46, P527, DOI 10.1093/jac/46.4.527; MCCABE KM, 1995, PEDIATRICS, V95, P165; Meury S, 2004, EUR J PEDIATR, V163, P359, DOI 10.1007/s00431-004-1445-6; Mothershed EA, 2006, CLIN CHIM ACTA, V363, P206, DOI 10.1016/j.cccn.2005.05.050; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAKAMURA S, 1993, VIRUS GENES, V7, P325, DOI 10.1007/BF01703389; Narayanan S, 1996, ADV CLIN CHEM, V32, P1, DOI 10.1016/S0065-2423(08)60424-2; Nolte FS, 2008, CLIN INFECT DIS, V47, pS123, DOI 10.1086/591392; Nolte FS, 2007, J CLIN MICROBIOL, V45, P2779, DOI 10.1128/JCM.00669-07; Nolte FS, 2011, J CLIN MICROBIOL, V49, P528, DOI 10.1128/JCM.01570-10; O'Shea MK, 2004, J VIROL METHODS, V118, P101, DOI 10.1016/j.jviromet.2004.01.022; Oh KW, 2005, LAB CHIP, V5, P845, DOI 10.1039/b503437j; Palka-Santini M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-1; Pepe M. S., 2003, STAT EVALUATION MED; Perez-Roth E, 2001, J CLIN MICROBIOL, V39, P4037, DOI 10.1128/JCM.39.11.4037-4041.2001; PERSING DH, 2010, MOL MICROBIOLOGY DIA; Petric M, 2006, J INFECT DIS, V194, pS98, DOI 10.1086/507554; Ramers C, 2000, JAMA-J AM MED ASSOC, V283, P2680, DOI 10.1001/jama.283.20.2680; Rand KH, 2011, J CLIN MICROBIOL, V49, P2449, DOI 10.1128/JCM.02582-10; Ratcliff RM, 2007, CURR ISSUES MOL BIOL, V9, P87; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; Robinson CC, 2002, PEDIATR INFECT DIS J, V21, P283, DOI 10.1097/00006454-200204000-00005; Rocholl C, 2004, PEDIATRICS, V113, pE51, DOI 10.1542/peds.113.1.e51; Sayers EW, 2010, NUCLEIC ACIDS RES, V38, pD5, DOI 10.1093/nar/gkp967; Sotlar K, 2004, J CLIN MICROBIOL, V42, P3176, DOI 10.1128/JCM.42.7.3176-3184.2004; Stellrecht KA, 2002, J CLIN VIROL, V25, pS19, DOI 10.1016/S1386-6532(02)00030-6; Stockton J, 1998, J CLIN MICROBIOL, V36, P2990, DOI 10.1128/JCM.36.10.2990-2995.1998; Strommenger B, 2003, J CLIN MICROBIOL, V41, P4089, DOI 10.1128/JCM.41.9.4089-4094.2003; Sung RYT, 2009, J MED VIROL, V81, P153, DOI 10.1002/jmv.21364; Van Eldere J, 2005, CLIN MICROBIOL INFEC, V11, P15, DOI 10.1111/j.1469-0691.2005.01084.x; Versalovic J, 2002, TRENDS MICROBIOL, V10, pS15, DOI 10.1016/S0966-842X(02)02438-1; Weitzel T, 2007, CLIN MICROBIOL INFEC, V13, P665, DOI 10.1111/j.1469-0691.2007.01739.x; Whiley DM, 2008, CRIT REV MICROBIOL, V34, P71, DOI 10.1080/10408410801960913 ; Whiley DM, 2005, PATHOLOGY, V37, P364, DOI 10.1080/00313020500254552; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Wittwer CT, 2003, CLIN CHEM, V49, P853, DOI 10.1373/49.6.853; Wittwer CT, 2001, METHODS, V25, P430, DOI 10.1006/meth.2001.1265; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005; Woo PCY, 1997, J CLIN MICROBIOL, V35, P1579, DOI 10.1128/JCM.35.6.1579-1581.1997; Wu WJ, 2009, CLIN LAB MED, V29, P673, DOI 10.1016/j.cll.2009.07.005; Yager P, 2006, NATURE, V442, P412, DOI 10.1038/nature05064; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8; Zhang KY, 2004, J CLIN MICROBIOL, V42, P4947, DOI 10.1128/JCM.42.11.4947-4955.2004; Zhang ZW, 2005, METH MOLEC MED, V114, P59	91	263	282	9	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26047	10.1371/journal.pone.0026047	http://dx.doi.org/10.1371/journal.pone.0026047			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039434	Green Submitted, gold, Green Published			2022-12-27	WOS:000296507500029
J	Almeida, S; Zhou, LJ; Gao, FB				Almeida, Sandra; Zhou, Lijuan; Gao, Fen-Biao			Progranulin, a Glycoprotein Deficient in Frontotemporal Dementia, Is a Novel Substrate of Several Protein Disulfide Isomerase Family Proteins	PLOS ONE			English	Article							DEPENDENT REDUCTASE ERP57; LOBAR DEGENERATION; EPITHELIN PRECURSOR; BRAIN; MUTATIONS; SORTILIN; DELETION; DISEASE; ERP72; GENE	The reduced production or activity of the cysteine-rich glycoprotein progranulin is responsible for about 20% of cases of familial frontotemporal dementia. However, little is known about the molecular mechanisms that govern the level and secretion of progranulin. Here we show that progranulin is expressed in mouse cortical neurons and more prominently in mouse microglia in culture and is abundant in the endoplasmic reticulum (ER) and Golgi. Using chemical crosslinking, immunoprecipitation, and mass spectrometry, we found that progranulin is bound to a network of ER Ca(2+)-binding chaperones including BiP, calreticulin, GRP94, and four members of the protein disulfide isomerase (PDI) family. Loss of ERp57 inhibits progranulin secretion. Thus, progranulin is a novel substrate of several PDI family proteins and modulation of the ER chaperone network may be a therapeutic target for controlling progranulin secretion.	[Almeida, Sandra; Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Zhou, Lijuan] Gladstone Inst Neurol Dis, San Francisco, CA USA	University of Massachusetts System; University of Massachusetts Worcester; University of California System; University of California San Francisco; The J David Gladstone Institutes	Almeida, S (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA.	fen-biao.gao@umassmed.edu	Zhou, Li/GSE-4531-2022		Consortium for Frontotemporal Dementia Research; National Institutes of Health [RO1 NS057553]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057553] Funding Source: NIH RePORTER	Consortium for Frontotemporal Dementia Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by a grant from the Consortium for Frontotemporal Dementia Research and RO1 NS057553 from the National Institutes of Health (F.-B.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; BOXER AL, 2005, ALZ DIS ASSOC DIS S1, V19, pS36; Capell A, 2011, J NEUROSCI, V31, P1885, DOI 10.1523/JNEUROSCI.5757-10.2011; Carrasquillo MM, 2010, AM J HUM GENET, V87, P890, DOI 10.1016/j.ajhg.2010.11.002; Cenik B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193433; Coe H, 2010, INT J BIOCHEM CELL B, V42, P796, DOI 10.1016/j.biocel.2010.01.009; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2003, DEV DYNAM, V227, P593, DOI 10.1002/dvdy.10341; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Frand AR, 2000, TRENDS CELL BIOL, V10, P203, DOI 10.1016/S0962-8924(00)01745-1; Gijselinck I, 2008, HUM MUTAT, V29, P53, DOI 10.1002/humu.20651; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Jiao J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010551; Kayasuga Y, 2007, BEHAV BRAIN RES, V185, P110, DOI 10.1016/j.bbr.2007.07.020; Kozlov G, 2010, J MOL BIOL, V401, P618, DOI 10.1016/j.jmb.2010.06.045; Kozlov G, 2009, STRUCTURE, V17, P651, DOI 10.1016/j.str.2009.02.016; Morrice NA, 1998, CURR BIOL, V8, P713, DOI 10.1016/S0960-9822(98)70279-9; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Petkau TL, 2010, J COMP NEUROL, V518, P3931, DOI 10.1002/cne.22430; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Rovelet-Lecrux A, 2008, NEUROBIOL DIS, V31, P41, DOI 10.1016/j.nbd.2008.03.004; Rutkevich LA, 2010, MOL BIOL CELL, V21, P3093, DOI 10.1091/mbc.E10-04-0356; Songsrirote K, 2010, J PROTEOMICS, V73, P1479, DOI 10.1016/j.jprot.2010.02.013; van der Zee J, 2007, HUM MUTAT, V28, P416, DOI 10.1002/humu.9484; Vossel KA, 2008, CURR OPIN NEUROL, V21, P708, DOI 10.1097/WCO.0b013e328318444d; Wang J, 2010, J NEUROCHEM, V112, P1305, DOI 10.1111/j.1471-4159.2009.06546.x; Wang WX, 2010, AM J PATHOL, V177, P334, DOI 10.2353/ajpath.2010.091202	29	51	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26454	10.1371/journal.pone.0026454	http://dx.doi.org/10.1371/journal.pone.0026454			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028881	Green Submitted, gold, Green Published			2022-12-27	WOS:000296186900065
J	Furtbauer, I; Mundry, R; Heistermann, M; Schulke, O; Ostner, J				Fuertbauer, Ines; Mundry, Roger; Heistermann, Michael; Schuelke, Oliver; Ostner, Julia			You Mate, I Mate: Macaque Females Synchronize Sex not Cycles	PLOS ONE			English	Article							ESTROUS SYNCHRONY; REPRODUCTIVE SYNCHRONY; OVARIAN SYNCHRONY; SOCIAL-GROUPS; ASYNCHRONY; EVOLUTION; PRIMATES; MALES; DOMINANCE; PATERNITY	Extended female sexuality in species living in multimale-multifemale groups appears to enhance benefits from multiple males. Mating with many males, however, requires a low female monopolizability, which is affected by the spatiotemporal distribution of receptive females. Ovarian cycle synchrony potentially promotes overlapping receptivity if fertile and receptive periods are tightly linked. In primates, however, mating is often decoupled from hormonal control, hence reducing the need for synchronizing ovarian events. Here, we test the alternative hypothesis that females behaviorally coordinate their receptivity while simultaneously investigating ovarian cycle synchrony in wild, seasonal Assamese macaques (Macaca assamensis), a promiscuous species with extremely extended female sexuality. Using fecal hormone analysis to assess ovarian activity we show that fertile phases are randomly distributed, and that dyadic spatial proximity does not affect their distribution. We present evidence for mating synchrony, i.e., the occurrence of the females' receptivity was significantly associated with the proportion of other females mating on a given day. Our results suggest social facilitation of mating synchrony, which explains (i) the high number of simultaneously receptive females, and (ii) the low male mating skew in this species. Active mating synchronization may serve to enhance the benefits of extended female sexuality, and may proximately explain its patterning and maintenance.	[Fuertbauer, Ines; Ostner, Julia] Univ Gottingen, Courant Res Ctr Evolut Social Behav, Primate Social Evolut Grp, Gottingen, Germany; [Fuertbauer, Ines; Schuelke, Oliver; Ostner, Julia] Max Planck Inst Evolutionary Anthropol, Integrat Primate Socioecol Grp, Leipzig, Germany; [Fuertbauer, Ines; Heistermann, Michael] German Primate Ctr, Reprod Biol Unit, Gottingen, Germany	University of Gottingen; Max Planck Society; Deutsches Primatenzentrum (DPZ)	Furtbauer, I (corresponding author), Univ Gottingen, Courant Res Ctr Evolut Social Behav, Primate Social Evolut Grp, Gottingen, Germany.	ifuertb@uni-goettingen.de		Furtbauer, Ines/0000-0003-1404-6280	National Geographic Society; Max-Planck Society; German Initiative of Excellence	National Geographic Society(National Geographic Society); Max-Planck Society(Max Planck SocietyFoundation CELLEX); German Initiative of Excellence	The project was supported with funds from the National Geographic Society, Max-Planck Society and the German Initiative of Excellence to the University of Gottingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN SA, 1962, ANN NY ACAD SCI, V102, P338, DOI 10.1111/j.1749-6632.1962.tb13650.x; ANDELMAN SJ, 1985, J ZOOL, V205, P467; ANDELMAN SJ, 1987, AM NAT, V129, P785, DOI 10.1086/284675; [Anonymous], 2010, R LANG ENV STAT COMP; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Bates D. M., 2010, LME4 MIXED EFFECTS M; BERCOVITCH FB, 1987, AM J PRIMATOL, V12, P189, DOI 10.1002/ajp.1350120206; Birkhead TR, 1992, SPERM COMPETITION BI; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Borries C, 1999, BEHAV ECOL SOCIOBIOL, V46, P350, DOI 10.1007/s002650050629; Brockman DK, 2005, CAM S BIO EVOL ANTHR, V44, P269, DOI 10.1017/CBO9780511542343.011; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Clarke Parry, 2009, P42; CORDS M, 1986, ETHOLOGY, V72, P214; CoussiKorbel S, 1995, ANIM BEHAV, V50, P1441, DOI 10.1016/0003-3472(95)80001-8; COWLISHAW G, 1991, ANIM BEHAV, V41, P1045, DOI 10.1016/S0003-3472(05)80642-6; Deschner T, 2004, HORM BEHAV, V46, P204, DOI 10.1016/j.yhbeh.2004.03.013; Dixson A.F., 1998, PRIMATE SEXUALITY CO; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Doran-Sheeny DM, 2009, AM J PRIMATOL, V71, P1011, DOI 10.1002/ajp.20743; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FRENCH JA, 1987, AM J PRIMATOL, V12, P469, DOI 10.1002/ajp.1350120403; Furtbauer I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023105; Furtbauer I, 2010, INT J PRIMATOL, V31, P501, DOI 10.1007/s10764-010-9409-3; Gangestad SW, 2008, P ROY SOC B-BIOL SCI, V275, P991, DOI 10.1098/rspb.2007.1425; Gattermann R, 2002, HORM BEHAV, V42, P70, DOI 10.1006/hbeh.2002.1800; HANDELMANN G, 1980, HORM BEHAV, V14, P107, DOI 10.1016/0018-506X(80)90002-1; Heistermann M, 2001, P ROY SOC B-BIOL SCI, V268, P2445, DOI 10.1098/rspb.2001.1833; HRDY SB, 1979, ETHOL SOCIOBIOL, V1, P13, DOI 10.1016/0162-3095(79)90004-9; Hrdy SB, 2000, ANN NY ACAD SCI, V907, P75, DOI 10.1111/j.1749-6632.2000.tb06617.x; IMS RA, 1990, TRENDS ECOL EVOL, V5, P135, DOI 10.1016/0169-5347(90)90218-3; IMS RA, 1988, EVOL ECOL, V2, P338, DOI 10.1007/BF02207565; Knobil E., 2006, PHYSL REPROD, V3rd ed; KNOWLTON N, 1979, ANIM BEHAV, V27, P1022, DOI 10.1016/0003-3472(79)90049-6; Kutsukake N, 2006, BEHAV ECOL SOCIOBIOL, V60, P695, DOI 10.1007/s00265-006-0213-1; Li Jin-Hua, 2005, Acta Zoologica Sinica, V51, P365; Maninger N, 2000, AM J PRIMATOL, V52, P81, DOI 10.1002/1098-2345(200010)52:2<81::AID-AJP2>3.0.CO;2-L; Matsumoto-Oda A, 2005, AM J PRIMATOL, V66, P159, DOI 10.1002/ajp.20135; Matsumoto-Oda A, 2007, BEHAV ECOL SOCIOBIOL, V61, P661, DOI 10.1007/s00265-006-0287-9; MCCLINTOCK MK, 1984, PHYSIOL BEHAV, V32, P701, DOI 10.1016/0031-9384(84)90181-1; MCCLINTOCK MK, 1978, HORM BEHAV, V10, P264, DOI 10.1016/0018-506X(78)90071-5; MCCLINTOCK MK, 1971, NATURE, V229, P244, DOI 10.1038/229244a0; Monfort SL, 1996, BIOL REPROD, V55, P875, DOI 10.1095/biolreprod55.4.875; Nunn CL, 1999, BEHAV ECOL SOCIOBIOL, V46, P1, DOI 10.1007/s002650050586; Nunn CL, 2001, BEHAV ECOL, V12, P646, DOI 10.1093/beheco/12.5.646; Ostner J, 2008, HORM BEHAV, V54, P613, DOI 10.1016/j.yhbeh.2008.05.020; Ostner J, 2008, BEHAV ECOL, V19, P1150, DOI 10.1093/beheco/arn093; Ostner J, 2011, HORM BEHAV, V59, P105, DOI 10.1016/j.yhbeh.2010.10.017; PEREIRA ME, 1991, PHYSIOL BEHAV, V49, P47, DOI 10.1016/0031-9384(91)90228-G; Pradhan GR, 2008, BEHAVIOUR, V145, P251, DOI 10.1163/156853907783244710; Radespiel U, 2001, INT J PRIMATOL, V22, P71, DOI 10.1023/A:1026466015443; RIDLEY M, 1986, ANIM BEHAV, V34, P1848, DOI 10.1016/S0003-3472(86)80271-8; Rodriguez-Girones MA, 2001, ANIM BEHAV, V61, P695, DOI 10.1006/anbe.2000.1630; ROWELL TE, 1978, BEHAV BIOL, V24, P141, DOI 10.1016/S0091-6773(78)93032-8; RUSSELL MJ, 1980, PHARMACOL BIOCHEM BE, V13, P737, DOI 10.1016/0091-3057(80)90020-9; Schank JC, 2001, BEHAV PROCESS, V56, P131, DOI 10.1016/S0376-6357(01)00194-2; Schank JC, 2001, J COMP PSYCHOL, V115, P3, DOI 10.1037//0735-7036.115.1.3; Schank JC, 2001, PHYSIOL BEHAV, V72, P129, DOI 10.1016/S0031-9384(00)00395-4; Schwensow N, 2008, P ROY SOC B-BIOL SCI, V275, P555, DOI 10.1098/rspb.2007.1433; Setchell JM, 2010, J EVOLUTION BIOL, V23, P136, DOI 10.1111/j.1420-9101.2009.01880.x; Setchell JM, 2011, PSYCHONEUROENDOCRINO, V36, P51, DOI 10.1016/j.psyneuen.2010.06.004; Sokal R.R., 2012, BIOMETRY; Soltis J, 2002, EVOL ANTHROPOL, V11, P187, DOI 10.1002/evan.10025; Stern K, 1998, NATURE, V392, P177, DOI 10.1038/32408; Stoinski TS, 2009, AM J PRIMATOL, V71, P587, DOI 10.1002/ajp.20692; Strassmann BI, 1997, CURR ANTHROPOL, V38, P123, DOI 10.1086/204592; Thornhill R., 2008, EVOLUTIONARY BIOL HU; Tobler R, 2010, ANIM BEHAV, V80, P829, DOI 10.1016/j.anbehav.2010.07.018; VAN HOOF J. A. R. A. M., 1967, P7; van Noordwijk Maria A., 2000, P322, DOI 10.1017/CBO9780511542312.016; van Schaik Carel P., 2004, P131, DOI 10.1017/CBO9780511542459.010; van Schaik Carel P., 1999, Cambridge Studies in Biological Anthropology, V22, P204; van Schaik Carel P., 2000, P361, DOI 10.1017/CBO9780511542312.017; VANDENBERGH JG, 1974, PHYSIOL BEHAV, V13, P373, DOI 10.1016/0031-9384(74)90090-0; WALLEN K, 1990, NEUROSCI BIOBEHAV R, V14, P233, DOI 10.1016/S0149-7634(05)80223-4; WALLIS J, 1985, INT J PRIMATOL, V6, P335, DOI 10.1007/BF02745505; ZINNER D, 1994, BEHAV ECOL SOCIOBIOL, V35, P175, DOI 10.1007/BF00167957	79	44	44	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26144	10.1371/journal.pone.0026144	http://dx.doi.org/10.1371/journal.pone.0026144			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022541	Green Published, gold			2022-12-27	WOS:000295976000074
J	Meier, C; Anastasiadou, S; Knoll, B				Meier, Christin; Anastasiadou, Sofia; Knoell, Bernd			Ephrin-A5 Suppresses Neurotrophin Evoked Neuronal Motility, ERK Activation and Gene Expression	PLOS ONE			English	Article							SERUM RESPONSE FACTOR; RECEPTOR TYROSINE KINASE; AXON GUIDANCE; GROWTH CONE; TRANSCRIPTION FACTORS; SYNAPTIC PLASTICITY; SIGNAL-TRANSDUCTION; HIPPOCAMPAL AXONS; NERVOUS-SYSTEM; CELL REPULSION	During brain development, growth cones respond to attractive and repulsive axon guidance cues. How growth cones integrate guidance instructions is poorly understood. Here, we demonstrate a link between BDNF (brain derived neurotrophic factor), promoting axonal branching and ephrin-A5, mediating axonal repulsion via Eph receptor tyrosine kinase activation. BDNF enhanced growth cone filopodial dynamics and neurite branching of primary neurons. We show that ephrin-A5 antagonized this BDNF-evoked neuronal motility. BDNF increased ERK phosphorylation (P-ERK) and nuclear ERK entry. Ephrin-A5 suppressed BDNF-induced ERK activity and might sequester P-ERK in the cytoplasm. Neurotrophins are well established stimulators of a neuronal immediate early gene (IEG) response. This is confirmed in this study by e.g. c-fos, Egr1 and Arc upregulation upon BDNF application. This BDNF-evoked IEG response required the transcription factor SRF (serum response factor). Notably, ephrin-A5 suppressed a BDNF-evoked neuronal IEG response, suggesting a role of Eph receptors in modulating gene expression. In opposite to IEGs, long-term ephrin-A5 application induced cytoskeletal gene expression of tropomyosin and actinin. To uncover specific Eph receptors mediating ephrin-As impact on neurotrophin signaling, EphA7 deficient mice were analyzed. In EphA7 deficient neurons alterations in growth cone morphology were observed. However, ephrin-A5 still counteracted neurotrophin signaling suggesting that EphA7 is not required for ephrin and BDNF crosstalk. In sum, our data suggest an interaction of ephrin-As and neurotrophin signaling pathways converging at ERK signaling and nuclear gene activity. As ephrins are involved in development and function of many organs, such modulation of receptor tyrosine kinase signaling and gene expression by Ephs might not be limited to the nervous system.	[Meier, Christin; Anastasiadou, Sofia; Knoell, Bernd] Univ Tubingen, Neuronal Gene Express Lab, Dept Mol Biol, Interfac Inst Cell Biol, Tubingen, Germany	Eberhard Karls University of Tubingen	Meier, C (corresponding author), Univ Tubingen, Neuronal Gene Express Lab, Dept Mol Biol, Interfac Inst Cell Biol, Tubingen, Germany.	bernd.knoell@uni-ulm.de		Meyer zu Reckendorf, Sofia/0000-0001-6978-1915; Meier, Christin/0000-0002-1586-9206	DFG [KN543/2-1, SFB 446 (Tp B19)]; Schram Foundation; Hertie Foundation; Tubingen University	DFG(German Research Foundation (DFG)); Schram Foundation; Hertie Foundation; Tubingen University	B.K. is supported by the DFG through the Emmy Noether Program (KN543/2-1; www.dfg.de) and SFB 446 (Tp B19), the Schram Foundation (www.stifterverband.de), the Hertie Foundation (www.ghst.de), and by Young Investigator Grants of Tubingen University (www.uni-tuebingen.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2005, P NATL ACAD SCI USA, V102, P6148, DOI 10.1073/pnas.0501191102; Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Aoki M, 2004, J BIOL CHEM, V279, P32643, DOI 10.1074/jbc.M313247200; Arancio O, 2007, CURR OPIN NEUROBIOL, V17, P325, DOI 10.1016/j.conb.2007.03.013; BI C, 2011, J NEUROPHYSIOL; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Chang SH, 2004, J NEUROSCI, V24, P2277, DOI 10.1523/JNEUROSCI.4868-03.2004; COHENCORY S, 1995, NATURE, V378, P192, DOI 10.1038/378192a0; Dail M, 2006, J CELL SCI, V119, P1244, DOI 10.1242/jcs.02842; Danzer SC, 2002, J NEUROSCI, V22, P9754; Drescher U, 2011, CURR BIOL, V21, pR30, DOI 10.1016/j.cub.2010.11.064; Dudanova I, 2010, CURR BIOL, V20, P2150, DOI 10.1016/j.cub.2010.11.021; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Elowe S, 2001, MOL CELL BIOL, V21, P7429, DOI 10.1128/MCB.21.21.7429-7441.2001; Encinas M, 1999, J NEUROCHEM, V73, P1409, DOI 10.1046/j.1471-4159.1999.0731409.x; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Faulkner RL, 2007, DEV NEUROSCI-BASEL, V29, P6, DOI 10.1159/000096207; Finkbeiner S, 1997, NEURON, V19, P1031, DOI 10.1016/S0896-6273(00)80395-5; Fitzgerald M, 2008, BIOCHEM BIOPH RES CO, V374, P625, DOI 10.1016/j.bbrc.2008.07.110; Gallo G, 2004, J NEUROBIOL, V58, P92, DOI 10.1002/neu.10282; Gao PP, 1999, P NATL ACAD SCI USA, V96, P4073, DOI 10.1073/pnas.96.7.4073; Gehler S, 2004, J NEUROSCI, V24, P10741, DOI 10.1523/JNEUROSCI.2836-04.2004; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huber AB, 2003, ANNU REV NEUROSCI, V26, P509, DOI 10.1146/annurev.neuro.26.010302.081139; Jessen U, 2001, J NEUROCHEM, V79, P1149, DOI 10.1046/j.1471-4159.2001.00636.x; Kalita K, 2006, J NEUROSCI, V26, P10020, DOI 10.1523/JNEUROSCI.2644-06.2006; Knoll B, 2009, TRENDS NEUROSCI, V32, P432, DOI 10.1016/j.tins.2009.05.004; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Knoll B, 2002, TRENDS NEUROSCI, V25, P145, DOI 10.1016/S0166-2236(00)02093-2; Knoll B, 2004, J NEUROSCI, V24, P6248, DOI 10.1523/JNEUROSCI.0985-04.2004; Knoll B, 2001, DEVELOPMENT, V128, P895; Kramer ER, 2006, NEURON, V50, P35, DOI 10.1016/j.neuron.2006.02.020; Levkovitz Y, 2001, J NEUROSCI, V21, P45, DOI 10.1523/JNEUROSCI.21-01-00045.2001; Lim YS, 2008, NEURON, V59, P746, DOI 10.1016/j.neuron.2008.07.032; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; Lowenstein DH, 1996, J NEUROSCI, V16, P1759; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Lykissas MG, 2007, CURR NEUROVASC RES, V4, P143, DOI 10.2174/156720207780637216; Marler KJM, 2010, NEURAL DEV, V5, DOI 10.1186/1749-8104-5-30; Marler KJM, 2008, J NEUROSCI, V28, P12700, DOI 10.1523/JNEUROSCI.1915-08.2008; Martinez A, 2005, BRAIN RES REV, V49, P211, DOI 10.1016/j.brainresrev.2005.02.001; Martinez A, 2005, NEUROSCIENCE, V135, P451, DOI 10.1016/j.neuroscience.2005.06.052; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Miao H, 2001, NAT CELL BIOL, V3, P527, DOI 10.1038/35074604; Nie D, 2010, NAT NEUROSCI, V13, P163, DOI 10.1038/nn.2477; Olschlager V, 2004, ONCOGENE, V23, P6639, DOI 10.1038/sj.onc.1207883; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Poliakov A, 2008, J CELL BIOL, V183, P933, DOI 10.1083/jcb.200807151; Poopalasundaram S, 2011, MOL CELL NEUROSCI, V47, P131, DOI 10.1016/j.mcn.2011.03.008; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Rashid T, 2005, NEURON, V47, P57, DOI 10.1016/j.neuron.2005.05.030; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Stern S, 2009, J NEUROSCI, V29, P4512, DOI 10.1523/JNEUROSCI.0333-09.2009; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Stritt C, 2009, NAT NEUROSCI, V12, P418, DOI 10.1038/nn.2280; Tong JF, 2003, J BIOL CHEM, V278, P6111, DOI 10.1074/jbc.M208972200; Vindis C, 2003, J CELL BIOL, V162, P661, DOI 10.1083/jcb.200302073; Wickramasinghe SR, 2008, NEURON, V58, P532, DOI 10.1016/j.neuron.2008.03.006; Wiegert JS, 2007, J BIOL CHEM, V282, P29621, DOI 10.1074/jbc.M701448200; Xu NJ, 2009, NAT NEUROSCI, V12, P268, DOI 10.1038/nn.2254; Yue X, 2008, DEV NEUROBIOL, V68, P1269, DOI 10.1002/dneu.20657; Yue Y, 2002, P NATL ACAD SCI USA, V99, P10777, DOI 10.1073/pnas.162354599; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	66	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26089	10.1371/journal.pone.0026089	http://dx.doi.org/10.1371/journal.pone.0026089			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022520	Green Published, gold, Green Submitted			2022-12-27	WOS:000295973200033
J	Chene, A; Nylen, S; Donati, D; Bejarano, MT; Kironde, F; Wahlgren, M; Falk, KI				Chene, Arnaud; Nylen, Susanne; Donati, Daria; Bejarano, Maria Teresa; Kironde, Fred; Wahlgren, Mats; Falk, Kerstin I.			Effect of Acute Plasmodium falciparum Malaria on Reactivation and Shedding of the Eight Human Herpes Viruses	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; CENTRAL-NERVOUS-SYSTEM; KAPOSIS-SARCOMA; INFECTION; DNA; CHILDREN; CYTOMEGALOVIRUS; ZOSTER; EPIDEMIOLOGY; SEROPREVALENCE	Human herpes viruses (HHVs) are widely distributed pathogens. In immuno-competent individuals their clinical outcomes are generally benign but in immuno-compromised hosts, primary infection or extensive viral reactivation can lead to critical diseases. Plasmodium falciparum malaria profoundly affects the host immune system. In this retrospective study, we evaluated the direct effect of acute P. falciparum infection on reactivation and shedding of all known human herpes viruses (HSV-1, HSV-2, VZV, EBV, CMV, HHV-6, HHV-7, HHV-8). We monitored their presence by real time PCR in plasma and saliva of Ugandan children with malaria at the day of admission to the hospital (day-0) and 14 days later (after treatment), or in children with mild infections unrelated to malaria. For each child screened in this study, at least one type of HHV was detected in the saliva. HHV-7 and HHV-6 were detected in more than 70% of the samples and CMV in approximately half. HSV-1, HSV-2, VZV and HHV-8 were detected at lower frequency. During salivary shedding the highest mean viral load was observed for HSV-1 followed by EBV, HHV-7, HHV-6, CMV and HHV-8. After anti-malarial treatment the salivary HSV-1 levels were profoundly diminished or totally cleared. Similarly, four children with malaria had high levels of circulating EBV at day-0, levels that were cleared after anti-malarial treatment confirming the association between P. falciparum infection and EBV reactivation. This study shows that acute P. falciparum infection can contribute to EBV reactivation in the blood and HSV-1 reactivation in the oral cavity. Taken together our results call for further studies investigating the potential clinical implications of HHVs reactivation in children suffering from malaria.	[Chene, Arnaud; Nylen, Susanne; Bejarano, Maria Teresa; Wahlgren, Mats; Falk, Kerstin I.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Donati, Daria; Bejarano, Maria Teresa] Karolinska Inst, Ctr Infect Med, Dept Med, Stockholm, Sweden; [Kironde, Fred] Makerere Univ, Fac Med, Dept Biochem, Kampala, Uganda; [Falk, Kerstin I.] Swedish Inst Communicable Dis, Solna, Sweden	Karolinska Institutet; Karolinska Institutet; Makerere University; Swedish Institute for Infectious Disease Control	Chene, A (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden.	mats.wahlgren@ki.se	Chene, Arnaud/O-4397-2017	Chene, Arnaud/0000-0002-6551-4382; Kironde, Fred/0000-0003-4981-6417; Nylen, Susanne/0000-0002-3875-3353	SIDA/SAREC; Swedish Research Council; EviMalaR	SIDA/SAREC; Swedish Research Council(Swedish Research CouncilEuropean Commission); EviMalaR	This work was supported by grants from SIDA/SAREC (www.sida.se), the Swedish Research Council (www.vr.se) and EviMalaR (www.evimalar.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRYTTING M, 1992, J CLIN MICROBIOL, V30, P1937, DOI 10.1128/JCM.30.8.1937-1941.1992; Carbone A, 2008, BRIT J HAEMATOL, V140, P13, DOI 10.1111/j.1365-2141.2007.06879.x; Chene A, 2007, PLOS PATHOG, V3, P826, DOI 10.1371/journal.ppat.0030080; Chene A, 2009, SEMIN CANCER BIOL, V19, P411, DOI 10.1016/j.semcancer.2009.10.002; Coluzzi M, 2003, MED VET ENTOMOL, V17, P461, DOI 10.1111/j.1365-2915.2003.00465.x; COOK IF, 1985, J TROP MED HYG, V88, P261; DOBBINS JG, 1994, PEDIATRICS, V94, P1016; Donati D, 2006, J INFECT DIS, V193, P971, DOI 10.1086/500839; Donati D, 2004, INFECT IMMUN, V72, P5412, DOI 10.1128/IAI.72.9.5412-5418.2004; Gabutti G, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-372; Holden SR, 2007, J CLIN VIROL, V40, P245, DOI 10.1016/j.jcv.2007.08.011; Huang LM, 1997, ACTA PAEDIATR, V86, P604, DOI 10.1111/j.1651-2227.1997.tb08942.x; Hudnall SD, 2008, TRANSFUSION, V48, P1180, DOI 10.1111/j.1537-2995.2008.01685.x; Katsafanas GC, 1996, P NATL ACAD SCI USA, V93, P9788, DOI 10.1073/pnas.93.18.9788; KONDO K, 1991, J GEN VIROL, V72, P1401, DOI 10.1099/0022-1317-72-6-1401; Lademann M, 2005, AM J TROP MED HYG, V72, P478, DOI 10.4269/ajtmh.2005.72.478; Lundberg R, 2006, ANTICANCER RES, V26, P3627; Malvy D, 2007, J EUR ACAD DERMATOL, V21, P1398, DOI 10.1111/j.1468-3083.2007.02302.x; Miller CS, 2005, J CLIN MICROBIOL, V43, P2173, DOI 10.1128/JCM.43.5.2173-2180.2005; Moormann AM, 2005, J INFECT DIS, V191, P1233, DOI 10.1086/428910; Ndungu FM, 2005, PARASITE IMMUNOL, V27, P373, DOI 10.1111/j.1365-3024.2005.00771.x; Rasti N, 2005, SCAND J IMMUNOL, V61, P461, DOI 10.1111/j.1365-3083.2005.01589.x; Regunath Hariharan, 2008, Journal of Vector Borne Diseases, V45, P251; Serraino D, 2003, INFECTION, V31, P47, DOI 10.1007/s15010-002-3107-9; Sowunmi A, 2008, ACTA TROP, V106, P68, DOI 10.1016/j.actatropica.2007.03.005; SPECTOR SA, 1992, J CLIN MICROBIOL, V30, P2359, DOI 10.1128/JCM.30.9.2359-2365.1992; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; SUGA S, 1993, ANN NEUROL, V33, P597, DOI 10.1002/ana.410330607; Tanaka N, 2000, BONE MARROW TRANSPL, V26, P1193, DOI 10.1038/sj.bmt.1702710; Taplitz Randy A, 2002, Semin Respir Infect, V17, P121, DOI 10.1053/srin.2002.33447; Taylor GS, CANC LETT, V305, P263; Tedeschi R, 2006, J MED VIROL, V78, P372, DOI 10.1002/jmv.20549; Thorley-Lawson DA, 2008, NAT REV MICROBIOL, V6, P913, DOI 10.1038/nrmicro2015; Torigoe S, 1996, J PEDIATR-US, V129, P301, DOI 10.1016/S0022-3476(96)70259-7; Tyler K. L., 2004, HERPES J IHMF, V11, P57; Urban BC, 2001, P NATL ACAD SCI USA, V98, P8750, DOI 10.1073/pnas.151028698; Wahlgren M, 1995, SCAND J IMMUNOL, V42, P626, DOI 10.1111/j.1365-3083.1995.tb03705.x; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; YAMAMOTO M, 1995, J CLIN MICROBIOL, V33, P1765, DOI 10.1128/JCM.33.7.1765-1768.1995; Yoshikawa T, 2000, ARCH DIS CHILD, V83, P170, DOI 10.1136/adc.83.2.170; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452	41	24	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26266	10.1371/journal.pone.0026266	http://dx.doi.org/10.1371/journal.pone.0026266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039454	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200008
J	Lim, PY; Keating, JA; Hoover, S; Striker, R; Bernard, KA				Lim, Pei-Yin; Keating, Julie A.; Hoover, Spencer; Striker, Rob; Bernard, Kristen A.			A Thiopurine Drug Inhibits West Nile Virus Production in Cell Culture, but Not in Mice	PLOS ONE			English	Article							DEPENDENT RNA-POLYMERASES; HEPATITIS-C VIRUS; 6-METHYLMERCAPTOPURINE RIBOSIDE; LIVER-TRANSPLANTATION; MYCOPHENOLIC-ACID; CHAIN-TERMINATORS; CRYSTAL-STRUCTURE; VIRAL LOAD; CDNA-CLONE; RIBAVIRIN	Many viruses within the Flavivirus genus cause significant disease in humans; however, effective antivirals against these viruses are not currently available. We have previously shown that a thiopurine drug, 6-methylmercaptopurine riboside (6MMPr), inhibits replication of distantly related viruses within the Flaviviridae family in cell culture, including bovine viral diarrhea virus and hepatitis C virus replicon. Here we further examined the potential antiviral effect of 6MMPr on several diverse flaviviruses. In cell culture, 6MMPr inhibited virus production of yellow fever virus, dengue virus-2 (DENV-2) and West Nile virus (WNV) in a dose-dependent manner, and DENV-2 was significantly more sensitive to 6MMPr treatment than WNV. We then explored the use of 6MMPr as an antiviral against WNV in an immunocompetent mouse model. Once a day treatment of mice with 0.5 mg 6MMPr was just below the toxic dose in our mouse model, and this dose was used in subsequent studies. Mice were treated with 6MMPr immediately after subcutaneous inoculation with WNV for eight consecutive days. Treatment with 6MMPr exacerbated weight loss in WNV-inoculated mice and did not significantly affect mortality. We hypothesized that 6MMPr has low bioavailability in the central nervous system (CNS) and examined the effect of pre-treatment with 6MMPr on viral loads in the periphery and CNS. Pre-treatment with 6MMPr had no significant effect on viremia or viral titers in the periphery, but resulted in significantly higher viral loads in the brain, suggesting that the effect of 6MMPr is tissue-dependent. In conclusion, despite being a potent inhibitor of flaviviruses in cell culture, 6MMPr was not effective against West Nile disease in mice; however, further studies are warranted to reduce the toxicity and/or improve the bioavailability of this potential antiviral drug.	[Lim, Pei-Yin; Bernard, Kristen A.] Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA; [Lim, Pei-Yin; Bernard, Kristen A.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY USA; [Striker, Rob] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Keating, Julie A.; Hoover, Spencer; Striker, Rob] Univ Wisconsin, Dept Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; State University of New York (SUNY) System; Wadsworth Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison	Lim, PY (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.	kbernard@vetmed.wisc.edu		Striker, Rob/0000-0002-0454-895X; Lim, Pei-Yin/0000-0003-4401-1265	National Institute of Allergy and Infectious Diseases; National Institutes of Health (NIH) [1U01-AI061193, 2T32AI007414]; Northeast Biodefence Center [U54-AI057158]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007414, U01AI061193, U54AI057158] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Northeast Biodefence Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was partially supported by federal funds from the National Institute of Allergy and Infectious Diseases, and the National Institutes of Health (NIH) under 1U01-AI061193. The BSL-3 animal core, which is funded in part by the Northeast Biodefence Center (U54-AI057158), was used for the animal studies conducted at the Wadsworth Center. JAK was supported by the NIH-funded Cellular and Molecular Parasitology Training Program (2T32AI007414). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bobbala D, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-102; Bode AV, 2006, CLIN INFECT DIS, V42, P1234, DOI 10.1086/503038; Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0; Brown AN, 2007, VIROLOGY, V368, P422, DOI 10.1016/j.virol.2007.06.033; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; D'Abramo CM, 2004, J MOL BIOL, V337, P1, DOI 10.1016/j.jmb.2004.01.030; Diamond MS, 2002, VIROLOGY, V304, P211, DOI 10.1006/viro.2002.1685; ERIKSSON B, 1977, ANTIMICROB AGENTS CH, V11, P946, DOI 10.1128/AAC.11.6.946; Hageboutros A, 1997, INVEST NEW DRUG, V15, P139, DOI 10.1023/A:1005812923473; HEWLETT JS, 1979, CANCER TREAT REP, V63, P156; Hoover S, 2008, J GEN VIROL, V89, P1000, DOI 10.1099/vir.0.83381-0; HUNT DE, 1968, CANCER RES, V28, P1095; Jordan I, 2000, J INFECT DIS, V182, P1214, DOI 10.1086/315847; Koh YH, 2005, J MED CHEM, V48, P2867, DOI 10.1021/jm049029u; Lipsky JJ, 1996, LANCET, V348, P1357, DOI 10.1016/S0140-6736(96)10310-X; MAGEE WC, 2011, ANTIMICROB AGENTS CH; Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200; MELVIN JB, 1984, CANCER RES, V44, P2794; Morrey JD, 2002, ANTIVIR RES, V55, P107, DOI 10.1016/S0166-3542(02)00013-X; Morrey John D., 2004, Antiviral Chemistry & Chemotherapy, V15, P101; Neyts J, 1996, ANTIVIR RES, V30, P125, DOI 10.1016/0166-3542(96)89697-5; Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003; REDEI I, 1994, INVEST NEW DRUG, V12, P319, DOI 10.1007/BF00873047; Rossi SL, 2005, VIROLOGY, V331, P457, DOI 10.1016/j.virol.2004.10.046; Samonakis DN, 2005, LIVER TRANSPLANT, V11, P386, DOI 10.1002/lt.20344; SCHEIDEL LM, 1991, VIROLOGY, V181, P490, DOI 10.1016/0042-6822(91)90881-B; Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026; Shackel NA, 2009, LIVER TRANSPLANT, V15, P709, DOI 10.1002/lt.21747; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; Stangl JR, 2004, TRANSPLANTATION, V77, P562, DOI 10.1097/01.TP.0000114610.40412.C6; VANSCOIK KG, 1985, DRUG METAB REV, V16, P157, DOI 10.3109/03602538508991433; WHO, 2011, IMP DENG; Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06; Zekry A, 2004, LIVER TRANSPLANT, V10, P52, DOI 10.1002/lt.20000	34	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26697	10.1371/journal.pone.0026697	http://dx.doi.org/10.1371/journal.pone.0026697			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039536	gold, Green Submitted, Green Published			2022-12-27	WOS:000296515200043
J	Matsumoto, M; Hikosaka, O				Matsumoto, Masayuki; Hikosaka, Okihide			Electrical Stimulation of the Primate Lateral Habenula Suppresses Saccadic Eye Movement through a Learning Mechanism	PLOS ONE			English	Article							ROSTROMEDIAL TEGMENTAL NUCLEUS; MIDBRAIN DOPAMINE NEURONS; NEGATIVE REWARD SIGNALS; DORSAL RAPHE NUCLEUS; SUBSTANTIA-NIGRA; BASAL GANGLIA; SEEKING BEHAVIOR; COMPLEX; RATS; AREA	The lateral habenula (LHb) is a brain structure which represents negative motivational value. Neurons in the LHb are excited by unpleasant events such as reward omission and aversive stimuli, and transmit these signals to midbrain dopamine neurons which are involved in learning and motivation. However, it remains unclear whether these phasic changes in LHb neuronal activity actually influence animal behavior. To answer this question, we artificially activated the LHb by electrical stimulation while monkeys were performing a visually guided saccade task. In one block of trials, saccades to one fixed direction (e.g., right direction) were followed by electrical stimulation of the LHb while saccades to the other direction (e. g., left direction) were not. The direction-stimulation contingency was reversed in the next block. We found that the post-saccadic stimulation of the LHb increased the latencies of saccades in subsequent trials. Notably, the increase of the latency occurred gradually as the saccade was repeatedly followed by the stimulation, suggesting that the effect of the post-saccadic stimulation was accumulated across trials. LHb stimulation starting before saccades, on the other hand, had no effect on saccade latency. Together with previous studies showing LHb activation by reward omission and aversive stimuli, the present stimulation experiment suggests that LHb activity contributes to learning to suppress actions which lead to unpleasant events.	[Matsumoto, Masayuki; Hikosaka, Okihide] NEI, Sensorimotor Res Lab, NIH, Bethesda, MD 20892 USA; [Matsumoto, Masayuki] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 484, Japan	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Kyoto University	Matsumoto, M (corresponding author), NEI, Sensorimotor Res Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.	mmatsumoto@pri.kyoto-u.ac.jp			National Institutes of Health, National Eye Institute; NATIONAL EYE INSTITUTE [ZIAEY000415] Funding Source: NIH RePORTER	National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This research was supported by the Intramural Research Program at the National Institutes of Health, National Eye Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Balcita-Pedicino JJ, 2011, J COMP NEUROL, V519, P1143, DOI 10.1002/cne.22561; Brinschwitz K, 2010, NEUROSCIENCE, V168, P463, DOI 10.1016/j.neuroscience.2010.03.050; CHRISTOPH GR, 1986, J NEUROSCI, V6, P613; Clarke HF, 2004, SCIENCE, V304, P878, DOI 10.1126/science.1094987; Cools R, 2008, TRENDS COGN SCI, V12, P31, DOI 10.1016/j.tics.2007.10.011; CORODIMAS KP, 1992, BEHAV NEUROSCI, V106, P853, DOI 10.1037/0735-7044.106.5.853; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Friedman A, 2010, NEUROPHARMACOLOGY, V59, P452, DOI 10.1016/j.neuropharm.2010.06.008; Gao DM, 1996, EUR J NEUROSCI, V8, P1474, DOI 10.1111/j.1460-9568.1996.tb01609.x; GERFEN CR, 1992, ANNU REV NEUROSCI, V15, P285, DOI 10.1146/annurev.neuro.15.1.285; Hikosaka O, 2006, J NEUROPHYSIOL, V95, P567, DOI 10.1152/jn.00458.2005; Hikosaka O, 2007, ANN NY ACAD SCI, V1104, P229, DOI 10.1196/annals.1390.012; Hong S, 2011, J NEUROSCI, V31, P11457, DOI 10.1523/JNEUROSCI.1384-11.2011; Jhou TC, 2009, NEURON, V61, P786, DOI 10.1016/j.neuron.2009.02.001; Jhou TC, 2009, J COMP NEUROL, V513, P566, DOI 10.1002/cne.21891; Ji HF, 2007, J NEUROSCI, V27, P6923, DOI 10.1523/JNEUROSCI.0958-07.2007; Kawagoe R, 2004, J NEUROPHYSIOL, V91, P1013, DOI 10.1152/jn.00721.2003; Klein TA, 2007, SCIENCE, V318, P1642, DOI 10.1126/science.1145044; Lecourtier L, 2005, NEUROPSYCHOPHARMACOL, V30, P484, DOI 10.1038/sj.npp.1300595; Lecourtier L, 2004, EUR J NEUROSCI, V19, P2551, DOI 10.1111/j.0953-816X.2004.03356.x; Lecourtier L, 2007, NEUROSCI BIOBEHAV R, V31, P658, DOI 10.1016/j.neubiorev.2007.01.004; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matsumoto M, 2009, NAT NEUROSCI, V12, P77, DOI 10.1038/nn.2233; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Murphy CA, 1996, BEHAV BRAIN RES, V81, P43, DOI 10.1016/S0166-4328(96)00041-1; Nakamura K, 2008, J NEUROSCI, V28, P5331, DOI 10.1523/JNEUROSCI.0021-08.2008; Nakamura K, 2006, J NEUROSCI, V26, P5360, DOI 10.1523/JNEUROSCI.4853-05.2006; Pessiglione M, 2006, NATURE, V442, P1042, DOI 10.1038/nature05051; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shumake J, 2010, J NEUROSCI, V30, P5876, DOI 10.1523/JNEUROSCI.3604-09.2010; SUTHERLAND RJ, 1982, NEUROSCI BIOBEHAV R, V6, P1, DOI 10.1016/0149-7634(82)90003-3; THORNTON EW, 1991, PHYSIOL BEHAV, V49, P819, DOI 10.1016/0031-9384(91)90324-H; Ullsperger M, 2003, J NEUROSCI, V23, P4308, DOI 10.1523/jneurosci.23-10-04308.2003; WANG RY, 1977, SCIENCE, V197, P89, DOI 10.1126/science.194312; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406	39	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26701	10.1371/journal.pone.0026701	http://dx.doi.org/10.1371/journal.pone.0026701			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039537	gold, Green Submitted, Green Published			2022-12-27	WOS:000296515200044
J	Mongrain, V; La Spada, F; Curie, T; Franken, P				Mongrain, Valerie; La Spada, Francesco; Curie, Thomas; Franken, Paul			Sleep Loss Reduces the DNA-Binding of BMAL1, CLOCK, and NPAS2 to Specific Clock Genes in the Mouse Cerebral Cortex	PLOS ONE			English	Article							E-BOX BINDING; CIRCADIAN-CLOCK; PERIPHERAL-TISSUES; MESSENGER-RNA; MOLECULAR CHARACTERIZATION; OVERLAPPING ROLES; EXPRESSION; TRANSCRIPTION; DEPRIVATION; RHYTHM	We have previously demonstrated that clock genes contribute to the homeostatic aspect of sleep regulation. Indeed, mutations in some clock genes modify the markers of sleep homeostasis and an increase in homeostatic sleep drive alters clock gene expression in the forebrain. Here, we investigate a possible mechanism by which sleep deprivation (SD) could alter clock gene expression by quantifying DNA-binding of the core-clock transcription factors CLOCK, NPAS2, and BMAL1 to the cis-regulatory sequences of target clock genes in mice. Using chromatin immunoprecipitation (ChIP), we first showed that, as reported for the liver, DNA-binding of CLOCK and BMAL1 to target clock genes changes in function of time-of-day in the cerebral cortex. Tissue extracts were collected at ZT0 (light onset), -6, -12, and -18, and DNA enrichment of E-box or E'-box containing sequences was measured by qPCR. CLOCK and BMAL1 binding to Cry1, Dbp, Per1, and Per2 depended on time-of-day, with maximum values reached at around ZT6. We then observed that SD, performed between ZT0 and -6, significantly decreased DNA-binding of CLOCK and BMAL1 to Dbp, consistent with the observed decrease in Dbp mRNA levels after SD. The DNA-binding of NPAS2 and BMAL1 to Per2 was also decreased by SD, although SD is known to increase Per2 expression in the cortex. DNA-binding to Per1 and Cry1 was not affected by SD. Our results show that the sleep-wake history can affect the clock molecular machinery directly at the level of chromatin binding thereby altering the cortical expression of Dbp and Per2 and likely other targets. Although the precise dynamics of the relationship between DNA-binding and mRNA expression, especially for Per2, remains elusive, the results also suggest that part of the reported circadian changes in DNA-binding of core clock components in tissues peripheral to the suprachiasmatic nuclei could, in fact, be sleep-wake driven.	[Mongrain, Valerie; La Spada, Francesco; Curie, Thomas; Franken, Paul] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Mongrain, Valerie] Univ Montreal, Dept Psychiat, Hop Sacre Coeur Montreal, Ctr Adv Res Sleep Med, Montreal, PQ H3C 3J7, Canada	University of Lausanne; Universite de Montreal	Mongrain, V (corresponding author), Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland.	valerie.mongrain@umontreal.ca; paul.franken@unil.ch	Mongrain, Valérie/A-3931-2012; Franken, Paul/A-9633-2018	Franken, Paul/0000-0002-2500-2921	University of Lausanne, Canton de Vaud (Switzerland); Swiss National Science Foundation [130825, 111974]; National Sciences and Engineering Research Council of Canada; Marie Curie Intra-European program fellowship [221254]	University of Lausanne, Canton de Vaud (Switzerland); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Marie Curie Intra-European program fellowship	This work was supported by the University of Lausanne, Canton de Vaud (Switzerland), by grants from the Swiss National Science Foundation to PF (130825 and 111974), a fellowship from the National Sciences and Engineering Research Council of Canada to VM, and a Marie Curie Intra-European program fellowship to TC (IEF-FP7-Project Number: 221254). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Baracchi F, 2008, BRAIN BEHAV IMMUN, V22, P982, DOI 10.1016/j.bbi.2008.02.001; Bertolucci C, 2008, MOL CELL BIOL, V28, P3070, DOI 10.1128/MCB.01931-07; Borbely A A, 1982, Hum Neurobiol, V1, P195; Cai W, 2008, MOL CELL BIOL, V28, P784, DOI 10.1128/MCB.00233-07; Curie T, GENES DEV UNPUB; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; DeBruyne JP, 2007, NAT NEUROSCI, V10, P543, DOI 10.1038/nn1884; Dijk DJ, 2002, J APPL PHYSIOL, V92, P852, DOI 10.1152/japplphysiol.00924.2001; Doi M, 2006, CELL, V125, P497, DOI 10.1016/j.cell.2006.03.033; Donlea JM, 2009, SCIENCE, V324, P105, DOI 10.1126/science.1166657; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Etchegaray JP, 2003, NATURE, V421, P177, DOI 10.1038/nature01314; Franken P, 2006, P NATL ACAD SCI USA, V103, P7118, DOI 10.1073/pnas.0602006103; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; FRANKEN P, 1991, AM J PHYSIOL, V261, pR198, DOI 10.1152/ajpregu.1991.261.1.R198; Franken P, 2000, J NEUROSCI, V20, P617, DOI 10.1523/JNEUROSCI.20-02-00617.2000; Franken P, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-87; Fustin JM, 2009, J BIOL RHYTHM, V24, P16, DOI 10.1177/0748730408329267; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Graves LA, 2003, J NEUROPHYSIOL, V90, P1152, DOI 10.1152/jn.00882.2002; Guillaumond F, 2010, MOL CELL BIOL, V30, P3059, DOI 10.1128/MCB.01141-09; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Hao HP, 2008, J NEUROSCI METH, V172, P38, DOI 10.1016/j.jneumeth.2008.04.002; Haque R, 2010, J NEUROCHEM, V113, P1296, DOI 10.1111/j.1471-4159.2010.06698.x; Hara Y, 2009, NUCLEIC ACIDS RES, V37, P1115, DOI 10.1093/nar/gkn1013; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hu J, 2003, BRAIN BEHAV IMMUN, V17, P498, DOI 10.1016/j.bbi.2003.03.001; Katada S, 2010, NAT STRUCT MOL BIOL, V17, P1414, DOI 10.1038/nsmb.1961; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Kondratov RV, 2006, CELL CYCLE, V5, P890, DOI 10.4161/cc.5.8.2684; Kondratov RV, 2006, FASEB J, V20, P530, DOI 10.1096/fj.05-5321fje; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Liu S, 2007, CHRONOBIOL INT, V24, P793, DOI 10.1080/07420520701672556; Mackiewicz M, 2007, PHYSIOL GENOMICS, V31, P441, DOI 10.1152/physiolgenomics.00275.2006; Maret S, 2007, P NATL ACAD SCI USA, V104, P20090, DOI 10.1073/pnas.0710131104; Maywood ES, 1999, P NATL ACAD SCI USA, V96, P15211, DOI 10.1073/pnas.96.26.15211; Menet JS, 2010, GENE DEV, V24, P358, DOI 10.1101/gad.1883910; Mongrain V, 2010, SLEEP, V33, P1147, DOI 10.1093/sleep/33.9.1147; Nader N, 2009, FASEB J, V23, P1572, DOI 10.1096/fj.08-117697; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Nakashima A, 2008, MOL CELL BIOL, V28, P4080, DOI 10.1128/MCB.02168-07; Naylor E, 2000, J NEUROSCI, V20, P8138; Oishi K, 2005, DNA RES, V12, P191, DOI 10.1093/dnares/dsi003; Patel SR, 2009, SLEEP, V32, P200, DOI 10.1093/sleep/32.2.200; Petrzilka S, 2009, J BIOL RHYTHM, V24, P283, DOI 10.1177/0748730409336579; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; Rey G, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000595; Reynolds AC, 2010, PROG BRAIN RES, V185, P91, DOI 10.1016/B978-0-444-53702-7.00006-3; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Sakai T, 2004, P NATL ACAD SCI USA, V101, P16058, DOI 10.1073/pnas.0401472101; Shirai H, 2007, BIOCHEM BIOPH RES CO, V357, P679, DOI 10.1016/j.bbrc.2007.04.002; Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810; Takahashi S, 1996, NEUROREPORT, V7, P642, DOI 10.1097/00001756-199601310-00063; Taylor P, 2008, MOL CELL BIOL, V28, P4642, DOI 10.1128/MCB.01612-07; Thompson CL, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00165; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Travnickova-Bendova Z, 2002, P NATL ACAD SCI USA, V99, P7728, DOI 10.1073/pnas.102075599; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Wakamatsu H, 2001, EUR J NEUROSCI, V13, P1190, DOI 10.1046/j.0953-816x.2001.01483.x; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020; Wisor JP, 2008, J NEUROSCI, V28, P7193, DOI 10.1523/JNEUROSCI.1150-08.2008; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Yamamoto T, 2005, J BIOL CHEM, V280, P42036, DOI 10.1074/jbc.M509600200; Yamamoto T, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-18; Yan LL, 2000, J NEUROSCI RES, V59, P291, DOI 10.1002/(SICI)1097-4547(20000115)59:2<291::AID-JNR16>3.0.CO;2-O; Yang SZ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r247; Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08; Yu WJ, 2006, GENE DEV, V20, P723, DOI 10.1101/gad.1404406; Zhou YD, 1997, P NATL ACAD SCI USA, V94, P713, DOI 10.1073/pnas.94.2.713	75	71	76	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26622	10.1371/journal.pone.0026622	http://dx.doi.org/10.1371/journal.pone.0026622			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039518	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200034
J	Welsh-Bacic, D; Nowik, M; Kaissling, B; Wagner, CA				Welsh-Bacic, Desa; Nowik, Marta; Kaissling, Brigitte; Wagner, Carsten A.			Proliferation of Acid-Secretory Cells in the Kidney during Adaptive Remodelling of the Collecting Duct	PLOS ONE			English	Article							RENAL TUBULAR-ACIDOSIS; INTERCALATED CELLS; TERMINAL DIFFERENTIATION; RAT-KIDNEY; METABOLIC-ACIDOSIS; EPITHELIAL-CELLS; H+-ATPASE; TRANSCRIPTION FACTOR; TRANSPORT PATHWAYS; ANION-EXCHANGER	The renal collecting duct adapts to changes in acid-base metabolism by remodelling and altering the relative number of acid or alkali secreting cells, a phenomenon termed plasticity. Acid secretory A intercalated cells (A-IC) express apical H+-ATPases and basolateral bicarbonate exchanger AE1 whereas bicarbonate secretory B intercalated cells (B-IC) express basolateral (and apical) H+-ATPases and the apical bicarbonate exchanger pendrin. Intercalated cells were thought to be terminally differentiated and unable to proliferate. However, a recent report in mouse kidney suggested that intercalated cells may proliferate and that this process is in part dependent on GDF-15. Here we extend these observations to rat kidney and provide a detailed analysis of regional differences and demonstrate that differentiated A-IC proliferate massively during adaptation to systemic acidosis. We used markers of proliferation (PCNA, Ki67, BrdU incorporation) and cell-specific markers for A-IC (AE1) and B-IC (pendrin). Induction of remodelling in rats with metabolic acidosis (with NH4Cl for 12 hrs, 4 and 7 days) or treatment with acetazolamide for 10 days resulted in a larger fraction of AE1 positive cells in the cortical collecting duct. A large number of AE1 expressing A-IC was labelled with proliferative markers in the cortical and outer medullary collecting duct whereas no labeling was found in B-IC. In addition, chronic acidosis also increased the rate of proliferation of principal collecting duct cells. The fact that both NH4Cl as well as acetazolamide stimulated proliferation suggests that systemic but not urinary pH triggers this response. Thus, during chronic acidosis proliferation of AE1 containing acid-secretory cells occurs and may contribute to the remodelling of the collecting duct or replace A-IC due to a shortened life span under these conditions.	[Welsh-Bacic, Desa; Nowik, Marta; Wagner, Carsten A.] Univ Zurich, Inst Physiol, Zurich, Switzerland; [Welsh-Bacic, Desa; Kaissling, Brigitte] Univ Zurich, Inst Anat, Zurich, Switzerland; [Welsh-Bacic, Desa; Nowik, Marta; Wagner, Carsten A.] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland	University of Zurich; University of Zurich; University of Zurich; Zurich Center Integrative Human Physiology (ZIHP)	Welsh-Bacic, D (corresponding author), Univ Zurich, Inst Physiol, Zurich, Switzerland.	Wagnerca@access.unizh.ch			Swiss National Science Foundation [3100A0-122217]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation to CAW(3100A0-122217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Awqati Q, 2003, J AM SOC NEPHROL, V14, pS16, DOI 10.1097/01.ASN.0000067633.19426.DD; Al-Awqati Q, 2003, ANNU REV PHYSIOL, V65, P567, DOI 10.1146/annurev.physiol.65.092101.142645; Al-Awqati Q, 2011, ANNU REV PHYSIOL, V73, P401, DOI 10.1146/annurev-physiol-012110-142253; AlAwqati Q, 1996, AM J PHYSIOL-CELL PH, V270, pC1571, DOI 10.1152/ajpcell.1996.270.6.C1571; ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; Ambuhl PM, 1996, AM J PHYSIOL-RENAL, V271, pF917, DOI 10.1152/ajprenal.1996.271.4.F917; Bagnis C, 2001, AM J PHYSIOL-RENAL, V280, pF437, DOI 10.1152/ajprenal.2001.280.3.F437; BASTANI B, 1991, J CLIN INVEST, V88, P126, DOI 10.1172/JCI115268; BERTHELOT MPE, 1959, REP CHEM APPL, V1, P284, DOI DOI 10.1056/NEJMOA1708131; Blomqvist SR, 2004, J CLIN INVEST, V113, P1560, DOI 10.1172/JCI200420665; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Breton S, 1995, AM J PHYSIOL-RENAL, V269, pF761, DOI 10.1152/ajprenal.1995.269.6.F761; BROWN D, 1988, NATURE, V331, P622, DOI 10.1038/331622a0; CAPASSO G, 1994, J CLIN INVEST, V94, P830, DOI 10.1172/JCI117403; CHAN JCM, 1972, CLIN BIOCHEM, V5, P94, DOI 10.1016/S0009-9120(72)80014-6; Christensen BM, 2006, AM J PHYSIOL-RENAL, V291, pF39, DOI 10.1152/ajprenal.00383.2005; Christensen BM, 2004, AM J PHYSIOL-CELL PH, V286, pC952, DOI 10.1152/ajpcell.00266.2003; DAWSON TP, 1989, J HISTOCHEM CYTOCHEM, V37, P39, DOI 10.1177/37.1.2535703; DIETRICH DR, 1993, CRIT REV TOXICOL, V23, P77, DOI 10.3109/10408449309104075; Gao X, 2010, P NATL ACAD SCI US; Hafner P, 2008, AM J PHYSIOL-CELL PH, V295, pC1658, DOI 10.1152/ajpcell.00419.2008; Hikita C, 2000, J CELL BIOL, V151, P1235, DOI 10.1083/jcb.151.6.1235; Jeong HW, 2009, J CLIN INVEST, V119, P3290, DOI 10.1172/JCI38416; Kim J, 1996, AM J PHYSIOL-RENAL, V270, pF575, DOI 10.1152/ajprenal.1996.270.4.F575; Kim J, 1999, J AM SOC NEPHROL, V10, P1; KIM J, 1992, AM J PHYSIOL, V262, pF288, DOI 10.1152/ajprenal.1992.262.2.F288; Kim YH, 2002, AM J PHYSIOL-RENAL, V283, pF744, DOI 10.1152/ajprenal.00037.2002; Loffing J, 1996, KIDNEY INT, V50, P1180, DOI 10.1038/ki.1996.426; Loffing J, 2003, AM J PHYSIOL-RENAL, V284, pF628, DOI 10.1152/ajprenal.00217.2002; Loffing J, 2001, AM J PHYSIOL-RENAL, V281, pF1021, DOI 10.1152/ajprenal.0085.2001; LOFFING J, 1995, KIDNEY INT, V47, P1615, DOI 10.1038/ki.1995.225; MADSEN KM, 1984, LAB INVEST, V51, P268; PRELICH G, 1987, NATURE, V326, P517, DOI 10.1038/326517a0; Purkerson JM, 2010, KIDNEY INT, V78, P993, DOI 10.1038/ki.2010.195; Quentin F, 2004, AM J PHYSIOL-RENAL, V287, pF1179, DOI 10.1152/ajprenal.00211.2004; Royaux IE, 2001, P NATL ACAD SCI USA, V98, P4221, DOI 10.1073/pnas.071516798; Sabolic I, 1997, KIDNEY INT, V51, P125, DOI 10.1038/ki.1997.16; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Schwartz GJ, 2002, J CLIN INVEST, V109, P89, DOI 10.1172/JCI13292; SCHWARTZ GJ, 1985, NATURE, V318, P368, DOI 10.1038/318368a0; SEATON B, 1984, MED LAB SCI, V41, P327; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; Song HK, 2007, J AM SOC NEPHROL, V18, P2672, DOI 10.1681/ASN.2006101076; Stehberger PA, 2003, J AM SOC NEPHROL, V14, P3027, DOI 10.1097/01.ASN.0000099375.74789.AB; Stehberger PA, 2007, J AM SOC NEPHROL, V18, P1408, DOI 10.1681/ASN.2006101072; Takito J, 1996, J CLIN INVEST, V98, P2324, DOI 10.1172/JCI119044; TengUmnuay P, 1996, J AM SOC NEPHROL, V7, P260; Vallet M, 2006, J AM SOC NEPHROL, V17, P2153, DOI 10.1681/ASN.2005101054; Van Huyen JPD, 2008, J AM SOC NEPHROL, V19, P1965, DOI 10.1681/ASN.2007070781; VERLANDER JW, 1994, AM J PHYSIOL, V266, pF633, DOI 10.1152/ajprenal.1994.266.4.F633; Verlander JW, 1996, KIDNEY INT, V50, pS137; Vijayakumar S, 1999, J CELL BIOL, V144, P1057, DOI 10.1083/jcb.144.5.1057; Vogetseder A, 2005, HISTOCHEM CELL BIOL, V124, P97, DOI 10.1007/s00418-005-0023-y; Vogetseder A, 2008, AM J PHYSIOL-CELL PH, V294, pC22, DOI 10.1152/ajpcell.00227.2007; Vogetseder A, 2007, AM J PHYSIOL-CELL PH, V292, pC807, DOI 10.1152/ajpcell.00301.2006; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wagner CA, 2008, AM J PHYSIOL-RENAL, V294, pF1373, DOI 10.1152/ajprenal.00613.2007; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Wehrli P, 2007, HISTOCHEM CELL BIOL, V127, P389, DOI 10.1007/s00418-006-0261-7; Yamaguchi Y, 2006, DEVELOPMENT, V133, P4737, DOI 10.1242/dev.02658; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144	61	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e25240	10.1371/journal.pone.0025240	http://dx.doi.org/10.1371/journal.pone.0025240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039408	Green Accepted, Green Published, gold			2022-12-27	WOS:000296515200001
J	Nassl, AM; Rubio-Aliaga, I; Sailer, M; Daniel, H				Naessl, Anna-Maria; Rubio-Aliaga, Isabel; Sailer, Manuela; Daniel, Hannelore			The Intestinal Peptide Transporter PEPT1 Is Involved in Food Intake Regulation in Mice Fed a High-Protein Diet	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; CONDITIONED TASTE-AVERSION; AMINO-ACIDS; LEUCINE SUPPLEMENTATION; HIGH-CARBOHYDRATE; INDUCED OBESITY; CALORIC-INTAKE; PLASMA LEPTIN; L-ARGININE; RATS	High-protein diets are effective in achieving weight loss which is mainly explained by increased satiety and thermogenic effects. Recent studies suggest that the effects of protein-rich diets on satiety could be mediated by amino acids like leucine or arginine. Although high-protein diets require increased intestinal amino acid absorption, amino acid and peptide absorption has not yet been considered to contribute to satiety effects. We here demonstrate a novel finding that links intestinal peptide transport processes to food intake, but only when a protein-rich diet is provided. When mice lacking the intestinal peptide transporter PEPT1 were fed diets containing 8 or 21 energy% of protein, no differences in food intake and weight gain were observed. However, upon feeding a high-protein (45 energy%) diet, Pept1(-/-) mice reduced food intake much more pronounced than control animals. Although there was a regain in food consumption after a few days, no weight gain was observed which was associated with a reduced intestinal energy assimilation and increased fecal energy losses. Pept1(-/-) mice on high-protein diet displayed markedly reduced plasma leptin levels during the period of very low food intake, suggesting a failure of leptin signaling to increase energy intake. This together with an almost two-fold elevated plasma arginine level in Pept1(-/-) but not wildtype mice, suggests that a cross-talk of arginine with leptin signaling in brain, as described previously, could cause these striking effects on food intake.	[Naessl, Anna-Maria; Rubio-Aliaga, Isabel; Sailer, Manuela; Daniel, Hannelore] Tech Univ Munich, Biochem Abt, ZIEL Res Ctr Nutr & Food Sci, D-8050 Freising Weihenstephan, Germany	Technical University of Munich	Nassl, AM (corresponding author), Tech Univ Munich, Biochem Abt, ZIEL Res Ctr Nutr & Food Sci, D-8050 Freising Weihenstephan, Germany.	daniel@wzw.tum.de	Daniel, Hannelore/B-8982-2009	Rubio-Aliaga, Isabel/0000-0003-1051-9511	Deutsche Forschungsgemeinschaft (DFG) [DA 190/8-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	Funding: This work was supported by a grant (DA 190/8-1) from the Deutsche Forschungsgemeinschaft (DFG). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adibi SA, 1997, GASTROENTEROLOGY, V113, P332, DOI 10.1016/S0016-5085(97)70112-4; Balage M, 2010, CURR OPIN CLIN NUTR, V13, P265, DOI 10.1097/MCO.0b013e328336f6b8; Bensaid A, 2003, PHYSIOL BEHAV, V78, P311, DOI 10.1016/S0031-9384(02)00977-0; Bensaid A, 2002, PHYSIOL BEHAV, V75, P577, DOI 10.1016/S0031-9384(02)00646-7; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Buchmann I, 1996, PHARMACOLOGY, V53, P133, DOI 10.1159/000139424; Buyse M, 2001, J CLIN INVEST, V108, P1483, DOI 10.1172/JCI13219; Calapi G, 1999, J CLIN INVEST, V104, P975, DOI 10.1172/JCI5867; CHEN M, 2010, AM J PHYSL GASTROINT; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; Denbow DM, 2000, PHYSIOL BEHAV, V69, P359, DOI 10.1016/S0031-9384(99)00258-9; Eastwood C, 1998, NEUROSCI LETT, V254, P145, DOI 10.1016/S0304-3940(98)00666-1; ERICKSON RH, 1995, BIOCHEM BIOPH RES CO, V216, P249, DOI 10.1006/bbrc.1995.2617; Faipoux R, 2008, J NUTR, V138, P1172, DOI 10.1093/jn/138.6.1172; Halatchev IG, 2005, CELL METAB, V1, P159, DOI 10.1016/j.cmet.2005.02.003; Hindlet P, 2007, J PHARMACOL EXP THER, V323, P192, DOI 10.1124/jpet.107.125799; Hindlet P, 2009, J BIOL CHEM, V284, P6801, DOI 10.1074/jbc.M805564200; Hiroshige K, 2001, NEPHROL DIAL TRANSPL, V16, P1856, DOI 10.1093/ndt/16.9.1856; Hu YG, 2008, MOL PHARMACEUT, V5, P1122, DOI 10.1021/mp8001655; Jean C, 2002, PHYSIOL BEHAV, V76, P65, DOI 10.1016/S0031-9384(02)00676-5; KRAUSS RM, 1965, AM J PHYSIOL, V209, P479, DOI 10.1152/ajplegacy.1965.209.3.479; Kuhla B, 2010, PROTEOMICS, V10, P2573, DOI 10.1002/pmic.200900789; Latner JD, 1999, APPETITE, V33, P119, DOI 10.1006/appe.1999.0237; LeBricon T, 1996, CLIN NUTR, V15, P337, DOI 10.1016/S0261-5614(96)80011-2; Lynch CJ, 2006, AM J PHYSIOL-ENDOC M, V291, pE621, DOI 10.1152/ajpendo.00462.2005; Martin G, 2007, BIOCHEM J, V401, P465, DOI 10.1042/BJ20061148; Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200; Mithieux G, 2005, CELL METAB, V2, P321, DOI 10.1016/j.cmet.2005.09.010; Mithieux G, 2009, NUTRITION, V25, P881, DOI 10.1016/j.nut.2009.06.010; Mithieux G, 2009, CURR OPIN CLIN NUTR, V12, P419, DOI 10.1097/MCO.0b013e32832c4d6a; Moran TH, 2000, NUTRITION, V16, P858, DOI 10.1016/S0899-9007(00)00419-6; MORLEY JE, 1991, LIFE SCI, V49, P707, DOI 10.1016/0024-3205(91)90102-H; Nairizi A, 2009, J NUTR, V139, P715, DOI 10.3945/jn.108.100081; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; NASSL A, 2011, AM J PHYSL GASTROINT; Noatsch A, 2011, EUR J NUTR, V50, P479, DOI 10.1007/s00394-010-0155-2; Palacin M, 1998, PHYSIOL REV, V78, P969, DOI 10.1152/physrev.1998.78.4.969; PETERS JC, 1985, J NUTR, V115, P382, DOI 10.1093/jn/115.3.382; Phillips RJ, 1996, AM J PHYSIOL-REG I, V271, pR766, DOI 10.1152/ajpregu.1996.271.3.R766; Potier M, 2009, CURR OPIN CLIN NUTR, V12, P54, DOI 10.1097/MCO.0b013e32831b9e01; REMESY C, 1978, BIOCHEM J, V170, P321, DOI 10.1042/bj1700321; Schwartz GJ, 2000, NUTRITION, V16, P866, DOI 10.1016/S0899-9007(00)00464-0; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Smeets AJ, 2008, J NUTR, V138, P698, DOI 10.1093/jn/138.4.698; SQUADRITO F, 1993, EUR J PHARMACOL, V230, P125, DOI 10.1016/0014-2999(93)90422-E; SQUADRITO F, 1994, EUR J PHARMACOL, V255, P51, DOI 10.1016/0014-2999(94)90081-7; SQUADRITO F, 1994, NEUROPHARMACOLOGY, V33, P83, DOI 10.1016/0028-3908(94)90100-7; Team RDC, 2009, R LANG ENV STAT COMP; Terada T, 2007, BIOCHEM PHARMACOL, V73, P440, DOI 10.1016/j.bcp.2006.10.010; Tome D, 2004, BRIT J NUTR, V92, pS27, DOI 10.1079/BJN20041138; Tome D, 2009, AM J CLIN NUTR, V90, p838S, DOI 10.3945/ajcn.2009.27462W; van't Hof RJ, 2004, ENDOCRINOLOGY, V145, P5068, DOI 10.1210/en.2004-0205; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; Wren AM, 2007, GASTROENTEROLOGY, V132, P2116, DOI 10.1053/j.gastro.2007.03.048; Yang SJ, 2007, PHYSIOL BEHAV, V92, P651, DOI 10.1016/j.physbeh.2007.05.009; Zhang YY, 2007, DIABETES, V56, P1647, DOI 10.2337/db07-0123	58	33	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26407	10.1371/journal.pone.0026407	http://dx.doi.org/10.1371/journal.pone.0026407			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031831	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200020
J	Fuka, G; Kauer, M; Kofler, R; Haas, OA; Panzer-Grumayer, R				Fuka, Gerhard; Kauer, Maximilian; Kofler, Reinhard; Haas, Oskar A.; Panzer-Gruemayer, Renate			The Leukemia-Specific Fusion Gene ETV6/RUNX1 Perturbs Distinct Key Biological Functions Primarily by Gene Repression	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; EXPRESSION PATTERNS; SET ENRICHMENT; CELLS; CANCER; CD133; CLASSIFICATION; TRANSLOCATIONS; REVEALS; STRESS	Background: ETV6/RUNX1 (E/R) (also known as TEL/AML1) is the most frequent gene fusion in childhood acute lymphoblastic leukemia (ALL) and also most likely the crucial factor for disease initiation; its role in leukemia propagation and maintenance, however, remains largely elusive. To address this issue we performed a shRNA-mediated knock-down (KD) of the E/R fusion gene and investigated the ensuing consequences on genome-wide gene expression patterns and deducible regulatory functions in two E/R-positive leukemic cell lines. Findings: Microarray analyses identified 777 genes whose expression was substantially altered. Although approximately equal proportions were either up-(KD-UP) or down-regulated (KD-DOWN), the effects on biological processes and pathways differed considerably. The E/R KD-UP set was significantly enriched for genes included in the "cell activation", "immune response", "apoptosis", "signal transduction" and "development and differentiation" categories, whereas in the E/R KD-DOWN set only the "PI3K/AKT/mTOR signaling" and "hematopoietic stem cells" categories became evident. Comparable expression signatures obtained from primary E/R-positive ALL samples underline the relevance of these pathways and molecular functions. We also validated six differentially expressed genes representing the categories "stem cell properties", "B-cell differentiation", "immune response", "cell adhesion" and "DNA damage" with RT-qPCR. Conclusion: Our analyses provide the first preliminary evidence that the continuous expression of the E/R fusion gene interferes with key regulatory functions that shape the biology of this leukemia subtype. E/R may thus indeed constitute the essential driving force for the propagation and maintenance of the leukemic process irrespective of potential consequences of associated secondary changes. Finally, these findings may also provide a valuable source of potentially attractive therapeutic targets.	[Fuka, Gerhard; Kauer, Maximilian; Panzer-Gruemayer, Renate] St Anna Childrens Hosp, Childrens Canc Res Inst, A-1090 Vienna, Austria; [Kofler, Reinhard] Innsbruck Med Univ, Div Mol Pathophysiol, Tyrolean Canc Res Inst, Innsbruck, Austria; [Kofler, Reinhard] Innsbruck Med Univ, Bioctr, Innsbruck, Austria; [Haas, Oskar A.; Panzer-Gruemayer, Renate] St Anna Childrens Hosp, Vienna, Austria	Saint Anna Children's Hospital; Medical University of Innsbruck; Medical University of Innsbruck; Saint Anna Children's Hospital	Fuka, G (corresponding author), St Anna Childrens Hosp, Childrens Canc Res Inst, Kinderspitalgasse 6, A-1090 Vienna, Austria.	renate.panzer@ccri.at	Haas, Oskar/AAM-5794-2020		Austrian National Bank ONB [12213, 13466]; St. Anna Kinderkrebsforschung; GENAU-CHILD Projekt [GZ200.136/1 -VI/1/2005]; ONCOTYROL; Austrian Research Promotion Agency; Tiroler Zukunftsstiftung; Styrian Business Promotion Agency	Austrian National Bank ONB; St. Anna Kinderkrebsforschung; GENAU-CHILD Projekt; ONCOTYROL; Austrian Research Promotion Agency; Tiroler Zukunftsstiftung; Styrian Business Promotion Agency	This work was supported by the Austrian National Bank ONB (12213 and 13466), the St. Anna Kinderkrebsforschung and GENAU-CHILD Projekt (GZ200.136/1 -VI/1/2005) to RP-G and by ONCOTYROL (a COMET Center funded by the Austrian Research Promotion Agency, the Tiroler Zukunftsstiftung and the Styrian Business Promotion Agency) to RK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Nabi AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012464; Akers SM, 2010, EXP HEMATOL, V38, P733, DOI 10.1016/j.exphem.2010.05.001; Andersson A, 2005, P NATL ACAD SCI USA, V102, P19069, DOI 10.1073/pnas.0506637102; Baal N, 2004, THROMB HAEMOSTASIS, V92, P767, DOI 10.1160/TH04-02-0079; Bomken S, 2010, BRIT J CANCER, V103, P439, DOI 10.1038/sj.bjc.6605821; Bouska A, 2009, TRENDS BIOCHEM SCI, V34, P279, DOI 10.1016/j.tibs.2009.02.006; Cox CV, 2009, BLOOD, V113, P3287, DOI 10.1182/blood-2008-04-154187; De Zen L, 2000, LEUKEMIA, V14, P1225, DOI 10.1038/sj.leu.2401824; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Diakos C, 2007, BLOOD, V109, P2607, DOI 10.1182/blood-2006-04-019612; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; Fine BM, 2004, BLOOD, V103, P1043, DOI 10.1182/blood-2003-05-1518; Ford AM, 2009, J CLIN INVEST, V119, P826, DOI 10.1172/JCI36428; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Gandemer V, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-385; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Greaves M, 2006, NAT REV CANCER, V6, P193, DOI 10.1038/nrc1816; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hiebert SW, 1996, MOL CELL BIOL, V16, P1349; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Horak P, 2010, P NATL ACAD SCI USA, V107, P4675, DOI 10.1073/pnas.0907705107; Inthal A, 2008, CLIN CANCER RES, V14, P7196, DOI 10.1158/1078-0432.CCR-07-5051; Jaatinen T, 2006, STEM CELLS, V24, P631, DOI 10.1634/stemcells.2005-0185; Kauer M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005415; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kuster L, 2011, BLOOD, V117, P2658, DOI 10.1182/blood-2010-03-275347; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Mizrak D, 2008, J PATHOL, V214, P3, DOI 10.1002/path.2283; Moorman AV, 2010, LANCET ONCOL, V11, P429, DOI 10.1016/S1470-2045(10)70066-8; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Pridans C, 2008, J IMMUNOL, V180, P1719, DOI 10.4049/jimmunol.180.3.1719; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Rossetti S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-38; Schindler JW, 2009, CELL STEM CELL, V5, P43, DOI 10.1016/j.stem.2009.04.019; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; van Zelm MC, 2005, J IMMUNOL, V175, P5912, DOI 10.4049/jimmunol.175.9.5912; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Wotton S, 2008, ONCOGENE, V27, P5856, DOI 10.1038/onc.2008.195; Yang G, 2007, ONCOGENE, V26, P594, DOI 10.1038/sj.onc.1209807; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	48	34	35	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26348	10.1371/journal.pone.0026348	http://dx.doi.org/10.1371/journal.pone.0026348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028862	Green Submitted, Green Published, gold			2022-12-27	WOS:000296510800037
J	Siltanen, S; Wahlfors, T; Schindler, M; Saramaki, OR; Mpindi, JP; Latonen, L; Vessella, RL; Tammela, TLJ; Kallioniemi, O; Visakorpi, T; Schleutker, J				Siltanen, Sanna; Wahlfors, Tiina; Schindler, Martin; Saramaki, Outi R.; Mpindi, John Patrick; Latonen, Leena; Vessella, Robert L.; Tammela, Teuvo L. J.; Kallioniemi, Olli; Visakorpi, Tapio; Schleutker, Johanna			Contribution of ARLTS1 Cys148Arg (T442C) Variant with Prostate Cancer Risk and ARLTS1 Function in Prostate Cancer Cells	PLOS ONE			English	Article							PROLIFERATIVE INFLAMMATORY ATROPHY; COLORECTAL-CANCER; ALLELIC IMBALANCE; FAMILIAL CANCER; GENE; EXPRESSION; CARCINOGENESIS; BREAST; TUMORS; ASSOCIATION	ARLTS1 is a recently characterized tumor suppressor gene at 13q14.3, a region frequently deleted in both sporadic and hereditary prostate cancer (PCa). ARLTS1 variants, especially Cys148Arg (T442C), increase susceptibility to different cancers, including PCa. In this study the role of Cys148Arg substitution was investigated as a risk factor for PCa using both genetic and functional analysis. Cys148Arg genotypes and expression of the ARLTS1 were explored in a large set of familial and unselected PCa cases, clinical tumor samples, xenografts, prostate cancer cell lines and benign prostatic hyperplasia (BPH) samples. The frequency of the variant genotype CC was significantly higher in familial (OR = 1.67, 95% CI = 1.08-2.56, P = 0.019) and unselected patients (OR = 1.52, 95% CI = 1.18-1.97, P = 0.001) and the overall risk was increased (OR = 1.54, 95% CI = 1.20-1.98, P = 0.0007). Additional analysis with clinicopathological data revealed an association with an aggressive disease (OR = 1.28, 95% CI = 1.05-infinity, P = 0.02). The CC genotype of the Cys148Arg variant was also contributing to the lowered ARLTS1 expression status in lymphoblastoid cells from familial patients. In addition significantly lowered ARLTS1 expression was observed in clinical tumor samples compared to BPH samples (P = 0.01). The ARLTS1 co-expression signature based on previously published microarray data was generated from 1587 cancer samples confirming the low expression of ARLTS1 in PCa and showed that ARLTS1 expression was strongly associated with immune processes. This study provides strong confirmation of the important role of ARLTS1 Cys148Arg variant as a contributor in PCa predisposition and a potential marker for aggressive disease outcome.	[Siltanen, Sanna; Wahlfors, Tiina; Schindler, Martin; Saramaki, Outi R.; Latonen, Leena; Visakorpi, Tapio] Univ Tampere, Inst Biomed Technol BioMediTech, FIN-33101 Tampere, Finland; [Siltanen, Sanna; Wahlfors, Tiina; Schindler, Martin; Saramaki, Outi R.; Latonen, Leena; Visakorpi, Tapio] Tampere Univ Hosp, Ctr Lab Med, Tampere, Finland; [Mpindi, John Patrick; Kallioniemi, Olli] Univ Helsinki, Inst Mol Med, Helsinki, Finland; [Vessella, Robert L.] Univ Washington, Dept Urol, Seattle, WA 98195 USA; [Vessella, Robert L.] Puget Sound VA Med Syst, Seattle, WA USA; [Tammela, Teuvo L. J.] Univ Tampere, Dept Urol, FIN-33101 Tampere, Finland; [Schleutker, Johanna] Univ Turku, Dept Med Biochem & Genet, Turku, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; University of Washington; University of Washington Seattle; Tampere University; University of Turku	Siltanen, S (corresponding author), Univ Tampere, Inst Biomed Technol BioMediTech, FIN-33101 Tampere, Finland.	Johanna.Schleutker@utu.fi	Latonen, Leena/C-8787-2016; Kallioniemi, Olli P/H-5111-2011; Wahlfors, Tiina/U-7635-2018	Latonen, Leena/0000-0003-4502-2193; Kallioniemi, Olli P/0000-0002-3231-0332; Visakorpi, Tapio/0000-0002-5004-0364; Schindler, Martin/0000-0002-6002-6953; Wahlfors, Tiina/0000-0002-3910-796X; Saramaki, Outi/0000-0001-7051-7855; Schleutker, Johanna/0000-0002-1863-0305	Pirkanmaa Hospital District [9L091]; Reino Lahtikari Foundation; Finnish Cancer Organisations; Sigrid Juselius Foundation; Academy of Finland [126714, 116437]	Pirkanmaa Hospital District; Reino Lahtikari Foundation; Finnish Cancer Organisations; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland(Academy of Finland)	This work was supported by The Competitive Research Funding of the Pirkanmaa Hospital District (grant number 9L091), Reino Lahtikari Foundation, Finnish Cancer Organisations, Sigrid Juselius Foundation and Academy of Finland [grant number 126714 to T.W. and 116437 to J.S.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bieche I, 1999, CANCER RES, V59, P2759; Brookman-Amissah N, 2007, CANCER GENET CYTOGEN, V179, P118, DOI 10.1016/j.cancergencyto.2007.08.017; Calin GA, 2005, NEW ENGL J MED, V352, P1667, DOI 10.1056/NEJMoa042280; CASTELLVIBEL S, 2007, CARCINOGENESIS; De Brakeleer S, 2005, NEW ENGL J MED, V353, P313; De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Frank B, 2006, INT J CANCER, V118, P2505, DOI 10.1002/ijc.21687; Frank B, 2006, CANCER LETT, V244, P172, DOI 10.1016/j.canlet.2005.12.006; Frank B, 2006, INT J CANCER, V119, P1736, DOI 10.1002/ijc.22008; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Ishkanian AS, 2009, PROSTATE, V69, P1091, DOI 10.1002/pros.20959; Kahn RA, 2005, BIOCHEM SOC T, V33, P1269, DOI 10.1042/BST0331269; KAHN RA, 1992, FASEB J, V6, P2512, DOI 10.1096/fasebj.6.8.1592203; Kilpinen S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r139; Kogan I, 2006, CANCER RES, V66, P3531, DOI 10.1158/0008-5472.CAN-05-2183; Kote-Jarai Z, 2008, CANCER EPIDEM BIOMAR, V17, P2052, DOI 10.1158/1055-9965.EPI-08-0317; Laitinen S, 2002, GENE CHROMOSOME CANC, V35, P66, DOI 10.1002/gcc.10097; Latil A, 2003, PROSTATE, V57, P39, DOI 10.1002/pros.10272; Linja MJ, 2001, CANCER RES, V61, P3550; Nakano M, 2008, PATHOL INT, V58, P415, DOI 10.1111/j.1440-1827.2008.02246.x; Petrocca F, 2006, CANCER RES, V66, P10287, DOI 10.1158/0008-5472.CAN-06-2289; Saramaki OR, 2006, INT J CANCER, V119, P1322, DOI 10.1002/ijc.21976; Saramaki OR, 2006, GENE CHROMOSOME CANC, V45, P639, DOI 10.1002/gcc.20327; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; Schleutker J, 2000, CLIN CANCER RES, V6, P4810; Sellick GS, 2006, LEUKEMIA RES, V30, P1573, DOI 10.1016/j.leukres.2006.02.021; Siltanen S, 2008, EUR J HUM GENET, V16, P983, DOI 10.1038/ejhg.2008.43; Valeri A, 2005, UROL ONCOL-SEMIN ORI, V23, P87, DOI 10.1016/j.urolonc.2004.08.015; van Leenders GJLH, 2003, AM J PATHOL, V162, P1529, DOI 10.1016/S0002-9440(10)64286-1; Yendamuri S, 2007, CANCER RES, V67, P7738, DOI 10.1158/0008-5472.CAN-07-1481	32	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26595	10.1371/journal.pone.0026595	http://dx.doi.org/10.1371/journal.pone.0026595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028916	gold, Green Published, Green Submitted			2022-12-27	WOS:000296510800058
J	Sugiyama, H; Kashimoto, T; Ueno, S; Ehara, H; Kodama, T; Iida, T; Susa, N				Sugiyama, Hiroyuki; Kashimoto, Takashige; Ueno, Shunji; Ehara, Hayato; Kodama, Toshio; Iida, Tetsuya; Susa, Nobuyuki			Relationship between Localization on Cellular Membranes and Cytotoxicity of Vibrio vulnificus Hemolysin	PLOS ONE			English	Article							PORE-FORMING TOXIN; LIPID RAFTS; ANCHORED PROTEIN; CHOLESTEROL; CYTOLYSIN; DETERGENT; REORGANIZATION; PURIFICATION; PATHOGENESIS; MECHANISM	Vibrio vulnificus secretes a hemolysin/cytolysin (VVH) that induces cytolysis in target cells. A detergent resistant membrane domain (DRM) fraction of the cells after sucrose gradient centrifugation includes cholesterol-rich membrane microdomains which have been called "lipid rafts". It was reported that some pore-forming toxins require association with DRM and/or lipid rafts to exert their cytotoxicity. It has also been thought that cellular cholesterol is involved in VVH cytotoxicity because VVH cytotoxicity was inhibited by pre-incubation with cholesterol. However, both cellular localization and mode of action of VVH cytotoxicity remain unclear. In this study, we investigated the relationship between VVH localization on the cellular membrane and its cytotoxicity. Oligomers of VVH were detected from DRM fractions by sucrose gradient ultracentrifugation but all of these oligomers shifted from DRM fractions to non-DRM fractions after treatment with methyl-beta-cyclodextrin (M beta CD), a cholesterol sequestering agent. On the other hand, immunofluorescence analysis showed that VVH did not co-localize with major lipid raft markers on cellular membrane of CHO cells. These data suggested that VVH localized at membrane regions which are relatively abundant in cholesterol but which are not identical with lipid rafts. To determine the linkage between localization and cytotoxicity of VVH, cytotoxicity was evaluated in M beta CD-treated CHO cells. The cytotoxicity of VVH was not decreased by the M beta CD treatment. In addition, the amount of VVH oligomer did not decrease in M beta CD-treated CHO cells. Thus, we found that the amount of oligomer on cellular membrane is important for induction of cytotoxicity, whereas localization to lipid rafts on the cellular membrane was not essential to cytotoxicity.	[Sugiyama, Hiroyuki; Kashimoto, Takashige; Ueno, Shunji; Ehara, Hayato; Susa, Nobuyuki] Kitasato Univ, Lab Vet Publ Hlth, Sch Vet Med, Aomori, Japan; [Kodama, Toshio] Osaka Univ, Dept Bacterial Infect, Microbial Dis Res Inst, Osaka, Japan; [Iida, Tetsuya] Osaka Univ, Int Res Ctr Infect Dis, Microbial Dis Res Inst, Osaka, Japan	Kitasato University; Osaka University; Osaka University	Sugiyama, H (corresponding author), Kitasato Univ, Lab Vet Publ Hlth, Sch Vet Med, Aomori, Japan.	kashimot@vmas.kitasato-u.ac.jp		Kodama, Toshio/0000-0002-6511-7301	School of Veterinary medicine, Kitasato University [S1004]; Grants-in-Aid for Scientific Research [23790474] Funding Source: KAKEN	School of Veterinary medicine, Kitasato University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by a grant from the School of Veterinary medicine, Kitasato University (No. S1004). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrami L, 1998, J CELL BIOL, V140, P525, DOI 10.1083/jcb.140.3.525; ALOUF JE, 1980, PHARMACOL THERAPEUT, V11, P661, DOI 10.1016/0163-7258(80)90045-5; Duncan MJ, 2004, J BIOL CHEM, V279, P18944, DOI 10.1074/jbc.M400769200; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; GEOFFROY C, 1982, TOXICON, V20, P239, DOI 10.1016/0041-0101(82)90208-2; GRAY LD, 1985, INFECT IMMUN, V48, P62, DOI 10.1128/IAI.48.1.62-72.1985; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hooper NM, 1999, MOL MEMBR BIOL, V16, P145, DOI 10.1080/096876899294607; Kim BS, 2002, EXP MOL MED, V34, P239, DOI 10.1038/emm.2002.33; KIM HR, 1993, LIFE SCI, V53, P571, DOI 10.1016/0024-3205(93)90714-E; Kim YR, 2010, BIOCHEM BIOPH RES CO, V399, P607, DOI 10.1016/j.bbrc.2010.07.122; KOENIG KL, 1991, WESTERN J MED, V155, P400; Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Linkous DA, 1999, FEMS MICROBIOL LETT, V174, P207, DOI 10.1111/j.1574-6968.1999.tb13570.x; London E, 2000, BBA-BIOMEMBRANES, V1508, P182, DOI 10.1016/S0304-4157(00)00007-1; Manes S, 2000, EMBO REP, V1, P190, DOI 10.1093/embo-reports/kvd025; Matsuda S, 2010, INFECT IMMUN, V78, P603, DOI 10.1128/IAI.00946-09; MIYOSHI S, 1993, J TOXICOL-TOXIN REV, V12, P253, DOI 10.3109/15569549309014409; Moran M, 1998, IMMUNITY, V9, P787, DOI 10.1016/S1074-7613(00)80644-5; Nelson KL, 2000, J BIOL CHEM, V275, P19839, DOI 10.1074/jbc.M002785200; Nelson KL, 1997, J BIOL CHEM, V272, P12170, DOI 10.1074/jbc.272.18.12170; OH EG, 1993, MICROBIOL IMMUNOL, V37, P975, DOI 10.1111/j.1348-0421.1993.tb01732.x; Shogomori H, 2008, BBA-GEN SUBJECTS, V1780, P612, DOI 10.1016/j.bbagen.2007.09.001; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Strom MS, 2000, MICROBES INFECT, V2, P177, DOI 10.1016/S1286-4579(00)00270-7; Villalba M, 2001, J CELL BIOL, V155, P331, DOI 10.1083/jcb.200107080; YAMANAKA H, 1987, J GEN MICROBIOL, V133, P2859; Yu HN, 2007, ARCH MICROBIOL, V187, P467, DOI 10.1007/s00203-007-0214-0	29	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26018	10.1371/journal.pone.0026018	http://dx.doi.org/10.1371/journal.pone.0026018			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028805	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800015
J	Woyke, T; Sczyrba, A; Lee, J; Rinke, C; Tighe, D; Clingenpeel, S; Malmstrom, R; Stepanauskas, R; Cheng, JF				Woyke, Tanja; Sczyrba, Alexander; Lee, Janey; Rinke, Christian; Tighe, Damon; Clingenpeel, Scott; Malmstrom, Rex; Stepanauskas, Ramunas; Cheng, Jan-Fang			Decontamination of MDA Reagents for Single Cell Whole Genome Amplification	PLOS ONE			English	Article							DAMAGE	Single cell genomics is a powerful and increasingly popular tool for studying the genetic make-up of uncultured microbes. A key challenge for successful single cell sequencing and analysis is the removal of exogenous DNA from whole genome amplification reagents. We found that UV irradiation of the multiple displacement amplification (MDA) reagents, including the Phi29 polymerase and random hexamer primers, effectively eliminates the amplification of contaminating DNA. The methodology is quick, simple, and highly effective, thus significantly improving whole genome amplification from single cells.	[Woyke, Tanja; Sczyrba, Alexander; Lee, Janey; Rinke, Christian; Tighe, Damon; Clingenpeel, Scott; Malmstrom, Rex; Cheng, Jan-Fang] US DOE, Joint Genome Inst, Walnut Creek, CA USA; [Stepanauskas, Ramunas] Bigelow Lab Ocean Sci, Boothbay Harbor, ME 04575 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Bigelow Laboratory for Ocean Sciences	Woyke, T (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA USA.	jfcheng@lbl.gov	t, lf/AAJ-4924-2020; Rinke, Christian/AAE-8100-2019; Malmstrom, Rex/K-7339-2012; Rinke, Christian/ABA-3139-2021	Rinke, Christian/0000-0003-4632-1187; Cheng, Jan-Fang/0000-0001-7315-7613; Malmstrom, Rex/0000-0002-4758-7369; Sczyrba, Alexander/0000-0002-4405-3847; Clingenpeel, Scott/0000-0002-6619-6320; Stepanauskas, Ramunas/0000-0003-4458-3108	U.S. Department of Energy Joint Genome Institute; Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; National Science Foundation (NSF) [EF-0633142, MCB-738232, EF-826924]	U.S. Department of Energy Joint Genome Institute(United States Department of Energy (DOE)); Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation (NSF)(National Science Foundation (NSF))	This work was conducted by the U.S. Department of Energy Joint Genome Institute and supported by the Office of Science of the U.S. Department of Energy under Contract No. DE-AC02-05CH11231. Dr. Stepanauskas was supported by National Science Foundation (NSF) grants EF-0633142, MCB-738232 and EF-826924. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blainey PC, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1074; BRASH DE, 1982, NATURE, V298, P189, DOI 10.1038/298189a0; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; CADET J, 1986, BIOCHIMIE, V68, P813, DOI 10.1016/S0300-9084(86)80097-9; Champlot S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013042; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Marcy Y, 2007, P NATL ACAD SCI USA, V104, P11889, DOI 10.1073/pnas.0704662104; OU CY, 1991, BIOTECHNIQUES, V10, P442; Raghunathan A, 2005, APPL ENVIRON MICROB, V71, P3342, DOI 10.1128/AEM.71.6.3342-3347.2005; Rodrigue S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006864; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; VARGHESE AJ, 1969, NATURE, V223, P299, DOI 10.1038/223299a0; Woyke T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010314; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang K, 2006, NAT BIOTECHNOL, V24, P680, DOI 10.1038/nbt1214	16	108	111	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26161	10.1371/journal.pone.0026161	http://dx.doi.org/10.1371/journal.pone.0026161			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028825	Green Published, gold			2022-12-27	WOS:000296510800022
J	Crone, JS; Ladurner, G; Holler, Y; Golaszewski, S; Trinka, E; Kronbichler, M				Crone, Julia Sophia; Ladurner, Gunther; Hoeller, Yvonne; Golaszewski, Stefan; Trinka, Eugen; Kronbichler, Martin			Deactivation of the Default Mode Network as a Marker of Impaired Consciousness: An fMRI Study	PLOS ONE			English	Article							PERSISTENT VEGETATIVE STATE; BRAIN ACTIVITY; RESTING-STATE; FUNCTIONAL CONNECTIVITY; OWN-NAME; DISORDERS; FLUCTUATIONS; RECOVERY; COMPREHENSION; WAKEFULNESS	Diagnosis of patients with a disorder of consciousness is very challenging. Previous studies investigating resting state networks demonstrate that 2 main features of the so-called default mode network (DMN), metabolism and functional connectivity, are impaired in patients with a disorder of consciousness. However, task-induced deactivation - a third main feature of the DMN - has not been explored in a group of patients. Deactivation of the DMN is supposed to reflect interruptions of introspective processes. Seventeen patients with unresponsive wakefulness syndrome (UWS, former vegetative state), 8 patients in minimally conscious state (MCS), and 25 healthy controls were investigated with functional magnetic resonance imaging during a passive sentence listening task. Results show that deactivation in medial regions is reduced in MCS and absent in UWS patients compared to healthy controls. Moreover, behavioral scores assessing the level of consciousness correlate with deactivation in patients. On single-subject level, all control subjects but only 2 patients in MCS and 6 with UWS exposed deactivation. Interestingly, all patients who deactivated during speech processing (except for one) showed activation in left frontal regions which are associated with conscious processing. Our results indicate that deactivation of the DMN can be associated with the level of consciousness by selecting those who are able to interrupt ongoing introspective processes. In consequence, deactivation of the DMN may function as a marker of consciousness.	[Crone, Julia Sophia; Ladurner, Gunther; Hoeller, Yvonne; Kronbichler, Martin] Paracelsus Private Med Univ, Christian Doppler Clin, Inst Neurosci, Salzburg, Austria; [Crone, Julia Sophia; Ladurner, Gunther; Hoeller, Yvonne; Kronbichler, Martin] Paracelsus Private Med Univ, Christian Doppler Clin, Ctr Neurocognit Res, Salzburg, Austria; [Crone, Julia Sophia; Ladurner, Gunther; Hoeller, Yvonne; Kronbichler, Martin] Salzburg Univ, Dept Psychol, A-5020 Salzburg, Austria; [Crone, Julia Sophia; Ladurner, Gunther; Hoeller, Yvonne; Kronbichler, Martin] Salzburg Univ, Ctr Neurocognit Res, A-5020 Salzburg, Austria; [Crone, Julia Sophia; Hoeller, Yvonne; Golaszewski, Stefan; Trinka, Eugen] Paracelsus Private Med Univ, Christian Doppler Clin, Dept Neurol, Salzburg, Austria	Paracelsus Private Medical University; Paracelsus Private Medical University; Salzburg University; Salzburg University; Paracelsus Private Medical University	Crone, JS (corresponding author), Paracelsus Private Med Univ, Christian Doppler Clin, Inst Neurosci, Salzburg, Austria.	j.crone@neurocognition.org	Höller, Yvonne/I-8928-2017; Håkansson, Gustaf/F-5409-2011; Kronbichler, Martin/AAY-1519-2021; Kronbichler, Martin/A-5599-2008	Höller, Yvonne/0000-0002-1727-8557; Kronbichler, Martin/0000-0003-2240-2812; Kronbichler, Martin/0000-0003-2240-2812; Trinka, Eugen/0000-0002-5950-2692; Crone, Julia Sophia/0000-0002-0787-7003	Jubilaumsfonds of the National Bank of Austria [13643]; Paracelsus Medical University Salzburg [R-09/02/005-KRO]	Jubilaumsfonds of the National Bank of Austria; Paracelsus Medical University Salzburg	This work was supported by the Jubilaumsfonds of the National Bank of Austria (grant number 13643) and by the Paracelsus Medical University Salzburg Research Funding (grant number R-09/02/005-KRO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews K, 1996, BRIT MED J, V313, P13, DOI 10.1136/bmj.313.7048.13; Boly M, 2008, ANN NY ACAD SCI, V1129, P119, DOI 10.1196/annals.1417.015; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Cauda F, 2009, J NEUROL NEUROSUR PS, V80, P429, DOI 10.1136/jnnp.2007.142349; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; Coleman MR, 2009, BRAIN, V132, P2541, DOI 10.1093/brain/awp183; Coleman MR, 2007, BRAIN, V130, P2494, DOI 10.1093/brain/awm170; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; Davis MH, 2007, P NATL ACAD SCI USA, V104, P16032, DOI 10.1073/pnas.0701309104; Diedrichsen J, 2005, NEUROIMAGE, V27, P624, DOI 10.1016/j.neuroimage.2005.04.039; Fernandez-Espejo D, 2011, NEUROIMAGE, V54, P103, DOI 10.1016/j.neuroimage.2010.08.035; Fernandez-Espejo D, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-77; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; GONG G, 2011, NEUROSCIENT IN RPESS; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Greicius MD, 2008, HUM BRAIN MAPP, V29, P839, DOI 10.1002/hbm.20537; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Holler Y, 2011, CLIN NEUROPHYSIOL, V122, P1744, DOI 10.1016/j.clinph.2011.02.009; Holler Y, 2011, CLIN NEUROPHYSIOL, V122, P99, DOI 10.1016/j.clinph.2010.05.029; Horovitz SG, 2008, HUM BRAIN MAPP, V29, P671, DOI 10.1002/hbm.20428; Kassubek J, 2003, J NEUROL SCI, V212, P85, DOI 10.1016/S0022-510X(03)00106-0; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Laureys S, 2004, LANCET NEUROL, V3, P537, DOI 10.1016/S1474-4422(04)00852-X; Laureys S, 1999, NEUROIMAGE, V9, P377, DOI 10.1006/nimg.1998.0414; Laureys S, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-68; Lustig C, 2003, P NATL ACAD SCI USA, V100, P14504, DOI 10.1073/pnas.2235925100; Mannell MV, 2010, HUM BRAIN MAPP, V31, P424, DOI 10.1002/hbm.20876; Monti MM, 2010, NEW ENGL J MED, V362, P579, DOI 10.1056/NEJMoa0905370; Owen AM, 2008, ANN NY ACAD SCI, V1124, P225, DOI 10.1196/annals.1440.013; Owen AM, 2008, FUNCT NEUROL, V23, P189; Qin PM, 2010, HUM BRAIN MAPP, V31, P1993, DOI 10.1002/hbm.20989; Raichle ME, 2006, ANNU REV NEUROSCI, V29, P449, DOI 10.1146/annurev.neuro.29.051605.112819; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Schiff ND, 2002, BRAIN, V125, P1210, DOI 10.1093/brain/awf131; Schnakers C, 2008, NEUROLOGY, V71, P1614, DOI 10.1212/01.wnl.0000334754.15330.69; Schnakers C, 2010, PAIN, V148, P215, DOI 10.1016/j.pain.2009.09.028; Schnakers C, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-35; Shiel A, 2000, CLIN REHABIL, V14, P408, DOI 10.1191/0269215500cr326oa; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Staffen W, 2006, J NEUROL NEUROSUR PS, V77, P1383, DOI 10.1136/jnnp.2006.095166; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758	50	73	76	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26373	10.1371/journal.pone.0026373	http://dx.doi.org/10.1371/journal.pone.0026373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039473	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500058
J	Ding, JR; Liao, W; Zhang, ZQ; Mantini, D; Xu, Q; Wu, GR; Lu, GM; Chen, HF				Ding, Ju-Rong; Liao, Wei; Zhang, Zhiqiang; Mantini, Dante; Xu, Qiang; Wu, Guo-Rong; Lu, Guangming; Chen, Huafu			Topological Fractionation of Resting-State Networks	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; SCALE BRAIN NETWORKS; SMALL-WORLD; FUNCTIONAL CONNECTIVITY; DEFAULT-MODE; LOW-FREQUENCY; COMPLEX NETWORKS; IN-VIVO; FMRI; MRI	Exploring topological properties of human brain network has become an exciting topic in neuroscience research. Large-scale structural and functional brain networks both exhibit a small-world topology, which is evidence for global and local parallel information processing. Meanwhile, resting state networks (RSNs) underlying specific biological functions have provided insights into how intrinsic functional architecture influences cognitive and perceptual information processing. However, topological properties of single RSNs remain poorly understood. Here, we have two hypotheses: i) each RSN also has optimized small-world architecture; ii) topological properties of RSNs related to perceptual and higher cognitive processes are different. To test these hypotheses, we investigated the topological properties of the default-mode, dorsal attention, central-executive, somato-motor, visual and auditory networks derived from resting-state functional magnetic resonance imaging (fMRI). We found small-world topology in each RSN. Furthermore, small-world properties of cognitive networks were higher than those of perceptual networks. Our findings are the first to demonstrate a topological fractionation between perceptual and higher cognitive networks. Our approach may be useful for clinical research, especially for diseases that show selective abnormal connectivity in specific brain networks.	[Ding, Ju-Rong; Liao, Wei; Xu, Qiang; Wu, Guo-Rong; Chen, Huafu] Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuroinformat, Chengdu 610054, Peoples R China; [Zhang, Zhiqiang; Lu, Guangming] Nanjing Univ, Coll Med, Nanjing Jinling Hosp, Dept Med Imaging,Clin Sch, Nanjing 210008, Peoples R China; [Mantini, Dante] KU Leuven Med Sch, Lab Neuropsychophysiol, Louvain, Belgium	University of Electronic Science & Technology of China; Nanjing University; KU Leuven	Ding, JR (corresponding author), Univ Elect Sci & Technol China, Sch Life Sci & Technol, Minist Educ, Key Lab Neuroinformat, Chengdu 610054, Peoples R China.	cjr.luguangming@vip.163.com; chenhf@uestc.edu.cn	Mantini, Dante/D-6989-2014; Mantini, Dante/H-3061-2011; Håkansson, Gustaf/F-5409-2011	Mantini, Dante/0000-0001-6485-5559; Xu, Qiang/0000-0002-7739-7515	Natural Scientific Foundation of China [61035006, 90820006]; Changjiang Scholars and Innovative Research Team in University; Natural Science Foundation of China [30800264, 81020108022]; Research Foundation Flanders [A4/5-SDS15387]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Foundation Flanders(FWO)	J-RD, WL, HC, QX and G-RW were supported by the Natural Scientific Foundation of China [Grant Nos. 61035006, 90820006] and Changjiang Scholars and Innovative Research Team in University. ZZ and GL were supported by the Natural Science Foundation of China [Grant No. 30800264, 81020108022]. DM is a post-doc fellow of the Research Foundation Flanders [Grant no. A4/5-SDS15387 to DM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Bartels A, 2005, NEUROIMAGE, V24, P339, DOI 10.1016/j.neuroimage.2004.08.044; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Bullmore ET, 2011, ANNU REV CLIN PSYCHO, V7, P113, DOI 10.1146/annurev-clinpsy-040510-143934; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carhart-Harris RL, 2010, BRAIN, V133, P1265, DOI 10.1093/brain/awq010; Cole DM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00008; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Damoiseaux JS, 2006, P NATL ACAD SCI USA, V103, P13848, DOI 10.1073/pnas.0601417103; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Doucet G, 2011, J NEUROPHYSIOL, V105, P2753, DOI 10.1152/jn.00895.2010; Fair DA, 2008, P NATL ACAD SCI USA, V105, P4028, DOI 10.1073/pnas.0800376105; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2007, NEURON, V56, P171, DOI 10.1016/j.neuron.2007.08.023; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Humphries MD, 2006, P ROY SOC B-BIOL SCI, V273, P503, DOI 10.1098/rspb.2005.3354; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jafri MJ, 2008, NEUROIMAGE, V39, P1666, DOI 10.1016/j.neuroimage.2007.11.001; Jann K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012945; Kaiser M, 2006, PLOS COMPUT BIOL, V2, P805, DOI 10.1371/journal.pcbi.0020095; Kang J, 2011, NEUROIMAGE, V56, P1222, DOI 10.1016/j.neuroimage.2011.03.033; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Liao W, 2010, NEUROIMAGE, V52, P1549, DOI 10.1016/j.neuroimage.2010.05.010; Liao W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008525; Liao W, 2010, BIOL CYBERN, V102, P57, DOI 10.1007/s00422-009-0350-5; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Mantini D, 2009, NEUROIMAGE, V44, P265, DOI 10.1016/j.neuroimage.2008.08.019; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mathias N, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.021117; Mesulam MM, 1998, BRAIN, V121, P1013, DOI 10.1093/brain/121.6.1013; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Reichle ME, 2010, TRENDS COGN SCI, V14, P180, DOI 10.1016/j.tics.2010.01.008; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shirer W, 2011, CEREB CORTEX; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Sporns O., 2010, NETWORKS BRAIN; Sporns O, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00005; Sporns O, 2011, ANN NY ACAD SCI, V1224, P109, DOI 10.1111/j.1749-6632.2010.05888.x; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stevens MC, 2007, HUM BRAIN MAPP, V28, P394, DOI 10.1002/hbm.20285; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tagliazucchi E, 2010, NEUROSCI LETT, V485, P26, DOI 10.1016/j.neulet.2010.08.053; Tomasi D, 2011, CEREB CORTEX, V21, P2003, DOI 10.1093/cercor/bhq268; Ungerleider Leslie G., 1994, Current Opinion in Neurobiology, V4, P157, DOI 10.1016/0959-4388(94)90066-3; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; ZHANG Z, 2011, ALTERED FUNCTIONAL S, DOI DOI 10.1093/BRAIN/AWR1223; Zielinski BA, 2010, P NATL ACAD SCI USA, V107, P18191, DOI 10.1073/pnas.1003109107; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012; Zuo XN, 2010, NEUROIMAGE, V49, P2163, DOI 10.1016/j.neuroimage.2009.10.080; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	72	35	36	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26596	10.1371/journal.pone.0026596	http://dx.doi.org/10.1371/journal.pone.0026596			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028917	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500093
J	Hamalukic, M; Huelsenbeck, J; Schad, A; Wirtz, S; Kaina, B; Fritz, G				Hamalukic, Melanie; Huelsenbeck, Johannes; Schad, Arno; Wirtz, Stefan; Kaina, Bernd; Fritz, Gerhard			Rac1-Regulated Endothelial Radiation Response Stimulates Extravasation and Metastasis That Can Be Blocked by HMG-CoA Reductase Inhibitors	PLOS ONE			English	Article							NF-KAPPA-B; CELL-ADHESION MOLECULES; COLON-CANCER CELLS; IONIZING-RADIATION; E-SELECTIN; BREAST-CANCER; SIALYL-LEWIS; VASCULAR ENDOTHELIUM; INDUCED APOPTOSIS; GROWTH-FACTOR	Radiotherapy (RT) plays a key role in cancer treatment. Although the benefit of ionizing radiation (IR) is well established, some findings raise the possibility that irradiation of the primary tumor not only triggers a killing response but also increases the metastatic potential of surviving tumor cells. Here we addressed the question of whether irradiation of normal cells outside of the primary tumor augments metastasis by stimulating the extravasation of circulating tumor cells. We show that IR exposure of human endothelial cells (EC), tumor cells (TC) or both increases TC-EC adhesion in vitro. IR-stimulated TC-EC adhesion was blocked by the HMG-CoA reductase inhibitor lovastatin. Glycyrrhizic acid from liquorice root, which acts as a Sialyl-Lewis X mimetic drug, and the Rac1 inhibitor NSC23766 also reduced TC-EC adhesion. To examine the in vivo relevance of these findings, tumorigenic cells were injected into the tail vein of immunodeficient mice followed by total body irradiation (TBI). The data obtained show that TBI dramatically enhances tumor cell extravasation and lung metastasis. This pro-metastatic radiation effect was blocked by pre-treating mice with lovastatin, glycyrrhizic acid or NSC23766. TBI of mice prior to tumor cell transplantation also stimulated metastasis, which was again blocked by lovastatin. The data point to a pro-metastatic trans-effect of RT, which likely rests on the endothelial radiation response promoting the extravasation of circulating tumor cells. Administration of the widely used lipid-lowering drug lovastatin prior to irradiation counteracts this process, likely by suppressing Rac1-regulated E-selectin expression following irradiation. The data support the concern that radiation exposure might increase the extravasation of circulating tumor cells and recommend co-administration of lipid-lowering drugs to avoid this adverse effect of ionizing radiation.	[Hamalukic, Melanie; Huelsenbeck, Johannes; Kaina, Bernd; Fritz, Gerhard] Johannes Gutenberg Univ Mainz, Inst Toxicol, Univ Med Ctr, D-6500 Mainz, Germany; [Schad, Arno] Johannes Gutenberg Univ Mainz, Inst Pathol, Univ Med Ctr, D-6500 Mainz, Germany; [Wirtz, Stefan] Johannes Gutenberg Univ Mainz, Inst Mol Med, Univ Med Ctr, D-6500 Mainz, Germany; [Fritz, Gerhard] Univ Dusseldorf, Inst Toxicol, Dusseldorf, Germany	Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Heinrich Heine University Dusseldorf	Hamalukic, M (corresponding author), Johannes Gutenberg Univ Mainz, Inst Toxicol, Univ Med Ctr, D-6500 Mainz, Germany.	fritz@uni-duesseldorf.de	Kaina, Bernd/AAE-4692-2020	Wirtz, Stefan/0000-0001-6936-7431	Wilhelm Sander-Stiftung [2005.120.1]	Wilhelm Sander-Stiftung	This work was supported by the Wilhelm Sander-Stiftung (2005.120.1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agemy L, 2008, PROSTATE, V68, P530, DOI 10.1002/pros.20702; Baeuerle PA, 1996, CELL, V87, P13, DOI 10.1016/S0092-8674(00)81318-5; Baichwal VR, 1997, CURR BIOL, V7, pR94, DOI 10.1016/S0960-9822(06)00046-7; Baluna RG, 2006, RADIAT RES, V166, P819, DOI 10.1667/RR0380.1; Bresalier RS, 1996, GASTROENTEROLOGY, V110, P1354, DOI 10.1053/gast.1996.v110.pm8613039; Brown PD, 2008, INT J RADIAT ONCOL, V70, P1305, DOI 10.1016/j.ijrobp.2007.11.047; Camphausen K, 2001, CANCER RES, V61, P2207; Chung YL, 2006, CLIN CANCER RES, V12, P2706, DOI 10.1158/1078-0432.CCR-05-2721; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; DELAMONTE SM, 1988, CANCER, V61, P2176; Fritz G, 2003, INT J RADIAT BIOL, V79, P601, DOI 10.1080/09553000310001609233; Fritz G, 2009, CURR CANCER DRUG TAR, V9, P626, DOI 10.2174/156800909789057033; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Gerhard R, 2005, J BIOL CHEM, V280, P1499, DOI 10.1074/jbc.M406014200; Haase O, 2004, RADIOTHER ONCOL, V73, pS144, DOI 10.1016/S0167-8140(04)80037-9; Hallahan D, 1996, CANCER RES, V56, P5150; Hallahan D. E., 1995, Proceedings of the American Association for Cancer Research Annual Meeting, V36, P605; Hallahan DE, 1997, CANCER RES, V57, P2096; Hallahan DE, 1998, CANCER RES, V58, P5484; Hallahan DE, 1997, RADIAT RES, V147, P41, DOI 10.2307/3579441; Hanley WD, 2005, CANCER RES, V65, P5812, DOI 10.1158/0008-5472.CAN-04-4557; Haydont V, 2007, CLIN CANCER RES, V13, P5331, DOI 10.1158/1078-0432.CCR-07-0625; Huang F, 2009, INT J RADIAT ONCOL, V73, P752, DOI 10.1016/j.ijrobp.2008.05.031; Imaizumi N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011084; ITO H, 1984, CLIN EXP METASTAS, V2, P235, DOI 10.1007/BF00132930; Jung JW, 2007, EUR J CANCER, V43, P1214, DOI 10.1016/j.ejca.2007.01.034; Kaliski A, 2005, MOL CANCER THER, V4, P1717, DOI 10.1158/1535-7163.MCT-05-0179; Kikkawa H, 2002, CLIN EXP METASTAS, V19, P717, DOI 10.1023/A:1021356019563; Kobayashi H, 2007, CURR MED CHEM, V14, P377, DOI 10.2174/092986707779941032; Krause T, 1999, CLIN EXP METASTAS, V17, P183, DOI 10.1023/A:1006626500852; Lee M, 2010, INT J RADIAT ONCOL, V76, P1528, DOI 10.1016/j.ijrobp.2009.11.022; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; Li NX, 1998, P NATL ACAD SCI USA, V95, P13012, DOI 10.1073/pnas.95.22.13012; Madani I, 2008, B CANCER, V95, P292, DOI 10.1684/bdc.2008.0598; Monceau V, 2010, CURR DRUG TARGETS, V11, P1395, DOI 10.2174/1389450111009011395; Nakayama T, 2007, RADIAT RES, V168, P433, DOI 10.1667/RR0869.1; Nubel T, 2004, FASEB J, V18, P140, DOI 10.1096/fj.03-0261fje; Nubel T, 2004, CARCINOGENESIS, V25, P1335, DOI 10.1093/carcin/bgh133; OSTRAU C, 2009, RADIOTHER ONCOL; Ostrau C, 2009, RADIOTHER ONCOL, V92, P492, DOI 10.1016/j.radonc.2009.06.020; Paquette B, 2007, BRIT J CANCER, V97, P1505, DOI 10.1038/sj.bjc.6604072; Park CM, 2006, CANCER RES, V66, P8511, DOI 10.1158/0008-5472.CAN-05-4340; Perona R, 1997, GENE DEV, V11, P463, DOI 10.1101/gad.11.4.463; RAO BNN, 1994, J BIOL CHEM, V269, P19663; Sauer KA, 2008, J IMMUNOL, V181, P6148, DOI 10.4049/jimmunol.181.9.6148; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820, DOI 10.1128/MCB.14.9.5820; Taccioli GE, 1998, IMMUNITY, V9, P355, DOI 10.1016/S1074-7613(00)80618-4; Tomlinson J, 2000, INT J ONCOL, V16, P347; Vala IS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011222; von Bardeleben R, 2003, BIOCHEM BIOPH RES CO, V307, P401, DOI 10.1016/S0006-291X(03)01205-1; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang J, 2007, INT J RADIAT ONCOL, V68, P1483, DOI 10.1016/j.ijrobp.2007.03.036; Wang TL, 2002, INT IMMUNOPHARMACOL, V2, P1509, DOI 10.1016/S1567-5769(02)00058-9; WITTIG BM, 1995, GASTROENTEROLOGY S; Yamada N, 1997, BRIT J CANCER, V76, P582, DOI 10.1038/bjc.1997.429; Zhao WL, 2009, CURR MED CHEM, V16, P130, DOI 10.2174/092986709787002790	56	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26413	10.1371/journal.pone.0026413	http://dx.doi.org/10.1371/journal.pone.0026413			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039482	gold, Green Submitted, Green Published			2022-12-27	WOS:000296507500064
J	Rosenbluh, J; Nijhawan, D; Chen, Z; Wong, KK; Masutomi, K; Hahn, WC				Rosenbluh, Joseph; Nijhawan, Deepak; Chen, Zhao; Wong, Kwok-Kin; Masutomi, Kenkichi; Hahn, William C.			RMRP Is a Non-Coding RNA Essential for Early Murine Development	PLOS ONE			English	Article							CARTILAGE-HAIR HYPOPLASIA; MUTATIONS	RMRP is a non-coding RNA that is ubiquitously expressed in both humans and mice. RMRP mutations that lead to decreased RMRP levels are found in the pleiotropic syndrome Cartilage Hair Hypoplasia. To assess the effects of deleting RMRP, we engineered a targeting vector that contains loxP sequences flanking RMRP and created hemizygous mice harboring this engineered allele (RMRP conditional). We found that insertion of this cassette suppressed RMRP expression, and we failed to obtain viable mice homozygous for the RMRP conditional allele. Furthermore, we were unable to obtain viable homozygous RMRP null mice, indicating that RMRP is essential for early embryonic development.	[Rosenbluh, Joseph; Nijhawan, Deepak; Chen, Zhao; Wong, Kwok-Kin; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Rosenbluh, Joseph; Nijhawan, Deepak; Chen, Zhao; Wong, Kwok-Kin; Hahn, William C.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Rosenbluh, Joseph; Nijhawan, Deepak; Chen, Zhao; Wong, Kwok-Kin; Hahn, William C.] Harvard Univ, Sch Med, Boston, MA USA; [Rosenbluh, Joseph; Nijhawan, Deepak; Hahn, William C.] Broad Inst Harvard & Massachusetts Inst Technol M, Cambridge, MA USA; [Masutomi, Kenkichi] Natl Canc Ctr, Res Inst, Div Canc Stem Cell, Tokyo 104, Japan	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; National Cancer Center - Japan	Rosenbluh, J (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	kmasutom@ncc.go.jp; William_Hahn@dfci.harvard.edu		Rosenbluh, Joseph/0000-0001-9815-8049; wong, kwok kin/0000-0001-6323-235X	US National Institutes of Health [F32GM090437-01, R01 AG23145]; NATIONAL CANCER INSTITUTE [R01CA122794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM090437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG023145] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by a US National Institutes of Health postdoctoral fellowship to J.R. F32GM090437-01, and R01 AG23145 (WCH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CHANG DD, 1987, SCIENCE, V235, P1178, DOI 10.1126/science.2434997; Hermanns P, 2005, HUM MOL GENET, V14, P3723, DOI 10.1093/hmg/ddi403; Hermanns P, 2006, AM J MED GENET A, V140A, P2121, DOI 10.1002/ajmg.a.31331; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Nakashima E, 2007, AM J MED GENET A, V143A, P2675, DOI 10.1002/ajmg.a.32053; Ridanpaa M, 2001, CELL, V104, P195, DOI 10.1016/S0092-8674(01)00205-7; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2	7	38	40	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26270	10.1371/journal.pone.0026270	http://dx.doi.org/10.1371/journal.pone.0026270			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039455	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500047
J	Sehm, B; Frisch, S; Thone-Otto, A; Horstmann, A; Villringer, A; Obrig, H				Sehm, Bernhard; Frisch, Stefan; Thoene-Otto, Angelika; Horstmann, Annette; Villringer, Arno; Obrig, Hellmuth			Focal Retrograde Amnesia: Voxel-Based Morphometry Findings in a Case without MRI Lesions	PLOS ONE			English	Article							REMOTE MEMORY; NEUROSCIENCE	Focal retrograde amnesia (FRA) is a rare neurocognitive disorder presenting with an isolated loss of retrograde memory. In the absence of detectable brain lesions, a differentiation of FRA from psychogenic causes is difficult. Here we report a case study of persisting FRA after an epileptic seizure. A thorough neuropsychological assessment confirmed severe retrograde memory deficits while anterograde memory abilities were completely normal. Neurological and psychiatric examination were unremarkable and high-resolution MRI showed no neuroradiologically apparent lesion. However, voxel-based morphometry (VBM)-comparing the MRI to an education-, age- and sex-matched control group (n = 20) disclosed distinct gray matter decreases in left temporopolar cortex and a region between right posterior parahippocampal and lingual cortex. Although the results of VBM-based comparisons between a single case and a healthy control group are generally susceptible to differences unrelated to the specific symptoms of the case, we believe that our data suggest a causal role of the cortical areas detected since the retrograde memory deficit is the preeminent neuropsychological difference between patient and controls. This was paralleled by grey matter differences in central nodes of the retrograde memory network. We therefore suggest that these subtle alterations represent structural correlates of the focal retrograde amnesia in our patient. Beyond the implications for the diagnosis and etiology of FRA, our results advocate the use of VBM in conditions that do not show abnormalities in clinical radiological assessment, but show distinct neuropsychological deficits.	[Sehm, Bernhard; Frisch, Stefan; Thoene-Otto, Angelika; Villringer, Arno; Obrig, Hellmuth] Univ Leipzig, Clin Cognit Neurol, Leipzig, Germany; [Sehm, Bernhard; Frisch, Stefan; Horstmann, Annette; Villringer, Arno; Obrig, Hellmuth] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany	Leipzig University; Max Planck Society	Sehm, B (corresponding author), Univ Leipzig, Clin Cognit Neurol, Leipzig, Germany.	sehm@cbs.mpg.de	Horstmann, Annette/C-9083-2011; Thoene-Otto, Angelika/GLQ-8280-2022	Horstmann, Annette/0000-0001-6184-8484; Thoene-Otto, Angelika/0000-0003-2701-5037; Villringer, Arno/0000-0003-2604-2404; Sehm, Bernhard/0000-0001-7195-0095; Frisch, Stefan/0000-0002-7294-4786	German Max Planck Society	German Max Planck Society(Max Planck Society)	The study was funded by the German Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschenbrenner S., 2000, REGENSBURGER WORTFLU; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Aster M. V., 2006, WECHSLER INTELLIGENZ; Buumler G., 1985, FARBE WORT INTERFERE; Crawford JR, 1998, CLIN NEUROPSYCHOL, V12, P482, DOI 10.1076/clin.12.4.482.7241; DeRenzi E, 1997, NEUROPSYCHOLOGIA, V35, P781, DOI 10.1016/S0028-3932(97)00018-3; Franke G. H., 2002, SYMPTOM CHECKLISTE V; GOLDBERG E, 1981, SCIENCE, V213, P1392, DOI 10.1126/science.7268442; Guedj E, 2010, NEUROPSYCHOLOGIA, V48, P2174, DOI 10.1016/j.neuropsychologia.2010.04.009; H?rting, 2000, WECHSLER GEDACHTNIST; Haid T., 2000, Z NEUROPSYCHOL, V13, P233; Hautzinger M., 1994, BECK DEPRESSIONSINVE, pHANS; Hayasaka S, 2004, NEUROIMAGE, V22, P676, DOI 10.1016/j.neuroimage.2004.01.041; Horn W, 1983, L P S LEISTUNGSPRUFS; KAPUR N, 1992, BRAIN, V115, P73, DOI 10.1093/brain/115.1.73; Kopelman M, 1990, COMMUNICATION; Kopelman MD, 2000, COGNITIVE NEUROPSYCH, V17, P585, DOI 10.1080/026432900750002172; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; LEPLOW B, 1993, DIAGNOSTICA, V39, P240; Markowitsch HJ, 2002, CORTEX, V38, P651, DOI 10.1016/S0010-9452(08)70030-3; Milton F, 2010, BRAIN, V133, P1368, DOI 10.1093/brain/awq055; Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013; Niemann H., 2008, CVLT CALIFORNIA VERB; Riederer F, 2008, NEUROLOGY, V71, P419, DOI 10.1212/01.wnl.0000324264.96100.e0; Schelling D., 2001, VVM VISUELLER VERBAL; Schmidtke K, 1999, Z NEUROPSYCHOL, V10, P13, DOI DOI 10.1024//1016-264X.10.1.13; Sellal FO, 2002, CORTEX, V38, P499, DOI 10.1016/S0010-9452(08)70019-4; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; Squire LR, 2007, CURR OPIN NEUROBIOL, V17, P185, DOI 10.1016/j.conb.2007.02.006; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; Tanaka Y, 1999, NEUROLOGY, V53, P344, DOI 10.1212/WNL.53.2.344; Wheeler MA, 2001, COGN AFFECT BEHAV NE, V1, P22, DOI 10.3758/CABN.1.1.22; Zimmermann P, 1993, TESTBATTERIE ERFASSU	33	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26538	10.1371/journal.pone.0026538	http://dx.doi.org/10.1371/journal.pone.0026538			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028902	Green Published, gold			2022-12-27	WOS:000296507500086
J	Sharma, AM; Wang, JB; Duffy, S; Zhang, SM; Wong, MK; Rashed, A; Cooper, ML; Daane, KM; Almeida, RPP				Sharma, Abhineet M.; Wang, Jinbo; Duffy, Siobain; Zhang, Siming; Wong, Michelle K.; Rashed, Arash; Cooper, Monica L.; Daane, Kent M.; Almeida, Rodrigo P. P.			Occurrence of Grapevine Leafroll-Associated Virus Complex in Napa Valley	PLOS ONE			English	Article							SPATIAL-ANALYSIS; GRAPEVINE-LEAFROLL-ASSOCIATED-VIRUS-3; VARIABILITY; VINEYARDS; DISEASE; SPREAD; DIVERSITY; AUSTRALIA; MEALYBUG; ISOLATE	Grapevine leafroll disease (GLD) is caused by a complex of several virus species (grapevine leafroll-associated viruses, GLRaV) in the family Closteroviridae. Because of its increasing importance, it is critical to determine which species of GLRaV is predominant in each region where this disease is occurring. A structured sampling design, utilizing a combination of RT-PCR based testing and sequencing methods, was used to survey GLRaVs in Napa Valley (California, USA) vineyards (n = 36). Of the 216 samples tested for GLRaV-1, -2, -3, -4, -5, and -9, 62% (n = 134) were GLRaV positive. Of the positives, 81% (n = 109) were single infections with GLRaV-3, followed by GLRaV-2 (4%, n = 5), while the remaining samples (15%, n = 20) were mixed infections of GLRaV-3 with GLRaV-1, 2, 4, or 9. Additionally, 468 samples were tested for genetic variants of GLRaV-3, and of the 65% (n = 306) of samples positive for GLRaV-3, 22% were infected with multiple GLRaV-3 variants. Phylogenetic analysis utilizing sequence data from the single infection GLRaV-3 samples produced seven well-supported GLRaV-3 variants, of which three represented 71% of all GLRaV-3 positive samples in Napa Valley. Furthermore, two novel variants, which grouped with a divergent isolate from New Zealand (NZ-1), were identified, and these variants comprised 6% of all positive GLRaV-3 samples. Spatial analyses showed that GLRaV-3a, 3b, and 3c were not homogeneously distributed across Napa Valley. Overall, 86% of all blocks (n = 31) were positive for GLRaVs and 90% of positive blocks (n = 28) had two or more GLRaV-3 variants, suggesting complex disease dynamics that might include multiple insect-mediated introduction events.	[Sharma, Abhineet M.; Wang, Jinbo; Zhang, Siming; Wong, Michelle K.; Daane, Kent M.; Almeida, Rodrigo P. P.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Duffy, Siobain] Rutgers State Univ, Dept Ecol Evolut & Nat Resources, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA; [Rashed, Arash] Texas A&M AgriLife Res, Amarillo, TX USA; [Cooper, Monica L.] Univ Calif, Napa, CA USA	University of California System; University of California Berkeley; Rutgers State University New Brunswick; Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research	Sharma, AM (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	rodrigoalmeida@berkeley.edu	Almeida, Rodrigo/GZH-0682-2022; Duffy, Siobain/A-9104-2009	Duffy, Siobain/0000-0003-0753-223X; Almeida, Rodrigo/0000-0003-2888-9617	Rutgers School of Environmental and Biological Sciences; New Jersey Agricultural Experiment Station; United States Department of Agriculture NIFA-SCRI [2009-51181-06027]; American Vineyard Foundation	Rutgers School of Environmental and Biological Sciences; New Jersey Agricultural Experiment Station; United States Department of Agriculture NIFA-SCRI; American Vineyard Foundation	SD acknowledges support from the Rutgers School of Environmental and Biological Sciences and the New Jersey Agricultural Experiment Station. This research was supported by an award from the United States Department of Agriculture NIFA-SCRI (award no. 2009-51181-06027), and a grant to MLC from the American Vineyard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbas B, 2007, J PHYTOPATHOL, V155, P122, DOI 10.1111/j.1439-0434.2007.01206.x; Bertazzon N, 2010, EUR J PLANT PATHOL, V127, P185, DOI 10.1007/s10658-010-9583-3; Cabaleiro C, 2008, EUR J PLANT PATHOL, V121, P121, DOI 10.1007/s10658-007-9254-1; Charles JG, 2009, AUSTRALAS PLANT PATH, V38, P576, DOI 10.1071/AP09042; DELINDEN AJO, 1970, NZ J AGR RES, V13, P689; Engel EA, 2008, VIRUS GENES, V37, P110, DOI 10.1007/s11262-008-0241-1; Fajardo Thor V. M., 2007, Fitopatologia Brasileira, V32, P335, DOI 10.1590/S0100-41582007000400008; Fiore N, 2008, J PLANT PATHOL, V90, P125; Fuchs M, 2009, PHYTOPATHOLOGY, V99, P1177, DOI 10.1094/PHYTO-99-10-1177; Fuchs M, 2009, PLANT DIS, V93, P395, DOI 10.1094/PDIS-93-4-0395; Golino DA, 2008, CALIF AGR, V62, P156, DOI 10.3733/ca.v062n04p156; Gribaudo I, 2009, J PLANT PATHOL, V91, P741; Habili N, 1997, PLANT DIS, V81, P625, DOI 10.1094/PDIS.1997.81.6.625; HABILI N, 1995, PHYTOPATHOLOGY, V85, P1418, DOI 10.1094/Phyto-85-1418; HOEFERT LL, 1967, HILGARDIA, V38, P403, DOI 10.3733/hilg.v38n11p403; Jooste AEC, 2010, ARCH VIROL, V155, P1997, DOI 10.1007/s00705-010-0793-y; Mahfoudhi N, 2008, J PHYTOPATHOL, V156, P556, DOI 10.1111/j.1439-0434.2008.01414.x; Maliogka VI, 2008, VIRUS RES, V135, P125, DOI 10.1016/j.virusres.2008.02.015; Maree HJ, 2008, ARCH VIROL, V153, P755, DOI 10.1007/s00705-008-0040-y; Martelli G P, 2002, Arch Virol, V147, P2039, DOI 10.1007/s007050200048; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin RR, 2005, PLANT DIS, V89, P763, DOI 10.1094/PD-89-0763; Osman F, 2007, J VIROL METHODS, V141, P22, DOI 10.1016/j.jviromet.2006.11.035; Pietersen G, 2007, S AFR J SCI, V103, pII; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Swofford D, 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/J.0014-3820.2002.TB00191.X; Tsai CW, 2010, PHYTOPATHOLOGY, V100, P830, DOI 10.1094/PHYTO-100-8-0830; Turturo C, 2005, J GEN VIROL, V86, P217, DOI 10.1099/vir.0.80395-0; Wang JB, 2011, PHYTOPATHOLOGY, V101, P445, DOI 10.1094/PHYTO-07-10-0173	29	61	62	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26227	10.1371/journal.pone.0026227	http://dx.doi.org/10.1371/journal.pone.0026227			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039446	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500040
J	Toth, Z; Griggio, M				Toth, Zoltan; Griggio, Matteo			Leaders Are More Attractive: Birds with Bigger Yellow Breast Patches Are Followed by More Group-Mates in Foraging Groups	PLOS ONE			English	Article							SPARROW PETRONIA-PETRONIA; ROCK SPARROW; FEMALE ORNAMENTATION; DECISION-MAKING; SOCIAL NETWORK; ZEBRA; EVOLUTION; DOMINANCE; BEHAVIOR; ORGANIZATION	Social network theory provides a perfect tool to better understand the population-level consequences of how individuals interact and make their decisions; however, this approach is generally overlooked among evolutionary biologists interested in social relationships. Here, we used social network analysis to examine the patterns of leader-follower interactions in relation to individual characteristics in foraging groups of free-living rock sparrows (Petronia petronia). We found that yellow feather ornamentation, a carotenoid-based trait, was the best predictor of leadership: birds with bigger ornaments exerted greater influence in the foraging groups and were followed by more group-mates than less elaborate individuals. An individual's tendency for eliciting followings was not influenced by sex, condition or the level of parental investment. None of the above individual characteristics had significant effect on the tendency of individuals to follow others. Our results indicate that a sexually selected trait can also play a significant role in group coordination and social organization of a species.	[Toth, Zoltan; Griggio, Matteo] Univ Vet Med Vienna, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria	University of Veterinary Medicine Vienna	Toth, Z (corresponding author), Univ Vet Med Vienna, Dept Integrat Biol & Evolut, Konrad Lorenz Inst Ethol, Vienna, Austria.	matteo.griggio@vetmeduni.ac.at		Toth, Zoltan/0000-0002-2634-8393; Griggio, Matteo/0000-0002-3298-2905				Andersson Malte, 1994; Beauchamp G, 2000, BEHAVIOUR, V137, P301, DOI 10.1163/156853900502097; Biard C, 2006, J EXP BIOL, V209, P1004, DOI 10.1242/jeb.02089; BIDDAU L, 1995, AVOCETTA, V19, P38; Borgatti S.P., 2002, NETDRAW GRAPH VISUAL; BRUSH AH, 1990, FASEB J, V4, P2969, DOI 10.1096/fasebj.4.12.2394316; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conradt L, 2007, P ROY SOC B-BIOL SCI, V274, P2317, DOI 10.1098/rspb.2007.0186; Conradt L, 2003, NATURE, V421, P155, DOI 10.1038/nature01294; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; CRAMP S, 1994, BIRDS W PALEARCTIC, V3; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Edgington E. S., 1995, RANDOMIZATION TESTS; Fischhoff IR, 2007, ANIM BEHAV, V73, P825, DOI 10.1016/j.anbehav.2006.10.012; Flack JC, 2006, NATURE, V439, P426, DOI 10.1038/nature04326; Garamszegi LZ, 2006, BEHAV ECOL, V17, P682, DOI 10.1093/beheco/ark005; Giraudoux P., 2006, PGIRMESS MISCELLANEO; GOTCEITAS V, 1991, BEHAV ECOL SOCIOBIOL, V29, P255, DOI 10.1007/BF00163982; Griggio M, 2003, ETHOLOGY, V109, P659, DOI 10.1046/j.1439-0310.2003.00909.x; Griggio M, 2003, ETHOL ECOL EVOL, V15, P389; Griggio M, 2005, ANIM BEHAV, V69, P1243, DOI 10.1016/j.anbehav.2004.10.004; Griggio M, 2009, J EVOLUTION BIOL, V22, P2077, DOI 10.1111/j.1420-9101.2009.01823.x; Griggio M, 2007, ANIM BEHAV, V74, P779, DOI 10.1016/j.anbehav.2007.01.007; Griggio M, 2007, BEHAV ECOL SOCIOBIOL, V61, P423, DOI 10.1007/s00265-006-0270-5; Griggio M, 2010, J ETHOL, V28, P455, DOI 10.1007/s10164-010-0205-5; Griggio M, 2009, BEHAV ECOL, V20, P1072, DOI 10.1093/beheco/arp099; Harcourt JL, 2009, ANIM BEHAV, V77, P1501, DOI 10.1016/j.anbehav.2009.03.004; James R, 2009, BEHAV ECOL SOCIOBIOL, V63, P989, DOI 10.1007/s00265-009-0742-5; Junker B. H., 2008, WILEY SERIES BIOINFO; Jurasinski G, 2007, SIMBA COLLECTION FUN; King AJ, 2010, BEHAV PROCESS, V84, P671, DOI 10.1016/j.beproc.2010.03.006; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; King Andrew J., 2009, Communicative & Integrative Biology, V2, P147; King AJ, 2008, CURR BIOL, V18, P1833, DOI 10.1016/j.cub.2008.10.048; Krause J, 2002, LIVING GROUPS; Lusseau D, 2003, P ROY SOC B-BIOL SCI, V270, pS186, DOI 10.1098/rsbl.2003.0057; Lusseau D, 2004, P ROY SOC B-BIOL SCI, V271, pS477, DOI 10.1098/rsbl.2004.0225; Lusseau D, 2007, EVOL ECOL, V21, P357, DOI 10.1007/s10682-006-9105-0; Mateos-Gonzalez F, 2011, BIOL LETTERS, V7, P668, DOI 10.1098/rsbl.2011.0163; McDonald DB, 2007, P NATL ACAD SCI USA, V104, P10910, DOI 10.1073/pnas.0701159104; Mery F, 2010, EVOL ECOL, V24, P571, DOI 10.1007/s10682-009-9336-y; Moller AP, 2000, AVIAN POULT BIOL REV, V11, P137; Mougeot F, 2010, J EVOLUTION BIOL, V23, P643, DOI 10.1111/j.1420-9101.2009.01926.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Oh KP, 2010, AM NAT, V176, pE80, DOI 10.1086/655216; Opsahl T., 2009, THESIS U LONDON LOND, P104; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; Peterson RO, 2002, CAN J ZOOL, V80, P1405, DOI 10.1139/Z02-124; Pilastro A, 2003, ANIM BEHAV, V66, P265, DOI 10.1006/anbe.2003.2203; Pilastro A, 2001, J AVIAN BIOL, V32, P68, DOI 10.1034/j.1600-048X.2001.320109.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rands SA, 2004, P ROY SOC B-BIOL SCI, V271, P2613, DOI 10.1098/rspb.2004.2906; Rands SA, 2003, NATURE, V423, P432, DOI 10.1038/nature01630; Rands SA, 2006, BEHAV ECOL SOCIOBIOL, V60, P572, DOI 10.1007/s00265-006-0202-4; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; Reebs SG, 2000, ANIM BEHAV, V59, P403, DOI 10.1006/anbe.1999.1314; Schuett W, 2009, ANIM BEHAV, V77, P1041, DOI 10.1016/j.anbehav.2008.12.024; Senar Juan Carlos, 2002, Avian Science, V2, P19; Serra L, 2007, J EVOLUTION BIOL, V20, P2028, DOI 10.1111/j.1420-9101.2007.01360.x; Sih A, 2009, BEHAV ECOL SOCIOBIOL, V63, P975, DOI 10.1007/s00265-009-0725-6; Sueur C, 2008, INT J PRIMATOL, V29, P1085, DOI 10.1007/s10764-008-9262-9; Sundaresan SR, 2007, OECOLOGIA, V151, P140, DOI 10.1007/s00442-006-0553-6; Surai PF, 1999, BIOL TRACE ELEM RES, V68, P63, DOI 10.1007/BF02784397; Szekely T., 2010, SOCIAL BEHAV GENES E; Tavecchia G, 2002, IBIS, V144, pE79, DOI 10.1046/j.1474-919X.2002.00059.x; WASSERMAN S., 1994, SOCIAL NETWORK ANAL, DOI DOI 10.1017/CBO9780511815478; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; Williams R, 2006, BIOL LETTERS, V2, P497, DOI 10.1098/rsbl.2006.0510; ZANETTE L, 1994, ANIM BEHAV, V48, P119, DOI 10.1006/anbe.1994.1218	71	17	17	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26605	10.1371/journal.pone.0026605	http://dx.doi.org/10.1371/journal.pone.0026605			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028920	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500094
J	Hollants, J; Leroux, O; Leliaert, F; Decleyre, H; De Clerck, O; Willems, A				Hollants, Joke; Leroux, Olivier; Leliaert, Frederik; Decleyre, Helen; De Clerck, Olivier; Willems, Anne			Who Is in There? Exploration of Endophytic Bacteria within the Siphonous Green Seaweed Bryopsis (Bryopsidales, Chlorophyta)	PLOS ONE			English	Article							PHYLOGENETIC CHARACTERIZATION; EPIPHYTIC BACTERIA; MARINE MACROALGAE; ACID BACTERIA; SP-NOV.; DIVERSITY; ABALONE; IDENTIFICATION; ENDOSYMBIONTS; VARIABILITY	Associations between marine seaweeds and bacteria are widespread, with endobiotic bacterial-algal interactions being described for over 40 years. Also within the siphonous marine green alga Bryopsis, intracellular bacteria have been visualized by electron microscopy in the early '70s, but were up to now never molecularly analyzed. To study this partnership, we examined the presence and phylogenetic diversity of microbial communities within the cytoplasm of two Bryopsis species by combining fluorescence in situ hybridization (FISH), denaturing gradient gel electrophoresis (DGGE) and 16S rRNA gene clone libraries. Sequencing results revealed the presence of Arcobacter, Bacteroidetes, Flavobacteriaceae, Mycoplasma, Labrenzia, Phyllobacteriaceae and Xanthomonadaceae species. Although the total diversity of the endobiotic communities was unique to each Bryopsis culture, Bacteroidetes, Mycoplasma, Phyllobacteriaceae, and in particular Flavobacteriaceae bacteria, were detected in several Bryopsis samples collected hundreds of kilometres apart. This suggests that Bryopsis closely associates with well-defined endophytic bacterial communities of which some members possibly maintain an endosymbiotic relationship with the algal host.	[Hollants, Joke; Decleyre, Helen; Willems, Anne] Univ Ghent, Microbiol Lab, Dept Biochem & Microbiol, B-9000 Ghent, Belgium; [Hollants, Joke; Leliaert, Frederik; De Clerck, Olivier] Univ Ghent, Phycol Res Grp, Dept Biol, B-9000 Ghent, Belgium; [Leroux, Olivier] Univ Ghent, Pteridol Res Grp, Dept Biol, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Hollants, J (corresponding author), Univ Ghent, Microbiol Lab, Dept Biochem & Microbiol, B-9000 Ghent, Belgium.	Joke.Hollants@UGent.be	Leliaert, Frederik/A-9162-2009; De Clerck, Olivier/A-9083-2010; Willems, Anne/B-2872-2010; De Clerck, Olivier/AAU-4295-2020	Leliaert, Frederik/0000-0002-4627-7318; De Clerck, Olivier/0000-0002-3699-8402; Willems, Anne/0000-0002-8421-2881; Leroux, Olivier/0000-0001-9723-5604	'Fonds Wetenschappelijk Onderzoek' FWO-Flanders [G.0045.08]	'Fonds Wetenschappelijk Onderzoek' FWO-Flanders(FWO)	This research was funded by 'Fonds Wetenschappelijk Onderzoek' FWO-Flanders project G.0045.08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashen JB, 2000, APPL ENVIRON MICROB, V66, P3024, DOI 10.1128/AEM.66.7.3024-3030.2000; Bano N, 2007, ENVIRON MICROBIOL, V9, P2636, DOI 10.1111/j.1462-2920.2007.01381.x; Biebl H, 2007, INT J SYST EVOL MICR, V57, P1095, DOI 10.1099/ijs.0.64821-0; BURR F A, 1970, Phycologia, V9, P17, DOI 10.2216/i0031-8884-9-1-17.1; Chisholm JRM, 1996, NATURE, V381, P382, DOI 10.1038/381382a0; Cocquyt E, 2010, MOL BIOL EVOL, V27, P2052, DOI 10.1093/molbev/msq091; COLOMBO PM, 1978, PHYCOLOGIA, V17, P148, DOI 10.2216/i0031-8884-17-2-148.1; CORREA JA, 1993, J PHYCOL, V29, P853, DOI 10.1111/j.0022-3646.1993.00853.x; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Daims H, 2005, MOL MICROBIAL ECOLOG, P213; DAWES C J, 1978, Revue Algologique, V13, P309; De Meyer SE, 2011, SOIL BIOL BIOCHEM, V43, P2384, DOI 10.1016/j.soilbio.2011.08.005; De Vuyst L, 2008, INT J FOOD MICROBIOL, V125, P79, DOI 10.1016/j.ijfoodmicro.2007.02.030; Delbridge L, 2004, SYMBIOSIS, V37, P335; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eloe EA, 2011, ENV MICROBIOL REP, V3, P449, DOI 10.1111/j.1758-2229.2010.00223.x; Goecke F, 2010, MAR ECOL PROG SER, V409, P267, DOI 10.3354/meps08607; Green DH, 2004, FEMS MICROBIOL ECOL, V47, P345, DOI 10.1016/S0168-6496(03)00298-8; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta RS, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-106; Hanyuda T, 2000, J PLANT RES, V113, P403, DOI 10.1007/PL00013948; Hempel M, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-58; Hollants J, 2010, SYMBIOSIS, V51, P131, DOI 10.1007/s13199-010-0068-0; Horn M, 2004, J EUKARYOT MICROBIOL, V51, P509, DOI 10.1111/j.1550-7408.2004.tb00278.x; Huang ZB, 2010, AQUAC RES, V41, pe760, DOI 10.1111/j.1365-2109.2010.02577.x; Huber T, 2004, BIOINFORMATICS, V20, P2317, DOI 10.1093/bioinformatics/bth226; Kan Y, 1999, J NAT PROD, V62, P1169, DOI 10.1021/np990053y; Kikuchi Y, 2009, MICROBES ENVIRON, V24, P195, DOI 10.1264/jsme2.ME09140S; Kim HM, 2010, INT J SYST EVOL MICR, V60, P531, DOI 10.1099/ijs.0.007740-0; KUYKENDALL LD, 2005, BERGEYS MANUAL SYS C; Lachnit T, 2011, ENVIRON MICROBIOL, V13, P655, DOI 10.1111/j.1462-2920.2010.02371.x; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Matsuo Y, 2003, ENVIRON MICROBIOL, V5, P25, DOI 10.1046/j.1462-2920.2003.00382.x; MCBRIDE DL, 1974, PROTOPLASMA, V79, P249, DOI 10.1007/BF01276605; Meusnier I, 2001, MOL ECOL, V10, P931, DOI 10.1046/j.1365-294X.2001.01245.x; Naidoo K, 2006, J APPL PHYCOL, V18, P437, DOI 10.1007/s10811-006-9045-7; Noel GR, 2006, INT J SYST EVOL MICR, V56, P1697, DOI 10.1099/ijs.0.64234-0; Nylund GM, 2008, MAR ECOL PROG SER, V369, P39, DOI 10.3354/meps07577; Penesyan A, 2009, FEMS MICROBIOL ECOL, V69, P113, DOI 10.1111/j.1574-6941.2009.00688.x; Pinhassi J, 2006, INT J SYST EVOL MICR, V56, P1489, DOI 10.1099/ijs.0.64232-0; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rao KV, 2008, J NAT PROD, V71, P772, DOI 10.1021/np070508g; Romero J, 2002, MICROBIAL ECOL, V44, P365, DOI 10.1007/s00248-002-1063-7; SADDLER GS, 2005, BERGEYS MANUAL SYS B; Seibold A, 2001, AQUAT MICROB ECOL, V25, P229, DOI 10.3354/ame025229; Staufenberger T, 2008, FEMS MICROBIOL ECOL, V64, P65, DOI 10.1111/j.1574-6941.2008.00445.x; Sunagawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009554; Sunagawa S, 2009, ISME J, V3, P512, DOI 10.1038/ismej.2008.131; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka R, 2004, AQUACULTURE, V241, P453, DOI 10.1016/j.aquaculture.2004.08.032; Thamdrup B, 2000, APPL ENVIRON MICROB, V66, P2888, DOI 10.1128/AEM.66.7.2888-2897.2000; Thiel V, 2007, MICROB ECOL, V54, P101, DOI 10.1007/s00248-006-9177-y; Tujula NA, 2006, J MICROBIOL METH, V65, P604, DOI 10.1016/j.mimet.2005.09.006; Tujula NA, 2010, ISME J, V4, P301, DOI 10.1038/ismej.2009.107; TURNER JB, 1974, J PHYCOL, V10, P125; Van Hoorde K, 2008, FOOD MICROBIOL, V25, P929, DOI 10.1016/j.fm.2008.06.006; Weber CF, 2007, APPL ENVIRON MICROB, V73, P1266, DOI 10.1128/AEM.01724-06; West JA, 1999, HYDROBIOLOGIA, V399, P101; Wiese J, 2009, MAR BIOTECHNOL, V11, P287, DOI 10.1007/s10126-008-9143-4; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002	61	50	51	2	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26458	10.1371/journal.pone.0026458	http://dx.doi.org/10.1371/journal.pone.0026458			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028882	Green Published, gold, Green Submitted			2022-12-27	WOS:000296186900066
J	Layana, C; Diambra, L				Layana, Carla; Diambra, Luis			Time-Course Analysis of Cyanobacterium Transcriptome: Detecting Oscillatory Genes	PLOS ONE			English	Article							EXPRESSION; CYCLE	The microarray technique allows the simultaneous measurements of the expression levels of thousands of mRNAs. By mining these data one can identify the dynamics of the gene expression time series. The detection of genes that are periodically expressed is an important step that allows us to study the regulatory mechanisms associated with the circadian cycle. The problem of finding periodicity in biological time series poses many challenges. Such challenge occurs due to the fact that the observed time series usually exhibit non-idealities, such as noise, short length, outliers and unevenly sampled time points. Consequently, the method for finding periodicity should preferably be robust against such anomalies in the data. In this paper, we propose a general and robust procedure for identifying genes with a periodic signature at a given significance level. This identification method is based on autoregressive models and the information theory. By using simulated data we show that the suggested method is capable of identifying rhythmic profiles even in the presence of noise and when the number of data points is small. By recourse of our analysis, we uncover the circadian rhythmic patterns underlying the gene expression profiles from Cyanobacterium Synechocystis.	[Layana, Carla; Diambra, Luis] Univ Nacl La Plata, CREG, Florencio Varela, Argentina	National University of La Plata	Layana, C (corresponding author), Univ Nacl La Plata, CREG, Florencio Varela, Argentina.	ldiambra@creg.org.ar	L, Diambra/F-6319-2015	L, Diambra/0000-0001-8052-4880; layana, carla/0000-0002-2313-2028	CONICET (Argentina)	CONICET (Argentina)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	CL thanks CONICET (Argentina) for financial support. LD is a researcher of CONICET (Argentina). The authors thank Ken-ichi Kucho for having provided the data, and Prof. Rolando Rivera-Pomar for valuable suggestions.	Ahdesmaki M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-117; Albrecht U, 2003, CURR OPIN GENET DEV, V13, P271, DOI 10.1016/S0959-437X(03)00055-8; [Anonymous], KEGG CATEGORIES; Chaudhuri P, 1996, J AM STAT ASSOC, V91, P862; de Hoon MJL, 2002, BIOINFORMATICS, V18, P1477, DOI 10.1093/bioinformatics/18.11.1477; de Lichtenberg U, 2005, BIOINFORMATICS, V21, P1164, DOI 10.1093/bioinformatics/bti093; Diambra L, 2008, PHYSICA A, V387, P2187, DOI 10.1016/j.physa.2007.12.006; Diambra L, 1996, PHYS LETT A, V216, P278, DOI 10.1016/0375-9601(96)00290-3; Ditty JL, 2003, ANNU REV GENET, V37, P513, DOI 10.1146/annurev.genet.37.110801.142716; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; Hogenesch John B, 2003, Novartis Found Symp, V253, P171; Hughes M, 2007, COLD SPRING HARB SYM, V72, P381, DOI 10.1101/sqb.2007.72.011; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; JAYNES ET, 1957, PHYS REV, V108, P171, DOI 10.1103/PhysRev.108.171; Johnson CH, 1999, ANNU REV MICROBIOL, V53, P389, DOI 10.1146/annurev.micro.53.1.389; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; Levine RD, 1978, MAXIMUM ENTROPY PRIN; Lu X, 2004, NUCLEIC ACIDS RES, V32, P447, DOI 10.1093/nar/gkh205; Luan Y, 2004, BIOINFORMATICS, V20, P332, DOI 10.1093/bioinformatics/btg413; McDonald MJ, 2001, CELL, V107, P567, DOI 10.1016/S0092-8674(01)00545-1; Muro-Pastor AM, 2001, J BACTERIOL, V183, P1090, DOI 10.1128/JB.183.3.1090-1095.2001; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Schmitt WA, 2004, GENOME RES, V14, P1654, DOI 10.1101/gr.2439804; Schmitt WA, 2003, BIOTECHNOL BIOENG, V84, P855, DOI 10.1002/bit.10843; Shannon C. E., 1949, MATH THEORY COMMUNIC; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Wichert S, 2004, BIOINFORMATICS, V20, P5, DOI 10.1093/bioinformatics/btg364	30	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26291	10.1371/journal.pone.0026291	http://dx.doi.org/10.1371/journal.pone.0026291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028849	Green Submitted, gold, Green Published			2022-12-27	WOS:000296186900043
J	Mizobata, T; Uemura, T; Isaji, K; Hirayama, T; Hongo, K; Kawata, Y				Mizobata, Tomohiro; Uemura, Tatsuya; Isaji, Kazuhiro; Hirayama, Takuma; Hongo, Kunihiro; Kawata, Yasushi			Probing the Functional Mechanism of Escherichia coli GroEL Using Circular Permutation	PLOS ONE			English	Article							INDUCED CONFORMATIONAL-CHANGES; CHAPERONIN GROEL; CRYSTAL-STRUCTURE; KINETIC-ANALYSIS; APICAL DOMAIN; PROTEIN; POLYPEPTIDE; INTERMEDIATE; BINDING; CYCLE	Background: The Escherichia coli chaperonin GroEL subunit consists of three domains linked via two hinge regions, and each domain is responsible for a specific role in the functional mechanism. Here, we have used circular permutation to study the structural and functional characteristics of the GroEL subunit. Methodology/Principal Findings: Three soluble, partially active mutants with polypeptide ends relocated into various positions of the apical domain of GroEL were isolated and studied. The basic functional hallmarks of GroEL (ATPase and chaperoning activities) were retained in all three mutants. Certain functional characteristics, such as basal ATPase activity and ATPase inhibition by the cochaperonin GroES, differed in the mutants while at the same time, the ability to facilitate the refolding of rhodanese was roughly equal. Stopped-flow fluorescence experiments using a fluorescent variant of the circularly permuted GroEL CP376 revealed that a specific kinetic transition that reflects movements of the apical domain was missing in this mutant. This mutant also displayed several characteristics that suggested that the apical domains were behaving in an uncoordinated fashion. Conclusions/Significance: The loss of apical domain coordination and a concomitant decrease in functional ability highlights the importance of certain conformational signals that are relayed through domain interlinks in GroEL. We propose that circular permutation is a very versatile tool to probe chaperonin structure and function.	[Mizobata, Tomohiro; Isaji, Kazuhiro; Hongo, Kunihiro; Kawata, Yasushi] Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 680, Japan; [Hirayama, Takuma] Tottori Univ, Fac Engn, Dept Biotechnol, Tottori 680, Japan; [Mizobata, Tomohiro; Uemura, Tatsuya; Hongo, Kunihiro; Kawata, Yasushi] Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Tottori 680, Japan	Tottori University; Tottori University; Tottori University	Mizobata, T (corresponding author), Tottori Univ, Grad Sch Engn, Dept Chem & Biotechnol, Tottori 680, Japan.	mizobata@bio.tottori-u.ac.jp	Mizobata, Tomohiro/V-6672-2019; Kawata, Yasushi/ABA-9608-2021	Mizobata, Tomohiro/0000-0002-7808-2099; Kawata, Yasushi/0000-0002-2744-1506	Japan Society for the Promotion of Science (JSPS) of Japan [22570119]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [22020025]; Faculty of Engineering, Tottori University; Venture Business Laboratory, Tottori University; Grants-in-Aid for Scientific Research [21570113] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Faculty of Engineering, Tottori University; Venture Business Laboratory, Tottori University; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 22570119 to T. M.) from the Japan Society for the Promotion of Science (JSPS) of Japan, a Grant-in-Aid for Scientific Research on Priority Areas (No. 22020025 to Y. K.) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, and also by grants to T. M. from the Faculty of Engineering, Tottori University and the Venture Business Laboratory, Tottori University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Chatellier J, 1998, P NATL ACAD SCI USA, V95, P9861, DOI 10.1073/pnas.95.17.9861; Cliff MJ, 1999, J MOL BIOL, V293, P667, DOI 10.1006/jmbi.1999.3138; Graf R, 1996, P NATL ACAD SCI USA, V93, P11591, DOI 10.1073/pnas.93.21.11591; Heinemann U, 1995, PROG BIOPHYS MOL BIO, V64, P121, DOI 10.1016/0079-6107(95)00013-5; Hennecke J, 1999, J MOL BIOL, V286, P1197, DOI 10.1006/jmbi.1998.2531; Horwich AL, 2006, CHEM REV, V106, P1917, DOI 10.1021/cr040435v; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; Iwasa H, 2011, J BIOL CHEM, V286, P21796, DOI 10.1074/jbc.M111.228445; JACKSON GS, 1993, BIOCHEMISTRY-US, V32, P2554, DOI 10.1021/bi00061a013; Kamireddi M, 1997, PROTEIN EXPRES PURIF, V11, P47, DOI 10.1006/prep.1997.0764; Kawata Y, 1999, BIOCHEMISTRY-US, V38, P15731, DOI 10.1021/bi9909750; KUBO T, 1993, J BIOL CHEM, V268, P19346; Li Y, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/45/455101; Machida K, 2008, J BIOL CHEM, V283, P6886, DOI 10.1074/jbc.M708002200; Machida K, 2009, BBA-PROTEINS PROTEOM, V1794, P1344, DOI 10.1016/j.bbapap.2008.12.003; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Miyazaki T, 2002, J BIOL CHEM, V277, P50621, DOI 10.1074/jbc.M209183200; Mizobata T, 2000, J BIOL CHEM, V275, P25600, DOI 10.1074/jbc.M000795200; MIZOBATA T, 1994, BBA-PROTEIN STRUCT M, V1209, P83, DOI 10.1016/0167-4838(94)90140-6; Motojima F, 2004, P NATL ACAD SCI USA, V101, P15005, DOI 10.1073/pnas.0406132101; Paavola CD, 2006, NANOTECHNOLOGY, V17, P1171, DOI 10.1088/0957-4484/17/5/001; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Taguchi H, 2004, J BIOL CHEM, V279, P45737, DOI 10.1074/jbc.M406795200; Taniguchi M, 2004, J BIOL CHEM, V279, P16368, DOI 10.1074/jbc.M311806200; Tehver R, 2009, J MOL BIOL, V387, P390, DOI 10.1016/j.jmb.2008.12.032; Wang QH, 2000, J MOL BIOL, V304, P873, DOI 10.1006/jmbi.2000.4276; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; WEISSMAN JS, 1995, CELL, V83, P577, DOI 10.1016/0092-8674(95)90098-5; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yifrach O, 1998, BIOCHEMISTRY-US, V37, P7083, DOI 10.1021/bi980370o; Yoshimi T, 2006, J BIOCHEM, V139, P407, DOI 10.1093/jb/mvj043	38	4	4	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26462	10.1371/journal.pone.0026462	http://dx.doi.org/10.1371/journal.pone.0026462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028884	Green Submitted, Green Published, gold			2022-12-27	WOS:000296186900067
J	Wu, ZQ; Xue, Y; Wang, B; Du, J; Jin, Q				Wu, Zhiqiang; Xue, Ying; Wang, Bei; Du, Jiang; Jin, Qi			Broad-Spectrum Antiviral Activity of RNA Interference against Four Genotypes of Japanese Encephalitis Virus Based on Single MicroRNA Polycistrons	PLOS ONE			English	Article							EXPRESSION VECTORS; MAMMALIAN-CELLS; REPLICATION; GENE; INHIBITION; SIRNAS; MIRNAS; CHINA	Japanese encephalitis virus (JEV), a neurotropic mosquito-borne flavivirus, causes acute viral encephalitis and neurologic disease with a high fatality rate in humans and a range of animals. Small interfering RNA (siRNA) is a powerful antiviral agent able to inhibit JEV replication. However, the high rate of genetic variability between JEV strains (of four confirmed genotypes, genotypes I, II, III and IV) hampers the broad-spectrum application of siRNAs, and mutations within the targeted sequences could facilitate JEV escape from RNA interference (RNAi)-mediated antiviral therapy. To improve the broad-spectrum application of siRNAs and prevent the generation of escape mutants, multiple siRNAs targeting conserved viral sequences need to be combined. In this study, using a siRNA expression vector based on the miR-155 backbone and promoted by RNA polymerase II, we initially identified nine siRNAs targeting highly conserved regions of seven JEV genes among strains of the four genotypes of JEV to effectively block the replication of the JEV vaccine strain SA14-14-2. Then, we constructed single microRNA-like polycistrons to simultaneously express these effective siRNAs under a single RNA polymerase II promoter. Finally, these single siRNAs or multiple siRNAs from the microRNA-like polycistrons showed effective anti-virus activity in genotype I and genotype III JEV wild type strains, which are the predominant genotypes of JEV in mainland China. The anti-JEV effect of these microRNA-like polycistrons was also predicted in other genotypes of JEV (genotypes II and IV), The inhibitory efficacy indicated that siRNAs69 could theoretically inhibit the replication of JEV genotypes II and IV.	[Wu, Zhiqiang] Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wu, ZQ (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, State Key Lab Mol Virol & Genet Engn, Beijing 100730, Peoples R China.	zdsys@vip.sina.com	Jin, Qi/B-5379-2009		National ST Major Project [2009ZX10004-102, 2009ZX10004-216]	National ST Major Project	This work was supported by the National S&T Major Project "Prevention and Control for AIDS, Viral Hepatitis and Other Major Infectious Diseases" (Grant No. 2009ZX10004-102 and 2009ZX10004-216). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard L, 2008, GENE THER, V15, P1536, DOI 10.1038/gt.2008.147; Amarzguioui M, 2005, FEBS LETT, V579, P5974, DOI 10.1016/j.febslet.2005.08.070; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chen WZ, 2004, J VIROL, V78, P6900, DOI 10.1128/JVI.78.13.6900-6907.2004; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Cullen BR, 2004, MOL CELL, V16, P861, DOI 10.1016/j.molcel.2004.12.002; Das AT, 2004, J VIROL, V78, P2601, DOI 10.1128/JVI.78.5.2601-2605.2004; Du GW, 2006, FEBS J, V273, P5421, DOI 10.1111/j.1742-4658.2006.05534.x; Du Q, 2005, NUCLEIC ACIDS RES, V33, P1671, DOI 10.1093/nar/gki312; Du Q, 2004, BIOCHEM BIOPH RES CO, V325, P243, DOI 10.1016/j.bbrc.2004.09.222; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; Gao XY, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000624; Gould EA, 2008, ANTIVIR RES, V78, P140, DOI 10.1016/j.antiviral.2007.10.005; Haasnoot J, 2007, NAT BIOTECHNOL, V25, P1435, DOI 10.1038/nbt1369; Hammond SM, 2001, NAT REV GENET, V2, P110, DOI 10.1038/35052556; Huang JH, 2010, EMERG INFECT DIS, V16, P876, DOI 10.3201/eid1605.091055; Israsena N, 2009, ANTIVIR RES, V84, P76, DOI 10.1016/j.antiviral.2009.07.012; Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901; Kumar P, 2006, PLOS MED, V3, P505, DOI 10.1371/journal.pmed.0030096; Lehto T, 2010, J CONTROL RELEASE, V141, P42, DOI 10.1016/j.jconrel.2009.08.028; Liu YP, 2008, NUCLEIC ACIDS RES, V36, P2811, DOI 10.1093/nar/gkn109; Manjunath N, 2009, ADV DRUG DELIVER REV, V61, P732, DOI 10.1016/j.addr.2009.03.004; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Morita K, 2009, VACCINE, V27, P7131, DOI 10.1016/j.vaccine.2009.09.051; Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067; Murakami M, 2005, MICROBIOL IMMUNOL, V49, P1047, DOI 10.1111/j.1348-0421.2005.tb03701.x; Qi WB, 2008, VIRUS RES, V132, P145, DOI 10.1016/j.virusres.2007.11.014; REED L. J., 1938, AMER JOUR HYG, V27, P493; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Siolas D, 2005, NAT BIOTECHNOL, V23, P227, DOI 10.1038/nbt1052; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Sui GC, 2002, P NATL ACAD SCI USA, V99, P5515, DOI 10.1073/pnas.082117599; Sui HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005671; Wang HY, 2007, J GEN VIROL, V88, P885, DOI 10.1099/vir.0.82185-0; Watanabe T, 2007, ADV DRUG DELIVER REV, V59, P1263, DOI 10.1016/j.addr.2007.03.022; Woodrow KA, 2009, NAT MATER, V8, P526, DOI [10.1038/NMAT2444, 10.1038/nmat2444]; Wu ZQ, 2008, ANTIVIR RES, V80, P295, DOI 10.1016/j.antiviral.2008.06.017; Yu YX, 2010, VACCINE, V28, P3635, DOI 10.1016/j.vaccine.2010.02.105; Yuan J, 2005, J VIROL, V79, P2151, DOI 10.1128/JVI.79.4.2151-2159.2005; Yun SM, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-127; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhiqiang W, 2010, ANTIVIR RES, V85, P559, DOI 10.1016/j.antiviral.2009.12.010; Zhu XC, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-98; Zimmermann TS, 2006, NATURE, V441, P111, DOI 10.1038/nature04688	45	21	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26304	10.1371/journal.pone.0026304	http://dx.doi.org/10.1371/journal.pone.0026304			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028851	gold, Green Submitted, Green Published			2022-12-27	WOS:000296186900045
J	Ponnala, S; Veeravalli, KK; Chetty, C; Dinh, DH; Rao, JS				Ponnala, Shivani; Veeravalli, Krishna Kumar; Chetty, Chandramu; Dinh, Dzung H.; Rao, Jasti S.			Regulation of DNA Repair Mechanism in Human Glioma Xenograft Cells both In Vitro and In Vivo in Nude Mice	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; PLASMINOGEN-ACTIVATOR RECEPTOR; GROWTH-FACTOR RECEPTOR; DEPENDENT PROTEIN-KINASE; UROKINASE RECEPTOR; IV COLLAGENASE; BRAIN-TUMORS; GENE-EXPRESSION; CATHEPSIN-B; LIPID RAFTS	Background: Glioblastoma Multiforme (GBM) is the most lethal form of brain tumor. Efficient DNA repair and anti-apoptotic mechanisms are making glioma treatment difficult. Proteases such as MMP9, cathepsin B and urokinase plasminogen activator receptor (uPAR) are over expressed in gliomas and contribute to enhanced cancer cell proliferation. Non-homologous end joining (NHEJ) repair mechanism plays a major role in double strand break (DSB) repair in mammalian cells. Methodology/Principal Findings: Here we show that silencing MMP9 in combination with uPAR/cathepsin B effects NHEJ repair machinery. Expression of DNA PKcs and Ku70/80 at both mRNA and protein levels in MMP9-uPAR (pMU) and MMP9-cathepsin B (pMC) shRNA-treated glioma xenograft cells were reduced. FACS analysis showed an increase in apoptotic peak and proliferation assays revealed a significant reduction in the cell population in pMU- and pMC-treated cells compared to untreated cells. We hypothesized that reduced NHEJ repair led to DSBs accumulation in pMU-and pMC-treated cells, thereby initiating cell death. This hypothesis was confirmed by reduced Ku70/Ku80 protein binding to DSB, increased comet tail length and elevated gamma H2AX expression in treated cells compared to control. Immunoprecipitation analysis showed that EGFR-mediated lowered DNA PK activity in treated cells compared to controls. Treatment with pMU and pMC shRNA reduced the expression of DNA PKcs and ATM, and elevated gamma H2AX levels in xenograft implanted nude mice. Glioma cells exposed to hypoxia and irradiation showed DSB accumulation and apoptosis after pMU and pMC treatments compared to respective controls. Conclusion/Significance: Our results suggest that pMU and pMC shRNA reduce glioma proliferation by DSB accumulation and increase apoptosis under normoxia, hypoxia and in combination with irradiation. Considering the radio- and chemo-resistant cancers favored by hypoxia, our study provides important therapeutic potential of MMP9, uPAR and cathepsin B shRNA in the treatment of glioma from clinical stand point.	[Ponnala, Shivani; Veeravalli, Krishna Kumar; Chetty, Chandramu; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA; [Dinh, Dzung H.; Rao, Jasti S.] Univ Illinois, Coll Med Peoria, Dept Neurosurg, Peoria, IL USA	University of Illinois System; University of Illinois Peoria; University of Illinois System; University of Illinois Peoria	Ponnala, S (corresponding author), Univ Illinois, Coll Med Peoria, Dept Canc Biol & Pharmacol, Peoria, IL USA.	jsrao@uic.edu		Veeravalli, Krishna Kumar/0000-0002-2243-004X	National Institute of Neurological Disorders and Stroke (N.I.N.D.S) [NS047699]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047699] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (N.I.N.D.S)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by a grant from National Institute of Neurological Disorders and Stroke (N.I.N.D.S), NS047699 (to JSR). The funders had no rule in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay D, 1998, J BIOL CHEM, V273, P1568, DOI 10.1074/jbc.273.3.1568; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Burma S, 2004, DNA REPAIR, V3, P909, DOI 10.1016/j.dnarep.2004.03.021; Chakravarti A, 2004, INT J RADIAT ONCOL, V58, P927, DOI 10.1016/j.ijrobp.2003.09.092; Chetty C, 2010, MOL CANCER THER, V9, P2605, DOI 10.1158/1535-7163.MCT-10-0245; Citri A, 2003, EXP CELL RES, V284, P54, DOI 10.1016/S0014-4827(02)00101-5; Dasika GK, 1999, ONCOGENE, V18, P7883, DOI 10.1038/sj.onc.1203283; Degryse B, 2005, J BIOL CHEM, V280, P24792, DOI 10.1074/jbc.M413954200; Ding Q, 2003, MOL CELL BIOL, V23, P5836, DOI 10.1128/MCB.23.16.5836-5848.2003; Durocher D, 2001, CURR OPIN CELL BIOL, V13, P225, DOI 10.1016/S0955-0674(00)00201-5; Ferrara N, 1999, J MOL MED, V77, P527, DOI 10.1007/s001099900019; Gopinath S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011668; GRAU C, 1988, RADIOTHER ONCOL, V13, P301, DOI 10.1016/0167-8140(88)90225-3; HALL EJ, 1994, INT J RADIAT ONCOL, V30, P241, DOI 10.1016/0360-3016(94)90542-8; Hockel M, 2001, JNCI-J NATL CANCER I, V93, P266, DOI 10.1093/jnci/93.4.266; Holcomb VB, 2008, CANCER RES, V68, P9497, DOI 10.1158/0008-5472.CAN-08-2085; James C. David, 1996, Current Opinion in Oncology, V8, P188; Jeggo PA, 2006, DNA REPAIR, V5, P1192, DOI 10.1016/j.dnarep.2006.05.011; Johannessen TCA, 2008, CANCER TREAT REV, V34, P558, DOI 10.1016/j.ctrv.2008.03.125; Kaanders JHAM, 2002, LANCET ONCOL, V3, P728, DOI 10.1016/S1470-2045(02)00929-4; Kao GD, 2007, J BIOL CHEM, V282, P21206, DOI 10.1074/jbc.M703042200; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Koschny R, 2002, CANCER GENET CYTOGEN, V135, P147, DOI 10.1016/S0165-4608(01)00650-1; Lakka SS, 2005, J BIOL CHEM, V280, P21882, DOI 10.1074/jbc.M408520200; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; Lavin MF, 2005, MUTAT RES-FUND MOL M, V569, P123, DOI 10.1016/j.mrfmmm.2004.04.020; LEROMANCER M, 1994, J BIOL CHEM, V269, P17464; Liu D, 2002, CANCER CELL, V1, P445, DOI 10.1016/S1535-6108(02)00072-7; Mazzieri R, 1997, EMBO J, V16, P2319, DOI 10.1093/emboj/16.9.2319; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Raghu H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-647; RAMPLING R, 1994, INT J RADIAT ONCOL, V29, P427, DOI 10.1016/0360-3016(94)90432-4; Rao JS, 2007, CANCER RES, V67, P4956, DOI 10.1158/0008-5472.CAN-07-0380; RAO JS, 1994, J NEURO-ONCOL, V18, P129, DOI 10.1007/BF01050419; RAO JS, 1993, CANCER RES, V53, P2208; REMPEL SA, 1994, CANCER RES, V54, P6027; RODRIGUEZ R, 1994, INT J RADIAT ONCOL, V29, P105, DOI 10.1016/0360-3016(94)90232-1; Rooprai HK, 1998, INT J ONCOL, V13, P1153; Ruano Y, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-39; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Seidel S, 2010, BRAIN, V133, P983, DOI 10.1093/brain/awq042; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; te Poele RH, 2002, CANCER RES, V62, P1876; TEICHER BA, 1990, CANCER RES, V50, P3339; Thompson LH, 2001, MUTAT RES-FUND MOL M, V477, P131, DOI 10.1016/S0027-5107(01)00115-4; Tovari J, 1998, CELL SIGNAL, V10, P277, DOI 10.1016/S0898-6568(97)00128-9; Veeravalli KK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011583; von Pawel J, 2000, J CLIN ONCOL, V18, P1351, DOI 10.1200/JCO.2000.18.6.1351; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wanner G, 2008, RADIOTHER ONCOL, V86, P383, DOI 10.1016/j.radonc.2007.10.041; Wei Y, 1996, SCIENCE, V273, P1551, DOI 10.1126/science.273.5281.1551; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; YAMAMOTO M, 1994, CANCER RES, V54, P5016; Yano K, 2009, J RADIAT RES, V50, P97, DOI 10.1269/jrr.08119; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004	56	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26191	10.1371/journal.pone.0026191	http://dx.doi.org/10.1371/journal.pone.0026191			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022560	Green Published, gold, Green Submitted			2022-12-27	WOS:000295981600036
J	Lee, CY; Jeffery, R; Hutchinson, G; Alison, MR; Poulsom, R; Wright, NA; Otto, WR				Lee, Chung-Yin; Jeffery, Rosemary; Hutchinson, Gillian; Alison, Malcolm R.; Poulsom, Richard; Wright, Nicholas A.; Otto, William R.			Bone Marrow Cells in Murine Colitis: Multi-Signal Analysis Confirms Pericryptal Myofibroblast Engraftment without Epithelial Involvement	PLOS ONE			English	Article							MOUSE AGGREGATION CHIMERAS; STEM-CELLS; INTESTINAL EPITHELIUM; HOST-CELLS; FUSION; MICE; TRANSPLANTATION; TISSUE; INFLAMMATION; REGENERATION	Background: The contribution of bone marrow-derived cells to epithelial tissues in the inflamed gut remains controversial. Recent reports have suggested that cell fusion between bone marrow-derived cells and the intestinal epithelium takes place in inflammatory conditions. Methods: In attempts to confirm this, we have undertaken gender mis-matched bone marrow (BM) transplants from male Swiss Webster (SWR) mice to B and T cell-deficient female Rag2 KO mice which, 4 weeks later, were given 5% dextran sodium sulphate in drinking water to induce acute colitis. A further BM-treated group of animals with a graft versus host-like condition was also studied. We developed a new method to combine up to three brightfield or fluorescent lectin-or immuno-histochemical signals with fluorescent in situ hybridisation for the Y and X chromosomes to enable us unequivocally to identify BM-derived male cells which presented as different cell types in the gastrointestinal tract. Principal Findings: In rolled preparations of whole intestines we scanned around 1.5 million crypts at many tissue levels. In no instance did we see a Y chromosome-positive cell in the epithelial compartment, which was not also CD45-positive. We saw no evidence of cell fusion, based on combined X and Y chromosome analysis. Levels of CD45-positive stromal and lymphoid cells and pericryptal myfibroblasts (positive for alpha-smooth muscle actin) increased with time up to a plateau, which resembled the level seen in untreated control grafted animals. We saw very few Y chromosome-positive endothelial cells in intestinal stromal vessels. Conclusions: We conclude that whole BM transplantation does not result in intestinal epithelial engraftment in this model. Our new methods can usefully assist in multi-signal analyses of cell phenotypes following BM transplant and in models of chimaerism and regenerative medicine.	[Lee, Chung-Yin; Jeffery, Rosemary; Poulsom, Richard; Wright, Nicholas A.; Otto, William R.] London Res Inst, Histopathol Lab, Canc Res UK, London, England; [Hutchinson, Gillian] London Res Inst, Biol Resources Unit, Canc Res UK, London, England; [Alison, Malcolm R.; Poulsom, Richard; Wright, Nicholas A.; Otto, William R.] Barts & London Queen Marys Sch Med & Dent, Ctr Digest Dis, Blizard Inst, London, England	Cancer Research UK; Cancer Research UK; University of London; Queen Mary University London	Lee, CY (corresponding author), London Res Inst, Histopathol Lab, Canc Res UK, London, England.	w.r.otto@qmul.ac.uk	Alison, Malcolm/H-6961-2019; Wright, Nicholas/HHY-7227-2022	Wright, Nicholas/0000-0002-5525-3457	Cancer Research United Kingdom	Cancer Research United Kingdom(Cancer Research UK)	This work was funded by Cancer Research United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bamba S, 2006, J PATHOL, V209, P265, DOI 10.1002/path.1967; Brittan M, 2005, GASTROENTEROLOGY, V128, P1984, DOI 10.1053/j.gastro.2005.03.028; Brittan M, 2005, J PATHOL, V205, P1, DOI 10.1002/path.1682; Brittan M, 2002, GUT, V50, P752, DOI 10.1136/gut.50.6.752; Burns TC, 2006, STEM CELLS, V24, P1121, DOI 10.1634/stemcells.2005-0463; Campbell TD, 2008, ETHNIC DIS, V18, P14; COOPER HS, 1993, LAB INVEST, V69, P238; Davies PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006530; Direkze NC, 2004, CANCER RES, V64, P8492, DOI 10.1158/0008-5472.CAN-04-1708; Direkze NC, 2003, STEM CELLS, V21, P514, DOI 10.1634/stemcells.21-5-514; Fang BJ, 2003, J HEMATOTH STEM CELL, V12, P603, DOI 10.1089/15258160360732632; Fang TC, 2005, J AM SOC NEPHROL, V16, P1723, DOI 10.1681/ASN.2004121089; Ferrand J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019569; Harris RG, 2004, SCIENCE, V305, P90, DOI 10.1126/science.1098925; Houghton J, 2004, SCIENCE, V306, P1568, DOI 10.1126/science.1099513; Hyun E, 2010, INFLAMM RES, V59, P699, DOI 10.1007/s00011-010-0181-9; Jeffery R, 2006, METH MOLEC MED, V120, P323; Jiang SG, 2004, P NATL ACAD SCI USA, V101, P16891, DOI 10.1073/pnas.0404398101; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; KIRKLAND SC, 1988, CANCER, V61, P1359, DOI 10.1002/1097-0142(19880401)61:7<1359::AID-CNCR2820610714>3.0.CO;2-0; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Krieglstein CF, 2002, J CLIN INVEST, V110, P1773, DOI 10.1172/JCI200215256; Matsumoto T, 2005, GASTROENTEROLOGY, V128, P1851, DOI 10.1053/j.gastro.2005.03.085; Montecalvo A, 2008, J IMMUNOL, V180, P3081, DOI 10.4049/jimmunol.180.5.3081; Naper C, 2010, INT IMMUNOL, V22, P973, DOI 10.1093/intimm/dxq452; Novelli MR, 1999, P NATL ACAD SCI USA, V96, P12553, DOI 10.1073/pnas.96.22.12553; Nygren JM, 2008, NAT CELL BIOL, V10, P584, DOI 10.1038/ncb1721; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Olson JA, 2009, J IMMUNOL, V183, P3219, DOI 10.4049/jimmunol.0804268; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; PONDER BAJ, 1986, HISTOCHEM J, V18, P217, DOI 10.1007/BF01676230; RANA R, 1990, RADIAT RES, V124, P96, DOI 10.2307/3577701; Reca R, 2007, STEM CELLS, V25, P3093, DOI 10.1634/stemcells.2007-0525; Rizvi AZ, 2006, P NATL ACAD SCI USA, V103, P6321, DOI 10.1073/pnas.0508593103; Rosenberg DW, 1995, CANCER LETT, V98, P33, DOI 10.1016/0304-3835(95)03997-B; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SCHMIDT GH, 1985, CELL, V40, P425, DOI 10.1016/0092-8674(85)90156-4; SCHMIDT GH, 1985, J EMBRYOL EXP MORPH, V88, P219; Soderberg A, 2007, FREE RADICAL BIO MED, V43, P90, DOI 10.1016/j.freeradbiomed.2007.03.026; Spyridonidis A, 2004, AM J PATHOL, V164, P1147, DOI 10.1016/S0002-9440(10)63203-8; Tolar J, 2006, BLOOD, V107, P4182, DOI 10.1182/blood-2005-08-3289; Vig P, 2006, HEPATOLOGY, V43, P316, DOI 10.1002/hep.21018; Wei YM, 2009, TRANSPLANTATION, V88, P42, DOI 10.1097/TP.0b013e3181a9f0a7; WILSON TJG, 1985, CELL TISSUE KINET, V18, P333, DOI 10.1111/j.1365-2184.1985.tb00662.x; Winton D J, 1992, Epithelial Cell Biol, V1, P59; WINTON DJ, 1989, MUTAGENESIS, V4, P404, DOI 10.1093/mutage/4.5.404; WRIGHT NA, 1984, BIOL EPITHELIAL CELL, P599; YABANA T, 2009, J PATHOL	49	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26082	10.1371/journal.pone.0026082	http://dx.doi.org/10.1371/journal.pone.0026082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022515	Green Published, gold, Green Submitted			2022-12-27	WOS:000295978600039
J	Christopher, DJ; James, P; Daley, P; Armstrong, L; Isaac, BTJ; Thangakunam, B; Premkumar, B; Zwerling, A; Pai, M				Christopher, Devasahayam J.; James, Prince; Daley, Peter; Armstrong, Lois; Isaac, Barney T. J.; Thangakunam, Balamugesh; Premkumar, Beulah; Zwerling, Alice; Pai, Madhukar			High Annual Risk of Tuberculosis Infection among Nursing Students in South India: A Cohort Study	PLOS ONE			English	Article							HEALTH-CARE WORKERS; GAMMA; ASSAYS; IMMUNODIAGNOSIS; TESTS	Background: Nurses in developing countries are frequently exposed to infectious tuberculosis (TB) patients, and have a high prevalence of TB infection. To estimate the incidence of new TB infection, we recruited a cohort of young nursing trainees at the Christian Medical College in Southern India. Annual tuberculin skin testing (TST) was conducted to assess the annual risk of TB infection (ARTI) in this cohort. Methodology/Principal Findings: 436 nursing students completed baseline two-step TST testing in 2007 and 217 were TST-negative and therefore eligible for repeat testing in 2008. 181 subjects completed a detailed questionnaire on exposure to tuberculosis from workplace and social contacts. A physician verified the questionnaire and clinical log book and screened the subjects for symptoms of active TB. The majority of nursing students (96.7%) were females, almost 84% were under 22 years of age, and 80% had BCG scars. Among those students who underwent repeat testing in 2008, 14 had TST conversions using the ATS/CDC/IDSA conversion definition of 10 mm or greater increase over baseline. The ARTI was therefore estimated as 7.8% (95%CI: 4.3-12.8%). This was significantly higher than the national average ARTI of 1.5%. Sputum collection and caring for pulmonary TB patients were both high risk activities that were associated with TST conversions in this young nursing cohort. Conclusions: Our study showed a high ARTI among young nursing trainees, substantially higher than that seen in the general Indian population. Indian healthcare providers and the Indian Revised National TB Control Programme will need to implement internationally recommended TB infection control interventions to protect its health care workforce.	[Christopher, Devasahayam J.; James, Prince; Armstrong, Lois; Isaac, Barney T. J.; Thangakunam, Balamugesh; Premkumar, Beulah] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India; [Daley, Peter] Mem Univ, St John, NF, Canada; [Zwerling, Alice; Pai, Madhukar] McGill Univ, Montreal, PQ, Canada	Christian Medical College & Hospital (CMCH) Vellore; Memorial University Newfoundland; McGill University	Christopher, DJ (corresponding author), Christian Med Coll & Hosp, Vellore, Tamil Nadu, India.	madhukar.pai@mcgill.ca	PAL, MRINAL/ABG-9676-2020; Daley, Peter/J-8908-2017; Thangakunam, Balamugesh/H-4931-2019; Pai, Madhukar/AAX-9901-2021	PAL, MRINAL/0000-0002-1032-272X; Daley, Peter/0000-0001-7068-8056; Thangakunam, Balamugesh/0000-0001-6799-065X; Pai, Madhukar/0000-0003-3667-4536	Canadian Institutes of Health Research (CIHR) [MOP-81362]; European Commission (EU); European and Developing Countries Clinical Trials Partnership [EDCTP]; Fonds de la recherche en sante du Quebec (FRSQ); College of Nursing, CMC, Vellore	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); European Commission (EU)(European CommissionEuropean Commission Joint Research Centre); European and Developing Countries Clinical Trials Partnership [EDCTP]; Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); College of Nursing, CMC, Vellore	This study was funded in part by the Canadian Institutes of Health Research (CIHR) operating grants [MOP-81362], European Commission (EU-FP7; TBSusgent grant), and European and Developing Countries Clinical Trials Partnership [EDCTP (TB-NEAT grant)]. MP is a recipient of a CIHR New Investigator award and a Fonds de la recherche en sante du Quebec (FRSQ) establishment grant. AZ is a recipient of a CIHR doctoral fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.; We are grateful to all the student nurses at the Christian Medical College, Vellore, for their participation in our study. We also appreciate the support of College of Nursing, CMC, Vellore.	[Anonymous], 2000, Am J Respir Crit Care Med, V161, pS221; Christopher DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010408; CTDTI, 2009, RNTCP STAT REP, P1; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Dunlap NE, 2000, AM J RESP CRIT CARE, V161, P1376, DOI 10.1164/ajrccm.161.4.16141; Farhat M, 2006, INT J TUBERC LUNG D, V10, P1192; Gopinath KG, 2004, J HOSP INFECT, V57, P339, DOI 10.1016/j.jhin.2004.03.029; Joshi R, 2006, PLOS MED, V3, P2376, DOI 10.1371/journal.pmed.0030494; Ling D, 2011, LANCET INFECT DIS; Mazurek Gerald H., 2005, Morbidity and Mortality Weekly Report, V54, P49; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; Organization WH, 2009, WHO POL TB INF CONTR, P1; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2008, ANN INTERN MED, V149, P177, DOI 10.7326/0003-4819-149-3-200808050-00241; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; Pai M, 2011, NATL MED J INDIA, V24, P198; Raj R, 2011, NATL MED J INDIA, V24, P201; RNTCP I, 2010, GUID AIRB INF CONTR; Swindells JE, 2009, J HOSP INFECT, V73, P101, DOI 10.1016/j.jhin.2009.05.005; Veening G J, 1968, Bull Int Union Tuberc, V41, P169; *WHO, 2010, WHO GLOB TUB CONTR W; Zwerling A, 2011, THORAX; Zwerling A, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001012	25	20	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26199	10.1371/journal.pone.0026199	http://dx.doi.org/10.1371/journal.pone.0026199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022565	Green Published, Green Accepted, gold			2022-12-27	WOS:000295976000084
J	Niskanen, E; Kononen, M; Maatta, S; Hallikainen, M; Kivipelto, M; Casarotto, S; Massimini, M; Vanninen, R; Mervaala, E; Karhu, J; Soininen, H				Niskanen, Eini; Kononen, Mervi; Maatta, Sara; Hallikainen, Merja; Kivipelto, Miia; Casarotto, Silvia; Massimini, Marcello; Vanninen, Ritva; Mervaala, Esa; Karhu, Jari; Soininen, Hilkka			New Insights into Alzheimer's Disease Progression: A Combined TMS and Structural MRI Study	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; MILD COGNITIVE IMPAIRMENT; CORTICAL THICKNESS ANALYSIS; MOTOR CORTEX EXCITABILITY; AUTOMATED 3-D EXTRACTION; WHITE-MATTER; HUMAN BRAIN; HAND AREA; THRESHOLD; INHIBITION	Background: Combination of structural and functional data of the human brain can provide detailed information of neurodegenerative diseases and the influence of the disease on various local cortical areas. Methodology and Principal Findings: To examine the relationship between structure and function of the brain the cortical thickness based on structural magnetic resonance images and motor cortex excitability assessed with transcranial magnetic stimulation were correlated in Alzheimer's disease (AD) and mild cognitive impairment (MCI) patients as well as in age-matched healthy controls. Motor cortex excitability correlated negatively with cortical thickness on the sensorimotor cortex, the precuneus and the cuneus but the strength of the correlation varied between the study groups. On the sensorimotor cortex the correlation was significant only in MCI subjects. On the precuneus and cuneus the correlation was significant both in AD and MCI subjects. In healthy controls the motor cortex excitability did not correlate with the cortical thickness. Conclusions: In healthy subjects the motor cortex excitability is not dependent on the cortical thickness, whereas in neurodegenerative diseases the cortical thinning is related to weaker cortical excitability, especially on the precuneus and cuneus. However, in AD subjects there seems to be a protective mechanism of hyperexcitability on the sensorimotor cortex counteracting the prominent loss of cortical volume since the motor cortex excitability did not correlate with the cortical thickness. Such protective mechanism was not found on the precuneus or cuneus nor in the MCI subjects. Therefore, our results indicate that the progression of the disease proceeds with different dynamics in the structure and function of neuronal circuits from normal conditions via MCI to AD.	[Niskanen, Eini] Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland; [Niskanen, Eini; Kononen, Mervi; Vanninen, Ritva] Kuopio Univ Hosp, Dept Clin Radiol, SF-70210 Kuopio, Finland; [Kononen, Mervi; Maatta, Sara; Mervaala, Esa] Kuopio Univ Hosp, Dept Clin Neurophysiol, SF-70210 Kuopio, Finland; [Hallikainen, Merja; Kivipelto, Miia; Vanninen, Ritva; Mervaala, Esa; Soininen, Hilkka] Univ Eastern Finland, Inst Clin Med, Kuopio, Finland; [Kivipelto, Miia] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Casarotto, Silvia; Massimini, Marcello] Univ Milan, Dept Clin Sci L Sacco, Milan, Italy; [Karhu, Jari] Nexstim Ltd, Helsinki, Finland; [Karhu, Jari] Univ Eastern Finland, Dept Physiol, Kuopio, Finland; [Soininen, Hilkka] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Karolinska Institutet; University of Milan; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Niskanen, E (corresponding author), Univ Eastern Finland, Dept Appl Phys, Kuopio, Finland.	Eini.Niskanen@uef.fi	Kivipelto, Miia/AAS-3557-2021; Casarotto, Silvia/F-1251-2015; Casarotto, Silvia/Q-9402-2019; Massimini, Marcello/T-8115-2017	Casarotto, Silvia/0000-0002-7548-7664; Casarotto, Silvia/0000-0002-7548-7664; Kononen, Mervi/0000-0002-9622-2796; Kivipelto, Miia/0000-0003-0992-3875; Massimini, Marcello/0000-0003-2271-957X	European Union [224328]; Academy of Finland [123579, 121038, 120676]; Kuopio University Hospital EVO [5772709]	European Union(European Commission); Academy of Finland(Academy of Finland); Kuopio University Hospital EVO	This study was partly funded by the European Union 7th Framework Program, PredictAD, from Patient Data to Personalised Healthcare in Alzheimer's Disease (grant agreement no. 224328), Academy of Finland (grants no. 123579, no. 121038 and no. 120676), and Kuopio University Hospital EVO funding (grant no. 5772709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbruzzese G, 2002, J CLIN NEUROPHYSIOL, V19, P307, DOI 10.1097/00004691-200208000-00005; Akgun Y, 2009, SEIZURE-EUR J EPILEP, V18, P387, DOI 10.1016/j.seizure.2009.02.002; Alagona G, 2001, NEUROSCI LETT, V314, P57, DOI 10.1016/S0304-3940(01)02288-1; Alberici A, 2008, ACTA NEUROL SCAND, V118, P275, DOI 10.1111/j.1600-0404.2008.01017.x; Battaglia F, 2007, BIOL PSYCHIAT, V62, P1405, DOI 10.1016/j.biopsych.2007.02.027; Bedard P, 2009, J NEUROPHYSIOL, V101, P834, DOI 10.1152/jn.90683.2008; Brookmeyer R, 2007, ALZHEIMERS DEMENT, V3, P186, DOI 10.1016/j.jalz.2007.04.381; Crockford DN, 2005, BIOL PSYCHIAT, V58, P787, DOI 10.1016/j.biopsych.2005.04.037; Danner N, 2008, J NEUROSCI METH, V174, P116, DOI 10.1016/j.jneumeth.2008.06.032; Danner N, 2011, SEIZURE-EUR J EPILEP, V20, P65, DOI 10.1016/j.seizure.2010.10.010; deCarvalho M, 1997, J NEUROL, V244, P304, DOI 10.1007/s004150050091; Di Lazzaro V, 2002, NEUROLOGY, V59, P392, DOI 10.1212/WNL.59.3.392; Dickerson BC, 2009, CEREB CORTEX, V19, P497, DOI 10.1093/cercor/bhn113; Ferreri F, 2003, ANN NEUROL, V53, P102, DOI 10.1002/ana.10416; Ferreri F, 2011, NEUROSCI LETT, V492, P94, DOI 10.1016/j.neulet.2011.01.064; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Granert O, 2011, NEUROIMAGE, V54, P32, DOI 10.1016/j.neuroimage.2010.08.013; Haldane M, 2008, J PSYCHOPHARMACOL, V22, P138, DOI 10.1177/0269881107082955; Hallett M, 2007, NEURON, V55, P187, DOI 10.1016/j.neuron.2007.06.026; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Hanninen T, 2002, ACTA NEUROL SCAND, V106, P148, DOI 10.1034/j.1600-0404.2002.01225.x; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Herbsman T, 2009, HUM BRAIN MAPP, V30, P2044, DOI 10.1002/hbm.20649; Im K, 2008, NEUROSCI LETT, V436, P227, DOI 10.1016/j.neulet.2008.03.032; Julkunen V, 2010, J ALZHEIMERS DIS, V21, P1141, DOI 10.3233/JAD-2010-100114; Julkunen V, 2009, DEMENT GERIATR COGN, V28, P404, DOI 10.1159/000256274; Kim JS, 2005, NEUROIMAGE, V27, P210, DOI 10.1016/j.neuroimage.2005.03.036; Kimiskidis VK, 2004, NEUROPHYSIOL CLIN, V34, P259, DOI 10.1016/j.neucli.2004.10.002; Kivipelto M, 2001, NEUROLOGY, V56, P1683, DOI 10.1212/WNL.56.12.1683; Kloppel S, 2008, NEUROIMAGE, V40, P1782, DOI 10.1016/j.neuroimage.2008.01.019; Kozel FA, 2000, J NEUROPSYCH CLIN N, V12, P376, DOI 10.1176/appi.neuropsych.12.3.376; Lehmann M, 2011, NEUROBIOL AGING, V32, P1466, DOI 10.1016/j.neurobiolaging.2009.08.017; Lerch JP, 2005, CEREB CORTEX, V15, P995, DOI 10.1093/cercor/bhh200; Lerch JP, 2005, NEUROIMAGE, V24, P163, DOI 10.1016/j.neuroimage.2004.07.045; MacDonald D, 2000, NEUROIMAGE, V12, P340, DOI 10.1006/nimg.1999.0534; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Morita Y, 2008, ACTA NEUROL SCAND, V118, P159, DOI 10.1111/j.1600-0404.2007.00988.x; Oishi K, 2005, NEUROSCI RES, V52, P37, DOI 10.1016/j.neures.2005.01.008; Peinemann A, 2001, NEUROSCI LETT, V313, P33, DOI 10.1016/S0304-3940(01)02239-X; Pennisi G, 2011, ARCH GERONTOL GERIAT, V53, pE111, DOI 10.1016/j.archger.2010.07.004; Pennisi G, 2011, J NEURAL TRANSM, V118, P587, DOI 10.1007/s00702-010-0554-9; Pepin JL, 1999, J NEUROL SCI, V170, P119, DOI 10.1016/S0022-510X(99)00206-3; PETERSEN RC, 1995, JAMA-J AM MED ASSOC, V273, P1274, DOI 10.1001/jama.273.16.1274; ROSSINI PM, 1994, ELECTROEN CLIN NEURO, V91, P79, DOI 10.1016/0013-4694(94)90029-9; Ruohonen J, 2010, NEUROPHYSIOL CLIN, V40, P7, DOI 10.1016/j.neucli.2010.01.006; RUOHONEN J, 1999, CLIN NEUROPHYSIOL, V51, P30; Saisanen L, 2008, J CLIN NEUROPHYSIOL, V25, P367, DOI 10.1097/WNP.0b013e31818e7944; Sakuma K, 2007, CLIN NEUROPHYSIOL, V118, P1460, DOI 10.1016/j.clinph.2007.03.018; Schroeter ML, 2009, NEUROIMAGE, V47, P1196, DOI 10.1016/j.neuroimage.2009.05.037; Seo SW, 2007, NEUROIMAGE, V36, P289, DOI 10.1016/j.neuroimage.2007.02.042; Silbert LC, 2006, CLIN NEUROPHYSIOL, V117, P1029, DOI 10.1016/j.clinph.2006.02.003; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Smith GE, 1996, AGING NEUROPSYCHOL C, V3, P141, DOI 10.1080/13825589608256619; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Stokes MG, 2007, CLIN NEUROPHYSIOL, V118, P1617, DOI 10.1016/j.clinph.2007.04.004; Terao Y, 2002, J CLIN NEUROPHYSIOL, V19, P322, DOI 10.1097/00004691-200208000-00006; Tian Y, 2008, BIOL PSYCHOL, V79, P171, DOI 10.1016/j.biopsycho.2008.04.006; Tohka J, 2004, NEUROIMAGE, V23, P84, DOI 10.1016/j.neuroimage.2004.05.007; Wassermann E., 2008, OXFORD HDB TRANSCRAN; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; Yousry TA, 1997, BRAIN, V120, P141, DOI 10.1093/brain/120.1.141	63	34	36	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26113	10.1371/journal.pone.0026113	http://dx.doi.org/10.1371/journal.pone.0026113			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022529	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000069
J	Bargielowski, I; Alphey, L; Koella, JC				Bargielowski, Irka; Alphey, Luke; Koella, Jacob C.			Cost of Mating and Insemination Capacity of a Genetically Modified Mosquito Aedes aegypti OX513A Compared to Its Wild Type Counterpart	PLOS ONE			English	Article							BORNE DISEASES; DOMINANT; SYSTEM; LONGEVITY; SIZE	The idea of implementing genetics-based insect control strategies modelled on the traditional SIT is becoming increasingly popular. In this paper we compare a genetically modified line of Aedes aegypti carrying a tetracycline repressible, lethal positive feedback system (OX513A) with its wild type counterpart with respect to their insemination capacities and the cost of courtship and mating. Genetically modified males inseminated just over half as many females as the wild type males during their lifetime. Providing days of rest from mating had no significant effect on the total number of females inseminated by males of either line, but it did increase their longevity. Producing sperm had a low cost in terms of energy investment; the cost of transferring this sperm to a receptive female was much higher. Continued mating attempts with refractory females suggest that males could not identify refractory females before investing substantial energy in courtship. Although over a lifetime OX513A males inseminated fewer females, the number of females inseminated over the first three days, was similar between males of the two lines, suggesting that the identified cost of RIDL may have little impact on the outcome of SIT-based control programmes with frequent releases of the genetically modified males.	[Bargielowski, Irka; Koella, Jacob C.] Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, London, England; [Bargielowski, Irka; Alphey, Luke] Oxitec Ltd, Oxford, England; [Alphey, Luke] Univ Oxford, Dept Zool, Oxford OX1 3PS, England	Imperial College London; University of Oxford	Bargielowski, I (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Nat Sci, London, England.	irka.bargielowski06@imperial.ac.uk		Alphey, Luke/0000-0002-2916-3802	BBSRC/CASE; Oxitec Ltd	BBSRC/CASE(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Oxitec Ltd	The research described in this paper was conducted as part of a BBSRC/CASE funded PhD (IB) with Oxitec Ltd as the industrial partner. The genetically modified line of Aedes aegypti used in the experiments is a product of Oxitec Ltd. Oxitec Ltd also supported this study through the employment of LA and the CASE studentship of IB. BBSRC had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphey L, 2002, SCIENCE, V298, P119, DOI 10.1126/science.1078278; Alphey L, 2002, INSECT BIOCHEM MOLEC, V32, P1243, DOI 10.1016/S0965-1748(02)00087-5; Alphey L, 2008, ADV EXP MED BIOL, V627, P93, DOI 10.1007/978-0-387-78225-6_8; Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014; Alphey Luke, 2009, Journal of Biology (London), V8, P40, DOI 10.1186/jbiol143; Atkinson MP, 2007, P NATL ACAD SCI USA, V104, P9540, DOI 10.1073/pnas.0610685104; Clements AN, 1999, REGULATION ADULT BEH, V2, P239; Clutton-Brock TH, 1992, BEHAV ECOLOGY, V8, P392; Cordts R, 1996, ANIM BEHAV, V52, P269, DOI 10.1006/anbe.1996.0172; CRAIG GB, 1967, SCIENCE, V156, P1499, DOI 10.1126/science.156.3781.1499; Dyck V.A., 2006, STERILE INSECT TECHN; FOSTER W A, 1975, Journal of Insect Physiology, V21, P1085, DOI 10.1016/0022-1910(75)90120-1; Fu GL, 2010, P NATL ACAD SCI USA, V107, P4550, DOI 10.1073/pnas.1000251107; Gaskin T, 2002, ANIM BEHAV, V63, P121, DOI 10.1006/anbe.2001.1896; Gong P, 2005, NAT BIOTECHNOL, V23, P453, DOI 10.1038/nbt1071; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; GWADZ RW, 1970, MOSQ NEWS, V30, P355; Hyashi F, 1993, ANIM BEHAV, V45, P343, DOI DOI 10.1006/ANBE.1993.1039; Jones JC, 1972, J INSECT PHYSL, V19, P435; LILES J. N., 1960, ANN ENT SOC AMER, V53, P277, DOI 10.1093/aesa/53.2.277; Mappes J, 1996, P ROY SOC B-BIOL SCI, V263, P785, DOI 10.1098/rspb.1996.0117; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Ponlawat A, 2007, J MED ENTOMOL, V44, P422, DOI 10.1603/0022-2585(2007)44[422:AABSIM]2.0.CO;2; SAKALUK SK, 1985, CAN J ZOOL, V63, P1652, DOI 10.1139/z85-245; South SH, 2009, P ROY SOC B-BIOL SCI, V276, P3671, DOI 10.1098/rspb.2009.0991; SPIELMAN A, 1967, BIOL BULL-US, V132, P404, DOI 10.2307/1539644; Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474; YOUNGSON JHAM, 1981, GENETICA, V54, P335, DOI 10.1007/BF00135050	29	32	32	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26086	10.1371/journal.pone.0026086	http://dx.doi.org/10.1371/journal.pone.0026086			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022518	gold, Green Published			2022-12-27	WOS:000295973200032
J	Lau, FH; Deo, RC; Mowrer, G; Caplin, J; Ahfeldt, T; Kaplan, A; Ptaszek, L; Walker, JD; Rosengard, BR; Cowan, CA				Lau, Frank H.; Deo, Rahul C.; Mowrer, Gregory; Caplin, Joshua; Ahfeldt, Tim; Kaplan, Adam; Ptaszek, Leon; Walker, Jennifer D.; Rosengard, Bruce R.; Cowan, Chad A.			Pattern Specification and Immune Response Transcriptional Signatures of Pericardial and Subcutaneous Adipose Tissue	PLOS ONE			English	Article							MONOCYTE CHEMOATTRACTANT PROTEIN-1; CORONARY-HEART-DISEASE; SMOOTH-MUSCLE-CELLS; RISK-FACTORS; BODY-FAT; ATHEROSCLEROSIS; EXPRESSION; OBESITY; GENES; INTERLEUKIN-6	Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality in the United States. Recent studies suggest that pericardial adipose tissue (PCAT) secretes inflammatory factors that contribute to the development of CVD. To better characterize the role of PCAT in the pathogenesis of disease, we performed a large-scale unbiased analysis of the transcriptional differences between PCAT and subcutaneous adipose tissue, analysing 53 microarrays across 19 individuals. As it was unknown whether PCAT-secreted factors are produced by adipocytes or cells in the supporting stromal fraction, we also sought to identify differentially expressed genes in isolated pericardial adipocytes vs. isolated subcutaneous adipocytes. Using microarray analysis, we found that: 1) pericardial adipose tissue and isolated pericardial adipocytes both overexpress atherosclerosis-promoting chemokines and 2) pericardial and subcutaneous fat depots, as well as isolated pericardial adipocytes and subcutaneous adipocytes, express specific patterns of homeobox genes. In contrast, a core set of lipid processing genes showed no significant overlap with differentially expressed transcripts. These depot-specific homeobox signatures and transcriptional profiles strongly suggest different functional roles for the pericardial and subcutaneous adipose depots. Further characterization of these inter-depot differences should be a research priority.	[Lau, Frank H.; Deo, Rahul C.; Mowrer, Gregory; Ahfeldt, Tim; Kaplan, Adam; Cowan, Chad A.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Lau, Frank H.; Deo, Rahul C.; Mowrer, Gregory; Ahfeldt, Tim; Kaplan, Adam; Cowan, Chad A.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Ahfeldt, Tim; Cowan, Chad A.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Caplin, Joshua; Ptaszek, Leon] Massachusetts Gen Hosp, Div Cardiol, Dept Med, Boston, MA 02114 USA; [Walker, Jennifer D.; Rosengard, Bruce R.] Massachusetts Gen Hosp, Div Cardiac Surg, Dept Surg, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Lau, FH (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	ccowan@fas.harvard.edu	Ahfeldt, Tim/E-2935-2017	Ahfeldt, Tim/0000-0001-6377-7376	GlaxoSmithKline; Stowers Institute for Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098361, R01HL110733] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Stowers Institute for Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a grant from GlaxoSmithKline (http://www.gsk.com/) and by the Stowers Institute for Medical Research (http://www.stowers-institute.org/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], LEAD CAUS DEATH; Babcock MJ, 2011, OBESITY, V19, P179, DOI 10.1038/oby.2010.121; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Bechara C, 2007, AM J PHYSIOL-HEART C, V293, pH3088, DOI 10.1152/ajpheart.00473.2007; Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498; Boisvert WA, 2006, AM J PATHOL, V168, P1385, DOI 10.2353/ajpath.2006.040748; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bosy-Westphal A, 2010, OBESITY, V18, P2111, DOI 10.1038/oby.2010.49; Breland UM, 2008, ARTERIOSCL THROM VAS, V28, P1005, DOI 10.1161/ATVBAHA.108.162305; Chang HY, 2009, SCIENCE, V326, P1206, DOI 10.1126/science.1175686; Cheng KH, 2008, INT J OBESITY, V32, P268, DOI 10.1038/sj.ijo.0803726; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; DESPRES JP, 1990, ARTERIOSCLEROSIS, V10, P497, DOI 10.1161/01.ATV.10.4.497; Ding JZ, 2008, OBESITY, V16, P1914, DOI 10.1038/oby.2008.278; Dutour A, 2010, J CLIN ENDOCR METAB, V95, P963, DOI 10.1210/jc.2009-1222; Fisher FM, 2002, HORM METAB RES, V34, P650, DOI 10.1055/s-2002-38246; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Ford ES, 2007, J AM COLL CARDIOL, V50, P2128, DOI 10.1016/j.jacc.2007.05.056; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Greif M, 2009, ARTERIOSCL THROM VAS, V29, P781, DOI 10.1161/ATVBAHA.108.180653; Hardoon SL, 2008, CIRCULATION, V117, P598, DOI 10.1161/CIRCULATIONAHA.107.705947; Holland PW, BMC BIOL, V5, P47; Iacobellis G, 2009, OBESITY, V17, P625, DOI 10.1038/oby.2008.575; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Kim TH, 2010, PERICARDIAL FAT AMOU; Kirii H, 2003, ARTERIOSCL THROM VAS, V23, P656, DOI 10.1161/01.ATV.0000064374.15232.C3; Lefebvre AM, 1998, DIABETES, V47, P98, DOI 10.2337/diabetes.47.1.98; Lindmark E, 2001, JAMA-J AM MED ASSOC, V286, P2107, DOI 10.1001/jama.286.17.2107; Liu JK, 2010, DIABETES CARE, V33, P1635, DOI 10.2337/dc10-0245; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Mei JJ, 2010, IMMUNITY, V33, P106, DOI 10.1016/j.immuni.2010.07.009; NELKEN NA, 1991, J CLIN INVEST, V88, P1121, DOI 10.1172/JCI115411; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rinn JL, 2008, J INVEST DERMATOL, V128, P776, DOI 10.1038/sj.jid.5700986; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schecter AD, 2000, J BIOL CHEM, V275, P5466, DOI 10.1074/jbc.275.8.5466; STOPECK AT, 1993, J BIOL CHEM, V268, P17489; Tadros TM, 2010, OBESITY, V18, P1039, DOI 10.1038/oby.2009.343; Thanassoulis G, 2010, CIRC-ARRHYTHMIA ELEC, V3, P345, DOI 10.1161/CIRCEP.109.912055; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Veillard NR, 2004, CIRC RES, V94, P253, DOI 10.1161/01.RES.0000109793.17591.4E; Vohl MC, 2004, OBES RES, V12, P1217, DOI 10.1038/oby.2004.153; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; YLAHERTTUALA S, 1991, P NATL ACAD SCI USA, V88, P5252, DOI 10.1073/pnas.88.12.5252; YU XH, 1992, P NATL ACAD SCI USA, V89, P6953, DOI 10.1073/pnas.89.15.6953; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0	54	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26092	10.1371/journal.pone.0026092	http://dx.doi.org/10.1371/journal.pone.0026092			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022522	Green Submitted, gold, Green Published			2022-12-27	WOS:000295973200034
J	Aslam, A; Chapel, H; Ogg, G				Aslam, Aamir; Chapel, Helen; Ogg, Graham			Direct Ex-Vivo Evaluation of Pneumococcal Specific T-Cells in Healthy Adults	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE COLONIZATION; NASOPHARYNGEAL CARRIAGE; CD4+T CELLS; VIRUS; POLYSACCHARIDE; ACTIVATION; ANTIBODIES; INFECTION; RESPONSES; CHILDREN	Streptococcus pneumoniae is an encapsulated bacterium that causes significant global morbidity and mortality. The nasopharynxes of children are believed to be the natural reservoir of pneumococcus and by adulthood nasopharyngeal carriage is infrequent; such infrequency may be due to demonstrable pneumococcal specific T and B-cell responses. HLA Class 2 tetrameric complexes have been used to characterise antigen specific T-cell responses in a variety of models of infection. We therefore sought to determine the frequency and phenotype of pneumococcal specific T-cells, using a novel HLA-DRB1*1501 tetramer complex incorporating a recently defined T-cell epitope derived from the conserved pneumococcal serine/threonine kinase (StkP). We were able to detect direct ex-vivo StkP(446-60)-tetramer binding in HLA-DRB1*1501 adults. These StkP(446-60)-tetramer binding T-cells had increased CD38 expression and were enriched in CCR7-CD45RA+ expression indicating recent and on-going activation and differentiation. Furthermore, these StkP(446-60)-tetramer binding T-cells demonstrated rapid effector function by secreting interferon-gamma on stimulation with recombinant StkP. This is the first study to directly enumerate and characterise pneumococcal specific T-cells using HLA class 2 tetrameric complexes. We found that ex-vivo pneumococcal-specific T cells were detectable in healthy adults and that they were enriched with cell surface markers associated with recent antigen exposure and later stages of antigen-driven differentiation. It is likely that these activated pneumococcal specific T-cells reflect recent immunostimulatory pneumococcal exposure in the nasopharynx and it is possible that they may be preventing subsequent colonisation and disease.	[Aslam, Aamir; Ogg, Graham] Univ Oxford, Weatherall Inst Mol Med, Oxford NIHR Biomed Res Ctr, MRC Human Immunol Unit, Oxford, England; [Chapel, Helen] Univ Oxford, Nuffield Dept Med, Clin Immunol Unit, Oxford, England	University of Oxford; University of Oxford	Ogg, G (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford NIHR Biomed Res Ctr, MRC Human Immunol Unit, Oxford, England.	graham.ogg@ndm.ox.ac.uk		Ogg, Graham/0000-0002-3097-045X	Medical Research Council [HBRRYDT]; NIHR Biomedical Research Centre; Medical Research Council [G1000800h] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by the Medical Research Council grant code: HBRRYDT, http://www.mrc.ac.uk/index.htm; and supported by the NIHR Biomedical Research Centre Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amyes E, 2003, J EXP MED, V198, P903, DOI 10.1084/jem.20022058; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Aslam A, 2010, FEMS IMMUNOL MED MIC, V60, P113, DOI 10.1111/j.1574-695X.2010.00724.x; Aslam A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011028; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bunce M, 1995, TISSUE ANTIGENS, V46, P355, DOI 10.1111/j.1399-0039.1995.tb03127.x; Centers for Disease Control and Prevention, 2010, ACT BACT COR SURV RE; Chan W, 1999, FMOC SOLID PHASE PEP, V222; Coin I, 2007, NAT PROTOC, V2, P3247, DOI 10.1038/nprot.2007.454; Flamaing J, 2010, J AM GERIATR SOC, V58, P396, DOI 10.1111/j.1532-5415.2009.02700.x; Gill CJ, 2008, J INFECT DIS, V197, P1000, DOI 10.1086/528806; Goldblatt D, 2005, J INFECT DIS, V192, P387, DOI 10.1086/431524; Im EJ, 2006, EUR J IMMUNOL, V36, P2574, DOI 10.1002/eji.200636482; Khan AQ, 2004, J IMMUNOL, V172, P532, DOI 10.4049/jimmunol.172.1.532; Lipsitch M, 2005, PLOS MED, V2, P62, DOI 10.1371/journal.pmed.0020015; Lu YJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000159; Lucas M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000649; Malavige GN, 2008, CLIN EXP IMMUNOL, V152, P522, DOI 10.1111/j.1365-2249.2008.03633.x; Malley R, 2007, J INFECT DIS, V196, P928, DOI 10.1086/520937; McCool TL, 2003, INFECT IMMUN, V71, P5402, DOI 10.1128/IAI.71.9.5402-5406.2003; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Regev-Yochay G, 2004, CLIN INFECT DIS, V38, P632, DOI 10.1086/381547; Sandoval-Montes C, 2005, J LEUKOCYTE BIOL, V77, P513, DOI 10.1189/jlb.0404262; Scriba TJ, 2005, J IMMUNOL, V175, P6334, DOI 10.4049/jimmunol.175.10.6334; Soininen A, 2001, J INFECT DIS, V184, P569, DOI 10.1086/322794; Wei HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006905; Zhang QB, 2007, J INFECT DIS, V195, P1194, DOI 10.1086/512617; Zhang QB, 2006, INFECT IMMUN, V74, P4735, DOI 10.1128/IAI.00165-06	28	10	10	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e25367	10.1371/journal.pone.0025367	http://dx.doi.org/10.1371/journal.pone.0025367			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039412	gold, Green Published, Green Submitted			2022-12-27	WOS:000296515200002
J	Castilho, A; Bohorova, N; Grass, J; Bohorov, O; Zeitlin, L; Whaley, K; Altmann, F; Steinkellner, H				Castilho, Alexandra; Bohorova, Natasha; Grass, Josephine; Bohorov, Ognian; Zeitlin, Larry; Whaley, Kevin; Altmann, Friedrich; Steinkellner, Herta			Rapid High Yield Production of Different Glycoforms of Ebola Virus Monoclonal Antibody	PLOS ONE			English	Article							RNA VIRUS; N-GLYCANS; GLYCOSYLATION; PLANTS; REPLICATION; EXPRESSION; GLYCOPROTEINS; LYMPHOMA; EPITOPES; RESIDUE	Background: Fc-glycosylation of monoclonal antibodies (mAbs) has profound implications on the Fc-mediated effector functions. Alteration of this glycosylation may affect the efficiency of an antibody. However, difficulties in the production of mAbs with homogeneous N-glycosylation profiles in sufficient amounts hamper investigations of the potential biological impact of different glycan residues. Methodology/Principal Findings: Here we set out to evaluate a transient plant viral based production system for the rapid generation of different glycoforms of a monoclonal antibody. Ebola virus mAb h-13F6 was generated using magnICON expression system in Nicotiana benthamiana, a plant species developed for commercial scale production of therapeutic proteins. h-13F6 was co-expressed with a series of modified mammalian enzymes involved in the processing of complex N-glycans. Using wild type (WT) plants and the glycosylation mutant Delta XTFT that synthesizes human like biantennary N-glycans with terminal N-acetylglucosamine on each branch (GnGn structures) as expression hosts we demonstrate the generation of h-13F6 complex N-glycans with (i) bisected structures, (ii) core alpha 1,6 fucosylation and (iii) beta 1,4 galactosylated oligosaccharides. In addition we emphasize the significance of precise sub Golgi localization of enzymes for engineering of IgG Fc-glycosylation. Conclusion: The method described here allows the efficient generation of a series of different human-like glycoforms at large homogeneity of virtually any antibody within one week after cDNA delivery to plants. This accelerates follow up functional studies and thus may contribute to study the biological role of N-glycan residues on Fcs and maximizing the clinical efficacy of therapeutic antibodies.	[Castilho, Alexandra; Steinkellner, Herta] Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria; [Bohorova, Natasha; Bohorov, Ognian; Zeitlin, Larry; Whaley, Kevin] Mapp Biopharmaceut, San Diego, CA USA; [Grass, Josephine; Altmann, Friedrich] Univ Nat Resources & Life Sci, Dept Chem, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna; University of Natural Resources & Life Sciences, Vienna	Castilho, A (corresponding author), Univ Nat Resources & Life Sci, Dept Appl Genet & Cell Biol, Vienna, Austria.	herta.steinkellner@boku.ac.at	Steinkellner, Herta/N-4267-2016; Castilho, Alexandra/AAC-8927-2020	Steinkellner, Herta/0000-0003-4823-1505; Castilho, Alexandra/0000-0003-4114-7861; Altmann, Friedrich/0000-0002-0112-7877	NIAID [AI061270]; Laura Bassi Centres of Expertise [822757]; FWF [L575-B13]; Austrian Science Fund (FWF) [L 575] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061270] Funding Source: NIH RePORTER	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Laura Bassi Centres of Expertise; FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grant Number AI061270 from NIAID, the Laura Bassi Centres of Expertise (Grant Number 822757), and the FWF (Grant Number L575-B13). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlquist P, 2005, VACCINE, V23, P1784, DOI 10.1016/j.vaccine.2004.11.005; Bakker H, 2006, P NATL ACAD SCI USA, V103, P7577, DOI 10.1073/pnas.0600879103; Bendandi M, 2010, ANN ONCOL, V21, P2420, DOI 10.1093/annonc/mdq256; Carette JE, 2002, J VIROL, V76, P6293, DOI 10.1128/JVI.76.12.6293-6301.2002; Castilho A, 2011, GLYCOBIOLOGY, V21, P813, DOI 10.1093/glycob/cwr009; Castilho A, 2010, J BIOL CHEM, V285, P15923, DOI 10.1074/jbc.M109.088401; Cox KM, 2006, NAT BIOTECHNOL, V24, P1591, DOI 10.1038/nbt1260; De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x; Ferrara C, 2006, BIOTECHNOL BIOENG, V93, P851, DOI 10.1002/bit.20777; Forthal DN, 2010, J IMMUNOL, V185, P6876, DOI 10.4049/jimmunol.1002600; Hamilton SR, 2007, CURR OPIN BIOTECH, V18, P387, DOI 10.1016/j.copbio.2007.09.001; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Junttila TT, 2010, CANCER RES, V70, P4481, DOI 10.1158/0008-5472.CAN-09-3704; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Marillonnet S, 2005, NAT BIOTECHNOL, V23, P718, DOI 10.1038/nbt1094; Rich JR, 2009, NAT CHEM BIOL, V5, P206, DOI 10.1038/nchembio.148; Rouwendal GJA, 2007, GLYCOBIOLOGY, V17, P334, DOI 10.1093/glycob/cwl078; RUDD PM, 1994, BIOCHEMISTRY-US, V33, P17, DOI 10.1021/bi00167a003; Sainsbury F, 2008, PLANT PHYSIOL, V148, P1212, DOI 10.1104/pp.108.126284; Sainsbury F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013976; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Schahs M, 2007, PLANT BIOTECHNOL J, V5, P657, DOI 10.1111/j.1467-7652.2007.00273.x; Schuster Manfred, 2007, Biotechnology Journal, V2, P700, DOI 10.1002/biot.200600255; Stadlmann J, 2008, PROTEOMICS, V8, P2858, DOI 10.1002/pmic.200700968; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Strasser R, 2009, J BIOL CHEM, V284, P20479, DOI 10.1074/jbc.M109.014126; TRETTER V, 1991, EUR J BIOCHEM, V199, P647, DOI 10.1111/j.1432-1033.1991.tb16166.x; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Wilson JA, 2000, SCIENCE, V287, P1664, DOI 10.1126/science.287.5458.1664; Yamamoto K, 2010, J CLIN ONCOL, V28, P1591, DOI 10.1200/JCO.2009.25.3575; ZEITLIN L, DESIGN TEST IN PRESS	31	48	53	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26040	10.1371/journal.pone.0026040	http://dx.doi.org/10.1371/journal.pone.0026040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039433	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200005
J	Frolov, RV; Ignatova, II; Singh, S				Frolov, Roman V.; Ignatova, Irina I.; Singh, Satpal			Inhibition of hERG Potassium Channels by Celecoxib and Its Mechanism	PLOS ONE			English	Article							LONG QT SYNDROME; TORSADES-DE-POINTES; CARDIAC-ARRHYTHMIAS; K+ CHANNEL; DRUG DEVELOPMENT; MUTATIONS; RECTIFIER; CURRENTS; KVLQT1; BLOCK	Background: Celecoxib (Celebrex), a widely prescribed selective inhibitor of cyclooxygenase-2, can modulate ion channels independently of cyclooxygenase inhibition. Clinically relevant concentrations of celecoxib can affect ionic currents and alter functioning of neurons and myocytes. In particular, inhibition of Kv2.1 channels by celecoxib leads to arrhythmic beating of Drosophila heart and of rat heart cells in culture. However, the spectrum of ion channels involved in human cardiac excitability differs from that in animal models, including mammalian models, making it difficult to evaluate the relevance of these observations to humans. Our aim was to examine the effects of celecoxib on hERG and other human channels critically involved in regulating human cardiac rhythm, and to explore the mechanisms of any observed effect on the hERG channels. Methods and Results: Celecoxib inhibited the hERG, SCN5A, KCNQ1 and KCNQ1/MinK channels expressed in HEK-293 cells with IC(50)s of 6.0 mu M, 7.5 mu M, 3.5 mu M and 3.7 mu M respectively, and the KCND3/KChiP2 channels expressed in CHO cells with an IC(50) of 10.6 mu M. Analysis of celecoxib's effects on hERG channels suggested gating modification as the mechanism of drug action. Conclusions: The above channels play a significant role in drug-induced long QT syndrome (LQTS) and short QT syndrome (SQTS). Regulatory guidelines require that all new drugs under development be tested for effects on the hERG channel prior to first administration in humans. Our observations raise the question of celecoxib's potential to induce cardiac arrhythmias or other channel related adverse effects, and make a case for examining such possibilities.	[Frolov, Roman V.; Ignatova, Irina I.; Singh, Satpal] SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA; [Frolov, Roman V.; Ignatova, Irina I.] Univ Oulu, Dept Phys Sci, Div Biophys, Oulu, Finland	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Oulu	Frolov, RV (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, Buffalo, NY 14260 USA.	singhs@buffalo.edu	Frolov, Roman/I-3889-2016; Frolov, Roman/H-8099-2012	Frolov, Roman/0000-0002-7431-5297; Ignatova, Irina/0000-0002-9861-2640	National Science Foundation, USA [MCB-0094477, MCB-0322461]	National Science Foundation, USA(National Science Foundation (NSF))	This work was supported by the National Science Foundation, USA, grant numbers MCB-0094477 and MCB-0322461 (http://nsf.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias II O, 2011, CHANNELS AUSTIN, V5; Bellocq C, 2004, CIRCULATION, V109, P2394, DOI 10.1161/01.CIR.0000130409.72142.FE; Brueggemann LI, 2009, MOL PHARMACOL, V76, P1053, DOI 10.1124/mol.109.057844; Brugada R, 2004, CIRCULATION, V109, P30, DOI 10.1161/01.CIR.0000109482.92774.3A; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; CURRAN ME, 1995, CELL, V80, P795, DOI 10.1016/0092-8674(95)90358-5; Davies NM, 2000, CLIN PHARMACOKINET, V38, P225, DOI 10.2165/00003088-200038030-00003; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; FDA US Food and Drug Administration, 2010, PROP WITHDR RISK CAR; Frolov RV, 2008, NEUROSCIENCE, V154, P1525, DOI 10.1016/j.neuroscience.2008.05.004; Frolov RV, 2010, BRIT J PHARMACOL, V159, P405, DOI 10.1111/j.1476-5381.2009.00539.x; Frolov RV, 2008, J BIOL CHEM, V283, P1518, DOI 10.1074/jbc.M708100200; Frolov RV, 2010, BRAIN RES, V1359, P67, DOI 10.1016/j.brainres.2010.08.062; Gaborit N, 2009, EUR HEART J, V30, P487, DOI 10.1093/eurheartj/ehn520; Hancox JC, 2008, PHARMACOL THERAPEUT, V119, P118, DOI 10.1016/j.pharmthera.2008.05.009; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; Kang JS, 2003, EUR J PHARMACOL, V458, P25, DOI 10.1016/S0014-2999(02)02700-0; Kuryshev YA, 2000, J PHARMACOL EXP THER, V295, P614; Liu Huajun, 2003, Am J Pharmacogenomics, V3, P173, DOI 10.2165/00129785-200303030-00003; Lupoglazoff JM, 2004, J AM COLL CARDIOL, V43, P826, DOI 10.1016/j.jacc.2003.09.049; Macias A, 2010, J MOL CELL CARDIOL, V49, P984, DOI 10.1016/j.yjmcc.2010.09.012; Milnes JT, 2003, FEBS LETT, V547, P20, DOI 10.1016/S0014-5793(03)00662-8; Park SY, 2007, BRAIN RES, V1148, P53, DOI 10.1016/j.brainres.2007.02.023; *PFIZ, 2009, PHYS PRESCR INF; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; Raschi E, 2008, PHARMACOL RES, V57, P181, DOI 10.1016/j.phrs.2008.01.009; Refaat M, 2008, PACE, V31, P1246, DOI 10.1111/j.1540-8159.2008.01173.x; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Shah RR, 2004, ANN MED, V36, P47, DOI 10.1080/17431380410032445; Snyders DJ, 1996, MOL PHARMACOL, V49, P949; Spector PS, 1996, CIRC RES, V78, P499, DOI 10.1161/01.RES.78.3.499; Ten Tusscher KHWJ, 2007, CIRC RES, V100, pE87, DOI 10.1161/CIRCRESAHA.107.150730; The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), 2005, S7B NONCL EV POT DEL; Tristani-Firouzi M, 1998, J PHYSIOL-LONDON, V510, P37, DOI 10.1111/j.1469-7793.1998.037bz.x; TRUDEAU MC, 1995, SCIENCE, V269, P92, DOI 10.1126/science.7604285; Vik T, 2008, PHARMACOL THERAPEUT, V119, P210, DOI 10.1016/j.pharmthera.2008.05.006; WANG Q, 1995, CELL, V80, P805, DOI 10.1016/0092-8674(95)90359-3; Wang Q, 1996, NAT GENET, V12, P17, DOI 10.1038/ng0196-17; Yang WP, 1997, P NATL ACAD SCI USA, V94, P4017, DOI 10.1073/pnas.94.8.4017; Zhang Y, 2007, ACTA PHYS SIN-CH ED, V56, P56, DOI 10.7498/aps.56.56; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3	42	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26344	10.1371/journal.pone.0026344	http://dx.doi.org/10.1371/journal.pone.0026344			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039467	Green Submitted, Green Published, gold			2022-12-27	WOS:000296515200014
J	Laroni, A; Gandhi, R; Beynon, V; Weiner, HL				Laroni, Alice; Gandhi, Roopali; Beynon, Vanessa; Weiner, Howard L.			IL-27 Imparts Immunoregulatory Function to Human NK Cell Subsets	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; CD4(+) T-CELLS; MULTIPLE-SCLEROSIS; ADAPTIVE IMMUNITY; LYMPH-NODES; INNATE; INTERLEUKIN-27; CYTOKINES; RECEPTOR; IL-10	Interleukin-27 (IL-27) is a cytokine with multiple roles in regulating the immune response, but its effect on human CD56(bright) and CD56(dim) NK cell subsets is unknown. NK cell subsets interact with other components of the immune system, leading to cytotoxicity or immunoregulation depending on stimulating factors. We found that IL-27 treatment results in increased IL-10 and IFN-gamma expression, increased viability and decreased proliferation in both CD56(bright) and CD56(dim) NK cell subsets. More importantly, IL-27 treatment imparts regulatory activity to CD56(bright) NK cells, which mediates its suppressive function on T cells in a contact-dependent manner. There is growing evidence that CD56(bright) NK cell-mediated immunoregulation plays an important role in the control of autoimmunity. Thus, understanding the role of IL-27 in NK cell function has important implications for treatment of autoimmune disorders.	[Laroni, Alice; Gandhi, Roopali; Beynon, Vanessa; Weiner, Howard L.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Laroni, A (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Ctr Neurol Dis, Boston, MA 02115 USA.	hweiner@rics.bwh.harvard.edu	Laroni, Alice/K-4714-2016	Laroni, Alice/0000-0001-5599-9788	National Multiple Sclerosis Society [RG4151-A-12]	National Multiple Sclerosis Society(National Multiple Sclerosis Society)	The study was funded by National Multiple Sclerosis Society (nationalmssociety.org) Grant RG4151-A-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre P, 2000, P NATL ACAD SCI USA, V97, P3400, DOI 10.1073/pnas.040569797; Awasthi A, 2007, NAT IMMUNOL, V8, P1380, DOI 10.1038/ni1541; Batten M, 2007, J MOL MED-JMM, V85, P661, DOI 10.1007/s00109-007-0164-7; Bielekova B, 2006, P NATL ACAD SCI USA, V103, P5941, DOI 10.1073/pnas.0601335103; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; de Rham C, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2336; Diveu C, 2008, CURR OPIN IMMUNOL, V20, P663, DOI 10.1016/j.coi.2008.09.003; Fehniger TA, 2003, BLOOD, V101, P3052, DOI 10.1182/blood-2002-09-2876; Fehniger TA, 2002, CYTOKINE GROWTH F R, V13, P169, DOI 10.1016/S1359-6101(01)00021-1; Feriazzo Guido, 2008, V415, P197, DOI 10.1007/978-1-59745-570-1_12; Flodstrom-Tullberg M, 2009, CURR OPIN IMMUNOL, V21, P634, DOI 10.1016/j.coi.2009.09.012; Martin-Fontecha A, 2004, NAT IMMUNOL, V5, P1260, DOI 10.1038/ni1138; Matsui M, 2009, CANCER RES, V69, P2523, DOI 10.1158/0008-5472.CAN-08-2793; Moretta A, 2008, CELL DEATH DIFFER, V15, P226, DOI 10.1038/sj.cdd.4402170; Murugaiyan G, 2009, J IMMUNOL, V183, P2435, DOI 10.4049/jimmunol.0900568; Perona-Wright G, 2009, CELL HOST MICROBE, V6, P503, DOI 10.1016/j.chom.2009.11.003; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Pflanz S, 2004, J IMMUNOL, V172, P2225, DOI 10.4049/jimmunol.172.4.2225; Saraste M, 2007, NEUROL SCI, V28, P121, DOI 10.1007/s10072-007-0803-3; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5; Villarino AV, 2005, J IMMUNOL, V174, P7684, DOI 10.4049/jimmunol.174.12.7684; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Wynn D, 2010, LANCET NEUROL, V9, P381, DOI 10.1016/S1474-4422(10)70033-8	24	41	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26173	10.1371/journal.pone.0026173	http://dx.doi.org/10.1371/journal.pone.0026173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039443	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500037
J	Lipps, DB; Galecki, AT; Ashton-Miller, JA				Lipps, David B.; Galecki, Andrzej T.; Ashton-Miller, James A.			On the Implications of a Sex Difference in the Reaction Times of Sprinters at the Beijing Olympics	PLOS ONE			English	Article							TWITCH CONTRACTILE PROPERTIES; WORLD-CLASS SPRINTERS; BRAIN-STEM RESPONSE; GENDER DIFFERENCES; POWER; MUSCLES; STARTS; AGE	Elite sprinters offer insights into the fastest whole body auditory reaction times. When, however, is a reaction so fast that it represents a false start? Currently, a false start is awarded if an athlete increases the force on their starting block above a given threshold before 100 ms has elapsed after the starting gun. To test the hypothesis that the fastest valid reaction times of sprinters really is 100 ms and that no sex difference exists in that time, we analyzed the fastest reaction times achieved by each of the 425 male and female sprinters who competed at the 2008 Beijing Olympics. After power transformation of the skewed data, a fixed effects ANOVA was used to analyze the effects of sex, race, round and lane position. The lower bounds of the 95, 99 and 99.9% confidence intervals were then calculated and back transformed. The mean fastest reaction time recorded by men was significantly faster than women (p<0.001). At the 99.9% confidence level, neither men nor women can react in 100 ms, but they can react in as little as 109 ms and 121 ms, respectively. However, that sex difference in reaction time is likely an artifact caused by using the same force threshold in women as men, and it permits a woman to false start by up to 21 ms without penalty. We estimate that female sprinters would have similar reaction times to male sprinters if the force threshold used at Beijing was lowered by 22% in order to account for their lesser muscle strength.	[Lipps, David B.; Ashton-Miller, James A.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Galecki, Andrzej T.] Univ Michigan, Sch Publ Hlth, Dept Biostat, Ann Arbor, MI 48109 USA; [Galecki, Andrzej T.; Ashton-Miller, James A.] Univ Michigan, Inst Gerontol, Ann Arbor, MI 48109 USA; [Ashton-Miller, James A.] Univ Michigan, Dept Mech Engn, Ann Arbor, MI 48109 USA; [Ashton-Miller, James A.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Lipps, DB (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	jaam@umich.edu	Lipps, David/A-7080-2013; Lipps, David/C-3964-2014	Lipps, David/0000-0003-1140-9891	National Defense Science and Engineering Graduate Fellowship; National Institutes of Health [P30 AG024824]; NATIONAL INSTITUTE ON AGING [P30AG024824] Funding Source: NIH RePORTER	National Defense Science and Engineering Graduate Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors acknowledge funding from a National Defense Science and Engineering Graduate Fellowship (DBL) and a National Institutes of Health grant (P30 AG024824) (ATG and JAAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER MJL, 1989, CAN J SPORT SCI, V14, P148; BOVAY JP, 1985, Patent No. 4523204; Brown AM, 2008, MED SCI SPORT EXER, V40, P1142, DOI 10.1249/MSS.0b013e31816770e1; Collet C, 1999, PERCEPT MOTOR SKILL, V88, P65, DOI 10.2466/PMS.88.1.65-75; DERG, 2006, PSYCHOL AGING, V21, P62; DON M, 1993, J ACOUST SOC AM, V94, P2135, DOI 10.1121/1.407485; *IAAF, 2008, COMP RUL 2008; Janssen I, 2000, J APPL PHYSIOL, V89, P81; KOMI PV, 2009, IAAF NEW STUDIES ATH, V24, P37; Mero A, 2006, J SPORT SCI, V24, P165, DOI 10.1080/02640410500131753; MERO A, 1990, EUR J APPL PHYSIOL O, V61, P73, DOI 10.1007/BF00236697; Paasuke M, 1999, EUR J APPL PHYSIOL O, V80, P448, DOI 10.1007/s004210050616; Paasuke M, 2002, MED SPORT, V55, P279; Pain MTG, 2007, J SPORT SCI, V25, P79, DOI 10.1080/02640410600718004; Thelen DG, 1996, J GERONTOL A-BIOL, V51, pM226, DOI 10.1093/gerona/51A.5.M226; TRUNE DR, 1988, HEARING RES, V32, P165, DOI 10.1016/0378-5955(88)90088-3; Uth N, 2005, J SPORT SCI MED, V4, P608; WIDDING E, 1999, Patent No. 6002336; Wunderlich RE, 2001, MED SCI SPORT EXER, V33, P605; ZEMPER ED, 2009, US TRACK FIELD START	20	24	25	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26141	10.1371/journal.pone.0026141	http://dx.doi.org/10.1371/journal.pone.0026141			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039438	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500032
J	Carinhas, N; Robitaille, AM; Moes, S; Carrondo, MJT; Jenoe, P; Oliveira, R; Alves, PM				Carinhas, Nuno; Robitaille, Aaron Mark; Moes, Suzette; Teixeira Carrondo, Manuel Jose; Jenoe, Paul; Oliveira, Rui; Alves, Paula Marques			Quantitative Proteomics of Spodoptera frugiperda Cells during Growth and Baculovirus Infection	PLOS ONE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; HEPATITIS-C VIRUS; MESSENGER-RNA; INSECT; GENE; NUCLEOPOLYHEDROVIRUS; SEQUENCE; DENSITY; COMPLEX; SYSTEMS	Baculovirus infection of Spodoptera frugiperda cells is a system of choice to produce a range of recombinant proteins, vaccines and, potentially, gene therapy vectors. While baculovirus genomes are well characterized, the genome of S. frugiperda is not sequenced and the virus-host molecular interplay is sparsely known. Herein, we describe the application of stable isotope labeling by amino acids in cell culture (SILAC) to obtain the first comparative proteome quantitation of S. frugiperda cells during growth and early baculovirus infection. The proteome coverage was maximized by compiling a search database with protein annotations from insect species. Of interest were differentially proteins related to energy metabolism, endoplasmic reticulum and oxidative stress, yet not investigated in the scope of baculovirus infection. Further, the reduced expression of key viral-encoded proteins early in the infection cycle is suggested to be related with decreased viral replication at high cell density culture. These findings have implications for virological research and improvement of baculovirus-based bioprocesses.	[Carinhas, Nuno; Teixeira Carrondo, Manuel Jose; Alves, Paula Marques] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Inst Biol Expt & Tecnol, Oeiras, Portugal; [Robitaille, Aaron Mark; Moes, Suzette; Jenoe, Paul] Univ Basel, Biozentrum, Dept Biochem, Basel, Switzerland; [Oliveira, Rui] Univ Nova Lisboa, Dept Quim, Fac Ciencias & Tecnol, REQUIMTE,Syst Biol & Engn Grp SBE, Caparica, Portugal	Universidade Nova de Lisboa; University of Basel; Universidade Nova de Lisboa	Carinhas, N (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Inst Biol Expt & Tecnol, Oeiras, Portugal.	marques@itqb.unl.pt	Carrondo, Manuel JT/C-8155-2011; Alves, Paula M/C-1070-2008; Oliveira, Rui/D-8815-2013	Alves, Paula M/0000-0003-1445-3556; Robitaille, Aaron Mark/0000-0003-2774-2066; Oliveira, Rui/0000-0001-8077-4177; Carrondo, Manuel/0000-0002-4550-4574; Carinhas, Nuno/0000-0002-3321-1221	BACULOGENES [FP6 LHSB-CT-2006-037541]; CLINIGENE-NoE [FP6 LSHB-CT-2004-018933]; Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/36676/2007]	BACULOGENES; CLINIGENE-NoE(European Commission); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was partially supported by the European Project BACULOGENES (FP6 LHSB-CT-2006-037541) and CLINIGENE-NoE (FP6 LSHB-CT-2004-018933). NC acknowledges Fundacao para a Ciencia e a Tecnologia (FCT) for his Ph.D. grant (SFRH/BD/36676/2007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya A, 2002, CURR SCI INDIA, V83, P455; Adam Petra, 2005, BMC Biochem, V6, P24, DOI 10.1186/1471-2091-6-24; BEIDLER DR, 1995, J BIOL CHEM, V270, P16526, DOI 10.1074/jbc.270.28.16526; Bernal V, 2009, BIOTECHNOL BIOENG, V104, P162, DOI 10.1002/bit.22364; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Carinhas N, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-34; Carinhas N, 2010, METAB ENG, V12, P39, DOI 10.1016/j.ymben.2009.08.008; Carinhas N, 2009, APPL MICROBIOL BIOT, V81, P1041, DOI 10.1007/s00253-008-1727-4; CARSTENS EB, 1979, VIROLOGY, V99, P386, DOI 10.1016/0042-6822(79)90017-5; Coombs KM, 2010, J VIROL, V84, P10888, DOI 10.1128/JVI.00431-10; Diamond DL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000719; Doverskog M, 1997, J BIOTECHNOL, V59, P103, DOI 10.1016/S0168-1656(97)00172-7; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Goley ED, 2006, SCIENCE, V314, P464, DOI 10.1126/science.1133348; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P1697, DOI 10.1074/mcp.M500190-MCP200; GRULA MA, 1981, J VIROL, V38, P916, DOI 10.1128/JVI.38.3.916-921.1981; Harvey AJ, 1997, MOL CELL BIOL, V17, P2835, DOI 10.1128/MCB.17.5.2835; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ikonomou L, 2003, APPL MICROBIOL BIOT, V62, P1, DOI 10.1007/s00253-003-1223-9; Imami K, 2010, MOL BIOSYST, V6, P594, DOI 10.1039/b921379a; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Lam YW, 2010, MOL CELL PROTEOMICS, V9, P117, DOI 10.1074/mcp.M900338-MCP200; Landais I, 2003, BIOINFORMATICS, V19, P2343, DOI 10.1093/bioinformatics/btg324; Liao LJ, 2008, P NATL ACAD SCI USA, V105, P15281, DOI 10.1073/pnas.0804678105; Lucas M, 2001, INT J EXP PATHOL, V82, P269, DOI 10.1046/j.1365-2613.2001.00204.x; Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067; Mannova P, 2006, MOL CELL PROTEOMICS, V5, P2319, DOI 10.1074/mcp.M600121-MCP200; Masutani H, 2005, CELL DEATH DIFFER, V12, P991, DOI 10.1038/sj.cdd.4401625; Maynard ND, 2010, BIOTECHNOL J, V5, P686, DOI 10.1002/biot.201000080; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Munger J, 2008, NAT BIOTECHNOL, V26, P1179, DOI 10.1038/nbt.1500; Negre V, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-322; Nobiron I, 2003, J GEN VIROL, V84, P3029, DOI 10.1099/vir.0.19270-0; Ohkawa T, 2010, J CELL BIOL, V190, P187, DOI 10.1083/jcb.201001162; Okano K, 2006, VIROLOGY, V344, P77, DOI 10.1016/j.virol.2005.09.019; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; OOI BG, 1988, VIROLOGY, V166, P515, DOI 10.1016/0042-6822(88)90522-3; OReilly D.R., 1992, BACULOVIRUS EXPRESSI; Pang Y, 2001, VIROLOGY, V287, P391, DOI 10.1006/viro.2001.1056; Popham HJR, 2010, J INSECT PHYSIOL, V56, P1237, DOI 10.1016/j.jinsphys.2010.03.024; Prikhodko EA, 1998, J VIROL, V72, P684; Ramachandran A, 2001, CURR SCI INDIA, V81, P998; Sah NK, 1999, P NATL ACAD SCI USA, V96, P4838, DOI 10.1073/pnas.96.9.4838; Salem TZ, 2011, VIROLOGY, V412, P167, DOI 10.1016/j.virol.2011.01.006; Scheper GC, 1997, J GEN VIROL, V78, P687, DOI 10.1099/0022-1317-78-3-687; Schultz KLW, 2009, J VIROL, V83, P11123, DOI 10.1128/JVI.01199-09; Tardif KD, 2005, TRENDS MICROBIOL, V13, P159, DOI 10.1016/j.tim.2005.02.004; van Oers MM, 2001, INSECT MOL BIOL, V10, P255, DOI 10.1046/j.1365-2583.2001.00263.x; vanStrien EA, 1997, J GEN VIROL, V78, P2365, DOI 10.1099/0022-1317-78-9-2365; Wang Y, 2001, FREE RADICAL BIO MED, V31, P1448, DOI 10.1016/S0891-5849(01)00728-6; Wu CH, 2004, NUCLEIC ACIDS RES, V32, pD112, DOI 10.1093/nar/gkh097; Wu CH, 2001, NUCLEIC ACIDS RES, V29, P52, DOI 10.1093/nar/29.1.52; Xiao W, 2009, VIROLOGY, V391, P83, DOI 10.1016/j.virol.2009.06.007	53	23	24	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26444	10.1371/journal.pone.0026444	http://dx.doi.org/10.1371/journal.pone.0026444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22039490	Green Submitted, gold, Green Published			2022-12-27	WOS:000296186900064
J	Deville, S; Viazzi, C; Leloup, J; Lasalle, A; Guizard, C; Maire, E; Adrien, J; Gremillard, L				Deville, Sylvain; Viazzi, Celine; Leloup, Jerome; Lasalle, Audrey; Guizard, Christian; Maire, Eric; Adrien, Jerome; Gremillard, Laurent			Ice Shaping Properties, Similar to That of Antifreeze Proteins, of a Zirconium Acetate Complex	PLOS ONE			English	Article							ADSORPTION	The control of the growth morphologies of ice crystals is a critical issue in fields as diverse as biomineralization, medicine, biology, civil or food engineering. Such control can be achieved through the ice-shaping properties of specific compounds. The development of synthetic ice-shaping compounds is inspired by the natural occurrence of such properties exhibited by antifreeze proteins. We reveal how a particular zirconium acetate complex is exhibiting ice-shaping properties very similar to that of antifreeze proteins, albeit being a radically different compound. We use these properties as a bioinspired approach to template unique faceted pores in cellular materials. These results suggest that ice-structuring properties are not exclusive to long organic molecules and should broaden the field of investigations and applications of such substances.	[Deville, Sylvain; Viazzi, Celine; Leloup, Jerome; Lasalle, Audrey; Guizard, Christian] UMR3080 CNRS St Gobain, Lab Synth & Fonctionnalisat Ceram, Cavaillon, France; [Maire, Eric; Adrien, Jerome; Gremillard, Laurent] Univ Lyon, INSA Lyon, MATEIS CNRS UMR5510, Villeurbanne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National des Sciences Appliquees de Lyon - INSA Lyon	Deville, S (corresponding author), UMR3080 CNRS St Gobain, Lab Synth & Fonctionnalisat Ceram, Cavaillon, France.	sylvain.deville@saint-gobain.com	Gremillard, Laurent/D-7813-2011; adrien, jerome/A-5912-2009; Deville, Sylvain/H-5515-2019	Gremillard, Laurent/0000-0001-7258-6483; adrien, jerome/0000-0003-0341-3559; Deville, Sylvain/0000-0002-3363-3184; , eric/0000-0003-1952-2602	National Research Agency (ANR) [BLAN07-2_192446]	National Research Agency (ANR)(French National Research Agency (ANR))	Financial support was provided for the development of the cooling cell for X-rays experiments by the National Research Agency (ANR), project NACRE in the non-thematic BLANC program, reference BLAN07-2_192446. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buckley SL, 2009, MODERN BIOPOLYMER SCIENCE: BRIDGING THE DIVIDE BETWEEN FUNDAMENTAL TREATISE AND INDUSTRIAL APPLICATION, P93, DOI 10.1016/B978-0-12-374195-0.00003-3; Cheng CHC, 1998, CURR OPIN GENET DEV, V8, P715, DOI 10.1016/S0959-437X(98)80042-7; Clarke CJ, 2002, CRYOLETTERS, V23, P89; Davies PL, 2002, PHILOS T R SOC B, V357, P927, DOI 10.1098/rstb.2002.1081; Deville S, 2006, SCIENCE, V311, P515, DOI 10.1126/science.1120937; Deville S, 2008, ADV ENG MATER, V10, P155, DOI 10.1002/adem.200700270; Geiculescu AC, 1999, J SOL-GEL SCI TECHN, V16, P243, DOI 10.1023/A:1008769204022; Graether SP, 2000, NATURE, V406, P325, DOI 10.1038/35018610; KNIGHT CA, 1995, CRYOBIOLOGY, V32, P23, DOI 10.1006/cryo.1995.1002; MULLIN JW, 1998, CRYSTALLIZATION; Munch E, 2008, SCIENCE, V322, P1516, DOI 10.1126/science.1164865; Sokolov O, 2002, J PHYS CHEM A, V106, P775, DOI 10.1021/jp013291m; XU MGH, 1998, CAN J MICROBIOL, V44, P64; Zepeda S, 2008, CRYST GROWTH DES, V8, P3666, DOI 10.1021/cg800269w; ZOU J, ACS NANO, V4, P7293	15	56	57	5	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26474	10.1371/journal.pone.0026474	http://dx.doi.org/10.1371/journal.pone.0026474			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028886	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900069
J	Garcia, AE; Mada, SR; Rico, MC; Dela Cadena, RA; Kunapuli, SP				Garcia, Analia E.; Mada, Sripal R.; Rico, Mario C.; Dela Cadena, Raul A.; Kunapuli, Satya P.			Clopidogrel, a P2Y12 Receptor Antagonist, Potentiates the Inflammatory Response in a Rat Model of Peptidoglycan Polysaccharide-Induced Arthritis	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; CELL-WALL; NEUTROPHIL ACTIVATION; CALCIUM MOBILIZATION; MOLECULAR-BASIS; ADP RECEPTORS; PLATELETS; BLOOD; CHEMOKINES; SYNOVITIS	The P2Y12 receptor plays a crucial role in the regulation of platelet activation by several agonists, which is irreversibly antagonized by the active metabolite of clopidogrel, a widely used anti-thrombotic drug. In this study, we investigated whether reduction of platelet reactivity leads to reduced inflammatory responses using a rat model of erosive arthritis. We evaluated the effect of clopidogrel on inflammation in Lewis rats in a peptidoglycan polysaccharide (PG-PS)-induced arthritis model with four groups of rats: 1) untreated, 2) clopidogrel-treated, 3) PG-PS-induced, and 4) PG-PS-induced and clopidogrel-treated. There were significant differences between the PG-PS+ clopidogrel group when compared to the PG-PS group including: increased joint diameter and clinical manifestations of inflammation, elevated plasma levels of proinflammatory cytokines (IL-1 beta, interferon (IFN) gamma, and IL-6), an elevated neutrophil blood count and an increased circulating platelet count. Plasma levels of IL-10 were significantly lower in the PG-PS+ clopidogrel group compared to the PG-PS group. Plasma levels of platelet factor 4 (PF4) were elevated in both the PG-PS and the PG-PS+ clopidogrel groups, however PF4 levels showed no difference upon clopidogrel treatment, suggesting that the pro-inflammatory effect of clopidogrel may be due to its action on cells other than platelets. Histology indicated an increase in leukocyte infiltration at the inflammatory area of the joint, increased pannus formation, blood vessel proliferation, subsynovial fibrosis and cartilage erosion upon treatment with clopidogrel in PG-PS-induced arthritis animals. In summary, animals treated with clopidogrel showed a pro-inflammatory effect in the PG-PS-induced arthritis animal model, which might not be mediated by platelets. Elucidation of the mechanism of clopidogrel-induced cell responses is important to understand the role of the P2Y12 receptor in inflammation.	[Garcia, Analia E.; Mada, Sripal R.; Rico, Mario C.; Dela Cadena, Raul A.; Kunapuli, Satya P.] Temple Univ, Sch Med, Temple Univ Hosp, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA; [Garcia, Analia E.; Dela Cadena, Raul A.; Kunapuli, Satya P.] Temple Univ, Sch Med, Temple Univ Hosp, Dept Physiol, Philadelphia, PA 19122 USA; [Kunapuli, Satya P.] Temple Univ, Sch Med, Temple Univ Hosp, Dept Pharmacol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Garcia, AE (corresponding author), Temple Univ, Sch Med, Temple Univ Hosp, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA.	agarcia@temple.edu		Rico, Mario/0000-0002-1356-0416	National Heart, Lung and Blood Institute of the National Institutes of Health (NHLBI-NIH) [K01 HL092586, R01 HL60683, R25 HL096331, T32 HL07777, K01 HL103197]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R25HL096331, K01HL092586, K01HL103197, R01HL060683, T32HL007777] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute of the National Institutes of Health (NHLBI-NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by Research Grants of the National Heart, Lung and Blood Institute of the National Institutes of Health (NHLBI-NIH): K01 HL092586 (AG), R01 HL60683 (SPK), R25 HL096331 (RADC), and T32 HL07777, K01 HL103197 (MR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angiolillo DJ, 2006, DIABETES, V55, P780, DOI 10.2337/diabetes.55.03.06.db05-1394; Blauwet L, 2003, JCR-J CLIN RHEUMATOL, V9, P128, DOI 10.1097/01.RHU.0000062515.74319.4b; Bleich A, 2009, INFLAMM BOWEL DIS, V15, P1794, DOI 10.1002/ibd.21018; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Boulman N, 2005, ISR MED ASSOC J, V7, P670; Burstein S A, 1996, Stem Cells, V14 Suppl 1, P154; Cattaneo Marco, 2007, Expert Rev Cardiovasc Ther, V5, P45, DOI 10.1586/14779072.5.1.45; Chen KK, 2003, INTERN MED J, V33, P618, DOI 10.1111/j.1445-5994.2003.00496.x; COWEN DS, 1989, J CLIN INVEST, V83, P1651, DOI 10.1172/JCI114064; CROMARTIE WJ, 1977, J EXP MED, V146, P1585, DOI 10.1084/jem.146.6.1585; Dangelmaier C, 2001, THROMB HAEMOSTASIS, V85, P341, DOI 10.1055/s-0037-1615690; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; DELACADENA RA, 1991, AM J PHYSIOL, V260, pG213, DOI 10.1152/ajpgi.1991.260.2.G213; Duffau P, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001001; Espinola RG, 2004, AM J PATHOL, V165, P969, DOI 10.1016/S0002-9440(10)63358-5; Fuseler JW, 1997, INFLAMMATION, V21, P113, DOI 10.1023/A:1027351111240; Garg A, 2000, BRIT MED J, V320, P483; GREENBLATT J, 1978, INFECT IMMUN, V19, P296, DOI 10.1128/IAI.19.1.296-303.1978; Hollopeter G, 2001, NATURE, V409, P202, DOI 10.1038/35051599; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Jy WC, 1995, BLOOD CELL MOL DIS, V21, P217, DOI 10.1006/bcmd.1995.0025; Kahner BN, 2006, J THROMB HAEMOST, V4, P2317, DOI 10.1111/j.1538-7836.2006.02192.x; Kannan Krishnaswamy, 2005, Pathophysiology, V12, P167, DOI 10.1016/j.pathophys.2005.07.011; Kawashiri SY, 2009, RHEUMATOL INT; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Klinger MHF, 2002, J INTERF CYTOK RES, V22, P913, DOI 10.1089/10799900260286623; Koizumi F, 1999, PATHOL INT, V49, P298, DOI 10.1046/j.1440-1827.1999.00863.x; Kowalska MA, 2000, BLOOD, V96, P50, DOI 10.1182/blood.V96.1.50.013k40_50_57; Kunapuli SP, 1998, BIOCHEM J, V336, P513, DOI 10.1042/bj3360513; Leon C, 2004, BLOOD, V103, P594, DOI 10.1182/blood-2003-05-1385; Paul BZS, 1999, J BIOL CHEM, V274, P29108, DOI 10.1074/jbc.274.41.29108; Rico MC, 2008, TRANSL RES, V152, P95, DOI 10.1016/j.trsl.2008.06.002; Rico MC, 2007, J CELL PHYSIOL, V211, P504, DOI 10.1002/jcp.20958; ROONEY M, 1988, ARTHRITIS RHEUM, V31, P956, DOI 10.1002/art.1780310803; RUF A, 1995, BRIT J HAEMATOL, V90, P791, DOI 10.1111/j.1365-2141.1995.tb05197.x; SAVI P, 1992, BIOCHEM PHARMACOL, V44, P527, DOI 10.1016/0006-2952(92)90445-O; Savi P, 2005, SEMIN THROMB HEMOST, V31, P174, DOI 10.1055/s-2005-869523; Schrijver IA, 2001, CLIN EXP IMMUNOL, V123, P140, DOI 10.1046/j.1365-2249.2001.01419.x; Shankar H, 2006, J THROMB HAEMOST, V4, P638, DOI 10.1111/j.1538-7836.2006.01789.x; Swennen ELR, 2005, EUR J IMMUNOL, V35, P852, DOI 10.1002/eji.200425423; Swennen ELR, 2006, BIOCHEM BIOPH RES CO, V348, P1194, DOI 10.1016/j.bbrc.2006.07.177; Tayyareci Y, 2008, JCR-J CLIN RHEUMATOL, V14, P254, DOI 10.1097/RHU.0b013e31818272a6; Telfer JF, 2004, MED SCI MONITOR, V10, pBR91; van Gestel MA, 2003, ARTERIOSCL THROM VAS, V23, P518, DOI 10.1161/01.ATV.0000057809.32354.22; von Hundelshausen P, 2001, CIRCULATION, V103, P1772, DOI 10.1161/01.CIR.103.13.1772; YAN ZQ, 1994, BLOOD, V84, P2329	46	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26035	10.1371/journal.pone.0026035	http://dx.doi.org/10.1371/journal.pone.0026035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028806	Green Published, gold, Green Submitted			2022-12-27	WOS:000296186900025
J	Liu, BR; Fu, YG; Wang, ZF; Zhou, SS; Sun, Y; Wu, YP; Xu, AL				Liu, Benrong; Fu, Yonggui; Wang, Zhifen; Zhou, Sisi; Sun, Yu; Wu, Yuping; Xu, Anlong			HLA-DRB1 May Be Antagonistically Regulated by the Coordinately Evolved Promoter and 3 '-UTR under Stabilizing Selection	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; CLASS-II GENES; HLA-DRB GENES; 3-DIMENSIONAL STRUCTURE; NATURAL-SELECTION; POLYMORPHISM; EXPRESSION; MHC; REGION; ASSOCIATION	HLA-DRB1 is the most polymorphic MHC (major histocompatibility complex) class II gene in human, and plays a crucial role in the development and function of the immune system. Extensive polymorphisms exist in the promoter and 3'-UTR of HLA-DRB1, especially a LTR (Long terminal repeat) element in the promoter, which may be involved in the expression regulation. However, it remains unknown how the polymorphisms in the whole promoter region and 3'-UTR to regulate the gene expression. In this study, we investigated the extensive polymorphisms in the HLA-DRB1 promoter and 3'-UTR, and how these polymorphisms affect the gene expression in both independent and jointly manners. It was observed that most of the haplotypes in the DRB1 promoter and 3'-UTR were clustered into 4 conserved lineages (H1, H2, H3 and H4), and showed high linkage disequilibrium. Compared with H1 and H2 lineage, a LTR element in the promoter of H3 and H4 lineage significantly suppressed the promoter activity, whereas the activity of the linked 3'-UTR increased, leading to no apparent difference in the final expression product between H1/H2 and H3/H4 lineage. Nevertheless, compared with the plasmid with a promoter and 3'-UTR from the same lineage, the recombinant plasmid with a promoter from H2 and a 3'-UTR from H3 showed about double fold increased luciferase activity, Conversely, the recombinant plasmid with a promoter from H3 and a 3'-UTR from H2 resulted in about 2-fold decreased luciferase activity. These results indicate that the promoter and 3'-UTR of HLA-DRB1 may antagonistically regulate the gene expression, which may be subjected to stabilizing selection. These findings may provide a novel insight into the mechanisms of the diseases associated with HLA-DRB1 genes.	[Liu, Benrong; Fu, Yonggui; Wang, Zhifen; Zhou, Sisi; Sun, Yu; Wu, Yuping; Xu, Anlong] Sun Yat Sen Zhongshan Univ, State Key Lab Biocontrol, Guangdong Prov Key Lab Pharmaceut Funct Genes, Dept Biochem,Coll Life Sci, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University	Liu, BR (corresponding author), Sun Yat Sen Zhongshan Univ, State Key Lab Biocontrol, Guangdong Prov Key Lab Pharmaceut Funct Genes, Dept Biochem,Coll Life Sci, Guangzhou, Guangdong, Peoples R China.	lssxal@mail.sysu.edu.cn	Sun, Yu/D-4237-2016		National Natural Science Foundation of China [30730089]; National Basic Research Program (973) [2007CB815800]; State High-Tech Development Project (863) [2006AA09Z433, 2008AA092603]; Ministry of Science and Technology of China [2007DFA30840]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program (973)(National Basic Research Program of China); State High-Tech Development Project (863)(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by Key Project (No 30730089) from National Natural Science Foundation of China (http://www.nsfc.gov.cn), Project 2007CB815800 of the National Basic Research Program (973), projects 2006AA09Z433 and 2008AA092603 of the State High-Tech Development Project (863), project 2007DFA30840 of International S&T Cooperation Program from the Ministry of Science and Technology of China (http://www.most.gov.cn). Dr. Xu is the recipent of "Outstanding Young Scientist Award'' from National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaez C, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-79; ASHTONRICKARDT PG, 1994, IMMUNOL TODAY, V15, P362, DOI 10.1016/0167-5699(94)90174-0; Baker CS, 2006, IMMUNOGENETICS, V58, P283, DOI 10.1007/s00251-006-0080-y; BERDOZ J, 1987, J IMMUNOL, V139, P1336; Bergstrom TF, 1999, IMMUNOL REV, V167, P351, DOI 10.1111/j.1600-065X.1999.tb01404.x; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Dharam P, 1995, IMMUNOGENETICS, V43, P50; Doherty P C, 1975, Nature, V256, P50; Fu YG, 2011, GENOME RES, V21, P741, DOI 10.1101/gr.115295.110; Garamszegi LZ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-73; Gilad Y, 2006, TRENDS GENET, V22, P456, DOI 10.1016/j.tig.2006.06.002; GRUSBY MJ, 1991, SCIENCE, V253, P1417, DOI 10.1126/science.1910207; JARDETZKY TS, 1994, NATURE, V368, P711, DOI 10.1038/368711a0; Jeffery KJM, 2000, MICROBES INFECT, V2, P1335, DOI 10.1016/S1286-4579(00)01287-9; Kadota Y, 2000, CLIN EXP IMMUNOL, V121, P59, DOI 10.1046/j.1365-2249.2000.01256.x; Kotsch K, 1999, TISSUE ANTIGENS, V53, P486, DOI 10.1034/j.1399-0039.1999.530505.x; Kuchroo VK, 2002, ANNU REV IMMUNOL, V20, P101, DOI 10.1146/annurev.immunol.20.081701.141316; Lemos B, 2005, EVOLUTION, V59, P126; Lincoln MR, 2005, NAT GENET, V37, P1108, DOI 10.1038/ng1647; Liu B, 2011, TISSUE ANTIGENS, V77, P159, DOI 10.1111/j.1399-0039.2010.01593.x; Liu XG, 2011, NAT IMMUNOL, V12, P416, DOI 10.1038/ni.2015; Liu XY, 2006, AM J HUM GENET, V78, P393, DOI 10.1086/500593; Loisel DA, 2006, P NATL ACAD SCI USA, V103, P16331, DOI 10.1073/pnas.0607662103; LOUIS P, 1994, J IMMUNOL, V153, P5059; LOUIS P, 1994, CR ACAD SCI III-VIE, V317, P161; Ludwig MZ, 1998, DEVELOPMENT, V125, P949; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Mach B, 1996, ANNU REV IMMUNOL, V14, P301, DOI 10.1146/annurev.immunol.14.1.301; Marsh SGE, 1998, TISSUE ANTIGENS, V51, P582, DOI 10.1111/j.1399-0039.1998.tb02998.x; Mueller-Hilke B, 2006, CURR PHARM DESIGN, V12, P3743; Oksenberg JR, 2004, AM J HUM GENET, V74, P160, DOI 10.1086/380997; Prugnolle F, 2005, CURR BIOL, V15, P1022, DOI 10.1016/j.cub.2005.04.050; QIU X, 1995, TRANSPLANT P, V27, P682; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Ridgway WM, 1998, J EXP MED, V188, P2267, DOI 10.1084/jem.188.12.2267; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sebzda E, 1999, ANNU REV IMMUNOL, V17, P829, DOI 10.1146/annurev.immunol.17.1.829; Shankarkumar U, 2009, JAIDS-J ACQ IMM DEF, V51, P640, DOI 10.1097/QAI.0b013e3181add600; SINGAL DP, 1994, MOL IMMUNOL, V31, P1117, DOI 10.1016/0161-5890(94)90107-4; Singal DP, 1996, IMMUNOGENETICS, V43, P50; Spielman RS, 2007, NAT GENET, V39, P226, DOI 10.1038/ng1955; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; STASTNY P, 1978, NEW ENGL J MED, V298, P869, DOI 10.1056/NEJM197804202981602; STUNZ LL, 1989, J IMMUNOL, V143, P3081; Sturniolo T, 1999, NAT BIOTECHNOL, V17, P555, DOI 10.1038/9858; TAKAHATA N, 1992, GENETICS, V130, P925; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tiwari J L, 1981, Prog Clin Biol Res, V58, P151; Tomilin NV, 2008, BIOESSAYS, V30, P338, DOI 10.1002/bies.20741; Viret C, 1999, Rev Immunogenet, V1, P91; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; WORDSWORTH BP, 1989, P NATL ACAD SCI USA, V86, P10049, DOI 10.1073/pnas.86.24.10049; Wray GA, 2003, MOL BIOL EVOL, V20, P1377, DOI 10.1093/molbev/msg140; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	56	0	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25794	10.1371/journal.pone.0025794	http://dx.doi.org/10.1371/journal.pone.0025794			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028790	Green Published, gold, Green Submitted			2022-12-27	WOS:000296186900018
J	Mauda-Havakuk, M; Litichever, N; Chernichovski, E; Nakar, O; Winkler, E; Mazkereth, R; Orenstein, A; Bar-Meir, E; Ravassard, P; Meivar-Levy, I; Ferber, S				Mauda-Havakuk, Michal; Litichever, Naomi; Chernichovski, Ellad; Nakar, Odelia; Winkler, Eyal; Mazkereth, Ram; Orenstein, Arie; Bar-Meir, Eran; Ravassard, Philippe; Meivar-Levy, Irit; Ferber, Sarah			Ectopic PDX-1 Expression Directly Reprograms Human Keratinocytes along Pancreatic Insulin-Producing Cells Fate	PLOS ONE			English	Article							HUMAN EPIDERMAL-KERATINOCYTES; PLURIPOTENT STEM-CELLS; BETA-CELLS; PROGENITOR CELLS; GENE-EXPRESSION; DIRECT CONVERSION; LIVER; TRANSDIFFERENTIATION; DIFFERENTIATION; HYPERGLYCEMIA	Background: Cellular differentiation and lineage commitment have previously been considered irreversible processes. However, recent studies have indicated that differentiated adult cells can be reprogrammed to pluripotency and, in some cases, directly into alternate committed lineages. However, although pluripotent cells can be induced in numerous somatic cell sources, it was thought that inducing alternate committed lineages is primarily only possible in cells of developmentally related tissues. Here, we challenge this view and analyze whether direct adult cell reprogramming to alternate committed lineages can cross the boundaries of distinct developmental germ layers. Methodology/Principal Findings: We ectopically expressed non-integrating pancreatic differentiation factors in ectoderm-derived human keratinocytes to determine whether these factors could directly induce endoderm-derived pancreatic lineage and beta-cell-like function. We found that PDX-1 and to a lesser extent other pancreatic transcription factors, could rapidly and specifically activate pancreatic lineage and beta-cell-like functional characteristics in ectoderm-derived human keratinocytes. Human keratinocytes transdifferentiated along the beta cell lineage produced processed and secreted insulin in response to elevated glucose concentrations. Using irreversible lineage tracing for KRT-5 promoter activity, we present supporting evidence that insulin-positive cells induced by ectopic PDX-1 expression are generated in ectoderm derived keratinocytes. Conclusions/Significance: These findings constitute the first demonstration of human ectoderm cells to endoderm derived pancreatic cells transdifferentiation. The study represents a proof of concept which suggests that transcription factors induced reprogramming is wider and more general developmental process than initially considered. These results expanded the arsenal of adult cells that can be used as a cell source for generating functional endocrine pancreatic cells. Directly reprogramming somatic cells into alternate desired tissues has important implications in developing patient-specific, regenerative medicine approaches.	[Mauda-Havakuk, Michal; Litichever, Naomi; Chernichovski, Ellad; Nakar, Odelia; Meivar-Levy, Irit; Ferber, Sarah] Sheba Med Ctr, Sheba Regenerat Med Stem Cells & Tissue Engn Ctr, Tel Hashomer, Israel; [Mauda-Havakuk, Michal; Litichever, Naomi; Chernichovski, Ellad; Nakar, Odelia; Ferber, Sarah] Tel Aviv Univ, Sackler Sch Med, Dept Human Genet & Mol Med, IL-69978 Tel Aviv, Israel; [Winkler, Eyal; Orenstein, Arie; Bar-Meir, Eran] Sheba Med Ctr, Dept Plast & Reconstruct, Tel Hashomer, Israel; [Mazkereth, Ram] Sheba Med Ctr, Albert Katz Dept Neonatol, Tel Hashomer, Israel; [Ravassard, Philippe] Univ Paris 06, Biotechnol & Biotherapy Grp,Ctr Recj, Inst Cerveau & Moelle, CNRS UMR7225,INSERM UMRS795, Paris, France	Chaim Sheba Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Chaim Sheba Medical Center; Chaim Sheba Medical Center; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Mauda-Havakuk, M (corresponding author), Sheba Med Ctr, Sheba Regenerat Med Stem Cells & Tissue Engn Ctr, Tel Hashomer, Israel.	sferber@sheba.health.gov.il		ravassard, philippe/0000-0002-0393-9262; Ferber, Sarah/0000-0003-2764-2786	Friends of Sheba in LA	Friends of Sheba in LA	The work was supported, in part, by the Friends of Sheba in LA (to S. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Aviv V, 2009, J BIOL CHEM, V284, P33509, DOI 10.1074/jbc.M109.017608; Ber I, 2003, J BIOL CHEM, V278, P31950, DOI 10.1074/jbc.M303127200; Deutsch G, 2001, DEVELOPMENT, V128, P871; ECKERT RL, 1989, ENVIRON HEALTH PERSP, V80, P109, DOI 10.2307/3430736; Endo M, 2008, MOL THER, V16, P131, DOI 10.1038/sj.mt.6300332; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Ferber S, 2000, ISR MED ASSOC J, V2, P32; Gefen-Halevi S, 2010, CELL REPROGRAM, V12, P655, DOI 10.1089/cell.2010.0030; GERMAN MS, 1990, J BIOL CHEM, V265, P22063; Gershengorn MC, 2005, CELL CYCLE, V4, P380, DOI 10.4161/cc.4.3.1538; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Green H, 1977, Prog Clin Biol Res, V17, P493; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Horb ME, 2003, CURR BIOL, V13, P105, DOI 10.1016/S0960-9822(02)01434-3; Jopling C, 2011, NAT REV MOL CELL BIO, V12, P79, DOI 10.1038/nrm3043; Kahn A, 2000, NAT MED, V6, P505, DOI 10.1038/74980; Kaneto H, 2005, J BIOL CHEM, V280, P15047, DOI 10.1074/jbc.M412013200; Kaneto H, 2005, DIABETES, V54, P1009, DOI 10.2337/diabetes.54.4.1009; Koizumi M, 2004, SURGERY, V136, P449, DOI 10.1016/j.surg.2004.05.024; Kojima H, 2003, NAT MED, V9, P596, DOI 10.1038/nm867; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Li WC, 2005, MECH DEVELOP, V122, P835, DOI 10.1016/j.mod.2005.01.001; Lister R, 2011, NATURE, V471, P68, DOI 10.1038/nature09798; MacDonald PE, 2005, PHILOS T R SOC B, V360, P2211, DOI 10.1098/rstb.2005.1762; Meivar-Levy I, 2007, HEPATOLOGY, V46, P898, DOI 10.1002/hep.21766; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; Nakajima-Nagata N, 2004, BIOCHEM BIOPH RES CO, V318, P625, DOI 10.1016/j.bbrc.2004.04.059; Niakan KK, 2010, GENE DEV, V24, P312, DOI 10.1101/gad.1833510; PANG ZP, 2011, NATURE, P26; Pera MF, 2011, NATURE, V471, P46, DOI 10.1038/471046a; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; RHEINWALD JG, 1975, CELL, V6, P331, DOI 10.1016/S0092-8674(75)80001-8; RHEINWALD JG, 1977, NATURE, V265, P421, DOI 10.1038/265421a0; Russ HA, 2008, DIABETES, V57, P1575, DOI 10.2337/db07-1283; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Seijffers R, 1999, ENDOCRINOLOGY, V140, P3311, DOI 10.1210/en.140.7.3311; Spence JR, 2009, DEV CELL, V17, P62, DOI 10.1016/j.devcel.2009.05.012; Szabo E, 2010, NATURE, V468, P521, DOI 10.1038/nature09591; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang DQ, 2006, LAB INVEST, V86, P829, DOI 10.1038/labinvest.3700434; Tang DQ, 2006, LAB INVEST, V86, P83, DOI 10.1038/labinvest.3700368; Theise ND, 2002, CR BIOL, V325, P1039, DOI 10.1016/S1631-0691(02)01525-1; Theise ND, 2010, EXP HEMATOL, V38, P529, DOI 10.1016/j.exphem.2010.04.013; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Vorburger SA, 2002, ONCOLOGIST, V7, P46, DOI 10.1634/theoncologist.7-1-46; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Zalzman M, 2005, DIABETES, V54, P2568, DOI 10.2337/diabetes.54.9.2568; Zalzman M, 2003, P NATL ACAD SCI USA, V100, P7253, DOI 10.1073/pnas.1136854100; ZHAO T, 2011, NATURE, P13; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	53	31	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26298	10.1371/journal.pone.0026298	http://dx.doi.org/10.1371/journal.pone.0026298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028850	Green Submitted, gold, Green Published			2022-12-27	WOS:000296186900044
J	Wang, TC; Chiu, H; Chang, YJ; Hsu, TY; Chiu, IM; Chen, LY				Wang, Tien-Cheng; Chiu, Hsun; Chang, Yu-Jung; Hsu, Tai-Yu; Chiu, Ing-Ming; Chen, Linyi			The Adaptor Protein SH2B3 (Lnk) Negatively Regulates Neurite Outgrowth of PC12 Cells and Cortical Neurons	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; GLUCOSE-HOMEOSTASIS; SIGNALING PATHWAYS; ENDOTHELIAL-CELLS; SELF-RENEWAL; SH2-B; DIFFERENTIATION; APS; ACTIVATION; RECEPTOR	SH2B adaptor protein family members (SH2B1-3) regulate various physiological responses through affecting signaling, gene expression, and cell adhesion. SH2B1 and SH2B2 were reported to enhance nerve growth factor (NGF)-induced neuronal differentiation in PC12 cells, a well-established neuronal model system. In contrast, SH2B3 was reported to inhibit cell proliferation during the development of immune system. No study so far addresses the role of SH2B3 in the nervous system. In this study, we provide evidence suggesting that SH2B3 is expressed in the cortex of embryonic rat brain. Overexpression of SH2B3 not only inhibits NGF-induced differentiation of PC12 cells but also reduces neurite outgrowth of primary cortical neurons. SH2B3 does so by repressing NGF-induced activation of PLC gamma, MEK-ERK1/2 and PI3K-AKT pathways and the expression of Egr-1. SH2B3 is capable of binding to phosphorylated NGF receptor, TrkA, as well as SH2B1 beta. Our data further demonstrate that overexpression of SH2B3 reduces the interaction between SH2B1 beta and TrkA. Consistent with this finding, overexpressing the SH2 domain of SH2B3 is sufficient to inhibit NGF-induced neurite outgrowth. Together, our data demonstrate that SH2B3, unlike the other two family members, inhibits neuronal differentiation of PC12 cells and primary cortical neurons. Its inhibitory mechanism is likely through the competition of TrkA binding with the positive-acting SH2B1 and SH2B2.	[Wang, Tien-Cheng; Chang, Yu-Jung; Hsu, Tai-Yu; Chen, Linyi] Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan; [Chiu, Hsun] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Chen, Linyi] Natl Tsing Hua Univ, Dept Med Sci, Hsinchu, Taiwan; [Chiu, Ing-Ming] Natl Hlth Res Inst, Inst Cellular & Syst Med, Miaoli, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Health Research Institutes - Taiwan	Wang, TC (corresponding author), Natl Tsing Hua Univ, Inst Mol Med, Hsinchu, Taiwan.	lchen@life.nthu.edu.tw	Chiu, Ing-Ming/B-1534-2008; Chen, Linyi/AAV-2632-2020	Chen, Linyi/0000-0001-7258-8817; Chang, Yu-Jung/0000-0002-4781-0946	National Science Council [NSC97-2311-B-007-007-MY3]; National Health Research Institutes of Taiwan [NHRI-EX100-NC9719]	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institutes of Taiwan(National Health Research Institutes - Taiwan)	This work is funded by National Science Council (http://web1.nsc.gov.tw/)(NSC97-2311-B-007-007-MY3) and National Health Research Institutes of Taiwan (http://english.nhri.org.tw/)(NHRI-EX100-NC9719). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed Z, 2001, BIOCHEM SOC T, V29, P529, DOI 10.1042/BST0290529; Bersenev A, 2008, J CLIN INVEST, V118, P2832, DOI 10.1172/JCI35808; Duan CJ, 2004, J BIOL CHEM, V279, P43684, DOI 10.1074/jbc.M408495200; Fitau J, 2006, J BIOL CHEM, V281, P20148, DOI 10.1074/jbc.M510997200; Gery S, 2007, BLOOD, V110, P3360, DOI 10.1182/blood-2007-05-089326; GREENE LA, 1978, J CELL BIOL, V78, P747, DOI 10.1083/jcb.78.3.747; Gueller S, 2011, EXP HEMATOL, V39, P591, DOI 10.1016/j.exphem.2011.02.001; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Hu JJ, 2005, J BIOL CHEM, V280, P18943, DOI 10.1074/jbc.M414157200; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iseki M, 2005, BIOCHEM BIOPH RES CO, V330, P1005, DOI 10.1016/j.bbrc.2005.03.073; Jantas D, 2009, APOPTOSIS, V14, P900, DOI 10.1007/s10495-009-0370-6; Kovalenko D, 2003, J BIOL CHEM, V278, P14087, DOI 10.1074/jbc.C200606200; Li M, 2006, ENDOCRINOLOGY, V147, P2163, DOI 10.1210/en.2005-1313; Lin WF, 2009, CELL SIGNAL, V21, P1060, DOI 10.1016/j.cellsig.2009.02.009; Minowada G, 1999, DEVELOPMENT, V126, P4465; Ng YP, 2006, J BIOL CHEM, V281, P15636, DOI 10.1074/jbc.M601863200; Nishi M, 2005, MOL CELL BIOL, V25, P2607, DOI 10.1128/MCB.25.7.2607-2621.2005; O'Brien KB, 2002, J BIOL CHEM, V277, P8673, DOI 10.1074/jbc.M109165200; Qian XZ, 2001, MOL CELL BIOL, V21, P1613, DOI 10.1128/MCB.21.5.1613-1620.2001; Qian XZ, 1998, NEURON, V21, P1017, DOI 10.1016/S0896-6273(00)80620-0; REN D, 2005, CELL METAB, V2, DOI DOI 10.1016/J.CMET.2005.1007.1004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; RUDKIN BB, 1989, EMBO J, V8, P3319, DOI 10.1002/j.1460-2075.1989.tb08493.x; Rui LY, 1999, J BIOL CHEM, V274, P10590, DOI 10.1074/jbc.274.15.10590; Rui LY, 1999, J BIOL CHEM, V274, P26485, DOI 10.1074/jbc.274.37.26485; Rui LY, 1999, P NATL ACAD SCI USA, V96, P7172, DOI 10.1073/pnas.96.13.7172; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Seita J, 2007, P NATL ACAD SCI USA, V104, P2349, DOI 10.1073/pnas.0606238104; Simon C, 2008, BLOOD, V112, P1039, DOI 10.1182/blood-2008-05-154849; Takaki S, 2000, IMMUNITY, V13, P599, DOI 10.1016/S1074-7613(00)00060-1; Tong W, 2005, BLOOD, V105, P4604, DOI 10.1182/blood-2004-10-4093; Tong W, 2004, J EXP MED, V200, P569, DOI 10.1084/jem.20040762; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Velazquez L, 2002, J EXP MED, V195, P1599, DOI 10.1084/jem.20011883; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Xiong SQ, 2003, J BIOL CHEM, V278, P50273, DOI 10.1074/jbc.M306936200; Yamada M, 2001, J NEUROCHEM, V78, P940, DOI 10.1046/j.1471-4159.2001.00497.x; Yang RB, 2003, J BIOL CHEM, V278, P33232, DOI 10.1074/jbc.M305022200; Yokouchi M, 1999, ONCOGENE, V18, P759, DOI 10.1038/sj.onc.1202326	40	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26433	10.1371/journal.pone.0026433	http://dx.doi.org/10.1371/journal.pone.0026433			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028877	Green Submitted, Green Published, gold			2022-12-27	WOS:000296186900062
J	Nakao, R; Hasegawa, H; Ochiai, K; Takashiba, S; Ainai, A; Ohnishi, M; Watanabe, H; Senpuku, H				Nakao, Ryoma; Hasegawa, Hideki; Ochiai, Kuniyasu; Takashiba, Shogo; Ainai, Akira; Ohnishi, Makoto; Watanabe, Haruo; Senpuku, Hidenobu			Outer Membrane Vesicles of Porphyromonas gingivalis Elicit a Mucosal Immune Response	PLOS ONE			English	Article							ESCHERICHIA-COLI; BACTEROIDES-GINGIVALIS; EXTRACELLULAR VESICLES; PROTECTIVE IMMUNITY; BIOFILM FORMATION; VACCINE PROTECTS; MICE; PERIODONTITIS; CELLS; LIPOPOLYSACCHARIDE	We previously reported that mutation of galE in Porphyromonas gingivalis has pleiotropic effects, including a truncated lipopolysaccharide (LPS) O-antigen and deglycosylation of the outer membrane protein OMP85 homolog. In the present study, further analysis of the galE mutant revealed that it produced little or no outer membrane vesicles (OMVs). Using three mouse antisera raised against whole cells of the P. gingivalis wild type strain, we performed ELISAs to examine the reactivity of these antisera with whole cells of the wild type or the galE mutant. All three antisera had significantly lower reactivity against the galE mutant compared to wild type. OMVs, but not LPS, retained the immunodominant determinant of P. gingivalis, as determined by ELISAs (with wild type LPS or OMVs as antigen) and absorption assays. In addition, we assessed the capacity of OMVs as a vaccine antigen by intranasal immunization to BALB/c mice. Synthetic double-stranded RNA polyriboinosinic polyribocytidylic acid [Poly (I: C)], an agonist of Toll-like receptor 3 (TLR3), was used as the mucosal adjuvant. Vaccination with OMV elicited dramatically high levels of P. gingivalis-specific IgA in nasal washes and saliva, as well as serum IgG and IgA. In conclusion, the OMVs of P. gingivalis have an important role in mucosal immunogenicity as well as in antigenicity. We propose that P. gingivalis OMV is an intriguing immunogen for development of a periodontal disease vaccine.	[Nakao, Ryoma; Ohnishi, Makoto; Watanabe, Haruo; Senpuku, Hidenobu] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Hasegawa, Hideki; Ainai, Akira] Natl Inst Infect Dis, Dept Pathol, Tokyo, Japan; [Ochiai, Kuniyasu] Nihon Univ, Dept Microbiol, Tokyo, Japan; [Takashiba, Shogo] Okayama Univ, Grad Sch Med, Dept Pathophysiol Periodontal Sci, Okayama 7008530, Japan	National Institute of Infectious Diseases (NIID); National Institute of Infectious Diseases (NIID); Nihon University; Okayama University	Nakao, R (corresponding author), Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan.	hsenpuku@nih.go.jp	Takashiba, Shogo/C-9830-2010; SENPUKU, HIDENOBU/ABC-6160-2021; Hasegawa, Hideki/C-7978-2014	Takashiba, Shogo/0000-0002-4712-6829; 	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT) [19791360, 22791822, 21390506, S1001024]; Ministry of Health, Labor and Welfare [H19 Iryo-Ippan-007]; Japan Health Science Foundation [KHC3308]	Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Health Science Foundation	This study was supported in part by Grants-in-Aid from the Scientific Research of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (19791360, 22791822, and 21390506); the Ministry of Health, Labor and Welfare (H19 Iryo-Ippan-007); and the Japan Health Science Foundation (No. KHC3308). This study was also supported in part by a grant of the "Strategic Research Base Development" Program for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2010-2014 (S1001024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaniz RC, 2007, J IMMUNOL, V179, P7692, DOI 10.4049/jimmunol.179.11.7692; Balsalobre C, 2006, MOL MICROBIOL, V59, P99, DOI 10.1111/j.1365-2958.2005.04938.x; Beveridge TJ, 1999, J BACTERIOL, V181, P4725, DOI 10.1128/JB.181.16.4725-4733.1999; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clinical trials.gov, SERV US NAT I HLTH; Couch RB, 2004, NEW ENGL J MED, V350, P860, DOI 10.1056/NEJMp048006; DESLAURIERS M, 1990, ORAL MICROBIOL IMMUN, V5, P1, DOI 10.1111/j.1399-302X.1990.tb00217.x; Desvarieux M, 2005, CIRCULATION, V111, P576, DOI 10.1161/01.CIR.0000154582.37101.15; Dorn BR, 1999, INFECT IMMUN, V67, P5792, DOI 10.1128/IAI.67.11.5792-5798.1999; Furuta N, 2009, INFECT IMMUN, V77, P4187, DOI 10.1128/IAI.00009-09; GRENIER D, 1987, INFECT IMMUN, V55, P111, DOI 10.1128/IAI.55.1.111-117.1987; Haurat MF, 2011, J BIOL CHEM, V286, P1269, DOI 10.1074/jbc.M110.185744; Holst J, 2009, VACCINE, V27, pB3, DOI 10.1016/j.vaccine.2009.04.071; Ichinohe T, 2005, J VIROL, V79, P2910, DOI 10.1128/JVI.79.5.2910-2919.2005; Ichinohe T, 2009, VACCINE, V27, P6276, DOI 10.1016/j.vaccine.2009.04.074; IMAMURA T, 1995, INFECT IMMUN, V63, P4877, DOI 10.1128/IAI.63.12.4877-4882.1995; Ishihara K, 2004, J CLIN MICROBIOL, V42, P1313, DOI 10.1128/JCM.42.3.1313-1315.2004; KESAVALU L, 1992, INFECT IMMUN, V60, P1455, DOI 10.1128/IAI.60.4.1455-1464.1992; Kesty NC, 2004, EMBO J, V23, P4538, DOI 10.1038/sj.emboj.7600471; Kouokam JC, 2006, INFECT IMMUN, V74, P2022, DOI 10.1128/IAI.74.4.2022-2030.2006; Kuehn MJ, 2005, GENE DEV, V19, P2645, DOI 10.1101/gad.1299905; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Li L, 2002, CIRCULATION, V105, P861, DOI 10.1161/hc0702.104178; Matsumoto N, 2004, ORAL MICROBIOL IMMUN, V19, P270, DOI 10.1111/j.1399-302X.2004.00151.x; Nakao R, 2008, BIOCHEM BIOPH RES CO, V365, P784, DOI 10.1016/j.bbrc.2007.11.035; Nakao R, 2006, INFECT IMMUN, V74, P6145, DOI 10.1128/IAI.00261-06; Ojima M, 2005, DIABETES CARE, V28, P433, DOI 10.2337/diacare.28.2.433; Schild S, 2008, INFECT IMMUN, V76, P4554, DOI 10.1128/IAI.00532-08; SMALLEY JW, 1991, ORAL MICROBIOL IMMUN, V6, P202, DOI 10.1111/j.1399-302X.1991.tb00478.x; Tsuha Y, 2004, CLIN EXP IMMUNOL, V137, P393, DOI 10.1111/j.1365-2249.2004.02548.x; Wai SN, 2003, CELL, V115, P25, DOI 10.1016/S0092-8674(03)00754-2; Yamamoto S, 1997, J EXP MED, V185, P1203, DOI 10.1084/jem.185.7.1203	34	70	74	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26163	10.1371/journal.pone.0026163	http://dx.doi.org/10.1371/journal.pone.0026163			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022548	Green Published, Green Submitted, gold			2022-12-27	WOS:000295981600033
J	Shorter, J				Shorter, James			The Mammalian Disaggregase Machinery: Hsp110 Synergizes with Hsp70 and Hsp40 to Catalyze Protein Disaggregation and Reactivation in a Cell-Free System	PLOS ONE			English	Article							HEAT-SHOCK-PROTEIN; NUCLEOTIDE EXCHANGE FACTORS; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; MOLECULAR CHAPERONES; AGGREGATED PROTEINS; HUNTINGTONS-DISEASE; ALPHA-SYNUCLEIN; IN-VITRO; YEAST	Bacteria, fungi, protozoa, chromista and plants all harbor homologues of Hsp104, a AAA+ ATPase that collaborates with Hsp70 and Hsp40 to promote protein disaggregation and reactivation. Curiously, however, metazoa do not possess an Hsp104 homologue. Thus, whether animal cells renature large protein aggregates has long remained unclear. Here, it is established that mammalian cytosol prepared from different sources possesses a potent, ATP-dependent protein disaggregase and reactivation activity, which can be accelerated and stimulated by Hsp104. This activity did not require the AAA+ ATPase, p97. Rather, mammalian Hsp110 (Apg-2), Hsp70 (Hsc70 or Hsp70) and Hsp40 (Hdj1) were necessary and sufficient to slowly dissolve large disordered aggregates and recover natively folded protein. This slow disaggregase activity was conserved to yeast Hsp110 (Sse1), Hsp70 (Ssa1) and Hsp40 (Sis1 or Ydj1). Hsp110 must engage substrate, engage Hsp70, promote nucleotide exchange on Hsp70, and hydrolyze ATP to promote disaggregation of disordered aggregates. Similarly, Hsp70 must engage substrate and Hsp110, and hydrolyze ATP for protein disaggregation. Hsp40 must harbor a functional J domain to promote protein disaggregation, but the J domain alone is insufficient. Optimal disaggregase activity is achieved when the Hsp40 can stimulate the ATPase activity of Hsp110 and Hsp70. Finally, Hsp110, Hsp70 and Hsp40 fail to rapidly remodel amyloid forms of the yeast prion protein, Sup35, or the Parkinson's disease protein, alpha-synuclein. However, Hsp110, Hsp70 and Hsp40 enhanced the activity of Hsp104 against these amyloid substrates. Taken together, these findings suggest that Hsp110 fulfils a subset of Hsp104 activities in mammals. Moreover, they suggest that Hsp104 can collaborate with the mammalian disaggregase machinery to rapidly remodel amyloid conformers.	Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs, Philadelphia, PA 19104 USA	University of Pennsylvania	Shorter, J (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Stellar Chance Labs, Philadelphia, PA 19104 USA.	jshorter@mail.med.upenn.edu	Shorter, James/ABE-7307-2020	Shorter, James/0000-0001-5269-8533	NIH [1DP2OD002177-01, R21 NS067354-0110]; Ellison Medical Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067354] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002177] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the following: an NIH Director's New Innovator Award 1DP2OD002177-01, an NIH R21 NS067354-0110, and an Ellison Medical Foundation New Scholar in Aging Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Ben-Zvi A, 2004, J BIOL CHEM, V279, P37298, DOI 10.1074/jbc.M405627200; Bieschke J, 2009, PROTEIN SCI, V18, P2231, DOI 10.1002/pro.234; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Cavalier-Smith T, 2004, P ROY SOC B-BIOL SCI, V271, P1251, DOI 10.1098/rspb.2004.2705; Chernoff YO, 2002, METHOD ENZYMOL, V351, P499; Chou TF, 2011, P NATL ACAD SCI USA, V108, P4834, DOI 10.1073/pnas.1015312108; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Cushman M, 2010, J CELL SCI, V123, P1191, DOI 10.1242/jcs.051672; Dandoy-Dron F, 2006, NEUROSCI LETT, V405, P181, DOI 10.1016/j.neulet.2006.05.066; De los Rios P, 2006, P NATL ACAD SCI USA, V103, P6166, DOI 10.1073/pnas.0510496103; Diamant S, 2000, J BIOL CHEM, V275, P21107, DOI 10.1074/jbc.M001293200; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Doyle SM, 2009, TRENDS BIOCHEM SCI, V34, P40, DOI 10.1016/j.tibs.2008.09.010; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Evans CG, 2006, J BIOL CHEM, V281, P33182, DOI 10.1074/jbc.M606192200; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; Fredenburg RA, 2007, BIOCHEMISTRY-US, V46, P7107, DOI 10.1021/bi7000246; Garrity SJ, 2010, P NATL ACAD SCI USA, V107, P10596, DOI 10.1073/pnas.0913280107; Gidalevitz T., 2011, COLD SPRING HARB PER, V3; Glover JR, 1998, CELL, V94, P73, DOI 10.1016/S0092-8674(00)81223-4; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Goloubinoff P, 1999, P NATL ACAD SCI USA, V96, P13732, DOI 10.1073/pnas.96.24.13732; Goloubinoff P, 2007, TRENDS BIOCHEM SCI, V32, P372, DOI 10.1016/j.tibs.2007.06.008; Halfmann R, 2010, SCIENCE, V330, P629, DOI 10.1126/science.1191081; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Kabani M, 2002, MOL CELL BIOL, V22, P4677, DOI 10.1128/MCB.22.13.4677-4689.2002; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Knowles TPJ, 2011, NAT NANOTECHNOL, V6, P469, DOI [10.1038/nnano.2011.102, 10.1038/NNANO.2011.102]; Kobayashi T, 2007, GENES CELLS, V12, P889, DOI 10.1111/j.1365-2443.2007.01099.x; Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128; LEEYOON D, 1995, J BIOL CHEM, V270, P15725, DOI 10.1074/jbc.270.26.15725; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Lo Bianco C, 2008, J CLIN INVEST, V118, P3087, DOI 10.1172/JCI35781; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; McClellan AJ, 2000, GENETICS, V156, P501; Mosser DD, 2004, BIOCHEMISTRY-US, V43, P8107, DOI 10.1021/bi0493766; Murray AN, 2010, PROTEIN SCI, V19, P836, DOI 10.1002/pro.363; Needham PG, 2008, ARCH BIOCHEM BIOPHYS, V478, P167, DOI 10.1016/j.abb.2008.07.023; Nishikori S, 2008, GENES CELLS, V13, P827, DOI 10.1111/j.1365-2443.2008.01214.x; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Okui M, 2000, NEUROCHEM INT, V36, P35, DOI 10.1016/S0197-0186(99)00095-9; PARSELL DA, 1994, NATURE, V372, P475, DOI 10.1038/372475a0; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Perrin V, 2007, MOL THER, V15, P903, DOI 10.1038/mt.sj.6300141; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Sadlish H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001763; SANCHEZ Y, 1992, EMBO J, V11, P2357, DOI 10.1002/j.1460-2075.1992.tb05295.x; SANCHEZ Y, 1990, SCIENCE, V248, P1112, DOI 10.1126/science.2188365; Satyal SH, 2000, P NATL ACAD SCI USA, V97, P5750, DOI 10.1073/pnas.100107297; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Shorter J, 2008, EMBO J, V27, P2712, DOI 10.1038/emboj.2008.194; Shorter J, 2008, NEUROSIGNALS, V16, P63, DOI 10.1159/000109760; Shorter J, 2006, MOL CELL, V23, P425, DOI 10.1016/j.molcel.2006.05.042; Sondermann H, 2002, J BIOL CHEM, V277, P33220, DOI 10.1074/jbc.M204624200; Song C, 2007, BIOCHEMISTRY-US, V46, P14889, DOI 10.1021/bi700499j; Sonnichsen B, 1996, J CELL BIOL, V134, P1411, DOI 10.1083/jcb.134.6.1411; STUART RA, 1993, J BIOL CHEM, V268, P4050; Sweeny EA, 2008, PRION, V2, P135, DOI 10.4161/pri.2.4.7952; Thoms S, 2002, FEBS LETT, V520, P107, DOI 10.1016/S0014-5793(02)02777-1; Tipton KA, 2008, MOL CELL, V32, P584, DOI 10.1016/j.molcel.2008.11.003; True HL, 2000, NATURE, V407, P477, DOI 10.1038/35035005; Vacher C, 2005, HUM MOL GENET, V14, P3425, DOI 10.1093/hmg/ddi372; Vashist S, 2010, BIOCHEM CELL BIOL, V88, P1, DOI [10.1139/O09-121, 10.1139/o09-121]; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Wakatsuki T, 1998, BIOL PHARM BULL, V21, P905; Weibezahn J, 2004, CELL, V119, P653, DOI 10.1016/j.cell.2004.11.027; Wong E, 2011, COLD SPRING HARB PER, V2; Yan W, 1999, MOL CELL BIOL, V19, P7751; Zietkiewicz S, 2006, J BIOL CHEM, V281, P7022, DOI 10.1074/jbc.M507893200; Zietkiewicz S, 2004, J BIOL CHEM, V279, P44376, DOI 10.1074/jbc.M402405200	81	209	210	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26319	10.1371/journal.pone.0026319	http://dx.doi.org/10.1371/journal.pone.0026319			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022600	gold, Green Published, Green Submitted			2022-12-27	WOS:000295981600055
J	Kumagai, A; Horike, N; Satoh, Y; Uebi, T; Sasaki, T; Itoh, Y; Hirata, Y; Uchio-Yamada, K; Kitagawa, K; Uesato, S; Kawahara, H; Takemori, H; Nagaoka, Y				Kumagai, Ayako; Horike, Nanao; Satoh, Yudai; Uebi, Tatsuya; Sasaki, Tsutomu; Itoh, Yumi; Hirata, Yoshiyuki; Uchio-Yamada, Kozue; Kitagawa, Kazuo; Uesato, Shinichi; Kawahara, Hidehisa; Takemori, Hiroshi; Nagaoka, Yasuo			A Potent Inhibitor of SIK2, 3, 3 ', 7-Trihydroxy-4 '-Methoxyflavon (4 '-O-Methylfisetin), Promotes Melanogenesis in B16F10 Melanoma Cells	PLOS ONE			English	Article							BINDING PROTEIN-ACTIVITY; SALT-INDUCIBLE KINASE-1; LONG-TERM POTENTIATION; SKIN PIGMENTATION; TRANSCRIPTION FACTOR; COACTIVATOR TORC2; SIGNALING CASCADE; CAMP; ACTIVATION; FLAVONOIDS	Flavonoids, which are plant polyphenols, are now widely used in supplements and cosmetics. Here, we report that 4'-methylflavonoids are potent inducers of melanogenesis in B16F10 melanoma cells and in mice. We recently identified salt inducible kinase 2 (SIK2) as an inhibitor of melanogenesis via the suppression of the cAMP-response element binding protein (CREB)-specific coactivator 1 (TORC1). Using an in vitro kinase assay targeting SIK2, we identified fisetin as a candidate inhibitor, possibly being capable of promoting melanogenesis. However, fisetin neither inhibited the CREB-inhibitory activity of SIK2 nor promoted melanogenesis in B16F10 melanoma cells. Conversely, mono-methyl-flavonoids, such as diosmetin (4'-O-metlylluteolin), efficiently inhibited SIK2 and promoted melanogenesis in this cell line. The cAMP-CREB system is impaired in A(y)/a mice and these mice have yellow hair as a result of pheomelanogenesis, while Sik2(+/-); A(y)/a mice also have yellow hair, but activate eumelanogenesis when they are exposed to CREB stimulators. Feeding Sik(2+/-); A(y)/a mice with diets supplemented with fisetin resulted in their hair color changing to brown, and metabolite analysis suggested the presence of mono-methylfisetin in their feces. Thus, we decided to synthesize 4'-O-methylfisetin (4'MF) and found that 4'MF strongly induced melanogenesis in B16F10 melanoma cells, which was accompanied by the nuclear translocation of TORC1, and the 4'-O-methylfisetin-induced melanogenic programs were inhibited by the overexpression of dominant negative TORC1. In conclusion, compounds that modulate SIK2 cascades are helpful to regulate melanogenesis via TORC1 without affecting cAMP levels, and the combined analysis of Sik2(+/-) mice and metabolites from these mice is an effective strategy to identify beneficial compounds to regulate CREB activity in vivo.	[Kumagai, Ayako; Horike, Nanao; Satoh, Yudai; Hirata, Yoshiyuki; Uesato, Shinichi; Kawahara, Hidehisa; Nagaoka, Yasuo] Kansai Univ, Dept Life Sci & Biotechnol, Fac Chem Mat & Bioengn, Osaka, Japan; [Kumagai, Ayako; Horike, Nanao; Uebi, Tatsuya; Itoh, Yumi; Takemori, Hiroshi] Natl Inst Biomed Innovat, Lab Cell Signaling & Metab Dis, Osaka, Japan; [Sasaki, Tsutomu; Kitagawa, Kazuo] Osaka Univ, Dept Neurol, Grad Sch Med, Osaka, Japan; [Uchio-Yamada, Kozue] Natl Inst Biomed Innovat, Lab Anim Models Human Dis, Osaka, Japan	Kansai University; National Institute of Health Sciences - Japan; Osaka University; National Institute of Health Sciences - Japan	Kumagai, A (corresponding author), Kansai Univ, Dept Life Sci & Biotechnol, Fac Chem Mat & Bioengn, Osaka, Japan.	takemori@nibio.go.jp		sasaki, tsutomu/0000-0001-8726-978X	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Sumitomo Foundation; Natural Scientists and the Strategic Project	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sumitomo Foundation; Natural Scientists and the Strategic Project	This study was supported by Grants-in-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Natural Scientists and the Strategic Project to Support the Formation of Research Bases at Private Universities; and a grant from the Sumitomo Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Bellei B, 2008, CELL SIGNAL, V20, P1750, DOI 10.1016/j.cellsig.2008.06.001; BLASKO G, 1989, J NAT PROD, V52, P1363, DOI 10.1021/np50066a035; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Bouktaib M, 2002, TETRAHEDRON, V58, P10001, DOI 10.1016/S0040-4020(02)01306-6; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Chan ALF, 2008, INVEST NEW DRUG, V26, P417, DOI 10.1007/s10637-008-9114-7; Cho M, 2009, BIOCHEM BIOPH RES CO, V390, P500, DOI 10.1016/j.bbrc.2009.09.124; D'Orazio JA, 2006, NATURE, V443, P340, DOI 10.1038/nature05098; Fujii T, 2009, BIOSCI BIOTECH BIOCH, V73, P1989, DOI 10.1271/bbb.90181; Hashimoto YK, 2008, J CELL BIOCHEM, V104, P1724, DOI 10.1002/jcb.21737; Hocker TL, 2008, J INVEST DERMATOL, V128, P2575, DOI 10.1038/jid.2008.226; Horike N, 2003, J BIOL CHEM, V278, P18440, DOI 10.1074/jbc.M211770200; Horike N, 2010, PIGM CELL MELANOMA R, V23, P809, DOI 10.1111/j.1755-148X.2010.00760.x; JIMBOW K, 1992, PIGM CELL RES, P36; Katoh Y, 2004, EUR J BIOCHEM, V271, P4307, DOI 10.1111/j.1432-1033.2004.04372.x; Katoh Y, 2006, FEBS J, V273, P2730, DOI 10.1111/j.1742-4658.2006.05291.x; Khaled M, 2002, J BIOL CHEM, V277, P33690, DOI 10.1074/jbc.M202939200; Kovacic P, 2011, J RECEPT SIG TRANSD, V31, P265, DOI 10.3109/10799893.2011.586353; Lee J, 2005, J INVEST DERMATOL, V124, P405, DOI 10.1111/j.0022-202X.2004.23606.x; Lee J, 2007, LIFE SCI, V81, P249, DOI 10.1016/j.lfs.2007.05.009; Li SA, 2009, J NEUROSCI, V29, P2334, DOI 10.1523/JNEUROSCI.2296-08.2009; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Liu Y, 2010, ENDOCRINOLOGY, V151, P1109, DOI 10.1210/en.2009-0963; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Muraoka M, 2009, AM J PHYSIOL-ENDOC M, V296, pE1430, DOI 10.1152/ajpendo.00024.2009; Nagase H, 2005, BIOCHEM BIOPH RES CO, V337, P1330, DOI 10.1016/j.bbrc.2005.10.001; NAKAYAMA T, 1994, CANCER RES, V54, pS1991; Oka M, 2000, J INVEST DERMATOL, V115, P699, DOI 10.1046/j.1523-1747.2000.00095.x; Peluso MR, 2006, EXP BIOL MED, V231, P1287, DOI 10.1177/153537020623100802; Sasaki T, 2011, NEURON, V69, P106, DOI 10.1016/j.neuron.2010.12.004; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shoji T, 2005, J AGR FOOD CHEM, V53, P6105, DOI 10.1021/jf050418m; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; Takemori H, 2009, ENDOCR J, V56, P121, DOI 10.1507/endocrj.K08E-173; Uebi T, 2010, AM J PHYSIOL-ENDOC M, V299, pE413, DOI 10.1152/ajpendo.00525.2009; Vachtenheim J, 2010, EXP DERMATOL, V19, P617, DOI 10.1111/j.1600-0625.2009.01053.x; Winkel-Shirley B, 2002, CURR OPIN PLANT BIOL, V5, P218, DOI 10.1016/S1369-5266(02)00256-X; Wu M, 2000, GENE DEV, V14, P301; Yamaguchi Y, 2009, BIOFACTORS, V35, P193, DOI 10.1002/biof.29; Yoon HS, 2007, BIOSCI BIOTECH BIOCH, V71, P1781, DOI 10.1271/bbb.70088; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	43	30	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26148	10.1371/journal.pone.0026148	http://dx.doi.org/10.1371/journal.pone.0026148			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022544	gold, Green Submitted, Green Published			2022-12-27	WOS:000295978600041
J	Cerutti, A; Maillard, P; Minisini, R; Vidalain, PO; Roohvand, F; Pecheur, EI; Pirisi, M; Budkowska, A				Cerutti, Andrea; Maillard, Patrick; Minisini, Rosalba; Vidalain, Pierre-Olivier; Roohvand, Farzin; Pecheur, Eve-Isabelle; Pirisi, Mario; Budkowska, Agata			Identification of a Functional, CRM-1-Dependent Nuclear Export Signal in Hepatitis C Virus Core Protein	PLOS ONE			English	Article							SUBCELLULAR-LOCALIZATION; DENGUE VIRUS; NUCLEOCYTOPLASMIC TRANSPORT; LIPID DROPLETS; HEPATOCELLULAR-CARCINOMA; INTRACELLULAR-LOCALIZATION; INTRAMEMBRANE PROTEOLYSIS; STRUCTURAL PROTEINS; VIRAL REPLICATION; INFECTED PATIENTS	Hepatitis C virus (HCV) infection is a major cause of chronic liver disease worldwide. HCV core protein is involved in nucleocapsid formation, but it also interacts with multiple cytoplasmic and nuclear molecules and plays a crucial role in the development of liver disease and hepatocarcinogenesis. The core protein is found mostly in the cytoplasm during HCV infection, but also in the nucleus in patients with hepatocarcinoma and in core-transgenic mice. HCV core contains nuclear localization signals (NLS), but no nuclear export signal (NES) has yet been identified. We show here that the aa(109-133) region directs the translocation of core from the nucleus to the cytoplasm by the CRM-1-mediated nuclear export pathway. Mutagenesis of the three hydrophobic residues (L119, I123 and L126) in the identified NES or in the sequence encoding the mature core aa(1-173) significantly enhanced the nuclear localisation of the corresponding proteins in transfected Huh7 cells. Both the NES and the adjacent hydrophobic sequence in domain II of core were required to maintain the core protein or its fragments in the cytoplasmic compartment. Electron microscopy studies of the JFH1 replication model demonstrated that core was translocated into the nucleus a few minutes after the virus entered the cell. The blockade of nucleocytoplasmic export by leptomycin B treatment early in infection led to the detection of core protein in the nucleus by confocal microscopy and coincided with a decrease in virus replication. Our data suggest that the functional NLS and NES direct HCV core protein shuttling between the cytoplasmic and nuclear compartments, with at least some core protein transported to the nucleus. These new properties of HCV core may be essential for virus multiplication and interaction with nuclear molecules, influence cell signaling and the pathogenesis of HCV infection.	[Cerutti, Andrea; Maillard, Patrick; Roohvand, Farzin; Budkowska, Agata] Inst Pasteur, Dept Virol, Unite Hepacivirus & Immunite Innee, Paris, France; [Cerutti, Andrea; Minisini, Rosalba; Pirisi, Mario] Univ Piemonte Orientale Amedeo Avogadro, Dipartimento Med Clin & Sperimentale, Novara, Italy; [Cerutti, Andrea; Maillard, Patrick; Vidalain, Pierre-Olivier; Roohvand, Farzin; Budkowska, Agata] CNRS, URA3015, Paris, France; [Vidalain, Pierre-Olivier] Inst Pasteur, Dept Virol, Unite Genom Virale & Vaccinat, Paris, France; [Roohvand, Farzin] Pasteur Inst Iran, Hepatitis & AIDS Dept, Tehran, Iran; [Pecheur, Eve-Isabelle] Univ Lyon 1, F-69365 Lyon, France; [Pecheur, Eve-Isabelle] CNRS, UMR5086, Lyon, France; [Pecheur, Eve-Isabelle] Bases Mol & Struct Syst Infect, IBCP, Lyon, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Eastern Piedmont Amedeo Avogadro; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS)	Cerutti, A (corresponding author), Inst Pasteur, Dept Virol, Unite Hepacivirus & Immunite Innee, Paris, France.	agata.budkowska@pasteur.fr	Minisini, Rosalba/ABF-9724-2021; Pirisi, Mario/ABF-2102-2020; Vidalain, Pierre-Olivier/F-9778-2019; Roohvand, Farzin/K-8931-2018	Vidalain, Pierre-Olivier/0000-0003-3082-7407; Roohvand, Farzin/0000-0002-9597-3555; Pirisi, Mario/0000-0001-9740-0155; Cerutti, Andrea/0000-0003-3026-4704; Pecheur, Eve/0000-0002-8613-862X	Agence Nationale de Recherche sur le Sida (ANRS); Italian Ministry for Education, University and Research; Ricerca Sanitaria Finalizzata Program, Regione Piemonte, Italy	Agence Nationale de Recherche sur le Sida (ANRS)(ANRSFrench National Research Agency (ANR)); Italian Ministry for Education, University and Research(Ministry of Education, Universities and Research (MIUR)); Ricerca Sanitaria Finalizzata Program, Regione Piemonte, Italy(Regione Piemonte)	The work was funded by a grant from Agence Nationale de Recherche sur le Sida (ANRS); AC was granted a fellowship from the Italian Ministry for Education, University and Research and was partially supported by a grant from Ricerca Sanitaria Finalizzata Program, Regione Piemonte, Italy; FR was supported by a fellowship grant from ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LS, 2009, J VIROL, V83, P9923, DOI 10.1128/JVI.00066-09; Anzola Monica, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006926; Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Balsano Clara, 2007, Dig Liver Dis, V39 Suppl 1, pS46, DOI 10.1016/S1590-8658(07)80010-7; Barba G, 1997, P NATL ACAD SCI USA, V94, P1200, DOI 10.1073/pnas.94.4.1200; Bartenschlager R, 2008, FUTURE MICROBIOL, V3, P155, DOI 10.2217/17460913.3.2.155; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999; Duvignaud JB, 2009, BIOCHEM BIOPH RES CO, V378, P27, DOI 10.1016/j.bbrc.2008.10.141; Falcon V, 2005, BIOCHEM BIOPH RES CO, V329, P1320, DOI 10.1016/j.bbrc.2005.02.107; Falcon V, 2003, BIOCHEM BIOPH RES CO, V310, P54, DOI 10.1016/j.bbrc.2003.08.118; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Fukuda M, 1997, NATURE, V390, P308, DOI 10.1038/36894; GONZALEZPERALTA RP, 1994, J HEPATOL, V21, P255, DOI 10.1016/S0168-8278(05)80405-2; Gorlich D, 1996, SCIENCE, V271, P1513, DOI 10.1126/science.271.5255.1513; Gowans EJ, 2000, SEMIN LIVER DIS, V20, P85, DOI 10.1055/s-2000-9503; Hakata Y, 1998, J VIROL, V72, P6602, DOI 10.1128/JVI.72.8.6602-6607.1998; Henderson BR, 2000, EXP CELL RES, V256, P213, DOI 10.1006/excr.2000.4825; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; Horie C, 1996, BIOCHEM BIOPH RES CO, V218, P674, DOI 10.1006/bbrc.1996.0121; Huang H, 2007, P NATL ACAD SCI USA, V104, P5848, DOI 10.1073/pnas.0700760104; Hutten S, 2007, TRENDS CELL BIOL, V17, P193, DOI 10.1016/j.tcb.2007.02.003; Jin DY, 2000, EMBO J, V19, P729, DOI 10.1093/emboj/19.4.729; Jirasko V, 2008, J BIOL CHEM, V283, P28546, DOI 10.1074/jbc.M803981200; Kanwal C, 2002, AAPS PHARMSCI, V4; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Kasprzak A, 2005, LIVER INT, V25, P896, DOI 10.1111/j.1478-3231.2005.01109.x; Kasprzak A, 2008, HEPATOL RES, V38, P1, DOI 10.1111/j.1872-034X.2007.00261.x; Kopp M, 2010, J VIROL, V84, P1666, DOI 10.1128/JVI.02043-09; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; Lee SK, 2007, BIOCHEM BIOPH RES CO, V352, P756, DOI 10.1016/j.bbrc.2006.11.098; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Liu QY, 1997, J VIROL, V71, P657, DOI 10.1128/JVI.71.1.657-662.1997; LO SY, 1995, VIROLOGY, V213, P455, DOI 10.1006/viro.1995.0018; MAKINO Y, 1989, J GEN VIROL, V70, P1417, DOI 10.1099/0022-1317-70-6-1417; MATSUURA Y, 1994, INTERVIROLOGY, V37, P114, DOI 10.1159/000150365; Matto M, 2004, J VIROL, V78, P12047, DOI 10.1128/JVI.78.21.12047-12053.2004; McLauchlan J, 2000, J VIRAL HEPATITIS, V7, P2; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; McLauchlan J, 2009, BIOCHEM SOC T, V37, P986, DOI 10.1042/BST0370986; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mori Y, 2005, J VIROL, V79, P3448, DOI 10.1128/JVI.79.6.3448-3458.2005; Moriishi K, 2003, J VIROL, V77, P10237, DOI 10.1128/JVI.77.19.10237-10249.2003; Moriishi K, 2007, P NATL ACAD SCI USA, V104, P1661, DOI 10.1073/pnas.0607312104; Moriishi K, 2010, HEPATOLOGY, V52, P411, DOI 10.1002/hep.23680; Moriya K, 1998, NAT MED, V4, P1065, DOI 10.1038/2053; Murray CL, 2007, J VIROL, V81, P10220, DOI 10.1128/JVI.00793-07; Nigg EA, 1997, NATURE, V386, P779, DOI 10.1038/386779a0; Oka K, 2003, MICROBIOL IMMUNOL, V47, P429, DOI 10.1111/j.1348-0421.2003.tb03380.x; Okamoto K, 2004, J VIROL, V78, P6370, DOI 10.1128/JVI.78.12.6370-6380.2004; Otero GC, 1998, J VIROL, V72, P7593, DOI 10.1128/JVI.72.9.7593-7597.1998; Owsianka AM, 1999, VIROLOGY, V257, P330, DOI 10.1006/viro.1999.9659; Polyak S. J., 2006, HEPATITIS C VIRUSES; Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200; Roingeard P, 2008, J VIRAL HEPATITIS, V15, P157, DOI 10.1111/j.1365-2893.2007.00953.x; Rouille Y, 2006, J VIROL, V80, P2832, DOI 10.1128/JVI.80.6.2832-2841.2006; Rowland RRR, 2003, VIRUS RES, V95, P23, DOI 10.1016/S0168-1702(03)00161-8; Ruggieri A, 2004, ARCH VIROL, V149, P61, DOI 10.1007/s00705-003-0202-x; Ruster B, 1996, BIOCHEM BIOPH RES CO, V219, P911, DOI 10.1006/bbrc.1996.0340; Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0; Sansonno D, 2004, J VIRAL HEPATITIS, V11, P27, DOI 10.1046/j.1365-2893.2003.00474.x; SANTOLINI E, 1994, J VIROL, V68, P3631, DOI 10.1128/JVI.68.6.3631-3641.1994; Schwer B, 2004, J VIROL, V78, P7958, DOI 10.1128/JVI.78.15.7958-7968.2004; Shavinskaya A, 2007, J BIOL CHEM, V282, P37158, DOI 10.1074/jbc.M707329200; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Stade K, 1997, CELL, V90, P1041, DOI 10.1016/S0092-8674(00)80370-0; Suzuki R, 2005, J VIROL, V79, P1271, DOI 10.1128/JVI.79.2.1271-1281.2005; SUZUKI R, 1995, J GEN VIROL, V76, P53, DOI 10.1099/0022-1317-76-1-53; TADANO M, 1989, J GEN VIROL, V70, P1409, DOI 10.1099/0022-1317-70-6-1409; Tanaka N, 2008, INT J CANCER, V122, P124, DOI 10.1002/ijc.23056; Tellinghuisen TL, 2002, CURR OPIN MICROBIOL, V5, P419, DOI 10.1016/S1369-5274(02)00341-7; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Walker FM, 1998, J HISTOCHEM CYTOCHEM, V46, P653, DOI 10.1177/002215549804600510; Wang SH, 2002, J GEN VIROL, V83, P3093, DOI 10.1099/0022-1317-83-12-3093; Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629; Williams P, 2008, J VIROL, V82, P10946, DOI 10.1128/JVI.01403-08; Yamaguchi R, 2004, INT J MOL MED, V14, P1097; Yamanaka T, 2002, BIOCHEM BIOPH RES CO, V294, P528, DOI 10.1016/S0006-291X(02)00508-9; Yamanaka T, 2002, BIOCHEM BIOPH RES CO, V294, P521, DOI 10.1016/S0006-291X(02)00507-7; YAP SH, 1994, J HEPATOL, V20, P275, DOI 10.1016/S0168-8278(05)80069-8; Yashiroda Y, 2003, CURR MED CHEM, V10, P741, DOI 10.2174/0929867033457791; Yasui K, 1998, J VIROL, V72, P6048, DOI 10.1128/JVI.72.7.6048-6055.1998; Yeh CT, 1997, J GEN VIROL, V78, P2761, DOI 10.1099/0022-1317-78-11-2761; You LR, 1999, J VIROL, V73, P2841, DOI 10.1128/JVI.73.4.2841-2853.1999	91	25	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e25854	10.1371/journal.pone.0025854	http://dx.doi.org/10.1371/journal.pone.0025854			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039426	Green Submitted, Green Published, gold			2022-12-27	WOS:000296515200003
J	Goudevenou, K; Martin, P; Yeh, YJ; Jones, P; Sablitzky, F				Goudevenou, Katerina; Martin, Paul; Yeh, Yu-Jung; Jones, Peter; Sablitzky, Fred			Def6 Is Required for Convergent Extension Movements during Zebrafish Gastrulation Downstream of Wnt5b Signaling	PLOS ONE			English	Article							NUCLEOTIDE EXCHANGE FACTOR; VERTEBRATE GASTRULATION; RHO-GTPASES; CELL MOVEMENTS; EMBRYONIC-DEVELOPMENT; TAIL FORMATION; DANIO-RERIO; NO TAIL; POLARITY; MECHANISMS	During gastrulation, convergent extension (CE) cell movements are regulated through the non-canonical Wnt signaling pathway. Wnt signaling results in downstream activation of Rho GTPases that in turn regulate actin cytoskeleton rearrangements essential for co-ordinated CE cell movement. Rho GTPases are bi-molecular switches that are inactive in their GDP-bound stage but can be activated to bind GTP through guanine nucleotide exchange factors (GEFs). Here we show that def6, a novel GEF, regulates CE cell movement during zebrafish gastrulation. Def6 morphants exhibit broadened and shortened body axis with normal cell fate specification, reminiscent of the zebrafish mutants silberblick and pipetail that lack Wnt11 or Wnt5b, respectively. Indeed, def6 morphants phenocopy Wnt5b mutants and ectopic overexpression of def6 essentially rescues Wnt5b morphants, indicating a novel role for def6 as a central GEF downstream of Wnt5b signaling. In addition, by knocking down both def6 and Wnt11, we show that def6 synergises with the Wnt11 signaling pathway.	[Goudevenou, Katerina; Martin, Paul; Yeh, Yu-Jung; Sablitzky, Fred] Univ Nottingham, Queens Med Ctr, Ctr Genet & Genom, Sch Biol, Nottingham NG7 2RD, England; [Jones, Peter] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2RD, England	University of Nottingham; University of Nottingham	Goudevenou, K (corresponding author), Univ London Imperial Coll Sci Technol & Med, Ctr Haematol, London, England.	fred.sablitzky@nottingham.ac.uk	Sablitzky, Fred/A-2276-2011	Sablitzky, Fred/0000-0001-9718-1546	University of Nottingham	University of Nottingham	This work was supported by The University of Nottingham. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carreira-Barbosa F, 2003, DEVELOPMENT, V130, P4037, DOI 10.1242/dev.00567; Daggett DF, 2004, CURR BIOL, V14, P1632, DOI 10.1016/j.cub.2004.08.024; Dale RM, 2009, ZEBRAFISH, V6, P9, DOI 10.1089/zeb.2008.0563; Djiane A, 2000, DEVELOPMENT, V127, P3091; Gupta S, 2003, J BIOL CHEM, V278, P43541, DOI 10.1074/jbc.M308960200; Gupta S, 2003, HUM IMMUNOL, V64, P389, DOI 10.1016/S0198-8859(03)00024-7; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Habas R, 2001, CELL, V107, P843, DOI 10.1016/S0092-8674(01)00614-6; Hammerschmidt M, 1996, DEVELOPMENT, V123, P143; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Heisenberg CP, 1996, DEVELOPMENT, V123, P191; Hotfilder M, 1999, BRIT J HAEMATOL, V106, P335, DOI 10.1046/j.1365-2141.1999.01551.x; Jopling C, 2007, MECH DEVELOP, V124, P129, DOI 10.1016/j.mod.2006.10.003; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Lele Z, 2001, GENESIS, V30, P190, DOI 10.1002/gene.1063; Lin F, 2005, J CELL BIOL, V169, P777, DOI 10.1083/jcb.200501104; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Mavrakis KJ, 2004, EXP CELL RES, V294, P335, DOI 10.1016/j.yexcr.2003.12.004; Miyakoshi A, 2004, DIFFERENTIATION, V72, P48, DOI 10.1111/j.1432-0436.2004.07201004.x; Mlodzik M, 2002, TRENDS GENET, V18, P564, DOI 10.1016/S0168-9525(02)02770-1; Myers DC, 2002, DEV BIOL, V243, P81, DOI 10.1006/dbio.2001.0523; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Oka T, 2007, J BIOL CHEM, V282, P2011, DOI 10.1074/jbc.M605153200; Piotrowski T, 1996, DEVELOPMENT, V123, P345; Raftopoulou M, 2004, DEV BIOL, V265, P23, DOI 10.1016/j.ydbio.2003.06.003; Rauch GJ, 1997, COLD SPRING HARB SYM, V62, P227, DOI 10.1101/SQB.1997.062.01.028; Rebagliati MR, 1998, P NATL ACAD SCI USA, V95, P9932, DOI 10.1073/pnas.95.17.9932; Samson T, 2007, J BIOL CHEM, V282, P15730, DOI 10.1074/jbc.M611197200; Schier AF, 1997, DEVELOPMENT, V124, P327; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; SCHULTEMERKER S, 1994, DEVELOPMENT, V120, P1009; Sepich DS, 2005, DEV DYNAM, V234, P279, DOI 10.1002/dvdy.20507; Solnica-Krezel L, 2003, DEVELOPMENT, V130, P4229, DOI 10.1242/dev.00693; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Sumanas S, 2001, GENESIS, V30, P114, DOI 10.1002/gene.1043; Tada M, 2009, ZEBRAFISH, V6, P29, DOI 10.1089/zeb.2008.0566; Tanegashima K, 2008, EMBO J, V27, P606, DOI 10.1038/emboj.2008.9; THISSE C, 1994, DEV BIOL, V164, P420, DOI 10.1006/dbio.1994.1212; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; WARGA RM, 1990, DEVELOPMENT, V108, P569; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE	46	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26548	10.1371/journal.pone.0026548	http://dx.doi.org/10.1371/journal.pone.0026548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039507	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200029
J	Dhasarathy, A; Phadke, D; Mav, D; Shah, RR; Wade, PA				Dhasarathy, Archana; Phadke, Dhiral; Mav, Deepak; Shah, Ruchir R.; Wade, Paul A.			The Transcription Factors Snail and Slug Activate the Transforming Growth Factor-Beta Signaling Pathway in Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; TGF-BETA-PAR6 POLARITY PATHWAY; REPRESSES E-CADHERIN; GENE-EXPRESSION; TGF-BETA; CLAUDIN-LOW; PROTEIN; SUPERFAMILY; FIBROBLASTS; OVARIAN	The transcriptional repressors Snail and Slug are situated at the core of several signaling pathways proposed to mediate epithelial to mesenchymal transition or EMT, which has been implicated in tumor metastasis. EMT involves an alteration from an organized, epithelial cell structure to a mesenchymal, invasive and migratory phenotype. In order to obtain a global view of the impact of Snail and Slug expression, we performed a microarray experiment using the MCF-7 breast cancer cell line, which does not express detectable levels of Snail or Slug. MCF-7 cells were infected with Snail, Slug or control adenovirus, and RNA samples isolated at various time points were analyzed across all transcripts. Our analyses indicated that Snail and Slug regulate many genes in common, but also have distinct sets of gene targets. Gene set enrichment analyses indicated that Snail and Slug directed the transcriptome of MCF-7 cells from a luminal towards a more complex pattern that includes many features of the claudin-low breast cancer signature. Of particular interest, genes involved in the TGF-beta signaling pathway are upregulated, while genes responsible for a differentiated morphology are downregulated following Snail or Slug expression. Further we noticed increased histone acetylation at the promoter region of the transforming growth factor beta-receptor II (TGFBR2) gene following Snail or Slug expression. Inhibition of the TGF-beta signaling pathway using selective small-molecule inhibitors following Snail or Slug addition resulted in decreased cell migration with no impact on the repression of cell junction molecules by Snail and Slug. We propose that there are two regulatory modules embedded within EMT: one that involves repression of cell junction molecules, and the other involving cell migration via TGF-beta and/or other pathways.	[Dhasarathy, Archana; Wade, Paul A.] NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA; [Phadke, Dhiral; Mav, Deepak; Shah, Ruchir R.] SRA Int Inc, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); SRA International	Dhasarathy, A (corresponding author), NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA.	wadep2@niehs.nih.gov	Wade, Paul A/D-2374-2019	Wade, Paul A/0000-0002-6042-357X	NIEHS, NIH [Z01ES101965]; National Institute of Environmental Health Sciences, National Institute of Health, Department of Health and Human Services [HHSN291200555547C]; GSA Contract [GS-00F-003L]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, Z01ES101965, ZIAES101965] Funding Source: NIH RePORTER	NIEHS, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute of Environmental Health Sciences, National Institute of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); GSA Contract; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Financial support was provided by the Intramural Research Program, NIEHS, NIH (Project number Z01ES101965 to P. A. W.). D. P., D. M. and R. R. S. were supported in whole or in part with federal funds from the National Institute of Environmental Health Sciences, National Institute of Health, Department of Health and Human Services, Delivery Order HHSN291200555547C, GSA Contract GS-00F-003L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blick T, 2010, J MAMMARY GLAND BIOL, V15, P235, DOI 10.1007/s10911-010-9175-z; Bradshaw AD, 2003, P NATL ACAD SCI USA, V100, P6045, DOI 10.1073/pnas.1030790100; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P2708, DOI 10.1167/iovs.06-0639; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Dhasarathy A, 2007, MOL ENDOCRINOL, V21, P2907, DOI 10.1210/me.2007-0293; Elloul S, 2005, CANCER-AM CANCER SOC, V103, P1631, DOI 10.1002/cncr.20946; Elloul S, 2006, VIRCHOWS ARCH, V449, P520, DOI 10.1007/s00428-006-0274-6; Fan C, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-3; Frazier K, 1996, J INVEST DERMATOL, V107, P404, DOI 10.1111/1523-1747.ep12363389; de Herreros AG, 2010, J MAMMARY GLAND BIOL, V15, P135, DOI 10.1007/s10911-010-9179-8; Gorelik L, 2001, NAT MED, V7, P1118, DOI 10.1038/nm1001-1118; Grotendorst GR, 1996, CELL GROWTH DIFFER, V7, P469; Hajra KM, 2002, CANCER RES, V62, P1613; IGARASHI A, 1993, MOL BIOL CELL, V4, P637, DOI 10.1091/mbc.4.6.637; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jamora C, 2005, PLOS BIOL, V3, P131, DOI 10.1371/journal.pbio.0030011; Kajita M, 2004, MOL CELL BIOL, V24, P7559, DOI 10.1128/MCB.24.17.7559-7566.2004; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kuphal S, 2005, MELANOMA RES, V15, P305, DOI 10.1097/00008390-200508000-00012; Medici D, 2006, MOL BIOL CELL, V17, P1871, DOI 10.1091/mbc.E05-08-0767; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Moody SE, 2005, CANCER CELL, V8, P197, DOI 10.1016/j.ccr.2005.07.009; Moreno-Bueno G, 2006, CANCER RES, V66, P9543, DOI 10.1158/0008-5472.CAN-06-0479; Moses H, 2011, COLD SPRING HARB PER, V3; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; Olmeda D, 2007, ONCOGENE, V26, P1862, DOI 10.1038/sj.onc.1209997; Padua D, 2009, CELL RES, V19, P89, DOI 10.1038/cr.2008.316; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Peinado H, 2004, MOL CELL BIOL, V24, P306, DOI 10.1128/MCB.24.1.306-319.2004; Perou CM, 2010, LANCET ONCOL, V11, P718, DOI 10.1016/S1470-2045(10)70176-5; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Romano LA, 2000, DEV BIOL, V223, P91, DOI 10.1006/dbio.2000.9750; Shiou SR, 2006, J BIOL CHEM, V281, P33971, DOI 10.1074/jbc.M607010200; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Strumane K, 2004, HANDB EXP PHARM, V165, P69, DOI 10.1007/978-3-540-68170-0_4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Taylor MA, 2010, J MAMMARY GLAND BIOL, V15, P169, DOI 10.1007/s10911-010-9181-1; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Thuault S, 2008, J BIOL CHEM, V283, P33437, DOI 10.1074/jbc.M802016200; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Viloria-Petit AM, 2010, CELL CYCLE, V9, P623, DOI 10.4161/cc.9.4.10779; Viloria-Petit AM, 2009, P NATL ACAD SCI USA, V106, P14028, DOI 10.1073/pnas.0906796106; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; WRANA JL, 1991, EUR J BIOCHEM, V197, P519, DOI 10.1111/j.1432-1033.1991.tb15940.x; Zavadil J, 2004, EMBO J, V23, P1155, DOI 10.1038/sj.emboj.7600069	56	117	122	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26514	10.1371/journal.pone.0026514	http://dx.doi.org/10.1371/journal.pone.0026514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028892	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800049
J	Mishima, T; Miner, JH; Morizane, M; Stahl, A; Sadovsky, Y				Mishima, Takuya; Miner, Jeffrey H.; Morizane, Mayumi; Stahl, Andreas; Sadovsky, Yoel			The Expression and Function of Fatty Acid Transport Protein-2 and-4 in the Murine Placenta	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; LIPID DROPLETS; TROPHOBLAST CELLS; ANIMAL-MODELS; WRINKLE-FREE; MOUSE; GENE; METABOLISM; TRIGLYCERIDE; PERILIPIN	Background: The uptake and trans-placental trafficking of fatty acids from the maternal blood into the fetal circulation are essential for embryonic development, and involve several families of proteins. Fatty acid transport proteins (FATPs) uniquely transport fatty acids into cells. We surmised that placental FATPs are germane for fetal growth, and are regulated during hypoxic stress, which is associated with reduced fat supply to the fetus. Methodology/Principal Findings: Using cultured primary term human trophoblasts we found that FATP2, FATP4 and FATP6 were highly expressed in trophoblasts. Hypoxia enhanced the expression of trophoblastic FATP2 and reduced the expression of FATP4, with no change in FATP6. We also found that Fatp2 and Fatp4 are expressed in the mouse amnion and placenta, respectively. Mice deficient in Fatp2 or Fatp4 did not deviate from normal Mendelian distribution, with both embryos and placentas exhibiting normal weight and morphology, triglyceride content, and expression of genes related to fatty acid mobilization. Conclusions/Significance: We conclude that even though hypoxia regulates the expression of FATP2 and FATP4 in human trophoblasts, mouse Fatp2 and Fatp4 are not essential for intrauterine fetal growth.	[Mishima, Takuya; Morizane, Mayumi; Sadovsky, Yoel] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15260 USA; [Miner, Jeffrey H.] Washington Univ, Dept Internal Med, St Louis, MO USA; [Miner, Jeffrey H.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO USA; [Stahl, Andreas] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Sadovsky, Yoel] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Washington University (WUSTL); Washington University (WUSTL); University of California System; University of California Berkeley; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Mishima, T (corresponding author), Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Magee Womens Res Inst, Pittsburgh, PA 15260 USA.	ysadovsky@mwri.magee.edu	Mishima, Takuya/G-1671-2011	Sadovsky, Yoel/0000-0003-2969-6737	Kobe University; National Institutes of Health [R01AR049269, R01ES011597]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011597] Funding Source: NIH RePORTER	Kobe University; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The project was supported by the Kobe University Overseas Visiting Program for Young Researchers (to MM), National Institutes of Health R01AR049269 (to JHM), and National Institutes of Health R01ES011597 (to YS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsat E, 1996, J CELL PHYSIOL, V168, P346, DOI 10.1002/(SICI)1097-4652(199608)168:2<346::AID-JCP13>3.0.CO;2-1; Araya J, 1995, Rev Med Chil, V122, P503; Belkacemi L, 2010, BIOL REPROD, V83, P325, DOI 10.1095/biolreprod.110.084517; Bionaz M, 2008, J NUTR, V138, P1019, DOI 10.1093/jn/138.6.1019; Biron-Shental T, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.066; BONET B, 1992, METABOLISM, V41, P596, DOI 10.1016/0026-0495(92)90051-B; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Brown DA, 2001, CURR BIOL, V11, pR446, DOI 10.1016/S0960-9822(01)00257-3; Burton GJ, 1999, AM J OBSTET GYNECOL, V181, P718, DOI 10.1016/S0002-9378(99)70518-1; Carter AM, 2007, PLACENTA, V28, pS41, DOI 10.1016/j.placenta.2006.11.002; Cetin I, 2002, PEDIATR RES, V52, P750, DOI 10.1203/00006450-200211000-00023; Cetin I, 2009, PLACENTA, V30, pS77, DOI 10.1016/j.placenta.2008.12.006; Cox B, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.37; Daoud G, 2005, BBA-MOL CELL BIOL L, V1687, P181, DOI 10.1016/j.bbalip.2004.11.017; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Ducharme NA, 2008, ENDOCRINOLOGY, V149, P942, DOI 10.1210/en.2007-1713; Dutta-Roy AK, 2000, CELL MOL LIFE SCI, V57, P1360, DOI 10.1007/PL00000621; Dutta-Roy AK, 2000, AM J CLIN NUTR, V71, p315S, DOI 10.1093/ajcn/71.1.315s; Duttaroy AK, 2009, PROG LIPID RES, V48, P52, DOI 10.1016/j.plipres.2008.11.001; Farese RV, 2009, CELL, V139, P855, DOI 10.1016/j.cell.2009.11.005; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; FOLCH J, 1957, J BIOL CHEM, V226, P497; FOX H, 1970, AM J OBSTET GYNECOL, V107, P1058, DOI 10.1016/0002-9378(70)90629-0; Georgiades P, 2002, PLACENTA, V23, P3, DOI 10.1053/plac.2001.0738; Gheorghe CP, 2007, REPROD SCI, V14, P223, DOI 10.1177/1933719107302860; Gimeno RE, 2003, J BIOL CHEM, V278, P49512, DOI 10.1074/jbc.M309759200; Gimeno RE, 2003, J BIOL CHEM, V278, P16039, DOI 10.1074/jbc.M211412200; Haggarty P, 2002, PLACENTA, V23, pS28, DOI 10.1053/plac.2002.0791; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; HANLEY T, 1991, BIOTECHNIQUES, V10, P56; Heinzer AK, 2003, ADV EXP MED BIOL, V544, P75; Heinzer AK, 2003, HUM MOL GENET, V12, P1145, DOI 10.1093/hmg/ddg126; Herrera E, 2000, DIABETES-METAB RES, V16, P202, DOI 10.1002/1520-7560(200005/06)16:3<202::AID-DMRR116>3.3.CO;2-R; Herrmann T, 2005, J INVEST DERMATOL, V125, P1228, DOI 10.1111/j.0022-202X.2005.23972.x; Herrmann T, 2003, J CELL BIOL, V161, P1105, DOI 10.1083/jcb.200207080; Herrmann T, 2001, GENE, V270, P31, DOI 10.1016/S0378-1119(01)00489-9; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; HORNSTRA G, 1995, EUR J OBSTET GYN R B, V61, P57, DOI 10.1016/0028-2243(95)02153-J; Johnson ACM, 2005, KIDNEY INT, V67, P2196, DOI 10.1111/j.1523-1755.2005.00325.x; Kim J, 2009, J IMMUNOL, V182, P2583, DOI 10.4049/jimmunol.0803247; Kimmel AR, 2010, J LIPID RES, V51, P468, DOI 10.1194/jlr.R000034; Klar J, 2009, AM J HUM GENET, V85, P248, DOI 10.1016/j.ajhg.2009.06.021; Knipp GT, 2000, PLACENTA, V21, P367, DOI 10.1053/plac.1999.0484; Knipp GT, 1999, ADV DRUG DELIVER REV, V38, P41, DOI 10.1016/S0169-409X(99)00005-8; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Larque E, 2002, ANN NY ACAD SCI, V967, P299; Lauritzen L, 2001, PROG LIPID RES, V40, P1, DOI 10.1016/S0163-7827(00)00017-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnusson AL, 2004, J CLIN ENDOCR METAB, V89, P4607, DOI 10.1210/jc.2003-032234; Magnusson-Olsson AL, 2007, AM J PHYSIOL-ENDOC M, V293, pE24, DOI 10.1152/ajpendo.00571.2006; Maity A, 2000, EXP CELL RES, V255, P250, DOI 10.1006/excr.1999.4804; Mando C, 2011, PLACENTA, V32, P44, DOI 10.1016/j.placenta.2010.10.009; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Meller M, 2005, PLACENTA, V26, P601, DOI 10.1016/j.placenta.2004.09.009; Miura S, 2002, J BIOL CHEM, V277, P32253, DOI 10.1074/jbc.M204410200; Mohanty S, 2010, J REPROD IMMUNOL, V84, P133, DOI 10.1016/j.jri.2009.10.008; Morice-Picard F, 2010, AM J MED GENET A, V152A, P2664, DOI 10.1002/ajmg.a.33648; Mouillet JF, 2010, FASEB J, V24, P2030, DOI 10.1096/fj.09-149724; Moulson CL, 2007, J BIOL CHEM, V282, P15912, DOI 10.1074/jbc.M701779200; Moulson CL, 2003, P NATL ACAD SCI USA, V100, P5274, DOI 10.1073/pnas.0431186100; NEURINGER M, 1986, P NATL ACAD SCI USA, V83, P4021, DOI 10.1073/pnas.83.11.4021; Peltier MR, 2011, AM J REPROD IMMUNOL; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Roh CR, 2005, PLACENTA, V26, P319, DOI 10.1016/j.placenta.2004.06.013; Schaffer JE, 2002, AM J PHYSIOL-ENDOC M, V282, pE239, DOI 10.1152/ajpendo.00462.2001; Schaiff WT, 2005, J CLIN ENDOCR METAB, V90, P4267, DOI 10.1210/jc.2004-2265; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Stahl A, 2001, TRENDS ENDOCRIN MET, V12, P266, DOI 10.1016/S1043-2760(01)00427-1; Takizawa T, 2005, J IMMUNOL, V175, P2331, DOI 10.4049/jimmunol.175.4.2331; UAUY R, 1989, SEMIN PERINATOL, V13, P118; Vuguin PM, 2007, HORM RES, V68, P113, DOI 10.1159/000100545	72	47	48	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25865	10.1371/journal.pone.0025865	http://dx.doi.org/10.1371/journal.pone.0025865			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028793	Green Accepted, Green Published, gold			2022-12-27	WOS:000296510800009
J	Lacroix, B; Citovsky, V				Lacroix, Benoit; Citovsky, Vitaly			Extracellular VirB5 Enhances T-DNA Transfer from Agrobacterium to the Host Plant	PLOS ONE			English	Article							IV SECRETION SYSTEMS; INCN PLASMID PKM101; GENETIC-TRANSFORMATION; MEDIATED TRANSFORMATION; TUMEFACIENS; PROTEIN; EXPRESSION; ASSOCIATION; ACTIVATION; MEMBRANES	VirB5 is a type 4 secretion system protein of Agrobacterium located on the surface of the bacterial cell. This localization pattern suggests a function for VirB5 which is beyond its known role in biogenesis and/or stabilization of the T-pilus and which may involve early interactions between Agrobacterium and the host cell. Here, we identify VirB5 as the first Agrobacterium virulence protein that can enhance infectivity extracellularly. Specifically, we show that elevating the amounts of the extracellular VirB5-by exogenous addition of the purified protein, its overexpression in the bacterium, or transgenic expression in and secretion out of the host cell-enhances the efficiency the Agrobacterium-mediated T-DNA transfer, as measured by transient expression of genes contained on the transferred T-DNA molecule. Importantly, the exogenous VirB5 enhanced transient T-DNA expression in sugar beet, a major crop recalcitrant to genetic manipulation. Increasing the pool of the extracellular VirB5 did not complement an Agrobacterium virB5 mutant, suggesting a dual function for VirB5: in the bacterium and at the bacterium-host cell interface. Consistent with this idea, VirB5 expressed in the host cell, but not secreted, had no effect on the transformation efficiency. That the increase in T-DNA expression promoted by the exogenous VirB5 was not due to its effects on bacterial growth, virulence gene induction, bacterial attachment to plant tissue, or host cell defense response suggests that VirB5 participates in the early steps of the T-DNA transfer to the plant cell.	[Lacroix, Benoit; Citovsky, Vitaly] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Lacroix, B (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	blacroix@notes.cc.sunysb.edu	Lacroix, Benoit/AAG-8607-2021	Lacroix, Benoit/0000-0002-3463-0452; Citovsky, Vitaly/0000-0003-2024-6844	National Science Foundation; United States Department of Agriculture National Institute of Food and Agriculture; National Institutes of Health; United States-Israel Binational Agricultural Research and Development Fund (BARD)	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States-Israel Binational Agricultural Research and Development Fund (BARD)(US-Israel Binational Science Foundation)	The work in our laboratory is supported by grants from the National Science Foundation, the United States Department of Agriculture National Institute of Food and Agriculture, the National Institutes of Health, and the United States-Israel Binational Agricultural Research and Development Fund (BARD) to VC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Aly KA, 2007, MICROBIOL-SGM, V153, P3766, DOI 10.1099/mic.0.2007/010462-0; Aly KA, 2008, J BACTERIOL, V190, P1595, DOI 10.1128/JB.01718-07; Backert S, 2008, TRENDS MICROBIOL, V16, P409, DOI 10.1016/j.tim.2008.07.001; BERGER BR, 1994, J BACTERIOL, V176, P3646, DOI 10.1128/JB.176.12.3646-3660.1994; Bundock P, 1996, P NATL ACAD SCI USA, V93, P15272, DOI 10.1073/pnas.93.26.15272; Christie PJ, 2004, BBA-MOL CELL RES, V1694, P219, DOI 10.1016/j.bbamcr.2004.02.013; Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630; Chung SM, 2005, TRENDS PLANT SCI, V10, P357, DOI 10.1016/j.tplants.2005.06.001; CITOVSKY V, 1989, P NATL ACAD SCI USA, V86, P1193, DOI 10.1073/pnas.86.4.1193; Citovsky V, 2007, CELL MICROBIOL, V9, P9, DOI 10.1111/j.1462-5822.2006.00830.x; De Caroli M, 2011, PLANT J, V65, P295, DOI 10.1111/j.1365-313X.2010.04421.x; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; Gelvin SB, 2010, ANNU REV PHYTOPATHOL, V48, P45, DOI 10.1146/annurev-phyto-080508-081852; Gomez-Gomez L, 2002, TRENDS PLANT SCI, V7, P251, DOI 10.1016/S1360-1385(02)02261-6; Goodin MM, 2002, PLANT J, V31, P375, DOI 10.1046/j.1365-313X.2002.01360.x; HORSCH RB, 1984, SCIENCE, V223, P496, DOI 10.1126/science.223.4635.496; JACQ B, 1993, PLANT CELL REP, V12, P621, DOI 10.1007/BF00232811; Krall L, 2002, P NATL ACAD SCI USA, V99, P11405, DOI 10.1073/pnas.172390699; Kunik T, 2001, P NATL ACAD SCI USA, V98, P1871, DOI 10.1073/pnas.041327598; Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187; Lacroix B, 2005, EMBO J, V24, P428, DOI 10.1038/sj.emboj.7600524; Lacroix B, 2006, TRENDS GENET, V22, P29, DOI 10.1016/j.tig.2005.10.004; Lacroix B, 2008, P NATL ACAD SCI USA, V105, P15429, DOI 10.1073/pnas.0805641105; Matthysse AG, 2005, MOL PLANT MICROBE IN, V18, P1002, DOI 10.1094/MPMI-18-1002; Miller J.H., 1972, EXPT MOL GENETICS; Nam J, 1999, MOL GEN GENET, V261, P429, DOI 10.1007/s004380050985; Narasimhulu SB, 1996, PLANT CELL, V8, P873, DOI 10.1105/tpc.8.5.873; Navarro L, 2004, PLANT PHYSIOL, V135, P1113, DOI 10.1104/pp.103.036749; Piers KL, 1996, P NATL ACAD SCI USA, V93, P1613, DOI 10.1073/pnas.93.4.1613; Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P5563, DOI 10.1128/JB.181.18.5563-5571.1999; Schmidt-Eisenlohr H, 1999, J BACTERIOL, V181, P7485, DOI 10.1128/JB.181.24.7485-7492.1999; STACHEL SE, 1986, EMBO J, V5, P1445, DOI 10.1002/j.1460-2075.1986.tb04381.x; STACHEL SE, 1985, EMBO J, V4, P891, DOI 10.1002/j.1460-2075.1985.tb03715.x; Tian GW, 2004, PLANT PHYSIOL, V135, P25, DOI 10.1104/pp.104.040139; Tzfira T, 2005, PLANT MOL BIOL, V57, P503, DOI 10.1007/s11103-005-0340-5; Vlot AC, 2009, ANNU REV PHYTOPATHOL, V47, P177, DOI 10.1146/annurev.phyto.050908.135202; WINANS SC, 1985, J BACTERIOL, V161, P402, DOI 10.1128/JB.161.1.402-410.1985; Wozniak CA, 1999, APPLIED PLANT BIOTECHNOLOGY, P301; Xiang CB, 1999, PLANT MOL BIOL, V40, P711, DOI 10.1023/A:1006201910593; Yeo HJ, 2003, P NATL ACAD SCI USA, V100, P15947, DOI 10.1073/pnas.2535211100; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhou AF, 2005, J BIOL CHEM, V280, P35554, DOI 10.1074/jbc.M503299200	44	16	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25578	10.1371/journal.pone.0025578	http://dx.doi.org/10.1371/journal.pone.0025578			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028781	Green Submitted, Green Published, gold			2022-12-27	WOS:000296186900010
J	Rimbaud, S; Ruiz, M; Piquereau, J; Mateo, P; Fortin, D; Veksler, V; Garnier, A; Ventura-Clapier, R				Rimbaud, Stephanie; Ruiz, Matthieu; Piquereau, Jerome; Mateo, Philippe; Fortin, Dominique; Veksler, Vladimir; Garnier, Anne; Ventura-Clapier, Renee			Resveratrol Improves Survival, Hemodynamics and Energetics in a Rat Model of Hypertension Leading to Heart Failure	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; INDUCED CARDIAC-HYPERTROPHY; KINASE-DEFICIENT MICE; MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM; TRANS-RESVERATROL; PROTEIN-KINASE; EXPRESSION; PREVENTS; FIBROSIS	Heart failure (HF) is characterized by contractile dysfunction associated with altered energy metabolism. This study was aimed at determining whether resveratrol, a polyphenol known to activate energy metabolism, could be beneficial as a metabolic therapy of HF. Survival, ventricular and vascular function as well as cardiac and skeletal muscle energy metabolism were assessed in a hypertensive model of HF, the Dahl salt-sensitive rat fed with a high-salt diet (HS-NT). Resveratrol (18 mg/kg/day; HS-RSV) was given for 8 weeks after hypertension and cardiac hypertrophy were established (which occurred 3 weeks after salt addition). Resveratrol treatment improved survival (64% in HS-RSV versus 15% in HS-NT, p < 0.001), and prevented the 25% reduction in body weight in HS-NT (P < 0.001). Moreover, RSV counteracted the development of cardiac dysfunction (fractional shortening -34% in HS-NT) as evaluated by echocardiography, which occurred without regression of hypertension or hypertrophy. Moreover, aortic endothelial dysfunction present in HS-NT was prevented in resveratrol-treated rats. Resveratrol treatment tended to preserve mitochondrial mass and biogenesis and completely protected mitochondrial fatty acid oxidation and PPAR alpha (peroxisome proliferator-activated receptor alpha) expression. We conclude that resveratrol treatment exerts beneficial protective effects on survival, endothelium-dependent smooth muscle relaxation and cardiac contractile and mitochondrial function, suggesting that resveratrol or metabolic activators could be a relevant therapy in hypertension-induced HF.	[Rimbaud, Stephanie; Ruiz, Matthieu; Piquereau, Jerome; Mateo, Philippe; Fortin, Dominique; Veksler, Vladimir; Garnier, Anne; Ventura-Clapier, Renee] Univ Paris 11, INSERM, UMR S 769, Chatenay Malabry, France; [Rimbaud, Stephanie; Ruiz, Matthieu; Piquereau, Jerome; Mateo, Philippe; Fortin, Dominique; Veksler, Vladimir; Garnier, Anne; Ventura-Clapier, Renee] Univ Paris 11, IFR 141, Chatenay Malabry, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Saclay	Rimbaud, S (corresponding author), Univ Paris 11, INSERM, UMR S 769, Chatenay Malabry, France.	renee.ventura@u-psud.fr		Ventura-Clapier, Renee/0000-0002-7488-4123; Piquereau, Jerome/0000-0002-6019-8683; Garnier, Anne/0000-0002-6241-4554; Veksler, Vladimir/0000-0002-8869-9594	Fondation de France [FDF_R08111LL]; European Union [LSHM-CT-2005-018833/EUGeneHeart]; Bonus Qualite Recherche Universite Paris-Sud	Fondation de France(Fondation de France); European Union(European Commission); Bonus Qualite Recherche Universite Paris-Sud	This work was supported by grants from Fondation de France (FDF_R08111LL), the European Union contract (LSHM-CT-2005-018833/EUGeneHeart) and Bonus Qualite Recherche Universite Paris-Sud. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Renee Ventura-Clapier is senior scientist at Centre National de la Recherche Scientifique.	Agouni A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005557; Bahi L, 2005, J CELL PHYSIOL, V203, P589, DOI 10.1002/jcp.20273; Biala A, 2010, BLOOD PRESSURE, V19, P196, DOI 10.3109/08037051.2010.481808; Bledsoe G, 2006, HUM GENE THER, V17, P545, DOI 10.1089/hum.2006.17.545; Chan AYM, 2008, J BIOL CHEM, V283, P24194, DOI 10.1074/jbc.M802869200; Chan DC, 2006, ANNU REV CELL DEV BI, V22, P79, DOI 10.1146/annurev.cellbio.22.010305.104638; Csiszar A, 2009, HYPERTENSION, V54, P668, DOI 10.1161/HYPERTENSIONAHA.109.133397; De Sousa E, 1999, CIRC RES, V85, P68; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; Duncan JG, 2008, PPAR RES, V2008, DOI 10.1155/2008/253817; Edwards JA, 2011, ANN NY ACAD SCI, V1215, P131, DOI 10.1111/j.1749-6632.2010.05855.x; Elliott PJ, 2008, CURR OPIN INVEST DR, V9, P371; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Garnier A, 2009, CIRC-HEART FAIL, V2, P342, DOI 10.1161/CIRCHEARTFAILURE.108.812099; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Inoue H, 2003, NEUROSCI LETT, V352, P203, DOI 10.1016/j.neulet.2003.09.001; Joubert F, 2008, J PHYSIOL-LONDON, V586, P5181, DOI 10.1113/jphysiol.2008.157677; Juric D, 2007, AM J PHYSIOL-HEART C, V292, pH2138, DOI 10.1152/ajpheart.00852.2006; Kaasik A, 2001, CIRC RES, V89, P153, DOI 10.1161/hh1401.093440; Kato T, 2010, CIRC-HEART FAIL, V3, P420, DOI 10.1161/CIRCHEARTFAILURE.109.888479; Klinge CM, 2008, FASEB J, V22, P2185, DOI 10.1096/fj.07-103366; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leblais V, 2008, CARDIOVASC RES, V77, P202, DOI 10.1093/cvr/cvm008; Liang B, 2007, BRIT J PHARMACOL, V152, P903, DOI 10.1038/sj.bjp.0707472; Lin JF, 2008, LIFE SCI, V83, P313, DOI 10.1016/j.lfs.2008.06.016; Liu ZP, 2005, CLIN EXP PHARMACOL P, V32, P1049, DOI 10.1111/j.1440-1681.2005.04303.x; Manger WM, 2009, J HYPERTENS, V27, P587, DOI 10.1097/HJH.0b013e32831ffec7; Mettauer B, 2006, PFLUG ARCH EUR J PHY, V452, P653, DOI 10.1007/s00424-006-0072-7; Miyazaki R, 2008, ARTERIOSCL THROM VAS, V28, P1263, DOI 10.1161/ATVBAHA.108.166991; Mueller SO, 2004, TOXICOL SCI, V80, P14, DOI 10.1093/toxsci/kfh147; Nagase M, 2006, HYPERTENSION, V47, P1084, DOI 10.1161/01.HYP.0000222003.28517.99; Neubauer S, 1997, CIRCULATION, V96, P2190; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Planavila A, 2011, CARDIOVASC RES, V90, P276, DOI 10.1093/cvr/cvq376; Prunier F, 2002, AM J PHYSIOL-HEART C, V283, pH346, DOI 10.1152/ajpheart.01050.2001; Rimbaud S, 2009, PHARMACOL REP, V61, P131, DOI 10.1016/S1734-1140(09)70015-5; Seymour EM, 2008, J GERONTOL A-BIOL, V63, P1034, DOI 10.1093/gerona/63.10.1034; Seymour EM, 2010, HYPERTENSION, V55, P1179, DOI 10.1161/HYPERTENSIONAHA.109.149393; Sihag S, 2009, J MOL CELL CARDIOL, V46, P201, DOI 10.1016/j.yjmcc.2008.10.025; Taegtmeyer H, 2004, CIRCULATION, V110, P894, DOI 10.1161/01.CIR.0000139340.88769.D5; Takeda Y, 2007, AM J HYPERTENS, V20, P1119, DOI 10.1016/j.amjhyper.2007.05.008; Thandapilly SJ, 2010, AM J HYPERTENS, V23, P192, DOI 10.1038/ajh.2009.228; Tian Q, 2006, CURR HYPERTENS REP, V8, P465, DOI 10.1007/s11906-006-0024-9; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Ungvari Z, 2007, AM J PHYSIOL-HEART C, V293, pH37, DOI 10.1152/ajpheart.01346.2006; VEKSLER VI, 1995, J BIOL CHEM, V270, P19921, DOI 10.1074/jbc.270.34.19921; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; Ventura-Clapier R, 2002, NEWS PHYSIOL SCI, V17, P191, DOI 10.1152/nips.01392.2002; Ventura-Clapier R, 2008, CARDIOVASC RES, V79, P208, DOI 10.1093/cvr/cvn098; Ventura-Clapier R, 2011, BBA-MOL CELL RES, V1813, P1360, DOI 10.1016/j.bbamcr.2010.09.006; von Haehling S, 2009, PHARMACOL THERAPEUT, V121, P227, DOI 10.1016/j.pharmthera.2008.09.009; Wojciechowski P, 2010, J NUTR, V140, P962, DOI 10.3945/jn.109.115006; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61	54	98	101	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26391	10.1371/journal.pone.0026391	http://dx.doi.org/10.1371/journal.pone.0026391			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028869	Green Submitted, gold, Green Published			2022-12-27	WOS:000296186900057
J	Tan, KY; Eminli, S; Hettmer, S; Hochedlinger, K; Wagers, AJ				Tan, Kah Yong; Eminli, Sarah; Hettmer, Simone; Hochedlinger, Konrad; Wagers, Amy J.			Efficient Generation of iPS Cells from Skeletal Muscle Stem Cells	PLOS ONE			English	Article							BETA-CELLS; DIFFERENTIATION; PROGENITORS; SYSTEM; MOUSE; FAT	Reprogramming of somatic cells into inducible pluripotent stem cells generally occurs at low efficiency, although what limits reprogramming of particular cell types is poorly understood. Recent data suggest that the differentiation status of the cell targeted for reprogramming may influence its susceptibility to reprogramming as well as the differentiation potential of the induced pluripotent stem (iPS) cells that are derived from it. To assess directly the influence of lineage commitment on iPS cell derivation and differentiation, we evaluated reprogramming in adult stem cell and mature cell populations residing in skeletal muscle. Our data using clonal assays and a second-generation inducible reprogramming system indicate that stem cells found in mouse muscle, including resident satellite cells and mesenchymal progenitors, reprogram with significantly greater efficiency than their more differentiated daughters (myoblasts and fibroblasts). However, in contrast to previous reports, we find no evidence of biased differentiation potential among iPS cells derived from myogenically committed cells. These data support the notion that adult stem cells reprogram more efficiently than terminally differentiated cells, and argue against the suggestion that "epigenetic memory" significantly influences the differentiation potential of iPS cells derived from distinct somatic cell lineages in skeletal muscle.	[Tan, Kah Yong; Hettmer, Simone; Wagers, Amy J.] Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA; [Tan, Kah Yong; Eminli, Sarah; Hettmer, Simone; Hochedlinger, Konrad; Wagers, Amy J.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Tan, Kah Yong; Eminli, Sarah; Hettmer, Simone; Hochedlinger, Konrad; Wagers, Amy J.] Harvard Stem Cell Inst, Cambridge, MA USA; [Tan, Kah Yong] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Eminli, Sarah; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Eminli, Sarah; Hochedlinger, Konrad] Ctr Regenerat Med, Boston, MA USA; [Eminli, Sarah] Free Univ Berlin, Dept Biol Chem & Pharm, D-1000 Berlin, Germany; [Hettmer, Simone] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Hettmer, Simone] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Hochedlinger, Konrad; Wagers, Amy J.] Howard Hughes Med Inst, Chevy Chase, MD USA	Harvard University; Joslin Diabetes Center, Inc.; Harvard University; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; Free University of Berlin; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Tan, KY (corresponding author), Joslin Diabet Ctr, Sect Islet Cell & Regenerat Biol, Boston, MA 02215 USA.	amy.wagers@joslin.harvard.edu		Hettmer, Simone/0000-0003-1709-4448; Tan, Kah Yong/0000-0002-6825-2752	Beckman Foundation; Joslin Diabetes Center; NIH [1DP2OD003266-01]; Harvard Stem Cell Institute [DP-0003-07-03, CF-0003-08-00]; Hope Street Kids; Alex's Lemonade Stand Foundation; Bear Necessities; NIDDK [P30DK036836]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK036836] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	Beckman Foundation; Joslin Diabetes Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Hope Street Kids; Alex's Lemonade Stand Foundation; Bear Necessities; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors gratefully acknowledge support for this project from the Beckman Foundation (http://www.beckman-foundation.com), and Joslin Diabetes Center (www.joslinresearch.org) (to AW, no Award Number), NIH Innovator Award (to KH, Award Number 1DP2OD003266-01), the Harvard Stem Cell Institute (www.hsci.harvard.edu, to AW and KH, Award number DP-0003-07-03), and by Hope Street Kids (www.hopestreetkids.org), P. A. L. S. Bermuda/St. Baldrick's (www.stbaldricks.org), Alex's Lemonade Stand Foundation (www.alexlemonade.org) and Bear Necessities (www.bearnecessities.org) (to SH). Flow cytometry facilities were supported in by grants from the Harvard Stem Cell Institute (Award Number CF-0003-08-00) and NIDDK (Award Number P30DK036836). KY is a fellow of the Agency of Science, Technology and Research, Singapore (www.a-star.edu.sg). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or other funding agencies that supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar-Nur O, 2011, CELL STEM CELL, V9, P17, DOI 10.1016/j.stem.2011.06.007; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Jang YC, 2011, COLD SPRING HARB S Q; Jing EX, 2007, CELL METAB, V6, P105, DOI 10.1016/j.cmet.2007.07.003; Joe AWB, 2010, NAT CELL BIOL, V12, P153, DOI 10.1038/ncb2015; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Quattrocelli M, 2011, J PATHOL, V223, P593, DOI 10.1002/path.2845; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Uezumi A, 2010, NAT CELL BIOL, V12, P143, DOI 10.1038/ncb2014; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Young AP, 2010, J CELL SCI, V123, P2632, DOI 10.1242/jcs.061606	22	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26406	10.1371/journal.pone.0026406	http://dx.doi.org/10.1371/journal.pone.0026406			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028872	Green Submitted, Green Published, gold			2022-12-27	WOS:000296186900059
J	Vitulo, N; Albiero, A; Forcato, C; Campagna, D; Dal Pero, F; Bagnaresi, P; Colaiacovo, M; Faccioli, P; Lamontanara, A; Simkova, H; Kubalakova, M; Perrotta, G; Facella, P; Lopez, L; Pietrella, M; Gianese, G; Dolezel, J; Giuliano, G; Cattivelli, L; Valle, G; Stanca, AM				Vitulo, Nicola; Albiero, Alessandro; Forcato, Claudio; Campagna, Davide; Dal Pero, Francesca; Bagnaresi, Paolo; Colaiacovo, Moreno; Faccioli, Primetta; Lamontanara, Antonella; Simkova, Hana; Kubalakova, Marie; Perrotta, Gaetano; Facella, Paolo; Lopez, Loredana; Pietrella, Marco; Gianese, Giulio; Dolezel, Jaroslav; Giuliano, Giovanni; Cattivelli, Luigi; Valle, Giorgio; Stanca, A. Michele			First Survey of the Wheat Chromosome 5A Composition through a Next Generation Sequencing Approach	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; TRANSPOSABLE ELEMENTS; MOLECULAR CHARACTERIZATION; GENOME EVOLUTION; PLANT MICRORNAS; HEXAPLOID WHEAT; BREAD WHEAT; SMALL RNAS; GENE; RICE	Wheat is one of the world's most important crops and is characterized by a large polyploid genome. One way to reduce genome complexity is to isolate single chromosomes using flow cytometry. Low coverage DNA sequencing can provide a snapshot of individual chromosomes, allowing a fast characterization of their main features and comparison with other genomes. We used massively parallel 454 pyrosequencing to obtain a 2x coverage of wheat chromosome 5A. The resulting sequence assembly was used to identify TEs, genes and miRNAs, as well as to infer a virtual gene order based on the synteny with other grass genomes. Repetitive elements account for more than 75% of the genome. Gene content was estimated considering non-redundant reads showing at least one match to ESTs or proteins. The results indicate that the coding fraction represents 1.08% and 1.3% of the short and long arm respectively, projecting the number of genes of the whole chromosome to approximately 5,000. 195 candidate miRNA precursors belonging to 16 miRNA families were identified. The 5A genes were used to search for syntenic relationships between grass genomes. The short arm is closely related to Brachypodium chromosome 4, sorghum chromosome 8 and rice chromosome 12; the long arm to regions of Brachypodium chromosomes 4 and 1, sorghum chromosomes 1 and 2 and rice chromosomes 9 and 3. From these similarities it was possible to infer the virtual gene order of 392 (5AS) and 1,480 (5AL) genes of chromosome 5A, which was compared to, and found to be largely congruent with the available physical map of this chromosome.	[Vitulo, Nicola; Albiero, Alessandro; Forcato, Claudio; Campagna, Davide; Valle, Giorgio] Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy; [Albiero, Alessandro; Dal Pero, Francesca] Bmr Genom Srl, Padua, Italy; [Bagnaresi, Paolo; Colaiacovo, Moreno; Faccioli, Primetta; Lamontanara, Antonella; Cattivelli, Luigi; Stanca, A. Michele] CRA Genom Res Ctr, Fiorenzuola Darda, Italy; [Simkova, Hana; Kubalakova, Marie; Dolezel, Jaroslav] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Olomouc, Czech Republic; [Perrotta, Gaetano; Facella, Paolo; Lopez, Loredana] TRISAIA Res Ctr, ENEA, Rotondella, Italy; [Pietrella, Marco; Giuliano, Giovanni] CASACCIA Res Ctr, ENEA, Rome, Italy; [Gianese, Giulio] Ylichron Srl, Rome, Italy	University of Padua; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA); Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Italian National Agency New Technical Energy & Sustainable Economics Development; Italian National Agency New Technical Energy & Sustainable Economics Development	Vitulo, N (corresponding author), Univ Padua, CRIBI Biotechnol Ctr, Padua, Italy.	luigi.cattivelli@entecra.it	Pietrella, Marco/ABE-3613-2020; Facella, Paolo/HHC-1895-2022; Giuliano, Giovanni/A-2701-2012; Dolezel, Jaroslav/B-7716-2008; cattivelli, luigi/AAE-7046-2020; Simkova, Hana/F-7734-2014; Kubaláková, Marie/F-8269-2014; Vitulo, Nicola/GVT-2319-2022	Facella, Paolo/0000-0001-9076-3754; Giuliano, Giovanni/0000-0002-2486-0510; Dolezel, Jaroslav/0000-0002-6263-0492; cattivelli, luigi/0000-0002-6067-4600; Simkova, Hana/0000-0003-4159-7619; Vitulo, Nicola/0000-0002-9571-0747; Pietrella, Marco/0000-0002-8789-6860; VALLE, GIORGIO/0000-0003-4377-5685; Perrotta, Gaetano/0000-0003-2037-1063; Bagnaresi, Paolo/0000-0001-8466-4805; Lamontanara, Antonella/0000-0003-3420-1524	Italian Ministry of Agriculture; Ministry of Education, Youth and Sports of the Czech Republic; European Regional Development Fund [CZ.1.05/2.1.00/01.0007]	Italian Ministry of Agriculture; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); European Regional Development Fund(European Commission)	This work was supported by the Italian Ministry of Agriculture "Progetto MAPPA 5A" and by the Ministry of Education, Youth and Sports of the Czech Republic and the European Regional Development Fund (Operational Programme Research and Development for Innovations No. CZ.1.05/2.1.00/01.0007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badawi M, 2007, MOL GENET GENOMICS, V277, P533, DOI 10.1007/s00438-006-0206-9; Bartos J, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-95; BEDBROOK JR, 1980, CELL, V19, P545, DOI 10.1016/0092-8674(80)90529-2; Bonnet E, 2004, P NATL ACAD SCI USA, V101, P11511, DOI 10.1073/pnas.0404025101; Capy P, 2000, HEREDITY, V85, P101, DOI 10.1046/j.1365-2540.2000.00751.x; Cattivelli L, 2002, PLANT MOL BIOL, V48, P649, DOI 10.1023/A:1014824404623; Charles M, 2008, GENETICS, V180, P1071, DOI 10.1534/genetics.108.092304; Choulet F, 2010, PLANT CELL, V22, P1686, DOI 10.1105/tpc.110.074187; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Danyluk J, 2003, PLANT PHYSIOL, V132, P1849, DOI 10.1104/pp.103.023523; Dolezel J, 2004, CHROMOSOME RES, V12, P77, DOI 10.1023/B:CHRO.0000009293.15189.e5; Dolezel J, 2007, CHROMOSOME RES, V15, P51, DOI 10.1007/s10577-006-1106-x; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Han YS, 2009, SCI CHINA SER C, V52, P1091, DOI 10.1007/s11427-009-0144-y; Huo NX, 2009, PLANT MOL BIOL, V70, P47, DOI 10.1007/s11103-009-9456-3; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Kadri S, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S1-S35; Kubalakova M, 2003, GENOME, V46, P893, DOI [10.1139/g03-054, 10.1139/G03-054]; Kubalakova M, 2002, THEOR APPL GENET, V104, P1362, DOI 10.1007/s00122-002-0888-2; Linkiewicz AM, 2004, GENETICS, V168, P665, DOI 10.1534/genetics.104.034835; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Mayer KFX, 2009, PLANT PHYSIOL, V151, P496, DOI 10.1104/pp.109.142612; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; NAGAKI K, 1995, GENOME, V38, P479, DOI 10.1139/g95-063; Naito K, 2009, NATURE, V461, P1130, DOI 10.1038/nature08479; Paux E, 2006, PLANT J, V48, P463, DOI 10.1111/j.1365-313X.2006.02891.x; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Safar J, 2010, CYTOGENET GENOME RES, V129, P211, DOI 10.1159/000313072; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Sarma RN, 2000, GENOME, V43, P191, DOI 10.1139/gen-43-1-191; Schnable PS, 2009, SCIENCE, V326, P1112, DOI 10.1126/science.1178534; SEARS ER, 1954, MO EXP STA RES B, V572, P1; Shukla LI, 2008, BBA-GENE REGUL MECH, V1779, P743, DOI 10.1016/j.bbagrm.2008.04.004; Simkova H, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-237, 10.1186/1471-2164-9-294]; Simons KJ, 2006, GENETICS, V172, P547, DOI 10.1534/genetics.105.044727; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Somers DJ, 2003, GENOME, V46, P555, DOI 10.1139/G03-033; Sorrells ME, 2003, GENOME RES, V13, P1818, DOI 10.1101/gr.1113003; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Vrana J, 2000, GENETICS, V156, P2033; Wei B, 2009, FUNCT INTEGR GENOMIC, V9, P499, DOI 10.1007/s10142-009-0128-9; Wicker T, 2009, PLANT PHYSIOL, V149, P258, DOI 10.1104/pp.108.129734; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Wicker T, 2009, PLANT J, V59, P712, DOI 10.1111/j.1365-313X.2009.03911.x; Yao YY, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r96; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	51	49	51	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26421	10.1371/journal.pone.0026421	http://dx.doi.org/10.1371/journal.pone.0026421			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028874	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900060
J	Chang, TC; Klabnik, JL; Liu, WS				Chang, Ti-Cheng; Klabnik, Jessica L.; Liu, Wan-Sheng			Regional Selection Acting on the OFD1 Gene Family	PLOS ONE			English	Article							FACIAL-DIGITAL SYNDROME; SYNDROME TYPE-1; I SYNDROME; PHYLOGENETIC ANALYSIS; MAXIMUM-LIKELIHOOD; SEX-CHROMOSOMES; Y-CHROMOSOME; PROTEIN; DISEASE; PSEUDOGENES	The OFD1 (oral-facial-digital, type 1) gene is implicated in several developmental disorders in humans. The X-linked OFD1 (OFD1X) is conserved in Eutheria. Knowledge about the Y-linked paralog (OFD1Y) is limited. In this study, we identified an OFD1Y on the bovine Y chromosome, which is expressed differentially from the bovine OFD1X. Phylogenetic analysis indicated that: a) the eutherian OFD1X and OFD1Y were derived from the pair of ancestral autosomes during sex chromosome evolution; b) the autosomal OFD1 pseudogenes, present in Catarrhini and Murinae, were derived from retropositions of OFD1X after the divergence of primates and rodents; and c) the presence of OFD1Y in the ampliconic region of the primate Y chromosome is an indication that the expansion of the ampliconic region may initiate from the X-degenerated sequence. In addition, we found that different regions of OFD1/OFD1X/OFD1Y are under differential selection pressures. The C-terminal half of OFD1 is under relaxed selection with an elevated Ka/Ks ratio and clustered positively selected sites, whereas the N-terminal half is under stronger constraints. This study provides some insights into why the OFD1X gene causes OFD1 (male-lethal X-linked dominant) and SGBS2 & JSRDs (X-linked recessive) syndromes in humans, and reveals the origin and evolution of the OFD1 family, which will facilitate further clinical investigation of the OFD1-related syndromes.	[Chang, Ti-Cheng; Liu, Wan-Sheng] Penn State Univ, Dept Dairy & Anim Sci, Ctr Reprod Biol & Hlth, Coll Agr Sci, University Pk, PA 16802 USA; [Chang, Ti-Cheng; Liu, Wan-Sheng] Penn State Univ, Huck Inst Life Sci, Integrat Biosci Program, University Pk, PA 16802 USA; [Klabnik, Jessica L.] Penn State Univ, Coll Agr Sci, Vet & Biomed Dept, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Chang, TC (corresponding author), Penn State Univ, Dept Dairy & Anim Sci, Ctr Reprod Biol & Hlth, Coll Agr Sci, University Pk, PA 16802 USA.	wul12@psu.edu	Chang, Ti-Cheng/HHS-7370-2022; Chang, Ti-Cheng/N-3252-2018; Klabnik, Jessica/V-6221-2017	Klabnik, Jessica/0000-0003-4843-6498	USDA-NIFA [2005-35205-18653, 2010-65205-20362]; Pennsylvania State University	USDA-NIFA(United States Department of Agriculture (USDA)); Pennsylvania State University	This work was supported by grants from USDA-NIFA (No. 2005-35205-18653 and No. 2010-65205-20362) and start-up funds from the Pennsylvania State University to Liu, W-S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Badano JL, 2006, ANNU REV GENOM HUM G, V7, P125, DOI 10.1146/annurev.genom.7.080505.115610; Balakirev ES, 2003, ANNU REV GENET, V37, P123, DOI 10.1146/annurev.genet.37.040103.103949; Bimonte S, 2011, DEV BIOL, V349, P179, DOI 10.1016/j.ydbio.2010.09.020; Bisgrove BW, 2006, DEVELOPMENT, V133, P4131, DOI 10.1242/dev.02595; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Bloom JD, 2006, MOL BIOL EVOL, V23, P1751, DOI 10.1093/molbev/msl040; BROSIUS J, 1991, SCIENCE, V251, P753, DOI 10.1126/science.1990437; Budny B, 2006, HUM GENET, V120, P171, DOI 10.1007/s00439-006-0210-5; Cardenas-Rodriguez M, 2009, AM J MED GENET C, V151C, P263, DOI 10.1002/ajmg.c.30227; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396; Choi SC, 2007, MOL BIOL EVOL, V24, P1769, DOI 10.1093/molbev/msm097; Coene KLM, 2009, AM J HUM GENET, V85, P465, DOI 10.1016/j.ajhg.2009.09.002; Comeron JM, 1999, BIOINFORMATICS, V15, P763, DOI 10.1093/bioinformatics/15.9.763; de Conciliis L, 1998, GENOMICS, V51, P243, DOI 10.1006/geno.1998.5348; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Emes RD, 2001, HUM MOL GENET, V10, P2813, DOI 10.1093/hmg/10.24.2813; Feather SA, 1997, HUM MOL GENET, V6, P1163, DOI 10.1093/hmg/6.7.1163; FELSENSTEIN J, 1985, EVOLUTION, V39, P791; Ferrante MI, 2009, HUM MOL GENET, V18, P289, DOI 10.1093/hmg/ddn356; Ferrante MI, 2006, NAT GENET, V38, P112, DOI 10.1038/ng1684; Ferrante MI, 2003, GENOMICS, V81, P560, DOI 10.1016/S0888-7543(03)00091-0; Ferrante MI, 2001, AM J HUM GENET, V68, P569, DOI 10.1086/318802; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Gerlitz G, 2005, CELL CYCLE, V4, P1632, DOI 10.4161/cc.4.11.2151; Giorgio G, 2007, MOL BIOL CELL, V18, P4397, DOI 10.1091/mbc.E07-03-0198; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Janecka JE, 2007, SCIENCE, V318, P792, DOI 10.1126/science.1147555; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Liu WS, 2002, MAMM GENOME, V13, P320, DOI 10.1007/s00335-001-2133-8; Macca M, 2009, AM J MED GENET C, V151C, P318, DOI 10.1002/ajmg.c.30224; Martin R.D., 1990, PRIMATE ORIGINS EVOL; Mighell AJ, 2000, FEBS LETT, V468, P109, DOI 10.1016/S0014-5793(00)01199-6; Morisawa T, 2004, HUM GENET, V115, P97, DOI 10.1007/s00439-004-1139-1; Morleo M, 2008, J MED GENET, V45, P401, DOI 10.1136/jmg.2008.058305; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prattichizzo C, 2008, HUM MUTAT, V29, P1237, DOI 10.1002/humu.20792; Rakkolainen A, 2002, J MED GENET, V39, P292, DOI 10.1136/jmg.39.4.292; Romio L, 2004, J AM SOC NEPHROL, V15, P2556, DOI 10.1097/01.ASN.0000140220.46477.5C; Romio L, 2003, J AM SOC NEPHROL, V14, P680, DOI 10.1097/01.ASN.0000054497.48394.D2; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Thauvin-Robinet C, 2006, J MED GENET, V43, P54, DOI 10.1136/jmg.2004.027672; Thauvin-Robinet C, 2009, HUM MUTAT, V30, pE320, DOI 10.1002/humu.20888; Van Laere AS, 2008, GENOME RES, V18, P1884, DOI 10.1101/gr.082487.108; Yang Yang, 2011, BMC Genomics, V12, P13, DOI 10.1186/1471-2164-12-13; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang ZL, 2004, CURR OPIN GENET DEV, V14, P328, DOI 10.1016/j.gde.2004.06.003	57	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26195	10.1371/journal.pone.0026195	http://dx.doi.org/10.1371/journal.pone.0026195			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022562	Green Published, Green Submitted, gold			2022-12-27	WOS:000295981600037
J	Tseng, AS; Carneiro, K; Lemire, JM; Levin, M				Tseng, Ai-Sun; Carneiro, Katia; Lemire, Joan M.; Levin, Michael			HDAC Activity Is Required during Xenopus Tail Regeneration	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; ACETYLATION; MORPHOGENESIS; CHROMATIN; PROTEIN; GROWTH; POTENT; ROLES; MSIN3; MODEL	The ability to fully restore damaged or lost organs is present in only a subset of animals. The Xenopus tadpole tail is a complex appendage, containing epidermis, muscle, nerves, spinal cord, and vasculature, which regenerates after amputation. Understanding the mechanisms of tail regeneration may lead to new insights to promote biomedical regeneration in non-regenerative tissues. Although chromatin remodeling is known to be critical for stem cell pluripotency, its role in complex organ regeneration in vivo remains largely uncharacterized. Here we show that histone deacetylase (HDAC) activity is required for the early stages of tail regeneration. HDAC1 is expressed during the 1(st) two days of regeneration. Pharmacological blockade of HDACs using Trichostatin A (TSA) increased histone acetylation levels in the amputated tail. Furthermore, treatment with TSA or another HDAC inhibitor, valproic acid, specifically inhibited regeneration. Over-expression of wild-type Mad3, a transcriptional repressor known to associate in a complex with HDACs via Sin3, inhibited regeneration. Similarly, expression of a Mad3 mutant lacking the Sin3-interacting domain that is required for HDAC binding also blocks regeneration, suggesting that HDAC and Mad3 may act together to regulate regeneration. Inhibition of HDAC function resulted in aberrant expression of Notch1 and BMP2, two genes known to be required for tail regeneration. Our results identify a novel early role for HDAC in appendage regeneration and suggest that modulation of histone acetylation is important in regenerative repair of complex appendages.	[Tseng, Ai-Sun; Lemire, Joan M.; Levin, Michael] Tufts Univ, Dept Dev Biol, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA; [Carneiro, Katia] Univ Fed Rio de Janeiro, Dept Histol & Embryol, Inst Biomed Sci, Rio De Janeiro, Brazil	Tufts University; Universidade Federal do Rio de Janeiro	Tseng, AS (corresponding author), Tufts Univ, Dept Dev Biol, Ctr Regenerat & Dev Biol, Medford, MA 02155 USA.	michael.levin@tufts.edu	Carneiro, Katia/AAQ-3415-2020; Levin, Michael/A-5918-2011; Carneiro, Katia/I-6014-2015	Carneiro, Katia/0000-0001-5915-5486; Levin, Michael/0000-0001-7292-8084; 	NIH [GM078484]; G. Harold and Leila Y. Mathers Charitable Foundation; Telemedicine and Advanced Technology Research Center (TATRC); U.S. Army Medical Research and Materiel Command (USAMRMC) [W81XWH-10-2-0058]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078484] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Telemedicine and Advanced Technology Research Center (TATRC); U.S. Army Medical Research and Materiel Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	ML gratefully acknowledges funding support of NIH grant GM078484, the G. Harold and Leila Y. Mathers Charitable Foundation, and the Telemedicine and Advanced Technology Research Center (TATRC) at the U.S. Army Medical Research and Materiel Command (USAMRMC) through award W81XWH-10-2-0058. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DS, 2007, DEVELOPMENT, V134, P1323, DOI 10.1242/dev.02812; Adler JT, 2008, SURGERY, V144, P956, DOI 10.1016/j.surg.2008.08.027; AYER DE, 1993, CELL, V72, P211, DOI 10.1016/0092-8674(93)90661-9; Beck CW, 2009, DEV DYNAM, V238, P1226, DOI 10.1002/dvdy.21890; Beck CW, 2003, DEV CELL, V5, P429, DOI 10.1016/S1534-5807(03)00233-8; Beck CW, 1999, DEVELOPMENT, V126, P1611; Beek CW, 2006, MECH DEVELOP, V123, P674, DOI 10.1016/j.mod.2006.07.001; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Carneiro K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-29; COFFMAN C, 1990, SCIENCE, V249, P1438, DOI 10.1126/science.2402639; Contreras EG, 2009, DEVELOPMENT, V136, P2987, DOI 10.1242/dev.035501; Damjanovski S, 2000, INT J DEV BIOL, V44, P769; Dekker FJ, 2009, DRUG DISCOV TODAY, V14, P942, DOI 10.1016/j.drudis.2009.06.008; Dovey OM, 2010, P NATL ACAD SCI USA, V107, P8242, DOI 10.1073/pnas.1000478107; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; Feledy JA, 1999, DEV BIOL, V212, P455, DOI 10.1006/dbio.1999.9374; Fukazawa T, 2009, DEVELOPMENT, V136, P2323, DOI 10.1242/dev.033985; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hageman J, 2010, MOL CELL, V37, P355, DOI 10.1016/j.molcel.2010.01.001; HARLAND RM, 1991, METHOD CELL BIOL, V36, P685; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Ho DM, 2008, DEV BIOL, V315, P203, DOI 10.1016/j.ydbio.2007.12.031; Hurlin PJ, 1997, GENE DEV, V11, P44, DOI 10.1101/gad.11.1.44; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Leipe DD, 1997, NUCLEIC ACIDS RES, V25, P3693, DOI 10.1093/nar/25.18.3693; Li X, 2008, Mol Biol (Mosk), V42, P990; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Mitsiades CS, 2004, P NATL ACAD SCI USA, V101, P540, DOI 10.1073/pnas.2536759100; Mochii M, 2007, DEV GROWTH DIFFER, V49, P155, DOI 10.1111/j.1440-169X.2007.00912.x; Montgomery RL, 2007, GENE DEV, V21, P1790, DOI 10.1101/gad.1563807; Nieukoop P, 1967, NORMAL TABLE XENOPUS; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Nowak SJ, 2004, TRENDS GENET, V20, P214, DOI 10.1016/j.tig.2004.02.007; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Reid B, 2009, DEV BIOL, V335, P198, DOI 10.1016/j.ydbio.2009.08.028; Riau AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014687; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shaw T, 2009, EMBO REP, V10, P881, DOI 10.1038/embor.2009.102; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; Slack JMW, 2004, PHILOS T R SOC B, V359, P745, DOI 10.1098/rstb.2004.1463; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Stewart S, 2009, P NATL ACAD SCI USA, V106, P19889, DOI 10.1073/pnas.0904132106; Sugiura T, 2009, MECH DEVELOP, V126, P56, DOI 10.1016/j.mod.2008.10.002; Tseng AS, 2008, J DENT RES, V87, P806, DOI 10.1177/154405910808700909; Tseng AS, 2010, J NEUROSCI, V30, P13192, DOI 10.1523/JNEUROSCI.3315-10.2010; Wolffe AP, 1999, NUCLEIC ACIDS RES, V27, P711, DOI 10.1093/nar/27.3.711; Xiao XM, 2009, MOL CANCER THER, V8, P350, DOI 10.1158/1535-7163.MCT-08-0585; Xiong L, 2011, J BIOL CHEM, V286, P13657, DOI 10.1074/jbc.M110.204800; Yakushiji N, 2007, DEV BIOL, V312, P171, DOI 10.1016/j.ydbio.2007.09.022; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174	52	46	47	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26382	10.1371/journal.pone.0026382	http://dx.doi.org/10.1371/journal.pone.0026382			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022609	gold, Green Submitted, Green Published			2022-12-27	WOS:000295981600057
J	Zembe, L; Burgers, WA; Jaspan, HB; Bekker, LG; Bredell, H; Stevens, G; Gilmour, J; Cox, JH; Fast, P; Hayes, P; Vardas, E; Williamson, C; Gray, CM				Zembe, Lycias; Burgers, Wendy A.; Jaspan, Heather B.; Bekker, Linda-Gail; Bredell, Helba; Stevens, Gwynneth; Gilmour, Jill; Cox, Josephine H.; Fast, Patricia; Hayes, Peter; Vardas, Eftyhia; Williamson, Carolyn; Gray, Clive M.			Intra- and Inter-clade Cross-reactivity by HIV-1 Gag Specific T-Cells Reveals Exclusive and Commonly Targeted Regions: Implications for Current Vaccine Trials	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; HLA-CLASS-I; COMPREHENSIVE EPITOPE ANALYSIS; IMMUNE-RESPONSES; VIRAL LOAD; IMMUNOGENICITY EVALUATION; CANDIDATE VACCINE; PHASE-1 SAFETY; TAP TRANSPORT; DOUBLE-BLIND	The genetic diversity of HIV-1 across the globe is a major challenge for developing an HIV vaccine. To facilitate immunogen design, it is important to characterize clusters of commonly targeted T-cell epitopes across different HIV clades. To address this, we examined 39 HIV-1 clade C infected individuals for IFN-gamma Gag-specific T-cell responses using five sets of overlapping peptides, two sets matching clade C vaccine candidates derived from strains from South Africa and China, and three peptide sets corresponding to consensus clades A, B, and D sequences. The magnitude and breadth of T-cell responses against the two clade C peptide sets did not differ, however clade C peptides were preferentially recognized compared to the other peptide sets. A total of 84 peptides were recognized, of which 19 were exclusively from clade C, 8 exclusively from clade B, one peptide each from A and D and 17 were commonly recognized by clade A, B, C and D. The entropy of the exclusively recognized peptides was significantly higher than that of commonly recognized peptides (p = 0.0128) and the median peptide processing scores were significantly higher for the peptide variants recognized versus those not recognized (p = 0.0001). Consistent with these results, the predicted Major Histocompatibility Complex Class I IC(50) values were significantly lower for the recognized peptide variants compared to those not recognized in the ELISPOT assay (p<0.0001), suggesting that peptide variation between clades, resulting in lack of cross-clade recognition, has been shaped by host immune selection pressure. Overall, our study shows that clade C infected individuals recognize clade C peptides with greater frequency and higher magnitude than other clades, and that a selection of highly conserved epitope regions within Gag are commonly recognized and give rise to cross-clade reactivities.	[Zembe, Lycias; Burgers, Wendy A.; Bredell, Helba; Williamson, Carolyn] Univ Cape Town, Inst Infect Dis & Mol Med, Div Med Virol, ZA-7925 Cape Town, South Africa; [Jaspan, Heather B.; Gray, Clive M.] Univ Cape Town, Inst Infect Dis & Mol Med, Div Immunol, ZA-7925 Cape Town, South Africa; [Jaspan, Heather B.; Bekker, Linda-Gail] Desmond Tutu HIV Ctr, Cape Town, South Africa; [Stevens, Gwynneth; Gilmour, Jill; Cox, Josephine H.; Fast, Patricia; Hayes, Peter] Int AIDS Vaccine Initiat, New York, NY USA; [Vardas, Eftyhia] Univ Stellenbosch, Dept Med Virol, ZA-7600 Stellenbosch, South Africa; [Gray, Clive M.] Natl Inst Communicable Dis, Johannesburg, South Africa	University of Cape Town; University of Cape Town; International AIDS Vaccine Initiative; Stellenbosch University; National Institute for Communicable Diseases (NICD)	Zembe, L (corresponding author), Univ Cape Town, Inst Infect Dis & Mol Med, Div Med Virol, ZA-7925 Cape Town, South Africa.	wendy.burgers@uct.ac.za	Bekker, Linda-Gail/AAZ-8929-2020	, Carolyn/0000-0003-0125-1226; BEKKER, LINDA-GAIL/0000-0002-0755-4386; Vardas, Eftyhia/0000-0002-7804-878X; Gray, Clive/0000-0002-9293-901X; Cox, Josephine/0000-0003-1301-7373; Burgers, Wendy/0000-0003-3396-9398	South African AIDS vaccine initiative; National Research Foundation; Poliomyelitis Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [UM1AI069519, U01AI069519] Funding Source: NIH RePORTER	South African AIDS vaccine initiative; National Research Foundation; Poliomyelitis Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was made possible by the generous support of the International AIDS Vaccine Initiative (IAVI) and its donors. IAVI is a not-for-profit organization whose mission is to ensure the development of safe, effective, preventive HIV vaccines for use throughout the world. For more information, go to www.iavi.org.IAVI played a direct role in study design and preparation of the manuscript. The study was also supported by South African AIDS vaccine initiative, the National Research Foundation and the Poliomyelitis Research Foundation.	Addo MM, 2003, J VIROL, V77, P2081, DOI 10.1128/JVI.77.3.2081-2092.2003; Aidoo M, 2008, VACCINE, V26, P4830, DOI 10.1016/j.vaccine.2008.06.097; Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Altfeld M, 2003, J VIROL, V77, P7330, DOI 10.1128/JVI.77.13.7330-7340.2003; Bansal A, 2003, AIDS RES HUM RETROV, V19, P1017, DOI 10.1089/088922203322588378; Barouch DH, 2010, NAT MED, V16, P319, DOI 10.1038/nm.2089; Bredell H, 2007, AIDS RES HUM RETROV, V23, P477, DOI 10.1089/aid.2006.0232; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Buseyne F, 1998, VIROLOGY, V250, P316, DOI 10.1006/viro.1998.9373; Cao HY, 2000, J INFECT DIS, V182, P1350, DOI 10.1086/315868; Carlson JM, 2008, MICROBES INFECT, V10, P455, DOI 10.1016/j.micinf.2008.01.013; Choisy M, 2004, J VIROL, V78, P1962, DOI 10.1128/JVI.78.4.1962-1970.2004; Currier JR, 2003, AIDS, V17, P2149, DOI 10.1097/00002030-200310170-00002; Dong T, 2011, BLOOD, V118, P98, DOI 10.1182/blood-2010-06-291963; Edwards BH, 2002, J VIROL, V76, P2298, DOI 10.1128/JVI.76.5.2298-2305.2002; Ferrari G, 1997, P NATL ACAD SCI USA, V94, P1396, DOI 10.1073/pnas.94.4.1396; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Frahm N, 2006, NAT IMMUNOL, V7, P173, DOI 10.1038/ni1281; Frahm N, 2007, J IMMUNOL, V179, P6638, DOI 10.4049/jimmunol.179.10.6638; Geels MJ, 2005, J VIROL, V79, P11247, DOI 10.1128/JVI.79.17.11247-11258.2005; Geldmacher C, 2007, J VIROL, V81, P2440, DOI 10.1128/JVI.01847-06; Geldmacher C, 2007, AIDS, V21, P135, DOI 10.1097/01.aids.0000247589.77061.f7; Gray GE, 2011, LANCET INFECT DIS, V11, P507, DOI 10.1016/S1473-3099(11)70098-6; Gudmundsdotter L, 2008, VACCINE, V26, P5182, DOI 10.1016/j.vaccine.2008.03.094; Gupta SB, 2006, JAIDS-J ACQ IMM DEF, V42, P135, DOI 10.1097/01.qai.0000223017.01568.e7; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Horig H, 1999, J IMMUNOL, V163, P4434; John M, 2010, J IMMUNOL, V184, P4368, DOI 10.4049/jimmunol.0903745; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kong WP, 2009, J VIROL, V83, P2201, DOI 10.1128/JVI.02256-08; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Kresge Kristen Jill, 2009, IAVI Rep, V13, P19; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Li FS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020479; Lundegaard C, 2008, BIOINFORMATICS, V24, P1397, DOI 10.1093/bioinformatics/btn128; Lundegaard C, 2008, NUCLEIC ACIDS RES, V36, pW509, DOI 10.1093/nar/gkn202; Malhotra U, 2007, VACCINE, V25, P381, DOI 10.1016/j.vaccine.2006.07.045; Martinez-Picado J, 2006, J VIROL, V80, P3617, DOI 10.1128/JVI.80.7.3617-3623.2006; Masemola A, 2004, J VIROL, V78, P3233, DOI 10.1128/JVI.78.7.3233-3243.2004; McKinney DM, 2004, J IMMUNOL, V173, P1941, DOI 10.4049/jimmunol.173.3.1941; McKinnon LR, 2005, JAIDS-J ACQ IMM DEF, V40, P245, DOI 10.1097/01.qai.0000184858.16447.04; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Peters B, 2003, BIOINFORMATICS, V19, P1765, DOI 10.1093/bioinformatics/btg247; Peters B, 2003, J IMMUNOL, V171, P1741, DOI 10.4049/jimmunol.171.4.1741; Peters BS, 2007, VACCINE, V25, P2120, DOI 10.1016/j.vaccine.2006.11.016; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Rolland M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017969; Rolland M, 2011, NAT MED, V17, P366, DOI 10.1038/nm.2316; Rosario M, 2010, EUR J IMMUNOL, V40, P1973, DOI 10.1002/eji.201040344; Santra S, 2010, NAT MED, V16, P324, DOI 10.1038/nm.2108; Tenzer S, 2005, CELL MOL LIFE SCI, V62, P1025, DOI 10.1007/s00018-005-4528-2; Vardas E, 2010, AIDS RES HUM RETROV, V26, P933, DOI 10.1089/aid.2009.0242; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008816; Vasan S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008617; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649; Wolinsky SM, 1996, SCIENCE, V272, P537, DOI 10.1126/science.272.5261.537; Woo J, 2010, J VIROL, V84, P12995, DOI 10.1128/JVI.00702-10; Yu XG, 2005, AIDS, V19, P1449, DOI 10.1097/01.aids.0000183126.32077.c8; Zuniga R, 2006, J VIROL, V80, P3122, DOI 10.1128/JVI.80.6.3122-3125.2006	63	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26096	10.1371/journal.pone.0026096	http://dx.doi.org/10.1371/journal.pone.0026096			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022524	Green Published, Green Submitted, gold			2022-12-27	WOS:000295976000067
J	Lee, SA; Leitao, R; Zheng, GA; Yang, S; Rodriguez, A; Yang, CH				Lee, Seung Ah; Leitao, Ricardo; Zheng, Guoan; Yang, Samuel; Rodriguez, Ana; Yang, Changhuei			Color Capable Sub-Pixel Resolving Optofluidic Microscope and Its Application to Blood Cell Imaging for Malaria Diagnosis	PLOS ONE			English	Article								Miniaturization of imaging systems can significantly benefit clinical diagnosis in challenging environments, where access to physicians and good equipment can be limited. Sub-pixel resolving optofluidic microscope (SROFM) offers high-resolution imaging in the form of an on-chip device, with the combination of microfluidics and inexpensive CMOS image sensors. In this work, we report on the implementation of color SROFM prototypes with a demonstrated optical resolution of 0.66 mu m at their highest acuity. We applied the prototypes to perform color imaging of red blood cells (RBCs) infected with Plasmodium falciparum, a particularly harmful type of malaria parasites and one of the major causes of death in the developing world.	[Lee, Seung Ah; Zheng, Guoan; Yang, Samuel; Yang, Changhuei] CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA; [Leitao, Ricardo; Rodriguez, Ana] NYU, Sch Med, Dept Microbiol, Div Med Parasitol, New York, NY 10016 USA; [Yang, Changhuei] CALTECH, Dept Bioengn, Pasadena, CA 91125 USA	California Institute of Technology; New York University; California Institute of Technology	Lee, SA (corresponding author), CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA.	salee30@caltech.edu		Rodriguez, Ana/0000-0002-0060-3405; Zheng, Guoan/0000-0002-4268-2690; Yang, Samuel/0000-0003-2460-6456	Gates Foundation [OPP1007336]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI096226] Funding Source: NIH RePORTER	Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a grant from the Gates Foundation (OPP1007336 GCE). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishara W, 2011, LAB CHIP, V11, P1276, DOI 10.1039/c0lc00684j; Bishara W, 2010, OPT EXPRESS, V18, P11181, DOI 10.1364/OE.18.011181; Breslauer D, 2009, MOBILE PHONE BASED C; Cui XQ, 2008, P NATL ACAD SCI USA, V105, P10670, DOI 10.1073/pnas.0804612105; Farsiu S, 2004, IEEE T IMAGE PROCESS, V13, P1327, DOI 10.1109/TIP.2004.834669; Gascoyne P, 2004, ACTA TROP, V89, P357, DOI 10.1016/j.actatropica.2003.11.009; Hu SW, 2002, ANAL CHEM, V74, P4117, DOI 10.1021/ac025700w; Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002; Oheim M, 2007, BRIT J PHARMACOL, V152, P1, DOI 10.1038/sj.bjp.0707348; Pang S, 2010, LAB CHIP, V10, P411, DOI 10.1039/b919004j; Park SC, 2003, IEEE SIGNAL PROC MAG, V20, P21, DOI 10.1109/MSP.2003.1203207; Wongsrichanalai C, 2007, AM J TROP MED HYG, V77, P119, DOI 10.4269/ajtmh.2007.77.119; Xuan XC, 2010, MICROFLUID NANOFLUID, V9, P1, DOI 10.1007/s10404-010-0602-7; Zheng GA, 2010, LAB CHIP, V10, P3125, DOI [10.1039/c01c00213e, 10.1039/c0lc00213e]	14	12	22	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26127	10.1371/journal.pone.0026127	http://dx.doi.org/10.1371/journal.pone.0026127			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022535	gold, Green Accepted, Green Published			2022-12-27	WOS:000295973200041
J	DiAngi, YT; Panozzo, CA; Ramogola-Masire, D; Steenhoff, AP; Brewer, NT				DiAngi, Yumi Taylor; Panozzo, Catherine A.; Ramogola-Masire, Doreen; Steenhoff, Andrew P.; Brewer, Noel T.			A Cross-Sectional Study of HPV Vaccine Acceptability in Gaborone, Botswana	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; ADOLESCENT GIRLS; KEY CHALLENGES; WOMEN; IMMUNIZATION; ATTITUDES; BARRIERS; AREA	Background: Cervical cancer is the most common cancer among women in Botswana and elsewhere in Sub-Saharan Africa. We sought to examine whether HPV vaccine is acceptable among parents in Botswana, which recently licensed the vaccine to prevent cervical cancer. Methods and Findings: We conducted a cross-sectional survey in 2009, around the time the vaccine was first licensed, with adults recruited in general medicine and HIV clinics in Gaborone, the capital of Botswana. Although only 9% (32/376) of respondents had heard of HPV vaccine prior to the survey, 88% (329/376) said they definitely will have their adolescent daughters receive HPV vaccine. Most respondents would get the vaccine for their daughters at a public or community clinic (42%) or a gynecology or obstetrician's office (39%), and 74% would get it for a daughter if it were available at her school. Respondents were more likely to say that they definitely will get HPV vaccine for their daughters if they had less education (OR = 0.20, 95% CI = 0.07-0.58) or lived more than 30 kilometers from the capital, Gaborone (OR = 2.29, 95% CI = 1.06-4.93). Other correlates of acceptability were expecting to be involved in the decision to get HPV vaccine, thinking the vaccine would be hard to obtain, and perceiving greater severity of HPV-related diseases. Conclusions: HPV vaccination of adolescent girls would be highly acceptable if the vaccine became widely available to the daughters of healthcare seeking parents in Gaborone, Botswana. Potential HPV vaccination campaigns should provide more information about HPV and the vaccine as well as work to minimize barriers.	[DiAngi, Yumi Taylor; Ramogola-Masire, Doreen] Univ Penn, Dept Internal Med, Philadelphia, PA 19104 USA; [DiAngi, Yumi Taylor; Ramogola-Masire, Doreen; Steenhoff, Andrew P.] Botswana Univ Penn Partnership, Gaborone, Botswana; [Panozzo, Catherine A.] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Ramogola-Masire, Doreen] Univ Penn, Dept Obstet & Gynecol, Philadelphia, PA 19104 USA; [Ramogola-Masire, Doreen] Univ Botswana, Dept Internal Med, Gaborone, Botswana; [Ramogola-Masire, Doreen] Univ Botswana, Dept Obstet & Gynecol, Gaborone, Botswana; [Steenhoff, Andrew P.] Univ Penn, Dept Pediat, Philadelphia, PA 19104 USA; [Steenhoff, Andrew P.] Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Brewer, Noel T.] Univ N Carolina, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Brewer, Noel T.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of Pennsylvania; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; University of Botswana; University of Botswana; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	DiAngi, YT (corresponding author), Univ Penn, Dept Internal Med, Philadelphia, PA 19104 USA.	ydiangi@gmail.com; ntb1@unc.edu	Brewer, Noel T/C-4375-2008; Ramogola-Masire, Doreen/AAP-2754-2020	Brewer, Noel T/0000-0003-2241-7002; Ramogola-Masire, Doreen/0000-0001-9624-8366	Penn Center for AIDS Research (CFAR), a National Institutes of Health (NIH) [P30 AI 045008]; American Cancer Society [MSRG-06-259-01-CPPB]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI045008] Funding Source: NIH RePORTER	Penn Center for AIDS Research (CFAR), a National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was made possible through core services and support from the Penn Center for AIDS Research (CFAR), a National Institutes of Health (NIH) funded program (P30 AI 045008). Additional support for publication of the findings was provided by a grant from the American Cancer Society (MSRG-06-259-01-CPPB). These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agosti JM, 2007, NEW ENGL J MED, V356, P1908, DOI 10.1056/NEJMp078053; Becker-Dreps S, 2010, VACCINE, V28, P4864, DOI 10.1016/j.vaccine.2010.05.034; *BEDIA, 2010, BOTSW STAT; Black LL, 2009, VACCINE, V27, P1668, DOI 10.1016/j.vaccine.2009.01.035; Brabin L, 2008, BRIT MED J, V336, P1056, DOI 10.1136/bmj.39541.534109.BE; Breitkopf CR, 2009, VACCINE, V27, P2367, DOI 10.1016/j.vaccine.2009.02.021; Brewer NT, 2007, PREV MED, V45, P107, DOI 10.1016/j.ypmed.2007.05.013; Brewer NT, 2011, SEX TRANSM DIS, V38, P197, DOI 10.1097/OLQ.0b013e3181f12dbf; Fazekas KI, 2008, J WOMENS HEALTH, V17, P539, DOI 10.1089/jwh.2007.0489; Harries J, 2009, VACCINE, V27, P38, DOI 10.1016/j.vaccine.2008.10.033; Katahoire R A, 2008, Afr J Reprod Health, V12, P159; Keating KM, 2008, J ADOLESCENT HEALTH, V43, pS61, DOI 10.1016/j.jadohealth.2008.06.015; Kwan TTC, 2008, SEX TRANSM INFECT, V84, P227, DOI 10.1136/sti.2007.029363; Li J, 2009, VACCINE, V27, P1210, DOI 10.1016/j.vaccine.2008.12.020; Madhivanan P, 2009, VACCINE, V27, P5203, DOI 10.1016/j.vaccine.2009.06.073; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; McFarland D M, 2003, Int Nurs Rev, V50, P167, DOI 10.1046/j.1466-7657.2003.00195.x; McRee AL, 2010, SEX TRANSM DIS, V37, P234, DOI 10.1097/OLQ.0b013e3181c37e15; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477; Reeve C, 2008, COMMUN DIS INTELL, V32, P94; Reiter PL, 2009, SOC SCI MED, V69, P475, DOI 10.1016/j.socscimed.2009.05.024; Sam IC, 2009, J ADOLESCENT HEALTH, V44, P610, DOI 10.1016/j.jadohealth.2008.11.014; UNAIDS WHO, 2010, 2008 REP GLOB AIDS E; *UNICEF, 2010, BOTSW STAT; *WHO, 2010, HPV REL CANC BOTSW; *WHO, 2010, HPV REL CANC AFR; Winkler JL, 2008, VACCINE, V26, pL73, DOI 10.1016/j.vaccine.2008.05.027; WRIGHT TC, 1994, OBSTET GYNECOL, V84, P591	28	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 25	2011	6	10							e25481	10.1371/journal.pone.0025481	http://dx.doi.org/10.1371/journal.pone.0025481			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MS	22039413	Green Published, Green Submitted, gold			2022-12-27	WOS:000296517000005
J	Bedolla, DE; Torre, V				Bedolla, Diana E.; Torre, Vincent			A Component of Retinal Light Adaptation Mediated by the Thyroid Hormone Cascade	PLOS ONE			English	Article							TYPE-2 IODOTHYRONINE DEIODINASE; PHOTORECEPTOR GUANYLYL CYCLASE; BROWN ADIPOSE-TISSUE; OTX2 HOMEOBOX GENE; CONE PHOTORECEPTORS; PINEAL-GLAND; PIGMENT GENES; MOUSE RETINA; DARK CYCLE; RAT RETINA	Analysis with DNA-microrrays and real time PCR show that several genes involved in the thyroid hormone cascade, such as deiodinase 2 and 3 (Dio2 and Dio3) are differentially regulated by the circadian clock and by changes of the ambient light. The expression level of Dio2 in adult rats (2-3 months of age) kept continuously in darkness is modulated by the circadian clock and is up-regulated by 2 fold at midday. When the diurnal ambient light was on, the expression level of Dio2 increased by 4-8 fold and a consequent increase of the related protein was detected around the nuclei of retinal photoreceptors and of neurons in inner and outer nuclear layers. The expression level of Dio3 had a different temporal pattern and was down-regulated by diurnal light. Our results suggest that DIO2 and DIO3 have a role not only in the developing retina but also in the adult retina and are powerfully regulated by light. As the thyroid hormone is a ligand-inducible transcription factor controlling the expression of several target genes, the transcriptional activation of Dio2 could be a novel genomic component of light adaptation.	[Bedolla, Diana E.; Torre, Vincent] Int Sch Adv Studies SISSA, Neurobiol Sect, I-34014 Trieste, Italy; [Torre, Vincent] Italian Inst Technol, SISSA Unit, Trieste, Italy	International School for Advanced Studies (SISSA); International School for Advanced Studies (SISSA); Istituto Italiano di Tecnologia - IIT	Bedolla, DE (corresponding author), Int Sch Adv Studies SISSA, Neurobiol Sect, I-34014 Trieste, Italy.	torre@sissa.it		Bedolla Orozco, Diana Eva/0000-0003-1902-1517	Fondo per gli Investimenti della Ricerca di Base (FIRB), Italian Government [RBLA03AF28_007]	Fondo per gli Investimenti della Ricerca di Base (FIRB), Italian Government	The present study was funded by the Fondo per gli Investimenti della Ricerca di Base (FIRB) grant #RBLA03AF28_007, from the Italian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attia RR, 2011, J BIOL CHEM, V286, P23799, DOI 10.1074/jbc.M111.246389; Bai L, 2008, BRAIN RES, V1203, P89, DOI 10.1016/j.brainres.2008.01.073; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Barrera-Hernandez G, 1999, ENDOCRINOLOGY, V140, P5267, DOI 10.1210/en.140.11.5267; Bassett JHD, 2008, BONE, V43, P418, DOI 10.1016/j.bone.2008.05.007; BIANCO AC, 1987, J CLIN INVEST, V79, P295, DOI 10.1172/JCI112798; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Burns ME, 2001, ANNU REV NEUROSCI, V24, P779, DOI 10.1146/annurev.neuro.24.1.779; CAHILL GM, 1993, NEURON, V10, P573, DOI 10.1016/0896-6273(93)90160-S; CARVALHO SD, 1991, ENDOCRINOLOGY, V128, P2149, DOI 10.1210/endo-128-4-2149; CERVETTO L, 1977, J PHYSIOL-LONDON, V267, P17, DOI 10.1113/jphysiol.1977.sp011799; Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3; Codega P, 2009, J PHYSIOL-LONDON, V587, P2457, DOI 10.1113/jphysiol.2009.168609; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Deeb SS, 2006, VISUAL NEUROSCI, V23, P371, DOI 10.1017/S0952523806233030; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; Elias R, 2004, MOL VIS, V10, P672; Fain G L, 2001, Prog Brain Res, V131, P383; FEIGENSPAN A, 1993, NATURE, V361, P159, DOI 10.1038/361159a0; Fischer AJ, 2011, NEUROSCIENCE, V178, P250, DOI 10.1016/j.neuroscience.2011.01.022; Forrest D, 2002, CURR OPIN NEUROBIOL, V12, P49, DOI 10.1016/S0959-4388(02)00289-1; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Galton VA, 2007, ENDOCRINOLOGY, V148, P3080, DOI 10.1210/en.2006-1727; Galton VA, 2009, ENDOCRINOLOGY, V150, P2957, DOI 10.1210/en.2008-1572; Gereben B, 2008, ENDOCR REV, V29, P898, DOI 10.1210/er.2008-0019; Glaschke A, 2011, J NEUROSCI, V31, P4844, DOI 10.1523/JNEUROSCI.6181-10.2011; IMAKI J, 1995, MOL BRAIN RES, V30, P48, DOI 10.1016/0169-328X(94)00270-O; KELLEY MW, 1995, DEVELOPMENT, V121, P3777; Koutalos Y, 1996, TRENDS NEUROSCI, V19, P73; Kramer RH, 2001, J EXP BIOL, V204, P2921; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Liu Y, 2007, VISION RES, V47, P2314, DOI 10.1016/j.visres.2007.04.023; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOLLEY RN, 1992, NEUROCHEM RES, V17, P81, DOI 10.1007/BF00966868; Marsh-Armstrong N, 1999, NEURON, V24, P871, DOI 10.1016/S0896-6273(00)81034-X; Martins RAP, 2006, EUR J NEUROSCI, V24, P969, DOI 10.1111/j.1460-9568.2006.04966.x; Morgan R, 2006, TRENDS GENET, V22, P67, DOI 10.1016/j.tig.2005.11.004; Nair KS, 2005, NEURON, V46, P555, DOI 10.1016/j.neuron.2005.03.023; Ng L, 2004, P NATL ACAD SCI USA, V101, P3474, DOI 10.1073/pnas.0307402101; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2010, J NEUROSCI, V30, P3347, DOI 10.1523/JNEUROSCI.5267-09.2010; NGO JT, 1990, GENOMICS, V7, P84, DOI 10.1016/0888-7543(90)90521-U; Nishida A, 2003, NAT NEUROSCI, V6, P1255, DOI 10.1038/nn1155; Opitz R, 2010, GEN COMP ENDOCR, V168, P199, DOI 10.1016/j.ygcen.2010.04.013; Osawa S, 2008, J NEUROCHEM, V107, P1314, DOI 10.1111/j.1471-4159.2008.05691.x; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; Paul BD, 2007, J BIOL CHEM, V282, P7472, DOI 10.1074/jbc.M607589200; Peng GH, 2007, HUM MOL GENET, V16, P2433, DOI 10.1093/hmg/ddm200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Politi LE, 2001, INVEST OPHTH VIS SCI, V42, P3008; Pugh E.N., 2000, HDB BIOL PHYS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; QIAN HH, 1993, NATURE, V361, P162, DOI 10.1038/361162a0; Qian J, 2005, NUCLEIC ACIDS RES, V33, P3479, DOI 10.1093/nar/gki658; Rath MF, 2009, J NEUROCHEM, V108, P285, DOI 10.1111/j.1471-4159.2008.05765.x; Rath MF, 2006, J NEUROCHEM, V97, P556, DOI 10.1111/j.1471-4159.2006.03773.x; Reidel B, 2006, VISION RES, V46, P4464, DOI 10.1016/j.visres.2006.07.019; Revel FG, 2006, ENDOCRINOLOGY, V147, P4680, DOI 10.1210/en.2006-0606; Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093; Roomets E, 2008, INVEST OPHTH VIS SCI, V49, P1660, DOI 10.1167/iovs.07-1094; Scheetz TE, 2006, P NATL ACAD SCI USA, V103, P14429, DOI 10.1073/pnas.0602562103; Schneider MJ, 2001, MOL ENDOCRINOL, V15, P2137, DOI 10.1210/me.15.12.2137; SCHREMSER JL, 1995, EXP EYE RES, V61, P25, DOI 10.1016/S0014-4835(95)80055-7; Shaaban SA, 1998, INVEST OPHTH VIS SCI, V39, P885; SharanjeetKaur, 1997, OPHTHAL PHYSL OPT, V17, P232, DOI 10.1111/j.1475-1313.1997.tb00050.x; Sokolov M, 2002, NEURON, V34, P95, DOI 10.1016/S0896-6273(02)00636-0; St Germain DL, 2009, ENDOCRINOLOGY, V150, P1097, DOI 10.1210/en.2008-1588; Strissel KJ, 2006, J NEUROSCI, V26, P1146, DOI 10.1523/JNEUROSCI.4289-05.2006; TORRE V, 1986, P NATL ACAD SCI USA, V83, P7109, DOI 10.1073/pnas.83.18.7109; Trimarchi JM, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-101; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; WILLIAMS GR, LOCAL CONTROL THYROI; Wu YF, 2000, TRENDS ENDOCRIN MET, V11, P207, DOI 10.1016/S1043-2760(00)00263-0; Yang XL, 2004, PROG NEUROBIOL, V73, P127, DOI 10.1016/j.pneurobio.2004.04.002; Yasuo S, 2007, ENDOCRINOLOGY, V148, P4385, DOI 10.1210/en.2007-0497; Yen PM, 2006, MOL CELL ENDOCRINOL, V246, P121, DOI 10.1016/j.mce.2005.11.030; YOSHIDA K, 1993, NEURON, V10, P1049, DOI 10.1016/0896-6273(93)90053-T; Yuan JS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-85; Zhang JS, 2000, ANNU REV PHYSIOL, V62, P439, DOI 10.1146/annurev.physiol.62.1.439; Zhang SSM, 2004, INVEST OPHTH VIS SCI, V45, P2407, DOI 10.1167/iovs.04-0003	80	15	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26334	10.1371/journal.pone.0026334	http://dx.doi.org/10.1371/journal.pone.0026334			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039463	Green Published, gold, Green Submitted			2022-12-27	WOS:000296515200012
J	Kentrup, D; Reuter, S; Schnockel, U; Grabner, A; Edemir, B; Pavenstadt, H; Schober, O; Schafers, M; Schlatter, E; Bussemaker, E				Kentrup, Dominik; Reuter, Stefan; Schnoeckel, Uta; Grabner, Alexander; Edemir, Bayram; Pavenstaedt, Hermann; Schober, Otmar; Schaefers, Michael; Schlatter, Eberhard; Buessemaker, Eckhart			Hydroxyfasudil-Mediated Inhibition of ROCK1 and ROCK2 Improves Kidney Function in Rat Renal Acute Ischemia-Reperfusion Injury	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; RHO-KINASE INHIBITOR; BINDING PROTEIN RHO; SMALL-ANIMAL PET; TRANSENDOTHELIAL MIGRATION; ALLOGRAFT-REJECTION; MATRIX METALLOPROTEINASES; SERINE/THREONINE KINASE; LEUKOCYTE RECRUITMENT; BLOOD-FLOW	Renal ischemia-reperfusion (IR) injury (IRI) is a common and important trigger of acute renal injury (AKI). It is inevitably linked to transplantation. Involving both, the innate and the adaptive immune response, IRI causes subsequent sterile inflammation. Attraction to and transmigration of immune cells into the interstitium is associated with increased vascular permeability and loss of endothelial and tubular epithelial cell integrity. Considering the important role of cytoskeletal reorganization, mainly regulated by RhoGTPases, in the development of IRI we hypothesized that a preventive, selective inhibition of the Rho effector Rho-associated coiled coil containing protein kinase (ROCK) by hydroxyfasudil may improve renal IRI outcome. Using an IRI-based animal model of AKI in male Sprague Dawley rats, animals treated with hydroxyfasudil showed reduced proteinuria and polyuria as well as increased urine osmolarity when compared with sham-treated animals. In addition, renal perfusion (as assessed by (18)F-fluoride Positron Emission Tomography (PET)), creatinine-and urea-clearances improved significantly. Moreover, endothelial leakage and renal inflammation was significantly reduced as determined by histology, (18)F-fluordesoxyglucose-microautoradiography, Evans Blue, and real-time PCR analysis. We conclude from our study that ROCK-inhibition by hydroxyfasudil significantly improves kidney function in a rat model of acute renal IRI and is therefore a potential new therapeutic option in humans.	[Kentrup, Dominik; Reuter, Stefan; Grabner, Alexander; Edemir, Bayram; Pavenstaedt, Hermann; Schlatter, Eberhard; Buessemaker, Eckhart] Univ Munster, Dept Internal Med D, Munster, Germany; [Schnoeckel, Uta; Schober, Otmar] Univ Munster, Dept Nucl Med, Munster, Germany; [Schaefers, Michael] Univ Munster, European Inst Mol Imaging, Munster, Germany; [Buessemaker, Eckhart] Dialysis Unit Hamm, Hamm, Germany	University of Munster; University of Munster; University of Munster	Kentrup, D (corresponding author), Univ Munster, Dept Internal Med D, Munster, Germany.	buessema@hotmail.com	Edemir, Bayram/AAF-6845-2020	Kentrup, Dominik/0000-0003-3887-4304	Innovative Medical Research (IMF) [I-BU 9844000]; Interdisciplinary Centre for Clinicial Research (IZKF, Core Unit SmAP) of the Medical Faculty Munster, Germany; German Research Foundation (DFG) [SFB656C7]; University of Muenster	Innovative Medical Research (IMF); Interdisciplinary Centre for Clinicial Research (IZKF, Core Unit SmAP) of the Medical Faculty Munster, Germany; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Muenster	Funding: This study was supported by the Innovative Medical Research (IMF, Project I-BU 9844000) and the Interdisciplinary Centre for Clinicial Research (IZKF, Core Unit SmAP) of the Medical Faculty Munster, Germany, and the German Research Foundation (DFG, SFB656C7). The authors acknowledge support by Open Access Publication Fund of University of Muenster. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alblas J, 2001, MOL BIOL CELL, V12, P2137, DOI 10.1091/mbc.12.7.2137; Awad AS, 2009, KIDNEY INT, V75, P689, DOI 10.1038/ki.2008.648; Bengatta S, 2009, J AM SOC NEPHROL, V20, P787, DOI 10.1681/ASN.2008050515; Bolisetty S, 2009, KIDNEY INT, V75, P674, DOI 10.1038/ki.2008.689; Carbajal JM, 2000, AM J PHYSIOL-CELL PH, V279, pC195; Coca SG, 2008, KIDNEY INT, V73, P1008, DOI 10.1038/sj.ki.5002729; De Greef KE, 2001, KIDNEY INT, V60, P1415, DOI 10.1046/j.1523-1755.2001.0600041415.x; Di Marco GS, 2011, EUR HEART J, V32, P1935, DOI 10.1093/eurheartj/ehq436; Ermolli M, 2003, TRANSPL IMMUNOL, V11, P137, DOI 10.1016/S0966-3274(02)00150-8; Gavard J, 2008, J BIOL CHEM, V283, P29888, DOI 10.1074/jbc.M803880200; HILSON AJW, 1978, J NUCL MED, V19, P994; Honing H, 2004, J LEUKOCYTE BIOL, V75, P523, DOI 10.1189/jlb.0203054; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Kahles T, 2007, STROKE, V38, P3000, DOI 10.1161/STROKEAHA.107.489765; Kaim AH, 2002, RADIOLOGY, V223, P446, DOI 10.1148/radiol.2232010914; Kanda T, 2003, KIDNEY INT, V64, P2009, DOI 10.1046/j.1523-1755.2003.00300.x; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Kinsey GR, 2008, NEPHRON EXP NEPHROL, V109, pE102, DOI 10.1159/000142934; Komers R, 2011, KIDNEY INT, V79, P432, DOI 10.1038/ki.2010.428; Kramer S, 2009, AM J PHYSIOL-RENAL, V297, pF218, DOI 10.1152/ajprenal.90617.2008; Lee JH, 2004, J CELL BIOL, V167, P327, DOI 10.1083/jcb.200403091; Lee S, 2011, J AM SOC NEPHROL, V22, P317, DOI 10.1681/ASN.2009060615; Legrand M, 2008, MOL MED, V14, P502, DOI 10.2119/2008-00006.Legrand; Letourneau I, 2002, NEPHRON, V90, P408, DOI 10.1159/000054728; Leung T, 1996, MOL CELL BIOL, V16, P5313; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Li L, 2008, KIDNEY INT, V74, P1526, DOI 10.1038/ki.2008.500; Liu Y, 2004, J IMMUNOL, V172, P7, DOI 10.4049/jimmunol.172.1.7; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Nagatoya K, 2002, KIDNEY INT, V61, P1684, DOI 10.1046/j.1523-1755.2002.00328.x; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nishikimi T, 2004, J HYPERTENS, V22, P1787, DOI 10.1097/00004872-200409000-00024; Noma K, 2008, J CLIN INVEST, V118, P1632, DOI 10.1172/JCI29226; PALLER MS, 1989, J LAB CLIN MED, V113, P379; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Peinnequin Andre, 2004, BMC Immunology, V5, P1, DOI 10.1186/1471-2172-5-3; Prakash J, 2008, J AM SOC NEPHROL; Rabb H, 2003, KIDNEY INT, V63, P600, DOI 10.1046/j.1523-1755.2003.00753.x; Rao RM, 2005, MICROCIRCULATION, V12, P83, DOI 10.1080/10739680590896018; Reuter S, 2010, J NUCL MED, V51, P1644, DOI 10.2967/jnumed.110.078550; Reuter S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005296; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Ronco P, 2008, KIDNEY INT, V74, P873, DOI 10.1038/ki.2008.349; Samaniego R, 2007, J CELL SCI, V120, P3534, DOI 10.1242/jcs.006296; Sarelius IH, 2006, AM J PHYSIOL-HEART C, V290, pH474, DOI 10.1152/ajpheart.00655.2005; Satoh S, 2002, EUR J PHARMACOL, V455, P169, DOI 10.1016/S0014-2999(02)02619-5; Schafers KP, 2005, J NUCL MED, V46, P996; Schnockel U, 2008, EUR J NUCL MED MOL I, V35, P2267, DOI 10.1007/s00259-008-0878-y; Shi JJ, 2007, ARCH IMMUNOL THER EX, V55, P61, DOI 10.1007/s00005-007-0009-7; Si J, 2010, LAB INVEST, V90, P448, DOI 10.1038/labinvest.2009.142; Takada M, 1997, J CLIN INVEST, V100, P1199, DOI 10.1172/JCI119632; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Teraishi K, 2004, EUR J PHARMACOL, V505, P205, DOI 10.1016/j.ejphar.2004.10.040; THORNTON MA, 1989, AM J PATHOL, V135, P509; Amerongen GPV, 2007, ARTERIOSCL THROM VAS, V27, P2332, DOI 10.1161/ATVBAHA.107.152322; Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222; Versteilen AMG, 2006, AM J PHYSIOL-RENAL, V291, pF606, DOI 10.1152/ajprenal.00434.2005; Versteilen AMG, 2011, NEPHRON EXP NEPHROL, V118, pE79, DOI 10.1159/000322605; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Ysebaert DK, 2000, NEPHROL DIAL TRANSPL, V15, P1562, DOI 10.1093/ndt/15.10.1562; Zarbock A, 2008, AM J PATHOL, V172, P1, DOI 10.2353/ajpath.2008.070502	63	19	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26419	10.1371/journal.pone.0026419	http://dx.doi.org/10.1371/journal.pone.0026419			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031832	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200021
J	Schreiber, S; Bueche, CZ; Garz, C; Kropf, S; Kuester, D; Amann, K; Heinze, HJ; Goertler, M; Reymann, KG; Braun, H				Schreiber, Stefanie; Bueche, Celine Z.; Garz, Cornelia; Kropf, Siegfried; Kuester, Doerthe; Amann, Kerstin; Heinze, Hans-Jochen; Goertler, Michael; Reymann, Klaus G.; Braun, Holger			Kidney Pathology Precedes and Predicts the Pathological Cascade of Cerebrovascular Lesions in Stroke Prone Rats	PLOS ONE			English	Article							SMALL-VESSEL DISEASE; SPONTANEOUSLY HYPERTENSIVE RAT; BRAIN; PROTEINURIA; EXPRESSION; FAILURE; INJURY; ATTACK; RENIN	Introduction: Human cerebral small vessel disease (CSVD) has been hypothesized to be an age-dependent disease accompanied by similar vascular changes in other organs. SHRSP feature numerous vascular risk factors and may be a valid model of some aspects of human CSVD. Here we compare renal histopathological changes with the brain pathology of spontaneously hypertensive stroke-prone rats (SHRSP). Material and Methods: We histologically investigated the brains and kidneys of 61 SHRSP at different stages of age (12 to 44 weeks). The brain pathology (aggregated erythrocytes in capillaries and arterioles, microbleeds, microthromboses) and the kidney pathology (aggregated erythrocytes within peritubular capillaries, tubular protein cylinders, glomerulosclerosis) were quantified separately. The prediction of the brain pathology by the kidney pathology was assessed by creating ROC-curves integrating the degree of kidney pathology and age of SHRSP. Results: Both, brain and kidney pathology, show an age-dependency and proceed in definite stages whereas an aggregation of erythrocytes in capillaries and arterioles, we parsimoniously interpreted as stases, represent the initial finding in both organs. Thus, early renal tubulointerstitial damage characterized by rather few intravasal erythrocyte aggregations and tubular protein cylinders predicts the initial step of SHRSPs' cerebral vascular pathology marked by accumulated erythrocytes. The combined increase of intravasal erythrocyte aggregations and protein cylinders accompanied by glomerulosclerosis and thrombotic renal microangiopathy in kidneys of older SHRSP predicts the final stages of SHRSPs' cerebrovascular lesions marked by microbleeds and thrombotic infarcts. Conclusion: Our results illustrate a close association between structural brain and kidney pathology and support the concept of small vessel disease to be an age-dependent systemic pathology. Further, an improved joined nephrologic and neurologic diagnostic may help to identify patients with CSVD at an early stage.	[Schreiber, Stefanie; Bueche, Celine Z.; Garz, Cornelia; Heinze, Hans-Jochen; Goertler, Michael] Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany; [Kropf, Siegfried] Otto Von Guericke Univ, Inst Biometry & Med Informat, Magdeburg, Germany; [Kuester, Doerthe] Otto Von Guericke Univ, Inst Pathol, Magdeburg, Germany; [Amann, Kerstin] Univ Erlangen Nurnberg, Dept Nephropathol, Erlangen, Germany; [Heinze, Hans-Jochen; Reymann, Klaus G.; Braun, Holger] Deutsch Zentrum Neurodegenerat Erkrankungen, Magdeburg, Germany; [Heinze, Hans-Jochen; Reymann, Klaus G.] Leibniz Inst Neurobiol, Magdeburg, Germany	Otto von Guericke University; Otto von Guericke University; Otto von Guericke University; University of Erlangen Nuremberg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Leibniz Institut fur Neurobiologie (LIN)	Schreiber, S (corresponding author), Otto Von Guericke Univ, Dept Neurol, Magdeburg, Germany.	stefanie.schreiber@med.ovgu.de	Reymann, Klaus G/J-8507-2013; Jechorek, Doerthe/J-4716-2014; Schreiber, Stefanie/S-3223-2019	Jechorek, Doerthe/0000-0002-1480-5200; Schreiber, Stefanie/0000-0003-4439-4374	Deutsches Zentrum fur Neurodegenerative Erkrankungen (DZNE), Magdeburg, Germany; Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany	Deutsches Zentrum fur Neurodegenerative Erkrankungen (DZNE), Magdeburg, Germany; Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany	Funding: This work was funded by the Deutsches Zentrum fur Neurodegenerative Erkrankungen (DZNE), Magdeburg, Germany, and the Department of Neurology, Otto-von-Guericke University, Magdeburg, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarenco P, 2009, CEREBROVASC DIS, V27, P493, DOI 10.1159/000210432; Anderson W P, 1994, Blood Press Suppl, V5, P57; Bailey EL, 2009, STROKE, V40, pE451, DOI 10.1161/STROKEAHA.108.528430; Cheung N, 2010, BRAIN, V133, P1987, DOI 10.1093/brain/awq127; FELD LG, 1977, KIDNEY INT, V12, P332, DOI 10.1038/ki.1977.120; FISHER CM, 1969, ACTA NEUROPATHOL, V12, P1, DOI 10.1007/BF00685305; Fotuhi M, 2009, NAT REV NEUROL, V5, P649, DOI 10.1038/nrneurol.2009.175; GATTONE VH, 1983, HYPERTENSION, V5, P8, DOI 10.1161/01.HYP.5.1.8; Grinberg LT, 2010, ACTA NEUROPATHOL, V119, P277, DOI 10.1007/s00401-010-0652-7; Hainsworth AH, 2008, J CEREBR BLOOD F MET, V28, P1877, DOI 10.1038/jcbfm.2008.91; Hayashi K, 1996, J HYPERTENS, V14, P1387, DOI 10.1097/00004872-199612000-00002; Hill GS, 2008, CURR OPIN NEPHROL HY, V17, P266, DOI 10.1097/MNH.0b013e3282f88a1f; Ikram MA, 2008, STROKE, V39, P55, DOI 10.1161/STROKEAHA.107.493494; INAGAMI T, 1991, BLOOD VESSELS, V28, P217; Johnson RJ, 2002, J HYPERTENS, V20, pS1; Khatri M, 2007, STROKE, V38, P3121, DOI 10.1161/STROKEAHA.107.493593; Lammie GA, 1997, STROKE, V28, P2222, DOI 10.1161/01.STR.28.11.2222; LARAGH JH, 1991, AM J HYPERTENS, V4, pS2, DOI 10.1093/ajh/4.1.2S; MCGIFF JC, 1981, CIRC RES, V48, P455, DOI 10.1161/01.RES.48.4.455; Meyrier A, 1998, KIDNEY INT, V54, P2, DOI 10.1046/j.1523-1755.1998.00968.x; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; Obata J, 2000, J HYPERTENS, V18, P1247, DOI 10.1097/00004872-200018090-00011; Ovbiagele B, 2010, ARCH NEUROL-CHICAGO, V67, P45, DOI 10.1001/archneurol.2009.310; Rodriguez-Iturbe B, 2004, AM J PHYSIOL-RENAL, V286, pF606, DOI 10.1152/ajprenal.00269.2003; Schreiber S, 2011, J CEREB BLO IN PRESS; Thompson CS, 2009, STROKE, V40, pE322, DOI 10.1161/STROKEAHA.108.542266	26	22	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26287	10.1371/journal.pone.0026287	http://dx.doi.org/10.1371/journal.pone.0026287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031827	Green Published, Green Submitted, gold			2022-12-27	WOS:000296513200014
J	Zheng, ZL; Andersson, AF; Ye, WM; Nyren, O; Normark, S; Engstrand, L				Zheng, Zongli; Andersson, Anders F.; Ye, Weimin; Nyren, Olof; Normark, Staffan; Engstrand, Lars			A Method for Metagenomics of Helicobacter pylori from Archived Formalin-Fixed Gastric Biopsies Permitting Longitudinal Studies of Carcinogenic Risk	PLOS ONE			English	Article							GENETIC DIVERSITY	The human microbiota has come into focus in the search for component causes of chronic diseases, such as gastrointestinal cancers. Presumably long induction periods and altered local environments after disease onset call for the development of methods for characterization of microorganisms colonizing the host decades before disease onset. Sequencing of microbial genomes in old formalin-fixed and paraffin-embedded (FFPE) gastrointestinal biopsies provides a means for such studies but is still challenging. Here we report a method based on laser capture micro-dissection and modified Roche 454 high-throughput pyrosequencing to obtain metagenomic profiles of Helicobacter pylori. We applied this method to two 15 year old FFPE biopsies from two patients. Frozen homogenized biopsies from the same gastroscopy sessions were also available for comparison after re-culture of H. pylori. For both patients, H. pylori DNA dissected from FFPE sections had similar to 96.4% identity with culture DNA from the same patients, while only similar to 92.5% identity with GenBank reference genomes, and with culture DNA from the other patient. About 82% and 60% of the predicted genes in the two genomes were captured by at least a single sequencing read. Along with sequences displaying high similarity to known H. pylori genes, novel and highly variant H. pylori sequences were identified in the FFPE sections by our physical enrichment approach, which would likely not have been detected by a sequence capture approach. The study demonstrates the feasibility of longitudinal metagenomic studies of H. pylori using decade-preserved FFPE biopsies.	[Zheng, Zongli; Ye, Weimin; Nyren, Olof] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Zheng, Zongli; Normark, Staffan; Engstrand, Lars] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Andersson, Anders F.] KTH Royal Inst Technol, Sci Life Lab, Stockholm, Sweden; [Normark, Staffan; Engstrand, Lars] Swedish Inst Communicable Dis Control, Solna, Sweden	Karolinska Institutet; Karolinska Institutet; Royal Institute of Technology; Swedish Institute for Infectious Disease Control	Zheng, ZL (corresponding author), Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden.	lars.engstrand@ki.se	zheng, zongli/B-2917-2011; Andersson, Anders/J-9310-2019; zheng, zongli/C-7309-2008	zheng, zongli/0000-0003-4849-4903; Andersson, Anders/0000-0002-3627-6899; 	European Union [LSHC-CT-2005-018704]; Swedish Cancer Society [4925-B06-03XCC]; Karolinska Institutet (KID)	European Union(European Commission); Swedish Cancer Society(Swedish Cancer Society); Karolinska Institutet (KID)	Funding: This work was supported by the Sixth Research Framework Program of the European Union, project INCA (LSHC-CT-2005-018704) to ON, SN and LE, and the Swedish Cancer Society (4925-B06-03XCC) to ON, WY and LE. ZZ was also supported by a scholarship from the Karolinska Institutet (KID). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen LP, 2009, FEMS IMMUNOL MED MIC, V56, P112, DOI 10.1111/j.1574-695X.2009.00556.x; Enroth H, 1999, HELICOBACTER, V4, P7, DOI 10.1046/j.1523-5378.1999.09034.x; Enroth H, 2000, CANCER EPIDEM BIOMAR, V9, P981; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Israel DA, 2001, P NATL ACAD SCI USA, V98, P14625, DOI 10.1073/pnas.251551698; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Quach Nancy, 2004, BMC Clin Pathol, V4, P1, DOI 10.1186/1472-6890-4-1; Salama N, 2000, P NATL ACAD SCI USA, V97, P14668, DOI 10.1073/pnas.97.26.14668; Teer JK, 2010, GENOME RES, V20, P1420, DOI 10.1101/gr.106716.110; Wang Y, 2010, APPL MICROBIOL BIOTE; Zheng ZL, 2011, NAT PROTOC, V6, P1367, DOI 10.1038/nprot.2011.369; Zheng ZL, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq332	12	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26442	10.1371/journal.pone.0026442	http://dx.doi.org/10.1371/journal.pone.0026442			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031833	Green Submitted, Green Published, gold			2022-12-27	WOS:000296513200022
J	Huang, YJA; Pereira, E; Roper, SD				Huang, Yijen A.; Pereira, Elizabeth; Roper, Stephen D.			Acid Stimulation (Sour Taste) Elicits GABA and Serotonin Release from Mouse Taste Cells	PLOS ONE			English	Article							BUDS; CALCIUM; ATP; EXPRESSION; NEUROTRANSMISSION; COMMUNICATION; HEMICHANNELS; ACTIVATION; RECEPTORS; INCREASES	Several transmitter candidates including serotonin (5-HT), ATP, and norepinephrine (NE) have been identified in taste buds. Recently, gamma-aminobutyric acid (GABA) as well as the associated synthetic enzymes and receptors have also been identified in taste cells. GABA reduces taste-evoked ATP secretion from Receptor cells and is considered to be an inhibitory transmitter in taste buds. However, to date, the identity of GABAergic taste cells and the specific stimulus for GABA release are not well understood. In the present study, we used genetically-engineered Chinese hamster ovary (CHO) cells stably co-expressing GABA(B) receptors and G alpha qo5 proteins to measure GABA release from isolated taste buds. We recorded robust responses from GABA biosensors when they were positioned against taste buds isolated from mouse circumvallate papillae and the buds were depolarized with KCl or a stimulated with an acid (sour) taste. In contrast, a mixture of sweet and bitter taste stimuli did not trigger GABA release. KCl- or acid-evoked GABA secretion from taste buds was Ca2+-dependent; removing Ca2+ from the bathing medium eliminated GABA secretion. Finally, we isolated individual taste cells to identify the origin of GABA secretion. GABA was released only from Presynaptic (Type III) cells and not from Receptor (Type II) cells. Previously, we reported that 5-HT released from Presynaptic cells inhibits taste-evoked ATP secretion. Combined with the recent findings that GABA depresses taste-evoked ATP secretion [1], the present results indicate that GABA and 5-HT are inhibitory transmitters in mouse taste buds and both likely play an important role in modulating taste responses.	[Huang, Yijen A.; Pereira, Elizabeth; Roper, Stephen D.] Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA; [Roper, Stephen D.] Univ Miami, Miller Sch Med, Program Neurosci, Miami, FL 33136 USA	University of Miami; University of Miami	Huang, YJA (corresponding author), Univ Miami, Miller Sch Med, Dept Physiol & Biophys, Miami, FL 33136 USA.	SRoper@med.miami.edu		Roper, Stephen/0000-0001-6049-8320; Tilahin, Shimelis/0000-0001-8975-8026	National Institutes of Health [2R01DC007630, 5R01DC000374]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000374, R01DC007630] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This research was funded by National Institutes of Health grants to SDR, 2R01DC007630 and 5R01DC000374. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baryshnikov SG, 2003, J NEUROPHYSIOL, V90, P3283, DOI 10.1152/jn.00312.2003; Cao Y, 2009, P NATL ACAD SCI USA, V106, P4006, DOI 10.1073/pnas.0808672106; Chandrashekar J, 2010, NATURE, V464, P297, DOI 10.1038/nature08783; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; Deshpande DA, 2010, NAT MED, V16, P1299, DOI 10.1038/nm.2237; Dvoryanchikov G, 2011, J NEUROSCI, V31, P5782, DOI 10.1523/JNEUROSCI.5559-10.2011; Eguchi K, 2008, CHEM SENSES, V33, P47, DOI 10.1093/chemse/bjm065; Finger TE, 2005, SCIENCE, V310, P1495, DOI 10.1126/science.1118435; Franek M, 1999, NEUROPHARMACOLOGY, V38, P1657, DOI 10.1016/S0028-3908(99)00135-5; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hacker K, 2008, J NEUROPHYSIOL, V100, P2177, DOI 10.1152/jn.90534.2008; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Huang YA, 2008, J PHYSIOL-LONDON, V586, P2903, DOI 10.1113/jphysiol.2008.151233; Huang YA, 2010, J PHYSIOL-LONDON, V588, P2343, DOI 10.1113/jphysiol.2010.191106; Huang YA, 2009, J NEUROSCI, V29, P13909, DOI 10.1523/JNEUROSCI.2351-09.2009; Huang YA, 2008, J NEUROSCI, V28, P13088, DOI 10.1523/JNEUROSCI.4187-08.2008; Huang YJ, 2005, J NEUROSCI, V25, P843, DOI 10.1523/JNEUROSCI.4446-04.2005; IREDALE PA, 1993, BRIT J PHARMACOL, V110, P1305, DOI 10.1111/j.1476-5381.1993.tb13960.x; Nagai T, 1998, J COMP NEUROL, V392, P199, DOI 10.1002/(SICI)1096-9861(19980309)392:2<199::AID-CNE4>3.0.CO;2-Y; Obata H, 1997, MOL BRAIN RES, V49, P29, DOI 10.1016/S0169-328X(97)00118-6; Ogura T, 2002, J NEUROPHYSIOL, V87, P2643, DOI 10.1152/jn.2002.87.6.2643; Ogura T, 2002, J NEUROPHYSIOL, V87, P3152, DOI 10.1152/jn.2002.87.6.3152; Pagano A, 2001, J NEUROSCI, V21, P1189; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Starostik MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013639; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Vandenbeuch A, 2010, J NEUROSCI, V30, P14695, DOI 10.1523/JNEUROSCI.1570-10.2010; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Yoshida R, 2009, J PHYSIOL-LONDON, V587, P4425, DOI 10.1113/jphysiol.2009.175075; Zhao FL, 2005, P NATL ACAD SCI USA, V102, P11100, DOI 10.1073/pnas.0501988102	31	33	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25471	10.1371/journal.pone.0025471	http://dx.doi.org/10.1371/journal.pone.0025471			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028776	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800006
J	van den Berg, S; van Wamel, WJB; Snijders, SV; Ouwerling, B; de Vogel, CP; Boelens, HA; Willems, RJL; Huijsdens, XW; Verreck, FAW; Kondova, I; Heidt, PJ; Verbrugh, HA; van Belkum, A				van den Berg, Sanne; van Wamel, Willem J. B.; Snijders, Susan V.; Ouwerling, Boudewijn; de Vogel, Corne P.; Boelens, Helene A.; Willems, Rob J. L.; Huijsdens, Xander W.; Verreck, Frank A. W.; Kondova, Ivanela; Heidt, Peter J.; Verbrugh, Henri A.; van Belkum, Alex			Rhesus Macaques (Macaca mulatta) Are Natural Hosts of Specific Staphylococcus aureus Lineages	PLOS ONE			English	Article							SURGICAL-SITE INFECTIONS; MUPIROCIN NASAL OINTMENT; HUMORAL IMMUNE-RESPONSE; METHICILLIN-RESISTANT; ANTIBODY-RESPONSES; MODEL HOST; CARRIAGE; CARRIERS; STRAINS; GENES	Currently, there is no animal model known that mimics natural nasal colonization by Staphylococcus aureus in humans. We investigated whether rhesus macaques are natural nasal carriers of S. aureus. Nasal swabs were taken from 731 macaques. S. aureus isolates were typed by pulsed-field gel electrophoresis (PFGE), spa repeat sequencing and multi-locus sequence typing (MLST), and compared with human strains. Furthermore, the isolates were characterized by several PCRs. Thirty-nine percent of 731 macaques were positive for S. aureus. In general, the macaque S. aureus isolates differed from human strains as they formed separate PFGE clusters, 50% of the isolates were untypeable by agr genotyping, 17 new spa types were identified, which all belonged to new sequence types (STs). Furthermore, 66% of macaque isolates were negative for all superantigen genes. To determine S. aureus nasal colonization, three nasal swabs from 48 duo-housed macaques were taken during a 5 month period. In addition, sera were analyzed for immunoglobulin G and A levels directed against 40 staphylococcal proteins using a bead-based flow cytometry technique. Nineteen percent of the animals were negative for S. aureus, and 17% were three times positive. S. aureus strains were easily exchanged between macaques. The antibody response was less pronounced in macaques compared to humans, and nasal carrier status was not associated with differences in serum anti-staphylococcal antibody levels. In conclusion, rhesus macaques are natural hosts of S. aureus, carrying host-specific lineages. Our data indicate that rhesus macaques are useful as an autologous model for studying S. aureus nasal colonization and infection prevention.	[van den Berg, Sanne; van Wamel, Willem J. B.; Snijders, Susan V.; de Vogel, Corne P.; Boelens, Helene A.; Verbrugh, Henri A.; van Belkum, Alex] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [Ouwerling, Boudewijn; Kondova, Ivanela; Heidt, Peter J.] Biomed Primate Res Ctr, Dept Anim Sci, Rijswijk, Netherlands; [Willems, Rob J. L.] Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Huijsdens, Xander W.] Natl Inst Publ Hlth & Environm, Lab Infect Dis & Screening, NL-3720 BA Bilthoven, Netherlands; [Verreck, Frank A. W.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands	Erasmus University Rotterdam; Erasmus MC; Utrecht University; Utrecht University Medical Center; Netherlands National Institute for Public Health & the Environment	van den Berg, S (corresponding author), Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands.	s.vandenberg@erasmusmc.nl	Willems, Rob JL/E-3681-2010; Heidt, Peter/GQQ-8459-2022	Willems, Rob JL/0000-0002-7370-0812; van den Berg, Sanne/0000-0001-9209-0178; van Wamel, Willem/0000-0001-9145-9121	Top Institute Pharma [T4-213]; EUPRIM-NET2 [262443]	Top Institute Pharma; EUPRIM-NET2	S.v.d.B. and A.v.B. were in part supported financially by the Top Institute Pharma project T4-213. B.O. and I.K. were in part supported financially by EUPRIM-NET2, grant agreement no. 262443. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acton DS, 2009, EUR J CLIN MICROBIOL, V28, P115, DOI 10.1007/s10096-008-0602-7; Aires-de-Sousa M, 2006, J CLIN MICROBIOL, V44, P619, DOI 10.1128/JCM.44.2.619-621.2006; Becker K, 2003, J CLIN MICROBIOL, V41, P1434, DOI 10.1128/JCM.41.4.1434-1439.2003; Bode LGM, 2010, NEW ENGL J MED, V362, P9, DOI 10.1056/NEJMoa0808939; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Collery MM, 2008, J MED MICROBIOL, V57, P348, DOI 10.1099/jmm.0.47734-0; Collins LV, 2006, GRAM POSITIVE PATHOG, P535; Dryla A, 2005, CLIN DIAGN LAB IMMUN, V12, P387, DOI 10.1128/CDLI.12.3.387-398.2005; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; ERIKSEN NHR, 1995, EPIDEMIOL INFECT, V115, P51, DOI 10.1017/S0950268800058118; Fitzgerald JR, 2001, J BACTERIOL, V183, P63, DOI 10.1128/JB.183.1.63-70.2001; Francisco AP, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-152; Herron LL, 2002, INFECT IMMUN, V70, P3978, DOI 10.1128/IAI.70.7.3978-3981.2002; Holtfreter S, 2007, J CLIN MICROBIOL, V45, P2669, DOI 10.1128/JCM.00204-07; HU L, 1995, J MED MICROBIOL, V42, P127, DOI 10.1099/00222615-42-2-127; Jarraud S, 2002, INFECT IMMUN, V70, P631, DOI 10.1128/IAI.70.2.631-641.2002; Kalmeijer MD, 2002, CLIN INFECT DIS, V35, P353, DOI 10.1086/341025; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Koning S, 2003, J CLIN MICROBIOL, V41, P3017, DOI 10.1128/JCM.41.7.3017-3021.2003; Kuklin NA, 2006, INFECT IMMUN, V74, P2215, DOI 10.1128/IAI.74.4.2215-2223.2006; LeClaire RD, 2002, INFECT IMMUN, V70, P2278, DOI 10.1128/IAI.70.5.2278-2281.2002; LEIGH DA, 1993, J ANTIMICROB CHEMOTH, V31, P909, DOI 10.1093/jac/31.6.909; Lu QJ, 2003, TOXICOL PATHOL, V31, P14, DOI 10.1080/01926230309741; Martins TB, 2006, J IMMUNOL METHODS, V316, P97, DOI 10.1016/j.jim.2006.08.007; Melles DC, 2004, J CLIN INVEST, V114, P1732, DOI 10.1172/JCI200423083; Mertz D, 2007, CLIN INFECT DIS, V45, P475, DOI 10.1086/520016; MURAKAMI K, 1991, J CLIN MICROBIOL, V29, P2240, DOI 10.1128/JCM.29.10.2240-2244.1991; Needham AJ, 2004, MICROBIOL-SGM, V150, P2347, DOI 10.1099/mic.0.27116-0; NOBLE WC, 1964, J CLIN PATHOL, V17, P79, DOI 10.1136/jcp.17.1.79; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Sifri CD, 2003, INFECT IMMUN, V71, P2208, DOI 10.1128/IAI.71.4.2208-2217.2003; Tarkowski A, 2001, TRENDS MICROBIOL, V9, P321, DOI 10.1016/S0966-842X(01)02078-9; Thomas Damien, 2007, Chem Immunol Allergy, V93, P24, DOI 10.1159/000100856; Tristan A, 2003, J CLIN MICROBIOL, V41, P4465, DOI 10.1128/JCM.41.9.4465-4467.2003; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; van Cleef BAGL, 2011, J CLIN MICROBIOL, V49, P1030, DOI 10.1128/JCM.00493-10; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Verkaik NJ, 2010, EUR J CLIN MICROBIOL, V29, P509, DOI 10.1007/s10096-010-0888-0; Verkaik N, 2008, J IMMUNOL METHODS, V335, P121, DOI 10.1016/j.jim.2008.02.022; Verkaik NJ, 2009, J INFECT DIS, V199, P625, DOI 10.1086/596743; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; WATANAKUNAKORN C, 1995, AM J INFECT CONTROL, V23, P306, DOI 10.1016/0196-6553(95)90061-6; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2005, ANTIMICROB AGENTS CH, V49, P1465, DOI 10.1128/AAC.49.4.1465-1467.2005; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; Wulf M, 2008, CLIN MICROBIOL INFEC, V14, P519, DOI 10.1111/j.1469-0691.2008.01970.x	48	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26170	10.1371/journal.pone.0026170	http://dx.doi.org/10.1371/journal.pone.0026170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028827	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800024
J	Gray, LJ; Yates, T; Davies, MJ; Brady, E; Webb, DR; Sattar, N; Khunti, K				Gray, Laura J.; Yates, Thomas; Davies, Melanie J.; Brady, Emer; Webb, David R.; Sattar, Naveed; Khunti, Kamlesh			Defining Obesity Cut-Off Points for Migrant South Asians	PLOS ONE			English	Article							BODY-MASS INDEX; DIABETES PREVENTION PROGRAM; IMPAIRED GLUCOSE-TOLERANCE; WAIST CIRCUMFERENCE; MULTIETHNIC POPULATION; METABOLIC SYNDROME; ABDOMINAL OBESITY; RISK-FACTORS; PREVALENCE; ADIPOSITY	Background: Body mass index (BMI) and waist circumference (WC) are used to define cardiovascular and type 2 diabetes risk. We aimed to derive appropriate BMI and WC obesity cut-off points in a migrant South Asian population. Methods: 4688 White Europeans and 1333 South Asians resident in the UK aged 40-75 years inclusive were screened for type 2 diabetes. Principal components analysis was used to derive a glycaemia, lipid, and a blood pressure factor. Regression models for each factor, adjusted for age and stratified by sex, were used to identify BMI and WC cut-off points in South Asians that correspond to those defined for White Europeans. Findings: For South Asian males, derived BMI obesity cut-off points equivalent to 30.0 kg/m(2) in White Europeans were 22.6 kg/m(2) (95% Confidence Interval (95% CI) 20.7 kg/m(2) to 24.5 kg/m(2)) for the glycaemia factor, 26.0 kg/m(2) (95% CI 24.7 kg/m(2) to 27.3 kg/m(2)) for the lipid factor, and 28.4 kg/m(2) (95% CI 26.5 kg/m(2) to 30.4 kg/m(2)) for the blood pressure factor. For WC, derived cut-off points for South Asian males equivalent to 102 cm in White Europeans were 83.8 cm (95% CI 79.3 cm to 88.2 cm) for the glycaemia factor, 91.4 cm (95% CI 86.9 cm to 95.8 cm) for the lipid factor, and 99.3 cm (95% CI 93.3 cm to 105.2 cm) for the blood pressure factor. Lower ethnicity cut-off points were seen for females for both BMI and WC. Conclusions: Substantially lower obesity cut-off points are needed in South Asians to detect an equivalent level of dysglycemia and dyslipidemia as observed in White Europeans. South Asian ethnicity could be considered as a similar level of risk as obesity (in White Europeans) for the development of type 2 diabetes.	[Gray, Laura J.; Khunti, Kamlesh] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Yates, Thomas; Davies, Melanie J.; Webb, David R.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Brady, Emer] Univ Hosp Leicester, Dept Diabet Res, Leicester, Leics, England; [Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	University of Leicester; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; University of Glasgow	Gray, LJ (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester, Leics, England.	kk22@le.ac.uk	/ABC-9527-2021	Webb, David/0000-0002-3932-3339; Khunti, Kamlesh/0000-0003-2343-7099; Gray, Laura/0000-0002-9284-9321; Davies, Melanie/0000-0002-9987-9371	NHS Department of Health; NIHR Biomedical Research Centre; NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC)	NHS Department of Health; NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC)	The project was funded for support and treatment costs by NHS Department of Health Support for Science and project grants. The sponsors of the study had no role in the study design, data collection, data analysis, interpretation or writing of the paper.; Departments of Health Sciences and Cardiovascular Sciences, University of Leicester are grateful for support from the NIHR Biomedical Research Centre and the NIHR Collaboration for Leadership in Applied Health Research and Care (CLAHRC). The study was hosted by the University Hospitals of Leicester, UK and was registered with an internationally recognized trials registry (Clinicaltrial.gov NCT00318032).	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Aujla N., 2010, DIABETIC MED S1, V27, P371; Cameron AJ, 2010, OBESITY, V18, P2039, DOI 10.1038/oby.2009.455; Fischbacher CM, 2004, J PUBLIC HEALTH-UK, V26, P250, DOI 10.1093/pubmed/fdh158; Gholap N, 2011, PRIM CARE DIABETES, V5, P45, DOI 10.1016/j.pcd.2010.08.002; He MZ, 2010, CAN FAM PHYSICIAN, V56, pE174; Herman WH, 2007, DIABETES CARE, V30, P2453, DOI 10.2337/dc06-2003; Hojgaard B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002619; Jafar TH, 2006, CAN MED ASSOC J, V175, P1071, DOI 10.1503/cmaj.060464; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Kumar S, 2011, INT J CLIN PRACT, V65, P378, DOI 10.1111/j.1742-1241.2010.02548.x; Kumar S., 2009, POSITION STATEMENT D; Lear SA, 2003, METABOLISM, V52, P1295, DOI 10.1016/S0026-0495(03)00196-3; Likhari T, 2010, J CLIN PATHOL, V63, P278, DOI 10.1136/jcp.2009.065821; MATHER HM, 1985, BRIT MED J, V291, P1081, DOI 10.1136/bmj.291.6502.1081; Misra A, 2006, INT J OBESITY, V30, P106, DOI 10.1038/sj.ijo.0803111; Misra A, 2005, DIABETES CARE, V28, P398, DOI 10.2337/diacare.28.2.398; Misra A, 2009, J Assoc Physicians India, V57, P163; Mohan V, 2007, METABOLISM, V56, P961, DOI 10.1016/j.metabol.2007.02.009; Organization WH, 1998, WELLB MEAS PRIM HLTH; Oza-Frank R, 2009, DIABETES CARE, V32, P1644, DOI 10.2337/dc09-0573; Ramachandran A, 2006, DIABETOLOGIA, V49, P289, DOI 10.1007/s00125-005-0097-z; Razak F, 2007, CIRCULATION, V115, P2111, DOI 10.1161/CIRCULATIONAHA.106.635011; SRINIVASAN BT, 2009, DIABETES S1, V58; Taylor AE, 2010, AM J CLIN NUTR, V91, P547, DOI 10.3945/ajcn.2009.28757; Tuan NT, 2009, AM J CLIN NUTR, V89, P1905, DOI 10.3945/ajcn.2008.26809; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wannamethee SG, 2010, DIABETOLOGIA, V53, P890, DOI 10.1007/s00125-010-1670-7; Webb DR, 2011, DIABETOLOGIA, V54, P2237, DOI 10.1007/s00125-011-2189-2; Webb DR, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-16; Wen CP, 2009, PUBLIC HEALTH NUTR, V12, P497, DOI 10.1017/S1368980008002802; WHO, 2004, LANCET, V363, P902	32	66	66	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26464	10.1371/journal.pone.0026464	http://dx.doi.org/10.1371/journal.pone.0026464			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039493	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000296507500071
J	Jia, SZ; Peng, JC; Gao, B; Chen, ZB; Zhou, Y; Fu, QX; Wang, HP; Zhan, LS				Jia, Shuaizheng; Peng, Jianchun; Gao, Bo; Chen, Zhongbin; Zhou, Yong; Fu, Qiuxia; Wang, Haiping; Zhan, Linsheng			Relative Quantification of Protein-Protein Interactions Using a Dual Luciferase Reporter Pull-Down Assay System	PLOS ONE			English	Article							HEPATITIS-C VIRUS; MAMMALIAN-CELLS; IN-VIVO; BIOTINYLATION; INNATE; CARDIF; MAVS	The identification and quantitative analysis of protein-protein interactions are essential to the functional characterization of proteins in the post-proteomics era. The methods currently available are generally time-consuming, technically complicated, insensitive and/or semi-quantitative. The lack of simple, sensitive approaches to precisely quantify protein-protein interactions still prevents our understanding of the functions of many proteins. Here, we develop a novel dual luciferase reporter pull-down assay by combining a biotinylated Firefly luciferase pull-down assay with a dual luciferase reporter assay. The biotinylated Firefly luciferase-tagged protein enables rapid and efficient isolation of a putative Renilla luciferase-tagged binding protein from a relatively small amount of sample. Both of these proteins can be quantitatively detected using the dual luciferase reporter assay system. Protein-protein interactions, including Fos-Jun located in the nucleus; MAVS-TRAF3 in cytoplasm; inducible IRF3 dimerization; viral protein-regulated interactions, such as MAVS-MAVS and MAVS-TRAF3; IRF3 dimerization; and protein interaction domain mapping, are studied using this novel assay system. Herein, we demonstrate that this dual luciferase reporter pull-down assay enables the quantification of the relative amounts of interacting proteins that bind to streptavidin-coupled beads for protein purification. This study provides a simple, rapid, sensitive, and efficient approach to identify and quantify relative protein-protein interactions. Importantly, the dual luciferase reporter pull-down method will facilitate the functional determination of proteins.	[Jia, Shuaizheng; Peng, Jianchun; Gao, Bo; Zhou, Yong; Fu, Qiuxia; Zhan, Linsheng] Beijing Inst Transfus Med, Beijing, Peoples R China; [Chen, Zhongbin] Beijing Inst Radiat Med, Beijing, Peoples R China; [Wang, Haiping] Hosp 307 Chinese Peoples Liberat Army, Dept Blood Transfus, Beijing, Peoples R China	Academy of Military Medical Sciences - China	Jia, SZ (corresponding author), Beijing Inst Transfus Med, Beijing, Peoples R China.	lszhan91@yahoo.com	ZHANG, LIN/GYD-9123-2022; Zhan, Linsheng/AAR-5687-2021; zhan, lin/AAP-5149-2020					Baril M, 2009, J VIROL, V83, P1299, DOI 10.1128/JVI.01659-08; Barrios-Rodiles M, 2005, SCIENCE, V307, P1621, DOI 10.1126/science.1105776; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Saha SK, 2006, EMBO J, V25, P3257, DOI 10.1038/sj.emboj.7601220; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sherf BA., 1996, PROMEGA NOTES, V57, P2; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tang ED, 2009, J VIROL, V83, P3420, DOI 10.1128/JVI.02623-08; Viens A, 2004, ANAL BIOCHEM, V325, P68, DOI 10.1016/j.ab.2003.10.015; Villalobos V, 2007, ANNU REV BIOMED ENG, V9, P321, DOI 10.1146/annurev.bioeng.9.060906.152044; Pinto MGV, 2009, PROTEOMICS, V9, P5303, DOI 10.1002/pmic.200900298	19	7	8	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26414	10.1371/journal.pone.0026414	http://dx.doi.org/10.1371/journal.pone.0026414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039483	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500065
J	McKinley, AC; Dafforn, KA; Taylor, MD; Johnston, EL				McKinley, Andrew C.; Dafforn, Katherine A.; Taylor, Matthew D.; Johnston, Emma L.			High Levels of Sediment Contamination Have Little Influence on Estuarine Beach Fish Communities	PLOS ONE			English	Article							AUSTRALIAN ESTUARIES; SEWAGE-SLUDGE; MARINE; INVERTEBRATES; EXPOSURE; METAANALYSIS; ASSEMBLAGES; RECRUITMENT; RICHNESS; IMPACTS	While contaminants are predicted to have measurable impacts on fish assemblages, studies have rarely assessed this potential in the context of natural variability in physico-chemical conditions within and between estuaries. We investigated links between the distribution of sediment contamination (metals and PAHs), physico-chemical variables (pH, salinity, temperature, turbidity) and beach fish assemblages in estuarine environments. Fish communities were sampled using a beach seine within the inner and outer zones of six estuaries that were either heavily modified or relatively unmodified by urbanization and industrial activity. All sampling was replicated over two years with two periods sampled each year. Shannon diversity, biomass and abundance were all significantly higher in the inner zone of estuaries while fish were larger on average in the outer zone. Strong differences in community composition were also detected between the inner and outer zones. Few differences were detected between fish assemblages in heavily modified versus relatively unmodified estuaries despite high concentrations of sediment contaminants in the inner zones of modified estuaries that exceeded recognized sediment quality guidelines. Trends in species distributions, community composition, abundance, Shannon diversity, and average fish weight were strongly correlated to physico-chemical variables and showed a weaker relationship to sediment metal contamination. Sediment PAH concentrations were not significantly related to the fish assemblage. These findings suggest that variation in some physico-chemical factors (salinity, temperature, pH) or variables that co-vary with these factors (e. g., wave activity or grain size) have a much greater influence on this fish assemblage than anthropogenic stressors such as contamination.	[McKinley, Andrew C.; Dafforn, Katherine A.; Taylor, Matthew D.; Johnston, Emma L.] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney	McKinley, AC (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	andrew.mckinley@hotmail.com	Johnston, Emma L/B-7210-2009; Johnston, Emma/AAC-2878-2022; Taylor, Matthew/C-4833-2008; Dafforn, Katherine A/J-9647-2013	Johnston, Emma L/0000-0002-2117-366X; Johnston, Emma/0000-0002-2117-366X; Dafforn, Katherine A/0000-0001-8848-377X	Australian Research Council; Canadian National Sciences and Engineering Research Council; Animal Care and Ethics Committee of the University of New South Wales [09/110A]; New South Wales Department of Primary Industries [P09/0072-1.0]	Australian Research Council(Australian Research Council); Canadian National Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Animal Care and Ethics Committee of the University of New South Wales; New South Wales Department of Primary Industries	This research was primarily supported by the Australian Research Council through an Australian Research Fellowship awarded to ELJ and a Linkage Grant awarded to ELJ. The writing of this manuscript was also supported through the Canadian National Sciences and Engineering Research Council through an award given to ACM. http://www.arc.gov.au/. http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Cian Foster-Thorpe, Shinjiro Ushiama, David Day, Valeriya Komyakova, and Anthousa Harris for their assistance in the field. We would also like to thank the Bluescope Steel Company for their generous support of this research and Marine Parks NSW for their help and advice. This study was approved and carried out in strict accordance with the recommendations of the Animal Care and Ethics Committee of the University of New South Wales (Project No. 09/110A) and the New South Wales Department of Primary Industries (Permit No. P09/0072-1.0).	Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDERSON MJ, 2003, PCO PRINCIPAL COORDI; *ANRA, 2009, LAND US CLYD RIV JER; ANZECC (Australian and New Zealand Environment and Conservation Council), 2000, GUID FRESH MAR WAT Q; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Burton GA, 2010, ENVIRON TOXICOL CHEM, V29, P2625, DOI 10.1002/etc.332; CASTILLA JC, 1983, MAR POLLUT BULL, V14, P459, DOI 10.1016/0025-326X(83)90046-2; Clark BM, 1997, ESTUAR COAST SHELF S, V44, P659, DOI 10.1006/ecss.1996.0151; COSTELLO MJ, 1994, MAR ENVIRON RES, V37, P23, DOI 10.1016/0141-1136(94)90061-2; DALLINGER R, 1987, OECOLOGIA, V73, P91, DOI 10.1007/BF00376982; Deegan LA, 2002, ESTUARIES, V25, P727, DOI 10.1007/BF02804902; DSEWPC, 2011, INT BIOG REG AUSTR; Edgar GJ, 1995, J EXP MAR BIOL ECOL, V194, P107, DOI 10.1016/0022-0981(95)00085-2; Element C., 2007, FRESEN J ANAL CHEM, V111, P362; Elliott M, 2007, FISH FISH, V8, P241, DOI 10.1111/j.1467-2679.2007.00253.x; Froese R., 2014, FISHBASE; Gomon M.F., 2008, FISHES AUSTRALIAS SO; Hall BD, 1997, WATER AIR SOIL POLL, V100, P13; IVERSON RL, 1990, LIMNOL OCEANOGR, V35, P1593, DOI 10.4319/lo.1990.35.7.1593; Johnston EL, 2009, ENVIRON POLLUT, V157, P1745, DOI 10.1016/j.envpol.2009.02.017; Kennish MJ, 2002, ENVIRON CONSERV, V29, P78, DOI 10.1017/S0376892902000061; Kingsford MJ, 1996, MAR POLLUT BULL, V33, P201, DOI 10.1016/S0025-326X(96)00166-X; Knott NA, 2009, J APPL ECOL, V46, P770, DOI 10.1111/j.1365-2664.2009.01679.x; Long ER, 2006, ENVIRON SCI TECHNOL, V40, P1726, DOI 10.1021/es058012d; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; MAHER WA, 1992, SCI TOTAL ENVIRON, V112, P143, DOI 10.1016/0048-9697(92)90184-T; MASSELINK G, 1993, J COASTAL RES, V9, P785; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; MCKINLEY AC, J APPL ECOL IN PRESS; McKinley A, 2010, MAR ECOL PROG SER, V420, P175, DOI 10.3354/meps08856; McKinley AC, 2011, ENVIRON POLLUT, V159, P1499, DOI 10.1016/j.envpol.2011.03.008; Miskiewicz A.G., 1998, LARVAE TEMPERATE AUS, P54; MISKIEWICZ AG, 1994, ENVIRON POLLUT, V84, P269, DOI 10.1016/0269-7491(94)90138-4; *NSWDNR, 2010, EST NEW S WAL; PAULY D, 2005, PHILOS T ROYAL SOC B, V360; Potter IC, 1999, AUST J ECOL, V24, P395, DOI 10.1046/j.1442-9993.1999.00980.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; RAKOCINSKI CF, 1992, MAR ECOL PROG SER, V80, P135, DOI 10.3354/meps080135; Reopanichkul P, 2009, MAR POLLUT BULL, V58, P1356, DOI 10.1016/j.marpolbul.2009.04.024; Rice CA, 2006, ESTUARIES COASTS, V29, P63, DOI 10.1007/BF02784699; Robinet TT, 2002, ECOTOXICOLOGY, V11, P265, DOI 10.1023/A:1016352305382; ROUGHGARDEN J, 1988, SCIENCE, V241, P1460, DOI 10.1126/science.11538249; Roy PS, 2001, ESTUAR COAST SHELF S, V53, P351, DOI 10.1006/ecss.2001.0796; Scanes P, 2010, NSW ESTUARINE CATCHM; Taylor MD, 2006, MAR ECOL PROG SER, V328, P237, DOI 10.3354/meps328237; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; van der Oost R, 2003, ENVIRON TOXICOL PHAR, V13, P57, DOI 10.1016/S1382-6689(02)00126-6; Waring CP, 1996, ENVIRON POLLUT, V93, P17, DOI 10.1016/0269-7491(96)00019-X	48	16	17	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26353	10.1371/journal.pone.0026353	http://dx.doi.org/10.1371/journal.pone.0026353			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039470	gold, Green Submitted, Green Published			2022-12-27	WOS:000296507500055
J	Suarez, R; Fernandez-Aburto, P; Manger, PR; Mpodozis, J				Suarez, Rodrigo; Fernandez-Aburto, Pedro; Manger, Paul R.; Mpodozis, Jorge			Deterioration of the G alpha o Vomeronasal Pathway in Sexually Dimorphic Mammals	PLOS ONE			English	Article							ACCESSORY OLFACTORY-BULB; PUTATIVE PHEROMONE RECEPTORS; CALIFORNIA GROUND-SQUIRRELS; SENSORY NEURONS; G-PROTEINS; DIFFERENTIAL LOCALIZATION; AFRICAN ELEPHANT; MULTIGENE FAMILY; SYSTEM; TRANSDUCTION	In mammals, social and sexual behaviours are largely mediated by the vomeronasal system (VNS). The accessory olfactory bulb (AOB) is the first synaptic locus of the VNS and ranges from very large in Caviomorph rodents, small in carnivores and ungulates, to its complete absence in apes, elephants, most bats and aquatic species. Two pathways have been described in the VNS of mammals. In mice, vomeronasal neurons expressing G alpha i2 protein project to the rostral portion of the AOB and respond mostly to small volatile molecules, whereas neurons expressing G alpha o project to the caudal AOB and respond mostly to large non-volatile molecules. However, the G alpha o-expressing pathway is absent in several species (horses, dogs, musk shrews, goats and marmosets) but no hypotheses have been proposed to date to explain the loss of that pathway. We noted that the species that lost the G alpha o pathway belong to Laurasiatheria and Primates lineages, both clades with ubiquitous sexual dimorphisms across species. To assess whether similar events of G alpha o pathway loss could have occurred convergently in dimorphic species we studied G-protein expression in the AOB of two species that independently evolved sexually dimorphic traits: the California ground squirrel Spermophilus beecheyi (Rodentia; Sciurognathi) and the cape hyrax Procavia capensis (Afrotheria; Hyracoidea). We found that both species show uniform expression of G alpha i2-protein throughout AOB glomeruli, while G alpha o expression is restricted to main olfactory glomeruli only. Our results suggest that the degeneration of the G alpha o-expressing vomeronasal pathway has occurred independently at least four times in Eutheria, possibly related to the emergence of sexual dimorphisms and the ability of detecting the gender of conspecifics at distance.	[Suarez, Rodrigo; Fernandez-Aburto, Pedro; Mpodozis, Jorge] Univ Chile, Fac Ciencias, Dept Biol, Lab Neurobiol & Biol Conocer, Santiago, Chile; [Manger, Paul R.] Univ Witwatersrand, Fac Hlth Sci, Sch Anat Sci, Johannesburg, South Africa	Universidad de Chile; University of Witwatersrand	Suarez, R (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	rsuarezsaa@gmail.com	mpodozis, jorge/A-1992-2013; Suarez, Rodrigo/N-9437-2016; Suarez, Rodrigo/J-1529-2014	Suarez, Rodrigo/0000-0001-5153-5652; Suarez, Rodrigo/0000-0001-5153-5652	Mecesup [UCH 0306]; Conicyt; Fondecyt [1080094]	Mecesup; Conicyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	The authors acknowledge financial support from Mecesup UCH 0306, Conicyt (Termino de tesis doctoral) and Fondecyt (1080094). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1999, WALKERS MAMMALS WORL; Arnason U, 2008, GENE, V421, P37, DOI 10.1016/j.gene.2008.05.024; Barry RE, 1998, AFR J ECOL, V36, P221, DOI 10.1046/j.1365-2028.1998.00145.x; Berghard A, 1996, J NEUROSCI, V16, P909; Bursten SN, 2000, J COMP PSYCHOL, V114, P281, DOI 10.1037//0735-7036.114.3.281; Chamero P, 2011, P NATL ACAD SCI USA, V108, P12898, DOI 10.1073/pnas.1107770108; Darwin C., 1871, P423; De Blieux DD, 2006, J VERTEBR PALEONTOL, V26, P160, DOI 10.1671/0272-4634(2006)26[160:SDOTIM]2.0.CO;2; De Blieux DD, 2002, J VERTEBR PALEONTOL, V22, P122, DOI 10.1671/0272-4634(2002)022[0122:CADAOA]2.0.CO;2; Dudley CA, 1999, NEUROSCIENCE, V91, P1549, DOI 10.1016/S0306-4522(98)00711-8; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Enomoto T, 2011, J NEUROSCI, V31, P10159, DOI 10.1523/JNEUROSCI.1245-11.2011; FREDES F, 2009, VIA TECTOFUGAL AVES; Gravett N, 2009, J CHEM NEUROANAT, V38, P57, DOI 10.1016/j.jchemneu.2009.02.005; Halem HA, 2001, J NEUROSCI, V21, P2474, DOI 10.1523/JNEUROSCI.21-07-02474.2001; Hallstrom BM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-162; Halpern M, 1998, MICROSC RES TECHNIQ, V41, P519, DOI 10.1002/(SICI)1097-0029(19980615)41:6<519::AID-JEMT7>3.3.CO;2-C; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; HALPERN M, 1995, BRAIN RES, V677, P157, DOI 10.1016/0006-8993(95)00159-N; HENDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; IMAMURA K, 1985, BRAIN RES, V328, P362, DOI 10.1016/0006-8993(85)91050-9; Inamura K, 1999, EUR J NEUROSCI, V11, P2254, DOI 10.1046/j.1460-9568.1999.00646.x; Isaac JL, 2005, MAMMAL REV, V35, P101, DOI 10.1111/j.1365-2907.2005.00045.x; Jia CP, 1996, BRAIN RES, V719, P117, DOI 10.1016/0006-8993(96)00110-2; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; KOREN L, 2006, THESIS TEL AVIV U TE; Kumar A, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-20-j0003.1999; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; LEE PC, 1986, BEHAV ECOL SOCIOBIOL, V18, P353, DOI 10.1007/BF00299666; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Leinders-Zufall T, 2009, NAT NEUROSCI, V12, P1551, DOI 10.1038/nn.2452; Liman ER, 2003, P NATL ACAD SCI USA, V100, P3328, DOI 10.1073/pnas.0636123100; LOUGHRY WJ, 1988, ANIM BEHAV, V36, P1533, DOI 10.1016/S0003-3472(88)80224-0; MANN G, 1961, J COMP NEUROL, V116, P135, DOI 10.1002/cne.901160204; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Matsuoka M, 1999, NEUROSCI RES, V35, P189, DOI 10.1016/S0168-0102(99)00082-6; Meisami E, 1998, MICROSC RES TECHNIQ, V43, P476, DOI 10.1002/(SICI)1097-0029(19981215)43:6<476::AID-JEMT2>3.3.CO;2-M; MIYASATO L, 2006, ASSESSMENT ALARM CAL; Murphy WJ, 2007, GENOME RES, V17, P413, DOI 10.1101/gr.5918807; Ngwenya A, 2011, BRAIN STRUCT FUNCT, V216, P403, DOI 10.1007/s00429-011-0316-y; RALLS K, 1977, AM NAT, V111, P917, DOI 10.1086/283223; ROSE KD, 2006, BEGINNING AGE MAMMAL; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Schulte-Hostedde Albrecht I., 2007, P115; Shi P, 2007, GENOME RES, V17, P166, DOI 10.1101/gr.6040007; SHINE R, 1989, Q REV BIOL, V64, P419, DOI 10.1086/416458; SHINOHARA H, 1992, J NEUROSCI, V12, P1275; Shrader AM, 2006, J ZOOL, V270, P40, DOI 10.1111/j.1469-7998.2006.00108.x; SUAREZ R, 2009, 39 ANN M SOC NEUR CH; Suarez R, 2011, J ANAT, V218, P558, DOI 10.1111/j.1469-7580.2011.01357.x; Suarez R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008005; Suarez R, 2009, BEHAV BRAIN RES, V198, P306, DOI 10.1016/j.bbr.2008.11.009; Sugai T, 1997, NEUROSCIENCE, V79, P871, DOI 10.1016/S0306-4522(96)00690-2; Sugai T, 2006, NEUROREPORT, V17, P1663, DOI 10.1097/01.wnr.0000239950.14954.59; Takigami S, 2000, CHEM SENSES, V25, P387, DOI 10.1093/chemse/25.4.387; Takigami S, 2004, CHEM SENSES, V29, P301, DOI 10.1093/chemse/bjh032; Thomas O., 1892, Proceedings of the Zoological Society, P50; Todd NE, 2010, ANAT REC, V293, P62, DOI 10.1002/ar.21011; Young JM, 2007, TRENDS GENET, V23, P212, DOI 10.1016/j.tig.2007.03.004; Zhang JZ, 2003, P NATL ACAD SCI USA, V100, P8337, DOI 10.1073/pnas.1331721100; Zhao HB, 2011, MOL BIOL EVOL, V28, P7, DOI 10.1093/molbev/msq207; [No title captured], DOI DOI 10.1007/BF00299371	64	17	17	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26436	10.1371/journal.pone.0026436	http://dx.doi.org/10.1371/journal.pone.0026436			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039487	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500069
J	Cortese, R; Lewin, J; Backdahl, L; Krispin, M; Wasserkort, R; Eckhardt, F; Beck, S				Cortese, Rene; Lewin, Joern; Baeckdahl, Liselotte; Krispin, Manuel; Wasserkort, Reinhold; Eckhardt, Florian; Beck, Stephan			Genome-Wide Screen for Differential DNA Methylation Associated with Neural Cell Differentiation in Mouse	PLOS ONE			English	Article							EPIGENETIC CONTROL; GENE-EXPRESSION; PLURIPOTENT; PROFILE	Cellular differentiation involves widespread epigenetic reprogramming, including modulation of DNA methylation patterns. Using Differential Methylation Hybridization (DMH) in combination with a custom DMH array containing 51,243 features covering more than 16,000 murine genes, we carried out a genome-wide screen for cell- and tissue-specific differentially methylated regions (tDMRs) in undifferentiated embryonic stem cells (ESCs), in in-vitro induced neural stem cells (NSCs) and 8 differentiated embryonic and adult tissues. Unsupervised clustering of the generated data showed distinct cell- and tissue-specific DNA methylation profiles, revealing 202 significant tDMRs (p<0.005) between ESCs and NSCs and a further 380 tDMRs (p<0.05) between NSCs/ESCs and embryonic brain tissue. We validated these tDMRs using direct bisulfite sequencing (DBS) and methylated DNA immunoprecipitation on chip (MeDIP-chip). Gene ontology (GO) analysis of the genes associated with these tDMRs showed significant (absolute Z score>1.96) enrichment for genes involved in neural differentiation, including, for example, Jag1 and Tcf4. Our results provide robust evidence for the relevance of DNA methylation in early neural development and identify novel marker candidates for neural cell differentiation.	[Cortese, Rene; Lewin, Joern; Krispin, Manuel; Wasserkort, Reinhold; Eckhardt, Florian] Epigenomics AG, Berlin, Germany; [Baeckdahl, Liselotte; Beck, Stephan] UCL, Univ Coll London UCL Canc Inst, London, England	University of London; University College London	Cortese, R (corresponding author), Ctr Addict & Mental Hlth, Krembil Family Epigenet Lab, Toronto, ON, Canada.	Rene_Cortese@camh.net		Cortese, Rene/0000-0001-9262-7828	European Union [LSHG-CT-2005-018883]; High-throughput Epigenetic Regulatory Organisation in Chromatin (HEROIC) [018883]; Wellcome Trust [084071]; Royal Society	European Union(European Commission); High-throughput Epigenetic Regulatory Organisation in Chromatin (HEROIC)(European Commission); Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London)	This work was partially supported by the European Union-sponsored project, High-throughput Epigenetic Regulatory Organisation in Chromatin (HEROIC), contract number 018883. LS was supported by a HEROIC grant, LSHG-CT-2005-018883, from the European Union under the Sixth Framework Programme to SB. SB was supported by the Wellcome Trust (084071) and a Royal Society Wolfson Research Merit Award. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Altun G, 2010, J CELL BIOCHEM, V109, P1, DOI 10.1002/jcb.22374; Backdahl L, 2009, EPIGENETICS-US, V4, P248; Beck S, 2010, NAT BIOTECHNOL, V28, P1026, DOI 10.1038/nbt1010-1026; Biswas A, 2007, STEM CELLS DEV, V16, P213, DOI 10.1089/scd.2006.0081; Campos LS, 2006, J BIOL CHEM, V281, P5300, DOI 10.1074/jbc.M511886200; Doniger SW, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-r7; Down TA, 2008, NAT BIOTECHNOL, V26, P779, DOI 10.1038/nbt1414; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Farooqui AA, 2007, J NEUROSCI RES, V85, P1834, DOI 10.1002/jnr.21268; Fassbender A, 2010, METHODS MOL BIOL, V576, P155, DOI 10.1007/978-1-59745-545-9_9; Geiman TM, 2010, MOL REPROD DEV, V77, P105, DOI 10.1002/mrd.21118; Ghosh S, 2010, EPIGENETICS-US, V5, DOI 10.4161/epi.5.6.12228; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hirabayashi Y, 2010, NAT REV NEUROSCI, V11, P377, DOI 10.1038/nrn2810; Huang THM, 1999, HUM MOL GENET, V8, P459, DOI 10.1093/hmg/8.3.459; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Kaminsky ZA, 2009, NAT GENET, V41, P240, DOI 10.1038/ng.286; Kulikov AV, 2010, ILAR J, V51, pE11, DOI 10.1093/ilar.51.2.E11; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lewin J, 2004, BIOINFORMATICS, V20, P3005, DOI 10.1093/bioinformatics/bth346; Lewin J, 2007, INT J BIOCHEM CELL B, V39, P1539, DOI 10.1016/j.biocel.2007.03.006; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; McNamara RK, 2009, LIPIDS, V44, P1, DOI 10.1007/s11745-008-3244-8; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mohn Fabio, 2009, V507, P55, DOI 10.1007/978-1-59745-522-0_5; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Rozen S, 2000, Methods Mol Biol, V132, P365; Sato S, 2010, GENES CELLS, V15, P607, DOI 10.1111/j.1365-2443.2010.01404.x; Schilling E, 2009, GENOME RES, V19, P2028, DOI 10.1101/gr.095562.109; Schuler GD, 1997, GENOME RES, V7, P541, DOI 10.1101/gr.7.5.541; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598	33	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26002	10.1371/journal.pone.0026002	http://dx.doi.org/10.1371/journal.pone.0026002			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028803	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900024
J	Scott, A; Weldon, S; Buchanan, PJ; Schock, B; Ernst, RK; McAuley, DF; Tunney, MM; Irwin, CR; Elborn, JS; Taggart, CC				Scott, Aaron; Weldon, Sinead; Buchanan, Paul J.; Schock, Bettina; Ernst, Robert K.; McAuley, Danny F.; Tunney, Michael M.; Irwin, Chris R.; Elborn, J. Stuart; Taggart, Clifford C.			Evaluation of the Ability of LL-37 to Neutralise LPS In Vitro and Ex Vivo	PLOS ONE			English	Article							CYSTIC-FIBROSIS LUNG; CATHELICIDIN ANTIMICROBIAL PEPTIDE; SECRETORY LEUCOPROTEASE INHIBITOR; AIRWAY SURFACE FLUID; PSEUDOMONAS-AERUGINOSA; HOST-DEFENSE; ANTIBACTERIAL ACTIVITY; EPITHELIAL-CELLS; BINDING PROTEIN; INNATE IMMUNITY	Background: Human cathelicidin LL-37 is a cationic antimicrobial peptide (AMP) which possesses a variety of activities including the ability to neutralise endotoxin. In this study, we investigated the role of LPS neutralisation in mediating LL-37's ability to inhibit Pseudomonas aeruginosa LPS signalling in human monocytic cells. Methodology/Principal Findings: Pre-treatment of monocytes with LL-37 significantly inhibited LPS-induced IL-8 production and the signalling pathway of associated transcription factors such as NF-kappa B. However, upon removal of LL-37 from the media prior to LPS stimulation, these inhibitory effects were abolished. These findings suggest that the ability of LL-37 to inhibit LPS signalling is largely dependent on extracellular LPS neutralisation. In addition, LL-37 potently inhibited cytokine production induced by LPS extracted from P. aeruginosa isolated from the lungs of cystic fibrosis (CF) patients. In the CF lung, polyanionic molecules such as glycosaminoglycans (GAGs) and DNA bind LL-37 and impact negatively on its antibacterial activity. In order to determine whether such interactions interfere with the LPS neutralising ability of LL-37, the status of LL-37 and its ability to bind LPS in CF sputum were investigated. Overall our findings suggest that in the CF lung, the ability of LL-37 to bind LPS and inhibit LPS-induced IL-8 production is attenuated as a result of binding to DNA and GAGs. However, LL-37 levels and its concomitant LPS-binding activity can be increased with a combination of DNase and GAG lyase (heparinase II) treatment. Conclusions/Significance: Overall, these findings suggest that a deficiency in available LL-37 in the CF lung may contribute to greater LPS-induced inflammation during CF lung disease.	[Scott, Aaron; Weldon, Sinead; Buchanan, Paul J.; Schock, Bettina; McAuley, Danny F.; Elborn, J. Stuart; Taggart, Clifford C.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland; [Ernst, Robert K.] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Tunney, Michael M.] Queens Univ Belfast, Sch Pharm, Belfast, Antrim, North Ireland; [Irwin, Chris R.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Dent Educ, Belfast, Antrim, North Ireland	Queens University Belfast; University System of Maryland; University of Maryland Baltimore; Queens University Belfast; Queens University Belfast	Scott, A (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Infect & Immun, Belfast, Antrim, North Ireland.	s.weldon@qub.ac.uk	Taggart, Clifford C/G-4492-2014; Weldon, Sinead/J-5451-2014; Scott, Aaron/AAB-5203-2019	Weldon, Sinead/0000-0001-5628-6624; Scott, Aaron/0000-0001-9325-5026; Taggart, Clifford/0000-0002-9930-2978; Ernst, Robert/0000-0001-5016-8694; Buchanan, Paul/0000-0002-9055-2794; McAuley, Daniel/0000-0002-3283-1947; elborn, joseph/0000-0002-2323-442X; TUNNEY, MICHAEL/0000-0002-7433-7074	Department for Employment and Learning; Public Health Agency [COM/4275/10, CDV/3650/07] Funding Source: researchfish	Department for Employment and Learning; Public Health Agency	The study was funded by the Department for Employment and Learning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bals R, 1999, J CLIN INVEST, V103, P303, DOI 10.1172/JCI6277; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Bals R, 2001, AM J RESP CELL MOL, V25, P21, DOI 10.1165/ajrcmb.25.1.4436; Bals R, 1999, INFECT IMMUN, V67, P6084, DOI 10.1128/IAI.67.11.6084-6089.1999; Baranska-Rybak W, 2006, J ANTIMICROB CHEMOTH, V57, P260, DOI 10.1093/jac/dki460; BAUGH RF, 1992, ANESTH ANALG, V74, P201, DOI 10.1213/00000539-199202000-00005; Benincasa M, 2009, J PEPT SCI, V15, P595, DOI 10.1002/psc.1142; Bergsson G, 2009, J IMMUNOL, V183, P543, DOI 10.4049/jimmunol.0803959; Bhaskar KR, 1998, HEPATOLOGY, V27, P7, DOI 10.1002/hep.510270103; Bowdish DME, 2005, J LEUKOCYTE BIOL, V77, P451, DOI 10.1189/jlb.0704380; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Bucki R, 2008, J ANTIMICROB CHEMOTH, V62, P329, DOI 10.1093/jac/dkn176; Burton MF, 2009, NAT PROD REP, V26, P1572, DOI 10.1039/b912533g; CAROFF M, 1988, CARBOHYD RES, V175, P273, DOI 10.1016/0008-6215(88)84149-1; Chakraborty K, 2009, J BIOL CHEM, V284, P21810, DOI 10.1074/jbc.M109.001180; Chen Christiane I-U, 2004, J Cyst Fibros, V3, P45, DOI 10.1016/j.jcf.2003.12.008; CHEN CP, 1995, FEBS LETT, V370, P46, DOI 10.1016/0014-5793(95)00792-8; Cigana C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008439; Cirioni O, 2006, ANTIMICROB AGENTS CH, V50, P1672, DOI 10.1128/AAC.50.5.1672-1679.2006; DARVEAU RP, 1983, J BACTERIOL, V155, P831, DOI 10.1128/JB.155.2.831-838.1983; Dooring G, 2009, CELL MICROBIOL, V11, P208, DOI 10.1111/j.1462-5822.2008.01271.x; Donaldson SH, 2007, CHEST, V132, P1631, DOI 10.1378/chest.07-0288; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Ernst RK, 2003, J ENDOTOXIN RES, V9, P395, DOI 10.1179/096805103225002764; Ernst RK, 2007, J INFECT DIS, V196, P1088, DOI 10.1086/521367; Felgentreff K, 2006, PEPTIDES, V27, P3100, DOI 10.1016/j.peptides.2006.07.018; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gibson RL, 2003, AM J RESP CRIT CARE, V168, P918, DOI 10.1164/rccm.200304-505SO; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hajjar AM, 2006, INFECT IMMUN, V74, P6730, DOI 10.1128/IAI.00934-06; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Herasimenka Y, 2005, PEPTIDES, V26, P1127, DOI 10.1016/j.peptides.2005.01.020; Hiemstra PS, 2007, EXP LUNG RES, V33, P537, DOI 10.1080/01902140701756687; Hilliard TN, 2007, THORAX, V62, P1074, DOI 10.1136/thx.2006.074641; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; LETHEM MI, 1990, EUR RESPIR J, V3, P19; Meyer KC, 1997, AM J RESP CRIT CARE, V156, P1536, DOI 10.1164/ajrccm.156.5.9701098; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Nagaoka I, 2001, J IMMUNOL, V167, P3329, DOI 10.4049/jimmunol.167.6.3329; Overhage J, 2008, INFECT IMMUN, V76, P4176, DOI 10.1128/IAI.00318-08; Papakonstantinou E, 2009, BRIT J PHARMACOL, V157, P1111, DOI 10.1111/j.1476-5381.2009.00279.x; Pier GB, 2007, INT J MED MICROBIOL, V297, P277, DOI 10.1016/j.ijmm.2007.03.012; RAHMOUNE H, 1991, AM J RESP CELL MOL, V5, P315, DOI 10.1165/ajrcmb/5.4.315; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Rosenfeld Y, 2006, BBA-BIOMEMBRANES, V1758, P1513, DOI 10.1016/j.bbamem.2006.05.017; Schmidtchen A, 2002, MOL MICROBIOL, V46, P157, DOI 10.1046/j.1365-2958.2002.03146.x; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Shriver Z, 1998, J BIOL CHEM, V273, P22904, DOI 10.1074/jbc.273.36.22904; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; Solic N, 2005, AM J RESP CRIT CARE, V172, P892, DOI 10.1164/rccm.200409-1207OC; Taggart CC, 2002, J BIOL CHEM, V277, P33648, DOI 10.1074/jbc.M203710200; Travis SM, 2000, INFECT IMMUN, V68, P2748, DOI 10.1128/IAI.68.5.2748-2755.2000; Turner J, 1998, ANTIMICROB AGENTS CH, V42, P2206, DOI 10.1128/AAC.42.9.2206; Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC; Weldon S, 2009, J IMMUNOL, V183, P8148, DOI 10.4049/jimmunol.0901716; Xiao W, 2005, CHEST, V128, P2316, DOI 10.1378/chest.128.4.2316	57	74	77	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26525	10.1371/journal.pone.0026525	http://dx.doi.org/10.1371/journal.pone.0026525			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028895	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900072
J	Kim, SH; Sehrawat, A; Sakao, K; Hahm, ER; Singh, SV				Kim, Su-Hyeong; Sehrawat, Anuradha; Sakao, Kozue; Hahm, Eun-Ryeong; Singh, Shivendra V.			Notch Activation by Phenethyl Isothiocyanate Attenuates Its Inhibitory Effect on Prostate Cancer Cell Migration	PLOS ONE			English	Article							DOWN-REGULATION; CRUCIFEROUS VEGETABLES; CHEMOPREVENTIVE AGENT; DIALLYL TRISULFIDE; ANDROGEN RECEPTOR; INDUCED APOPTOSIS; GENE-EXPRESSION; IN-VITRO; ARREST; GROWTH	Phenethyl isothiocyanate (PEITC) is a promising cancer chemopreventive component of edible cruciferous vegetables with in vivo efficacy against prostate cancer in experimental rodents. Cancer chemopreventive response to PEITC is characterized by its ability to inhibit multiple oncogenic signaling pathways, including nuclear factor-kappa B, Akt, and androgen receptor. The present study demonstrates, for the first time, that PEITC treatment activates Notch signaling in malignant as well as normal human prostate cells. Exposure of human prostate cancer cells (LNCaP, PC-3, and DU145) and a normal human prostate epithelial cell line (PrEC) to PEITC resulted in cleavage (active form) of Notch1 and Notch2, and increased transcriptional activity of Notch. In PC-3 and LNCaP cells, PEITC treatment caused induction of Notch ligands Jagged1 and Jagged2 (PC-3), overexpression of c-secretase complex components Presenilin1 and Nicastrin (PC-3), nuclear enrichment of cleaved Notch2, and/or up-regulation of Notch1, Notch2, Jagged1, and/or Jagged2 mRNA. PEITC-induced apoptosis in LNCaP and PC-3 cells was significantly attenuated by RNA interference of Notch2, but not by pharmacological inhibition of Notch1. Inhibition of PC-3 and LNCaP cell migration resulting from PEITC exposure was significantly augmented by knockdown of Notch2 protein as well as pharmacological inhibition of Notch1 activation. Nuclear expression of cleaved Notch2 protein was significantly higher in PC-3 xenografts from PEITC-treated mice and dorsolateral prostates from PEITC-fed TRAMP mice compared with respective control. Because Notch signaling is implicated in epithelial-mesenchymal transition and metastasis, the present study suggests that anti-metastatic effect of PEITC may be augmented by a combination regimen involving a Notch inhibitor.	[Kim, Su-Hyeong] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Sch Med, Univ Pittsburgh Canc Inst, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim, SH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	singhs@upmc.edu			National Cancer Institute [RO1 CA101753-08]; NATIONAL CANCER INSTITUTE [R01CA101753] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This investigation was supported by the National Cancer Institute grant RO1 CA101753-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alimirah F, 2007, NEOPLASIA, V9, P427, DOI 10.1593/neo.07211; Barve A, 2008, PHARM RES-DORDR, V25, P2181, DOI 10.1007/s11095-008-9574-7; Belandia B, 2005, MOL CELL BIOL, V25, P1425, DOI 10.1128/MCB.25.4.1425-1436.2005; Bin Hafeez B, 2009, CLIN CANCER RES, V15, P452, DOI 10.1158/1078-0432.CCR-08-1631; Bommareddy A, 2009, CANCER RES, V69, P3704, DOI 10.1158/0008-5472.CAN-08-4344; Chiao JW, 2004, CARCINOGENESIS, V25, P1403, DOI 10.1093/carcin/bgh136; Clementz AG, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2900; Gong AY, 2009, MOL NUTR FOOD RES, V53, P878, DOI 10.1002/mnfr.200800253; Hecht SS, 2000, DRUG METAB REV, V32, P395, DOI 10.1081/DMR-100102342; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji Y, 2005, PHARM RES-DORDR, V22, P1658, DOI 10.1007/s11095-005-7097-z; Khor TO, 2008, MOL CARCINOGEN, V47, P321, DOI 10.1002/mc.20390; Kim YA, 2007, MOL CANCER THER, V6, P1599, DOI 10.1158/1535-7163.MCT-06-0754; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Kolonel LN, 2000, CANCER EPIDEM BIOMAR, V9, P795; Konsue N, 2010, MOL NUTR FOOD RES, V54, P426, DOI 10.1002/mnfr.200900090; Leong KG, 2008, DIFFERENTIATION, V76, P699, DOI 10.1111/j.1432-0436.2008.00288.x; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; O'Neill CF, 2007, AM J PATHOL, V171, P1023, DOI 10.2353/ajpath.2007.061029; Powolny AA, 2011, JNCI-J NATL CANCER I, V103, P571, DOI 10.1093/jnci/djr029; Powolny AA, 2010, PHARM RES-DORDR, V27, P2766, DOI 10.1007/s11095-010-0278-4; Santagata S, 2004, CANCER RES, V64, P6854, DOI 10.1158/0008-5472.CAN-04-2500; Scorey N, 2006, PROSTATE CANCER P D, V9, P399, DOI 10.1038/sj.pcan.4500894; Shou JY, 2001, CANCER RES, V61, P7291; Song J, 2008, FEBS LETT, V582, P1693, DOI 10.1016/j.febslet.2008.04.024; STONER GD, 1991, CANCER RES, V51, P2063; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wakabayashi N, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000762; Wang LG, 2006, CARCINOGENESIS, V27, P2124, DOI 10.1093/carcin/bgl075; Wang ZW, 2010, J CELL BIOCHEM, V109, P726, DOI 10.1002/jcb.22451; WATTENBERG LW, 1977, J NATL CANCER I, V58, P395, DOI 10.1093/jnci/58.2.395; Xiao D, 2003, CARCINOGENESIS, V24, P891, DOI 10.1093/carcin/bgg023; Xiao D, 2005, CLIN CANCER RES, V11, P2670, DOI 10.1158/1078-0432.CCR-04-1545; Xiao D, 2004, ONCOGENE, V23, P5594, DOI 10.1038/sj.onc.1207747; Xiao D, 2004, MOL CANCER THER, V3, P567; Xiao D, 2007, CANCER RES, V67, P2239, DOI 10.1158/0008-5472.CAN-06-3645; Xiao D, 2006, CARCINOGENESIS, V27, P2223, DOI 10.1093/carcin/bgl087; Xiao D, 2010, J BIOL CHEM, V285, P26558, DOI 10.1074/jbc.M109.063255; Xiao D, 2010, PHARM RES-DORDR, V27, P722, DOI 10.1007/s11095-010-0079-9; Xu CJ, 2005, ONCOGENE, V24, P4486, DOI 10.1038/sj.onc.1208656; Zhang YX, 2006, INT J CANCER, V119, P2071, DOI 10.1002/ijc.22077	45	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26615	10.1371/journal.pone.0026615	http://dx.doi.org/10.1371/journal.pone.0026615			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039516	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000296515200031
J	Giritharan, G; Ilic, D; Gormley, M; Krtolica, A				Giritharan, Gnanaratnam; Ilic, Dusko; Gormley, Matthew; Krtolica, Ana			Human Embryonic Stem Cells Derived from Embryos at Different Stages of Development Share Similar Transcription Profiles	PLOS ONE			English	Article							TERMINAL DOMAIN; GENE; EXPRESSION; FAMILY; PROTEIN; 4-CELL; BLASTOMERES; GALECTINS	We have derived hESC from biopsied blastomeres of cleavage stage embryos under virtually the same conditions we used for the derivation of hESC lines from inner cell mass of blastocyst stage embryos. Blastomere-derived hESC lines exhibited all the standard characteristics of hESC including undifferentiated proliferation, genomic stability, expression of pluripotency markers and the ability to differentiate into the cells of all three germ layers both in vitro and in vivo. To examine whether hESC lines derived from two developmental stages of the embryo differ in gene expression, we have subjected three blastomere-derived hESC lines and two ICM-derived hESC lines grown under identical culture conditions to transcriptome analysis using gene expression arrays. Unlike previously reported comparisons of hESC lines which demonstrated, apart from core hESC-associated pluripotency signature, significant variations in gene expression profiles of different lines, our data show that hESC lines derived and grown under well-controlled defined culture conditions adopt nearly identical gene expression profiles. Moreover, blastomere-derived and ICM-derived hESC exhibited very similar transcriptional profiles independent of the developmental stage of the embryo from which they originated. Furthermore, this profile was evident in very early passages of the cells and did not appear to be affected by extensive passaging. These results suggest that during derivation process cells which give rise to hESC acquire virtually identical stable phenotype and are not affected by the developmental stage of the starting cell population.	[Giritharan, Gnanaratnam; Ilic, Dusko; Krtolica, Ana] StemLifeLine Inc, SLL Sci, San Carlos, CA USA; [Gormley, Matthew] Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Giritharan, G (corresponding author), StemLifeLine Inc, SLL Sci, San Carlos, CA USA.	akrtolica@sllsciences.com		ILIC, DUSKO/0000-0003-1647-0026	StemLifeLine, Inc.	StemLifeLine, Inc.	This work was supported by StemLifeLine, Inc. through the employment of Gnanaratnam Giritharan, Dusko Ilic and Ana Krtolica. StemLifeLine conceived, designed and performed the experiments and analyzed the data.	Abedin MJ, 2003, J LEUKOCYTE BIOL, V73, P650, DOI 10.1189/jlb.0402163; Aberg K, 2006, P NATL ACAD SCI USA, V103, P7482, DOI 10.1073/pnas.0601213103; Ackerman SJ, 2002, J BIOL CHEM, V277, P14859, DOI 10.1074/jbc.M200221200; Albrecht DE, 2004, J BIOL CHEM, V279, P7014, DOI 10.1074/jbc.M312205200; Ballow DJ, 2006, GENE EXPR PATTERNS, V6, P1014, DOI 10.1016/j.modgep.2006.04.007; Becker R, 2008, J BIOL CHEM, V283, P22659, DOI 10.1074/jbc.M803540200; Bock C, 2011, CELL, V144, P439, DOI 10.1016/j.cell.2010.12.032; BRAUDE P, 1988, NATURE, V332, P459, DOI 10.1038/332459a0; Bresson-Mazet C, 2008, CELL PROLIFERAT, V41, P726, DOI 10.1111/j.1365-2184.2008.00554.x; Chen TP, 1998, MOL CELL BIOL, V18, P4863, DOI 10.1128/MCB.18.8.4863; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Cole MF, 2008, COLD SH Q B, V73, P183, DOI 10.1101/sqb.2008.73.027; Fulka H, 2004, REPRODUCTION, V128, P703, DOI 10.1530/rep.1.00217; Geens M, 2009, HUM REPROD, V24, P2709, DOI 10.1093/humrep/dep262; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gong TWL, 2003, GENOMICS, V82, P143, DOI 10.1016/S0888-7543(03)00111-3; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guy J, 2003, GENOME RES, V13, P159, DOI 10.1101/gr.644503; Ilic D, 2009, STEM CELLS DEV, V18, P1343, DOI 10.1089/scd.2008.0416; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kikani CK, 2010, J BIOL CHEM, V285, P41034, DOI 10.1074/jbc.M110.157594; Krtolica A, 2007, STEM CELLS, V25, P2215, DOI 10.1634/stemcells.2007-0230; Kruger M, 2000, P NATL ACAD SCI USA, V97, P8566, DOI 10.1073/pnas.97.15.8566; Laurent LC, 2011, CELL STEM CELL, V8, P106, DOI 10.1016/j.stem.2010.12.003; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lerner M, 2007, MOL BIOL CELL, V18, P1670, DOI 10.1091/mbc.E06-03-0248; Long KR, 2010, J CELL BIOL, V190, P115, DOI 10.1083/jcb.201004132; Mao M, 1996, P NATL ACAD SCI USA, V93, P5910, DOI 10.1073/pnas.93.12.5910; O'Toole JF, 2010, J CLIN INVEST, V120, P791, DOI 10.1172/JCI40076; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Petit MMR, 1999, GENOMICS, V57, P438, DOI 10.1006/geno.1999.5778; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Than NG, 2009, P NATL ACAD SCI USA, V106, P9731, DOI 10.1073/pnas.0903568106; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Turner S, 2010, MOL HUM REPROD, V16, P685, DOI 10.1093/molehr/gaq048; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Van de Velde H, 2008, HUM REPROD, V23, P1742, DOI 10.1093/humrep/den190; Yuryev A, 1996, P NATL ACAD SCI USA, V93, P6975, DOI 10.1073/pnas.93.14.6975; ZAHRAOUI A, 1989, J BIOL CHEM, V264, P12394; Zhang P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007844	43	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26570	10.1371/journal.pone.0026570	http://dx.doi.org/10.1371/journal.pone.0026570			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039509	Green Published, Green Submitted			2022-12-27	WOS:000296513200030
J	Kapoor, A; Shandilya, M; Kundu, S				Kapoor, Abhijeet; Shandilya, Manish; Kundu, Suman			Structural Insight of Dopamine beta-Hydroxylase, a Drug Target for Complex Traits, and Functional Significance of Exonic Single Nucleotide Polymorphisms	PLOS ONE			English	Article							FAST INTERACTION REFINEMENT; STRUCTURE PREDICTION; STRUCTURE VALIDATION; CHROMAFFIN GRANULES; PARKINSONS-DISEASE; MONONUCLEAR COPPER; MOLECULAR DOCKING; SULFUR LIGAND; WEB SERVER; DBH GENE	Background: Human dopamine beta-hydroxylase (DBH) is an important therapeutic target for complex traits. Several single nucleotide polymorphisms (SNPs) have also been identified in DBH with potential adverse physiological effect. However, difficulty in obtaining diffractable crystals and lack of a suitable template for modeling the protein has ensured that neither crystallographic three-dimensional structure nor computational model for the enzyme is available to aid rational drug design, prediction of functional significance of SNPs or analytical protein engineering. Principal Findings: Adequate biochemical information regarding human DBH, structural coordinates for peptidylglycine alpha-hydroxylating monooxygenase and computational data from a partial model of rat DBH were used along with logical manual intervention in a novel way to build an in silico model of human DBH. The model provides structural insight into the active site, metal coordination, subunit interface, substrate recognition and inhibitor binding. It reveals that DOMON domain potentially promotes tetramerization, while substrate dopamine and a potential therapeutic inhibitor nepicastat are stabilized in the active site through multiple hydrogen bonding. Functional significance of several exonic SNPs could be described from a structural analysis of the model. The model confirms that SNP resulting in Ala318Ser or Leu317Pro mutation may not influence enzyme activity, while Gly482Arg might actually do so being in the proximity of the active site. Arg549Cys may cause abnormal oligomerization through non-native disulfide bond formation. Other SNPs like Glu181, Glu250, Lys239 and Asp290 could potentially inhibit tetramerization thus affecting function. Conclusions: The first three-dimensional model of full-length human DBH protein was obtained in a novel manner with a set of experimental data as guideline for consistency of in silico prediction. Preliminary physicochemical tests validated the model. The model confirms, rationalizes and provides structural basis for several biochemical data and claims testable hypotheses regarding function. It provides a reasonable template for drug design as well.	[Kapoor, Abhijeet; Shandilya, Manish; Kundu, Suman] Univ Delhi S Campus, Dept Biochem, New Delhi, India	University of Delhi	Kapoor, A (corresponding author), Univ Delhi S Campus, Dept Biochem, New Delhi, India.	sumankundu7@gmail.com	Shandilya, Manish/AAU-7961-2020; Kapoor, Abhijeet/V-3284-2019	Shandilya, Manish/0000-0003-2983-7958; Kapoor, Abhijeet/0000-0002-3606-3463	Department of Biotechnology (DBT), Government of India [BT/01/COE/07/UDSC]; University of Delhi University; University Grants Commission, Government of India	Department of Biotechnology (DBT), Government of India(Department of Biotechnology (DBT) India); University of Delhi University; University Grants Commission, Government of India(University Grants Commission, India)	Financial assistance from Department of Biotechnology (DBT,http://dbtindia.nic.in/index.asp#), Government of India in the form of research grant to SK (BT/01/COE/07/UDSC) is especially acknowledged. Research and Development funding by University of Delhi (www.du.ac.in) University are also duly acknowledged. Financial assistance to MS in the form of research fellowship by University Grants Commission (www.ugc.ac.in), Government of India is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Aravind L, 2001, TRENDS BIOCHEM SCI, V26, P524, DOI 10.1016/S0968-0004(01)01924-7; ASH DE, 1984, J BIOL CHEM, V259, P3395; Bhaduri N, 2003, INT ARCH BIOSCI, P1122; Bhaduri N, 2008, CELL MOL NEUROBIOL, V28, P343, DOI 10.1007/s10571-007-9256-8; BLACKBURN NJ, 1991, J BIOL CHEM, V266, P23120; BLACKBURN NJ, 1988, BIOCHEMISTRY-US, V27, P6001, DOI 10.1021/bi00416a026; BLACKBURN NJ, 1990, J BIOL CHEM, V265, P15383; BRENNER MC, 1989, BIOCHEMISTRY-US, V28, P4656, DOI 10.1021/bi00437a022; Bulheller BM, 2009, BIOINFORMATICS, V25, P539, DOI 10.1093/bioinformatics/btp016; Cargill M, 1999, NAT GENET, V22, P231, DOI 10.1038/10290; Champloy F, 1998, INORG CHEM, V37, P3910, DOI 10.1021/ic9709281; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Comings DE, 1996, AM J MED GENET, V67, P264, DOI 10.1002/(SICI)1096-8628(19960531)67:3<264::AID-AJMG4>3.0.CO;2-N; Cubells JF, 1997, AM J MED GENET, V74, P374, DOI 10.1002/(SICI)1096-8628(19970725)74:4<374::AID-AJMG7>3.0.CO;2-P; DUONG LT, 1985, J BIOL CHEM, V260, P2393; Fernandez F, 2009, NEUROGENETICS, V10, P199, DOI 10.1007/s10048-009-0176-2; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202; GOLDSTEIN M, 1964, LIFE SCI, V3, P763, DOI 10.1016/0024-3205(64)90031-1; GOLDSTEIN M, 1964, BIOCHEM PHARMACOL, V13, P1103, DOI 10.1016/0006-2952(64)90109-1; Grimmelikhuijzen CJP, 1994, BIOSYNTHESIS NEUROPE, P97; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; ISHII A, 1991, NEUROSCI LETT, V125, P25, DOI 10.1016/0304-3940(91)90121-9; Iyer LM, 2007, BIOINFORMATICS, V23, P2660, DOI 10.1093/bioinformatics/btm411; Kamachi T, 2005, INORG CHEM, V44, P4226, DOI 10.1021/ic048477p; Karshikoff A, 2007, METHODS PROTEIN STRU, P71; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kieling C, 2008, AM J MED GENET B, V147B, P485, DOI 10.1002/ajmg.b.30636; KLINMAN JP, 1984, J BIOL CHEM, V259, P3399; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LAMOUROUX A, 1987, EMBO J, V6, P3931, DOI 10.1002/j.1460-2075.1987.tb02734.x; Li B, 1996, BIOCHEM J, V313, P57, DOI 10.1042/bj3130057; LIEBERMAN AN, 1972, LANCET, V1, P153; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; MCCRACKEN J, 1988, BIOCHEMISTRY-US, V27, P4133, DOI 10.1021/bi00411a034; Narita M, 1996, FEBS LETT, V396, P208, DOI 10.1016/0014-5793(96)01091-5; Nunes T, 2010, HLTH SUBJECTS DRUGS, V10, P225; OBATA A, 1987, BIOCHEMISTRY-US, V26, P4962, DOI 10.1021/bi00390a012; OCONNOR DT, 1979, MOL PHARMACOL, V16, P529; PETTINGILL TM, 1991, J BIOL CHEM, V266, P16996; Pierce B, 2008, PROTEINS, V72, P270, DOI 10.1002/prot.21920; Prigge ST, 2004, SCIENCE, V304, P864, DOI 10.1126/science.1094583; Prigge ST, 2000, CELL MOL LIFE SCI, V57, P1236, DOI 10.1007/PL00000763; REEDY BJ, 1994, J AM CHEM SOC, V116, P1924, DOI 10.1021/ja00084a037; ROBERTSON JG, 1994, BIOCHEMISTRY-US, V33, P11563, DOI 10.1021/bi00204a019; Ross OA, 2008, PARKINSONISM RELAT D, V14, P544, DOI 10.1016/j.parkreldis.2008.07.002; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Santra BK, 2002, INORG CHEM, V41, P1328, DOI 10.1021/ic010926n; SAXENA A, 1985, J BIOL CHEM, V260, P3386; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Stanley W.C., 1998, HEART FAIL REV, V2, P195, DOI [10.1023/A:1009721100943, DOI 10.1023/A:1009721100943]; Stanley WC, 1997, BRIT J PHARMACOL, V121, P1803, DOI 10.1038/sj.bjp.0701315; STEWART LC, 1988, ANNU REV BIOCHEM, V57, P551; Tang Y, 2007, EUR J HUM GENET, V15, P878, DOI 10.1038/sj.ejhg.5201838; Tang YL, 2006, BIOL PSYCHIAT, V60, P1034, DOI 10.1016/j.biopsych.2006.02.017; Thakurta PG, 2004, BIOCHEMISTRY-US, V43, P1532, DOI 10.1021/bi0357659; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Togsverd M, 2008, J AFFECT DISORDERS, V106, P169, DOI 10.1016/j.jad.2007.06.010; Voss NR, 2010, NUCLEIC ACIDS RES, V38, pW555, DOI 10.1093/nar/gkq395; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Zabetian CP, 2001, AM J HUM GENET, V68, P515, DOI 10.1086/318198; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702	69	22	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26509	10.1371/journal.pone.0026509	http://dx.doi.org/10.1371/journal.pone.0026509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028891	gold, Green Published			2022-12-27	WOS:000296510800048
J	Luoto, J; Najnin, N; Mahmud, M; Albert, J; Islam, MS; Luby, S; Unicomb, L; Levine, DI				Luoto, Jill; Najnin, Nusrat; Mahmud, Minhaj; Albert, Jeff; Islam, M. Sirajul; Luby, Stephen; Unicomb, Leanne; Levine, David I.			What Point-of-Use Water Treatment Products Do Consumers Use? Evidence from a Randomized Controlled Trial among the Urban Poor in Bangladesh	PLOS ONE			English	Article							HOUSEHOLD DRINKING-WATER; PROVIDING SUSTAINED ACCESS; FILTRATION; QUALITY	Background: There is evidence that household point-of-use (POU) water treatment products can reduce the enormous burden of water-borne illness. Nevertheless, adoption among the global poor is very low, and little evidence exists on why. Methods: We gave 600 households in poor communities in Dhaka, Bangladesh randomly-ordered two-month free trials of four water treatment products: dilute liquid chlorine (sodium hypochlorite solution, marketed locally as Water Guard), sodium dichloroisocyanurate tablets (branded as Aquatabs), a combined flocculant-disinfectant powdered mixture (the PUR Purifier of Water), and a silver-coated ceramic siphon filter. Consumers also received education on the dangers of untreated drinking water. We measured which products consumers used with self-reports, observation (for the filter), and chlorine tests (for the other products). We also measured drinking water's contamination with E. coli (compared to 200 control households). Findings: Households reported highest usage of the filter, although no product had even 30% usage. E. coli concentrations in stored drinking water were generally lowest when households had Water Guard. Households that self-reported product usage had large reductions in E. coli concentrations with any product as compared to controls. Conclusion: Traditional arguments for the low adoption of POU products focus on affordability, consumers' lack of information about germs and the dangers of unsafe water, and specific products not meshing with a household's preferences. In this study we provided free trials, repeated informational messages explaining the dangers of untreated water, and a variety of product designs. The low usage of all products despite such efforts makes clear that important barriers exist beyond cost, information, and variation among these four product designs. Without a better understanding of the choices and aspirations of the target end-users, household-based water treatment is unlikely to reduce morbidity and mortality substantially in urban Bangladesh and similar populations.	[Luoto, Jill] RAND Corp, Santa Monica, CA 90406 USA; [Najnin, Nusrat; Mahmud, Minhaj; Islam, M. Sirajul; Luby, Stephen; Unicomb, Leanne] Int Ctr Diarrheal Dis Res, Dhaka, Bangladesh; [Mahmud, Minhaj] Bangladesh Inst Dev Studies, Dhaka, Bangladesh; [Albert, Jeff] Aquaya Inst, San Francisco, CA USA; [Levine, David I.] Univ Calif Berkeley, Haas Sch Business, Berkeley, CA 94720 USA	RAND Corporation; International Centre for Diarrhoeal Disease Research (ICDDR); Bangladesh Institute of Development Studies (BIDS); University of California System; University of California Berkeley	Luoto, J (corresponding author), RAND Corp, Santa Monica, CA 90406 USA.	jluoto@rand.org	Mahmud, Minhaj/ABF-8644-2020; Unicomb, Leanne Elizabeth/AAW-4900-2021	Mahmud, Minhaj/0000-0003-2432-6972; Unicomb, Leanne Elizabeth/0000-0002-7757-5641	The Blum Center for Developing Economies; Institute for Research on Labor and Employment at the University of California, Berkeley; Swedish International Development Cooperation Agency; Greater Cincinnati Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD056581] Funding Source: NIH RePORTER	The Blum Center for Developing Economies; Institute for Research on Labor and Employment at the University of California, Berkeley; Swedish International Development Cooperation Agency; Greater Cincinnati Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors gratefully acknowledge financial support from The Blum Center for Developing Economies (http://blumcenter.berkeley.edu/) and the Institute for Research on Labor and Employment (http://irle.berkeley.edu/) at the University of California, Berkeley; Swedish International Development Cooperation Agency (http://www.sida.se/English/); and the Procter & Gamble (P&G) Fund of the Greater Cincinnati Foundation (http://www.gcfdn.org/default.aspx). The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. However, they had no role in study design nor did our other funders.	Albert J, 2010, ENVIRON SCI TECHNOL, V44, P4426, DOI 10.1021/es1000566; Arnold BF, 2007, AM J TROP MED HYG, V76, P354, DOI 10.4269/ajtmh.2007.76.354; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Bridgewater L.L., 2017, STANDARD METHODS EXA, V23rd; Clasen T, 2005, AM J TROP MED HYG, V73, P790, DOI 10.4269/ajtmh.2005.73.790; Clasen T., 2007, BMJ-BRIT MED J, V334, P334; Corker J, 2007, POINT OF USE WATER T; Crump JA, 2005, BMJ-BRIT MED J, V331, P478, DOI 10.1136/bmj.38512.618681.E0; Futures C, 2007, POINT OF USE WATER T; Hoque B, 2007, PUR SAFE DRINKING WA; IMBENS GW, 1994, ECONOMETRICA, V62, P467, DOI 10.2307/2951620; Jain S, 2010, AM J TROP MED HYG, V82, P16, DOI 10.4269/ajtmh.2010.08-0584; JANZ NK, 1984, HEALTH EDUC QUART, V11, P1, DOI 10.1177/109019818401100101; Kols A., 2010, EXTENDED USER TESTIN; Kremer M, 2009, TRICKLE CHLORINE DIS; Lantagne D., 2009, POINT USE WATER TREA; Lantagne D, 2009, ENVIRON SCI TECHNOL, V43, P968, DOI 10.1021/es802252c; Luby SP, 2008, AM J TROP MED HYG, V78, P382, DOI 10.4269/ajtmh.2008.78.382; Luoto J, 2011, LEARNING DISLIKE SAF; Norton DM, 2009, INT J ENVIRON HEAL R, V19, P17, DOI 10.1080/09603120802272219; Rosa G, 2009, SAFE WATER ALL HARNE; SHEPPARD BH, 1988, J CONSUM RES, V15, P325, DOI 10.1086/209170; Sobsey MD, 2008, ENVIRON SCI TECHNOL, V42, P4261, DOI 10.1021/es702746n; Sobsey MD, 2009, ENVIRON SCI TECHNOL, V43, P970, DOI 10.1021/es8026133; Trevett AF, 2004, INT J ENVIRON HEAL R, V14, P273, DOI 10.1080/09603120410001725612; Waddington H., 2009, WATER SANITATION HYG; *WHO, 2005, WORLD HLTH REP	27	53	52	2	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26132	10.1371/journal.pone.0026132	http://dx.doi.org/10.1371/journal.pone.0026132			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028817	gold, Green Submitted, Green Published			2022-12-27	WOS:000296510800020
J	Patrick, SC; Browning, LE				Patrick, Samantha C.; Browning, Lucy E.			Exploration Behaviour Is Not Associated with Chick Provisioning in Great Tits	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; AVIAN PERSONALITIES; PARTNER CONTRIBUTION; PARENTAL EFFORT; OFFSPRING CARE; PARUS-MAJOR; TRADE-OFFS; EVOLUTION; POPULATIONS; QUALITY	In biparental systems, members of the same pair can vary substantially in the amount of parental care they provide to offspring. The extent of this asymmetry should depend on the relative costs and benefits of care. Individual variation in personality is likely to influence this trade-off, and hence is a promising candidate to explain differences in care. In addition, plasticity in parental care may also be associated with personality differences. Using exploration behaviour (EB) as a measure of personality, we investigated these possibilities using both natural and experimental data from a wild population of great tits (Parus major). Contrary to predictions, we found no association between EB and natural variation in provisioning behaviour. Nor was EB linked to responsiveness to experimentally increased brood demand. These results are initially surprising given substantial data from other studies suggesting personality should influence investment in parental care. However, they are consistent with a recent study showing selection on EB is weak and highly context-specific in the focal population. This emphasises the difficulty faced by personality studies attempting to make predictions based on previous work, given that personalities often vary among populations of the same species.	[Patrick, Samantha C.] Univ Oxford, Edward Grey Inst, Oxford, England; [Patrick, Samantha C.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Browning, Lucy E.] Univ New S Wales, Arid Zone Res Stn, Sydney, NSW, Australia	University of Oxford; University of Plymouth; University of New South Wales Sydney	Patrick, SC (corresponding author), Univ Oxford, Edward Grey Inst, Oxford, England.	samantha.patrick@plymouth.ac.uk	Browning, Lucy/B-6030-2011		NERC (Natural Environment Research Council); BBSRC (Biotechnology and Biological Sciences Research Council)	NERC (Natural Environment Research Council)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC (Biotechnology and Biological Sciences Research Council)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Samantha C. Patrick was funded by a NERC (Natural Environment Research Council) studentship, and Lucy E. Browning was funded by a BBSRC (Biotechnology and Biological Sciences Research Council) studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell AM, 2005, J EVOLUTION BIOL, V18, P464, DOI 10.1111/j.1420-9101.2004.00817.x; Benus RF, 1996, ANIM BEHAV, V51, P67, DOI 10.1006/anbe.1996.0006; Biro PA, 2008, TRENDS ECOL EVOL, V23, P361, DOI 10.1016/j.tree.2008.04.003; Boon AK, 2007, ECOL LETT, V10, P1094, DOI 10.1111/j.1461-0248.2007.01106.x; Both C, 2005, J ANIM ECOL, V74, P667, DOI 10.1111/j.1365-2656.2005.00962.x; Brydges NM, 2008, J ANIM ECOL, V77, P229, DOI 10.1111/j.1365-2656.2007.01343.x; Budaev SV, 1999, PERS INDIV DIFFER, V26, P801, DOI 10.1016/S0191-8869(98)00179-2; Burley NT, 2002, PHILOS T R SOC B, V357, P241, DOI 10.1098/rstb.2001.0923; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; Cockburn A, 2006, P ROY SOC B-BIOL SCI, V273, P1375, DOI 10.1098/rspb.2005.3458; Cote J, 2007, P R SOC B, V274, P383, DOI 10.1098/rspb.2006.3734; Dingemanse NJ, 2007, J ANIM ECOL, V76, P1128, DOI 10.1111/j.1365-2656.2007.01284.x; Dingemanse NJ, 2004, BEHAV ECOL, V15, P1023, DOI 10.1093/beheco/arh115; Dingemanse NJ, 2004, P ROY SOC B-BIOL SCI, V271, P847, DOI 10.1098/rspb.2004.2680; Drent P.J., 1999, P 22 INT ORNITHOLOGI, P896; Garcia-Navas V, 2011, IBIS, V153, P59, DOI 10.1111/j.1474-919X.2010.01077.x; Gosler A, 1993, GREAT TIT; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P137, DOI 10.1016/j.neubiorev.2004.06.010; Hinde CA, 2006, BEHAV ECOL, V17, P6, DOI 10.1093/beheco/ari092; Hinde CA, 2007, P ROY SOC B-BIOL SCI, V274, P53, DOI 10.1098/rspb.2006.3692; Hollander FA, 2008, ETHOLOGY, V114, P405, DOI 10.1111/j.1439-0310.2008.01488.x; Houston AI, 1985, ECOLOGICAL CONSEQUEN, P471; Johnstone RA, 2006, BEHAV ECOL, V17, P818, DOI 10.1093/beheco/arl009; Lack D., 1968, pvii; Macleod R, 2005, J ANIM ECOL, V74, P956, DOI 10.1111/j.1365-2656.2005.00993.x; Marchetti C, 2000, ANIM BEHAV, V60, P131, DOI 10.1006/anbe.2000.1443; McNamara JM, 1999, NATURE, V401, P368, DOI 10.1038/43869; MINOT EO, 1986, J ANIM ECOL, V55, P331, DOI 10.2307/4712; Quinn JL, 2009, J ANIM ECOL, V78, P1203, DOI 10.1111/j.1365-2656.2009.01585.x; Roulin A, 2010, ETHOLOGY, V116, P787, DOI 10.1111/j.1439-0310.2010.01793.x; Sanz JJ, 2000, J ANIM ECOL, V69, P74, DOI 10.1046/j.1365-2656.2000.00373.x; Sih A, 2004, TRENDS ECOL EVOL, V19, P622, DOI 10.1016/j.tree.2004.09.018; Sih A, 2004, Q REV BIOL, V79, P241, DOI 10.1086/422893; SLAGSVOLD T, 1994, BEHAVIOUR, V131, P115, DOI 10.1163/156853994X00244; Smiseth PT, 2003, P ROY SOC B-BIOL SCI, V270, P1773, DOI 10.1098/rspb.2003.2444; SMITH HG, 1988, BEHAV ECOL SOCIOBIOL, V22, P447, DOI 10.1007/BF00294983; Stauss MJ, 2005, J AVIAN BIOL, V36, P47, DOI 10.1111/j.0908-8857.2005.02855.x; Tabachnick B.G., 2013, USING MULTIVARIATE S, V6th ed; Thorogood R, 2011, P ROYAL SOC B; Tinbergen JM, 2000, J ANIM ECOL, V69, P323, DOI 10.1046/j.1365-2656.2000.00395.x; TRIVERS RL, 1972, AM ZOOL, V12, P648; van Oers K, 2005, BEHAVIOUR, V142, P1185, DOI 10.1163/156853905774539364; van Overveld T, 2011, BEHAV ECOL, V22, P899, DOI 10.1093/beheco/arr063; van Overveld T, 2010, BIOL LETTERS, V6, P187, DOI 10.1098/rsbl.2009.0764; VERBEEK MEM, 1994, ANIM BEHAV, V48, P1113, DOI 10.1006/anbe.1994.1344; Webb TJ, 2010, METHODS ECOL EVOL, V1, P221, DOI 10.1111/j.2041-210X.2010.00027.x; Wilkin TA, 2009, J AVIAN BIOL, V40, P135, DOI 10.1111/j.1600-048X.2009.04362.x; Wilson DS, 1998, PHILOS T R SOC B, V353, P199, DOI 10.1098/rstb.1998.0202; WILSON DS, 1994, TRENDS ECOL EVOL, V9, P442, DOI 10.1016/0169-5347(94)90134-1; Wolf M, 2007, NATURE, V447, P581, DOI 10.1038/nature05835; Woon-Kee Paek, 1996, Acta Ornithologica (Warsaw), V31, P155; Wright J, 1998, J ANIM ECOL, V67, P620, DOI 10.1046/j.1365-2656.1998.00221.x; Wright J, 1990, BEHAV ECOL, V1, P116, DOI 10.1093/beheco/1.2.116	54	19	19	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26383	10.1371/journal.pone.0026383	http://dx.doi.org/10.1371/journal.pone.0026383			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028867	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800039
J	Sormani, MP; Calabrese, M; Signori, A; Giorgio, A; Gallo, P; De Stefano, N				Sormani, Maria Pia; Calabrese, Massimiliano; Signori, Alessio; Giorgio, Antonio; Gallo, Paolo; De Stefano, Nicola			Modeling the Distribution of New MRI Cortical Lesions in Multiple Sclerosis Longitudinal Studies	PLOS ONE			English	Article							PATHOLOGY; COUNTS	Objective: Recent studies have shown the relevance of the cerebral grey matter involvement in multiple sclerosis (MS). The number of new cortical lesions (CLs), detected by specific MRI sequences, has the potential to become a new research outcome in longitudinal MS studies. Aim of this study is to define the statistical model better describing the distribution of new CLs developed over 12 and 24 months in patients with relapsing-remitting (RR) MS. Methods: Four different models were tested (the Poisson, the Negative Binomial, the zero-inflated Poisson and the zero-inflated Negative Binomial) on a group of 191 RRMS patients untreated or treated with 3 different disease modifying therapies. Sample size for clinical trials based on this new outcome measure were estimated by a bootstrap resampling technique. Results: The zero-inflated Poisson model gave the best fit, according to the Akaike criterion to the observed distribution of new CLs developed over 12 and 24 months both in each treatment group and in the whole RRMS patients group adjusting for treatment effect. Conclusions: The sample size calculations based on the zero-inflated Poisson model indicate that randomized clinical trials using this new MRI marker as an outcome are feasible.	[Sormani, Maria Pia; Signori, Alessio] Univ Genoa, Biostat Unit, Dept Hlth Sci, Genoa, Italy; [Calabrese, Massimiliano; Gallo, Paolo] Univ Hosp Padua, Dept Neurosci, Multiple Sclerosis Ctr, Padua, Italy; [Giorgio, Antonio; De Stefano, Nicola] Univ Siena, Dept Neurol & Behav Sci, I-53100 Siena, Italy	University of Genoa; University of Padua; Azienda Ospedaliera - Universita di Padova; University of Siena	Sormani, MP (corresponding author), Univ Genoa, Biostat Unit, Dept Hlth Sci, Genoa, Italy.	mariapia.sormani@unige.it	Sormani, Maria Pia/ABH-8756-2020; Calabrese, Massimiliano/AAB-7082-2022; Calabrese, Massimiliano/I-6195-2012; Signori, Alessio/L-3081-2016	Calabrese, Massimiliano/0000-0002-3362-7403; Signori, Alessio/0000-0001-6289-9144; De Stefano, Nicola/0000-0003-4930-7639; SORMANI, MARIA PIA/0000-0001-6892-104X	Biogen IDEC; Merck Serono; Actelion; Synthon; Teva; Sanofi Aventis	Biogen IDEC(Biogen); Merck Serono(Merck & Company); Actelion; Synthon; Teva(Teva Pharmaceutical Industries); Sanofi Aventis(Sanofi-Aventis)	Maria Pia Sormani has received consulting fee or honoraria from Biogen IDEC, Merck Serono, Actelion, Synthon. Alessio Signori and Antonio Giorgio have no conflict of interest. Nicola De Stefano has received consulting fee or honoraria and support for travel to meetings by Merck Serono, Teva, Biogen Idec, Sanofi Aventis. Massimiliano Calabrese and Paolo Gallo have received consulting fee or honoraria and support for travel to meetings by Merck Serono, Biogen Idec, Sanofi Aventis. This does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	Calabrese M, 2007, ARCH NEUROL-CHICAGO, V64, P1416, DOI 10.1001/archneur.64.10.1416; Calabrese M, 2012, MULT SCLER INT, V2012, DOI 10.1155/2012/760254; Calabrese M, 2010, NAT REV NEUROL, V6, P438, DOI 10.1038/nrneurol.2010.93; Geurts JJG, 2011, NEUROLOGY, V76, P418, DOI 10.1212/WNL.0b013e31820a0cc4; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Sormani M, 2011, MULT SCLER; Sormani MP, 1999, J NEUROL SCI, V163, P74, DOI 10.1016/S0022-510X(99)00015-5; Stadelmann C, 2008, CURR OPIN NEUROL, V21, P229, DOI 10.1097/01.wco.0000318863.65635.9a; van den Elskamp IJ, 2009, MULT SCLER, V15, P42, DOI 10.1177/1352458508096683	9	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26712	10.1371/journal.pone.0026712	http://dx.doi.org/10.1371/journal.pone.0026712			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028937	gold, Green Published, Green Submitted			2022-12-27	WOS:000296510800066
J	Zins, M; Gueguen, A; Kivimaki, M; Singh-Manoux, A; Leclerc, A; Vahtera, J; Westerlund, H; Ferrie, JE; Goldberg, M				Zins, Marie; Gueguen, Alice; Kivimaki, Mika; Singh-Manoux, Archana; Leclerc, Annette; Vahtera, Jussi; Westerlund, Hugo; Ferrie, Jane E.; Goldberg, Marcel			Effect of Retirement on Alcohol Consumption: Longitudinal Evidence from the French Gazel Cohort Study	PLOS ONE			English	Article							DRINKING; ADULTS; POPULATION; PREDICTORS; MORTALITY; MIDLIFE; GENDER; TRENDS; LIFE; AGE	Background: Little is known about the effect of retirement on alcohol consumption. The objectives were to examine changes in alcohol consumption following retirement, and whether these patterns differ by gender and socioeconomic status. Methods and Findings: We assessed alcohol consumption annually from 5 years before to 5 years after retirement among 10,023 men and 2,361 women of the French Gazel study. Data were analyzed separately for men and women, using repeated-measures logistic regression analysis with generalized estimating equations. Five years prior to retirement, the prevalence of heavy drinking was about 16% among men, and not patterned by socioeconomic status. Among women, this prevalence was 19.5% in managers, 14.7% in intermediate occupations, and 12.8% in clerical workers. Around retirement, the estimated prevalence of heavy drinking increased in both sexes. In men, this increase was 3.1 percentage points for managers, 3.2 in intermediate occupations, 4.6 in clerical workers, and 1.3 in manual workers. In women, this increase was 6.6 percentage points among managers, 4.3 in intermediate occupations, and 3.3 among clerical workers. In men the increase around retirement was followed by a decrease over the following four years, not significant among manual workers; among women such a decrease was also observed in the non-managerial occupations. It is difficult to assess the extent to which the results observed in this cohort would hold for other working populations, other conditions of employment, or in other cultural settings. A plausible explanation for the increase in heavy drinking around retirement could be that increased leisure time after retirement provides more opportunities for drinking, and not having to work during the day after may decrease constraints on drinking. Conclusions: Our findings of increased consumption around retirement suggest that information about negative effects of alcohol consumption should be included in pre-retirement planning programs.	[Zins, Marie; Gueguen, Alice; Singh-Manoux, Archana; Leclerc, Annette; Goldberg, Marcel] Ctr Res Epidemiol & Populat Hlth, Inserm Epidemiol Occupat & Social Determinants Hl, Villejuif, France; [Zins, Marie; Gueguen, Alice; Leclerc, Annette; Goldberg, Marcel] Versailles St Quentin Univ, Versailles, France; [Kivimaki, Mika; Singh-Manoux, Archana; Ferrie, Jane E.] UCL, Dept Epidemiol & Publ Hlth, London, England; [Vahtera, Jussi] Finnish Inst Occupat Hlth, Helsinki, Finland; [Vahtera, Jussi] Univ Turku, Dept Publ Hlth, Turku, Finland; [Westerlund, Hugo] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden; [Kivimaki, Mika; Singh-Manoux, Archana; Ferrie, Jane E.] Univ Helsinki, Dept Epidemiol & Publ Hlth, Helsinki, Finland	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of London; University College London; Finnish Institute of Occupational Health; University of Turku; Stockholm University; University of Helsinki	Zins, M (corresponding author), Ctr Res Epidemiol & Populat Hlth, Inserm Epidemiol Occupat & Social Determinants Hl, Villejuif, France.	marie.zins@inserm.fr	Vahtera, Jussi/J-3271-2013; Kivimaki, Mika/B-3607-2012; Ferrie, Jane/AAZ-2009-2020; Westerlund, Hugo/A-3049-2012; Zins, Marie/AAX-6551-2021; Singh-Manoux, Archana/F-6804-2013; Goldberg, Marcel/I-7834-2012	Kivimaki, Mika/0000-0002-4699-5627; Westerlund, Hugo/0000-0002-8806-5698; Singh-Manoux, Archana/0000-0002-1244-5037; Goldberg, Marcel/0000-0002-6161-5880	INSERM; Versailles Saint Quentin University; Academy of Finland [117604, 124271, 124322, 129262]; BUPA; European Union; National Heart, Lung and Blood Institute and National Institute on Aging, NIH, USA [R01HL036310-20A2, R01AG013196]; Swedish Council for Working Life and Social Research (FAS) [2004-2021, 2007-1143, 2009-1758]; National Institute on Aging, NIH [R01AG013196, R01AG034454]; European Science Foundation; EDF-GDF; Cohortes Sante TGIR Program; Agence Nationale de la Recherche-ANR; Agence francaise de securite sanitaire de l'environnement et du travail-AFSSET; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL036310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034454, R01AG013196] Funding Source: NIH RePORTER; ESRC [RES-451-26-0491] Funding Source: UKRI; MRC [G0902037] Funding Source: UKRI; British Heart Foundation [RG/07/008/23674] Funding Source: researchfish; Economic and Social Research Council [RES-451-26-0491] Funding Source: researchfish; Medical Research Council [G19/35, G0902037, G8802774, G0100222] Funding Source: researchfish	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Versailles Saint Quentin University; Academy of Finland(Academy of Finland); BUPA; European Union(European Commission); National Heart, Lung and Blood Institute and National Institute on Aging, NIH, USA; Swedish Council for Working Life and Social Research (FAS)(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte)); National Institute on Aging, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); European Science Foundation(European Science Foundation (ESF)European Commission); EDF-GDF; Cohortes Sante TGIR Program; Agence Nationale de la Recherche-ANR(French National Research Agency (ANR)); Agence francaise de securite sanitaire de l'environnement et du travail-AFSSET; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	MZ, AG, AL and MG are supported by INSERM and Versailles Saint Quentin University, JV and MK are supported by the Academy of Finland (grants #117604, #124271, #124322 and #129262), MK is additionally supported by the BUPA Specialist research grant, European Union New OSH ERA research programme and the National Heart, Lung and Blood Institute and National Institute on Aging (R01HL036310-20A2; R01AG013196), NIH, USA. HW is supported by the Swedish Council for Working Life and Social Research (FAS, grants #2004-2021, #2007-1143, #2009-1758), JEF is supported by the National Institute on Aging, NIH (R01AG013196), ASM is supported by a EUYRI award from the European Science Foundation and the National Institute on Aging, NIH (R01AG013196; R01AG034454). The Gazel Cohort Study was supported by EDF-GDF and INSERM, and received grants from the 'Cohortes Sante TGIR Program' (http://www.iresp.net/), Agence Nationale de la Recherche-ANR (http://www.agence-nationale-recherche.fr/) and Agence francaise de securite sanitaire de l'environnement et du travail-AFSSET (http://www.afsset.fr/index_2010.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bacharach SB, 2004, J STUD ALCOHOL, V65, P537, DOI 10.15288/jsa.2004.65.537; Beck F, 2008, PRESSE MED, V37, P207, DOI 10.1016/j.lpm.2007.07.011; Bhatti JA, 2008, SCAND J WORK ENV HEA, V34, P307, DOI 10.5271/sjweh.1271; BOSSE R, 1991, J GERONTOL, V46, pP9, DOI 10.1093/geronj/46.1.P9; Bowling A, 2005, BRIT MED J, V331, P1548, DOI 10.1136/bmj.331.7531.1548; Brennan PL, 2010, J STUD ALCOHOL DRUGS, V71, P165, DOI 10.15288/jsad.2010.71.165; Britton A, 2008, J AM GERIATR SOC, V56, P1098, DOI 10.1111/j.1532-5415.2008.01740.x; Chan KK, 2007, ADDICT BEHAV, V32, P967, DOI 10.1016/j.addbeh.2006.07.003; Corrao G, 1991, Epidemiol Prev, V13, P45; EKERDT DJ, 1989, J STUD ALCOHOL, V50, P347, DOI 10.15288/jsa.1989.50.347; Ferreira MP, 2008, J AM DIET ASSOC, V108, P1668, DOI 10.1016/j.jada.2008.07.011; Gmel G, 2000, ADDICTION, V95, P123, DOI 10.1046/j.1360-0443.2000.95112313.x; Goldberg M, 2001, AM J EPIDEMIOL, V154, P373, DOI 10.1093/aje/154.4.373; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Goldberg M, 2006, J CLIN EPIDEMIOL, V59, P1213, DOI 10.1016/j.jclinepi.2006.02.020; Guilbert P, 2007, BAROMETRE SANTE 2005; Harrell FE, 2001, REGRESSION MODELING; Jokela M, 2010, EPIDEMIOLOGY, V21, P284, DOI 10.1097/EDE.0b013e3181d61f53; Kraus L, 2001, ADDICTION, V96, P459, DOI 10.1046/j.1360-0443.2001.9634599.x; Leclerc A, 1994, ARCH MAL PROF, V55, P509; Lemke S, 2008, J STUD ALCOHOL DRUGS, V69, P695, DOI 10.15288/jsad.2008.69.695; LIPSITZ SR, 1994, STAT MED, V13, P1149, DOI 10.1002/sim.4780131106; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Melchior M, 2006, J EPIDEMIOL COMMUN H, V60, P937, DOI 10.1136/jech.2005.042440; Menvielle G, 2007, INT J CANCER, V121, P649, DOI 10.1002/ijc.22721; Perreira KM, 2001, J STUD ALCOHOL, V62, P501, DOI 10.15288/jsa.2001.62.501; Rehm J, 2003, EUR ADDICT RES, V9, P147, DOI 10.1159/000072221; Richman JA, 2006, ADDICT BEHAV, V31, P767, DOI 10.1016/j.addbeh.2005.06.001; Vahtera J, 2009, SLEEP, V32, P1459, DOI 10.1093/sleep/32.11.1459; Westerlund H, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6149; Westerlund H, 2009, LANCET, V374, P1889, DOI 10.1016/S0140-6736(09)61570-1; Wilsnack RW, 2006, J STUD ALCOHOL, V67, P341, DOI 10.15288/jsa.2006.67.341; World Health Organization, 2000, INT GUID MON ALC CON; Zins M, 1999, ADDICTION, V94, P385, DOI 10.1046/j.1360-0443.1999.9433858.x; Zins M, 2009, ADV LIFE COURSE RES, V14, P135, DOI 10.1016/j.alcr.2010.02.003	35	53	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26531	10.1371/journal.pone.0026531	http://dx.doi.org/10.1371/journal.pone.0026531			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028898	Green Published, gold			2022-12-27	WOS:000296510800050
J	Kutiyanawalla, A; Terry, AV; Pillai, A				Kutiyanawalla, Ammar; Terry, Alvin V., Jr.; Pillai, Anilkumar			Cysteamine Attenuates the Decreases in TrkB Protein Levels and the Anxiety/Depression-Like Behaviors in Mice Induced by Corticosterone Treatment	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; DENDRITIC GROWTH; FRONTAL-CORTEX; BRAIN; DEPRESSION; STRESS; BDNF; SCHIZOPHRENIA; EXPRESSION; ANXIETY	Objective: Stress and glucocorticoid hormones, which are released into the circulation following stressful experiences, have been shown to contribute significantly to the manifestation of anxiety-like behaviors observed in many neuropsychiatric disorders. Brain-derived neurotrophic factor (BDNF) signaling through its receptor TrkB plays an important role in stress-mediated changes in structural as well as functional neuroplasticity. Studies designed to elucidate the mechanisms whereby TrkB signaling is regulated in chronic stress might provide valuable information for the development of new therapeutic strategies for several stress-related psychiatric disorders. Materials and Methods: We examined the potential of cysteamine, a neuroprotective compound to attenuate anxiety and depression like behaviors in a mouse model of anxiety/depression induced by chronic corticosterone exposure. Results: Cysteamine administration (150 mg/kg/day, through drinking water) for 21 days significantly ameliorated chronic corticosterone-induced decreases in TrkB protein levels in frontal cortex and hippocampus. Furthermore, cysteamine treatment reversed the anxiety and depression like behavioral abnormalities induced by chronic corticosterone treatment. Finally, mice deficient in TrkB, showed a reduced response to cysteamine in behavioral tests, suggesting that TrkB signaling plays an important role in the antidepressant effects of cysteamine. Conclusions: The animal studies described here highlight the potential use of cysteamine as a novel therapeutic strategy for glucocorticoid-related symptoms of psychiatric disorders.	[Kutiyanawalla, Ammar; Pillai, Anilkumar] Georgia Hlth Sci Univ, Dept Psychiat & Hlth Behav, Augusta, GA USA; [Terry, Alvin V., Jr.] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA USA; [Kutiyanawalla, Ammar; Pillai, Anilkumar] Charlie Norwood Vet Affairs Med Ctr, Med Res Serv, Augusta, GA USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Kutiyanawalla, A (corresponding author), Georgia Hlth Sci Univ, Dept Psychiat & Hlth Behav, Augusta, GA USA.	apillai@georgiahealth.edu	PILLAI, ANILKUMAR/N-4809-2017	Terry, Alvin/0000-0003-2071-4767				Ao MRB, 2008, AUST NZ J PSYCHIAT, V42, P995, DOI 10.1080/00048670802512073; Ardayfio P, 2006, BEHAV NEUROSCI, V120, P249, DOI 10.1037/0735-7044.120.2.249; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Borrell-Pages M, 2006, J CLIN INVEST, V116, P1410, DOI 10.1172/JCI27607; Bourin M, 2003, EUR J PHARMACOL, V463, P55, DOI 10.1016/S0014-2999(03)01274-3; Calabrese F, 2007, NEUROPSYCHOPHARMACOL, V32, P2351, DOI 10.1038/sj.npp.1301360; Castren E, 2010, DEV NEUROBIOL, V70, P289, DOI 10.1002/dneu.20758; Choleris E, 2001, NEUROSCI BIOBEHAV R, V25, P235, DOI 10.1016/S0149-7634(01)00011-2; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Dulawa SC, 2004, NEUROPSYCHOPHARMACOL, V29, P1321, DOI 10.1038/sj.npp.1300433; Duman RS, 2006, BIOL PSYCHIAT, V59, P1116, DOI 10.1016/j.biopsych.2006.02.013; Dwivedi Y, 2010, ANN MED, V42, P87, DOI 10.3109/07853890903485730; Ernst C, 2011, BIOL PSYCHIAT, V69, P604, DOI 10.1016/j.biopsych.2010.10.008; Holmes A, 2001, BEHAV BRAIN RES, V122, P159, DOI 10.1016/S0166-4328(01)00184-X; Horch HW, 2002, NAT NEUROSCI, V5, P1177, DOI 10.1038/nn927; Howell KR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020198; Karl T, 2003, EXP TOXICOL PATHOL, V55, P69, DOI 10.1078/0940-2993-00301; Kessler A, 2008, METAB BRAIN DIS, V23, P81, DOI 10.1007/s11011-007-9078-x; KUTIYANAWALLA A, 2011, INT J NEUROPSYCHOPH, V22, P1; Leitch MM, 2003, NEUROPSYCHOPHARMACOL, V28, P119, DOI 10.1038/sj.npp.1300016; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; McEwen BS, 2010, ANN NY ACAD SCI, V1186, P190, DOI 10.1111/j.1749-6632.2009.05331.x; Pandey GN, 2008, INT J NEUROPSYCHOPH, V11, P1047, DOI 10.1017/S1461145708009000; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pillai A, 2008, J NEUROCHEM, V107, P941, DOI 10.1111/j.1471-4159.2008.05665.x; Pillai A, 2008, NEUROSIGNALS, V16, P183, DOI 10.1159/000111562; Pillai A, 2008, SCHIZOPHR RES, V100, P325, DOI 10.1016/j.schres.2007.11.030; Pollack MH, 2005, J CLIN PSYCHIAT, V66, P22; Rohrer B, 2004, VISUAL NEUROSCI, V21, P703, DOI 10.1017/S095252380421505X; Shieh CH, 2008, PROG NEURO-PSYCHOPH, V32, P1590, DOI 10.1016/j.pnpbp.2008.06.003; Smith MA, 1995, ANN NY ACAD SCI, V771, P234, DOI 10.1111/j.1749-6632.1995.tb44684.x; Sommerfeld MT, 2000, J BIOL CHEM, V275, P8982, DOI 10.1074/jbc.275.12.8982; Weickert CS, 2005, MOL PSYCHIATR, V10, P637, DOI 10.1038/sj.mp.4001678; Wolkowitz OM, 2009, ANN NY ACAD SCI, V1179, P19, DOI 10.1111/j.1749-6632.2009.04980.x; YOUNG EA, 1995, J NEUROENDOCRINOL, V7, P37, DOI 10.1111/j.1365-2826.1995.tb00665.x	36	42	44	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26153	10.1371/journal.pone.0026153	http://dx.doi.org/10.1371/journal.pone.0026153			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039440	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500034
J	Li, RQ; Zou, QH; Chen, LJ; Zhang, HR; Wang, YM				Li, Renqing; Zou, Qinghua; Chen, Lijuan; Zhang, Herun; Wang, Yumei			Molecular Analysis of Virulent Determinants of Enterovirus 71	PLOS ONE			English	Article							MOUTH-DISEASE; STRUCTURE PREDICTION; SECONDARY STRUCTURE; RNA; POLIOVIRUS; HAND; FOOT; STRAINS; NEUROVIRULENCE; ATTENUATION	Enterovirus 71 (EV71) is the most important causative agent of hand, foot and mouth disease (HFMD) in children. In most cases, it is a self-limiting illness. However some EV71 infectious cases can develop severe clinical outcomes, such as encephalitis, meningitis, poliomyelitis like paralysis, and even death. To identify the determinants of virulence, the deduced amino acid sequence of polyprotein and nucleotide sequence of 5'-NTR and 3'-NTR in 25 SC-EV71 strains (strains from severe cases) and 31 MC-EV71 strains (strains from mild cases) were analyzed. Results showed four amino acids on two positions (Gly(P710)/Gln(P710)/Arg(P710) and Glu(P729)) on the DE and EF loop of VP1, one (Lys(P930)) on the surface of protease 2A and four nucleotides on three positions (G(P272), U-P488 and A(P700)/U-P700) in the 5'-NTR region are associated with EV71 virulent phenotype. Predicted secondary structure of RNA using the consensus sequence of 5'-NTR by RNAStructure showed the mutation of nucleotide at position 488 in strain BJ08-Z004-3 (position 491 in prototype strain BrCr) can result in the discrepancy of an additional pair of nucleotides and thus change the stability of the second structure of IRES. Fragment base content analysis showed that in the region 696 to 714 bp at the 5'-NTR, where the A(P700)/U-P700 was located, the nucleotide constitution ratios differed significantly between SC-EV71 and MC-EV71 strains. In conclusion, comparative genomic analysis showed that virulence of EV71 strains are mainly determined by the amino acids on two positions of VP1, one position of protease 2A and the nucleotides on three positions in 5'-NTR.	[Li, Renqing; Chen, Lijuan; Zhang, Herun; Wang, Yumei] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zou, Qinghua] Peking Univ, Hlth Sci Ctr, Dept Microbiol, Beijing 100871, Peoples R China	Peking University	Li, RQ (corresponding author), Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China.	lirenqingz@sina.com			Chinese government	Chinese government	This work was funded by the funds for enterovirus surveillance from Chinese government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbuBakar S, 1999, VIRUS RES, V61, P1, DOI 10.1016/S0168-1702(99)00019-2; ALEXANDER JP, 1994, J INFECT DIS, V169, P905, DOI 10.1093/infdis/169.4.905; Arita M, 2005, J GEN VIROL, V86, P1391, DOI 10.1099/vir.0.80784-0; Arita M, 2008, J VIROL, V82, P1787, DOI 10.1128/JVI.01798-07; Bernhart SH, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-474; Chang GH, 2010, VIRUS RES, V151, P66, DOI 10.1016/j.virusres.2010.04.001; Chang LY, 1998, LANCET, V352, P367, DOI 10.1016/S0140-6736(98)24031-1; CHRISTODOULOU C, 1990, J VIROL, V64, P4922, DOI 10.1128/JVI.64.10.4922-4929.1990; Chua BH, 2008, J GEN VIROL, V89, P1622, DOI 10.1099/vir.0.83676-0; Fujimoto T, 2002, MICROBIOL IMMUNOL, V46, P621, DOI 10.1111/j.1348-0421.2002.tb02743.x; Gromeier M, 1996, P NATL ACAD SCI USA, V93, P2370, DOI 10.1073/pnas.93.6.2370; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; HAGIWARA A, 1984, ARCH VIROL, V79, P273, DOI 10.1007/BF01310816; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Hofacker IL, 2002, J MOL BIOL, V319, P1059, DOI 10.1016/S0022-2836(02)00308-X; Jee YM, 2003, ARCH VIROL, V148, P1735, DOI 10.1007/s00705-003-0133-6; MCGOLDRICK A, 1995, J VIROL, V69, P7601, DOI 10.1128/JVI.69.12.7601-7605.1995; McMinn P, 2001, J VIROL, V75, P7732, DOI 10.1128/JVI.75.16.7732-7738.2001; McMinn PC, 2002, FEMS MICROBIOL REV, V26, P91, DOI 10.1111/j.1574-6976.2002.tb00601.x; Melchers WJG, 1997, J VIROL, V71, P686, DOI 10.1128/JVI.71.1.686-696.1997; MELNICK JL, 1984, REV INFECT DIS, V6, pS387; Merkle I, 2002, J VIROL, V76, P9900, DOI 10.1128/JVI.76.19.9900-9909.2002; Singh S, 2002, MICROBIOL IMMUNOL, V46, P801, DOI 10.1111/j.1348-0421.2002.tb02767.x; SKINNER MA, 1989, J MOL BIOL, V207, P379, DOI 10.1016/0022-2836(89)90261-1; Thompson SR, 2003, VIROLOGY, V315, P259, DOI 10.1016/S0042-6822(03)00544-0; Van Tu P, 2007, EMERG INFECT DIS, V13, P1733, DOI 10.3201/eid1311.070632	26	47	60	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26237	10.1371/journal.pone.0026237	http://dx.doi.org/10.1371/journal.pone.0026237			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039449	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500043
J	Lin, MY; Chen, MC; Wu, IC; Wu, DC; Cheng, YJ; Wu, CC; Chai, CY; Lee, JM; Wu, MT				Lin, Ming-Yen; Chen, Mei-Chin; Wu, I-Chen; Wu, Deng-Chyang; Cheng, Yu-Jen; Wu, Chun-Chieh; Chai, Chee-Yin; Lee, Jang-Ming; Wu, Ming-Tsang			Areca Users in Combination with Tobacco and Alcohol Use Are Associated with Younger Age of Diagnosed Esophageal Cancer in Taiwanese Men	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HIGH-RISK POPULATION; BETEL QUID; ANYANG COUNTY; ORAL-CANCER; SMOKING; CIGARETTE; CHINA; CARCINOGENESIS; PHARYNGEAL	Background: Whether the habitual use of substances (tobacco, alcohol, or areca nut (seed of the Areca palm)) can affect the age of esophageal squamous cell carcinoma (ESCC) presentation has rarely been examined. Methods: The study subjects were those who were males and the first time to be diagnosed as ESCC (ICD-9 150) and who visited any of three medical centers in Taiwan between 2000 and 2009. A standardized questionnaire was used to collect substance uses and other variables. Results: Mean age (+/- SD) at presentation of ESCC was 59.2 (+/- 11.3) years in a total of 668 cases. After adjusting for other covariates, alcohol drinkers were 3.58 years younger to have ESCC than non-drinkers (p = 0.002). A similar result was found among areca chewers, who were 6.34 years younger to have ESCC than non-chewers (p < 0.0001), but not among cigarette smokers (p = 0.10). When compared to the group using 0-1 substances, subjects using both cigarettes and alcohol were nearly 3 years younger to contract ESCC. Furthermore, those who use areca plus another substance were 7-8 years younger. Subjects using all three substances had the greatest age difference, 9.20 years younger (p < 0.0001), compared to the comparison group. Conclusion: Our findings suggest that habitually consuming tobacco, alcohol, and areca nut can influence the age-onset of ESCC. Since the development of ESCC is insidious and life-threatening, our observation is worthy to be reconfirmed in the large-scale and long-term follow-up prospective cohort studies to recommend the screening strategy of this disease.	[Lin, Ming-Yen; Wu, Ming-Tsang] Kaohsiung Med Univ, Grad Inst Occupat Safety & Hlth, Kaohsiung, Taiwan; [Chen, Mei-Chin; Wu, Ming-Tsang] Kaohsiung Med Univ Hosp, Dept Family Med, Kaohsiung, Taiwan; [Wu, I-Chen; Wu, Deng-Chyang] Kaohsiung Med Univ Hosp, Dept Internal Med, Div Gastroenterol, Kaohsiung, Taiwan; [Wu, I-Chen; Wu, Deng-Chyang; Cheng, Yu-Jen; Chai, Chee-Yin; Wu, Ming-Tsang] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan; [Cheng, Yu-Jen] I Shou Univ, E Da Hosp, Div Thorac Surg, Kaohsiung, Taiwan; [Wu, Chun-Chieh; Chai, Chee-Yin] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan; [Lee, Jang-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan; [Wu, Ming-Tsang] Kaohsiung Municipal Hsiaokang Hosp, Ctr Environm & Occupat Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; E-Da Hospital; I Shou University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Taiwan University; National Taiwan University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital	Lin, MY (corresponding author), Kaohsiung Med Univ, Grad Inst Occupat Safety & Hlth, Kaohsiung, Taiwan.	minica@kmu.edu.tw; 960021@ms.kmuh.org.tw	Lin, Ming Yen/A-8637-2010; Wu, Ming-Tsang/G-5637-2012	Lin, Ming Yen/0000-0002-8194-4833; Wu, Ming-Tsang/0000-0001-7307-7816; Chai, Chee-Yin/0000-0003-0486-9742; LEE, JANG-MING/0000-0001-9727-227X	Taiwan National Science Council [NSC97-2314-B-037-MY3]; Department of Health [DOH778-8876-768]; Kaohsiung Medical University [KMUO-O100001]; Kaohsiung Medical University Hospital [KMUH98-8R05]; National Institutes of Health (NIH) [2 R01 ES011297-06]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011297] Funding Source: NIH RePORTER	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Department of Health; Kaohsiung Medical University; Kaohsiung Medical University Hospital; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported in part by grants from the Taiwan National Science Council (NSC97-2314-B-037-MY3), Department of Health (DOH778-8876-768), Kaohsiung Medical University (KMUO-O100001), Kaohsiung Medical University Hospital (KMUH98-8R05), and the National Institutes of Health (NIH 2 R01 ES011297-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boyle P, 1997, LUNG CANCER, V17, P1, DOI 10.1016/S0169-5002(97)00648-X; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; *BUR HLTH PROM DEP, CANC REG REP; Chung CS, 2010, J FORMOS MED ASSOC, V109, P408, DOI 10.1016/S0929-6646(10)60072-1; Dawsey SM, 1998, CANCER-AM CANCER SOC, V83, P220; Department of Health Executive Yuan Taiwan R.O.C., STAT CAUS DEATH; Endo M, 1995, Gan To Kagaku Ryoho, V22, P192; Enzinger PC, 2003, NEW ENGL J MED, V349, P2241, DOI 10.1056/NEJMra035010; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Headrick JR, 2002, ANN THORAC SURG, V73, P1697, DOI 10.1016/S0003-4975(02)03496-3; *INT AG RES CANC, 1988, ALC DRINK, V44; International Agency for Research on Cancer, 2004, IARC MONOGRAPHS EVAL, V83, P1; Jeng JH, 2003, CARCINOGENESIS, V24, P1301, DOI 10.1093/carcin/bgg083; Kim MK, 2009, INT J RADIAT ONCOL, V75, P115, DOI 10.1016/j.ijrobp.2008.10.074; KO YC, 1992, J ORAL PATHOL MED, V21, P261, DOI 10.1111/j.1600-0714.1992.tb01007.x; Kuraoka K, 2009, HEPATO-GASTROENTEROL, V56, P63; Lee CH, 2005, INT J CANCER, V113, P475, DOI 10.1002/ijc.20619; Lee CH, 2007, EUR J CANCER, V43, P1188, DOI 10.1016/j.ejca.2007.01.039; Lee JM, 2005, MUTAT RES-GEN TOX EN, V565, P121, DOI 10.1016/j/mrgentox.2004.10.007; Lee KD, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-373; Lee KW, 2005, INT J CANCER, V117, P831, DOI 10.1002/ijc.21237; Pellegrino S, 1999, J CHROMATOGR B, V729, P103, DOI 10.1016/S0378-4347(99)00131-0; Salaspuro M, 2009, SCAND J GASTROENTERO, V44, P912, DOI 10.1080/00365520902912563; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Smith RA, 2010, CA-CANCER J CLIN, V60, P99, DOI 10.3322/caac.20063; Spechler SJ, 2002, NEW ENGL J MED, V346, P836, DOI 10.1056/NEJMcp012118; Streppel MT, 2007, TOB CONTROL, V16, P107, DOI 10.1136/tc.2006.017715; Tsai HT, 2007, GYNECOL ONCOL, V105, P181, DOI 10.1016/j.ygyno.2006.11.012; TUYNS AJ, 1987, MED ONCOL TUMOR PHAR, V4, P241; Umar SB, 2008, NAT CLIN PRACT GASTR, V5, P517, DOI 10.1038/ncpgasthep1223; Wang LD, 2005, CANCER DETECT PREV, V29, P317, DOI 10.1016/j.cdp.2005.06.004; Wang YC, 2010, ORAL ONCOL, V46, P255, DOI 10.1016/j.oraloncology.2010.01.003; Wen CP, 2010, CANCER CAUSE CONTROL, V21, P1427, DOI 10.1007/s10552-010-9570-1; Wu MT, 2001, BRIT J CANCER, V85, P658, DOI 10.1054/bjoc.2001.1927; Yang HH, 2002, ACTA CYTOL, V46, P445, DOI 10.1159/000326859; YOKOYAMA A, 1995, CANCER, V76, P928, DOI 10.1002/1097-0142(19950915)76:6<928::AID-CNCR2820760604>3.0.CO;2-5; Yoshida M, 1995, Gan To Kagaku Ryoho, V22, P847	37	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25347	10.1371/journal.pone.0025347	http://dx.doi.org/10.1371/journal.pone.0025347			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039411	gold, Green Published, Green Submitted			2022-12-27	WOS:000296507500011
J	Ajjawi, I; Coku, A; Froehlich, JE; Yang, Y; Osteryoung, KW; Benning, C; Last, RL				Ajjawi, Imad; Coku, Ardian; Froehlich, John E.; Yang, Yue; Osteryoung, Katherine W.; Benning, Christoph; Last, Robert L.			A J-Like Protein Influences Fatty Acid Composition of Chloroplast Lipids in Arabidopsis	PLOS ONE			English	Article							J-DOMAIN; MOLECULAR CHAPERONE; PLASTID DIVISION; IMPORT MOTOR; INTERMEMBRANE SPACE; FUNCTIONAL-ANALYSIS; ENVELOPE MEMBRANES; MUTANT DEFICIENT; LEAF LIPIDS; THALIANA	A comprehensive understanding of the lipid and fatty acid metabolic machinery is needed for optimizing production of oils and fatty acids for fuel, industrial feedstocks and nutritional improvement in plants. T-DNA mutants in the poorly annotated Arabidopsis thaliana gene At1g08640 were identified as containing moderately high levels (50-100%) of 16:1 Delta 7 and 18:1 Delta 9 leaf fatty acids and subtle decreases (5-30%) of 16:3 and 18:3 (http://www.plastid.msu.edu/). TLC separation of fatty acids in the leaf polar lipids revealed that the chloroplastic galactolipids monogalactosyldiacylglycerol (MGDG) and digalactosyldiacylglycerol (DGDG) were the main lipid types affected by this mutation. Analysis of the inferred amino acid sequence of At1g08640 predicted the presence of a transit peptide, three transmembrane domains and an N-terminal J-like domain, and the gene was named CJD1 for Chloroplast J-like Domain 1. GFP reporter experiments and in vitro chloroplast import assays demonstrated CJD1 is a chloroplast membrane protein. Screening of an Arabidopsis cDNA library by yeast-2-hybrid (Y2H) using the J-like domain of CJD1 as bait identified a plastidial inner envelope protein (Accumulation and Replication of Chloroplasts 6, ARC6) as the primary interacting partner in the Y2H assay. ARC6 plays a central role in chloroplast division and binds CJD1 via its own J-like domain along with an adjacent conserved region whose function is not fully known. These results provide a starting point for future investigations of how mutations in CJD1 affect lipid composition.	[Ajjawi, Imad; Coku, Ardian; Froehlich, John E.; Benning, Christoph; Last, Robert L.] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Froehlich, John E.] Michigan State Univ, Dept Engn DOE Plant Res Labs, E Lansing, MI 48824 USA; [Yang, Yue; Osteryoung, Katherine W.; Last, Robert L.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; United States Department of Energy (DOE); Michigan State University	Ajjawi, I (corresponding author), Synthet Genom Inc, La Jolla, CA USA.	lastr@msu.edu	Benning, Christoph/Y-2528-2019	Benning, Christoph/0000-0001-8585-3667; Coku, Ardian/0000-0001-7154-9162; Last, Robert/0000-0001-6974-9587	National Science Foundation [MCB-0519740]; Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy (DOE) [DE-FG02-91ER20021]; United States DOE, Office of Basic Energy Sciences [DE-FG02-10ER15808]	National Science Foundation(National Science Foundation (NSF)); Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy (DOE)(United States Department of Energy (DOE)); United States DOE, Office of Basic Energy Sciences(United States Department of Energy (DOE))	The Chloroplast 2010 Project was funded by National Science Foundation Arabidopsis 2010 Program grant number MCB-0519740 awarded to CB, KWO, RLL and others. JEF was funded by the Chemical Sciences, Geosciences, and Biosciences Division, Office of Basic Energy Sciences, Office of Science, United States Department of Energy (DOE), through grant DE-FG02-91ER20021 awarded to KK (Michigan State University (MSU)-DOE Plant Research Laboratory, East Lansing, Michigan). YY was funded by the United States DOE, Office of Basic Energy Sciences through Grant DE-FG02-10ER15808 awarded to KWO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajjawi I, 2010, PLANT PHYSIOL, V152, P529, DOI 10.1104/pp.109.148494; Akita M, 1997, J CELL BIOL, V136, P983, DOI 10.1083/jcb.136.5.983; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bonaventure G, 2002, PLANT PHYSIOL, V128, P223, DOI 10.1104/pp.010397; Bowen AJ, 2010, J MOL BIOL, V395, P937, DOI 10.1016/j.jmb.2009.11.065; Brautigam A, 2008, J BIOTECHNOL, V136, P44, DOI 10.1016/j.jbiotec.2008.02.007; Branen JK, 2003, PLANT PHYSIOL, V132, P748, DOI 10.1104/pp.102.018622; BROWSE J, 1989, PLANT PHYSIOL, V90, P522, DOI 10.1104/pp.90.2.522; BROWSE J, 1986, PLANT PHYSIOL, V81, P859, DOI 10.1104/pp.81.3.859; BROWSE J, 1985, SCIENCE, V227, P763, DOI 10.1126/science.227.4688.763; Bruce BD, 1998, PLANT MOL BIOL, V38, P223, DOI 10.1023/A:1006094308805; Cline K, 2008, CURR OPIN PLANT BIOL, V11, P585, DOI 10.1016/j.pbi.2008.10.008; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; D'Silva PR, 2005, P NATL ACAD SCI USA, V102, P12419, DOI 10.1073/pnas.0505969102; DORMANN P, 1995, PLANT CELL, V7, P1801, DOI 10.1105/tpc.7.11.1801; Durrett TP, 2008, PLANT J, V54, P593, DOI 10.1111/j.1365-313X.2008.03442.x; Dyer JM, 2008, PLANT J, V54, P640, DOI 10.1111/j.1365-313X.2008.03430.x; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; FALCONE DL, 1994, PLANT PHYSIOL, V106, P1453, DOI 10.1104/pp.106.4.1453; Ferro M, 2010, MOL CELL PROTEOMICS, V9, P1063, DOI 10.1074/mcp.M900325-MCP200; Friso G, 2004, PLANT CELL, V16, P478, DOI 10.1105/tpc.017814; Froehlich JE, 2003, J PROTEOME RES, V2, P413, DOI 10.1021/pr034025j; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; GAO J, 2010, PLANT J, V152, P529; Gebauer M, 1997, FEBS LETT, V417, P109, DOI 10.1016/S0014-5793(97)01267-2; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Glynn JM, 2008, PLANT CELL, V20, P2460, DOI 10.1105/tpc.108.061440; Greene MK, 1998, P NATL ACAD SCI USA, V95, P6108, DOI 10.1073/pnas.95.11.6108; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HLOUSEKRADOJCIC A, 1992, PLANT PHYSIOL, V98, P206, DOI 10.1104/pp.98.1.206; Kachroo A, 2007, PLANT MOL BIOL, V63, P257, DOI 10.1007/s11103-006-9086-y; Kelley WL, 1998, TRENDS BIOCHEM SCI, V23, P222, DOI 10.1016/S0968-0004(98)01215-8; Kelley WL, 1997, P NATL ACAD SCI USA, V94, P3679, DOI 10.1073/pnas.94.8.3679; Kleffmann T, 2004, CURR BIOL, V14, P354, DOI 10.1016/j.cub.2004.02.039; Kubis Sybille E., 2008, V425, P171, DOI 10.1007/978-1-60327-210-0_16; KUNST L, 1988, P NATL ACAD SCI USA, V85, P4143, DOI 10.1073/pnas.85.12.4143; KUNST L, 1989, PLANT PHYSIOL, V90, P943, DOI 10.1104/pp.90.3.943; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li YF, 2004, J BIOL CHEM, V279, P38047, DOI 10.1074/jbc.M404319200; LIBEISSON Y, 2010, ACYL LIPID METABOLIS, DOI DOI 10.1199/TAB.0133; Lu CF, 2009, P NATL ACAD SCI USA, V106, P18837, DOI 10.1073/pnas.0908848106; Lu Y, 2008, PLANT PHYSIOL, V146, P1482, DOI 10.1104/pp.107.115220; Lu Y, 2011, PLANT PHYSIOL, V155, P1589, DOI 10.1104/pp.110.170118; Madera M, 2008, BIOINFORMATICS, V24, P2630, DOI 10.1093/bioinformatics/btn504; Maple J, 2005, PLANT J, V43, P811, DOI 10.1111/j.1365-313X.2005.02493.x; Miernyk JA, 2001, CELL STRESS CHAPERON, V6, P209, DOI 10.1379/1466-1268(2001)006<0209:TJDPOA>2.0.CO;2; Moellering ER, 2010, PLANT PHYSIOL, V152, P1951, DOI 10.1104/pp.110.153262; Mokranjac D, 2005, J BIOL CHEM, V280, P31608, DOI 10.1074/jbc.M502397200; Mokranjac D, 2006, EMBO J, V25, P4675, DOI 10.1038/sj.emboj.7601334; Napier JA, 2010, CURR OPIN PLANT BIOL, V13, P330, DOI 10.1016/j.pbi.2010.01.008; Nicoll WS, 2006, PROTEIN EXPRES PURIF, V46, P1, DOI 10.1016/j.pep.2005.08.005; Nielsen E, 1997, EMBO J, V16, P935, DOI 10.1093/emboj/16.5.935; Noiriel A, 2007, PLANT J, V51, P378, DOI 10.1111/j.1365-313X.2007.03143.x; OLSEN LJ, 1992, J BIOL CHEM, V267, P433; Sambrook J., 2002, MOL CLONING LAB MANU; Schwacke R, 2003, PLANT PHYSIOL, V131, P16, DOI 10.1104/pp.011577; SHANKLIN J, 1995, PLANT CELL, V7, P1713, DOI 10.1105/tpc.7.10.1713; Su PH, 2008, PLANT PHYSIOL, V146, P1231, DOI 10.1104/pp.107.114496; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Viana AAB, 2010, J BIOL CHEM, V285, P12948, DOI 10.1074/jbc.M110.109744; Vitha S, 2003, PLANT CELL, V15, P1918, DOI 10.1105/tpc.013292; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Wallis JG, 2002, PROG LIPID RES, V41, P254, DOI 10.1016/S0163-7827(01)00027-3; Walsh P, 2004, EMBO REP, V5, P567, DOI 10.1038/sj.embor.7400172; Xu CC, 2008, PLANT CELL, V20, P2190, DOI 10.1105/tpc.108.061176; Yang Y, 2008, CURR OPIN PLANT BIOL, V11, P577, DOI 10.1016/j.pbi.2008.10.001; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	69	21	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25368	10.1371/journal.pone.0025368	http://dx.doi.org/10.1371/journal.pone.0025368			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028775	Green Published, gold, Green Submitted			2022-12-27	WOS:000296186900006
J	Hegde, P; Maddur, MS; Friboulet, A; Bayry, J; Kaveri, SV				Hegde, Pushpa; Maddur, Mohan S.; Friboulet, Alain; Bayry, Jagadeesh; Kaveri, Srini V.			Viscum album Exerts Anti-Inflammatory Effect by Selectively Inhibiting Cytokine-Induced Expression of Cyclooxygenase-2	PLOS ONE			English	Article							NF-KAPPA-B; CHRONIC HEPATITIS-C; QUALITY-OF-LIFE; EUROPEAN MISTLETOE; COX-2 EXPRESSION; CANCER-PATIENTS; NITRIC-OXIDE; IN-VIVO; THERAPEUTIC-IMPLICATIONS; ANTICANCER ACTIVITIES	Viscum album (VA) preparations are extensively used as complementary therapy in cancer and are shown to exert antitumor activities which involve the cytotoxic properties, induction of apoptosis, inhibition of angiogenesis and several other immunomodulatory mechanisms. In addition to their application in cancer therapy, VA preparations have also been successfully utilized in the treatment of several inflammatory pathologies. Owing to the intricate association of inflammation and cancer and in view of the fact that several anti-tumor phytotherapeutics also exert a potent anti-inflammatory effect, we hypothesized that VA exerts an anti-inflammatory effect that is responsible for its therapeutic benefit. Since, inflammatory cytokine-induced cyclo-oxygenase-2 (COX-2) and prostaglandin E2 (PGE2) play a critical role in the pathogenesis of inflammatory diseases, we investigated the anti-inflammatory effect of VA on regulation of cyclooxygenase expression and PGE2 biosynthesis by using human lung adenocarcinoma cells (A549 cells) as a model. A549 cells were stimulated with IL-1 beta and treated with VA preparation (VA Qu Spez) for 18 hours. PGE2 was analysed in the culture supernatants by enzyme immunoassay. Expression of COX-2 and COX-1 proteins was analyzed by immunoblotting and the expression of COX-2 mRNA was assessed by semi-quantitative RT-PCR. We found that VA Qu Spez inhibit the secretion of IL-1 beta-induced PGE2 in a dose-dependent manner. Further, we also show that this inhibitory action was associated with a reduced expression of COX-2 without modulating the COX-1 expression. Together these results demonstrate a novel anti-inflammatory mechanism of action of VA preparations wherein VA exerts an anti-inflammatory effect by inhibiting cytokine-induced PGE2 via selective inhibition of COX-2.	[Hegde, Pushpa; Maddur, Mohan S.; Bayry, Jagadeesh; Kaveri, Srini V.] Inst Natl Sante & Rech Med, Unite 872, Paris, France; [Friboulet, Alain] Univ Technol Compiegne, UMR CNRS 6022, F-60206 Compiegne, France; [Maddur, Mohan S.; Bayry, Jagadeesh; Kaveri, Srini V.] Univ Paris 06, Equipe Immunopathol & Therapeut Immunointervent 1, Ctr Rech Cordeliers, UMR S 872, Paris, France; [Maddur, Mohan S.; Bayry, Jagadeesh; Kaveri, Srini V.] Univ Paris 05, UMR S 872, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Technologie de Compiegne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Hegde, P (corresponding author), Inst Natl Sante & Rech Med, Unite 872, Paris, France.	srini.kaveri@crc.jussieu.fr	Maddur, Mohan/E-4763-2015; Bayry, Jagadeesh/A-6589-2011	Bayry, Jagadeesh/0000-0003-0498-9808; Hegde, Pushpa/0000-0002-2376-8659; Kaveri, Srini/0000-0002-0837-4053; Maddur, Mohan/0000-0002-7085-1762	Institut National de la Sante et de la Recherche Medicale (INSERM); Centre National de la Recherche Scientifique (CNRS); Universite Pierre et Marie Curie; Universite Paris Descartes; Weleda AG, Switzerland	Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie; Universite Paris Descartes; Weleda AG, Switzerland	This work is Supported by Institut National de la Sante et de la Recherche Medicale (INSERM), Centre National de la Recherche Scientifique (CNRS), Universite Pierre et Marie Curie and Universite Paris Descartes, regional program Bio-Asie 2011 and Weleda AG, Switzerland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achoui M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015105; Aimanianda V, 2009, TRENDS PHARMACOL SCI, V30, P287, DOI 10.1016/j.tips.2009.03.005; Andre S, 2009, AM J PATHOL, V174, P1575, DOI 10.2353/ajpath.2009.080987; Augustin M, 2005, ARZNEIMITTELFORSCH, V55, P38; Bayry J, 2007, DRUG DISCOV TODAY, V12, P548, DOI 10.1016/j.drudis.2007.05.002; Bayry J, 2011, NAT REV RHEUMATOL, V7, P349, DOI 10.1038/nrrheum.2011.61; Bayry J, 2010, NAT REV RHEUMATOL, V6, P67, DOI 10.1038/nrrheum.2009.263; Bayry J, 2009, NAT REV RHEUMATOL, V5, P244, DOI 10.1038/nrrheum.2009.77; Bereswill S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015099; Bock PR, 2004, ARZNEIMITTELFORSCH, V54, P456; Bussing A, 1999, ANTICANCER RES, V19, P23; Bussing A, 2005, ANTICANCER RES, V25, P4753; Carey MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011610; Cerella C, 2010, BIOCHEM PHARMACOL, V80, P1801, DOI 10.1016/j.bcp.2010.06.050; Chell S, 2006, BBA-REV CANCER, V1766, P104, DOI 10.1016/j.bbcan.2006.05.002; Christen-Clottu O, 2010, J VET INTERN MED, V24, P1483, DOI 10.1111/j.1939-1676.2010.0597.x; Chrubasik S, 2001, RHEUMATOLOGY, V40, P1388, DOI 10.1093/rheumatology/40.12.1388; Chun KS, 2004, BIOCHEM PHARMACOL, V68, P1089, DOI 10.1016/j.bcp.2004.05.031; Correa-Costa M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014298; Cravotto G, 2010, J CLIN PHARM THER, V35, P11, DOI 10.1111/j.1365-2710.2009.01096.x; Elluru SR, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-161; Frank U, 2003, EUR J CLIN MICROBIOL, V22, P501, DOI 10.1007/s10096-003-0964-9; FRANZ H, 1981, BIOCHEM J, V195, P481, DOI 10.1042/bj1950481; Gardin NE, 2009, PHYTOTHER RES, V23, P407, DOI 10.1002/ptr.2643; GOLDYNE ME, 1973, PROSTAG OTH LIPID M, V4, P737, DOI 10.1016/S0090-6980(73)80058-9; Habib SHM, 2008, CLINICS, V63, P807, DOI 10.1590/S1807-59322008000600017; Hamsa TP, 2011, INFLAMMATION, V34, P171, DOI 10.1007/s10753-010-9221-4; Hegeman MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015653; Heinzerling L, 2006, J CLIN IMMUNOL, V26, P347, DOI 10.1007/s10875-006-9023-5; Hong JG, 2006, CARCINOGENESIS, V27, P278, DOI 10.1093/carcin/bgi208; Hostanska K, 1995, NAT IMMUN, V14, P295; Hwang YP, 2011, FOOD CHEM TOXICOL, V49, P93, DOI 10.1016/j.fct.2010.10.002; Jin M, 2010, FOOD CHEM TOXICOL, V48, P3073, DOI 10.1016/j.fct.2010.07.048; Kaegi E, 1998, CAN MED ASSOC J, V158, P1157; Kale A, 2008, PHYTOTHER RES, V22, P567, DOI 10.1002/ptr.2283; Karagoz A, 2003, PHYTOTHER RES, V17, P560, DOI 10.1002/ptr.1163; KARMALI RA, 1983, BRIT J CANCER, V48, P689, DOI 10.1038/bjc.1983.251; Kaveri SV, 2010, NEW ENGL J MED, V363, P1080, DOI 10.1056/NEJMcibr1006936; KHWAJA TA, 1986, ONCOLOGY, V43, P42, DOI 10.1159/000226419; Kienle GS, 2010, INTEGR CANCER THER, V9, P142, DOI 10.1177/1534735410369673; Klopp R, 2005, ANTICANCER RES, V25, P601; Kunnumakkara AB, 2009, INT J CANCER, V125, P2187, DOI 10.1002/ijc.24593; Lavastre V, 2004, CLIN EXP IMMUNOL, V137, P272, DOI 10.1111/j.1365-2249.2004.02545.x; Libby P, 2007, NUTR REV, V65, pS140, DOI [10.1111/j.1753-4887.2007.tb00352.x, 10.1301/nr.2007.dec.S140-S146]; Maddur MS, 2010, TRENDS IMMUNOL, V31, P45, DOI 10.1016/j.it.2009.12.004; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Medzhitov R, 2010, CELL, V140, P771, DOI 10.1016/j.cell.2010.03.006; Meyer-Kirchrath J, 2000, CURR MED CHEM, V7, P1121, DOI 10.2174/0929867003374219; Min KJ, 2011, INT IMMUNOPHARMACOL, V11, P1137, DOI 10.1016/j.intimp.2011.02.029; OLSNES S, 1982, J BIOL CHEM, V257, P13263; Orhan DD, 2006, Z NATURFORSCH C, V61, P26; Pairet M, 1996, FUND CLIN PHARMACOL, V10, P1, DOI 10.1111/j.1472-8206.1996.tb00144.x; PASSWELL J, 1983, CLIN EXP IMMUNOL, V51, P61; Pozzi A, 2009, WIRES SYST BIOL MED, V1, P254, DOI 10.1002/wsbm.7; Radenkovic M, 2006, PHYTOTHER RES, V20, P374, DOI 10.1002/ptr.1865; Redondo S, 2011, DIABETOLOGIA, V54, P190, DOI 10.1007/s00125-010-1947-x; Rosenkranz HS, 2003, ONCOL RES, V13, P529, DOI 10.3727/000000003108748054; Salazar AT, 2011, INT J CLIN PHARM TH, V49, P93, DOI 10.5414/CPP49093; Sharma C, 2006, TOXICOLOGY, V228, P1, DOI 10.1016/j.tox.2006.07.027; Stein GM, 2000, ANTICANCER RES, V20, P2987; Stein GM, 2000, ANTICANCER RES, V20, P1673; Stein GM, 2002, ANTICANCER RES, V22, P4215; Tenorio FA, 2005, FITOTERAPIA, V76, P204, DOI 10.1016/j.fitote.2004.12.013; Tetsuka T, 1996, J BIOL CHEM, V271, P11689, DOI 10.1074/jbc.271.20.11689; Tomlinson KL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013136; Tusenius KJ, 2005, ARZNEIMITTELFORSCH, V55, P749; Tusenius KJ, 2001, COMPLEMENT THER MED, V9, P12, DOI 10.1054/ctim.2000.0408; Urech K, 2006, ARZNEIMITTEL-FORSCH, V56, P428; Van Huyen JPD, 2006, CANCER LETT, V243, P32, DOI 10.1016/j.canlet.2005.11.016; Van Huyen JPD, 2003, CHEMOTHERAPY, V49, P298, DOI 10.1159/000074530; Van Huyen JPD, 2002, MOL MED, V8, P600, DOI 10.1007/BF03402170; Van Huyen JPD, 2001, CHEMOTHERAPY, V47, P366, DOI 10.1159/000048545; Vane JR, 1996, SCAND J RHEUMATOL, P9; Yoon TJ, 2001, INT IMMUNOPHARMACOL, V1, P881, DOI 10.1016/S1567-5769(01)00024-8; Zhou HY, 2008, EUR J PHARMACOL, V586, P340, DOI 10.1016/j.ejphar.2008.02.044	75	38	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26312	10.1371/journal.pone.0026312	http://dx.doi.org/10.1371/journal.pone.0026312			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028854	Green Submitted, Green Published, gold			2022-12-27	WOS:000296186900047
J	Kurzawa, L; Pellerano, M; Coppolani, JB; Morris, MC				Kurzawa, Laetitia; Pellerano, Morgan; Coppolani, J. B.; Morris, May C.			Peptide Biosensor for Probing the Relative Abundance of Cyclin-Dependent Kinases in Living Cells	PLOS ONE			English	Article							FLUORESCENT BIOSENSORS; RECOGNITION PROPERTIES; RECRUITMENT PEPTIDES; PENETRATING PEPTIDES; MAMMALIAN-CELLS; CANCER; ACTIVATION; MECHANISM; SUBSTRATE; DELIVERY	Cyclin-dependant kinases play a central role in coordinating cell growth and division, and in sustaining proliferation of cancer cells, thereby constituting attractive pharmacological targets. However, there are no direct means of assessing their relative abundance in living cells, current approaches being limited to antigenic and proteomic analysis of fixed cells. In order to probe the relative abundance of these kinases directly in living cells, we have developed a fluorescent peptide biosensor with biligand affinity for CDKs and cyclins in vitro, that retains endogenous CDK/cyclin complexes from cell extracts, and that bears an environmentally-sensitive probe, whose fluorescence increases in a sensitive fashion upon recognition of its targets. CDKSENS was introduced into living cells, through complexation with the cell-penetrating carrier CADY2 and applied to assess the relative abundance of CDK/Cyclins through fluorescence imaging and ratiometric quantification. This peptide biosensor technology affords direct and sensitive readout of CDK/cyclin complex levels, and reports on differences in complex formation when tampering with a single CDK or cyclin. CDKSENS further allows for detection of differences between different healthy and cancer cell lines, thereby enabling to distinguish cells that express high levels of these heterodimeric kinases, from cells that present decreased or defective assemblies. This fluorescent biosensor technology provides information on the overall status of CDK/Cyclin complexes which cannot be obtained through antigenic detection of individual subunits, in a non-invasive fashion which does not require cell fixation or extraction procedures. As such it provides promising perspectives for monitoring the response to therapeutics that affect CDK/Cyclin abundance, for cell-based drug discovery strategies and fluorescence-based cancer diagnostics.	[Kurzawa, Laetitia; Pellerano, Morgan; Coppolani, J. B.; Morris, May C.] Univ Montpellier, CRBM, CNRS, Dept Mol Biophys & Therapeut,UMR 5237, F-34059 Montpellier, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier	Kurzawa, L (corresponding author), Univ Montpellier, CRBM, CNRS, Dept Mol Biophys & Therapeut,UMR 5237, F-34059 Montpellier, France.	may.morris@crbm.cnrs.fr	MORRIS, May/ABB-2629-2021; Pellerano, Morgan/AAF-9057-2019; MORRIS, May C/J-5940-2016	MORRIS, May/0000-0001-8106-9728; Pellerano, Morgan/0000-0001-6951-2344; MORRIS, May C/0000-0001-8106-9728	CNRS (Centre National de la Recherche Scientifique); Association de Recherche contre le Cancer (ARC); Region Languedoc-Roussillon; Fondation pour la Recherche Medicale (FRM)	CNRS (Centre National de la Recherche Scientifique)(Centre National de la Recherche Scientifique (CNRS)); Association de Recherche contre le Cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Region Languedoc-Roussillon(Region Ile-de-FranceRegion Occitanie); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by the CNRS (Centre National de la Recherche Scientifique) and grants from the Association de Recherche contre le Cancer (ARC) and the Region Languedoc-Roussillon (Subvention "Chercheuse d'Avenir") to MCM. LK is recipient of a fellowship from the Region Languedoc-Roussillon and the CNRS. MP is funded by a grant from the the Fondation pour la Recherche Medicale (FRM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown NR, 2007, CELL CYCLE, V6, P1350, DOI 10.4161/cc.6.11.4278; Brown NR, 1999, NAT CELL BIOL, V1, P438, DOI 10.1038/15674; Crombez L, 2009, NUCLEIC ACIDS RES, V37, P4559, DOI 10.1093/nar/gkp451; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; Ekberg J, 2005, EUR J HAEMATOL, V75, P106, DOI 10.1111/j.1600-0609.2005.00473.x; Hahn AT, 2009, CELL CYCLE, V8, P1044, DOI 10.4161/cc.8.7.8042; Harwell RM, 2004, J BIOL CHEM, V279, P12695, DOI 10.1074/jbc.M313407200; Heitz F, 1997, BIOCHEMISTRY-US, V36, P4995, DOI 10.1021/bi962349y; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Holmes JK, 1996, J BIOL CHEM, V271, P25240, DOI 10.1074/jbc.271.41.25240; Husdal A, 2006, CELL ONCOL, V28, P107; Ionov Y, 2010, ONCOTARGET, V1, P148, DOI 10.18632/oncotarget.118; Itzhaki JE, 1997, NAT GENET, V15, P258, DOI 10.1038/ng0397-258; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Jiang T, 2004, P NATL ACAD SCI USA, V101, P17867, DOI 10.1073/pnas.0408191101; Kim JK, 2009, J CELL PHYSIOL, V220, P292, DOI 10.1002/jcp.21791; Kurzawa L, 2010, BBA-BIOMEMBRANES, V1798, P2274, DOI 10.1016/j.bbamem.2010.02.027; Kurzawa L, 2010, CHEMBIOCHEM, V11, P1037, DOI 10.1002/cbic.200900729; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Lolli G, 2010, CELL CYCLE, V9, P1551, DOI 10.4161/cc.9.8.11195; Loving GS, 2010, TRENDS BIOTECHNOL, V28, P73, DOI 10.1016/j.tibtech.2009.11.002; Lowe ED, 2002, BIOCHEMISTRY-US, V41, P15625, DOI 10.1021/bi0268910; Lukovic E, 2009, ANGEW CHEM INT EDIT, V48, P6828, DOI 10.1002/anie.200902374; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Malumbres M, 2001, NAT REV CANCER, V1, P222, DOI 10.1038/35106065; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Merrick KA, 2010, CELL CYCLE, V9, P706, DOI 10.4161/cc.9.4.10732; Morgan DO, 1997, ANNU REV CELL DEV BI, V13, P261, DOI 10.1146/annurev.cellbio.13.1.261; Morris MC, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm053; Morris MC, 2010, CELL BIOCHEM BIOPHYS, V56, P19, DOI 10.1007/s12013-009-9070-7; Morris MC, 2002, J BIOL CHEM, V277, P23847, DOI 10.1074/jbc.M107890200; Nalbant P, 2004, SCIENCE, V305, P1615, DOI 10.1126/science.1100367; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Satyanarayana A, 2009, ONCOGENE, V28, P2925, DOI 10.1038/onc.2009.170; Schulman BA, 1998, P NATL ACAD SCI USA, V95, P10453, DOI 10.1073/pnas.95.18.10453; Shanna V, 2008, BBA-PROTEINS PROTEOM, V1784, P94, DOI 10.1016/j.bbapap.2007.07.016; Suzuki T, 2007, CANCER SCI, V98, P644, DOI 10.1111/j.1349-7006.2007.00444.x; Wang HX, 2009, CHEMBIOCHEM, V10, P2560, DOI 10.1002/cbic.200900249	42	18	21	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26555	10.1371/journal.pone.0026555	http://dx.doi.org/10.1371/journal.pone.0026555			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028905	Green Published, gold			2022-12-27	WOS:000296186900073
J	Michallet, AS; Mondiere, P; Taillardet, M; Leverrier, Y; Genestier, L; Defrance, T				Michallet, Anne-Sophie; Mondiere, Paul; Taillardet, Morgan; Leverrier, Yann; Genestier, Laurent; Defrance, Thierry			Compromising the Unfolded Protein Response Induces Autophagy-Mediated Cell Death in Multiple Myeloma Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; TRANSCRIPTION FACTOR; MESSENGER-RNA; APOPTOSIS; SURVIVAL; PERK; ACTIVATION; INHIBITION; BORTEZOMIB	Objective: To determine whether the Unfolded Protein Response (UPR) sensors (PERK, ATF6 and IRE-1) can be targeted to promote death of Multiple Myeloma (MM) cells. Methods: We have knocked-down separately each UPR stress sensor in human MM cell lines using RNA interference and followed MM cell death by monitoring the membrane, mitochondrial and nuclear alterations. Involvement of caspases in MM cell death consecutive to UPR sensor knock-down was analyzed by western blotting, measurement of their enzymatic activity using fluorigenic substrates and susceptibility to a pan-caspase inhibitor. Activation of the autophagic process was measured directly by detection of autophagosomes (electronic microscopy), monodansylcadaverine staining, production of the cleaved form of the microtubule-associated protein 1A/1B light chain 3 (LC3) and indirectly by analyzing the impact of pharmacological inhibitors of autophagy such as 3MA and bafilomycin A1. Results: We show that extinction of a single UPR stress sensor (PERK) induces a non-apoptotic form of cell death in MM cells that requires autophagy for its execution. We also show that this cytotoxic autophagic process represses the apoptosis program by reducing the cytosolic release of the apoptogenic factors Smac/DIABLO and cytochrome c. Interpretation: Altogether our findings suggest that autophagy can contribute to execution of death in mammalian cells that are exposed to mild ER stress. They also suggest that the autophagic process can regulate the intrinsic apoptotic pathway by inhibiting production of death effectors by the mitochondria, thus preventing formation of a functional apoptosome. Altogether these findings give credit to the idea that UPR sensors can be envisaged as therapeutic targets for the treatment of MM.	[Michallet, Anne-Sophie; Mondiere, Paul; Taillardet, Morgan; Leverrier, Yann; Genestier, Laurent; Defrance, Thierry] INSERM, F-69008 Lyon, France; [Michallet, Anne-Sophie; Mondiere, Paul; Taillardet, Morgan; Leverrier, Yann; Genestier, Laurent; Defrance, Thierry] Univ Lyon, Lyon, France; [Michallet, Anne-Sophie] Ctr Hosp Lyon Sud, Hosp Civils Lyon, F-69310 Pierre Benite, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Lyon	Michallet, AS (corresponding author), INSERM, F-69008 Lyon, France.	thierry.defrance@inserm.fr	LEVERRIER, Yann/M-3767-2014; MICHALLET, Anne-Sophie/M-6505-2014; Genestier, Laurent/H-6443-2016; DEFRANCE, Thierry/G-1460-2013; Taillardet, Morgan/M-1749-2014	LEVERRIER, Yann/0000-0002-4227-5446; Genestier, Laurent/0000-0002-0527-4583; DEFRANCE, Thierry/0000-0002-6943-358X	Association pour le Recherche Contre le Cancer; National and Regional Committees of la Ligue Contre le Cancer; la Fondation de France	Association pour le Recherche Contre le Cancer; National and Regional Committees of la Ligue Contre le Cancer; la Fondation de France(Fondation de France)	This work was supported by grants from the Association pour le Recherche Contre le Cancer, the National and Regional Committees of la Ligue Contre le Cancer, and la Fondation de France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauvy C, 2001, EXP CELL RES, V268, P139, DOI 10.1006/excr.2001.5285; BIEDERBICK A, 1995, EUR J CELL BIOL, V66, P3; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Breckenridge DG, 2003, ONCOGENE, V22, P8608, DOI 10.1038/sj.onc.1207108; Chen Q, 2008, BLOOD, V111, P4690, DOI 10.1182/blood-2007-09-112904; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Elgendy M, 2011, MOL CELL; Fels DR, 2006, CANCER BIOL THER, V5, P723, DOI 10.4161/cbt.5.7.2967; Fernandez Y, 2006, J BIOL CHEM, V281, P1107, DOI 10.1074/jbc.M511607200; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Han J, 2008, J BIOL CHEM; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Iida K, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-38; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim KW, 2010, ONCOGENE, V29, P3241, DOI 10.1038/onc.2010.74; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Lai WL, 2008, EXP CELL RES, V314, P1667, DOI 10.1016/j.yexcr.2008.02.002; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Lerena C, 2008, CURR MOL MED, V8, P92; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Meister S, 2010, NEOPLASIA, V12, P550, DOI 10.1593/neo.10228; Molinari A, 2005, CURR TOP MICROBIOL, V300, P1; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Palumbo A, 2007, J CLIN ONCOL, V25, P4459, DOI 10.1200/JCO.2007.12.3463; Pelletier N, 2006, J IMMUNOL, V176, P1340, DOI 10.4049/jimmunol.176.3.1340; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Richardson PG, 2007, BRIT J HAEMATOL, V137, P429, DOI 10.1111/j.1365-2141.2007.06585.x; Rieder SE, 2001, CURR PROTOC CELL BIO; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Schewe DM, 2009, CANCER RES, V69, P1545, DOI 10.1158/0008-5472.CAN-08-3858; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Waterhouse NJ, 2002, BIOCHIMIE, V84, P113, DOI 10.1016/S0300-9084(02)01379-2; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoneda T, 2001, J BIOL CHEM, V276, P13935, DOI 10.1074/jbc.M010677200; Yorimitsu T, 2006, J BIOL CHEM, V281, P30299, DOI 10.1074/jbc.M607007200; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zismanov V, 2009, BRIT J CANCER, V101, P1402, DOI 10.1038/sj.bjc.6605291	51	37	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25820	10.1371/journal.pone.0025820	http://dx.doi.org/10.1371/journal.pone.0025820			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028791	Green Submitted, Green Published, gold			2022-12-27	WOS:000296186900019
J	Ma, CW; Xiu, ZL; Zeng, AP				Ma, Cheng-Wei; Xiu, Zhi-Long; Zeng, An-Ping			A New Concept to Reveal Protein Dynamics Based on Energy Dissipation	PLOS ONE			English	Article							LYSINE-SENSITIVE ASPARTOKINASE; MOLECULAR-DYNAMICS; STRUCTURAL DYNAMICS; ESCHERICHIA-COLI; ENZYME CATALYSIS; BINDING-SITES; PERSPECTIVE; NMR; SIMULATIONS; CONSTRAINTS	Protein dynamics is essential for its function, especially for intramolecular signal transduction. In this work we propose a new concept, energy dissipation model, to systematically reveal protein dynamics upon effector binding and energy perturbation. The concept is applied to better understand the intramolecular signal transduction during allostery of enzymes. The E. coli allosteric enzyme, aspartokinase III, is used as a model system and special molecular dynamics simulations are designed and carried out. Computational results indicate that the number of residues affected by external energy perturbation (i.e. caused by a ligand binding) during the energy dissipation process shows a sigmoid pattern. Using the two-state Boltzmann equation, we define two parameters, the half response time and the dissipation rate constant, which can be used to well characterize the energy dissipation process. For the allostery of aspartokinase III, the residue response time indicates that besides the ACT2 signal transduction pathway, there is another pathway between the regulatory site and the catalytic site, which is suggested to be the beta 15-alpha K loop of ACT1. We further introduce the term "protein dynamical modules" based on the residue response time. Different from the protein structural modules which merely provide information about the structural stability of proteins, protein dynamical modules could reveal protein characteristics from the perspective of dynamics. Finally, the energy dissipation model is applied to investigate E. coli aspartokinase III mutations to better understand the desensitization of product feedback inhibition via allostery. In conclusion, the new concept proposed in this paper gives a novel holistic view of protein dynamics, a key question in biology with high impacts for both biotechnology and biomedicine.	[Ma, Cheng-Wei; Zeng, An-Ping] Hamburg Univ Technol, Inst Bioproc & Biosyst Engn, Hamburg, Germany; [Ma, Cheng-Wei; Xiu, Zhi-Long] Dalian Univ Technol, Sch Life Sci & Biotechnol, Dalian, Peoples R China	Hamburg University of Technology; Dalian University of Technology	Ma, CW (corresponding author), Hamburg Univ Technol, Inst Bioproc & Biosyst Engn, Hamburg, Germany.	aze@tu-harburg.de		Zeng, An-Ping/0000-0001-9768-7096	China Scholarship Council	China Scholarship Council(China Scholarship Council)	Financial support for this work was provided by the China Scholarship Council (to CWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brunori M, 2000, BIOPHYS CHEM, V86, P221, DOI 10.1016/S0301-4622(00)00142-3; CASSAN M, 1986, J BIOL CHEM, V261, P1052; Cecchini M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000129; Chen Z, 2011, J BIOTECHNOL, V154, P248, DOI 10.1016/j.jbiotec.2011.05.005; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; Daily MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000293; Dubois JM, 2009, PROG BIOPHYS MOL BIO, V99, P87, DOI 10.1016/j.pbiomolbio.2009.07.001; Fischer MWF, 1998, PROG NUCL MAG RES SP, V33, P207, DOI 10.1016/S0079-6565(98)00023-5; Freire E, 1999, P NATL ACAD SCI USA, V96, P10118, DOI 10.1073/pnas.96.18.10118; Hawkins RJ, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098104; HAYWARD S, 1995, PROTEINS, V23, P177, DOI 10.1002/prot.340230207; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1982, J CHEM PHYS, V77, P4156, DOI 10.1063/1.444325; Kay LE, 1998, NAT STRUCT BIOL, V5, P513, DOI 10.1038/755; Kern D, 2003, CURR OPIN STRUC BIOL, V13, P748, DOI 10.1016/j.sbi.2003.10.008; Kikuchi Y, 1999, FEMS MICROBIOL LETT, V173, P211, DOI 10.1111/j.1574-6968.1999.tb13504.x; Kolomeisky AB, 2007, ANNU REV PHYS CHEM, V58, P675, DOI 10.1146/annurev.physchem.58.032806.104532; Kotaka M, 2006, J BIOL CHEM, V281, P31544, DOI 10.1074/jbc.M605886200; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; Malmendal A, 1999, J MOL BIOL, V293, P883, DOI 10.1006/jmbi.1999.3188; Martinez KL, 2002, FEBS LETT, V528, P251, DOI 10.1016/S0014-5793(02)03306-9; Matoba Y, 2003, PROTEINS, V51, P453, DOI 10.1002/prot.10360; Miyata YO, 2001, BIOSCI BIOTECH BIOCH, V65, P1149; Olsson MHM, 2006, CHEM REV, V106, P1737, DOI 10.1021/cr040427e; Ota N, 2005, J MOL BIOL, V351, P345, DOI 10.1016/j.jmb.2005.05.043; Pan H, 2000, P NATL ACAD SCI USA, V97, P12020, DOI 10.1073/pnas.220240297; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Ramon-Maiques S, 2002, STRUCTURE, V10, P329, DOI 10.1016/S0969-2126(02)00721-9; Rousseau F, 2005, CURR OPIN STRUC BIOL, V15, P23, DOI 10.1016/j.sbi.2005.01.007; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Stacklies W, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000574; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Wand AJ, 2001, NAT STRUCT BIOL, V8, P926, DOI 10.1038/nsb1101-926; WEBER G, 1972, BIOCHEMISTRY-US, V11, P864, DOI 10.1021/bi00755a028; Whitten ST, 2005, P NATL ACAD SCI USA, V102, P4282, DOI 10.1073/pnas.0407499102; Yang Z, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000360	40	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26453	10.1371/journal.pone.0026453	http://dx.doi.org/10.1371/journal.pone.0026453			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022616	Green Published, Green Submitted, gold			2022-12-27	WOS:000295984400060
J	Ong, YC; Boyle, JP; Boothroyd, JC				Ong, Yi-Ching; Boyle, Jon P.; Boothroyd, John C.			Strain-Dependent Host Transcriptional Responses to Toxoplasma Infection Are Largely Conserved in Mammalian and Avian Hosts	PLOS ONE			English	Article							NF-KAPPA-B; TYROSINE PHOSPHORYLATION; VIRULENCE FACTORS; GONDII; EXPRESSION; CELLS; STAT5; RESISTANCE; DIVERSITY; ZEBRAFISH	Toxoplasma gondii has a remarkable ability to infect an enormous variety of mammalian and avian species. Given this, it is surprising that three strains (Types I/II/III) account for the majority of isolates from Europe/North America. The selective pressures that have driven the emergence of these particular strains, however, remain enigmatic. We hypothesized that strain selection might be partially driven by adaptation of strains for mammalian versus avian hosts. To test this, we examine in vitro, strain-dependent host responses in fibroblasts of a representative avian host, the chicken (Gallus gallus). Using gene expression profiling of infected chicken embryonic fibroblasts and pathway analysis to assess host response, we show here that chicken cells respond with distinct transcriptional profiles upon infection with Type II versus III strains that are reminiscent of profiles observed in mammalian cells. To identify the parasite drivers of these differences, chicken fibroblasts were infected with individual F1 progeny of a Type II x III cross and host gene expression was assessed for each by microarray. QTL mapping of transcriptional differences suggested, and deletion strains confirmed, that, as in mammalian cells, the polymorphic rhoptry kinase ROP16 is the major driver of strain-specific responses. We originally hypothesized that comparing avian versus mammalian host response might reveal an inversion in parasite strain-dependent phenotypes; specifically, for polymorphic effectors like ROP16, we hypothesized that the allele with most activity in mammalian cells might be less active in avian cells. Instead, we found that activity of ROP16 alleles appears to be conserved across host species; moreover, additional parasite loci that were previously mapped for strain-specific effects on mammalian response showed similar strain-specific effects in chicken cells. These results indicate that if different hosts select for different parasite genotypes, the selection operates downstream of the signaling occurring during the beginning of the host's immune response.	[Ong, Yi-Ching; Boothroyd, John C.] Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Boyle, Jon P.] Univ Pittsburgh, Dept Mol Biol, Pittsburgh, PA USA	Stanford University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ong, YC (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford, CA 94305 USA.	jboothr@stanford.edu		Boothroyd, John C./0000-0001-9719-745X; Boyle, Jon/0000-0003-0000-9243	National Science Foundation; Pew Scholarship in the Biomedical Sciences; NIH [K22AI080977, AI73756]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073756, K22AI080977] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Pew Scholarship in the Biomedical Sciences; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Y-CO was supported by a National Science Foundation Graduate Research Fellowship and Smith Stanford Graduate Fellowship. JPB was supported by a Pew Scholarship in the Biomedical Sciences and an NIH Research Scholar Award K22AI080977. JCB was supported by the NIH AI73756. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzenberg D, 2004, INT J PARASITOL, V34, P1185, DOI 10.1016/j.ijpara.2004.06.007; Angeloni MB, 2009, PLACENTA, V30, P785, DOI 10.1016/j.placenta.2009.07.002; Blader IJ, 2001, J BIOL CHEM, V276, P24223, DOI 10.1074/jbc.M100951200; Boothroyd JC, 2009, MEM I OSWALDO CRUZ, V104, P179, DOI 10.1590/S0074-02762009000200009; Boyle JP, 2006, P NATL ACAD SCI USA, V103, P10514, DOI 10.1073/pnas.0510319103; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dobbin CA, 2002, J IMMUNOL, V169, P958, DOI 10.4049/jimmunol.169.2.958; Dubey JP, 2007, VET PARASITOL, V148, P207, DOI 10.1016/j.vetpar.2007.06.033; Dubey JP, 2010, ZOONOSES PUBLIC HLTH, V57, P60, DOI 10.1111/j.1863-2378.2009.01274.x; DUBEY JP, 1993, AM J VET RES, V54, P1668; Dubey JP, 2002, VET PARASITOL, V106, P121, DOI 10.1016/S0304-4017(02)00034-1; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Friedrich K, 1999, INT IMMUNOL, V11, P1283, DOI 10.1093/intimm/11.8.1283; Gajria B, 2008, NUCLEIC ACIDS RES, V36, pD553, DOI 10.1093/nar/gkm981; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Hemmers S, 2009, NAT IMMUNOL, V10, P806, DOI 10.1038/ni0809-806; HERNANDEZ R, 2010, CURRENT PROTOCOLS MI, V17, P2046; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; IKEDA T, 1993, GENE, V133, P237, DOI 10.1016/0378-1119(93)90645-J; IRIZARRY R, 2003, NUCL ACIDS RES, P2046; Jensen KDC, 2011, CELL HOST MICROBE, V9, P472, DOI 10.1016/j.chom.2011.04.015; Jourdan P, 1998, J IMMUNOL, V160, P4153; Kaiser P, 2007, CYTOGENET GENOME RES, V117, P221, DOI 10.1159/000103183; Kaiser P, 2010, AVIAN PATHOL, V39, P309, DOI 10.1080/03079457.2010.508777; Kaneto CN, 1997, VET PARASITOL, V69, P203, DOI 10.1016/S0304-4017(96)01126-0; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Khan A, 2007, P NATL ACAD SCI USA, V104, P14872, DOI 10.1073/pnas.0702356104; Khan A, 2011, INT J PARASITOL, V41, P645, DOI 10.1016/j.ijpara.2011.01.005; Kieslinger M, 2000, GENE DEV, V14, P232; Laliberte J, 2008, CELL MOL LIFE SCI, V65, P1900, DOI 10.1007/s00018-008-7556-x; Lewis RS, 2004, GENE, V338, P65, DOI 10.1016/j.gene.2004.05.012; Miller MA, 2008, INT J PARASITOL, V38, P1319, DOI 10.1016/j.ijpara.2008.02.005; Mitra S, 2010, FEBS J, V277, P128, DOI 10.1111/j.1742-4658.2009.07460.x; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Peixoto L, 2010, CELL HOST MICROBE, V8, P208, DOI 10.1016/j.chom.2010.07.004; Pollard AM, 2009, TRENDS PARASITOL, V25, P491, DOI 10.1016/j.pt.2009.07.009; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Robben PM, 2004, J IMMUNOL, V172, P3686, DOI 10.4049/jimmunol.172.6.3686; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; Rosowski EE, 2011, J EXP MED, V208, P195, DOI 10.1084/jem.20100717; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeij JPJ, 2007, NATURE, V445, P324, DOI 10.1038/nature05395; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Stumhofer JS, 2006, NAT IMMUNOL, V7, P937, DOI 10.1038/ni1376; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; YAMAMOTO M, 2009, J EXP MED; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Yap GS, 2006, MICROBES INFECT, V8, P1174, DOI 10.1016/j.micinf.2005.10.031	56	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26369	10.1371/journal.pone.0026369	http://dx.doi.org/10.1371/journal.pone.0026369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022607	Green Published, gold			2022-12-27	WOS:000295978600051
J	Ho, DWH; Yiu, WC; Yap, MKH; Fung, WY; Ng, PW; Yip, SP				Ho, Daniel W. H.; Yiu, Wai Chi; Yap, Maurice K. H.; Fung, Wai Yan; Ng, Po Wah; Yip, Shea Ping			Genotyping Performance Assessment of Whole Genome Amplified DNA with Respect to Multiplexing Level of Assay and Its Period of Storage	PLOS ONE			English	Article							AMPLIFICATION; SEQUENCE; FIDELITY	Whole genome amplification can faithfully amplify genomic DNA (gDNA) with minimal bias and substantial genome coverage. Whole genome amplified DNA (wgaDNA) has been tested to be workable for high-throughput genotyping arrays. However, issues about whether wgaDNA would decrease genotyping performance at increasing multiplexing levels and whether the storage period of wgaDNA would reduce genotyping performance have not been examined. Using the Sequenom MassARRAY iPLEX Gold assays, we investigated 174 single nucleotide polymorphisms for 3 groups of matched samples: group 1 of 20 gDNA samples, group 2 of 20 freshly prepared wgaDNA samples, and group 3 of 20 stored wgaDNA samples that had been kept frozen at -70 degrees C for 18 months. MassARRAY is a medium-throughput genotyping platform with reaction chemistry different from those of high-throughput genotyping arrays. The results showed that genotyping performance (efficiency and accuracy) of freshly prepared wgaDNA was similar to that of gDNA at various multiplexing levels (17-plex, 21-plex, 28-plex and 36-plex) of the MassARRAY assays. However, compared with gDNA or freshly prepared wgaDNA, stored wgaDNA was found to give diminished genotyping performance (efficiency and accuracy) due to potentially inferior quality. Consequently, no matter whether gDNA or wgaDNA was used, better genotyping efficiency would tend to have better genotyping accuracy.	[Ho, Daniel W. H.; Yiu, Wai Chi; Yap, Maurice K. H.; Ng, Po Wah] Hong Kong Polytech Univ, Sch Optometry, Ctr Myopia Res, Hong Kong, Hong Kong, Peoples R China; [Ho, Daniel W. H.; Fung, Wai Yan; Ng, Po Wah; Yip, Shea Ping] Hong Kong Polytech Univ, Dept Hlth Technol & Informat, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University	Ho, DWH (corresponding author), Hong Kong Polytech Univ, Sch Optometry, Ctr Myopia Res, Hong Kong, Hong Kong, Peoples R China.	shea.ping.yip@inet.polyu.edu.hk	Yip, Shea Ping/A-1185-2016; Ho, Daniel Wai Hung WH/O-1194-2016; Yap, Maurice KH/K-4927-2016	Yip, Shea Ping/0000-0002-2170-8185; Ho, Daniel Wai Hung WH/0000-0003-3884-296X; Yap, Maurice KH/0000-0003-4687-4101	Hong Kong Polytechnic University [G-YX2V, 87TP, J-BB7P]	Hong Kong Polytechnic University(Hong Kong Polytechnic University)	This work is a contribution from the Centre for Myopia Research, The Hong Kong Polytechnic University, and was supported by grants (G-YX2V, 87TP and J-BB7P) from the Hong Kong Polytechnic University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Barker DL, 2004, GENOME RES, V14, P901, DOI 10.1101/gr.1949704; Bergen AW, 2005, HUM MUTAT, V26, P262, DOI 10.1002/humu.20213; Bergen AW, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-24; Berthier-Schaad Y, 2007, ELECTROPHORESIS, V28, P2812, DOI 10.1002/elps.200600674; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gunderson KL, 2005, NAT GENET, V37, P549, DOI 10.1038/ng1547; Hollegaard MV, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-297; Hollegaard MV, 2009, ELECTROPHORESIS, V30, P2532, DOI 10.1002/elps.200800655; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmore JP, 2002, PHARMACOGENOMICS, V3, P557, DOI 10.1517/14622416.3.4.557; Lovmar L, 2006, HUM MUTAT, V27, P603, DOI 10.1002/humu.20341; Magee DA, 2010, J ANIM SCI, V88, P3183, DOI 10.2527/jas.2009-2723; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Park JW, 2005, CLIN CHEM, V51, P1520, DOI 10.1373/clinchem.2004.047076; Pask R, 2004, BMC BIOTECHNOL, V4, DOI 10.1186/1472-6750-4-15; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	22	9	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26119	10.1371/journal.pone.0026119	http://dx.doi.org/10.1371/journal.pone.0026119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022531	Green Submitted, Green Published, gold			2022-12-27	WOS:000295973200038
J	Wu, JM; Richards, MH; Huang, JH; Al-Harthi, L; Xu, XL; Lin, R; Xie, FL; Gibson, AW; Edberg, JC; Kimberly, RP				Wu, Jianming; Richards, Maureen H.; Huang, Jinhai; Al-Harthi, Lena; Xu, Xiulong; Lin, Rui; Xie, Fenglong; Gibson, Andrew W.; Edberg, Jeffrey C.; Kimberly, Robert P.			Human FasL Gene Is a Target of beta-Catenin/T-Cell Factor Pathway and Complex FasL Haplotypes Alter Promoter Functions	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; APO-1/FAS LIGAND PROMOTER; COLON-CANCER; CD95 LIGAND; TRANSCRIPTION FACTOR; LYMPHOPROLIFERATIVE SYNDROME; INDUCED APOPTOSIS; IMMUNE PRIVILEGE; HMG DOMAIN; T-CELLS	FasL expression on human immune cells and cancer cells plays important roles in immune homeostasis and in cancer development. Our previous study suggests that polymorphisms in the FasL promoter can significantly affect the gene expression in human cells. In addition to the functional FasL SNP -844C>T (rs763110), three other SNPs (SNP -756A>G or rs2021837, SNP -478A>T or rs41309790, and SNP -205 C>G or rs74124371) exist in the proximal FasL promoter. In the current study, we established three major FasL hyplotypes in humans. Interestingly, a transcription motif search revealed that the FasL promoter possessed two consensus T-cell factor (TCF/LEF1) binding elements (TBEs), which is either polymorphic (SNP -205C>G) or close to the functional SNP -844C>T. Subsequently, we demonstrate that both FasL TBEs formed complexes with the TCF-4 and beta-catenin transcription factors in vitro and in vivo. Co-transfection of LEF-1 and beta-catenin transcription factors significantly increased FasL promoter activities, suggesting that FasL is a target gene of the beta-catenin/T-cell factor pathway. More importantly, we found that the rare allele (-205G) of the polymorphic FasL TBE (SNP -205C>G) failed to bind the TCF-4 transcription factor and that SNP -205 C>G significantly affected the promoter activity. Furthermore, promoter reporter assays revealed that FasL SNP haplotypes influenced promoter activities in human colon cancer cells and in human T cells. Finally, beta-catenin knockdown significantly decreased the FasL expression in human SW480 colon cancer cells. Collectively, our data suggest that beta-catenin may be involved in FasL gene regulation and that FasL expression is influenced by FasL SNP haplotypes, which may have significant implications in immune response and tumorigenesis.	[Wu, Jianming; Huang, Jinhai; Lin, Rui] Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA; [Richards, Maureen H.; Al-Harthi, Lena] Rush Presbyterian St Lukes Med Ctr, Dept Immunol & Microbiol, Chicago, IL 60612 USA; [Xu, Xiulong] Rush Presbyterian St Lukes Med Ctr, Dept Gen Surg, Chicago, IL 60612 USA; [Xie, Fenglong; Gibson, Andrew W.; Edberg, Jeffrey C.; Kimberly, Robert P.] Univ Alabama, Div Clin Immunol & Rheumatol, Birmingham, IL USA	University of Minnesota System; University of Minnesota Twin Cities; Rush University; Rush University; University of Alabama System; University of Alabama Birmingham	Wu, JM (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, St Paul, MN 55108 USA.	jmwu@umn.edu	huang, jinhai/B-1334-2016	huang, jinhai/0000-0002-1073-533X; Kimberly, Robert/0000-0002-5330-3086	Lupus Research Institute; National Institutes of Health [R01-AR33062, P01-AR49084]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR033062, P01AR049084] Funding Source: NIH RePORTER	Lupus Research Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Lupus Research Institute grant (J.W.) and National Institutes of Health grants R01-AR33062 (RPK), and P01-AR49084 (RPK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDERBRIDGES M, 1992, J CELL BIOCHEM, V48, P129, DOI 10.1002/jcb.240480204; ASHANY D, 1995, P NATL ACAD SCI USA, V92, P11225, DOI 10.1073/pnas.92.24.11225; Barker N, 2000, ADV CANCER RES, V77, P1; BELLGRAU D, 1995, NATURE, V377, P630, DOI 10.1038/377630a0; Bennett MW, 1999, GUT, V44, P156, DOI 10.1136/gut.44.2.156; Bennett MW, 2001, J CLIN PATHOL, V54, P598, DOI 10.1136/jcp.54.8.598; Bennett MW, 1998, J IMMUNOL, V160, P5669; Borges VM, 2001, J EXP MED, V194, P155, DOI 10.1084/jem.194.2.155; Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027; BRUNNER T, 1995, NATURE, V373, P441, DOI 10.1038/373441a0; Chen L, 2010, NATURE, V465, P492, DOI 10.1038/nature09075; Clevers H, 1997, TRENDS GENET, V13, P485, DOI 10.1016/S0168-9525(97)01305-X; DosReis GA, 2004, J CELL MOL MED, V8, P285, DOI 10.1111/j.1582-4934.2004.tb00318.x; Duran S, 2008, ARTHRIT RHEUM-ARTHR, V59, P1332, DOI 10.1002/art.24020; Elkon KB, 1996, CURR OPIN IMMUNOL, V8, P852, DOI 10.1016/S0952-7915(96)80015-X; GIESE K, 1992, CELL, V69, P185, DOI 10.1016/0092-8674(92)90129-Z; GRIFFITH TS, 1995, SCIENCE, V270, P1189, DOI 10.1126/science.270.5239.1189; Hahne M, 1996, SCIENCE, V274, P1363, DOI 10.1126/science.274.5291.1363; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; Houston A, 2004, CURR OPIN PHARMACOL, V4, P321, DOI 10.1016/j.coph.2004.03.008; Houston A, 2003, BRIT J CANCER, V89, P1345, DOI 10.1038/sj.bjc.6601240; Hsu SC, 1998, MOL CELL BIOL, V18, P4807, DOI 10.1128/MCB.18.8.4807; Ioannidis V, 2001, NAT IMMUNOL, V2, P691, DOI 10.1038/90623; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kirchhoff S, 2002, J IMMUNOL, V168, P1226, DOI 10.4049/jimmunol.168.3.1226; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Li HC, 2009, GASTROENTEROLOGY, V137, P934, DOI 10.1053/j.gastro.2009.06.004; Li-Weber M, 1998, EUR J IMMUNOL, V28, P2373, DOI 10.1002/(SICI)1521-4141(199808)28:08<2373::AID-IMMU2373>3.0.CO;2-T; Li-Weber M, 2002, J CLIN INVEST, V110, P681, DOI [10.1172/JCI0215073, 10.1172/JCI200215073]; Li-Weber M, 1999, EUR J IMMUNOL, V29, P3017, DOI 10.1002/(SICI)1521-4141(199909)29:09<3017::AID-IMMU3017>3.0.CO;2-R; Liu Y, 2009, EUR J CANCER, V45, P2574, DOI 10.1016/j.ejca.2009.04.001; Lovatt M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012794; LOVE JJ, 1995, NATURE, V376, P791, DOI 10.1038/376791a0; Ma YY, 2004, NAT IMMUNOL, V5, P380, DOI 10.1038/ni1054; Maeda A, 1998, BRIT J DERMATOL, V139, P198; Mittelstadt PR, 1998, MOL CELL BIOL, V18, P3744, DOI 10.1128/MCB.18.7.3744; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Niehans GA, 1997, CANCER RES, V57, P1007; Norian LA, 1998, J IMMUNOL, V161, P1078; O'Connell J, 1998, J PATHOL, V186, P240; O'Connell J, 1999, IMMUNOL TODAY, V20, P46, DOI 10.1016/S0167-5699(98)01382-6; OConnell J, 1996, J EXP MED, V184, P1075, DOI 10.1084/jem.184.3.1075; OOSTERWEGEL MA, 1991, INT IMMUNOL, V3, P1189, DOI 10.1093/intimm/3.11.1189; Rabinowich H, 1998, J CLIN INVEST, V101, P2579, DOI 10.1172/JCI1518; Rescigno M, 2000, J EXP MED, V192, P1661, DOI 10.1084/jem.192.11.1661; Rieux-Laucat F, 1999, BLOOD, V94, P2575; Roose J, 1998, NATURE, V395, P608, DOI 10.1038/26989; Rubinfeld B, 1997, CANCER RES, V57, P4624; Saas P, 1997, J CLIN INVEST, V99, P1173, DOI 10.1172/JCI119273; Shiraki K, 1997, P NATL ACAD SCI USA, V94, P6420, DOI 10.1073/pnas.94.12.6420; SINGER GG, 1994, IMMUNITY, V1, P365, DOI 10.1016/1074-7613(94)90067-1; Sneller MC, 1997, BLOOD, V89, P1341, DOI 10.1182/blood.V89.4.1341; Sparks AB, 1998, CANCER RES, V58, P1130; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Strand S, 1996, NAT MED, V2, P1361, DOI 10.1038/nm1296-1361; Sun T, 2004, JNCI-J NATL CANCER I, V96, P1030, DOI 10.1093/jnci/djh187; Sun T, 2005, J EXP MED, V202, P967, DOI 10.1084/jem.20050707; TAKAHASHI T, 1994, CELL, V76, P969, DOI 10.1016/0092-8674(94)90375-1; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; WATANABEFUKUNAGA R, 1992, NATURE, V356, P314, DOI 10.1038/356314a0; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439; Wu JG, 1996, J CLIN INVEST, V98, P1107, DOI 10.1172/JCI118892; Wu JM, 2003, J IMMUNOL, V170, P132, DOI 10.4049/jimmunol.170.1.132; Xu YY, 2003, NAT IMMUNOL, V4, P1177, DOI 10.1038/ni1008; Yokomizo H, 2003, ANTICANCER RES, V23, P5221; Zhang H, 1999, J IMMUNOL, V162, P1423; Zhang W, 2005, WORLD J GASTROENTERO, V11, P3632, DOI 10.3748/wjg.v11.i23.3632	72	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26143	10.1371/journal.pone.0026143	http://dx.doi.org/10.1371/journal.pone.0026143			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022540	Green Submitted, Green Published, gold			2022-12-27	WOS:000295973200044
J	Egginger, JG; Parmentier, C; Garrel, G; Cohen-Tannoudji, J; Camus, A; Calas, A; Hardin-Pouzet, H; Grange-Messent, V				Egginger, Johann-Guenther; Parmentier, Caroline; Garrel, Ghislaine; Cohen-Tannoudji, Joelle; Camus, Alain; Calas, Andre; Hardin-Pouzet, Helene; Grange-Messent, Valerie			Direct Evidence for the Co-Expression of URP and GnRH in a Sub-Population of Rat Hypothalamic Neurones: Anatomical and Functional Correlation	PLOS ONE			English	Article							II-RELATED PEPTIDE; GONADOTROPIN-RELEASING-HORMONE; UROTENSIN-II; MESSENGER-RNA; GALANIN; RECEPTOR; REPRODUCTION; EXPRESSION; PITUITARY; PUBERTY	Urotensin-II-related peptide (URP) is an eight amino-acid neuropeptide recently isolated from rat brain and considered as the endogenous ligand for the GPR14 receptor. Using single and double immunohistochemical labelling, in situ hybridization and ultrastructural immunocytochemistry, we explored the cellular and subcellular localization of URP in the male rat brain. URP peptide was detected in numerous varicose fibres of the median eminence (ME) and organum vasculosum laminae terminalis (OVLT) as well as in neuronal cell bodies of the medial septal nucleus and diagonal band of Broca where corresponding mRNA were also detected. Combining in situ hybridization with immunohistochemistry, we showed that cell bodies of the rat anterior hypothalamus contained both URP mRNA and GnRH peptide. In addition, double ultrastructural immunodetection of URP and GnRH peptides clearly revealed, in the median eminence, the co-localization of both peptides in the same neuronal processes in the vicinity of fenestrated portal vessels. This remarkable cellular and subcellular distribution led us to test the effect of URP on the GnRH-induced gonadotrophins release in the anterior pituitary, and to discuss its putative role at the level of the median eminence.	[Egginger, Johann-Guenther] Univ Paris 06, CNRS, UMR 7101, Lab Neurobiol Signaux Intercellulaires, Paris, France; [Parmentier, Caroline; Hardin-Pouzet, Helene; Grange-Messent, Valerie] Univ Paris 06, CNRS, UMR 7224,INSERM, Lab Physiopathol Malad Syst Nerveux Cent,U952, Paris, France; [Garrel, Ghislaine; Cohen-Tannoudji, Joelle] Univ Paris 07, CNRS, EAC 4413, Unit Biol Fonct & Adaptat, Paris, France; [Camus, Alain] Univ Paris 06, CNRS, UMR 7101, Lab Neurobiol Signaux Intercellulaires, Paris, France; [Calas, Andre] Univ Bordeaux Segalen, CNRS, UMR 5297, Interdisciplinary Inst Neurosci IINS, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Egginger, JG (corresponding author), Univ Artois, Fac Sci Jean Perrin, Lab Physiopathol Barriere Hemato Encephalique, Univ Lille Nord France, Lens, France.	valerie.messent@snv.jussieu.fr	Parmentier, Caroline/B-3341-2014; GARREL, Ghislaine/L-2654-2017	GARREL, Ghislaine/0000-0001-8547-1191; Messent, Valerie/0000-0001-7038-1302; Hardin-Pouzet, Helene/0000-0001-9401-2456				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Brann DW, 1997, ENDOCR REV, V18, P678, DOI 10.1210/er.18.5.678; Ciofi P, 2000, NEUROSCIENCE, V99, P133, DOI 10.1016/S0306-4522(00)00186-X; de Lecea L, 2008, PEPTIDES, V29, P845, DOI 10.1016/j.peptides.2008.02.009; do Rego JC, 2008, PEPTIDES, V29, P838, DOI 10.1016/j.peptides.2007.12.016; Dubessy C, 2008, J NEUROCHEM, V107, P361, DOI 10.1111/j.1471-4159.2008.05624.x; Dudas B, 2006, J NEUROENDOCRINOL, V18, P79, DOI 10.1111/j.1365-2826.2005.01398.x; Egginger JG, 2005, CR BIOL, V328, P724, DOI 10.1016/j.crvi.2005.06.002; Esclapez M, 1996, HIPPOCAMPUS, V6, P225; Herbison AE, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P1415; Jegou S, 2006, J COMP NEUROL, V495, P21, DOI 10.1002/cne.20845; Leprince J, 2008, PEPTIDES, V29, P658, DOI 10.1016/j.peptides.2007.08.014; MERCHENTHALER I, 1990, P NATL ACAD SCI USA, V87, P6326, DOI 10.1073/pnas.87.16.6326; MERCHENTHALER I, 1993, P NATL ACAD SCI USA, V90, P10479, DOI 10.1073/pnas.90.22.10479; MOHR E, 1995, P NATL ACAD SCI USA, V92, P4377, DOI 10.1073/pnas.92.10.4377; Mori M, 2004, PEPTIDES, V25, P1815, DOI 10.1016/j.peptides.2004.06.025; Ojeda S.R., 2001, CURR OPIN ENDOCRINOL, V8, P154; Ojeda SR, 2006, KNOBIL AND NEILL'S PHYSIOLOGY OF REPRODUCTION, VOLS 1 AND 2, 3RD EDITON, P2061; Peters EEM, 2009, NEUROENDOCRINOLOGY, V89, P18, DOI 10.1159/000151446; Prevot V, 2010, FRONT NEUROENDOCRIN, V31, P241, DOI 10.1016/j.yfrne.2010.05.003; Ross B, 2010, AM J PHYSIOL-REG I, V298, pR1156, DOI 10.1152/ajpregu.00706.2009; ROSSMANITH WG, 1994, ENDOCRINOLOGY, V135, P1401, DOI 10.1210/en.135.4.1401; Ruifrok AC, 2001, ANAL QUANT CYTOL, V23, P291; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; STARZEC A, 1989, MOL ENDOCRINOL, V3, P618, DOI 10.1210/mend-3-4-618; Sugo T, 2003, BIOCHEM BIOPH RES CO, V310, P860, DOI 10.1016/j.bbrc.2003.09.102; Sugo T, 2008, PEPTIDES, V29, P809, DOI 10.1016/j.peptides.2007.06.005; Terasawa E, 2001, ENDOCR REV, V22, P111, DOI 10.1210/er.22.1.111; TREMBLEAU A, 1994, J NEUROSCI, V14, P39; Vaudry H, 2008, PEPTIDES, V29, P647, DOI 10.1016/j.peptides.2008.01.010	30	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26611	10.1371/journal.pone.0026611	http://dx.doi.org/10.1371/journal.pone.0026611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039515	Green Submitted, Green Published, gold			2022-12-27	WOS:000296515200030
J	Humphries, WH; Szymanski, CJ; Payne, CK				Humphries, William H.; Szymanski, Craig J.; Payne, Christine K.			Endo-Lysosomal Vesicles Positive for Rab7 and LAMP1 Are Terminal Vesicles for the Transport of Dextran	PLOS ONE			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; ENDOCYTIC PATHWAY; LATE ENDOSOMES; MEMBRANE-PROTEINS; LIVING CELLS; RAT-LIVER; BIOGENESIS; ENZYMES; TRAFFICKING; FUSION	The endo-lysosomal pathway is essential for intracellular transport and the degradation of extracellular cargo. The relationship between three populations of endo-lysosomal vesicles-Rab7-positive, LAMP1-positive, and both Rab7- and LAMP1-postive-was probed with fluorescence microscopy and single particle tracking. Of specific interest was determining if these vesicles were intermediate or terminal vesicles in the transport of extracellular cargo. We find that the major organelle in the endo-lysosomal pathway, both in terms of population and cargo transport, is positive for Rab7 and LAMP1. Dextran, a fluid phase cargo, shifts from localization within all three populations of vesicles at 30 minutes and 1 hour to primarily LAMP1- and Rab7/LAMP1-vesicles at longer times. This demonstrates that LAMP1- and Rab7/LAMP1-vesicles are terminal vesicles in the endo-lysosomal pathway. We tested two possible mechanisms for this distribution of cargo, delivery to mannose 6-phosphate receptor (M6PR)-negative vesicles and the fusion dynamics of individual vesicles. We find no correlation with M6PR but do find that Rab7-vesicles undergo significantly fewer fusion events than LAMP1- or Rab7/LAMP1-vesicles suggesting that the distribution of fluid phase cargo is driven by vesicle dynamics.	[Humphries, William H.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Humphries, WH (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.	christine.payne@chemistry.gatech.edu	Payne, Christine K./E-5954-2010		National Institutes of Health (NIH) [R01-GM086195, 1DP2OD006470]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086195] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006470] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by National Institutes of Health (NIH) grant R01-GM086195 and an NIH Director's New Innovator Award 1DP2OD006470 (to CKP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B., 1994, MOL BIOL CELL; Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030; BOWSER R, 1990, J CELL PHYSIOL, V143, P110, DOI 10.1002/jcp.1041430115; Bright NA, 1997, J CELL SCI, V110, P2027; BROWN WJ, 1986, J CELL BIOL, V103, P1235, DOI 10.1083/jcb.103.4.1235; Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467; CHAVRIER P, 1990, CELL, V62, P317, DOI 10.1016/0092-8674(90)90369-P; CHEN JW, 1985, J CELL BIOL, V101, P85, DOI 10.1083/jcb.101.1.85; Cho YW, 2003, J PHARM PHARMACOL, V55, P721, DOI 10.1211/002235703765951311; Clague MJ, 1998, BIOCHEM J, V336, P271, DOI 10.1042/bj3360271; Duan HW, 2007, J AM CHEM SOC, V129, P3333, DOI 10.1021/ja068158s; Eskelinen EL, 2003, TRENDS CELL BIOL, V13, P137, DOI 10.1016/S0962-8924(03)00005-9; GEUZE HJ, 1988, J CELL BIOL, V107, P2491, DOI 10.1083/jcb.107.6.2491; GEUZE HJ, 1985, J CELL BIOL, V101, P2253, DOI 10.1083/jcb.101.6.2253; GRIFFITHS G, 1988, CELL, V52, P329, DOI 10.1016/S0092-8674(88)80026-6; Hacker U, 1997, J CELL SCI, V110, P105; Humphries WH, 2010, INTEGR BIOL-UK, V2, P536, DOI 10.1039/c0ib00035c; Kang JX, 1998, P NATL ACAD SCI USA, V95, P13687, DOI 10.1073/pnas.95.23.13687; KJEKEN R, 1995, EXP CELL RES, V216, P290, DOI 10.1006/excr.1995.1037; Kundra R, 1999, J BIOL CHEM, V274, P31039, DOI 10.1074/jbc.274.43.31039; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; LEWIS V, 1985, J CELL BIOL, V100, P1839, DOI 10.1083/jcb.100.6.1839; LIPPINCOTTSCHWARTZ J, 1986, J CELL BIOL, V102, P1593, DOI 10.1083/jcb.102.5.1593; LUDWIG T, 1991, J CELL BIOL, V115, P1561, DOI 10.1083/jcb.115.6.1561; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; Luzio JP, 2003, MOL MEMBR BIOL, V20, P141, DOI 10.1080/0968768031000089546; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; MERESSE S, 1995, J CELL SCI, V108, P3349; Mullock BM, 1998, J CELL BIOL, V140, P591, DOI 10.1083/jcb.140.3.591; Pfeffer SR, 2001, TRENDS CELL BIOL, V11, P487, DOI 10.1016/S0962-8924(01)02147-X; Pillay CS, 2002, BIOCHEM J, V363, P417, DOI 10.1042/0264-6021:3630417; RACOOSIN EL, 1993, J CELL BIOL, V121, P1011, DOI 10.1083/jcb.121.5.1011; REGGIO H, 1984, J CELL BIOL, V99, P1511, DOI 10.1083/jcb.99.4.1511; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; RUNQUIST EA, 1991, J BIOL CHEM, V266, P22557; Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745; SAHAGIAN GG, 1983, J BIOL CHEM, V258, P7121; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; SOLDATI T, 1995, J BIOL CHEM, V270, P25541, DOI 10.1074/jbc.270.43.25541; Szymanski CJ, 2011, ANALYST, V136, P3527, DOI 10.1039/c0an00855a; THILO L, 1995, J CELL SCI, V108, P1791; Tjelle TE, 1996, J CELL SCI, V109, P2905; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391	45	65	65	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26626	10.1371/journal.pone.0026626	http://dx.doi.org/10.1371/journal.pone.0026626			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039519	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200035
J	Paweletz, CP; Andersen, JN; Pollock, R; Nagashima, K; Hayashi, ML; Yu, SU; Guo, HB; Bobkova, EV; Xu, ZW; Northrup, A; Blume-Jensen, P; Hendrickson, RC; Chi, A				Paweletz, Cloud P.; Andersen, Jannik N.; Pollock, Roy; Nagashima, Kumiko; Hayashi, Mansuo L.; Yu, Shangshuan U.; Guo, Hongbo; Bobkova, Ekaterina V.; Xu, Zangwei; Northrup, Alan; Blume-Jensen, Peter; Hendrickson, Ronald C.; Chi, An			Identification of Direct Target Engagement Biomarkers for Kinase-Targeted Therapeutics	PLOS ONE			English	Article							EARLY CLINICAL-TRIALS; PROTEIN; AUTOPHOSPHORYLATION; PROTEOMICS; DISCOVERY; CANCER; VERIFICATION; ENRICHMENT; INHIBITORS; MECHANISM	Pharmacodynamic (PD) biomarkers are an increasingly valuable tool for decision-making and prioritization of lead compounds during preclinical and clinical studies as they link drug-target inhibition in cells with biological activity. They are of particular importance for novel, first-in-class mechanisms, where the ability of a targeted therapeutic to impact disease outcome is often unknown. By definition, proximal PD biomarkers aim to measure the interaction of a drug with its biological target. For kinase drug discovery, protein substrate phosphorylation sites represent candidate PD biomarkers. However, substrate phosphorylation is often controlled by input from multiple converging pathways complicating assessment of how potently a small molecule drug hits its target based on substrate phoshorylation measurements alone. Here, we report the use of quantitative, differential mass-spectrometry to identify and monitor novel drug-regulated phosphorylation sites on target kinases. Autophosphorylation sites constitute clinically validated biomarkers for select protein tyrosine kinase inhibitors. The present study extends this principle to phosphorylation sites in serine/threonine kinases looking beyond the T-loop autophosphorylation site. Specifically, for the 3'-phosphoinositide-dependent protein kinase 1 (PDK1), two phospho-residues p-PDK1(Ser410) and p-PDK1(Thr513) are modulated by small-molecule PDK1 inhibitors, and their degree of dephosphorylation correlates with inhibitor potency. We note that classical, ATP-competitive PDK1 inhibitors do not modulate PDK1 T-loop phosphorylation (p-PDK1(Ser241)), highlighting the value of an unbiased approach to identify drug target-regulated phosphorylation sites as these are complementary to pathway PD biomarkers. Finally, we extend our analysis to another protein Ser/Thr kinase, highlighting a broader utility of our approach for identification of kinase drug-target engagement biomarkers.	[Paweletz, Cloud P.; Andersen, Jannik N.; Pollock, Roy; Nagashima, Kumiko; Hayashi, Mansuo L.; Yu, Shangshuan U.; Guo, Hongbo; Bobkova, Ekaterina V.; Xu, Zangwei; Northrup, Alan; Chi, An] Merck & Co Inc, Boston, MA USA; [Hayashi, Mansuo L.] Merck & Co Inc, West Point, PA USA; [Blume-Jensen, Peter] Metamark Genet Inc, Cambridge, MA USA; [Hendrickson, Ronald C.] Merck & Co Inc, Rahway, NJ 07065 USA	Merck & Company; Merck & Company; Merck & Company	Paweletz, CP (corresponding author), Merck & Co Inc, Boston, MA USA.	pblumejensen@metamarkgenetics.com; an_chi@merck.com		Andersen, Jannik/0000-0003-4528-2120	Merck Company	Merck Company(Merck & Company)	This work was funded by Merck & Company who had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to all the PLoS ONE policies on sharing data and materials.	Addona TA, 2011, NAT BIOTECHNOL, V29, P635, DOI 10.1038/nbt.1899; Andersen JN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001065; Baselga J, 2001, EUR J CANCER, V37, pS16; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bobkova EV, 2010, J BIOL CHEM, V285, P18838, DOI 10.1074/jbc.M109.089946; Casamayor A, 1999, BIOCHEM J, V342, P287, DOI 10.1042/0264-6021:3420287; Collins I, 2006, NAT CHEM BIOL, V2, P689, DOI 10.1038/nchembio840; Dancey JE, 2010, CLIN CANCER RES, V16, P1745, DOI 10.1158/1078-0432.CCR-09-2167; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Ellwood-Yen K, 2011, CANCER RES, V71, P3052, DOI 10.1158/0008-5472.CAN-10-2282; Gao XX, 2006, BIOORG CHEM, V34, P200, DOI 10.1016/j.bioorg.2006.05.002; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kuhn E, 2009, CLIN CHEM, V55, P1108, DOI 10.1373/clinchem.2009.123935; Lochhead PA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pe4; Luo FR, 2006, CLIN CANCER RES, V12, P7180, DOI 10.1158/1078-0432.CCR-06-1112; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nagashima K, 2011, J BIOL CHEM, V286, P6433, DOI 10.1074/jbc.M110.156463; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Oppermann FS, 2009, MOL CELL PROTEOMICS, V8, P1751, DOI 10.1074/mcp.M800588-MCP200; Pan BS, 2010, CANCER RES, V70, P1524, DOI 10.1158/0008-5472.CAN-09-2541; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Paweletz CP, 2010, J PROTEOME RES, V9, P1392, DOI 10.1021/pr900925d; Petricoin EF, 2002, NAT REV DRUG DISCOV, V1, P683, DOI 10.1038/nrd891; Phillips KA, 2006, NAT REV DRUG DISCOV, V5, P463, DOI 10.1038/nrd2033; Rifai N, 2006, NAT BIOTECHNOL, V24, P971, DOI 10.1038/nbt1235; Sarker D, 2007, BIOMARK MED, V1, P399, DOI 10.2217/17520363.1.3.399; Sequist LV, 2011, CANCER DISCOV, V1, P14, DOI 10.1158/2159-8274.CD-11-0044; Songyang Z, 1996, MOL CELL BIOL, V16, P6486; Tan DSW, 2009, CANCER J, V15, P406, DOI 10.1097/PPO.0b013e3181bd0445; Wagner JA, 2007, CLIN PHARMACOL THER, V81, P104, DOI 10.1038/sj.clpt.6100017; Wagner JA, 2008, ANNU REV PHARMACOL, V48, P631, DOI 10.1146/annurev.pharmtox.48.113006.094611; Wang J, 2011, J BIOL CHEM, V286, P2689, DOI 10.1074/jbc.M110.156505; Whiteaker JR, 2011, NAT BIOTECHNOL, V29, P625, DOI 10.1038/nbt.1900; Woodcock J, 2008, ANNU REV MED, V59, P1, DOI 10.1146/annurev.med.59.090506.155819; Wulfkuhle JD, 2006, NAT CLIN PRACT ONCOL, V3, P256, DOI 10.1038/ncponc0485; Xu DZ, 2010, J BIOL CHEM, V285, P39935, DOI 10.1074/jbc.M110.166462; Xu ZW, 2009, J BIOMOL SCREEN, V14, P1257, DOI 10.1177/1087057109349356	42	22	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26459	10.1371/journal.pone.0026459	http://dx.doi.org/10.1371/journal.pone.0026459			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039492	gold, Green Published, Green Submitted			2022-12-27	WOS:000296515200021
J	Yusuf, E; Bijsterbosch, J; Slagboom, PE; Kroon, HM; Rosendaal, FR; Huizinga, TWJ; Kloppenburg, M				Yusuf, Erlangga; Bijsterbosch, Jessica; Slagboom, P. Eline; Kroon, Herman M.; Rosendaal, Frits R.; Huizinga, Tom W. J.; Kloppenburg, Margreet			Association between Several Clinical and Radiological Determinants with Long-Term Clinical Progression and Good Prognosis of Lower Limb Osteoarthritis	PLOS ONE			English	Article							RADIOGRAPHIC KNEE OSTEOARTHRITIS; HIP OSTEOARTHRITIS; HEALTH SURVEY; RISK-FACTORS; COMMUNITY; INDEX; CLASSIFICATION; ARTHRITIS; CRITERIA; OUTCOMES	Objective: To investigate the factors associated with clinical progression and good prognosis in patients with lower limb osteoarthritis (OA). Methods: Cohort study of 145 patients with OA in either knee, hip or both. Progression was defined as 1) new joint prosthesis or 2) increase in WOMAC pain or function score during 6-years follow-up above pre-defined thresholds. Patients without progression with decrease in WOMAC pain or function score lower than pre-defined thresholds were categorized as good prognosis. Relative risks (RRs) for progression and good prognosis with 95% confidence interval (95% CI) were calculated by comparing the highest tertile or category to the lowest tertile, for baseline determinants (age, sex, BMI, WOMAC pain and function scores, pain on physical examination, total range of motion (tROM), osteophytes and joint space narrowing (JSN) scores), and for worsening in WOMAC pain and function score in 1-year. Adjustments were performed for age, sex, and BMI. Results: Follow-up was completed by 117 patients (81%, median age 60 years, 84% female); 62 (53%) and 31 patients (26%) showed progression and good prognosis, respectively. These following determinants were associated with progression: pain on physical examination (RR 1.2 (1.0 to 1.5)); tROM (1.4 (1.1 to 1.6); worsening in WOMAC pain (1.9 (1.2 to 2.3)); worsening in WOMAC function (2.4 (1.7 to 2.6)); osteophytes 1.5 (1.0 to 1.8); and JSN scores (2.3 (1.5 to 2.7)). Worsening in WOMAC pain (0.1 (0.1 to 0.8)) and function score (0.1 (0.1 to 0.7)), were negatively associated with good prognosis. Conclusion: Worsening of self-reported pain and function in one year, limited tROM and higher osteophytes and JSN scores were associated with clinical progression. Worsening in WOMAC pain and function score in 1-year were associated with lower risk to have good prognosis. These findings help to inform patients with regard to their OA prognosis.	[Yusuf, Erlangga; Bijsterbosch, Jessica; Huizinga, Tom W. J.; Kloppenburg, Margreet] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands; [Slagboom, P. Eline] Leiden Univ, Dept Mol Epidemiol, Med Ctr, Leiden, Netherlands; [Kroon, Herman M.] Leiden Univ, Dept Radiol, Med Ctr, Leiden, Netherlands; [Rosendaal, Frits R.; Kloppenburg, Margreet] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Yusuf, E (corresponding author), Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands.	angga.yusuf@gmail.com	Slagboom, P. Eline/R-4790-2016; Yusuf, Erlangga/H-5166-2019; Rosendaal, Frits/Q-3842-2017	Slagboom, P. Eline/0000-0002-2875-4723; Yusuf, Erlangga/0000-0003-4779-2191; Rosendaal, Frits/0000-0003-2558-7496	Pfizer (Groton, CT, USA); Dutch Arthritis Association; TI-Pharma	Pfizer (Groton, CT, USA)(Pfizer); Dutch Arthritis Association; TI-Pharma	Funding: This study was financially supported by Pfizer (Groton, CT, USA), the Dutch Arthritis Association, and TI-Pharma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; Belo JN, 2007, ARTHRIT RHEUM-ARTHR, V57, P13, DOI 10.1002/art.22475; Bijsterbosch J, 2010, OSTEOARTHR CARTILAGE, V18, P1046, DOI 10.1016/j.joca.2010.05.009; Bykerk V, 2009, J RHEUMATOL, V36, P1565, DOI 10.3899/jrheum.090673; Cooper C, 2000, ARTHRITIS RHEUM, V43, P995, DOI 10.1002/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1; Dieppe P, 2000, OSTEOARTHR CARTILAGE, V8, P63, DOI 10.1053/joca.1999.0272; DOYLE DV, 1981, ANN RHEUM DIS, V40, P75, DOI 10.1136/ard.40.1.75; Ehrich EW, 2000, J RHEUMATOL, V27, P2635; Felson DT, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2531; Lacey RJ, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-82; Lane NE, 2004, ARTHRITIS RHEUM-US, V50, P1477, DOI 10.1002/art.20213; Lawrence RC, 1998, ARTHRITIS RHEUM-US, V41, P778, DOI 10.1002/1529-0131(199805)41:5<778::AID-ART4>3.0.CO;2-V; LEDINGHAM J, 1995, ANN RHEUM DIS, V54, P53, DOI 10.1136/ard.54.1.53; Nilsdotter AK, 2009, ACTA ORTHOP, V80, P55, DOI 10.1080/17453670902805007; O'Reilly SC, 2000, OSTEOARTHR CARTILAGE, V8, P78, DOI 10.1053/joca.1999.0274; Riyazi N, 2005, ANN RHEUM DIS, V64, P438, DOI 10.1136/ard.2004.024661; Roos EM, 2008, ANN RHEUM DIS, V67, P505, DOI 10.1136/ard.2007.074088; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wright AA, 2009, ARTHRIT RHEUM-ARTHR, V61, P925, DOI 10.1002/art.24641; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zhang W, 2010, ANN RHEUM DIS, V69, P483, DOI 10.1136/ard.2009.113100; Zhang YQ, 2010, ARTHRIT CARE RES, V62, P1527, DOI 10.1002/acr.20287	25	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e25426	10.1371/journal.pone.0025426	http://dx.doi.org/10.1371/journal.pone.0025426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031816	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200003
J	Baradez, MO; Marshall, D				Baradez, Marc-Olivier; Marshall, Damian			The Use of Multidimensional Image-Based Analysis to Accurately Monitor Cell Growth in 3D Bioreactor Culture	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; ANCHORAGE-DEPENDENT CELLS; MICROCARRIER; EXPANSION; CULTIVATION; FEATURES; DESIGN	The transition from traditional culture methods towards bioreactor based bioprocessing to produce cells in commercially viable quantities for cell therapy applications requires the development of robust methods to ensure the quality of the cells produced. Standard methods for measuring cell quality parameters such as viability provide only limited information making process monitoring and optimisation difficult. Here we describe a 3D image-based approach to develop cell distribution maps which can be used to simultaneously measure the number, confluency and morphology of cells attached to microcarriers in a stirred tank bioreactor. The accuracy of the cell distribution measurements is validated using in silico modelling of synthetic image datasets and is shown to have an accuracy >90%. Using the cell distribution mapping process and principal component analysis we show how cell growth can be quantitatively monitored over a 13 day bioreactor culture period and how changes to manufacture processes such as initial cell seeding density can significantly influence cell morphology and the rate at which cells are produced. Taken together, these results demonstrate how image-based analysis can be incorporated in cell quality control processes facilitating the transition towards bioreactor based manufacture for clinical grade cells.	[Baradez, Marc-Olivier; Marshall, Damian] LGC, Div Sci & Technol, Teddington, Middx, England		Baradez, MO (corresponding author), LGC, Div Sci & Technol, Teddington, Middx, England.	damian.marshall@lgc.co.uk			UK National Measurement System; UK government's department for business, innovation and skills (BIS)	UK National Measurement System; UK government's department for business, innovation and skills (BIS)	The work presented in this paper was supported by the UK National Measurement System which is funded by an executive agency of the UK government's department for business, innovation and skills (BIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. LGC funded this study through the employment of Marc-Olivier Baradez and Damian Marshall who both conceived and designed the experiments and analyzed the data. Marc-Olivier Baradez also performed the experiments.	Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012; Abranches E, 2007, BIOTECHNOL BIOENG, V96, P1211, DOI 10.1002/bit.21191; Arien-Zakay H, 2009, J MOL NEUROSCI, V37, P225, DOI 10.1007/s12031-008-9123-1; Bleckwenn NA, 2004, CURR PROTOC IMMU S59; Borg DJ, 2009, J BIOMED MATER RES A, V88A, P184, DOI 10.1002/jbm.a.31864; Boudreault P, 2001, J BIOTECHNOL, V91, P63, DOI 10.1016/S0168-1656(01)00291-7; Chen R, 2006, BIOMATERIALS, V27, P4453, DOI 10.1016/j.biomaterials.2006.04.011; De Leon A, 1998, CYTOTECHNOLOGY, V28, P127, DOI 10.1023/A:1008042000744; Dietz A, 2009, CLIN PHARMACOL THER, V82, P320; DUVAL D, 1990, J IMMUNOL METHODS, V134, P177, DOI 10.1016/0022-1759(90)90379-A; Eibes G, 2010, J BIOTECHNOL, V146, P194, DOI 10.1016/j.jbiotec.2010.02.015; Fernandes AM, 2007, J BIOTECHNOL, V132, P227, DOI 10.1016/j.jbiotec.2007.05.031; FORESTELL SP, 1992, BIOTECHNOL BIOENG, V39, P305, DOI 10.1002/bit.260390308; Franco R, 1999, CYTOTECHNOLOGY, V29, P11, DOI 10.1023/A:1008075423609; Frondoza C, 1996, BIOMATERIALS, V17, P879, DOI 10.1016/0142-9612(96)83283-2; Gilbertson JA, 2006, BIOTECHNOL BIOENG, V94, P783, DOI 10.1002/bit.20900; Guez JS, 2010, PROCESS BIOCHEM, V45, P288, DOI 10.1016/j.procbio.2009.09.021; Han Y, 2006, J BIOSCI BIOENG, V102, P430, DOI 10.1263/jbb.102.430; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Justice BA, 2009, DRUG DISCOV TODAY, V14, P102, DOI 10.1016/j.drudis.2008.11.006; King JA, 2007, CURR OPIN CHEM BIOL, V11, P394, DOI 10.1016/j.cbpa.2007.05.034; Kino-Oka M, 2005, TISSUE ENG, V11, P535, DOI 10.1089/ten.2005.11.535; Kozak K, 2010, J BIOMOL SCREEN, V15, P892, DOI 10.1177/1087057110377354; Lock LT, 2009, TISSUE ENG PT A, V15, P2051, DOI 10.1089/ten.tea.2008.0455; Lu G., 2006, TSINGHUA SCI TECHNOL, V11, P427, DOI [10.1016/S1007-0214(06)70212-7, DOI 10.1016/S1007-0214(06)70212-7]; Marolt D, 2006, BIOMATERIALS, V27, P6138, DOI 10.1016/j.biomaterials.2006.07.015; Martin I, 2009, TRENDS BIOTECHNOL, V27, P495, DOI 10.1016/j.tibtech.2009.06.002; Mendonca RZ, 2002, J BIOTECHNOL, V97, P13, DOI 10.1016/S0168-1656(02)00048-2; Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005; Paran Y, 2007, J STRUCT BIOL, V158, P233, DOI 10.1016/j.jsb.2006.12.013; Rudolph G, 2008, BIOTECHNOL BIOENG, V99, P136, DOI 10.1002/bit.21523; Sabino DMU, 2004, REAL-TIME IMAGING, V10, P205, DOI 10.1016/j.rti.2004.02.007; Sart S, 2009, J BIOTECHNOL, V139, P291, DOI 10.1016/j.jbiotec.2008.12.011; Schop D, 2008, J TISSUE ENG REGEN M, V2, P126, DOI 10.1002/term.73; Serra M, 2010, J BIOTECHNOL, V148, P208, DOI 10.1016/j.jbiotec.2010.06.015; Serra M, 2009, ANN ANAT, V191, P104, DOI 10.1016/j.aanat.2008.09.005; Soh LK, 1999, IEEE T GEOSCI REMOTE, V37, P780, DOI 10.1109/36.752194; Solchaga LA, 2006, TISSUE ENG, V12, P1851, DOI 10.1089/ten.2006.12.1851; Varani J, 1998, CYTOTECHNOLOGY, V28, P101, DOI 10.1023/A:1008029715765; Williams DJ, 2006, NANOBIOTECHNOLOGY, V152, P207; Yang HS, 2010, CELL TRANSPLANT, V19, P1123, DOI 10.3727/096368910X516664; Yu YQ, 2009, APPL BIOCHEM BIOTECH, V159, P110, DOI 10.1007/s12010-009-8556-5; Zandstra PW, 2001, ANNU REV BIOMED ENG, V3, P275, DOI 10.1146/annurev.bioeng.3.1.275; Zanella F, 2010, TRENDS BIOTECHNOL, V28, P237, DOI 10.1016/j.tibtech.2010.02.005	44	14	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26104	10.1371/journal.pone.0026104	http://dx.doi.org/10.1371/journal.pone.0026104			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028809	Green Submitted, Green Published, gold			2022-12-27	WOS:000296510800017
J	Schaaf, S; Shibamiya, A; Mewe, M; Eder, A; Stohr, A; Hirt, MN; Rau, T; Zimmermann, WH; Conradi, L; Eschenhagen, T; Hansen, A				Schaaf, Sebastian; Shibamiya, Aya; Mewe, Marco; Eder, Alexandra; Stoehr, Andrea; Hirt, Marc N.; Rau, Thomas; Zimmermann, Wolfram-Hubertus; Conradi, Lenard; Eschenhagen, Thomas; Hansen, Arne			Human Engineered Heart Tissue as a Versatile Tool in Basic Research and Preclinical Toxicology	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; INFARCTED RAT HEARTS; CARDIAC-MUSCLE; CARDIOMYOCYTES; DIFFERENTIATION; POPULATION; COCULTURE; MYOCYTES; GROWTH	Human embryonic stem cell (hESC) progenies hold great promise as surrogates for human primary cells, particularly if the latter are not available as in the case of cardiomyocytes. However, high content experimental platforms are lacking that allow the function of hESC-derived cardiomyocytes to be studied under relatively physiological and standardized conditions. Here we describe a simple and robust protocol for the generation of fibrin-based human engineered heart tissue (hEHT) in a 24-well format using an unselected population of differentiated human embryonic stem cells containing 30-40% alpha-actinin-positive cardiac myocytes. Human EHTs started to show coherent contractions 5-10 days after casting, reached regular (mean 0.5 Hz) and strong (mean 100 mu N) contractions for up to 8 weeks. They displayed a dense network of longitudinally oriented, interconnected and cross-striated cardiomyocytes. Spontaneous hEHT contractions were analyzed by automated video-optical recording and showed chronotropic responses to calcium and the beta-adrenergic agonist isoprenaline. The proarrhythmic compounds E-4031, quinidine, procainamide, cisapride, and sertindole exerted robust, concentration-dependent and reversible decreases in relaxation velocity and irregular beating at concentrations that recapitulate findings in hERG channel assays. In conclusion this study establishes hEHT as a simple in vitro model for heart research.	[Schaaf, Sebastian; Shibamiya, Aya; Eder, Alexandra; Stoehr, Andrea; Hirt, Marc N.; Rau, Thomas; Zimmermann, Wolfram-Hubertus; Eschenhagen, Thomas; Hansen, Arne] Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Cardiovasc Res Ctr, Hamburg, Germany; [Mewe, Marco] Univ Med Ctr Hamburg Eppendorf, Dept Pharmacol Pharmacists, Cardiovasc Res Ctr, Hamburg, Germany; [Conradi, Lenard] Univ Med Ctr Hamburg Eppendorf, Dept Cardiovasc Surg, Cardiovasc Res Ctr, Hamburg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Hamburg; University Medical Center Hamburg-Eppendorf	Schaaf, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Expt Pharmacol & Toxicol, Cardiovasc Res Ctr, Hamburg, Germany.	ar.hansen@uke.de	Zimmermann, Wolfram-Hubertus H/I-6838-2012; Stoehr, Andrea/F-7452-2018; Conradi, Lenard/AAQ-7476-2021	Zimmermann, Wolfram-Hubertus H/0000-0003-1190-4040; Stoehr, Andrea/0000-0003-3573-1818; Conradi, Lenard/0000-0003-2237-9050	Deutsche Forschungsgemeinschaft [HA 3423/3-1, ZI 708/7-1, 8-1]; Deutsche Herzstiftung [F/13/10]; European Union; Novartis-Stiftung; Bundesministerium fur Bildung und Forschung [DLR FKZ: 01GN0520]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Herzstiftung; European Union(European Commission); Novartis-Stiftung; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This study was supported by funds from the Deutsche Forschungsgemeinschaft (HA 3423/3-1, ZI 708/7-1, 8-1), Deutsche Herzstiftung (F/13/10), European Union (FP6 EUGene Heart, FP7 Angioscaff), Novartis-Stiftung and Bundesministerium fur Bildung und Forschung (DLR FKZ: 01GN0520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braam SR, 2010, STEM CELL RES, V4, P107, DOI 10.1016/j.scr.2009.11.004; Burridge PW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018293; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff; Caspi O, 2009, STEM CELLS DEV, V18, P161, DOI 10.1089/scd.2007.0280; El-Armouche A, 2007, J MOL CELL CARDIOL, V43, P371, DOI 10.1016/j.yjmcc.2007.05.021; EMA, 2005, NONCL EV POT DEL VEN; Eschenhagen T, 1997, FASEB J, V11, P683, DOI 10.1096/fasebj.11.8.9240969; EVERETT AW, 1986, J MOL CELL CARDIOL, V18, P607, DOI 10.1016/S0022-2828(86)80968-3; FDA, 2005, GUID IND S7B NONCL E; Hansen A, 2010, CIRC RES, V107, P35, DOI 10.1161/CIRCRESAHA.109.211458; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; MALTSEV VA, 1993, MECH DEVELOP, V44, P41, DOI 10.1016/0925-4773(93)90015-P; Muhlhauser U, 2006, FASEB J, V20, P785, DOI 10.1096/fj.05-5067fje; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Redfern WS, 2003, CARDIOVASC RES, V58, P32, DOI 10.1016/S0008-6363(02)00846-5; Shapira-Schweitzer K, 2009, J MOL CELL CARDIOL, V46, P213, DOI 10.1016/j.yjmcc.2008.10.018; Stevens KR, 2009, P NATL ACAD SCI USA, V106, P16568, DOI 10.1073/pnas.0908381106; Tulloch NL, 2011, CIRC RES, V109, P47, DOI 10.1161/CIRCRESAHA.110.237206; Vandenburgh H, 2008, MUSCLE NERVE, V37, P438, DOI 10.1002/mus.20931; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu XQ, 2008, DIFFERENTIATION, V76, P958, DOI 10.1111/j.1432-0436.2008.00284.x; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Zhou ZF, 1998, BIOPHYS J, V74, P230, DOI 10.1016/S0006-3495(98)77782-3; Zhu WZ, 2010, CIRC RES, V107, P776, DOI 10.1161/CIRCRESAHA.110.223917; Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	29	240	256	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26397	10.1371/journal.pone.0026397	http://dx.doi.org/10.1371/journal.pone.0026397			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028871	Green Published, gold, Green Submitted			2022-12-27	WOS:000296510800040
J	Lee, AW				Lee, Angel W.			The Role of Atypical Protein Kinase C in CSF-1-Dependent Erk Activation and Proliferation in Myeloid Progenitors and Macrophages	PLOS ONE			English	Article							STIMULATING FACTOR-I; NF-KAPPA-B; CSF-1 RECEPTOR; SIGNAL-TRANSDUCTION; PHOSPHATIDYLINOSITOL 3-KINASE; DIFFERENTIAL EXPRESSION; BINDING-SITE; PI 3-KINASE; PKC-ZETA; SPECIFICITY	Colony stimulating factor-1 (CSF-1 or M-CSF) is the major physiological regulator of the proliferation, differentiation and survival of cells of the mononuclear phagocyte lineage. CSF-1 binds to a receptor tyrosine kinase, the CSF-1 receptor (CSF-1R). Multiple pathways are activated downstream of the CSF-1R; however, it is not clear which pathways regulate proliferation and survival. Here, we investigated the role of atypical protein kinase Cs (PKCf) in a myeloid progenitor cell line that expressed CSF-1R (32D. R) and in primary murine bone marrow derived macrophages (BMMs). In 32D. R cells, CSF-1 induced the phosphorylation of PKCf and increased its kinase activity. PKC inhibitors and transfections with mutant PKCs showed that optimal CSF-1-dependent Erk activation and proliferation depended on the activity of PKCf. We previously reported that CSF-1 activated the Erk pathway through an A-Raf-dependent and an A-Raf independent pathway (Lee and States, Mol. Cell. Biol. 18, 6779). PKC inhibitors did not affect CSF-1 induced Ras and A-Raf activity but markedly reduced MEK and Erk activity, implying that PKCf regulated the CSF-1-Erk pathway at the level of MEK. PKCf has been implicated in activating the NF-kappa B pathway. However, CSF-1 promoted proliferation in an NF-kB independent manner. We established stable 32D. R cell lines that overexpressed PKCf. Overexpression of PKCf increased the intensity and duration of CSF-1 induced Erk activity and rendered cells more responsive to CSF-1 mediated proliferation. In contrast to 32D. R cells, PKCf inhibition in BMMs had only a modest effect on proliferation. Moreover, PKCf-specific and pan-PKC inhibitors induced a paradoxical increase in MEK-Erk phosphorylation suggesting that PKCs targeted a common negative regulatory step upstream of MEK. Our results demonstrated that CSF-1 dependent Erk activation and proliferation are regulated differentially in progenitors and differentiated cells.	[Lee, Angel W.] Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Lee, Angel W.] Univ Texas Hlth Sci Ctr, Ctr Prote & Syst Biol, Inst Mol Med, Houston, TX USA; [Lee, Angel W.] OncProTech, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Texas System; University of Texas Health Science Center Houston	Lee, AW (corresponding author), Univ Michigan, Sch Med, Dept Pharmacol, Ann Arbor, MI 48109 USA.	awmlee@angelleelab.org			Public Health Service, National Cancer Institute [RO1-CA85368]; NATIONAL CANCER INSTITUTE [R01CA085368] Funding Source: NIH RePORTER	Public Health Service, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)United States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The initial phase of the work was supported by Public Health Service grant RO1-CA85368 from the National Cancer Institute (to AWL). No additional external funding was received for this study. There is no financial conflict of interest to disclose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandyopadhyay G, 1997, J BIOL CHEM, V272, P2551; Berra E, 1995, EMBO J, V14, P6157, DOI 10.1002/j.1460-2075.1995.tb00306.x; BUSCHER D, 1995, MOL CELL BIOL, V15, P466; Chang F, 2003, LEUKEMIA, V17, P1263, DOI 10.1038/sj.leu.2402945; Chen J, 2001, P NATL ACAD SCI USA, V98, P7783, DOI 10.1073/pnas.141224398; Chitu V, 2006, CURR OPIN IMMUNOL, V18, P39, DOI 10.1016/j.coi.2005.11.006; Chou MM, 1998, CURR BIOL, V8, P1069, DOI 10.1016/S0960-9822(98)70444-0; Cohen EEW, 2006, CANCER RES, V66, P6296, DOI 10.1158/0008-5472.CAN-05-3139; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; DEBRUIJN MFTR, 1994, EUR J IMMUNOL, V24, P2279, DOI 10.1002/eji.1830241003; Diaz-Meco MT, 2001, MOL CELL BIOL, V21, P1218, DOI 10.1128/MCB.21.4.1218-1227.2001; Garcia-Paramio P, 1998, BIOCHEM J, V333, P631, DOI 10.1042/bj3330631; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Guo H, 2009, J LEUKOCYTE BIOL, V85, P911, DOI 10.1189/jlb.0708429; Hamdorf M, 2011, STEM CELLS, V29, P297, DOI 10.1002/stem.564; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hunter M, 2009, FRONT BIOSCI-LANDMRK, V14, P4079, DOI 10.2741/3514; Ito Y, 2010, J CLIN INVEST, V120, P1981, DOI 10.1172/JCI39650; Junttila I, 2003, J LEUKOCYTE BIOL, V73, P281, DOI 10.1189/jlb.0702359; Kacinski BM, 1997, MOL REPROD DEV, V46, P71, DOI 10.1002/(SICI)1098-2795(199701)46:1<71::AID-MRD11>3.0.CO;2-6; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Le Good JA, 1998, SCIENCE, V281, P2042, DOI 10.1126/science.281.5385.2042; Lee AWM, 2006, CELL DEATH DIFFER, V13, P1900, DOI 10.1038/sj.cdd.4401884; Lee AW, 1999, BLOOD, V93, P537, DOI 10.1182/blood.V93.2.537.402k30_537_553; LEE AW, 1990, P NATL ACAD SCI USA, V87, P7270, DOI 10.1073/pnas.87.18.7270; Lee AWM, 2000, MOL CELL BIOL, V20, P6779, DOI 10.1128/MCB.20.18.6779-6798.2000; Lee MC, 2008, J LEUKOCYTE BIOL, V84, P835, DOI 10.1189/jlb.1007691; Lee PSW, 1999, EMBO J, V18, P3616, DOI 10.1093/emboj/18.13.3616; Lin HS, 2008, SCIENCE, V320, P807, DOI 10.1126/science.1154370; Mancini A, 1997, ONCOGENE, V15, P1565, DOI 10.1038/sj.onc.1201518; Martin P, 2002, EMBO J, V21, P4049, DOI 10.1093/emboj/cdf407; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; McDonald C, 2005, J BIOL CHEM, V280, P40301, DOI 10.1074/jbc.M508538200; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Moscat J, 2011, NAT IMMUNOL, V12, P12, DOI 10.1038/ni0111-12; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; OHTSUKA M, 1990, MOL CELL BIOL, V10, P1664, DOI 10.1128/MCB.10.4.1664; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; REEDIJK M, 1992, EMBO J, V11, P1365, DOI 10.1002/j.1460-2075.1992.tb05181.x; Roberts NA, 2004, BIOCHEM PHARMACOL, V68, P1923, DOI 10.1016/j.bcp.2004.07.040; Rohde CM, 2004, J BIOL CHEM, V279, P43448, DOI 10.1074/jbc.M314170200; Schonwasser DC, 1998, MOL CELL BIOL, V18, P790, DOI 10.1128/MCB.18.2.790; Shaul YD, 2007, BBA-MOL CELL RES, V1773, P1213, DOI 10.1016/j.bbamcr.2006.10.005; Standaert ML, 1997, J BIOL CHEM, V272, P30075, DOI 10.1074/jbc.272.48.30075; Trakul N, 2005, J BIOL CHEM, V280, P24931, DOI 10.1074/jbc.M413929200; Valledor AF, 1999, J IMMUNOL, V163, P2452; VANDERGEER P, 1993, EMBO J, V12, P5161, DOI 10.1002/j.1460-2075.1993.tb06211.x; vanDijk MCM, 1997, BIOCHEM J, V323, P693, DOI 10.1042/bj3230693; Wei SW, 2010, J LEUKOCYTE BIOL, V88, P495, DOI 10.1189/jlb.1209822; Wilhelmsen K, 2002, ONCOGENE, V21, P1079, DOI 10.1038/sj.onc.1205166; WOOTEN MW, 1994, CELL GROWTH DIFFER, V5, P395; Xiong Y, 2011, J BIOL CHEM, V286, P952, DOI 10.1074/jbc.M110.166702; Xu D, 2010, BLOOD, V116, P3611, DOI 10.1182/blood-2010-01-265652	56	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25580	10.1371/journal.pone.0025580	http://dx.doi.org/10.1371/journal.pone.0025580			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028782	Green Published, gold, Green Submitted			2022-12-27	WOS:000296186900011
J	Zhang, HY; Zhang, L; Myerson, J; Bibee, K; Scott, M; Allen, J; Sicard, G; Lanza, G; Wickline, S				Zhang, Huiying; Zhang, Lei; Myerson, Jacob; Bibee, Kristin; Scott, Michael; Allen, John; Sicard, Gregorio; Lanza, Gregory; Wickline, Samuel			Quantifying the Evolution of Vascular Barrier Disruption in Advanced Atherosclerosis with Semipermeant Nanoparticle Contrast Agents	PLOS ONE			English	Article							RISK-ASSESSMENT STRATEGIES; ENDOTHELIAL SENESCENCE; CORONARY-THROMBOSIS; VULNERABLE PATIENT; NITRIC-OXIDE; PLAQUE; ANGIOGENESIS; PERMEABILITY; NANOTECHNOLOGY; IDENTIFICATION	Rationale: Acute atherothrombotic occlusion in heart attack and stroke implies disruption of the vascular endothelial barrier that exposes a highly procoagulant intimal milieu. However, the evolution, severity, and pathophysiological consequences of vascular barrier damage in atherosclerotic plaque remain unknown, in part because quantifiable methods and experimental models are lacking for its in vivo assessment. Objective: To develop quantitative nondestructive methodologies and models for detecting vascular barrier disruption in advanced plaques. Methods and Results: Sustained hypercholesterolemia in New Zealand White (NZW) rabbits for >7-14 months engendered endothelial barrier disruption that was evident from massive and rapid passive penetration and intimal trapping of perfluorocarbon-core nanoparticles (PFC-NP: similar to 250 nm diameter) after in vivo circulation for as little as 1 hour. Only older plaques (>7 mo), but not younger plaques (<3 mo) demonstrated the marked enhancement of endothelial permeability to these particles. Electron microscopy revealed a complex of subintimal spongiform channels associated with endothelial apoptosis, superficial erosions, and surface-penetrating cholesterol crystals. Fluorine (F-19) magnetic resonance imaging and spectroscopy (MRI/MRS) enabled absolute quantification (in nanoMolar) of the passive permeation of PFC-NP into the disrupted vascular lesions by sensing the unique spectral signatures from the fluorine core of plaque-bound PFC-NP. Conclusions: The application of semipermeant nanoparticles reveals the presence of profound barrier disruption in later stage plaques and focuses attention on the disrupted endothelium as a potential contributor to plaque vulnerability. The response to sustained high cholesterol levels yields a progressive deterioration of the vascular barrier that can be quantified with fluorine MRI/MRS of passively permeable nanostructures. The possibility of plaque classification based on the metric of endothelial permeability to nanoparticles is suggested.	[Zhang, Huiying; Zhang, Lei; Myerson, Jacob; Bibee, Kristin; Scott, Michael; Allen, John; Lanza, Gregory; Wickline, Samuel] Washington Univ, Dept Med, St Louis, MO 63130 USA; [Myerson, Jacob; Lanza, Gregory; Wickline, Samuel] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Bibee, Kristin; Wickline, Samuel] Washington Univ, Dept Cellular Biol, St Louis, MO USA; [Sicard, Gregorio] Washington Univ, Dept Surg, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zhang, HY (corresponding author), Washington Univ, Dept Med, St Louis, MO 63130 USA.	wicklines@wuphys.wustl.edu	Zhang, Lei/K-4587-2019		NIH [R01 HL 73646, R01 NS059302]; Edith and Allan Wolff Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059302] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edith and Allan Wolff Charitable Trust; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH R01 HL 73646, R01 NS059302, and the Edith and Allan Wolff Charitable Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abela GS, 2009, AM J CARDIOL, V103, P959, DOI 10.1016/j.amjcard.2008.12.019; Amerongen GPV, 2000, CIRCULATION, V102, P2803; Arora R, 2008, AM J THER; Borissoff JI, 2009, CARDIOVASC RES, V82, P392, DOI 10.1093/cvr/cvp066; Brix G, 2010, EUR J NUCL MED MOL I, V37, pS30, DOI 10.1007/s00259-010-1448-7; Calcagno C, 2010, ANGIOGENESIS, V13, P87, DOI 10.1007/s10456-010-9172-2; Chen YL, 1997, ATHEROSCLEROSIS, V133, P7, DOI 10.1016/S0021-9150(97)06111-X; DAVIES MJ, 1993, J PATHOL, V171, P223, DOI 10.1002/path.1711710311; DAVIES MJ, 1985, BRIT HEART J, V53, P363; Durand E, 2004, CIRCULATION, V109, P2503, DOI 10.1161/01.CIR.0000130172.62481.90; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Farb A, 1996, CIRCULATION, V93, P1354, DOI 10.1161/01.CIR.93.7.1354; FLAIM SF, 1994, ARTIF CELL BLOOD SUB, V22, P1043, DOI 10.3109/10731199409138801; Frank PG, 2009, CELL TISSUE RES, V335, P41, DOI 10.1007/s00441-008-0659-8; Gates PE, 2009, EXP PHYSIOL, V94, P311, DOI 10.1113/expphysiol.2008.043349; Hayashi T, 2010, GERIATR GERONTOL INT, V10, P115, DOI 10.1111/j.1447-0594.2009.00581.x; Jaffer FA, 2007, CIRCULATION, V116, P1052, DOI 10.1161/CIRCULATIONAHA.106.647164; Kolodgie FD, 2002, ARTERIOSCL THROM VAS, V22, P1642, DOI 10.1161/01.ATV.0000034021.92658.4C; Lee K, 2005, CIRC RES, V97, P450, DOI 10.1161/01.RES.0000181026.94390.c9; Lee K, 2008, AM J PHYSIOL-HEART C, V295, pH2273, DOI 10.1152/ajpheart.00242.2008; Liu YW, 2000, THERMOCHIM ACTA, V351, P51; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Morawski AM, 2004, MAGN RESON MED, V52, P1255, DOI 10.1002/mrm.20287; Mun GI, 2010, AM J PHYSIOL-HEART C, V298, pH2102, DOI 10.1152/ajpheart.00835.2009; Naghavi M, 2003, CIRCULATION, V108, P1772, DOI 10.1161/01.CIR.0000087481.55887.C9; Naghavi M, 2003, CIRCULATION, V108, P1664, DOI 10.1161/01.CIR.0000087480.94275.97; Op den Buijs J, 2004, AM J PHYSIOL-HEART C, V287, pH2651, DOI 10.1152/ajpheart.00332.2004; Partlow KC, 2007, FASEB J, V21, P1647, DOI 10.1096/fj.06-6505com; Pedersen SF, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-10; Peter A, 2008, AM J PHYSIOL-ENDOC M, V295, pE339, DOI 10.1152/ajpendo.00022.2008; Sadeghi MM, 2010, J NUCL MED, V51, p51S, DOI 10.2967/jnumed.109.068163; Schapira K, 2007, CURR PHARM DESIGN, V13, P1013, DOI 10.2174/138161207780487575; Schwartz RS, 2009, J AM COLL CARDIOL, V54, P2167, DOI 10.1016/j.jacc.2009.07.042; Shaish A, 2001, PATHOBIOLOGY, V69, P225, DOI 10.1159/000055947; Sima AV, 2009, CELL TISSUE RES, V335, P191, DOI 10.1007/s00441-008-0678-5; Simionescu M, 2007, ARTERIOSCL THROM VAS, V27, P266, DOI 10.1161/01.ATV.0000253884.13901.e4; Staiger K, 2006, DIABETES, V55, P3121, DOI 10.2337/db06-0188; Stone GW, 2011, NEW ENGL J MED, V364, P226, DOI 10.1056/NEJMoa1002358; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Underhill HR, 2010, NAT REV CARDIOL, V7, P165, DOI 10.1038/nrcardio.2009.246; Vasa M, 2000, CIRC RES, V87, P540, DOI 10.1161/01.RES.87.7.540; Waters EA, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-43; Wickline SA, 2006, ARTERIOSCL THROM VAS, V26, P435, DOI 10.1161/01.ATV.0000201069.47550.8b; Wickline SA, 2003, CIRCULATION, V107, P1092, DOI 10.1161/01.CIR.0000059651.17045.77; Wickline SA, 2010, MOL IMAGING PRINCIPL, P542; Wickline SA, 2007, J MAGN RESON IMAGING, V25, P667, DOI 10.1002/jmri.20866; Winter PM, 2003, CIRCULATION, V108, P2270, DOI 10.1161/01.CIR.0000093185.16083.95; Yeh HI, 2003, ARTERIOSCL THROM VAS, V23, P1391, DOI 10.1161/01.ATV.0000083508.21989.15; Yuan C, 2001, RADIOLOGY, V221, P285, DOI 10.1148/radiol.2212001612; Yuan C, 2002, J MAGN RESON IMAGING, V15, P62, DOI 10.1002/jmri.10030	51	13	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26385	10.1371/journal.pone.0026385	http://dx.doi.org/10.1371/journal.pone.0026385			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028868	gold, Green Submitted, Green Published			2022-12-27	WOS:000296186900056
J	Boehler, CN; Appelbaum, LG; Krebs, RM; Chen, LC; Woldorff, MG				Boehler, Carsten N.; Appelbaum, Lawrence G.; Krebs, Ruth M.; Chen, Ling-Chia; Woldorff, Marty G.			The Role of Stimulus Salience and Attentional Capture Across the Neural Hierarchy in a Stop-Signal Task	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; EVENT-RELATED FMRI; RESPONSE-INHIBITION; COGNITIVE CONTROL; DEFICIT/HYPERACTIVITY DISORDER; FRONTOPARIETAL NETWORK; ANTERIOR INSULA; FUNCTIONAL MRI; PERFORMANCE; CORTEX	Inhibitory motor control is a core function of cognitive control. Evidence from diverse experimental approaches has linked this function to a mostly right-lateralized network of cortical and subcortical areas, wherein a signal from the frontal cortex to the basal ganglia is believed to trigger motor-response cancellation. Recently, however, it has been recognized that in the context of typical motor-control paradigms those processes related to actual response inhibition and those related to the attentional processing of the relevant stimuli are highly interrelated and thus difficult to distinguish. Here, we used fMRI and a modified Stop-signal task to specifically examine the role of perceptual and attentional processes triggered by the different stimuli in such tasks, thus seeking to further distinguish other cognitive processes that may precede or otherwise accompany the implementation of response inhibition. In order to establish which brain areas respond to sensory stimulation differences by rare Stop-stimuli, as well as to the associated attentional capture that these may trigger irrespective of their task-relevance, we compared brain activity evoked by Stop-trials to that evoked by Go-trials in task blocks where Stop-stimuli were to be ignored. In addition, region-of-interest analyses comparing the responses to these task-irrelevant Stop-trials, with those to typical relevant Stop-trials, identified separable activity profiles as a function of the task-relevance of the Stop-signal. While occipital areas were mostly blind to the task-relevance of Stop-stimuli, activity in temporo-parietal areas dissociated between task-irrelevant and task-relevant ones. Activity profiles in frontal areas, in turn, were activated mainly by task-relevant Stop-trials, presumably reflecting a combination of triggered top-down attentional influences and inhibitory motor-control processes.	[Boehler, Carsten N.; Appelbaum, Lawrence G.; Krebs, Ruth M.; Chen, Ling-Chia; Woldorff, Marty G.] Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA; [Boehler, Carsten N.; Krebs, Ruth M.] Univ Ghent, Dept Expt Psychol, B-9000 Ghent, Belgium; [Woldorff, Marty G.] Duke Univ, Dept Psychiat, Durham, NC 27706 USA	Duke University; Ghent University; Duke University	Boehler, CN (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27708 USA.	c.n.boehler@gmail.com	Chen, Ling-Chia/K-3686-2019; Boehler, Carsten/J-8619-2015; Krebs, Ruth M/E-9042-2016	Boehler, Carsten/0000-0001-5963-2780; Krebs, Ruth M/0000-0002-0676-7611; Appelbaum, Lawrence/0000-0002-3184-6725; Woldorff, Marty/0000-0002-2683-4551; Chen, Ling-Chia/0000-0001-5782-6047	NIH [R01-MH060415, R01-NS051048]; Deutsche Forschungsgemeinschaft [BO 3345/1-1]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051048] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by NIH grants R01-MH060415 and R01-NS051048 to M. G. W. and funds from the Deutsche Forschungsgemeinschaft (BO 3345/1-1) to C.N.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2007, J NEUROSCI, V27, P11860, DOI 10.1523/JNEUROSCI.3644-07.2007; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Aron AR, 2007, J NEUROSCI, V27, P3743, DOI 10.1523/JNEUROSCI.0519-07.2007; Aron AR, 2009, NEUROSCI BIOBEHAV R, V33, P611, DOI 10.1016/j.neubiorev.2008.10.003; Aron AR, 2003, NAT NEUROSCI, V6, P115, DOI 10.1038/nn1003; ARON AR, 2011, BIOL PSYCHI IN PRESS; Bekker EM, 2005, ARCH GEN PSYCHIAT, V62, P1129, DOI 10.1001/archpsyc.62.10.1129; Bekker EM, 2005, INT J PSYCHOPHYSIOL, V55, P191, DOI 10.1016/j.ijpsycho.2004.07.005; Boehler CN, 2010, NEUROIMAGE, V52, P1621, DOI 10.1016/j.neuroimage.2010.04.276; Boehler CN, 2009, CEREB CORTEX, V19, P134, DOI 10.1093/cercor/bhn063; Boehler CN, 2011, J COGNITIVE NEUROSCI, V23, P362, DOI 10.1162/jocn.2010.21473; Brass M, 2002, CEREB CORTEX, V12, P908, DOI 10.1093/cercor/12.9.908; Burnham BR, 2010, J EXP PSYCHOL HUMAN, V36, P317, DOI 10.1037/a0015871; Cai WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020840; Cai WD, 2009, BRAIN RES, V1261, P20, DOI 10.1016/j.brainres.2008.12.073; Chambers CD, 2006, J COGNITIVE NEUROSCI, V18, P444, DOI 10.1162/jocn.2006.18.3.444; Chambers CD, 2009, NEUROSCI BIOBEHAV R, V33, P631, DOI 10.1016/j.neubiorev.2008.08.016; Chikazoe J, 2010, CURR OPIN PSYCHIATR, V23, P267, DOI 10.1097/YCO.0b013e3283387a9f; Chikazoe J, 2009, J NEUROSCI, V29, P15870, DOI 10.1523/JNEUROSCI.3645-09.2009; Chikazoe J, 2009, CEREB CORTEX, V19, P146, DOI 10.1093/cercor/bhn065; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; de Fockert J, 2004, J COGNITIVE NEUROSCI, V16, P751, DOI 10.1162/089892904970762; Derrfuss J, 2005, HUM BRAIN MAPP, V25, P22, DOI 10.1002/hbm.20127; Dodds CM, 2011, CEREB CORTEX, V21, P1155, DOI 10.1093/cercor/bhq187; Duann JR, 2009, J NEUROSCI, V29, P10171, DOI 10.1523/JNEUROSCI.1300-09.2009; Eckert MA, 2009, HUM BRAIN MAPP, V30, P2530, DOI 10.1002/hbm.20688; Fassbender C, 2006, J PSYCHOPHYSIOL, V20, P286, DOI 10.1027/0269-8803.20.4.286; Fenker DB, 2010, J COGNITIVE NEUROSCI, V22, P2926, DOI 10.1162/jocn.2009.21340; Friston KJ, 1998, NEUROIMAGE, V7, P30, DOI 10.1006/nimg.1997.0306; Groman SM, 2009, NEUROSCI BIOBEHAV R, V33, P690, DOI 10.1016/j.neubiorev.2008.08.008; Hampshire A, 2010, NEUROIMAGE, V50, P1313, DOI 10.1016/j.neuroimage.2009.12.109; Hinrichs H, 2000, J COGNITIVE NEUROSCI, V12, P76, DOI 10.1162/089892900564082; Knyazev GG, 2008, CLIN NEUROPHYSIOL, V119, P556, DOI 10.1016/j.clinph.2007.11.041; Kramer UM, 2011, J COGNITIVE NEUROSCI, V23, P2481, DOI 10.1162/jocn.2010.21573; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Leung HC, 2007, J NEUROSCI, V27, P9893, DOI 10.1523/JNEUROSCI.2837-07.2007; Lijffijt M, 2005, J ABNORM PSYCHOL, V114, P216, DOI 10.1037/0021-843X.114.2.216; LOGAN GD, 1984, J EXP PSYCHOL HUMAN, V10, P276, DOI 10.1037/0096-1523.10.2.276; LOGAN GD, 1984, PSYCHOL REV, V91, P295, DOI 10.1037/0033-295X.91.3.295; Logan Gordon D., 1994, P189; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mostofsky SH, 2003, COGNITIVE BRAIN RES, V17, P419, DOI 10.1016/S0926-6410(03)00144-7; Nakata H, 2008, NEUROIMAGE, V39, P1858, DOI 10.1016/j.neuroimage.2007.10.041; Nelson SM, 2010, BRAIN STRUCT FUNCT, V214, P669, DOI 10.1007/s00429-010-0260-2; Neubert FX, 2010, P NATL ACAD SCI USA, V107, P13240, DOI 10.1073/pnas.1000674107; Overtoom CCE, 2009, BIOL PSYCHIAT, V65, P614, DOI 10.1016/j.biopsych.2008.10.048; Padmala S, 2010, COGN AFFECT BEHAV NE, V10, P279, DOI 10.3758/CABN.10.2.279; Pliszka SR, 2000, BIOL PSYCHIAT, V48, P238, DOI 10.1016/S0006-3223(00)00890-8; Schmajuk M, 2006, NEUROPSYCHOLOGIA, V44, P384, DOI 10.1016/j.neuropsychologia.2005.06.005; Sharp DJ, 2010, P NATL ACAD SCI USA, V107, P6106, DOI 10.1073/pnas.1000175107; Swann N, 2009, J NEUROSCI, V29, P12675, DOI 10.1523/JNEUROSCI.3359-09.2009; Swick D, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-102; Verbruggen F, 2008, TRENDS COGN SCI, V12, P418, DOI 10.1016/j.tics.2008.07.005; Verbruggen F, 2010, P NATL ACAD SCI USA, V107, P13966, DOI 10.1073/pnas.1001957107; Wager TD, 2005, NEUROIMAGE, V27, P323, DOI 10.1016/j.neuroimage.2005.01.054; Williams BR, 1999, DEV PSYCHOL, V35, P205, DOI 10.1037/0012-1649.35.1.205; Xue G, 2008, CEREB CORTEX, V18, P1923, DOI 10.1093/cercor/bhm220	57	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2011	6	10							e26386	10.1371/journal.pone.0026386	http://dx.doi.org/10.1371/journal.pone.0026386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834SM	22022611	Green Published, Green Submitted, gold			2022-12-27	WOS:000295984400053
J	Ma, LF; Jiang, Y; Bai, JE; Gong, QY; Liu, HC; Chen, HC; He, S; Weng, XC				Ma, Lifei; Jiang, Yi; Bai, Jian'e; Gong, Qiyong; Liu, Haicheng; Chen, Hsuan-Chih; He, Sheng; Weng, Xuchu			Robust and Task-Independent Spatial Profile of the Visual Word Form Activation in Fusiform Cortex	PLOS ONE			English	Article							AREA; FMRI; SYSTEM; GYRUS; FACE	Written language represents a special category of visual information. There is strong evidence for the existence of a cortical region in ventral occipitotemporal cortex for processing the visual form of written words. However, due to inconsistent findings obtained with different tasks, the level of specialization and selectivity of this so called visual word form area (VWFA) remains debated. In this study, we examined category selectivity for Chinese characters, a non-alphabetic script, in native Chinese readers. In contrast to traditional approaches of examining response levels in a restricted predefined region of interest (ROI), a detailed distribution of the BOLD signal across the mid-fusiform cortical surface and the spatial patterns of responses to Chinese characters were obtained. Results show that a region tuned for Chinese characters could be consistently found in the lateral part of the left fusiform gyrus in Chinese readers, and this spatial pattern of selectivity for written words was not influenced by top-down tasks such as phonological or semantic modulations. These results provide strong support for the robust spatial coding of category selective response in the mid-fusiform cortex, and demonstrate the utility of the spatial distribution analysis as a more meaningful approach to examine functional magnetic resonance imaging (fMRI) data.	[Ma, Lifei; Jiang, Yi; Bai, Jian'e; Liu, Haicheng; Weng, Xuchu] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Jiang, Yi; He, Sheng] Univ Minnesota, Dept Psychol, Minneapolis, MN 55455 USA; [Gong, Qiyong] Sichuan Univ, HMRRC, Dept Radiol, W China Hosp, Chengdu 610064, Peoples R China; [Chen, Hsuan-Chih] Chinese Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Weng, Xuchu] Hangzhou Normal Univ, Ctr Cognit & Brain Disorders, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; University of Minnesota System; University of Minnesota Twin Cities; Sichuan University; Chinese University of Hong Kong; Hangzhou Normal University	Ma, LF (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	sheng@umn.edu; wengxc@psych.ac.cn	Gong, Qiyong/W-3052-2019; Jiang, Yi/I-1688-2018	Gong, Qiyong/0000-0002-5912-4871; Jiang, Yi/0000-0002-5746-7301	National Natural Science Foundation of China [31070903, 31070905]; National Science Foundation of US [BCS-0818588]; Chinese Ministry of Science and Technology [2007CB512300]; Chinese University of Hong Kong; United States NIH [R01-EY002934, BTRR P41 RR008079, P30 NS057091]; MIND foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY002934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057091] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of US(National Science Foundation (NSF)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese University of Hong Kong(Chinese University of Hong Kong); United States NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MIND foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by grants from the National Natural Science Foundation of China (31070903 and 31070905); National Science Foundation of US (BCS-0818588); Chinese Ministry of Science and Technology (2007CB512300); a departmental grant from the Chinese University of Hong Kong; United States NIH (R01-EY002934, BTRR P41 RR008079, and P30 NS057091); the MIND foundation. http://www.nsfc.gov.cn/Portal0/default124.htm. http://www.nsf.gov/index.jsp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker CI, 2007, P NATL ACAD SCI USA, V104, P9087, DOI 10.1073/pnas.0703300104; Binder JR, 2006, NEUROIMAGE, V33, P739, DOI 10.1016/j.neuroimage.2006.06.053; Cai Q, 2008, J COGNITIVE NEUROSCI, V20, P672, DOI 10.1162/jocn.2008.20043; Cohen L, 2002, BRAIN, V125, P1054, DOI 10.1093/brain/awf094; Cohen L, 2000, BRAIN, V123, P291, DOI 10.1093/brain/123.2.291; Devlin JT, 2006, J COGNITIVE NEUROSCI, V18, P911, DOI 10.1162/jocn.2006.18.6.911; Fiez JA, 1998, P NATL ACAD SCI USA, V95, P914, DOI 10.1073/pnas.95.3.914; Fox CJ, 2008, HUM BRAIN MAPP; Gaillard R, 2006, NEURON, V50, P191, DOI 10.1016/j.neuron.2006.03.031; Glezer LS, 2009, NEURON, V62, P199, DOI 10.1016/j.neuron.2009.03.017; Joseph JE, 2006, NEUROIMAGE, V32, P806, DOI 10.1016/j.neuroimage.2006.04.175; Joseph JE, 2003, COGNITIVE BRAIN RES, V17, P56, DOI 10.1016/S0926-6410(03)00080-6; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kherif F, 2011, CEREB CORTEX, V21, P103, DOI 10.1093/cercor/bhq063; Liu JG, 2009, NEUROREPORT, V20, P273, DOI 10.1097/WNR.0b013e32832000f8; McCandliss BD, 2003, TRENDS COGN SCI, V7, P293, DOI 10.1016/S1364-6613(03)00134-7; Mei LL, 2010, NEUROIMAGE, V52, P371, DOI 10.1016/j.neuroimage.2010.03.067; Polk TA, 2002, J EXP PSYCHOL GEN, V131, P65, DOI 10.1037//0096-3445.131.1.65; Price CJ, 2011, TRENDS COGN SCI, V15, P246, DOI 10.1016/j.tics.2011.04.001; Price CJ, 2003, NEUROIMAGE, V19, P473, DOI 10.1016/S1053-8119(03)00084-3; Puce A, 1996, J NEUROSCI, V16, P5205; Reich L, 2011, CURR BIOL, V21, P363, DOI 10.1016/j.cub.2011.01.040; Reinke K, 2008, BRAIN LANG, V104, P180, DOI 10.1016/j.bandl.2007.04.006; Song YY, 2010, BRAIN RES, V1316, P83, DOI 10.1016/j.brainres.2009.11.086; Szwed M, 2011, NEUROIMAGE, V56, P330, DOI 10.1016/j.neuroimage.2011.01.073; Tan LH, 2001, NEUROREPORT, V12, P83, DOI 10.1097/00001756-200101220-00024; Tan LH, 2001, NEUROIMAGE, V13, P836, DOI 10.1006/nimg.2001.0749; Twomey T, 2011, NEUROIMAGE, V55, P1242, DOI 10.1016/j.neuroimage.2011.01.001; Woodhead ZVJ, 2011, J NEUROSCI, V31, P193, DOI 10.1523/JNEUROSCI.2705-10.2011; Wright ND, 2008, HUM BRAIN MAPP, V29, P986, DOI 10.1002/hbm.20443; Xue G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013204; Yoncheva YN, 2010, CEREB CORTEX, V20, P622, DOI 10.1093/cercor/bhp129	32	78	78	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26310	10.1371/journal.pone.0026310	http://dx.doi.org/10.1371/journal.pone.0026310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834RQ	22022597	Green Submitted, gold, Green Published			2022-12-27	WOS:000295981600053
J	Shen, LX; Xie, XT; Su, Y; Luo, CF; Zhang, CQ; Zeng, BF				Shen, Longxiang; Xie, Xuetao; Su, Yan; Luo, Congfeng; Zhang, Changqing; Zeng, Bingfang			Parathyroid Hormone versus Bisphosphonate Treatment on Bone Mineral Density in Osteoporosis Therapy: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							POSTMENOPAUSAL OSTEOPOROSIS; MECHANICAL-PROPERTIES; CORTICAL BONE; TERIPARATIDE; ALENDRONATE; WOMEN; EFFICACY; MANAGEMENT; COMBINATION; LY333334	Background: Bisphosphonates and parathyroid hormone (PTH) represent the antiresorptive and anabolic classes of drugs for osteoporosis treatment. Bone mineral density (BMD) is an essential parameter for the evaluation of anti-osteoporotic drugs. The aim of this study was to evaluate the effects of PTH versus bisphosphonates on BMD for the treatment of osteoporosis. Methods/Principal Findings: We performed a literature search to identify studies that investigated the effects of PTH versus bisphosphonates treatment on BMD. A total of 7 articles were included in this study, representing data on 944 subjects. The pooled data showed that the percent change of increased BMD in the spine is higher with PTH compared to bisphosphonates (WMD = 5.90, 95% CI: 3.69-8.10, p<0.01,). In the hip, high dose (40 mu g) PTH (1-34) showed significantly higher increments of BMD compared to alendronate (femoral neck: WMD=5.67, 95% CI: 3.47-7.87, p<0.01; total hip: WMD=2.40, 95%CI: 0.49-4.31, p<0.05). PTH treatment has yielded significantly higher increments than bisphosphonates with a duration of over 12 months (femoral neck: WMD=5.67, 95% CI: 3.47-7.86, p<0.01; total hip: WMD=2.40, 95%CI: 0.49-4.31, P<0.05) and significantly lower increments at 12 months (femoral neck: WMD=-1.05, 95% CI: -2.26-0.16, p<0.01; total hip: WMD: -1.69, 95% CI: -3.05-0.34, p<0.05). In the distal radius, a reduction in BMD was significant between PTH and alendronate treatment. (WMD = -3.68, 95% CI: -5.57-1.79, p<0.01). Discussion: Our results demonstrated that PTH significantly increased lumbar spine BMD as compared to treatment with bisphosphonates and PTH treatment induced duration-and dose-dependent increases in hip BMD as compared to bisphosphonates treatment. This study has also disclosed that for the distal radius, BMD was significantly lower from PTH treatment than alendronate treatment.	[Shen, Longxiang; Xie, Xuetao; Su, Yan; Luo, Congfeng; Zhang, Changqing; Zeng, Bingfang] Shanghai Jiao Tong Univ, Dept Orthoped Surg, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University	Shen, LX (corresponding author), Shanghai Jiao Tong Univ, Dept Orthoped Surg, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China.	xiang9669@yahoo.com		zhang, changqing/0000-0002-7408-4126	China Postdoctoral Science Foundation [20100470700]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Funding provided by China Postdoctoral Science Foundation (20100470700) http://www.chinapostdoctor.org.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adami S, 2010, CLIN CASES MINER BON, V7, P114; Anastasilakis AD, 2008, INT J CLIN PRACT, V62, P919, DOI 10.1111/j.1742-1241.2008.01768.x; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Black DM, 2005, NEW ENGL J MED, V353, P555, DOI 10.1056/NEJMoa050336; Body JJ, 2002, J CLIN ENDOCR METAB, V87, P4528, DOI 10.1210/jc.2002-020334; Boonen S, 2008, J INTERN MED, V264, P315, DOI 10.1111/j.1365-2796.2008.02010.x; Borba VZC, 2010, ARQ BRAS ENDOCRINOL, V54, P213, DOI 10.1590/S0004-27302010000200018; Cosman F, 2005, NEW ENGL J MED, V353, P566, DOI 10.1056/NEJMoa050157; Cosman F, 2011, J BONE MINER RES, V26, P503, DOI 10.1002/jbmr.238; Cremers SCLM, 2005, CLIN PHARMACOKINET, V44, P551, DOI 10.2165/00003088-200544060-00001; Finkelstein JS, 2010, J CLIN ENDOCR METAB, V95, P1838, DOI 10.1210/jc.2009-1703; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Heaney RP, 1997, J BONE MINER RES, V12, P1143, DOI 10.1359/jbmr.1997.12.8.1143; Hirano T, 1999, J BONE MINER RES, V14, P536, DOI 10.1359/jbmr.1999.14.4.536; Hodsman AB, 2003, J CLIN ENDOCR METAB, V88, P5212, DOI 10.1210/jc.2003-030768; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jodar-Gimeno E, 2007, CLIN INTERV AGING, V2, P163, DOI 10.2147/ciia.2007.2.1.163; Johnell O, 2005, J BONE MINER RES, V20, P1185, DOI 10.1359/JBMR.050304; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lyritis GP, 2010, ANN NY ACAD SCI, V1205, P277, DOI 10.1111/j.1749-6632.2010.05666.x; Macedo JMS, 1998, J CLIN PHARM THER, V23, P345, DOI 10.1046/j.1365-2710.1998.00168.x; Mashiba T, 2001, BONE, V28, P538, DOI 10.1016/S8756-3282(01)00433-1; McClung MR, 2005, ARCH INTERN MED, V165, P1762, DOI 10.1001/archinte.165.15.1762; Miller PD, 2005, CLIN THER, V27, P361, DOI 10.1016/j.clinthera.2005.04.005; Moricke R, 2011, CLIN DRUG INVEST, V31, P87, DOI 10.2165/11538880-000000000-00000; Mulder JE, 2006, NAT CLIN PRACT ENDOC, V2, P670, DOI 10.1038/ncpendmet0325; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Nevitt MC, 2006, OSTEOPOROSIS INT, V17, P273, DOI 10.1007/s00198-005-2013-2; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; PECK WA, 1993, AM J MED, V94, P646; Reszka Alfred A, 2003, Curr Osteoporos Rep, V1, P45, DOI 10.1007/s11914-003-0008-5; Rittmaster RS, 2000, J CLIN ENDOCR METAB, V85, P2129, DOI 10.1210/jc.85.6.2129; Saag KG, 2007, NEW ENGL J MED, V357, P2028, DOI 10.1056/NEJMoa071408; Schneider PF, 1999, J BONE MINER RES, V14, P1387, DOI 10.1359/jbmr.1999.14.8.1387; Vahle JL, 2002, TOXICOL PATHOL, V30, P312, DOI 10.1080/01926230252929882; Verhaar H J J, 2009, Arch Gerontol Geriatr, V49, pe130, DOI 10.1016/j.archger.2008.11.004; Vestergaard P, 2007, OSTEOPOROSIS INT, V18, P45, DOI 10.1007/s00198-006-0204-0	38	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26267	10.1371/journal.pone.0026267	http://dx.doi.org/10.1371/journal.pone.0026267			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022584	Green Published, gold, Green Submitted			2022-12-27	WOS:000295976000095
J	Leggat, W; Seneca, F; Wasmund, K; Ukani, L; Yellowlees, D; Ainsworth, TD				Leggat, William; Seneca, Francois; Wasmund, Kenneth; Ukani, Lubna; Yellowlees, David; Ainsworth, Tracy D.			Differential Responses of the Coral Host and Their Algal Symbiont to Thermal Stress	PLOS ONE			English	Article							REEF-BUILDING CORALS; GENE-EXPRESSION; HEAT-STRESS; MICROARRAY ANALYSIS; INVERTEBRATE SYMBIOSIS; ACROPORA-MILLEPORA; REGULATED GENES; DINOFLAGELLATE; TEMPERATURE; SYMBIODINIUM	The success of any symbiosis under stress conditions is dependent upon the responses of both partners to that stress. The coral symbiosis is particularly susceptible to small increases of temperature above the long term summer maxima, which leads to the phenomenon known as coral bleaching, where the intracellular dinoflagellate symbionts are expelled. Here we for the first time used quantitative PCR to simultaneously examine the gene expression response of orthologs of the coral Acropora aspera and their dinoflagellate symbiont Symbiodinium. During an experimental bleaching event significant up-regulation of genes involved in stress response (HSP90 and HSP70) and carbon metabolism (glyceraldehyde-3-phosphate dehydrogenase, alpha-ketoglutarate dehydrogenase, glycogen synthase and glycogen phosphorylase) from the coral host were observed. In contrast in the symbiont, HSP90 expression decreased, while HSP70 levels were increased on only one day, and only the alpha-ketoglutarate dehydrogenase expression levels were found to increase. In addition the changes seen in expression patterns of the coral host were much larger, up to 10.5 fold, compared to the symbiont response, which in all cases was less than 2-fold. This targeted study of the expression of key metabolic and stress genes demonstrates that the response of the coral and their symbiont vary significantly, also a response in the host transcriptome was observed prior to what has previously been thought to be the temperatures at which thermal stress events occur.	[Leggat, William; Seneca, Francois; Wasmund, Kenneth; Ukani, Lubna] James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia; [Leggat, William; Yellowlees, David; Ainsworth, Tracy D.] James Cook Univ, Ctr Excellence Coral Reef Studies, Australian Res Council, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Leggat, W (corresponding author), James Cook Univ, Sch Pharm & Mol Sci, Townsville, Qld 4811, Australia.	bill.leggat@jcu.edu.au	Seneca, Francois/F-9040-2010; Wasmund, Kenneth/A-2265-2016; Leggat, William/C-4532-2012; Yellowlees, David/A-5379-2013; Ainsworth, Tracy D/L-7309-2016; Leggat, Bill/AAJ-8929-2020	Seneca, Francois/0000-0002-8908-1227; Wasmund, Kenneth/0000-0001-6706-7291; Ainsworth, Tracy D/0000-0001-6476-9263; Leggat, Bill/0000-0003-4148-2555	Australian Research Council Centre of Excellence for Coral Reef Studies [CE0561435]; Australian Research Council [DP0877226]	Australian Research Council Centre of Excellence for Coral Reef Studies(Australian Research Council); Australian Research Council(Australian Research Council)	This project was supported by funding from the Australian Research Council Centre of Excellence for Coral Reef Studies (CE0561435, http://www.coralcoe.org.au/) and an Australian Research Council funded discovery project to TA (DP0877226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth TD, 2008, J EXP MAR BIOL ECOL, V364, P63, DOI 10.1016/j.jembe.2008.06.032; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Bachvaroff TR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002929; Baird AH, 2009, TRENDS ECOL EVOL, V24, P16, DOI 10.1016/j.tree.2008.09.005; Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; Boldt L, 2010, P 11 ICRS FT LAUD FL, P118; Brown BE, 2002, MAR ECOL PROG SER, V242, P119, DOI 10.3354/meps242119; COLES SL, 1977, MAR BIOL, V43, P209, DOI 10.1007/BF00402313; Csaszar NBM, 2009, MAR ECOL PROG SER, V392, P93, DOI 10.3354/meps08194; Desalvo MK, 2008, MOL ECOL, V17, P3952, DOI 10.1111/j.1365-294X.2008.03879.x; Diaz-Almeyda E, 2011, CORAL REEFS, V30, P217, DOI 10.1007/s00338-010-0691-5; Dove S, 2004, MAR ECOL PROG SER, V272, P99, DOI 10.3354/meps272099; Dunn SR, 2004, CELL DEATH DIFFER, V11, P1213, DOI 10.1038/sj.cdd.4401484; Edmunds PJ, 2005, MAR BIOL, V146, P655, DOI 10.1007/s00227-004-1485-5; Fagan T, 1999, BIOCHEMISTRY-US, V38, P7689, DOI 10.1021/bi9826005; FALKOWSKI PG, 1984, BIOSCIENCE, V34, P705, DOI 10.2307/1309663; Fitt WK, 2001, CORAL REEFS, V20, P51, DOI 10.1007/s003380100146; GATES RD, 1992, BIOL BULL, V182, P324, DOI 10.2307/1542252; Gordon BR, 2010, MAR DRUGS, V8, P2546, DOI 10.3390/md8102546; Hoegh-Guldberg O, 2004, CORAL REEFS, V23, P444, DOI 10.1007/s00338-004-0401-2; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Jones RJ, 1998, PLANT CELL ENVIRON, V21, P1219, DOI 10.1046/j.1365-3040.1998.00345.x; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; LaJeunesse TC, 2001, J PHYCOL, V37, P866, DOI 10.1046/j.1529-8817.2001.01031.x; Leggat W, 2003, PLANT CELL ENVIRON, V26, P1951, DOI 10.1046/j.0016-8025.2003.01111.x; LEGGAT W, 2011, J EXPT MARI IN PRESS; Leggat W, 2007, J PHYCOL, V43, P1010, DOI 10.1111/j.1529-8817.2007.00387.x; Levy O, 2011, SCIENCE, V331, P175, DOI 10.1126/science.1196419; Luo YJ, 2009, CORAL REEFS, V28, P289, DOI 10.1007/s00338-008-0462-8; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Middlebrook R, 2008, J EXP BIOL, V211, P1050, DOI 10.1242/jeb.013284; Miller DJ, 2011, J EXP MAR BIOL ECOL, V408, P114, DOI 10.1016/j.jembe.2011.07.031; Montllor CB, 2002, ECOL ENTOMOL, V27, P189, DOI 10.1046/j.1365-2311.2002.00393.x; Moustafa A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009688; OHTAKA C, 1991, SYMBIOSIS, V11, P19; Okamoto OK, 2003, GENE, V321, P73, DOI 10.1016/j.gene.2003.07.003; Okamoto OK, 2003, J PHYCOL, V39, P519, DOI 10.1046/j.1529-8817.2003.02170.x; Okamoto OK, 2001, J BIOL CHEM, V276, P19989, DOI 10.1074/jbc.M101169200; Papina M, 2007, COMP BIOCHEM PHYS B, V147, P583, DOI 10.1016/j.cbpb.2007.02.011; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Robbart ML, 2004, MAR ECOL PROG SER, V283, P151, DOI 10.3354/meps283151; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x; ROSIC N, 2010, MARINE BIOTECHNOLOGY, P1; ROSIC N, 2010, CELL STRESS CHAPERON, P1; SENECA F, 2010, MARINE BIOTECHNOLOGY, P1; SHARP VA, 1994, J EXP MAR BIOL ECOL, V179, P179, DOI 10.1016/0022-0981(94)90113-9; Sharp VA, 1997, J THERM BIOL, V22, P11, DOI 10.1016/S0306-4565(96)00029-0; Takahashi S, 2004, PLANT CELL PHYSIOL, V45, P251, DOI 10.1093/pcp/pch028; Takahashi S, 2008, P NATL ACAD SCI USA, V105, P4203, DOI 10.1073/pnas.0708554105; Van Dolah FM, 2007, J PHYCOL, V43, P741, DOI 10.1111/j.1529-8817.2007.00354.x; van Ham RCHJ, 2003, P NATL ACAD SCI USA, V100, P581, DOI 10.1073/pnas.0235981100; Voolstra CR, 2009, COMP BIOCHEM PHYS D, V4, P67, DOI 10.1016/j.cbd.2008.11.001; Wang JT, 1998, J EXP BIOL, V201, P2445; Wang JT, 1999, MAR BIOL, V135, P219, DOI 10.1007/s002270050619; Warner ME, 1999, P NATL ACAD SCI USA, V96, P8007, DOI 10.1073/pnas.96.14.8007; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wilcox JL, 2003, MOL MICROBIOL, V48, P1491, DOI 10.1046/j.1365-2958.2003.03522.x; Yamashiro H, 2005, FISHERIES SCI, V71, P448, DOI 10.1111/j.1444-2906.2005.00983.x; Yellowlees D, 2008, PLANT CELL ENVIRON, V31, P679, DOI 10.1111/j.1365-3040.2008.01802.x	60	100	100	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26687	10.1371/journal.pone.0026687	http://dx.doi.org/10.1371/journal.pone.0026687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039532	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000296515200041
J	Bauer, AK; Cho, HY; Miller-DeGraff, L; Walker, C; Helms, K; Fostel, J; Yamamoto, M; Kleeberger, SR				Bauer, Alison K.; Cho, Hye-Youn; Miller-DeGraff, Laura; Walker, Christopher; Helms, Katherine; Fostel, Jennifer; Yamamoto, Masayuki; Kleeberger, Steven R.			Targeted Deletion of Nrf2 Reduces Urethane-Induced Lung Tumor Development in Mice	PLOS ONE			English	Article							PULMONARY INFLAMMATION; KNOCKOUT MICE; EXPRESSION; INJURY; MUTATIONS; TUMORIGENESIS; PROTECTION; PATHWAYS; EFFICACY; GENE	Nrf2 is a key transcription factor that regulates cellular redox and defense responses. However, permanent Nrf2 activation in human lung carcinomas promotes pulmonary malignancy and chemoresistance. We tested the hypothesis that Nrf2 has cell survival properties and lack of Nrf2 suppresses chemically-induced pulmonary neoplasia by treating Nrf2(+/+) and Nrf2(-/-) mice with urethane. Airway inflammation and injury were assessed by bronchoalveolar lavage analyses and histopathology, and lung tumors were analyzed by gross and histologic analysis. We used transcriptomics to assess Nrf2-dependent changes in pulmonary gene transcripts at multiple stages of neoplasia. Lung hyperpermeability, cell death and apoptosis, and inflammatory cell infiltration were significantly higher in Nrf2(-/-) mice compared to Nrf2(+/+) mice 9 and 11 wk after urethane. Significantly fewer lung adenomas were found in Nrf2(-/-) mice than in Nrf2(+/+) mice at 12 and 22 wk. Nrf2 modulated expression of genes involved cell-cell signaling, glutathione metabolism and oxidative stress response, and immune responses during early stage neoplasia. In lung tumors, Nrf2-altered genes had roles in transcriptional regulation of cell cycle and proliferation, carcinogenesis, organismal injury and abnormalities, xenobiotic metabolism, and cell-cell signaling genes. Collectively, Nrf2 deficiency decreased susceptibility to urethane-induced lung tumorigenesis in mice. Cell survival properties of Nrf2 were supported, at least in part, by reduced early death of initiated cells and heightened advantage for tumor cell expansion in Nrf2(+/+) mice relative to Nrf2(-/-) mice. Our results were consistent with the concept that Nrf2 over-activation is an adaptive response of cancer conferring resistance to anti-cancer drugs and promoting malignancy.	[Bauer, Alison K.; Helms, Katherine] Michigan State Univ, Coll Vet Med, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA; [Cho, Hye-Youn; Miller-DeGraff, Laura; Walker, Christopher; Fostel, Jennifer; Kleeberger, Steven R.] NIEHS, Lab Resp Biol, NIH, Res Triangle Pk, NC 27709 USA; [Yamamoto, Masayuki] Tohoku Univ, Grad Sch Med, Div Med Biochem, Sendai, Miyagi 980, Japan	Michigan State University; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Tohoku University	Bauer, AK (corresponding author), Michigan State Univ, Coll Vet Med, Dept Pathobiol & Diagnost Invest, E Lansing, MI 48824 USA.	alison.bauer@ucdenver.edu	Yamamoto, Masayuki/A-4873-2010; Kleeberger, Steven R/F-1807-2019; Bauer, Alison/AHD-3288-2022; Bauer, Alison K./K-2372-2019	Yamamoto, Masayuki/0000-0002-9073-9436; Kleeberger, Steven R/0000-0003-2948-8452; Bauer, Alison/0000-0003-4477-9899; 	National Institute of Environmental Health Sciences; Michigan State University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES100513] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Michigan State University; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Intramural Research Program of the National Institute of Environmental Health Sciences and Michigan State University internal funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer AK, 2005, J NATL CANCER I, V97, P1778, DOI 10.1093/jnci/dji403; Bauer AK, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-107; Becks L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-540; Cho HY, 2002, AM J RESP CELL MOL, V26, P175, DOI 10.1165/ajrcmb.26.2.4501; Cho HY, 2007, AM J RESP CRIT CARE, V175, P829, DOI 10.1164/rccm.200509-1527OC; Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC; Cho HY, 2010, TOXICOL APPL PHARM, V244, P43, DOI 10.1016/j.taap.2009.07.024; Colby TV, 2004, WHO CLASSIFICATION T, P35; Harvey CJ, SCI TRANSL MED; Homma S, 2009, CLIN CANCER RES, V15, P3423, DOI 10.1158/1078-0432.CCR-08-2822; Iida K, 2004, CANCER RES, V64, P6424, DOI 10.1158/0008-5472.CAN-04-1906; Keith RL, 2002, CANCER RES, V62, P734; Khor TO, 2008, CANCER PREV RES, V1, P187, DOI 10.1158/1940-6207.CAPR-08-0028; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Lugade AA, 2011, AM J RESP CELL MOL B; Malkinson AM, 1998, EXP LUNG RES, V24, P541, DOI 10.3109/01902149809087385; MALKINSON AM, 1992, CANCER RES, V52, pS2670; Mason RJ, 2000, AM J PATHOL, V156, P175, DOI 10.1016/S0002-9440(10)64717-7; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Ohta T, 2008, CANCER RES, V68, P1303, DOI 10.1158/0008-5472.CAN-07-5003; Osburn WO, 2007, INT J CANCER, V121, P1883, DOI 10.1002/ijc.22943; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Redente EF, 2007, AM J PATHOL, V170, P693, DOI 10.2353/ajpath.2007.060566; Satoh H, CARCINOGENESIS; Schottenfeld D., 2005, LUNG CANC PRINCIPLES, P3; Schultz MJ, 2009, THORAX, V64, P95, DOI 10.1136/thx.2008.106955; SELVARAJ P, 1994, EUR RESPIR J, V7, P1227, DOI 10.1183/09031936.94.07071227; Shibata T, 2008, P NATL ACAD SCI USA, V105, P13568, DOI 10.1073/pnas.0806268105; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; Stacy DR, 2006, HEAD NECK-J SCI SPEC, V28, P813, DOI 10.1002/hed.20430; Stathopoulos GT, 2007, P NATL ACAD SCI USA, V104, P18514, DOI 10.1073/pnas.0705316104; Stearman RS, 2005, AM J PATHOL, V167, P1763, DOI 10.1016/S0002-9440(10)61257-6; Surh YJ, 2010, ANTIOXID REDOX SIGNA; Wang R, 2008, BIOCHEM BIOPH RES CO, V373, P151, DOI 10.1016/j.bbrc.2008.06.004; WEI HC, 1991, CANCER RES, V51, P4443; Xu CJ, 2006, CANCER RES, V66, P8293, DOI 10.1158/0008-5472.CAN-06-0300; Zhang P, 2010, MOL CANCER THER, V9, P336, DOI 10.1158/1535-7163.MCT-09-0589	40	68	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26590	10.1371/journal.pone.0026590	http://dx.doi.org/10.1371/journal.pone.0026590			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039513	Green Published, gold, Green Submitted			2022-12-27	WOS:000296513200033
J	Osan, R; Su, E; Shinbrot, T				Osan, Remus; Su, Emily; Shinbrot, Troy			The Interplay between Branching and Pruning on Neuronal Target Search during Developmental Growth: Functional Role and Implications	PLOS ONE			English	Article							MOLECULAR-MECHANISMS; PYRAMIDAL NEURONS; SENSORY NEURONS; MAP DEVELOPMENT; INTERNEURONS; PLASTICITY; ARBORS; CELLS; AXONS; OPTIMIZATION	Regenerative strategies that facilitate the regrowth and reconnection of neurons are some of the most promising methods in spinal cord injury research. An essential part of these strategies is an increased understanding of the mechanisms by which growing neurites seek out and synapse with viable targets. In this paper, we use computational and theoretical tools to examine the targeting efficiency of growing neurites subject to limited resources, such as maximum total neural tree length. We find that in order to efficiently reach a particular target, growing neurites must achieve balance between pruning and branching: rapidly growing neurites that do not prune will exhaust their resources, and frequently pruning neurites will fail to explore space effectively. We also find that the optimal branching/pruning balance must shift as the target distance changes: different strategies are called for to reach nearby vs. distant targets. This suggests the existence of a currently unidentified higher-level regulatory factor to control arborization dynamics. We propose that these findings may be useful in future therapies seeking to improve targeting rates through manipulation of arborization behaviors.	[Osan, Remus] Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA; [Osan, Remus] Boston Univ, Dept Math & Stat, Boston, MA 02215 USA; [Su, Emily; Shinbrot, Troy] Rutgers State Univ, Dept Biomed Engn, Piscataway, NJ USA	University System of Georgia; Georgia State University; Boston University; Rutgers State University New Brunswick	Osan, R (corresponding author), Georgia State Univ, Dept Math & Stat, Atlanta, GA 30303 USA.	rosan@gsu.edu			Center for Neuroscience, Boston University; New Jersey Commission on Spinal Cord Research [06-3055-SCR-E-0, 07-2932-SCR-E-0]	Center for Neuroscience, Boston University; New Jersey Commission on Spinal Cord Research	R.O. has received funding from the Center for Neuroscience, Boston University (internal grant). E.S. and T.S. have received funding from the New Jersey Commission on Spinal Cord Research (06-3055-SCR-E-0 and 07-2932-SCR-E-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ascoli GA, 2001, ANAT EMBRYOL, V204, P283, DOI 10.1007/s004290100201; Awasaki T, 2004, CURR BIOL, V14, P668, DOI 10.1016/j.cub.2004.04.001; Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8; Bastian J, 2001, J NEUROPHYSIOL, V85, P10, DOI 10.1152/jn.2001.85.1.10; Benichou O, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198101; Bishop DL, 2004, NEURON, V44, P651, DOI 10.1016/j.neuron.2004.10.026; Bunge MB, 2008, J SPINAL CORD MED, V31, P262, DOI 10.1080/10790268.2008.11760720; BURKE RE, 1992, J NEUROSCI, V12, P2403; Cherniak C, 1999, PHYS REV E, V59, P6001, DOI 10.1103/PhysRevE.59.6001; CHERNIAK C, 1992, BIOL CYBERN, V66, P503, DOI 10.1007/BF00204115; Chklovskii DB, 2000, J NEUROPHYSIOL, V83, P2113, DOI 10.1152/jn.2000.83.4.2113; Chklovskii DB, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-18; COWAN WM, 1984, SCIENCE, V225, P1258, DOI 10.1126/science.6474175; Dantzker JL, 2000, NAT NEUROSCI, V3, P701, DOI 10.1038/76656; Ethell IM, 2005, PROG NEUROBIOL, V75, P161, DOI 10.1016/j.pneurobio.2005.02.003; Faulkner RL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-21; Friedrich BM, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/2/026007; Gan WB, 1998, SCIENCE, V282, P1508, DOI 10.1126/science.282.5393.1508; Godfrey KB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000600; Gupta A, 2000, SCIENCE, V287, P273, DOI 10.1126/science.287.5451.273; Kandel E., 2000, PRINCIPLES NEURAL SC; KATER SB, 1994, PROG BRAIN RES, V102, P49; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; LETOURNEAU PC, 1994, PROG BRAIN RES, V102, P35; Lindsay KA, 2007, MATH BIOSCI, V205, P271, DOI 10.1016/j.mbs.2006.08.005; Low LK, 2006, PHILOS T R SOC B, V361, P1531, DOI 10.1098/rstb.2006.1883; Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632; Ma L, 2007, J NEUROSCI, V27, P6843, DOI 10.1523/JNEUROSCI.1479-07.2007; Maskery SM, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-22; McAllister AK, 2000, CEREB CORTEX, V10, P963, DOI 10.1093/cercor/10.10.963; Navarro X, 2007, PROG NEUROBIOL, V82, P163, DOI 10.1016/j.pneurobio.2007.06.005; O'Leary DDM, 1900, COLD SPRING HARB SYM, V55, P453; Petros TJ, 2008, ANNU REV NEUROSCI, V31, P295, DOI 10.1146/annurev.neuro.31.060407.125609; Sang Q, 2002, MOL CELL NEUROSCI, V21, P250, DOI 10.1006/mcne.2002.1156; Schaefer AT, 2003, J NEUROPHYSIOL, V89, P3143, DOI 10.1152/jn.00046.2003; Schierwagen A, 2008, NEUROPHYSIOLOGY+, V40, P310, DOI 10.1007/s11062-009-9054-7; Sheasby BW, 1999, J NEUROPHYSIOL, V81, P1685, DOI 10.1152/jn.1999.81.4.1685; Shefi O, 2004, NEUROCOMPUTING, V58, P487, DOI [10.1016/j.neucom.2004.01.85, 10.1016/j.neucom.2004.01.085]; Snider WD, 2002, NEURON, V35, P13, DOI 10.1016/S0896-6273(02)00762-6; Soussi-Yanicostas N, 2002, CELL, V109, P217, DOI 10.1016/S0092-8674(02)00713-4; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; TOLBERT DL, 1987, DEV BRAIN RES, V33, P11, DOI 10.1016/0165-3806(87)90171-4; Uylings HBM, 2002, NETWORK-COMP NEURAL, V13, P397, DOI 10.1088/0954-898X/13/3/309; van Ooyen A, 2002, NETWORK-COMP NEURAL, V13, P311, DOI 10.1088/0954-898X/13/3/304; Van Pelt J., 2005, MODELING NEUROSCIENC, P89, DOI DOI 10.1201/9780203390979.CH5; Washington SD, 2000, NEUROCOMPUTING, V32, P261, DOI 10.1016/S0925-2312(00)00173-9; Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941; Yates PA, 2004, J NEUROBIOL, V59, P95, DOI 10.1002/neu.10341; Yates PA, 2001, J NEUROSCI, V21, P8548, DOI 10.1523/JNEUROSCI.21-21-08548.2001; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	50	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e25135	10.1371/journal.pone.0025135	http://dx.doi.org/10.1371/journal.pone.0025135			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028773	gold, Green Submitted, Green Published			2022-12-27	WOS:000296510800004
J	Maier, S; Schleberger, P; Lu, W; Wacker, T; Pfluger, T; Litz, C; Andrade, SLA				Maier, Sarah; Schleberger, Paula; Lu, Wei; Wacker, Tobias; Pflueger, Tobias; Litz, Claudia; Andrade, Susana L. A.			Mechanism of Disruption of the Amt-GlnK Complex by P-II-Mediated Sensing of 2-Oxoglutarate	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PROTEIN; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; GLUTAMINE-SYNTHETASE; AMMONIA TRANSPORT; NITROGEN; PII; REVEALS; ARABIDOPSIS; CYANOBACTERIA	GlnK proteins regulate the active uptake of ammonium by Amt transport proteins by inserting their regulatory T-loops into the transport channels of the Amt trimer and physically blocking substrate passage. They sense the cellular nitrogen status through 2-oxoglutarate, and the energy level of the cell by binding both ATP and ADP with different affinities. The hyperthermophilic euryarchaeon Archaeoglobus fulgidus possesses three Amt proteins, each encoded in an operon with a GlnK ortholog. One of these proteins, GlnK2 was recently found to be incapable of binding 2-OG, and in order to understand the implications of this finding we conducted a detailed structural and functional analysis of a second GlnK protein from A. fulgidus, GlnK3. Contrary to Af-GlnK2 this protein was able to bind both ATP/2-OG and ADP to yield inactive and functional states, respectively. Due to the thermostable nature of the protein we could observe the exact positioning of the notoriously flexible T-loops and explain the binding behavior of GlnK proteins to their interaction partner, the Amt proteins. A thermodynamic analysis of these binding events using microcalorimetry evaluated by microstate modeling revealed significant differences in binding cooperativity compared to other characterized P-II proteins, underlining the diversity and adaptability of this class of regulatory signaling proteins.	[Maier, Sarah; Schleberger, Paula; Lu, Wei; Wacker, Tobias; Pflueger, Tobias; Litz, Claudia; Andrade, Susana L. A.] Univ Freiburg, Inst Organ Chem & Biochem, D-7800 Freiburg, Germany	University of Freiburg	Maier, S (corresponding author), Univ Freiburg, Inst Organ Chem & Biochem, Albertstr 21, D-7800 Freiburg, Germany.	andrade@bio.chemie.uni-freiburg.de	Andrade, Susana L. A./D-5119-2012	Andrade, Susana L. A./0000-0003-2267-8499; Litz, Claudia/0000-0002-7527-0633	Deutsche Forschungsgemeinschaft [AN 676/1, IRTG 1478]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft (http://www.dfg.de), grants AN 676/1 and IRTG 1478. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade SLA, 2005, P NATL ACAD SCI USA, V102, P14994, DOI 10.1073/pnas.0506254102; Andrade SLA, 2007, MOL MEMBR BIOL, V24, P357, DOI 10.1080/09687680701388423; Arcondeguy T, 2001, MICROBIOL MOL BIOL R, V65, P80, DOI 10.1128/MMBR.65.1.80-105.2001; Atkinson MR, 1998, MOL MICROBIOL, V29, P431, DOI 10.1046/j.1365-2958.1998.00932.x; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Blauwkamp TA, 2002, MOL MICROBIOL, V46, P203, DOI 10.1046/j.1365-2958.2002.03153.x; Boogerd FC, 2011, FEBS LETT, V585, P23, DOI 10.1016/j.febslet.2010.11.055; Britto DT, 2001, P NATL ACAD SCI USA, V98, P4255, DOI 10.1073/pnas.061034698; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; Coutts G, 2002, EMBO J, V21, P536, DOI 10.1093/emboj/21.4.536; Durand A, 2006, J BIOL CHEM, V281, P29558, DOI 10.1074/jbc.M602477200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fokina O, 2010, P NATL ACAD SCI USA, V107, P19760, DOI 10.1073/pnas.1007653107; Fokina O, 2010, J MOL BIOL, V399, P410, DOI 10.1016/j.jmb.2010.04.018; Forchhammer K, 2004, FEMS MICROBIOL REV, V28, P319, DOI 10.1016/j.femsre.2003.11.001; Forchhammer K, 1997, EUR J BIOCHEM, V244, P869, DOI 10.1111/j.1432-1033.1997.00869.x; FORCHHAMMER K, 1994, J BACTERIOL, V176, P84, DOI 10.1128/JB.176.1.84-91.1994; Gruswitz F, 2007, P NATL ACAD SCI USA, V104, P42, DOI 10.1073/pnas.0609796104; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; Heinrich A, 2006, J BIOL CHEM, V281, P34909, DOI 10.1074/jbc.M607582200; Helfmann S, 2010, J MOL BIOL, V402, P165, DOI 10.1016/j.jmb.2010.07.020; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; HURWITZ C, 1967, J BIOL CHEM, V242, P3719; Jaggi R, 1996, FEBS LETT, V391, P223, DOI 10.1016/0014-5793(96)00737-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAMBEROV ES, 1995, J BIOL CHEM, V270, P17797, DOI 10.1074/jbc.270.30.17797; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leigh JA, 2007, ANNU REV MICROBIOL, V61, P349, DOI 10.1146/annurev.micro.61.080706.093409; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Litz C, 2011, ACTA CRYSTALLOGR F, V67, P178, DOI 10.1107/S1744309110047482; Llacer JL, 2007, P NATL ACAD SCI USA, V104, P17644, DOI 10.1073/pnas.0705987104; Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104; Mizuno Y, 2007, BIOCHEMISTRY-US, V46, P1477, DOI 10.1021/bi062149e; Ninfa AJ, 2005, CURR OPIN MICROBIOL, V8, P168, DOI 10.1016/j.mib.2005.02.011; Radchenko MV, 2010, J BIOL CHEM, V285, P31037, DOI 10.1074/jbc.M110.153908; Smith CS, 2003, PLANT J, V33, P353, DOI 10.1046/j.1365-313X.2003.01634.x; Stadtman ER, 2001, J BIOL CHEM, V276, P44357, DOI 10.1074/jbc.R100055200; TEMPEST DW, 1970, BIOCHEM J, V117, P405, DOI 10.1042/bj1170405; Truan D, 2010, J MOL BIOL, V400, P531, DOI 10.1016/j.jmb.2010.05.036; Uhrig RG, 2009, TRENDS PLANT SCI, V14, P505, DOI 10.1016/j.tplants.2009.07.003; vanHeeswijk WC, 1996, MOL MICROBIOL, V21, P133, DOI 10.1046/j.1365-2958.1996.6281349.x; Yildiz O, 2007, EMBO J, V26, P589, DOI 10.1038/sj.emboj.7601492; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	45	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26327	10.1371/journal.pone.0026327	http://dx.doi.org/10.1371/journal.pone.0026327			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039461	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500050
J	Rosidi, NL; Zhou, J; Pattanaik, S; Wang, P; Jin, WY; Brophy, M; Olbricht, WL; Nishimura, N; Schaffer, CB				Rosidi, Nathanael L.; Zhou, Joan; Pattanaik, Sanket; Wang, Peng; Jin, Weiyang; Brophy, Morgan; Olbricht, William L.; Nishimura, Nozomi; Schaffer, Chris B.			Cortical Microhemorrhages Cause Local Inflammation but Do Not Trigger Widespread Dendrite Degeneration	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; BETA-AMYLOID DEPOSITION; IN-VIVO; ALZHEIMERS-DISEASE; CEREBRAL-ISCHEMIA; FRACTALKINE-RECEPTOR; MICROGLIAL CELLS; EDEMA FORMATION; CRANIAL WINDOW	Microhemorrhages are common in the aging brain, and their incidence is correlated with increased risk of neurodegenerative disease. Past work has shown that occlusion of individual cortical microvessels as well as large-scale hemorrhages can lead to degeneration of neurons and increased inflammation. Using two-photon excited fluorescence microscopy in anesthetized mice, we characterized the acute and chronic dynamics of vessel bleeding, tissue compression, blood flow change, neural degeneration, and inflammation following a microhemorrhage caused by rupturing a single penetrating arteriole with tightly-focused femtosecond laser pulses. We quantified the extravasation of red blood cells (RBCs) and blood plasma into the brain and determined that the bleeding was limited by clotting. The vascular bleeding formed a RBC-filled core that compressed the surrounding parenchymal tissue, but this compression was not sufficient to crush nearby brain capillaries, although blood flow speeds in these vessels was reduced by 20%. Imaging of cortical dendrites revealed no degeneration of the large-scale structure of the dendritic arbor up to 14 days after the microhemorrhage. Dendrites close to the RBC core were displaced by extravasating RBCs but began to relax back one day after the lesion. Finally, we observed a rapid inflammatory response characterized by morphology changes in microglia/macrophages up to 200 mu m from the microhemorrhage as well as extension of cellular processes into the RBC core. This inflammation persisted over seven days. Taken together, our data suggest that a cortical microhemorrhage does not directly cause significant neural pathology but does trigger a sustained, local inflammatory response.	[Rosidi, Nathanael L.; Zhou, Joan; Pattanaik, Sanket; Jin, Weiyang; Brophy, Morgan; Olbricht, William L.; Nishimura, Nozomi; Schaffer, Chris B.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Wang, Peng; Olbricht, William L.] Cornell Univ, Dept Chem & Biomol Engn, Ithaca, NY USA	Cornell University; Cornell University	Rosidi, NL (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	cs385@cornell.edu	Schaffer, Chris B./A-7409-2008; Nishimura, Nozomi/P-8908-2015; Nishimura, Nozomi/AAV-2425-2020	Schaffer, Chris B./0000-0002-7800-9596; Nishimura, Nozomi/0000-0003-4342-9416; Nishimura, Nozomi/0000-0003-4342-9416	American Heart Association [0735644T]; Ellison Medical Foundation [AG-NS-0330-86]; National Institutes of Health [1F32AG031620-01A2]; L'Oreal USA Fellowship for Women in Science; National Science Foundation [0841291]; NATIONAL INSTITUTE ON AGING [F32AG031620] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Ellison Medical Foundation(Lawrence Ellison Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); L'Oreal USA Fellowship for Women in Science; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by grants from the American Heart Association (0735644T to CBS) and the Ellison Medical Foundation (AG-NS-0330-86 to CBS), by a National Institutes of Health post-doctoral fellowship (1F32AG031620-01A2 to NN), a L'Oreal USA Fellowship for Women in Science fellowship (NN), and a National Science Foundation GK-12 fellowship (0841291 to NLR). We would also like to thank IMRA America, Inc. for the loan of laser equipment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; NN received a L'Oreal USA Fellowship for Women in Science. The authors received a loan of laser equipment (mu Jewel FCPA) that was used in these experiments from IMRA America, Inc. This support does not alter the authors' adherence to all the PLoS ONE policies on sharing data and materials.	BASSER PJ, 1992, MICROVASC RES, V44, P143, DOI 10.1016/0026-2862(92)90077-3; BEAL MF, 1992, ANN NEUROL, V31, P119, DOI 10.1002/ana.410310202; Biber K, 2008, J NEUROIMMUNOL, V198, P69, DOI 10.1016/j.jneuroim.2008.04.012; BIGNAMI A, 1972, BRAIN RES, V43, P429, DOI 10.1016/0006-8993(72)90398-8; Cullen KM, 2006, NEUROBIOL AGING, V27, P1786, DOI 10.1016/j.neurobiolaging.2005.10.016; Cullen KM, 2005, J CEREBR BLOOD F MET, V25, P1656, DOI 10.1038/sj.jcbfm.9600155; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Denes A, 2008, J CEREBR BLOOD F MET, V28, P1707, DOI 10.1038/jcbfm.2008.64; Enright LE, 2007, J CEREBR BLOOD F MET, V27, P1185, DOI 10.1038/sj.jcbfm.9600428; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Flaherty ML, 2008, NEUROLOGY, V71, P1084, DOI 10.1212/01.wnl.0000326895.58992.27; Fuhrmann M, 2010, NAT NEUROSCI, V13, P411, DOI 10.1038/nn.2511; Fujimoto S, 2008, J CEREBR BLOOD F MET, V28, P506, DOI 10.1038/sj.jcbfm.9600547; Gong C, 2001, NEUROSURGERY, V48, P875, DOI 10.1097/00006123-200104000-00037; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Holtmaat A, 2009, NAT PROTOC, V4, P1128, DOI 10.1038/nprot.2009.89; Jung S, 2000, MOL CELL BIOL, V20, P4106, DOI 10.1128/MCB.20.11.4106-4114.2000; Kim JV, 2006, J IMMUNOL, V177, P5269, DOI 10.4049/jimmunol.177.8.5269; Ladeby R, 2005, BRAIN RES REV, V48, P196, DOI 10.1016/j.brainresrev.2004.12.009; LAUER A, 2011, CIRCULATION; Lee S, 2010, AM J PATHOL, V177, P2549, DOI 10.2353/ajpath.2010.100265; Lipowsky HH, 2005, MICROCIRCULATION, V12, P5, DOI 10.1080/10739680590894966; MacLellan CL, 2010, STROKE, V41, pS95, DOI 10.1161/STROKEAHA.110.594457; Malm TM, 2005, NEUROBIOL DIS, V18, P134, DOI 10.1016/j.nbd.2004.09.009; Mendelow A D, 1984, Neurol Res, V6, P189; Moller T, 2000, J NEUROCHEM, V75, P1539, DOI 10.1046/j.1471-4159.2000.0751539.x; Mostany R, 2011, J NEUROSCI, V31, P1734, DOI 10.1523/JNEUROSCI.4386-10.2011; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Nishimura N, 2006, NAT METHODS, V3, P99, DOI 10.1038/NMETH844; Nishimura N, 2007, P NATL ACAD SCI USA, V104, P365, DOI 10.1073/pnas.0609551104; Nishino Hitoo, 1994, Neurobiology (Budapest), V2, P223; PETITO CK, 1984, J NEUROPATH EXP NEUR, V43, P141, DOI 10.1097/00005072-198403000-00004; Qureshi AI, 1999, NEUROLOGY, V52, P266, DOI 10.1212/WNL.52.2.266; Rappert A, 2004, J NEUROSCI, V24, P8500, DOI 10.1523/JNEUROSCI.2451-04.2004; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Tanaka R, 2003, NEUROSCIENCE, V117, P531, DOI 10.1016/S0306-4522(02)00954-5; Terai K, 2003, NEUROCHEM RES, V28, P779, DOI 10.1023/A:1022826220469; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wardlaw JM, 2003, STROKE, V34, P806, DOI 10.1161/01.STR.0000058480.77236.B3; Werring DJ, 2004, BRAIN, V127, P2265, DOI 10.1093/brain/awh253; Wu JM, 2002, BRAIN RES, V953, P45, DOI 10.1016/S0006-8993(02)03268-7; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0; Xi GH, 1998, J NEUROSURG, V89, P991, DOI 10.3171/jns.1998.89.6.0991; Xi GH, 2001, STROKE, V32, P2932, DOI 10.1161/hs1201.099820; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Yang G, 2010, NAT PROTOC, V5, P201, DOI 10.1038/nprot.2009.222; YANG GY, 1994, J NEUROSURG, V81, P93, DOI 10.3171/jns.1994.81.1.0093; Zazulia AR, 2001, J CEREBR BLOOD F MET, V21, P804, DOI 10.1097/00004647-200107000-00005; Zhang SX, 2007, PLOS BIOL, V5, P1152, DOI 10.1371/journal.pbio.0050119; Zhang SX, 2005, J NEUROSCI, V25, P5333, DOI 10.1523/JNEUROSCI.1085-05.2005	52	54	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26612	10.1371/journal.pone.0026612	http://dx.doi.org/10.1371/journal.pone.0026612			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028924	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500098
J	Turner, T; Pihur, V; Chakravarti, A				Turner, Tychele; Pihur, Vasyl; Chakravarti, Aravinda			Quantifying and Modeling Birth Order Effects in Autism	PLOS ONE			English	Article							SPONTANEOUS MUTATION; MATERNAL AGE; NONVERBAL IQ; DISORDER; IDENTIFICATION; FAMILIES; RESOURCE; ETIOLOGY; SHANK3; TWIN	Autism is a complex genetic disorder with multiple etiologies whose molecular genetic basis is not fully understood. Although a number of rare mutations and dosage abnormalities are specific to autism, these explain no more than 10% of all cases. The high heritability of autism and low recurrence risk suggests multifactorial inheritance from numerous loci but other factors also intervene to modulate risk. In this study, we examine the effect of birth rank on disease risk which is not expected for purely hereditary genetic models. We analyzed the data from three publicly available autism family collections in the USA for potential birth order effects and studied the statistical properties of three tests to show that adequate power to detect these effects exist. We detect statistically significant, yet varying, patterns of birth order effects across these collections. In multiplex families, we identify V-shaped effects where middle births are at high risk; in simplex families, we demonstrate linear effects where risk increases with each additional birth. Moreover, the birth order effect is gender-dependent in the simplex collection. It is currently unknown whether these patterns arise from ascertainment biases or biological factors. Nevertheless, further investigation of parental age-dependent risks yields patterns similar to those observed and could potentially explain part of the increased risk. A search for genes considering these patterns is likely to increase statistical power and uncover novel molecular etiologies.	[Turner, Tychele; Pihur, Vasyl; Chakravarti, Aravinda] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21218 USA	Johns Hopkins University	Turner, T (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Ctr Complex Dis Genom, Baltimore, MD 21218 USA.	aravinda@jhmi.edu		Turner, Tychele/0000-0001-8246-6477	NIH (Autism Center for Excellence) [MH081754]; Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH081754] Funding Source: NIH RePORTER	NIH (Autism Center for Excellence)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation Autism Research Initiative; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by grants from the NIH (Autism Center for Excellence, MH081754) and the Simons Foundation Autism Research Initiative. The funders had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; BAILEY A, 1995, PSYCHOL MED, V25, P63, DOI 10.1017/S0033291700028099; BARTON DE, 1958, ANN HUM GENET, V22, P250, DOI 10.1111/j.1469-1809.1958.tb01420.x; BROMAN B, 1950, Acta Obstet Gynecol Scand, V30, P75; Cook EH, 1997, AM J HUM GENET, V60, P928; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Durand CM, 2007, NAT GENET, V39, P25, DOI 10.1038/ng1933; Emison ES, 2010, AM J HUM GENET, V87, P60, DOI 10.1016/j.ajhg.2010.06.007; ERICKSON JD, 1978, ANN HUM GENET, V41, P289, DOI 10.1111/j.1469-1809.1978.tb01896.x; Fischbach GD, 2010, NEURON, V68, P192, DOI 10.1016/j.neuron.2010.10.006; Fombonne E, 2003, J AUTISM DEV DISORD, V33, P365, DOI 10.1023/A:1025054610557; Geschwind DH, 2001, AM J HUM GENET, V69, P463, DOI 10.1086/321292; GESCHWIND DH, 2008, AUTISM, V135, P391; HALDANE JBS, 1948, ANN EUGENIC, V14, P117; HALPERIN M, 1953, ANN EUGENIC, V18, P99; Hassold T, 1996, ENVIRON MOL MUTAGEN, V28, P167; Landsteiner K, 1941, J EXP MED, V74, P309, DOI 10.1084/jem.74.4.309; LORD C, 1992, J AUTISM DEV DISORD, V22, P663, DOI 10.1007/BF01046335; Moessner R, 2007, AM J HUM GENET, V81, P1289, DOI 10.1086/522590; Ogbuanu Ikechukwu U, 2010, Allergy Asthma Clin Immunol, V6, P6, DOI 10.1186/1710-1492-6-6; Reichenberg A, 2007, PSYCHIAT RES, V150, P199, DOI 10.1016/j.psychres.2004.09.012; RISCH N, 1987, AM J HUM GENET, V41, P218; Risch N, 1999, AM J HUM GENET, V65, P493, DOI 10.1086/302497; SHERMAN SL, 1994, HUM MOL GENET, V3, P1529, DOI 10.1093/hmg/3.9.1529; Spiker D, 2001, J AUTISM DEV DISORD, V31, P449, DOI 10.1023/A:1012217807469; STEFFENBURG S, 1989, J CHILD PSYCHOL PSYC, V30, P405, DOI 10.1111/j.1469-7610.1989.tb00254.x; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wilkin DJ, 1998, AM J HUM GENET, V63, P711, DOI 10.1086/302000; Zhao X, 2007, P NATL ACAD SCI USA, V104, P12831, DOI 10.1073/pnas.0705803104	29	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26418	10.1371/journal.pone.0026418	http://dx.doi.org/10.1371/journal.pone.0026418			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039484	Green Published, gold, Green Submitted			2022-12-27	WOS:000296507500066
J	Bogaert, S; De Vos, M; Olievier, K; Peeters, H; Elewaut, D; Lambrecht, B; Pouliot, P; Laukens, D				Bogaert, Sara; De Vos, Martine; Olievier, Kim; Peeters, Harald; Elewaut, Dirk; Lambrecht, Bart; Pouliot, Philippe; Laukens, Debby			Involvement of Endoplasmic Reticulum Stress in Inflammatory Bowel Disease: A Different Implication for Colonic and Ileal Disease?	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; XBP1 MESSENGER-RNA; ER STRESS; ATF6; EXPRESSION; IRE1; TRANSLATION; INHIBITION; CLEAVAGE; KINASE	Background: Endoplasmic reticulum (ER) stress has been suggested to play a role in inflammatory bowel disease (IBD). The three branches (ATF6, IRE1 and PERK) of the unfolded protein response (UPR) have different roles and are not necessarily activated simultaneously. Methodology/Principal Findings: Expression of UPR-related genes was investigated in colonic and ileal biopsies of 23 controls, 15 ulcerative colitis (UC) and 54 Crohn's disease (CD) patients. This expression was confirmed at protein level in colonic and ileal samples of five controls, UC and CD patients. HSPA5, PDIA4 and XBP1s were significantly increased in colonic IBD at mRNA and/or protein levels, indicating activation of the ATF6 and IRE1 branch. Colonic IBD was associated with increased phosphorylation of EIF2A suggesting the activation of the PERK branch, but subsequent induction of GADD34 was not observed. In ileal CD, no differential expression of the UPR-related genes was observed, but our data suggested a higher basal activation of the UPR in the ileal mucosa of controls. This was confirmed by the increased expression of 16 UPR-related genes as 12 of them were significantly more expressed in ileal controls compared to colonic controls. Tunicamycin stimulation of colonic and ileal samples of healthy individuals revealed that although the ileal mucosa is exhibiting this higher basal UPR activation, it is still responsive to ER stress, even more than colonic mucosa. Conclusions/Significance: Activation of the three UPR-related arms is seen in colonic IBD-associated inflammation. However, despite EIF2A activation, inflamed colonic tissue did not increase GADD34 expression, which is usually involved in re-establishment of ER homeostasis. This study also implies the presence of a constitutive UPR activation in healthy ileal mucosa, with no further activation during inflammation. Therefore, engagement of the UPR differs between colon and ileum and this could be a factor in the development of ileal or colonic disease.	[Bogaert, Sara; De Vos, Martine; Olievier, Kim; Peeters, Harald; Laukens, Debby] Univ Ghent, Dept Gastroenterol, B-9000 Ghent, Belgium; [Elewaut, Dirk] Univ Ghent, Dept Rheumatol, B-9000 Ghent, Belgium; [Lambrecht, Bart; Pouliot, Philippe] Univ Ghent, Lab Immunoregulat & Mucosal Immunol, B-9000 Ghent, Belgium	Ghent University; Ghent University; Ghent University	Bogaert, S (corresponding author), Univ Ghent, Dept Gastroenterol, B-9000 Ghent, Belgium.	martine.devos@ugent.be	Lambrecht, Bart N/K-2484-2014; Elewaut, Dirk/K-6831-2014	Lambrecht, Bart N/0000-0003-4376-6834; Laukens, Debby/0000-0002-1984-5850; Elewaut, Dirk/0000-0002-7468-974X	Ghent University [GOA2001/12051501]; MSD; Abott; Ghent University (GROUP-ID-MRP)	Ghent University(Ghent University); MSD; Abott; Ghent University (GROUP-ID-MRP)(Ghent University)	This study is supported by a concerted action grant GOA2001/12051501 of Ghent University, a grant of MSD and a grant of Abott. MSD and Abott had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Dr. Lambrecht, Dr. Elewaut and Dr. Pouliot are supported by a MRP grant of Ghent University (GROUP-ID-MRP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barmada MM, 2004, INFLAMM BOWEL DIS, V10, P15, DOI 10.1097/00054725-200401000-00002; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Boden G, 2010, J CLIN ENDOCR METAB, V95, P349, DOI 10.1210/jc.2009-1815; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Daig R, 1996, GUT, V38, P216, DOI 10.1136/gut.38.2.216; Hampe J, 1999, AM J HUM GENET, V64, P808, DOI 10.1086/302294; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hirota Morihiko, 2006, Journal of Toxicological Sciences, V31, P149, DOI 10.2131/jts.31.149; Ishiguro Y, 1999, J GASTROENTEROL, V34, P66, DOI 10.1007/s005350050218; Jung KA, 2010, MOLECULES, V15, P7266, DOI 10.3390/molecules15107266; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Liu CY, 2000, J BIOL CHEM, V275, P24881, DOI 10.1074/jbc.M004454200; MAHONEY WC, 1979, J BIOL CHEM, V254, P6572; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; MAZZUCCHELLI L, 1994, AM J PATHOL, V144, P997; McGuckin MA, 2010, AM J PHYSIOL-GASTR L, V298, pG820, DOI 10.1152/ajpgi.00063.2010; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; OLDEN K, 1979, P NATL ACAD SCI USA, V76, P791, DOI 10.1073/pnas.76.2.791; Satsangi J, 2006, GUT, V55, P749, DOI 10.1136/gut.2005.082909; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Shi YG, 1998, MOL CELL BIOL, V18, P7499, DOI 10.1128/MCB.18.12.7499; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vermeire S, 2004, GUT, V53, P980, DOI 10.1136/gut.2003.034033; Vermeulen Joelle, 2009, BMC Res Notes, V2, P235, DOI 10.1186/1756-0500-2-235; Werner ED, 1996, P NATL ACAD SCI USA, V93, P13797, DOI 10.1073/pnas.93.24.13797; Woo CW, 2009, NAT CELL BIOL, V11, P1473, DOI 10.1038/ncb1996; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang KZ, 2006, NEUROLOGY, V66, pS102, DOI 10.1212/01.wnl.0000192306.98198.ec; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	43	53	55	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25589	10.1371/journal.pone.0025589	http://dx.doi.org/10.1371/journal.pone.0025589			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028783	Green Published, Green Submitted, gold			2022-12-27	WOS:000296186900012
J	Galsworthy, SJ; ten Bosch, QA; Hoye, BJ; Heesterbeek, JAP; Klaassen, M; Klinkenberg, D				Galsworthy, Stephen J.; ten Bosch, Quirine A.; Hoye, Bethany J.; Heesterbeek, Johan A. P.; Klaassen, Marcel; Klinkenberg, Don			Effects of Infection-Induced Migration Delays on the Epidemiology of Avian Influenza in Wild Mallard Populations	PLOS ONE			English	Article							A VIRUS; ANAS-PLATYRHYNCHOS; ENVIRONMENTAL TRANSMISSION; SATELLITE TELEMETRY; NORTHERN EUROPE; H5N1 VIRUS; BIRDS; SPREAD; DUCKS; SURVEILLANCE	Wild waterfowl populations form a natural reservoir of Avian Influenza (AI) virus, and fears exist that these birds may contribute to an AI pandemic by spreading the virus along their migratory flyways. Observational studies suggest that individuals infected with AI virus may delay departure from migratory staging sites. Here, we explore the epidemiological dynamics of avian influenza virus in a migrating mallard (Anas platyrhynchos) population with a specific view to understanding the role of infection-induced migration delays on the spread of virus strains of differing transmissibility. We develop a host-pathogen model that combines the transmission dynamics of influenza with the migration, reproduction and mortality of the host bird species. Our modeling predicts that delayed migration of individuals influences both the timing and size of outbreaks of AI virus. We find that (1) delayed migration leads to a lower total number of cases of infection each year than in the absence of migration delay, (2) when the transmission rate of a strain is high, the outbreak starts at the staging sites at which birds arrive in the early part of the fall migration, (3) when the transmission rate is low, infection predominantly occurs later in the season, which is further delayed when there is a migration delay. As such, the rise of more virulent AI strains in waterfowl could lead to a higher prevalence of infection later in the year, which could change the exposure risk for farmed poultry. A sensitivity analysis shows the importance of generation time and loss of immunity for the effect of migration delays. Thus, we demonstrate, in contrast to many current transmission risk models solely using empirical information on bird movements to assess the potential for transmission, that a consideration of infection-induced delays is critical to understanding the dynamics of AI infection along the entire flyway.	[Galsworthy, Stephen J.; ten Bosch, Quirine A.; Heesterbeek, Johan A. P.; Klinkenberg, Don] Univ Utrecht, Fac Vet Med, Utrecht, Netherlands; [ten Bosch, Quirine A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Hoye, Bethany J.; Klaassen, Marcel] Netherlands Inst Ecol NIOO KNAW, Dept Anim Ecol, Wageningen, Netherlands; [Klaassen, Marcel] Deakin Univ, Ctr Integrat Ecol, Geelong, Vic 3217, Australia	Utrecht University; University of Notre Dame; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Deakin University	Galsworthy, SJ (corresponding author), Univ Utrecht, Fac Vet Med, Utrecht, Netherlands.	d.klinkenberg@uu.nl	Hoye, Bethany J/A-4486-2010; Bosch, Quirine ten/H-6734-2019; Klaassen, Marcel/B-4325-2008	Hoye, Bethany J/0000-0001-9502-5582; Bosch, Quirine ten/0000-0002-5227-1406; Klaassen, Marcel/0000-0003-3907-9599; Klinkenberg, Don/0000-0002-9449-6873; Heesterbeek, Hans/0000-0001-8537-6418	Research Council for Earth and Life Sciences (ALW); Netherlands Organization for Scientific Research (NWO) [851.40.073, 851.40.074]; National Institutes of Health [NIAIDNIH HHSN266200700010C]	Research Council for Earth and Life Sciences (ALW)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Research Council for Earth and Life Sciences (ALW) and through the Bird Health programme within the International Polar Year, by the Netherlands Organization for Scientific Research (NWO), grants 851.40.073 and 851.40.074. Further support was received from the Intramural Research Programme of the National Institutes of Health, contract NIAIDNIH HHSN266200700010C. This is publication 5110 of the NIOO-KNAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Bourouiba L, 2010, J R SOC INTERFACE, V7, P1627, DOI 10.1098/rsif.2010.0126; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Brochet AL, 2009, ECOHEALTH, V6, P449, DOI 10.1007/s10393-010-0275-4; Capua I, 2007, INFLUENZA OTHER RESP, V1, P11, DOI 10.1111/j.1750-2659.2006.00004.x; Chen H, 2005, NATURE, V436, P191, DOI 10.1038/nature03974; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Costa TP, 2010, AVIAN DIS, V54, P581, DOI 10.1637/8692-031309-ResNote.1; Cumming GS, 2008, ECOL SOC, V13; Delany S, 2006, WATERBIRD POPULATION; Domanska-Blicharz K, 2010, AVIAN DIS, V54, P734, DOI 10.1637/8786-040109-ResNote.1; Feare CJ, 2010, AVIAN DIS, V54, P201, DOI 10.1637/8766-033109-ResNote.1; Fine PEM, 2003, AM J EPIDEMIOL, V158, P1039, DOI 10.1093/aje/kwg251; Gaidet N, 2010, J APPL ECOL, V47, P1147, DOI 10.1111/j.1365-2664.2010.01845.x; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Henaux V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010997; HIGGINS DA, 1987, IMMUNOLOGY, V62, P499; Hirschfeld Axel, 2005, Berichte zum Vogelschutz, V42, P47; Hubalek Z, 2004, J WILDLIFE DIS, V40, P639, DOI 10.7589/0090-3558-40.4.639; Hulse-Post DJ, 2005, P NATL ACAD SCI USA, V102, P10682, DOI 10.1073/pnas.0504662102; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Lebarbenchon C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007289; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Munster VJ, 2005, EMERG INFECT DIS, V11, P1545, DOI 10.3201/eid1110.050546; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Reperant LA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000854; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Schekkerman H, 2008, POPULATION DYNAMICS; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Sturm-Ramirez KM, 2004, J VIROL, V78, P4892, DOI 10.1128/JVI.78.9.4892-4901.2004; Svensson A, 2007, MATH BIOSCI, V208, P300, DOI 10.1016/j.mbs.2006.10.010; van der Goot JA, 2008, VIROLOGY, V382, P91, DOI 10.1016/j.virol.2008.08.037; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; van Roomen M., 2007, WATERVOGELS NEDERLAN; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Yamaguchi N, 2008, ZOOL SCI, V25, P875, DOI 10.2108/zsj.25.875	41	23	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26118	10.1371/journal.pone.0026118	http://dx.doi.org/10.1371/journal.pone.0026118			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028812	Green Published, gold			2022-12-27	WOS:000296186900027
J	Stockl, D; Meisinger, C; Peters, A; Thorand, B; Huth, C; Heier, M; Rathmann, W; Kowall, B; Stockl, H; Doring, A				Stoeckl, Doris; Meisinger, Christa; Peters, Annette; Thorand, Barbara; Huth, Cornelia; Heier, Margit; Rathmann, Wolfgang; Kowall, Bernd; Stoeckl, Heidi; Doering, Angela			Age at Menarche and Its Association with the Metabolic Syndrome and Its Components: Results from the KORA F4 Study	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE RISK; POSTMENOPAUSAL WOMEN; CHILDHOOD PREDICTORS; REPRODUCTIVE HISTORY; ADULTHOOD; OBESITY; DEFINITIONS; POPULATION; MENOPAUSE; HEALTH	Objective: The metabolic syndrome is a major public health challenge and identifies persons at risk for diabetes and cardiovascular disease. The aim of this study was to examine the association between age at menarche and the metabolic syndrome (IDF and NCEP ATP III classification) and its components. Design: 1536 women aged 32 to 81 years of the German population based KORA F4 study were investigated. Data was collected by standardized interviews, physical examinations, and whole blood and serum measurements. Results: Young age at menarche was significantly associated with elevated body mass index (BMI), greater waist circumference, higher fasting glucose levels, and 2 hour glucose (oral glucose tolerance test), even after adjusting for the difference between current BMI and BMI at age 25. The significant effect on elevated triglycerides and systolic blood pressure was attenuated after adjustment for the BMI change. Age at menarche was inversely associated with the metabolic syndrome adjusting for age (p-values: <0.001 IDF, 0.003 NCEP classification) and additional potential confounders including lifestyle and reproductive history factors (p-values: 0.001, 0.005). Associations remain significant when additionally controlling for recollected BMI at age 25 (p-values: 0.008, 0.033) or the BMI change since age 25 (p-values: 0.005, 0.022). Conclusion: Young age at menarche might play a role in the development of the metabolic syndrome. This association is only partially mediated by weight gain and increased BMI. A history of early menarche may help to identify women at risk for the metabolic syndrome.	[Stoeckl, Doris; Meisinger, Christa; Peters, Annette; Thorand, Barbara; Huth, Cornelia; Heier, Margit] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany; [Stoeckl, Doris] Univ Munich, Dept Obstet & Gynaecol, Munich, Germany; [Meisinger, Christa] Cent Hosp Augsburg, MONICA KORA Myocardial Infarct Registry, Augsburg, Germany; [Rathmann, Wolfgang; Kowall, Bernd] Univ Dusseldorf, Inst Biometr & Epidemiol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Stoeckl, Heidi] London Sch Hyg & Trop Med, Social & Math Epidemiol Grp, London WC1, England; [Doering, Angela] Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 1, Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; University of London; London School of Hygiene & Tropical Medicine; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Stockl, D (corresponding author), Helmholtz Zentrum Munchen, German Res Ctr Environm Hlth, Inst Epidemiol 2, Neuherberg, Germany.	doris.stoeckl@helmholtz-muenchen.de	Stöckl, Doris/B-5352-2014; Thorand, Barbara/B-5349-2014; Peters, Annette/A-6117-2011; Meisinger, Christine/B-5358-2014; Heier, Margit/AAT-5280-2020; Huth, Cornelia/B-5350-2014	Thorand, Barbara/0000-0002-8416-6440; Peters, Annette/0000-0001-6645-0985; Huth, Cornelia/0000-0003-2421-433X; Stockl, Heidi/0000-0002-0907-8483; Meisinger, Christa/0000-0002-9026-6544	Helmholtz Zentrum Munchen; German Research Center for Environmental Health; German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Federal Ministry of Education and Research; MRC [G0802699] Funding Source: UKRI; Medical Research Council [G0802699] Funding Source: researchfish	Helmholtz Zentrum Munchen(Helmholtz Association); German Research Center for Environmental Health; German Federal Ministry of Education, Science, Research and Technology; State of Bavaria; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The KORA research platform (KORA, Cooperative Research in the Region of Augsburg) was initiated and financed by the Helmholtz Zentrum Munchen, German Research Center for Environmental Health, which is funded by the German Federal Ministry of Education, Science, Research and Technology and by the State of Bavaria and Cornelia Huth was supported by a grant from the German Federal Ministry of Education and Research to the German Center for Diabetes Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Biro FM, 2010, AM J CLIN NUTR, V91, p1499S, DOI 10.3945/ajcn.2010.28701B; Boronat M, 2009, NUTR METAB CARDIOVAS, V19, P417, DOI 10.1016/j.numecd.2008.07.010; Bosetti C, 2001, J CLIN EPIDEMIOL, V54, P902, DOI 10.1016/S0895-4356(01)00362-6; Boudreau DM, 2009, METAB SYNDR RELAT D, V7, P305, DOI 10.1089/met.2008.0070; Cho GJ, 2009, MENOPAUSE, V16, P998, DOI 10.1097/gme.0b013e3181a03807; Cui R, 2006, J EPIDEMIOL, V16, P177, DOI 10.2188/jea.16.177; Day Caroline, 2007, Diab Vasc Dis Res, V4, P32, DOI 10.3132/dvdr.2007.003; de Kleijn MJJ, 1999, MATURITAS, V33, P7, DOI 10.1016/S0378-5122(99)00038-9; Duvnjak L, 2009, J PHYSIOL PHARMACOL, V60, P19; Elks CE., 2010, NAT GENET, V42, P1077; Feng Y, 2008, ATHEROSCLEROSIS, V196, P590, DOI 10.1016/j.atherosclerosis.2007.06.016; Freedman David S, 2003, BMC Pediatr, V3, P3, DOI 10.1186/1471-2431-3-3; Frontini MG, 2003, INT J OBESITY, V27, P1398, DOI 10.1038/sj.ijo.0802422; GARN SM, 1986, AM J CLIN NUTR, V43, P879, DOI 10.1093/ajcn/43.6.879; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gunderson EP, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.03.031; He CY, 2010, AM J EPIDEMIOL, V171, P334, DOI 10.1093/aje/kwp372; Heys M, 2007, EPIDEMIOLOGY, V18, P740, DOI 10.1097/EDE.0b013e3181567faf; Kivimaki M, 2008, AM J CLIN NUTR, V87, P1876, DOI 10.1093/ajcn/87.6.1876; Lakshman R, 2008, DIABETOLOGIA, V51, P781, DOI 10.1007/s00125-008-0948-5; Lakshman R, 2009, J CLIN ENDOCR METAB, V94, P4953, DOI 10.1210/jc.2009-1789; Lao XQ, 2006, CLIN ENDOCRINOL, V65, P460, DOI 10.1111/j.1365-2265.2006.02615.x; Mattsson N, 2008, ANN MED, V40, P542, DOI 10.1080/07853890802307709; Mousavi E, 2009, METAB SYNDR RELAT D, V7, P519, DOI 10.1089/met.2008.0076; Must A, 2002, AM J EPIDEMIOL, V155, P672, DOI 10.1093/aje/155.7.672; Parsons TJ, 1999, INT J OBESITY, V23, pS1; Perry JRB, 2009, NAT GENET, V41, P648, DOI 10.1038/ng.386; Pierce MB, 2005, AM J CLIN NUTR, V82, P733, DOI 10.1093/ajcn/82.4.733; Rathmann W, 2006, DIABETES CARE, V29, P461, DOI 10.2337/diacare.29.02.06.dc05-1885; Rathmann W, 2009, DIABETIC MED, V26, P1212, DOI 10.1111/j.1464-5491.2009.02863.x; Remsberg KE, 2005, J CLIN ENDOCR METAB, V90, P2718, DOI 10.1210/jc.2004-1991; ROWLAND ML, 1990, AM J CLIN NUTR, V52, P1125, DOI 10.1093/ajcn/52.6.1125; Towne B, 2005, AM J PHYS ANTHROPOL, V128, P210, DOI 10.1002/ajpa.20106; vanLenthe FJ, 1996, AM J CLIN NUTR, V64, P18, DOI 10.1093/ajcn/64.1.18	35	77	81	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26076	10.1371/journal.pone.0026076	http://dx.doi.org/10.1371/journal.pone.0026076			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028807	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000296186900026
J	Tori, K; Perler, FB				Tori, Kazuo; Perler, Francine B.			The Arthrobacter Species FB24 Arth_1007 (DnaB) Intein Is a Pseudogene	PLOS ONE			English	Article							PROTEIN; IDENTIFICATION; MECHANISM	An Arthrobacter species FB24 gene (locus tag Arth_1007) was previously annotated as a putative intein-containing DnaB helicase of phage origin (Arsp-FB24 DnaB intein). However, it is not a helicase gene because the sequence similarity is limited to inteins. In fact, the flanking exteins total only 66 amino acids. Therefore, the intein should be referred to as the Arsp-FB24 Arth_1007 intein. The Arsp-FB24 Arth_1007 intein failed to splice in its native precursor and in a model precursor. We previously noted that the Arsp-FB24 Arth_1007 intein is the only putative Class 3 intein that is missing the catalytically essential Cys at position 4 of intein Motif F, which is one of the three defining signature residues of this class. Additionally, a catalytically essential His in position 10 of intein Motif B is also absent; this His is the most conserved residue amongst all inteins. Splicing activity was not rescued when these two catalytically important positions were 'reverted' back to their consensus residues. This study restores the unity of the Class 3 intein signature sequence in active inteins by demonstrating that the Arsp-FB24 Arth_1007 intein is an inactive pseudogene.	[Tori, Kazuo; Perler, Francine B.] New England Biolabs Inc, Ipswich, MA USA	New England Biolabs	Tori, K (corresponding author), New England Biolabs Inc, Ipswich, MA USA.	perler@neb.com			New England Biolabs	New England Biolabs	We thank Manoj Cheriyan (New England Biolabs) for helpful discussions, Lise Raleigh for reading of the manuscript (New England Biolabs) and Don Comb (New England Biolabs) for support and encouragement.	Brace LE, 2010, PROTEIN SCI, V19, P1525, DOI 10.1002/pro.431; Dalgaard JZ, 1997, J COMPUT BIOL, V4, P193, DOI 10.1089/cmb.1997.4.193; Huelsenbeck JP, 2001, SCIENCE, V294, P2310, DOI 10.1126/science.1065889; Kawasaki M, 1997, J BIOL CHEM, V272, P15668, DOI 10.1074/jbc.272.25.15668; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Mills KV, 2005, PROTEIN PEPTIDE LETT, V12, P751, DOI 10.2174/0929866054864337; Noren CJ, 2000, ANGEW CHEM INT EDIT, V39, P450; Paulus H, 1998, CHEM SOC REV, V27, P375, DOI 10.1039/a827375z; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; Perler FB, 1997, NUCLEIC ACIDS RES, V25, P1087, DOI 10.1093/nar/25.6.1087; Pietrokovski S, 1998, PROTEIN SCI, V7, P64, DOI 10.1002/pro.5560070106; PIETROKOVSKI S, 1994, PROTEIN SCI, V3, P2340, DOI 10.1002/pro.5560031218; Romanelli A, 2004, P NATL ACAD SCI USA, V101, P6397, DOI 10.1073/pnas.0306616101; Southworth MW, 2000, EMBO J, V19, P5019, DOI 10.1093/emboj/19.18.5019; Tori K, 2011, J BACTERIOL, V193, P2035, DOI 10.1128/JB.01407-10; Tori K, 2010, J BIOL CHEM, V285, P2515, DOI 10.1074/jbc.M109.069567	16	6	7	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26361	10.1371/journal.pone.0026361	http://dx.doi.org/10.1371/journal.pone.0026361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028863	Green Published, gold, Green Submitted			2022-12-27	WOS:000296186900053
J	Ligr, M; Patwa, RR; Daniels, G; Pan, L; Wu, XY; Li, YR; Tian, LT; Wang, ZX; Xu, RL; Wu, JJ; Chen, F; Liu, JS; Wei, JJ; Lee, P				Ligr, Martin; Patwa, Ruzeen Rohintan; Daniels, Garrett; Pan, Lorraine; Wu, Xinyu; Li, Yirong; Tian, Liantian; Wang, Zhenxing; Xu, Ruliang; Wu, Jingjing; Chen, Fan; Liu, Jinsong; Wei, Jian-Jun; Lee, Peng			Expression and Function of Androgen Receptor Coactivator p44/Mep50/WDR77 in Ovarian Cancer	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; PROGESTERONE-RECEPTOR; CARCINOMA; ALPHA; CELLS; POLYMORPHISMS; ASSOCIATION; BIOMARKER; SURVIVAL; HORMONES	Hormones, including estrogen and progesterone, and their receptors play an important role in the development and progression of ovarian carcinoma. Androgen, its receptor and coactivators have also been implicated in these processes. p44/Mep50/WDR77 was identified as a subunit of the methylosome complex and lately characterized as a steroid receptor coactivator that enhances androgen receptor as well as estrogen receptor-mediated transcriptional activity in a ligand-dependent manner. We previously described distinct expression and function of p44 in prostate, testis, and breast cancers. In this report, we examined the expression and function of p44 in ovarian cancer. In contrast to findings in prostate and testicular cancer and similar to breast cancer, p44 shows strong cytoplasmic localization in morphologically normal ovarian surface and fallopian tube epithelia, while nuclear p44 is observed in invasive ovarian carcinoma. We observed that p44 can serve as a coactivator of both androgen receptor (AR) and estrogen receptor (ER) in ovarian cells. Further, overexpression of nuclear-localized p44 stimulates proliferation and invasion in ovarian cancer cells in the presence of estrogen or androgen. These findings strongly suggest that p44 plays a role in mediating the effects of hormones during ovarian tumorigenesis.	[Ligr, Martin; Patwa, Ruzeen Rohintan; Daniels, Garrett; Pan, Lorraine; Wu, Xinyu; Li, Yirong; Tian, Liantian; Xu, Ruliang; Chen, Fan; Lee, Peng] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Lee, Peng] NYU, Sch Med, Dept Urol, New York, NY 10003 USA; [Lee, Peng] NYU, Sch Med, NYU Canc Inst, New York, NY USA; [Lee, Peng] New York Harbor Healthcare Syst, New York, NY USA; [Wu, Jingjing; Wei, Jian-Jun] Northwestern Univ, Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Liu, Jinsong] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA; [Wang, Zhenxing] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	New York University; New York University; New York University; Northwestern University; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Ligr, M (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	jianjun-wei@northwestern.edu; peng.lee@nyumc.org	WEI, JJ/AAN-2638-2020	xu, ruliang/0000-0002-9165-4610	Northwestern Memorial Hospital; NATIONAL CANCER INSTITUTE [T32CA009161] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029893, UL1RR025741] Funding Source: NIH RePORTER	Northwestern Memorial Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was funded by Northwestern Memorial Hospital Dixon Translational Research Fund grant to JJW. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen MH, 2000, INT J CANCER, V86, P40, DOI 10.1002/(SICI)1097-0215(20000401)86:1<40::AID-IJC6>3.0.CO;2-E; Cardillo MR, 1998, J EXP CLIN CANC RES, V17, P231; Fogh J., 1975, HUMAN TUMOR CELLS IN, P115, DOI 10.1007/978-1-4757-1647-4_5; Friesen WJ, 2002, J BIOL CHEM, V277, P8243, DOI 10.1074/jbc.M109984200; Fujimura M, 2001, AM J SURG PATHOL, V25, P667, DOI 10.1097/00000478-200105000-00016; Geisler JP, 2008, EUR J GYNAECOL ONCOL, V29, P126; Grimmler M, 2005, EMBO REP, V6, P70, DOI 10.1038/sj.embor.7400301; Halperin R, 2001, EUR J GYNAECOL ONCOL, V22, P122; HAMILTON TC, 1983, CANCER RES, V43, P5379; Hosohata K, 2003, MOL CELL BIOL, V23, P7019, DOI 10.1128/MCB.23.19.7019-7029.2003; Howlader NNA, 2010, SEER CANC STAT REV 1; Hua WH, 1995, J STEROID BIOCHEM, V55, P279, DOI 10.1016/0960-0760(95)00187-5; Ilekis JV, 1997, GYNECOL ONCOL, V66, P250, DOI 10.1006/gyno.1997.4764; Kaku Tsunehisa, 2003, Medical Electron Microscopy, V36, P9, DOI 10.1007/s007950300002; Karst AM, 2010, J ONCOL, V2010, DOI 10.1155/2010/932371; Kobel M, 2008, PLOS MED, V5, P1749, DOI 10.1371/journal.pmed.0050232; Lau KM, 1999, P NATL ACAD SCI USA, V96, P5722, DOI 10.1073/pnas.96.10.5722; Lee P, 2005, GYNECOL ONCOL, V96, P671, DOI 10.1016/j.ygyno.2004.11.010; Levine DA, 2001, CANCER RES, V61, P908; Li AJ, 2005, CANCER EPIDEM BIOMAR, V14, P2919, DOI 10.1158/1055-9965.EPI-05-0540; Liang JJ, 2007, J UROLOGY, V177, P1918, DOI 10.1016/j.juro.2007.01.017; LIPSETT MB, 1979, CANCER-AM CANCER SOC, V43, P1967, DOI 10.1002/1097-0142(197905)43:5+<1967::AID-CNCR2820430704>3.0.CO;2-7; Liu JS, 2004, CANCER RES, V64, P1655, DOI 10.1158/0008-5472.CAN-03-3380; Lukanova A, 2005, CANCER EPIDEM BIOMAR, V14, P98; Mahajan A, 2010, MODERN PATHOL, V23, P673, DOI 10.1038/modpathol.2010.49; Menin C, 2001, CANCER LETT, V168, P31, DOI 10.1016/S0304-3835(01)00473-6; Modugno F, 2004, AM J EPIDEMIOL, V159, P319, DOI 10.1093/aje/kwh046; Munstedt K, 2000, CANCER, V89, P1783, DOI 10.1002/1097-0142(20001015)89:8<1783::AID-CNCR19>3.0.CO;2-D; O'Donnell AJM, 2005, ENDOCR-RELAT CANCER, V12, P851, DOI 10.1677/erc.1.01039; OZOLS RF, 1987, CURR PROB CANCER, V11, P57; PENG Y, 2009, J CELL MOL MED; Peng Y, 2008, P NATL ACAD SCI USA, V105, P5236, DOI 10.1073/pnas.0712262105; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; SLOTMAN BJ, 1989, GYNECOL ONCOL, V33, P76, DOI 10.1016/0090-8258(89)90607-0; TALERMAN A, 1992, CURR OPIN OBSTET GYN, V4, P608; Wang PH, 2004, EUR J GYNAECOL ONCOL, V25, P157	36	34	34	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26250	10.1371/journal.pone.0026250	http://dx.doi.org/10.1371/journal.pone.0026250			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022581	Green Submitted, Green Published, gold			2022-12-27	WOS:000295978600047
J	Kim, HJ; Song, DE; Lim, SY; Lee, SH; Kang, JL; Lee, SJ; Benveniste, EN; Choi, YH				Kim, Hee Ja; Song, Dong Eun; Lim, Seul Ye; Lee, Sung-Hee; Kang, Jihee Lee; Lee, Sun Jung; Benveniste, Etty N.; Choi, Youn-Hee			Loss of the Promyelocytic Leukemia Protein in Gastric Cancer: Implications for IP-10 Expression and Tumor-Infiltrating Lymphocytes	PLOS ONE			English	Article							PML-RAR-ALPHA; SUPPRESSOR PML; T-CELLS; KAPPA-B; STAT3 ACTIVATION; POOR-PROGNOSIS; INFLAMMATION; TRANSCRIPTION; GENE; MICROENVIRONMENT	Gastric cancer is one of the most common causes of cancer-related mortality worldwide. Expression of the tumor suppressor, promyelocytic leukemia (PML) protein, is reduced or abolished in gastric carcinomas, in association with an increased level of lymphatic invasion, development of higher pTNM staging, and unfavorable prognosis. Herein, we investigated the relationship between the extent of tumor-infiltrating lymphocytes and the status of PML protein expression in advanced gastric carcinoma. We observed higher numbers of infiltrating T-cells in gastric carcinoma tissues in which PML expression was reduced or abolished, compared to tissues positive for PML. The extent of T-cell migration toward culture supernatants obtained from interferon-gamma (IFN-gamma-stimulated gastric carcinoma cell lines was additionally affected by expression of PML in vitro. Interferon-gamma-inducible protein 10 (IP-10/CXCL10) expression was increased in gastric carcinoma tissues displaying reduced PML levels. Moreover, both Pml knockout and knockdown cells displayed enhanced IP-10 mRNA and protein expression in the presence of IFN-gamma. PML knockdown increased IFN-gamma-mediated Signal Transducer and Activator of Transcription-1 (STAT-1) binding to the IP-10 promoter, resulting in elevated transcription of the IP-10 gene. Conversely, PML IV protein expression suppressed IP-10 promoter activation. Based on these results, we propose that loss of PML protein expression in gastric cancer cells contributes to increased IP-10 transcription via enhancement of STAT-1 activity, which, in turn, promotes lymphocyte trafficking within tumor regions.	[Kim, Hee Ja; Lim, Seul Ye; Lee, Sung-Hee; Kang, Jihee Lee; Choi, Youn-Hee] Ewha Womans Univ, Sch Med, Dept Physiol, Seoul, South Korea; [Kim, Hee Ja; Lim, Seul Ye; Lee, Sung-Hee; Kang, Jihee Lee] Ewha Womans Univ, Sch Med, Tissue Injury Def Res Ctr, Seoul, South Korea; [Song, Dong Eun] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea; [Lee, Sun Jung] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Benveniste, Etty N.] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA	Ewha Womans University; Ewha Womans University; University of Ulsan; Asan Medical Center; Harvard University; Harvard Medical School; University of Alabama System; University of Alabama Birmingham	Kim, HJ (corresponding author), Ewha Womans Univ, Sch Med, Dept Physiol, Seoul, South Korea.	yc@ewha.ac.kr	LEE, Sunghee/HCH-4510-2022		National Research Foundation of Korea (NRF); Ministry of Education, Science, and Technology [2010-0015506]; Korea government (MEST) [2010-0029353, RO1 NS50665]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050665] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science, and Technology (2010-0015506) to Y-HC, by the National Research Foundation of Korea (NRF) funded by the Korea government (MEST) (2010-0029353) to JLK, and by RO1 NS50665 to ENB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Ben-Baruch A, 2006, CANCER METAST REV, V25, P357, DOI 10.1007/s10555-006-9003-5; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; BORROW J, 1990, SCIENCE, V249, P1577, DOI 10.1126/science.2218500; Cairo S, 2005, ONCOGENE, V24, P2195, DOI 10.1038/sj.onc.1208338; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Choi YH, 2006, P NATL ACAD SCI USA, V103, P18715, DOI 10.1073/pnas.0604800103; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Visser KE, 2006, CONTRIB MICROBIOL, V13, P118, DOI 10.1159/000092969; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; FRUMAN DA, 1995, MOL CELL BIOL, V15, P3857; Gao SP, 2007, J CLIN INVEST, V117, P3846, DOI 10.1172/JCI31871; GODDARD AD, 1991, SCIENCE, V254, P1371, DOI 10.1126/science.1720570; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; Gurrieri C, 2004, JNCI-J NATL CANCER I, V96, P269, DOI 10.1093/jnci/djh043; Harvey CE, 2003, J LEUKOCYTE BIOL, V74, P360, DOI 10.1189/jlb.0303093; Hsu MC, 2010, MODERN PATHOL, V23, P1393, DOI 10.1038/modpathol.2010.130; KAKIZUKA A, 1991, CELL, V66, P663, DOI 10.1016/0092-8674(91)90112-C; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Kawasaki A, 2003, BLOOD, V101, P3668, DOI 10.1182/blood-2002-08-2474; Khan MM, 2001, MOL CELL, V7, P1233, DOI 10.1016/S1097-2765(01)00257-X; Kyrlagkitsis I, 2004, HEPATO-GASTROENTEROL, V51, P320; LaMorte VJ, 1998, P NATL ACAD SCI USA, V95, P4991, DOI 10.1073/pnas.95.9.4991; Lee EY, 2009, AUTOIMMUN REV, V8, P379, DOI 10.1016/j.autrev.2008.12.002; Lee HE, 2007, CANCER LETT, V247, P103, DOI 10.1016/j.canlet.2006.03.034; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Maltby S, 2009, BBA-REV CANCER, V1796, P19, DOI 10.1016/j.bbcan.2009.02.001; Nakano O, 2001, CANCER RES, V61, P5132; Naugler WE, 2008, TRENDS MOL MED, V14, P109, DOI 10.1016/j.molmed.2007.12.007; Nazareth MR, 2007, J IMMUNOL, V178, P5552, DOI 10.4049/jimmunol.178.9.5552; Neville Lewis F., 1997, Cytokine and Growth Factor Reviews, V8, P207, DOI 10.1016/S1359-6101(97)00015-4; Nie CQ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000369; O'Hayre M, 2008, BIOCHEM J, V409, P635, DOI 10.1042/BJ20071493; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Olsnes AM, 2006, CANCER IMMUNOL IMMUN, V55, P830, DOI 10.1007/s00262-005-0080-z; PANDOLFI PP, 1991, ONCOGENE, V6, P1285; Porta C, 2007, ADV EXP MED BIOL, V604, P67, DOI 10.1007/978-0-387-69116-9_5; Silzle T, 2004, INT J CANCER, V108, P173, DOI 10.1002/ijc.11542; Stadler M, 1995, ONCOGENE, V11, P2565; Takanami I, 2000, CANCER, V88, P2686, DOI 10.1002/1097-0142(20000615)88:12<2686::AID-CNCR6>3.0.CO;2-6; Tamura G, 2006, WORLD J GASTROENTERO, V12, P192, DOI 10.3748/wjg.v12.i2.192; Vallian S, 1998, ONCOGENE, V16, P2843, DOI 10.1038/sj.onc.1201837; Vazquez-Cintron EJ, 2010, J IMMUNOL, V185, P7133, DOI 10.4049/jimmunol.1001157; Wakabayashi O, 2003, CANCER SCI, V94, P1003, DOI 10.1111/j.1349-7006.2003.tb01392.x; Wang ZG, 1998, SCIENCE, V279, P1547; Wu WS, 2003, J BIOL CHEM, V278, P12294, DOI 10.1074/jbc.M211849200; Wu WS, 2002, ONCOGENE, V21, P3925, DOI 10.1038/sj.onc.1205491; Wu WS, 2001, MOL CELL BIOL, V21, P2259, DOI 10.1128/MCB.21.7.2259-2268.2001; Zhang P, 2000, INT J CANCER, V85, P599, DOI 10.1002/(SICI)1097-0215(20000301)85:5<599::AID-IJC1>3.0.CO;2-#	55	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26264	10.1371/journal.pone.0026264	http://dx.doi.org/10.1371/journal.pone.0026264			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022583	Green Published, gold, Green Submitted			2022-12-27	WOS:000295976000094
J	Tai, AW; Salloum, S				Tai, Andrew W.; Salloum, Shadi			The Role of the Phosphatidylinositol 4-Kinase PI4KA in Hepatitis C Virus-Induced Host Membrane Rearrangement	PLOS ONE			English	Article							CELL-CULTURE; EFFICIENT REPLICATION; RNA; PROTEIN; EXPRESSION; SYSTEM; ALPHA; RECRUITMENT; SCREEN; GENOME	Background: Hepatitis C virus (HCV), like other positive-sense RNA viruses, replicates on an altered host membrane compartment that has been called the "membranous web." The mechanisms by which the membranous web are formed from cellular membranes are poorly understood. Several recent RNA interference screens have demonstrated a critical role for the host phosphatidylinositol 4-kinase PI4KA in HCV replication. We have sought to define the function of PI4KA in viral replication. Methodology/Principal Findings: Using a nonreplicative model of membranous web formation, we show that PI4KA silencing leads to aberrant web morphology. Furthermore, we find that PI4KA and its product, phosphatidylinositol 4-phosphate, are enriched on membranous webs and that PI4KA is found in association with NS5A in HCV-infected cells. While the related lipid kinase PI4KB also appears to support HCV replication, it does not interact with NS5A. Silencing of PI4KB does not overtly impair membranous web morphology or phosphatidylinositol 4-phosphate enrichment at webs, suggesting that it acts at a different point in viral replication. Finally, we demonstrate that the aberrant webs induced by PI4KA silencing require the activity of the viral NS3-4A serine protease but not integrity of the host secretory pathway. Conclusions/Significance: PI4KA is necessary for the local enrichment of PI 4-phosphate at the HCV membranous web and for the generation of morphologically normal webs. We also show that nonreplicative systems of web formation can be used to order molecular events that drive web assembly.	[Tai, Andrew W.; Salloum, Shadi] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Tai, Andrew W.] Ann Arbor Vet Adm Hlth Syst, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Tai, AW (corresponding author), Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA.	andrewwt@med.umich.edu	Tai, Andrew W./M-8380-2017	Tai, Andrew W./0000-0002-6877-450X	National Institute of Allergy and Infectious Diseases [AI083785]; Foundation of the American Gastroenterological Association; University of Michigan GI Peptide Center; Greenview Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI083785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034933] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Foundation of the American Gastroenterological Association; University of Michigan GI Peptide Center(University of Michigan System); Greenview Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Public Health Service grant AI083785 from the National Institute of Allergy and Infectious Diseases, the Foundation of the American Gastroenterological Association (http://www.gastro.org/aga-foundation), the University of Michigan GI Peptide Center (http://www.med.umich.edu/mgpc/), and the Greenview Foundation (http://www.hepcfund.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amako Y, 2009, J VIROL, V83, P9237, DOI 10.1128/JVI.00958-09; Backes P, 2010, J VIROL, V84, P5775, DOI 10.1128/JVI.02343-09; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; BERGER KL, 2011, J VIROLOGY; Berger KL, 2009, P NATL ACAD SCI USA, V106, P7577, DOI 10.1073/pnas.0902693106; Borawski J, 2009, J VIROL, V83, P10058, DOI 10.1128/JVI.02418-08; Chung RT, 2001, P NATL ACAD SCI USA, V98, P9847, DOI 10.1073/pnas.171319698; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; Egger D, 2002, J VIROL, V76, P5974, DOI 10.1128/JVI.76.12.5974-5984.2002; ELROYSTEIN O, 1990, P NATL ACAD SCI USA, V87, P6743, DOI 10.1073/pnas.87.17.6743; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; Godi A, 1999, NAT CELL BIOL, V1, P280, DOI 10.1038/12993; Gonzalez G, 2007, J VIROL METHODS, V145, P14, DOI 10.1016/j.jviromet.2007.04.013; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Goueslain L, 2010, J VIROL, V84, P773, DOI 10.1128/JVI.01190-09; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Ikeda M, 2005, BIOCHEM BIOPH RES CO, V329, P1350, DOI 10.1016/j.bbrc.2005.02.138; Kato T, 2003, GASTROENTEROLOGY, V125, P1808, DOI 10.1053/j.gastro.2003.09.023; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Lamarre D, 2003, NATURE, V426, P186, DOI 10.1038/nature02099; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Lindenbach Brett D., 2009, V510, P329, DOI 10.1007/978-1-59745-394-3_24; Matto M, 2011, J VIROL, V85, P946, DOI 10.1128/JVI.00753-10; Moradpour D, 2004, J VIROL, V78, P7400, DOI 10.1128/JVI.78.14.7400-7409.2004; MOSS B, 1990, NATURE, V348, P91, DOI 10.1038/348091a0; Ng CY, 2007, ANTIVIR RES, V76, P222, DOI 10.1016/j.antiviral.2007.06.007; PFEIFER U, 1980, VIRCHOWS ARCH B, V33, P233, DOI 10.1007/BF02899184; Phan T, 2009, J VIROL, V83, P8379, DOI 10.1128/JVI.00891-09; Reesink HW, 2006, GASTROENTEROLOGY, V131, P997, DOI 10.1053/j.gastro.2006.07.013; Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002; Schmidt-Mende J, 2001, J BIOL CHEM, V276, P44052, DOI 10.1074/jbc.M103358200; Shi ST, 2003, J VIROL, V77, P4160, DOI 10.1128/JVI.77.7.4160-4168.2003; Stone M, 2007, J VIROL, V81, P4551, DOI 10.1128/JVI.01366-06; Tai AW, 2011, ANAL BIOCHEM, V417, P97, DOI 10.1016/j.ab.2011.05.046; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Trotard M, 2009, FASEB J, V23, P3780, DOI 10.1096/fj.09-131920; Vaillancourt FH, 2009, VIROLOGY, V387, P5, DOI 10.1016/j.virol.2009.02.039; Wang YJ, 2003, CELL, V114, P299, DOI 10.1016/S0092-8674(03)00603-2; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	40	67	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26300	10.1371/journal.pone.0026300	http://dx.doi.org/10.1371/journal.pone.0026300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022594	Green Published, gold, Green Submitted			2022-12-27	WOS:000295976000096
J	Reguero, L; Puente, N; Elezgarai, I; Mendizabal-Zubiaga, J; Canduela, MJ; Buceta, I; Ramos, A; Suarez, J; de Fonseca, FR; Marsicano, G; Grandes, P				Reguero, Leire; Puente, Nagore; Elezgarai, Izaskun; Mendizabal-Zubiaga, Juan; Josune Canduela, Miren; Buceta, Ianire; Ramos, Almudena; Suarez, Juan; Rodriguez de Fonseca, Fernando; Marsicano, Giovanni; Grandes, Pedro			GABAergic and Cortical and Subcortical Glutamatergic Axon Terminals Contain CB1 Cannabinoid Receptors in the Ventromedial Nucleus of the Hypothalamus	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; ENDOCANNABINOID SYSTEM; FOOD-INTAKE; RAT-BRAIN; NEURONS; EXPRESSION; PROTEIN; APPETITE; BEHAVIOR; ENHANCER	Background: Type-1 cannabinoid receptors (CB1R) are enriched in the hypothalamus, particularly in the ventromedial hypothalamic nucleus (VMH) that participates in homeostatic and behavioral functions including food intake. Although CB1R activation modulates excitatory and inhibitory synaptic transmission in the brain, CB1R contribution to the molecular architecture of the excitatory and inhibitory synaptic terminals in the VMH is not known. Therefore, the aim of this study was to investigate the precise subcellular distribution of CB1R in the VMH to better understand the modulation exerted by the endocannabinoid system on the complex brain circuitries converging into this nucleus. Methodology/Principal Findings: Light and electron microscopy techniques were used to analyze CB1R distribution in the VMH of CB1R-WT, CB1R-KO and conditional mutant mice bearing a selective deletion of CB1R in cortical glutamatergic (Glu-CB1R-KO) or GABAergic neurons (GABA-CB1R-KO). At light microscopy, CB1R immunolabeling was observed in the VMH of CB1R-WT and Glu-CB1R-KO animals, being remarkably reduced in GABA-CB1R-KO mice. In the electron microscope, CB1R appeared in membranes of both glutamatergic and GABAergic terminals/preterminals. There was no significant difference in the percentage of CB1R immunopositive profiles and CB1R density in terminals making asymmetric or symmetric synapses in CB1R-WT mice. Furthermore, the proportion of CB1R immunopositive terminals/preterminals in CB1R-WT and Glu-CB1R-KO mice was reduced in GABA-CB1R-KO mutants. CB1R density was similar in all animal conditions. Finally, the percentage of CB1R labeled boutons making asymmetric synapses slightly decreased in Glu-CB1R-KO mutants relative to CB1R-WT mice, indicating that CB1R was distributed in cortical and subcortical excitatory synaptic terminals. Conclusions/Significance: Our anatomical results support the idea that the VMH is a relevant hub candidate in the endocannabinoid-mediated modulation of the excitatory and inhibitory neurotransmission of cortical and subcortical pathways regulating essential hypothalamic functions for the individual's survival such as the feeding behavior.	[Reguero, Leire; Puente, Nagore; Elezgarai, Izaskun; Mendizabal-Zubiaga, Juan; Josune Canduela, Miren; Buceta, Ianire; Ramos, Almudena; Grandes, Pedro] Univ Basque Country, Fac Med & Dent, Dept Neurosci, Leioa, Spain; [Suarez, Juan; Rodriguez de Fonseca, Fernando] Fdn IMABIS, Malaga, Spain; [Marsicano, Giovanni] Univ Bordeaux 2, INSERM, U862, NeuroCtr Magendie, F-33076 Bordeaux, France	University of Basque Country; FIMABIS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Reguero, L (corresponding author), Univ Basque Country, Fac Med & Dent, Dept Neurosci, Leioa, Spain.	pedro.grandes@ehu.es	Ramos-Uriarte, Almudena/H-3179-2015; Ramos, Almudena/AAS-1563-2020; Puente, Nagore/H-7054-2015; Grandes, Pedro/AAA-1627-2019; Grandes, Pedro/H-7494-2015; Suarez, Juan/I-5188-2015; Marsicano, Giovanni/I-9603-2016; Mendizabal, Juan Luis/H-6874-2015; Elezgarai, Izaskun/H-7076-2015; DE FONSECA, FERNANDO RODRIGUEZ/E-9767-2012; Reguero, Leire/H-6865-2015	Ramos-Uriarte, Almudena/0000-0002-2632-1625; Ramos, Almudena/0000-0002-2632-1625; Puente, Nagore/0000-0003-0866-5747; Grandes, Pedro/0000-0003-3947-4230; Suarez, Juan/0000-0001-5254-9802; Mendizabal, Juan Luis/0000-0002-4750-4797; Elezgarai, Izaskun/0000-0003-0880-8058; Alonso-Alconada, Daniel/0000-0002-9874-2947; Reguero, Leire/0000-0002-0267-5568; Marsicano, Giovanni/0000-0003-3804-1951	Basque Country Government [BFI 07.286, GIC07/70-IT-432-07]; Basque Country University; Ministerio de Ciencia e Innovacion [SAF2009-07065]; Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III, MICINN [RD07/0001/2001]; AVENIR/INSERM; Fondation Bettencourt-Schueller; ANR [ANR-06-NEURO-043-01]; European Foundation for the Study of Diabetes (EFSD); EU [HEALTH-F2-2008-223713]; European Commission Coordination Action ENINET [LSHM-CT-2005-19063]	Basque Country Government(Basque Government); Basque Country University; Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III, MICINN(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); AVENIR/INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation Bettencourt-Schueller; ANR(French National Research Agency (ANR)); European Foundation for the Study of Diabetes (EFSD); EU(European Commission); European Commission Coordination Action ENINET(European CommissionEuropean Commission Joint Research Centre)	L. Reguero is in receipt of a Predoctoral Fellowship from the Basque Country Government (BFI 07.286); I. Buceta is in receipt of a Predoctoral Fellowship from the Basque Country University. Dr. Pedro Grandes' laboratory is supported by The Basque Country Government grant GIC07/70-IT-432-07, by Ministerio de Ciencia e Innovacion (SAF2009-07065) and by Red de Trastornos Adictivos, RETICS, Instituto de Salud Carlos III, MICINN, grant RD07/0001/2001. Dr. Giovanni Marsicano's laboratory is supported by AVENIR/INSERM (with the Fondation Bettencourt-Schueller), by ANR (ANR-06-NEURO-043-01), by European Foundation for the Study of Diabetes (EFSD), by the EU-FP7 (REPROBESITY, contract number HEALTH-F2-2008-223713) and European Commission Coordination Action ENINET (contract number LSHM-CT-2005-19063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTHOLOMA A, 1994, MECH DEVELOP, V48, P217, DOI 10.1016/0925-4773(94)90061-2; Bellocchio L, 2010, NAT NEUROSCI, V13, P281, DOI 10.1038/nn.2494; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Breivogel CS, 1997, J PHARMACOL EXP THER, V282, P1632; Chee MJS, 2010, J NEUROSCI, V30, P3380, DOI 10.1523/JNEUROSCI.4031-09.2010; Colombo G, 1998, LIFE SCI, V63, pPL113, DOI 10.1016/S0024-3205(98)00322-1; Cota D, 2003, J CLIN INVEST, V112, P423, DOI 10.1172/JCI17725; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Fremeau RT, 2004, TRENDS NEUROSCI, V27, P98, DOI 10.1016/j.tins.2003.11.005; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Hrabovszky E, 2005, NEUROSCIENCE, V133, P657, DOI 10.1016/j.neuroscience.2005.03.042; Jamshidi N, 2001, BRIT J PHARMACOL, V134, P1151, DOI 10.1038/sj.bjp.0704379; Jelsing J, 2008, NEUROSCIENCE, V154, P641, DOI 10.1016/j.neuroscience.2008.03.051; Kano M, 2009, PHYSIOL REV, V89, P309, DOI 10.1152/physrev.00019.2008; Kawamura Y, 2006, J NEUROSCI, V26, P2991, DOI 10.1523/JNEUROSCI.4872-05.2006; Kim KW, 2008, MOL ENDOCRINOL, V22, P1950, DOI 10.1210/me.2008-0127; Kirkham TC, 2002, BRIT J PHARMACOL, V136, P550, DOI 10.1038/sj.bjp.0704767; Kiss J, 2011, NEUROSCIENCE, V176, P210, DOI 10.1016/j.neuroscience.2010.12.047; Kleppisch T, 2003, J NEUROSCI, V23, P6005, DOI 10.1523/JNEUROSCI.23-14-06005.2003; Kurrasch DM, 2007, J NEUROSCI, V27, P13624, DOI 10.1523/JNEUROSCI.2858-07.2007; Lafourcade M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000709; MAILLEUX P, 1992, NEUROSCIENCE, V48, P655, DOI 10.1016/0306-4522(92)90409-U; Marsicano G, 1999, EUR J NEUROSCI, V11, P4213, DOI 10.1046/j.1460-9568.1999.00847.x; Marsicano G, 2003, SCIENCE, V302, P84, DOI 10.1126/science.1088208; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Marsicano Giovanni, 2008, P161, DOI 10.1007/978-0-387-74349-3_10; Matias I, 2007, TRENDS ENDOCRIN MET, V18, P27, DOI 10.1016/j.tem.2006.11.006; McClellan KM, 2006, FRONT NEUROENDOCRIN, V27, P193, DOI 10.1016/j.yfrne.2006.02.002; Meister B, 2007, PHYSIOL BEHAV, V92, P263, DOI 10.1016/j.physbeh.2007.05.021; Monory K, 2006, NEURON, V51, P455, DOI 10.1016/j.neuron.2006.07.006; Monory Krisztina, 2007, PLoS Biol, V5, pe269, DOI 10.1371/journal.pbio.0050269; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Puente N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008869; Schwab MH, 2000, J NEUROSCI, V20, P3714, DOI 10.1523/JNEUROSCI.20-10-03714.2000; Sternson SM, 2005, NAT NEUROSCI, V8, P1356, DOI 10.1038/nn1550; Stuhmer T, 2002, CEREB CORTEX, V12, P75, DOI 10.1093/cercor/12.1.75; Wittmann G, 2007, J COMP NEUROL, V503, P270, DOI 10.1002/cne.21383; Wu SX, 2005, P NATL ACAD SCI USA, V102, P17172, DOI 10.1073/pnas.0508560102; Yee CL, 2009, J COMP NEUROL, V517, P37, DOI 10.1002/cne.22132; Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000	42	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26167	10.1371/journal.pone.0026167	http://dx.doi.org/10.1371/journal.pone.0026167			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834OZ	22022550	Green Published, gold, Green Submitted			2022-12-27	WOS:000295973200045
J	Sasaki, M; Honmou, O; Radtke, C; Kocsis, JD				Sasaki, Masanori; Honmou, Osamu; Radtke, Christine; Kocsis, Jeffery D.			Development of a Middle Cerebral Artery Occlusion Model in the Nonhuman Primate and a Safety Study of IV Infusion of Human Mesenchymal Stem Cells	PLOS ONE			English	Article							MARROW STROMAL CELLS; PROMOTE FUNCTIONAL RECOVERY; AUTOLOGOUS BONE-MARROW; SPINAL-CORD-INJURY; ISCHEMIC-STROKE; ADULT-RAT; THERAPEUTIC BENEFITS; FOLLOW-UP; TRANSPLANTATION; BRAIN	Background: Most experimental stroke research is carried out in rodents, but given differences between rodents and human, nonhuman primate (NHP) models may provide a valuable tool to study therapeutic interventions. The authors developed a surgical method for transient occlusion of the M1 branch of middle cerebral artery (MCA) in the African green monkey to evaluate safety aspects of intravenous infusion of mesenchymal stem cells (hMSCs) derived from human bone marrow. Methods: The left Sylvian fissure was exposed by a small fronto-temporal craniotomy. The M1 branch of the MCA was exposed by microsurgical dissection and clipped for 2 to 4 hours. Neurological examinations and magnetic resonance imaging (MRI) were carried out at regular post-operative course. hMSCs were infused 1 hour after reperfusion (clip release) in the 3-hour occlusion model. Results: During M1 occlusion, two patterns of changes were observed in the lateral hemisphere surface. One pattern (Pattern 1) was darkening of venous blood, small vessel collapse, and blood pooling with no venous return in cortical veins. Animals with these three features had severe and lasting hemiplegia and MRI demonstrated extensive MCA territory infarction. Animals in the second pattern (Pattern 2) displayed darkening of venous blood, small vessel collapse, and reduced but incompletely occluded venous flow and the functional deficit was much less severe and MRI indicated smaller infarction areas in brain. The severe group (Pattern 1) likely had less extensive collateral circulation than the less severe group (Pattern 2) where venous pooling of blood was not observed. The hMSC infused animals showed a trend for greater functional improvement that was not statistically significant in the acute phase and no additive negative effects. Conclusions: These results indicate inter-animal variability of collateral circulation after complete M1 occlusion and that hMSC infusion is safe in the developed NHP stroke model.	[Sasaki, Masanori; Honmou, Osamu; Radtke, Christine; Kocsis, Jeffery D.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Sasaki, Masanori; Honmou, Osamu; Radtke, Christine; Kocsis, Jeffery D.] Vet Affairs Connecticut Healthcare Syst, Ctr Neurosci & Regenerat Res, West Haven, CT USA; [Sasaki, Masanori] Sapporo Med Univ, Sch Med, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Honmou, Osamu] Sapporo Med Univ, Sch Med, Res Inst Frontier Med, Dept Neural Regenerat Med, Sapporo, Hokkaido, Japan; [Radtke, Christine] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, D-3000 Hannover, Germany	Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Sapporo Medical University; Sapporo Medical University; Hannover Medical School	Sasaki, M (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	Jeffery.Kocsis@yale.edu	Radtke, Christine/M-2927-2013; Sasaki, Masanori/B-3246-2008; Radtke, Christine/B-8491-2018	Sasaki, Masanori/0000-0001-7961-9698; honmou, Osamu/0000-0001-8697-7530; Radtke, Christine/0000-0001-6877-5038	Medical and Rehabilitation and Development Research Services of Department of Veterans Affairs (VA); VA Spinal Cord Injury Translational Collaborative Consortium for Regenerative Medicine; National Institutes of Health [NS43432]; National Multiple Sclerosis Society [RG2135, CA1009A10]; Paralyzed Veterans of America Research Foundation [2469]; Japanese Ministry of Education, Science, Sports and Culture [19591691, 20390388, 20591717]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS043432] Funding Source: NIH RePORTER	Medical and Rehabilitation and Development Research Services of Department of Veterans Affairs (VA)(US Department of Veterans Affairs); VA Spinal Cord Injury Translational Collaborative Consortium for Regenerative Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Paralyzed Veterans of America Research Foundation; Japanese Ministry of Education, Science, Sports and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part by the Medical and Rehabilitation and Development Research Services of Department of Veterans Affairs (VA); the VA Spinal Cord Injury Translational Collaborative Consortium for Regenerative Medicine; the National Institutes of Health [NS43432 to J.D.K.]; the National Multiple Sclerosis Society [RG2135, CA1009A10 to J.D.K.]; the Paralyzed Veterans of America Research Foundation [2469 to M. S.]; and the Japanese Ministry of Education, Science, Sports and Culture [19591691; 20390388; 20591717 to O.H.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Bang OY, 2005, ANN NEUROL, V57, P874, DOI 10.1002/ana.20501; Boltze J, 2008, J CEREBR BLOOD F MET, V28, P1951, DOI 10.1038/jcbfm.2008.89; Chen Jieli, 2006, NeuroRx, V3, P466, DOI 10.1016/j.nurx.2006.07.007; Chen XG, 2002, NEUROPATHOLOGY, V22, P275, DOI 10.1046/j.1440-1789.2002.00450.x; Chopp M, 2006, ADV EXP MED BIOL, V585, P49; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; de Crespigny Alex J, 2005, J Stroke Cerebrovasc Dis, V14, P80, DOI 10.1016/j.jstrokecerebrovasdis.2004.12.005; Feinklestein SP, 1999, STROKE, V30, P2752, DOI 10.1161/01.STR.30.12.2752; Fisher M, 2009, STROKE, V40, P2244, DOI 10.1161/STROKEAHA.108.541128; Fukuda S, 2003, ILAR J, V44, P96, DOI 10.1093/ilar.44.2.96; Furuichi Y, 2003, J CEREBR BLOOD F MET, V23, P1183, DOI 10.1097/01.WCB.0000088761.02615.EB; Honma T, 2006, EXP NEUROL, V199, P56, DOI 10.1016/j.expneurol.2005.05.004; Honmou O, 2011, BRAIN, V134, P1790, DOI 10.1093/brain/awr063; Horita Y, 2006, J NEUROSCI RES, V84, P1495, DOI 10.1002/jnr.21056; Iihoshi S, 2004, BRAIN RES, V1007, P1, DOI 10.1016/j.brainres.2003.09.084; Imai H, 2006, J NEUROSURG, V104, P123, DOI 10.3171/ped.2006.104.2.123; Isakova IA, 2007, STEM CELLS, V25, P3261, DOI 10.1634/stemcells.2007-0543; Isakova LA, 2006, MOL THER, V13, P1173, DOI 10.1016/j.ymthe.2005.12.014; JONES TH, 1981, J NEUROSURG, V54, P773, DOI 10.3171/jns.1981.54.6.0773; KALFAS IH, 1988, NEUROSURGERY, V23, P343, DOI 10.1227/00006123-198809000-00010; Kataoka Y, 2010, J COMP NEUROL, V518, P277, DOI 10.1002/cne.22206; Kobune M, 2003, EXP HEMATOL, V31, P715, DOI 10.1016/S0301-472X(03)00177-2; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lee JS, 2010, STEM CELLS, V28, P1099, DOI 10.1002/stem.430; Li Y, 2006, EXP NEUROL, V198, P313, DOI 10.1016/j.expneurol.2005.11.029; Li Y, 2002, NEUROLOGY, V59, P514, DOI 10.1212/WNL.59.4.514; Li Y, 2009, NEUROSCI LETT, V456, P120, DOI 10.1016/j.neulet.2008.03.096; Liu H, 2006, BRAIN, V129, P2734, DOI 10.1093/brain/awl207; Liu ZW, 2010, J CEREBR BLOOD F MET, V30, P1288, DOI 10.1038/jcbfm.2010.8; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Miki Y, 2007, NEUROSURGERY, V61, P586, DOI 10.1227/01.NEU.0000290907.30814.42; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Omori Y, 2008, BRAIN RES, V1236, P30, DOI 10.1016/j.brainres.2008.07.116; Onda T, 2008, J CEREBR BLOOD F MET, V28, P329, DOI 10.1038/sj.jcbfm.9600527; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Pavlichenko N, 2008, BRAIN RES, V1233, P203, DOI 10.1016/j.brainres.2008.06.123; Radtke C, 2003, FASEB J, V17, P335, DOI 10.1096/fj.03-0214fje; Rasmussen PA, 2009, J NEUROIMAGING, V19, p30S, DOI 10.1111/j.1552-6569.2009.00420.x; Rink C, 2008, P NATL ACAD SCI USA, V105, P14100, DOI 10.1073/pnas.0806678105; Roitberg B, 2003, NEUROL RES, V25, P68, DOI 10.1179/016164103101200950; Roitberg BZ, 2006, J NEUROSURG, V105, P96, DOI 10.3171/jns.2006.105.1.96; Sasaki M, 2009, J NEUROSCI, V29, P14932, DOI 10.1523/JNEUROSCI.2769-09.2009; Sasaki Masanori, 2009, V549, P187, DOI 10.1007/978-1-60327-931-4_13; Shen LH, 2006, NEUROSCIENCE, V137, P393, DOI 10.1016/j.neuroscience.2005.08.092; Shen LH, 2007, STROKE, V38, P2150, DOI 10.1161/STROKEAHA.106.481218; Shen LH, 2007, J CEREBR BLOOD F MET, V27, P6, DOI 10.1038/sj.jcbfm.9600311; Suarez-Monteagudo C, 2009, RESTOR NEUROL NEUROS, V27, P151, DOI 10.3233/RNN-2009-0483; Toyama K, 2009, EXP NEUROL, V216, P47, DOI 10.1016/j.expneurol.2008.11.010; Virley D, 2004, J CEREBR BLOOD F MET, V24, P24, DOI 10.1097/01.WCB.0000095801.98378.4A; West GA, 2009, J CEREBR BLOOD F MET, V29, P1175, DOI 10.1038/jcbfm.2009.43; Zacharek A, 2010, STROKE, V41, P524, DOI 10.1161/STROKEAHA.109.568881; Zhang J, 2009, J CEREBR BLOOD F MET, V29, P1166, DOI 10.1038/jcbfm.2009.41	54	44	45	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2011	6	10							e26577	10.1371/journal.pone.0026577	http://dx.doi.org/10.1371/journal.pone.0026577			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841MA	22039510	Green Published, Green Submitted, gold			2022-12-27	WOS:000296515200027
J	Negin, J; van Lettow, M; Semba, M; Martiniuk, A; Chan, A; Cumming, RG				Negin, Joel; van Lettow, Monique; Semba, Medson; Martiniuk, Alexandra; Chan, Adrienne; Cumming, Robert G.			Anti-Retroviral Treatment Outcomes among Older Adults in Zomba District, Malawi	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; SUB-SAHARAN AFRICA; FOLLOW-UP; PATIENTS LOST; THERAPY; MORTALITY; SURVIVAL; AIDS; AGE; DETERMINANTS	Background: There are approximately 3 million people aged 50 and older in sub-Saharan Africa who are HIV-positive. Despite this, little is known about the characteristics of older adults who are on treatment and their treatment outcomes. Methods: A retrospective cohort analysis was performed using routinely collected data with Malawi Ministry of Health monitoring tools from facilities providing antiretroviral therapy services in Zomba district. Patients aged 25 years and older initiated on treatment from July 2005 to June 2010 were included. Differences in survival, by age group, were determined using Kaplan-Meier survival plots and Cox proportional hazards regression models. Results: There were 10,888 patients aged 25 and older. Patients aged 50 and older (N = 1419) were more likely to be male (P < 0.0001) and located in rural areas (P = 0.003) than those aged 25-49. Crude survival estimates among those aged 50-59 were not statistically different from those aged 25-49 (P = 0.925). However, survival among those aged 60 and older (N = 345) was worse (P = 0.019) than among those 25-59. In the proportional hazards model, after controlling for sex and stage at initiation, survival in those aged 50-59 did not differ significantly from those aged 25-49 (hazard ratio 1.00 (95% CI: 0.79 to 1.27; P = 0.998) but the hazard ratio was 1.46 (95% CI: 1.03 to 2.06; P = 0.032) for those aged 60 and older compared to those aged 25-49. Conclusions: Treatment outcomes of those aged 50-59 are similar to those aged 25-49. A better understanding of how older adults present for and respond to treatment is critical to improving HIV services.	[Negin, Joel; Cumming, Robert G.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [van Lettow, Monique; Chan, Adrienne] Dignitas Int, Zomba, Malawi; [van Lettow, Monique; Martiniuk, Alexandra; Chan, Adrienne] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Semba, Medson] Minist Hlth, Zomba, Malawi; [Martiniuk, Alexandra] George Inst Global Hlth, Sydney, NSW, Australia; [Martiniuk, Alexandra] Univ Toronto, Sunnybrook Hlth Sci Res Inst, Toronto, ON, Canada; [Chan, Adrienne] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada	University of Sydney; University of Toronto; George Institute for Global Health; University of Sydney; University of Toronto; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Negin, J (corresponding author), Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia.	joel.negin@sydney.edu.au	Martiniuk, Alexandra/K-2600-2019; Cumming, Robert G/R-1548-2016	Martiniuk, Alexandra/0000-0003-1368-8206; Cumming, Robert G/0000-0002-0261-6103	Dignitas International Data Management Team	Dignitas International Data Management Team	We are grateful to the ART providers at Zomba Central Hospital and in Zomba District for their dedication to patient care. We are grateful to the Zomba Central Hospital, Zomba District Health Office Management and the MOH of Malawi for the collaboration and encouragement in trying to implement HIV-related activities. We would also like to thank the Dignitas International Data Management Team for their meticulous work with data collection and support.	[Anonymous], 2010, WORLD POP PROSP 2010; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Bakanda C, 2011, AIDS, V25, P701, DOI 10.1097/QAD.0b013e3283437ed7; Bonnet F, 2005, HIV MED, V6, P198, DOI 10.1111/j.1468-1293.2005.00290.x; Brinkhof MWG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005790; Brinkhof MWG, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000066; Castle SC, 2000, CLIN INFECT DIS, V31, P578, DOI 10.1086/313947; Chan AK, 2010, TROP MED INT HEALTH, V15, P90, DOI 10.1111/j.1365-3156.2010.02503.x; Chen SCC, 2008, TROP MED INT HEALTH, V13, P513, DOI 10.1111/j.1365-3156.2008.02029.x; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group, 2008, AIDS, V22, P1463, DOI 10.1097/QAD.0b013e3282f88d02; Darby SC, 1996, LANCET, V347, P1573, DOI 10.1016/S0140-6736(96)91073-9; Egger M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000390; Ettenhofer ML, 2009, AM J GERIAT PSYCHIAT, V17, P281, DOI 10.1097/JGP.0b013e31819431bd; Gebo KA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1460; Geng EH, 2010, TROP MED INT HEALTH, V15, P63, DOI 10.1111/j.1365-3156.2010.02507.x; Goetz MB, 2001, AIDS, V15, P1576, DOI 10.1097/00002030-200108170-00017; Grimes RM, 2002, CLIN INFECT DIS, V34, P1530, DOI 10.1086/340404; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2009, MON DECL COMM HIV AI; Justice Amy C, 2010, Curr HIV/AIDS Rep, V7, P69, DOI 10.1007/s11904-010-0041-9; Kasunda A, 2010, NATION SUNDAY   1106; Kimokoti RW, 2008, NUTR REV, V66, P611, DOI 10.1111/j.1753-4887.2008.00113.x; Kipp W, 2010, AIDS CARE, V22, P271, DOI 10.1080/09540120903193625; Knobel H, 2001, AIDS, V15, P1591, DOI 10.1097/00002030-200108170-00025; Lacerda HR, 2008, INT J STD AIDS, V19, P450, DOI 10.1258/ijsa.2008.007317; Manfredi R, 2000, AIDS, V14, P1475, DOI 10.1097/00002030-200007070-00034; Martin CP, 2008, AM J MED, V121, P1032, DOI 10.1016/j.amjmed.2008.08.009; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Mills EJ, 2010, LANCET, V377, P1131; Mutevedzi PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021795; Negin J, 2011, AIDS BEHAV      0708; Negin J, 2010, B WORLD HEALTH ORGAN, V88, P847, DOI 10.2471/BLT.10.076349; Nguyen N, 2008, CLIN INTERV AGING, V3, P453; Perez JL, 2003, CLIN INFECT DIS, V36, P212, DOI 10.1086/345669; Schmid GP, 2009, B WORLD HEALTH ORGAN, V87, P162, DOI 10.2471/BLT.09.064030; Smith RD, 2010, AIDS, V24, P2109, DOI 10.1097/QAD.0b013e32833c7b9c; Tweya H, 2010, TROP MED INT HEALTH, V15, P82, DOI 10.1111/j.1365-3156.2010.02509.x; UNAIDS, 2010, REP GLOB AIDS EP; United Nations, 2010, MILL DEV GOALS REP 2; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; Weigel R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-31; Wellons MF, 2002, J AM GERIATR SOC, V50, P603, DOI 10.1046/j.1532-5415.2002.50152.x; Weng NP, 2006, IMMUNITY, V24, P495, DOI 10.1016/j.immuni.2006.05.001; Yu JKL, 2007, B WORLD HEALTH ORGAN, V85, P550, DOI 10.2471/BLT.06.037739	43	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26546	10.1371/journal.pone.0026546	http://dx.doi.org/10.1371/journal.pone.0026546			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031839	gold, Green Published, Green Submitted			2022-12-27	WOS:000296513200028
J	Totino, PRR; Daniel-Ribeiro, CT; Ferreira-da-Cruz, MD				Rivas Totino, Paulo Renato; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima			Refractoriness of Eryptotic Red Blood Cells to Plasmodium falciparum Infection: A Putative Host Defense Mechanism Limiting Parasitaemia	PLOS ONE			English	Article							ERYTHROCYTE PHOSPHATIDYLSERINE; MALARIA; APOPTOSIS; PATHOGENESIS; EXPOSURE; SPECTRIN; DISEASE; ACTIN; DEATH	Recently, we have described that apoptosis-like process of red blood cells (RBC) - eryptosis - in malaria is not restricted to parasitized cells, occurring also in non-parasitized RBC (nRBC). Besides to pathogenic proprieties, apoptosis also participates in the innate defense trough restriction of intracellular pathogens propagation. In the present study, we investigated the capacity of P. falciparum parasites to infect eryptotic RBC. Schizont parasitized RBC concentrated by magnetic separation were cultured with eryptotic RBC obtained by ionomycin treatment and, then, parasite growth was evaluated in Giemsa-stained thin blood smears. While parasites infected and developed normally in control non-eryptotic RBC, cultures performed with eryptotic RBC had a marked decrease in parasitaemia. It was noteworthy a great number of free merozoites in eryptotic RBC cultures, indicating that these cells were not susceptible to invasion. We suggest that although eryptosis could be involved in malaria pathogenesis, it could also acting protectively by controlling parasite propagation.	[Rivas Totino, Paulo Renato; Daniel-Ribeiro, Claudio Tadeu; Ferreira-da-Cruz, Maria de Fatima] Fiocruz MS, Inst Oswaldo Cruz, Malaria Res Lab, BR-21045900 Rio De Janeiro, Brazil	Fundacao Oswaldo Cruz	Totino, PRR (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Malaria Res Lab, BR-21045900 Rio De Janeiro, Brazil.	mffcruz@ioc.fiocruz.br	Daniel-Ribeiro, Cláudio Tadeu/G-2216-2015; Totino, Paulo/GLV-4516-2022	Totino, Paulo/0000-0002-4790-3317	Instituto Oswaldo Cruz-Fiocruz; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj)	Instituto Oswaldo Cruz-Fiocruz; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by Instituto Oswaldo Cruz-Fiocruz and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (Faperj). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alesutan I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-118; Basu S, 2008, BRIT J HAEMATOL, V141, P92, DOI 10.1111/j.1365-2141.2008.06995.x; Bienvenu AL, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-106; Bobbala D, 2010, ACTA TROP, V116, P39, DOI 10.1016/j.actatropica.2010.05.005; Brown SB, 1997, BIOCHEM J, V323, P233, DOI 10.1042/bj3230233; Carmen JC, 2007, MOL MICROBIOL, V64, P904, DOI 10.1111/j.1365-2958.2007.05714.x; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Dockrell DH, 2001, J INFECTION, V42, P227, DOI 10.1053/jinf.2001.0836; Eda S, 2002, CELL PHYSIOL BIOCHEM, V12, P373, DOI 10.1159/000067908; Gonzalez V, 2009, CELL HOST MICROBE, V5, P259, DOI 10.1016/j.chom.2009.01.011; Henson PM, 2001, CURR BIOL, V11, pR795, DOI 10.1016/S0960-9822(01)00474-2; Kempe DS, 2007, J MOL MED-JMM, V85, P269, DOI 10.1007/s00109-006-0123-8; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Koka S, 2008, CELL PHYSIOL BIOCHEM, V22, P261, DOI 10.1159/000149804; Komba AN, 2009, CLIN INFECT DIS, V49, P216, DOI 10.1086/599834; Lang F, 2004, PFLUG ARCH EUR J PHY, V448, P319, DOI 10.1007/s00424-004-1254-9; Lang F, 2008, CELL PHYSIOL BIOCHEM, V22, P373, DOI 10.1159/000185448; Lang PA, 2009, CELL PHYSIOL BIOCHEM, V24, P415, DOI 10.1159/000257529; Ljungstr?m I., 2004, METHODS MALARIA RES; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Setty BNY, 2002, BLOOD, V99, P1564, DOI 10.1182/blood.V99.5.1564; SHEAR HL, 1991, BRIT J HAEMATOL, V78, P555, DOI 10.1111/j.1365-2141.1991.tb04488.x; Totino PRR, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-350; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Wang KKW, 1998, J BIOL CHEM, V273, P22490, DOI 10.1074/jbc.273.35.22490; Williams G T, 1994, Trends Microbiol, V2, P463, DOI 10.1016/0966-842X(94)90648-3; Wood BL, 1996, BLOOD, V88, P1873	27	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26575	10.1371/journal.pone.0026575	http://dx.doi.org/10.1371/journal.pone.0026575			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031840	Green Published, Green Submitted, gold			2022-12-27	WOS:000296513200031
J	Simbaqueba, J; Sanchez, P; Sanchez, E; Zarantes, VMN; Chacon, MI; Barrero, LS; Marino-Ramirez, L				Simbaqueba, Jaime; Sanchez, Pilar; Sanchez, Erika; Nunez Zarantes, Victor Manuel; Isabel Chacon, Maria; Stella Barrero, Luz; Marino-Ramirez, Leonardo			Development and Characterization of Microsatellite Markers for the Cape Gooseberry Physalis peruviana	PLOS ONE			English	Article							EST-SSRS; ANTIINFLAMMATORY ACTIVITY; IN-VITRO; EXTRACTS; PLANTS; WHEAT; DNA; L.	Physalis peruviana, commonly known as Cape gooseberry, is an Andean Solanaceae fruit with high nutritional value and interesting medicinal properties. In the present study we report the development and characterization of microsatellite loci from a P. peruviana commercial Colombian genotype. We identified 932 imperfect and 201 perfect Simple Sequence Repeats (SSR) loci in untranslated regions (UTRs) and 304 imperfect and 83 perfect SSR loci in coding regions from the assembled Physalis peruviana leaf transcriptome. The UTR SSR loci were used for the development of 162 primers for amplification. The efficiency of these primers was tested via PCR in a panel of seven P. peruviana accessions including Colombia, Kenya and Ecuador ecotypes and one closely related species Physalis floridana. We obtained an amplification rate of 83% and a polymorphic rate of 22%. Here we report the first P. peruviana specific microsatellite set, a valuable tool for a wide variety of applications, including functional diversity, conservation and improvement of the species.	[Simbaqueba, Jaime; Sanchez, Erika; Nunez Zarantes, Victor Manuel; Stella Barrero, Luz; Marino-Ramirez, Leonardo] Colombian Corp Agr Res CORPOICA, CBB, Plant Mol Genet Lab, Bogota, Colombia; [Sanchez, Pilar; Isabel Chacon, Maria] Univ Nacl Colombia, Fac Agron, Bogota, Colombia; [Stella Barrero, Luz; Marino-Ramirez, Leonardo] PanAmer Bioinformat Inst, Santa Marta, Magdalena, Colombia; [Marino-Ramirez, Leonardo] NIH, Computat Biol Branch, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD USA	Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Universidad Nacional de Colombia; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Simbaqueba, J (corresponding author), Colombian Corp Agr Res CORPOICA, CBB, Plant Mol Genet Lab, Bogota, Colombia.	marino@ncbi.nlm.nih.gov	Mariño-Ramírez, Leonardo/I-5759-2013; Mariño-Ramírez, Leonardo/N-5395-2019	Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Mariño-Ramírez, Leonardo/0000-0002-5716-8512; Sanchez-Betancourt, Erika/0000-0002-3024-3180; simbaqueba, jaime/0000-0003-4389-9418	Colombian Ministry of Agriculture [054/08072-2008L4787-3281, 054/08190-2008L7922-3322]; National Institutes of Health; National Library of Medicine; National Center for Biotechnology Information; NATIONAL LIBRARY OF MEDICINE [ZIALM082713] Funding Source: NIH RePORTER	Colombian Ministry of Agriculture; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); National Center for Biotechnology Information; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Support for this research was provided by a grant from the Colombian Ministry of Agriculture Contract Nos. 054/08072-2008L4787-3281 to LSB and 054/08190-2008L7922-3322 to VMNZ. This research was supported in part by the Intramural Research Program of the National Institutes of Health, National Library of Medicine, and National Center for Biotechnology Information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barchi L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-304; Bonilla M, 2009, AGENDA PROSPECTIVA I; Bozhko M, 2003, MOL ECOL, V12, P3147, DOI 10.1046/j.1365-294X.2003.01983.x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Csencsics D, 2010, J HERED, V101, P789, DOI 10.1093/jhered/esq069; Eujayl I, 2004, THEOR APPL GENET, V108, P414, DOI 10.1007/s00122-003-1450-6; Franco LA, 2007, BIOMEDICA, V27, P110, DOI 10.7705/biomedica.v27i1.237; Fujimori S, 2003, FEBS LETT, V554, P17, DOI 10.1016/S0014-5793(03)01041-X; Goldstein D, 1999, MICROSATELLITES EVOL; Gonzalez OT, 2008, REV BRAS FRUTIC, V30, P708, DOI 10.1590/S0100-29452008000300025; La Rota M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-23; Lagos-Burbano TC, 2003, FITOTEC COLOMB, V3, P1; LIGARRETO G., 2005, AVANCES CULTIVO POSC, P9; Lu FH, 2011, MOL BIOL REP; Luro FL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-287; Martinez W, 2010, IMMUNOPHARM IMMUNOT, V32, P63, DOI 10.1080/08923970903143957; MAYER C, 2008, PHOBOS TANDEM REPEAT; MENZEL M. Y., 1951, Proceedings of the American Philosophical Society, V95, P132; Morgante M, 2002, NAT GENET, V30, P194, DOI 10.1038/ng822; Munoz Florez J. E., 2008, Acta Agronomica, Universidad Nacional de Colombia, V57, P219; Pinto MD, 2009, J MED FOOD, V12, P278, DOI 10.1089/jmf.2008.0113; Popenoe H, 1990, LOST CROPS INCAS LIT, P241; Ramadan MF, 2003, J AGR FOOD CHEM, V51, P969, DOI 10.1021/jf020778z; Rodriguez C. N. C., 2006, Acta Biologica Colombiana, V11, P75; Rozen S, 2000, Methods Mol Biol, V132, P365; Scott KD, 2000, THEOR APPL GENET, V100, P723, DOI 10.1007/s001220051344; Toth G, 2000, GENOME RES, V10, P967, DOI 10.1101/gr.10.7.967; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; Wu SJ, 2009, FOOD CHEM TOXICOL; Yen CY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-46; Yu JK, 2004, MOL GENET GENOMICS, V271, P742, DOI 10.1007/s00438-004-1027-3; Zeng SH, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-94	33	20	29	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26719	10.1371/journal.pone.0026719	http://dx.doi.org/10.1371/journal.pone.0026719			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22039540	Green Submitted, gold, Green Published			2022-12-27	WOS:000296513200047
J	Allali, S; Muller, JB; Brauner, R; Lourenco, D; Boudjenah, R; Karageorgou, V; Trivin, C; Lottmann, H; Lortat-Jacob, S; Nihoul-Fekete, C; De Dreuzy, O; McElreavey, K; Bashamboo, A				Allali, Slimane; Muller, Jean-Baptiste; Brauner, Raja; Lourenco, Diana; Boudjenah, Radia; Karageorgou, Vasiliki; Trivin, Christine; Lottmann, Henri; Lortat-Jacob, Stephen; Nihoul-Fekete, Claire; De Dreuzy, Olivier; McElreavey, Ken; Bashamboo, Anu			Mutation Analysis of NR5A1 Encoding Steroidogenic Factor 1 in 77 Patients with 46, XY Disorders of Sex Development (DSD) Including Hypospadias	PLOS ONE			English	Article							INHIBIN B; ADRENAL INSUFFICIENCY; GONADAL DEVELOPMENT; HORMONE; GENE; BOYS; TRANSCRIPTION; REVERSAL; AD4BP; SF-1	Background: Mutations of the NR5A1 gene encoding steroidogenic factor-1 have been reported in association with a wide spectrum of 46, XY DSD (Disorder of Sex Development) phenotypes including severe forms of hypospadias. Methodology/Principal Findings: We evaluated the frequency of NR5A1 gene mutations in a large series of patients presenting with 46, XY DSD and hypospadias. Based on their clinical presentation 77 patients were classified either as complete or partial gonadal dysgenesis (uterus seen at genitography and/or surgery, n = 11), ambiguous external genitalia without uterus (n = 33) or hypospadias (n = 33). We identified heterozygous NR5A1 mutations in 4 cases of ambiguous external genitalia without uterus (12.1%; p. Trp279Arg, pArg39Pro, c.390delG, c140_141insCACG) and a de novo missense mutation in one case with distal hypospadias (3%; p.Arg313Cys). Mutant proteins showed reduced transactivation activity and mutants p.Arg39Pro and p.Arg313Cys did not synergize with the GATA4 cofactor to stimulate reporter gene activity, although they retained their ability to physically interact with the GATA4 protein. Conclusions/Significance: Mutations in NR5A1 were observed in 5/77 (6.5%) cases of 46, XY DSD including hypospadias. Excluding the cases of 46, XY gonadal dysgenesis the incidence of NR5A1 mutations was 5/66 (7.6%). An individual with isolated distal hypopadias carried a de novo heterozygous missense mutation, thus extending the range of phenotypes associated with NR5A1 mutations and suggesting that this group of patients should be screened for NR5A1 mutations.	[Allali, Slimane; Muller, Jean-Baptiste; Brauner, Raja] Univ Paris 05, Fac Med, Le Kremlin Bicetre, France; [Allali, Slimane; Muller, Jean-Baptiste; Brauner, Raja] Hop Bicetre, AP HP, Unite Endocrinol, Le Kremlin Bicetre, France; [Lourenco, Diana; Boudjenah, Radia; Karageorgou, Vasiliki; McElreavey, Ken; Bashamboo, Anu] Inst Pasteur, Paris, France; [Trivin, Christine] Hop Necker Enfants Malad, AP HP, Serv Explorat Fonct, Paris, France; [Lottmann, Henri; Lortat-Jacob, Stephen] Hop Necker Enfants Malad, AP HP, Serv Chirurg Viscerale Pediat, Paris, France; [Nihoul-Fekete, Claire] Univ Paris 05, Paris, France; [De Dreuzy, Olivier] Hop Bicetre, AP HP, Serv Chirurg Pediat, Le Kremlin Bicetre, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay	Allali, S (corresponding author), Univ Paris 05, Fac Med, Le Kremlin Bicetre, France.	kenmce@pasteur.fr; anu.bashamboo@pasteur.fr	Allali, Slimane/AGW-0037-2022	Allali, Slimane/0000-0001-7068-4530	Agence Nationale de la Recherche-GIS Institut des Maladies Rares; March of Dimes Foundation [1-FY07-490]; EuroDSD in the European Community [201444]; Portuguese Foundation for Science and Technology	Agence Nationale de la Recherche-GIS Institut des Maladies Rares(French National Research Agency (ANR)); March of Dimes Foundation(March of Dimes); EuroDSD in the European Community; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by research grants rewarded to KM from the Agence Nationale de la Recherche-GIS Institut des Maladies Rares and a grant (1-FY07-490) from the March of Dimes Foundation. Authors KM and AB received support from the EuroDSD in the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreement no 201444 (www.euroDSD.eu). Author DL was supported by a research grant from the Portuguese Foundation for Science and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Andersson AM, 1998, J CLIN ENDOCR METAB, V83, P675, DOI 10.1210/jc.83.2.675; Andersson AM, 1997, J CLIN ENDOCR METAB, V82, P3976, DOI 10.1210/jc.82.12.3976; Bashamboo A, 2010, AM J HUM GENET, V87, P505, DOI 10.1016/j.ajhg.2010.09.009; Baskin LS, 2006, J PEDIATR SURG, V41, P463, DOI 10.1016/j.jpedsurg.2005.11.059; Beleza-Meireles A, 2007, EUR J HUM GENET, V15, P405, DOI 10.1038/sj.ejhg.5201777; Chen YG, 2010, EUR J MED GENET, V53, P122, DOI 10.1016/j.ejmg.2010.03.005; Correa RV, 2004, J CLIN ENDOCR METAB, V89, P1767, DOI 10.1210/jc.2003-031240; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; FLATAU E, 1975, J PEDIATR-US, V87, P663, DOI 10.1016/S0022-3476(75)80877-8; Fukami M, 2006, NAT GENET, V38, P1369, DOI 10.1038/ng1900; Hanley NA, 1999, MECH DEVELOP, V87, P175, DOI 10.1016/S0925-4773(99)00123-9; Hoivik EA, 2010, MOL CELL ENDOCRINOL, V315, P27, DOI 10.1016/j.mce.2009.07.003; Hughes IA, 2006, ARCH DIS CHILD, V91, P554, DOI [10.1136/adc.2006.098319, 10.1016/j.jpurol.2006.03.004]; Ito M, 2000, J BIOL CHEM, V275, P31708, DOI 10.1074/jbc.M002892200; Kohler B, 2009, EUR J ENDOCRINOL, V161, P237, DOI 10.1530/EJE-09-0067; Lin L, 2008, SEX DEV, V2, P200, DOI 10.1159/000152036; Lin L, 2007, J CLIN ENDOCR METAB, V92, P991, DOI 10.1210/jc.2006-1672; Lourenco D, 2009, NEW ENGL J MED, V360, P1200, DOI 10.1056/NEJMoa0806228; LUO XR, 1994, CELL, V77, P481, DOI 10.1016/0092-8674(94)90211-9; Main KM, 2010, BEST PRACT RES CL EN, V24, P279, DOI 10.1016/j.beem.2009.10.003; MOROHASHI K, 1994, MOL ENDOCRINOL, V8, P643, DOI 10.1210/me.8.5.643; MOROHASHI K, 1992, J BIOL CHEM, V267, P17913; Mortlock DP, 1997, NAT GENET, V15, P179, DOI 10.1038/ng0297-179; Philibert P, 2007, HUM REPROD, V22, P3255, DOI 10.1093/humrep/dem278; Rey RA, 1999, J CLIN ENDOCR METAB, V84, P627, DOI 10.1210/jc.84.2.627; Schnack TH, 2008, AM J EPIDEMIOL, V167, P251, DOI 10.1093/aje/kwm317; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; Seminara SB, 1996, J CLIN ENDOCR METAB, V81, P3692, DOI 10.1210/jc.81.10.3692; Tremblay JJ, 2003, J BIOL CHEM, V278, P42637, DOI 10.1074/jbc.M305485200; Tremblay JJ, 2001, MOL ENDOCRINOL, V15, P1636, DOI 10.1210/me.15.9.1636; van der Zanden LFM, 2010, J CLIN ENDOCR METAB, V95, P2384, DOI 10.1210/jc.2009-2101; Wang MH, 2008, J ANDROL, V29, P499, DOI 10.2164/jandrol.108.004945	33	61	61	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e24117	10.1371/journal.pone.0024117	http://dx.doi.org/10.1371/journal.pone.0024117			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028768	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800003
J	Li, S; Xiong, RY; Wang, XF; Zhou, YJ				Li, Shuo; Xiong, Ruyi; Wang, Xifeng; Zhou, Yijun			Five Proteins of Laodelphax striatellus Are Potentially Involved in the Interactions between Rice Stripe Virus and Vector	PLOS ONE			English	Article							GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; KINASE-C; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; MOLECULAR-BIOLOGY; GENE-EXPRESSION; MYZUS-PERSICAE; INSECT VECTOR; MOSAIC-VIRUS; BINDING	Rice stripe virus (RSV) is the type member of the genus Tenuivirus, which relies on the small brown planthopper (Laodelphax striatellus Fallen) for its transmission in a persistent, circulative-propagative manner. To be transmitted, virus must cross the midgut and salivary glands epithelial barriers in a transcytosis mechanism where vector receptors interact with virions, and as propagative virus, RSV need utilize host components to complete viral propagation in vector cells. At present, these mechanisms remain unknown. In this paper, we screened L. striatellus proteins, separated by two-dimensional electrophoresis (2-DE), as potential RSV binding molecules using a virus overlay assay of protein blots. The results, five L. striatellus proteins that bound to purified RSV particles in vitro were resolved and identified using mass spectrometry. The virus-binding capacities of five proteins were further elucidated in yeast two-hybrid screen (YTHS) and virus-binding experiments of expressed proteins. Among five proteins, the receptor for activated protein kinase C (RACK) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH3) did not interact with RSV nucleocapsid protein (NCP) in YTHS and in far-Western blot, and three ribosomal proteins (RPL5, RPL7a and RPL8) had specific interactions with RSV. In dot immunobinding assay (DIBA), all five proteins were able to bind to RSV particles. The five proteins' potential contributions to the interactions between RSV and L. striatellus were discussed. We proposed that RACK and GAPDH3 might be involved in the epithelial transcytosis of virus particles, and three ribosomal proteins probably played potential crucial roles in the infection and propagation of RSV in vector cells.	[Li, Shuo; Zhou, Yijun] Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect,Minist Agr, Key Lab Monitoring & Management Crop Dis & Pest I, Nanjing, Peoples R China; [Li, Shuo; Xiong, Ruyi; Zhou, Yijun] Jiangsu Acad Agr Sci, Inst Plant Protect, Jiangsu Tech Serv Ctr Diag & Detect Plant Virus D, Nanjing, Peoples R China; [Wang, Xifeng] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China	Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University; Jiangsu Academy of Agricultural Sciences; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Li, S (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect,Minist Agr, Key Lab Monitoring & Management Crop Dis & Pest I, Nanjing, Peoples R China.	yjzhou@jaas.ac.cn	Wang, Xifeng/A-6476-2016	Wang, Xifeng/0000-0002-4982-8947	National Key Basic Research and Development Program (973 Program) of China [2010CB126203]; National Natural Science Foundation of China [30970132]; Special Fund for Agro-scientific Research in the Public Interest of China [201003031]; Natural Science Foundation of Jiangsu Province [BK2010018]	National Key Basic Research and Development Program (973 Program) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest of China; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This research was supported by the National Key Basic Research and Development Program (973 Program) of China (grant no. 2010CB126203), the National Natural Science Foundation of China (grant no. 30970132), the Special Fund for Agro-scientific Research in the Public Interest of China (grant no. 201003031) and the Natural Science Foundation of Jiangsu Province (grant no. BK2010018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albinsson B, 1999, VIRUS RES, V64, P125, DOI 10.1016/S0168-1702(99)00087-8; Bandla MD, 1998, PHYTOPATHOLOGY, V88, P98, DOI 10.1094/PHYTO.1998.88.2.98; Bee A, 2006, CLIN CANCER RES, V12, P2061, DOI 10.1158/1078-0432.CCR-05-2445; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bureau M, 2004, J GEN VIROL, V85, P3765, DOI 10.1099/vir.0.80242-0; Chen F W, 1999, Int Rev Immunol, V18, P429, DOI 10.3109/08830189909088492; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Choi DS, 2003, MOL PHARMACOL, V64, P1541, DOI 10.1124/mol.64.6.1541; Dardick C, 2007, MOL PLANT MICROBE IN, V20, P1004, DOI 10.1094/MPMI-20-8-1004; Delgado ML, 2001, MICROBIOL-SGM, V147, P411, DOI 10.1099/00221287-147-2-411; Falk BW, 1998, ANNU REV PHYTOPATHOL, V36, P139, DOI 10.1146/annurev.phyto.36.1.139; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; GOUDOTCROZEL V, 1989, J EXP MED, V170, P2065, DOI 10.1084/jem.170.6.2065; Gozalbo D, 1998, INFECT IMMUN, V66, P2052, DOI 10.1128/IAI.66.5.2052-2059.1998; Gray S, 2003, ANNU REV PHYTOPATHOL, V41, P539, DOI 10.1146/annurev.phyto.41.012203.105815; Gray SM, 1999, MICROBIOL MOL BIOL R, V63, P128, DOI 10.1128/MMBR.63.1.128-148.1999; Hibino H, 1996, ANNU REV PHYTOPATHOL, V34, P249, DOI 10.1146/annurev.phyto.34.1.249; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Jen CH, 2006, PLANT J, V46, P336, DOI 10.1111/j.1365-313X.2006.02681.x; Kikkert M, 1998, PHYTOPATHOLOGY, V88, P63, DOI 10.1094/PHYTO.1998.88.1.63; KOGANEZAWA H, 1975, Annals of the Phytopathological Society of Japan, V41, P148, DOI 10.3186/jjphytopath.41.148; Li CY, 2001, VIROLOGY, V286, P125, DOI 10.1006/viro.2001.0929; Liang DL, 2005, VIRUS GENES, V31, P211, DOI 10.1007/s11262-005-1798-6; Liedtke CM, 2002, J BIOL CHEM, V277, P22925, DOI 10.1074/jbc.M201917200; Liliental J, 1998, J BIOL CHEM, V273, P2379, DOI 10.1074/jbc.273.4.2379; Lindstrom MS, 2009, BIOCHEM BIOPH RES CO, V379, P167, DOI 10.1016/j.bbrc.2008.12.083; McCahill A, 2002, MOL PHARMACOL, V62, P1261, DOI 10.1124/mol.62.6.1261; Meskauskas A, 2001, RNA, V7, P1084, DOI 10.1017/S1355838201001480; Mir MA, 2008, EMBO J, V27, P3129, DOI 10.1038/emboj.2008.228; Morin S, 2000, VIROLOGY, V276, P404, DOI 10.1006/viro.2000.0549; Nguyen TTA, 2007, J INSECT PHYSIOL, V53, P601, DOI [10.1016/j.jinphys.2007.02.018, 10.1016/j.jinsphys.2007.02.018]; PEDERSEN KJ, 1991, ACTA ZOOL-STOCKHOLM, V72, P181, DOI 10.1111/j.1463-6395.1991.tb01196.x; RAMIREZ BC, 1994, J GEN VIROL, V75, P467, DOI 10.1099/0022-1317-75-3-467; Rocha CS, 2008, VIROLOGY, V380, P165, DOI 10.1016/j.virol.2008.08.005; Ron D, 1999, J BIOL CHEM, V274, P27039, DOI 10.1074/jbc.274.38.27039; RON D, 1995, P NATL ACAD SCI USA, V92, P492, DOI 10.1073/pnas.92.2.492; Seddas P, 2004, VIROLOGY, V325, P399, DOI 10.1016/j.virol.2004.05.014; Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Suzuki Yoshihiko, 1992, Annals of the Phytopathological Society of Japan, V58, P480, DOI 10.3186/jjphytopath.58.480; Tisdale EJ, 2002, J BIOL CHEM, V277, P3334, DOI 10.1074/jbc.M109744200; TORIYAMA S, 1983, CMI ABB DESCRIPTION, V269, P15; VANDENHEUVEL JFJM, 1994, J GEN VIROL, V75, P2559, DOI 10.1099/0022-1317-75-10-2559; VandenHeuvel JFJM, 1997, J VIROL, V71, P7258, DOI 10.1128/JVI.71.10.7258-7265.1997; VOLKER KW, 1995, COMP BIOCHEM PHYS B, V112, P503, DOI 10.1016/0305-0491(95)00096-8; Wang GuiZhen, 2004, Acta Phytopathologica Sinica, V34, P302; Wang W, 2002, INT J BIOCHEM CELL B, V34, P93, DOI 10.1016/S1357-2725(01)00094-2; Xie L. H., 1991, Journal of Fujian Agricultural College, V20, P144; Yang CL, 2007, MOL PLANT MICROBE IN, V20, P358, DOI 10.1094/MPMI-20-4-0358; Yang CL, 2009, VIROLOGY, V390, P163, DOI 10.1016/j.virol.2009.05.018; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhou GY, 1999, ANN APPL BIOL, V135, P573, DOI 10.1111/j.1744-7348.1999.tb00888.x	52	28	39	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26585	10.1371/journal.pone.0026585	http://dx.doi.org/10.1371/journal.pone.0026585			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028913	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800057
J	Barazzoni, R; Zanetti, M; Semolic, A; Cattin, MR; Pirulli, A; Cattin, L; Guarnieri, G				Barazzoni, Rocco; Zanetti, Michela; Semolic, Annamaria; Cattin, Maria Rosa; Pirulli, Alessia; Cattin, Luigi; Guarnieri, Gianfranco			High-Fat Diet with Acyl-Ghrelin Treatment Leads to Weight Gain with Low Inflammation, High Oxidative Capacity and Normal Triglycerides in Rat Muscle	PLOS ONE			English	Article							SKELETAL-MUSCLE; LIPID-PEROXIDATION; INSULIN-RESISTANCE; IN-VIVO; EXPRESSION; ACTIVATION; EXERCISE; STRESS; LIVER	Obesity is associated with muscle lipid accumulation. Experimental models suggest that inflammatory cytokines, low mitochondrial oxidative capacity and paradoxically high insulin signaling activation favor this alteration. The gastric orexigenic hormone acylated ghrelin (A-Ghr) has antiinflammatory effects in vitro and it lowers muscle triglycerides while modulating mitochondrial oxidative capacity in lean rodents. We tested the hypothesis that A-Ghr treatment in high-fat feeding results in a model of weight gain characterized by low muscle inflammation and triglycerides with high muscle mitochondrial oxidative capacity. A-Ghr at a non-orexigenic dose (HFG: twice-daily 200-mu g s.c.) or saline (HF) were administered for 4 days to rats fed a high-fat diet for one month. Compared to lean control (C) HF had higher body weight and plasma free fatty acids (FFA), and HFG partially prevented FFA elevation (P<0.05). HFG also had the lowest muscle inflammation (nuclear NFkB, tissue TNF-alpha) with mitochondrial enzyme activities higher than C (P<0.05 vs C, P = NS vs HF). Under these conditions HFG prevented the HF-associated muscle triglyceride accumulation (P<0.05). The above effects were independent of changes in redox state (total-oxidized glutathione, glutathione peroxidase activity) and were not associated with changes in phosphorylation of AKT and selected AKT targets. Ghrelin administration following high-fat feeding results in a novel model of weight gain with low inflammation, high mitochondrial enzyme activities and normalized triglycerides in skeletal muscle. These effects are independent of changes in tissue redox state and insulin signaling, and they suggest a potential positive metabolic impact of ghrelin in fat-induced obesity.	[Barazzoni, Rocco; Zanetti, Michela; Semolic, Annamaria; Cattin, Maria Rosa; Pirulli, Alessia; Cattin, Luigi; Guarnieri, Gianfranco] Univ Trieste, Dept Med Surg & Hlth Sci, Med Clin, Trieste, Italy	University of Trieste	Barazzoni, R (corresponding author), Univ Trieste, Dept Med Surg & Hlth Sci, Med Clin, Trieste, Italy.	barazzon@units.it		ZANETTI, MICHELA/0000-0002-2634-6363				Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004; Barazzoni R, 2007, OBESITY, V15, P2614, DOI 10.1038/oby.2007.313; Barazzoni R, 2010, KIDNEY INT, V77, P23, DOI 10.1038/ki.2009.411; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Choi KC, 2003, ENDOCRINOLOGY, V144, P754, DOI 10.1210/en.2002-220783; Dixit VD, 2004, J CLIN INVEST, V114, P57, DOI 10.1172/JCI200421134; Greathouse KL, 2005, EUR J NUTR, V44, P429, DOI 10.1007/s00394-005-0548-9; Kheradmand A, 2010, REGUL PEPTIDES, V162, P84, DOI 10.1016/j.regpep.2010.02.008; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Liu HY, 2009, AM J PHYSIOL-ENDOC M, V297, pE898, DOI 10.1152/ajpendo.00374.2009; Liu L, 2010, EXP NEUROL, V222, P25, DOI 10.1016/j.expneurol.2009.11.009; Morino K, 2006, DIABETES, V55, pS9, DOI 10.2337/db06-S002; Nakazato M, 2001, NATURE, V409, P194, DOI 10.1038/35051587; Thompson NM, 2004, ENDOCRINOLOGY, V145, P234, DOI 10.1210/en.2003-0899; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Valerio A, 2006, J CLIN INVEST, V116, P2791, DOI [10.1172/JCI28570, 10.1172/JCI28570.]; Wei Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE345, DOI 10.1152/ajpendo.00456.2007; Yokota T, 2009, AM J PHYSIOL-HEART C, V297, pH1069, DOI 10.1152/ajpheart.00267.2009	18	26	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26224	10.1371/journal.pone.0026224	http://dx.doi.org/10.1371/journal.pone.0026224			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039445	gold, Green Published, Green Submitted			2022-12-27	WOS:000296507500039
J	Ge, C; Beauchamp, G; Li, ZQ				Ge, Chen; Beauchamp, Guy; Li, Zhongqiu			Coordination and Synchronisation of Anti-Predation Vigilance in Two Crane Species	PLOS ONE			English	Article							GROUP-SIZE; COLLECTIVE DETECTION; SOCIAL INFORMATION; BEHAVIOR; FLOCKS; INDIVIDUALS; HABITAT; WINTER; COSTS; BIRDS	Much of the previous research on anti-predation vigilance in groups has assumed independent scanning for threats among group members. Alternative patterns that are based on monitoring the vigilance levels of companions can also be adaptive. Coordination of vigilance, in which foragers avoid scanning at the same time as others, should decrease the odds that no group member is alert. Synchronisation of vigilance implies that individuals are more likely to be vigilant when companions are already vigilant. While synchronisation will increase the odds that no one is vigilant, it may allow a better assessment of potential threats. We investigated temporal sequences of vigilance in family flocks consisting of two parents and at most two juveniles in two species of cranes in coastal China. We established whether the observed probability that at least one parent is alert was greater (coordination) or lower (synchronisation) than that predicted under the null hypothesis of independent vigilance. We documented coordination of vigilance in common cranes (Grus grus) foraging in an area with high potential for disturbance by people. We documented synchronisation of vigilance in red-crowned cranes (Grus japonensis) in the less but not in the more disturbed area. Coordination in small flocks leads to high collective vigilance but low foraging rates that may not be suitable in areas with low disturbance. We also argue that synchronisation should break down in areas with high disturbance because periods with low vigilance are riskier. Results highlight the view that temporal patterns of vigilance can take many forms depending on ecological factors.	[Ge, Chen; Li, Zhongqiu] Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Beauchamp, Guy] Univ Montreal, Fac Med Vet, St Hyacinthe, PQ J2S 7C6, Canada	Nanjing University; Universite de Montreal	Ge, C (corresponding author), Nanjing Univ, Sch Life Sci, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China.	lizq0314@gmail.com	Li, Zhong-qiu/A-1748-2011	Li, Zhong-qiu/0000-0003-2004-293X	Key Projects in the National Science and Technology Pillar Program during the Eleventh Five-Year Plan Period [2008BAC39B03]; Nanjing University	Key Projects in the National Science and Technology Pillar Program during the Eleventh Five-Year Plan Period; Nanjing University(Nanjing University)	We thank the Key Projects in the National Science and Technology Pillar Program during the Eleventh Five-Year Plan Period (2008BAC39B03) and Nanjing University Funds for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALONSO JA, 1993, AUK, V110, P78; ARTISS T, 1995, ANIM BEHAV, V49, P1249, DOI 10.1006/anbe.1995.0157; Aviles JM, 2007, J AVIAN BIOL, V38, P690, DOI 10.1111/j.2007.0908-8857.04002.x; Beauchamp G, 2009, BIOL LETTERS, V5, P9, DOI 10.1098/rsbl.2008.0490; Bednekoff PA, 1998, TRENDS ECOL EVOL, V13, P284, DOI 10.1016/S0169-5347(98)01327-5; BERTRAM BCR, 1980, ANIM BEHAV, V28, P278, DOI 10.1016/S0003-3472(80)80030-3; Caro T., 2005, ANTIPREDATOR DEFENCE; Clutton-Brock TH, 1999, SCIENCE, V284, P1640, DOI 10.1126/science.284.5420.1640; Conover MR, 2000, AM NAT, V156, P193, DOI 10.1086/303377; Ebensperger LA, 2006, ETHOLOGY, V112, P879, DOI 10.1111/j.1439-0310.2006.01242.x; ELGAR MA, 1989, BIOL REV, V64, P13, DOI 10.1111/j.1469-185X.1989.tb00636.x; Fernandez-Juricic E, 2004, BEHAV ECOL, V15, P898, DOI 10.1093/beheco/arh092; Giraldeau LA, 1999, TRENDS ECOL EVOL, V14, P102, DOI 10.1016/S0169-5347(98)01542-0; Giraldeau LA, 2002, PHILOS T R SOC B, V357, P1559, DOI 10.1098/rstb.2002.1065; Jackson AL, 2006, BEHAV ECOL, V17, P532, DOI 10.1093/beheco/arj060; Jonsson JE, 2008, WILSON J ORNITHOL, V120, P725, DOI 10.1676/07-124.1; King AJ, 2007, BIOL LETTERS, V3, P137, DOI 10.1098/rsbl.2007.0017; Ma ZJ, 1999, IBIS, V141, P135, DOI 10.1111/j.1474-919X.1999.tb04272.x; MA ZJ, 2000, CONSERVATION RED CRO; MCGOWAN KJ, 1989, ANIM BEHAV, V37, P1000, DOI 10.1016/0003-3472(89)90144-9; MCNAMARA JM, 1992, ANIM BEHAV, V43, P641, DOI 10.1016/0003-3472(92)90086-O; Michelena P, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016014, 10.1371/journal.pone.0018631]; Ost M, 2011, BEHAV ECOL, V22, P378, DOI 10.1093/beheco/arq223; Pays O, 2007, P ROY SOC B-BIOL SCI, V274, P1287, DOI 10.1098/rspb.2006.0204; Pays O, 2007, ANIM BEHAV, V73, P595, DOI 10.1016/j.anbehav.2006.06.007; Pays O, 2009, BEHAV ECOL, V20, P469, DOI 10.1093/beheco/arp019; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; PULLIAM HR, 1982, J THEOR BIOL, V95, P89, DOI 10.1016/0022-5193(82)90289-2; Radford AN, 2007, BIOLOGY LETT, V3, P249, DOI 10.1098/rsbl.2007.0110; Radford AN, 2009, P ROY SOC B-BIOL SCI, V276, P2437, DOI 10.1098/rspb.2009.0187; Rands SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011705; Rands SA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-51; RASA OAE, 1986, ETHOLOGY, V71, P340, DOI 10.1111/j.1439-0310.1986.tb00598.x; Rodriguez-Girones MA, 2002, P ROY SOC B-BIOL SCI, V269, P1803, DOI 10.1098/rspb.2002.2043; Ruxton GD, 1999, ANIM BEHAV, V57, P493, DOI 10.1006/anbe.1998.0965; SAINO N, 1995, IBIS, V137, P227, DOI 10.1111/j.1474-919X.1995.tb03243.x; Sirot E, 2006, ANIM BEHAV, V72, P373, DOI 10.1016/j.anbehav.2005.10.028; Sirot E, 2009, AM NAT, V173, P47, DOI 10.1086/593358; Stillman RA, 2002, J ANIM ECOL, V71, P874, DOI 10.1046/j.1365-2656.2002.00652.x; TACHA TC, 1988, WILDL MONOGR; Wang Z, 2011, BIOL CONSERV, V144, P101, DOI 10.1016/j.biocon.2010.06.025; WARD PI, 1985, J THEOR BIOL, V114, P383, DOI 10.1016/S0022-5193(85)80173-9	42	26	32	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26447	10.1371/journal.pone.0026447	http://dx.doi.org/10.1371/journal.pone.0026447			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028880	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500070
J	Schnell, C; Fresemann, J; Hulsmann, S				Schnell, Christian; Fresemann, Jens; Huelsmann, Swen			Determinants of Functional Coupling between Astrocytes and Respiratory Neurons in the Pre-Botzinger Complex	PLOS ONE			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; CENTRAL-NERVOUS-SYSTEM; IN-VITRO; HIPPOCAMPAL SYNAPSES; FLUORESCENT PROTEINS; MEDULLARY SLICES; NETWORK ACTIVITY; TRANSGENIC MICE; CALCIUM; RHYTHM	Respiratory neuronal network activity is thought to require efficient functioning of astrocytes. Here, we analyzed neuronastrocyte communication in the pre-Botzinger Complex (preBotC) of rhythmic slice preparations from neonatal mice. In astrocytes that exhibited rhythmic potassium fluxes and glutamate transporter currents, we did not find a translation of respiratory neuronal activity into phase-locked astroglial calcium signals. In up to 20% of astrocytes, 2-photon calcium imaging revealed spontaneous calcium fluctuations, although with no correlation to neuronal activity. Calcium signals could be elicited in preBotC astrocytes by metabotropic glutamate receptor activation or after inhibition of glial glutamate uptake. In the latter case, astrocyte calcium elevation preceded a surge of respiratory neuron discharge activity followed by network failure. We conclude that astrocytes do not exhibit respiratory-rhythmic calcium fluctuations when they are able to prevent synaptic glutamate accumulation. Calcium signaling is, however, observed when glutamate transport processes in astrocytes are suppressed or neuronal discharge activity is excessive.	[Schnell, Christian; Fresemann, Jens; Huelsmann, Swen] Univ Gottingen, Zentrum Physiol & Pathophysiol, Abt Neuro & Sinnesphysiol, Gottingen, Germany; [Schnell, Christian; Fresemann, Jens; Huelsmann, Swen] DFG Ctr Mol Physiol Brain CMPB, Gottingen, Germany	University of Gottingen	Schnell, C (corresponding author), Univ Gottingen, Zentrum Physiol & Pathophysiol, Abt Neuro & Sinnesphysiol, Gottingen, Germany.	shuelsm2@uni-goettingen.de	Schnell, Christian/E-3140-2014; Hülsmann, Swen/F-7169-2010	Schnell, Christian/0000-0002-3499-9217; Hülsmann, Swen/0000-0001-5042-8724	Deutsche Forschungsgemeinschaft [CMPB, SPP1172]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by The Deutsche Forschungsgemeinschaft (grants to S.H.; CMPB and SPP1172). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Araque A, 2000, J NEUROSCI, V20, P666, DOI 10.1523/JNEUROSCI.20-02-00666.2000; BROCKHAUS J, 1993, J PHYSIOL-LONDON, V462, P421, DOI 10.1113/jphysiol.1993.sp019562; Drobizhev M, 2009, J PHYS CHEM B, V113, P855, DOI 10.1021/jp8087379; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; Feldman JL, 2006, NAT REV NEUROSCI, V7, P232, DOI 10.1038/nrn1871; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; FUNK GD, 1995, J NEUROSCI, V15, P4046; Gomeza J, 2003, NEURON, V40, P785, DOI 10.1016/S0896-6273(03)00672-X; Gourine AV, 2010, SCIENCE, V329, P571, DOI 10.1126/science.1190721; Grass D, 2004, J NEUROSCI, V24, P1358, DOI 10.1523/JNEUROSCI.4022-03.2004; GREER JJ, 1991, J PHYSIOL-LONDON, V437, P727, DOI 10.1113/jphysiol.1991.sp018622; Haak LL, 1997, J NEUROSCI, V17, P1825; Hartel K, 2007, CELL CALCIUM, V42, P271, DOI 10.1016/j.ceca.2006.12.004; Hartel K, 2009, GLIA, V57, P815, DOI 10.1002/glia.20808; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Hulsmann S, 2000, EUR J NEUROSCI, V12, P856, DOI 10.1046/j.1460-9568.2000.00973.x; Hulsmann S, 2000, EUR J NEUROSCI, V12, P239, DOI 10.1046/j.1460-9568.2000.00902.x; Huxtable AG, 2010, J NEUROSCI, V30, P3947, DOI 10.1523/JNEUROSCI.6027-09.2010; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Koshiya N, 1999, NATURE, V400, P360, DOI 10.1038/22540; Kullmann DM, 1998, TRENDS NEUROSCI, V21, P8, DOI 10.1016/S0166-2236(97)01150-8; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Nolte C, 2001, GLIA, V33, P72; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Richter DW, 2001, TRENDS NEUROSCI, V24, P464, DOI 10.1016/S0166-2236(00)01867-1; RICHTER DW, 1982, J EXP BIOL, V100, P93; Richter DW, 1999, J PHYSIOL-LONDON, V514, P567, DOI 10.1111/j.1469-7793.1999.567ae.x; RICHTER DW, 1978, PFLUG ARCH EUR J PHY, V376, P139, DOI 10.1007/BF00581577; Rusakov DA, 1999, TRENDS NEUROSCI, V22, P382, DOI 10.1016/S0166-2236(99)01425-3; Scemes E, 2006, GLIA, V54, P716, DOI 10.1002/glia.20374; Shimamoto K, 2004, MOL PHARMACOL, V65, P1008, DOI 10.1124/mol.65.4.1008; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; Somjen GG, 2008, J COMPUT NEUROSCI, V25, P349, DOI 10.1007/s10827-008-0083-9; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Winter SM, 2009, PFLUG ARCH EUR J PHY, V458, P459, DOI 10.1007/s00424-009-0647-1; Zur Nieden R, 2006, CEREB CORTEX, V16, P676, DOI 10.1093/cercor/bhj013	38	28	28	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26309	10.1371/journal.pone.0026309	http://dx.doi.org/10.1371/journal.pone.0026309			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039458	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000296507500048
J	Yoon, JS; Lee, HJ; Choi, SH; Chang, EJ; Lee, SY; Lee, EJ				Yoon, Jin Sook; Lee, Hyun Jung; Choi, Soo Hyun; Chang, Eun-Ju; Lee, Sang Yeul; Lee, Eun Jig			Quercetin Inhibits IL-1 beta-Induced Inflammation, Hyaluronan Production and Adipogenesis in Orbital Fibroblasts from Graves' Orbitopathy	PLOS ONE			English	Article							THYROID-ASSOCIATED OPHTHALMOPATHY; 3T3-L1 ADIPOCYTES; EYE DISEASE; EXPRESSION; DIFFERENTIATION; PATHOGENESIS; RESVERATROL; MECHANISMS; CELLS; PROLIFERATION	Management of Graves' orbitopathy (GO) is challenging, as no reliable, specific, and safe medical therapeutic agents have yet been developed. We investigated the effect of quercetin in primary cultured orbital fibroblasts from GO, targeting pathways of inflammation, aberrant accumulation of extracellular matrix macromolecules, and adipose tissue expansion. Quercetin significantly attenuated intercellular adhesion molecule-1 (ICAM-1), interleukin (IL) -6, IL-8, and cyclooxygenase (COX) -2 mRNA expression, and inhibited IL-1 beta-induced increases in ICAM-1, IL-6, and IL-8 mRNA. Increased hyaluronan production induced by IL-1 beta or tumor necrosis factor-alpha was suppressed by quercetin in a dose-and time-dependent manner. Treatment with noncytotoxic doses of quercetin inhibited accumulation of intracytoplasmic lipid droplets and resulted in a dose-dependent decrease in expression of peroxisome proliferator-activated receptor gamma, CCAAT/enhancer-binding protein (C/EBP) alpha, and C/EBP beta proteins. In conclusion, inhibition of inflammation, hyaluronan production, and adipogenesis by the natural plant product quercetin in vitro provides the basis for further study of its potential use in the treatment of GO.	[Yoon, Jin Sook; Choi, Soo Hyun; Lee, Sang Yeul] Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea; [Chang, Eun-Ju] Univ Ulsan, Coll Med, Dept Anat & Cell Biol, Cellular Dysfunct Res Ctr, Seoul, South Korea; [Lee, Hyun Jung; Lee, Eun Jig] Inst Endocrine Res, Brain Korea Project Med Sci 21, Seoul, South Korea; [Lee, Hyun Jung; Lee, Eun Jig] Severance Integrat Res Inst Cerebral & Cardiovasc, Seoul, South Korea	Yonsei University; Yonsei University Health System; University of Ulsan	Yoon, JS (corresponding author), Yonsei Univ, Coll Med, Dept Ophthalmol, Inst Vis Res, Seoul, South Korea.	sylee@yuhs.ac; EJLEE423@yuhs.ac		Lee, Eun Jig/0000-0002-9876-8370; Yoon, Jin Sook/0000-0002-8751-9467	National Research Foundation of Korea [2009-0067080]; Ministry for Health, Welfare Family Affairs [A085136]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry for Health, Welfare Family Affairs	This work was supported by the National Research Foundation of Korea Grant (grant numbers: 2009-0067080 [to JSY]) (URL: http://www.nrf.re.kr/html/en/) and by the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs (grant numbers : A085136 [to EJL]) (URL: http://eng.khidi.or.kr/index.jsp). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2008, BIOCHEM BIOPH RES CO, V373, P545, DOI 10.1016/j.bbrc.2008.06.077; BAHN RS, 1993, NEW ENGL J MED, V329, P1468; Bartalena L, 2000, ENDOCR REV, V21, P168, DOI 10.1210/er.21.2.168; Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8; Burnstine MA, 1998, BRIT J OPHTHALMOL, V82, P318, DOI 10.1136/bjo.82.3.318; Cao HJ, 1998, J BIOL CHEM, V273, P29615, DOI 10.1074/jbc.273.45.29615; Cawood TJ, 2007, J CLIN ENDOCR METAB, V92, P59, DOI 10.1210/jc.2006-1824; Cawood TJ, 2006, EUR J ENDOCRINOL, V155, P395, DOI 10.1530/eje.1.02242; Chen BL, 2005, J IMMUNOL, V175, P1310, DOI 10.4049/jimmunol.175.2.1310; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; Crisp M, 2000, INVEST OPHTH VIS SCI, V41, P3249; Feldon SE, 2006, AM J PATHOL, V169, P1183, DOI 10.2353/ajpath.2006.060434; Garrity JA, 2006, AM J OPHTHALMOL, V142, P147, DOI 10.1016/j.ajo.2006.02.047; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; HEUFELDER AE, 1992, EUR J CLIN INVEST, V22, P529, DOI 10.1111/j.1365-2362.1992.tb01501.x; Hiromatsu Y, 2000, J CLIN ENDOCR METAB, V85, P1194, DOI 10.1210/jc.85.3.1194; Hwang CJ, 2009, INVEST OPHTH VIS SCI, V50, P2262, DOI 10.1167/iovs.08-2328; Kaback LA, 1999, J CLIN ENDOCR METAB, V84, P4079, DOI 10.1210/jc.84.11.4079; Kawada N, 1998, HEPATOLOGY, V27, P1265, DOI 10.1002/hep.510270512; KUPPUSAMY UR, 1994, BIOCHEM PHARMACOL, V47, P521, DOI 10.1016/0006-2952(94)90184-8; Kuriyan AE, 2008, CURR OPIN OPHTHALMOL, V19, P499, DOI 10.1097/ICU.0b013e3283131557; Lehmann GM, 2008, THYROID, V18, P959, DOI 10.1089/thy.2007.0407; Lisi S, 2011, J ENDOCRINOL INVEST, V34, P521, DOI 10.3275/7321; Mertens-Talcott SU, 2003, J NUTR, V133, P2669, DOI 10.1093/jn/133.8.2669; Ong CS, 2004, ONCOL REP, V11, P727; Park HJ, 2008, J MED FOOD, V11, P773, DOI 10.1089/jmf.2008.0077; Pritchard J, 2002, J IMMUNOL, V168, P942, DOI 10.4049/jimmunol.168.2.942; Rayalam S, 2008, PHYTOTHER RES, V22, P1367, DOI 10.1002/ptr.2503; SMITH TJ, 1995, AM J PHYSIOL-CELL PH, V268, pC382, DOI 10.1152/ajpcell.1995.268.2.C382; Sorisky A, 1996, J CLIN ENDOCR METAB, V81, P3428, DOI 10.1210/jc.81.9.3428; Visentin V, 2003, EUR J PHARMACOL, V466, P235, DOI 10.1016/S0014-2999(03)01562-0; Wakelkamp IMMJ, 2003, CLIN ENDOCRINOL, V58, P280, DOI 10.1046/j.1365-2265.2003.01708.x; Ying BW, 2009, MOL BIOL REP, V36, P1825, DOI 10.1007/s11033-008-9386-1; Zhao LQ, 2010, INVEST OPHTH VIS SCI, V51, P4652, DOI 10.1167/iovs.09-3789; Zieleniak A, 2008, ARCH IMMUNOL THER EX, V56, P331, DOI 10.1007/s00005-008-0037-y	35	53	56	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26261	10.1371/journal.pone.0026261	http://dx.doi.org/10.1371/journal.pone.0026261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039452	Green Published, Green Submitted, gold			2022-12-27	WOS:000296507500045
J	Egger, B; Klaefiger, Y; Theis, A; Salzburger, W				Egger, Bernd; Klaefiger, Yuri; Theis, Anya; Salzburger, Walter			A Sensory Bias Has Triggered the Evolution of Egg-Spots in Cichlid Fishes	PLOS ONE			English	Article							ALGAL-FORAGING ABILITY; MUTUAL MATE CHOICE; SEXUAL SELECTION; RECEIVER BIASES; COLORATION; PREFERENCE; SPECIATION; AFRICAN; DUMMIES; TRAITS	Although, generally, the origin of sex-limited traits remains elusive, the sensory exploitation hypothesis provides an explanation for the evolution of male sexual signals. Anal fin egg-spots are such a male sexual signal and a key characteristic of the most species-rich group of cichlid fishes, the haplochromines. Males of about 1500 mouth-brooding species utilize these conspicuous egg-dummies during courtship - apparently to attract females and to maximize fertilization success. Here we test the hypothesis that the evolution of haplochromine egg-spots was triggered by a pre-existing bias for eggs or egg-like coloration. To this end, we performed mate-choice experiments in the basal haplochromine Pseudocrenilabrus multicolor, which manifests the plesiomorphic character-state of an egg-spot-less anal fin. Experiments using computer-animated photographs of males indeed revealed that females prefer images of males with virtual ('in-silico') egg-spots over images showing unaltered males. In addition, we tested for color preferences (outside a mating context) in a phylogenetically representative set of East African cichlids. We uncovered a strong preference for yellow, orange or reddish spots in all haplochromines tested and, importantly, also in most other species representing more basal lines. This preexisting female sensory bias points towards high-quality (carotenoids-enriched) food suggesting that it is adaptive.	[Egger, Bernd; Klaefiger, Yuri; Theis, Anya; Salzburger, Walter] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland	University of Basel	Egger, B (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.	walter.salzburger@unibas.ch	Salzburger, Walter/G-1598-2011	Salzburger, Walter/0000-0002-9988-1674	European Research Council (ERC); Austrian Science Foundation (FWF); Department of Fisheries	European Research Council (ERC)(European Research Council (ERC)European Commission); Austrian Science Foundation (FWF)(Austrian Science Fund (FWF)); Department of Fisheries	This work has been supported by the European Research Council (ERC; Starting Grant 'INTERGENADAPT') and the Austrian Science Foundation (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the Ministry of Agriculture, Food and Fisheries, Republic of Zambia, for permissions to conduct this research. We are very grateful to T. Veall, without whom the experiments in Africa would not have been possible, and to L. Makasa from the Department of Fisheries for support. We thank our field assistants L. Baldo, S. Rutschmann, L. Schild, L. Walther; and A. Indermaur for assistance with fish keeping. We would like to thank V. Amrhein, D. Berner and M. Kolliker for advice on statistical analyses; V. Amrhein, M. Dittmann, M. Kolliker, and the members of the SalzburgerLab for valuable comments on the manuscript.	Arnqvist G, 2006, PHILOS T R SOC B, V361, P375, DOI 10.1098/rstb.2005.1790; Arnqvist G, 2010, J EVOLUTION BIOL, V23, P1907, DOI 10.1111/j.1420-9101.2010.02055.x; Baldauf SA, 2009, J FISH BIOL, V75, P738, DOI 10.1111/j.1095-8649.2009.02347.x; Baldauf SA, 2011, BEHAV ECOL, V22, P478, DOI 10.1093/beheco/arq226; Baldauf SA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-129; Boughman JW, 2002, TRENDS ECOL EVOL, V17, P571, DOI 10.1016/S0169-5347(02)02595-8; Boughman JW, 2001, NATURE, V411, P944, DOI 10.1038/35082064; Senar JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010716; Endler JA, 1998, TRENDS ECOL EVOL, V13, P415, DOI 10.1016/S0169-5347(98)01471-2; ENDLER JA, 1988, ANNU REV ECOL SYST, V19, P395, DOI 10.1146/annurev.es.19.110188.002143; Fryer G, 1972, CICHLID FISHES GREAT; Fuller RC, 2009, EVOLUTION, V63, P1697, DOI 10.1111/j.1558-5646.2009.00659.x; Grether GF, 2005, P ROY SOC B-BIOL SCI, V272, P2181, DOI 10.1098/rspb.2005.3197; Grether GF, 2001, P ROY SOC B-BIOL SCI, V268, P1245, DOI 10.1098/rspb.2001.1624; HERT E, 1989, ANIM BEHAV, V37, P726, DOI 10.1016/0003-3472(89)90058-4; HERT E, 1991, J FISH BIOL, V38, P951, DOI 10.1111/j.1095-8649.1991.tb03634.x; Karino K, 2005, BEHAV ECOL SOCIOBIOL, V59, P1, DOI 10.1007/s00265-005-0001-3; Karino K, 2007, ZOOL SCI, V24, P571, DOI 10.2108/zsj.24.571; KIRKPATRICK M, 1991, NATURE, V350, P33, DOI 10.1038/350033a0; Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; MADDISON WP, 2005, MESQUITE MODULAR SYS; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; Rodd FH, 2002, P ROY SOC B-BIOL SCI, V269, P475, DOI 10.1098/rspb.2001.1891; Ryan M.J., 1990, Oxford Surveys in Evolutionary Biology, V7, P157; Ryan MJ, 1998, SCIENCE, V281, P1999, DOI 10.1126/science.281.5385.1999; Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17; Salzburger W, 2002, SYST BIOL, V51, P113, DOI 10.1080/106351502753475907; Salzburger W, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-51; Salzburger W, 2009, MOL ECOL, V18, P169, DOI 10.1111/j.1365-294X.2008.03981.x; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Tobler Michael, 2006, Zeitschrift fuer Fischkunde, V8, P39; Verheyen E, 2003, SCIENCE, V300, P325, DOI 10.1126/science.1080699; WESTEBERHARD MJ, 1979, P AM PHILOS SOC, V123, P222; Wickler W., 1962, Zeitschrift fuer Tierpsychologie, V19, P129; WICKLER W, 1962, NATURE, V194, P1092, DOI 10.1038/1941092a0	36	28	28	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e25601	10.1371/journal.pone.0025601	http://dx.doi.org/10.1371/journal.pone.0025601			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028784	Green Submitted, Green Published, gold			2022-12-27	WOS:000296186900013
J	Klinge, A; Beutelmann, R; Klump, GM				Klinge, Astrid; Beutelmann, Rainer; Klump, Georg M.			Effect of Harmonicity on the Detection of a Signal in a Complex Masker and on Spatial Release from Masking	PLOS ONE			English	Article							NONSPEECH AUDITORY PATTERNS; INFORMATIONAL MASKING; LEVEL DIFFERENCES; FREE-FIELD; MULTICOMPONENT MASKERS; SPEECH-INTELLIGIBILITY; FREQUENCY; MODEL; IDENTIFICATION; SEGREGATION	The amount of masking of sounds from one source (signals) by sounds from a competing source (maskers) heavily depends on the sound characteristics of the masker and the signal and on their relative spatial location. Numerous studies investigated the ability to detect a signal in a speech or a noise masker or the effect of spatial separation of signal and masker on the amount of masking, but there is a lack of studies investigating the combined effects of many cues on the masking as is typical for natural listening situations. The current study using free-field listening systematically evaluates the combined effects of harmonicity and inharmonicity cues in multi-tone maskers and cues resulting from spatial separation of target signal and masker on the detection of a pure tone in a multi-tone or a noise masker. A linear binaural processing model was implemented to predict the masked thresholds in order to estimate whether the observed thresholds can be accounted for by energetic masking in the auditory periphery or whether other effects are involved. Thresholds were determined for combinations of two target frequencies (1 and 8 kHz), two spatial configurations (masker and target either co-located or spatially separated by 90 degrees azimuth), and five different masker types (four complex multi-tone stimuli, one noise masker). A spatial separation of target and masker resulted in a release from masking for all masker types. The amount of masking significantly depended on the masker type and frequency range. The various harmonic and inharmonic relations between target and masker or between components of the masker resulted in a complex pattern of increased or decreased masked thresholds in comparison to the predicted energetic masking. The results indicate that harmonicity cues affect the detectability of a tonal target in a complex masker.	[Klinge, Astrid; Beutelmann, Rainer; Klump, Georg M.] Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, Anim Physiol & Behav Grp, D-2900 Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg	Klinge, A (corresponding author), Carl von Ossietzky Univ Oldenburg, Dept Biol & Environm Sci, Anim Physiol & Behav Grp, D-2900 Oldenburg, Germany.	astrid.klinge@uni-oldenburg.de		Beutelmann, Rainer/0000-0001-9708-4113	Deutsche Forschungsgemeinschaft [Sonderforschungsbereich SFB/TRR31]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft within the Sonderforschungsbereich SFB/TRR31 "The Active Auditory System". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agus TR, 2010, NEURON, V66, P610, DOI 10.1016/j.neuron.2010.04.014; Best V, 2005, J ACOUST SOC AM, V118, P3766, DOI 10.1121/1.2130949; Beutelmann R, 2010, J ACOUST SOC AM, V127, P2479, DOI 10.1121/1.3295575; Breebaart J, 2001, J ACOUST SOC AM, V110, P1074, DOI 10.1121/1.1383297; Bronkhorst AW, 2000, ACUSTICA, V86, P117; BUUS S, 1997, AUDITORY MASKING, P1427; CARHART R, 1969, J ACOUST SOC AM, V45, P694, DOI 10.1121/1.1911445; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; COHEN MF, 1991, J ACOUST SOC AM, V89, P3007, DOI 10.1121/1.400739; Du Y, 2011, CEREB CORTEX, V21, P698, DOI 10.1093/cercor/bhq136; Durlach NI, 2003, J ACOUST SOC AM, V113, P2984, DOI 10.1121/1.1570435; DURLACH NI, 1963, J ACOUST SOC AM, V35, P1206, DOI 10.1121/1.1918675; Epp B, 2009, J COMPUT NEUROSCI, V26, P393, DOI 10.1007/s10827-008-0118-2; Freyman RL, 2001, J ACOUST SOC AM, V109, P2112, DOI 10.1121/1.1354984; Gescheider GA, 1997, PSYCHOPHYSICS FUNDAM; Gilkey RH, 1995, HUM FACTORS, V37, P835, DOI 10.1518/001872095778995580; GLASBERG BR, 1990, HEARING RES, V47, P103, DOI 10.1016/0378-5955(90)90170-T; Green D. M., 1966, SIGNAL DETECTION THE, V1; HAFTER ER, 1971, J ACOUST SOC AM, V50, P1116, DOI 10.1121/1.1912743; HARTMANN WM, 1988, PITCH PERCEPTION SEG, P623; Hohmann V, 2002, ACTA ACUST UNITED AC, V88, P433; Kidd G, 2002, J ACOUST SOC AM, V111, P1367, DOI 10.1121/1.1448342; KIDD G, 1994, J ACOUST SOC AM, V95, P3475, DOI 10.1121/1.410023; Kidd G, 1998, J ACOUST SOC AM, V104, P422, DOI 10.1121/1.423246; Klinge A, 2010, J ACOUST SOC AM, V128, P280, DOI 10.1121/1.3436552; Leung AWS, 2011, J EXP PSYCHOL HUMAN, V37, P727, DOI 10.1037/a0021932; LUTFI RA, 1990, J ACOUST SOC AM, V88, P2607, DOI 10.1121/1.399980; MARIN M, 1994, J PHYS IV, V4, P233, DOI 10.1051/jp4:1994546; McDonald KL, 2005, J ACOUST SOC AM, V118, P1593, DOI 10.1121/1.2000747; Moore BCJ, 2003, J ACOUST SOC AM, V114, P408, DOI 10.1121/1.1577552; MOORE BCJ, 1985, J ACOUST SOC AM, V77, P1861, DOI 10.1121/1.391937; MOORE BCJ, 1989, J ACOUST SOC AM, V86, P1351, DOI 10.1121/1.398695; NEFF DL, 1995, J ACOUST SOC AM, V98, P125, DOI 10.1121/1.413748; NEFF DL, 1987, PERCEPT PSYCHOPHYS, V41, P409, DOI 10.3758/BF03203033; Oh EL, 2000, J ACOUST SOC AM, V108, P706, DOI 10.1121/1.429603; Roberts B, 2001, J ACOUST SOC AM, V110, P2479, DOI 10.1121/1.1410965; SABERI K, 1991, J ACOUST SOC AM, V90, P1355, DOI 10.1121/1.401927; Shinn-Cunningham BG, 2005, ACTA ACUST UNITED AC, V91, P967; van de Par S, 1999, J ACOUST SOC AM, V106, P1940, DOI 10.1121/1.427942; Warusfel O., LISTEN HRTF DATABASE; ZUREK PM, 1993, BINAURAL ADVANTAGES, P255	41	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26124	10.1371/journal.pone.0026124	http://dx.doi.org/10.1371/journal.pone.0026124			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028814	Green Submitted, Green Published, gold			2022-12-27	WOS:000296186900028
J	Liu, JX; Qin, W; Yuan, K; Li, J; Wang, W; Li, Q; Wang, YR; Sun, JB; von Deneen, KM; Liu, YJ; Tian, J				Liu, Jixin; Qin, Wei; Yuan, Kai; Li, Jing; Wang, Wei; Li, Qiang; Wang, Yarong; Sun, Jinbo; von Deneen, Karen M.; Liu, Yijun; Tian, Jie			Interaction between Dysfunctional Connectivity at Rest and Heroin Cues-Induced Brain Responses in Male Abstinent Heroin-Dependent Individuals	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; SMALL-WORLD; INTRINSIC CONNECTIVITY; NEUROIMAGING EVIDENCE; PREFRONTAL CORTEX; NETWORKS; PATTERNS; STRESS; USERS; PERFORMANCE	Background: The majority of previous heroin cue-reactivity functional magnetic resonance imaging (fMRI) studies focused on local function impairments, such as inhibitory control, decision-making and stress regulation. Our previous studies have demonstrated that these brain circuits also presented dysfunctional connectivity during the resting state. Yet few studies considered the relevance of resting state dysfunctional connectivity to task-related neural activity in the same chronic heroin user (CHU). Methodology/Principal Findings: We employed the method of graph theory analysis, which detected the abnormality of brain regions and dysregulation of brain connections at rest between 16 male abstinent chronic heroin users (CHUs) and 16 non-drug users (NDUs). Using a cue-reactivity task, we assessed the relationship between drug-related cue-induced craving activity and the abnormal topological properties of the CHUs' resting networks. Comparing NDUs' brain activity to that of CHUs, the intensity of functional connectivity of the medial frontal gyrus (meFG) in patients' resting state networks was prominently greater and positively correlated with the same region's neural activity in the heroin-related task; decreased functional connectivity intensity of the anterior cingulate cortex (ACC) in CHUs at rest was associated with more drug-related cue-induced craving activities. Conclusions: These results may indicate that there exist two brain systems interacting simultaneously in the heroin-addicted brain with regards to a cue-reactivity task. The current study may shed further light on the neural architecture that supports craving responses in heroin dependence.	[Liu, Jixin; Qin, Wei; Yuan, Kai; Li, Jing; Sun, Jinbo; von Deneen, Karen M.; Tian, Jie] Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China; [Wang, Wei; Li, Qiang; Wang, Yarong] Fourth Mil Med Univ, Xian 710032, Shaanxi, Peoples R China; [Liu, Yijun] Univ Florida, Dept Psychiat, McKnight Brain Inst, Gainesville, FL 32611 USA; [Liu, Yijun] Univ Florida, Dept Neurosci, McKnight Brain Inst, Gainesville, FL 32610 USA; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Air Force Military Medical University; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Chinese Academy of Sciences; Institute of Automation, CAS	Liu, JX (corresponding author), Xidian Univ, Sch Life Sci & Technol, Life Sci Res Ctr, Xian, Shaanxi, Peoples R China.	qinwei@life.xidian.edu.cn; tian@ieee.org	Yuan, Kai/I-4150-2016; tian, jie/M-6336-2013; 秦, 伟/J-9770-2016; Yuan, Kai/M-9403-2013; JinBo, Sun/GLT-2082-2022; Tian, Jie/H-1190-2011; Life, PAM/M-9552-2013	Yuan, Kai/0000-0002-3098-1124; 秦, 伟/0000-0003-4583-0406; Tian, Jie/0000-0003-0498-0432; 	Chinese Academy of Sciences [KGCX2-YW-129]; National Natural Science Foundation of China [81000641, 81000640, 30970774, 60901064, 30873462, 30870685, 81071142]; National Key Basic Research and Development Program (973) [2006CB705700]; 863 program [2008AA01Z411]; Fundamental Research Funds for the Central Universities	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program (973)(National Basic Research Program of China); 863 program(National High Technology Research and Development Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study is supported by CAS Hundred Talents Program, the National Natural Science Foundation of China under Grant Nos. 81000641, 81000640, 30970774, 60901064, 30873462, 30870685, 30870685,81071142; the Knowledge Innovation Program of the Chinese Academy of Sciences under grant No. KGCX2-YW-129; the Project for the National Key Basic Research and Development Program (973) under Grant No. 2006CB705700; and 863 program under Grant No. 2008AA01Z411, the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Balleine BW, 1998, NEUROPHARMACOLOGY, V37, P407, DOI 10.1016/S0028-3908(98)00033-1; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; Dyer KR, 1997, ADDICTION, V92, P1445, DOI 10.1111/j.1360-0443.1997.tb02866.x; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; Fair DA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000381; Forman SD, 2004, BIOL PSYCHIAT, V55, P531, DOI 10.1016/j.biopsych.2003.09.011; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Fu LP, 2008, NEUROSCI LETT, V438, P322, DOI 10.1016/j.neulet.2008.04.033; Goldstein RZ, 2002, AM J PSYCHIAT, V159, P1642, DOI 10.1176/appi.ajp.159.10.1642; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hayasaka S, 2010, NEUROIMAGE, V50, P499, DOI 10.1016/j.neuroimage.2009.12.051; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Krawczyk DC, 2002, NEUROSCI BIOBEHAV R, V26, P631, DOI 10.1016/S0149-7634(02)00021-0; Kreek MJ, 2000, ANN NY ACAD SCI, V909, P186; Latora V, 2003, EUR PHYS J B, V32, P249, DOI 10.1140/epjb/e2003-00095-5; Lee TM, 2002, BRAIN INJURY, V16, P885, DOI 10.1080/02699050210128915; Lee TMC, 2005, NEUROSCI LETT, V382, P211, DOI 10.1016/j.neulet.2005.03.053; Li CSR, 2008, NEUROSCI BIOBEHAV R, V32, P581, DOI 10.1016/j.neubiorev.2007.10.003; Liu JX, 2011, J MAGN RESON IMAGING, V33, P33, DOI 10.1002/jmri.22393; Liu JX, 2010, NEUROSCI LETT, V468, P353, DOI 10.1016/j.neulet.2009.11.031; Liu JX, 2009, NEUROSCI LETT, V460, P72, DOI 10.1016/j.neulet.2009.05.038; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Mantini D, 2007, P NATL ACAD SCI USA, V104, P13170, DOI 10.1073/pnas.0700668104; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; Northoff G, 2010, TRENDS NEUROSCI, V33, P277, DOI 10.1016/j.tins.2010.02.006; Pruessner JC, 2004, J NEUROSCI, V24, P2825, DOI 10.1523/JNEUROSCI.3422-03.2004; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shaham Y, 2000, BRAIN RES REV, V33, P13, DOI 10.1016/S0165-0173(00)00024-2; Upadhyay J, 2010, BRAIN, V133, P2098, DOI 10.1093/brain/awq138; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Volkow ND, 2003, J CLIN INVEST, V111, P1444, DOI 10.1172/JCI200318533; Wallis JD, 2003, EUR J NEUROSCI, V18, P2069, DOI 10.1046/j.1460-9568.2003.02922.x; Wang L, 2010, NEUROIMAGE, V51, P910, DOI 10.1016/j.neuroimage.2010.02.046; Wang L, 2010, NEUROIMAGE, V50, P862, DOI 10.1016/j.neuroimage.2010.01.044; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wilson SJ, 2004, NAT NEUROSCI, V7, P211, DOI 10.1038/nn1200; Xiao ZW, 2006, DRUG ALCOHOL DEPEN, V83, P157, DOI 10.1016/j.drugalcdep.2005.11.012; Yuan K, 2010, NEUROSCI LETT, V482, P101, DOI 10.1016/j.neulet.2010.07.005; Yuan K, 2010, NEUROSCI LETT, V477, P37, DOI 10.1016/j.neulet.2010.04.032; Yuan K, 2010, NEUROSCI LETT, V475, P20, DOI 10.1016/j.neulet.2010.03.033; Zhang XC, 2011, NEUROIMAGE, V54, P131, DOI 10.1016/j.neuroimage.2010.07.063	51	84	89	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e23098	10.1371/journal.pone.0023098	http://dx.doi.org/10.1371/journal.pone.0023098			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028765	gold, Green Published, Green Submitted			2022-12-27	WOS:000296186900001
J	Palanisamy, GS; Kirk, NM; Ackart, DF; Shanley, CA; Orme, IM; Basaraba, RJ				Palanisamy, Gopinath S.; Kirk, Natalie M.; Ackart, David F.; Shanley, Crystal A.; Orme, Ian M.; Basaraba, Randall J.			Evidence for Oxidative Stress and Defective Antioxidant Response in Guinea Pigs with Tuberculosis	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; CELLULAR IMMUNE-RESPONSE; SUBUNIT GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; LIGHT SUBUNIT; INFECTION; CELLS; MODEL; LUNG	The development of granulomatous inflammation with caseous necrosis is an important but poorly understood manifestation of tuberculosis in humans and some animal models. In this study we measured the byproducts of oxidative stress in granulomatous lesions as well as the systemic antioxidant capacity of BCG vaccinated and non-vaccinated guinea pigs experimentally infected with Mycobacterium tuberculosis. In non-vaccinated guinea pigs, oxidative stress was evident within 2 weeks of infection as measured by a decrease in the serum total antioxidant capacity and blood glutathione levels accompanied by an increase in malondialdehyde, a byproduct of lipid peroxidation, within lesions. Despite a decrease in total and reduced blood glutathione concentrations, there was an increase in lesion glutathione by immunohistochemistry in response to localized oxidative stress. In addition there was an increase in the expression of the host transcription factor nuclear erythroid 2 p45-related factor 2 (Nrf2), which regulates several protein and non-proteins antioxidants, including glutathione. Despite the increase in cytoplasmic expression of Nrf2, immunohistochemical staining revealed a defect in Nrf2 nuclear translocation within granulomatous lesions as well as a decrease in the expression of the Nrf2-regulated antioxidant protein NQO1. Treating M. tuberculosis-infected guinea pigs with the antioxidant drug N-acetyl cysteine (NAC) partially restored blood glutathione concentrations and the serum total antioxidant capacity. Treatment with NAC also decreased spleen bacterial counts, as well as decreased the lung and spleen lesion burden and the severity of lesion necrosis. These data suggest that the progressive oxidative stress during experimental tuberculosis in guinea pigs is due in part to a defect in host antioxidant defenses, which, we show here, can be partially restored with antioxidant treatment. These data suggest that the therapeutic strategies that reduce oxidant-mediated tissue damage may be beneficial as an adjunct therapy in the treatment and prevention of tuberculosis in humans.	[Palanisamy, Gopinath S.; Kirk, Natalie M.; Ackart, David F.; Shanley, Crystal A.; Orme, Ian M.; Basaraba, Randall J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	Colorado State University	Palanisamy, GS (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	Randall.Basaraba@colostate.edu			National Institutes of Health at Colorado State University [AI070456, AI083856]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI070456, R21AI083856] Funding Source: NIH RePORTER	National Institutes of Health at Colorado State University; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Support was provided by the National Institutes of Health grants AI070456 (RJB) and AI083856 (IMO) at Colorado State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basaraba RJ, 2008, TUBERCULOSIS, V88, pS35, DOI 10.1016/S1472-9792(08)70035-0; Basaraba RJ, 2007, TUBERCULOSIS EDINB; Biswas SK, 2009, MOL ASPECTS MED, V30, P60, DOI 10.1016/j.mam.2008.07.001; Cai JX, 1997, BIOCHEM J, V326, P167, DOI 10.1042/bj3260167; Canetti G., 1955, TUBERCLE BACILLUS PU; Castandet J, 2005, RES MICROBIOL, V156, P1005, DOI 10.1016/j.resmic.2005.05.013; Chan KM, 2001, P NATL ACAD SCI USA, V98, P4611, DOI 10.1073/pnas.081082098; Chen C, 2004, FREE RADICAL BIO MED, V37, P1578, DOI 10.1016/j.freeradbiomed.2004.07.021; Espinal MA, 2003, TUBERCULOSIS, P33; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Galloway DC, 1998, BIOCHEM J, V336, P535, DOI 10.1042/bj3360535; JACK CIA, 1994, TUBERCLE LUNG DIS, V75, P132, DOI 10.1016/0962-8479(94)90042-6; Juge N, 2007, CELL MOL LIFE SCI, V64, P1105, DOI 10.1007/s00018-007-6484-5; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Kode A, 2008, AM J PHYSIOL-LUNG C, V294, pL478, DOI 10.1152/ajplung.00361.2007; Kwiatkowska S, 1999, RESP MED, V93, P272, DOI 10.1016/S0954-6111(99)90024-0; Larnsal Madhab, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P695; Lasunskaia EB, 2006, J LEUKOCYTE BIOL, V80, P1480, DOI 10.1189/jlb.0106066; Lenaerts AJ, 2007, ANTIMICROB AGENTS CH, V51, P3338, DOI 10.1128/AAC.00276-07; Madebo T, 2003, AM J CLIN NUTR, V78, P117, DOI 10.1093/ajcn/78.1.117; McMurray DN, 2003, TUBERCULOSIS, V83, P131, DOI 10.1016/S1472-9792(02)00079-3; McMurray DN, 1994, GUINEA PIG MODEL TUB, P135; McWalter GK, 2004, J NUTR, V134, p3499S, DOI 10.1093/jn/134.12.3499S; Mithen R, 2003, THEOR APPL GENET, V106, P727, DOI 10.1007/s00122-002-1123-x; Ordway D, 2008, CLIN VACCINE IMMUNOL, V15, P1248, DOI 10.1128/CVI.00019-08; Ordway D, 2007, J IMMUNOL, V179, P2532, DOI 10.4049/jimmunol.179.4.2532; Ordway DJ, 2010, ANTIMICROB AGENTS CH, V54, P1820, DOI 10.1128/AAC.01521-09; Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003; Qian Y, 2003, J BIOL CHEM, V278, P16189, DOI 10.1074/jbc.M207517200; SCHORAH CJ, 1992, P NUTR SOC, V51, P189, DOI 10.1079/PNS19920029; SMITH DW, 1970, AM REV RESPIR DIS, V102, P937; Turner OC, 2003, INFECT IMMUN, V71, P864, DOI 10.1128/IAI.71.2.864-871.2003; Vijayamalini A, 2004, CELL BIOCHEM FUNCT, V22, P19, DOI [10.1002/cbf.1039, 10.1027/cbf.1039]; Walubo A, 1998, METHOD FIND EXP CLIN, V20, P649, DOI 10.1358/mf.1998.20.8.487491; WHO, 2010, GLOB TB CONTR REP 20; Wild AC, 1999, J BIOL CHEM, V274, P33627, DOI 10.1074/jbc.274.47.33627; Wolschendorf F, 2011, P NATL ACAD SCI USA, V108, P1621, DOI 10.1073/pnas.1009261108	37	79	81	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26254	10.1371/journal.pone.0026254	http://dx.doi.org/10.1371/journal.pone.0026254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028843	Green Submitted, Green Published, gold			2022-12-27	WOS:000296186900039
J	Emmerson, CD; van der Vlist, EJ; Braam, MR; Vanlandschoot, P; Merchiers, P; de Haard, HJW; Verrips, CT; Henegouwen, PMPVE; Dolk, E				Emmerson, Chris D.; van der Vlist, Els J.; Braam, Myrthe R.; Vanlandschoot, Peter; Merchiers, Pascal; de Haard, Hans J. W.; Verrips, C. Theo; Henegouwen, Paul M. P. van Bergen En; Dolk, Edward			Enhancement of Polymeric Immunoglobulin Receptor Transcytosis by Biparatopic VHH	PLOS ONE			English	Article							EPITHELIAL-CELLS; SECRETORY COMPONENT; IG RECEPTOR; DIMERIC IGA; MDCK CELLS; TRANSPORT; BINDING; NANOBODIES; SIGNAL	The polymeric immunoglobulin receptor (pIgR) ensures the transport of dimeric immunoglobulin A (dIgA) and pentameric immunoglobulin M (pIgM) across epithelia to the mucosal layer of for example the intestines and the lungs via transcytosis. Per day the human pIgR mediates the excretion of 2 to 5 grams of dIgA into the mucosa of luminal organs. This system could prove useful for therapies aiming at excretion of compounds into the mucosa. Here we investigated the use of the variable domain of camelid derived heavy chain only antibodies, also known as VHHs or Nanobodies (R), targeting the human pIgR, as a transport system across epithelial cells. We show that VHHs directed against the human pIgR are able to bind the receptor with high affinity (similar to 1 nM) and that they compete with the natural ligand, dIgA. In a transcytosis assay both native and phage-bound VHH were only able to get across polarized MDCK cells that express the human pIgR gene in a basolateral to apical fashion. Indicating that the VHHs are able to translocate across epithelia and to take along large particles of cargo. Furthermore, by making multivalent VHHs we were able to enhance the transport of the compounds both in a MDCK-hpIgR and Caco-2 cell system, probably by inducing receptor clustering. These results show that VHHs can be used as a carrier system to exploit the human pIgR transcytotic system and that multivalent compounds are able to significantly enhance the transport across epithelial monolayers.	[Emmerson, Chris D.; van der Vlist, Els J.; Braam, Myrthe R.; Verrips, C. Theo; Henegouwen, Paul M. P. van Bergen En; Dolk, Edward] Univ Utrecht, Dept Biol, Fac Sci, Utrecht, Netherlands; [Vanlandschoot, Peter; Merchiers, Pascal; de Haard, Hans J. W.] Ablynx NV, Zwijnaarde, Belgium	Utrecht University	Emmerson, CD (corresponding author), Univ Utrecht, Dept Biol, Fac Sci, Utrecht, Netherlands.	peter.vanlandschoot@ablynx.com; e.dolk@qvquality.com	van Bergen en Henegouwen, Paul/B-8870-2011	van Bergen en Henegouwen, Paul/0000-0001-6050-9042	Ablynx	Ablynx(Ablynx)	This study was funded by Ablynx, who had a say in study design, data collection and analysis. To be specific, the selection of anti-human pIgR VHHs.	APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; Braathen R, 2006, J BIOL CHEM, V281, P7075, DOI 10.1074/jbc.M508509200; Brock SC, 2002, INFECT IMMUN, V70, P5091, DOI 10.1128/IAI.70.9.5091-5095.2002; CASANOVA JE, 1991, CELL, V66, P65, DOI 10.1016/0092-8674(91)90139-P; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Dolk E, 2005, APPL ENVIRON MICROB, V71, P442, DOI 10.1128/AEM.71.1.442-450.2005; Giffroy D, 2001, SCAND J IMMUNOL, V53, P56, DOI 10.1046/j.1365-3083.2001.00843.x; HOFMAN EG, 2010, J BIOL CHEM; Hubatsch I, 2007, NAT PROTOC, V2, P2111, DOI 10.1038/nprot.2007.303; Jerdeva GV, 2010, TRAFFIC, V11, P1205, DOI 10.1111/j.1600-0854.2010.01083.x; Johansen FE, 2000, SCAND J IMMUNOL, V52, P240; Kaetzel CS, 2005, IMMUNOL REV, V206, P83, DOI 10.1111/j.0105-2896.2005.00278.x; KAETZEL CS, 1991, P NATL ACAD SCI USA, V88, P8796, DOI 10.1073/pnas.88.19.8796; Kaetzel CS, 2001, CURR BIOL, V11, pR35, DOI 10.1016/S0960-9822(00)00041-5; LINDH E, 1975, J IMMUNOL, V114, P284; Liu AP, 2010, J CELL BIOL, V191, P1381, DOI 10.1083/jcb.201008117; Luton F, 1999, MOL BIOL CELL, V10, P1409, DOI 10.1091/mbc.10.5.1409; Mostov K, 2003, NAT CELL BIOL, V5, P287, DOI 10.1038/ncb0403-287; Mostov K, 1991, Semin Cell Biol, V2, P411; MOSTOV KE, 1982, J BIOL CHEM, V257, P1816; Muyldermans S, 2001, J Biotechnol, V74, P277; Reich V, 1996, J CELL SCI, V109, P2133; Roovers RC, 2007, CANCER IMMUNOL IMMUN, V56, P303, DOI 10.1007/s00262-006-0180-4; Singer KL, 1998, MOL BIOL CELL, V9, P901, DOI 10.1091/mbc.9.4.901; SONG WX, 1994, P NATL ACAD SCI USA, V91, P163, DOI 10.1073/pnas.91.1.163; Su T, 2010, NAT CELL BIOL, V12, P1143, DOI 10.1038/ncb2118; Van Bockstaele F, 2009, CURR OPIN INVEST DR, V10, P1212; Zhang JR, 2000, CELL, V102, P827, DOI 10.1016/S0092-8674(00)00071-4	28	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26299	10.1371/journal.pone.0026299	http://dx.doi.org/10.1371/journal.pone.0026299			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022593	Green Submitted, Green Published, gold			2022-12-27	WOS:000295981600051
J	Gardiner, C; Tannetta, DS; Simms, CA; Harrison, P; Redman, CWG; Sargent, IL				Gardiner, Chris; Tannetta, Dionne S.; Simms, Carol A.; Harrison, Paul; Redman, Christopher W. G.; Sargent, Ian L.			Syncytiotrophoblast Microvesicles Released from Pre-Eclampsia Placentae Exhibit Increased Tissue Factor Activity	PLOS ONE			English	Article							AUTOMATED THROMBIN GENERATION; FACTOR PATHWAY INHIBITOR; HORMONE MESSENGER-RNA; NORMAL-PREGNANCY; TROPHOBLAST CELLS; FIBRINOPEPTIDE-A; MATERNAL PLASMA; PRE-ECLAMPSIA; WHOLE-BLOOD; MICROPARTICLES	Background: Pre-eclampsia is a complication of pregnancy associated with activation of coagulation. It is caused by the placenta, which sheds increased amounts of syncytiotrophoblast microvesicles (STBM) into the maternal circulation. We hypothesized that STBM could contribute to the haemostatic activation observed in pre-eclampsia. Methodology/Principal Findings: STBM were collected by perfusion of the maternal side of placentae from healthy pregnant women and women with pre-eclampsia at caesarean section. Calibrated automated thrombography was used to assess thrombin generation triggered by STBM-borne tissue factor in platelet poor plasma (PPP). No thrombin was detected in PPP alone but the addition of STBM initiated thrombin generation in 14/16 cases. Pre-eclampsia STBM significantly shortened the lag time (LagT, P = 0.01) and time to peak thrombin generation (TTP, P = 0.005) when compared to normal STBM. Blockade of tissue factor eliminated thrombin generation, while inhibition of tissue factor pathway inhibitor significantly shortened LagT (p = 0.01) and TTP (P < 0.0001), with a concomitant increase in endogenous thrombin potential. Conclusions/Significance: STBM triggered thrombin generation in normal plasma in a tissue factor dependent manner, indicating that TF activity is expressed by STBM. This is more pronounced in STBM shed from pre-eclampsia placentae. As more STBM are shed in pre-eclampsia these observations give insight into the disordered haemostasis observed in this condition.	[Gardiner, Chris; Tannetta, Dionne S.; Simms, Carol A.; Redman, Christopher W. G.; Sargent, Ian L.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Oxford OX3 9DU, England; [Harrison, Paul] Churchill Hosp, Oxford Haemophilia & Thrombosis Ctr, Oxford OX3 7LJ, England	University of Oxford; University of Oxford	Gardiner, C (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Obstet & Gynaecol, Womens Ctr, Level 3, Oxford OX3 9DU, England.	chris.gardiner@obs-gyn.ox.ac.uk	Harrison, Paul/AAN-1916-2021; Gardiner, Chris/F-1178-2011	Harrison, Paul/0000-0003-4610-8909; Gardiner, Chris/0000-0002-2318-0062	Wellcome Trust [GR079862, GR0877930]; Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's National Institute for Health Research Biomedical Research Centres	Wellcome Trust(Wellcome TrustEuropean Commission); Oxford Partnership Comprehensive Biomedical Research Centre; Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust grants GR079862 and GR0877930, and the Oxford Partnership Comprehensive Biomedical Research Centre with funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. http://www.wellcome.ac.uk. http://www.oxfordbrc.org. http://www.nihr.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aharon A, 2004, THROMB HAEMOSTASIS, V92, P776, DOI 10.1160/TH04-01-0033; Aharon A, 2009, J THROMB HAEMOST, V7, P1047, DOI 10.1111/j.1538-7836.2009.03342.x; Bellart J, 1999, BRIT J OBSTET GYNAEC, V106, P594, DOI 10.1111/j.1471-0528.1999.tb08330.x; Biro E, 2003, J THROMB HAEMOST, V1, P2561, DOI 10.1046/j.1538-7836.2003.00456.x; Bonnar J, 1976, Perspect Nephrol Hypertens, V5, P85; BONNAR J, 1971, BRIT MED J, V2, P12, DOI 10.1136/bmj.2.5752.12; Butenas S, 2005, BLOOD, V105, P2764, DOI 10.1182/blood-2004-09-3567; Butenas S, 2009, ARTERIOSCL THROM VAS, V29, P1989, DOI 10.1161/ATVBAHA.108.177402; CADROY Y, 1993, BRIT J OBSTET GYNAEC, V100, P416, DOI 10.1111/j.1471-0528.1993.tb15264.x; DOUGLAS JT, 1982, THROMB HAEMOSTASIS, V47, P54; Erez O, 2008, J MATERN-FETAL NEO M, V21, P345, DOI 10.1080/14767050802034859; Estelles A, 1998, THROMB HAEMOSTASIS, V79, P500; FAULK WP, 1990, BLOOD, V76, P86; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; Freeman DJ, 2008, J THROMB HAEMOST, V6, P421, DOI 10.1111/j.1538-7836.2007.02882.x; Germain SJ, 2007, J IMMUNOL, V178, P5949, DOI 10.4049/jimmunol.178.9.5949; Girardi G, 2011, J THROMB HAEMOST, V9, P250, DOI 10.1111/j.1538-7836.2010.04135.x; Goswami D, 2006, PLACENTA, V27, P56, DOI 10.1016/j.placenta.2004.11.007; Guller S, 2011, PLACENTA, V32, P63, DOI 10.1016/j.placenta.2010.10.011; HALLIGAN A, 1994, BRIT J OBSTET GYNAEC, V101, P488, DOI 10.1111/j.1471-0528.1994.tb13147.x; Hellgren M, 2003, SEMIN THROMB HEMOST, V29, P125, DOI 10.1055/s-2003-38897; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; Key NS, 2010, SEMIN THROMB HEMOST, V36, P865, DOI 10.1055/s-0030-1267040; Knight M, 1998, BRIT J OBSTET GYNAEC, V105, P632, DOI 10.1111/j.1471-0528.1998.tb10178.x; Krudysz-Amblo J, 2010, J BIOL CHEM, V285, P3371, DOI 10.1074/jbc.M109.055178; Kumpel B, 2008, ANN NY ACAD SCI, V1137, P144, DOI 10.1196/annals.1448.017; Lakasing L, 1999, AM J OBSTET GYNECOL, V181, P180, DOI 10.1016/S0002-9378(99)70457-6; Lanir N, 2003, SEMIN THROMB HEMOST, V29, P175, DOI 10.1055/s-2003-38833; Lok CAR, 2008, REPROD SCI, V15, P1002, DOI 10.1177/1933719108324133; Lok CAR, 2008, HYPERTENS PREGNANCY, V27, P344, DOI 10.1080/10641950801955733; Luddington R, 2004, J THROMB HAEMOST, V2, P1954, DOI 10.1111/j.1538-7836.2004.00964.x; Mackman N, 2009, J THROMB HAEMOST, V7, P136, DOI 10.1111/j.1538-7836.2009.03368.x; Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911; Monroe DM, 2007, J THROMB HAEMOST, V5, P1097, DOI 10.1111/j.1538-7836.2007.02435.x; Mutter WP, 2008, MICROVASC RES, V75, P1, DOI 10.1016/j.mvr.2007.04.009; Ng EKO, 2003, CLIN CHEM, V49, P727, DOI 10.1373/49.5.727; Ollivier V, 2010, THROMB RES, V125, P90, DOI 10.1016/j.thromres.2009.03.003; Osterud B, 2010, THROMB RES, V125, pS31, DOI 10.1016/j.thromres.2010.01.032; Rank A, 2011, PLATELETS, V22, P111, DOI 10.3109/09537104.2010.520373; Redecha P, 2009, BLOOD, V113, P4101, DOI 10.1182/blood-2008-12-194258; Redman CW, 2005, SCIENCE, V308, P1592, DOI 10.1126/science.1111726; REVERDIAU P, 1995, THROMB HAEMOSTASIS, V73, P49; Rosenkranz A, 2008, THROMB HAEMOSTASIS, V99, P331, DOI 10.1160/TH07-05-0359; Rousseau A, 2009, EUR J OBSTET GYN R B, V146, P46, DOI 10.1016/j.ejogrb.2009.06.001; Ruf W, 2003, J THROMB HAEMOST, V1, P1495, DOI 10.1046/j.1538-7836.2003.00300.x; So AK, 2003, J THROMB HAEMOST, V1, P2510, DOI 10.1111/j.1538-7836.2003.00462.x; Steegers EAP, 2010, LANCET, V376, P631, DOI 10.1016/S0140-6736(10)60279-6; ten Cate JW, 1989, AM J OBSTET GYNECOL, V160, P95; Teng YC, 2009, J PERINAT MED, V37, P343, DOI 10.1515/JPM.2009.060; Teng YC, 2010, THROMB RES, V126, pE41, DOI 10.1016/j.thromres.2010.02.012; VanWijk MJ, 2002, THROMB HAEMOSTASIS, V88, P415	51	62	69	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26313	10.1371/journal.pone.0026313	http://dx.doi.org/10.1371/journal.pone.0026313			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022598	gold, Green Published, Green Submitted			2022-12-27	WOS:000295981600054
J	Shih, YY; Lee, H; Nakagawara, A; Juan, HF; Jeng, YM; Tsay, YG; Lin, DT; Hsieh, FJ; Pan, CY; Hsu, WM; Liao, YF				Shih, Yu-Yin; Lee, Hsinyu; Nakagawara, Akira; Juan, Hseuh-Fen; Jeng, Yung-Ming; Tsay, Yeou-Guang; Lin, Dong-Tsamn; Hsieh, Fon-Jou; Pan, Chien-Yuan; Hsu, Wen-Ming; Liao, Yung-Feng			Nuclear GRP75 Binds Retinoic Acid Receptors to Promote Neuronal Differentiation of Neuroblastoma	PLOS ONE			English	Article							HIGH-RISK NEUROBLASTOMA; CHILDRENS ONCOLOGY GROUP; GENE-EXPRESSION; 13-CIS-RETINOIC ACID; MYELOABLATIVE THERAPY; MOLECULAR CHAPERONES; SIGNALING PATHWAY; STEROID-RECEPTORS; NERVOUS-SYSTEM; RAR-ALPHA	Retinoic acid (RA) has been approved for the differentiation therapy of neuroblastoma (NB). Previous work revealed a correlation between glucose-regulated protein 75 (GRP75) and the RA-elicited neuronal differentiation of NB cells. The present study further demonstrated that GRP75 translocates into the nucleus and physically interacts with retinoid receptors (RAR alpha and RXR alpha) to augment RA-elicited neuronal differentiation. GRP75 was required for RAR alpha/RXR alpha-mediated transcriptional regulation and was shown to reduce the proteasome-mediated degradation of RAR alpha/RXR alpha in a RA-dependent manner. More intriguingly, the level of GRP75/RAR alpha/RXR alpha tripartite complexes was tightly associated with the RA-induced suppression of tumor growth in animals and the histological grade of differentiation in human NB tumors. The formation of GRP75/RAR alpha/RXR alpha complexes was intimately correlated with a normal MYCN copy number of NB tumors, possibly implicating a favorable prognosis of NB tumors. The present findings reveal a novel function of nucleus-localized GRP75 in actively promoting neuronal differentiation, delineating the mode of action for the differentiation therapy of NB by RA.	[Shih, Yu-Yin; Liao, Yung-Feng] Acad Sinica, Mol Neurobiol Lab, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Shih, Yu-Yin; Lee, Hsinyu; Pan, Chien-Yuan] Natl Taiwan Univ, Inst Zool, Taipei 10764, Taiwan; [Lee, Hsinyu; Juan, Hseuh-Fen; Pan, Chien-Yuan] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Nakagawara, Akira] Chiba Univ, Grad Sch Med, Chiba Canc Ctr Res Inst, Dept Mol Biol & Oncol, Chiba, Japan; [Juan, Hseuh-Fen] Natl Taiwan Univ, Inst Mol & Cellular Biol, Taipei 10764, Taiwan; [Jeng, Yung-Ming] Natl Taiwan Univ Hosp, Dept Pathol, Taipei 100, Taiwan; [Hsieh, Fon-Jou] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Tsay, Yeou-Guang] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Tsay, Yeou-Guang] Natl Yang Ming Univ, Prote Res Ctr, Taipei 112, Taiwan; [Lin, Dong-Tsamn] Natl Taiwan Univ Hosp, Dept Pediat, Taipei 10016, Taiwan; [Lin, Dong-Tsamn; Hsu, Wen-Ming] Childhood Canc Fdn, Taipei, Taiwan; [Hsu, Wen-Ming] Natl Taiwan Univ Hosp, Dept Surg, Taipei 100, Taiwan	Academia Sinica - Taiwan; Academia Sinica - Taiwan; National Taiwan University; National Taiwan University; Chiba Cancer Center; Chiba University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Shih, YY (corresponding author), Acad Sinica, Mol Neurobiol Lab, Inst Cellular & Organism Biol, Taipei 115, Taiwan.	cypan@ccms.ntu.edu.tw; billwmhsu@gmail.com; yliao@sinica.edu.tw	Tsay, Yeou-Guang/HGE-2076-2022; Liao, Yung-Feng/A-9761-2011	LIN, DONG-TSAMN/0000-0002-5773-3200; HSU, WEN-MING/0000-0002-5145-9538; JUAN, HSUEH-FEN/0000-0003-4876-3309; Lee, Hsinyu/0000-0002-1477-0183; Tsay, Yeou-Guang/0000-0001-6511-9158; JENG, YUNG-MING/0000-0002-3878-4491; PAN, CHIEN-YUAN/0000-0002-6654-9309	National Health Research Institutes [NHRI-EX96-9620NI]; National Science Council, Taiwan [NSC 95-2314-B-002-155-MY2]; Academia Sinica; NSC [NSC 100-2319-B-001-002]; Grants-in-Aid for Scientific Research [21390317] Funding Source: KAKEN	National Health Research Institutes(National Health Research Institutes, Japan); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Academia Sinica(Academia Sinica - Taiwan); NSC(Ministry of Science and Technology, Taiwan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the National Health Research Institutes (NHRI-EX96-9620NI to W.-M. H.), National Science Council, Taiwan (NSC 95-2314-B-002-155-MY2 to W.-M. H.), and Academia Sinica (to Y.-F.L.). The National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, is supported by the National Core Facility Program for Biotechnology Grants of NSC (NSC 100-2319-B-001-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almgren MAE, 2004, MOL CANCER RES, V2, P387; Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; Boudjelal M, 2000, CANCER RES, V60, P2247; Brodeur GM, 2003, NAT REV CANCER, V3, P203, DOI 10.1038/nrc1014; BURNS K, 1994, NATURE, V367, P476, DOI 10.1038/367476a0; Chang HH, 2010, CLIN CANCER RES, V16, P4411, DOI 10.1158/1078-0432.CCR-09-3360; CRAIG EA, 1989, MOL CELL BIOL, V9, P3000, DOI 10.1128/MCB.9.7.3000; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; DEDHAR S, 1994, NATURE, V367, P480, DOI 10.1038/367480a0; Deocaris CC, 2007, ANN NY ACAD SCI, V1119, P165, DOI 10.1196/annals.1404.007; Desai D, 1996, J BIOL CHEM, V271, P15153, DOI 10.1074/jbc.271.25.15153; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Ding XD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005949; Gabriele N, 2010, SYNAPSE, V64, P808, DOI 10.1002/syn.20794; Gianni M, 2002, EMBO J, V21, P3760, DOI 10.1093/emboj/cdf374; Heinlein CA, 2001, ENDOCRINE, V14, P143, DOI 10.1385/ENDO:14:2:143; Hsu WM, 2008, CLIN CANCER RES, V14, P6237, DOI 10.1158/1078-0432.CCR-07-4181; Jeong H, 2006, J NEUROCHEM, V98, P386, DOI 10.1111/j.1471-4159.2006.03866.x; Kaul SC, 2002, EXP GERONTOL, V37, P1157, DOI 10.1016/S0531-5565(02)00135-3; Kawai A, 2001, J CELL SCI, V114, P3565; Keriel A, 2002, CELL, V109, P125, DOI 10.1016/S0092-8674(02)00692-X; Knutson DC, 2008, ARCH BIOCHEM BIOPHYS, V477, P163, DOI 10.1016/j.abb.2008.06.005; Lefebvre P, 2005, VITAM HORM, V70, P199, DOI 10.1016/S0083-6729(05)70007-8; Liao YF, 2007, MOL PHARMACOL, V71, P588, DOI 10.1124/mol.106.024299; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Mark M, 2006, ANNU REV PHARMACOL, V46, P451, DOI 10.1146/annurev.pharmtox.46.120604.141156; Matthay KK, 2009, J CLIN ONCOL, V27, P1007, DOI 10.1200/JCO.2007.13.8925; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Mayer MP, 2010, MOL CELL, V39, P321, DOI 10.1016/j.molcel.2010.07.012; McGrane MM, 2007, J NUTR BIOCHEM, V18, P497, DOI 10.1016/j.jnutbio.2006.10.006; Merrill RA, 2004, BIOL CHEM, V385, P605, DOI 10.1515/BC.2004.075; Merrill RA, 2002, P NATL ACAD SCI USA, V99, P3422, DOI 10.1073/pnas.052017399; Michalak M, 1996, J BIOL CHEM, V271, P29436, DOI 10.1074/jbc.271.46.29436; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Park JR, 2009, PEDIATR BLOOD CANCER, V52, P44, DOI 10.1002/pbc.21784; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Peverali FA, 1996, ONCOGENE, V12, P457; Reynolds C P, 1994, Prog Clin Biol Res, V385, P237; Rochette-Egly C, 2003, CELL SIGNAL, V15, P355, DOI 10.1016/S0898-6568(02)00115-8; Shimada H, 2003, Pathologica, V95, P240; SIDELL N, 1983, EXP CELL RES, V148, P21, DOI 10.1016/0014-4827(83)90184-2; Smith DF, 2008, MOL ENDOCRINOL, V22, P2229, DOI 10.1210/me.2008-0089; Srinivas H, 2006, BIOCHEM J, V395, P653, DOI 10.1042/BJ20051794; Suenaga Y, 2009, BIOCHEM BIOPH RES CO, V390, P21, DOI 10.1016/j.bbrc.2009.09.044; THIELE CJ, 1985, NATURE, V313, P404, DOI 10.1038/313404a0; WADHWA R, 1995, EXP CELL RES, V216, P101, DOI 10.1006/excr.1995.1013; Wadhwa R, 2002, CELL STRESS CHAPERON, V7, P309, DOI 10.1379/1466-1268(2002)007<0309:AHFCMM>2.0.CO;2; Wadhwa R, 2000, CANCER RES, V60, P6818; Wagner LM, 2009, J CELL BIOCHEM, V107, P46, DOI 10.1002/jcb.22094; Zhao HL, 2009, BIOCHEM BIOPH RES CO, V383, P119, DOI 10.1016/j.bbrc.2009.03.141; Zoubeidi A, 2007, CANCER RES, V67, P10455, DOI 10.1158/0008-5472.CAN-07-2057	53	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26236	10.1371/journal.pone.0026236	http://dx.doi.org/10.1371/journal.pone.0026236			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022577	Green Published, Green Submitted, gold			2022-12-27	WOS:000295981600042
J	Zhang, EJ; Zhang, XY; Liu, J; Wang, BJ; Tian, YJ; Kosinska, AD; Ma, ZY; Xu, Y; Dittmer, U; Roggendorf, M; Yang, DL; Lu, MJ				Zhang, Ejuan; Zhang, Xiaoyong; Liu, Jia; Wang, Baoju; Tian, Yongjun; Kosinska, Anna D.; Ma, Zhiyong; Xu, Yang; Dittmer, Ulf; Roggendorf, Michael; Yang, Dongliang; Lu, Mengji			The Expression of PD-1 Ligands and Their Involvement in Regulation of T Cell Functions in Acute and Chronic Woodchuck Hepatitis Virus Infection	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; ENDOTHELIAL-CELLS; IMMUNE-RESPONSES; DENDRITIC CELLS; B PATIENTS; DYSFUNCTION; ACTIVATION; LIVER; MODEL; IMMUNOMODULATION	Background: The programmed cell death 1 (PD-1)/programmed death-1 ligand 1 (PD-L1) system may play a role in the negative regulation of T cell functions in hepatitis B virus (HBV) infection. Thus, it is important to study its role in the widely used animal model for HBV infection of woodchucks with woodchuck hepatitis virus (WHV). Methods: Woodchuck PD-L1 (wPD-L1) and -L2 (wPD-L2) were cloned and characterized. The levels of wPD-L1 expression in primary woodchuck hepatocytes (PWH), peripheral blood mononuclear cells (PBMCs), and liver tissue of naive and WHV-infected woodchucks were examined by real time reverse transcription (RT)-PCR and flow cytometry. Using antibodies against wPD-L1 and -L2, the effect of blocking PD-1/PD-L1/PD-L2 interaction on the proliferation and degranulation of woodchuck PBMCs was examined. Principal Findings: Both wPD-L1 and -L2 showed a high homology to their counterparts of other mammalian species and humans. WPD-L1 expression in PWH and PBMCs of naive animals was low but could be stimulated by Toll-like receptor (TLR) ligands and interferons (IFN). WPD-L1 expression in liver tissue was significantly higher than that measured in PWHs and was slightly elevated during acute and chronic WHV infection. However, wPD-1 and wPD-L1 expression on PBMCs was strongly up-regulated during acute and chronic infection. In vitro blockade with antibodies against wPD-L1 and -L2 partially enhanced proliferation and degranulation of PBMCs from WHV-infected woodchucks. Conclusions: Our results demonstrated that wPD-1/wPD-L1 expression in hepatocytes and PBMCs can be induced by different inflammatory stimuli and is up-regulated mainly on PBMCs during WHV infection. A blockade of the woodchuck PD-1/PD-L pathway could partially enhance T cell functions in WHV infection.	[Zhang, Ejuan; Zhang, Xiaoyong; Xu, Yang; Lu, Mengji] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Microbiol, Wuhan 430074, Peoples R China; [Zhang, Ejuan; Zhang, Xiaoyong; Liu, Jia; Kosinska, Anna D.; Ma, Zhiyong; Dittmer, Ulf; Roggendorf, Michael; Lu, Mengji] Univ Hosp Essen, Inst Virol, Essen, Germany; [Wang, Baoju; Tian, Yongjun; Yang, Dongliang] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Div Clin Immunol, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology; University of Duisburg Essen; Huazhong University of Science & Technology	Zhang, EJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Microbiol, Wuhan 430074, Peoples R China.	dlyang@tjh.tjmu.edu.cn; mengji.lu@uni-due.de	Tian, Yongjun/F-8007-2011; Lu, Mengji/ABF-9410-2020	Kosinska, Anna D./0000-0002-6352-1415	Deutsche Forschungsgemeinschaft [Transregio TRR60]; International Science & Technology Cooperation Program of China [2011DFA31030]; National Natural Science Foundation of China [30271170]; National Key Basic Research Program of China [2005CB522901, 2007CB512804, 2009CB522506]; National Major Science and Technology Special Project for Infectious Diseases of China [2008ZX10002-011]; China Scholarship Council [2008102014]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Science & Technology Cooperation Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National Major Science and Technology Special Project for Infectious Diseases of China; China Scholarship Council(China Scholarship Council)	This work is partially supported by grants from the Deutsche Forschungsgemeinschaft (Transregio TRR60), the International Science & Technology Cooperation Program of China (2011DFA31030), the National Natural Science Foundation of China (30271170), the National Key Basic Research Program of China (2005CB522901, 2007CB512804, 2009CB522506), and National Major Science and Technology Special Project for Infectious Diseases of China (2008ZX10002-011). EZ was supported by the China Scholarship Council (2008102014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bengsch B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000947; Bertoletti A, 2006, J GEN VIROL, V87, P1439, DOI 10.1099/vir.0.81920-0; Boni C, 2007, J VIROL, V81, P4215, DOI 10.1128/JVI.02844-06; Brown JA, 2003, J IMMUNOL, V170, P1257, DOI 10.4049/jimmunol.170.3.1257; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Diehl L, 2008, HEPATOLOGY, V47, P296, DOI 10.1002/hep.21965; Fisicaro P, 2010, GASTROENTEROLOGY, V138, P682, DOI 10.1053/j.gastro.2009.09.052; Frank I, 2007, J VIROL, V81, P7156, DOI 10.1128/JVI.02711-06; Groschel S, 2008, J MOL MED, V86, P443, DOI 10.1007/s00109-008-0310-x; Iwai YH, 2003, J EXP MED, V198, P39, DOI 10.1084/jem.20022235; Kassel R, 2009, HEPATOLOGY, V50, P1625, DOI 10.1002/hep.23173; Knolle Percy A., 2006, V43, P151, DOI 10.1007/018; Lu M, 2005, J VIROL, V79, P6368, DOI 10.1128/JVI.79.10.6368-6376.2005; Lu MJ, 2008, J VIROL, V82, P2598, DOI 10.1128/JVI.01613-07; Lu MJ, 2007, EXPERT OPIN INV DRUG, V16, P787, DOI 10.1517/13543784.16.6.787; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Muhlbauer M, 2006, J HEPATOL, V45, P520, DOI 10.1016/j.jhep.2006.05.007; Mueller SN, 2010, J CLIN INVEST, V120, P2508, DOI 10.1172/JCI40040; Okazaki T, 2006, TRENDS IMMUNOL, V27, P195, DOI 10.1016/j.it.2006.02.001; Overstreet MG, 2010, EUR J IMMUNOL, V40, P124, DOI 10.1002/eji.200939493; Peng GP, 2008, MOL IMMUNOL, V45, P963, DOI 10.1016/j.molimm.2007.07.038; Penna A, 2007, HEPATOLOGY, V45, P588, DOI 10.1002/hep.21541; Raziorrouh B, 2010, HEPATOLOGY, V52, P1934, DOI 10.1002/hep.23936; Rodig N, 2003, EUR J IMMUNOL, V33, P3117, DOI 10.1002/eji.200324270; Roggendorf M, 2007, J VIRAL HEPATITIS, V14, P51, DOI 10.1111/j.1365-2893.2007.00914.x; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Sauce D, 2007, AIDS, V21, P2005, DOI 10.1097/QAD.0b013e3282eee548; Sharpe AH, 2002, NAT REV IMMUNOL, V2, P116, DOI 10.1038/nri727; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Yamazaki T, 2002, J IMMUNOL, V169, P5538, DOI 10.4049/jimmunol.169.10.5538; Zhang XY, 2009, CELL MICROBIOL, V11, P1624, DOI 10.1111/j.1462-5822.2009.01353.x; Zhang Z, 2009, J HEPATOL, V50, P1163, DOI 10.1016/j.jhep.2009.01.026	36	34	41	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26196	10.1371/journal.pone.0026196	http://dx.doi.org/10.1371/journal.pone.0026196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022563	Green Published, gold, Green Submitted			2022-12-27	WOS:000295981600038
J	Eleswarapu, SV; Responte, DJ; Athanasiou, KA				Eleswarapu, Sriram V.; Responte, Donald J.; Athanasiou, Kyriacos A.			Tensile Properties, Collagen Content, and Crosslinks in Connective Tissues of the Immature Knee Joint	PLOS ONE			English	Article							ANTERIOR CRUCIATE LIGAMENT; MARROW STROMAL CELLS; ARTICULAR-CARTILAGE; IN-VITRO; MECHANICAL-PROPERTIES; COMPOSITE SCAFFOLD; STEM-CELLS; INJURIES; GROWTH; REPAIR	Background: The major connective tissues of the knee joint act in concert during locomotion to provide joint stability, smooth articulation, shock absorption, and distribution of mechanical stresses. These functions are largely conferred by the intrinsic material properties of the tissues, which are in turn determined by biochemical composition. A thorough understanding of the structure-function relationships of the connective tissues of the knee joint is needed to provide design parameters for efforts in tissue engineering. Methodology/Principal Findings: The objective of this study was to perform a comprehensive characterization of the tensile properties, collagen content, and pyridinoline crosslink abundance of condylar cartilage, patellar cartilage, medial and lateral menisci, cranial and caudal cruciate ligaments (analogous to anterior and posterior cruciate ligaments in humans, respectively), medial and lateral collateral ligaments, and patellar ligament from immature bovine calves. Tensile stiffness and strength were greatest in the menisci and patellar ligament, and lowest in the hyaline cartilages and cruciate ligaments; these tensile results reflected trends in collagen content. Pyridinoline crosslinks were found in every tissue despite the relative immaturity of the joints, and significant differences were observed among tissues. Notably, for the cruciate ligaments and patellar ligament, crosslink density appeared more important in determining tensile stiffness than collagen content. Conclusions/Significance: To our knowledge, this study is the first to examine tensile properties, collagen content, and pyridinoline crosslink abundance in a direct head-to-head comparison among all of the major connective tissues of the knee. This is also the first study to report results for pyridinoline crosslink density that suggest its preferential role over collagen in determining tensile stiffness for certain tissues.	[Eleswarapu, Sriram V.; Responte, Donald J.] Rice Univ, Dept Bioengn, Houston, TX 77251 USA; [Eleswarapu, Sriram V.] Baylor Coll Med, Med Scientist Training Program, Houston, TX 77030 USA; [Athanasiou, Kyriacos A.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA	Rice University; Baylor College of Medicine; University of California System; University of California Davis	Eleswarapu, SV (corresponding author), Rice Univ, Dept Bioengn, Houston, TX 77251 USA.	athanasiou@ucdavis.edu			National Institutes of Health [R01 AR053286, R01 AR047839]; UC Davis; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR047839, R01AR053286] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Davis; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was performed with funding from grants R01 AR053286 and R01 AR047839 by the National Institutes of Health, as well as UC Davis institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almarza AJ, 2004, TISSUE ENG, V10, P1787, DOI 10.1089/ten.2004.10.1787; Almarza AJ, 2004, ANN BIOMED ENG, V32, P2, DOI 10.1023/B:ABME.0000007786.37957.65; American Academy Of Orthopaedic Surgeons, 2008, US BON JOINT DEC BUR; Aufderheide AC, 2006, ANN BIOMED ENG, V34, P1463, DOI 10.1007/s10439-006-9157-x; Bank RA, 1997, J CHROMATOGR B, V703, P37, DOI 10.1016/S0378-4347(97)00391-5; BROOM ND, 1984, J ANAT, V139, P275; Buckwalter JA, 1998, J ORTHOP SPORT PHYS, V28, P192, DOI 10.2519/jospt.1998.28.4.192; Butler DL, 2008, J ORTHOP RES, V26, P1, DOI 10.1002/jor.20456; Calve S, 2004, TISSUE ENG, V10, P755, DOI 10.1089/1076327041348464; Chan BP, 1998, J ORTHOP RES, V16, P597, DOI 10.1002/jor.1100160512; CHU CR, 1995, J BIOMED MATER RES, V29, P1147, DOI 10.1002/jbm.820290915; Elbjeirami WM, 2003, J BIOMED MATER RES A, V66A, P513, DOI 10.1002/jbm.a.10021; Elder SH, 2006, J ORTHOP RES, V24, P740, DOI 10.1002/jor.20086; EYRE DR, 1984, ANAL BIOCHEM, V137, P380, DOI 10.1016/0003-2697(84)90101-5; Gooch KJ, 2002, TISSUE ENG, V8, P591, DOI 10.1089/107632702760240517; Hayami JWS, 2010, J BIOMED MATER RES A, V92A, P1407, DOI 10.1002/jbm.a.32472; Hoben GA, 2008, BIOTECHNOL BIOENG, V100, P587, DOI 10.1002/bit.21768; Hootman JM, 2006, ARTHRITIS RHEUM-US, V54, P226, DOI 10.1002/art.21562; Hu JC, 2006, TISSUE ENG, V12, P969, DOI 10.1089/ten.2006.12.969; HUEY DJ, BIOMATERIALS, V32, P2052; KUROSAWA H, 1980, CLIN ORTHOP RELAT R, P283; Lim JJ, 2011, BIOTECHNOL BIOENG, V108, P151, DOI 10.1002/bit.22909; Lohmander LS, 2007, AM J SPORT MED, V35, P1756, DOI 10.1177/0363546507307396; Louw QA, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.035360; Mauck RL, 2000, J BIOMECH ENG-T ASME, V122, P252, DOI 10.1115/1.429656; MeridaVelasco JA, 1997, ANAT REC, V248, P259, DOI 10.1002/(SICI)1097-0185(199706)248:2<259::AID-AR13>3.0.CO;2-O; Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822; Natoli RM, 2009, TISSUE ENG PT A, V15, P3119, DOI 10.1089/ten.TEA.2008.0478; Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje; RALPHS JR, 1994, J ANAT, V184, P503; REGINATO AM, 1994, ARTHRITIS RHEUM, V37, P1338, DOI 10.1002/art.1780370912; Responte Donald J., 2007, Critical Reviews in Biomedical Engineering, V35, P363, DOI 10.1615/CritRevBiomedEng.v35.i5.20; Sah RL, 1996, J ORTHOPAED RES, V14, P44, DOI 10.1002/jor.1100140109; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; Smith KD, 2011, J ANAT, V218, P600, DOI 10.1111/j.1469-7580.2011.01374.x; Tanimori S, 2000, BIOSCI BIOTECH BIOCH, V64, P1758, DOI 10.1271/bbb.64.1758; Van Eijk F, 2004, TISSUE ENG, V10, P893, DOI 10.1089/1076327041348428; Walsh CJ, 1999, TISSUE ENG, V5, P327, DOI 10.1089/ten.1999.5.327; Williamson AK, 2003, J ORTHOPAED RES, V21, P872, DOI 10.1016/S0736-0266(03)00030-5; Williamson AK, 2003, TISSUE ENG, V9, P625, DOI 10.1089/107632703768247322; Woo SLY, 2000, ANNU REV BIOMED ENG, V2, P83, DOI 10.1146/annurev.bioeng.2.1.83	41	79	81	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2011	6	10							e26178	10.1371/journal.pone.0026178	http://dx.doi.org/10.1371/journal.pone.0026178			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834QT	22022553	Green Published, gold			2022-12-27	WOS:000295978600042
J	De Stefani, E; Pinello, L; Campana, G; Mazzarolo, M; Lo Giudice, G; Casco, C				De Stefani, Elisa; Pinello, Luisa; Campana, Gianluca; Mazzarolo, Monica; Lo Giudice, Giuseppe; Casco, Clara			Illusory Contours over Pathological Retinal Scotomas	PLOS ONE			English	Article							PERCEPTUAL FILLING-IN; PRIMARY VISUAL-CORTEX; BLIND-SPOT; MACULAR DEGENERATION; NEURAL RESPONSES; CORTICAL MAPS; ARTIFICIAL SCOTOMAS; STRIATE CORTEX; DYNAMIC NOISE; HUMAN VISION	Our visual percepts are not fully determined by physical stimulus inputs. Thus, in visual illusions such as the Kanizsa figure, inducers presented at the corners allow one to perceive the bounding contours of the figure in the absence of luminance-defined borders. We examined the discrimination of the curvature of these illusory contours that pass across retinal scotomas caused by macular degeneration. In contrast with previous studies with normal-sighted subjects that showed no perception of these illusory contours in the region of physiological scotomas at the optic nerve head, we demonstrated perfect discrimination of the curvature of the illusory contours over the pathological retinal scotoma. The illusion occurred despite the large scar around the macular lesion, strongly reducing discrimination of whether the inducer openings were acute or obtuse and suggesting that the coarse information in the inducers (low spatial frequency) sufficed. The result that subjective contours can pass through the pathological retinal scotoma suggests that the visual cortex, despite the loss of bottom-up input, can use low-spatial frequency information from the inducers to form a neural representation of new complex geometrical shapes inside the scotoma.	[De Stefani, Elisa] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Pinello, Luisa; Mazzarolo, Monica] Univ Padua, Dept Paediat, Paediat Low Vis Ctr, Padua, Italy; [Campana, Gianluca; Casco, Clara] Univ Padua, Dept Gen Psychol, Padua, Italy; [Lo Giudice, Giuseppe] San Antonio Hosp, San Paolo Ophthalm Ctr, Padua, Italy	University of Parma; University of Padua; University of Padua; ULSS 6 Euganea; Ospedale Sant'antonio Padova	De Stefani, E (corresponding author), Univ Parma, Dept Neurosci, I-43100 Parma, Italy.	elidestefani@gmail.com	Campana, Gianluca/AAC-5909-2022; Campana, Gianluca/F-8981-2010; LO GIUDICE, GIUSEPPE/GQB-0418-2022; De Stefani, Elisa/C-3154-2018	Campana, Gianluca/0000-0003-4019-085X; De Stefani, Elisa/0000-0003-4492-3926				Baker CI, 2008, VISION RES, V48, P1910, DOI 10.1016/j.visres.2008.05.020; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Baseler HA, 2002, NAT NEUROSCI, V5, P364, DOI 10.1038/nn817; BROWN RJ, 1993, PERCEPT PSYCHOPHYS, V53, P200, DOI 10.3758/BF03211730; Calford MB, 2000, J PHYSIOL-LONDON, V524, P587, DOI 10.1111/j.1469-7793.2000.t01-1-00587.x; Casco C, 2003, VISUAL NEUROSCI, V20, P501, DOI 10.1017/S0952523803205046; Cheong AMY, 2007, VISION RES, V47, P2943, DOI 10.1016/j.visres.2007.07.010; CHINO YM, 1992, VISION RES, V32, P789, DOI 10.1016/0042-6989(92)90021-A; Crossland MD, 2009, INVEST OPHTH VIS SCI, V50, P1464, DOI 10.1167/iovs.08-2690; DARIANSMITH C, 1995, J NEUROSCI, V15, P1631, DOI 10.1523/JNEUROSCI.15-03-01631.1995; Dennett D. C., 1992, COGNITION CONCEPTUAL; DEWEERD P, 1995, NATURE, V377, P731, DOI 10.1038/377731a0; Dilks DD, 2009, J NEUROSCI, V29, P2768, DOI 10.1523/JNEUROSCI.5258-08.2009; Finney D.J., 1971, PROBIT ANAL; FIORANI M, 1992, P NATL ACAD SCI USA, V89, P8547, DOI 10.1073/pnas.89.18.8547; GERRITS HJM, 1969, VISION RES, V9, P439, DOI 10.1016/0042-6989(69)90092-3; GILBERT TN, 1992, NATURE, V356, P150; HEINEN SJ, 1991, EXP BRAIN RES, V83, P670; Howell D., 2009, STAT METHODS PSYCHOL, V7th; KAAS JH, 1990, SCIENCE, V248, P229, DOI 10.1126/science.2326637; KANIZSA K, 1976, SCI AM, V234, P48; KAPADIA MK, 1994, J NEUROSCI, V14, P451; Komatsu H, 2006, NAT REV NEUROSCI, V7, P220, DOI 10.1038/nrn1869; Komatsu H, 2002, NEUROSCI RES, V44, P231, DOI 10.1016/S0168-0102(02)00149-9; Komatsu H, 2000, J NEUROSCI, V20, P9310; Maertens M, 2005, J COGNITIVE NEUROSCI, V17, P1553, DOI 10.1162/089892905774597209; Maertens M, 2007, J COGNITIVE NEUROSCI, V19, P91, DOI 10.1162/jocn.2007.19.1.91; Maertens M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.002.2008; Masuda Y, 2008, CEREB CORTEX, V18, P2483, DOI 10.1093/cercor/bhm256; Matsumoto M, 2005, J NEUROPHYSIOL, V93, P2374, DOI 10.1152/jn.00811.2004; Meng M, 2005, NAT NEUROSCI, V8, P1248, DOI 10.1038/nn1518; Mihaylov P, 2007, VISION RES, V47, P1479, DOI 10.1016/j.visres.2007.01.028; Murakami I, 1997, VISUAL NEUROSCI, V14, P89, DOI 10.1017/S0952523800008798; OREGAN JK, 1992, CAN J PSYCHOL, V46, P461, DOI 10.1037/h0084327; PELLI DG, 1988, CLIN VISION SCI, V2, P187; Pessoa L, 1998, BEHAV BRAIN SCI, V21, P723; PETTET MW, 1992, P NATL ACAD SCI USA, V89, P8366, DOI 10.1073/pnas.89.17.8366; RAMACHANDRAN VS, 1991, NATURE, V350, P699, DOI 10.1038/350699a0; RAMACHANDRAN VS, 1992, NATURE, V356, P115, DOI 10.1038/356115a0; Reich LN, 2000, VISION RES, V40, P805, DOI 10.1016/S0042-6989(99)00215-1; Safran AB, 1999, BRIT J OPHTHALMOL, V83, P137, DOI 10.1136/bjo.83.2.137; SAFRAN AB, 1996, VISION RES, V36, pS214; Sasaki Y, 2004, P NATL ACAD SCI USA, V101, P18251, DOI 10.1073/pnas.0406293102; Schumacher EH, 2008, RESTOR NEUROL NEUROS, V26, P391; SPILLMANN L, 1992, VISION RES, V32, P1941, DOI 10.1016/0042-6989(92)90053-L; Spillmann L, 2006, VISION RES, V46, P4252, DOI 10.1016/j.visres.2006.08.033; Sunness JS, 2004, OPHTHALMOLOGY, V111, P1595, DOI 10.1016/j.ophtha.2003.12.050; Tailby C, 2004, VISUAL NEUROSCI, V21, P79, DOI 10.1017/S0952523804041082; Tong F, 2001, NATURE, V411, P195, DOI 10.1038/35075583; TRIPATHY SP, 1994, VISION RES, V34, P1127, DOI 10.1016/0042-6989(94)90295-X; Tripathy SP, 1999, VISION RES, V39, P1917, DOI 10.1016/S0042-6989(98)00230-2; Tyler CW, 1998, PERCEPTION, V27, P203, DOI 10.1068/p270203; Wittich W, 2006, VISION RES, V46, P4064, DOI 10.1016/j.visres.2006.07.005; YATES F, 1984, J ROY STAT SOC A STA, V147, P426, DOI 10.2307/2981577; Zur D, 2003, VISION RES, V43, P971, DOI 10.1016/S0042-6989(03)00038-5	55	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26154	10.1371/journal.pone.0026154	http://dx.doi.org/10.1371/journal.pone.0026154			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022546	gold, Green Submitted, Green Published			2022-12-27	WOS:000295976000076
J	Yager, JE; Kadiyala, S; Weiser, SD				Yager, Jessica E.; Kadiyala, Suneetha; Weiser, Sheri D.			HIV/AIDS, Food Supplementation and Livelihood Programs in Uganda: A Way Forward?	PLOS ONE			English	Article							HIV-INFECTED INDIVIDUALS; ANTIRETROVIRAL TREATMENT; ADHERENCE; INSECURITY; NUTRITION; HEALTH; CARE; INTERVENTION; ASSOCIATION; SERVICES	Background: Over the last decade, health, nutrition and policy experts have become increasingly aware of the many ways in which food insecurity and HIV infection negatively impact and reinforce one another. In response, many organizations providing HIV care began supplying food aid to clients in need. Food supplementation, however, was quickly recognized as an unsustainable and incomplete intervention. Many HIV care organizations therefore developed integrated HIV and livelihood programs (IHLPs) to target the root causes of food insecurity. Methods and Findings: We conducted a qualitative study using in-depth interviews with 21 key informants who worked at seven organizations providing HIV care, food aid, or IHLPs in Kampala, Uganda in 2007-2008 to better understand the impact of IHLPs on the well-being of people living with HIV and AIDS (PLWHAs) and the challenges in transitioning clients from food aid to IHLPs. There was strong consensus among those interviewed that IHLPs are an important intervention in addressing food insecurity and its adverse health consequences among PLWHAs. Key informants identified three main challenges in transitioning PLWHAs from food supplementation programs to IHLPs: (1) lack of resources (2) timing of the transition and (3) logistical considerations including geography and weather. Factors seen as contributing to the success of programs included: (1) close involvement of community leaders (2) close ties with local and national government (3) diversification of IHLP activities and (4) close integration with food supplementation programs, all linked through a central program of HIV care. Conclusion: Health, policy and development experts should continue to strengthen IHLPs for participants in need. Further research is needed to determine when and how participants should be transitioned from food supplementation to IHLPs, and to determine how to better correlate measures of food insecurity with objective clinical outcomes so as to better evaluate program results.	[Yager, Jessica E.] Univ Washington, Dept Med, Div Infect Dis, Seattle, WA 98195 USA; [Yager, Jessica E.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98104 USA; [Kadiyala, Suneetha] Int Food Policy Res Inst, Poverty Hlth & Nutr Div, New Delhi, India; [Weiser, Sheri D.] San Francisco Gen Hosp, Div HIV AIDS, San Francisco, CA 94110 USA; [Weiser, Sheri D.] Univ Calif San Francisco, Ctr AIDS Prevent Studies, San Francisco, CA 94143 USA	University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; CGIAR; International Food Policy Research Institute (IFPRI); San Francisco General Hospital Medical Center; University of California System; University of California San Francisco	Yager, JE (corresponding author), Univ Washington, Dept Med, Div Infect Dis, Seattle, WA 98195 USA.	jeyager@fhcrc.org		Kadiyala, Suneetha/0000-0002-9101-1471	Regional Network on AIDS, Livelihoods and Food Security (RENEWAL) initiative; Irish Aid; Swedish International Development Cooperation Agency (SIDA); NIMH [5K23MH079713-01]; California HIV/AIDS Research Program [ID08-SF-054]; Burke Global Health Faculty Award; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH079713] Funding Source: NIH RePORTER	Regional Network on AIDS, Livelihoods and Food Security (RENEWAL) initiative; Irish Aid(CGIAR); Swedish International Development Cooperation Agency (SIDA); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California HIV/AIDS Research Program; Burke Global Health Faculty Award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Dr. Kadiyala's time was funded by the Regional Network on AIDS, Livelihoods and Food Security (RENEWAL) initiative, and facilitated by the International Food Policy Research Institute (IFPRI). RENEWAL is grateful for support from Irish Aid and from the Swedish International Development Cooperation Agency (SIDA). Dr. Weiser receives funding from NIMH: 5K23MH079713-01, California HIV/AIDS Research Program grant number ID08-SF-054 and the Burke Global Health Faculty Award. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anema Aranka, 2009, Curr HIV/AIDS Rep, V6, P224, DOI 10.1007/s11904-009-0030-z; Au JT, 2006, AIDS, V20, P2116, DOI 10.1097/01.aids.0000247580.16073.1b; Bradley EH, 2007, HEALTH SERV RES, V42, P1758, DOI 10.1111/j.1475-6773.2006.00684.x; Bukusuba J, 2007, BRIT J NUTR, V98, P211, DOI 10.1017/S0007114507691806; Cantrell RA, 2008, JAIDS-J ACQ IMM DEF, V49, P190, DOI 10.1097/QAI.0b013e31818455d2; de Waal A, 2003, LANCET, V362, P1234, DOI 10.1016/S0140-6736(03)14548-5; Fields-Gardner C, 2010, J AM DIET ASSOC, V110, P1105, DOI 10.1016/j.jada.2010.05.020; Gillespie S, 2005, INT FOOD POLICY RES; Ivers LC, 2009, CLIN INFECT DIS, V49, P1096, DOI 10.1086/605573; Kadiyala S, 2009, J DEV EFFECT, V1, P470, DOI 10.1080/19439340903370469; Kalichman SC, 2010, J URBAN HEALTH, V87, P631, DOI 10.1007/s11524-010-9446-4; Mamlin J, 2009, AM J PUBLIC HEALTH, V99, P215, DOI 10.2105/AJPH.2008.137174; MAYS N, 1995, BRIT MED J, V311, P109, DOI 10.1136/bmj.311.6997.109; Miller CL, 2011, AIDS BEHAV, V15, P1512, DOI 10.1007/s10461-010-9693-0; Olupot-Olupot P, 2008, AIDS, V22, P1882, DOI 10.1097/QAD.0b013e3283112ba6; Pandit JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-245; Rawat R, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-316; Sanjobo N, 2008, SAHARA J-J SOC ASP H, V5, P136, DOI 10.1080/17290376.2008.9724912; SEUMEFOSSO E, 2004, FOOD NUTR TECHNICAL; *UN, 2006, UN GEN ASS; *UN ADM COMM COORD, 2001, NUTR HIV AIDS; *UN WORLD FOOD PRO, 2008, HIV AIDS AN INT HIV; Unge C, 2008, AIDS CARE, V20, P146, DOI 10.1080/09540120701513677; van Oosterhout JJ, 2010, AIDS CARE, V22, P737, DOI 10.1080/09540120903373581; Weiser SD, 2007, PLOS MED, V4, P1589, DOI 10.1371/journal.pmed.0040260; Weiser SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010340; Weiser SD, 2009, JAIDS-J ACQ IMM DEF, V52, P342, DOI 10.1097/QAI.0b013e3181b627c2; Weiser SD, 2009, J GEN INTERN MED, V24, P14, DOI 10.1007/s11606-008-0824-5; World Food Programme, 2003, PROGR ER AIDS WPFS R	29	29	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26117	10.1371/journal.pone.0026117	http://dx.doi.org/10.1371/journal.pone.0026117			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834PW	22022530	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000295976000070
J	Adarkwah, CC; Gandjour, A; Akkerman, M; Evers, SM				Adarkwah, Charles Christian; Gandjour, Afschin; Akkerman, Maren; Evers, Silvia M.			Cost-Effectiveness of Angiotensin-Converting Enzyme Inhibitors for the Prevention of Diabetic Nephropathy in The Netherlands - A Markov Model	PLOS ONE			English	Article							II RECEPTOR BLOCKERS; STAGE RENAL-DISEASE; QUALITY-OF-LIFE; TIME TRADE-OFF; HEALTH STATES; RISK-FACTORS; ALBUMINURIA; MELLITUS; MICROALBUMINURIA; PREVALENCE	Objective: Type 2 diabetes is the main cause of end-stage renal disease (ESRD) in Europe and the USA. Angiotensin-converting enzyme (ACE) inhibitors have a potential to slow down the progression of renal disease and therefore provide a renal-protective effect. The aim of our study was to assess the most cost-effective time to start an ACE inhibitor (or an angiotensin II receptor blocker [ARB] if coughing as a side effect occurs) in patients with newly diagnosed type 2 diabetes in The Netherlands. Methods: A lifetime Markov decision model with simulated 50-year-old patients with newly diagnosed diabetes mellitus was developed using published data on costs and health outcomes and simulating the progression of renal disease. A health insurance perspective was adopted. Three strategies were compared: treating all patients at the time of diagnosing type 2 diabetes, screening for microalbuminuria, and screening for macroalbuminuria. Results: In the base-case analysis, the treat-all strategy is associated with the lowest costs and highest benefit and therefore dominates screening both for macroalbuminuria and microalbuminuria. A multivariate sensitivity analysis shows that the probability of savings is 70%. Conclusions: In The Netherlands for patients with type 2 diabetes prescription of an ACE inhibitor immediately after diagnosis should be considered if they do not have contraindications. An ARB should be considered for those patients developing a dry cough under ACE inhibitor therapy. The potential for cost savings would be even larger if the prevention of cardiovascular events were considered.	[Adarkwah, Charles Christian; Evers, Silvia M.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [Adarkwah, Charles Christian] RWTH Univ Hosp Aachen, Dept Med 3, Aachen, Germany; [Gandjour, Afschin] Frankfurt Sch Finance & Management, Frankfurt, Germany; [Akkerman, Maren] Rhein Westfal TH Aachen, Fac Med, Aachen, Germany	Maastricht University; RWTH Aachen University; RWTH Aachen University Hospital; Frankfurt School Finance & Management; RWTH Aachen University	Adarkwah, CC (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands.	s.evers@maastrichtuniversity.nl	Evers, Silvia MAA/K-9720-2015; Gandjour, Afschin/I-8963-2019; Evers, Silvia/ABG-2128-2020	Evers, Silvia MAA/0000-0003-1026-570X; Evers, Silvia/0000-0003-1026-570X; Adarkwah, Charles Christian/0000-0002-1073-5866				Adarkwah CC, 2011, EXPERT REV PHARM OUT, V11, P215, DOI [10.1586/erp.11.18, 10.1586/ERP.11.8]; Adarkwah CC, 2010, INT J TECHNOL ASSESS, V26, P62, DOI 10.1017/S0266462309990584; Ahmad J, 1997, DIABETES CARE, V20, P1576, DOI 10.2337/diacare.20.10.1576; [Anonymous], 2011, CONS PRIC PRIC 2009; [Anonymous], 2009, OV; [Anonymous], 2003, VA DOD CLIN PRACT GU; Arnesen Trude, 2004, J Health Serv Res Policy, V9, P43, DOI 10.1258/135581904322716111; Atthobari J, 2006, CLIN THER, V28, P432, DOI 10.1016/j.clinthera.2006.03.012; Bakker A J, 2004, Ned Tijdschr Geneeskd, V148, P2012; Bakker AJ, 1998, NED TIJDSCHR KLIN CH, V23, P129; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Bertoni AG, 2002, DIABETES CARE, V25, P471, DOI 10.2337/diacare.25.3.471; Bleichrodt H, 1997, J HEALTH ECON, V16, P155, DOI 10.1016/S0167-6296(96)00509-7; Boersma C, 2010, CLIN THER, V32, P1103, DOI 10.1016/j.clinthera.2010.06.013; Briggs AH, 2003, MED DECIS MAKING, V23, P341, DOI 10.1177/0272989X03255922; Brouwer WBF, 2005, BRIT MED J, V331, P446, DOI 10.1136/bmj.331.7514.446; Brown GC, 2000, J DIABETES COMPLICAT, V14, P18, DOI 10.1016/S1056-8727(00)00061-1; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; CHURCHILL DN, 1987, CLIN INVEST MED, V10, P14; College voor Zorgverzekeringen (CVZ), 2009, DUTCH GUID PHARM RES; College Voor Zorgverzekeringen (CVZ), 2009, GIPCILINGEN; Comper WD, 2003, AM J KIDNEY DIS, V41, P336, DOI 10.1053/ajkd.2003.50041; Dale PL, 2008, CURR MED RES OPIN, V24, P193, DOI 10.1185/030079908X253410; de Wit GA, 1998, HEALTH POLICY, V44, P215, DOI 10.1016/S0168-8510(98)00017-7; Dolan P, 1996, J HEALTH ECON, V15, P209, DOI 10.1016/0167-6296(95)00038-0; Dutch End-Stage Renal Disease Registry, 2011, DUTCH END STAGE RENA; Farmacotherapeutisch kompas, 2010, FARM KOMP; Farmacotherapeutisch kompas, 2002, FARM KOMP; Frei U, 2006, NIERENERSATZTHERAPIE; Gandjour A, 2002, DIABETIC MED, V19, P594, DOI 10.1046/j.1464-5491.2002.00763.x; Gansevoort RT, 2005, KIDNEY INT, V67, pS28, DOI 10.1111/j.1523-1755.2005.09408.x; Gerstein HC, 2000, LANCET, V355, P253; Giani G, 2004, EVIDENZBASIERTE DIAB; Golan L, 1999, ANN INTERN MED, V131, P660, DOI 10.7326/0003-4819-131-9-199911020-00005; Hasslacher C, 2000, EVIDENZBASIERTE DIAB; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; John JA, 2006, STAT THINKING BUSINE; Koopman RJ, 2005, ANN FAM MED, V3, P60, DOI 10.1370/afm.214; Kuntz KM, 2005, EC EVALUATION HLTH C, P141; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; LEWIS EJ, 1993, NEW ENGL J MED, V329, P1456, DOI 10.1056/NEJM199311113292004; Matchar DB, 2008, ANN INTERN MED, V148, P16, DOI 10.7326/0003-4819-148-1-200801010-00189; McIntosh AHA, 2002, CLIN GUIDELINES EVID; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; MOLITCH ME, 2004, DIABETES CARE S1, V27, pS79, DOI DOI 10.2337/DIACARE.27.5.1240-A; Nederlandse internisten vereniging (NIV), 2006, RICHTL DIAB NEFR MON, P16; Nederlandse internisten vereniging (NIV), 2006, RICHTL DIAB NEFR SAM, P3; Nederlandse Zorgautoriteit, 2010, RAPP INK PRAKT AP, p[Nov, 52]; Niskanen LK, 1996, DIABETES CARE, V19, P486, DOI 10.2337/diacare.19.5.486; Oostenbrink J, 2004, HANDLEIDING KOSTENON; Parving HH, 2001, NEW ENGL J MED, V345, P870, DOI 10.1056/NEJMoa011489; Peeters P, 2000, HEALTH POLICY, V54, P209, DOI 10.1016/S0168-8510(00)00112-3; Renine Statistic Report, 2007, DEV RENAL REPLACEMEN; Ritz E, 1999, AM J KIDNEY DIS, V34, P795, DOI 10.1016/S0272-6386(99)70035-1; Rosen AB, 2005, ANN INTERN MED, V143, P89, DOI 10.7326/0003-4819-143-2-200507190-00007; Scheid DC, 2001, J FAM PRACTICE, V50, P661; Schroeder A, 2005, GMS HLTH TECHNOL ASS, V2; Strippoli GFM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006257; Strippoli GFM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004136.pub2; Third National Health and Nutrition Examination Survey 1988-1994, 1996, 76200 US DEP HHS NAT; *US REN DAT SYST, 2001, USRDS 2001 ANN DAT R; van Os N, 2000, HEALTH POLICY, V51, P135, DOI 10.1016/S0168-8510(00)00063-4; Vegter S, 2009, PHARMACOGENET GENOM, V19, P695, DOI 10.1097/FPC.0b013e3283307ca0	63	19	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2011	6	10							e26139	10.1371/journal.pone.0026139	http://dx.doi.org/10.1371/journal.pone.0026139			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	834OZ	22022539	gold, Green Published, Green Submitted			2022-12-27	WOS:000295973200043
J	Muhlhans, J; Brandstatter, JH; Giessl, A				Muehlhans, Johanna; Brandstaetter, Johann Helmut; Giessl, Andreas			The Centrosomal Protein Pericentrin Identified at the Basal Body Complex of the Connecting Cilium in Mouse Photoreceptors	PLOS ONE			English	Article							MICROTUBULE ORGANIZATION; VERTEBRATE PHOTORECEPTOR; SPINDLE ORGANIZATION; PRIMORDIAL DWARFISM; VESICLE TRANSPORT; CG-NAP; CELLS; KENDRIN; GENE; TRANSLOCATION	Background: Pericentrin (Pcnt), a conserved protein of the pericentriolar material, serves as a multifunctional scaffold for numerous proteins and plays an important role in microtubule organization. Recent studies indicate that Pcnt mutations are associated with a range of diseases including primordial dwarfism and ciliopathies. To date, three Pcnt splice variants from orthologous genes in mice and humans are known. Principal Findings: We generated a specific Pcnt antiserum detecting all known Pcnt splice variants and examined the cellular and subcellular distribution of Pcnt in ciliated tissues of the mouse, the olfactory epithelium and the retina. For the first time, we identified Pcnt and its centrosomal interaction partners at the basal body complex of mouse retinal photoreceptors. Photoreceptors are morphologically and functionally subdivided into the light sensitive outer segment and the inner segment comprising the metabolic function of the cell. The two compartments are linked via a modified, specialized, non-motile cilium, the connecting cilium. Here, Pcnt colocalized with the whole protein machinery responsible for transport processes between the two compartments. Surprisingly, photoreceptors expressed a small Pcnt splice transcript - most likely a modified variant of Pcnt S - which was not present in receptor neurons of the olfactory epithelium. Conclusions: Our findings suggest distinct functional roles of several Pcnt variants in different ciliated tissues and sensory neurons, like the olfactory epithelium and the retina of the mouse. The individual patchwork of different Pcnt splice transcripts seems to reflect the complexity of Pcnt function, an assumption corroborated by the heterogeneous clinical manifestations associated with mutations in the Pcnt gene.	[Muehlhans, Johanna; Brandstaetter, Johann Helmut; Giessl, Andreas] Univ Erlangen Nurnberg, Dept Biol, Erlangen, Germany	University of Erlangen Nuremberg	Giessl, A (corresponding author), Univ Erlangen Nurnberg, Dept Biol, Erlangen, Germany.	agiessl@biologie.uni-erlangen.de		Giessl, Andreas/0000-0002-9768-2049	Deutsche Forschungsgemeinschaft [GI 770/1-1]; Dr. Hertha und Helmut Schmauser-Stiftung (Erlangen, Germany); Universitatsbund Erlangen-Nurnberg e.V. (Erlangen, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dr. Hertha und Helmut Schmauser-Stiftung (Erlangen, Germany); Universitatsbund Erlangen-Nurnberg e.V. (Erlangen, Germany)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (GI 770/1-1), the funds of the Dr. Hertha und Helmut Schmauser-Stiftung (Erlangen, Germany) and the Universitatsbund Erlangen-Nurnberg e.V. (Erlangen, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALCZON R, 1994, J CELL BIOL, V124, P783, DOI 10.1083/jcb.124.5.783; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Chakarova CF, 2011, HUM MOL GENET, V20, P975, DOI 10.1093/hmg/ddq543; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; Dammermann A, 2002, J CELL BIOL, V159, P255, DOI 10.1083/jcb.200204023; Delaval B, 2010, J CELL BIOL, V188, P181, DOI 10.1083/jcb.200908114; Dictenberg JB, 1998, J CELL BIOL, V141, P163, DOI 10.1083/jcb.141.1.163; Diviani D, 2000, CURR BIOL, V10, P417, DOI 10.1016/S0960-9822(00)00422-X; Doxsey S, 2005, TRENDS CELL BIOL, V15, P303, DOI 10.1016/j.tcb.2005.04.008; DOXSEY SJ, 1994, CELL, V76, P639, DOI 10.1016/0092-8674(94)90504-5; Endoh-Yamagami S, 2010, DEV BIOL, V340, P41, DOI 10.1016/j.ydbio.2010.01.017; Evans RJ, 2010, HUM MOL GENET, V19, P1358, DOI 10.1093/hmg/ddq012; Flory MR, 2003, GENOMICS, V82, P401, DOI 10.1016/S0888-7543(03)00119-8; GieBl A, 2010, E NEUROFORUM, DOI [10.1007/s13295-13010-10007-13299, DOI 10.1007/S13295-13010-10007-13299]; Giessl A, 2004, J BIOL CHEM, V279, P51472, DOI 10.1074/jbc.M406770200; GIESSL A, 2004, CELL BIOL RELATED DI, P122; Giessl A, 2006, VISION RES, V46, P4502, DOI 10.1016/j.visres.2006.07.029; Gillingham AK, 2000, EMBO REP, V1, P524; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Hurd T, 2010, HUM MOL GENET, V19, P4330, DOI 10.1093/hmg/ddq355; Insinna C, 2008, DEV BIOL, V316, P160, DOI 10.1016/j.ydbio.2008.01.025; Jenkins PM, 2009, CHEM SENSES, V34, P451, DOI 10.1093/chemse/bjp020; Jurczyk A, 2004, J CELL BIOL, V166, P637, DOI 10.1083/jcb.200405023; Karcher C, 2005, DIFFERENTIATION, V73, P425, DOI 10.1111/j.1432-0436.2005.00048.x; Kawaguchi S, 2004, MOL BIOL CELL, V15, P37, DOI 10.1091/mbc.E03-03-0191; Kennedy B, 2009, DEV DYNAM, V238, P2115, DOI 10.1002/dvdy.22010; Kersten FFJ, 2010, INVEST OPHTH VIS SCI, V51, P2338, DOI 10.1167/iovs.09-4650; Li C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000044; Liu QQ, 2001, J CELL SCI, V114, P797; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010902; Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130; Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Miyoshi K, 2006, BIOCHEM BIOPH RES CO, V351, P745, DOI 10.1016/j.bbrc.2006.10.101; Miyoshi K, 2006, DEV GENES EVOL, V216, P537, DOI 10.1007/s00427-006-0065-8; Miyoshi K, 2009, FASEB J, V23, P3289, DOI 10.1096/fj.08-124420; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108; Piane M, 2009, AM J MED GENET A, V149A, P2452, DOI 10.1002/ajmg.a.33035; Purohit A, 1999, J CELL BIOL, V147, P481, DOI 10.1083/jcb.147.3.481; Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174; Reidel B, 2008, CELL MOTIL CYTOSKEL, V65, P785, DOI 10.1002/cm.20300; Roepman Ronald, 2007, V43, P209, DOI 10.1007/978-1-4020-5943-8_10; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Sedmak T, 2010, J CELL BIOL, V189, P171, DOI 10.1083/jcb.200911095; Sedmak T, 2009, METHOD CELL BIOL, V94, P259, DOI 10.1016/S0091-679X(08)94013-9; Shimizu S, 2008, BIOCHEM BIOPH RES CO, V377, P1051, DOI 10.1016/j.bbrc.2008.10.100; Shu X, 2005, HUM MOL GENET, V14, P1183, DOI 10.1093/hmg/ddi129; Sung CH, 2000, INT REV CYTOL, V195, P215; Takahashi M, 2002, MOL BIOL CELL, V13, P3235, DOI 10.1091/mbc.E02-02-0112; Willems M, 2010, J MED GENET, V47, P797, DOI 10.1136/jmg.2009.067298; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	53	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2011	6	10							e26496	10.1371/journal.pone.0026496	http://dx.doi.org/10.1371/journal.pone.0026496			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841LG	22031837	Green Published, Green Submitted, gold			2022-12-27	WOS:000296513200026
J	Huang, KY; Chen, GD; Cheng, CH; Liao, KY; Hung, CC; Chang, GD; Hwang, PP; Lin, SY; Tsai, MC; Khoo, KH; Lee, MT; Huang, CJ				Huang, Kai-Yun; Chen, Gen-Der; Cheng, Chia-Hsiung; Liao, Kuan-Ya; Hung, Chin-Chun; Chang, Geen-Dong; Hwang, Pung-Pung; Lin, Shu-Yu; Tsai, Ming-Chieh; Khoo, Kay-Hooi; Lee, Ming-Ting; Huang, Chang-Jen			Phosphorylation of the Zebrafish M6Ab at Serine 263 Contributes to Filopodium Formation in PC12 Cells and Neurite Outgrowth in Zebrafish Embryos	PLOS ONE			English	Article							PROTEIN-KINASE-II; CENTRAL-NERVOUS-SYSTEM; PROTEOLIPID PROTEIN; PHOSPHOPROTEOMIC ANALYSIS; DENDRITIC FILOPODIA; SYNAPSE FORMATION; GENOME EVOLUTION; SPINE FORMATION; HOX CLUSTERS; GENE FAMILY	Background: Mammalian M6A, a member of the proteolipid protein (PLP/DM20) family expressed in neurons, was first isolated by expression cloning with a monoclonal antibody. Overexpression of M6A was shown to induce filopodium formation in neuronal cells; however, the underlying mechanism of is largely unknown. Possibly due to gene duplication, there are two M6A paralogs, M6Aa and M6Ab, in the zebrafish genome. In the present study, we used the zebrafish as a model system to investigate the role of zebrafish M6Ab in filopodium formation in PC12 cells and neurite outgrowth in zebrafish embryos. Methodology/Principal Findings: We demonstrated that zebrafish M6Ab promoted extensive filopodium formation in NGF-treated PC12 cells, which is similar to the function of mammalian M6A. Phosphorylation at serine 263 of zebrafish M6Ab contributed to this induction. Transfection of the S263A mutant protein greatly reduced filopodium formation in PC12 cells. In zebrafish embryos, only S263D could induce neurite outgrowth. Conclusions/Significance: Our results reveal that the phosphorylation status of zebrafish M6Ab at serine 263 is critical for its role in regulating filopodium formation and neurite outgrowth.	[Huang, Kai-Yun; Chang, Geen-Dong; Khoo, Kay-Hooi; Lee, Ming-Ting; Huang, Chang-Jen] Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan; [Huang, Kai-Yun; Chen, Gen-Der; Cheng, Chia-Hsiung; Liao, Kuan-Ya; Hung, Chin-Chun; Khoo, Kay-Hooi; Lee, Ming-Ting; Huang, Chang-Jen] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Hwang, Pung-Pung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Lin, Shu-Yu] Acad Sinica, Inst Biol Chem, Common Mass Spectrometry Facil, Taipei, Taiwan; [Tsai, Ming-Chieh] Acad Sinica, Inst Biol Chem, NRPGM, Core Facil Prote & Glycomcis, Taipei, Taiwan	National Taiwan University; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan; Academia Sinica - Taiwan	Huang, KY (corresponding author), Natl Taiwan Univ, Inst Biochem Sci, Taipei, Taiwan.	mtlee@gate.sinica.edu.tw; cjibc@gate.sinica.edu.tw	Khoo, Kay-Hooi/E-1989-2019; Hwang, Pung-Pung/AAH-1538-2022; Hwang, Pung-Pung/AEQ-4633-2022; hwang, pp/A-3641-2011; lin, shuyu/GRF-5383-2022; Cheng, Chia-Hsiung/A-6044-2019; Hung, Chin-Chun/G-8879-2019	Khoo, Kay-Hooi/0000-0003-2906-406X; Cheng, Chia-Hsiung/0000-0003-0307-9650; Hung, Chin-Chun/0000-0003-4769-7194	Academia Sinica, Taipei, Taiwan [AS-99-TP-B08]	Academia Sinica, Taipei, Taiwan(Academia Sinica - Taiwan)	This study was supported by a grant (AS-99-TP-B08) from Academia Sinica, Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfonso J, 2005, P NATL ACAD SCI USA, V102, P17196, DOI 10.1073/pnas.0504262102; Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Amores A, 2004, GENOME RES, V14, P1, DOI 10.1101/gr.1717804; BRAUN AP, 1995, ANNU REV PHYSIOL, V57, P417, DOI 10.1146/annurev.ph.57.030195.002221; Brocco MA, 2010, EUR J NEUROSCI, V31, P195, DOI 10.1111/j.1460-9568.2009.07064.x; Chang MH, 2004, BIOCHEM BIOPH RES CO, V321, P502, DOI 10.1016/j.bbrc.2004.06.172; Chen GD, 2006, BIOCHEM BIOPH RES CO, V344, P272, DOI 10.1016/j.bbrc.2006.03.136; Cullen PJ, 2002, NAT REV MOL CELL BIO, V3, P339, DOI 10.1038/nrm808; DeGiorgis JA, 2005, J PROTEOME RES, V4, P306, DOI 10.1021/pr0498436; Douard V, 2008, J PHYSIOL-LONDON, V586, P3657, DOI 10.1113/jphysiol.2008.155226; Fiala JC, 1998, J NEUROSCI, V18, P8900; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Fuchsova B, 2009, J BIOL CHEM, V284, P32075, DOI 10.1074/jbc.M109.012377; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; HANSON PI, 1992, ANNU REV BIOCHEM, V61, P559, DOI 10.1146/annurev.bi.61.070192.003015; Hering H, 2003, J NEUROSCI, V23, P11759; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; Jourdain P, 2003, J NEUROSCI, V23, P10645; Kassahn KS, 2009, BIOL REV, V84, P277, DOI 10.1111/j.1469-185X.2008.00073.x; LAGENAUR C, 1992, J NEUROBIOL, V23, P71, DOI 10.1002/neu.480230108; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; MILNER RJ, 1985, CELL, V42, P931, DOI 10.1016/0092-8674(85)90289-2; Mukobata S, 2002, BIOCHEM BIOPH RES CO, V297, P722, DOI 10.1016/S0006-291X(02)02284-2; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; NAVE KA, 1987, P NATL ACAD SCI USA, V84, P5665, DOI 10.1073/pnas.84.16.5665; Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898; Rothschild SC, 2007, DEV DYNAM, V236, P295, DOI 10.1002/dvdy.21005; Schweitzer M, 2006, MOL CELL NEUROSCI, V31, P161, DOI 10.1016/j.mcn.2005.10.007; SILVA AJ, 1992, SCIENCE, V257, P206, DOI 10.1126/science.1321493; Tombes RM, 2003, GENE, V322, P17, DOI 10.1016/j.gene.2003.08.023; Westerfield M, 2007, ZEBRAFISH BOOK; Wong YH, 2007, NUCLEIC ACIDS RES, V35, pW588, DOI 10.1093/nar/gkm322; Wu DF, 2007, J BIOL CHEM, V282, P22239, DOI 10.1074/jbc.M700941200; Xia QW, 2008, J PROTEOME RES, V7, P2845, DOI 10.1021/pr8000496; Yamauchi T, 2005, BIOL PHARM BULL, V28, P1342, DOI 10.1248/bpb.28.1342; YAN YM, 1993, NEURON, V11, P423, DOI 10.1016/0896-6273(93)90147-J; Yan YM, 1996, J COMP NEUROL, V370, P465, DOI 10.1002/(SICI)1096-9861(19960708)370:4<465::AID-CNE4>3.0.CO;2-2; Ziv NE, 1996, NEURON, V17, P91, DOI 10.1016/S0896-6273(00)80283-4	39	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26461	10.1371/journal.pone.0026461	http://dx.doi.org/10.1371/journal.pone.0026461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028883	Green Published, Green Submitted, gold			2022-12-27	WOS:000296510800044
J	Wang, JN; Gerretsen, SC; Maki, JH; Jaarsma, C; Kooi, ME; Herzka, D; Chu, BC; Yarnykh, VL; Yuan, C; Leiner, T				Wang, Jinnan; Gerretsen, Suzanne C.; Maki, Jeffrey H.; Jaarsma, Caroline; Kooi, M. Eline; Herzka, Daniel; Chu, Baocheng; Yarnykh, Vasily L.; Yuan, Chun; Leiner, Tim			Time-Efficient Black Blood RCA Wall Imaging at 3T Using Improved Motion Sensitized Driven Equilibrium (iMSDE): Feasibility and Reproducibility	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; SPIN-ECHO TSE; CORONARY ATHEROSCLEROSIS; HEART-DISEASE; RISK; MRI; SEQUENCE	Background: The aim of this study was to explore the feasibility and reproducibility of a time-efficient coronary vessel wall measurement approach using an improved motion-sensitized driven equilibrium (iMSDE) pulse sequence. Methodology: In this study, the iMSDE pulse sequence was first optimized and then applied on a group of healthy volunteers (N = 10) to evaluate its feasibility of vessel wall visualization. The same technique was also applied on a separate group of volunteers (N = 19) for a reproducibility study by scanning the same subject in two separate sessions. The iMSDE sequence was found to provide good coronary vessel wall delineation. It was also found to provide reproducible coronary vessel wall diameter and thickness measurements in both proximal and middle segments of the right coronary artery. Conclusion: The feasibility and reproducibility of iMSDE based coronary vessel wall imaging were demonstrated for the first time, paving the way for further testing in a clinical environment for fast and accurate coronary artery disease detection.	[Wang, Jinnan; Maki, Jeffrey H.; Chu, Baocheng; Yarnykh, Vasily L.; Yuan, Chun; Leiner, Tim] Univ Washington, Dept Radiol, Seattle, WA 98195 USA; [Wang, Jinnan] Philips Res N Amer, Clin Sites Res Program, Briarcliff Manor, NY USA; [Gerretsen, Suzanne C.; Jaarsma, Caroline; Kooi, M. Eline; Leiner, Tim] Maastricht Univ Med Ctr, Dept Radiol & Cardiol, Cardiovasc Res Inst Maastricht CARIM, Maastricht, Netherlands; [Herzka, Daniel] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Leiner, Tim] Univ Utrecht, Med Ctr, Utrecht, Netherlands	University of Washington; University of Washington Seattle; Philips; Philips Research; Maastricht University; Maastricht University Medical Centre (MUMC); Johns Hopkins University; Utrecht University	Wang, JN (corresponding author), Univ Washington, Dept Radiol, Seattle, WA 98195 USA.	timleiner@gmail.com	Yarnykh, Vasiliy L./N-7635-2014; Yarnykh, Vasily L/G-8757-2016; Yarnykh, Vasily/ABF-7873-2021; Kooi, M. Eline/D-3848-2016	Yarnykh, Vasily L/0000-0002-1583-8979; Kooi, M. Eline/0000-0001-7562-5724; Herzka, Daniel/0000-0002-9400-7814	National Institutes of Health (NIH) [HL56874, NIH HL076378-01]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL056874, R29HL056874, R01HL076378] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH HL56874 and NIH HL076378-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assmann G, 2002, CIRCULATION, V105, P310, DOI 10.1161/hc0302.102575; Austen W G, 1975, Circulation, V51, P5; Desai MY, 2005, EUR HEART J, V26, P2320, DOI 10.1093/eurheartj/ehi357; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; EDELMAN RR, 1991, RADIOLOGY, V181, P655, DOI 10.1148/radiology.181.3.1947077; Etienne A, 2002, MAGNET RESON MED, V48, P658, DOI 10.1002/mrm.10253; Fan ZY, 2010, J MAGN RESON IMAGING, V31, P645, DOI 10.1002/jmri.22058; Gerretsen SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012998; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Hazirolan T, 2005, J CARDIOVASC MAGN R, V7, P409, DOI 10.1081/JCMR-200053464; Henningsson M, 2011, J CARDIOVASC MAGN S1, V13, pP229; KANNEL WB, 1982, ANN NY ACAD SCI, V382, P3, DOI 10.1111/j.1749-6632.1982.tb55203.x; Katscher U, 2006, NMR BIOMED, V19, P393, DOI 10.1002/nbm.1049; Leiner T, 2005, J MAGN RESON IMAGING, V22, P577, DOI 10.1002/jmri.20399; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lloyd-Jones DM, 2006, ARCH INTERN MED, V166, P1342, DOI 10.1001/archinte.166.13.1342; Narula J, 2008, NAT CLIN PRACT CARD, V5, pS2, DOI 10.1038/ncpcardio1247; Scott AD, 2011, J MAGN RESON IMAGING, V33, P77, DOI 10.1002/jmri.22398; Tuzcu EM, 2001, CIRCULATION, V103, P2705; Vogl TJ, 2002, RADIOLOGY, V223, P212, DOI 10.1148/radiol.2231010515; Wang J, 2007, MAGN RESON MED, V58, P973, DOI 10.1002/mrm.21385; Wang JN, 2010, J MAGN RESON IMAGING, V31, P1256, DOI 10.1002/jmri.22149; Wilson PWF, 1998, CIRCULATION, V97, P1837, DOI 10.1161/01.CIR.97.18.1837; Yang Q, 2009, J AM COLL CARDIOL, V54, P69, DOI 10.1016/j.jacc.2009.03.016	24	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2011	6	10							e26567	10.1371/journal.pone.0026567	http://dx.doi.org/10.1371/journal.pone.0026567			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841KI	22028910	Green Submitted, gold, Green Published			2022-12-27	WOS:000296510800055
J	Sprung, CN; Li, J; Hovan, D; Mckay, MJ; Forrester, HB				Sprung, Carl N.; Li, Jason; Hovan, Daniel; Mckay, Michael J.; Forrester, Helen B.			Alternative Transcript Initiation and Splicing as a Response to DNA Damage	PLOS ONE			English	Article							RADIOSENSITIVE CANCER-PATIENTS; DIFFERENTIAL GENE-EXPRESSION; MESSENGER-RNA DECAY; IONIZING-RADIATION; EXON ARRAY; STRESS; CELLS; INDUCTION; DISEASE; CHECKPOINT	Humans are exposed to the DNA damaging agent, ionizing radiation (IR), from background radiation, medical treatments, occupational and accidental exposures. IR causes changes in transcription, but little is known about alternative transcription in response to IR on a genome-wide basis. These investigations examine the response to IR at the exon level in human cells, using exon arrays to comprehensively characterize radiation-induced transcriptional expression products. Previously uncharacterized alternative transcripts that preferentially occur following IR exposure have been discovered. A large number of genes showed alternative transcription initiation as a response to IR. Dose-response and time course kinetics have also been characterized. Interestingly, most genes showing alternative transcript induction maintained these isoforms over the dose range and times tested. Finally, clusters of co-ordinately up- and down-regulated radiation response genes were identified at specific chromosomal loci. These data provide the first genome-wide view of the transcriptional response to ionizing radiation at the exon level. This study provides novel insights into alternative transcripts as a mechanism for response to DNA damage and cell stress responses in general.	[Sprung, Carl N.; Hovan, Daniel; Forrester, Helen B.] Monash Univ, Ctr Innate Immun & Infect Dis, Monash Inst Med Res, Clayton, Vic, Australia; [Li, Jason] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia; [Mckay, Michael J.] Canberra Hosp, Dept Radiat Oncol, Garran, ACT, Australia; [Mckay, Michael J.] Australian Natl Univ, Canberra, ACT, Australia	Monash University; Peter Maccallum Cancer Center; Australian National University; Canberra Hospital; Australian National University	Sprung, CN (corresponding author), Monash Univ, Ctr Innate Immun & Infect Dis, Monash Inst Med Res, Clayton, Vic, Australia.	carl.sprung@monash.edu	McKay, Michael/ABA-9029-2021	Li, Jason/0000-0002-1150-3549	Australian National Health and Medical Research Council [145780, 288713]; Australian National Breast Cancer Foundation [PG-08-06]; Victorian Government	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian National Breast Cancer Foundation; Victorian Government	This work was supported by the Australian National Health and Medical Research Council [grant numbers 145780, 288713; http://www.nhmrc.gov.au/]; and the Australian National Breast Cancer Foundation [grant PG-08-06; http://www.nbcf.org.au/]. Support was also provided by the Victorian Government's Operational Infrastructure Support Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amundson SA, 2000, RADIAT RES, V154, P342, DOI 10.1667/0033-7587(2000)154[0342:IOPMBI]2.0.CO;2; Amundson SA, 1999, ONCOGENE, V18, P3666, DOI 10.1038/sj.onc.1202676; Bailis JM, 2008, MOL CELL BIOL, V28, P1724, DOI 10.1128/MCB.01717-07; BARAK Y, 1994, GENE DEV, V8, P1739, DOI 10.1101/gad.8.15.1739; BENGTSSON H, 2006, AROMA AFFYMETRIS GEN; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Chen MS, 2001, GENE, V277, P145, DOI 10.1016/S0378-1119(01)00692-8; Clark TA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r64; Dalenc F, 2002, INT J CANCER, V100, P662, DOI 10.1002/ijc.10558; Deran M, 2008, MOL CELL BIOL, V28, P435, DOI 10.1128/MCB.00607-07; Fan FY, 2002, ONCOGENE, V21, P7488, DOI 10.1038/sj.onc.1205896; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Hashimoto Y, 2002, NUCLEIC ACIDS RES, V30, P2398, DOI 10.1093/nar/30.11.2398; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hughes TA, 2006, TRENDS GENET, V22, P119, DOI 10.1016/j.tig.2006.01.001; Iliakis G, 2004, CYTOGENET GENOME RES, V104, P14, DOI 10.1159/000077461; Jen KY, 2003, GENOME RES, V13, P2092, DOI 10.1101/gr.1240103; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Katzenberger RJ, 2006, MOL CELL BIOL, V26, P9256, DOI 10.1128/MCB.01125-06; Kis E, 2006, INT J RADIAT ONCOL, V66, P1506, DOI 10.1016/j.ijrobp.2006.08.004; Klokov D, 2004, MUTAT RES-FUND MOL M, V568, P97, DOI 10.1016/j.mrfmmm.2004.06.049; Kool J, 2003, ONCOGENE, V22, P4235, DOI 10.1038/sj.onc.1206611; Lavin MF, 2007, RADIOTHER ONCOL, V83, P231, DOI 10.1016/j.radonc.2007.04.032; Leek JT, 2006, BIOINFORMATICS, V22, P507, DOI 10.1093/bioinformatics/btk005; Leong T, 2000, INT J RADIAT ONCOL, V48, P959, DOI 10.1016/S0360-3016(00)00728-8; Lewis BP, 2003, P NATL ACAD SCI USA, V100, P189, DOI 10.1073/pnas.0136770100; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Matsumoto A, 2006, BIOCHEM BIOPH RES CO, V350, P114, DOI 10.1016/j.bbrc.2006.09.003; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; McGlincy NJ, 2008, TRENDS BIOCHEM SCI, V33, P385, DOI 10.1016/j.tibs.2008.06.001; Mendrysa SM, 2000, MOL CELL BIOL, V20, P2023, DOI 10.1128/MCB.20.6.2023-2030.2000; Mullen TE, 2008, GENE DEV, V22, P50, DOI 10.1101/gad.1622708; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Nakagomi S, 2003, J NEUROSCI, V23, P5187; NEITZEL H, 1986, HUM GENET, V73, P320, DOI 10.1007/BF00279094; Niu NF, 2010, GENOME RES, V20, P1482, DOI 10.1101/gr.107672.110; Orengo JP, 2007, ADV EXP MED BIOL, V623, P212, DOI 10.1007/978-0-387-77374-2_13; Pio R, 2009, J THORAC ONCOL, V4, P674, DOI 10.1097/JTO.0b013e3181a520dc; Purdom E, 2008, BIOINFORMATICS, V24, P1707, DOI 10.1093/bioinformatics/btn284; Rajan P, 2009, NAT REV UROL, V6, P454, DOI 10.1038/nrurol.2009.125; Ree AH, 2003, ONCOGENE, V22, P8952, DOI 10.1038/sj.onc.1207000; Rieger KE, 2004, NUCLEIC ACIDS RES, V32, P4786, DOI 10.1093/nar/gkh783; Rodningen AK, 2005, RADIOTHER ONCOL, V77, P231, DOI 10.1016/j.radonc.2005.09.020; Rossi M, 2008, NUCLEIC ACIDS RES, V36, P7168, DOI 10.1093/nar/gkn888; Rozen S, 2000, PRIMER3 WWW GEN USER; Severin DM, 2001, INT J RADIAT ONCOL, V50, P1323, DOI 10.1016/S0360-3016(01)01608-X; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Smyth GK., LIMMA LINEAR MODELS, P397; Sprung CN, 2005, CLIN CANCER RES, V11, P6352, DOI 10.1158/1078-0432.CCR-04-1931; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Storey JD, 2005, P NATL ACAD SCI USA, V102, P12837, DOI 10.1073/pnas.0504609102; Su C, 2004, EMBO J, V23, P1133, DOI 10.1038/sj.emboj.7600120; Tazi J, 2009, BBA-MOL BASIS DIS, V1792, P14, DOI 10.1016/j.bbadis.2008.09.017; Toung J, 2011, GENOME RES; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509	60	42	43	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e25758	10.1371/journal.pone.0025758	http://dx.doi.org/10.1371/journal.pone.0025758			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22039421	Green Published, gold			2022-12-27	WOS:000296507500018
J	Trimble, MJ; van Aarde, RJ; Ferreira, SM; Norgaard, CF; Fourie, J; Lee, PC; Moss, CJ				Trimble, Morgan J.; van Aarde, Rudi J.; Ferreira, Sam M.; Norgaard, Camilla F.; Fourie, Johan; Lee, Phyllis C.; Moss, Cynthia J.			Age Determination by Back Length for African Savanna Elephants: Extending Age Assessment Techniques for Aerial-Based Surveys	PLOS ONE			English	Article							LOXODONTA-AFRICANA; NATIONAL-PARK; POPULATION; SURVIVAL; DENSITY; GROWTH; KENYA; IVORY; TRADE; DNA	Determining the age of individuals in a population can lead to a better understanding of population dynamics through age structure analysis and estimation of age-specific fecundity and survival rates. Shoulder height has been used to accurately assign age to free-ranging African savanna elephants. However, back length may provide an analog measurable in aerial-based surveys. We assessed the relationship between back length and age for known-age elephants in Amboseli National Park, Kenya, and Addo Elephant National Park, South Africa. We also compared age-and sex-specific back lengths between these populations and compared adult female back lengths across 11 widely dispersed populations in five African countries. Sex-specific Von Bertalanffy growth curves provided a good fit to the back length data of known-age individuals. Based on back length, accurate ages could be assigned relatively precisely for females up to 23 years of age and males up to 17. The female back length curve allowed more precise age assignment to older females than the curve for shoulder height does, probably because of divergence between the respective growth curves. However, this did not appear to be the case for males, but the sample of known-age males was limited to <= 27 years. Age-and sex-specific back lengths were similar in Amboseli National Park and Addo Elephant National Park. Furthermore, while adult female back lengths in the three Zambian populations were generally shorter than in other populations, back lengths in the remaining eight populations did not differ significantly, in support of claims that growth patterns of African savanna elephants are similar over wide geographic regions. Thus, the growth curves presented here should allow researchers to use aerial-based surveys to assign ages to elephants with greater precision than previously possible and, therefore, to estimate population variables.	[Trimble, Morgan J.; van Aarde, Rudi J.; Ferreira, Sam M.; Norgaard, Camilla F.; Fourie, Johan] Univ Pretoria, Dept Zool & Entomol, Conservat Ecol Res Unit, ZA-0002 Pretoria, South Africa; [Ferreira, Sam M.] S African Natl Pk, Sci Serv, Skukuza, South Africa; [Lee, Phyllis C.; Moss, Cynthia J.] Amboseli Trust Elephants, Nairobi, Kenya; [Lee, Phyllis C.] Univ Stirling, Sch Nat Sci, Behav & Evolut Res Grp, Stirling FK9 4LA, Scotland	University of Pretoria; University of Stirling	Trimble, MJ (corresponding author), Univ Pretoria, Dept Zool & Entomol, Conservat Ecol Res Unit, ZA-0002 Pretoria, South Africa.	rjvaarde@zoology.up.ac.za	Trimble, Morgan J/B-1161-2010	Trimble, Morgan J/0000-0002-9914-0788; Lee, Phyllis/0000-0002-4296-3513	International Fund for Animal Welfare; Peace Parks Foundation; United States Fish & Wildlife Services; National Research Foundation; National Science Foundation	International Fund for Animal Welfare; Peace Parks Foundation; United States Fish & Wildlife Services; National Research Foundation; National Science Foundation(National Science Foundation (NSF))	Grants to R.J.v.A. from the International Fund for Animal Welfare, the Peace Parks Foundation, the United States Fish & Wildlife Services, and the National Research Foundation funded the project. M.J.T. is supported by a National Science Foundation Graduate Research Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CROZE H, 1972, AFR J ECOL, V10, P91; Douglas-Hamilton I, 1972, THESIS OXFORD U OXFO; Eberhardt LL, 2002, ECOLOGY, V83, P2841, DOI 10.2307/3072020; Ferreira SM, 2008, J WILDLIFE MANAGE, V72, P822, DOI 10.2193/2007-151; Forchhammer MC, 2001, J ANIM ECOL, V70, P721, DOI 10.1046/j.0021-8790.2001.00532.x; Hanks J., 1972, East African Wildlife Journal, V10, P251; Laws R. M., 1969, Journal of Reproduction and Fertility Suppl, VNo. 6, P495; LAWS RM, 1968, S ZOOL SOC LOND, V21, P319; LEE PC, 1995, J ZOOL, V236, P29, DOI 10.1111/j.1469-7998.1995.tb01782.x; Lee Phyllis C., 2011, P74; LEUTHOLD W, 1976, J APPL ECOL, V13, P435, DOI 10.2307/2401793; MICHOD RE, 1980, ECOLOGY, V61, P265, DOI 10.2307/1935184; Moss CJ, 2001, J ZOOL, V255, P145, DOI 10.1017/S0952836901001212; Moss Cynthia, 1996, P58; Shrader AM, 2006, J ZOOL, V270, P40, DOI 10.1111/j.1469-7998.2006.00108.x; Shrader AM, 2006, S AFR J WILDL RES, V36, P1; Shrader AM, 2010, BIODIVERS CONSERV, V19, P2235, DOI 10.1007/s10531-010-9836-7; Sibly RM, 1998, J ANIM ECOL, V67, P17, DOI 10.1046/j.1365-2656.1998.00178.x; Trimble MJ, 2009, J ZOOL, V279, P18, DOI 10.1111/j.1469-7998.2009.00560.x; Udevitz MS, 1998, J WILDLIFE MANAGE, V62, P779, DOI 10.2307/3802355; van aarde Rudi, 2008, P84; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; Wasser SK, 2008, CONSERV BIOL, V22, P1065, DOI 10.1111/j.1523-1739.2008.01012.x; Wasser SK, 2007, P NATL ACAD SCI USA, V104, P4228, DOI 10.1073/pnas.0609714104; Whitehouse AM, 2000, ORYX, V34, P46, DOI 10.1046/j.1365-3008.2000.00093.x; Wolf P.R., 1974, ELEMENTS PHOTOGRAMME; Young KD, 2010, J ANIM ECOL, V79, P662, DOI 10.1111/j.1365-2656.2010.01667.x	27	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26614	10.1371/journal.pone.0026614	http://dx.doi.org/10.1371/journal.pone.0026614			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22028925	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500099
J	Daskin, JH; Alford, RA; Puschendorf, R				Daskin, Joshua H.; Alford, Ross A.; Puschendorf, Robert			Short-Term Exposure to Warm Microhabitats Could Explain Amphibian Persistence with Batrachochytrium dendrobatidis	PLOS ONE			English	Article							FOREST STREAM FROGS; EMERGING DISEASE; CHYTRIDIOMYCOSIS; DECLINES; POPULATION; PREVALENCE; EXTINCTION; INFECTION; AUSTRALIA; DEFENSES	Environmental conditions can alter the outcomes of symbiotic interactions. Many amphibian species have declined due to chytridiomycosis, caused by the pathogenic fungus Batrachochytrium dendrobatidis (Bd), but many others persist despite high Bd infection prevalence. This indicates that Bd's virulence is lower, or it may even be a commensal, in some hosts. In the Australian Wet Tropics, chytridiomycosis extirpated Litoria nannotis from high-elevation rain forests in the early 1990 s. Although the species is recolonizing many sites, no population has fully recovered. Litoria lorica disappeared from all known sites in the early 1990 s and was thought globally extinct, but a new population was discovered in 2008, in an upland dry forest habitat it shares with L. nannotis. All frogs of both species observed during three population censuses were apparently healthy, but most carried Bd. Frogs perch on sun-warmed rocks in dry forest streams, possibly keeping Bd infections below the lethal threshold attained in cooler rain forests. We tested whether short-term elevated temperatures can hamper Bd growth in vitro over one generation (four days). Simulating the temperatures available to frogs on strongly and moderately warmed rocks in dry forests, by incubating cultures at 33 degrees C for one hour daily, reduced Bd growth below that of Bd held at 15 degrees C constantly (representing rain forest habitats). Even small decreases in the exponential growth rate of Bd on hosts may contribute to the survival of frogs in dry forests.	[Daskin, Joshua H.; Alford, Ross A.; Puschendorf, Robert] James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University	Daskin, JH (corresponding author), Archbold Biol Stat, Lake Placid, FL USA.	jhdaskin@gmail.com	Puschendorf, Robert/B-6280-2011; Alford, Ross A/H-1577-2011	Puschendorf, Robert/0000-0002-8105-171X; Alford, Ross A/0000-0002-3010-6768	Australian Research Council; Australian-American Fulbright Commission	Australian Research Council(Australian Research Council); Australian-American Fulbright Commission	Research funding was provided by the Australian Research Council (http://www.arc.gov.au/) Discovery Grant Understanding and managing resistance to the amphibian chytrid fungus Batrachochytrium dendrobatidis in Australian tropical rainforest frogs. JHD was supported by a U.S. Postgraduate Fulbright Scholarship from the Australian-American Fulbright Commission (http://www.fulbright.com.au) during this project. RP was supported by a Postdoctoral Research Fellowship of the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre SE, 2008, J WILDLIFE DIS, V44, P716, DOI 10.7589/0090-3558-44.3.716; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Briggs CJ, 2010, P NATL ACAD SCI USA, V107, P9695, DOI 10.1073/pnas.0912886107; Carey C, 2006, ECOHEALTH, V3, P5, DOI 10.1007/s10393-005-0006-4; Cunningham Michael, 2002, Memoirs of the Queensland Museum, V48, P93; Hero JM, 2004, IUCN 2010 IUCN RED L; Kilpatrick AM, 2010, TRENDS ECOL EVOL, V25, P109, DOI 10.1016/j.tree.2009.07.011; Kriger KM, 2007, J ZOOL, V271, P352, DOI 10.1111/j.1469-7998.2006.00220.x; McDonald K, 1999, DECLINES DISAPPEARAN, P14; Patz JA, 1996, JAMA-J AM MED ASSOC, V275, P217, DOI 10.1001/jama.275.3.217; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Puschendorf R, 2009, ENV EFFECTS HOST PAT; Puschendorf R, 2011, CONSERV BIOL, V25, P956, DOI 10.1111/j.1523-1739.2011.01728.x; Ramsey JP, 2010, INFECT IMMUN, V78, P3981, DOI 10.1128/IAI.00402-10; RIBAS L, 2009, PLOS ONE, V4; Richards-Zawacki CL, 2010, P ROY SOC B-BIOL SCI, V277, P519, DOI 10.1098/rspb.2009.1656; Rollins-Smith LA, 2002, BIOCHEM BIOPH RES CO, V297, P361, DOI 10.1016/S0006-291X(02)02217-9; Rowley JJL, 2007, WILDLIFE RES, V34, P371, DOI 10.1071/WR07014; Rowley JJL, 2007, DIS AQUAT ORGAN, V77, P1, DOI 10.3354/dao01830; Skerratt LF, 2007, ECOHEALTH, V4, P125, DOI 10.1007/s10393-007-0093-5; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Thurber RV, 2009, ENVIRON MICROBIOL, V11, P2148, DOI 10.1111/j.1462-2920.2009.01935.x; Woodhams DC, 2005, CONSERV BIOL, V19, P1449, DOI 10.1111/j.1523-1739.2005.004403.x; Woodhams DC, 2003, DIS AQUAT ORGAN, V55, P65, DOI 10.3354/dao055065; Woodhams DC, 2008, ECOLOGY, V89, P1627, DOI 10.1890/06-1842.1	25	37	37	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26215	10.1371/journal.pone.0026215	http://dx.doi.org/10.1371/journal.pone.0026215			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028834	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000296186900036
J	Liao, JY; Thakur, SA; Zalinger, ZB; Gerrish, KE; Imani, F				Liao, Jie-ying; Thakur, Sheetal A.; Zalinger, Zachary B.; Gerrish, Kevin E.; Imani, Farhad			Inosine-Containing RNA Is a Novel Innate Immune Recognition Element and Reduces RSV Infection	PLOS ONE			English	Article							DOUBLE-STRANDED-RNA; NF-KAPPA-B; TOLL-LIKE RECEPTOR-3; PROTEIN-KINASE; ADENOSINE-DEAMINASE; VIRUS-REPLICATION; EPITHELIAL-CELLS; BIASED HYPERMUTATION; MESSENGER-RNA; RIG-I	During viral infections, single-and double-stranded RNA (ssRNA and dsRNA) are recognized by the host and induce innate immune responses. The cellular enzyme ADAR-1 (adenosine deaminase acting on RNA-1) activation in virally infected cells leads to presence of inosine-containing RNA (Ino-RNA). Here we report that ss-Ino-RNA is a novel viral recognition element. We synthesized unmodified ssRNA and ssRNA that had 6% to16% inosine residues. The results showed that in primary human cells, or in mice, 10% ss-Ino-RNA rapidly and potently induced a significant increase in inflammatory cytokines, such as interferon (IFN)-beta (35 fold), tumor necrosis factor (TNF)-alpha (9.7 fold), and interleukin (IL)-6 (11.3 fold) (p<0.01). Flow cytometry data revealed a corresponding 4-fold increase in influx of neutrophils into the lungs by ss-Ino-RNA treatment. In our in vitro experiments, treatment of epithelial cells with ss-Ino-RNA reduced replication of respiratory syncytial virus (RSV). Interestingly, RNA structural analysis showed that ss-Ino-RNA had increased formation of secondary structures. Our data further revealed that extracellular ss-Ino-RNA was taken up by scavenger receptor class-A (SR-A) which activated downstream MAP Kinase pathways through Toll-like receptor 3 (TLR3) and dsRNA-activated protein kinase (PKR). Our data suggests that ss-Ino-RNA is an as yet undescribed virus-associated innate immune stimulus.	[Liao, Jie-ying; Thakur, Sheetal A.; Zalinger, Zachary B.] NIEHS, Lab Resp Biol, NIH, Durham, NC USA; [Gerrish, Kevin E.] NIEHS, Gene Array Core Facil, NIH, Durham, NC USA; [Imani, Farhad] ViraSource Labs, Durham, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Liao, JY (corresponding author), NIEHS, Lab Resp Biol, NIH, Durham, NC USA.	fimani@virasource.com			Intramural National Institute of Health (NIH)	Intramural National Institute of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was fully funded by Intramural National Institute of Health (NIH) funding, and the authors are NIH employees. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Allen IC, 2009, IMMUNITY, V30, P556, DOI 10.1016/j.immuni.2009.02.005; BASS BL, 1988, CELL, V55, P1089, DOI 10.1016/0092-8674(88)90253-X; Bass BL, 1997, TRENDS BIOCHEM SCI, V22, P157, DOI 10.1016/S0968-0004(97)01035-9; BASS BL, 1989, CELL, V56, P331, DOI 10.1016/0092-8674(89)90234-1; CATTANEO R, 1988, CELL, V55, P255, DOI 10.1016/0092-8674(88)90048-7; CHANG HW, 1992, P NATL ACAD SCI USA, V89, P4825, DOI 10.1073/pnas.89.11.4825; de Bouteiller O, 2005, J BIOL CHEM, V280, P38133, DOI 10.1074/jbc.M507163200; DER SD, 1995, P NATL ACAD SCI USA, V92, P8841, DOI 10.1073/pnas.92.19.8841; DeWitte-Orr SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000829; DOUKAS J, 1994, AM J PATHOL, V145, P137; FELDER MP, 1994, J VIROL, V68, P4759, DOI 10.1128/JVI.68.8.4759-4767.1994; Gamper HB, 2004, BIOCHEMISTRY-US, V43, P10224, DOI 10.1021/bi049196w; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; HAJJAR AM, 1995, J VIROL, V69, P5878, DOI 10.1128/JVI.69.9.5878-5882.1995; Hartner JC, 2009, NAT IMMUNOL, V10, P109, DOI 10.1038/ni.1680; IMANI F, 1988, P NATL ACAD SCI USA, V85, P7887, DOI 10.1073/pnas.85.21.7887; Jayan GC, 2002, J VIROL, V76, P3819, DOI 10.1128/JVI.76.8.3819-3827.2002; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; Kalali BN, 2008, J IMMUNOL, V181, P2694, DOI 10.4049/jimmunol.181.4.2694; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kumar A, 1997, EMBO J, V16, P406, DOI 10.1093/emboj/16.2.406; LEBLEU B, 1976, P NATL ACAD SCI USA, V73, P3107, DOI 10.1073/pnas.73.9.3107; LEE JY, 1994, VIROLOGY, V200, P307, DOI 10.1006/viro.1994.1192; Lei M, 1998, VIROLOGY, V245, P188, DOI 10.1006/viro.1998.9162; Levanon EY, 2004, NAT BIOTECHNOL, V22, P1001, DOI 10.1038/nbt996; Limmon GV, 2008, FASEB J, V22, P159, DOI 10.1096/fj.07-8348com; Majde JA, 1998, ARCH VIROL, V143, P2371, DOI 10.1007/s007050050467; Marshall-Clarke S, 2007, J BIOL CHEM, V282, P24759, DOI 10.1074/jbc.M700188200; MCMASTER GK, 1977, P NATL ACAD SCI USA, V74, P4835, DOI 10.1073/pnas.74.11.4835; MEROLLA R, 1995, AM J RESP CRIT CARE, V152, P1358, DOI 10.1164/ajrccm.152.4.7551395; Meusel TR, 2002, J IMMUNOL, V168, P6429, DOI 10.4049/jimmunol.168.12.6429; Minor RAC, 2010, J INTERF CYTOK RES, V30, P263, DOI 10.1089/jir.2009.0051; Morse DP, 1997, BIOCHEMISTRY-US, V36, P8429, DOI 10.1021/bi9709607; MURPHY DG, 1991, VIROLOGY, V181, P760, DOI 10.1016/0042-6822(91)90913-V; Nallagatla SR, 2007, SCIENCE, V318, P1455, DOI 10.1126/science.1147347; NISHIKURA K, 1991, EMBO J, V10, P3523, DOI 10.1002/j.1460-2075.1991.tb04916.x; OHARA PJ, 1984, CELL, V36, P915, DOI 10.1016/0092-8674(84)90041-2; PATTERSON JB, 1995, MOL CELL BIOL, V15, P5376, DOI 10.1128/mcb.15.10.5376; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; POLSON AG, 1994, EMBO J, V13, P5701, DOI 10.1002/j.1460-2075.1994.tb06908.x; RUEDA P, 1994, VIROLOGY, V198, P653, DOI 10.1006/viro.1994.1077; Sadler AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000311; Saito T, 2008, J EXP MED, V205, P1523, DOI 10.1084/jem.20081210; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Taylor DR, 2005, J VIROL, V79, P6291, DOI 10.1128/JVI.79.10.6291-6298.2005; Vitali P, 2010, NAT STRUCT MOL BIOL, V17, P1043, DOI 10.1038/nsmb.1864; Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zahn RC, 2007, J VIROL, V81, P457, DOI 10.1128/JVI.00067-06	50	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2011	6	10							e26463	10.1371/journal.pone.0026463	http://dx.doi.org/10.1371/journal.pone.0026463			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	837ID	22028885	gold, Green Published, Green Submitted			2022-12-27	WOS:000296186900068
J	Gathercole, LL; Morgan, SA; Bujalska, IJ; Hauton, D; Stewart, PM; Tomlinson, JW				Gathercole, Laura L.; Morgan, Stuart A.; Bujalska, Iwona J.; Hauton, David; Stewart, Paul M.; Tomlinson, Jeremy W.			Regulation of Lipogenesis by Glucocorticoids and Insulin in Human Adipose Tissue	PLOS ONE			English	Article							11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE-1; DE-NOVO LIPOGENESIS; VISCERAL OBESITY; HORMONAL-REGULATION; GLUCOSE-TOLERANCE; CUSHINGS-SYNDROME; HUMAN ADIPOCYTES; KNOCKOUT MICE	Patients with glucocorticoid (GC) excess, Cushing's syndrome, develop a classic phenotype characterized by central obesity and insulin resistance. GCs are known to increase the release of fatty acids from adipose, by stimulating lipolysis, however, the impact of GCs on the processes that regulate lipid accumulation has not been explored. Intracellular levels of active GC are dependent upon the activity of 11 beta-Hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) and we have hypothesized that 11 beta-HSD1 activity can regulate lipid homeostasis in human adipose tissue (Chub-S7 cell line and primary cultures of human subcutaneous (sc) and omental (om) adipocytes. Across adipocyte differentiation, lipogenesis increased whilst beta-oxidation decreased. GC treatment decreased lipogenesis but did not alter rates of beta-oxidation in Chub-S7 cells, whilst insulin increased lipogenesis in all adipocyte cell models. Low dose Dexamethasone pre-treatment (5 nM) of Chub-S7 cells augmented the ability of insulin to stimulate lipogenesis and there was no evidence of adipose tissue insulin resistance in primary sc cells. Both cortisol and cortisone decreased lipogenesis; selective 11 beta-HSD1 inhibition completely abolished cortisone-mediated repression of lipogenesis. GCs have potent actions upon lipid homeostasis and these effects are dependent upon interactions with insulin. These in vitro data suggest that manipulation of GC availability through selective 11 beta-HSD1 inhibition modifies lipid homeostasis in human adipocytes.	[Gathercole, Laura L.; Morgan, Stuart A.; Bujalska, Iwona J.; Hauton, David; Stewart, Paul M.; Tomlinson, Jeremy W.] Univ Birmingham, Sch Clin & Expt Med, Inst Biomed Res, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England	University of Birmingham	Gathercole, LL (corresponding author), Univ Birmingham, Sch Clin & Expt Med, Inst Biomed Res, Ctr Endocrinol Diabet & Metab, Birmingham, W Midlands, England.	J.W.Tomlinson@bham.ac.uk		gathercole, laura/0000-0001-5983-0306; Tomlinson, Jeremy/0000-0002-3170-8533	Medical Research Council; Wellcome Trust [066357]; Medical Research Council [G0802765] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10356] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by a Medical Research Council senior clinical fellowship (JWT), Wellcome Trust programme grant 066357 (PMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abu-Elheiga L, 2005, P NATL ACAD SCI USA, V102, P12011, DOI 10.1073/pnas.0505714102; Alberts P, 2003, ENDOCRINOLOGY, V144, P4755, DOI 10.1210/en.2003-0344; Berthiaume M, 2007, ENDOCRINOLOGY, V148, P2391, DOI 10.1210/en.2006-1199; Bujalska IJ, 2008, J ENDOCRINOL, V197, P297, DOI 10.1677/JOE-08-0050; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; Christ-Crain M, 2008, FASEB J, V22, P1672, DOI 10.1096/fj.07-094144; DIAMANT S, 1975, EUR J BIOCHEM, V53, P541, DOI 10.1111/j.1432-1033.1975.tb04097.x; Djurhuus CB, 2002, AM J PHYSIOL-ENDOC M, V283, pE172, DOI 10.1152/ajpendo.00544.2001; FONTBONNE A, 1992, DIABETOLOGIA, V35, P464, DOI 10.1007/BF02342445; FRIED SK, 1993, J CLIN INVEST, V92, P2191, DOI 10.1172/JCI116821; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Gathercole LL, 2007, J CLIN ENDOCR METAB, V92, P4332, DOI 10.1210/jc.2007-1399; HAUNER H, 1987, J CLIN ENDOCR METAB, V64, P832, DOI 10.1210/jcem-64-4-832; Hausman D B, 2001, Obes Rev, V2, P239, DOI 10.1046/j.1467-789X.2001.00042.x; JAMDAR SC, 1978, BIOCHEM J, V170, P153, DOI 10.1042/bj1700153; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; Kola B, 2008, J CLIN ENDOCR METAB, V93, P4969, DOI 10.1210/jc.2008-1297; Lammert O, 2000, BRIT J NUTR, V84, P233; Laviola L, 2006, DIABETES, V55, P952, DOI 10.2337/diabetes.55.04.06.db05-1414; Lundgren M, 2008, HORM METAB RES, V40, P854, DOI 10.1055/s-0028-1087168; Mao J, 2006, P NATL ACAD SCI USA, V103, P8552, DOI 10.1073/pnas.0603115103; Masuzaki H, 2001, SCIENCE, V294, P2166, DOI 10.1126/science.1066285; Morgan SA, 2009, DIABETES, V58, P2506, DOI 10.2337/db09-0525; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; Paulmyer-Lacroix O, 2002, J CLIN ENDOCR METAB, V87, P2701, DOI 10.1210/jc.87.6.2701; POULIOT MC, 1992, DIABETES, V41, P826, DOI 10.2337/diabetes.41.7.826; Qiao LP, 2005, DIABETES, V54, P1744, DOI 10.2337/diabetes.54.6.1744; Rask E, 2002, J CLIN ENDOCR METAB, V87, P3330, DOI 10.1210/jc.87.7.3330; Rosenstock J, 2010, DIABETES CARE, V33, P1516, DOI 10.2337/dc09-2315; Ruderman NB, 2003, ENDOCRINOLOGY, V144, P5166, DOI 10.1210/en.2003-0849; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; SIMACOPOULOSJEA.F, 1995, METABOLISM, V44, P228; SLAVIN BG, 1994, J LIPID RES, V35, P1535; Strawford A, 2004, AM J PHYSIOL-ENDOC M, V286, pE577, DOI 10.1152/ajpendo.00093.2003; Tomlinson JW, 2007, J CLIN ENDOCR METAB, V92, P857, DOI 10.1210/jc.2006-2325; Tomlinson JJ, 2010, MOL ENDOCRINOL, V24, P104, DOI 10.1210/me.2009-0091; Tomlinson JW, 2004, ENDOCR REV, V25, P831, DOI 10.1210/er.2003-0031; Viana AYI, 2006, DIABETES RES CLIN PR, V73, P135, DOI 10.1016/j.diabres.2005.12.011; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; VOLPE JJ, 1975, BIOCHIM BIOPHYS ACTA, V380, P454, DOI 10.1016/0005-2760(75)90113-7; Wang YX, 2004, J NUTR, V134, P1032; Zammit VA, 1999, BIOCHEM J, V343, P505, DOI 10.1042/0264-6021:3430505; Zierath JR, 1998, DIABETOLOGIA, V41, P1343, DOI 10.1007/s001250051075	43	99	101	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26223	10.1371/journal.pone.0026223	http://dx.doi.org/10.1371/journal.pone.0026223			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022575	Green Published, gold			2022-12-27	WOS:000295981600041
J	Polini, A; Pisignano, D; Parodi, M; Quarto, R; Scaglione, S				Polini, Alessandro; Pisignano, Dario; Parodi, Manuela; Quarto, Rodolfo; Scaglione, Silvia			Osteoinduction of Human Mesenchymal Stem Cells by Bioactive Composite Scaffolds without Supplemental Osteogenic Growth Factors	PLOS ONE			English	Article							MARROW STROMAL CELLS; ALKALINE-PHOSPHATASE; EXTRACELLULAR-MATRIX; NANOFIBROUS SCAFFOLD; TISSUE REGENERATION; BONE REGENERATION; IN-VITRO; DIFFERENTIATION; EXPRESSION; NANOTECHNOLOGY	The development of a new family of implantable bioinspired materials is a focal point of bone tissue engineering. Implant surfaces that better mimic the natural bone extracellular matrix, a naturally nano-composite tissue, can stimulate stem cell differentiation towards osteogenic lineages in the absence of specific chemical treatments. Herein we describe a bioactive composite nanofibrous scaffold, composed of poly-caprolactone (PCL) and nano-sized hydroxyapatite (HA) or beta-tricalcium phosphate (TCP), which was able to support the growth of human bone marrow mesenchymal stem cells (hMSCs) and guide their osteogenic differentiation at the same time. Morphological and physical/chemical investigations were carried out by scanning, transmission electron microscopy, Fourier-transform infrared (FTIR) spectroscopy, mechanical and wettability analysis. Upon culturing hMSCs on composite nanofibers, we found that the incorporation of either HA or TCP into the PCL nanofibers did not affect cell viability, meanwhile the presence of the mineral phase increases the activity of alkaline phosphatase (ALP), an early marker of bone formation, and mRNA expression levels of osteoblast-related genes, such as the Runt-related transcription factor 2 (Runx-2) and bone sialoprotein (BSP), in total absence of osteogenic supplements. These results suggest that both the nanofibrous structure and the chemical composition of the scaffolds play a role in regulating the osteogenic differentiation of hMSCs.	[Polini, Alessandro; Pisignano, Dario] CNR Natl Res Council Italy, NNL Natl Nanotechnol Lab, Inst Nanosci, Lecce, Italy; [Pisignano, Dario] Univ Salento, Dipartimento Ingn Innovaz, Lecce, Italy; [Parodi, Manuela; Quarto, Rodolfo] Univ Genoa, Dipartimento Med Sperimentale DIMES, Genoa, Italy; [Scaglione, Silvia] CNR Natl Res Council Italy, IEIIT Inst, Genoa, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); University of Salento; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Elettronica e di Ingegneria dell'Informazione e delle Telecomunicazioni (IEIIT-CNR)	Polini, A (corresponding author), CNR Natl Res Council Italy, NNL Natl Nanotechnol Lab, Inst Nanosci, Lecce, Italy.	alessandro.polini@nano.cnr.it; dario.pisignano@unisalento.it	scaglione, silvia/K-5378-2019; Quarto, Rodolfo/AAB-2182-2019; Polini, Alessandro/A-2077-2012; Pisignano, Dario/M-8309-2015; Scaglione, Silvia/B-7124-2014	scaglione, silvia/0000-0002-9464-3554; Polini, Alessandro/0000-0002-3188-983X; Pisignano, Dario/0000-0003-3758-5199; Scaglione, Silvia/0000-0002-9464-3554; Quarto, Rodolfo/0000-0002-1146-894X	Italian Minister of University and Research [RBIP068JL9, RBNE08BNL7]	Italian Minister of University and Research(Ministry of Education, Universities and Research (MIUR))	Financial support was provided by the Italian Minister of University and Research through the FIRB Contracts RBIP068JL9 and RBNE08BNL7 (MERIT Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes CP, 2007, ADV DRUG DELIVER REV, V59, P1413, DOI 10.1016/j.addr.2007.04.022; Bianco P, 2001, NATURE, V414, P118, DOI 10.1038/35102181; Binulal NS, 2010, TISSUE ENG PT A, V16, P393, DOI [10.1089/ten.tea.2009.0242, 10.1089/ten.TEA.2009.0242]; Dalby MJ, 2008, J R SOC INTERFACE, V5, P1055, DOI 10.1098/rsif.2008.0016; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028; Deng M, 2010, BIOMATERIALS, V31, P4898, DOI 10.1016/j.biomaterials.2010.02.058; Franceschi RT, 1999, CRIT REV ORAL BIOL M, V10, P40, DOI 10.1177/10454411990100010201; Frank O, 2002, J CELL BIOCHEM, V85, P737, DOI 10.1002/jcb.10174; Hild N, 2011, NANOSCALE, V3, P401, DOI 10.1039/c0nr00615g; Hinnebusch BF, 2004, AM J PHYSIOL-GASTR L, V286, pG23, DOI 10.1152/ajpgi.00203.2003; Hollister SJ, 2002, BIOMATERIALS, V23, P4095, DOI 10.1016/S0142-9612(02)00148-5; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hu J, 2009, BIOMATERIALS, V30, P5061, DOI 10.1016/j.biomaterials.2009.06.013; Hubbell JA, 1995, NAT BIOTECHNOL, V13, P565, DOI DOI 10.1038/NBT0695-565; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kaur G, 2010, BIOMATERIALS, V31, P1732, DOI 10.1016/j.biomaterials.2009.11.041; Kim HW, 2007, J BIOMED MATER RES A, V83A, P169, DOI 10.1002/jbm.a.31247; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Kolambkar YM, 2010, TISSUE ENG PT A, V16, P3219, DOI [10.1089/ten.tea.2010.0004, 10.1089/ten.TEA.2010.0004]; Kon E, 2000, J BIOMED MATER RES, V49, P328; Langer R, 2004, NATURE, V428, P487, DOI 10.1038/nature02388; LeGeros RZ, 2008, CHEM REV, V108, P4742, DOI 10.1021/cr800427g; Li CM, 2006, BIOMATERIALS, V27, P3115, DOI 10.1016/j.biomaterials.2006.01.022; Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002; Martinez E, 2009, NANOMEDICINE-UK, V4, P65, DOI 10.2217/17435889.4.1.65; MATSUMOTO H, 1990, GASTROENTEROLOGY, V98, P1199, DOI 10.1016/0016-5085(90)90334-W; Muraglia A, 1998, BONE, V22, p131S, DOI 10.1016/S8756-3282(98)00009-X; Nandakumar A, 2010, MACROMOL BIOSCI, V10, P1365, DOI 10.1002/mabi.201000145; Ngiam M, 2009, BONE, V45, P4, DOI 10.1016/j.bone.2009.03.674; Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106; Parekh SH, 2011, BIOMATERIALS, V32, P2256, DOI 10.1016/j.biomaterials.2010.11.065; Patlolla A, 2010, ACTA BIOMATER, V6, P90, DOI 10.1016/j.actbio.2009.07.028; Phipps MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016813; Polini A, 2010, SOFT MATTER, V6, P1668, DOI 10.1039/b921932c; Ruckh TT, 2010, ACTA BIOMATER, V6, P2949, DOI 10.1016/j.actbio.2010.02.006; Sanchez-Salcedo S, 2009, ACTA BIOMATER, V5, P2738, DOI 10.1016/j.actbio.2009.03.025; Satomura K, 2000, J CELL BIOCHEM, V78, P391; Savarino L, 2007, BIOMATERIALS, V28, P3101, DOI 10.1016/j.biomaterials.2007.03.011; STEIN GS, 1993, ENDOCR REV, V14, P424, DOI 10.1210/er.14.4.424; Tay CY, 2011, SMALL, V7, P1416, DOI 10.1002/smll.201002298; Teixeira AI, 2006, BIOMATERIALS, V27, P3945, DOI 10.1016/j.biomaterials.2006.01.044; Teng SH, 2008, MATER LETT, V62, P3055, DOI 10.1016/j.matlet.2008.01.104; Teplyuk NM, 2008, J BIOL CHEM, V283, P27585, DOI 10.1074/jbc.M802453200; Thomas V, 2007, BIOMACROMOLECULES, V8, P631, DOI 10.1021/bm060879w; Tran N, 2009, WIRES NANOMED NANOBI, V1, P336, DOI 10.1002/wnan.23; Tsang KY, 2010, CELL TISSUE RES, V339, P93, DOI 10.1007/s00441-009-0893-8; Venugopal JR, 2008, ARTIF ORGANS, V32, P388, DOI 10.1111/j.1525-1594.2008.00557.x; Woo KM, 2003, J BIOMED MATER RES A, V67A, P531, DOI 10.1002/jbm.a.10098; Xin XJ, 2007, BIOMATERIALS, V28, P316, DOI 10.1016/j.biomaterials.2006.08.042; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; You MH, 2010, BIOMACROMOLECULES, V11, P1856, DOI 10.1021/bm100374n; Zhang LJ, 2009, NANO TODAY, V4, P66, DOI 10.1016/j.nantod.2008.10.014; Zhang YZ, 2008, BIOMATERIALS, V29, P4314, DOI 10.1016/j.biomaterials.2008.07.038	54	154	156	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26211	10.1371/journal.pone.0026211	http://dx.doi.org/10.1371/journal.pone.0026211			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022571	Green Submitted, Green Published, gold			2022-12-27	WOS:000295976000088
J	Verspoor, RL; Haddrill, PR				Verspoor, Rudi L.; Haddrill, Penelope R.			Genetic Diversity, Population Structure and Wolbachia Infection Status in a Worldwide Sample of Drosophila melanogaster and D. simulans Populations	PLOS ONE			English	Article							NON-AFRICAN POPULATIONS; AUTOSOMAL NUCLEOTIDE VARIATION; MULTILOCUS GENOTYPE DATA; CYTOPLASMIC INCOMPATIBILITY; NATURAL-POPULATIONS; ENDOSYMBIONT WOLBACHIA; NONEQUILIBRIUM MODELS; CONTRASTING PATTERNS; MOLECULAR EVOLUTION; POSITIVE SELECTION	Drosophila melanogaster and its close relatives have been extremely important model species in the development of population genetic models that serve to explain patterns of diversity in natural populations, a major goal of evolutionary biology. A detailed picture of the evolutionary history of these species is beginning to emerge, as the relative importance of forces including demographic changes and natural selection is established. A continuing aim is to characterise levels of genetic diversity in a large number of populations of these species, covering a wide geographic area. We have used collections from five previously un-sampled wild populations of D. melanogaster and two of D. simulans, across three continents. We estimated levels of genetic diversity within, and divergence between, these populations, and looked for evidence of genetic structure both between ancestral and derived populations, and amongst derived populations. We also investigated the prevalence of infection with the bacterial endosymbiont Wolbachia. We found that D. melanogaster populations from Sub-Saharan Africa are the most diverse, and that divergence is highest between these and non-Sub-Saharan populations. There is strong evidence for structuring of populations between Sub-Saharan Africa and the rest of the world, and some evidence for weak structure amongst derived populations. Populations from Sub-Saharan Africa also differ in the prevalence of Wolbachia infection, with very low levels of infection compared to populations from the rest of the world.	[Verspoor, Rudi L.; Haddrill, Penelope R.] Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Verspoor, RL (corresponding author), Univ Edinburgh, Sch Biol Sci, Inst Evolutionary Biol, Edinburgh, Midlothian, Scotland.	p.haddrill@ed.ac.uk	Haddrill, Penelope R/H-4439-2011	Haddrill, Penelope/0000-0001-6805-0694; Verspoor, Rudi/0000-0002-4328-7721	Natural Environment Research Council [NE/G013195/1]; NERC [NE/G013195/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by a Natural Environment Research Council (http://www.nerc.ac.uk/) Fellowship, reference NE/G013195/1, to PRH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKASHI H, 1995, GENETICS, V139, P1067; Akashi H, 1996, GENETICS, V144, P1297; Andolfatto P, 2001, MOL BIOL EVOL, V18, P279, DOI 10.1093/oxfordjournals.molbev.a003804; Andolfatto P, 2000, GENETICS, V156, P257; Baldo L, 2006, APPL ENVIRON MICROB, V72, P7098, DOI 10.1128/AEM.00731-06; Baudry E, 2004, MOL BIOL EVOL, V21, P1482, DOI 10.1093/molbev/msh089; Begun DJ, 1996, MOL BIOL EVOL, V13, P1405, DOI 10.1093/oxfordjournals.molbev.a025587; BEGUN DJ, 1993, NATURE, V365, P548, DOI 10.1038/365548a0; Begun DJ, 2000, P NATL ACAD SCI USA, V97, P5960, DOI 10.1073/pnas.97.11.5960; CABALLERO A, 1995, GENETICS, V139, P1007; Caracristi G, 2003, MOL BIOL EVOL, V20, P792, DOI 10.1093/molbev/msg091; Charlesworth B, 1996, GENET RES, V68, P131, DOI 10.1017/S0016672300034029; Charlesworth B, 2001, GENET RES, V77, P153, DOI 10.1017/S0016672301004979; Clark ME, 2005, GENETICS, V170, P1667, DOI 10.1534/genetics.104.038901; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Dean MD, 2004, MOL PHYLOGENET EVOL, V32, P998, DOI 10.1016/j.ympev.2004.03.013; Dieringer D, 2005, MOL ECOL, V14, P563, DOI 10.1111/j.1365-294X.2004.02422.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; ElMousadik A, 1996, THEOR APPL GENET, V92, P832, DOI 10.1007/BF00221895; Engelstadter J, 2009, ANNU REV ECOL EVOL S, V40, P127, DOI 10.1146/annurev.ecolsys.110308.120206; Eyre-Walker A, 2002, MOL BIOL EVOL, V19, P2142, DOI 10.1093/oxfordjournals.molbev.a004039; Falush D, 2003, GENETICS, V164, P1567; Fry AJ, 2004, HEREDITY, V93, P379, DOI 10.1038/sj.hdy.6800514; Galtier N, 2000, GENETICS, V155, P981; Glinka S, 2003, GENETICS, V165, P1269; Haddrill PR, 2008, MOL BIOL EVOL, V25, P1825, DOI 10.1093/molbev/msn125; Haddrill PR, 2005, GENOME RES, V15, P790, DOI 10.1101/gr.3541005; Hamblin MT, 1999, GENETICS, V153, P305; Harr B, 2002, P NATL ACAD SCI USA, V99, P12949, DOI 10.1073/pnas.202336899; HOFFMANN AA, 1994, GENETICS, V136, P993; Hoffmann AA, 1998, GENETICS, V148, P221; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Hutter S, 2007, GENETICS, V177, P469, DOI 10.1534/genetics.107.074922; Kauer M, 2003, MOL BIOL EVOL, V20, P1329, DOI 10.1093/molbev/msg148; Kauer M, 2002, GENETICS, V160, P247; Kauer MO, 2003, GENETICS, V165, P1137; Kliman RM, 2000, GENETICS, V156, P1913; Krebs C.J., 2014, ECOLOGICAL METHODOLO; LACHAISE D, 1988, EVOL BIOL, V22, P159; Li HP, 2006, PLOS GENET, V2, P1580, DOI 10.1371/journal.pgen.0020166; MARUYAMA T, 1985, GENETICS, V111, P691; MARUYAMA T, 1985, GENETICS, V111, P675; Montenegro H, 2006, GENETICA, V127, P207, DOI 10.1007/s10709-005-3766-4; Mousset S, 2003, GENETICS, V163, P599; Nolte V, 2008, GENETICS, V178, P405, DOI 10.1534/genetics.107.080200; Nunes MDS, 2008, MOL ECOL, V17, P4470, DOI 10.1111/j.1365-294X.2008.03944.x; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Olsen K, 2001, HEREDITY, V86, P731, DOI 10.1046/j.1365-2540.2001.00892.x; Ometto L, 2005, MOL BIOL EVOL, V22, P2119, DOI 10.1093/molbev/msi207; Orengo DJ, 2004, GENETICS, V167, P1759, DOI 10.1534/genetics.104.028969; Orozco-terWengel P, 2011, MOL ECOL, V20, P1108, DOI 10.1111/j.1365-294X.2010.04990.x; Pool JE, 2006, HEREDITY, V97, P27, DOI 10.1038/sj.hdy.6800830; Pool JE, 2008, MOL BIOL EVOL, V25, P1728, DOI 10.1093/molbev/msn124; Pool JE, 2006, GENETICS, V174, P915, DOI 10.1534/genetics.106.058693; Pritchard JK, 2000, GENETICS, V155, P945; Przeworski M, 2001, MOL BIOL EVOL, V18, P291, DOI 10.1093/oxfordjournals.molbev.a003805; Reynolds KT, 2002, GENET RES, V80, P79, DOI 10.1017/S0016672302005827; Riegler M, 2005, CURR BIOL, V15, P1428, DOI 10.1016/j.cub.2005.06.069; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sella G, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000495; Singh ND, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-202; Sokal RR, 1995, BIOMETRY; SOLIGNAC M, 1994, CR ACAD SCI III-VIE, V317, P461; Stephan W, 2007, HEREDITY, V98, P65, DOI 10.1038/sj.hdy.6800901; Thornton K, 2006, GENETICS, V172, P1607, DOI 10.1534/genetics.105.048223; TURELLI M, 1991, NATURE, V353, P440, DOI 10.1038/353440a0; TURELLI M, 1995, GENETICS, V140, P1319; Wall JD, 2002, GENETICS, V162, P203; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; WIEHE THE, 1993, MOL BIOL EVOL, V10, P842, DOI 10.1093/oxfordjournals.molbev.a040046; Yukilevich R, 2008, EVOLUTION, V62, P2112, DOI 10.1111/j.1558-5646.2008.00427.x; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	73	32	35	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26318	10.1371/journal.pone.0026318	http://dx.doi.org/10.1371/journal.pone.0026318			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022599	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000295976000097
J	Wakabayashi-Ito, N; Doherty, OM; Moriyama, H; Breakefield, XO; Gusella, JF; O'Donnell, JM; Ito, N				Wakabayashi-Ito, Noriko; Doherty, Olugbenga M.; Moriyama, Hideaki; Breakefield, Xandra O.; Gusella, James F.; O'Donnell, Janis M.; Ito, Naoto			dtorsin, the Drosophila Ortholog of the Early-Onset Dystonia TOR1A (DYT1), Plays a Novel Role in Dopamine Metabolism	PLOS ONE			English	Article							TYROSINE-HYDROXYLASE; TORSION DYSTONIA; PHENOTYPIC ANALYSIS; PROTEIN TORSINA; PUNCH LOCUS; MOUSE MODEL; GENE; IDENTIFICATION; LOCOMOTION; BIOSYNTHESIS	Dystonia represents the third most common movement disorder in humans. At least 15 genetic loci (DYT1-15) have been identified and some of these genes have been cloned. TOR1A (formally DYT1), the gene responsible for the most common primary hereditary dystonia, encodes torsinA, an AAA ATPase family protein. However, the function of torsinA has yet to be fully understood. Here, we have generated and characterized a complete loss-of-function mutant for dtorsin, the only Drosophila ortholog of TOR1A. Null mutation of the X-linked dtorsin was semi-lethal with most male flies dying by the pre-pupal stage and the few surviving adults being sterile and slow moving, with reduced cuticle pigmentation and thin, short bristles. Third instar male larvae exhibited locomotion defects that were rescued by feeding dopamine. Moreover, biochemical analysis revealed that the brains of third instar larvae and adults heterozygous for the loss-of-function dtorsin mutation had significantly reduced dopamine levels. The dtorsin mutant showed a very strong genetic interaction with Pu (Punch: GTP cyclohydrolase), the ortholog of the human gene underlying DYT14 dystonia. Biochemical analyses revealed a severe reduction of GTP cyclohydrolase protein and activity, suggesting that dtorsin plays a novel role in dopamine metabolism as a positive-regulator of GTP cyclohydrolase protein. This dtorsin mutant line will be valuable for understanding this relationship and potentially other novel torsin functions that could play a role in human dystonia.	[Wakabayashi-Ito, Noriko; Gusella, James F.; Ito, Naoto] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Doherty, Olugbenga M.; O'Donnell, Janis M.] Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA; [Moriyama, Hideaki] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Wakabayashi-Ito, Noriko; Breakefield, Xandra O.; Ito, Naoto] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol & Radiol, Boston, MA USA; [Wakabayashi-Ito, Noriko; Breakefield, Xandra O.; Ito, Naoto] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; University of Alabama System; University of Alabama Tuscaloosa; University of Nebraska System; University of Nebraska Lincoln; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School	Wakabayashi-Ito, N (corresponding author), Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA.	iton@chgr.mgh.harvard.edu			NIH/NIDS [NS037409]; Nebraska Tobacco Settlement Biomedical Research Development Funds; Dystonia Medical Research Foundation; University of Alabama; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS087997, P50NS037409, P01NS037409] Funding Source: NIH RePORTER	NIH/NIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Nebraska Tobacco Settlement Biomedical Research Development Funds; Dystonia Medical Research Foundation; University of Alabama; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	NIH/NIDS Grant NS037409 (JFG) (http://www.ninds.nih.gov/), Nebraska Tobacco Settlement Biomedical Research Development Funds (HM), Dystonia Medical Research Foundation (NI and JFG) (http://www.dystonia-foundation.org/) and The University of Alabama (JMO and OMD)(http://www.ua.edu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balcioglu A, 2007, J NEUROCHEM, V102, P783, DOI 10.1111/j.1471-4159.2007.04590.x; Bhidayasiri R, 2011, POSTGRAD MED J, V87, P132, DOI 10.1136/pgmj.2010.103234; Blair SS, 2000, DROSOPHILA PROTOCOLS, P159; BRAND AH, 1993, DEVELOPMENT, V118, P401; Breakefield XO, 2008, NAT REV NEUROSCI, V9, P222, DOI 10.1038/nrn2337; Breakefield XO, 2001, NEURON, V31, P9, DOI 10.1016/S0896-6273(01)00350-6; Bruggemann N, 2010, CURR NEUROL NEUROSCI, V10, P199, DOI 10.1007/s11910-010-0107-5; Carbon M, 2010, EUR J NEUROL, V17, P58, DOI 10.1111/j.1468-1331.2010.03054.x; Chaudhuri A, 2007, J NEUROSCI, V27, P2457, DOI 10.1523/JNEUROSCI.4239-06.2007; CHEN XY, 1994, J CELL SCI, V107, P3501; Cheng LE, 2010, NEURON, V67, P373, DOI 10.1016/j.neuron.2010.07.004; Dasari S, 2004, NEUROSCI RES, V48, P221, DOI 10.1016/j.neures.2003.10.005; DAVIS MD, 1991, FEBS LETT, V285, P17, DOI 10.1016/0014-5793(91)80714-E; DiAntonio A, 1999, J NEUROSCI, V19, P3023; DiMonte DA, 1996, BRAIN RES, V738, P53, DOI 10.1016/0006-8993(96)00761-5; Fox LE, 2006, J NEUROSCI, V26, P1486, DOI 10.1523/JNEUROSCI.4749-05.2006; Gibson S, 2003, COMPUT GRAPH-UK, V27, P293, DOI 10.1016/S0097-8493(02)00285-6; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; Gong WJ, 2003, P NATL ACAD SCI USA, V100, P2556, DOI 10.1073/pnas.0535280100; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Hewett J, 2010, J NEUROCHEM, V113, P228, DOI 10.1111/j.1471-4159.2010.06590.x; Hewett JW, 2007, P NATL ACAD SCI USA, V104, P7271, DOI 10.1073/pnas.0701185104; Hirsh J, 2000, EXPOSING DROSOPHILA; Hughes CL, 2007, MOL CELL NEUROSCI, V35, P383, DOI 10.1016/j.mcn.2007.04.001; Kamm C, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-48; Kock N, 2006, HUM MOL GENET, V15, P1355, DOI 10.1093/hmg/ddl055; Koh YH, 2004, HUM MOL GENET, V13, P2019, DOI 10.1093/hmg/ddh208; Krishnakumar S, 2000, J NEUROGENET, V14, P1, DOI 10.3109/01677060009083474; Kume K, 2005, J NEUROSCI, V25, P7377, DOI 10.1523/JNEUROSCI.2048-05.2005; Lee DW, 2009, MOL CELLS, V27, P89, DOI 10.1007/s10059-009-0009-z; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Muraro NI, 2006, J NEUROBIOL, V66, P1338, DOI 10.1002/neu.20313; Neckameyer W, 2001, J NEUROBIOL, V47, P280, DOI 10.1002/neu.1035; NECKAMEYER WS, 1993, J NEUROGENET, V8, P189, DOI 10.3109/01677069309083448; Neckameyer WS, 1996, DEV BIOL, V176, P209, DOI 10.1006/dbio.1996.0128; NECKAMEYER WS, 1989, NEURON, V2, P1167, DOI 10.1016/0896-6273(89)90183-9; Neckameyer WS, 2000, NEUROBIOL AGING, V21, P145, DOI 10.1016/S0197-4580(99)00109-8; ODONNELL JM, 1989, DEV GENET, V10, P273, DOI 10.1002/dvg.1020100316; Ozelius LJ, 1999, GENOMICS, V62, P377, DOI 10.1006/geno.1999.6039; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Page ME, 2010, NEUROBIOL DIS, V39, P318, DOI 10.1016/j.nbd.2010.04.016; Perlmutter JS, 1997, NEUROLOGY, V49, P1432, DOI 10.1212/WNL.49.5.1432; REYNOLDS ER, 1987, DEV BIOL, V123, P430, DOI 10.1016/0012-1606(87)90401-5; REYNOLDS ER, 1988, GENETICS, V119, P609; Saraswati S, 2004, J NEUROBIOL, V58, P425, DOI 10.1002/neu.10298; Sciamanna G, 2009, NEUROBIOL DIS, V34, P133, DOI 10.1016/j.nbd.2009.01.001; Segawa Masaya, 2009, Chang Gung Med J, V32, P1; Song W, 2007, P NATL ACAD SCI USA, V104, P5199, DOI 10.1073/pnas.0700895104; Thony B, 2000, BIOCHEM J, V347, P1, DOI 10.1042/0264-6021:3470001; Vie A, 1999, J BIOL CHEM, V274, P16788, DOI 10.1074/jbc.274.24.16788; Wang JW, 2002, J NEUROGENET, V16, P45, DOI 10.1080/01677060213106; Watschinger K, 2010, P NATL ACAD SCI USA, V107, P13672, DOI 10.1073/pnas.1002404107; Wichmann T, 2008, EXP NEUROL, V212, P242, DOI 10.1016/j.expneurol.2008.04.020; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wright TRF, 1996, J HERED, V87, P175, DOI 10.1093/oxfordjournals.jhered.a022983; Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336; Zhao Y, 2008, EXP NEUROL, V210, P719, DOI 10.1016/j.expneurol.2007.12.027	57	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26183	10.1371/journal.pone.0026183	http://dx.doi.org/10.1371/journal.pone.0026183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022556	gold, Green Published			2022-12-27	WOS:000295976000082
J	Zhou, M; Kindt, M; Joels, M; Krugers, HJ				Zhou, Ming; Kindt, Merel; Joels, Marian; Krugers, Harm J.			Blocking Mineralocorticoid Receptors prior to Retrieval Reduces Contextual Fear Memory in Mice	PLOS ONE			English	Article							DAY-OLD CHICKS; GLUCOCORTICOID-RECEPTORS; PROTEIN-SYNTHESIS; RECONSOLIDATION; CORTICOSTERONE; EXTINCTION; STRESS; CONSOLIDATION; ANTAGONISTS; AMYGDALA	Background: Corticosteroid hormones regulate appraisal and consolidation of information via mineralocorticoid receptors (MRs) and glucocorticoid receptors (GRs) respectively. How activation of these receptors modulates retrieval of fearful information and the subsequent expression of fear is largely unknown. We tested here whether blockade of MRs or GRs during retrieval also affects subsequent expression of fear memory. Methodology/Principal Findings: Mice were trained in contextual or tone cue fear conditioning paradigms, by pairing mild foot shocks with a particular context or tone respectively. Twenty-four hours after training, context-conditioned animals were re-exposed to the context for 3 or 30 minutes (day 2); tone-conditioned animals were placed in a different context and re-exposed to one or six tones. Twenty-four hours (day 3) and one month later, freezing behavior to the aversive context/tone was scored again. MR or GR blockade was achieved by giving spironolactone or RU486 subcutaneously one hour before retrieval on day 2. Spironolactone administered prior to brief context re-exposure reduced freezing behavior during retrieval and 24 hours later, but not one month later. Administration of spironolactone without retrieval of the context or immediately after retrieval on day 2 did not reduce freezing on day 3. Re-exposure to the context for 30 minutes on day 2 significantly reduced freezing on day 3 and one month later, but freezing was not further reduced by spironolactone. Administration of spironolactone prior to tone-cue re-exposure on day 2 did not affect freezing behavior. Treatment with RU486 prior to re-exposure did not affect context or tone-cue fear memories at any time point. Conclusions/Significance: We conclude that MR blockade prior to retrieval strongly reduces the expression of contextual fear, implying that MRs, rather than GRs, play an important role in retrieval of emotional information and subsequent fear expression.	[Zhou, Ming; Joels, Marian; Krugers, Harm J.] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Kindt, Merel] Univ Amsterdam, Dept Clin Psychol, NL-1018 WB Amsterdam, Netherlands; [Joels, Marian] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Dept Neurosci & Pharmacol, Utrecht, Netherlands	University of Amsterdam; University of Amsterdam; Utrecht University; Utrecht University Medical Center	Zhou, M (corresponding author), Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands.	h.krugers@uva.nl	Joëls, Marian/P-6415-2016	Joels, Marian/0000-0002-4826-6209	Cognitive Science Center Amsterdam; Royal Dutch Academy of Arts and Sciences [05CDP013, 08CDP004]; Dutch Brain Foundation [2008 (1).07]	Cognitive Science Center Amsterdam; Royal Dutch Academy of Arts and Sciences; Dutch Brain Foundation	This project is supported by a special grant from the Cognitive Science Center Amsterdam, the Royal Dutch Academy of Arts and Sciences (05CDP013 and 08CDP004) and grant 2008 (1).07 from the Dutch Brain Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamec R, 2007, BEHAV BRAIN RES, V179, P192, DOI 10.1016/j.bbr.2007.02.001; Atkinson HC, 2008, AM J PHYSIOL-ENDOC M, V294, pE1011, DOI 10.1152/ajpendo.00721.2007; Berger S, 2006, P NATL ACAD SCI USA, V103, P195, DOI 10.1073/pnas.0503878102; Bitran D, 1998, PHARMACOL BIOCHEM BE, V60, P879, DOI 10.1016/S0091-3057(98)00071-9; Blundell J, 2011, NEUROBIOL LEARN MEM, V95, P453, DOI 10.1016/j.nlm.2011.02.006; Brinks V, 2009, EXP NEUROL, V216, P375, DOI 10.1016/j.expneurol.2008.12.011; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; de Quervain DJF, 1998, NATURE, V394, P787, DOI 10.1038/29542; de Quervain DJF, 2000, NAT NEUROSCI, V3, P313, DOI 10.1038/73873; Eisenberg M, 2003, SCIENCE, V301, P1102, DOI 10.1126/science.1086881; Herman JP, 1998, J NEUROSCI, V18, P7462; Karst H, 2005, P NATL ACAD SCI USA, V102, P19204, DOI 10.1073/pnas.0507572102; Karst H, 2010, P NATL ACAD SCI USA, V107, P14449, DOI 10.1073/pnas.0914381107; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; Koenig HN, 2004, PSYCHONEUROENDOCRINO, V29, P999, DOI 10.1016/j.psyneuen.2003.09.004; Kumar G, 2007, PSYCHONEUROENDOCRINO, V32, P834, DOI 10.1016/j.psyneuen.2007.05.011; Mamiya N, 2009, J NEUROSCI, V29, P402, DOI 10.1523/JNEUROSCI.4639-08.2009; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nikzad S, 2011, STRESS, V14, P459, DOI 10.3109/10253890.2010.548171; OITZL MS, 1992, BEHAV NEUROSCI, V106, P62, DOI 10.1037/0735-7044.106.1.62; Olijslagers JE, 2008, EUR J NEUROSCI, V27, P2542, DOI 10.1111/j.1460-9568.2008.06220.x; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Pugh CR, 1997, NEUROBIOL LEARN MEM, V67, P75, DOI 10.1006/nlme.1996.3741; REUL JMHM, 1985, ENDOCRINOLOGY, V117, P2505, DOI 10.1210/endo-117-6-2505; Roozendaal B, 2002, NEUROBIOL LEARN MEM, V78, P578, DOI 10.1006/nlme.2002.4080; Roozendaal B, 2009, J NEUROSCI, V29, P14299, DOI 10.1523/JNEUROSCI.3626-09.2009; SANDI C, 1994, EUR J NEUROSCI, V6, P1292, DOI 10.1111/j.1460-9568.1994.tb00319.x; SANDI C, 1994, BRAIN RES, V647, P106, DOI 10.1016/0006-8993(94)91404-4; Sangha S, 2003, J NEUROSCI, V23, P8034; Schiller D, 2010, NATURE, V463, P49, DOI 10.1038/nature08637; Soeter M, 2011, LEARN MEMORY, V18, P357, DOI 10.1101/lm.2148511; Soeter M, 2010, NEUROBIOL LEARN MEM, V94, P30, DOI 10.1016/j.nlm.2010.03.004; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Wiegert O, 2006, LEARN MEMORY, V13, P110, DOI 10.1101/lm.87706; Yang YL, 2006, NEUROPSYCHOPHARMACOL, V31, P912, DOI 10.1038/sj.npp.1300899; Zhou M, 2010, NEUROBIOL LEARN MEM, V94, P530, DOI 10.1016/j.nlm.2010.09.005; Zhou M, 2009, EUR J NEUROSCI, V30, P1559, DOI 10.1111/j.1460-9568.2009.06951.x	42	37	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26220	10.1371/journal.pone.0026220	http://dx.doi.org/10.1371/journal.pone.0026220			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	22022574	gold, Green Published, Green Submitted			2022-12-27	WOS:000295976000090
J	Chen, H; Zhang, BC; Hicks, LM; Xiong, LM				Chen, Hao; Zhang, Baichen; Hicks, Leslie M.; Xiong, Liming			A Nucleotide Metabolite Controls Stress-Responsive Gene Expression and Plant Development	PLOS ONE			English	Article							3'-PHOSPHATE 5'-PHOSPHOSULFATE TRANSPORTER; INOSITOL POLYPHOSPHATE 1-PHOSPHATASE; ACID SIGNAL-TRANSDUCTION; ABSCISIC-ACID; ARABIDOPSIS-THALIANA; SALT TOLERANCE; 3(2),5-BISPHOSPHATE NUCLEOTIDASE; NEGATIVE REGULATOR; FREEZING TOLERANCE; SULFUR METABOLISM	Abiotic stress, such as drought and high salinity, activates a network of signaling cascades that lead to the expression of many stress-responsive genes in plants. The Arabidopsis FIERY1 (FRY1) protein is a negative regulator of stress and abscisic acid (ABA) signaling and exhibits both an inositol polyphosphatase and a 3',5'-bisphosphate nucleotidase activity in vitro. The FRY1 nucleotidase degrades the sulfation byproduct 3'-phosphoadenosine-5'-phosphate (PAP), yet its in vivo functions and particularly its roles in stress gene regulation remain unclear. Here we developed a LC-MS/MS method to quantitatively measure PAP levels in plants and investigated the roles of this nucleotidase activity in stress response and plant development. It was found that PAP level was tightly controlled in plants and did not accumulate to any significant level either under normal conditions or under NaCl, LiCl, cold, or ABA treatments. In contrast, high levels of PAP were detected in multiple mutant alleles of FRY1 but not in mutants of other FRY1 family members, indicating that FRY1 is the major enzyme that hydrolyzes PAP in vivo. By genetically reducing PAP levels in fry1 mutants either through overexpression of a yeast PAP nucleotidase or by generating a triple mutant of fry1 apk1 apk2 that is defective in the biosynthesis of the PAP precursor 3'-phosphoadenosine-5'-phosphosulfate (PAPS), we demonstrated that the developmental defects and superinduction of stress-responsive genes in fry1 mutants correlate with PAP accumulation in planta. We also found that the hypersensitive stress gene regulation in fry1 requires ABH1 but not ABI1, two other negative regulators in ABA signaling pathways. Unlike in yeast, however, FRY1 overexpression in Arabidopsis could not enhance salt tolerance. Taken together, our results demonstrate that PAP is critical for stress gene regulation and plant development, yet the FRY1 nucleotidase that catabolizes PAP may not be an in vivo salt toxicity target in Arabidopsis.	[Chen, Hao; Zhang, Baichen; Hicks, Leslie M.; Xiong, Liming] Donald Danforth Plant Sci Ctr, St Louis, MO USA; [Chen, Hao; Xiong, Liming] King Abdullah Univ Sci & Technol, Div Chem & Life Sci & Engn, Thuwal, Saudi Arabia	Donald Danforth Plant Science Center; King Abdullah University of Science & Technology	Chen, H (corresponding author), Donald Danforth Plant Sci Ctr, St Louis, MO USA.	liming.xiong@kaust.edu.sa	Hicks, Leslie M/E-8015-2010; Chen, Hao/AAF-3704-2020	Hicks, Leslie M/0000-0002-8008-3998; Xiong, Liming/0000-0001-8099-0806	National Science Foundation [0446359]	National Science Foundation(National Science Foundation (NSF))	This study was supported by the National Science Foundation grant #0446359 (to L.X). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown E, 2007, BIOCHEM CELL BIOL, V85, P444, DOI 10.1139/O07-059; Chen H, 2005, PLANT J, V44, P396, DOI 10.1111/j.1365-313X.2005.02538.x; Chen H, 2011, PLANT SIGNAL BEHAV, V6, P123, DOI 10.4161/psb.6.1.14231; Chen H, 2010, PLANT CELL ENVIRON, V33, P2180, DOI 10.1111/j.1365-3040.2010.02218.x; Chen H, 2010, J BIOL CHEM, V285, P24238, DOI 10.1074/jbc.M110.123661; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; Davidian JC, 2010, MOL PLANT, V3, P314, DOI 10.1093/mp/ssq001; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fiehn O, 2000, NAT BIOTECHNOL, V18, P1157, DOI 10.1038/81137; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Gibon Y, 2002, PLANT J, V30, P221, DOI 10.1046/j.1365-313X.2001.01278.x; Gil-Mascarell R, 1999, PLANT J, V17, P373, DOI 10.1046/j.1365-313X.1999.00385.x; GLASER HU, 1993, EMBO J, V12, P3105, DOI 10.1002/j.1460-2075.1993.tb05979.x; Gregory BD, 2008, DEV CELL, V14, P854, DOI 10.1016/j.devcel.2008.04.005; Gy I, 2007, PLANT CELL, V19, P3451, DOI 10.1105/tpc.107.055319; Hauser F, 2011, CURR BIOL, V21, pR346, DOI 10.1016/j.cub.2011.03.015; Hirsch J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016724; Hugouvieux V, 2001, CELL, V106, P477, DOI 10.1016/S0092-8674(01)00460-3; Ishitani M, 1997, PLANT CELL, V9, P1935, DOI 10.1105/tpc.9.11.1935; Kamiyama S, 2006, J BIOL CHEM, V281, P10945, DOI 10.1074/jbc.M508991200; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; Kim BH, 2009, PLANT J, V58, P208, DOI 10.1111/j.1365-313X.2008.03770.x; Koiwa H, 2006, J EXP BOT, V57, P1119, DOI 10.1093/jxb/erj093; Lee H, 1999, PLANT J, V17, P301, DOI 10.1046/j.1365-313X.1999.00375.x; Lee S, 1998, BIOCHEM BIOPH RES CO, V247, P171, DOI 10.1006/bbrc.1998.8751; Leustek T, 2000, ANNU REV PLANT PHYS, V51, P141, DOI 10.1146/annurev.arplant.51.1.141; Leustek T, 1999, PLANT PHYSIOL, V120, P637, DOI 10.1104/pp.120.3.637; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Lillig CH, 2001, ARCH BIOCHEM BIOPHYS, V392, P303, DOI 10.1006/abbi.2001.2453; Lu C, 2000, PLANT CELL, V12, P2351, DOI 10.1105/tpc.12.12.2351; Luders F, 2003, EMBO J, V22, P3635, DOI 10.1093/emboj/cdg345; LUNN JE, 1990, PLANT PHYSIOL, V94, P1345, DOI 10.1104/pp.94.3.1345; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; MANDON EC, 1994, P NATL ACAD SCI USA, V91, P10707, DOI 10.1073/pnas.91.22.10707; Mechold U, 2006, NUCLEIC ACIDS RES, V34, P2364, DOI 10.1093/nar/gkl247; Mugford SG, 2009, PLANT CELL, V21, P910, DOI 10.1105/tpc.109.065581; MURGUIA JR, 1995, SCIENCE, V267, P232; Murguia JR, 1996, J BIOL CHEM, V271, P29029, DOI 10.1074/jbc.271.46.29029; NEUWALD AF, 1992, J BACTERIOL, V174, P415, DOI 10.1128/jb.174.2.415-425.1992; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Peltier JB, 2006, MOL CELL PROTEOMICS, V5, P114, DOI 10.1074/mcp.M500180-MCP200; Quintero FJ, 1996, PLANT CELL, V8, P529, DOI 10.1105/tpc.8.3.529; Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c; RENOSTO F, 1993, ARCH BIOCHEM BIOPHYS, V307, P272, DOI 10.1006/abbi.1993.1590; Robles P, 2010, PLANT PHYSIOL, V152, P1357, DOI 10.1104/pp.109.149369; Rodriguez VM, 2010, PLANT PHYSIOL, V152, P1335, DOI 10.1104/pp.109.150474; SCHMIDT A, 1992, ANNU REV PLANT PHYS, V43, P325, DOI 10.1146/annurev.pp.43.060192.001545; STITT M, 1986, PLANT PHYSIOL, V81, P1115, DOI 10.1104/pp.81.4.1115; Takahashi H, 2011, ANNU REV PLANT BIOL, V62, P157, DOI 10.1146/annurev-arplant-042110-103921; THOMAS D, 1992, J GEN MICROBIOL, V138, P2021, DOI 10.1099/00221287-138-10-2021; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tyler JK, 2002, EUR J BIOCHEM, V269, P2268, DOI 10.1046/j.1432-1033.2002.02890.x; Verslues PE, 2006, PLANT J, V47, P776, DOI 10.1111/j.1365-313X.2006.02833.x; Wilson PB, 2009, PLANT J, V58, P299, DOI 10.1111/j.1365-313X.2008.03780.x; Xiong LM, 2004, PLANT J, V40, P536, DOI 10.1111/j.1365-313X.2004.02225.x; Xiong LM, 2001, DEV CELL, V1, P771, DOI 10.1016/S1534-5807(01)00087-9; Xiong LM, 2001, GENE DEV, V15, P1971, DOI 10.1101/gad.891901; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; ZARUBA ME, 1988, BIOCHEM BIOPH RES CO, V155, P1271, DOI 10.1016/S0006-291X(88)81278-6; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 1998, PLANT CELL, V10, P1181, DOI 10.1105/tpc.10.7.1181	65	109	112	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26661	10.1371/journal.pone.0026661	http://dx.doi.org/10.1371/journal.pone.0026661			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	21792361	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500105
J	Mohan, RR; Tovey, JCK; Sharma, A; Schultz, GS; Cowden, JW; Tandon, A				Mohan, Rajiv R.; Tovey, Jonathan C. K.; Sharma, Ajay; Schultz, Gregory S.; Cowden, John W.; Tandon, Ashish			Targeted Decorin Gene Therapy Delivered with Adeno-Associated Virus Effectively Retards Corneal Neovascularization In Vivo	PLOS ONE			English	Article							SUBCONJUNCTIVAL INJECTION; COLLAGEN FIBRILLOGENESIS; ENDOTHELIAL-CELLS; ANGIOGENESIS; EXPRESSION; AAV; INJURY; VECTORS; BEVACIZUMAB; INHIBITION	Decorin, small leucine-rich proteoglycan, has been shown to modulate angiogenesis in nonocular tissues. This study tested a hypothesis that tissue-selective targeted decorin gene therapy delivered to the rabbit stroma with adeno-associated virus serotype 5 (AAV5) impedes corneal neovascularization (CNV) in vivo without significant side effects. An established rabbit CNV model was used. Targeted decorin gene therapy in the rabbit stroma was delivered with a single topical AAV5 titer (100 mu l; 5 x 10(12) vg/ml) application onto the stroma for two minutes after removing corneal epithelium. The levels of CNV were examined with stereomicroscopy, H&E staining, lectin, collagen type IV, CD31 immunocytochemistry and CD31 immunoblotting. Real-time PCR quantified mRNA expression of pro-and anti-angiogenic genes. Corneal health in live animals was monitored with clinical, slit-lamp and optical coherence tomography biomicroscopic examinations. Selective decorin delivery into stroma showed significant 52% (p<0.05), 66% (p<0.001), and 63% (p<0.01) reduction at early (day 5), mid (day 10), and late (day 14) stages of CNV in decorin-delivered rabbit corneas compared to control (no decorin delivered) corneas in morphometric analysis. The H&E staining, lectin, collagen type IV, CD31 immunostaining (57-65, p<0.5), and CD31 immunoblotting (62-67%, p<0.05) supported morphometric findings. Quantitative PCR studies demonstrated decorin gene therapy down-regulated expression of VEGF, MCP1 and angiopoietin (pro-angiogenic) and up-regulated PEDF (anti-angiogenic) genes. The clinical, biomicroscopy and transmission electron microscopy studies revealed that AAV5-mediated decorin gene therapy is safe for the cornea. Tissue-targeted AAV5-mediated decorin gene therapy decreases CNV with no major side effects, and could potentially be used for treating patients.	[Mohan, Rajiv R.; Tovey, Jonathan C. K.; Sharma, Ajay; Tandon, Ashish] Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA; [Mohan, Rajiv R.; Tovey, Jonathan C. K.; Sharma, Ajay; Cowden, John W.; Tandon, Ashish] Univ Missouri, Mason Eye Inst, Columbia, MO USA; [Mohan, Rajiv R.] Univ Missouri, Coll Vet Med, Columbia, MO USA; [Schultz, Gregory S.] Univ Florida, Dept Ophthalmol & Obstet & Gynecol, Gainesville, FL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; State University System of Florida; University of Florida	Mohan, RR (corresponding author), Harry S Truman Mem Vet Hosp, Columbia, MO 65201 USA.	mohanr@health.missouri.edu	Wong, Pak Kin/A-7974-2012; Bercovici, Moran/F-6076-2013	Wong, Pak Kin/0000-0001-7388-2110; Liao, Joseph/0000-0003-2448-5463; Bercovici, Moran/0000-0002-7803-4791	National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States [RO1EY17294, RO1EY17294S2]; Veteran Health Affairs, Washington, DC, United States [1I01BX000357-01]; Research to Prevent Blindness, New York, New York, United States	National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)NIH National Eye Institute (NEI)); Veteran Health Affairs, Washington, DC, United States; Research to Prevent Blindness, New York, New York, United States(Research to Prevent Blindness (RPB))	The work was supported by the RO1EY17294 (RRM) and RO1EY17294S2 (RRM) grants from the National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States; 1I01BX000357-01 (RRM) grant from the Veteran Health Affairs, Washington, DC, United States and an unrestricted grant from the Research to Prevent Blindness, New York, New York, United States. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aydin E, 2008, CORNEA, V27, P446, DOI 10.1097/ICO.0b013e3181605ff9; Buss DG, 2010, VET OPHTHALMOL, V13, P301, DOI 10.1111/j.1463-5224.2010.00813.x; Chen WL, 2009, INVEST OPHTH VIS SCI, V50, P1659, DOI 10.1167/iovs.08-1997; Cheng HC, 2007, MOL VIS, V13, P2344; Chung ES, 2009, INVEST OPHTH VIS SCI, V50, P1613, DOI 10.1167/iovs.08-2212; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dastjerdi MH, 2009, ARCH OPHTHALMOL-CHIC, V127, P381, DOI 10.1001/archophthalmol.2009.18; Davies CD, 2001, MICROVASC RES, V62, P26, DOI 10.1006/mvre.2001.2311; Ellenberg D, 2010, PROG RETIN EYE RES, V29, P208, DOI 10.1016/j.preteyeres.2010.01.002; Gaudana R, 2010, AAPS J, V12, P348, DOI 10.1208/s12248-010-9183-3; Goldoni S, 2008, INT J CANCER, V123, P2473, DOI 10.1002/ijc.23930; Grant DS, 2002, ONCOGENE, V21, P4765, DOI 10.1038/sj.onc.1205595; Jani PD, 2007, INVEST OPHTH VIS SCI, V48, P2030, DOI 10.1167/iovs.06-0853; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kinsella MG, 2000, J BIOL CHEM, V275, P13924, DOI 10.1074/jbc.275.18.13924; Kuo CN, 2009, EXP EYE RES, V89, P678, DOI 10.1016/j.exer.2009.06.021; Lai LJ, 2007, J BIOMED SCI, V14, P313, DOI 10.1007/s11373-007-9153-7; Lee P, 1998, SURV OPHTHALMOL, V43, P245, DOI 10.1016/S0039-6257(98)00035-6; Liu J, 2008, MOL VIS, V14, P2087; Mimura T, 2009, J VASC RES, V46, P541, DOI 10.1159/000226222; Mohan RR, 2011, CURR MOL MED, V11, P110; Mohan RR, 2010, MOL VIS, V16, P2494; Mohan RR, 2005, PROG RETIN EYE RES, V24, P537, DOI 10.1016/j.preteyeres.2005.04.001; Mohan RR, 2003, EXP EYE RES, V76, P373, DOI 10.1016/S0014-4835(02)00275-0; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Perez-Santonja JJ, 2010, AM J OPHTHALMOL, V150, P519, DOI 10.1016/j.ajo.2010.04.024; Qazi Y, 2009, J GENET, V88, P495, DOI 10.1007/s12041-009-0068-0; Ramos JLB, 2009, CLIN EXP OPHTHALMOL, V37, P81, DOI 10.1111/j.1442-9071.2008.01823.x; Reed CC, 2002, GLYCOCONJUGATE J, V19, P249, DOI 10.1023/A:1025383913444; Seghezzi G, 1998, J CELL BIOL, V141, P1659, DOI 10.1083/jcb.141.7.1659; SHARMA A, 2010, ENCY EYE, P185; Sharma A, 2010, EXP EYE RES, V91, P440, DOI 10.1016/j.exer.2010.06.020; Sharma A, 2010, MOL VIS, V16, P720; Sharma A, 2010, BRAIN RES BULL, V81, P273, DOI 10.1016/j.brainresbull.2009.07.005; Sulochana KN, 2005, J BIOL CHEM, V280, P27935, DOI 10.1074/jbc.M414320200; Wilson SE, 2004, INVEST OPHTH VIS SCI, V45, P2201, DOI 10.1167/iovs.03-1162; Wilson SE, 2002, ADV EXP MED BIOL, V506, P821; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	39	111	118	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2011	6	10							e26432	10.1371/journal.pone.0026432	http://dx.doi.org/10.1371/journal.pone.0026432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	841JB	22066011	Green Submitted, Green Published, gold			2022-12-27	WOS:000296507500068
J	Li, YH; Romeis, J; Wang, P; Peng, YF; Shelton, AM				Li, Yunhe; Romeis, Joerg; Wang, Ping; Peng, Yufa; Shelton, Anthony M.			A Comprehensive Assessment of the Effects of Bt Cotton on Coleomegilla maculata Demonstrates No Detrimental Effects by Cry1Ac and Cry2Ab	PLOS ONE			English	Article							RESISTANT TRANSGENIC PLANTS; BACILLUS-THURINGIENSIS; CORN POLLEN; LEPIDOPTERA; NONTARGET; SURVIVAL; TOXIN; COLEOPTERA; PREDATORS; PROTEINS	The ladybird beetle, Coleomegilla maculata (DeGeer), is a common and abundant predator in many cropping systems. Its larvae and adults are predaceous, feeding on aphids, thrips, lepidopteran larvae and plant tissues, such as pollen. Therefore, this species is exposed to insecticidal proteins expressed in insect-resistant, genetically engineered cotton expressing Cry proteins derived from Bacillus thuringiensis (Bt). A tritrophic bioassay was conduced to evaluate the potential impact of Cry2Ab- and Cry1Ac-expressing cotton on fitness parameters of C. maculata using Bt-susceptible and -resistant larvae of Trichoplusia ni as prey. Coleomegilla maculata survival, development time, adult weight and fecundity were not different when they were fed with resistant T. ni larvae reared on either Bt or control cotton. To ensure that C. maculata were not sensitive to the tested Cry toxins independent from the plant background and to add certainty to the hazard assessment, C. maculata larvae were fed artificial diet incorporated with Cry2Ab, Cry1Ac or both at > 10 times higher concentrations than in cotton tissue. Artificial diet containing E-64 was included as a positive control. No differences were detected in any life-table parameters between Cry protein-containing diet treatments and the control diet. In contrast, larvae of C. maculata fed the E-64 could not develop to the pupal stage and the 7-d larval weight was significantly negatively affected. In both feeding assays, the stability and bioactivity of Cry proteins in the food sources were confirmed by ELISA and sensitive-insect bioassays. Our results show that C. maculata is not affected by Bt cotton and is not sensitive to Cry2Ab and Cry1Ac at concentrations exceeding the levels in Bt cotton, thus demonstrating that Bt cotton will pose a negligible risk to C. maculata. More importantly, this study demonstrates a comprehensive system for assessing the risk of genetically modified plants on non-target organisms.	[Li, Yunhe; Wang, Ping; Shelton, Anthony M.] Cornell Univ, Dept Entomol, NYSAES, Geneva, NY USA; [Li, Yunhe; Peng, Yufa] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Romeis, Joerg] Agroscope Reckenholz Tanikon Res Stn ART, Zurich, Switzerland	Cornell University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Swiss Federal Research Station Agroscope; Swiss Federal Research Station for Agroecology & Agriculture	Shelton, AM (corresponding author), Cornell Univ, Dept Entomol, NYSAES, Geneva, NY USA.	ams5@cornell.edu	peng, yu/GXW-2071-2022; li, Yu/HCI-9086-2022; Chen, Yong/B-9051-2008; Romeis, Joerg/J-5360-2013; li, yu/HGL-9518-2022	Chen, Yong/0000-0003-2580-5895; Romeis, Joerg/0000-0003-3652-8360; 	National Key Basic Research and Development (973) Program in China [2007CB109204]; Swiss National Science Foundation [PBBEP3-125563]	National Key Basic Research and Development (973) Program in China(National Basic Research Program of China); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This research was supported by the National Key Basic Research and Development (973) Program (2007CB109204) in China and funded by a postdoctoral grant from the Swiss National Science Foundation (PBBEP3-125563). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Alfageme F, 2011, TRANSGENIC RES, V20, P467, DOI 10.1007/s11248-010-9430-5; BOODLEY JW, 1977, CORNELL U COOPERATIO, V43; BROOKES G, 2010, GM CROPS GLOBAL SOCI; CAB International, 2007, CROP PROT COMP; Chen M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002284; Duan JJ, 2002, ENTOMOL EXP APPL, V104, P271, DOI 10.1023/A:1021258803866; Dutton A, 2003, BIOCONTROL, V48, P611, DOI 10.1023/A:1026313719424; Ferry N, 2007, TRANSGENIC RES, V16, P795, DOI 10.1007/s11248-007-9088-9; Garcia-Alonso Monica, 2006, Environmental Biosafety Research, V5, P57, DOI 10.1051/ebr:2006018; Greenplate JT, 2003, J APPL ENTOMOL, V127, P340, DOI 10.1046/j.1439-0418.2003.00766.x; Groot AT, 2002, PLANT J, V31, P387, DOI 10.1046/j.1365-313X.2002.01366.x; Hogervorst PAM, 2006, J INSECT PHYSIOL, V52, P614, DOI 10.1016/j.jinsphys.2006.02.011; Kain WC, 2004, J ECON ENTOMOL, V97, P2073, DOI 10.1603/0022-0493-97.6.2073; Kennedy George G., 2008, V5, P1; Knox O. G. G., 2008, The Open Agriculture Journal, V2, P105, DOI 10.2174/1874331500802010105; Lawo NC, 2010, J INSECT PHYSIOL, V56, P1702, DOI 10.1016/j.jinsphys.2010.06.012; Li YX, 2006, CROP PROT, V25, P940, DOI 10.1016/j.cropro.2005.12.007; Li YH, 2011, ENVIRON ENTOMOL, V40, P496, DOI 10.1603/EN10248; Li YH, 2010, BIOL CONTROL, V53, P337, DOI 10.1016/j.biocontrol.2009.12.003; LIU CX, 2010, SCIENCE CHINA C, V8, P934; Lundgren JG, 2004, J INSECT PHYSIOL, V50, P567, DOI 10.1016/j.jinsphys.2004.04.003; Lundgren JG, 2002, ENVIRON ENTOMOL, V31, P1213, DOI 10.1603/0046-225X-31.6.1213; Naranjo S., 2009, CAB REV PERSPECTIVES, V4; Naranjo SE, 2011, J AGR FOOD CHEM, V59, P5842, DOI 10.1021/jf102939c; Naranjon Steven E., 2008, V5, P159, DOI 10.1007/978-1-4020-8373-0_6; NAS (National Academy of Sciences), 2002, ENV EFF TRANSG PLANT; Organisation for Economic Co-operation and Development (OECD), 2007, SER HARM REG OV BIOT; Pilcher CD, 1997, ENVIRON ENTOMOL, V26, P446, DOI 10.1093/ee/26.2.446; Raybould A, 2010, TRANSGENIC RES, V20, P599, DOI DOI 10.1007/S11248-010-9442-1; ROGER C, 1999, THESIS MCGILI U MONT; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis J, 2008, NAT BIOTECHNOL, V26, P203, DOI 10.1038/nbt1381; Romeis J, 2011, TRANSGENIC RES, V20, P1, DOI 10.1007/s11248-010-9446-x; SHELTON AM, 1991, J ENTOMOL SCI, V26, P17, DOI 10.18474/0749-8004-26.1.17; Stewart SD, 2001, J ECON ENTOMOL, V94, P752, DOI 10.1603/0022-0493-94.3.752; USEPA, 2002, 006487 EPA AMENDED	36	76	84	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2011	6	7							e22185	10.1371/journal.pone.0022185	http://dx.doi.org/10.1371/journal.pone.0022185			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	791WM	22022595	Green Submitted, gold, Green Published			2022-12-27	WOS:000292699000028
J	Hume, JCC; Hamilton, H; Lee, KL; Lehmann, T				Hume, Jen C. C.; Hamilton, Howard, III; Lee, Kevin L.; Lehmann, Tovi			Susceptibility of Anopheles stephensi to Plasmodium gallinaceum: A Trait of the Mosquito, the Parasite, and the Environment	PLOS ONE			English	Article							COEVOLUTIONARY INTERACTIONS; CULICOIDES-VARIIPENNIS; MALARIA TRANSMISSION; WUCHERERIA-BANCROFTI; VECTOR COMPETENCE; LOCAL ADAPTATION; HOST; GAMBIAE; INFECTION; EPIDEMIOLOGY	Background: Vector susceptibility to Plasmodium infection is treated primarily as a vector trait, although it is a composite trait expressing the joint occurrence of the parasite and the vector with genetic contributions of both. A comprehensive approach to assess the specific contribution of genetic and environmental variation on "vector susceptibility" is lacking. Here we developed and implemented a simple scheme to assess the specific contributions of the vector, the parasite, and the environment to "vector susceptibility." To the best of our knowledge this is the first study that employs such an approach. Methodology/Principal Findings: We conducted selection experiments on the vector (while holding the parasite "constant") and on the parasite (while holding the vector "constant") to estimate the genetic contributions of the mosquito and the parasite to the susceptibility of Anopheles stephensi to Plasmodium gallinaceum. We separately estimated the realized heritability of (i) susceptibility to parasite infection by the mosquito vector and (ii) parasite compatibility (transmissibility) with the vector while controlling the other. The heritabilities of vector and the parasite were higher for the prevalence, i. e., fraction of infected mosquitoes, than the corresponding heritabilities of parasite load, i. e., the number of oocysts per mosquito. Conclusions: The vector's genetics (heritability) comprised 67% of "vector susceptibility" measured by the prevalence of mosquitoes infected with P. gallinaceum oocysts, whereas the specific contribution of parasite genetics (heritability) to this trait was only 5%. Our parasite source might possess minimal genetic diversity, which could explain its low heritability (and the high value of the vector). Notably, the environment contributed 28%. These estimates are relevant only to the particular system under study, but this experimental design could be useful for other parasite-host systems. The prospects and limitations of the genetic manipulation of vector populations to render the vector resistant to the parasite are better considered on the basis of this framework.	[Hume, Jen C. C.; Hamilton, Howard, III; Lee, Kevin L.; Lehmann, Tovi] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Hume, JCC (corresponding author), Seattle Biomed Res Inst, 4 Nickerson St, Seattle, WA 98109 USA.	tlehmann@niaid.nih.gov	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875; Lehmann, Tovi/0000-0002-8142-3915	NIH, NIAID; Direct For Biological Sciences [1153218] Funding Source: National Science Foundation	NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was supported by the Intramural Research Program in NIH, NIAID. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alavi Y, 2003, INT J PARASITOL, V33, P933, DOI 10.1016/S0020-7519(03)00112-7; Alto BW, 2008, AM J TROP MED HYG, V79, P688, DOI 10.4269/ajtmh.2008.79.688; Alto BW, 2005, ECOLOGY, V86, P3279, DOI 10.1890/05-0209; Beard C.B., 1993, Insect Molecular Biology, V2, P103, DOI 10.1111/j.1365-2583.1993.tb00131.x; Boakye DA, 2004, ANN TROP MED PARASIT, V98, P501, DOI 10.1179/000349804225003514; Brumpt E, 1936, CR HEBD ACAD SCI, V203, P750; COLLINS FH, 1994, SCIENCE, V264, P1874, DOI 10.1126/science.8009215; Collins FH, 2000, B WORLD HEALTH ORGAN, V78, P1412; COLLINS RC, 1995, AM J TROP MED HYG, V52, P213, DOI 10.4269/ajtmh.1995.52.213; Dia I, 2003, J MED ENTOMOL, V40, P279, DOI 10.1603/0022-2585-40.3.279; DIMOPOULOS G, 2007, J VIS EXP; EBERT D, 1994, SCIENCE, V265, P1084, DOI 10.1126/science.265.5175.1084; ESCALANTE AA, 1995, P NATL ACAD SCI USA, V92, P5793, DOI 10.1073/pnas.92.13.5793; FALCONER DS, 1996, INTRO QANTITATIVE GE; Fontenille D, 1997, T ROY SOC TROP MED H, V91, P647, DOI 10.1016/S0035-9203(97)90506-X; FONTENILLE D, 1992, J MED ENTOMOL, V29, P197, DOI 10.1093/jmedent/29.2.197; Fontenille D, 1997, AM J TROP MED HYG, V56, P247, DOI 10.4269/ajtmh.1997.56.247; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Gubler DJ, 2009, REV SCI TECH OIE, V28, P583, DOI 10.20506/rst.28.2.1904; Hogg JC, 1996, MED VET ENTOMOL, V10, P385, DOI 10.1111/j.1365-2915.1996.tb00761.x; HOGG JC, 1995, MED VET ENTOMOL, V9, P176, DOI 10.1111/j.1365-2915.1995.tb00175.x; HUFF CLAY G., 1929, ANN TROP MED & PARASIT [LIVERPOOL], V23, P427; Hume JCC, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-139; HUNT RH, 1990, ANN TROP MED PARASIT, V84, P381, DOI 10.1080/00034983.1990.11812483; Hurd H, 2005, EVOLUTION, V59, P2560, DOI 10.1111/j.0014-3820.2005.tb00969.x; JAMES AA, 2007, J VIS EXP; JONES JS, 1987, NATURE, V325, P298, DOI 10.1038/325298a0; Koella JC, 1998, PARASITOLOGY, V116, pS47, DOI 10.1017/S0031182000084936; Lambrechts L, 2006, TRENDS PARASITOL, V22, P12, DOI 10.1016/j.pt.2005.11.008; Lambrechts L, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-3; Lambrechts L, 2006, P ROY SOC B-BIOL SCI, V273, P1501, DOI 10.1098/rspb.2006.3483; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; Laurence B. R., 1967, Journal of Helminthology, V41, P365, DOI 10.1017/S0022149X00021908; LEHMANN T, 1993, PARASITOL TODAY, V9, P8, DOI 10.1016/0169-4758(93)90153-7; Lemasson JJ, 1997, J MED ENTOMOL, V34, P396, DOI 10.1093/jmedent/34.4.396; Liu WM, 2010, NATURE, V467, P420, DOI 10.1038/nature09442; Ljungstr?m I., 2004, METHODS MALARIA RES; LYNCH M, 2008, EVOLUTION SELECTION, V2; Nace D, 2004, J AM MOSQUITO CONTR, V20, P272; NILES WJ, 1965, NATURE, V205, P411, DOI 10.1038/205411a0; Poulin R., 2007, EVOL ECOL, V2; Price P W, 1980, Monogr Popul Biol, V15, P1; RAMSDALE C D, 1975, Parassitologia (Rome), V17, P39; Ricklefs RE, 2004, SYST BIOL, V53, P111, DOI 10.1080/10635150490264987; Ricklefs RE, 2002, P ROY SOC B-BIOL SCI, V269, P885, DOI 10.1098/rspb.2001.1940; *SAS I INC, 2002, SAS WIND VERS 9 0; Shahabuddin M, 1995, EXP PARASITOL, V81, P386, DOI 10.1006/expr.1995.1129; Tabachnick WJ, 2010, J EXP BIOL, V213, P946, DOI 10.1242/jeb.037564; Tabachnick WJ, 1996, ANNU REV ENTOMOL, V41, P23, DOI 10.1146/annurev.en.41.010196.000323; TABACHNICK WJ, 1991, AM J TROP MED HYG, V45, P666, DOI 10.4269/ajtmh.1991.45.666; VERNICK KD, 1995, EXP PARASITOL, V80, P583, DOI 10.1006/expr.1995.1074; Garamszegi LZ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-110	52	86	91	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 9	2011	6	6							e20156	10.1371/journal.pone.0020156	http://dx.doi.org/10.1371/journal.pone.0020156			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JX	21694762	Green Published, gold, Green Submitted			2022-12-27	WOS:000291612900006
J	Mohan, R; Mach, KE; Bercovici, M; Pan, Y; Dhulipala, L; Wong, PK; Liao, JC				Mohan, Ruchika; Mach, Kathleen E.; Bercovici, Moran; Pan, Ying; Dhulipala, Lakshmi; Wong, Pak Kin; Liao, Joseph C.			Clinical Validation of Integrated Nucleic Acid and Protein Detection on an Electrochemical Biosensor Array for Urinary Tract Infection Diagnosis	PLOS ONE			English	Article							UROPATHOGENS; LACTOFERRIN; SAMPLES	Background: Urinary tract infection (UTI) is a common infection that poses a substantial healthcare burden, yet its definitive diagnosis can be challenging. There is a need for a rapid, sensitive and reliable analytical method that could allow early detection of UTI and reduce unnecessary antibiotics. Pathogen identification along with quantitative detection of lactoferrin, a measure of pyuria, may provide useful information towards the overall diagnosis of UTI. Here, we report an integrated biosensor platform capable of simultaneous pathogen identification and detection of urinary biomarker that could aid the effectiveness of the treatment and clinical management. Methodology/Principal Findings: The integrated pathogen 16S rRNA and host lactoferrin detection using the biosensor array was performed on 113 clinical urine samples collected from patients at risk for complicated UTI. For pathogen detection, the biosensor used sandwich hybridization of capture and detector oligonucleotides to the target analyte, bacterial 16S rRNA. For detection of the protein biomarker, the biosensor used an analogous electrochemical sandwich assay based on capture and detector antibodies. For this assay, a set of oligonucleotide probes optimized for hybridization at 37 degrees C to facilitate integration with the immunoassay was developed. This probe set targeted common uropathogens including E. coli, P. mirabilis, P. aeruginosa and Enterococcus spp. as well as less common uropathogens including Serratia, Providencia, Morganella and Staphylococcus spp. The biosensor assay for pathogen detection had a specificity of 97% and a sensitivity of 89%. A significant correlation was found between LTF concentration measured by the biosensor and WBC and leukocyte esterase (p<0.001 for both). Conclusion/Significance: We successfully demonstrate simultaneous detection of nucleic acid and host immune marker on a single biosensor array in clinical samples. This platform can be used for multiplexed detection of nucleic acid and protein as the next generation of urinary tract infection diagnostics.	[Mohan, Ruchika; Mach, Kathleen E.; Bercovici, Moran; Pan, Ying; Liao, Joseph C.] Stanford Univ, Dept Urol, Sch Med, Stanford, CA 94305 USA; [Mohan, Ruchika; Mach, Kathleen E.; Bercovici, Moran; Pan, Ying; Liao, Joseph C.] Stanford Univ, Biox Program, Sch Med, Stanford, CA 94305 USA; [Mohan, Ruchika; Mach, Kathleen E.; Pan, Ying; Dhulipala, Lakshmi; Liao, Joseph C.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Wong, Pak Kin] Univ Arizona, Dept Aerosp & Mech Engn, Tucson, AZ 85721 USA	Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; University of Arizona	Mohan, R (corresponding author), Stanford Univ, Dept Urol, Sch Med, Stanford, CA 94305 USA.	jliao@stanford.edu	Wong, Pak Kin/A-7974-2012; Bercovici, Moran/F-6076-2013	Wong, Pak Kin/0000-0001-7388-2110; Liao, Joseph/0000-0003-2448-5463; Bercovici, Moran/0000-0002-7803-4791	National Institutes of Health/National Institute of Allergy and Infectious Diseases [U01 AI082457]; National Science Foundation [ECCS-0901292]	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF))	This study was funded in part by National Institutes of Health/National Institute of Allergy and Infectious Diseases U01 AI082457 (http://grants.nih.gov/grants/) and National Science Foundation ECCS-0901292 (http://www.nsf.gov/) to Joseph C. Liao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arao S, 1999, J CLIN MICROBIOL, V37, P553, DOI 10.1128/JCM.37.3.553-557.1999; Ashelford KE, 2002, NUCLEIC ACIDS RES, V30, P3481, DOI 10.1093/nar/gkf450; Bremer H., 1987, ESCHERICHIA COLI SAL, V2, P1527, DOI [10.1046/j.1365-2486.2000.06017.x, DOI 10.1046/J.1365-2486.2000.06017.X]; CARDENAS DD, 1995, ARCH PHYS MED REHAB, V76, P272, DOI 10.1016/S0003-9993(95)80615-6; Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De Ruz AE, 2000, J UROLOGY, V164, P1285, DOI 10.1016/S0022-5347(05)67157-1; DRUMMOND AJ, 2009, GENEIOUS V4 7; Gao J, 2011, LAB CHIP, V11, P1770, DOI [10.1039/c1lc20054b, 10.1039/c11c20054b]; Hooton TM, 2010, CLIN INFECT DIS, V50, P625, DOI 10.1086/650482; Jolkkonen S, 2010, J CLIN MICROBIOL, V48, P3117, DOI 10.1128/JCM.00617-10; Lazcka O, 2007, BIOSENS BIOELECTRON, V22, P1205, DOI 10.1016/j.bios.2006.06.036; Liao JC, 2006, J CLIN MICROBIOL, V44, P561, DOI 10.1128/JCM.44.2.561-570.2006; Liao JC, 2007, J MOL DIAGN, V9, P158, DOI 10.2353/jmoldx.2007.060052; Mach KE, 2011, TRENDS PHARMACOL SCI, V32, P330, DOI 10.1016/j.tips.2011.03.001; Mach KE, 2011, J UROLOGY, V185, P148, DOI 10.1016/j.juro.2010.09.022; Mach KE, 2009, J UROLOGY, V182, P2735, DOI 10.1016/j.juro.2009.08.028; Manoni F, 2009, DIAGN MICR INFEC DIS, V65, P103, DOI 10.1016/j.diagmicrobio.2009.06.003; Mariella R, 2008, BIOMED MICRODEVICES, V10, P777, DOI 10.1007/s10544-008-9190-7; Mastali M, 2008, J CLIN MICROBIOL, V46, P2707, DOI 10.1128/JCM.00423-08; Nanda N, 2009, BIOMARK INSIGHTS, V4, P111; Nayak M, 2009, BIOSENS BIOELECTRON, V25, P661, DOI 10.1016/j.bios.2009.08.037; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Pan Y, 2010, BIOSENS BIOELECTRON, V26, P649, DOI 10.1016/j.bios.2010.07.002; Pieretti B, 2010, J CLIN MICROBIOL, V48, P3990, DOI 10.1128/JCM.00975-10; Sin MLY, 2011, J BIOL ENG, V5, DOI 10.1186/1754-1611-5-6; Summanen PH, 2005, J CLIN MICROBIOL, V43, P4455, DOI 10.1128/JCM.43.9.4455-4459.2005	27	111	118	5	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 31	2011	6	10							e26846	10.1371/journal.pone.0026846	http://dx.doi.org/10.1371/journal.pone.0026846			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	846PP	22066011	Green Submitted, Green Published, gold			2022-12-27	WOS:000296916000027
J	Li, YC; Li, YM; Zhang, H; Chen, Y				Li, Yichen; Li, Yumin; Zhang, Hui; Chen, Yong			MicroRNA-Mediated Positive Feedback Loop and Optimized Bistable Switch in a Cancer Network Involving miR-17-92	PLOS ONE			English	Article							CELL-CYCLE OSCILLATOR; GENE-REGULATION; NOISE; HETEROGENEITY; BIOGENESIS; MOTIFS; MEMORY	MicroRNAs (miRNAs) are small, noncoding RNAs that play an important role in many key biological processes, including development, cell differentiation, the cell cycle and apoptosis, as central post-transcriptional regulators of gene expression. Recent studies have shown that miRNAs can act as oncogenes and tumor suppressors depending on the context. The present work focuses on the physiological significance of miRNAs and their role in regulating the switching behavior. We illustrate an abstract model of the Myc/E2F/miR-17-92 network presented by Aguda et al. (2008), which is composed of coupling between the E2F/Myc positive feedback loops and the E2F/Myc/miR-17-92 negative feedback loop. By systematically analyzing the network in close association with plausible experimental parameters, we show that, in the presence of miRNAs, the system bistability emerges from the system, with a bistable switch and a one-way switch presented by Aguda et al. instead of a single one-way switch. Moreover, the miRNAs can optimize the switching process. The model produces a diverse array of response-signal behaviors in response to various potential regulating scenarios. The model predicts that this transition exists, one from cell death or the cancerous phenotype directly to cell quiescence, due to the existence of miRNAs. It was also found that the network involving miR-17-92 exhibits high noise sensitivity due to a positive feedback loop and also maintains resistance to noise from a negative feedback loop.	[Li, Yichen; Li, Yumin] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China; [Li, Yichen; Li, Yumin; Chen, Yong] Key Lab Digest Syst Tumors, Lanzhou, Peoples R China; [Zhang, Hui; Chen, Yong] Lanzhou Univ, Inst Theoret Phys, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University	Li, YC (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.	liym@lzu.edu.cn; ychen@lzu.edu.cn	peng, yu/GXW-2071-2022; li, Yu/HCI-9086-2022; Chen, Yong/B-9051-2008; Romeis, Joerg/J-5360-2013; li, yu/HGL-9518-2022	Chen, Yong/0000-0003-2580-5895; Romeis, Joerg/0000-0003-3652-8360; 	National Natural Science Foundation of China [10975063, 30870364]; High Technology Research and Development Program of China (863 program) [2007AA021807]; Key Technology R&D Program of Gansu Province [0708NKCA129]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); High Technology Research and Development Program of China (863 program)(National High Technology Research and Development Program of China); Key Technology R&D Program of Gansu Province	This work was supported by the National Natural Science Foundation of China (Grant No. 10975063, 30870364), the High Technology Research and Development Program of China (863 program, Grant No. 2007AA021807), and The Key Technology R&D Program of Gansu Province (Grant No. 0708NKCA129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; Barrio M, 2006, PLOS COMPUT BIOL, V2, P1017, DOI 10.1371/journal.pcbi.0020117; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 2001, CHAOS, V11, P221, DOI 10.1063/1.1350440; Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546; Brandman O, 2005, SCIENCE, V310, P496, DOI 10.1126/science.1113834; Bratsun D, 2005, P NATL ACAD SCI USA, V102, P14593, DOI 10.1073/pnas.0503858102; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Carthew RW, 2006, CURR OPIN GENET DEV, V16, P203, DOI 10.1016/j.gde.2006.02.012; Coller HA, 2007, PLOS GENET, V3, P1319, DOI 10.1371/journal.pgen.0030146; Cui QH, 2007, TRENDS GENET, V23, P372, DOI 10.1016/j.tig.2007.04.003; Dews M, 2006, NAT GENET, V38, P1060, DOI 10.1038/ng1855; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Hornung G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040008; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; KASDIN NJ, 1995, P IEEE, V83, P802, DOI 10.1109/5.381848; KASDIN NJ, 1995, J GUID CONTROL DYNAM, V18, P114, DOI 10.2514/3.56665; Khanin R, 2008, J COMPUT BIOL, V15, P305, DOI 10.1089/cmb.2007.0184; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Lee K, 2000, SCIENCE, V289, P107, DOI 10.1126/science.289.5476.107; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li MF, 2010, AAPS J, V12, P309, DOI 10.1208/s12248-010-9194-0; Lindner B, 2004, PHYS REP, V392, P321, DOI 10.1016/j.physrep.2003.10.015; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Nevozhay D, 2009, P NATL ACAD SCI USA, V106, P5123, DOI 10.1073/pnas.0809901106; Novak B, 2008, NAT REV MOL CELL BIO, V9, P981, DOI 10.1038/nrm2530; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Paulsson J, 2004, NATURE, V427, P415, DOI 10.1038/nature02257; Petrocca F, 2008, CANCER CELL, V13, P272, DOI 10.1016/j.ccr.2008.02.013; Pomerening JR, 2005, CELL, V122, P565, DOI 10.1016/j.cell.2005.06.016; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Ramsey SA, 2006, NAT GENET, V38, P1082, DOI 10.1038/ng1869; Schlicht R, 2008, J MATH BIOL, V57, P613, DOI 10.1007/s00285-008-0178-y; Shearman LP, 2000, SCIENCE, V288, P1013, DOI 10.1126/science.288.5468.1013; Smolen P, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031902; Tian XJ, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.011926; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; van der Pol B, 1926, PHILOS MAG, V2, P978; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wee KB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004407; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wolf DM, 2003, CURR OPIN MICROBIOL, V6, P125, DOI 10.1016/S1369-5274(03)00033-X; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhang XP, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.031924; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106	53	76	84	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2011	6	10							e26302	10.1371/journal.pone.0026302	http://dx.doi.org/10.1371/journal.pone.0026302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834RQ	22022595	Green Submitted, Green Published, gold			2022-12-27	WOS:000295981600052
J	Hamilton, CA; Formanowicz, DR; Bond, JE				Hamilton, Chris A.; Formanowicz, Daniel R.; Bond, Jason E.			Species Delimitation and Phylogeography of Aphonopelma hentzi (Araneae, Mygalomorphae, Theraphosidae): Cryptic Diversity in North American Tarantulas	PLOS ONE			English	Article							MULTIPLE PLEISTOCENE REFUGIA; GENETIC DIFFERENTIATION; CONSERVATION GENETICS; POPULATION HISTORY; STATISTICAL TESTS; TRAPDOOR SPIDERS; COMPUTER-PROGRAM; TIGER SALAMANDER; DNA BARCODES; SPECIATION	Background: The primary objective of this study is to reconstruct the phylogeny of the hentzi species group and sister species in the North American tarantula genus, Aphonopelma, using a set of mitochondrial DNA markers that include the animal "barcoding gene". An mtDNA genealogy is used to consider questions regarding species boundary delimitation and to evaluate timing of divergence to infer historical biogeographic events that played a role in shaping the present-day diversity and distribution. We aimed to identify potential refugial locations, directionality of range expansion, and test whether A. hentzi post-glacial expansion fit a predicted time frame. Methods and Findings: A Bayesian phylogenetic approach was used to analyze a 2051 base pair (bp) mtDNA data matrix comprising aligned fragments of the gene regions CO1 (1165 bp) and ND1-16S (886 bp). Multiple species delimitation techniques (DNA tree-based methods, a "barcode gap" using percent of pairwise sequence divergence (uncorrected p-distances), and the GMYC method) consistently recognized a number of divergent and genealogically exclusive groups. Conclusions: The use of numerous species delimitation methods, in concert, provide an effective approach to dissecting species boundaries in this spider group; as well they seem to provide strong evidence for a number of nominal, previously undiscovered, and cryptic species. Our data also indicate that Pleistocene habitat fragmentation and subsequent range expansion events may have shaped contemporary phylogeographic patterns of Aphonopelma diversity in the southwestern United States, particularly for the A. hentzi species group. These findings indicate that future species delimitation approaches need to be analyzed in context of a number of factors, such as the sampling distribution, loci used, biogeographic history, breadth of morphological variation, ecological factors, and behavioral data, to make truly integrative decisions about what constitutes an evolutionary lineage recognized as a "species".	[Hamilton, Chris A.; Bond, Jason E.] Auburn Univ, Auburn Univ Museum Nat Hist, Auburn, AL 36849 USA; [Hamilton, Chris A.; Bond, Jason E.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Formanowicz, Daniel R.] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; University of Texas System; University of Texas Arlington	Hamilton, CA (corresponding author), Auburn Univ, Auburn Univ Museum Nat Hist, Auburn, AL 36849 USA.	chamilton@auburn.edu	Bond, Jason E./P-1501-2017	Bond, Jason E./0000-0001-6373-3875; Lehmann, Tovi/0000-0002-8142-3915	American Arachnological Society (AAS); NSF REVSYS [DEB0841610]; Direct For Biological Sciences [1153218] Funding Source: National Science Foundation	American Arachnological Society (AAS); NSF REVSYS(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the American Arachnological Society (AAS) (2009) Vincent Roth Fund for Systematic Research (http://www.americanarachnology.org) to C. Hamilton; NSF REVSYS #DEB0841610 "Systematics and taxonomy of the tarantula spider genus Aphonopelma (Araneae, Mygalomorphae, Theraphosidae)" (http://www.nsf.gov) to J. Bond. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens D, 2007, MOL PHYLOGENET EVOL, V44, P436, DOI 10.1016/j.ympev.2007.02.024; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Amato ML, 2008, MOL ECOL, V17, P570, DOI 10.1111/j.1365-294X.2007.03580.x; Arnedo MA, 2007, CONSERV GENET, V8, P1147, DOI 10.1007/s10592-006-9270-2; Astrin JJ, 2006, ZOOL SCR, V35, P441, DOI 10.1111/j.1463-6409.2006.00239.x; Avise JC, 1998, P ROY SOC B-BIOL SCI, V265, P1707, DOI 10.1098/rspb.1998.0492; Avise John C., 1994, pi; Ayoub NA, 2004, MOL ECOL, V13, P3453, DOI 10.1111/j.1365-294X.2004.02335.x; Ayoub NA, 2007, MOL PHYLOGENET EVOL, V42, P394, DOI 10.1016/j.ympev.2006.07.018; Baerg WJ, 1958, TARANTULA; Bailey AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012744; Barrett RDH, 2005, CAN J ZOOL, V83, P481, DOI 10.1139/Z05-024; Bond JE, 2008, SYST BIOL, V57, P628, DOI 10.1080/10635150802302443; Bond JE, 2006, ANIM CONSERV, V9, P145, DOI 10.1111/j.1469-1795.2006.00024.x; Bond JE, 2001, MOL ECOL, V10, P899, DOI 10.1046/j.1365-294X.2001.01233.x; Bond JE, 2004, INVERTEBR SYST, V18, P361, DOI 10.1071/IS04008; Bond JE, 2002, ZOOL J LINN SOC-LOND, V136, P487, DOI 10.1046/j.1096-3642.2002.00035.x; Bortolus A, 2008, AMBIO, V37, P114, DOI 10.1579/0044-7447(2008)37[114:ECITBS]2.0.CO;2; Boulton AM, 1998, BIOL J LINN SOC, V64, P69, DOI 10.1111/j.1095-8312.1998.tb01534.x; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; Burbrink FT, 2000, EVOLUTION, V54, P2107, DOI 10.1554/0014-3820(2000)054[2107:MDPOTP]2.0.CO;2; Carstens BC, 2007, MOL ECOL, V16, P619, DOI 10.1111/j.1365-294X.2006.03167.x; CASTELLOE J, 1994, MOL PHYLOGENET EVOL, V3, P102, DOI 10.1006/mpev.1994.1013; Castoe TA, 2007, MOL PHYLOGENET EVOL, V42, P193, DOI 10.1016/j.ympev.2006.07.002; Chamberlin R. V., 1939, Bulletin of the University of Utah Biological Series, V5, P1; Chamberlin R. V., 1940, Bulletin of the University of Utah Biological Series, V5, P1; Church SA, 2003, EVOLUTION, V57, P372; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cooper SJB, 2011, MOL ECOL, V20, P3219, DOI 10.1111/j.1365-294X.2011.05160.x; Costa FG, 2002, J ARACHNOL, V30, P571, DOI 10.1636/0161-8202(2002)030[0571:RBOUTA]2.0.CO;2; COYNE JA, 1994, EVOLUTION, V48, P19, DOI 10.1111/j.1558-5646.1994.tb01290.x; Croucher PJP, 2004, BIOL J LINN SOC, V81, P79, DOI 10.1111/j.1095-8312.2004.00280.x; de Thoisy B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-278; Drummond AJ, 2010, BEAST V1 5 4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ELIAS SA, 1992, SOUTHWEST NAT, V37, P101, DOI 10.2307/3671658; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Ezard T, 2009, PACKAGE SPLITS SPECI; Foelix RF, 1996, BIOL SPIDERS; Fontaneto D, 2007, PLOS BIOL, V5, P914, DOI 10.1371/journal.pbio.0050087; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gantenbein BI, 2003, J ARACHNOL, V31, P412, DOI 10.1636/H01-23; Gershoni M, 2009, BIOESSAYS, V31, P642, DOI 10.1002/bies.200800139; Girard C, 1854, EXPLORATION RED RIVE, P262; Goloboff P.A., 1993, American Museum Novitates, P1; Goloboff PA, 2006, CLADISTICS, V22, P589, DOI 10.1111/j.1096-0031.2006.00122.x; Hamilton CA, 2009, THESIS U TEXAS ARLIN; Hamilton DE, 2008, THESIS TEXAS TU; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hedin M, 2006, MOL PHYLOGENET EVOL, V41, P454, DOI 10.1016/j.ympev.2006.05.017; Hendrixson BE, 2005, MOL PHYLOGENET EVOL, V36, P405, DOI 10.1016/j.ympev.2005.01.021; Hendrixson BE, 2009, MOL PHYLOGENET EVOL, V53, P300, DOI 10.1016/j.ympev.2009.06.001; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hewitt GM, 2001, MOL ECOL, V10, P537, DOI 10.1046/j.1365-294x.2001.01202.x; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hull JM, 2010, MOL PHYLOGENET EVOL, V56, P212, DOI 10.1016/j.ympev.2010.02.027; Jackson ND, 2010, EVOLUTION, V64, P409, DOI 10.1111/j.1558-5646.2009.00840.x; Jaeger JR, 2005, MOL ECOL, V14, P3033, DOI 10.1111/j.1365-294X.2005.02645.x; Janowski-Bell ME, 2001, THESIS U MISSOURI CO; Jennings CE, 2007, ENCY QUATERNARY SCI, P1044; Knowles LL, 2008, EVOLUTION, V62, P2713, DOI 10.1111/j.1558-5646.2008.00481.x; Knowles LL, 2005, MOL ECOL, V14, P4023, DOI 10.1111/j.1365-294X.2005.02711.x; Knowles LL, 2000, EVOLUTION, V54, P1337, DOI 10.1111/j.0014-3820.2000.tb00566.x; Kozak KH, 2006, MOL ECOL, V15, P191, DOI 10.1111/j.1365-294X.2005.02757.x; Lane N, 2009, NATURE, V462, P272, DOI 10.1038/462272a; Lemmon AR, 2008, SYST BIOL, V57, P544, DOI 10.1080/10635150802304761; Lipscomb D, 2003, TRENDS ECOL EVOL, V18, P65, DOI 10.1016/S0169-5347(02)00060-5; Longhorn SJ, 2007, J ARACHNOL, V35, P278, DOI 10.1636/S05-62.1; Maddison W.P., 2010, MESQUITE MODULAR SYS; Mao XG, 2010, MOL ECOL, V19, P2754, DOI 10.1111/j.1365-294X.2010.04704.x; Masta SE, 2000, EVOLUTION, V54, P1699; McGaughran A, 2008, MOL PHYLOGENET EVOL, V46, P606, DOI 10.1016/j.ympev.2007.10.003; Monaghan MT, 2009, SYST BIOL, V58, P298, DOI 10.1093/sysbio/syp027; Murray EA, 2006, THESIS KANSAS STATE; Musgrove M, 2001, GEOL SOC AM BULL, V113, P1532, DOI 10.1130/0016-7606(2001)113<1532:GOLPTH>2.0.CO;2; Okello JBA, 2005, HEREDITY, V95, P206, DOI 10.1038/sj.hdy.6800711; Papadopoulou A, 2008, PHILOS T R SOC B, V363, P2987, DOI 10.1098/rstb.2008.0066; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Papadopoulou A, 2009, MOL PHYLOGENET EVOL, V53, P935, DOI 10.1016/j.ympev.2009.08.027; Papadopoulou A, 2009, MOL ECOL, V18, P2503, DOI 10.1111/j.1365-294X.2009.04207.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pedersen AA, 2001, MOL ECOL, V10, P1133, DOI 10.1046/j.1365-294X.2001.01266.x; Perez-Miles Fernando, 1996, Mygalomorph, V1, P33; Petersen SD, 2007, CONSERV GENET, V8, P497, DOI 10.1007/s10592-006-9173-2; Peterson AT, 1999, SCIENCE, V285, P1265, DOI 10.1126/science.285.5431.1265; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Prentice TR, 1997, J ARACHNOL, V25, P137; Prentice TR, 2005, SPIDERS N AM IDENTIF, P54; Punzo F., 1989, Bulletin of the British Arachnological Society, V8, P72; Punzo F., 1991, Bulletin of the British Arachnological Society, V8, P277; Punzo F, 2007, J HYMENOPT RES, V16, P297; Punzo Fred, 1999, Bulletin of the British Arachnological Society, V11, P121; Rambaut A, 2010, TRACER V1 6 1; Rambaut A., 2002, TREEEDIT PHYLOGENETI; Ramirez MG, 2004, BIOL J LINN SOC, V82, P27, DOI 10.1111/j.1095-8312.2004.00312.x; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Raven R.J., 1990, Bulletin of Zoological Nomenclature, V47, P126; RAVEN RJ, 1985, B AM MUS NAT HIST, V182, P1; Rebernig CA, 2010, MOL ECOL, V19, P3421, DOI 10.1111/j.1365-294X.2010.04754.x; Reichling SB, 2000, SW NATURALIST, V44, P518; Riddle BR, 2006, J ARID ENVIRON, V66, P435, DOI 10.1016/j.jaridenv.2006.01.014; Riddle BR, 2000, P NATL ACAD SCI USA, V97, P14438, DOI 10.1073/pnas.250413397; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rowe KC, 2004, P NATL ACAD SCI USA, V101, P10355, DOI 10.1073/pnas.0401338101; Roy M, 2004, EARTH PLANET SC LETT, V227, P281, DOI 10.1016/j.epsl.2004.09.001; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Seberg O, 2003, TRENDS ECOL EVOL, V18, P63, DOI 10.1016/S0169-5347(02)00059-9; Smith A. M., 1994, TARANTULA SPIDERS TA; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Starrett J, 2007, MOL ECOL, V16, P583, DOI 10.1111/j.1365-294X.2006.03164.x; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tajima F, 1996, GENETICS, V143, P1457; TAJIMA F, 1989, GENETICS, V123, P585; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; Tautz D, 2002, NATURE, V418, P479, DOI 10.1038/418479a; TEMPLETON AR, 1995, GENETICS, V140, P767; Turgeon J, 2002, MOL ECOL, V11, P1989, DOI 10.1046/j.1365-294X.2002.01580.x; VANDEVENDER TR, 1979, SCIENCE, V204, P701, DOI 10.1126/science.204.4394.701; Velasco JD, 2009, BIOL PHILOS, V24, P473, DOI 10.1007/s10539-009-9151-4; Walker MJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-25; Warriner W., 2008, Journal of the Arkansas Academy of Science, V62, P107; WELLS PV, 1966, SCIENCE, V153, P970, DOI 10.1126/science.153.3739.970; Wiens JJ, 2002, SYST BIOL, V51, P69, DOI 10.1080/106351502753475880; Wilcox TP, 1997, MOL PHYLOGENET EVOL, V7, P208, DOI 10.1006/mpev.1996.0388; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Will KW, 2004, CLADISTICS, V20, P47, DOI 10.1111/j.1096-0031.2003.00008.x	133	86	91	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2011	6	10							e26207	10.1371/journal.pone.0026207	http://dx.doi.org/10.1371/journal.pone.0026207			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834PW	21694762	gold, Green Submitted, Green Published			2022-12-27	WOS:000295976000087
J	Kim, SH; Lu, HF; Alano, CC				Kim, Sun Hee; Lu, Hua Fei; Alano, Conrad C.			Neuronal Sirt3 Protects against Excitotoxic Injury in Mouse Cortical Neuron Culture	PLOS ONE			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; POLY(ADP-RIBOSE) PAR POLYMER; APOPTOSIS-INDUCING FACTOR; NMDA RECEPTOR ACTIVATION; CEREVISIAE LIFE-SPAN; INDUCED CELL-DEATH; NAD(+) DEPLETION; OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; CEREBRAL-ISCHEMIA	Background: Sirtuins (Sirt), a family of nicotinamide adenine nucleotide (NAD) dependent deacetylases, are implicated in energy metabolism and life span. Among the known Sirt isoforms (Sirt1-7), Sirt3 was identified as a stress responsive deacetylase recently shown to play a role in protecting cells under stress conditions. Here, we demonstrated the presence of Sirt3 in neurons, and characterized the role of Sirt3 in neuron survival under NMDA-induced excitotoxicity. Methodology/Principal Findings: To induce excitotoxic injury, we exposed primary cultured mouse cortical neurons to NMDA (30 mu M). NMDA induced a rapid decrease of cytoplasmic NAD (but not mitochondrial NAD) in neurons through poly (ADP-ribose) polymerase-1 (PARP-1) activation. Mitochondrial Sirt3 was increased following PARP-1 mediated NAD depletion, which was reversed by either inhibition of PARP-1 or exogenous NAD. We found that massive reactive oxygen species (ROS) produced under this NAD depleted condition mediated the increase in mitochondrial Sirt3. By transfecting primary neurons with a Sirt3 overexpressing plasmid or Sirt3 siRNA, we showed that Sirt3 is required for neuroprotection against excitotoxicity. Conclusions: This study demonstrated for the first time that mitochondrial Sirt3 acts as a prosurvival factor playing an essential role to protect neurons under excitotoxic injury.	[Kim, Sun Hee; Lu, Hua Fei; Alano, Conrad C.] Vet Affairs Med Ctr, Dept Neurol, San Francisco, CA 94121 USA; [Alano, Conrad C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco	Kim, SH (corresponding author), Vet Affairs Med Ctr, Dept Neurol, San Francisco, CA 94121 USA.	conrad.alano@ucsf.edu	Kim, Sun/GSN-4867-2022; Gaquerel, Emmanuel/I-2503-2014	Gaquerel, Emmanuel/0000-0003-0796-6417; Baldwin, Ian/0000-0001-5371-2974; Yon, Felipe/0000-0002-5667-873X; Gulati, Jyotasana/0000-0003-0163-1296	Department of Veterans Affairs; American Heart Association	Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association)	This work was supported by the Department of Veterans Affairs (CCA) and the American Heart Association (CCA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Alano CC, 2002, J NEUROCHEM, V80, P531, DOI 10.1046/j.0022-3042.2001.00738.x; Alano CC, 2007, J NEUROSCI RES, V85, P3378, DOI 10.1002/jnr.21479; Alano CC, 2006, P NATL ACAD SCI USA, V103, P9685, DOI 10.1073/pnas.0600554103; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Castilho RF, 1999, J NEUROCHEM, V72, P1394, DOI 10.1046/j.1471-4159.1999.721394.x; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Ciani E, 1996, BRAIN RES, V728, P1; Cooper HM, 2008, BIOCHEM J, V411, P279, DOI 10.1042/BJ20071624; Cooper HM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004986; D'Amours D, 1999, BIOCHEM J, V342, P249, DOI 10.1042/0264-6021:3420249; Du LN, 2003, J BIOL CHEM, V278, P18426, DOI 10.1074/jbc.M301295200; Duan YT, 2007, J PHYSIOL-LONDON, V585, P741, DOI 10.1113/jphysiol.2007.145409; Eliasson MJL, 1997, NAT MED, V3, P1089, DOI 10.1038/nm1097-1089; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Goebel DJ, 2006, J NEUROCHEM, V98, P1732, DOI 10.1111/j.1471-4159.2006.04065.x; GOTTLIEB S, 1989, CELL, V56, P771, DOI 10.1016/0092-8674(89)90681-8; Guarente L, 1999, NAT GENET, V23, P281, DOI 10.1038/15458; Gwag BJ, 1997, NEUROSCIENCE, V77, P393, DOI 10.1016/S0306-4522(96)00473-3; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Halmosi R, 2001, MOL PHARMACOL, V59, P1497, DOI 10.1124/mol.59.6.1497; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kaundal RK, 2006, LIFE SCI, V79, P2293, DOI 10.1016/j.lfs.2006.07.034; Kim D, 2007, EMBO J, V26, P3169, DOI 10.1038/sj.emboj.7601758; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim S, 1999, MOL BIOL CELL, V10, P3125, DOI 10.1091/mbc.10.10.3125; KOH JY, 1995, SCIENCE, V268, P573, DOI 10.1126/science.7725105; Leibiger IB, 2006, NAT MED, V12, P34, DOI 10.1038/nm0106-34; Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829; Liu D, 2009, NEUROMOL MED, V11, P28, DOI 10.1007/s12017-009-8058-1; Liu D, 2008, ANN NY ACAD SCI, V1147, P275, DOI 10.1196/annals.1427.028; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Loo S, 1995, ANNU REV CELL DEV BI, V11, P519, DOI 10.1146/annurev.cellbio.11.1.519; Mattson MP, 2002, NEUROMOL MED, V2, P215, DOI 10.1385/NMM:2:2:215; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Pfister JA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004090; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Rose G, 2003, EXP GERONTOL, V38, P1065, DOI 10.1016/S0531-5565(03)00209-2; Saunders LR, 2007, ONCOGENE, V26, P5489, DOI 10.1038/sj.onc.1210616; Scher MB, 2007, GENE DEV, V21, P920, DOI 10.1101/gad.1527307; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; SOKOLOFF L, 1981, FED PROC, V40, P2311; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; TAO R, 2010, J CARDIOVASC PHARM; Tao R, 2007, BIOCHEM BIOPH RES CO, V363, P257, DOI 10.1016/j.bbrc.2007.08.041; Vergun O, 2001, J PHYSIOL-LONDON, V531, P147, DOI 10.1111/j.1469-7793.2001.0147j.x; Wang J, 2005, J CELL BIOL, V170, P349, DOI 10.1083/jcb.200504028; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; YAN T, 2009, NEUROCHEM INT; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yang YJ, 2010, J CELL BIOCHEM, V111, P1051, DOI 10.1002/jcb.22795; Ying WJ, 2007, FRONT BIOSCI-LANDMRK, V12, P2728, DOI 10.2741/2267; Ying WH, 2001, P NATL ACAD SCI USA, V98, P12227, DOI 10.1073/pnas.211202598; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Yu SW, 2006, P NATL ACAD SCI USA, V103, P18314, DOI 10.1073/pnas.0606528103; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221; Zelphati O, 2001, J BIOL CHEM, V276, P35103, DOI 10.1074/jbc.M104920200; Zeng JY, 2007, J CEREBR BLOOD F MET, V27, P304, DOI 10.1038/sj.jcbfm.9600335	71	166	176	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 1	2011	6	3							e14731	10.1371/journal.pone.0014731	http://dx.doi.org/10.1371/journal.pone.0014731			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729ET	21390294	Green Published, gold, Green Submitted			2022-12-27	WOS:000287932100001
J	Du, J; Xu, R; Hu, ZZ; Tian, YH; Zhu, YC; Gu, L; Zhou, L				Du, Jun; Xu, Rui; Hu, Zhenzhen; Tian, Yinhui; Zhu, Yichao; Gu, Luo; Zhou, Lei			PI3K and ERK-Induced Rac1 Activation Mediates Hypoxia-Induced HIF-1 alpha Expression in MCF-7 Breast Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; PROXIMAL TUBULE CELLS; ANGIOGENESIS IN-VITRO; INDUCIBLE FACTOR-1-ALPHA; GENE-TRANSCRIPTION; EPITHELIAL-CELLS; NADPH OXIDASE; UP-REGULATION; TUMOR-GROWTH; ROS	Background: Hypoxia-inducible factor 1 (HIF-1 alpha) expression induced by hypoxia plays a critical role in promoting tumor angiogenesis and metastasis. However, the molecular mechanisms underlying the induction of HIF-1 alpha in tumor cells remain unknown. Methodology/Principal Findings: In this study, we reported that hypoxia could induce HIF-1 alpha and VEGF expression accompanied by Rac1 activation in MCF-7 breast cancer cells. Blockade of Rac1 activation with ectopic expression of an inactive mutant form of Rac1 (T17N) or Rac1 siRNA downregulated hypoxia-induced HIF-1 alpha and VEGF expression. Furthermore, Hypoxia increased PI3K and ERK signaling activity. Both PI3K inhibitor LY294002 and ERK inhibitor U0126 suppressed hypoxia-induced Rac1 activation as well as HIF-1 alpha expression. Moreover, hypoxia treatment resulted in a remarkable production of reactive oxygen species (ROS). N-acetyl-L-cysteine, a scavenger of ROS, inhibited hypoxia-induced ROS generation, PI3K, ERK and Rac1 activation as well as HIF-1 alpha expression. Conclusions/Significance: Taken together, our study demonstrated that hypoxia-induced HIF-1 alpha expression involves a cascade of signaling events including ROS generation, activation of PI3K and ERK signaling, and subsequent activation of Rac1.	[Du, Jun; Xu, Rui; Hu, Zhenzhen; Tian, Yinhui; Gu, Luo] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Peoples R China; [Xu, Rui; Hu, Zhenzhen; Tian, Yinhui] Nanjing Med Univ, Dept Physiol, Nanjing, Peoples R China; [Zhu, Yichao; Gu, Luo] Nanjing Med Univ, Ctr Canc, Nanjing, Peoples R China; [Zhou, Lei] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Du, J (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Peoples R China.	lgu@njmu.edu.cn; zhoulei7005@hotmail.com			National Natural Science Foundation of China [30872926]; Program for Advanced Talents within Six Industries of Jiangsu Province [08-D]; Postdoctoral Science Foundation of Jiangsu Province; Science Development Foundation of Nanjing Medical University [2010NJMUZ35]; School of Basic Medical Sciences, Nanjing Medical University; State Key Laboratory of Reproductive Medicine, China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for Advanced Talents within Six Industries of Jiangsu Province; Postdoctoral Science Foundation of Jiangsu Province(China Postdoctoral Science Foundation); Science Development Foundation of Nanjing Medical University; School of Basic Medical Sciences, Nanjing Medical University; State Key Laboratory of Reproductive Medicine, China	This work was supported by grants from the National Natural Science Foundation of China (No. 30872926) and the Program for Advanced Talents within Six Industries of Jiangsu Province (08-D) to Dr. Luo Gu, the Postdoctoral Science Foundation of Jiangsu Province, the Science Development Foundation of Nanjing Medical University (2010NJMUZ35) and the Research Program funded by the School of Basic Medical Sciences, Nanjing Medical University to Dr. Jun Du. This work was also partially supported by a research grant from State Key Laboratory of Reproductive Medicine, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros P, 2009, MOL CELL BIOL, V29, P4156, DOI 10.1128/MCB.01813-08; Blanchetot C, 2008, CRIT REV EUKAR GENE, V18, P35, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.30; Bos R, 2005, HISTOPATHOLOGY, V46, P31, DOI 10.1111/j.1365-2559.2005.02045.x; Brunet A, 1999, EMBO J, V18, P664, DOI 10.1093/emboj/18.3.664; Chen MJ, 2007, J CELL BIOCHEM, V101, P1316, DOI 10.1002/jcb.21254; Choi UJ, 2009, CELL BIOCHEM FUNCT, V27, P40, DOI 10.1002/cbf.1532; Chung BH, 2008, BIOCHEM BIOPH RES CO, V376, P404, DOI 10.1016/j.bbrc.2008.09.001; Chung BH, 2010, PHYTOTHER RES, V24, P934, DOI 10.1002/ptr.3063; Colley NJ, 2000, SCIENCE, V290, P1902, DOI 10.1126/science.290.5498.1902; Criss AK, 2001, J CELL SCI, V114, P1331; Dales JP, 2005, INT J CANCER, V116, P734, DOI 10.1002/ijc.20984; Desireddi JR, 2010, ANTIOXID REDOX SIGN, V12, P595, DOI 10.1089/ars.2009.2862; Diebold I, 2009, CIRC RES, V104, P1169, DOI 10.1161/CIRCRESAHA.109.196592; Du J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015940; Du J, 2010, CELL PHYSIOL BIOCHEM, V25, P501, DOI 10.1159/000303055; Farooqui R, 2006, EXP CELL RES, V312, P1514, DOI 10.1016/j.yexcr.2006.01.018; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Grider MH, 2009, J NEUROSCI RES, V87, P3033, DOI 10.1002/jnr.22140; Grijelmo C, 2007, CELL SIGNAL, V19, P1722, DOI 10.1016/j.cellsig.2007.03.008; Grimshaw MJ, 2007, ENDOCR-RELAT CANCER, V14, P233, DOI 10.1677/ERC-07-0057; Hakoshima T, 2003, J BIOCHEM, V134, P327, DOI 10.1093/jb/mvg149; Han G, 2008, ONCOL REP, V20, P929, DOI 10.3892/or_00000093; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hess AR, 2003, CANCER RES, V63, P4757; Holmquist L, 2006, ADV EXP MED BIOL, V587, P179; Hsu HY, 2002, J BIOL CHEM, V277, P22131, DOI 10.1074/jbc.M111883200; Johnson E, 2010, J BIOL CHEM, V285, P29491, DOI 10.1074/jbc.M110.136770; Kim J, 2008, MOL BIOL CELL, V19, P433, DOI 10.1091/mbc.E07-02-0182; Koshikawa N, 2009, J BIOL CHEM, V284, P33185, DOI 10.1074/jbc.M109.054221; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Lee TK, 2006, CLIN CANCER RES, V12, P5082, DOI 10.1158/1078-0432.CCR-05-2794; Li SM, 2010, ENDOCRINOLOGY, V151, P5315, DOI 10.1210/en.2010-0178; Lim JH, 2004, ONCOGENE, V23, P9427, DOI 10.1038/sj.onc.1208003; McDonald P, 2007, AM J PHYSIOL-CELL PH, V292, pC1216, DOI 10.1152/ajpcell.00467.2006; Nijmeh J, 2010, AM J PHYSIOL-LUNG C, V299, pL535, DOI 10.1152/ajplung.00002.2010; Papaiahgari S, 2006, ANTIOXID REDOX SIGN, V8, P43, DOI 10.1089/ars.2006.8.43; PARK JH, 2011, ONCOGENE; Perez VADJ, 2009, J CELL BIOL, V184, P83, DOI 10.1083/jcb.200806049; Qian Y, 2005, ONCOGENE, V24, P3154, DOI 10.1038/sj.onc.1208525; Rathore R, 2008, FREE RADICAL BIO MED, V45, P1223, DOI 10.1016/j.freeradbiomed.2008.06.012; Ribatti D, 2010, STEM CELLS DEV, V19, P1, DOI 10.1089/scd.2009.0402; Sang NL, 2003, J BIOL CHEM, V278, P14013, DOI 10.1074/jbc.M209702200; Sawada N, 2008, CIRC RES, V103, P360, DOI 10.1161/CIRCRESAHA.108.178897; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shi YH, 2005, J PATHOL, V205, P530, DOI 10.1002/path.1734; Tobar N, 2008, CANCER LETT, V267, P125, DOI 10.1016/j.canlet.2008.03.011; Turcotte S, 2003, J CELL SCI, V116, P2247, DOI 10.1242/jcs.00427; Vamesu S, 2008, ROM J MORPHOL EMBRYO, V49, P181; Vermeulen PB, 2010, CANCER-AM CANCER SOC, V116, P2748, DOI 10.1002/cncr.25169; Whaley-Connell AT, 2007, AM J NEPHROL, V27, P15, DOI 10.1159/000098432; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Xue Y, 2006, INT J CANCER, V118, P2965, DOI 10.1002/ijc.21763; Yang XM, 2009, INVEST OPHTH VIS SCI, V50, P1873, DOI 10.1167/iovs.08-2591; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200; Yuan LP, 2010, CLIN EXP METASTAS, V27, P481, DOI 10.1007/s10585-010-9337-9; Yuan YG, 2011, AM J PHYSIOL-RENAL, V300, pF393, DOI 10.1152/ajprenal.00418.2010; Zhang Jun, 2007, Cancer Ther, V5, P273; ZHANG L, 2011, J PHARM EXP THER; Zhang L, 2011, PHARMACOLOGY, V87, P265, DOI 10.1159/000326082	61	128	136	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 27	2011	6	9							e25213	10.1371/journal.pone.0025213	http://dx.doi.org/10.1371/journal.pone.0025213			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	834BW	21980400	gold, Green Published, Green Submitted			2022-12-27	WOS:000295933700021
J	Lee, DH; Steffes, MW; Sjodin, A; Jones, RS; Needham, LL; Jacobs, DR				Lee, Duk-Hee; Steffes, Michael W.; Sjoedin, Andreas; Jones, Richard S.; Needham, Larry L.; Jacobs, David R., Jr.			Low Dose Organochlorine Pesticides and Polychlorinated Biphenyls Predict Obesity, Dyslipidemia, and Insulin Resistance among People Free of Diabetes	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; ENDOCRINE-DISRUPTING CHEMICALS; SERUM CONCENTRATIONS; NONDIABETIC ADULTS; NATIONAL-HEALTH; ASSOCIATION; MECHANISMS	Background: There is emerging evidence that background exposure to persistent organic pollutants (POPs) are important in the development of conditions predisposing to diabetes as well as of type 2 diabetes itself. We recently reported that low dose POPs predicted incident type 2 diabetes in a nested case-control study. The current study examined if low dose POPs predicted future adiposity, dyslipidemia, and insulin resistance among controls without diabetes in that study. Methodology/Principal Findings: The 90 controls were diabetes-free during 20 years follow-up. They were a stratified random sample, enriched with overweight and obese persons. POPs measured in 1987-88 (year 2) sera included 8 organochlorine (OC) pesticides, 22 polychlorinated biphenyls (PCBs), and 1 polybrominated biphenyl (PBB). Body mass index (BMI), triglycerides, HDL-cholesterol, LDL-cholesterol, and homeostasis model assessment value for insulin resistance (HOMA-IR) were study outcomes at 2005-06 (year 20). The evolution of study outcomes during 18 years by categories of serum concentrations of POPs at year 2 was evaluated by adjusting for the baseline values of outcomes plus potential confounders. Parallel to prediction of type 2 diabetes, many statistically significant associations of POPs with dysmetabolic conditions appeared at low dose, forming inverted U-shaped dose-response relations. Among OC pesticides, p,p'-DDE most consistently predicted higher BMI, triglycerides, and HOMA-IR and lower HDL-cholesterol at year 20 after adjusting for baseline values. Oxychlordane, trans-nonachlor, and hexachlorobenzene also significantly predicted higher triglycerides. Persistent PCBs with >= 7 chlorides predicted higher BMI, triglycerides, and HOMA-IR and lower HDL-cholesterol at year 20 with similar dose-response curves. Conclusions/Significance: Simultaneous exposure to various POPs in the general population may contribute to development of obesity, dyslipidemia, and insulin resistance, common precursors of type 2 diabetes and cardiovascular diseases. Although obesity is a primary cause of these metabolic abnormalities, POPs exposure may contribute to excess adiposity and other features of dysmetabolism.	[Lee, Duk-Hee] Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Taegu, South Korea; [Steffes, Michael W.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Sjoedin, Andreas; Jones, Richard S.; Needham, Larry L.] Ctr Dis Control & Prevent, Organ Analyt Toxicol Branch OAT, DLS, NCEH, Atlanta, GA USA; [Jacobs, David R., Jr.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol, Minneapolis, MN 55455 USA; [Jacobs, David R., Jr.] Univ Oslo, Dept Nutr, Oslo, Norway	Kyungpook National University; University of Minnesota System; University of Minnesota Twin Cities; Centers for Disease Control & Prevention - USA; University of Minnesota System; University of Minnesota Twin Cities; University of Oslo	Lee, DH (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Preventat Med, Taegu, South Korea.	jacob004@umn.edu	Needham, Larry/E-4930-2011; Sjodin, Andreas/F-2464-2010	Jacobs, David/0000-0002-7232-0543; Palsson, Bernhard/0000-0003-2357-6785	National Heart, Lung, and Blood Institute (CARDIA field centers), (CARDIA Coordinating Center) [N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050, N01-HC-95095]; YALTA [R01-HL-53560]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC048048, N01HC048049, N01HC095095, N01HC048047, N01HC048050] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL048048, R01HL053560, R01HL048050, R01HL048049, R01HL048048] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (CARDIA field centers), (CARDIA Coordinating Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); YALTA; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by National Heart, Lung, and Blood Institute contracts N01-HC-48047, N01-HC-48048, N01-HC-48049, N01-HC-48050 (CARDIA field centers), N01-HC-95095 (CARDIA Coordinating Center), and grant R01-HL-53560 (YALTA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baillie-Hamilton PF, 2002, J ALTERN COMPLEM MED, V8, P185, DOI 10.1089/107555302317371479; Daston GP, 2003, TOXICOL SCI, V74, P245, DOI 10.1093/toxsci/kfg105; Desvergne B, 2009, MOL CELL ENDOCRINOL, V304, P43, DOI 10.1016/j.mce.2009.02.017; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; Grun F, 2009, MOL CELL ENDOCRINOL, V304, P19, DOI 10.1016/j.mce.2009.02.018; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Karmaus W, 2009, OCCUP ENVIRON MED, V66, P143, DOI 10.1136/oem.2008.041921; KELCE WR, 1995, NATURE, V375, P581, DOI 10.1038/375581a0; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Lee DH, 2007, DIABETOLOGIA, V50, P1841, DOI 10.1007/s00125-007-0755-4; LEE DH, 2010, LOW DOSE PERSISTENT; Lee DH, 2007, DIABETES CARE, V30, P1596, DOI 10.2337/dc07-0072; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lopez MCC, 2003, ENVIRON INT, V28, P751, DOI 10.1016/S0160-4120(02)00120-4; Newbold RR, 2009, MOL CELL ENDOCRINOL, V304, P84, DOI 10.1016/j.mce.2009.02.024; OBANA H, 1987, ENVIRON RES, V42, P500, DOI 10.1016/S0013-9351(87)80217-7; Ruzzin J, 2010, ENVIRON HEALTH PERSP, V118, P465, DOI 10.1289/ehp.0901321; Schisterman EF, 2005, ENVIRON HEALTH PERSP, V113, P853, DOI 10.1289/ehp.7640; Sjodin A, 2004, ANAL CHEM, V76, P1921, DOI 10.1021/ac030381; Szapary PO, 2004, AM HEART J, V148, P211, DOI 10.1016/j.ahj.2004.03.037; Turyk M, 2009, ENVIRON HEALTH PERSP, V117, P1076, DOI 10.1289/ehp.0800281; Welshons WV, 2003, ENVIRON HEALTH PERSP, V111, P994, DOI 10.1289/ehp.5494	23	276	299	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 26	2011	6	1							e15977	10.1371/journal.pone.0015977	http://dx.doi.org/10.1371/journal.pone.0015977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712JL	22028828	Green Published, gold, Green Submitted			2022-12-27	WOS:000286662800014
J	Kumar, A; Gao, H; Xu, J; Reuben, J; Yu, DH; Mehta, K				Kumar, Anupam; Gao, Hui; Xu, Jia; Reuben, James; Yu, Dihua; Mehta, Kapil			Evidence That Aberrant Expression of Tissue Transglutaminase Promotes Stem Cell Characteristics in Mammary Epithelial Cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; DRUG-RESISTANT; GLAND CELLS; BREAST; PROLIFERATION; MECHANISMS	Cancer stem cells (CSCs) or tumor initiating cells (TICs) make up only a small fraction of total tumor cell population, but recent evidence suggests that they are responsible for tumor initiation and the maintenance of tumor growth. Whether CSCs/TICs originate from normal stem cells or result from the dedifferentiation of terminally differentiated cells remains unknown. Here we provide evidence that sustained expression of the proinflammatory protein tissue transglutaminase (TG2) confers stem cell like properties in non-transformed and transformed mammary epithelial cells. Sustained expression of TG2 was associated with increase in CD44(high)/CD24(low/-) subpopulation, increased ability of cells to form mammospheres, and acquisition of self-renewal ability. Mammospheres derived from TG2-transfected mammary epithelial cells (MCF10A) differentiated into complex secondary structures when grown in Matrigel cultures. Cells in these secondary structures differentiated into Muc1-positive (luminal marker) and integrin alpha 6-positive (basal marker) cells in response to prolactin treatment. Highly aggressive MDA-231 and drug-resistant MCF-7/RT breast cancer cells, which express high basal levels of TG2, shared many traits with TG2-transfected MCF10A stem cells but unlike MCF10A-derived stem cells they failed to form the secondary structures and to differentiate into Muc1-positive luminal cells when grown in Matrigel culture. Downregulation of TG2 attenuated stem cell properties in both non-transformed and transformed mammary epithelial cells. Taken together, these results suggested a new function for TG2 and revealed a novel mechanism responsible for promoting the stem cell characteristics in adult mammary epithelial cells.	[Kumar, Anupam; Mehta, Kapil] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA; [Gao, Hui; Reuben, James] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Xu, Jia; Yu, Dihua] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Xu, Jia; Reuben, James; Yu, Dihua; Mehta, Kapil] Univ Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Houston, TX USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Kumar, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA.	kmehta@mdanderson.org	Kumar, Amit/E-8052-2018; kumar, Anupam/AFM-6318-2022; Rangachari, vijay/K-1420-2015	Kumar, Amit/0000-0001-7669-0712; Yu, Dihua/0000-0001-6231-9381; Xu, Jia/0000-0003-0254-6261; Bienkiewicz, Ewa (Ava)/0000-0002-5282-6360	Susan G. Komen for the Cure Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	Susan G. Komen for the Cure Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by a grant from Susan G. Komen for the Cure Foundation (http://ww5.komen.org/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai LB, 2008, CARCINOGENESIS, V29, P510, DOI 10.1093/carcin/bgm280; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Gamucci T, 2007, BRIT J CANCER, V97, P1040, DOI 10.1038/sj.bjc.6603982; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Herman JF, 2006, ONCOGENE, V25, P3049, DOI 10.1038/sj.onc.1209324; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Kim DS, 2006, CANCER RES, V66, P10936, DOI 10.1158/0008-5472.CAN-06-1521; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013390; Lacerda L, 2010, DRUG RESIST UPDATE, V13, P99, DOI 10.1016/j.drup.2010.08.001; Lawson JC, 2009, BREAST CANCER RES TR, V118, P241, DOI 10.1007/s10549-009-0524-9; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; LU S, 1995, J BIOL CHEM, V270, P9748, DOI 10.1074/jbc.270.17.9748; Mangala LS, 2007, ONCOGENE, V26, P2459, DOI 10.1038/sj.onc.1210035; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mehta K, 2004, CLIN CANCER RES, V10, P8068, DOI 10.1158/1078-0432.CCR-04-1107; Mehta K, 2010, BIOCHEM PHARMACOL, V80, P1921, DOI 10.1016/j.bcp.2010.06.029; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Santisteban M, 2009, CANCER RES, V69, P2887, DOI 10.1158/0008-5472.CAN-08-3343; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; SUTO N, 1993, J BIOL CHEM, V268, P7469; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Weaver VM, 1999, J MAMMARY GLAND BIOL, V4, P193, DOI 10.1023/A:1018781325716	31	106	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 8	2011	6	6							e20701	10.1371/journal.pone.0020701	http://dx.doi.org/10.1371/journal.pone.0020701			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777JJ	21526230	Green Published, gold, Green Submitted			2022-12-27	WOS:000291611500037
J	Kumar, A; Bullard, RL; Patel, P; Paslay, LC; Singh, D; Bienkiewicz, EA; Morgan, SE; Rangachari, V				Kumar, Amit; Bullard, Rebekah L.; Patel, Pritesh; Paslay, Lea C.; Singh, Dipti; Bienkiewicz, Ewa A.; Morgan, Sarah E.; Rangachari, Vijayaraghavan			Non-Esterified Fatty Acids Generate Distinct Low-Molecular Weight Amyloid-beta (A beta 42) Oligomers along Pathway Different from Fibril Formation	PLOS ONE			English	Article							SODIUM DODECYL-SULFATE; ALZHEIMERS-DISEASE; GM1 GANGLIOSIDE; ALPHA-SYNUCLEIN; IN-VITRO; CONTAINING MEMBRANES; APOLIPOPROTEIN-E; ENDOGENOUS SEED; LIPID-MEMBRANES; TRANSGENIC MICE	Amyloid-beta (A beta) peptide aggregation is known to play a central role in the etiology of Alzheimer's disease (AD). Among various aggregates, low-molecular weight soluble oligomers of A beta are increasingly believed to be the primary neurotoxic agents responsible for memory impairment. Anionic interfaces are known to influence the A beta aggregation process significantly. Here, we report the effects of interfaces formed by medium-chain (C9-C12), saturated non-esterified fatty acids (NEFAs) on A beta 42 aggregation. NEFAs uniquely affected A beta 42 aggregation rates that depended on both the ratio of A beta:NEFA as well the critical micelle concentration (CMC) of the NEFAs. More importantly, irrespective of the kind of NEFA used, we observed that two distinct oligomers, 12-18 mers and 4-5 mers were formed via different pathway of aggregation under specific experimental conditions: (i) 12-18 mers were generated near the CMC in which NEFAs augment the rate of A beta 42 aggregation towards fibril formation, and, (ii) 4-5 mers were formed above the CMC, where NEFAs inhibit fibril formation. The data indicated that both 12-18 mers and 4-5 mers are formed along an alternate pathway called 'off-pathway' that did not result in fibril formation and yet have subtle structural and morphological differences that distinguish their bulk molecular behavior. These observations, (i) reflect the possible mechanism of A beta aggregation in physiological lipid-rich environments, and (ii) reiterate the fact that all oligomeric forms of A beta need not be obligatory intermediates of the fibril formation pathway.	[Kumar, Amit; Bullard, Rebekah L.; Patel, Pritesh; Rangachari, Vijayaraghavan] Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Paslay, Lea C.; Singh, Dipti; Morgan, Sarah E.] Univ So Mississippi, Sch Polymers & High Performance Mat, Hattiesburg, MS 39406 USA; [Bienkiewicz, Ewa A.] Florida State Univ, Dept Biomed Sci, Coll Med, Tallahassee, FL 32306 USA	University of Southern Mississippi; University of Southern Mississippi; State University System of Florida; Florida State University	Kumar, A (corresponding author), Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	vijay.rangachari@usm.edu	Kumar, Amit/E-8052-2018; kumar, Anupam/AFM-6318-2022; Rangachari, vijay/K-1420-2015	Kumar, Amit/0000-0001-7669-0712; Yu, Dihua/0000-0001-6231-9381; Xu, Jia/0000-0003-0254-6261; Bienkiewicz, Ewa (Ava)/0000-0002-5282-6360	Alzheimer's Association [NIRG-09-132721]; American Heart Association [0535185N]; National Science Foundation [DMR-0213883]; National Center for Research Resources, National Institutes of Health [P20RR016476]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016476] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by NIRG grant from Alzheimer's Association (NIRG-09-132721) (www.Alz.org) and an American Heart Association SDG award (0535185N) for VR (www.AHA.org). Partial support by the MRSEC program of the National Science Foundation (DMR-0213883) as well as Mississippi INBRE funded by the National Center for Research Resources, National Institutes of Health (award# P20RR016476) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assayag K, 2007, AM J PATHOL, V171, P2000, DOI 10.2353/ajpath.2007.070373; Barghorn S, 2005, J NEUROCHEM, V95, P834, DOI 10.1111/j.1471-4159.2005.03407.x; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Bisaglia M, 2005, BIOCHEMISTRY-US, V44, P329, DOI 10.1021/bi048448q; Bokvist M, 2004, J MOL BIOL, V335, P1039, DOI 10.1016/j.jmb.2003.11.046; Carpentier YA, 2006, PROSTAG LEUKOTR ESS, V75, P145, DOI 10.1016/j.plefa.2006.05.004; ChooSmith LP, 1997, FEBS LETT, V402, P95, DOI 10.1016/S0014-5793(96)01504-9; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; CISTOLA DP, 1988, BIOCHEMISTRY-US, V27, P1881, DOI 10.1021/bi00406a013; DICKSON DW, 1995, NEUROBIOL AGING, V16, P285, DOI 10.1016/0197-4580(95)00013-5; EDWARDS K, 1994, BIOCHEMISTRY-US, V33, P13304, DOI 10.1021/bi00249a017; EVANS KC, 1995, P NATL ACAD SCI USA, V92, P763, DOI 10.1073/pnas.92.3.763; Fletcher TG, 1997, PROTEIN SCI, V6, P666; Gellermann GP, 2008, NEUROBIOL DIS, V30, P212, DOI 10.1016/j.nbd.2008.01.010; Hagihara Y, 2002, BIOCHEMISTRY-US, V41, P1020, DOI 10.1021/bi015693q; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hasegawa K, 1999, BIOCHEMISTRY-US, V38, P15514, DOI 10.1021/bi991161m; Hasegawa K, 2008, BIOCHEM J, V416, P307, DOI 10.1042/BJ20080543; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kakio A, 2002, BIOCHEMISTRY-US, V41, P7385, DOI 10.1021/bi0255874; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; Kurganov B, 2004, PEPTIDES, V25, P217, DOI 10.1016/j.peptides.2004.01.001; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Lucke C, 2006, J LIPID RES, V47, P1714, DOI 10.1194/jlr.M600003-JLR200; Lukiw WJ, 2008, J NUTR, V138, P2510, DOI 10.3945/jn.108.096016; LUZZATI V, 1966, ANN NY ACAD SCI, V137, P409, DOI 10.1111/j.1749-6632.1966.tb50172.x; Ma Z, 2002, MOL MED, V8, P863, DOI 10.1007/BF03402092; Mandal PK, 2004, NEUROCHEM RES, V29, P2273, DOI 10.1007/s11064-004-7036-0; Matsuzaki K, 1999, BIOCHEMISTRY-US, V38, P4137, DOI 10.1021/bi982345o; MAYES PA, 2000, LANGE MED BOOKS, P268; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; MICHAEL R, 2005, BIOCHEMISTRY-US, V44, P165; Miyashita N, 2009, J AM CHEM SOC, V131, P17843, DOI 10.1021/ja905457d; Necula M, 2007, J BIOL CHEM, V282, P10311, DOI 10.1074/jbc.M608207200; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Perczel A., 1996, CIRCULAR DICHROISM C, P285; Pillot T, 1996, J BIOL CHEM, V271, P28757, DOI 10.1074/jbc.271.46.28757; Rangachari V, 2007, BIOCHEMISTRY-US, V46, P12451, DOI 10.1021/bi701213s; Rangachari V, 2006, BIOCHEMISTRY-US, V45, P8639, DOI 10.1021/bi060323t; REISSHUSSON F, 1966, J COLLOID INTERF SCI, V21, P534, DOI 10.1016/0095-8522(66)90051-1; Ross BP, 2004, MOL PHARMACEUT, V1, P233, DOI 10.1021/mp049964d; Ryan TM, 2008, J BIOL CHEM, V283, P35118, DOI 10.1074/jbc.M804004200; Schlame M, 1996, J LIPID RES, V37, P2608; Scrocchi LA, 2002, J MOL BIOL, V318, P697, DOI 10.1016/S0022-2836(02)00164-X; SOLFRIZZI V, 2009, AGEING RES REV; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e; TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525; TOMIYAMA T, 1994, BIOCHEM BIOPH RES CO, V204, P76, DOI 10.1006/bbrc.1994.2428; Waiter MF, 1997, BIOCHEM BIOPH RES CO, V233, P760, DOI 10.1006/bbrc.1997.6547; Wakabayashi M, 2005, BIOCHEM BIOPH RES CO, V328, P1019, DOI 10.1016/j.bbrc.2005.01.060; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; Wood SJ, 1996, J MOL BIOL, V256, P870, DOI 10.1006/jmbi.1996.0133; Wood SJ, 1996, J BIOL CHEM, V271, P4086; Woody RW, 1985, PEPTIDES ANAL SYNTHE, P15; Yamamoto N, 2005, FEBS LETT, V579, P2185, DOI 10.1016/j.febslet.2005.03.013; Yamamoto N, 2004, FEBS LETT, V569, P135, DOI 10.1016/j.febslet.2004.05.037; Yamamoto N, 2004, J NEUROCHEM, V90, P62, DOI 10.1111/j.1471-4159.2004.02459.x; Yamamoto S, 2004, BIOCHEMISTRY-US, V43, P11075, DOI 10.1021/bi049262u; Yanagisawa K, 2005, NEUROSCIENTIST, V11, P250, DOI 10.1177/1073858405275177; Yanagisawa K, 1998, NEUROBIOL AGING, V19, pS65, DOI 10.1016/S0197-4580(98)00032-3; Yip CM, 2001, BIOPHYS J, V80, P1359, DOI 10.1016/S0006-3495(01)76109-7; Zhao HX, 2004, BIOCHEMISTRY-US, V43, P10302, DOI 10.1021/bi049002c	71	106	107	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 19	2011	6	4							e18759	10.1371/journal.pone.0018759	http://dx.doi.org/10.1371/journal.pone.0018759			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	752EC	21526230	Green Published, gold, Green Submitted			2022-12-27	WOS:000289671100019
J	Zhang, LJ; Xi, J; Xu, GQ; Shu, H; Wang, XY; Li, P				Zhang, Linjun; Xi, Jie; Xu, Guoqing; Shu, Hua; Wang, Xiaoyi; Li, Ping			Cortical Dynamics of Acoustic and Phonological Processing in Speech Perception	PLOS ONE			English	Article							HUMAN AUDITORY-CORTEX; TOP-DOWN INFLUENCES; HIERARCHICAL ORGANIZATION; INTELLIGIBLE SPEECH; MECHANISMS; PITCH; NEUROANATOMY; INFORMATION; MODULATION; NETWORKS	In speech perception, a functional hierarchy has been proposed by recent functional neuroimaging studies: Core auditory areas on the dorsal plane of superior temporal gyrus (STG) are sensitive to basic acoustic characteristics, whereas downstream regions, specifically the left superior temporal sulcus (STS) and middle temporal gyrus (MTG) ventral to Heschl's gyrus (HG) are responsive to abstract phonological features. What is unclear so far is the relationship between the dorsal and ventral processes, especially with regard to whether low-level acoustic processing is modulated by high-level phonological processing. To address the issue, we assessed sensitivity of core auditory and downstream regions to acoustic and phonological variations by using within-and across-category lexical tonal continua with equal physical intervals. We found that relative to within-category variation, across-category variation elicited stronger activation in the left middle MTG (mMTG), apparently reflecting the abstract phonological representations. At the same time, activation in the core auditory region decreased, resulting from the top-down influences of phonological processing. These results support a hierarchical organization of the ventral acoustic-phonological processing stream, which originates in the right HG/STG and projects to the left mMTG. Furthermore, our study provides direct evidence that low-level acoustic analysis is modulated by high-level phonological representations, revealing the cortical dynamics of acoustic and phonological processing in speech perception. Our findings confirm the existence of reciprocal progression projections in the auditory pathways and the roles of both feed-forward and feedback mechanisms in speech perception.	[Zhang, Linjun; Xi, Jie; Shu, Hua] Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China; [Zhang, Linjun] Beijing Language & Culture Univ, Coll Chinese Studies, Beijing, Peoples R China; [Xi, Jie] Chinese Acad Sci, Inst Psychol, Beijing 100101, Peoples R China; [Xu, Guoqing] Dalian Med Univ, Dept Psychol, Dalian, Peoples R China; [Wang, Xiaoyi] Capital Med Univ, Xuanwu Hosp, Dept Radiol, Beijing, Peoples R China; [Li, Ping] Penn State Univ, Dept Psychol, University Pk, PA 16802 USA; [Li, Ping] Penn State Univ, Ctr Language Sci, University Pk, PA 16802 USA	Beijing Normal University; Beijing Language & Culture University; Chinese Academy of Sciences; Institute of Psychology, CAS; Dalian Medical University; Capital Medical University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Zhang, LJ (corresponding author), Beijing Normal Univ, State Key Lab Cognit Neurosci & Learning, Beijing 100875, Peoples R China.	shuh@bnu.edu.cn; pul8@psu.edu	; Speicher, Andreas/B-3134-2014	Li, Ping/0000-0002-3314-943X; Speicher, Andreas/0000-0001-6608-3994; Lin, Jinxing/0000-0001-9338-1356	Program for Changjiang Scholars and Innovative Research Team in University [IRT0710]; Natural Science Foundation of China [30870758]; Natural Science Foundation of Beijing [7092051]; Fund for Foreign Scholars in University Research and Teaching Programs [B07008]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Fund for Foreign Scholars in University Research and Teaching Programs	The research was supported by the Program for Changjiang Scholars and Innovative Research Team in University (IRT0710, http://www.cksp.edu.cn/index.php), by grants from the Natural Science Foundation of China (30870758, http://www.nsfc.gov.cn/Portal0/default124.htm), by grants from the Natural Science Foundation of Beijing (7092051, http://www.bjnsf.org/) to HS, and the Fund for Foreign Scholars in University Research and Teaching Programs (B07008, http://www.bjnsf.org/) to PL and HS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendor D, 2006, CURR OPIN NEUROBIOL, V16, P391, DOI 10.1016/j.conb.2006.07.001; Binder J, 2000, BRAIN, V123, P2371, DOI 10.1093/brain/123.12.2371; Brechmann A, 2005, CEREB CORTEX, V15, P578, DOI 10.1093/cercor/bhh159; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Dehaene-Lambertz G, 2005, NEUROIMAGE, V24, P21, DOI 10.1016/j.neuroimage.2004.09.039; Gandour J, 2004, NEUROIMAGE, V23, P344, DOI 10.1016/j.neuroimage.2004.06.004; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Hesling I, 2005, NEUROIMAGE, V24, P937, DOI 10.1016/j.neuroimage.2004.11.003; Hickok G, 2004, COGNITION, V92, P67, DOI 10.1016/j.cognition.2003.10.011; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Humphries C, 2005, HUM BRAIN MAPP, V26, P128, DOI 10.1002/hbm.20148; Joanisse MF, 2007, CEREB CORTEX, V17, P2084, DOI 10.1093/cercor/bhl124; Li W, 2004, NAT NEUROSCI, V7, P651, DOI 10.1038/nn1255; Liebenthal E, 2005, CEREB CORTEX, V15, P1621, DOI 10.1093/cercor/bhi040; Liebenthal E, 2010, CEREB CORTEX, V20, P2958, DOI 10.1093/cercor/bhq045; Meyer M, 2004, BRAIN LANG, V89, P277, DOI 10.1016/S0093-934X(03)00350-X; Naatanen R, 1997, NATURE, V385, P432, DOI 10.1038/385432a0; Narain C, 2003, CEREB CORTEX, V13, P1362, DOI 10.1093/cercor/bhg083; Obleser J, 2007, CEREB CORTEX, V17, P2251, DOI 10.1093/cercor/bhl133; Okada K, 2010, CEREB CORTEX, V20, P2486, DOI 10.1093/cercor/bhp318; Patterson RD, 2002, NEURON, V36, P767, DOI 10.1016/S0896-6273(02)01060-7; Rinne T, 2009, J NEUROSCI, V29, P13338, DOI 10.1523/JNEUROSCI.3012-09.2009; Rogalsky C, 2009, CEREB CORTEX, V19, P786, DOI 10.1093/cercor/bhn126; Schofield TM, 2009, P NATL ACAD SCI USA, V106, P11765, DOI 10.1073/pnas.0811402106; Scott SK, 2004, COGNITION, V92, P13, DOI 10.1016/j.cognition.2002.12.002; Scott SK, 2000, BRAIN, V123, P2400, DOI 10.1093/brain/123.12.2400; Scott SK, 2006, J ACOUST SOC AM, V120, P1075, DOI 10.1121/1.2216725; Shulman GL, 1997, CEREB CORTEX, V7, P193, DOI 10.1093/cercor/7.3.193; Sussman E, 2002, COGNITIVE BRAIN RES, V13, P393, DOI 10.1016/S0926-6410(01)00131-8; Talairach J., 1988, COPLANAR STEREOTAXIC; Tervaniemi M, 2000, HUM BRAIN MAPP, V10, P74, DOI 10.1002/(SICI)1097-0193(200006)10:2<74::AID-HBM30>3.0.CO;2-2; Tervaniemi M, 2006, J NEUROSCI, V26, P8647, DOI 10.1523/JNEUROSCI.0995-06.2006; Wessinger CM, 2001, J COGNITIVE NEUROSCI, V13, P1, DOI 10.1162/089892901564108; Xi J, 2010, NEUROSCIENCE, V170, P223, DOI 10.1016/j.neuroscience.2010.06.077; ZATORRE RJ, 1994, J NEUROSCI, V14, P1908, DOI 10.1523/jneurosci.14-04-01908.1994; Zhang LJ, 2010, HUM BRAIN MAPP, V31, P1106, DOI 10.1002/hbm.20922	36	344	349	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2011	6	6							e20963	10.1371/journal.pone.0020963	http://dx.doi.org/10.1371/journal.pone.0020963			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	777ZG	22163016	Green Submitted, gold, Green Published			2022-12-27	WOS:000291663300033
